Citrus Sinensis ID: 003978
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 782 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.346 | 0.290 | 0.612 | 1e-100 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.350 | 0.333 | 0.604 | 5e-95 | |
| Q54TM7 | 1288 | Probable serine/threonine | yes | no | 0.351 | 0.213 | 0.428 | 4e-66 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.337 | 0.352 | 0.437 | 5e-64 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.324 | 0.395 | 0.437 | 1e-61 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.333 | 0.284 | 0.422 | 5e-61 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.326 | 0.153 | 0.399 | 4e-60 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.333 | 0.378 | 0.422 | 5e-60 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.335 | 0.161 | 0.396 | 2e-56 | |
| Q5UQG7 | 1651 | Putative serine/threonine | N/A | no | 0.327 | 0.155 | 0.406 | 4e-56 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 366 bits (940), Expect = e-100, Method: Compositional matrix adjust.
Identities = 166/271 (61%), Positives = 206/271 (76%)
Query: 494 DNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEV 553
D D + EI W DL I E+IG GS G VYHA W+G++VAVK F Q++S + FR EV
Sbjct: 656 DADVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEV 715
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
+M+RLRHPNV+ F+GAVT P L IVTEFLPRGSL+R+L R + +D RRRI MALD+A
Sbjct: 716 RIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVA 775
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 673
G++ LH P I+HRDLK+ NLLVD +W VKVGDFGLSRLKH T+L++K+ GTP+WMA
Sbjct: 776 MGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMA 835
Query: 674 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733
PEVLRNEPS+EK DVYSFGVILWELAT ++PW +N MQV+GAVGF N+RLEIPK++DP
Sbjct: 836 PEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPV 895
Query: 734 WAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764
I+ CW +DP RPSF +L + L+ L R
Sbjct: 896 VGRIILECWQTDPNLRPSFAQLTEVLKPLNR 926
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 349 bits (895), Expect = 5e-95, Method: Compositional matrix adjust.
Identities = 168/278 (60%), Positives = 217/278 (78%), Gaps = 4/278 (1%)
Query: 487 AVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVI 546
A ++ LD D D +I W DL I E+IG GS GTV+ A W+GSDVAVK+ Q++ E +
Sbjct: 533 ANRELGLDGD--DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERV 590
Query: 547 HSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK--LDWRR 604
+ F +EV++MKRLRHPN++LFMGAVT P L IVTE+L RGSL+RLL ++ + LD RR
Sbjct: 591 NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 650
Query: 605 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664
R+ MA D+A+G++YLH+ NPPI+HRDLKS NLLVDK +TVKV DFGLSRLK T+L++K+
Sbjct: 651 RLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS 710
Query: 665 GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL 724
GTP+WMAPEVLR+EPS+EKSDVYSFGVILWELAT + PW NLN QV+ AVGF +RL
Sbjct: 711 AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL 770
Query: 725 EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
EIP++++P+ AAI+E CW ++P RPSF ++D LR L
Sbjct: 771 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 808
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 253 bits (646), Expect = 4e-66, Method: Compositional matrix adjust.
Identities = 119/278 (42%), Positives = 178/278 (64%), Gaps = 3/278 (1%)
Query: 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
++E+ ++ IG +IG+G G V+ W G++VAVK+ + ++I R+EV L+
Sbjct: 842 FEWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLKLISDLRKEVDLLC 901
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVS 617
+LRHPN++LFMGA T P CIVTE+L RGSL +L + ++DW R+ + D ARG++
Sbjct: 902 KLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMT 961
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL 677
YLH NP IIHRDLK+ NLLVD W VKV DFGL+ +K T+ KT GT W+APEVL
Sbjct: 962 YLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTF--AKTMCGTTGWVAPEVL 1019
Query: 678 RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737
E EK+DVYS+ ++LWEL T IP+ N+MQV+ ++ +RL +P P++AA+
Sbjct: 1020 AEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSID-RGERLPMPAWCPPKYAAL 1078
Query: 738 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVG 775
+ CW +DP RPSF E++ + + ++ + + ++
Sbjct: 1079 MNRCWETDPTHRPSFPEILPIMEGMISEFQKEKKESIA 1116
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 246 bits (628), Expect = 5e-64, Method: Compositional matrix adjust.
Identities = 120/274 (43%), Positives = 171/274 (62%), Gaps = 10/274 (3%)
Query: 499 DYEILWE-------DLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDE-VIHSFR 550
DY+ L+E ++ + +IG+GSC V+ W G VA+K DE ++
Sbjct: 476 DYKTLFEIKPIDISEIVVQNRIGRGSCAEVFTGTWRGIIVAIKKAKLLNEDDEDFLNELA 535
Query: 551 QEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
QE ++M +LRHPN+ F+G +P + IV E++P GSL+R+L + LDW R MAL
Sbjct: 536 QEATIMSQLRHPNICQFLGTCNNPPEILIVMEYMPLGSLYRILHDPSISLDWPRMKSMAL 595
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RL-KHETYLTTKTGKGT 668
DIA+G++YLH C+P +IHRDLKS NLLVD+H+ VK+ DFGLS R KH T T GT
Sbjct: 596 DIAKGMNYLHCCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKHLDKKTAMTPVGT 655
Query: 669 PQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 728
P W APEVLRN+P EK+DV+SF ++LWE+ T + P+ + + Q++ +VG R +P
Sbjct: 656 PCWTAPEVLRNDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQHKLRPIVPP 715
Query: 729 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
V + ++ CW DPQ RPSFQE+V +L +
Sbjct: 716 QVSAPFTRLITECWSEDPQQRPSFQEIVKRLEAM 749
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 238 bits (608), Expect = 1e-61, Method: Compositional matrix adjust.
Identities = 112/256 (43%), Positives = 165/256 (64%), Gaps = 2/256 (0%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
+ IG +IG+G+ G VY W GS VAVK ++ ++ F +E++LMK LRHPNV+
Sbjct: 374 IKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLRHPNVIQ 433
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
F+G+ P +CI TE++PRGSL+ +L +L W I M +D A+GV YLH+ P I
Sbjct: 434 FLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVIYLHNSTPVI 493
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS 686
+HRDLKS NLLVD++W VKV DFGLS ++ + T T GTP W +PEVLR++ EK+
Sbjct: 494 LHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSPEVLRSQRYTEKA 551
Query: 687 DVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 746
DVYSFG+ILWE AT + P+ + QVI AVG R +P++ P++ ++ C + +P
Sbjct: 552 DVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKYIQLLIDCLNENP 611
Query: 747 QCRPSFQELVDKLRDL 762
RP+ ++ +++L +
Sbjct: 612 SHRPTMEQCLERLESI 627
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 236 bits (602), Expect = 5e-61, Method: Compositional matrix adjust.
Identities = 112/265 (42%), Positives = 178/265 (67%), Gaps = 4/265 (1%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVK-VFSRQEYSDEVIHSFRQEVSLMK 557
D EI + +L I ++G+G+ G VY +W GS VA+K + ++ +++V+ FR+E++++
Sbjct: 654 DIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILS 713
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVS 617
RLRHPN++L M A T+P LC +TE+LP GSL+ L K++ + +A+ IA+G++
Sbjct: 714 RLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMN 773
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL 677
YLH +IHRD+KS NLL+D+H VK+ DFGLS+LK ++ TK+ G+P WM+PE+L
Sbjct: 774 YLHLSG--VIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKS-IGSPIWMSPELL 830
Query: 678 RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737
E EK DVY+FG+ILWEL T ++P+ L+S+Q+ AV + R IP + + +
Sbjct: 831 MGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHL 890
Query: 738 VESCWHSDPQCRPSFQELVDKLRDL 762
+++CWH DP RPSF E+++ L ++
Sbjct: 891 IQACWHQDPLKRPSFTEILNLLNEI 915
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 233 bits (595), Expect = 4e-60, Method: Compositional matrix adjust.
Identities = 103/258 (39%), Positives = 170/258 (65%), Gaps = 3/258 (1%)
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH 561
I ++++ +GEQIG GS G VY W DVA+K F +Q+ + + R+E++ +K+L H
Sbjct: 1394 INYDEIKMGEQIGLGSYGVVYRGKWKNVDVAIKKFIKQKIDENHLLGIREEIAFLKKLHH 1453
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
PN++ +GA +CIVTE++ +G+L ++ T KL+W ++I + ++IA+G+SYLH
Sbjct: 1454 PNIITMVGASLKKPNICIVTEYMAKGNLRDAMRTCTPKLEWHQKIKILVNIAKGISYLHS 1513
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
+PPIIHRD+K SN+L+D++W VK+ DFG +R+K E + T+ GTP W APE++RN+
Sbjct: 1514 FDPPIIHRDIKPSNILIDENWNVKIADFGFARIKEENAIMTRC--GTPCWTAPEIIRNDI 1571
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741
DEK DV+SFG+++WE+ T K P+ N M++ + + R +IP+D +A ++ C
Sbjct: 1572 YDEKVDVFSFGIVMWEVLTCKEPFIGANFMKITMDI-LEDVRPKIPQDCPEEFAKLMRKC 1630
Query: 742 WHSDPQCRPSFQELVDKL 759
WH+ RP+ +++ L
Sbjct: 1631 WHAKSTKRPTMDDVIIVL 1648
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 233 bits (594), Expect = 5e-60, Method: Compositional matrix adjust.
Identities = 111/263 (42%), Positives = 164/263 (62%), Gaps = 2/263 (0%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+ + IG +IG+G+ G VY W GS VAVK ++ ++ F +E++LMK LRHPNV
Sbjct: 389 QQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLRHPNV 448
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ F+G+ +CI TE++PRGSL+ +L K+ W M +D A+G+ YLH P
Sbjct: 449 IQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGIIYLHGSTP 508
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDE 684
I+HRDLKS NLLVD++W VKV DFGLS ++ + T T GTP W +PEVLR++ E
Sbjct: 509 VILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSPEVLRSQRYTE 566
Query: 685 KSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHS 744
K+DVYSFG+ILWE AT + P+ + QVI AVG R PK P++ +++ C +
Sbjct: 567 KADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYIQLLKDCLNE 626
Query: 745 DPQCRPSFQELVDKLRDLQRQYF 767
+P RP+ ++ ++ L ++ + F
Sbjct: 627 NPSQRPTMEQCLEILESIETKGF 649
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 221 bits (562), Expect = 2e-56, Method: Compositional matrix adjust.
Identities = 105/265 (39%), Positives = 165/265 (62%), Gaps = 3/265 (1%)
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH 561
I +++++IG+QIG GS G V++ W G DVAVK F +Q+ S+ + FR E++ + L+H
Sbjct: 1359 INYDEISIGKQIGLGSYGIVFNGKWKGVDVAVKKFVKQKLSETQLLEFRAEMAFLSELKH 1418
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
N++ F+GA +CIVTE++ G+L +L+ K+ + ++ + A G+ YLH
Sbjct: 1419 SNIVTFIGACIKKPNICIVTEYMRMGNLRDVLKNPDIKITFANKLKLLYGAAMGIDYLHS 1478
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
NP I+HRD+K +N+LVD+H+ VK+ DFG +R+K + TT T GTP W APEV+R E
Sbjct: 1479 SNPMIVHRDIKPANILVDEHFNVKIADFGFARIKEDN--TTMTRCGTPCWTAPEVIRGEK 1536
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741
EK+DV+SFGV++WE+ T K P+ N M+V + R IP D +A +++ C
Sbjct: 1537 YCEKADVFSFGVVMWEVLTGKEPFAECNFMKVSLDI-LEGGRPIIPSDCPHEFAKLIKKC 1595
Query: 742 WHSDPQCRPSFQELVDKLRDLQRQY 766
WH+ RP+ E+V +L + Q+
Sbjct: 1596 WHAKAHKRPTMTEVVQQLMLITEQF 1620
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5UQG7|YR818_MIMIV Putative serine/threonine-protein kinase/receptor R818 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R818 PE=4 SV=1 | Back alignment and function description |
|---|
Score = 220 bits (560), Expect = 4e-56, Method: Compositional matrix adjust.
Identities = 106/261 (40%), Positives = 163/261 (62%), Gaps = 5/261 (1%)
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH 561
I ++D+ IG+QIG GS G V W +VAVK F +Q+ ++ + FR E++ + +LRH
Sbjct: 1389 INYDDIQIGKQIGVGSYGIVNMGKWKNINVAVKKFVKQKIDEKQMLEFRAEIAFLSQLRH 1448
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
P+++L +GA +CIVTEF+ GSL +++ TTK +W+ +I M A G+ YLH+
Sbjct: 1449 PHIILMIGACLKRPNICIVTEFMGNGSLRNVIK--TTKPEWKLKIKMLYQTALGIGYLHN 1506
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
+P IIHRD+K SN+LVD VK+ DFG +R+K E + T+ GTP W APE++R E
Sbjct: 1507 SDPIIIHRDIKPSNILVDDSMNVKIADFGFARIKEENSVMTRC--GTPCWTAPEIIRGEK 1564
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741
EK DV+SFG+++WE+ T K P+ N M+V + R +IP D + +++ C
Sbjct: 1565 YTEKVDVFSFGIVMWEVLTCKEPFSGCNFMKVSMDI-LEGARPQIPSDCPIDFTKLMKQC 1623
Query: 742 WHSDPQCRPSFQELVDKLRDL 762
WH+ P RPS ++++ L D+
Sbjct: 1624 WHAKPDKRPSMEDVIMGLNDM 1644
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 782 | ||||||
| 224108736 | 781 | predicted protein [Populus trichocarpa] | 0.982 | 0.983 | 0.748 | 0.0 | |
| 255556394 | 796 | map3k delta-1 protein kinase, putative [ | 0.983 | 0.966 | 0.767 | 0.0 | |
| 224101557 | 759 | predicted protein [Populus trichocarpa] | 0.962 | 0.992 | 0.743 | 0.0 | |
| 225431966 | 771 | PREDICTED: uncharacterized protein LOC10 | 0.974 | 0.988 | 0.721 | 0.0 | |
| 356521762 | 770 | PREDICTED: uncharacterized protein LOC10 | 0.965 | 0.980 | 0.711 | 0.0 | |
| 356564864 | 771 | PREDICTED: uncharacterized protein LOC10 | 0.966 | 0.980 | 0.712 | 0.0 | |
| 296083240 | 732 | unnamed protein product [Vitis vinifera] | 0.927 | 0.990 | 0.694 | 0.0 | |
| 147827145 | 760 | hypothetical protein VITISV_034769 [Viti | 0.947 | 0.975 | 0.688 | 0.0 | |
| 449462150 | 774 | PREDICTED: LOW QUALITY PROTEIN: uncharac | 0.948 | 0.958 | 0.663 | 0.0 | |
| 357448913 | 744 | Protein kinase-like protein [Medicago tr | 0.930 | 0.978 | 0.659 | 0.0 |
| >gi|224108736|ref|XP_002314950.1| predicted protein [Populus trichocarpa] gi|222863990|gb|EEF01121.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1195 bits (3091), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 595/795 (74%), Positives = 672/795 (84%), Gaps = 27/795 (3%)
Query: 1 MDANTGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVS 60
M++ AEELL+KIQ+LEAG HL+Q++SKLK+S +TTT QQRSHS+S
Sbjct: 1 MESTAPQAEELLKKIQQLEAGHHHLQQQMSKLKLS--------STTTDPKPTQQRSHSIS 52
Query: 61 PRRPRLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNS 120
P+R +GP +R GG TG +AWK SASFRHSSPLQRES+ +S + + G+SN
Sbjct: 53 PQR---SGPRNRVAGGPTGSSFEAAWK-KGSASFRHSSPLQRESRSLNSNNA-SDGHSNG 107
Query: 121 G----------PSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEA 170
G PS+ FTD+QYLNILQS+GQSVHIFD S RIIYWNR+AE LYGYSA EA
Sbjct: 108 GGEGGDGNRGGPSSVKFTDKQYLNILQSVGQSVHIFDHSGRIIYWNRTAENLYGYSAAEA 167
Query: 171 LGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGT 230
LGQDAIELL D RD+ VA IV R+ MGE+WTG+FP K K ER VVATNTP YDDDG
Sbjct: 168 LGQDAIELLIDSRDYAVANGIVQRVSMGEKWTGKFPVKNKMAERFTVVATNTPLYDDDGA 227
Query: 231 LVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASKI 290
LVGI+CVS+DSRPFQE AL D++N + +S+ + PRN V +KLGLDSQQPLQA +ASKI
Sbjct: 228 LVGIICVSSDSRPFQEVGVALLDSRNLEAESSNSSPRNIVMSKLGLDSQQPLQAAVASKI 287
Query: 291 SNLATKVSNKVKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRG 350
SNLA+KVSNKVKS+IR G+N MDREGGSGDSH+SDHG+SDAALSDHRED SSGASTPRG
Sbjct: 288 SNLASKVSNKVKSKIRPGENSMDREGGSGDSHYSDHGYSDAALSDHREDANSSGASTPRG 347
Query: 351 DVPPCPFGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNE 410
DV P PFGVFSH+D++SP +S R+SGDESEGKPAIHKI TSKAE W+GKKGLSWPWKGNE
Sbjct: 348 DVHPSPFGVFSHLDDRSPAQSCRESGDESEGKPAIHKIFTSKAEAWIGKKGLSWPWKGNE 407
Query: 411 REGSDAKTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVN 470
+EGS+A+T RF WPW DQ++E+ Q+SPS G K ESH+ E NR NNEA GSWSSS+N
Sbjct: 408 KEGSEARTTRFGWPWLQNDQESETFHQRSPSSGAKSESHVSESNRPANNEASGSWSSSIN 467
Query: 471 VNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD 530
VNSTSS SSC ++SS VNKVD D DCLDYEILWEDLTIGEQIGQGSCGTVYHA+WYGSD
Sbjct: 468 VNSTSSASSC-GSTSSTVNKVDPDTDCLDYEILWEDLTIGEQIGQGSCGTVYHALWYGSD 526
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 590
VAVKVFS+QEYSD+VI +F+QEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF
Sbjct: 527 VAVKVFSKQEYSDDVILAFKQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 586
Query: 591 RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
RLLQRNTTKLDWRRR MALDIARG++YLHH NPPIIHRDLKSSNLLVDK+WTVKVGDFG
Sbjct: 587 RLLQRNTTKLDWRRRAHMALDIARGMNYLHHYNPPIIHRDLKSSNLLVDKNWTVKVGDFG 646
Query: 651 LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710
LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYS+GVILWELATEKIPWDNLNS
Sbjct: 647 LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSYGVILWELATEKIPWDNLNS 706
Query: 711 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY---F 767
MQVIGAVGFMNQ+LEIPKDVDP+WA+I+ SCWHSDPQCRP+FQEL++KLRDLQRQY F
Sbjct: 707 MQVIGAVGFMNQQLEIPKDVDPQWASIIGSCWHSDPQCRPTFQELLEKLRDLQRQYAIQF 766
Query: 768 QASRSTVGDSTQKEL 782
QA+RS GD+TQKEL
Sbjct: 767 QAARSAAGDNTQKEL 781
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255556394|ref|XP_002519231.1| map3k delta-1 protein kinase, putative [Ricinus communis] gi|223541546|gb|EEF43095.1| map3k delta-1 protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1179 bits (3050), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 611/796 (76%), Positives = 671/796 (84%), Gaps = 27/796 (3%)
Query: 8 AEELLRKIQELEAGQEHLKQELSKLKISNDPKSET-----------ITTTTTTTHHQQRS 56
AEELL+KIQELEAGQ HLK+++SK K+++DP S++ QQRS
Sbjct: 7 AEELLKKIQELEAGQAHLKEQMSKFKLTSDPVSDSQLHHHHHHHHHHHRQQQQQQQQQRS 66
Query: 57 HSVSPRRPRLAGPASRRKGGGTGP---DAASAWKATNSASFRHSSPLQRESKGGDSGGSD 113
HS+SP+R +RR GGG G + +AWK S SFRHSSPLQRES+ + +
Sbjct: 67 HSISPQRT-----GTRRSGGGAGAGGFEVVAAWKK-GSTSFRHSSPLQRESRSSSADKIN 120
Query: 114 AA----GNSNSGPSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEE 169
AA G + GPSA FTD+QYLNILQSMGQSVHIF LS RIIYWNR+AE LYGYS+ E
Sbjct: 121 AAVKEEGGNKCGPSAVKFTDKQYLNILQSMGQSVHIFYLSGRIIYWNRTAENLYGYSSAE 180
Query: 170 ALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDG 229
ALGQDAIELL D RDF VA +IVHR+ MGERWTGQFP K K ER VATNTPFYDDDG
Sbjct: 181 ALGQDAIELLVDPRDFAVANNIVHRVAMGERWTGQFPVKNKMGERFTAVATNTPFYDDDG 240
Query: 230 TLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASK 289
TL+GI+CVS D RPFQETR AL KNS+ DS+ +RPR+TVT KLGLDSQQPLQA IASK
Sbjct: 241 TLIGIICVSGDVRPFQETRVALIGPKNSEADSSFSRPRSTVTTKLGLDSQQPLQAVIASK 300
Query: 290 ISNLATKVSNKVKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPR 349
I+NLA++VSNKVKS+IRTGDN MDREGGSGDSH SDHGFSDAALSDHRED SSGASTPR
Sbjct: 301 ITNLASRVSNKVKSKIRTGDNIMDREGGSGDSHQSDHGFSDAALSDHREDANSSGASTPR 360
Query: 350 GDVPPCPFGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGN 409
GD+ P FG FSHVDEKSP K++RDSG ESEGKP IHKIITSKAE W+GKKGLSWPWKG
Sbjct: 361 GDIHPSQFGTFSHVDEKSPMKAIRDSGYESEGKPGIHKIITSKAEAWIGKKGLSWPWKGI 420
Query: 410 EREGSDAKTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSV 469
EREG D KT+RF WPW DQ++E + Q+SP G KPES + E NR NNEA GSWSSSV
Sbjct: 421 EREGPDTKTSRFVWPWLQNDQESELLHQRSPPAGAKPESQLNESNRPTNNEASGSWSSSV 480
Query: 470 NVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS 529
NVNSTSS SSCGSTSSSA+NKVD+D DCLDYEILWEDLTIGEQIGQGSCGTVYHA+WYGS
Sbjct: 481 NVNSTSSASSCGSTSSSAINKVDMDIDCLDYEILWEDLTIGEQIGQGSCGTVYHALWYGS 540
Query: 530 DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589
DVAVKVFS+QEYSD+VI +FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI+TEFLPRGSL
Sbjct: 541 DVAVKVFSKQEYSDDVILAFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIITEFLPRGSL 600
Query: 590 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649
FRLLQRNTTKLDWRRRI MALDI RG++YLHHCNPPIIHRDLKSSNLLVDK+WTVKVGDF
Sbjct: 601 FRLLQRNTTKLDWRRRIHMALDIVRGMNYLHHCNPPIIHRDLKSSNLLVDKNWTVKVGDF 660
Query: 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709
GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN
Sbjct: 661 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 720
Query: 710 SMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY--- 766
SMQVIGAVGFMNQRLEIPKDVDP WA+I+ESCWHSDPQCRP+FQEL++KLRDLQRQY
Sbjct: 721 SMQVIGAVGFMNQRLEIPKDVDPLWASIIESCWHSDPQCRPTFQELLEKLRDLQRQYAIQ 780
Query: 767 FQASRSTVGDSTQKEL 782
FQA+RS GD+TQKEL
Sbjct: 781 FQAARSAAGDNTQKEL 796
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224101557|ref|XP_002312329.1| predicted protein [Populus trichocarpa] gi|222852149|gb|EEE89696.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1169 bits (3025), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 581/781 (74%), Positives = 655/781 (83%), Gaps = 28/781 (3%)
Query: 4 NTGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRR 63
+T PAEELL+KI+ELEAG HL+QE+SKLK+S +TTT QQRSHS+SP+R
Sbjct: 3 STAPAEELLKKIEELEAGHHHLQQEVSKLKLS--------STTTDPRSTQQRSHSISPQR 54
Query: 64 PRLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNSGPS 123
+GP R GG TG +AW SAS RHSSPLQ+E G+ NSGPS
Sbjct: 55 ---SGPRRRVSGGPTGSSFEAAWNK-GSASSRHSSPLQKER-----------GDGNSGPS 99
Query: 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183
A FTD+QYLNILQSMGQSVHIFD+S RIIYWNR+AE LYGYSA EALGQDAI LL D R
Sbjct: 100 AVKFTDKQYLNILQSMGQSVHIFDVSGRIIYWNRTAENLYGYSAAEALGQDAIGLLIDPR 159
Query: 184 DFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243
D+ +A I+ R+ MGE+WTG+FP K K ER VATNTP YDDDG LVGI+CVS+DSRP
Sbjct: 160 DYALANGIIQRVSMGEKWTGKFPVKNKMAERFTAVATNTPLYDDDGALVGIICVSSDSRP 219
Query: 244 FQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISNLATKVSNKVKS 303
FQE AL D++N +T+S+ RP+NTV KLGLDSQQPLQ +ASKISNLA+KVSNKVKS
Sbjct: 220 FQEMEVALSDSRNLETESSHRRPKNTVMTKLGLDSQQPLQTAVASKISNLASKVSNKVKS 279
Query: 304 RIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCPFGVFSHV 363
+I G++ DRE GSGDSH+SDHG+SDAALSDHRED SSGASTPRGD+ P PFGVFS++
Sbjct: 280 KIHMGESNTDREVGSGDSHYSDHGYSDAALSDHREDANSSGASTPRGDLHPSPFGVFSNL 339
Query: 364 DEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTARFAW 423
D+KSP K RDSGDESEGKPAIHKIITSKAE W+GKKGLSWPWKGNE+EGS+A+T RF W
Sbjct: 340 DDKSPVKPSRDSGDESEGKPAIHKIITSKAEAWIGKKGLSWPWKGNEKEGSEARTTRFGW 399
Query: 424 PWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGST 483
PW DQ++E+ Q SPS G K ES + E R NEA GSWSS +NVNSTSS SSC +
Sbjct: 400 PWLQNDQESETYHQTSPSSGAKSESQVSESIRPATNEASGSWSS-INVNSTSSASSC-GS 457
Query: 484 SSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSD 543
+SS VNKVD+D DCLDYEILWEDLTIGEQIGQGSCGTVYHA+WYGSDVAVKVFS+QEYSD
Sbjct: 458 TSSTVNKVDMDTDCLDYEILWEDLTIGEQIGQGSCGTVYHALWYGSDVAVKVFSKQEYSD 517
Query: 544 EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR 603
++I +FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR
Sbjct: 518 DIILAFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR 577
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
RR+ MALDIARG++YLHHCNPPIIHRDLKSSNLLVDK+WTVKVGDFGLSRLKHETYLTTK
Sbjct: 578 RRVHMALDIARGMNYLHHCNPPIIHRDLKSSNLLVDKNWTVKVGDFGLSRLKHETYLTTK 637
Query: 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR 723
TGKGTPQWMAPEVLRNEPSDEKSD+YS+GVILWEL+TEKIPWDNLNSMQVIGAVGFMNQR
Sbjct: 638 TGKGTPQWMAPEVLRNEPSDEKSDIYSYGVILWELSTEKIPWDNLNSMQVIGAVGFMNQR 697
Query: 724 LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ---YFQASRSTVGDSTQK 780
LEIPKDVDP+WA+I+ESCWHSDP+CRP+FQEL++KLRDLQRQ QA+RS GD+TQK
Sbjct: 698 LEIPKDVDPQWASIIESCWHSDPRCRPTFQELLEKLRDLQRQCAIQVQAARSATGDNTQK 757
Query: 781 E 781
E
Sbjct: 758 E 758
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225431966|ref|XP_002278360.1| PREDICTED: uncharacterized protein LOC100256793 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1114 bits (2882), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 568/787 (72%), Positives = 658/787 (83%), Gaps = 25/787 (3%)
Query: 4 NTGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRR 63
+T PAEELLRKIQELEAG HLK+E+SKL +S PKS+ H QRSHS SP+R
Sbjct: 2 DTPPAEELLRKIQELEAGHAHLKEEMSKLMVSG-PKSD---------HGHQRSHSTSPQR 51
Query: 64 PRLAGPA--SRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNSG 121
R + PA S RKG G G D + W+ SASFRHSSPLQRES+ D + G
Sbjct: 52 SRFSSPATSSWRKGSG-GFDGPAGWR-RGSASFRHSSPLQRESRSRDPS---STAGGGGG 106
Query: 122 PSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTD 181
P+A+ F D+QY NILQSMGQS+HIFDL+ R+IYWNR+AE LYGYSAEEALGQ AIELL+D
Sbjct: 107 PAAYKFNDKQYSNILQSMGQSIHIFDLNGRVIYWNRTAEKLYGYSAEEALGQQAIELLSD 166
Query: 182 GRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDS 241
+D+ +A +IV R+ GE WTGQFP K K ER L VATNTPFYDDDGTL+GI+CVS+DS
Sbjct: 167 VQDYAIANNIVDRVSRGESWTGQFPVKNKMGERFLAVATNTPFYDDDGTLIGIICVSSDS 226
Query: 242 RPFQETRAALWDTKNSDTDSNINRPRNTVTA-KLGLDSQQPLQATIASKISNLATKVSNK 300
+PFQE R A+ + + S+ +++ NR R++ + KLGLD QQP+QA IASKISNLA+KVSNK
Sbjct: 227 QPFQEIRVAMSNERQSEANASYNRSRSSSASAKLGLDPQQPIQAAIASKISNLASKVSNK 286
Query: 301 VKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCPFGVF 360
V+ +I+ G+N + REGGSGDSHHSDHGFSDAA SDHRED SSGASTPRGDV P PFG+F
Sbjct: 287 VR-KIKAGENNVVREGGSGDSHHSDHGFSDAAFSDHREDATSSGASTPRGDVAPSPFGIF 345
Query: 361 SHV--DEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKT 418
S DEKSPGK++RDSGDE+EGKP IH++ITSKAE W+GKK +SWPWKGNEREGS+ KT
Sbjct: 346 SQATADEKSPGKNLRDSGDENEGKPGIHRVITSKAEAWIGKKVMSWPWKGNEREGSEVKT 405
Query: 419 ARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVS 478
RF WPW D +N+ VQ K+P++G K E+ + E NR NN+A GSWSS NVNSTSSVS
Sbjct: 406 NRFGWPWLQNDHENDMVQPKNPNFGAKTENLVSESNRHGNNDASGSWSS-FNVNSTSSVS 464
Query: 479 SCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSR 538
SCGSTSSSAVNKVD++ DCLDYEILWEDLTIGEQIGQGSCGTVYH +WYGSDVA+KVFS+
Sbjct: 465 SCGSTSSSAVNKVDMETDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWYGSDVAIKVFSK 524
Query: 539 QEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT 598
QEYSD+VI SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT+
Sbjct: 525 QEYSDDVILSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTS 584
Query: 599 KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658
+LDWRRR+ MALDIA+G++YLHH NPPIIHRDLKSSNLLVD++WTVKVGDFGLSRLKHET
Sbjct: 585 RLDWRRRVHMALDIAQGMNYLHHFNPPIIHRDLKSSNLLVDRNWTVKVGDFGLSRLKHET 644
Query: 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVG 718
YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYS+GVILWELATEKIPWDNLN+MQVIGAVG
Sbjct: 645 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSYGVILWELATEKIPWDNLNTMQVIGAVG 704
Query: 719 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ---YFQASRSTVG 775
FMNQRL+IPK+VD RWA+I+ESCWHSDP+ RP+FQEL+ K +D+ RQ FQA+R+ G
Sbjct: 705 FMNQRLDIPKEVDLRWASIIESCWHSDPRSRPTFQELLGKFKDILRQQTMQFQAARAAAG 764
Query: 776 DSTQKEL 782
D+TQKEL
Sbjct: 765 DNTQKEL 771
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521762|ref|XP_003529520.1| PREDICTED: uncharacterized protein LOC100800867 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1099 bits (2842), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 561/789 (71%), Positives = 637/789 (80%), Gaps = 34/789 (4%)
Query: 5 TGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRRP 64
T P +EL++KIQ+LE G HLKQE+SKLK+S+ HH+QRSHSVSP+R
Sbjct: 3 TPPTDELVKKIQQLEEGHAHLKQEMSKLKLSD----------VRHGHHRQRSHSVSPQRS 52
Query: 65 RLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGD------SGGSDAAGNS 118
RL P +R DA +AWK S SF+ SSPLQRES+GG GG +AA
Sbjct: 53 RLGAPPKKRS------DAPAAWK-RGSCSFKQSSPLQRESRGGGDPQIHGGGGEEAA--P 103
Query: 119 NSGPSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIEL 178
GPSA NFT+RQYLNILQSMGQSVHI DL+ RIIYWNRSAE LYGY+AEEALGQD IEL
Sbjct: 104 RRGPSAVNFTERQYLNILQSMGQSVHILDLNCRIIYWNRSAENLYGYTAEEALGQDGIEL 163
Query: 179 LTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVS 238
L D RD D+A + V+R+ MGE WTGQFP K K E+ L VATNTPFYDDDG+LVG++CVS
Sbjct: 164 LVDPRDLDLANNTVNRVMMGESWTGQFPIKNKMGEKFLAVATNTPFYDDDGSLVGLICVS 223
Query: 239 TDSRPFQETRAALWDTKN--SDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISNLATK 296
D RPF E + + +N SD+DS RPR+++T KLGLD+QQPLQA+IASKISNLA+K
Sbjct: 224 IDLRPFLEMKVPMPSVRNIESDSDSGGTRPRSSITNKLGLDTQQPLQASIASKISNLASK 283
Query: 297 VSNKVKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCP 356
V NKVKSRI TG+N +DRE GSG+SHHS+H S++ + RED SSGASTPRGDVPP
Sbjct: 284 VGNKVKSRIWTGENNLDRESGSGESHHSEHSLSESVFLEQREDANSSGASTPRGDVPPSH 343
Query: 357 FGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDA 416
FG F HV+EKS GK++R+SGDESEGK +IHKII KAE W+ +K LSWPW+ +REGSDA
Sbjct: 344 FGAFPHVEEKSQGKALRESGDESEGK-SIHKIIP-KAEAWIQRKTLSWPWRTKDREGSDA 401
Query: 417 KTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSS 476
R A PW DQ+NESV QK S K ES E NR N+EA GSWSS NVNSTSS
Sbjct: 402 ANVRVAGPWRQNDQENESVNQKILSSSLKQESQAGESNRPTNHEASGSWSS-FNVNSTSS 460
Query: 477 VSSCGSTSSSAVN-KVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKV 535
SSCGS S AVN KVD+D DCLDYEILWEDLTIGEQIGQGSCGTVYHA+WYGSDVAVKV
Sbjct: 461 ASSCGSAGSGAVNNKVDVDTDCLDYEILWEDLTIGEQIGQGSCGTVYHALWYGSDVAVKV 520
Query: 536 FSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR 595
FS+QEYSD+VI SFRQEVS+MKRLRHPN+LLFMGAVTSPQRLCIVTEFLPRGSL RLL R
Sbjct: 521 FSKQEYSDDVILSFRQEVSVMKRLRHPNILLFMGAVTSPQRLCIVTEFLPRGSLCRLLHR 580
Query: 596 NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655
NT+KLDWRRR+ MALDIARGV+YLHHCNPPIIHRDLKSSNLLVDK+WTVKVGDFGLSRLK
Sbjct: 581 NTSKLDWRRRVHMALDIARGVNYLHHCNPPIIHRDLKSSNLLVDKNWTVKVGDFGLSRLK 640
Query: 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIG 715
HET+LTTKTG+GTPQWMAPEVLRNEPSDEKSDVY FGVILWE+ TEKIPWDNLNSMQVIG
Sbjct: 641 HETFLTTKTGRGTPQWMAPEVLRNEPSDEKSDVYGFGVILWEIVTEKIPWDNLNSMQVIG 700
Query: 716 AVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY---FQASRS 772
AVGFMNQRLEIPK+VDPRWA+I+ESCWHSDP CRP+F EL+++LRDLQ+QY FQA+RS
Sbjct: 701 AVGFMNQRLEIPKNVDPRWASIIESCWHSDPACRPTFPELLERLRDLQKQYAIQFQAARS 760
Query: 773 TVGDSTQKE 781
T +STQKE
Sbjct: 761 TAKESTQKE 769
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356564864|ref|XP_003550667.1| PREDICTED: uncharacterized protein LOC100785569 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1097 bits (2838), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 562/789 (71%), Positives = 638/789 (80%), Gaps = 33/789 (4%)
Query: 5 TGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRRP 64
T P +EL++KIQ+LE G HLKQE+SKLK+S+ HH+QRSHSVSP+R
Sbjct: 3 TPPTDELVKKIQQLEEGHAHLKQEMSKLKLSD----------VRHGHHRQRSHSVSPQRS 52
Query: 65 RLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGG-----DSGGSDAAGNSN 119
RL P +R A+AWK S SF+ SSPLQRES+GG GG +AA
Sbjct: 53 RLGAPPKKRSDA-----PAAAWK-RGSCSFKQSSPLQRESRGGGDPQIHGGGEEAA--PR 104
Query: 120 SGPSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL 179
GPSA NFT+RQYLNIL+SMGQSVHI DL+ RIIYWNRSAE LYGY+AEEALGQD IELL
Sbjct: 105 RGPSAVNFTERQYLNILRSMGQSVHILDLNCRIIYWNRSAENLYGYTAEEALGQDGIELL 164
Query: 180 TDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVST 239
D RD D+A + V+R+ MGE WTGQFP K KT E+ L VATNTPFYDDDG+LVG++CVS
Sbjct: 165 VDPRDLDLANNTVNRVMMGESWTGQFPVKNKTGEKFLAVATNTPFYDDDGSLVGLICVSI 224
Query: 240 DSRPFQETRAAL-WDTKN--SDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISNLATK 296
D RPF E + + +N SD+DS RPR+++T KLGLD+QQPLQA+IASKISNLA+K
Sbjct: 225 DLRPFLEMKVPMPTSVRNIESDSDSGGTRPRSSITNKLGLDTQQPLQASIASKISNLASK 284
Query: 297 VSNKVKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCP 356
V NKVKSRI G+N +DRE GSG+SHHS+H ++ + RED SSGASTPRGDVPP
Sbjct: 285 VGNKVKSRIWMGENNLDRESGSGESHHSEHSLLESVFLEQREDANSSGASTPRGDVPPSH 344
Query: 357 FGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDA 416
FG FSHV+EKS GK++R+SGDESEGK +IHKII KAE W+ +K LSWPW+ +REGSDA
Sbjct: 345 FGAFSHVEEKSQGKALRESGDESEGK-SIHKIIP-KAEAWIQRKTLSWPWRTKDREGSDA 402
Query: 417 KTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSS 476
R A W DQ+NESV QK S G K ES E NR NNEA GSWSS NVNSTSS
Sbjct: 403 MNVRVAGSWRQNDQENESVNQKILSSGLKQESQAGESNRPTNNEASGSWSS-FNVNSTSS 461
Query: 477 VSSCGSTSSSAVN-KVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKV 535
SSCGS S AVN KVD+D DCLDYEILWEDLTIGEQIGQGSCGTVYHA+WYGSDVAVKV
Sbjct: 462 ASSCGSAGSGAVNNKVDVDTDCLDYEILWEDLTIGEQIGQGSCGTVYHALWYGSDVAVKV 521
Query: 536 FSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR 595
FS+QEYSD+VI SFRQEVS+MKRLRHPN+LL+MGAVTSPQRLCIVTEFLPRGSL RLL R
Sbjct: 522 FSKQEYSDDVILSFRQEVSVMKRLRHPNILLYMGAVTSPQRLCIVTEFLPRGSLCRLLHR 581
Query: 596 NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655
NT+KLDWRRR+ MALDIARGV+YLHHCNPPIIHRDLKSSNLLVDK+WTVKVGDFGLSRLK
Sbjct: 582 NTSKLDWRRRVHMALDIARGVNYLHHCNPPIIHRDLKSSNLLVDKNWTVKVGDFGLSRLK 641
Query: 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIG 715
HETYLTTKTG+GTPQWMAPEVLRNEPSDEKSDVYSFGVILWE+ATEKIPWDNLNSMQVIG
Sbjct: 642 HETYLTTKTGRGTPQWMAPEVLRNEPSDEKSDVYSFGVILWEIATEKIPWDNLNSMQVIG 701
Query: 716 AVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY---FQASRS 772
AVGFMNQRLEIPK+VDPRWA+I+ESCWHSDP CRP+F EL+DKL++LQ+QY FQA+RS
Sbjct: 702 AVGFMNQRLEIPKNVDPRWASIIESCWHSDPACRPTFPELLDKLKELQKQYAIQFQAARS 761
Query: 773 TVGDSTQKE 781
T +STQKE
Sbjct: 762 TAKESTQKE 770
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296083240|emb|CBI22876.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1073 bits (2775), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 545/785 (69%), Positives = 633/785 (80%), Gaps = 60/785 (7%)
Query: 4 NTGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRR 63
+T PAEELLRKIQELEAG HLK+E+SKL +S PKS+ H QRSHS SP+R
Sbjct: 2 DTPPAEELLRKIQELEAGHAHLKEEMSKLMVSG-PKSD---------HGHQRSHSTSPQR 51
Query: 64 PRLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNSGPS 123
R + PA+ + GP+
Sbjct: 52 SRFSSPAT------------------------------------------STAGGGGGPA 69
Query: 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183
A+ F D+QY NILQSMGQS+HIFDL+ R+IYWNR+AE LYGYSAEEALGQ AIELL+D +
Sbjct: 70 AYKFNDKQYSNILQSMGQSIHIFDLNGRVIYWNRTAEKLYGYSAEEALGQQAIELLSDVQ 129
Query: 184 DFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243
D+ +A +IV R+ GE WTGQFP K K ER L VATNTPFYDDDGTL+GI+CVS+DS+P
Sbjct: 130 DYAIANNIVDRVSRGESWTGQFPVKNKMGERFLAVATNTPFYDDDGTLIGIICVSSDSQP 189
Query: 244 FQETRAALWDTKNSDTDSNINRPRNTVTA-KLGLDSQQPLQATIASKISNLATKVSNKVK 302
FQE R A+ + + S+ +++ NR R++ + KLGLD QQP+QA IASKISNLA+KVSNKV+
Sbjct: 190 FQEIRVAMSNERQSEANASYNRSRSSSASAKLGLDPQQPIQAAIASKISNLASKVSNKVR 249
Query: 303 SRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCPFGVFSH 362
+I+ G+N + REGGSGDSHHSDHGFSDAA SDHRED SSGASTPRGDV P PFG+FS
Sbjct: 250 -KIKAGENNVVREGGSGDSHHSDHGFSDAAFSDHREDATSSGASTPRGDVAPSPFGIFSQ 308
Query: 363 V--DEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTAR 420
DEKSPGK++RDSGDE+EGKP IH++ITSKAE W+GKK +SWPWKGNEREGS+ KT R
Sbjct: 309 ATADEKSPGKNLRDSGDENEGKPGIHRVITSKAEAWIGKKVMSWPWKGNEREGSEVKTNR 368
Query: 421 FAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSC 480
F WPW D +N+ VQ K+P++G K E+ + E NR NN+A GSWSS NVNSTSSVSSC
Sbjct: 369 FGWPWLQNDHENDMVQPKNPNFGAKTENLVSESNRHGNNDASGSWSS-FNVNSTSSVSSC 427
Query: 481 GSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQE 540
GSTSSSAVNKVD++ DCLDYEILWEDLTIGEQIGQGSCGTVYH +WYGSDVA+KVFS+QE
Sbjct: 428 GSTSSSAVNKVDMETDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWYGSDVAIKVFSKQE 487
Query: 541 YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL 600
YSD+VI SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT++L
Sbjct: 488 YSDDVILSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTSRL 547
Query: 601 DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660
DWRRR+ MALDIA+G++YLHH NPPIIHRDLKSSNLLVD++WTVKVGDFGLSRLKHETYL
Sbjct: 548 DWRRRVHMALDIAQGMNYLHHFNPPIIHRDLKSSNLLVDRNWTVKVGDFGLSRLKHETYL 607
Query: 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM 720
TTKTGKGTPQWMAPEVLRNEPSDEKSDVYS+GVILWELATEKIPWDNLN+MQVIGAVGFM
Sbjct: 608 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSYGVILWELATEKIPWDNLNTMQVIGAVGFM 667
Query: 721 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ---YFQASRSTVGDS 777
NQRL+IPK+VD RWA+I+ESCWHSDP+ RP+FQEL+ K +D+ RQ FQA+R+ GD+
Sbjct: 668 NQRLDIPKEVDLRWASIIESCWHSDPRSRPTFQELLGKFKDILRQQTMQFQAARAAAGDN 727
Query: 778 TQKEL 782
TQKEL
Sbjct: 728 TQKEL 732
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147827145|emb|CAN70981.1| hypothetical protein VITISV_034769 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1056 bits (2731), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 549/797 (68%), Positives = 636/797 (79%), Gaps = 56/797 (7%)
Query: 4 NTGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRR 63
+T PAEELLRKIQELEAG HLK+E+SKL +S PKS+ H Q
Sbjct: 2 DTPPAEELLRKIQELEAGHAHLKEEMSKLMVSG-PKSD---------HGHQ--------- 42
Query: 64 PRLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNSGPS 123
RKG G G D + W+ SASFRHSSPLQRES+ D + GP+
Sbjct: 43 ---------RKGSG-GFDGPAGWR-RGSASFRHSSPLQRESRSRDPS---STAGGGGGPA 88
Query: 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183
A+ F D+QY NILQSMGQS+HIFDL+ R+IYWNR+AE LYGYSAEEALGQ AIELL+D +
Sbjct: 89 AYKFNDKQYSNILQSMGQSIHIFDLNGRVIYWNRTAEKLYGYSAEEALGQQAIELLSDVQ 148
Query: 184 DFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243
D+ +A +IV R+ GE WTGQFP K K ER L VATNTPFYDDDGTL+GI+CVS+DS+P
Sbjct: 149 DYAIANNIVDRVSRGESWTGQFPVKNKMGERFLAVATNTPFYDDDGTLIGIICVSSDSQP 208
Query: 244 FQETRAALWDTKNSDTDSNIN-RPRNTVTAKLGLDSQQPLQATIASKISNLATKVSNKVK 302
FQE R A+ + + S+ +++ N ++ +AKLGLD QQP+QA IASKISNL VSNKV+
Sbjct: 209 FQEIRVAMSNERQSEANASYNRSRSSSASAKLGLDPQQPIQAAIASKISNL---VSNKVR 265
Query: 303 SRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCPFGVFSH 362
+I+ G+N + REGGSGDSHHSDHGFSDAA SDHRED SSGASTPRGDV P PFG+FS
Sbjct: 266 -KIKAGENNVVREGGSGDSHHSDHGFSDAAFSDHREDATSSGASTPRGDVAPSPFGIFSQ 324
Query: 363 --VDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTAR 420
DEKSPGK++RDSGDE+EGKP IH++ITSKAE W+GKK +SWPWKGNEREGS+ KT R
Sbjct: 325 ATADEKSPGKNLRDSGDENEGKPGIHRVITSKAEAWIGKKVMSWPWKGNEREGSEVKTNR 384
Query: 421 FAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSC 480
F WPW D +N+ VQ K+P++G K E+ + E NR NN+A GSW SS NVNSTSSVSSC
Sbjct: 385 FGWPWLQNDHENDMVQPKNPNFGAKTENLVSESNRHGNNDASGSW-SSFNVNSTSSVSSC 443
Query: 481 GSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQE 540
GSTSSSAVNKVD++ DCLDYEILWEDLTIGEQIGQGSCGTVYH +WYGSDVA+KVFS+QE
Sbjct: 444 GSTSSSAVNKVDMETDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWYGSDVAIKVFSKQE 503
Query: 541 YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL----------- 589
YSD+VI SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR L
Sbjct: 504 YSDDVILSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRCVLCFPIENFLKQA 563
Query: 590 -FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648
F L NT++LDWRRR+LMALDIA+G++YLHH NPPIIHRDLKSSNLLVD++WTVKVGD
Sbjct: 564 YFMCLALNTSRLDWRRRVLMALDIAQGMNYLHHFNPPIIHRDLKSSNLLVDRNWTVKVGD 623
Query: 649 FGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708
FGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYS+GVILWELATEKIPWDNL
Sbjct: 624 FGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSYGVILWELATEKIPWDNL 683
Query: 709 NSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ--- 765
N+MQVIGAVGFMNQRL+IPK+VD RWA+I+ESCWHSDP+ RP+FQEL+ K +D+ RQ
Sbjct: 684 NTMQVIGAVGFMNQRLDIPKEVDLRWASIIESCWHSDPRSRPTFQELLGKFKDILRQQTM 743
Query: 766 YFQASRSTVGDSTQKEL 782
FQA+R+ GD+TQKEL
Sbjct: 744 QFQAARAAAGDNTQKEL 760
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449462150|ref|XP_004148804.1| PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein LOC101221874 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1008 bits (2605), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 518/781 (66%), Positives = 605/781 (77%), Gaps = 39/781 (4%)
Query: 5 TGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRRP 64
T PAEELLRK+QELE GQ HLK+E+SKL +S + + + S+
Sbjct: 3 TPPAEELLRKVQELEEGQAHLKKEMSKLLLSVQ-----LRPPNPPSPPSPSTFSI----- 52
Query: 65 RLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESK--------GGDSGGSDAAG 116
GG G AA+AWK S+SFRHSSPLQ+E+ +S D G
Sbjct: 53 -------HTTGGLDG--AAAAWK-RGSSSFRHSSPLQKEALPRFDISPLQRESRTRDPIG 102
Query: 117 NSNSGPSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAI 176
S GP+A NFT++QYLNILQS+GQ V+IFDL+ IIYWNR+AE++YGYSA EALGQDAI
Sbjct: 103 CS--GPAAVNFTNKQYLNILQSLGQPVYIFDLNYHIIYWNRAAEIVYGYSAAEALGQDAI 160
Query: 177 ELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVC 236
ELL D DF + ++ R+ GE WTG P K K ++ +VVATNTPFYDD G L+GI+C
Sbjct: 161 ELLVDPEDFAITNHVILRVMAGENWTGHLPVKNKMGQKFVVVATNTPFYDD-GALIGIIC 219
Query: 237 VSTDSRPFQETRAAL-WDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISNLAT 295
+S+DSRPFQ+ + L +K D DS++ R R V+ KLGLD QQPLQ IASK+SNLA+
Sbjct: 220 ISSDSRPFQDLKIPLSIGSKQQDADSSMVRSRVPVSVKLGLDPQQPLQVAIASKLSNLAS 279
Query: 296 KVSNKVKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPC 355
KVSNKVKS+IRTG+N +DREGGSGD +HSDHG DA L D+R+D SSGASTPRGD
Sbjct: 280 KVSNKVKSKIRTGENSLDREGGSGDGYHSDHGHPDAVLCDNRDDANSSGASTPRGD--ST 337
Query: 356 PFGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREG-S 414
G FS V+EK G+ VRDS DE +GKP I KI++SKAE+W+ KKGLSWPWKG E+EG S
Sbjct: 338 AHGAFSQVEEKLSGRLVRDSSDEGKGKPTIQKILSSKAEEWIAKKGLSWPWKGTEQEGGS 397
Query: 415 DAKTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNST 474
+ + ARF WPW DQ+ E KS S K E +G+R+VNNEA GSWSS +++
Sbjct: 398 ETRAARFVWPWVQIDQEAEPANHKSSSISGKLEMQQNDGHRAVNNEASGSWSSININSTS 457
Query: 475 SSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVK 534
S S STSSSAVNKV+ D DCLD+EILWEDLTIGEQIGQGSCGTVYHA+WYGSDVAVK
Sbjct: 458 SVSSCG-STSSSAVNKVESDMDCLDHEILWEDLTIGEQIGQGSCGTVYHALWYGSDVAVK 516
Query: 535 VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ 594
VFS+QEYSD+VI SF+QEVSLMK+LRHPN+LLFMG VTSPQRLCIVTEFLPRGSLFRLLQ
Sbjct: 517 VFSKQEYSDDVILSFKQEVSLMKKLRHPNILLFMGVVTSPQRLCIVTEFLPRGSLFRLLQ 576
Query: 595 RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
RNT KLDWRRR+ MALDIARG++YLHHCNPPIIHRDLKSSNLL+DK+WTVKVGDFGLSRL
Sbjct: 577 RNTGKLDWRRRVHMALDIARGMNYLHHCNPPIIHRDLKSSNLLIDKNWTVKVGDFGLSRL 636
Query: 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVI 714
KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSD+YSFGVILWELATEKIPW+NLNSMQVI
Sbjct: 637 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDIYSFGVILWELATEKIPWENLNSMQVI 696
Query: 715 GAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY---FQASR 771
GAVGFMNQRLEIPKDVDP+W +I+ESCWHS+P RPSFQ L++KLRDLQR+Y QA+R
Sbjct: 697 GAVGFMNQRLEIPKDVDPQWISIIESCWHSEPSNRPSFQVLIEKLRDLQRKYTIQLQAAR 756
Query: 772 S 772
S
Sbjct: 757 S 757
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357448913|ref|XP_003594732.1| Protein kinase-like protein [Medicago truncatula] gi|355483780|gb|AES64983.1| Protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1003 bits (2592), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 518/785 (65%), Positives = 610/785 (77%), Gaps = 57/785 (7%)
Query: 7 PAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRRPRL 66
P ELL+KI+ LEAGQ HLKQE+SKLK+S ++RSHSVSP+R RL
Sbjct: 6 PEAELLKKIERLEAGQVHLKQEMSKLKLS----------------QRRRSHSVSPQRSRL 49
Query: 67 AGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGG---DSGGSDAAGNSNSGPS 123
G A+SA A +++S SSPLQRES+ +GG
Sbjct: 50 ------------GASASSASSAASASSKGCSSPLQRESRSSHDPQNGGG----------- 86
Query: 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183
+YLNILQS+G SVHI DL RIIYWN SAE LYGY+AEE LG D IE+L D
Sbjct: 87 -------KYLNILQSIGHSVHILDLQCRIIYWNPSAENLYGYTAEEVLGLDGIEVLVDPS 139
Query: 184 DFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243
+FD+A DI +R+KMGE WTGQFP K K +R +VVAT+TPFYDDDG+LVG++CV++DSRP
Sbjct: 140 EFDIANDIFNRVKMGESWTGQFPVKNKIGDRFVVVATDTPFYDDDGSLVGVICVTSDSRP 199
Query: 244 FQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISNLATKVSNKVKS 303
F E KN + DS +N PR +T KLGLD +QPLQ +ASKISNLATKVSNKVKS
Sbjct: 200 FLENIVPFSARKNEEKDSGVNFPRIAITNKLGLDPEQPLQNALASKISNLATKVSNKVKS 259
Query: 304 RIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDG-MSSGASTPRGDVPPCPFGVFSH 362
+IRT +N ++ EGGS +SHHS+HGFSD SD REDG SSGASTP G+VPP PFG FS
Sbjct: 260 KIRTRENNVNGEGGSSESHHSEHGFSDYGHSDQREDGGNSSGASTPAGEVPPTPFGSFSR 319
Query: 363 VDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTARFA 422
+E+S GK++R+SGDESE KP IHKIITS+AE W+ KK +SWPWK N+RE S+AK R +
Sbjct: 320 AEERSQGKTMRNSGDESEEKP-IHKIITSRAEAWIQKKTMSWPWKTNDREESEAKNVRVS 378
Query: 423 WPWSHGDQDNESVQQKSPSYGTKP-ESHMYEGNRSVNNEAWGSWSS--SVNVNSTSSVSS 479
WPW GDQD E QK+ S G KP ES E + V NEA GSWSS + + +STSS S
Sbjct: 379 WPWLQGDQDKEPANQKNASSGLKPPESRAVESYQPVQNEATGSWSSFNANSTSSTSSCGS 438
Query: 480 CGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQ 539
+SS+A N+VD+D+DCLDYEILWEDLTIGE IGQGSCGTVYHA+WYGSDVAVKVFS+Q
Sbjct: 439 GSGSSSAANNRVDVDSDCLDYEILWEDLTIGESIGQGSCGTVYHALWYGSDVAVKVFSKQ 498
Query: 540 EYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK 599
EYS++VI SFRQEVSLMKRLRHPN+LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT+K
Sbjct: 499 EYSEDVIQSFRQEVSLMKRLRHPNILLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTSK 558
Query: 600 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659
DWRRR+ MA+DIARGV+YLHHCNPPIIHRDLK+SNLLVDK+WTVKVGDFGLSR+KHETY
Sbjct: 559 PDWRRRVHMAVDIARGVNYLHHCNPPIIHRDLKTSNLLVDKNWTVKVGDFGLSRIKHETY 618
Query: 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF 719
L TKTGKGTPQWMAPEVLRNEPS+EKSDVYSFGVI+WELATEKIPWD LN+MQVIGAVGF
Sbjct: 619 LETKTGKGTPQWMAPEVLRNEPSNEKSDVYSFGVIMWELATEKIPWDTLNAMQVIGAVGF 678
Query: 720 MNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY---FQASRSTVGD 776
MN RLEIP+D+DP+WA+I+ESCWH+DP RP+FQEL+++L++LQR+Y FQA+RS G+
Sbjct: 679 MNHRLEIPEDIDPQWASIIESCWHTDPALRPTFQELLERLKELQRRYAIQFQAARSAGGE 738
Query: 777 STQKE 781
TQKE
Sbjct: 739 KTQKE 743
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 782 | ||||||
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.955 | 0.966 | 0.586 | 5.5e-244 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.945 | 0.966 | 0.574 | 5.3e-241 | |
| TAIR|locus:2158019 | 831 | AT5G49470 [Arabidopsis thalian | 0.704 | 0.663 | 0.493 | 4.1e-230 | |
| TAIR|locus:2084304 | 671 | AT3G06630 [Arabidopsis thalian | 0.785 | 0.915 | 0.592 | 1.4e-209 | |
| TAIR|locus:2127228 | 736 | AT4G23050 [Arabidopsis thalian | 0.350 | 0.372 | 0.574 | 7e-113 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.351 | 0.266 | 0.608 | 1e-92 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.337 | 0.3 | 0.617 | 5.1e-90 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.352 | 0.278 | 0.597 | 1.4e-89 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.346 | 0.290 | 0.612 | 2.2e-89 | |
| TAIR|locus:2144613 | 821 | CTR1 "CONSTITUTIVE TRIPLE RESP | 0.346 | 0.330 | 0.607 | 6e-87 |
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2351 (832.7 bits), Expect = 5.5e-244, P = 5.5e-244
Identities = 463/789 (58%), Positives = 567/789 (71%)
Query: 7 PAEELLRKIQELEAGQEHLKQELSKLKISNDPKSEXXXXXXXXXHHQQRSHSVSPRRPRL 66
PAEELL+KI ELE QEHLKQE+S+LK+S + + QRSHSVSP RP
Sbjct: 5 PAEELLKKILELEESQEHLKQEMSRLKVSTELR--------------QRSHSVSPHRP-- 48
Query: 67 AGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKXXXXXXXXXXXXXXXXPSAFN 126
+RR G + A +W+ + +ASFR++SPL++ES+ PSA
Sbjct: 49 ----ARRNIG----EGAPSWRKSGAASFRNASPLRKESRIQNSMRLRSEVGGGG-PSAGK 99
Query: 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFD 186
FTD+QYLNILQSM Q+VH FDL+ RII+WN AE +YGYSA EALG++ I ++ D RD
Sbjct: 100 FTDKQYLNILQSMAQAVHAFDLNMRIIFWNAMAEKVYGYSAAEALGENPINVIADDRDAA 159
Query: 187 VAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246
A +I R GE WTG+FP K+K+ +R V T +PFYDDDG L+GI+C+++++ P+
Sbjct: 160 FAMNIARRCVRGESWTGEFPVKSKSGDRFSAVTTCSPFYDDDGALMGIICITSNTAPYLN 219
Query: 247 TRAALWDTKNSDTDSNINRP-RNT------------VTAKLGLDSQQPLQATIASKISNL 293
R +L K + + P RN+ V +KLGLDS QP+Q IASKIS+L
Sbjct: 220 PRISLAKLKAQEEGETSSIPARNSFASKLGLDSRGAVISKLGLDSDQPIQVAIASKISDL 279
Query: 294 ATKVSNKVKSRIRTGDNFMD-REXXXXXXXXXXXXXXXAALSDHREDGMSSGASTPRGDV 352
A+KVSNKV+S++R GDN E A L DHR+D SSGASTPRGD
Sbjct: 280 ASKVSNKVRSKMRAGDNSATLSEGGSGDSHQKDHNVFGATLVDHRDDAASSGASTPRGDF 339
Query: 353 PPCPFGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNERE 412
PFGVF+ DEK K +DS DES+GKPAIHK++TSKAE+WM KKGLSWPWKGNE+E
Sbjct: 340 IQSPFGVFTCNDEKFVSKPFKDSSDESDGKPAIHKVLTSKAEEWMVKKGLSWPWKGNEQE 399
Query: 413 GSDAKTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEXXXXXXXXXXXX 472
GS + WPW +Q E Q +PS G + ESH +E N+ +NNE
Sbjct: 400 GSKGRPTNSVWPWVQNEQKKERCHQINPSAGVQYESHAFESNKPINNEASSLWSSPINAN 459
Query: 473 XXXXXXXXXXXXXXXXNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVA 532
NKVD D++ L+YEILW+DLTIGEQ+GQGSCGTVYH +W+GSDVA
Sbjct: 460 STSSASSCGSTSSSVMNKVDTDSEGLEYEILWDDLTIGEQVGQGSCGTVYHGLWFGSDVA 519
Query: 533 VKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL 592
VKVFS+QEYS EVI SF+QEV LMKRLRHPNVLLFMGAVTSPQRLCIV+EFLPRGSLFRL
Sbjct: 520 VKVFSKQEYSAEVIESFKQEVLLMKRLRHPNVLLFMGAVTSPQRLCIVSEFLPRGSLFRL 579
Query: 593 LQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
LQ++T+KLDWRRRI MALDIARG++YLHHC+PPIIHRDLKSSNLLVDK+WTVKV DFGLS
Sbjct: 580 LQKSTSKLDWRRRIHMALDIARGMNYLHHCSPPIIHRDLKSSNLLVDKNWTVKVADFGLS 639
Query: 653 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
R+KHETYLT+K+GKGTPQWMAPEVLRNE +DEKSD+YSFGV+LWELATEKIPW+ LNSMQ
Sbjct: 640 RIKHETYLTSKSGKGTPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKIPWETLNSMQ 699
Query: 713 VIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY---FQA 769
VIGAVGFM+QRLEIPKD+DPRW +++ESCWHSD + RP+FQEL+DKLRDLQR+Y FQA
Sbjct: 700 VIGAVGFMDQRLEIPKDIDPRWISLMESCWHSDTKLRPTFQELMDKLRDLQRKYMIQFQA 759
Query: 770 SRSTVGDST 778
+R+ + D++
Sbjct: 760 TRAALSDNS 768
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2227 (789.0 bits), Expect = 5.3e-241, Sum P(2) = 5.3e-241
Identities = 446/776 (57%), Positives = 539/776 (69%)
Query: 23 EHLKQELSKLKISNDPKSEXXXXXXXXXHHQQRSHSVSPRRPRLAGPASRRKGGGTGPDA 82
E L +++ +L+ S + ++RSHS SP+RP SRR G P
Sbjct: 9 EKLLKKIRELEESQEDLKREMSKLKVSAEIKRRSHSSSPKRP------SRRNSGEGTP-- 60
Query: 83 ASAWKATNSASFRHSSPLQRESKXXXXXXXXXXXXXXXXPSAFNFTDRQYLNILQSMGQS 142
W+ T +ASFRH+SPL++ES PSA FTD+QYLNILQSM Q+
Sbjct: 61 --LWRKTGAASFRHASPLRKESHSKDGVAGGGDG-----PSAGKFTDKQYLNILQSMAQA 113
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT 202
VH+FDL+ +II+WN AE LYG+SA EALG+D+I +L DG+D VA +I R GE WT
Sbjct: 114 VHVFDLNGQIIFWNSMAEKLYGFSAAEALGKDSINILVDGQDAAVAKNIFQRCSSGESWT 173
Query: 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSN 262
G+FP K K ER VV T +PFYDDDG L+GI+C++ DS FQ R + + DS+
Sbjct: 174 GEFPVKNKMGERFSVVTTISPFYDDDGLLIGIICITNDSALFQRPRVPPAKNRWQEGDSS 233
Query: 263 INRPRN------------TVTAKLGLDSQQPLQATIASKISNLATKVSNKVKSRIRTGDN 310
R N V +KLGLDSQQP+QA IASKIS+LA+KV NKV+S++R GDN
Sbjct: 234 FCRGTNGVASRLGFDSKEAVVSKLGLDSQQPIQAAIASKISDLASKVGNKVRSKMRAGDN 293
Query: 311 FMDR-EXXXXXXXXXXXXXXXAALSDHREDGMSSGASTPRGDVPPCPFGVFSHVDEKSPG 369
E AA SD RED ++ ASTPRG++ PFGVF D+KS
Sbjct: 294 NASHPEGGNGGSHQSDQGFFDAAFSDQREDAETNDASTPRGNLIQSPFGVFLCNDDKSSS 353
Query: 370 KSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTARFAWPWSHGD 429
K+ +S DE++ + K +TSK E+WM KKGLSWPWKGNEREG + + A WPW H +
Sbjct: 354 KASGESNDENDRNSVVPKKLTSKTEEWMVKKGLSWPWKGNEREGLERRNAHSVWPWVHNE 413
Query: 430 QDNESVQQKSPSYGTKPESHMYEGNRSVNNEXXXXXXXXXXXXXXXXXXXXXXXXXXXXN 489
Q E + K ES E N+ NNE N
Sbjct: 414 QQKEEAHHSNSYNSVKSESLASESNKPANNENMGSVNVNSASSASSCGSTSSSVM----N 469
Query: 490 KVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSF 549
KVD+D+DCLDYEILWEDLTIGEQIGQGSCGTVYH +W+GSDVAVKVFS+QEYS+E+I SF
Sbjct: 470 KVDMDSDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEIITSF 529
Query: 550 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMA 609
+QEVSLMKRLRHPNVLLFMGAV SPQRLCIVTEFLPRGSLFRLLQRN +KLD RRRI MA
Sbjct: 530 KQEVSLMKRLRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKSKLDLRRRIHMA 589
Query: 610 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP 669
DIARG++YLHHC+PPIIHRDLKSSNLLVD++WTVKV DFGLSR+KHETYLTT G+GTP
Sbjct: 590 SDIARGMNYLHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETYLTTN-GRGTP 648
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKD 729
QWMAPEVLRNE +DEKSDVYSFGV+LWEL TEKIPW+NLN+MQVIGAVGFMNQRLE+PKD
Sbjct: 649 QWMAPEVLRNEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQRLEVPKD 708
Query: 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY---FQASRS-TVGDSTQKE 781
VDP+W A++ESCWHS+PQCRPSFQEL+DKLR+LQR+Y FQA+R+ ++ +S+ KE
Sbjct: 709 VDPQWIALMESCWHSEPQCRPSFQELMDKLRELQRKYTIQFQAARAASIDNSSLKE 764
|
|
| TAIR|locus:2158019 AT5G49470 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1378 (490.1 bits), Expect = 4.1e-230, Sum P(3) = 4.1e-230
Identities = 288/584 (49%), Positives = 359/584 (61%)
Query: 23 EHLKQELSKLKISNDPKSEXXXXXXXXXHHQQRSHSVSPRRPRLAGPASRRKGGGTGPDA 82
E L +++ +L+ S + +QRSHS SP+RP R GT P
Sbjct: 9 EELLKKIRELEESQEHLKREMSRLKVSAEMKQRSHSASPQRP-----VRRNSNDGT-P-- 60
Query: 83 ASAWKATNSASFRHSSPLQRESKXXXXXXXXXXXXXXXXPSAFNFTDRQYLNILQSMGQS 142
W+ T +ASFRH+SPL++ES SA FTD+QYLNILQSM Q+
Sbjct: 61 --MWRKTGAASFRHASPLRKESHAKVAGGGGEGQ------SAGKFTDKQYLNILQSMAQA 112
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT 202
VH+FDL+ +II+WN AE LYG+SA EALG+D I++L D +D VA +I R GE WT
Sbjct: 113 VHVFDLNGQIIFWNSMAEKLYGFSASEALGKDPIDILVDVQDASVAQNITRRCSSGESWT 172
Query: 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNS-DTDS 261
G+FP K K ER VV T +P YDDDG L+GI+C++ DS FQ+ R + T+ + ++
Sbjct: 173 GEFPVKNKAGERFSVVTTMSPSYDDDGCLIGIICITNDSALFQDPRGSPAKTRRGQEGET 232
Query: 262 NINR------------PRNTVTAKLGLDSQQPLQATIASKISNLATKVSNKVKSRIRTGD 309
+ +R + V +KLGLDSQQP+Q IASKIS+L V NKVKS++R GD
Sbjct: 233 SFSRVTSSVASKLGLDSKEAVVSKLGLDSQQPIQVAIASKISDL---VGNKVKSKMRAGD 289
Query: 310 N-FMDREXXXXXXXXXXXXXXXAALSDHREDGMSSGASTPRGDVPPCPFGVFSHVDEKSP 368
N + E AA +D RED +SGA TPRGD PFGVF DEK+
Sbjct: 290 NNAANLEGGSGDSHQSDQGFFDAAFADRREDAATSGADTPRGDFIQSPFGVFLRSDEKAS 349
Query: 369 GKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTARFAWPWSHG 428
K RDS DES+G + K +TSKAE+WM KKGLSWPWKGNEREG + + + WPW
Sbjct: 350 TKPFRDSSDESDGNSVVPKTLTSKAEEWMVKKGLSWPWKGNEREGLEGRRSHSVWPWVRN 409
Query: 429 DQDNESVQQKSPSYGTKPESHMYEGNRSVNNEXXXXXXXXXXXXXXXXXXXXXXXXXXXX 488
+Q + Q + ++ K ES E ++ +NE
Sbjct: 410 EQQKQQAYQSNSNHSVKSESQACESIKASSNEPMGYWSSSVNVNSTSSSSSCGSTSSSVM 469
Query: 489 NKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHS 548
NKVD+D+DCLDYEILWEDLTIGEQIGQGSCGTVYH +W+GSDVAVKVFS+QEYS+E+I S
Sbjct: 470 NKVDMDSDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEIITS 529
Query: 549 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL 592
FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR L L
Sbjct: 530 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRFGLITL 573
|
|
| TAIR|locus:2084304 AT3G06630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1954 (692.9 bits), Expect = 1.4e-209, Sum P(2) = 1.4e-209
Identities = 369/623 (59%), Positives = 456/623 (73%)
Query: 122 PSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTD 181
PS FTD+QYLNILQS+ QSVH+ DL+ RII+WN +E LYGYSA E +G++ + ++ D
Sbjct: 56 PSPGKFTDKQYLNILQSLAQSVHVLDLNTRIIFWNAMSEKLYGYSAAEVVGRNPVHVIVD 115
Query: 182 GRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDS 241
++ A ++ R GE WTG+FP KTK+ + V T +PFYDD+GT+VGI+ +++D
Sbjct: 116 DQNAAFALNVARRCANGESWTGEFPVKTKSGKIFSAVTTCSPFYDDNGTVVGIISITSDI 175
Query: 242 RPFQETRAALWDTKNSDTDSNINRP-RNTVTAKLGLDSQQPLQATIASKISNLATKVSNK 300
P+ R +L K + + + + V +K GLDS QP+Q +IASKIS+LA+K+SNK
Sbjct: 176 APYLNPRLSLPRLKPQEPERKLGLDSKGAVISKPGLDSDQPIQVSIASKISSLASKLSNK 235
Query: 301 VKSRIRTGDNFMDREXXXXXXXXXXXXXXXAALSDHREDGMSSGASTPRGDVPPCPFGVF 360
V+S++R GDN LSDHR+D SSGASTPRGD PFGVF
Sbjct: 236 VRSKMRAGDN-----SACGDSHHSDHDVFGDTLSDHRDDAASSGASTPRGDFIQSPFGVF 290
Query: 361 SHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTAR 420
+ D+K P K +DS D KPAIHK+ TSKAE+WM KKGLS PWKGNE+EGS +
Sbjct: 291 TCYDDKFPSKPSKDSSDR---KPAIHKVPTSKAEEWMVKKGLSRPWKGNEQEGSRVRPTH 347
Query: 421 FAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEXXXXXXXXXXXXXXXXXXXX 480
W W +Q+ + Q PS G K ESH E N+ ++E
Sbjct: 348 SVWSWVENEQEKDKYHQIYPSAGVKSESHGSESNKPTDDEASNMWSSSINANSTNSASSC 407
Query: 481 XXXXXXXXNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQE 540
+KVD+D+D L++EILW+DLTIGEQIG+GSCGTVYH +W+GSDVAVKVFS+QE
Sbjct: 408 GSTSRSVMDKVDIDSDPLEHEILWDDLTIGEQIGRGSCGTVYHGIWFGSDVAVKVFSKQE 467
Query: 541 YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL 600
YS+ VI SF +EVSLMKRLRHPNVLLFMGAVTSPQRLCIV+EF+PRGSLFRLLQR+ +KL
Sbjct: 468 YSESVIKSFEKEVSLMKRLRHPNVLLFMGAVTSPQRLCIVSEFVPRGSLFRLLQRSMSKL 527
Query: 601 DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660
DWRRRI MALDIARG++YLH C+PPIIHRDLKSSNLLVD++WTVKV DFGLSR+KH+TYL
Sbjct: 528 DWRRRINMALDIARGMNYLHCCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHQTYL 587
Query: 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM 720
T+K+GKGTPQWMAPEVLRNE +DEKSD+YSFGV+LWELATEKIPW+NLNSMQVIGAVGFM
Sbjct: 588 TSKSGKGTPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKIPWENLNSMQVIGAVGFM 647
Query: 721 NQRLEIPKDVDPRWAAIVESCWH 743
NQRLEIPKD DP W +++ESCWH
Sbjct: 648 NQRLEIPKDTDPDWISLIESCWH 670
|
|
| TAIR|locus:2127228 AT4G23050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 900 (321.9 bits), Expect = 7.0e-113, Sum P(2) = 7.0e-113
Identities = 159/277 (57%), Positives = 220/277 (79%)
Query: 489 NKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHS 548
N++ D+ C EI WEDL +GE++G+GS V+ VW GSDVA+KV+ +Y+ +
Sbjct: 453 NRLVTDSSC---EIRWEDLQLGEEVGRGSFAAVHRGVWNGSDVAIKVYFDGDYNAMTLTE 509
Query: 549 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 608
++E+++MK+LRHPNVLLFMGAV + ++ I+ E++PRGSLF++L LD +RR+ M
Sbjct: 510 CKKEINIMKKLRHPNVLLFMGAVCTEEKSAIIMEYMPRGSLFKILHNTNQPLDKKRRLRM 569
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT 668
ALD+ARG++YLH NPPI+HRDLKSSNLLVDK+W VKVGDFGLS+ K+ T+L+TK+GKGT
Sbjct: 570 ALDVARGMNYLHRRNPPIVHRDLKSSNLLVDKNWNVKVGDFGLSKWKNATFLSTKSGKGT 629
Query: 669 PQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 728
PQWMAPEVLR+EPS+EK DV+SFGVILWEL T +PWD LNS+QV+G VGFM++RL++P+
Sbjct: 630 PQWMAPEVLRSEPSNEKCDVFSFGVILWELMTTLVPWDRLNSIQVVGVVGFMDRRLDLPE 689
Query: 729 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765
++PR A+I++ CW +DP RPSF+EL+ ++ L R+
Sbjct: 690 GLNPRIASIIQDCWQTDPAKRPSFEELISQMMSLFRK 726
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 905 (323.6 bits), Expect = 1.0e-92, Sum P(2) = 1.0e-92
Identities = 168/276 (60%), Positives = 212/276 (76%)
Query: 489 NKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHS 548
+K D D D D EILWE++T+GE+IG GS G VY W+G++VAVK F Q+ + E +
Sbjct: 731 SKSDCD-DVSDCEILWEEITVGERIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALEE 789
Query: 549 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 608
FR EV +MK+LRHPN++LFMGAVT P L IVTEFLPRGSL+RL+ R +LD RRR+ M
Sbjct: 790 FRSEVRIMKKLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERRRLRM 849
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT 668
ALD ARG++YLH CNP I+HRDLKS NLLVDK+W VKV DFGLSR+KH TYL++K+ GT
Sbjct: 850 ALDAARGMNYLHSCNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKSTAGT 909
Query: 669 PQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 728
+WMAPEVLRNEP+DEK DVYS+GVILWEL T + PW +N MQV+GAVGF ++RL+IP
Sbjct: 910 AEWMAPEVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPD 969
Query: 729 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764
VDP A ++ CW +D + RPSF E++ L+ LQ+
Sbjct: 970 FVDPAIADLISKCWQTDSKLRPSFAEIMASLKRLQK 1005
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 898 (321.2 bits), Expect = 5.1e-90, P = 5.1e-90
Identities = 163/264 (61%), Positives = 207/264 (78%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 559
+EI+WEDL IGE+IG GS G VY A W G++VAVK F Q++S + + F+ E+ +M RL
Sbjct: 602 WEIMWEDLQIGERIGIGSYGEVYRAEWNGTEVAVKKFLDQDFSGDALTQFKSEIEIMLRL 661
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
RHPNV+LFMGAVT P I+TEFLPRGSL+RLL R +LD +RR+ MALD+A+G++YL
Sbjct: 662 RHPNVVLFMGAVTRPPNFSILTEFLPRGSLYRLLHRPNHQLDEKRRMRMALDVAKGMNYL 721
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 679
H +P ++HRDLKS NLLVDK+W VKV DFGLSR+KH TYL++K+ GTP+WMAPEVLRN
Sbjct: 722 HTSHPTVVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHHTYLSSKSTAGTPEWMAPEVLRN 781
Query: 680 EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 739
EP++EK DVYSFGVILWELAT ++PW LN MQV+GAVGF N+RLEIP D+D A I+
Sbjct: 782 EPANEKCDVYSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDDIDLTVAQIIR 841
Query: 740 SCWHSDPQCRPSFQELVDKLRDLQ 763
CW ++P RPSF +L+ L+ LQ
Sbjct: 842 ECWQTEPHLRPSFTQLMQSLKRLQ 865
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 894 (319.8 bits), Expect = 1.4e-89, P = 1.4e-89
Identities = 165/276 (59%), Positives = 212/276 (76%)
Query: 495 NDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVS 554
+D + EILWE++T+ E+IG GS G VY W+G+ VAVK F Q+ + E + FR EV
Sbjct: 703 DDVAECEILWEEITVAERIGLGSYGEVYRGDWHGTAVAVKKFIDQDITGEALEEFRSEVR 762
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR 614
+M+RLRHPN++LFMGAVT P L IVTEFLPRGSL+RL+ R +LD R+R+ MALD AR
Sbjct: 763 MMRRLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERKRLRMALDAAR 822
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAP 674
G++YLH CNP I+HRDLKS NLLVDK+W VKV DFGLSR+K TYL++K+ GT +WMAP
Sbjct: 823 GMNYLHSCNPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTYLSSKSTAGTAEWMAP 882
Query: 675 EVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734
EVLRNEP+DEK DVYS+GVILWEL T + PW +N MQV+GAVGF ++RL+IP+ VDP
Sbjct: 883 EVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPEFVDPGI 942
Query: 735 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770
A I+ CW +DP+ RPSF E++D L+ LQ+ +A+
Sbjct: 943 ADIIRKCWQTDPRLRPSFGEIMDSLKQLQKPIQRAA 978
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 892 (319.1 bits), Expect = 2.2e-89, P = 2.2e-89
Identities = 166/271 (61%), Positives = 206/271 (76%)
Query: 494 DNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEV 553
D D + EI W DL I E+IG GS G VYHA W+G++VAVK F Q++S + FR EV
Sbjct: 656 DADVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEV 715
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
+M+RLRHPNV+ F+GAVT P L IVTEFLPRGSL+R+L R + +D RRRI MALD+A
Sbjct: 716 RIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVA 775
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 673
G++ LH P I+HRDLK+ NLLVD +W VKVGDFGLSRLKH T+L++K+ GTP+WMA
Sbjct: 776 MGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMA 835
Query: 674 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733
PEVLRNEPS+EK DVYSFGVILWELAT ++PW +N MQV+GAVGF N+RLEIPK++DP
Sbjct: 836 PEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPV 895
Query: 734 WAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764
I+ CW +DP RPSF +L + L+ L R
Sbjct: 896 VGRIILECWQTDPNLRPSFAQLTEVLKPLNR 926
|
|
| TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 869 (311.0 bits), Expect = 6.0e-87, P = 6.0e-87
Identities = 167/275 (60%), Positives = 216/275 (78%)
Query: 490 KVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSF 549
++ LD D D +I W DL I E+IG GS GTV+ A W+GSDVAVK+ Q++ E ++ F
Sbjct: 536 ELGLDGD--DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEF 593
Query: 550 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK--LDWRRRIL 607
+EV++MKRLRHPN++LFMGAVT P L IVTE+L RGSL+RLL ++ + LD RRR+
Sbjct: 594 LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS 653
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667
MA D+A+G++YLH+ NPPI+HRDLKS NLLVDK +TVKV DFGLSRLK T+L++K+ G
Sbjct: 654 MAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAG 713
Query: 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP 727
TP+WMAPEVLR+EPS+EKSDVYSFGVILWELAT + PW NLN QV+ AVGF +RLEIP
Sbjct: 714 TPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP 773
Query: 728 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
++++P+ AAI+E CW ++P RPSF ++D LR L
Sbjct: 774 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 808
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00101399 | hypothetical protein (781 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 782 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-82 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-81 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-80 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-75 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-73 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-71 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-70 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-59 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-50 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-49 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-48 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-47 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-47 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-47 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-47 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-46 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-46 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-45 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-45 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-45 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-45 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-43 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-43 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-43 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-43 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-42 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-41 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-41 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-40 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-40 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-40 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-40 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-39 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-38 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-38 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-38 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-38 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-37 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-37 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-37 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-37 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-37 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-37 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-37 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-37 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-36 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-36 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-36 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-35 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-35 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-35 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-34 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-34 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-34 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-34 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-34 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-34 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-34 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-33 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-33 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-33 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-33 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-33 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-33 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-33 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-33 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-32 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-32 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-32 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-32 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-32 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-31 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-31 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-31 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-31 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-31 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-31 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-31 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-31 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-31 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-30 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-30 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-30 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-30 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-30 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-29 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-29 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-29 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-29 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-29 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-29 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-29 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-29 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-29 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-29 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-29 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-29 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-28 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-28 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-28 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-28 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-28 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-28 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-28 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-28 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-27 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-27 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-27 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-27 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-27 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-27 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-26 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-26 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-26 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-26 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-26 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-26 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-26 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-26 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-26 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-26 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-25 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-25 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-25 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-25 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-25 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-25 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-25 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-25 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-24 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-24 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-24 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-23 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-23 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-23 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-23 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-23 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-23 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-23 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-23 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-23 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-23 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-22 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-22 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-22 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-22 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-22 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-21 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-21 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-21 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-21 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-21 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-21 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-21 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-20 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-20 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-20 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-19 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-19 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-19 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-19 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-19 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-18 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-17 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-17 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-17 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-16 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-16 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-16 | |
| pfam13426 | 101 | pfam13426, PAS_9, PAS domain | 2e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-16 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-15 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-15 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-15 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-15 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-14 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-14 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-14 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-14 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-13 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-13 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-12 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| pfam00989 | 113 | pfam00989, PAS, PAS fold | 3e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-10 | |
| cd00130 | 103 | cd00130, PAS, PAS domain; PAS motifs appear in arc | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-10 | |
| COG2202 | 232 | COG2202, AtoS, FOG: PAS/PAC domain [Signal transdu | 9e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-09 | |
| TIGR00229 | 124 | TIGR00229, sensory_box, PAS domain S-box | 3e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-08 | |
| smart00091 | 67 | smart00091, PAS, PAS domain | 2e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| pfam08448 | 110 | pfam08448, PAS_4, PAS fold | 2e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 3e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-06 | |
| COG3829 | 560 | COG3829, RocR, Transcriptional regulator containin | 6e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-05 | |
| pfam13188 | 64 | pfam13188, PAS_8, PAS domain | 5e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 8e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 1e-04 | |
| PRK11360 | 607 | PRK11360, PRK11360, sensory histidine kinase AtoS; | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| pfam08447 | 90 | pfam08447, PAS_3, PAS fold | 0.002 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.003 | |
| PRK11359 | 799 | PRK11359, PRK11359, cyclic-di-GMP phosphodiesteras | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 261 bits (670), Expect = 8e-82
Identities = 98/262 (37%), Positives = 150/262 (57%), Gaps = 13/262 (4%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGS------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
L +G+++G+G+ G VY G VAVK ++ S+E F +E S+MK+L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLEEASIMKKLS 59
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
HPN++ +G T + L IVTE++P G L L+++ KL + + MAL IA+G+ YL
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLTTKTGKGTPQ-WMAPEVLR 678
N +HRDL + N LV ++ VK+ DFGLSR +E Y + G P WMAPE L+
Sbjct: 120 SKN--FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 679 NEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737
+ KSDV+SFGV+LWE+ T + P+ +++ +V+ + RL P++ +
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENCPDELYEL 236
Query: 738 VESCWHSDPQCRPSFQELVDKL 759
+ CW DP+ RP+F ELV+ L
Sbjct: 237 MLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 259 bits (664), Expect = 6e-81
Identities = 100/263 (38%), Positives = 151/263 (57%), Gaps = 16/263 (6%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGS------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
LT+G+++G+G+ G VY G +VAVK +++ S++ I F +E +M++L
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
HPNV+ +G T + L IV E++ G L L++N KL + AL IARG+ YL
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRN 679
N IHRDL + N LV ++ VK+ DFGLSR L + Y + GK +WMAPE L+
Sbjct: 120 SKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 680 EPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAA 736
KSDV+SFGV+LWE+ T + P+ +++ +V+ + G+ RL P + P
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGY---RLPQPPNCPPELYD 234
Query: 737 IVESCWHSDPQCRPSFQELVDKL 759
++ CW DP+ RP+F ELV+ L
Sbjct: 235 LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 258 bits (662), Expect = 1e-80
Identities = 99/262 (37%), Positives = 150/262 (57%), Gaps = 13/262 (4%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGS------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
LT+G+++G+G+ G VY G +VAVK +++ S++ I F +E +M++L
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYL 619
HPN++ +G T + L IV E++P G L L++N +L + AL IARG+ YL
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLR 678
N IHRDL + N LV ++ VK+ DFGLSR L + Y K GK +WMAPE L+
Sbjct: 120 ESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 679 NEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737
KSDV+SFGV+LWE+ T + P+ +++ +V+ + RL P + P +
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK-KGYRLPKPPNCPPELYKL 236
Query: 738 VESCWHSDPQCRPSFQELVDKL 759
+ CW DP+ RP+F ELV+ L
Sbjct: 237 MLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 244 bits (626), Expect = 2e-75
Identities = 93/268 (34%), Positives = 147/268 (54%), Gaps = 24/268 (8%)
Query: 511 EQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+++G+G+ G VY G +VAVK +++ S+E F +E +MK+L HPNV+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT-LKEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT--------TKLDWRRRILMALDIARGVS 617
+G T + L +V E++ G L L+++ + L + + A+ IA+G+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP-QWMAPE 675
YL +HRDL + N LV + VK+ DFGLSR + + Y KTG P +WMAPE
Sbjct: 120 YLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 676 VLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDP 732
L++ KSDV+SFGV+LWE+ T P+ L++ +V+ + G+ RL P+
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY---RLPKPEYCPD 234
Query: 733 RWAAIVESCWHSDPQCRPSFQELVDKLR 760
++ SCW DP+ RP+F ELV++L
Sbjct: 235 ELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 237 bits (608), Expect = 7e-73
Identities = 92/269 (34%), Positives = 139/269 (51%), Gaps = 17/269 (6%)
Query: 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+ ++G GS GTVY A G VAVK+ ++ + + R+E+ +++RL HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ + A L +V E+ G LF L R L +AL I RG+ YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLHSNG- 118
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR-NEPSD 683
IIHRDLK N+L+D++ VK+ DFGL++ ++ + T GTP +MAPEVL
Sbjct: 119 -IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 684 EKSDVYSFGVILWELATEKIPW---DNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI--V 738
K DV+S GVIL+EL T K P+ + L+ +Q+I + + PK A +
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYF 767
+ C + DP RP+ +E+ LQ +F
Sbjct: 238 KKCLNKDPSKRPTAEEI------LQHPWF 260
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 232 bits (595), Expect = 4e-71
Identities = 82/269 (30%), Positives = 128/269 (47%), Gaps = 25/269 (9%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
I E++G+GS G VY A + VA+KV +++ + +E+ ++K+L+HPN++
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRER-ILREIKILKKLKHPNIV 60
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNP 624
+L +V E+ G LF LL++ D R I + YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFY--LRQILSALEYLHSKG- 117
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDE 684
I+HRDLK N+L+D+ VK+ DFGL+R T T GTP++MAPEVL + +
Sbjct: 118 -IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT-TFVGTPEYMAPEVLLGKGYGK 175
Query: 685 KSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW------AAIV 738
D++S GVIL+EL T K P+ + + + F P P W ++
Sbjct: 176 AVDIWSLGVILYELLTGKPPFPGDDQLLEL----FKKIGKPKPPFPPPEWDISPEAKDLI 231
Query: 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYF 767
DP+ R + +E LQ +F
Sbjct: 232 RKLLVKDPEKRLTAEEA------LQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 229 bits (586), Expect = 2e-70
Identities = 84/251 (33%), Positives = 122/251 (48%), Gaps = 40/251 (15%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570
+G+G GTVY A + VA+K+ +E S ++ +E+ ++K+L HPN++ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIK-KEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 571 VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRD 630
L +V E+ GSL LL+ N KL + + L I G+ YLH IIHRD
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRD 117
Query: 631 LKSSNLLVDK-HWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDV 688
LK N+L+D + VK+ DFGLS+L KT GTP +MAPEVL + EKSD+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 689 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQC 748
+S GVIL+EL P ++ DP+
Sbjct: 178 WSLGVILYEL---------------------------------PELKDLIRKMLQKDPEK 204
Query: 749 RPSFQELVDKL 759
RPS +E+++ L
Sbjct: 205 RPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 3e-59
Identities = 86/257 (33%), Positives = 135/257 (52%), Gaps = 10/257 (3%)
Query: 506 DLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
+ T GE +G+GS G+VY A G +AVK S+E + + +E+ ++ L+HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 564 VLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
++ + G+ ++ L I E++ GSL LL++ KL I G++YLH
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHS 119
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT--TKTGKGTPQWMAPEVLRN 679
I+HRD+K +N+LVD VK+ DFG ++ + T + +GTP WMAPEV+R
Sbjct: 120 NG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 680 EPSDEKSDVYSFGVILWELATEKIPWDNL-NSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738
E +D++S G + E+AT K PW L N M + +G + EIP+ + +
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237
Query: 739 ESCWHSDPQCRPSFQEL 755
C DP+ RP+ EL
Sbjct: 238 RKCLRRDPKKRPTADEL 254
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 5e-50
Identities = 95/284 (33%), Positives = 152/284 (53%), Gaps = 29/284 (10%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQE 552
+E+ E +T+ ++GQGS G VY + G + VA+K + E I F E
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNE 59
Query: 553 VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ------RNTTKLD---WR 603
S+MK +V+ +G V++ Q +V E + +G L L+ N L +
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
+ I MA +IA G++YL +HRDL + N +V + TVK+GDFG++R +ET K
Sbjct: 120 KFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 664 TGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQV---IGAV 717
GKG P +WMAPE L++ KSDV+SFGV+LWE+AT + P+ L++ +V +
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG 237
Query: 718 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRD 761
G ++ P++ + ++ CW +P+ RP+F E+V L+D
Sbjct: 238 GHLDL----PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 1e-49
Identities = 88/257 (34%), Positives = 136/257 (52%), Gaps = 9/257 (3%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+LT +++G G G V+ W G DVA+K+ S++ F +E +M +L HPN+
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNL 61
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ G T + + IVTE++ G L L+ KL + M D+ + YL
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG- 120
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVLRNEPSD 683
IHRDL + N LV + VKV DFGL+R + T+ G P +W PEV
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 684 EKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742
KSDV+SFGV++WE+ +E K+P++ ++ +V+ +V RL PK I+ SCW
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIMYSCW 238
Query: 743 HSDPQCRPSFQELVDKL 759
H P+ RP+F++L+ +L
Sbjct: 239 HEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 4e-48
Identities = 88/257 (34%), Positives = 137/257 (53%), Gaps = 11/257 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
++L +G IG+G G V + G VAVK +F E S+M LRHPN+
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNL 62
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARGVSYLHHCN 623
+ +G V L IVTE++ +GSL L+ R + +++ ALD+ G+ YL N
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSD 683
+HRDL + N+LV + KV DFGL++ E +GK +W APE LR +
Sbjct: 123 --FVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKLPVKWTAPEALREKKFS 177
Query: 684 EKSDVYSFGVILWEL-ATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742
KSDV+SFG++LWE+ + ++P+ + V+ V R+E P+ P +++ CW
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYKVMKDCW 236
Query: 743 HSDPQCRPSFQELVDKL 759
DP RP+F++L ++L
Sbjct: 237 ELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 1e-47
Identities = 96/273 (35%), Positives = 141/273 (51%), Gaps = 12/273 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEVS 554
YEI ED+T+G IG+G G VY V+ + VAVK + S V F QE
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVREKFLQEAY 59
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR 614
+M++ HP+++ +G V + + IV E P G L LQ N LD IL + ++
Sbjct: 60 IMRQFDHPHIVKLIG-VITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMA 673
++YL +HRD+ + N+LV VK+GDFGLSR L+ E+Y GK +WMA
Sbjct: 119 ALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMA 176
Query: 674 PEVLRNEPSDEKSDVYSFGVILWE-LATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 732
PE + SDV+ FGV +WE L P+ + + VIG + +RL +P + P
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP 235
Query: 733 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765
+++ CW DP RP F EL +L D+ ++
Sbjct: 236 TLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 1e-47
Identities = 90/267 (33%), Positives = 130/267 (48%), Gaps = 30/267 (11%)
Query: 511 EQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+++G GS G V W S VAVK + SD ++ F +E ++M L H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD-IMDDFLKEAAIMHSLDHENLI 59
Query: 566 LFMGAV-TSPQRLCIVTEFLPRGSLFRLLQRN-------TTKLDWRRRILMALDIARGVS 617
G V T P L +VTE P GSL L+++ +T D+ A+ IA G+
Sbjct: 60 RLYGVVLTHP--LMMVTELAPLGSLLDRLRKDALGHFLISTLCDY------AVQIANGMR 111
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR---LKHETYLTTKTGKGTPQWMAP 674
YL IHRDL + N+L+ VK+GDFGL R + Y+ + K W AP
Sbjct: 112 YLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169
Query: 675 EVLRNEPSDEKSDVYSFGVILWELAT--EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 732
E LR SDV+ FGV LWE+ T E+ PW L+ Q++ + +RLE P+
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEE-PWAGLSGSQILKKIDKEGERLERPEACPQ 228
Query: 733 RWAAIVESCWHSDPQCRPSFQELVDKL 759
++ CW +P RP+F L + L
Sbjct: 229 DIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 2e-47
Identities = 84/267 (31%), Positives = 130/267 (48%), Gaps = 36/267 (13%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWY---GSDVAVKV--FSRQEYSDEVIHSFRQEVSLMKRLR 560
I E+IG+G G VY + G +VA+KV +E +++I E+ ++K+ +
Sbjct: 1 LFEILEKIGKGGFGEVY-KARHKRTGKEVAIKVIKLESKEKKEKII----NEIQILKKCK 55
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR------RRILMALDIAR 614
HPN++ + G+ L IV EF GSL LL+ L + +L L+
Sbjct: 56 HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLE--- 112
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMA 673
YLH IIHRD+K++N+L+ VK+ DFGLS +L T GTP WMA
Sbjct: 113 ---YLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK--ARNTMVGTPYWMA 165
Query: 674 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733
PEV+ +P D K+D++S G+ ELA K P+ L M+ + F P +P
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL----FKIATNGPPGLRNPE 221
Query: 734 WA-----AIVESCWHSDPQCRPSFQEL 755
++ C +P+ RP+ ++L
Sbjct: 222 KWSDEFKDFLKKCLQKNPEKRPTAEQL 248
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 2e-47
Identities = 84/278 (30%), Positives = 136/278 (48%), Gaps = 28/278 (10%)
Query: 507 LTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
L +Q+G+G G V + G VAVK ++ F +E+ +++ L
Sbjct: 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLD 64
Query: 561 HPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
H N++ + G P L ++ E+LP GSL LQR+ +++ +R +L + I +G+ Y
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDY 124
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWMAPE 675
L + IHRDL + N+LV+ VK+ DFGL+++ + Y + G+ W APE
Sbjct: 125 LG--SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 676 VLRNEPSDEKSDVYSFGVILWELAT--EKIPWDNLNSMQVIG-AVGFM-----------N 721
LR SDV+SFGV L+EL T + +++IG A G M
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242
Query: 722 QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 759
+RL P +++ CW ++PQ RPSF +L+ +
Sbjct: 243 ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 3e-46
Identities = 90/268 (33%), Positives = 140/268 (52%), Gaps = 14/268 (5%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E L + ++G G G V+ W G+ VAVK S E +F QE +MK+
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE---AFLQEAQIMKK 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVS 617
LRH ++ + + + IVTE++ +GSL L+ KL + + MA IA G++
Sbjct: 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMA 117
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 676
YL N IHRDL + N+LV ++ K+ DFGL+RL + T + G P +W APE
Sbjct: 118 YLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEA 175
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPR 733
KSDV+SFG++L E+ T ++P+ + + +V+ V G+ R+ P +
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY---RMPRPPNCPEE 232
Query: 734 WAAIVESCWHSDPQCRPSFQELVDKLRD 761
++ CW DP+ RP+F+ L L D
Sbjct: 233 LYDLMLQCWDKDPEERPTFEYLQSFLED 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 5e-46
Identities = 82/274 (29%), Positives = 136/274 (49%), Gaps = 35/274 (12%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
YEI+ +QIG+GS G VY G +K S++ EV ++
Sbjct: 1 KYEII-------KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKIL 53
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---------LDWRRRIL 607
K+L HPN++ + + +LCIV E+ G L + +++ + LDW ++
Sbjct: 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667
+AL YLH I+HRD+K N+ + + VK+GDFG+S++ T KT G
Sbjct: 114 LALK------YLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVG 165
Query: 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD--NLNS--MQVIGAVGFMNQR 723
TP +++PE+ +N+P + KSD++S G +L+EL T K P++ NL ++++ Q
Sbjct: 166 TPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG-----QY 220
Query: 724 LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVD 757
IP +V S DP+ RPS +++
Sbjct: 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 1e-45
Identities = 92/263 (34%), Positives = 139/263 (52%), Gaps = 15/263 (5%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
+E+ D+T+ ++G G G VY VW Y VAVK + F +E ++MK
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMK 57
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGV 616
++HPN++ +G T I+TEF+ G+L L+ N +++ + MA I+ +
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPE 675
YL N IHRDL + N LV ++ VKV DFGLSRL T G P +W APE
Sbjct: 118 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEKI-PWDNLNSMQVIGAV--GFMNQRLEIPKDVDP 732
L KSDV++FGV+LWE+AT + P+ ++ QV + G+ R+E P+ P
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY---RMERPEGCPP 232
Query: 733 RWAAIVESCWHSDPQCRPSFQEL 755
+ ++ +CW +P RPSF E+
Sbjct: 233 KVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 2e-45
Identities = 87/267 (32%), Positives = 130/267 (48%), Gaps = 10/267 (3%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI + + ++G G G V+ +W + VAVK + F E +MK+
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---DFLAEAQIMKK 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVS 617
LRHP ++ T + + IVTE + GSL LQ L + I MA +A G++
Sbjct: 58 LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 676
YL N IHRDL + N+LV ++ KV DFGL+R+ E + G P +W APE
Sbjct: 118 YLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEA 175
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735
KSDV+SFG++L E+ T ++P+ + + +V+ V R+ P
Sbjct: 176 ALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKELY 234
Query: 736 AIVESCWHSDPQCRPSFQELVDKLRDL 762
I+ CW DP RP+F+ L KL D
Sbjct: 235 DIMLDCWKEDPDDRPTFETLQWKLEDF 261
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 5e-45
Identities = 81/257 (31%), Positives = 131/257 (50%), Gaps = 20/257 (7%)
Query: 510 GEQIGQGSCGTVYHAV--WYGSDVAVK---VFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
GE +G GS G+VY + G AVK + + E + QE++L+ +L+HPN+
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARGVSYL 619
+ ++G L I E +P GSL +LL++ + R+IL+ G+ YL
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL------GLEYL 118
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 679
H N +HRD+K +N+LVD + VK+ DFG+++ + + K+ KG+P WMAPEV+
Sbjct: 119 HDRN--TVHRDIKGANILVDTNGVVKLADFGMAK-QVVEFSFAKSFKGSPYWMAPEVIAQ 175
Query: 680 E-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738
+ +D++S G + E+AT K PW L + + +G + IP + +
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI 235
Query: 739 ESCWHSDPQCRPSFQEL 755
C DP RP+ EL
Sbjct: 236 LKCLQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 5e-45
Identities = 74/252 (29%), Positives = 136/252 (53%), Gaps = 6/252 (2%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
+ +G+ IG+G+ G VY + G VA+K S ++ +E + S QE+ L+K L+HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
++ ++G++ + L I+ E+ GSL +++++ + + +G++YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH--E 117
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSD 683
+IHRD+K++N+L K VK+ DFG++ ++ + GTP WMAPEV+ +
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 684 EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWH 743
SD++S G + EL T P+ +LN M + + + +P+ + P + C+
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQ 236
Query: 744 SDPQCRPSFQEL 755
DP RP+ ++L
Sbjct: 237 KDPNLRPTAKQL 248
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 92/266 (34%), Positives = 137/266 (51%), Gaps = 20/266 (7%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
+TI + IG G G V DVA+K + SD+ F E S+M +
Sbjct: 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFD 63
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
HPN++ G VT + + I+TE++ GSL + L+ N K + + M IA G+ YL
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE---TYLTTKTGKGTPQWMAPEVL 677
N +HRDL + N+LV+ + KV DFGLSR + TY TTK GK +W APE +
Sbjct: 124 EMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY-TTKGGKIPIRWTAPEAI 180
Query: 678 RNEPSDEKSDVYSFGVILWELAT--EKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPR 733
SDV+SFG+++WE+ + E+ P+ ++++ VI AV G+ RL P D
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGER-PYWDMSNQDVIKAVEDGY---RLPPPMDCPSA 236
Query: 734 WAAIVESCWHSDPQCRPSFQELVDKL 759
++ CW D RP+F ++V L
Sbjct: 237 LYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 4e-43
Identities = 86/255 (33%), Positives = 135/255 (52%), Gaps = 9/255 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
+DLT +++G G G V + W G DVA+K+ S++ F +E +M +L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEK 60
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
++ G T + + IVTE++ G L L+ + + + + M D+ G++YL +
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE--S 118
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVLRNEPS 682
IHRDL + N LVD VKV DFGLSR + T+ G P +W PEVL
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKF 178
Query: 683 DEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741
KSDV++FGV++WE+ + K+P++ N+ + + V RL P + AI+ SC
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMYSC 237
Query: 742 WHSDPQCRPSFQELV 756
WH + RP+FQ+L+
Sbjct: 238 WHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 4e-43
Identities = 82/273 (30%), Positives = 138/273 (50%), Gaps = 22/273 (8%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGS------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
L + +G G+ GTVY VW VA+KV R+E S + E +M +
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-REETSPKANKEILDEAYVMASVD 67
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL- 619
HP+V+ +G S Q + ++T+ +P G L ++ + + + + + IA+G+SYL
Sbjct: 68 HPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126
Query: 620 -HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEV 676
++HRDL + N+LV VK+ DFGL++L E + GK +WMA E
Sbjct: 127 EKR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 677 LRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735
+ + KSDV+S+GV +WEL T P++ + ++++ + +RL P
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICTIDVY 241
Query: 736 AIVESCWHSDPQCRPSFQELVDKL----RDLQR 764
++ CW D + RP+F+EL+++ RD QR
Sbjct: 242 MVLVKCWMIDAESRPTFKELINEFSKMARDPQR 274
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 5e-43
Identities = 76/254 (29%), Positives = 129/254 (50%), Gaps = 9/254 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
E I E++G+GS G+VY A+ G VA+KV +E + +E+S++K+ P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDSP 58
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
++ + G+ L IV E+ GS+ +++ L + +G+ YLH
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 682
IHRD+K+ N+L+++ K+ DFG+S +T T GTP WMAPEV++
Sbjct: 119 K--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 683 DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QRLEIPKDVDPRWAAIVESC 741
+ K+D++S G+ E+A K P+ +++ M+ I + L P+ P + V+ C
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236
Query: 742 WHSDPQCRPSFQEL 755
DP+ RPS +L
Sbjct: 237 LVKDPEERPSAIQL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 81/258 (31%), Positives = 133/258 (51%), Gaps = 8/258 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
E+ T+ ++G G G V+ +W VA+K+ F++EV +KRLRH +
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKH 63
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVSYLHHC 622
++ + + + I+TE + +GSL L+ + L I MA +A G++YL
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 682
N IHRDL + N+LV + KV DFGL+RL E + K +W APE +
Sbjct: 124 N--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTF 181
Query: 683 DEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741
KSDV+SFG++L+E+ T ++P+ +N+ +V + R+ P I+ C
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKIMLEC 240
Query: 742 WHSDPQCRPSFQELVDKL 759
W ++P+ RPSF+ L ++L
Sbjct: 241 WAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 1e-41
Identities = 89/259 (34%), Positives = 135/259 (52%), Gaps = 13/259 (5%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+LT +++G G G V+ W VA+K + S+E F +E +M +L HP +
Sbjct: 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKL 61
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ G T + L IVTEF+ G L L++ KL + M D+ G+ YL +
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS- 120
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVLRNEPSD 683
IHRDL + N LV VKV DFG++R + T+ +G P +W PEV
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 684 EKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVES 740
KSDV+SFGV++WE+ TE K+P++ ++ +V+ + GF RL PK ++ S
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF---RLYRPKLASMTVYEVMYS 236
Query: 741 CWHSDPQCRPSFQELVDKL 759
CWH P+ RP+F EL+ +
Sbjct: 237 CWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 1e-41
Identities = 84/253 (33%), Positives = 134/253 (52%), Gaps = 8/253 (3%)
Query: 511 EQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
E+IG+G+ G VY V ++VAVK R ++ F QE ++K+ HPN++ +G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKT-CRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHR 629
Q + IV E +P GSL L++ +L ++ + M+LD A G+ YL N IHR
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHR 117
Query: 630 DLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG-KGTP-QWMAPEVLRNEPSDEKSD 687
DL + N LV ++ +K+ DFG+SR + T G K P +W APE L +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 688 VYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 746
V+S+G++LWE + P+ +++ Q + R+ P+ ++ CW DP
Sbjct: 178 VWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWAYDP 236
Query: 747 QCRPSFQELVDKL 759
+ RPSF E+ ++L
Sbjct: 237 ENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 9e-41
Identities = 77/257 (29%), Positives = 137/257 (53%), Gaps = 26/257 (10%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E+IG+G+ G VY A G +VA+K ++ + E+I E+ +MK +HPN++ +
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNIVDYY 81
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ L +V E++ GSL ++ +N +++ + + ++ +G+ YLH + +IH
Sbjct: 82 DSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH--SQNVIH 139
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK-----GTPQWMAPEVLRNEPSD 683
RD+KS N+L+ K +VK+ DFG + LT + K GTP WMAPEV++ +
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFA-----AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG 194
Query: 684 EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP-RWAAI----V 738
K D++S G++ E+A + P+ ++ + F+ IP +P +W+ +
Sbjct: 195 PKVDIWSLGIMCIEMAEGEPPYLREPPLRAL----FLITTKGIPPLKNPEKWSPEFKDFL 250
Query: 739 ESCWHSDPQCRPSFQEL 755
C DP+ RPS +EL
Sbjct: 251 NKCLVKDPEKRPSAEEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 88/260 (33%), Positives = 137/260 (52%), Gaps = 13/260 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD-VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
+LT+ ++IG G G V+ W VA+K S+E F +E +M +L HP
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPK 60
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
++ G T +C+V EF+ G L L+ K + M LD+ G++YL N
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVLRNEPS 682
+IHRDL + N LV ++ VKV DFG++R + T+ TG P +W +PEV
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY 178
Query: 683 DEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVE 739
KSDV+SFGV++WE+ +E K P++N ++ +V+ + GF RL P+ +++
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF---RLYKPRLASQSVYELMQ 235
Query: 740 SCWHSDPQCRPSFQELVDKL 759
CW P+ RPSF L+ +L
Sbjct: 236 HCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 87/263 (33%), Positives = 141/263 (53%), Gaps = 17/263 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
++L + + IG+G G V + G+ VAVK +D +F E S+M +LRH N+
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNL 61
Query: 565 LLFMGAVTSPQ-RLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARGVSYLHHC 622
+ +G + + L IVTE++ +GSL L+ R + L + +LD+ + YL
Sbjct: 62 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 682
N +HRDL + N+LV + KV DFGL++ E T TGK +W APE LR +
Sbjct: 122 N--FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEALREKKF 176
Query: 683 DEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVE 739
KSDV+SFG++LWE+ + ++P+ + V+ V G+ +++ P P +++
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPPVVYDVMK 233
Query: 740 SCWHSDPQCRPSFQELVDKLRDL 762
CWH D RPSF +L ++L +
Sbjct: 234 QCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 3e-40
Identities = 86/264 (32%), Positives = 133/264 (50%), Gaps = 29/264 (10%)
Query: 510 GEQIGQGSCGTVY--HAVWYGSDVAVKVF----SRQEYSDEVIHSFRQEVSLMKRLRHPN 563
G+ +GQG+ G VY + V G ++AVK E EV ++ E+ L+K L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEV-NALECEIQLLKNLQHER 65
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGS------LFRLLQRNTTKLDWRRRILMALDIARGVS 617
++ + G + + L I E++P GS + L T+ + R+IL GV
Sbjct: 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQIL------EGVE 118
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLK----HETYLTTKTGKGTPQWM 672
YLH + I+HRD+K +N+L D VK+GDFG S RL+ T + + TG TP WM
Sbjct: 119 YLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG--TPYWM 174
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 732
+PEV+ E K+DV+S G + E+ TEK PW +M I + ++P V P
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSP 234
Query: 733 RWAAIVESCWHSDPQCRPSFQELV 756
+ + + + RPS +EL+
Sbjct: 235 DARNFLRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 4e-40
Identities = 95/268 (35%), Positives = 147/268 (54%), Gaps = 15/268 (5%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E L + +++G G G V+ W G + VAVK S E SF +E +MK+
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKK 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVS 617
LRH + L+ + AV S + + IVTE++ +GSL L+ + L + MA +A G++
Sbjct: 58 LRH-DKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 676
Y+ N IHRDL+S+N+LV K+ DFGL+RL + T + G P +W APE
Sbjct: 117 YIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPR 733
KSDV+SFG++L EL T+ ++P+ +N+ +V+ V G+ R+ P+D
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY---RMPCPQDCPIS 231
Query: 734 WAAIVESCWHSDPQCRPSFQELVDKLRD 761
++ CW DP+ RP+F+ L L D
Sbjct: 232 LHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 2e-39
Identities = 84/259 (32%), Positives = 140/259 (54%), Gaps = 17/259 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+ LT+GE IG+G G V + G VAVK D +F +E ++M +L H N+
Sbjct: 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIK----CDVTAQAFLEETAVMTKLHHKNL 61
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARGVSYLHHCN 623
+ +G + L IV E + +G+L L+ R + + + +LD+A G+ YL +
Sbjct: 62 VRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE--S 118
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSD 683
++HRDL + N+LV + KV DFGL+R+ +K +W APE L+++
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL---PVKWTAPEALKHKKFS 175
Query: 684 EKSDVYSFGVILWEL-ATEKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVES 740
KSDV+S+GV+LWE+ + + P+ ++ +V V G+ R+E P+ ++ S
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY---RMEPPEGCPADVYVLMTS 232
Query: 741 CWHSDPQCRPSFQELVDKL 759
CW ++P+ RPSF +L +KL
Sbjct: 233 CWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 93/283 (32%), Positives = 146/283 (51%), Gaps = 38/283 (13%)
Query: 511 EQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+Q+G+G+ G+V + G VAVK Q + E + F +E+ ++K L+H N+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKL--QHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 565 LLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
+ + G S R L +V E+LP GSL LQ++ +LD R+ +L A I +G+ YL
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG-- 125
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWMAPEVLRN 679
+ +HRDL + N+LV+ VK+GDFGL+++ E Y + G+ W APE L
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE 185
Query: 680 EPSDEKSDVYSFGVILWELATEKIPWDNLNS------MQVIG--AVGFM----------- 720
SDV+SFGV+L+EL T + + + M+++G G M
Sbjct: 186 SKFSVASDVWSFGVVLYELFT----YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241
Query: 721 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 763
N RL P AI++ CW++DP RPSF EL ++ ++
Sbjct: 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 5e-38
Identities = 94/291 (32%), Positives = 149/291 (51%), Gaps = 29/291 (9%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQE 552
+E+ E +T+ ++GQGS G VY + VAVK + E I F E
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNE 59
Query: 553 VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL-------QRNTTKL--DWR 603
S+MK +V+ +G V+ Q +V E + G L L + N + +
Sbjct: 60 ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 119
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
I MA +IA G++YL+ +HRDL + N +V +TVK+GDFG++R +ET K
Sbjct: 120 EMIQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 177
Query: 664 TGKG--TPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAV--- 717
GKG +WMAPE L++ SD++SFGV+LWE+ + + P+ L++ QV+ V
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 237
Query: 718 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
G+++Q P + R ++ CW +P+ RP+F E+V+ L+D F
Sbjct: 238 GYLDQ----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 5e-38
Identities = 93/268 (34%), Positives = 147/268 (54%), Gaps = 15/268 (5%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E L + ++GQG G V+ W G+ VA+K S E +F QE +MK+
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKK 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVS 617
LRH L+ + AV S + + IVTE++ +GSL L+ K L + + MA IA G++
Sbjct: 58 LRHEK-LVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 676
Y+ N +HRDL+++N+LV ++ KV DFGL+RL + T + G P +W APE
Sbjct: 117 YVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPR 733
KSDV+SFG++L EL T+ ++P+ + + +V+ V G+ R+ P +
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---RMPCPPECPES 231
Query: 734 WAAIVESCWHSDPQCRPSFQELVDKLRD 761
++ CW +P+ RP+F+ L L D
Sbjct: 232 LHDLMCQCWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 7e-38
Identities = 76/265 (28%), Positives = 112/265 (42%), Gaps = 26/265 (9%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVI-HSFRQEVSLMKRLRH 561
DL + +GQGS G VY G A+K DE +E+ ++
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSCES 58
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL--DIARGVSYL 619
P V+ GA + IV E++ GSL LL++ +L + I +G+ YL
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK---IPEPVLAYIARQILKGLDYL 115
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 679
H IIHRD+K SNLL++ VK+ DFG+S++ T T GT +M+PE ++
Sbjct: 116 HTKRH-IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG 174
Query: 680 EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW----- 734
E +D++S G+ L E A K P+ F I P
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFPFLPPGQP------SFFELMQAICDGPPPSLPAEEF 228
Query: 735 ----AAIVESCWHSDPQCRPSFQEL 755
+ +C DP+ RPS EL
Sbjct: 229 SPEFRDFISACLQKDPKKRPSAAEL 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 1e-37
Identities = 92/263 (34%), Positives = 133/263 (50%), Gaps = 21/263 (7%)
Query: 511 EQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
IG+G G VYH SD AVK +R +EV F +E +MK HPNVL
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKDFSHPNVL 59
Query: 566 LFMGAVTSPQRL-CIVTEFLPRGSL---FRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
+G + +V ++ G L R N T D I L +A+G+ YL
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL---IGFGLQVAKGMEYL-- 114
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETY-LTTKTGKGTP-QWMAPEVL 677
+ +HRDL + N ++D+ +TVKV DFGL+R E Y + TG P +WMA E L
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 678 RNEPSDEKSDVYSFGVILWELATEKI-PWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 736
+ + KSDV+SFGV+LWEL T P+ +++S + + +RL P+
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-LQGRRLLQPEYCPDPLYE 233
Query: 737 IVESCWHSDPQCRPSFQELVDKL 759
++ SCWH P+ RP+F ELV ++
Sbjct: 234 VMLSCWHPKPEMRPTFSELVSRI 256
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 86/257 (33%), Positives = 135/257 (52%), Gaps = 15/257 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
E T+ E IG+GS G VY A+ ++ VA+KV +E DE I +QE+ + + R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSP 59
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
+ + G+ +L I+ E+ GS LL+ KLD + ++ G+ YLH
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEE 117
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 682
IHRD+K++N+L+ + VK+ DFG+S T T GTP WMAPEV++
Sbjct: 118 GK--IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175
Query: 683 DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA----IV 738
DEK+D++S G+ ELA + P +L+ M+V+ F+ + P +++ V
Sbjct: 176 DEKADIWSLGITAIELAKGEPPLSDLHPMRVL----FLIPKNNPPSLEGNKFSKPFKDFV 231
Query: 739 ESCWHSDPQCRPSFQEL 755
C + DP+ RPS +EL
Sbjct: 232 SLCLNKDPKERPSAKEL 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 81/260 (31%), Positives = 134/260 (51%), Gaps = 16/260 (6%)
Query: 510 GEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
G +IG G+ G VY AV G +AVK Q+ + I E+ +++ L+HPN++ +
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
G +++ I E+ G+L LL + LD + L + G++YLH I+
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEGLAYLHSHG--IV 121
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGK---GTPQWMAPEVLRNEPSD 683
HRD+K +N+ +D + +K+GDFG + +LK+ T + + GTP +MAPEV+
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181
Query: 684 EK---SDVYSFGVILWELATEKIPWDNL-NSMQVIGAVGFMNQRLEIPKDVDPRWAAI-- 737
+D++S G ++ E+AT K PW L N Q++ VG + IP +
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAG-HKPPIPDSLQLSPEGKDF 240
Query: 738 VESCWHSDPQCRPSFQELVD 757
++ C SDP+ RP+ EL+
Sbjct: 241 LDRCLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 86/281 (30%), Positives = 135/281 (48%), Gaps = 51/281 (18%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLM 556
DYE++ ++IG G+ G VY A + VA+KV + + +QE+S++
Sbjct: 4 DYELI-------QRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISML 54
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA--- 613
K RHPN++ + G+ +L IV E+ GSL + Q R L L IA
Sbjct: 55 KECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVT-------RGPLSELQIAYVC 107
Query: 614 ----RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP 669
+G++YLH IHRD+K +N+L+ + VK+ DFG+S T K+ GTP
Sbjct: 108 RETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTP 165
Query: 670 QWMAPEVL---RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEI 726
WMAPEV R D K D+++ G+ ELA + P +L+ M+ + F+ I
Sbjct: 166 YWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL----FL-----I 216
Query: 727 PKDVDP--------RWAAI----VESCWHSDPQCRPSFQEL 755
K P +W+ + ++ C DP+ RP+ +L
Sbjct: 217 SKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKL 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 5e-37
Identities = 89/281 (31%), Positives = 150/281 (53%), Gaps = 23/281 (8%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQE 552
+E+ E +T+ ++GQGS G VY + G + VA+K + E I F E
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNE 59
Query: 553 VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD---------WR 603
S+MK +V+ +G V+ Q ++ E + RG L L+ +++ +
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
+ I MA +IA G++YL+ +HRDL + N +V + +TVK+GDFG++R +ET K
Sbjct: 120 KMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177
Query: 664 TGKG--TPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFM 720
GKG +WM+PE L++ SDV+SFGV+LWE+AT + P+ +++ QV+ V
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV-ME 236
Query: 721 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRD 761
L+ P + ++ CW +P+ RPSF E++ +++
Sbjct: 237 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 6e-37
Identities = 92/266 (34%), Positives = 144/266 (54%), Gaps = 11/266 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E L + ++GQG G V+ W G+ VA+K E +F QE +MK+
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE---AFLQEAQIMKK 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVS 617
LRH + L+ + AV S + + IVTEF+ +GSL L+ K L + + MA IA G++
Sbjct: 58 LRH-DKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA 116
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 676
Y+ N IHRDL+++N+LV + K+ DFGL+RL + T + G P +W APE
Sbjct: 117 YIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735
KSDV+SFG++L EL T+ ++P+ + + +V+ V R+ P+
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLH 233
Query: 736 AIVESCWHSDPQCRPSFQELVDKLRD 761
+++ CW DP RP+F+ + L D
Sbjct: 234 ELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 7e-37
Identities = 84/264 (31%), Positives = 130/264 (49%), Gaps = 23/264 (8%)
Query: 511 EQIGQGSCGTVYHAVWY---GS--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+++G G+ G+V V+ G +VAVK QE+ F +E S+M +L HP ++
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLK-QEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQ--RNTTKLDWRRRILMALDIARGVSYLHHCN 623
+G L +V E P G L + L+ R D +A +A G++YL +
Sbjct: 60 RLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESKH 115
Query: 624 PPIIHRDLKSSN-LLVDKHWTVKVGDFGLSR---LKHETYLTTKTGKGTPQWMAPEVLRN 679
+HRDL + N LLV++H K+ DFG+SR + Y T G+ +W APE +
Sbjct: 116 --FVHRDLAARNVLLVNRHQ-AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 680 EPSDEKSDVYSFGVILWELAT--EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737
KSDV+S+GV LWE + K P+ + +VI + +RL P++ +I
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAK-PYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSI 230
Query: 738 VESCWHSDPQCRPSFQELVDKLRD 761
+ SCW P+ RP+F EL R
Sbjct: 231 MLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 8e-37
Identities = 87/266 (32%), Positives = 144/266 (54%), Gaps = 11/266 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+E+ E L + +++G G G V+ + G + VA+K + S E +F E +LMK+
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---AFLAEANLMKQ 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVS 617
L+HP L+ + AV + + + I+TE++ GSL L+ KL + I MA IA G++
Sbjct: 58 LQHPR-LVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 676
++ N IHRDL+++N+LV + K+ DFGL+RL + T + G P +W APE
Sbjct: 117 FIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 174
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735
+ KSDV+SFG++L E+ T +IP+ + + +VI + R+ P +
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELY 233
Query: 736 AIVESCWHSDPQCRPSFQELVDKLRD 761
++ CW P+ RP+F+ L L D
Sbjct: 234 ELMRLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 86/289 (29%), Positives = 139/289 (48%), Gaps = 62/289 (21%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA---------VW----YGSDVAVKVFSRQEYSDEV 545
DYE+L E IG+GS GTV VW YG+ + +E V
Sbjct: 1 DYEVL-------ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN------MTEKEKQQLV 47
Query: 546 IHSFRQEVSLMKRLRHPNVLLFMG--AVTSPQRLCIVTEFLPRGSLFRLLQR---NTTKL 600
EV++++ L+HPN++ + S Q L IV E+ G L +L+Q+ +
Sbjct: 48 S-----EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYI 102
Query: 601 D----WRRRILMALDIARGVSYLHHC------NPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
+ WR IL L +A L+ C ++HRDLK +N+ +D + VK+GDFG
Sbjct: 103 EEEFIWR--ILTQLLLA-----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG 155
Query: 651 LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710
L+++ KT GTP +M+PE L + DEKSD++S G +++EL P+ N
Sbjct: 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ 215
Query: 711 MQVIGAVGFMNQRLEIPKDVDPRWA----AIVESCWHSDPQCRPSFQEL 755
+Q+ + + + + R++ +++S + DP RPS +EL
Sbjct: 216 LQLASKI----KEGKFR-RIPYRYSSELNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 92/292 (31%), Positives = 141/292 (48%), Gaps = 39/292 (13%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEV 553
EI + E++G+G+ G VY G + VA+K ++ +V FRQE
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL-KENAEPKVQQEFRQEA 59
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------T 598
LM L+HPN++ +G T Q C++ E+L G L L RN+ +
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 599 KLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-- 654
LD + +A+ IA G+ YL HH +HRDL + N LV + TVK+ DFGLSR
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHH----FVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKI-PWDNLNSMQV 713
+ Y +WM PE + +SD++SFGV+LWE+ + + P+ ++ +V
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235
Query: 714 IGAVGFM---NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
I M Q L P+D R A++ CW+ P RP F+++ +LR
Sbjct: 236 I----EMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 76/264 (28%), Positives = 130/264 (49%), Gaps = 21/264 (7%)
Query: 510 GEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDE--------VIHSFRQEVSLMKRL 559
GE IG+G+ G VY A V G +AVK ++ + R E+ +K L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
H N++ ++G T+ + L I E++P GS+ L R + + + + G++YL
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVL 677
H + I+HRDLK+ NLLVD K+ DFG+S+ + Y + +G+ WMAPEV+
Sbjct: 125 H--SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 678 RNEPS--DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735
+ K D++S G ++ E+ + PW + ++ + +G IP DV +
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLS 242
Query: 736 AI----VESCWHSDPQCRPSFQEL 755
+ + +C+ +P RP+ +EL
Sbjct: 243 PVALDFLNACFTINPDNRPTAREL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 86/280 (30%), Positives = 127/280 (45%), Gaps = 43/280 (15%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
DYE++ E IG G+ VY A+ VA+K ++ V R+EV M
Sbjct: 2 DYELI-------EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAM 53
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA--- 613
+ HPNV+ + + L +V +L GSL ++ K + R L IA
Sbjct: 54 SQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIM-----KSSYPRGGLDEAIIATVL 108
Query: 614 ----RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE----TYLTTKTG 665
+G+ YLH + IHRD+K+ N+L+ + +VK+ DFG+S + T KT
Sbjct: 109 KEVLKGLEYLH--SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF 166
Query: 666 KGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-- 722
GTP WMAPEV+ D K+D++SFG+ ELAT P+ M+V M
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-----LMLTLQ 221
Query: 723 ----RLEIPKDVDPRWAA---IVESCWHSDPQCRPSFQEL 755
LE D + ++ C DP RP+ +EL
Sbjct: 222 NDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEEL 261
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 83/269 (30%), Positives = 134/269 (49%), Gaps = 33/269 (12%)
Query: 510 GEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYS----DEVIHSFRQEVSLMKRLRHPN 563
G+Q+G G+ + Y A V G+ +AVK + + +EV+ + R+E+ LM RL HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARGVSY 618
++ +GA + E++ GS+ LL + +++ ++L RG+SY
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL------RGLSY 118
Query: 619 LHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLS-RLKHETYLTTKTGK------GTPQ 670
LH IIHRD+K +NLL+D +++ DFG + RL T G+ GT
Sbjct: 119 LH--ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL---AAKGTGAGEFQGQLLGTIA 173
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN---LNSMQVIGAVGFMNQRLEIP 727
+MAPEVLR E DV+S G ++ E+AT K PW+ N + +I + IP
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP 233
Query: 728 KDVDPRWAAIVESCWHSDPQCRPSFQELV 756
+ + P + C P+ RP +EL+
Sbjct: 234 EHLSPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 90/295 (30%), Positives = 142/295 (48%), Gaps = 48/295 (16%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVF----SRQEYSDEVIHS 548
+E+ + LT+G+ +G+G+ G V A G D VAVK+ + ++ SD V
Sbjct: 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLV--- 63
Query: 549 FRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN----------- 596
E+ +MK + +H N++ +G T L +V E+ G+L L+
Sbjct: 64 --SEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDD 121
Query: 597 ----TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
L + + A +ARG+ +L + IHRDL + N+LV + +K+ DFGL+
Sbjct: 122 PRPPEETLTQKDLVSFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLA 179
Query: 653 RLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT------EKIP 704
R H KT G P +WMAPE L + +SDV+SFGV+LWE+ T IP
Sbjct: 180 RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239
Query: 705 WDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 759
+ L + G R+E P++ ++ CWH P RP+F++LV+ L
Sbjct: 240 VEELFKLLKEG------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 76/260 (29%), Positives = 127/260 (48%), Gaps = 20/260 (7%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSD---VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
D + +++G+GS G+VY V SD A+K S + E+ ++ + HP
Sbjct: 1 DFKVLKKLGKGSYGSVYK-VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHP 59
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN-------TTKLDWRRRILMALDIARG 615
N++ + A +LCIV E+ P G L + + + + WR + + + RG
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLRG 115
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
+ LH I+HRDLKS+N+L+ + VK+GD G+S++ + T+ G TP +MAPE
Sbjct: 116 LQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIG--TPHYMAPE 171
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735
V + P KSD++S G +L+E+AT P+ SMQ + + IP
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPPIPPIYSQDLQ 230
Query: 736 AIVESCWHSDPQCRPSFQEL 755
+ S P+ RP+ ++
Sbjct: 231 NFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 72/265 (27%), Positives = 130/265 (49%), Gaps = 33/265 (12%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA-------VWYGSDVAVKVFSRQEYSDEVIHSFRQ 551
D+EIL +IG+GS G V+ V+ + + +R+E + +
Sbjct: 1 DFEIL-------NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-----D 48
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL-----QRNTTKLDWRRRI 606
E ++ +L ++ + + +L IV E+ G L +LL + WR I
Sbjct: 49 EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI 108
Query: 607 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666
+ L G+++LH + I+HRD+KS NL +D + VK+GD G+++L + T
Sbjct: 109 QILL----GLAHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV 162
Query: 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE- 725
GTP +++PE+ ++P +EKSDV++ GV+L+E T K P+D N +I + +
Sbjct: 163 GTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI--IRGVFPP 220
Query: 726 IPKDVDPRWAAIVESCWHSDPQCRP 750
+ + + A +++ C D + RP
Sbjct: 221 VSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 85/268 (31%), Positives = 138/268 (51%), Gaps = 31/268 (11%)
Query: 510 GEQIGQGSCGTVY---HAVWYGSDVAVKVF-------SRQEYSDEVIHSFRQEVSLMKRL 559
G IG GS G+VY +A G +AVK S ++ ++ + +E++L+K L
Sbjct: 5 GALIGSGSFGSVYLGMNAS-SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIAR 614
+H N++ ++G+ L I E++P GS+ LL T ++ R+IL +
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL------K 117
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ---- 670
G++YLH N IIHRD+K +N+LVD +K+ DFG+S+ L+TKT P
Sbjct: 118 GLNYLH--NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 671 --WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 728
WMAPEV++ K+D++S G ++ E+ T K P+ + +Q I +G N EIP
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPS 234
Query: 729 DVDPRWAAIVESCWHSDPQCRPSFQELV 756
++ +E + D RP+ EL+
Sbjct: 235 NISSEAIDFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 82/275 (29%), Positives = 135/275 (49%), Gaps = 22/275 (8%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH 561
L +G+ +G+G G+V D VAVK ++ I F E + MK H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 562 PNVLLFMG------AVTSPQRLCIVTEFLPRGSL--FRLLQR---NTTKLDWRRRILMAL 610
PNV+ +G ++ + ++ F+ G L F L R KL + + +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETYLTTKTGKGT 668
DIA G+ YL + N IHRDL + N ++ + TV V DFGLS+ + Y + K
Sbjct: 121 DIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178
Query: 669 PQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIP 727
+W+A E L + KSDV++FGV +WE+AT + P+ + + ++ + RL+ P
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL-RHGNRLKQP 237
Query: 728 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
+D ++ SCW +DP+ RP+F +L + L ++
Sbjct: 238 EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 82/267 (30%), Positives = 142/267 (53%), Gaps = 10/267 (3%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E + + +++G G G V+ + S VAVK S + +F +E +LMK
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKT 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVS 617
L+H ++ VT + + I+TE++ +GSL L+ + K+ + I + IA G++
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 676
Y+ N IHRDL+++N+LV + K+ DFGL+R+ + T + G P +W APE
Sbjct: 118 YIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 175
Query: 677 LRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735
+ KSDV+SFG++L+E+ T KIP+ +++ V+ A+ R+ ++
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRMPRMENCPDELY 234
Query: 736 AIVESCWHSDPQCRPSFQELVDKLRDL 762
I+++CW + RP+F L L D
Sbjct: 235 DIMKTCWKEKAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 3e-34
Identities = 86/256 (33%), Positives = 129/256 (50%), Gaps = 15/256 (5%)
Query: 511 EQIGQGSCGTVYHAVWYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
E+IG+G+ G V+ + V V S R+ ++ F QE ++K+ HPN++ +G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH--HCNPPII 627
T Q + IV E + G L+ +L + I M + A G+ YL HC I
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC----I 116
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHE-TYLTTKTGKGTP-QWMAPEVLRNEPSDEK 685
HRDL + N LV + +K+ DFG+SR + + Y +T K P +W APE L +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 686 SDVYSFGVILWE-LATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHS 744
SDV+SFG++LWE + +P+ NL++ Q A+ RL P+ ++E CW
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWEY 235
Query: 745 DPQCRPSF----QELV 756
DP RPSF QEL
Sbjct: 236 DPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 81/283 (28%), Positives = 135/283 (47%), Gaps = 35/283 (12%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
+ + + ++G+G+ G V+ Y VAVK ++ S++ F +E L+
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFEREAELLT 63
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN-------------TTKLDWRR 604
+H N++ F G T +V E++ G L + L+ + +L +
Sbjct: 64 NFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQ 123
Query: 605 RILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLT 661
+ +A+ IA G+ YL H +HRDL + N LV VK+GDFG+SR + T Y
Sbjct: 124 LLQIAVQIASGMVYLASQH----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR 179
Query: 662 TKTGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGF 719
P +WM PE + +SDV+SFGV+LWE+ T K PW L++ +VI
Sbjct: 180 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI---EC 236
Query: 720 MNQR--LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 760
+ Q L+ P+ I+ CW DPQ R + +++ ++L+
Sbjct: 237 ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 86/275 (31%), Positives = 133/275 (48%), Gaps = 22/275 (8%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH 561
T+G +G+G G+V A D VAVK+ +S I F +E + MK H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 562 PNVLLFMGAV---TSPQRLCI---VTEFLPRGSL--FRLLQR---NTTKLDWRRRILMAL 610
PNV+ +G + RL I + F+ G L F L+ R L + + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETYLTTKTGKGT 668
DIA G+ YL N IHRDL + N +++++ TV V DFGLS+ + Y K
Sbjct: 121 DIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178
Query: 669 PQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIP 727
+W+A E L + SDV++FGV +WE+ T + P+ + + ++ + RL+ P
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL-IKGNRLKQP 237
Query: 728 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
D ++ CW +P+CRPSFQ L D+L +
Sbjct: 238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 84/263 (31%), Positives = 131/263 (49%), Gaps = 17/263 (6%)
Query: 509 IGEQIGQGSCGTVY-----HAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
I E IG G G V VA+K + Y+++ F E S+M + HPN
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
++ G VT + + I+TEF+ G+L L++N + + + M IA G+ YL N
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN 126
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE-----TYLTTKTGKGTPQWMAPEVLR 678
+HRDL + N+LV+ + KV DFGLSR + TY ++ GK +W APE +
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 679 NEPSDEKSDVYSFGVILWELAT--EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 736
SDV+S+G+++WE+ + E+ WD +++ VI A+ + RL P D
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERPYWD-MSNQDVINAIE-QDYRLPPPMDCPTALHQ 242
Query: 737 IVESCWHSDPQCRPSFQELVDKL 759
++ CW D RP F ++V L
Sbjct: 243 LMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 82/274 (29%), Positives = 137/274 (50%), Gaps = 32/274 (11%)
Query: 503 LWEDLTIGEQIGQGSCGTVYHA-VWYGSDVAVKVF----SRQEYSDEVIHSFRQEVSLMK 557
W T GE +G+G+ GTVY G +AVK S +++ ++EV L+K
Sbjct: 1 EW---TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLK 57
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR--NTTKLDWRRRILMALDIARG 615
L+H N++ ++G + I EF+P GS+ +L R + + + LD G
Sbjct: 58 SLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD---G 114
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--------LKHETYLTTKTGKG 667
V+YLH+ ++HRD+K +N+++ + +K+ DFG +R H L K+ G
Sbjct: 115 VAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML--KSMHG 170
Query: 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP 727
TP WMAPEV+ KSD++S G ++E+AT K P +++ + + +G R +P
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG--AHRGLMP 228
Query: 728 KDVDPRWAA----IVESCWHSDPQCRPSFQELVD 757
+ + ++A V SC D RPS +L+
Sbjct: 229 R-LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (324), Expect = 3e-33
Identities = 83/256 (32%), Positives = 140/256 (54%), Gaps = 24/256 (9%)
Query: 511 EQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E+IG+GS G VY + + VA+K+ +E DE I +QE++++ + P + +
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYITRYY 68
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
G+ +L I+ E+L GS LL+ + + IL +I +G+ YLH + IH
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR--EILKGLDYLH--SERKIH 124
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RD+K++N+L+ + VK+ DFG++ +T + T GTP WMAPEV++ D K+D+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADI 184
Query: 689 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR--------WAAIVES 740
+S G+ ELA + P +L+ M+V+ F+ IPK+ P + VE+
Sbjct: 185 WSLGITAIELAKGEPPNSDLHPMRVL----FL-----IPKNSPPTLEGQYSKPFKEFVEA 235
Query: 741 CWHSDPQCRPSFQELV 756
C + DP+ RP+ +EL+
Sbjct: 236 CLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 76/268 (28%), Positives = 132/268 (49%), Gaps = 22/268 (8%)
Query: 512 QIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHS-FRQEVSLMKRLRHPN 563
+G+G G V+ A G + V VK Q+ DE + S FR+E+ + ++L H N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL--QKTKDENLQSEFRRELDMFRKLSHKN 69
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR--------RILMALDIARG 615
V+ +G + ++ E+ G L + L+ +K + + ++ + IA G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLTTKTGKGTPQWMAP 674
+ +L N +HRDL + N LV VKV LS+ + + Y + +W+AP
Sbjct: 130 MDHLS--NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187
Query: 675 EVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733
E ++ + KSDV+SFGV++WE+ T ++P+ L+ +V+ + L +P+ R
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSR 247
Query: 734 WAAIVESCWHSDPQCRPSFQELVDKLRD 761
++ CW +P+ RPSF ELV L +
Sbjct: 248 LYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 85/270 (31%), Positives = 150/270 (55%), Gaps = 17/270 (6%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E L + +++G G G V+ A + + VAVK S + +F E ++MK
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKT 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVS 617
L+H + L+ + AV + + + I+TEF+ +GSL L+ + +K + I + IA G++
Sbjct: 58 LQH-DKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 116
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 676
++ N IHRDL+++N+LV K+ DFGL+R+ + T + G P +W APE
Sbjct: 117 FIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 174
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLE-IPKDVDP 732
+ KSDV+SFG++L E+ T +IP+ +++ +VI A+ G+ R E P+++
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL-- 232
Query: 733 RWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
+ ++ CW + P+ RP+F+ + L D
Sbjct: 233 -YNIMMR-CWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 73/248 (29%), Positives = 121/248 (48%), Gaps = 24/248 (9%)
Query: 513 IGQGSCGTVYHAV-------WYGSDVAVKVFSRQEYSD--EVIHSFRQEVSLMKRLRHPN 563
+G+GS G V V Y A+KV +++ EV H+ E +++ R+ HP
Sbjct: 1 LGKGSFGKVL-LVRKKDTGKLY----AMKVLKKKKIIKRKEVEHTLT-ERNILSRINHPF 54
Query: 564 V--LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
+ L + A + ++L +V E+ P G LF L + + R R A +I + YLH
Sbjct: 55 IVKLHY--AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA-EIVLALEYLHS 111
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
II+RDLK N+L+D +K+ DFGL++ T T GTP+++APEVL +
Sbjct: 112 LG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG 169
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741
+ D +S GV+L+E+ T K P+ + ++ + + L P+ + P ++
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI--LKDPLRFPEFLSPEARDLISGL 227
Query: 742 WHSDPQCR 749
DP R
Sbjct: 228 LQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 7e-33
Identities = 78/254 (30%), Positives = 130/254 (51%), Gaps = 24/254 (9%)
Query: 528 GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLCIVTEFLP 585
G VAVK R E + +++E++++K L H N++ + G + + L ++ E++P
Sbjct: 33 GEMVAVKTLKR-ECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP 91
Query: 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 645
GSL L ++ KL+ + +L A I G++YLH + IHRDL + N+L+D VK
Sbjct: 92 LGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH--SQHYIHRDLAARNVLLDNDRLVK 147
Query: 646 VGDFGLSRL---KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEK 702
+GDFGL++ HE Y + G W A E L+ SDV+SFGV L+EL T
Sbjct: 148 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHC 207
Query: 703 IPWDNLNS--MQVIG-AVGFMN-----------QRLEIPKDVDPRWAAIVESCWHSDPQC 748
+ ++IG G M RL PK+ ++++CW ++ +
Sbjct: 208 DSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKF 267
Query: 749 RPSFQELVDKLRDL 762
RP+F+ L+ L+++
Sbjct: 268 RPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 71/292 (24%), Positives = 127/292 (43%), Gaps = 41/292 (14%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEV-IHSFRQEVSLMKRL-R 560
+D G+ IG+GS TV A ++ A+K+ +++ E + + E ++ RL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRR----RILMALDIARG 615
HP ++ + L V E+ P G L + +++ + R IL+AL+
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE---- 116
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK--------- 666
YLH IIHRDLK N+L+DK +K+ DFG +++
Sbjct: 117 --YLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 667 -----------GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIG 715
GT ++++PE+L +P+ + SD+++ G I++++ T K P+ N
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ 232
Query: 716 AVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767
+ + P + P ++E DPQ R E D+L+ +F
Sbjct: 233 KI--LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK--AHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 2e-32
Identities = 87/302 (28%), Positives = 146/302 (48%), Gaps = 46/302 (15%)
Query: 498 LDYEILWE----DLTIGEQIGQGSCGTVYHAVWYGSD---------VAVKVFSRQEYSDE 544
L + WE L +G+ +G+G G V A YG D VAVK+ + +D+
Sbjct: 1 LPLDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDK 59
Query: 545 VIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-------------- 589
+ E+ LMK + +H N++ +G T L ++ E+ +G+L
Sbjct: 60 DLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDY 119
Query: 590 -FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648
F + + +L ++ + A +ARG+ YL + IHRDL + N+LV + +K+ D
Sbjct: 120 TFDITKVPEEQLSFKDLVSCAYQVARGMEYLE--SRRCIHRDLAARNVLVTEDNVMKIAD 177
Query: 649 FGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT------ 700
FGL+R H+ Y T G+ +WMAPE L + +SDV+SFG+++WE+ T
Sbjct: 178 FGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
Query: 701 EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 760
IP + L + G R++ P + ++ CWH+ P RP+F++LV+ L
Sbjct: 238 PGIPVEELFKLLREG------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291
Query: 761 DL 762
+
Sbjct: 292 KV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 2e-32
Identities = 85/279 (30%), Positives = 139/279 (49%), Gaps = 37/279 (13%)
Query: 511 EQIGQGSCGTVYHAVWY--GSD----VAVKVF----SRQEYSDEVIHSFRQEVSLMKRLR 560
E++G+ + G +Y Y G D VA+K + Q++ + F+QE SLM L
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE-----FQQEASLMAELH 65
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL--------------QRNTTK--LDWRR 604
HPN++ +G VT Q +C++ E+L +G L L + T K LD
Sbjct: 66 HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125
Query: 605 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTK 663
+ +A+ IA G+ YL + +H+DL + N+L+ + VK+ D GLSR + Y +
Sbjct: 126 FLHIAIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 664 TGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKI-PWDNLNSMQVIGAVGFMN 721
P +WM PE + SD++SFGV+LWE+ + + P+ ++ +VI V
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR-KR 242
Query: 722 QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 760
Q L +D PR +++ CW P RP F+++ +LR
Sbjct: 243 QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 8e-32
Identities = 78/254 (30%), Positives = 132/254 (51%), Gaps = 11/254 (4%)
Query: 511 EQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
E +G+G+ G V+ + VAVK +++ E+ F E ++K+ HPN++ +G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKT-CKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHR 629
T Q + IV E +P G L++ +L ++ + ALD A G++YL N IHR
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHR 117
Query: 630 DLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVLRNEPSDEKSDV 688
DL + N LV ++ +K+ DFG+SR + + ++ K P +W APE L +SDV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 689 YSFGVILWELATEKI-PWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSD 745
+S+G++LWE + + P+ + + Q V G+ R+ P+ +++ CW
Sbjct: 178 WSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY---RMSCPQKCPDDVYKVMQRCWDYK 234
Query: 746 PQCRPSFQELVDKL 759
P+ RP F EL +L
Sbjct: 235 PENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 8e-32
Identities = 75/266 (28%), Positives = 120/266 (45%), Gaps = 24/266 (9%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIH-SFRQEVSLMKRLRHP-NVL 565
I ++G+GS G VY A VA+KV +++ S F +E+ ++ L HP N++
Sbjct: 3 RILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN--TTKLDWRRRILMALDIARGVSYLHHCN 623
L +V E++ GSL LL++ L + + I + YLH
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121
Query: 624 PPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRL------KHETYLTTKTGKGTPQWMAPEV 676
IIHRD+K N+L+D+ VK+ DFGL++L T GTP +MAPEV
Sbjct: 122 --IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 677 LR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733
L + SD++S G+ L+EL T P++ + +Q L+I ++
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS------ATSQTLKIILELPTP 233
Query: 734 WAAIVESCWHSDPQCRPSFQELVDKL 759
A S + + +L+ KL
Sbjct: 234 SLASPLS-PSNPELISKAASDLLKKL 258
|
Length = 384 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 82/282 (29%), Positives = 138/282 (48%), Gaps = 28/282 (9%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIH-SFRQEVSLMKRL- 559
WED+ + IG+G+ G V A+ G + + +E++ E H F E+ ++ +L
Sbjct: 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG 60
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------------TTKLDWRR 604
HPN++ +GA + L I E+ P G+L L+++ + L ++
Sbjct: 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 605 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664
+ A D+A G+ YL IHRDL + N+LV ++ K+ DFGLSR E Y+
Sbjct: 121 LLQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSR-GEEVYVKKTM 177
Query: 665 GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAV--GFMN 721
G+ +WMA E L KSDV+SFGV+LWE+ + P+ + ++ + G+
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-- 235
Query: 722 QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 763
R+E P++ D ++ CW P RP F ++ +L +
Sbjct: 236 -RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 93/295 (31%), Positives = 139/295 (47%), Gaps = 57/295 (19%)
Query: 507 LTIGEQIGQGSCGTVYHA----------------VWYGSD--VAVKVFSRQEYSDEVIHS 548
L E++G+G G V+ + VAVKV R + SD
Sbjct: 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-RPDASDNARED 65
Query: 549 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR----------NTT 598
F +EV ++ RL PN+ +G T LC++ E++ G L + LQ+ N+
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 599 KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658
L + + MA IA G+ YL N +HRDL + N LV K++T+K+ DFG+SR
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNYTIKIADFGMSR---NL 180
Query: 659 YLTT--KTGKGTP---QWMAPE-VLRNEPSDEKSDVYSFGVILWE---LATEKIPWDNLN 709
Y + + P +WMA E VL + + KSDV++FGV LWE L E+ P+++L
Sbjct: 181 YSSDYYRVQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQ-PYEHLT 238
Query: 710 SMQVIGAVGFMNQR------LEIPKDVDPRWAAIVE---SCWHSDPQCRPSFQEL 755
QVI G + L P + P+ I E CW D + RP+F+E+
Sbjct: 239 DQQVIENAGHFFRDDGRQIYLPRPPNC-PK--DIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 80/266 (30%), Positives = 136/266 (51%), Gaps = 41/266 (15%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH---PNVL 565
E IG+G+ G VY V G VA+K+ + D+V ++EV+L+ +LR PN+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV-SDIQREVALLSQLRQSQPPNIT 65
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR------RRILMALDIARGVSYL 619
+ G+ RL I+ E+ GS+ L++ + + R +L+AL Y+
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMK--AGPIAEKYISVIIREVLVAL------KYI 117
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 679
H +IHRD+K++N+LV VK+ DFG++ L ++ T GTP WMAPEV+
Sbjct: 118 HKV--GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITE 175
Query: 680 EPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR----- 733
D K+D++S G+ ++E+AT P+ ++++ + + + IPK PR
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM---------MLIPKSKPPRLEDNG 226
Query: 734 WAA----IVESCWHSDPQCRPSFQEL 755
++ V +C +P+ R S +EL
Sbjct: 227 YSKLLREFVAACLDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 124 bits (311), Expect = 2e-31
Identities = 83/256 (32%), Positives = 138/256 (53%), Gaps = 24/256 (9%)
Query: 511 EQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E+IG+GS G V+ + + VA+K+ +E DE I +QE++++ + P V +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYY 68
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
G+ +L I+ E+L GS LL+ LD + + +I +G+ YLH + IH
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH--SEKKIH 124
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RD+K++N+L+ +H VK+ DFG++ +T + T GTP WMAPEV++ D K+D+
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 184
Query: 689 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA--------IVES 740
+S G+ ELA + P L+ M+V+ F+ IPK+ P VE+
Sbjct: 185 WSLGITAIELAKGEPPHSELHPMKVL----FL-----IPKNNPPTLEGNYSKPLKEFVEA 235
Query: 741 CWHSDPQCRPSFQELV 756
C + +P RP+ +EL+
Sbjct: 236 CLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 85/287 (29%), Positives = 145/287 (50%), Gaps = 31/287 (10%)
Query: 498 LDYEILWE----DLTIGEQIGQGSCGTVYHAVWYG---SD----VAVKVFSRQEYSDEVI 546
L Y++ WE +L+ G+ +G G+ G V A YG SD VAVK+ +S E
Sbjct: 24 LPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER- 82
Query: 547 HSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRR 604
+ E+ +M L H N++ +GA T + ++TE+ G L L+R L
Sbjct: 83 EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLED 142
Query: 605 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTK 663
+ + +A+G+++L N IHRDL + N+L+ VK+ DFGL+R + +++ K
Sbjct: 143 LLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVK 200
Query: 664 TGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELAT------EKIPWDNLNSMQVIGA 716
P +WMAPE + N +SDV+S+G++LWE+ + +P D+ +
Sbjct: 201 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI--K 258
Query: 717 VGF-MNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
G+ M Q P ++ I+++CW +DP RP+F+++V +
Sbjct: 259 EGYRMAQPEHAPAEI----YDIMKTCWDADPLKRPTFKQIVQLIGKQ 301
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 124 bits (311), Expect = 2e-31
Identities = 79/256 (30%), Positives = 135/256 (52%), Gaps = 24/256 (9%)
Query: 511 EQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E+IG+GS G V+ + VA+K+ +E DE I +QE++++ + P V +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYY 68
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
G+ +L I+ E+L GS LL+ D + M +I +G+ YLH + IH
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLH--SEKKIH 124
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RD+K++N+L+ + VK+ DFG++ +T + T GTP WMAPEV++ D K+D+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 184
Query: 689 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP--------RWAAIVES 740
+S G+ ELA + P +++ M+V+ IPK+ P + +++
Sbjct: 185 WSLGITAIELAKGEPPNSDMHPMRVL---------FLIPKNNPPTLTGEFSKPFKEFIDA 235
Query: 741 CWHSDPQCRPSFQELV 756
C + DP RP+ +EL+
Sbjct: 236 CLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 85/269 (31%), Positives = 129/269 (47%), Gaps = 26/269 (9%)
Query: 513 IGQGSCGTVYHA-----VWYGSD---VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+G G+ G VY + GS VAVK + E F +E LM HPN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK-EFLKEAHLMSNFNHPNI 61
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ--RNTTK----LDWRRRILMALDIARGVSY 618
+ +G + I+ E + G L L+ R L + + + LD+A+G Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 619 LHHCNPPIIHRDLKSSNLLV-----DKHWTVKVGDFGLSR--LKHETYLTTKTGKGTPQW 671
L + IHRDL + N LV D VK+GDFGL+R K + Y G +W
Sbjct: 122 LEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 672 MAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 730
MAPE L + +SDV+SFGV++WE+ T + P+ LN+ +V+ V RL+ P++
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQKPENC 238
Query: 731 DPRWAAIVESCWHSDPQCRPSFQELVDKL 759
+ ++ +CW DP RP+F + + L
Sbjct: 239 PDKIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 78/239 (32%), Positives = 127/239 (53%), Gaps = 14/239 (5%)
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 590
VA+K + Y+++ F E S+M + HPN++ G VT + + IVTE++ GSL
Sbjct: 35 VAIKTL-KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD 93
Query: 591 RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
L+++ + + + M IA G+ YL + +HRDL + N+LV+ + KV DFG
Sbjct: 94 AFLRKHDGQFTVIQLVGMLRGIASGMKYL--SDMGYVHRDLAARNILVNSNLVCKVSDFG 151
Query: 651 LSRLKH---ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT--EKIPW 705
LSR+ E TT+ GK +W APE + SDV+S+G+++WE+ + E+ W
Sbjct: 152 LSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 211
Query: 706 DNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
+ +++ VI A+ G+ RL P D ++ CW D RP F+++V L L
Sbjct: 212 E-MSNQDVIKAIEEGY---RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 80/276 (28%), Positives = 138/276 (50%), Gaps = 23/276 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVW----YGSDVAVKVFSRQEYSDEV-IHSFRQEVSLMKRLRHP 562
T+ + + +G+ G +++ + G + V V + ++++ E+ + QE L+ L H
Sbjct: 9 TLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQ 68
Query: 563 NVLLFMGAVTS-PQRLCIVTEFLPRGSLFRLLQR-------NTTKLDWRRRILMALDIAR 614
N+L + + ++ ++ G+L LQ+ N L ++ + MA+ IA
Sbjct: 69 NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP-QWM 672
G+SYLH +IH+D+ + N ++D+ VK+ D LSR L Y + P +WM
Sbjct: 129 GMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM 186
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAV--GFMNQRLEIPKD 729
A E L N+ SDV+SFGV+LWEL T + P+ ++ ++ + G+ RL P +
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY---RLAQPIN 243
Query: 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765
A++ CW DP+ RPSF +LV L D Q
Sbjct: 244 CPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 84/263 (31%), Positives = 134/263 (50%), Gaps = 21/263 (7%)
Query: 513 IGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
IG G G V+ + VA+K + Y+++ F E S+M + H N++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
G VT + I+TE++ G+L + L+ + + + + M IA G+ YL N +
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YV 129
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHE----TYLTTKTGKGTPQWMAPEVLRNEPSD 683
HRDL + N+LV+ + KV DFGLSR+ + TY TT GK +W APE +
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTY-TTSGGKIPIRWTAPEAIAYRKFT 188
Query: 684 EKSDVYSFGVILWELAT--EKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVE 739
SDV+SFG+++WE+ + E+ WD +++ +V+ A+ GF RL P D ++
Sbjct: 189 SASDVWSFGIVMWEVMSFGERPYWD-MSNHEVMKAINDGF---RLPAPMDCPSAVYQLML 244
Query: 740 SCWHSDPQCRPSFQELVDKLRDL 762
CW D RP F ++V+ L L
Sbjct: 245 QCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 66/255 (25%), Positives = 126/255 (49%), Gaps = 14/255 (5%)
Query: 513 IGQGSCG--TVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570
+G+G+ G T+Y S V K + S++ E+ ++ L+HPN++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 571 VTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHR 629
L I E+ G+L+ +++++ + + I VSY+H I+HR
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHR 125
Query: 630 DLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVY 689
D+K+ N+ + K +K+GDFG+S++ Y +T GTP +M+PE+ + + KSD++
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIW 185
Query: 690 SFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA----IVESCWHSD 745
+ G +L+EL T K +D N + ++ V + V +++ +V S D
Sbjct: 186 ALGCVLYELLTLKRTFDATNPLNLV--VKIVQGNYT---PVVSVYSSELISLVHSLLQQD 240
Query: 746 PQCRPSFQELVDKLR 760
P+ RP+ E++D+
Sbjct: 241 PEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 81/270 (30%), Positives = 137/270 (50%), Gaps = 29/270 (10%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+DL ++G G+ G V G +AVK R E ++ + +E+ ++ + P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTI-RLEINEAIQKQILRELDILHKCNSP 59
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL--MALDIARGVSYLH 620
++ F GA + + I E++ GSL ++L+ ++ RIL +A+ + +G++YLH
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIP--ERILGKIAVAVLKGLTYLH 117
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT---TKTGKGTPQWMAPEVL 677
IIHRD+K SN+LV+ +K+ DFG+S L KT GT +MAPE +
Sbjct: 118 E-KHKIIHRDVKPSNILVNSRGQIKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERI 171
Query: 678 RNEPSDEKSDVYSFGVILWELATEKIPWDNLNS-----MQVIGAVGFMNQ---RLEIPKD 729
+ KSD++S G+ L ELAT + P+ N +++ + +N+ RL P
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI--VNEPPPRL--PSG 227
Query: 730 V-DPRWAAIVESCWHSDPQCRPSFQELVDK 758
P + V C DP+ RPS++EL++
Sbjct: 228 KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 4e-30
Identities = 85/262 (32%), Positives = 133/262 (50%), Gaps = 16/262 (6%)
Query: 513 IGQGSCGTVYHAVWY--GSD----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
+G G+ GTVY +W G + VA+KV R+ S + E +M + P V
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVL-RENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 567 FMG-AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
+G +TS +L VT+ +P G L ++ N ++ + + + IA+G+SYL
Sbjct: 74 LLGICLTSTVQL--VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR-- 129
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH--ETYLTTKTGKGTPQWMAPEVLRNEPSD 683
++HRDL + N+LV VK+ DFGL+RL ET GK +WMA E + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189
Query: 684 EKSDVYSFGVILWELATEKI-PWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742
+SDV+S+GV +WEL T P+D + + ++ + +RL P I+ CW
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGERLPQPPICTIDVYMIMVKCW 248
Query: 743 HSDPQCRPSFQELVDKLRDLQR 764
D +CRP F+ELVD+ + R
Sbjct: 249 MIDSECRPRFRELVDEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 8e-30
Identities = 83/280 (29%), Positives = 134/280 (47%), Gaps = 32/280 (11%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIH-SFRQEVSLMKR 558
W D+ + IG+G+ G V A D A+K +EY+ + H F E+ ++ +
Sbjct: 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIK--RMKEYASKDDHRDFAGELEVLCK 63
Query: 559 L-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSL---------------FRLLQRNTTKLDW 602
L HPN++ +GA L + E+ P G+L F + + L
Sbjct: 64 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 603 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
++ + A D+ARG+ YL IHRDL + N+LV +++ K+ DFGLSR E Y+
Sbjct: 124 QQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKK 180
Query: 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAV--GF 719
G+ +WMA E L SDV+S+GV+LWE+ + P+ + ++ + G+
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 240
Query: 720 MNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 759
RLE P + D ++ CW P RPSF +++ L
Sbjct: 241 ---RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 9e-30
Identities = 84/293 (28%), Positives = 145/293 (49%), Gaps = 42/293 (14%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD---------VAVKVFSRQEYSDEVIHSFR 550
+E+ + L +G+ +G+G G V A G D VAVK+ + + +++ +
Sbjct: 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML-KSDATEKDLSDLI 71
Query: 551 QEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------------- 596
E+ +MK + +H N++ +GA T L ++ E+ +G+L L+
Sbjct: 72 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131
Query: 597 --TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
+L ++ + A +ARG+ YL + IHRDL + N+LV + +K+ DFGL+R
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189
Query: 655 KH--ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT------EKIPWD 706
H + Y T G+ +WMAPE L + +SDV+SFGV+LWE+ T +P +
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249
Query: 707 NLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 759
L + G R++ P + ++ CWH+ P RP+F++LV+ L
Sbjct: 250 ELFKLLKEG------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 84/280 (30%), Positives = 141/280 (50%), Gaps = 29/280 (10%)
Query: 505 EDLTIGEQIGQGSCGTVY----HAVWYGSD---VAVKVFSRQEYSDEVIHSFRQEVSLMK 557
D+ + ++G+G+ G V+ H + D VAVK +E S+ F++E L+
Sbjct: 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLT 62
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN--------------TTKLDWR 603
L+H +++ F G T + L +V E++ G L R L+ + +L
Sbjct: 63 VLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLG 122
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
+ + +A IA G+ YL + +HRDL + N LV + VK+GDFG+SR + T
Sbjct: 123 QMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180
Query: 664 TGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFM 720
G+ P +WM PE + +SD++SFGV+LWE+ T K PW L++ + I +
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT-Q 239
Query: 721 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 760
+ LE P+ P AI++ CW +PQ R +++ +L+
Sbjct: 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-29
Identities = 80/243 (32%), Positives = 127/243 (52%), Gaps = 27/243 (11%)
Query: 505 EDLTIGEQIGQGSCGTVY--HAVWYGSDVAVKVF----SRQEYSDEVIHSFRQEVSLMKR 558
+ +G+ +G+G+ G VY + G ++AVK QE S EV ++ E+ L+K
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEV-NALECEIQLLKN 60
Query: 559 LRHPNVLLFMGAVTSPQ--RLCIVTEFLPRGSL------FRLLQRNTTKLDWRRRILMAL 610
LRH ++ + G + P+ +L I E++P GS+ + L N T+ + R+IL
Sbjct: 61 LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQIL--- 116
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT---TKTGKG 667
+GVSYLH + I+HRD+K +N+L D VK+GDFG S+ ++ K+ G
Sbjct: 117 ---QGVSYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171
Query: 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP 727
TP WM+PEV+ E K+DV+S + E+ TEK PW +M I + + +P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLP 231
Query: 728 KDV 730
V
Sbjct: 232 DGV 234
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 78/245 (31%), Positives = 126/245 (51%), Gaps = 23/245 (9%)
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 590
VAVK+ R++ + + F +E+ +M RL+ PN++ + + LC++TE++ G L
Sbjct: 49 VAVKML-REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 591 RLLQR----------NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK 640
+ L R + + + I MA IA G+ YL N +HRDL + N LV K
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGK 165
Query: 641 HWTVKVGDFGLSR-LKHETYLTTKTGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWEL 698
++T+K+ DFG+SR L Y + P +WM+ E + SDV++FGV LWE+
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
Query: 699 AT--EKIPWDNLNSMQVIGAVG--FMNQRLEI----PKDVDPRWAAIVESCWHSDPQCRP 750
T ++ P+ L+ QVI G F +Q ++ P ++ SCW + + RP
Sbjct: 226 LTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERP 285
Query: 751 SFQEL 755
SFQE+
Sbjct: 286 SFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 73/285 (25%), Positives = 133/285 (46%), Gaps = 46/285 (16%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQ----EVSLMKR 558
+ I ++IG+G VY A+ G VA+K E D RQ E+ L+K+
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDA---KARQDCLKEIDLLKQ 58
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL---QRNTTKLDWRRRILMALDIARG 615
L HPNV+ ++ + L IV E G L R++ ++ + R + +
Sbjct: 59 LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK-----GTPQ 670
+ ++H + I+HRD+K +N+ + VK+GD GL R + ++KT GTP
Sbjct: 119 LEHMH--SKRIMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPY 171
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW--DNLNSMQVIGAVGFMNQRLE--- 725
+M+PE + + KSD++S G +L+E+A + P+ D +N + +++E
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC-------KKIEKCD 224
Query: 726 ---IPKDVDPRWAA----IVESCWHSDPQCRPSFQELVDKLRDLQ 763
+P D ++ +V C + DP+ RP ++ +++
Sbjct: 225 YPPLPAD---HYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 84/295 (28%), Positives = 140/295 (47%), Gaps = 47/295 (15%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+L +G+ +G+G G V A + + VAVK+ S E + E +L+K+
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE-LRDLLSEFNLLKQ 59
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ---------------RNTTKLD-- 601
+ HP+V+ GA + L ++ E+ GSL L+ RN++ LD
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 602 ------WRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655
I A I+RG+ YL ++HRDL + N+LV + +K+ DFGLSR
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 656 HE--TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT------EKIPWDN 707
+E +Y+ G+ +WMA E L + +SDV+SFGV+LWE+ T I +
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237
Query: 708 LNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
L ++ G R+E P++ ++ +CW +P RP+F ++ +L +
Sbjct: 238 LFNLLKTG------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 89/293 (30%), Positives = 146/293 (49%), Gaps = 42/293 (14%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD---------VAVKVFSRQEYSDEVIHSFR 550
+E+ LT+G+ +G+G G V A G D VAVK+ + + +D+ +
Sbjct: 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDDATDKDLSDLV 65
Query: 551 QEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDW------ 602
E+ +MK + +H N++ +GA T L ++ E+ +G+L L+ R +D+
Sbjct: 66 SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 603 --------RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
+ + A +ARG+ YL + IHRDL + N+LV + +K+ DFGL+R
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183
Query: 655 KH--ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT------EKIPWD 706
H + Y T G+ +WMAPE L + +SDV+SFGV+LWE+ T IP +
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243
Query: 707 NLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 759
L + G R++ P + I+ CWH+ P RP+F++LV+ L
Sbjct: 244 ELFKLLKEG------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 85/293 (29%), Positives = 146/293 (49%), Gaps = 42/293 (14%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD---------VAVKVFSRQEYSDEVIHSFR 550
+E + LT+G+ +G+G G V A G D VAVK+ + + +++ +
Sbjct: 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV 68
Query: 551 QEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILM 608
E+ +MK + +H N++ +GA T L ++ E+ +G+L L+ R +++ I
Sbjct: 69 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128
Query: 609 ALD--------------IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
D +ARG+ YL + IHRDL + N+LV ++ +K+ DFGL+R
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 186
Query: 655 KH--ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT------EKIPWD 706
+ + Y T G+ +WMAPE L + +SDV+SFGV++WE+ T IP +
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246
Query: 707 NLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 759
L + G R++ P + ++ CWH+ P RP+F++LV+ L
Sbjct: 247 ELFKLLKEG------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 67/259 (25%), Positives = 127/259 (49%), Gaps = 33/259 (12%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRL 559
+D + +G GS G V V + G A+K+ S+ + +V H E +++ +
Sbjct: 1 DDFEFIKTLGTGSFGRV-MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLN-EKRILQSI 58
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT-KLDWRR----RILMALDIAR 614
RHP ++ G+ L +V E++P G LF L+++ R ++++AL+
Sbjct: 59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE--- 115
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMA 673
YLH + I++RDLK NLL+D +K+ DFG + R+K TY T GTP+++A
Sbjct: 116 ---YLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY----TLCGTPEYLA 166
Query: 674 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQV---IGAVGFMNQRLEIPKDV 730
PE++ ++ + D ++ G++++E+ P+ + N +Q+ I + ++ P
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI-----LEGKVRFPSFF 221
Query: 731 DPRWAAIVESCWHSDPQCR 749
P ++ + D R
Sbjct: 222 SPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 83/252 (32%), Positives = 129/252 (51%), Gaps = 24/252 (9%)
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 590
VAVK+ R + + + F +E+ +M RL++PN++ +G S LC++TE++ G L
Sbjct: 47 VAVKML-RADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 591 RLL-QR----------NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD 639
+ L QR N + + MA+ IA G+ YL N +HRDL + N LV
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVG 163
Query: 640 KHWTVKVGDFGLSR-LKHETYLTTKTGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWE 697
H+T+K+ DFG+SR L Y + P +WMA E + SDV++FGV LWE
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 698 LAT--EKIPWDNLNSMQVIGAVG--FMNQRLEIPKDVDPRWAA----IVESCWHSDPQCR 749
+ T ++ P+ L+ QVI G F NQ +I P + ++ CW D + R
Sbjct: 224 MFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDR 283
Query: 750 PSFQELVDKLRD 761
P+F ++ LR+
Sbjct: 284 PTFNKIHHFLRE 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 6e-29
Identities = 73/260 (28%), Positives = 131/260 (50%), Gaps = 32/260 (12%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570
+G+G+ G V+ V +K ++ + + + + E ++K L HPN++ +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 571 VTSPQRLCIVTEFLPRGSLFRLLQR-------NTTKLDWRRRILMALDIARGVSYLHHCN 623
+ L IV E+ P G+L +Q+ T L + +IL+AL H
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH--------HVHT 119
Query: 624 PPIIHRDLKSSNLLVDKHWTV-KVGDFGLSRLKHETYLTTK----TGKGTPQWMAPEVLR 678
I+HRDLK+ N+L+DKH V K+GDFG+S++ L++K T GTP +++PE+
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKI-----LSSKSKAYTVVGTPCYISPELCE 174
Query: 679 NEPSDEKSDVYSFGVILWELATEKIPWD--NLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 736
+P ++KSD+++ G +L+ELA+ K ++ NL ++ + G I P
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA---PISDRYSPDLRQ 231
Query: 737 IVESCWHSDPQCRPSFQELV 756
++ S + DP RP +++
Sbjct: 232 LILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 83/269 (30%), Positives = 132/269 (49%), Gaps = 33/269 (12%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVWYGSDV--AVKVFSRQEYSDEVIHSFRQEVSLMKRLRH 561
WE IGE +G G+ G VY A + + A K+ + S+E + F E+ ++ +H
Sbjct: 7 WE--IIGE-LGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKH 61
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
PN++ A +L I+ EF G+L ++ L + + + +++LH
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH- 120
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL---- 677
+ +IHRDLK+ N+L+ VK+ DFG+S T T GTP WMAPEV+
Sbjct: 121 -SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179
Query: 678 -RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP---- 732
++ P D K+D++S G+ L ELA + P LN M+V+ L+I K P
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL---------LKILKSEPPTLDQ 230
Query: 733 --RWAA----IVESCWHSDPQCRPSFQEL 755
+W++ ++SC DP RP+ EL
Sbjct: 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 8e-29
Identities = 77/255 (30%), Positives = 122/255 (47%), Gaps = 11/255 (4%)
Query: 513 IGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 572
+G+G+ G VY A + V + + E + +E++L L+H N++ ++G+ +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 573 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR--ILMALDIARGVSYLHHCNPPIIHRD 630
I E +P GSL LL+ L + I I G+ YLH + I+HRD
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH--DNQIVHRD 133
Query: 631 LKSSNLLVDKH-WTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS--DEKSD 687
+K N+LV+ + VK+ DFG S+ T+T GT Q+MAPEV+ P +D
Sbjct: 134 IKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPAD 193
Query: 688 VYSFGVILWELATEKIPWDNLNSMQ-VIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 746
++S G + E+AT K P+ L Q + VG EIP+ + + C+ DP
Sbjct: 194 IWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDP 253
Query: 747 QCRPSFQELVDKLRD 761
R S +L L+D
Sbjct: 254 DKRASAHDL---LQD 265
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 84/268 (31%), Positives = 130/268 (48%), Gaps = 28/268 (10%)
Query: 511 EQIGQGSCGTVY----HAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
++IG G G V H + V VK DE + F QEV + L HPNVL
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQL-LFLQEVQPYRELNHPNVLQ 59
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRN--TTKLDWRRRIL--MALDIARGVSYLHHC 622
+G +V EF P G L L+ N ++ +L MA ++A G+ +LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH-ETYLTTKTGKGTP-QWMAPEVLRNE 680
+ IH DL N + +VK+GD+GL+ ++ E Y TK P +W+APE++
Sbjct: 120 D--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 681 PSD-------EKSDVYSFGVILWELATEKI-PWDNLNSMQVIGAVGFMNQRLEIPK---- 728
D +KS+++S GV +WEL T P+ +L+ QV+ V Q +++PK
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV-VREQDIKLPKPQLD 236
Query: 729 -DVDPRWAAIVESCWHSDPQCRPSFQEL 755
RW +++ CW DP+ RP+ +E+
Sbjct: 237 LKYSDRWYEVMQFCW-LDPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 77/284 (27%), Positives = 129/284 (45%), Gaps = 31/284 (10%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVK----VFSRQEYSDEVIHSF 549
E+ + +T+ +G G+ G VY ++ G D VAVK S Q+ SD F
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESD-----F 56
Query: 550 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL------QRNTTKLDWR 603
E +M + H N++ +G I+ E + G L L + L +
Sbjct: 57 LMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMK 116
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRLKHETYL 660
+ A D+A+G YL + IHRD+ + N L+ K+ DFG++R +
Sbjct: 117 DLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY 174
Query: 661 TTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWEL-ATEKIPWDNLNSMQVIGAV 717
K G+ P +WM PE + K+DV+SFGV+LWE+ + +P+ + +V+ V
Sbjct: 175 YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234
Query: 718 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRD 761
RL+ PK I+ CW P+ RP+F ++++++
Sbjct: 235 -TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 74/265 (27%), Positives = 122/265 (46%), Gaps = 33/265 (12%)
Query: 513 IGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRHPNVLLFMG 569
I +G+ G V+ A G A+KV + + + + E ++ + + P V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD--WRR----RILMALDIARGVSYLHHCN 623
+ + L +V E+LP G L LL N LD R I++AL+ YLH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLL-ENVGSLDEDVARIYIAEIVLALE------YLHSNG 113
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLS------RLKHETYLTTKTGK--GTPQWMAPE 675
IIHRDLK N+L+D + +K+ DFGLS R + + + GTP ++APE
Sbjct: 114 --IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735
V+ + + D +S G IL+E P+ ++ + +N ++E P+DV+
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI--LNGKIEWPEDVEVSDE 229
Query: 736 AI--VESCWHSDPQCRP---SFQEL 755
AI + DP+ R S +E+
Sbjct: 230 AIDLISKLLVPDPEKRLGAKSIEEI 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 82/284 (28%), Positives = 134/284 (47%), Gaps = 40/284 (14%)
Query: 513 IGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
IGQG+ G V+ A G + VAVK+ ++E S ++ F++E +LM HPN++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDHPNIV 71
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---------------------LDWRR 604
+G + +C++ E++ G L L+ + + L
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 605 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLTTK 663
++ +A +A G++YL +HRDL + N LV ++ VK+ DFGLSR + Y
Sbjct: 132 QLCIAKQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 664 TGKGTP-QWMAPE-VLRNEPSDEKSDVYSFGVILWELATEKI-PWDNLNSMQVIGAVGFM 720
P +WM PE + N + E SDV+++GV+LWE+ + + P+ + +VI V
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDG 248
Query: 721 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764
N L P + ++ CW P RPSF + R LQR
Sbjct: 249 NV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASIN---RILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 80/279 (28%), Positives = 133/279 (47%), Gaps = 45/279 (16%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNV 564
+ E IG+G+ G VY A G VA+K+ + ++ ++E +++++ HPN+
Sbjct: 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKI---MDIIEDEEEEIKEEYNILRKYSNHPNI 65
Query: 565 LLFMGA------VTSPQRLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIA 613
F GA + +L +V E GS+ L++ K +W IL +
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR--ETL 123
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 673
RG++YLH +IHRD+K N+L+ K+ VK+ DFG+S T T GTP WMA
Sbjct: 124 RGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181
Query: 674 PEVLRNEPS-----DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 728
PEV+ + D +SDV+S G+ ELA K P +++ M+ + +IP+
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL---------FKIPR 232
Query: 729 DVDPR------WAA----IVESCWHSDPQCRPSFQELVD 757
+ P W+ + C + + RP +EL++
Sbjct: 233 NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 64/208 (30%), Positives = 117/208 (56%), Gaps = 6/208 (2%)
Query: 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
++IG+GS G +Y A +K + + + ++EV L+ +++HPN++ F
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL-MALDIARGVSYLHHCNPPII 627
+ RL IV E+ G L + + R L +IL + I+ G+ ++H + I+
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH--DRKIL 123
Query: 628 HRDLKSSNLLVDKHWTV-KVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS 686
HRD+KS N+ + K+ V K+GDFG++R +++ T GTP +++PE+ +N P + K+
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKT 183
Query: 687 DVYSFGVILWELATEKIPWDNLNSMQVI 714
D++S G +L+EL T K P++ N Q++
Sbjct: 184 DIWSLGCVLYELCTLKHPFEGNNLHQLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 30/205 (14%)
Query: 511 EQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHS--FRQEVSLMKRLRHP 562
E++G+G+ G VY A D VA+K R + +E I S R E+SL+K L+HP
Sbjct: 5 EKLGEGTYGVVYKAR----DKKTGEIVALKKI-RLDNEEEGIPSTALR-EISLLKELKHP 58
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH-H 621
N++ + + + ++L +V E+ L + L + L + + RG++Y H H
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ----WM-APEV 676
I+HRDLK N+L+++ +K+ DFGL+R T + W APE+
Sbjct: 118 R---ILHRDLKPQNILINRDGVLKLADFGLAR-----AFGIPLRTYTHEVVTLWYRAPEI 169
Query: 677 LRNEPSDEKS-DVYSFGVILWELAT 700
L + D++S G I E+ T
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMIT 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 7e-28
Identities = 84/265 (31%), Positives = 132/265 (49%), Gaps = 28/265 (10%)
Query: 509 IGEQIGQGSCGTVY--HAVWYGSDVAVKVFSRQEYSDEV---IHSFRQEVSLMKRLRHPN 563
+G+ +GQG+ G VY + G ++AVK S E +++ E+ L+K L H
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 564 VLLFMGAVTSPQR--LCIVTEFLPRGSL------FRLLQRNTTKLDWRRRILMALDIARG 615
++ + G + P L I E +P GS+ + L N T+ + R+IL G
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR-KYTRQIL------EG 118
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG----KGTPQW 671
VSYLH + I+HRD+K +N+L D VK+GDFG S+ + +T + TG GTP W
Sbjct: 119 VSYLH--SNMIVHRDIKGANILRDSVGNVKLGDFGASK-RLQTICLSGTGMKSVTGTPYW 175
Query: 672 MAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 731
M+PEV+ E K+D++S G + E+ TEK PW +M I + +P V
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVS 235
Query: 732 PRWAAIVESCWHSDPQCRPSFQELV 756
++ + + + RPS EL+
Sbjct: 236 DHCRDFLKRIF-VEAKLRPSADELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 77/248 (31%), Positives = 118/248 (47%), Gaps = 22/248 (8%)
Query: 528 GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLCIVTEFLP 585
G VAVK + E I ++E+ +++ L H N++ + G T + ++ EFLP
Sbjct: 33 GEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 91
Query: 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 645
GSL L RN K++ ++++ A+ I +G+ YL +HRDL + N+LV+ VK
Sbjct: 92 SGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVK 149
Query: 646 VGDFGLSRL--KHETYLTTKTGKGTPQ-WMAPEVLRNEPSDEKSDVYSFGVILWELATE- 701
+GDFGL++ + Y T K +P W APE L SDV+SFGV L+EL T
Sbjct: 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYC 209
Query: 702 -----------KIPWDNLNSMQVIGAVGFMNQ--RLEIPKDVDPRWAAIVESCWHSDPQC 748
K+ M V V + + RL P + ++ CW P
Sbjct: 210 DSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSK 269
Query: 749 RPSFQELV 756
R +FQ L+
Sbjct: 270 RTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 69/296 (23%), Positives = 119/296 (40%), Gaps = 56/296 (18%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+IG+G+ G VY A G VA+K + S+ + + +E+ L+K L HPN++ +
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
L +V EF+ L++L++ L + +G+++ H I+H
Sbjct: 65 DVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILH 121
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQ----WM-APEVLRNE 680
RDLK NLL++ +K+ DFGL+R Y T W APE+L +
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPY--------THYVVTRWYRAPELLLGD 173
Query: 681 PS-DEKSDVYSFGVILWELATEKIPW------DNLNSM-QVIG------------AVGFM 720
D++S G I EL + + + D L + + +G
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233
Query: 721 N------QRLEIPK---DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767
+ +PK + P+ ++ H DP R + ++ L YF
Sbjct: 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQA------LAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 2e-27
Identities = 80/269 (29%), Positives = 130/269 (48%), Gaps = 28/269 (10%)
Query: 513 IGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIH-SFRQEVSLMKRL-RHPNVLL 566
IG+G+ G V A D A+K +EY+ + H F E+ ++ +L HPN++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------------TTKLDWRRRILMALD 611
+GA L + E+ P G+L L+++ + L ++ + A D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQW 671
+ARG+ YL IHRDL + N+LV +++ K+ DFGLSR E Y+ G+ +W
Sbjct: 121 VARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGRLPVRW 177
Query: 672 MAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 730
MA E L SDV+S+GV+LWE+ + P+ + ++ + RLE P +
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNC 236
Query: 731 DPRWAAIVESCWHSDPQCRPSFQELVDKL 759
D ++ CW P RPSF +++ L
Sbjct: 237 DDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 75/259 (28%), Positives = 129/259 (49%), Gaps = 25/259 (9%)
Query: 513 IGQGSCGTVYHAVWYGSD---VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
+G+GS G V V + +D +K + + S + QE L+ +L+HPN++ +
Sbjct: 8 VGKGSYGEV-SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 570 AVTSPQ-RLCIVTEFLPRGSLFRLLQRNTTKL-------DWRRRILMALDIARGVSYLHH 621
+ L IV F G L+ L+ KL +W +I MAL YLH
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL------QYLHE 120
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
+ I+HRDLK+ N+ + + +KVGD G++R+ T GTP +M+PE+ N+P
Sbjct: 121 KH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP 178
Query: 682 SDEKSDVYSFGVILWELATEKIPWD--NLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 739
+ KSDV++ G ++E+AT K ++ ++NS+ G + +PKD P ++
Sbjct: 179 YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---MPKDYSPELGELIA 235
Query: 740 SCWHSDPQCRPSFQELVDK 758
+ P+ RPS + ++ +
Sbjct: 236 TMLSKRPEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 76/262 (29%), Positives = 129/262 (49%), Gaps = 16/262 (6%)
Query: 513 IGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
+G G+ GTVY +W VA+K R+ S + E +M + +P+V
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 567 FMG-AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
+G +TS +L +T+ +P G L ++ + + + + + IA+G++YL
Sbjct: 74 LLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR-- 129
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRNEPSD 683
++HRDL + N+LV VK+ DFGL++L E + GK +WMA E + +
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYT 189
Query: 684 EKSDVYSFGVILWELATEKI-PWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742
+SDV+S+GV +WEL T P+D + + + I ++ +RL P I+ CW
Sbjct: 190 HQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMVKCW 248
Query: 743 HSDPQCRPSFQELVDKLRDLQR 764
D RP F+EL+ + + R
Sbjct: 249 MIDADSRPKFRELIIEFSKMAR 270
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 78/241 (32%), Positives = 121/241 (50%), Gaps = 9/241 (3%)
Query: 513 IGQGSCGTVYHAVWY--GSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+GS G V A GS AVKV ++ E H + L+K L+HP ++
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + ++L V +++ G LF LQR L+ R R A ++A + YLH N II+
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRAR-FYAAEVASAIGYLHSLN--IIY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK N+L+D V + DFGL + E TT T GTP+++APEVLR EP D D
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179
Query: 689 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQC 748
+ G +L+E+ P+ + + Q+ +++ L++P ++ H D +
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYD--NILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237
Query: 749 R 749
R
Sbjct: 238 R 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 9e-27
Identities = 92/292 (31%), Positives = 138/292 (47%), Gaps = 46/292 (15%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQ-EYSDEVIHSFRQEVSL 555
D E L+ DL +IG GS G VY A V VA+K S + S+E +EV
Sbjct: 12 DPEKLFTDLR---EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA-- 613
+++LRHPN + + G +V E+ L + L+ ++ L ++IA
Sbjct: 69 LQQLRHPNTIEYKGCYLREHTAWLVMEYC--------LGSASDILEVHKKPLQEVEIAAI 120
Query: 614 -----RGVSYLH-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667
+G++YLH H IHRD+K+ N+L+ + TVK+ DFG + L + G
Sbjct: 121 CHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVS----PANSFVG 173
Query: 668 TPQWMAPEVL--RNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL 724
TP WMAPEV+ +E D K DV+S G+ ELA K P N+N+M + + N
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNDSP 232
Query: 725 EIPKDVDPRWA----AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772
+ + W+ V+SC PQ RPS +EL L+ ++ R
Sbjct: 233 TLSSN---DWSDYFRNFVDSCLQKIPQDRPSSEEL------LKHRFVLRERP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 64/257 (24%), Positives = 126/257 (49%), Gaps = 18/257 (7%)
Query: 513 IGQGSCGTVYHAVWYGSDVAVKVFSR-QEYSDEVIHSFRQEVSLMKRLRHPNVL----LF 567
I + ++Y ++ +V ++ F + + +I E+ ++R+ N+L
Sbjct: 28 IKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI 87
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH-HCNPPI 626
+ V RL ++ E+ RG L +L L ++ ++ MA+D +G+ L+ + N P
Sbjct: 88 IDIVDDLPRLSLILEYCTRGYLREVL-DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP- 145
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK--GTPQWMAPEVLRN--EPS 682
+++L S + LV +++ +K+ GL E L++ K + + ++L +
Sbjct: 146 -YKNLTSVSFLVTENYKLKIICHGL-----EKILSSPPFKNVNFMVYFSYKMLNDIFSEY 199
Query: 683 DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742
K D+YS GV+LWE+ T KIP++NL + ++ + N L++P D IVE+C
Sbjct: 200 TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACT 259
Query: 743 HSDPQCRPSFQELVDKL 759
D RP+ +E++ L
Sbjct: 260 SHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 83/267 (31%), Positives = 136/267 (50%), Gaps = 34/267 (12%)
Query: 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQ--------EYSDEVIHSFRQEVSLMKRLRH 561
G+ +GQG+ G VY + Y D ++ ++Q E S EV + E+ L+K L+H
Sbjct: 7 GKLLGQGAFGRVY--LCYDVDTGRELAAKQVQFDPESPETSKEV-SALECEIQLLKNLQH 63
Query: 562 PNVLLFMGAVT--SPQRLCIVTEFLPRGSL------FRLLQRNTTKLDWRRRILMALDIA 613
++ + G + + + L I E++P GS+ + L + T+ + R+IL
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQIL------ 116
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG----KGTP 669
G+SYLH + I+HRD+K +N+L D VK+GDFG S+ + +T + TG GTP
Sbjct: 117 EGMSYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASK-RLQTICMSGTGIRSVTGTP 173
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKD 729
WM+PEV+ E K+DV+S G + E+ TEK PW +M I + ++P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSH 233
Query: 730 VDPRWAAIVESCWHSDPQCRPSFQELV 756
+ + C + + RPS +EL+
Sbjct: 234 ISEHARDFL-GCIFVEARHRPSAEELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 71/257 (27%), Positives = 126/257 (49%), Gaps = 11/257 (4%)
Query: 505 EDLTIGEQIGQGSCGTV--YHAVWYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRH 561
L +IG+GS G V G VAVK R++ E++ + EV +M+ +H
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN---EVVIMRDYQH 75
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
PN++ + L +V EFL G+L ++ T+++ + + L + + +S+LH
Sbjct: 76 PNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLH- 132
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
+IHRD+KS ++L+ VK+ DFG + K+ GTP WMAPEV+ P
Sbjct: 133 -AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLP 191
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QRLEIPKDVDPRWAAIVES 740
+ D++S G+++ E+ + P+ N +Q + + +L+ V PR + ++
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDR 251
Query: 741 CWHSDPQCRPSFQELVD 757
DP R + EL++
Sbjct: 252 MLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 77/279 (27%), Positives = 136/279 (48%), Gaps = 23/279 (8%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
++ + ++G+G+ G V+ A Y + V V + ++ SD F +E L+ L+
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------------TTKLDWRRRILM 608
H +++ F G L +V E++ G L + L+ + +L + + +
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLTTKTGKG 667
A IA G+ YL + +HRDL + N LV ++ VK+GDFG+SR + T Y
Sbjct: 126 AQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183
Query: 668 TP-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLE 725
P +WM PE + +SDV+S GV+LWE+ T K PW L++ +VI + + L+
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-QGRVLQ 242
Query: 726 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764
P+ ++ CW +P R + +E+ L++L +
Sbjct: 243 RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 73/241 (30%), Positives = 119/241 (49%), Gaps = 9/241 (3%)
Query: 513 IGQGSCGTVYHAVWYGSDV--AVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+GS G V A AVKV ++ E H + L+K ++HP ++
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + +L V +++ G LF LQR + + R R A +IA + YLH N II+
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRAR-FYAAEIASALGYLHSLN--IIY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK N+L+D V + DFGL + E TT T GTP+++APEVLR +P D D
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179
Query: 689 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQC 748
+ G +L+E+ P+ + ++ ++ + +N+ L + ++ ++E D
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNI--LNKPLRLKPNISVSARHLLEGLLQKDRTK 237
Query: 749 R 749
R
Sbjct: 238 R 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 85/279 (30%), Positives = 131/279 (46%), Gaps = 37/279 (13%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSD----VAVK-----VFSRQEYSDEVIHSFRQEVSLMK 557
L +G+ +G+G G+V D VAVK + +R E D F E MK
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMED-----FLSEAVCMK 55
Query: 558 RLRHPNVLLFMG---------AVTSPQRLCIVTEFLPRGSL--FRLLQR---NTTKLDWR 603
HPNV+ +G SP ++ F+ G L F L R L +
Sbjct: 56 EFDHPNVMRLIGVCLQTVESEGYPSP---VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQ 112
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETYLT 661
+ DIA G+ YL + IHRDL + N +++++ V V DFGLS+ + Y
Sbjct: 113 MLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ 170
Query: 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFM 720
+ K +W+A E L + KSDV+SFGV +WE+AT + P+ + + ++ +
Sbjct: 171 GRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG 230
Query: 721 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 759
N RL+ P D +++ SCW +P+ RPSF+ L +L
Sbjct: 231 N-RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 109 bits (272), Expect = 5e-26
Identities = 77/264 (29%), Positives = 124/264 (46%), Gaps = 16/264 (6%)
Query: 513 IGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIH-----SFRQEVSLMKRLRHPNVLLF 567
+G G+ GTVY +W VK+ + +E F E +M + HP+++
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+G SP + +VT+ +P G L + + + + + + IA+G+ YL ++
Sbjct: 75 LGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LV 131
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKH--ETYLTTKTGKGTPQWMAPEVLRNEPSDEK 685
HRDL + N+LV VK+ DFGL+RL E GK +WMA E + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 191
Query: 686 SDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHS 744
SDV+S+GV +WEL T P+D + + ++ + +RL P ++ CW
Sbjct: 192 SDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-KGERLPQPPICTIDVYMVMVKCWMI 250
Query: 745 DPQCRPSFQELVDKL----RDLQR 764
D RP F+EL + RD QR
Sbjct: 251 DADSRPKFKELAAEFSRMARDPQR 274
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 79/313 (25%), Positives = 130/313 (41%), Gaps = 72/313 (23%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIH--SFRQEVSL 555
YE+L +G+G+ G V G VA+K F ++ DE + + R EV +
Sbjct: 3 YEVL-------GVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALR-EVKV 53
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR--RRILMALDIA 613
+++LRH N++ A RL +V E++ R +L LL+ + L R + L
Sbjct: 54 LRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQL--L 110
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE-------TYLTTKTGK 666
+ ++Y H N IIHRD+K N+LV + +K+ DFG +R Y+ T+
Sbjct: 111 QAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR--- 165
Query: 667 GTPQWM-APEVLRNEPSDEKS-DVYSFGVILWELATEKIPWDNLNS-------MQVIG-- 715
W APE+L + + K DV++ G I+ EL + + + + +G
Sbjct: 166 ----WYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPL 221
Query: 716 -----------------AVGFMNQRLEI----PKDVDPRWAAIVESCWHSDPQCRPSFQE 754
A +Q + P V +++C DP+ R + E
Sbjct: 222 PPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281
Query: 755 LVDKLRDLQRQYF 767
L LQ YF
Sbjct: 282 L------LQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 67/234 (28%), Positives = 111/234 (47%), Gaps = 12/234 (5%)
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 590
VA+ R SD+ F E + + H N++ G +T + IVTE++ G+L
Sbjct: 36 VAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALD 94
Query: 591 RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
L+++ +L + + M +A G+ YL +H+ L + +LV+ K+ F
Sbjct: 95 SFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFR 152
Query: 651 -LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT--EKIPWDN 707
L K E TT +GK W APE ++ SDV+SFG+++WE+ + E+ WD
Sbjct: 153 RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD- 211
Query: 708 LNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 759
++ VI AV GF RL P++ ++ CW + RP F ++ L
Sbjct: 212 MSGQDVIKAVEDGF---RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 8e-26
Identities = 74/253 (29%), Positives = 120/253 (47%), Gaps = 31/253 (12%)
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 590
VAVK+ R + + + F +EV ++ RL+ PN++ +G LC++TE++ G L
Sbjct: 49 VAVKIL-RPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 591 RLLQRNTTK------------------LDWRRRILMALDIARGVSYLHHCNPPIIHRDLK 632
+ L + + + + +AL IA G+ YL N +HRDL
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLA 165
Query: 633 SSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP-QWMAPEVLRNEPSDEKSDVYS 690
+ N LV ++ T+K+ DFG+SR L Y + P +WMA E + SDV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 691 FGVILWELAT--EKIPWDNLNSMQVIGAVG--FMNQRLEI----PKDVDPRWAAIVESCW 742
FGV LWE+ ++ P+ L QVI G F +Q ++ P ++ CW
Sbjct: 226 FGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCW 285
Query: 743 HSDPQCRPSFQEL 755
D + RPSF ++
Sbjct: 286 SRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 52/160 (32%), Positives = 92/160 (57%), Gaps = 15/160 (9%)
Query: 550 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL--QRNT-----TKLDW 602
R+EV+++ ++HPN++ + + L IV ++ G L++ + QR LDW
Sbjct: 47 RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW 106
Query: 603 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
+I +AL H + I+HRD+KS N+ + K T+K+GDFG++R+ + T
Sbjct: 107 FVQICLALK--------HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158
Query: 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEK 702
+T GTP +++PE+ N P + KSD+++ G +L+E+ T K
Sbjct: 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 2e-25
Identities = 73/249 (29%), Positives = 128/249 (51%), Gaps = 9/249 (3%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E+IGQG+ GTV+ A V G +VA+K + Q+ + + E+ +MK L++PN++ F+
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKELKNPNIVNFL 82
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ L +V E+L GSL ++ T +D + + + + + +LH +IH
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQ--VIH 138
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RD+KS N+L+ +VK+ DFG T GTP WMAPEV+ + K D+
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 689 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRWAAIVESCWHSDPQ 747
+S G++ E+ + P+ N N ++ + + L+ P+ + P + + C D +
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVE 258
Query: 748 CRPSFQELV 756
R S +EL+
Sbjct: 259 KRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 70/257 (27%), Positives = 126/257 (49%), Gaps = 14/257 (5%)
Query: 509 IGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYS------DEVIHSFRQEVSLMKRLRHP 562
+ +++G+GS GTVY + ++ +E +E + + QE L+ +L HP
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHP 62
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSL---FRLLQRNTTKLDWRRRILMALDIARGVSYL 619
++ F + CI+TE+ L L+ L + + + GV Y+
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 679
H I+HRDLK+ N+ + + +K+GDFG+SRL + T GTP +M+PE L++
Sbjct: 123 HQRR--ILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179
Query: 680 EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 739
+ D KSD++S G IL+E+ ++ N + V+ + +P+ + +I++
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI-VEGPTPSLPETYSRQLNSIMQ 238
Query: 740 SCWHSDPQCRPSFQELV 756
S + DP RPS E++
Sbjct: 239 SMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 81/275 (29%), Positives = 130/275 (47%), Gaps = 30/275 (10%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
D+ + ++G+G+ G V+ A Y VAVK + F++E L+
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTN 63
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ---------------RNTTKLDWR 603
L+H +++ F G L +V E++ G L + L+ + +L
Sbjct: 64 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLTT 662
+ + +A IA G+ YL + +HRDL + N LV + VK+GDFG+SR + T Y
Sbjct: 124 QMLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181
Query: 663 KTGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFM 720
P +WM PE + +SDV+SFGVILWE+ T K PW L++ +VI +
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT-Q 240
Query: 721 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQEL 755
+ LE P+ I+ CW +PQ R + +E+
Sbjct: 241 GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 85/274 (31%), Positives = 137/274 (50%), Gaps = 27/274 (9%)
Query: 498 LDYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSL 555
LD +WE IGE +G G+ G VY A G+ A KV + S+E + + E+ +
Sbjct: 8 LDPNEVWE--IIGE-LGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEI 62
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL---LQRNTTKLDWR---RRILMA 609
+ HP ++ +GA +L I+ EF P G++ + L R T+ + R++L A
Sbjct: 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEA 122
Query: 610 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP 669
L YLH + IIHRDLK+ N+L+ +K+ DFG+S +T + GTP
Sbjct: 123 L------QYLH--SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTP 174
Query: 670 QWMAPEV-----LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QR 723
WMAPEV +++ P D K+D++S G+ L E+A + P LN M+V+ +
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT 234
Query: 724 LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVD 757
L P + +++ P+ RPS +L++
Sbjct: 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 74/259 (28%), Positives = 125/259 (48%), Gaps = 15/259 (5%)
Query: 512 QIGQGSCGTV----YHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
++G G+ GTV Y VAVK+ + +E ++M++L +P ++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+G + + +V E G L + LQ+N + + + ++ G+ YL N +
Sbjct: 62 IG-ICEAESWMLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLEETN--FV 117
Query: 628 HRDLKSSN-LLVDKHWTVKVGDFGLSRL--KHETYLTTKT-GKGTPQWMAPEVLRNEPSD 683
HRDL + N LLV +H+ K+ DFGLS+ E Y KT GK +W APE +
Sbjct: 118 HRDLAARNVLLVTQHYA-KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 684 EKSDVYSFGVILWE-LATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742
KSDV+SFGV++WE + + P+ + +V + +R+E P+ P +++ CW
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLCW 235
Query: 743 HSDPQCRPSFQELVDKLRD 761
RP F + +LR+
Sbjct: 236 TYGVDERPGFAVVELRLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 73/248 (29%), Positives = 127/248 (51%), Gaps = 31/248 (12%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
E+IGQG+ GTVY A V G +VA+K + +Q+ E+I + E+ +M+ +HPN++ +
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN---EILVMRENKHPNIVNY 81
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+ + L +V E+L GSL ++ T +D + + + + + +LH + +I
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH--SNQVI 137
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSD 687
HRD+KS N+L+ +VK+ DFG T GTP WMAPEV+ + K D
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 688 VYSFGVILWELATEKIPWDNLNSMQVIGAVG-------------------FMNQRLEIPK 728
++S G++ E+ + P+ N N ++ + + F+N+ LE+
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM-- 255
Query: 729 DVDPRWAA 736
DV+ R +A
Sbjct: 256 DVEKRGSA 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 84/301 (27%), Positives = 140/301 (46%), Gaps = 44/301 (14%)
Query: 492 DLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSF 549
DL N EDL +G G+ G+V + G+ +A KV V
Sbjct: 1 DLRN---------EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVV-HIGAKSSVRKQI 50
Query: 550 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILM 608
+E+ +M R P ++ F GA + +C+ EF+ GSL R+ ++ ++ +I
Sbjct: 51 LRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKI-- 108
Query: 609 ALDIARGVSYL---HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKT 664
A+ + G++YL H I+HRD+K SN+LV+ +K+ DFG+S L + T
Sbjct: 109 AVAVVEGLTYLYNVHR----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---ADT 161
Query: 665 GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD--NLNSMQVIGAVGFMNQ 722
GT +M+PE ++ KSDV+S G+ + ELA K P+ N++ +G ++
Sbjct: 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL 221
Query: 723 RLEIPKDVDPRWAA---------IVESCWHSDPQCRPSFQELVDKLRDLQRQYF-QASRS 772
+I ++ PR + V++C DP RP+ Q+L F QA R+
Sbjct: 222 LQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCA------MPPFIQALRA 275
Query: 773 T 773
+
Sbjct: 276 S 276
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 69/258 (26%), Positives = 130/258 (50%), Gaps = 15/258 (5%)
Query: 512 QIGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
++G G+ G V V+ DVA+KV + E V +E +M +L +P ++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVL-KNENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+G V + L +V E G L + L ++ + + ++ G+ YL N +
Sbjct: 61 IG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FV 117
Query: 628 HRDLKSSN-LLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP-QWMAPEVLRNEPSD 683
HRDL + N LLV++H+ K+ DFGLS+ ++Y ++ P +W APE +
Sbjct: 118 HRDLAARNVLLVNQHYA-KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 684 EKSDVYSFGVILWE-LATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742
+SDV+S+G+ +WE + + P+ + +V+ + +RL+ P + P A+++ CW
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCW 235
Query: 743 HSDPQCRPSFQELVDKLR 760
+ RP+F ++ +++R
Sbjct: 236 IYKWEDRPNFAKVEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 90/277 (32%), Positives = 133/277 (48%), Gaps = 25/277 (9%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQ-EYSDEVIHSFRQEVSL 555
D E L+ DL +IG GS G VY A V VA+K S + S+E +EV
Sbjct: 12 DPEKLFSDL---REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
+++LRHPN + + G +V E+ GS LL+ + L + +G
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
++YLH N +IHRD+K+ N+L+ + VK+GDFG + + GTP WMAPE
Sbjct: 128 LAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANXFVGTPYWMAPE 181
Query: 676 V---LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 732
V + D K DV+S G+ ELA K P N+N+M + + + E P
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNESPALQSG 237
Query: 733 RWAA----IVESCWHSDPQCRPSFQELVDKLRDLQRQ 765
W+ V+SC PQ RP+ E++ K R + R+
Sbjct: 238 HWSEYFRNFVDSCLQKIPQDRPT-SEVLLKHRFVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 104 bits (259), Expect = 3e-24
Identities = 85/271 (31%), Positives = 129/271 (47%), Gaps = 24/271 (8%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVY--HAVWYGSDVAVKVFSRQ-EYSDEVIHSFRQEVSL 555
D E L+ DL +IG GS G VY V VA+K S + S+E +EV
Sbjct: 22 DPEKLFTDL---REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKF 78
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
++R++HPN + + G +V E+ GS LL+ + L + +G
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQG 137
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
++YLH N +IHRD+K+ N+L+ + VK+ DFG + + + GTP WMAPE
Sbjct: 138 LAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIAS----PANSFVGTPYWMAPE 191
Query: 676 V---LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 732
V + D K DV+S G+ ELA K P N+N+M + + + E P
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNESPTLQSN 247
Query: 733 RWA----AIVESCWHSDPQCRPSFQELVDKL 759
W+ V+SC PQ RP+ +EL+ +
Sbjct: 248 EWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 69/219 (31%), Positives = 108/219 (49%), Gaps = 22/219 (10%)
Query: 512 QIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFR--QEVSLMKRLRHPNVLLF 567
IG G+ G V AV G VA+K S D++I + R +E+ L++ LRH N++
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISN--VFDDLIDAKRILREIKLLRHLRHENIIGL 64
Query: 568 MGAVTSPQRLC-----IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
+ + P IVTE + L ++++ D + + I RG+ YLH
Sbjct: 65 LDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFL-YQILRGLKYLHSA 122
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK--HETYLTTKTGKGTPQWM-APEVLRN 679
N +IHRDLK SN+LV+ + +K+ DFGL+R E T +W APE+L +
Sbjct: 123 N--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 680 EPSDEKS-DVYSFGVILWELATEKIPW---DNLNSMQVI 714
K+ D++S G I EL T K + D ++ + +I
Sbjct: 181 SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLI 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 83/267 (31%), Positives = 133/267 (49%), Gaps = 32/267 (11%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLF 567
E +G G+ G VY V G A+KV E +E I + E++++K+ H N+ +
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEI---KLEINMLKKYSHHRNIATY 78
Query: 568 MGAVT--SP----QRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSY 618
GA SP +L +V EF GS+ L++ N K DW I +I RG+++
Sbjct: 79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI--CREILRGLAH 136
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 678
LH +IHRD+K N+L+ ++ VK+ DFG+S T T GTP WMAPEV+
Sbjct: 137 LHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 194
Query: 679 NEPS-----DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733
+ + D +SD++S G+ E+A P +++ M+ + F+ R PK +
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----FLIPRNPPPKLKSKK 250
Query: 734 WA----AIVESCWHSDPQCRPSFQELV 756
W+ +E C + RPS ++L+
Sbjct: 251 WSKKFIDFIEGCLVKNYLSRPSTEQLL 277
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 72/246 (29%), Positives = 122/246 (49%), Gaps = 9/246 (3%)
Query: 513 IGQGSCGTVYHAVWYGSDV--AVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+GS G V A + AVKV ++ E H + L+K ++HP ++
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + +L V +++ G LF LQR L+ R R A +IA + YLH N I++
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRAR-FYAAEIASALGYLHSLN--IVY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK N+L+D + + DFGL + E TT T GTP+++APEVL +P D D
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179
Query: 689 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQC 748
+ G +L+E+ P+ + N+ ++ + +N+ L++ ++ ++E D
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNI--LNKPLQLKPNITNSARHLLEGLLQKDRTK 237
Query: 749 RPSFQE 754
R ++
Sbjct: 238 RLGAKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 72/259 (27%), Positives = 128/259 (49%), Gaps = 25/259 (9%)
Query: 511 EQIGQGSCGTVYHAVWY----GSDVAVK-VFSR-------QEYSDEVIHSFRQEVSLMK- 557
E +G G+ G VY V + +A+K + + D+ I EV+++K
Sbjct: 6 EHLGSGAFGCVY-KVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFL---PRGSLFRLLQRNTTKLDWRRRILMALDIAR 614
+LRHPN++ + RL IV + + P G F L+ + R + + +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH-ETYLTTKTGKGTPQWMA 673
+ YLH I+HRDL +N+++ + V + DFGL++ K E+ LT+ G T +
Sbjct: 125 ALRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVG--TILYSC 181
Query: 674 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE-IPKDV-D 731
PE+++NEP EK+DV++FG IL+++ T + P+ + N + + A + E +P+ +
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL--ATKIVEAVYEPLPEGMYS 239
Query: 732 PRWAAIVESCWHSDPQCRP 750
++ SC D + RP
Sbjct: 240 EDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 82/267 (30%), Positives = 134/267 (50%), Gaps = 32/267 (11%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLF 567
E +G G+ G VY V G A+KV +E I +QE++++K+ H N+ +
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEI---KQEINMLKKYSHHRNIATY 68
Query: 568 MGAVTSPQ------RLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSY 618
GA +L +V EF GS+ L++ NT K +W I +I RG+S+
Sbjct: 69 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI--CREILRGLSH 126
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 678
LH +IHRD+K N+L+ ++ VK+ DFG+S T T GTP WMAPEV+
Sbjct: 127 LHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184
Query: 679 NEPS-----DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733
+ + D KSD++S G+ E+A P +++ M+ + F+ R P+ +
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL----FLIPRNPAPRLKSKK 240
Query: 734 WA----AIVESCWHSDPQCRPSFQELV 756
W+ + +ESC + RP+ ++L+
Sbjct: 241 WSKKFQSFIESCLVKNHSQRPTTEQLM 267
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-23
Identities = 69/218 (31%), Positives = 107/218 (49%), Gaps = 18/218 (8%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLM 556
Y +L +G+GS G SD A+K R S + R+E L+
Sbjct: 1 QYNVL-------RVVGEGSFGRALLVQHVNSDQKYAMKEI-RLPKSSSAVEDSRKEAVLL 52
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM-ALDIARG 615
+++HPN++ F + + L IV E+ G L + ++ KL IL + + G
Sbjct: 53 AKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG 112
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
V ++H ++HRD+KS N+ + ++ VK+GDFG +RL T GTP ++ PE
Sbjct: 113 VQHIH--EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE 170
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEKIP-----WDNL 708
+ N P + KSD++S G IL+EL T K P W NL
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 5e-23
Identities = 77/270 (28%), Positives = 124/270 (45%), Gaps = 23/270 (8%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
Y DL +IG G+CG VY + G +AVK R +E ++K
Sbjct: 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK 69
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL--MALDIARG 615
P ++ G + + I E L L +LL+R + IL M + I +
Sbjct: 70 SHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKR--IQGPIPEDILGKMTVAIVKA 126
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
+ YL +IHRD+K SN+L+D VK+ DFG+S ++ T++ G +MAPE
Sbjct: 127 LHYLKE-KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-AGCAAYMAPE 184
Query: 676 VLRNEPSDEK------SDVYSFGVILWELATEKIPWDNLNS-MQVIGAVGFMNQ---RLE 725
R +P D +DV+S G+ L ELAT + P+ N + +V+ + + + L
Sbjct: 185 --RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI--LQEEPPSLP 240
Query: 726 IPKDVDPRWAAIVESCWHSDPQCRPSFQEL 755
+ P + + V+ C D + RP ++EL
Sbjct: 241 PNEGFSPDFCSFVDLCLTKDHRKRPKYREL 270
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 6e-23
Identities = 84/268 (31%), Positives = 127/268 (47%), Gaps = 41/268 (15%)
Query: 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDV--AVKVFSRQEYSDEVIHSFRQEVSL 555
L+ E WE IGE +G G+ G VY A + V A KV + S+E + + E+ +
Sbjct: 1 LNPEEFWE--IIGE-LGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDI 55
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL---LQRNTTKLDWRRRILMALDI 612
+ HPN++ + A L I+ EF G++ + L+R T+ R L+
Sbjct: 56 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE- 114
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM 672
++YLH IIHRDLK+ N+L +K+ DFG+S T + GTP WM
Sbjct: 115 --ALNYLH--ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 170
Query: 673 APEVL-----RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVG--------- 718
APEV+ ++ P D K+DV+S G+ L E+A + P LN M+V+ +
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQ 230
Query: 719 ----------FMNQRLEIPKDVDPRWAA 736
F+ + LE K+VD RW
Sbjct: 231 PSRWSSEFKDFLKKCLE--KNVDARWTT 256
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 7e-23
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNV 564
+ +Q+G G+ G+VY A G VA+K ++ YS +E + + R+ SL K HPN+
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECM-NLREVKSLRKLNEHPNI 60
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL-------DWRRRILMALDIARGVS 617
+ L V E++ G+L++L++ K +IL L
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLA------ 113
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL-----SRLKHETYLTTKTGKGTPQWM 672
++H HRDLK NLLV VK+ DFGL SR + Y++T+ W
Sbjct: 114 HIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-------WY 164
Query: 673 -APEV-LRNEPSDEKSDVYSFGVILWELAT 700
APE+ LR+ D+++ G I+ EL T
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 8e-23
Identities = 82/268 (30%), Positives = 128/268 (47%), Gaps = 28/268 (10%)
Query: 511 EQIGQGSCGTVY----HAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
++IG G G V ++ + + V VK E + F +E + L+H N+L
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK-FLEEAQPYRSLQHSNLLQ 59
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQ--RNTTKLDWRRRIL--MALDIARGVSYLHHC 622
+G T +V EF P G L L+ R + L MA +IA G+ +LH
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH-ETYLTTKTGKGTP-QWMAPEVLRNE 680
N IH DL N L+ TVK+GD+GLS K+ E Y T P +W+APE++
Sbjct: 120 N--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 681 PSD-------EKSDVYSFGVILWEL-ATEKIPWDNLNSMQVIGAVGFMNQRLEIPK---- 728
+ ++S+V+S GV +WEL P+ +L+ QV+ Q+L++PK
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT-VREQQLKLPKPRLK 236
Query: 729 -DVDPRWAAIVESCWHSDPQCRPSFQEL 755
+ RW +++ CW P+ RPS +E+
Sbjct: 237 LPLSDRWYEVMQFCW-LQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 9e-23
Identities = 78/263 (29%), Positives = 134/263 (50%), Gaps = 19/263 (7%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
ED + ++IG G+ G VY A V G A+KV + D + +QE+ +MK +H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV--VQQEIIMMKDCKHS 66
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
N++ + G+ +L I EF GSL + + T L + ++ + +G+ YLH
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSL-QDIYHVTGPLSESQIAYVSRETLQGLYYLH-- 123
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL---RN 679
+ +HRD+K +N+L+ + VK+ DFG+S T K+ GTP WMAPEV R
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 680 EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDP-RWAA- 736
++ D+++ G+ ELA + P +L+ M+ A+ M + + PK D +W+
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---ALFLMTKSNFQPPKLKDKMKWSNS 240
Query: 737 ---IVESCWHSDPQCRPSFQELV 756
V+ +P+ RP+ ++L+
Sbjct: 241 FHHFVKMALTKNPKKRPTAEKLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 1e-22
Identities = 56/165 (33%), Positives = 88/165 (53%), Gaps = 4/165 (2%)
Query: 543 DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDW 602
DEV H+ E +++ RHP + + + RLC V E+ G LF L R +
Sbjct: 37 DEVAHTL-TESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED 95
Query: 603 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
R R A +I + YLH C+ +++RDLK NL++DK +K+ DFGL + T
Sbjct: 96 RARFYGA-EIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM 152
Query: 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707
KT GTP+++APEVL + D + GV+++E+ ++P+ N
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 1e-22
Identities = 73/254 (28%), Positives = 124/254 (48%), Gaps = 25/254 (9%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRH 561
D +GE +G GS G V A G+ A+K ++E +V H QE S++ L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQH-VAQEKSILMELSH 77
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARGV 616
P ++ M + R+ + EF+ G LF L++ N + +++A +
Sbjct: 78 PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE----- 132
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPE 675
YLH + II+RDLK NLL+D VKV DFG + ++ T+ T GTP+++APE
Sbjct: 133 -YLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF----TLCGTPEYLAPE 185
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735
V++++ + D ++ GV+L+E P+ + ++ + + RL+ P D R
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI--LAGRLKFPNWFDGRAR 243
Query: 736 AIVESCWHSDPQCR 749
+V+ +D R
Sbjct: 244 DLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-22
Identities = 70/272 (25%), Positives = 124/272 (45%), Gaps = 22/272 (8%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEVSLMKRL 559
+L + +G G GTV+ +W VA+K + + + M L
Sbjct: 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSL 66
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
H ++ +G L +VT+ P GSL ++++ LD +R + + IA+G+ YL
Sbjct: 67 DHAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL 125
Query: 620 H-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-----KHETYLTTKTGKGTPQWMA 673
H ++HR+L + N+L+ V++ DFG++ L K Y KT +WMA
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT---PIKWMA 179
Query: 674 PEVLRNEPSDEKSDVYSFGVILWELATEKI-PWDNLNSMQVIGAVGFMNQRLEIPKDVDP 732
E + +SDV+S+GV +WE+ + P+ + +V + +RL P+
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQPQICTI 238
Query: 733 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764
++ CW D RP+F+EL ++ + R
Sbjct: 239 DVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 66/251 (26%), Positives = 116/251 (46%), Gaps = 27/251 (10%)
Query: 513 IGQGSCGTVY--HAVWYGSDVAVKVFSRQEYSDEVI--HSFRQEVSLMKRLRHPNVLLFM 568
+G G G V A+K ++ + H F E +++ HP ++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIF-SEKEILEECNHPFIVKLY 59
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR--------GVSYLH 620
+ + ++ E+ G L+ +L R R L AR YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTIL---------RDRGLFDEYTARFYIACVVLAFEYLH 110
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 680
+ II+RDLK NLL+D + VK+ DFG ++ K ++ T T GTP+++APE++ N+
Sbjct: 111 NRG--IIYRDLKPENLLLDSNGYVKLVDFGFAK-KLKSGQKTWTFCGTPEYVAPEIILNK 167
Query: 681 PSDEKSDVYSFGVILWELATEKIPW--DNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738
D D +S G++L+EL T + P+ D+ + M++ + N +LE P +D ++
Sbjct: 168 GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLI 227
Query: 739 ESCWHSDPQCR 749
+ +P+ R
Sbjct: 228 KQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-22
Identities = 74/278 (26%), Positives = 126/278 (45%), Gaps = 35/278 (12%)
Query: 511 EQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
E++G+ G VY +G+ VA+K + + + F+ E + RL+HPN
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHEAMMRSRLQHPN 69
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLL-----QRNTTKLDWRRRILMALD------- 611
++ +G VT Q L ++ + L L + D + + L+
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 612 ---IARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLTTKTG 665
IA G+ +L HH ++H+DL + N+LV VK+ D GL R + Y
Sbjct: 130 VTQIAAGMEFLSSHH----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185
Query: 666 KGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKI-PWDNLNSMQVIGAVGFMNQR 723
P +WM+PE + SD++S+GV+LWE+ + + P+ ++ VI + Q
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR-NRQV 244
Query: 724 LEIPKDVDPRWA-AIVESCWHSDPQCRPSFQELVDKLR 760
L P D P W ++ CW+ P RP F+++ +LR
Sbjct: 245 LPCPDDC-PAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 3e-22
Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 6/207 (2%)
Query: 543 DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDW 602
DEV H+ E +++ RHP + A + RLC V E+ G LF L R +
Sbjct: 37 DEVAHTV-TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE 95
Query: 603 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
R R A +I + YLH + +++RD+K NL++DK +K+ DFGL + T
Sbjct: 96 RARFYGA-EIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 152
Query: 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ 722
KT GTP+++APEVL + D + GV+++E+ ++P+ N + ++ + + +
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LME 210
Query: 723 RLEIPKDVDPRWAAIVESCWHSDPQCR 749
+ P+ + P +++ DP+ R
Sbjct: 211 EIRFPRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 9/199 (4%)
Query: 513 IGQGSCGTVYHAVWY---GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+G+ G V V A+K ++Q+ + + E +++ L HP ++
Sbjct: 8 IGKGAFGKVC-IVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + + +V + L G L L + + + + + +I + YLH IIH
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EIVLALEYLHSKG--IIH 123
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RD+K N+L+D+ V + DF ++ LTT + GTP +MAPEVL + D
Sbjct: 124 RDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT-STSGTPGYMAPEVLCRQGYSVAVDW 182
Query: 689 YSFGVILWELATEKIPWDN 707
+S GV +E K P+
Sbjct: 183 WSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 4e-22
Identities = 71/250 (28%), Positives = 129/250 (51%), Gaps = 11/250 (4%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
E+IGQG+ GTVY A + G +VA+K + +Q+ E+I + E+ +M+ ++PN++ +
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN---EILVMRENKNPNIVNY 81
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+ + L +V E+L GSL ++ T +D + + + + + +LH + +I
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLH--SNQVI 137
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSD 687
HRD+KS N+L+ +VK+ DFG T GTP WMAPEV+ + K D
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 688 VYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRWAAIVESCWHSDP 746
++S G++ E+ + P+ N N ++ + + L+ P+ + + + C D
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDV 257
Query: 747 QCRPSFQELV 756
R S +EL+
Sbjct: 258 DRRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 5e-22
Identities = 80/273 (29%), Positives = 127/273 (46%), Gaps = 41/273 (15%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+D+ E +G G+ GTVY A + +AVKV + + E+ E+ ++ + P
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIP-LDITVELQKQIMSELEILYKCDSP 59
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRI------LMALDIARGV 616
++ F GA R+ I TEF+ GSL D R+I +A+ + +G+
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGL 108
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEV 676
+YL I+HRD+K SN+LV+ VK+ DFG+S + KT GT +MAPE
Sbjct: 109 TYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTYVGTNAYMAPER 164
Query: 677 LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN--QRLEIPKDVDP-- 732
+ E SDV+S G+ ELA + P+ Q+ G + Q L+ D DP
Sbjct: 165 ISGEQYGIHSDVWSLGISFMELALGRFPY-----PQIQKNQGSLMPLQLLQCIVDEDPPV 219
Query: 733 --------RWAAIVESCWHSDPQCRPSFQELVD 757
++ + C P+ RP+ + L+D
Sbjct: 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 5e-22
Identities = 81/298 (27%), Positives = 130/298 (43%), Gaps = 35/298 (11%)
Query: 475 SSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VA 532
S SS S+SSSA L +L +IG G+ GTVY + + A
Sbjct: 50 PSSSSSSSSSSSASGSAPSAAKSL------SELERVNRIGSGAGGTVYKVIHRPTGRLYA 103
Query: 533 VKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL 592
+KV + D V +E+ +++ + HPNV+ + ++ EF+ GSL
Sbjct: 104 LKVIY-GNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL--- 159
Query: 593 LQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
T D + +A I G++YLH + I+HRD+K SNLL++ VK+ DFG+S
Sbjct: 160 --EGTHIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVS 215
Query: 653 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK-----SDVYSFGVILWELATEKIP--- 704
R+ +T + GT +M+PE + + + D++S GV + E + P
Sbjct: 216 RILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275
Query: 705 -----WDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVD 757
W +L M I M+Q E P + + C +P R S +L+
Sbjct: 276 GRQGDWASL--MCAIC----MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 6e-22
Identities = 74/265 (27%), Positives = 136/265 (51%), Gaps = 17/265 (6%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
E+IGQG+ GTVY A V G +VA++ + +Q+ E+I + E+ +M+ ++PN++ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRENKNPNIVNY 82
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+ + L +V E+L GSL ++ T +D + + + + + +LH + +I
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH--SNQVI 138
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSD 687
HRD+KS N+L+ +VK+ DFG T GTP WMAPEV+ + K D
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 688 VYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRWAAIVESCWHSDP 746
++S G++ E+ + P+ N N ++ + + L+ P+ + + + C D
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDV 258
Query: 747 QCRPSFQELVDKLRDLQRQYFQASR 771
+ R S +EL LQ Q+ + ++
Sbjct: 259 EKRGSAKEL------LQHQFLKIAK 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 68/216 (31%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDE--VIHSFRQEVSL 555
YE + QIG+G+ G VY A G VA+K R E E I + R E+ L
Sbjct: 1 YEKI-------AQIGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIR-EIKL 51
Query: 556 MKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKL-DWRRRILMALDI 612
+++LRHPN++ VTS + + +V E++ L LL K + + + M +
Sbjct: 52 LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYM-KQL 109
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ-- 670
G+ YLH I+HRD+K SN+L++ +K+ DFGL+R Y + T +
Sbjct: 110 LEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLAR----PYTKRNSADYTNRVI 163
Query: 671 --WM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
W PE+L + D++S G IL EL K
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-21
Identities = 80/274 (29%), Positives = 127/274 (46%), Gaps = 18/274 (6%)
Query: 492 DLDNDCLDYEILWEDLTIG-EQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFR 550
D + L Y+ E++ +G +IG GS G VY A ++ V V + YS + +
Sbjct: 7 DPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAV-KKMSYSGKQTNEKW 65
Query: 551 Q----EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRI 606
Q EV +++L+HPN + + G +V E+ GS LL+ + L
Sbjct: 66 QDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA 124
Query: 607 LMALDIARGVSYLH-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665
+ +G++YLH H +IHRD+K+ N+L+ + VK+ DFG + +
Sbjct: 125 AITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANSF 177
Query: 666 KGTPQWMAPEV---LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ 722
GTP WMAPEV + D K DV+S G+ ELA K P N+N+M + + +
Sbjct: 178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS 237
Query: 723 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELV 756
+ + V+ C PQ RP+ EL+
Sbjct: 238 PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 68/258 (26%), Positives = 111/258 (43%), Gaps = 37/258 (14%)
Query: 513 IGQGSCGTVYHA--VWYGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
I +G+ G+VY A G A+KV + + ++V + + +M + P V
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+ S L +V E+L G L++ DW ++ ++ GV LH II
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQ--YIAEVVLGVEDLHQRG--II 119
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSD 687
HRD+K NLL+D+ +K+ DFGLSR L K GTP ++APE + D+ SD
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNG----LENKKFVGTPDYLAPETILGVGDDKMSD 175
Query: 688 VYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES--CWHSD 745
+S G +++E G+ E P V + I+ W +
Sbjct: 176 WWSLGCVIFEFLF-----------------GYPPFHAETPDAV---FDNILSRRINWPEE 215
Query: 746 PQ--CRPSFQELVDKLRD 761
+ C P +L+++L
Sbjct: 216 VKEFCSPEAVDLINRLLC 233
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 5/207 (2%)
Query: 543 DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDW 602
DEV H+ E +++ RHP + + + RLC V E+ G LF L R +
Sbjct: 37 DEVAHTL-TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED 95
Query: 603 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
R R A +I + YLH +++RDLK NL++DK +K+ DFGL + + T
Sbjct: 96 RARFYGA-EIVSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 153
Query: 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ 722
KT GTP+++APEVL + D + GV+++E+ ++P+ N + ++ + + +
Sbjct: 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--LME 211
Query: 723 RLEIPKDVDPRWAAIVESCWHSDPQCR 749
+ P+ + P +++ DP+ R
Sbjct: 212 EIRFPRTLSPEAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 71/266 (26%), Positives = 134/266 (50%), Gaps = 20/266 (7%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
DYE++ +++G G+ G VY A + G AVK+ + D + +QE+ ++
Sbjct: 10 DYELI-------QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL--IQQEIFMV 60
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 616
K +H N++ + G+ S ++L I E+ GSL + + T L + + + +G+
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSL-QDIYHVTGPLSELQIAYVCRETLQGL 119
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEV 676
+YLH + +HRD+K +N+L+ + VK+ DFG++ T K+ GTP WMAPEV
Sbjct: 120 AYLH--SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177
Query: 677 L---RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ---VIGAVGFMNQRLEIPKDV 730
+N ++ D+++ G+ ELA + P +L+ M+ ++ F +L+
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKW 237
Query: 731 DPRWAAIVESCWHSDPQCRPSFQELV 756
+ V+ +P+ RP+ + L+
Sbjct: 238 SSTFHNFVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 68/241 (28%), Positives = 119/241 (49%), Gaps = 10/241 (4%)
Query: 513 IGQGSCGTV--YHAVWYGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+G+ G V G A+K+ ++ DEV H+ E ++K RHP +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTL-TESRVLKNTRHPFLTSLK 61
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + RLC V E++ G LF L R + R R A +I + YLH + I++
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-EIVSALDYLH--SGKIVY 118
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK NL++DK +K+ DFGL + T KT GTP+++APEVL + D
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 689 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQC 748
+ GV+++E+ ++P+ N + ++ + + + ++ P+ + +++ DP
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHEKLFELI--LMEDIKFPRTLSADAKSLLSGLLIKDPNK 236
Query: 749 R 749
R
Sbjct: 237 R 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 3e-21
Identities = 66/190 (34%), Positives = 101/190 (53%), Gaps = 7/190 (3%)
Query: 513 IGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD--EVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+GS G V A G AVKV ++ + E H + L+K ++HP ++
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + ++L V +F+ G LF LQR + + R R A +IA + YLH N I++
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHSIN--IVY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK N+L+D V + DFGL + TT T GTP+++APEV+R +P D D
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDW 179
Query: 689 YSFGVILWEL 698
+ G +L+E+
Sbjct: 180 WCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 69/247 (27%), Positives = 122/247 (49%), Gaps = 21/247 (8%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEV-SLM--KRL-----RHP 562
+G+GS G V A G+D AVKV + D ++ +V M KR+ +HP
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKK----DVILQ--DDDVECTMTEKRVLALAGKHP 56
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
+ + RL V E++ G L +QR + + D R A +I G+ +LH
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLH-- 113
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 682
II+RDLK N+L+D +K+ DFG+ + +TT T GTP ++APE+L +P
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY 173
Query: 683 DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742
D ++ GV+L+E+ + P++ + ++ ++ + + P+ + +I++S
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI--LEDEVRYPRWLSKEAKSILKSFL 231
Query: 743 HSDPQCR 749
+P+ R
Sbjct: 232 TKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-21
Identities = 81/277 (29%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 504 WEDLTIGEQIGQGSCGTVY--HAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR- 560
WE I E IG+G+ G V+ GS AVK+ DE I + E +++K L
Sbjct: 20 WE---IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA---EYNILKALSD 73
Query: 561 HPNVLLFMGA-----VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
HPNV+ F G V + +L +V E GS+ L++ + + ++A +
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 616 VSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAP 674
+ L H IHRD+K +N+L+ VK+ DFG+S T L T GTP WMAP
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193
Query: 675 EVLRNEPS-----DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKD 729
EV+ E D + DV+S G+ EL P +L+ M+ + +IP++
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL---------FKIPRN 244
Query: 730 VDPR------WAA----IVESCWHSDPQCRPSFQELV 756
P W+ + C D + RP+ +L+
Sbjct: 245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 1e-20
Identities = 54/148 (36%), Positives = 89/148 (60%), Gaps = 16/148 (10%)
Query: 619 LHHCNPP-IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK---GTPQWMAP 674
+HH + +IHRD+KS+N+L+ + VK+GDFG S++ T ++ G+ GTP ++AP
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT-VSDDVGRTFCGTPYYVAP 214
Query: 675 EVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE-----IPKD 729
E+ R +P +K+D++S GV+L+EL T K P+D N +V M++ L +P
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV------MHKTLAGRYDPLPPS 268
Query: 730 VDPRWAAIVESCWHSDPQCRPSFQELVD 757
+ P IV + SDP+ RPS +L++
Sbjct: 269 ISPEMQEIVTALLSSDPKRRPSSSKLLN 296
|
Length = 496 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 71/249 (28%), Positives = 123/249 (49%), Gaps = 11/249 (4%)
Query: 512 QIGQGSCGTVYHAV--WYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+IG+GS G V A G VAVK R++ E++ + EV +M+ H NV+
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN---EVVIMRDYHHENVVDMY 85
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ L +V EFL G+L ++ T+++ + + L + R +SYLH N +IH
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLH--NQGVIH 141
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RD+KS ++L+ +K+ DFG + K+ GTP WMAPEV+ P + D+
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDI 201
Query: 689 YSFGVILWELATEKIPWDNLNSMQVIGAV-GFMNQRLEIPKDVDPRWAAIVESCWHSDPQ 747
+S G+++ E+ + P+ N +Q + + + R++ V ++ +P
Sbjct: 202 WSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPS 261
Query: 748 CRPSFQELV 756
R + QEL+
Sbjct: 262 QRATAQELL 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-20
Identities = 56/167 (33%), Positives = 89/167 (53%), Gaps = 19/167 (11%)
Query: 606 ILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETYLTTK 663
I + +ARG+ +L + IHRDL + N+L+ ++ VK+ DFGL+R K Y+
Sbjct: 176 ISYSFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 233
Query: 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWE---LATEKIPWDNLNSMQVIGAVGFM 720
+ +WMAPE + ++ +SDV+SFGV+LWE L P ++ F
Sbjct: 234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-------EFC 286
Query: 721 NQ-----RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
+ R+ P+ P +I+ CWH++P+ RP+F ELV+ L DL
Sbjct: 287 RRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-20
Identities = 56/167 (33%), Positives = 88/167 (52%), Gaps = 19/167 (11%)
Query: 606 ILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETYLTTK 663
I + +ARG+ +L + IHRDL + N+L+ ++ VK+ DFGL+R K Y+
Sbjct: 177 ICYSFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 234
Query: 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWE---LATEKIPWDNLNSMQVIGAVGFM 720
+ + +WMAPE + ++ +SDV+SFGV+LWE L P +N F
Sbjct: 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-------EFC 287
Query: 721 NQ-----RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
+ R+ P++ P I+ +CW DP+ RP+F LV+ L DL
Sbjct: 288 QRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 7e-20
Identities = 83/280 (29%), Positives = 125/280 (44%), Gaps = 43/280 (15%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-R 560
WE I E IG+G+ G VY GS AVK+ DE I + E ++++ L
Sbjct: 24 WE---IIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA---EYNILQSLPN 77
Query: 561 HPNVLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALDI 612
HPNV+ F G + L +V E GS+ L++ +LD +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM 672
G+ +LH N IIHRD+K +N+L+ VK+ DFG+S T L T GTP WM
Sbjct: 138 LLGLQHLH--NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 195
Query: 673 APEVLRNEPS-----DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP 727
APEV+ E D + DV+S G+ EL P +++ ++ + +IP
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL---------FKIP 246
Query: 728 KDVDP------RWAA----IVESCWHSDPQCRPSFQELVD 757
++ P +W + C D + RPS L++
Sbjct: 247 RNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 8e-20
Identities = 71/251 (28%), Positives = 124/251 (49%), Gaps = 15/251 (5%)
Query: 512 QIGQGSCGTVYHAV--WYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+IG+GS G V A G VAVK R++ E++ + EV +M+ +H NV+
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQHENVVEMY 83
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ L +V EFL G+L ++ T+++ + + L + + +S LH +IH
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLH--AQGVIH 139
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RD+KS ++L+ VK+ DFG + K+ GTP WMAPE++ P + D+
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDI 199
Query: 689 YSFGVILWELATEKIPWDN---LNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSD 745
+S G+++ E+ + P+ N L +M++I + +L+ V P ++ D
Sbjct: 200 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIR--DNLPPKLKNLHKVSPSLKGFLDRLLVRD 257
Query: 746 PQCRPSFQELV 756
P R + EL+
Sbjct: 258 PAQRATAAELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 9e-20
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 25/205 (12%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGSD--VAVK---VFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
G+++G+G+ VY A + VA+K + R+E D + + +E+ L++ L+HP
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHP 62
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL---DWRRRILMALDIARGVSYL 619
N++ + + +V EF+ L ++++ + L D + +LM L RG+ YL
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL---RGLEYL 118
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ----WM-AP 674
H I+HRDLK +NLL+ +K+ DFGL+R ++ + K T Q W AP
Sbjct: 119 HSNW--ILHRDLKPNNLLIASDGVLKLADFGLAR----SFGSPNR-KMTHQVVTRWYRAP 171
Query: 675 EVLRNEPSDEKS-DVYSFGVILWEL 698
E+L D++S G I EL
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFAEL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 68/260 (26%), Positives = 122/260 (46%), Gaps = 24/260 (9%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHP 562
+ I ++IG+G VY A VA+K E D + +E+ L+K+L HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ--RNTTKLDWRRRILMA-LDIARGVSYL 619
NV+ ++ + L IV E G L ++++ + +L R + + + V ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 679
H + ++HRD+K +N+ + VK+GD GL R + GTP +M+PE +
Sbjct: 123 H--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 680 EPSDEKSDVYSFGVILWELATEKIPW--DNLNSMQVIGAVGFMNQRLE------IPKD-V 730
+ KSD++S G +L+E+A + P+ D +N + Q++E +P +
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLC-------QKIEQCDYPPLPTEHY 233
Query: 731 DPRWAAIVESCWHSDPQCRP 750
+ +V C + DP RP
Sbjct: 234 SEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 69/239 (28%), Positives = 105/239 (43%), Gaps = 13/239 (5%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQ--EYSDEVIHSFRQEVSLMKRLRH 561
D I Q+GQG G V+ A + VA+K + +EV H E ++ +
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRH-VLTERDILTTTKS 60
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIARGVSYLH 620
++ + A + L + E++P G FR L N L R MA ++ V LH
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGD-FRTLLNNLGVLSEDHARFYMA-EMFEAVDALH 118
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 680
IHRDLK N L+D +K+ DFGLS+ + G+P +MAPEVLR +
Sbjct: 119 ELG--YIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRGK 173
Query: 681 PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 739
D D +S G +L+E P+ + + + + L+ P DPR+ E
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDE 232
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 3e-19
Identities = 63/224 (28%), Positives = 114/224 (50%), Gaps = 17/224 (7%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLM-KRL-----RHPNV 564
+G+GS G V A G+D A+K+ + D +I E +++ KR+ + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKK----DVIIQDDDVECTMVEKRVLALPGKPPFL 63
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ RL V E++ G L +Q+ K + A +IA G+ +LH +
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLH--SK 120
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDE 684
II+RDLK N+++D +K+ DFG+ + TT+T GTP ++APE++ +P +
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGK 180
Query: 685 KSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 728
D ++FGV+L+E+ + P+D + ++ ++ M + PK
Sbjct: 181 SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI--MEHNVSYPK 222
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 3e-19
Identities = 51/160 (31%), Positives = 83/160 (51%), Gaps = 5/160 (3%)
Query: 606 ILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETYLTTK 663
I + +A+G+ +L + IHRDL + N+L+ ++ VK+ DFGL+R K Y+
Sbjct: 182 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239
Query: 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL-ATEKIPWDNLNSMQVIGAVGFMNQ 722
+ +WMAPE + + +SDV+SFGV+LWE+ + P+ + +
Sbjct: 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 299
Query: 723 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
R+ P P + CWH +P RP+F ELV+ L +L
Sbjct: 300 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 66/254 (25%), Positives = 120/254 (47%), Gaps = 12/254 (4%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHP 562
+ I ++IG+G VY A G VA+K + D + +E+ L+K+L HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ--RNTTKLDWRRRILMA-LDIARGVSYL 619
NV+ + + L IV E G L R+++ + +L + + + + + ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 679
H + ++HRD+K +N+ + VK+GD GL R + GTP +M+PE +
Sbjct: 123 H--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 680 EPSDEKSDVYSFGVILWELATEKIPW--DNLNSMQVIGAVGFMNQRLEIPKD-VDPRWAA 736
+ KSD++S G +L+E+A + P+ D +N + + + +P D
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP-PLPSDHYSEELRQ 239
Query: 737 IVESCWHSDPQCRP 750
+V C + DP+ RP
Sbjct: 240 LVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 68/206 (33%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHPNVLLF 567
E+IG+G+ G VY A G VA+K R E DE + S +E+SL+K L HPN++
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMAL-DIARGVSYLHHCNPP 625
+ V S +L +V EFL L + + T LD I L + +G++Y H +
Sbjct: 64 LDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLD-PPLIKSYLYQLLQGIAYCH--SHR 119
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSR--------LKHETYLTTKTGKGTPQWMAPEVL 677
++HRDLK NLL+D+ +K+ DFGL+R HE T + APE+L
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--------TLWYRAPEIL 171
Query: 678 RNEPSDEKS-DVYSFGVILWELATEK 702
D++S G I E+ +
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-19
Identities = 67/245 (27%), Positives = 121/245 (49%), Gaps = 17/245 (6%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLM-KRL-----RHPNV 564
+G+GS G V A G+D A+K+ + D VI E +++ KR+ + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKK----DVVIQDDDVECTMVEKRVLALSGKPPFL 63
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ RL V E++ G L +Q+ + + A +IA G+ +LH +
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLH--SK 120
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDE 684
II+RDLK N+++D +K+ DFG+ + +TTKT GTP ++APE++ +P +
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK 180
Query: 685 KSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHS 744
D ++FGV+L+E+ + P++ + ++ ++ M + PK + AI +
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--MEHNVAYPKSMSKEAVAICKGLMTK 238
Query: 745 DPQCR 749
P R
Sbjct: 239 HPGKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 51/159 (32%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 550 RQEV-SLM--KRL-------RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK 599
R EV SLM KR+ RHP ++ + +C V E+ G L + +
Sbjct: 40 RDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDV-- 97
Query: 600 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659
R + A + G+ YLH I++RDLK NLL+D VK+ DFGL +
Sbjct: 98 FSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155
Query: 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL 698
T T GTP+++APEVL D + GV+++E+
Sbjct: 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEM 194
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 61/223 (27%), Positives = 110/223 (49%), Gaps = 21/223 (9%)
Query: 551 QEVSLMKRLRHPNVLLFMGAVTSPQ--RLCIVTEFLPRGSLFRLLQRNTTKLDWR--RRI 606
+E+ + K + P ++ + GA + I E+ GSL + ++ K R ++
Sbjct: 48 RELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKK-VKKRGGRIGEKV 106
Query: 607 L--MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664
L +A + +G+SYLH IIHRD+K SN+L+ + VK+ DFG+S + T T
Sbjct: 107 LGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT 164
Query: 665 GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW--DNLNSMQVIGAVGFM-- 720
GT +MAPE ++ +P SDV+S G+ L E+A + P+ + + I + ++
Sbjct: 165 --GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN 222
Query: 721 --NQRLEIPKDVDPRWA----AIVESCWHSDPQCRPSFQELVD 757
N L+ +W+ ++ C DP RP+ ++++
Sbjct: 223 MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-19
Identities = 71/255 (27%), Positives = 127/255 (49%), Gaps = 21/255 (8%)
Query: 512 QIGQGSCGTVYHA--VWYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+IG+GS G V A G VAVK+ R++ E++ + EV +M+ +H NV+
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMRDYQHQNVVEMY 84
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + L ++ EFL G+L ++ + T+L+ + + + + + YLH + +IH
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLH--SQGVIH 140
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RD+KS ++L+ VK+ DFG + K+ GTP WMAPEV+ P + D+
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDI 200
Query: 689 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP------KDVDPRWAAIVESCW 742
+S G+++ E+ + P+ + + +Q + + R P + P +E
Sbjct: 201 WSLGIMVIEMVDGEPPYFSDSPVQAMKRL-----RDSPPPKLKNAHKISPVLRDFLERML 255
Query: 743 HSDPQCRPSFQELVD 757
+PQ R + QEL+D
Sbjct: 256 TREPQERATAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-19
Identities = 82/272 (30%), Positives = 130/272 (47%), Gaps = 37/272 (13%)
Query: 511 EQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
++IG G G V + Y + V VK S E + F Q+ + L+HPN+L
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ-NEFLQQGDPYRILQHPNILQ 59
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR---IL----MALDIARGVSYL 619
+G +V E+ G L L + W RR +L MA +IA GV+++
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLSQE----QWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL--SRLKHETYLTTKTGKGTP-QWMAPEV 676
H N +H DL N + TVKVGD+G+ SR K E Y+ T+ K P +W+APE+
Sbjct: 116 HKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK-EDYIETEDDKCVPLRWLAPEL 172
Query: 677 -------LRNEPSDEKSDVYSFGVILWEL-ATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 728
L + S+V++ GV LWEL P+ +L+ +V+ V +Q++++ K
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV-IKDQQVKLFK 231
Query: 729 -----DVDPRWAAIVESCWHSDPQCRPSFQEL 755
RW +++ CW S P+ R + +E+
Sbjct: 232 PQLELPYSERWYEVLQFCWLS-PEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
I +IG+G+ G V+ A + VA+K + + + + +E+ ++ +HP V+
Sbjct: 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVV 62
Query: 566 LFMGAVTSPQRLCIVTEFLPRG--SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
+ +V E++P + R +R + + + M L GV+Y+H
Sbjct: 63 KLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLK---GVAYMHANG 119
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ----W-MAPEVLR 678
I+HRDLK +NLL+ +K+ DFGL+RL + + + Q W APE+L
Sbjct: 120 --IMHRDLKPANLLISADGVLKIADFGLARL----FSEEEPRLYSHQVATRWYRAPELLY 173
Query: 679 NEPS-DEKSDVYSFGVILWEL 698
D D+++ G I EL
Sbjct: 174 GARKYDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 67/202 (33%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVK-VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
IG+G+ G VY A S VA+K V E I S R E++L+ LRHPN++
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELKE 73
Query: 570 AVTSPQ--RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH-HCNPPI 626
V + +V E+ + L LL T + + L + RG+ YLH + I
Sbjct: 74 VVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---I 129
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ----WM-APEVLRNEP 681
IHRDLK SNLL+ +K+ DFGL+R TP+ W APE+L
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-----KPMTPKVVTLWYRAPELLLGCT 184
Query: 682 SDEKS-DVYSFGVILWELATEK 702
+ + D+++ G IL EL K
Sbjct: 185 TYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 68/211 (32%), Positives = 99/211 (46%), Gaps = 35/211 (16%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPN 563
+IG+G+ GTVY A + G VA+K + + S +E++L+K+L HPN
Sbjct: 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 564 VLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQR--------NTTKLDWRRRILMAL 610
++ + P+ L +V E + + L L + T K D R++L
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIK-DLMRQLL--- 117
Query: 611 DIARGVSYLH-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETYLTTKTGKGT 668
RGV +LH H I+HRDLK N+LV VK+ DFGL+R+ E LT+
Sbjct: 118 ---RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVV---V 168
Query: 669 PQWM-APEVLRNEPSDEKSDVYSFGVILWEL 698
W APEVL D++S G I EL
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 69/217 (31%), Positives = 101/217 (46%), Gaps = 38/217 (17%)
Query: 506 DLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHP 562
D T E+IG+G+ G VY G VA+K R E +E + S +E+SL+K L+HP
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHP 59
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH- 621
N++ + RL ++ EFL L + L ++ +D SYL+
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSM-DLKKYL--DSLPKG------QYMDAELVKSYLYQI 110
Query: 622 ------CNPP-IIHRDLKSSNLLVDKHWTVKVGDFGLSR--------LKHETYLTTKTGK 666
C+ ++HRDLK NLL+D +K+ DFGL+R HE
Sbjct: 111 LQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV------- 163
Query: 667 GTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEK 702
T + APEVL P D++S G I E+AT+K
Sbjct: 164 -TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 77/294 (26%), Positives = 132/294 (44%), Gaps = 55/294 (18%)
Query: 513 IGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570
+G+GS G V G VA+K F E V +E+ ++K+LRH N++ +
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 571 VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRD 630
+RL +V EF+ ++ L++ LD R I RG+ + H N IIHRD
Sbjct: 69 FRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRD 125
Query: 631 LKSSNLLVDKHWTVKVGDFGLSRL------KHETYLTTKTGKGTPQWM-APEVLRNEPSD 683
+K N+LV + VK+ DFG +R + Y+ T+ W APE+L +
Sbjct: 126 IKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-------WYRAPELLVGDTKY 178
Query: 684 EKS-DVYSFGVILWELATEK--IPWD-NLNSM-QVIGAVG---------------FMNQR 723
++ D+++ G ++ E+ T + P D +++ + +I +G F R
Sbjct: 179 GRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238
Query: 724 LEIPKDVD------PRWAAIV----ESCWHSDPQCRPSFQELVDKLRDLQRQYF 767
L K+++ P+ + +V + C DP RPS +L L ++F
Sbjct: 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL------LHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-17
Identities = 64/228 (28%), Positives = 111/228 (48%), Gaps = 14/228 (6%)
Query: 511 EQIGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLL 566
+ +G+GS G V+ A G++ A+K + D+V + ++ L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
+ + L V E+L G L +Q + K D R A +I G+ +LH + I
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQ-SCHKFDLPRATFYAAEIICGLQFLH--SKGI 117
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS 686
++RDLK N+L+D +K+ DFG+ + T T GTP ++APE+L + +
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV 177
Query: 687 DVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734
D +SFGV+L+E+ + P+ + ++ F + R++ P PRW
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEEL-----FQSIRMDNP--CYPRW 218
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-17
Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 12/200 (6%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVWYGSD---VAVKVFSRQEY--SDEVIHSFRQEVSLMKR 558
+ED +G GS G V A + D VA+K F + + +V H F E ++
Sbjct: 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNY 87
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
+ HP + G+ L +V EF+ G F L+RN + A I Y
Sbjct: 88 INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEY 146
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 678
L N I++RDLK NLL+DK +K+ DFG +++ +T T T GTP+++APE+L
Sbjct: 147 LQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVV-DT--RTYTLCGTPEYIAPEILL 201
Query: 679 NEPSDEKSDVYSFGVILWEL 698
N + +D ++ G+ ++E+
Sbjct: 202 NVGHGKAADWWTLGIFIYEI 221
|
Length = 340 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 71/242 (29%), Positives = 110/242 (45%), Gaps = 41/242 (16%)
Query: 501 EILWE---DLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFR--QEV 553
+ +WE +G G+ G V A + VA+K SR S IH+ R +E+
Sbjct: 8 KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYREL 65
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRL------CIVTEFLPRGSLFRLLQRNTTKL-DWRRRI 606
L+K + H NV+ + T L +VT + L +++ KL D +
Sbjct: 66 RLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVK--CQKLSDDHIQF 122
Query: 607 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE---TYLTTK 663
L I RG+ Y+H IIHRDLK SN+ V++ +K+ DFGL+R + Y+ T+
Sbjct: 123 L-VYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR 179
Query: 664 TGKGTPQW-MAPEVLRNEPSDEKS-DVYSFGVILWELATEKI------PWDNLNS-MQVI 714
W APE++ N ++ D++S G I+ EL T K D L M ++
Sbjct: 180 -------WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLV 232
Query: 715 GA 716
G
Sbjct: 233 GT 234
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-17
Identities = 62/241 (25%), Positives = 119/241 (49%), Gaps = 9/241 (3%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+GS G V A G+D A+K+ + D+V + ++ L + + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ RL V E++ G L +Q+ K + + A +I+ G+ +LH II+
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRG--IIY 124
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK N+++D +K+ DFG+ + +TT+T GTP ++APE++ +P + D
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184
Query: 689 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQC 748
+++GV+L+E+ + P+D + ++ ++ M + PK + +I + P
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSI--MEHNVSYPKSLSKEAVSICKGLMTKHPSK 242
Query: 749 R 749
R
Sbjct: 243 R 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 64/243 (26%), Positives = 124/243 (51%), Gaps = 35/243 (14%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFS-------RQEYSDEVIHSFRQEVSL 555
+DL + +G G+ G V+ A+KV + +QE + +H+ E +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQE---QHVHN---EKRV 54
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-----RNTTKLDWRRRILMAL 610
+K + HP ++ + L ++ E++P G LF L+ N+T L + I+ AL
Sbjct: 55 LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCAL 114
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP 669
+ YLH I++RDLK N+L+DK +K+ DFG ++ L+ T+ T GTP
Sbjct: 115 E------YLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW----TLCGTP 162
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKD 729
+++APEV++++ ++ D ++ G++++E+ P+ + N + + + +LE P+
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI--LAGKLEFPRH 220
Query: 730 VDP 732
+D
Sbjct: 221 LDL 223
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 76/272 (27%), Positives = 121/272 (44%), Gaps = 32/272 (11%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDV--AVKVFSRQEYSDEVIHSFRQEVSLMKRLRH- 561
EDL +IG+G+ GTV + S AVK R ++ ++ ++ R
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR--RRIL--MALDIARGVS 617
P ++ F GA+ I E L SL + + L IL +A+ + ++
Sbjct: 63 PYIVKFYGALFREGDCWICME-LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALN 121
Query: 618 YL---HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK----GTPQ 670
YL IIHRD+K SN+L+D++ +K+ DFG+S L K G
Sbjct: 122 YLKEELK----IIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRP 172
Query: 671 WMAPEVL---RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM--QVIGAVGFMNQRL- 724
+MAPE + + D +SDV+S G+ L+E+AT K P+ NS+ Q+ V L
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS 232
Query: 725 -EIPKDVDPRWAAIVESCWHSDPQCRPSFQEL 755
++ P + + C D RP ++EL
Sbjct: 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKEL 264
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 57/180 (31%), Positives = 91/180 (50%), Gaps = 25/180 (13%)
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK- 666
+A+ I + + YLH +IHRD+K SN+L++++ VK+ DFG+S YL K
Sbjct: 108 IAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFGIS-----GYLVDSVAKT 161
Query: 667 ---GTPQWMAPEVLRNEPS----DEKSDVYSFGVILWELATEKIPWDNLNSM--QVIGAV 717
G +MAPE + E + D KSDV+S G+ + ELAT + P+D+ + Q+ V
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV 221
Query: 718 GFMNQRLEIPKD-VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGD 776
+ +L P + P + V C + + RP++ EL LQ +F+ S D
Sbjct: 222 EEPSPQL--PAEKFSPEFQDFVNKCLKKNYKERPNYPEL------LQHPFFELHLSKNTD 273
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 3e-17
Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 15/206 (7%)
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
P V + +R ++ + +L+ + LD + + +A+G+S+L
Sbjct: 173 PGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS 232
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP-QWMAPEVLRN 679
N IHRDL + N+L+ K+ DFGL+R +++++ K P +WMAPE + N
Sbjct: 233 KN--CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN 290
Query: 680 EPSDEKSDVYSFGVILWELAT------EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733
+SDV+S+G++LWE+ + +P D+ ++I G+ R+ P+
Sbjct: 291 CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKE-GY---RMLSPECAPSE 345
Query: 734 WAAIVESCWHSDPQCRPSFQELVDKL 759
I++SCW +DP RP+F+++V +
Sbjct: 346 MYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 4e-17
Identities = 74/258 (28%), Positives = 113/258 (43%), Gaps = 34/258 (13%)
Query: 528 GSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRHPN-VLLFMGAVTSPQRLCIVTEFLP 585
G +VA+K+ +E FR+E +L RL HPN V L P L V E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 586 RGSLFRLLQRN--TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DK 640
+L +L + + R +L LD ++ H N I+HRDLK N++V
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLD---ALACAH--NQGIVHRDLKPQNIMVSQTGV 117
Query: 641 HWTVKVGDFGLSRL---KHETYLTTKTGK----GTPQWMAPEVLRNEPSDEKSDVYSFGV 693
KV DFG+ L + + T T GTP + APE LR EP SD+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 694 ILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD-PRW------AAIVESCWHSDP 746
I E T + + +++ + P DV P W ++ + DP
Sbjct: 178 IFLECLTGQRVVQGASVAEIL-------YQQLSPVDVSLPPWIAGHPLGQVLRKALNKDP 230
Query: 747 QCRP-SFQELVDKLRDLQ 763
+ R S L ++ R L+
Sbjct: 231 RQRAASAPALAERFRALE 248
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 5e-17
Identities = 68/243 (27%), Positives = 114/243 (46%), Gaps = 13/243 (5%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSR----QEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
+G+GS G V A S AVKV + Q+ E + ++ +SL + HP +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN--HPFLTQ 60
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
+P RL V EF+ G L +Q+ + + D R A +I + +LH + I
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEITSALMFLH--DKGI 117
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS 686
I+RDLK N+L+D K+ DFG+ + TT T GTP ++APE+L+
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSV 177
Query: 687 DVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 746
D ++ GV+L+E+ P++ N + A+ +N + P + I+++ +P
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAI--LNDEVVYPTWLSQDAVDILKAFMTKNP 235
Query: 747 QCR 749
R
Sbjct: 236 TMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 66/291 (22%), Positives = 116/291 (39%), Gaps = 48/291 (16%)
Query: 509 IGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+ + + VAVK + S E + +QE+ ++L+HPN+L ++
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL---DIARGVSYLHHCNPP 625
+ L +V+ + GS LL+ + + + +A D+ + Y+H
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSKG-- 121
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDF--GLSRLKH-----ETYLTTKTGKGTPQWMAPEVLR 678
IHR +K+S++L+ V + +S +KH + K+ W++PEVL+
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181
Query: 679 NEPS--DEKSDVYSFGVILWELA---------------TEKI-------------PWDNL 708
+EKSD+YS G+ ELA EK+ P
Sbjct: 182 QNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241
Query: 709 NSMQVIGAVGFMN--QRLEIP--KDVDPRWAAIVESCWHSDPQCRPSFQEL 755
+ Q + N ++ P + + VE C DP+ RPS +L
Sbjct: 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQL 292
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 6/138 (4%)
Query: 570 AVTSPQRLCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
A + LC+V + G L + + R I A I G+ +LH I++
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVY 118
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSD 687
RDLK N+L+D H V++ D GL+ LK K GTP +MAPEVL+ E D D
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGEVYDFSVD 176
Query: 688 VYSFGVILWELATEKIPW 705
++ G L+E+ + P+
Sbjct: 177 WFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 41/227 (18%)
Query: 509 IGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQ-------------EV 553
G +G+G+ G V A G VA+K E S++V RQ E+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKD-RQLVGMCGIHFTTLREL 71
Query: 554 SLMKRLRHPNVLLFMGAV---TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
+M ++H N+ MG V + +V + + L +++ R + + + ++ L
Sbjct: 72 KIMNEIKHENI---MGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCIL-L 126
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP 669
I G++ LH +HRDL +N+ ++ K+ DFGL+R + Y T + T
Sbjct: 127 QILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 670 Q------------WM-APEVLRN-EPSDEKSDVYSFGVILWELATEK 702
Q W APE+L E D++S G I EL T K
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 23/203 (11%)
Query: 513 IGQGSCGTV---YHAVWYGSDVAVKVFSRQEYSDEVIHSFR--QEVSLMKRLRHPNVLLF 567
IG G+ G V Y V G +VA+K SR V H+ R +E+ LMK + H N++
Sbjct: 24 IGSGAQGIVCAAYDTV-TGQNVAIKKLSRP--FQNVTHAKRAYRELVLMKLVNHKNIIGL 80
Query: 568 MGAVTSPQR-------LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
+ T PQ+ + +V E + +L +++Q + LD R + + G+ +LH
Sbjct: 81 LNVFT-PQKSLEEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH 135
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 680
+ IIHRDLK SN++V T+K+ DFGL+R +++ T T + APEV+
Sbjct: 136 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-VVTRYYRAPEVILGM 192
Query: 681 PSDEKSDVYSFGVILWELATEKI 703
E D++S G I+ E+ +
Sbjct: 193 GYKENVDIWSVGCIMGEMIRGTV 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 7/201 (3%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+GS G V A G+D A+KV + D+V + ++ L +HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ RL V E++ G L +QR + K D R A ++ + +LH +I+
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHG--VIY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK N+L+D K+ DFG+ + +TT T GTP ++APE+L+ D
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179
Query: 689 YSFGVILWELATEKIPWDNLN 709
++ GV+++E+ + P++ N
Sbjct: 180 WALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 66/247 (26%), Positives = 124/247 (50%), Gaps = 20/247 (8%)
Query: 513 IGQGSCGTVYHA-VWYGSDV----AVKVFSRQ--EYSDEVIHSFRQEVSLMKRLRHPNVL 565
+GQGS G V+ G D A+KV + + D V + E ++ + HP ++
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV--RTKMERDILAEVNHPFIV 61
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
A + +L ++ +FL G LF L + + + +A ++A + +LH
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLHSLG-- 118
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 685
II+RDLK N+L+D+ +K+ DFGLS+ + + GT ++MAPEV+ +
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178
Query: 686 SDVYSFGVILWELATEKIPW---DNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742
+D +SFGV+++E+ T +P+ D +M +I + +L +P+ + P +++ + +
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI-----LKAKLGMPQFLSPEAQSLLRALF 233
Query: 743 HSDPQCR 749
+P R
Sbjct: 234 KRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 10/208 (4%)
Query: 544 EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR 603
EV H+ E +++ ++ P ++ + SP++L +V F+ G LF LQR R
Sbjct: 36 EVTHTL-AERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSR 94
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
R A ++ + LH N +I+RDLK N+L+D + + DFGL +L + T
Sbjct: 95 ARFYTA-ELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN 151
Query: 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW--DNLNSMQVIGAVGFMN 721
T GTP+++APE+L + D ++ GV+L+E+ T P+ +N+N M +
Sbjct: 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY----RKILQ 207
Query: 722 QRLEIPKDVDPRWAAIVESCWHSDPQCR 749
+ L P D ++ DP R
Sbjct: 208 EPLRFPDGFDRDAKDLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|222120 pfam13426, PAS_9, PAS domain | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-16
Identities = 29/96 (30%), Positives = 47/96 (48%)
Query: 145 IFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQ 204
+ D RI+Y N +A L GY+ EE LG+ +L G D + + ++ G +
Sbjct: 3 VLDPDGRIVYANDAALRLLGYTREELLGKSIRDLFGPGDDEEAVARLREALRNGGEVEVE 62
Query: 205 FPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ K E V+ + +P D+DG +VGIV + D
Sbjct: 63 LELRRKDGEPFPVLVSASPVRDEDGEVVGIVGILRD 98
|
Length = 101 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-16
Identities = 69/253 (27%), Positives = 124/253 (49%), Gaps = 24/253 (9%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSD-EVIHSFRQEVSLMKRL-RHPNVLLFM 568
IG+GS V ++ A+KV ++ +D E I + E + ++ HP ++
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ RL V E++ G L +QR KL + +I+ ++YLH II+
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERG--IIY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK N+L+D +K+ D+G+ + TT T GTP ++APE+LR E D
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 689 YSFGVILWELATEKIPWDNLNS------------MQVIGAVGFMNQRLEIPKDVDPRWAA 736
++ GV+++E+ + P+D + S QVI + +++ IP+ + + A+
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-----LEKQIRIPRSLSVKAAS 234
Query: 737 IVESCWHSDPQCR 749
+++S + DP+ R
Sbjct: 235 VLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 69/252 (27%), Positives = 116/252 (46%), Gaps = 31/252 (12%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKR------LRHPNV 564
+G+GS G V A G++ A+K + D V+ E ++++R HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKK----DVVLEDDDVECTMVERRVLALAWEHPFL 58
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ + L V E+L G L +Q ++ + D R A +I G+ +LH
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGDLMFHIQ-SSGRFDEARARFYAAEIICGLQFLHKKG- 116
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK--GTPQWMAPEVLRNEPS 682
II+RDLK N+L+DK +K+ DFG+ K K GTP ++APE+L+ +
Sbjct: 117 -IIYRDLKLDNVLLDKDGHIKIADFGMC--KENMNGEGKASTFCGTPDYIAPEILKGQKY 173
Query: 683 DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW-----AAI 737
+E D +SFGV+L+E+ + P+ + ++ F + + P PRW
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-----FDSILNDRPH--FPRWISKEAKDC 226
Query: 738 VESCWHSDPQCR 749
+ + DP R
Sbjct: 227 LSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 67/258 (25%), Positives = 121/258 (46%), Gaps = 28/258 (10%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFM 568
IG+GS V + A+KV ++ + DE I + E + + HP ++
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ RL V EF+ G L +QR KL + +I+ +++LH II+
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQR-KLPEEHARFYSAEISLALNFLHERG--IIY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK N+L+D +K+ D+G+ + TT T GTP ++APE+LR E D
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 689 YSFGVILWELATEKIPWDNLNS------------MQVIGAVGFMNQRLEIPKDVDPRWAA 736
++ GV+++E+ + P+D + QVI + +++ IP+ + + ++
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI-----LEKQIRIPRSLSVKASS 234
Query: 737 IVESCWHSDPQ----CRP 750
+++ + DP+ C P
Sbjct: 235 VLKGFLNKDPKERLGCHP 252
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 4e-16
Identities = 59/233 (25%), Positives = 98/233 (42%), Gaps = 51/233 (21%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD---VAVKVFSRQEY--SDEVIHSFRQEVSLMKRL 559
+D + + IG+G+ G V+ V A+KV + + +++ H R E ++
Sbjct: 1 DDFEVIKVIGRGAFGEVW-LVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADA 58
Query: 560 RHPNVL-LFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRR----RILMALDIA 613
P ++ L+ + + L +V E++P G L LL R + + R +++ALD
Sbjct: 59 DSPWIVKLYY-SFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-------------RLKHETYL 660
+ + IHRD+K N+L+D +K+ DFGL H
Sbjct: 118 HKLGF--------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 661 TTKTGK----------------GTPQWMAPEVLRNEPSDEKSDVYSFGVILWE 697
GTP ++APEVLR P + D +S GVIL+E
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 65/234 (27%), Positives = 108/234 (46%), Gaps = 48/234 (20%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFR------ 550
DYEIL ++G+G+ G VY A G VA+K ++H+ +
Sbjct: 9 DYEIL-------GKLGEGTFGEVYKARQIKTGRVVALKKI--------LMHNEKDGFPIT 53
Query: 551 --QEVSLMKRLRHPNV--LLFMGAVTSPQ----RLCI--VTEFLPRGSLFRLLQRNTTKL 600
+E+ ++K+L+HPNV L+ M + R + VT ++ L LL+ + KL
Sbjct: 54 ALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKL 112
Query: 601 DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660
+ L + G++YLH N I+HRD+K++N+L+D +K+ DFGL+R
Sbjct: 113 TESQIKCYMLQLLEGINYLH-ENH-ILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
Query: 661 TTKTGKG-----------TPQWMAPEVLRNEPSDEKS-DVYSFGVILWELATEK 702
K G G T + PE+L E + D++ G + E+ T +
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 5e-16
Identities = 80/280 (28%), Positives = 132/280 (47%), Gaps = 51/280 (18%)
Query: 513 IGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVI--HSFRQEVSLMKRLRHPNVLLFM 568
+G G+ G V A G +VA+K + +S V+ ++R E+ L+K LRH N++
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMK-PFSTPVLAKRTYR-ELKLLKHLRHENIISLS 75
Query: 569 GAVTSP-QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
SP + + VTE L L RLL + L+ + I RG+ Y+H ++
Sbjct: 76 DIFISPLEDIYFVTELLGT-DLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAG--VV 130
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLK--HET-YLTTKTGKGTPQWMAPEV-LRNEPSD 683
HRDLK SN+L++++ +K+ DFGL+R++ T Y++T+ + APE+ L + D
Sbjct: 131 HRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTR------YYRAPEIMLTWQKYD 184
Query: 684 EKSDVYSFGVILWELATEK--IPW-DNLNSMQVI------------------GAVGFMN- 721
+ D++S G I E+ K P D++N +I + F+
Sbjct: 185 VEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS 244
Query: 722 --QRLEIP-----KDVDPRWAAIVESCWHSDPQCRPSFQE 754
+R +P K+ DP ++E DPQ R S E
Sbjct: 245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAE 284
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 7e-16
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 27/210 (12%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKV---FSRQEYSDEVIHSFRQEVSLMKRL 559
IG+G+ G V A G VA+K F Q + + R E+ +++R
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFC---QRTLR-EIKILRRF 60
Query: 560 RHPNVLLFMGAVTSP-----QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR 614
+H N++ + + P + IV E + L++L++ T L I R
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIK--TQHLSNDHIQYFLYQILR 117
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-----KHETYLTTKTGKGTP 669
G+ Y+H N ++HRDLK SNLL++ + +K+ DFGL+R+ H +LT T
Sbjct: 118 GLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV--ATR 173
Query: 670 QWMAPEVLRNEPSDEKS-DVYSFGVILWEL 698
+ APE++ N K+ D++S G IL E+
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEM 203
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 7e-16
Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 40/212 (18%)
Query: 513 IGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFR--QEVSLMKRLRHPNV 564
IG+G+ G V A VA+K F D I + R +E+ L++ L H NV
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAF------DNRIDAKRTLREIKLLRHLDHENV 66
Query: 565 LLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
+ + P R + IV E L L ++++ + T D + + + RG+ Y+
Sbjct: 67 IAIKDIMPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQTLSDDHCQYFL-YQLLRGLKYI 124
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET------YLTTKTGKGTPQWMA 673
H N ++HRDLK SNLL++ + +K+ DFGL+R E Y+ T+ + A
Sbjct: 125 HSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR------WYRA 176
Query: 674 PEVLRNEPSDEKS---DVYSFGVILWELATEK 702
PE+L N E + DV+S G I EL K
Sbjct: 177 PELLLN--CSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 67/230 (29%), Positives = 113/230 (49%), Gaps = 39/230 (16%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVK-VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL---- 565
+G GS G V+ AV D VAVK + S V H+ R E+ +++RL H N++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS--VKHALR-EIKIIRRLDHDNIVKVYE 69
Query: 566 -LF---------MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
L +G++T + IV E++ L +L++ + R L + RG
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHAR--LFMYQLLRG 126
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTV-KVGDFGLSRL-----KHETYLTTKTGKGTP 669
+ Y+H N ++HRDLK +N+ ++ V K+GDFGL+R+ H+ YL+
Sbjct: 127 LKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL---VT 181
Query: 670 QWM-APEVLRNEPSDEKS-DVYSFGVILWELATEK--IPWDN-LNSMQVI 714
+W +P +L + + K+ D+++ G I E+ T K + L MQ+I
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 50/224 (22%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFR--QEVSL 555
Y+ + E IG G+ G V A+ G VA+K D + R +E+ +
Sbjct: 7 YKPI-------ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA--FDVPTLAKRTLRELKI 57
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFR-------LLQRNTTKLDWRRRILM 608
++ +H N++ I P G+ F+ L++ + + + L
Sbjct: 58 LRHFKHDNII------------AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLT 105
Query: 609 A-------LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL------K 655
+ RG+ Y+H N +IHRDLK SNLLV++ +++GDFG++R +
Sbjct: 106 EEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163
Query: 656 HETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWEL 698
H+ ++T T + APE+L + P D++S G I E+
Sbjct: 164 HKYFMTEYV--ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 70/276 (25%), Positives = 115/276 (41%), Gaps = 42/276 (15%)
Query: 511 EQIGQGSCGTVYHAVW----------YGSDVAV--KVFSRQEYSDEVIHSFRQEVSLMKR 558
E +GQG+ +Y V G +V+V KV +F + SLM +
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL---AFFETASLMSQ 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT--KLDWRRRILMALDIARGV 616
L H +++ G V +V E++ G L L R L W+ + L A +
Sbjct: 58 LSHKHLVKLYG-VCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQL--ASAL 114
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWT-------VKVGDFGLSRLKHETYLTTKTGKGTP 669
YL + ++H ++ N+LV ++ +K+ D G+ T L+ +
Sbjct: 115 HYLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI----TVLSREERVERI 168
Query: 670 QWMAPEVLRNEPS--DEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEI 726
W+APE +RN + +D +SFG L E+ + + P L+S + F + +
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFYQDQHRL 225
Query: 727 PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
P A ++ CW DP RPSF+ LRDL
Sbjct: 226 PMPDCAELANLINQCWTYDPTKRPSFR---AILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHPNVLLF 567
E+IG+G+ GTV+ A VA+K R + DE + S +E+ L+K L+H N++
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVRL 64
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+ S ++L +V E+ + L + +D + +G+++ H N ++
Sbjct: 65 YDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VL 121
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSR--------LKHETYLTTKTGKGTPQWMAPEVLRN 679
HRDLK NLL++K+ +K+ DFGL+R E T + P+VL
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--------TLWYRPPDVLFG 173
Query: 680 EPSDEKS-DVYSFGVILWELATEKIP 704
S D++S G I ELA P
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-15
Identities = 52/159 (32%), Positives = 84/159 (52%), Gaps = 15/159 (9%)
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP- 669
+ARG+ +L N +HRDL + N+L+ + VK+ DFGL+R + H++ +K P
Sbjct: 246 VARGMEFLASKN--CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWEL-ATEKIPWDNLNSMQVIGAVGFMNQ-----R 723
+WMAPE + + SDV+S+G++LWE+ + P+ + I F N+ R
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM-----IVDSTFYNKIKSGYR 358
Query: 724 LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
+ P I+ CW+S+P+ RPSF L D + L
Sbjct: 359 MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 66/252 (26%), Positives = 124/252 (49%), Gaps = 18/252 (7%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQ-EYSDEVIHSFRQEVSLMKRLR-HPNVLLFM 568
IG+GS V +D A+KV ++ + DE I + E + ++ +P ++
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ RL +V E++ G L +QR KL A +I +++LH II+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHERG--IIY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK N+L+D +K+ D+G+ + TT T GTP ++APE+LR E D
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179
Query: 689 YSFGVILWELATEKIPWD------NLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742
++ GV+++E+ + P+D ++N+ + V + + + IP+ + + + +++
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV-ILEKPIRIPRFLSVKASHVLKGFL 238
Query: 743 HSDPQ----CRP 750
+ DP+ C+P
Sbjct: 239 NKDPKERLGCQP 250
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-15
Identities = 53/186 (28%), Positives = 92/186 (49%), Gaps = 28/186 (15%)
Query: 528 GSDVAVKVFSRQEYSDEVIHSFRQ------EVSLMKRLRHPNVL-----LFMGAVTSPQR 576
GS+ V V ++ D V+ Q E L++ + HP+V+ L GA+T
Sbjct: 77 GSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAIT---- 132
Query: 577 LCIVTEFLP--RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 634
C+V LP L+ L + + L + +++ I G+ YLH IIHRD+K+
Sbjct: 133 -CMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTE 186
Query: 635 NLLVDKHWTVKVGDFGLSR--LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFG 692
N+ ++ V +GD G ++ + +L GT + APEVL + + K+D++S G
Sbjct: 187 NIFINDVDQVCIGDLGAAQFPVVAPAFLGL---AGTVETNAPEVLARDKYNSKADIWSAG 243
Query: 693 VILWEL 698
++L+E+
Sbjct: 244 IVLFEM 249
|
Length = 357 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 4e-15
Identities = 66/225 (29%), Positives = 115/225 (51%), Gaps = 12/225 (5%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRH--PNVLL 566
IG+G+ G VY + A+KV S++E EV H+ + L++ L P ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
+ + L +VT+++ G LF LQ+ + R + +A ++ + +LH + I
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLHKYD--I 117
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS 686
++RDLK N+L+D + + DFGLS+ TT T GT +++APEVL +E K
Sbjct: 118 VYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKH 177
Query: 687 -DVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 730
D +S GV+++E+ P+ ++ Q+ + F R PK+V
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF--PKNV 220
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E+IG+G+ G VY A G VA+K ++ V + +E+SL+K L HPN++ +
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 569 GAVTSPQRLCIVTEFLPRG--SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
+ + +L +V EFL + + L + L L +G+++ H + +
Sbjct: 66 DVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFCH--SHRV 121
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM-APEVLRN-EPSDE 684
+HRDLK NLL++ +K+ DFGL+R + T T + W APE+L +
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180
Query: 685 KSDVYSFGVILWELATEK 702
D++S G I E+ T +
Sbjct: 181 AVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-15
Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEY---SDEVIHSFRQEVSLMKRL 559
ED + + IG+G+ G V S A+K+ S+ E SD F +E +M
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFA 100
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR----RILMALDIARG 615
P V+ A + L +V E++P G L L+ W + +++ALD
Sbjct: 101 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHS 160
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT-TKTGKGTPQWMAP 674
+ +IHRD+K N+L+DKH +K+ DFG ET + T GTP +++P
Sbjct: 161 MG--------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISP 212
Query: 675 EVLRNEPSD----EKSDVYSFGVILWELATEKIPW 705
EVL+++ D + D +S GV L+E+ P+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 62/243 (25%), Positives = 105/243 (43%), Gaps = 26/243 (10%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV---WYGSDVAVKVFSR-QEYSDEVIHSFRQEVSLMKRLR 560
+D + +G+G G V V G A+KV + + E + F +E ++
Sbjct: 1 KDFDVKSLVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD------WRRRILMALDIAR 614
P + A L +V E+ P G L LL R + D + +++A+
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH 119
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMA 673
+ Y +HRD+K N+L+D+ +K+ DFG + RL + +K GTP ++A
Sbjct: 120 QMGY--------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIA 171
Query: 674 PEVLRNEPSDEKS------DVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP 727
PEVL D K D +S GVI +E+ + P+ S + + + L+ P
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFP 231
Query: 728 KDV 730
+D
Sbjct: 232 EDP 234
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 52/192 (27%), Positives = 87/192 (45%), Gaps = 12/192 (6%)
Query: 577 LCIVTEFLPRGSL-FRL--LQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633
LC+V + G L + + + R I G+ +LH II+RDLK
Sbjct: 68 LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKP 125
Query: 634 SNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGV 693
N+L+D V++ D GL+ + TK GTP +MAPE+L+ E D D ++ GV
Sbjct: 126 ENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGV 185
Query: 694 ILWELATEKIPW----DNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 749
L+E+ + P+ + + + ++ + +N + P P + E+ DP+ R
Sbjct: 186 TLYEMIAARGPFRARGEKVENKELKQRI--LNDSVTYPDKFSPASKSFCEALLAKDPEKR 243
Query: 750 PSFQ-ELVDKLR 760
F+ D LR
Sbjct: 244 LGFRDGNCDGLR 255
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 66/229 (28%), Positives = 107/229 (46%), Gaps = 26/229 (11%)
Query: 492 DLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD---VAVKVFSRQEY---SDEV 545
D N D + ED + + IG+G+ G V V + S A+K+ S+ E SD
Sbjct: 30 DTINKIRDLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSA 88
Query: 546 IHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR- 604
F +E +M P V+ A + L +V E++P G L L+ W R
Sbjct: 89 F--FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF 146
Query: 605 ---RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYL 660
+++ALD + + IHRD+K N+L+DK +K+ DFG ++ E +
Sbjct: 147 YTAEVVLALDAIHSMGF--------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198
Query: 661 TTKTGKGTPQWMAPEVLRNEPSD----EKSDVYSFGVILWELATEKIPW 705
T GTP +++PEVL+++ D + D +S GV L+E+ P+
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 63/199 (31%), Positives = 96/199 (48%), Gaps = 15/199 (7%)
Query: 513 IGQGSCGTV---YHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
IG G+ G V Y AV +VA+K SR + +E+ LMK + H N++ +
Sbjct: 25 IGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 570 AVTSPQRLCIVTEFLPRGSLFRLLQRN-----TTKLDWRRRILMALDIARGVSYLHHCNP 624
T PQ+ + EF + L+ N +LD R + + G+ +LH
Sbjct: 84 VFT-PQK--SLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG- 139
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDE 684
IIHRDLK SN++V T+K+ DFGL+R +++ T T + APEV+ E
Sbjct: 140 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-VVTRYYRAPEVILGMGYKE 197
Query: 685 KSDVYSFGVILWELATEKI 703
D++S G I+ E+ KI
Sbjct: 198 NVDIWSVGCIMGEMVRHKI 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 59/192 (30%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E++G+GS TVY + G VA+KV S + + V + +E SL+K L+H N++L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVIS-MKTEEGVPFTAIREASLLKGLKHANIVLLH 69
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + + L V E++ L + + ++ L L + RG++Y+H + I+H
Sbjct: 70 DIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILH 126
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS-- 686
RDLK NLL+ +K+ DFGL+R K T + T + P+VL +D S
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGA-TDYSSAL 185
Query: 687 DVYSFGVILWEL 698
D++ G I E+
Sbjct: 186 DIWGAGCIFIEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-14
Identities = 49/154 (31%), Positives = 77/154 (50%), Gaps = 5/154 (3%)
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTP- 669
+A G+ +L N +HRDL + N+L+ + VK+ DFGL+R + ++ +K P
Sbjct: 248 VANGMEFLASKN--CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPK 728
+WMAPE + N SDV+SFG++LWE+ T P+ L + R+ P
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPA 365
Query: 729 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
I++ CW + RP F +LV + DL
Sbjct: 366 HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-14
Identities = 83/336 (24%), Positives = 136/336 (40%), Gaps = 89/336 (26%)
Query: 512 QIGQGSCG--TVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
+IG+G C +VY A G+ V V++ + ++E + + + EV L RHPN++
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQR------NTTKLDWRRRILMALDIARGVSYLHH 621
T+ L +++ F+ GS LL+ + + IL RG++YLH
Sbjct: 65 WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALI---GNILFG--ALRGLNYLHQ 119
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT------PQ----- 670
IHR++K+S++L+ V + GLS L Y + G+ PQ
Sbjct: 120 NG--YIHRNIKASHILISGDGLVSLS--GLSHL----YSLVRNGQKAKVVYDFPQFSTSV 171
Query: 671 --WMAPEVLRNEPS--DEKSDVYSFGVILWELATEKIPWDNL------------------ 708
W++PE+LR + + KSD+YS G+ ELAT ++P+ ++
Sbjct: 172 LPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPL 231
Query: 709 ------------------------NSMQVIGAVGFMN-QRLEIP--KDVDPRWAAIVESC 741
S+ G M +RL P K P + +VE C
Sbjct: 232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELC 291
Query: 742 WHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGDS 777
DP+ RPS L L +F+ + S
Sbjct: 292 LQQDPEKRPSASSL------LSHAFFKQVKEQTQGS 321
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-14
Identities = 62/193 (32%), Positives = 95/193 (49%), Gaps = 11/193 (5%)
Query: 511 EQIGQGSCGTVYH--AVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E++G+GS TVY + G VA+KV QE + R E SL+K L+H N++L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLH 69
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + + L +V E++ L + + ++ L L + RG+SY+H I+H
Sbjct: 70 DIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ--RYILH 126
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS-- 686
RDLK NLL+ +K+ DFGL+R K T T + P+VL S E S
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG--STEYSTC 184
Query: 687 -DVYSFGVILWEL 698
D++ G I E+
Sbjct: 185 LDMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 511 EQIGQGSCGTVY--HAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+++G+G+ TV+ + + VA+K R E+ + + +EVSL+K L+H N++
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIREVSLLKNLKHANIVTLH 69
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + + L +V E+L L + L + + + RG+SY H I+H
Sbjct: 70 DIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK--RKILH 126
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS-- 686
RDLK NLL+++ +K+ DFGL+R K T T + P+VL S E S
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG--STEYSTP 184
Query: 687 -DVYSFGVILWELAT 700
D++ G IL+E+AT
Sbjct: 185 IDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-14
Identities = 54/206 (26%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 550 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR------NTTKLDWR 603
+ E ++++ ++HP ++ + A + +L ++ E+L G LF L+R +T +
Sbjct: 48 KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACF-YL 106
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
I +AL+ +LH II+RDLK N+L+D VK+ DFGL + T
Sbjct: 107 SEISLALE------HLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158
Query: 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR 723
T GT ++MAPE+L + D +S G +++++ T P+ N + I + + +
Sbjct: 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI--LKGK 216
Query: 724 LEIPKDVDPRWAAIVESCWHSDPQCR 749
L +P + P +++ +P R
Sbjct: 217 LNLPPYLTPEARDLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 7e-14
Identities = 69/264 (26%), Positives = 124/264 (46%), Gaps = 26/264 (9%)
Query: 511 EQIGQGSCGTVYHAVWYGSDV--AVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+++G+G+ G+VY + + V A+K R E + + E+ ++ + P ++ F
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEI-RLELDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL----DWRRRILMALDIARGVSYLHHCNP 624
GA + + E++ GSL +L D RRI A + +G+ +L
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYA--VVKGLKFLKE-EH 122
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE-PSD 683
IIHRD+K +N+LV+ + VK+ DFG+S + KT G +MAPE +++ P+
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVS--GNLVASLAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 684 E-----KSDVYSFGVILWELATEKIPW-----DNLNSMQVIGAVGFMNQRLEIPKDVDPR 733
+SDV+S G+ + E+A + P+ N+ + Q+ V L P
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA-QLSAIVDGDPPTL--PSGYSDD 237
Query: 734 WAAIVESCWHSDPQCRPSFQELVD 757
V C + P RP++ +L++
Sbjct: 238 AQDFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 511 EQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHPNVLLF 567
E++G+G+ TVY G VA+K ++E S +E+SLMK L+H N++
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLD--AEEGTPSTAIREISLMKELKHENIVRL 63
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK--LDWRRRILMALDIARGVSYLHHCNPP 625
+ + +L +V E++ L + + + + LD + +G+++ H
Sbjct: 64 HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR-- 120
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 685
++HRDLK NLL++K +K+ DFGL+R T T + AP+VL +
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYST 180
Query: 686 S-DVYSFGVILWELAT 700
S D++S G I+ E+ T
Sbjct: 181 SIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 9e-14
Identities = 69/278 (24%), Positives = 129/278 (46%), Gaps = 47/278 (16%)
Query: 511 EQIGQGSCGTVYHAV---------WYGSDVAVKVF--SRQEYSDEVIHSFRQEVSLMKRL 559
E +GQG+ ++ + + ++V +KV S + YS+ SF + S+M +L
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSE----SFFEAASMMSQL 56
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY- 618
H +++L G +V E++ GSL L++N ++ I L++A+ +++
Sbjct: 57 SHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLIN----ISWKLEVAKQLAWA 112
Query: 619 LHHC-NPPIIHRDLKSSNLLV-----DKHWT---VKVGDFGLSRLKHETYLTTKTGKGTP 669
LH + + H ++ + N+L+ K +K+ D G+S T L +
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS----ITVLPKEILLERI 168
Query: 670 QWMAPEVLRNEPS-DEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIP 727
W+ PE + N + +D +SFG LWE+ + P L+S + + F R ++P
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQFYEDRHQLP 225
Query: 728 KDVDPRW---AAIVESCWHSDPQCRPSFQELVDKLRDL 762
P+W A ++ C +P RPSF+ ++ RDL
Sbjct: 226 A---PKWTELANLINQCMDYEPDFRPSFRAII---RDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 67/247 (27%), Positives = 114/247 (46%), Gaps = 36/247 (14%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD---VAVKVFSRQEY---SDEVIHSFRQEVSLMKR 558
ED + + IG+G+ G V V + S A+K+ S+ E SD F +E +M
Sbjct: 43 EDFDVIKVIGRGAFGEV-QLVRHKSSKQVYAMKLLSKFEMIKRSDSAF--FWEERDIMAH 99
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR----RILMALDIAR 614
++ A + L +V E++P G L L+ W R +++ALD
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIH 159
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMA 673
+ + IHRD+K N+L+DK +K+ DFG ++ + T GTP +++
Sbjct: 160 SMGF--------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYIS 211
Query: 674 PEVLRNEPSD----EKSDVYSFGVILWELATEKIPW--DNLNSMQVIGAVG-FMNQR--L 724
PEVL+++ D + D +S GV L+E+ P+ D+L +G M+ + L
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMDHKNSL 266
Query: 725 EIPKDVD 731
P D++
Sbjct: 267 TFPDDIE 273
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 32/209 (15%)
Query: 511 EQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHPNVLLF 567
E+IG+G+ G VY A +A+K R E DE + S +E+SL+K ++H N++
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR--RILMAL--DIARGVSYLHHCN 623
V S +RL +V E+L L + + D+ + R++ I RG++Y H +
Sbjct: 67 QDVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH--S 120
Query: 624 PPIIHRDLKSSNLLVDKHW-TVKVGDFGLSR--------LKHETYLTTKTGKGTPQWMAP 674
++HRDLK NLL+D+ +K+ DFGL+R HE T + AP
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--------TLWYRAP 172
Query: 675 EVLRNEPS-DEKSDVYSFGVILWELATEK 702
E+L D++S G I E+ +K
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 45/151 (29%), Positives = 78/151 (51%), Gaps = 15/151 (9%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIH--SFRQEVSLMKRLRHPNVLL 566
+IG+GS G V+ G VA+K F E D VI + R E+ ++K+L+HPN++
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESE-DDPVIKKIALR-EIRMLKQLKHPNLVN 64
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD---WRRRILMALDIARGVSYLHHCN 623
+ ++L +V E+ ++ L++N + ++ I L V++ H N
Sbjct: 65 LIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQ---AVNFCHKHN 120
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
IHRD+K N+L+ K +K+ DFG +R+
Sbjct: 121 --CIHRDVKPENILITKQGQIKLCDFGFARI 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 66/216 (30%), Positives = 108/216 (50%), Gaps = 20/216 (9%)
Query: 511 EQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+Q+G G+ GTV A+ G+ VA+K R S+ +E+ L+K ++H NV+ +
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 569 GAVTSPQRLCIVTEF---LP-RGS-LFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
T L +F +P G+ L +L++ KL R + + +G+ Y+H
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIHAAG 138
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM-APEVLRN-EP 681
IIHRDLK NL V++ +K+ DFGL+R + TG +W APEV+ N
Sbjct: 139 --IIHRDLKPGNLAVNEDCELKILDFGLARQTD----SEMTGYVVTRWYRAPEVILNWMH 192
Query: 682 SDEKSDVYSFGVILWELATEKIPW---DNLNSMQVI 714
+ D++S G I+ E+ T K + D+L+ + I
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI 228
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 513 IGQGSCGTV---YHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
IG G+ G V Y A+ +VA+K SR + +E+ LMK + H N++ +
Sbjct: 32 IGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 570 AVTSPQR-------LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
T PQ+ + IV E + +L +++Q +LD R + + G+ +LH
Sbjct: 91 VFT-PQKSLEEFQDVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA 145
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 682
IIHRDLK SN++V T+K+ DFGL+R +++ T T + APEV+
Sbjct: 146 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-VVTRYYRAPEVILGMGY 202
Query: 683 DEKSDVYSFGVILWELATEKI 703
E D++S G I+ E+ +
Sbjct: 203 KENVDIWSVGCIMGEMIKGGV 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQ----EVSLMKRLR 560
+D ++G G+ G V + S + + +R+ E+ + R E+ ++
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGL---IMARKLIHLEIKPAIRNQIIRELKVLHECN 57
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRI----LMALDIA--R 614
P ++ F GA S + I E + GSL ++L++ RI L + IA R
Sbjct: 58 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-------AGRIPENILGKISIAVLR 110
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAP 674
G++YL I+HRD+K SN+LV+ +K+ DFG+S ++ + GT +M+P
Sbjct: 111 GLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSP 167
Query: 675 EVLRNEPSDEKSDVYSFGVILWELATEKIP 704
E L+ +SD++S G+ L E+A + P
Sbjct: 168 ERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 69/248 (27%), Positives = 115/248 (46%), Gaps = 23/248 (9%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+GS G V A G AVK + D+V + ++ L +P +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + L V EFL G L +Q + + D R A +I G+ +LH + II+
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQ-DKGRFDLYRATFYAAEIVCGLQFLH--SKGIIY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK--TGKGTPQWMAPEVLRNEPSDEKS 686
RDLK N+++D+ +K+ DFG+ K + + T GTP ++APE+L+
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV 177
Query: 687 DVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA-----IVESC 741
D +SFGV+L+E+ + P+ + ++ F + R++ P PRW I+E
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDEL-----FESIRVDTPH--YPRWITKESKDILEKL 230
Query: 742 WHSDPQCR 749
+ DP R
Sbjct: 231 FERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 54/193 (27%), Positives = 98/193 (50%), Gaps = 7/193 (3%)
Query: 511 EQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+++G+G+ TVY +D VA+K R E+ + + +EVSL+K L+H N++
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + + L +V E+L + L + L ++ L + RG++Y H ++H
Sbjct: 71 DIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR--RKVLH 127
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSD 687
RDLK NLL+++ +K+ DFGL+R K T T + P++L + D
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQID 187
Query: 688 VYSFGVILWELAT 700
++ G I +E++T
Sbjct: 188 MWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 511 EQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+++G+GS TVY + VA+K + + R E SL+K L+H N++
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLH 69
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + + L +V E+L L + + L L + RG++Y H ++H
Sbjct: 70 DIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLH 126
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG---TPQWMAPEVLRNEPSDEK 685
RDLK NLL+ + +K+ DFGL+R K + +KT T + P+VL S E
Sbjct: 127 RDLKPQNLLISERGELKLADFGLARAKS---VPSKTYSNEVVTLWYRPPDVLLG--STEY 181
Query: 686 S---DVYSFGVILWELAT 700
S D++ G I +E+AT
Sbjct: 182 STSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 57/195 (29%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 511 EQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E++G+G+ TV+ ++ VA+K R E+ + + +EVSL+K L+H N++
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
V + + L +V E+L + L + + + + I RG++Y H ++H
Sbjct: 71 DIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH--RRKVLH 127
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS-- 686
RDLK NLL+++ +K+ DFGL+R K T T + P+VL S E S
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG--SSEYSTQ 185
Query: 687 -DVYSFGVILWELAT 700
D++ G I +E+A+
Sbjct: 186 IDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 67/217 (30%), Positives = 112/217 (51%), Gaps = 26/217 (11%)
Query: 513 IGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFR--QEVSLMKRLRHPNVLLFM 568
+G G+ G+V A G VAVK SR S +IH+ R +E+ L+K ++H NV+ +
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 569 GAVTSPQRL------CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
T + L +VT + G+ + + D + L+ I RG+ Y+H
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA 139
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM-APEVLRN-E 680
+ IIHRDLK SNL V++ +K+ DFGL+R + TG +W APE++ N
Sbjct: 140 D--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWM 193
Query: 681 PSDEKSDVYSFGVILWELATEKIPW---DNLNSMQVI 714
++ D++S G I+ EL T + + D+++ +++I
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-13
Identities = 47/183 (25%), Positives = 77/183 (42%), Gaps = 34/183 (18%)
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH--ETYLT-------- 661
I + Y+H + ++HRDLK N+L+ V + D+G + K E L
Sbjct: 122 ICATIEYVH--SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 662 ------TKTGK--GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQV 713
T GK GTP +MAPE L P+ E +D+Y+ GVIL+++ T P+ ++
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239
Query: 714 IGAVGFMNQRLEIP------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767
+ P +++ P + I DP R + V +L+ +
Sbjct: 240 S-----YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAER--YSS-VQELKQDLEPHL 291
Query: 768 QAS 770
Q S
Sbjct: 292 QGS 294
|
Length = 932 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 5e-13
Identities = 61/193 (31%), Positives = 92/193 (47%), Gaps = 13/193 (6%)
Query: 513 IGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570
IG G+ G V A G +VAVK SR + +E+ L+K + H N++ +
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 571 VTSPQRLCIVTEFLPRGSLFRLLQRNTTK-----LDWRRRILMALDIARGVSYLHHCNPP 625
T PQ+ + EF + L+ N + LD R + + G+ +LH
Sbjct: 89 FT-PQK--SLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG-- 143
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 685
IIHRDLK SN++V T+K+ DFGL+R ++ T T + APEV+ E
Sbjct: 144 IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPY-VVTRYYRAPEVILGMGYKEN 202
Query: 686 SDVYSFGVILWEL 698
D++S G I+ EL
Sbjct: 203 VDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 5e-13
Identities = 43/153 (28%), Positives = 80/153 (52%), Gaps = 11/153 (7%)
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR--LKHETYLTTKTGK 666
+ +A+G+ +L N IHRD+ + N+L+ K+ DFGL+R + Y+ +
Sbjct: 218 SSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275
Query: 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL-ATEKIPWDNL---NSMQVIGAVGFMNQ 722
+WMAPE + + +SDV+S+G++LWE+ + K P+ + + + G+
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS 335
Query: 723 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQEL 755
R P P +I++ CW+ +P RP+F ++
Sbjct: 336 R---PDFAPPEIYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 6e-13
Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 37/220 (16%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEV----IHSFRQE 552
+YE L +I +G+ G VY A + VA+K + + E I S R E
Sbjct: 6 EYEKL-------NRIEEGTYGVVYRARDKKTGEIVALK---KLKMEKEKEGFPITSLR-E 54
Query: 553 VSLMKRLRHPNVL----LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 608
++++ +L+HPN++ + +G ++ ++ +V E++ L L++ +
Sbjct: 55 INILLKLQHPNIVTVKEVVVG--SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCL 111
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-----LKHETYLTTK 663
L + GV++LH I+HRDLK+SNLL++ +K+ DFGL+R LK T L
Sbjct: 112 MLQLLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV- 168
Query: 664 TGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEK 702
T + APE+L D++S G I EL T+K
Sbjct: 169 ----TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 67/230 (29%), Positives = 102/230 (44%), Gaps = 43/230 (18%)
Query: 497 CLD-YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVK-VFSRQEYSDEVIHSFRQE 552
C+D ++I+ QIG+G+ G VY A G VA+K V E I + R E
Sbjct: 5 CVDKFDII-------GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-E 56
Query: 553 VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL-- 610
+ ++++L H N++ VT Q +F F L+ ++ LM L
Sbjct: 57 IKILRQLNHRNIVNLKEIVTDKQD---ALDFKKDKGAFYLV------FEYMDHDLMGLLE 107
Query: 611 ----------------DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
+ G++Y H N +HRD+K SN+L++ +K+ DFGL+RL
Sbjct: 108 SGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARL 165
Query: 655 KHETYLTTKTGKGTPQWM-APEVLRNEPSDEKS-DVYSFGVILWELATEK 702
+ T K W PE+L E + DV+S G IL EL T+K
Sbjct: 166 YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 550 RQEVSLMKRLRH-PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRIL 607
R E +++ +R P ++ A + +L ++ +++ G LF L QR R+
Sbjct: 52 RTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVY 110
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK- 666
+A +I + +LH II+RD+K N+L+D V + DFGLS+ +L + +
Sbjct: 111 IA-EIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKE----FLAEEEERA 163
Query: 667 ----GTPQWMAPEVLRNEPS--DEKSDVYSFGVILWELATEKIPW---DNLNSMQVIGAV 717
GT ++MAPEV+R D+ D +S GV+ +EL T P+ NS I +
Sbjct: 164 YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI-SR 222
Query: 718 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 749
+ + PK + ++ DP+ R
Sbjct: 223 RILKSKPPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-12
Identities = 62/243 (25%), Positives = 118/243 (48%), Gaps = 24/243 (9%)
Query: 528 GSDVAVKVFSR-QEYSDEVIHSF-RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585
GSD KV ++ +DE ++ R E+ + H ++ S +L ++ E+
Sbjct: 89 GSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148
Query: 586 RGSLFRLL-QRNTTKLDWRR--------RILMALDIARGVSYLHHCNPPIIHRDLKSSNL 636
G L + + QR L ++ +I++ALD +H + ++HRDLKS+N+
Sbjct: 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALD------EVH--SRKMMHRDLKSANI 200
Query: 637 LVDKHWTVKVGDFGLSRLKHETYLTTKTGK---GTPQWMAPEVLRNEPSDEKSDVYSFGV 693
+ +K+GDFG S+ ++ ++ GTP ++APE+ + +K+D++S GV
Sbjct: 201 FLMPTGIIKLGDFGFSK-QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGV 259
Query: 694 ILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQ 753
IL+EL T P+ + +++ V + P V A+++ +P RP+ Q
Sbjct: 260 ILYELLTLHRPFKGPSQREIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNPALRPTTQ 318
Query: 754 ELV 756
+L+
Sbjct: 319 QLL 321
|
Length = 478 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 42/158 (26%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMAL 610
E +++++ P ++ A S LC+V + G L + + L+ R I +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTP 669
I G+ +LH + I++RD+K N+L+D ++ D GL+ LK +T + G T
Sbjct: 103 QITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAG--TN 158
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707
+MAPE+L+ EP D ++ G ++E+ + P+ +
Sbjct: 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-12
Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 12/157 (7%)
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD 611
E++ M +L+HPN++ +G S + ++ E++ +L +L RN L W RR +A+
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-RN---LSWERRRKIAIG 788
Query: 612 IARGVSYLH-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG-TP 669
IA+ + +LH C+P ++ +L +++D D RL L T T +
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIID------GKDEPHLRLSLPGLLCTDTKCFISS 842
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 706
++APE + EKSD+Y FG+IL EL T K P D
Sbjct: 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 4/155 (2%)
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMAL 610
E +++++ V+ A + LC+V + G L F + + R + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ 670
+I G+ LH I++RDLK N+L+D H +++ D GL+ E T K GT
Sbjct: 110 EICCGLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVG 166
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705
+MAPEV++NE D ++ G +L+E+ + P+
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 68/209 (32%), Positives = 100/209 (47%), Gaps = 29/209 (13%)
Query: 512 QIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVLL 566
+IG G+ GTVY A G VA+K Q D + S +EV+L+KRL HPN++
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 567 FMGAVTSPQ-----RLCIVTEFLP---RGSLFRL----LQRNTTKLDWRRRILMALDIAR 614
M + + ++ +V E + R L ++ L T K D R+ L R
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK-DLMRQFL------R 119
Query: 615 GVSYLH-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 673
G+ +LH +C I+HRDLK N+LV VK+ DFGL+R+ + + T + A
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI-YSCQMALTPVVVTLWYRA 175
Query: 674 PEVLRNEPSDEKSDVYSFGVILWELATEK 702
PEVL D++S G I E+ K
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 21/158 (13%)
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR--GSLFRLLQRNTTKLDWRRRI--- 606
E +++ + HP+++ G T + C++ LPR L+ L +R I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAA-------KRNIAIC 182
Query: 607 -LMALD--IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
++A++ + R + YLH IIHRD+K+ N+ ++ V +GDFG + +
Sbjct: 183 DILAIERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240
Query: 664 TG-KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
G GT APE+L +P D++S G++L+E+AT
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 50/159 (31%), Positives = 84/159 (52%), Gaps = 14/159 (8%)
Query: 551 QEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR---RIL 607
+E+ ++ P ++ F GA S + I E + GSL ++L+ + +R IL
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK------EAKRIPEEIL 105
Query: 608 MALDIA--RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665
+ IA RG++YL I+HRD+K SN+LV+ +K+ DFG+S ++ +
Sbjct: 106 GKVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 163
Query: 666 KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIP 704
GT +M+PE L+ +SD++S G+ L ELA + P
Sbjct: 164 -GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 34/168 (20%)
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR------ 614
+P V+ + + + LC+V E++ G LL +N L +D+AR
Sbjct: 60 NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLL-KNIGAL--------PVDMARMYFAET 110
Query: 615 --GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK--------HETYLTTKT 664
+ YLH N I+HRDLK NLL+ +K+ DFGLS++ +E ++ T
Sbjct: 111 VLALEYLH--NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168
Query: 665 GK-------GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705
+ GTP+++APEV+ + + D ++ G+IL+E +P+
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 36/215 (16%)
Query: 512 QIGQGSCGTVYHAVWY----GSDVAVKVF-SRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
IG+G+ G VY A G + A+K F +E + S +E++L++ L+H NV+
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 567 FMGAVTSPQRLCI--VTEFLP----------RGSLFRLLQRNTTK-LDWRRRILMALDIA 613
+ + + ++ R + + + K L W+ I
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ--------IL 118
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSRLKHETYLTTKTGKG-- 667
GV YLH + ++HRDLK +N+LV + VK+GD GL+RL +
Sbjct: 119 NGVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 668 -TPQWMAPEVLRNEPSDEKS-DVYSFGVILWELAT 700
T + APE+L K+ D+++ G I EL T
Sbjct: 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 15/206 (7%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFR----QEVSLMKRLR 560
+D ++G G+ G V+ S + + +R+ E+ + R +E+ ++
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGL---IMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA--RGVSY 618
P ++ F GA S + I E + GSL ++L++ ++ +IL + IA +G++Y
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIP--EQILGKVSIAVIKGLTY 118
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 678
L I+HRD+K SN+LV+ +K+ DFG+S ++ + GT +M+PE L+
Sbjct: 119 LRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQ 175
Query: 679 NEPSDEKSDVYSFGVILWELATEKIP 704
+SD++S G+ L E+A + P
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|216228 pfam00989, PAS, PAS fold | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-11
Identities = 28/109 (25%), Positives = 48/109 (44%), Gaps = 1/109 (0%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
IL+S+ + + D RI+Y N +AE L G S EE +G+ ++L+ + D +VA
Sbjct: 1 EDLRAILESLPDGIFVVDEDGRILYVNAAAEELLGLSREEVIGKSLLDLIPEDDDAEVAE 60
Query: 190 DIVHRIKMGERW-TGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCV 237
+ + GE + + V +P D G + G + V
Sbjct: 61 LLRQALLQGEESRGFEVSFRVPDGRPRHVEVRASPVRDAGGEVRGFLGV 109
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 113 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 3e-11
Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 41/223 (18%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVK-VFSRQEYSDEVIHSFRQE 552
YEIL +++G+G+ Y VW D VA+K +F + + +FR E
Sbjct: 9 YEIL-------QKLGKGA----YGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-E 56
Query: 553 VSLMKRLR-HPNV--LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMA 609
+ ++ L HPN+ LL + + + + +V E++ L +++ N + +R I+
Sbjct: 57 IMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-ETDLHAVIRANILEDVHKRYIMYQ 115
Query: 610 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP 669
L + + Y+H N +IHRDLK SN+L++ VK+ DFGL+R + + P
Sbjct: 116 L--LKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLAR----SLSELEENPENP 167
Query: 670 --------QWM-APEVLRNEPSDEKS-DVYSFGVILWELATEK 702
+W APE+L K D++S G IL E+ K
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 52/193 (26%), Positives = 95/193 (49%), Gaps = 12/193 (6%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570
+G+G+ G V + VA+K F E ++EV + +E+ +++ L+ N++ A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 571 VTSPQRLCIVTEFLPRGSLFRLLQR--NTTKLDWRRRILMALDIARGVSYLHHCNP-PII 627
+L +V E++ + ++ LL+ N + R + L + +H C+ I+
Sbjct: 69 FRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQL-----IKAIHWCHKNDIV 122
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM-APEVLRNEPSDEKS 686
HRD+K NLL+ + +K+ DFG +R E T +W +PE+L P +
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAV 182
Query: 687 DVYSFGVILWELA 699
D++S G IL EL+
Sbjct: 183 DMWSVGCILGELS 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 47/227 (20%)
Query: 511 EQIGQGSCGTVYHAVWYGSDV--AVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLF 567
+ +G+G G V+ G+ A+KV ++E + E ++ L HP +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL---DWRR----RILMALDIARGVSYLH 620
+ + LC+V ++ P G LFRLLQR K + R +L+AL+ YLH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALE------YLH 120
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGK------------- 666
I++RDLK N+L+ + + + DF LS + E +K +
Sbjct: 121 --LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 667 ---------------GTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL 698
GT +++APEV+ + D ++ G++L+E+
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 6e-11
Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 10/155 (6%)
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
LMK +PN + +VT+ + ++ +++ G LF LL++ KL + +
Sbjct: 63 QLMKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLV 119
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHETYLTTKTGKGTPQWM 672
++ LH N IIH D+K N+L D+ + + D+GL ++ T GT +
Sbjct: 120 EALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG----TPSCYDGTLDYF 173
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATEKIPWDN 707
+PE ++ D D ++ GV+ +EL T K P+
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208
|
Length = 267 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 6e-11
Identities = 63/217 (29%), Positives = 94/217 (43%), Gaps = 45/217 (20%)
Query: 512 QIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
IG G+ G V+ G VA+K VF V FR E+ ++ +H NVL
Sbjct: 7 PIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRV---FR-ELKMLCFFKHDNVL 62
Query: 566 LFMGAVTSP-----QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMA-------LDIA 613
+ + P + + +VTE L+Q + K+ + L + I
Sbjct: 63 SALDILQPPHIDPFEEIYVVTE---------LMQSDLHKIIVSPQPLSSDHVKVFLYQIL 113
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL------KHETYLTTKTGKG 667
RG+ YLH I+HRD+K NLLV+ + +K+ DFGL+R+ KH T
Sbjct: 114 RGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV----- 166
Query: 668 TPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKI 703
T + APE+L D++S G I EL +I
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI 203
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 4/155 (2%)
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMAL 610
E +++++ V+ A + LC+V + G L F + D R + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ 670
+I G+ LH I++RDLK N+L+D + +++ D GL+ ++ T + GT
Sbjct: 110 EITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRVGTVG 166
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705
+MAPEV++NE D + G +++E+ K P+
Sbjct: 167 YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 37/220 (16%)
Query: 504 WEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVK-VFSRQEYSDEVIHSFRQEVSLMKRLR 560
+E L IGQG+ G V+ A VA+K V E I + R E+ +++ L+
Sbjct: 14 YEKLAK---IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLK 69
Query: 561 HPNVLLFMGAVTSPQR--------LCIVTEFLPRGSLFRLLQRNTTKLDW---RRRILMA 609
H NV+ + + +V EF L LL K ++ + M
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKML 128
Query: 610 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG-- 667
L+ G+ Y+H I+HRD+K++N+L+ K +K+ DFGL+R + +K K
Sbjct: 129 LN---GLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLAR----AFSLSKNSKPNR 179
Query: 668 ------TPQWMAPEVLRNEPS-DEKSDVYSFGVILWELAT 700
T + PE+L E D++ G I+ E+ T
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 513 IGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFR--QEVSLMKRLRHPNVLLFM 568
+G G+ G+V A VAVK SR S +IH+ R +E+ L+K ++H NV+ +
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS--LIHARRTYRELRLLKHMKHENVIGLL 80
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---LDWRRRILMALDIARGVSYLHHCNPP 625
T + E +L N K L + + RG+ Y+H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG-- 138
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM-APEVLRN-EPSD 683
IIHRDLK SN+ V++ +++ DFGL+R + TG +W APE++ N +
Sbjct: 139 IIHRDLKPSNVAVNEDCELRILDFGLARQADDEM----TGYVATRWYRAPEIMLNWMHYN 194
Query: 684 EKSDVYSFGVILWELATEKI 703
+ D++S G I+ EL K
Sbjct: 195 QTVDIWSVGCIMAELLKGKA 214
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 24/201 (11%)
Query: 512 QIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFM 568
+IG+G+ V A G A+K + S E +++ R E+ ++RL HPN+L +
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILRLI 64
Query: 569 GAV--TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
+ RL +V E L +L+ L++ L +R + + + ++H I
Sbjct: 65 EVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--I 121
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFG-----LSRLKHETYLTTKTGKGTPQWM-APEVLRNE 680
HRD+K N+L+ +K+ DFG S+ + Y++T+ W APE L +
Sbjct: 122 FHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR-------WYRAPECLLTD 173
Query: 681 PS-DEKSDVYSFGVILWELAT 700
K D+++ G + +E+ +
Sbjct: 174 GYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|238075 cd00130, PAS, PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-10
Identities = 30/103 (29%), Positives = 54/103 (52%), Gaps = 2/103 (1%)
Query: 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYD-IVHRIKM 197
+ V + DL RI+Y N +AE L GYS EE +G+ ++L+ D + + + + +
Sbjct: 1 LPDGVIVLDLDGRILYANPAAEQLLGYSPEELIGKSLLDLI-HPEDREELRERLENLLSG 59
Query: 198 GERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
GE T + + K + V+ + TP D+ G ++G++ V D
Sbjct: 60 GEPVTLEVRLRRKDGSVIWVLVSLTPIRDEGGEVIGLLGVVRD 102
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. Length = 103 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 512 QIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
Q+G G+ G+V A+ G VA+K SR S+ +E++L+K ++H NV+ +
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 570 AVTSPQRLCIVTEF-LPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
TS +F L + LQ+ L + + + G+ Y+H II
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG--II 139
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM-APEVLRNEPSDEKS 686
HRDLK NL V++ +K+ DFGL+R H TG +W APEV+ N ++
Sbjct: 140 HRDLKPGNLAVNEDCELKILDFGLAR--HAD--AEMTGYVVTRWYRAPEVILNWMHYNQT 195
Query: 687 -DVYSFGVILWELATEK 702
D++S G I+ E+ T K
Sbjct: 196 VDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 50/199 (25%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 528 GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587
G V V+ + + ++E++ + E+ + K HPN++ + + L +VT F+ G
Sbjct: 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84
Query: 588 SLFRLLQRNTTKLDWRRRILMA---LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTV 644
S L+ T +D + +A + + + Y+HH +HR +K+S++L+ V
Sbjct: 85 SAKDLI--CTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKV 140
Query: 645 KVGDF--GLSRLKHETYLTT-----KTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVIL 695
+ LS + H L K W++PEVL+ + D KSD+YS G+
Sbjct: 141 YLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITA 200
Query: 696 WELATEKIPWDNLNSMQVI 714
ELA +P+ ++ + Q++
Sbjct: 201 CELANGHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 58/238 (24%), Positives = 109/238 (45%), Gaps = 17/238 (7%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEV-IHSFRQEVSLMKRLRH 561
ED I + IG+G+ G V +D A+K+ ++ E FR+E ++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL--DWRRRILMALDIA-RGVSY 618
+ A L +V ++ G L LL + +L D R L + IA V
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPEVL 677
LH+ +HRD+K N+L+D + +++ DFG +L + + + GTP +++PE+L
Sbjct: 121 LHY-----VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175
Query: 678 RNEPSDE-----KSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 730
+ + + D +S GV ++E+ + P+ + ++ G + +R + P V
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 51/211 (24%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 550 RQEVSLMKRLRH-PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRIL 607
R E +++ +R P ++ A + +L ++ +++ G LF L QR + + +
Sbjct: 52 RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQI 109
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK- 666
+ +I + +LH II+RD+K N+L+D + V + DFGLS+ + + +
Sbjct: 110 YSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK----EFHEDEVERA 163
Query: 667 ----GTPQWMAPEVLRNEPS--DEKSDVYSFGVILWELATEKIPW--DNLNSMQVIGAVG 718
GT ++MAP+++R D+ D +S GV+++EL T P+ D + Q +
Sbjct: 164 YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR 223
Query: 719 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 749
+ P+++ I++ DP+ R
Sbjct: 224 ILKSEPPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 36/92 (39%), Positives = 50/92 (54%), Gaps = 7/92 (7%)
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK---TGKGT 668
I G+ Y+H N ++HRDLK NLLV+ +K+ DFGL+R E T
Sbjct: 114 ILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA 171
Query: 669 PQWM-APEVLRNEPSDEKS-DVYSFGVILWEL 698
+W APE++ + S K+ DV+S G IL EL
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 513 IGQGSCGTVY--HAVWYGSDVAVKVFSRQ----EYSDEVIHSFRQEVSLMKRLRHPNVLL 566
IG+G G VY G A+K ++ + + + + R +SL+ P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
A +P +LC + + + G L L ++ + R A +I G+ ++H N +
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMR-FYATEIILGLEHMH--NRFV 118
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGL----SRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 682
++RDLK +N+L+D+H V++ D GL S+ K + GT +MAPEVL+ +
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV------GTHGYMAPEVLQKGTA 172
Query: 683 -DEKSDVYSFGVILWELATEKIPW 705
D +D +S G +L++L P+
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 48/164 (29%), Positives = 88/164 (53%), Gaps = 16/164 (9%)
Query: 550 RQEVSLMKRLRH-PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRR--- 604
R E ++++ +R P ++ A + +L ++ +++ G +F L QR+ D R
Sbjct: 52 RTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYS 111
Query: 605 -RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTT 662
I++AL+ +LH I++RD+K N+L+D V + DFGLS+ E T
Sbjct: 112 GEIILALE------HLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT 163
Query: 663 KTGKGTPQWMAPEVLRNEPSDEKS-DVYSFGVILWELATEKIPW 705
+ GT ++MAPE++R + K+ D +S G++++EL T P+
Sbjct: 164 YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|225112 COG2202, AtoS, FOG: PAS/PAC domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 59.5 bits (142), Expect = 9e-10
Identities = 29/113 (25%), Positives = 53/113 (46%), Gaps = 2/113 (1%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+ +L++ + + D RI+Y N +AE L GYS EE LG+ +L+ +
Sbjct: 112 ERLRALLEASPDGIWVLDEDGRILYANPAAEELLGYSPEEELGRGLSDLIHPEDEERREL 171
Query: 190 DIVHRIKMGER--WTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
++ + G ++ + K ERV + + DDG +VG+V ++ D
Sbjct: 172 ELARALAEGRGGPLEIEYRVRRKDGERVRWILSRISPVRDDGEIVGVVGIARD 224
|
Length = 232 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 50/198 (25%), Positives = 93/198 (46%), Gaps = 19/198 (9%)
Query: 550 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRNT-TKLDWRRRIL 607
R +SL+ P ++ A +P +L + + + G L + L Q ++ + R
Sbjct: 45 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMR---F 101
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL----SRLKHETYLTTK 663
A +I G+ ++H N +++RDLK +N+L+D+H V++ D GL S+ K +
Sbjct: 102 YAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 156
Query: 664 TGKGTPQWMAPEVL-RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGA-VGFMN 721
GT +MAPEVL + D +D +S G +L++L P+ + +
Sbjct: 157 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 213
Query: 722 QRLEIPKDVDPRWAAIVE 739
+E+P P +++E
Sbjct: 214 MAVELPDSFSPELRSLLE 231
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 40/155 (25%), Positives = 75/155 (48%), Gaps = 4/155 (2%)
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMAL 610
E +++++ V+ A + LC+V + G L F + + R + A
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ 670
+I G+ LH N ++RDLK N+L+D + +++ D GL+ +K + + GT
Sbjct: 110 EILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRVGTVG 166
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705
+MAPEVL N+ D + G +++E+ + P+
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 61/244 (25%), Positives = 110/244 (45%), Gaps = 50/244 (20%)
Query: 478 SSCGSTSS----SAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--- 530
C +TSS S V + Y IL + GS G V+ +G +
Sbjct: 76 EPCETTSSSDPASVVR--------MQYNIL-------SSLTPGSEGEVFVCTKHGDEQRK 120
Query: 531 -VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP--RG 587
V VK + + + +E+ ++K + H ++ + A +C+V +P +
Sbjct: 121 KVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKC 170
Query: 588 SLFRLLQRNT-----TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642
LF + R+ + +RR+L AL +YLH IIHRD+K+ N+ +D+
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEAL------AYLH--GRGIIHRDVKTENIFLDEPE 222
Query: 643 TVKVGDFGLS-RLKHETYLTTKTG-KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
+GDFG + +L G GT + +PE+L +P K+D++S G++L+E++
Sbjct: 223 NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV 282
Query: 701 EKIP 704
+ +
Sbjct: 283 KNVT 286
|
Length = 392 |
| >gnl|CDD|232884 TIGR00229, sensory_box, PAS domain S-box | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-09
Identities = 30/125 (24%), Positives = 60/125 (48%), Gaps = 4/125 (3%)
Query: 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLT-DGRDFDV 187
+ +Y I +S ++ + DL I+Y N + E ++GYSAEE +G++ +EL+ + R+
Sbjct: 2 EERYRAIFESSPDAIIVIDLEGNILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVR 61
Query: 188 AYDIVHRIKMGERWTGQ-FPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246
I R++ + + K + V + +P +G +G+V + D ++
Sbjct: 62 ER-IERRLEGEREPVSEERRVRRKDGSEIWVEVSVSP-IRTNGGELGVVGIVRDITERKQ 119
Query: 247 TRAAL 251
AL
Sbjct: 120 AEEAL 124
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator [Regulatory functions, Small molecule interactions]. Length = 124 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 4e-09
Identities = 55/195 (28%), Positives = 96/195 (49%), Gaps = 44/195 (22%)
Query: 552 EVSLMKRLRHPNVLLFMGAV--TSPQRLCIVTEFLPRGSLFRLLQR---------NTTKL 600
EV++M+ L+H N++ ++ + Q+L I+ EF G L R +Q+ +
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 601 DWRRRILMALDIARGVSYLHHCN-----PPIIHRDLKSSNLLVD---KHW---------- 642
D R++L AL +Y H+ ++HRDLK N+ + +H
Sbjct: 122 DITRQLLHAL------AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175
Query: 643 ----TVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRNEPS--DEKSDVYSFGVIL 695
K+GDFGLS+ + E+ + GTP + +PE+L +E D+KSD+++ G I+
Sbjct: 176 NGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233
Query: 696 WELATEKIPWDNLNS 710
+EL + K P+ N+
Sbjct: 234 YELCSGKTPFHKANN 248
|
Length = 1021 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 55/190 (28%), Positives = 87/190 (45%), Gaps = 15/190 (7%)
Query: 520 TVYHAVWYGSDVAVKVFSRQEYSDEVI------HSFRQEVSLMKRLRHPNVLLFMGAVTS 573
++ A+ GS+ V S +Y V+ S E L++RL HP VL +
Sbjct: 172 AIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVV 231
Query: 574 PQRLCIVTEFLP--RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDL 631
C+V LP R L+ L L + +A + + Y+H IIHRD+
Sbjct: 232 GGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH--GEGIIHRDI 286
Query: 632 KSSNLLVDKHWTVKVGDFGLSRLKHETYLT-TKTG-KGTPQWMAPEVLRNEPSDEKSDVY 689
K+ N+LV+ + +GDFG + ++ T G GT APEVL +P D++
Sbjct: 287 KTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIW 346
Query: 690 SFGVILWELA 699
S G++++E A
Sbjct: 347 SAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 14/198 (7%)
Query: 512 QIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVL 565
+IG+G+ G V+ A G VA+K Q + + S +EV++++ L HPNV+
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 566 LFMGAVTSPQ-----RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
T + +L +V E + + L + + M + RG+ +LH
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 680
+ ++HRDLK N+LV +K+ DFGL+R+ T T + APEVL
Sbjct: 128 --SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-VVTLWYRAPEVLLQS 184
Query: 681 PSDEKSDVYSFGVILWEL 698
D++S G I E+
Sbjct: 185 SYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 38/143 (26%), Positives = 66/143 (46%), Gaps = 13/143 (9%)
Query: 577 LCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN 635
LC+V + G L F + D +R I A ++ G+ L I++RDLK N
Sbjct: 75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR--ERIVYRDLKPEN 132
Query: 636 LLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVIL 695
+L+D +++ D GL+ E T + GT +MAPEV+ NE D + G ++
Sbjct: 133 ILLDDRGHIRISDLGLAVQIPEGE-TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLI 191
Query: 696 WELA---------TEKIPWDNLN 709
+E+ E++ + ++
Sbjct: 192 YEMIQGQSPFRKRKERVKREEVD 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 61/216 (28%), Positives = 92/216 (42%), Gaps = 41/216 (18%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHPNVLLF 567
E+IG+G+ G VY A G VA+K +R E +E I +E+SL++ L ++
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSESIYIVR 65
Query: 568 MGAVTSPQR------LCIVTEFLP----------RGSLFRLLQRNTTKLDWRRRILMALD 611
+ V + L +V E+L R L T K
Sbjct: 66 LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKS-------FMYQ 118
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTV-KVGDFGLSR-----LKHETYLTTKTG 665
+ +GV++ H ++HRDLK NLLVDK + K+ D GL R +K T+
Sbjct: 119 LLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--- 173
Query: 666 KGTPQWMAPEVLRNEPSDEKS-DVYSFGVILWELAT 700
T + APEVL D++S G I E++
Sbjct: 174 --TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 70/300 (23%), Positives = 119/300 (39%), Gaps = 63/300 (21%)
Query: 423 WPWSHGDQDNESVQQKSPSYGT----KPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVS 478
WP E K+ G+ + + E RS NN A +++ + S
Sbjct: 4 WPIDEDINIYEEKNHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRS 63
Query: 479 SCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAVK-V 535
S +G IG GS G VY A+ + VA+K V
Sbjct: 64 PNKS------------------------YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV 99
Query: 536 FSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL-----FMGAVTSPQR---LCIVTEFLPRG 587
+Y + +E+ +MK L H N++ + ++ L +V EF+P+
Sbjct: 100 LQDPQYKN-------RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQT 152
Query: 588 --SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTV 644
+ RN L L + + R ++Y+H + I HRDLK NLL+D T+
Sbjct: 153 VHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNTHTL 210
Query: 645 KVGDFG-----LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWEL 698
K+ DFG L+ + +Y+ ++ + APE++ + D++S G I+ E+
Sbjct: 211 KLCDFGSAKNLLAGQRSVSYICSRF------YRAPELMLGATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 56/243 (23%), Positives = 97/243 (39%), Gaps = 44/243 (18%)
Query: 528 GSDVAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585
G A+K + E ++V H R E ++ +P V+ + L ++ E+LP
Sbjct: 26 GHIYAMKKLRKSEMLEKEQVAH-VRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP 84
Query: 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 645
G + LL + T + R +A + + +H IHRD+K NLL+D +K
Sbjct: 85 GGDMMTLLMKKDTFTEEETRFYIA-ETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIK 141
Query: 646 VGDFGLS-------------RLKH-------ETYLTTKTGK------------------G 667
+ DFGL L H + + K G
Sbjct: 142 LSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVG 201
Query: 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP 727
TP ++APEV +++ D +S GVI++E+ P+ + N + + + L+ P
Sbjct: 202 TPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFP 261
Query: 728 KDV 730
+V
Sbjct: 262 DEV 264
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRH 561
I E IG+GS G V A+ G VA+K VF + SD +E+ L++ LRH
Sbjct: 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDA--TRILREIKLLRLLRH 58
Query: 562 PNVLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 616
P+++ + P R + +V E L L ++++ N + + + R +
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFL-YQLLRAL 116
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK--TGKGTPQWM-A 673
Y+H N + HRDLK N+L + +K+ DFGL+R+ T T +W A
Sbjct: 117 KYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 674 PEVLRNEPSDEKS--DVYSFGVILWELATEK 702
PE+ + S D++S G I E+ T K
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|214512 smart00091, PAS, PAS domain | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-08
Identities = 20/50 (40%), Positives = 31/50 (62%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL 179
+ IL+S+ + + DL RI+Y N +AE L GYS EE +G+ +EL+
Sbjct: 1 ERLRAILESLPDGIFVLDLDGRILYANPAAEELLGYSPEELIGKSLLELI 50
|
PAS motifs appear in archaea, eubacteria and eukarya. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. Length = 67 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 48/189 (25%), Positives = 78/189 (41%), Gaps = 38/189 (20%)
Query: 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNL 636
L ++ EFLP G + LL + T + + +A + + +H IHRD+K NL
Sbjct: 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQLG--FIHRDIKPDNL 132
Query: 637 LVDKHWTVKVGDFGL------------------------------SRLKHETYLTTK--- 663
L+D VK+ DFGL S+ K ET+ +
Sbjct: 133 LLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQL 192
Query: 664 --TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN 721
+ GTP ++APEV ++ D +S GVI++E+ P+ + + V
Sbjct: 193 AFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWK 252
Query: 722 QRLEIPKDV 730
+ L P +V
Sbjct: 253 ETLIFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 43/159 (27%), Positives = 69/159 (43%), Gaps = 38/159 (23%)
Query: 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 634
+ L ++ EFLP G + LL + T + + +A + + +H IHRD+K
Sbjct: 74 RNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIHQLG--FIHRDIKPD 130
Query: 635 NLLVDKHWTVKVGDFGL------------------------------SRLKHETYLTTK- 663
NLL+D VK+ DFGL S+ K ET+ +
Sbjct: 131 NLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRR 190
Query: 664 ----TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL 698
+ GTP ++APEV ++ D +S GVI++E+
Sbjct: 191 QLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 54/224 (24%), Positives = 100/224 (44%), Gaps = 21/224 (9%)
Query: 548 SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 607
+F + SLM ++ H ++ G +V EF+ G L L++ ++ +I
Sbjct: 62 AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKIT 121
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-------VKVGDFGLSRLKHETYL 660
+A +A +SYL N ++H ++ + N+L+ + +K+ D G+S T L
Sbjct: 122 VAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSF----TAL 175
Query: 661 TTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVG 718
+ + W+APE + S +D +SFG L E+ + ++P L
Sbjct: 176 SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP---LKERTPSEKER 232
Query: 719 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
F ++ +P+ A ++ C +P RPSF+ + LRDL
Sbjct: 233 FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTI---LRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 48/218 (22%), Positives = 96/218 (44%), Gaps = 18/218 (8%)
Query: 548 SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 607
+F + S+M+++ H +++L G +V EF+ G L + R + L +
Sbjct: 50 AFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFK 109
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-------VKVGDFGLSRLKHETYL 660
+A +A +SYL + ++H ++ + N+L+ + +K+ D G+ T L
Sbjct: 110 VAKQLASALSYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI----TVL 163
Query: 661 TTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVG 718
+ + W+APE + + + +D +SFG LWE+ +IP L +
Sbjct: 164 SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP---LKDKTLAEKER 220
Query: 719 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELV 756
F + + A ++ C + DP RP F+ ++
Sbjct: 221 FYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 40/172 (23%), Positives = 66/172 (38%), Gaps = 46/172 (26%)
Query: 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNL 636
L V +++P G + LL R + R +A ++ + +H IHRD+K N+
Sbjct: 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVH--KMGFIHRDIKPDNI 132
Query: 637 LVDKHWTVKVGDFGLS-------------------------------------------R 653
L+D+ +K+ DFGL R
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRR 192
Query: 654 LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705
+ + GTP ++APEVL + D +S GVIL+E+ + P+
Sbjct: 193 KRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 51/238 (21%), Positives = 108/238 (45%), Gaps = 17/238 (7%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEV-IHSFRQEVSLMKRLRH 561
+D I + IG+G+ G V ++ A+K+ ++ E FR+E +++
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL--DWRRRILMALDIA-RGVSY 618
+ A L +V ++ G L LL + +L D R + + +A +
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPEVL 677
LH+ +HRD+K N+L+D + +++ DFG ++ + + + GTP +++PE+L
Sbjct: 121 LHY-----VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175
Query: 678 RNEPS-----DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 730
+ + D +S GV ++E+ + P+ + ++ G + +R + P +
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|219845 pfam08448, PAS_4, PAS fold | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 28/105 (26%), Positives = 46/105 (43%), Gaps = 1/105 (0%)
Query: 136 LQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRI 195
L S+ ++ + D R+ Y N +A L+G EE LG+ ELL + + +
Sbjct: 1 LDSLPDALAVLDPDGRVRYANAAAAELFGLPPEELLGKTLAELLPPEDAARLERALRRAL 60
Query: 196 KMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ E EER + TP D DG ++G++ +S D
Sbjct: 61 EGEEPIDFLEELLLNGEERHYEL-RLTPLRDPDGEVIGVLVISRD 104
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 110 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 59/244 (24%), Positives = 97/244 (39%), Gaps = 55/244 (22%)
Query: 505 EDLTIGEQIGQGSCGTV--YHAVWYGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLR 560
ED + IG+G+ G V G A+K + E D++ H + E ++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAH-VKAERDVLAESD 59
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
P V+ + Q L ++ EFLP G L +L + T + R MA + + +H
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA-ECVLAIEAVH 118
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--------LTTKTGK------ 666
IHRD+K N+L+D+ +K+ DFGLS H+ + L K+ K
Sbjct: 119 KLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 667 ---------------------------------GTPQWMAPEVLRNEPSDEKSDVYSFGV 693
GTP ++APE+ + ++ D +S G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236
Query: 694 ILWE 697
I++E
Sbjct: 237 IMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 15/48 (31%), Positives = 29/48 (60%)
Query: 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711
+ P +MAPEV++ + EK+D+YS G+ L+E ++P++ +
Sbjct: 63 QSRPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL 110
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 4e-06
Identities = 42/159 (26%), Positives = 73/159 (45%), Gaps = 16/159 (10%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRH 561
E+ I + I +G+ G VY AVKV + + ++ ++H + E + +
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-----RNTTKLDWRRRILMALDIARGV 616
P ++ ++ S + +V E+L G + LL + + + +ALD
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALD----- 118
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655
YLH IIHRDLK N+L+ +K+ DFGLS++
Sbjct: 119 -YLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|226350 COG3829, RocR, Transcriptional regulator containing PAS, AAA-type ATPase, and DNA-binding domains [Transcription / Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 6e-06
Identities = 30/121 (24%), Positives = 49/121 (40%), Gaps = 16/121 (13%)
Query: 130 RQYL-NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD---F 185
RQ L IL S+ + + D IIY+N++ L G S EE LG+ +++++ G D
Sbjct: 116 RQRLEAILDSIDDGLLVVDEDGIIIYYNKAYAKLLGLSPEEVLGKHLLDVVSAGEDSTLL 175
Query: 186 DVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQ 245
+V ++V N DG L+G+V +S D +
Sbjct: 176 EVLRTGKPIRD----------VVQTYNGNKIIV--NVAPVYADGQLIGVVGISKDVSELE 223
Query: 246 E 246
Sbjct: 224 R 224
|
Length = 560 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 42/166 (25%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 577 LCIVTEFLPRGSLFRLLQRNTTKL--DWRR----RILMALDIARGVSYLHHCNPPIIHRD 630
L +V ++ G L LL + +L D R +++A+D V L + +HRD
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAID---SVHQLGY-----VHRD 127
Query: 631 LKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS--- 686
+K N+L+DK+ +++ DFG RL + + + GTP +++PE+L+ +
Sbjct: 128 IKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGP 187
Query: 687 --DVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 730
D +S GV ++E+ + P+ + ++ G + + + P DV
Sbjct: 188 ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV 233
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 54/222 (24%), Positives = 97/222 (43%), Gaps = 43/222 (19%)
Query: 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQ------------EVSLMK 557
G ++G+G+ G VY A R++ DE ++ +Q E++L++
Sbjct: 6 GCKVGRGTYGHVYKA------------KRKDGKDEKEYALKQIEGTGISMSACREIALLR 53
Query: 558 RLRHPNVLLFMGAVT--SPQRLCIVTEFLPRG-----SLFRLLQRNTTKLDWRRRILMAL 610
L+HPNV+ S +++ ++ ++ R + N + R ++ +L
Sbjct: 54 ELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSL 113
Query: 611 --DIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSRLKHETYLTTKT 664
I G+ YLH ++HRDLK +N+LV + VK+ D G +RL +
Sbjct: 114 LYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171
Query: 665 GKG---TPQWMAPEVLRNEPSDEKS-DVYSFGVILWELATEK 702
T + APE+L K+ D+++ G I EL T +
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|221967 pfam13188, PAS_8, PAS domain | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 5e-05
Identities = 12/57 (21%), Positives = 24/57 (42%), Gaps = 1/57 (1%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFD 186
+ + ++ + + D DRI+Y N +A L GY L + ++ L +
Sbjct: 1 ERLRALFENAPDGILVLD-GDRILYANPAALELLGYELLGELLGELLDDLEALAEEA 56
|
Length = 64 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 8e-05
Identities = 40/158 (25%), Positives = 64/158 (40%), Gaps = 28/158 (17%)
Query: 513 IGQGSCGTVYHAVWYGSDVAVKVFSRQEYS----DEVIHSFR--QEVSLMKRLRH----- 561
I +G+ +Y + G +K + Y DE I R +E +M R R
Sbjct: 4 IKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNV 63
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
P V P+ IV E++ L L+ N + ++ +I R V LH
Sbjct: 64 PAVYFV-----DPENFIIVMEYIEGEPLKDLINSNGMEELE-----LSREIGRLVGKLHS 113
Query: 622 CNPPIIHRDLKSSNLLV--DKHWTVKVGDFGLSRLKHE 657
IIH DL +SN+++ K + + DFGL+ +
Sbjct: 114 AG--IIHGDLTTSNMILSGGKIYLI---DFGLAEFSKD 146
|
Length = 211 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 37/161 (22%), Positives = 70/161 (43%), Gaps = 16/161 (9%)
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE--------FLPRGSLFRLLQRNTTKLDWR 603
E+ + RL H N+L + S ++T+ F+ + L +
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF----DWKDRPLLKQ 268
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
R +M + V Y+H + +IHRD+K N+ ++ + +GDFG + +
Sbjct: 269 TRAIMK-QLLCAVEYIH--DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFD 325
Query: 664 TG-KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKI 703
G GT +PE+L + E +D++S G+IL ++ +
Sbjct: 326 YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366
|
Length = 501 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 53/222 (23%), Positives = 97/222 (43%), Gaps = 43/222 (19%)
Query: 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQ------------EVSLMK 557
G ++G+G+ G VY A R++ D+ ++ +Q E++L++
Sbjct: 6 GCKVGRGTYGHVYKA------------KRKDGKDDRDYALKQIEGTGISMSACREIALLR 53
Query: 558 RLRHPNVLLFMGAVTS--PQRLCIVTEFLPRG-----SLFRLLQRNTTKLDWRRRILMAL 610
L+HPNV+ S +++ ++ ++ R + N + R ++ +L
Sbjct: 54 ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 113
Query: 611 --DIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSRLKHETYLTTKT 664
I G+ YLH ++HRDLK +N+LV + VK+ D G +RL +
Sbjct: 114 LYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171
Query: 665 GKG---TPQWMAPEVLRNEPSDEKS-DVYSFGVILWELATEK 702
T + APE+L K+ D+++ G I EL T +
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 33/151 (21%), Positives = 55/151 (36%), Gaps = 25/151 (16%)
Query: 513 IGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVI------HSFRQEVSLMKRLRHPNV-- 564
I QG+ +Y + G VK + Y + R+E ++ + R V
Sbjct: 4 IKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPV 63
Query: 565 --LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
+ P IV E++ G L + R + ++ R V LH
Sbjct: 64 PIVYD----VDPDNGLIVMEYIE-GELLK-------DALEEARPDLLREVGRLVGKLHKA 111
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
I+H DL +SN+++ + DFGL
Sbjct: 112 G--IVHGDLTTSNIILSGGRIYFI-DFGLGE 139
|
Length = 204 |
| >gnl|CDD|236901 PRK11360, PRK11360, sensory histidine kinase AtoS; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 19/108 (17%), Positives = 43/108 (39%), Gaps = 4/108 (3%)
Query: 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH 193
IL+S+ V D +I N +AE++ G E +G+ EL F +
Sbjct: 266 LILESIADGVIAIDRQGKITTMNPAAEVITGLQRHELVGKPYSELFPPNTPF---ASPLL 322
Query: 194 R-IKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
++ G + + + + + + ++ G ++G + + +D
Sbjct: 323 DTLEHGTEHVDLEISFPGRDRTIELSVSTSLLHNTHGEMIGALVIFSD 370
|
Length = 607 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 38/127 (29%), Positives = 56/127 (44%), Gaps = 13/127 (10%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWE----DLTIGEQIGQGSCGTVYHAVWYG-------SD 530
S SS + +D L Y+ WE +L +G +G G+ G V A +G
Sbjct: 10 SVSSDGHEYIYVDPMQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMK 69
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589
VAVK+ S E + E+ +M L H N++ +GA T + I+TE+ G L
Sbjct: 70 VAVKMLKSTARSSEK-QALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDL 128
Query: 590 FRLLQRN 596
L RN
Sbjct: 129 VDYLHRN 135
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 44/176 (25%), Positives = 69/176 (39%), Gaps = 50/176 (28%)
Query: 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNL 636
L V +++P G + LL R + R +A ++ + +H IHRD+K N+
Sbjct: 76 LYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVHKMG--FIHRDIKPDNI 132
Query: 637 LVDKHWTVKVGDFGL---------------------------------------SRLKHE 657
L+D +K+ DFGL RLK
Sbjct: 133 LIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTL 192
Query: 658 TYLTTKTGK--------GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705
TK + GTP ++APEVL + + D +S GVIL+E+ + P+
Sbjct: 193 EQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 9e-04
Identities = 45/177 (25%), Positives = 70/177 (39%), Gaps = 52/177 (29%)
Query: 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNL 636
L V +++P G + LL R + R +A ++ V +H IHRD+K N+
Sbjct: 76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVHKMG--FIHRDIKPDNI 132
Query: 637 LVDKHWTVKVGDFGL---------------------------------------SRLK-- 655
L+D+ +K+ DFGL RLK
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPL 192
Query: 656 -------HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705
H+ L + GTP ++APEVL + D +S GVIL+E+ + P+
Sbjct: 193 ERRAARQHQRCL-AHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 30/110 (27%), Positives = 52/110 (47%), Gaps = 13/110 (11%)
Query: 498 LDYEILWE----DLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVI 546
L Y WE +L G+ +G G+ G V A +G VAVK+ ++DE
Sbjct: 27 LPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDER- 85
Query: 547 HSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR 595
+ E+ ++ L +H N++ +GA T + ++TE+ G L L++
Sbjct: 86 EALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRK 135
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|219844 pfam08447, PAS_3, PAS fold | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.002
Identities = 26/100 (26%), Positives = 42/100 (42%), Gaps = 25/100 (25%)
Query: 152 IIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH--------------RIKM 197
IIYW+ E + GY+ E EL + + D+VH +K
Sbjct: 1 IIYWSPRFEEILGYTPE--------ELKSSYEGW---LDLVHPEDRERVRRALQEFSLKK 49
Query: 198 GERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCV 237
GE ++G++ + K E V A P D++G V ++ V
Sbjct: 50 GEPYSGEYRIRRKDGEYRWVEARGRPIRDENGKPVRVIGV 89
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 90 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.003
Identities = 41/154 (26%), Positives = 60/154 (38%), Gaps = 31/154 (20%)
Query: 513 IGQGSCGTVYHAVWYGSDVAVKVFSRQEYS----DEVIHSFR--QEVSLMKRLRH----- 561
I +G+ +Y + G +K + Y DE I R E L+ R R
Sbjct: 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNT 61
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
P V P IV E++ G + + D R +I R V LH
Sbjct: 62 PVVYDV-----DPDNKTIVMEYIE-GKPLKDV--IEEGNDELLR-----EIGRLVGKLHK 108
Query: 622 CNPPIIHRDLKSSNLLV--DKHWTVKVGDFGLSR 653
I+H DL +SN++V DK + + DFGL +
Sbjct: 109 AG--IVHGDLTTSNIIVRDDKLYLI---DFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|183097 PRK11359, PRK11359, cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 24/99 (24%), Positives = 41/99 (41%), Gaps = 1/99 (1%)
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW- 201
V + D RI+ NR+ ++GY EA G LL + ++
Sbjct: 149 VIVLDPERRIVQCNRAFTEMFGYCISEASGMQPDTLLNIPEFPADNRIRLQQLLWKTARD 208
Query: 202 TGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+F T+T E++ + A+ +P YD L +V +D
Sbjct: 209 QDEFLLLTRTGEKIWIKASISPVYDVLAHLQNLVMTFSD 247
|
Length = 799 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 782 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| PF13426 | 104 | PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_ | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.63 | |
| PF08448 | 110 | PAS_4: PAS fold; InterPro: IPR013656 The PAS fold | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| PF00989 | 113 | PAS: PAS fold; InterPro: IPR013767 PAS domains are | 99.58 | |
| PRK11091 | 779 | aerobic respiration control sensor protein ArcB; P | 99.52 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.5 | |
| PRK13557 | 540 | histidine kinase; Provisional | 99.48 | |
| PRK13559 | 361 | hypothetical protein; Provisional | 99.48 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.4 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.37 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.34 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.33 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.3 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| TIGR02938 | 494 | nifL_nitrog nitrogen fixation negative regulator N | 99.26 | |
| TIGR00229 | 124 | sensory_box PAS domain S-box. The PAS domain was p | 99.25 | |
| PRK13560 | 807 | hypothetical protein; Provisional | 99.21 | |
| PRK10060 | 663 | RNase II stability modulator; Provisional | 99.2 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.19 | |
| TIGR02040 | 442 | PpsR-CrtJ transcriptional regulator PpsR. This mod | 99.18 | |
| PRK11073 | 348 | glnL nitrogen regulation protein NR(II); Provision | 99.18 | |
| PRK13558 | 665 | bacterio-opsin activator; Provisional | 99.18 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.12 | |
| PRK09776 | 1092 | putative diguanylate cyclase; Provisional | 99.1 | |
| PRK09776 | 1092 | putative diguanylate cyclase; Provisional | 99.1 | |
| TIGR02966 | 333 | phoR_proteo phosphate regulon sensor kinase PhoR. | 99.09 | |
| PRK11360 | 607 | sensory histidine kinase AtoS; Provisional | 99.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.06 | |
| PF13596 | 106 | PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D. | 99.0 | |
| COG5002 | 459 | VicK Signal transduction histidine kinase [Signal | 98.96 | |
| PRK11359 | 799 | cyclic-di-GMP phosphodiesterase; Provisional | 98.95 | |
| PRK13560 | 807 | hypothetical protein; Provisional | 98.93 | |
| cd00130 | 103 | PAS PAS domain; PAS motifs appear in archaea, euba | 98.92 | |
| PF08447 | 91 | PAS_3: PAS fold; InterPro: IPR013655 The PAS fold | 98.9 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| COG3829 | 560 | RocR Transcriptional regulator containing PAS, AAA | 98.86 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.86 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.83 | |
| PRK11086 | 542 | sensory histidine kinase DcuS; Provisional | 98.8 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.75 | |
| PRK10820 | 520 | DNA-binding transcriptional regulator TyrR; Provis | 98.74 | |
| PRK11006 | 430 | phoR phosphate regulon sensor protein; Provisional | 98.72 | |
| PRK11359 | 799 | cyclic-di-GMP phosphodiesterase; Provisional | 98.71 | |
| PF12860 | 115 | PAS_7: PAS fold | 98.67 | |
| TIGR02040 | 442 | PpsR-CrtJ transcriptional regulator PpsR. This mod | 98.61 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.57 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.53 | |
| TIGR02938 | 494 | nifL_nitrog nitrogen fixation negative regulator N | 98.46 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.41 | |
| COG3852 | 363 | NtrB Signal transduction histidine kinase, nitroge | 98.4 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.38 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.37 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.33 | |
| COG3290 | 537 | CitA Signal transduction histidine kinase regulati | 98.33 | |
| KOG0501 | 971 | consensus K+-channel KCNQ [Inorganic ion transport | 98.32 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.27 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.25 | |
| PRK15053 | 545 | dpiB sensor histidine kinase DpiB; Provisional | 98.24 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.16 | |
| PF14598 | 111 | PAS_11: PAS domain; PDB: 1P97_A 3F1O_A 2A24_A 3H7W | 98.15 | |
| PRK09959 | 1197 | hybrid sensory histidine kinase in two-component r | 98.12 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.1 | |
| PRK11388 | 638 | DNA-binding transcriptional regulator DhaR; Provis | 98.06 | |
| COG2202 | 232 | AtoS FOG: PAS/PAC domain [Signal transduction mech | 98.06 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=416.20 Aligned_cols=260 Identities=31% Similarity=0.482 Sum_probs=231.5
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc-
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR- 576 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~- 576 (782)
..+...+++.++.||+|..|+|||+.++ ++-+|+|++ .........+++.+|+++++.++|||||.+|++|..+..
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I-~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVI-LLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEee-cccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 3456678888999999999999999996 666999999 445567788899999999999999999999999999995
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~-~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
++|+||||++|+|.+++... .++++.....++.+|++||.|||. ++ ||||||||+||||+..|.|||||||.+...
T Consensus 153 isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVSGIL 229 (364)
T ss_pred EEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccccccHHh
Confidence 99999999999999999865 469999999999999999999996 66 999999999999999999999999999877
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-----ChHHHHHHhhccccccCCCCC-
Q 003978 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL-----NSMQVIGAVGFMNQRLEIPKD- 729 (782)
Q Consensus 656 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~-----~~~~~~~~i~~~~~~~~~p~~- 729 (782)
... ...+++||..|||||.+.+..|+.++||||||++++||.+|++||... ...+.+..|. ....+.+|..
T Consensus 230 vnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~~~ 306 (364)
T KOG0581|consen 230 VNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPEGE 306 (364)
T ss_pred hhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCccc
Confidence 665 445789999999999999999999999999999999999999999874 5566666664 3456777776
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 730 ~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
+++++++||..||++||.+||++.+| +.|+|++....
T Consensus 307 fS~ef~~FV~~CL~Kdp~~R~s~~qL------l~Hpfi~~~~~ 343 (364)
T KOG0581|consen 307 FSPEFRSFVSCCLRKDPSERPSAKQL------LQHPFIKKFED 343 (364)
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHH------hcCHHHhhccc
Confidence 99999999999999999999999999 67888876544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-48 Score=426.73 Aligned_cols=254 Identities=28% Similarity=0.490 Sum_probs=235.7
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.+|+.++.||+|+|..||.++. .|..||+|++.+... .....+++.+||+|.+.|+|||||++|++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6899999999999999999987 788899999987654 4466788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
|+|..++|..++++ ..++++..++.++.||+.||.|||+++ |||||||..|+||+++.+|||+|||+|.....+...
T Consensus 98 ELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 99999999999984 568999999999999999999999999 999999999999999999999999999988877677
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHh
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 741 (782)
..+.+|||.|.|||++....++..+||||+||+||-||+|++||...+-.+.+..|. .....+|..++.++++||.+|
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik--~~~Y~~P~~ls~~A~dLI~~l 252 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK--LNEYSMPSHLSAEAKDLIRKL 252 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH--hcCcccccccCHHHHHHHHHH
Confidence 778999999999999999999999999999999999999999999998888888884 456677889999999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 742 WHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 742 L~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
|.+||.+|||++++ |.|+||+.
T Consensus 253 L~~~P~~Rpsl~~v------L~h~Ff~~ 274 (592)
T KOG0575|consen 253 LRPNPSERPSLDEV------LDHPFFKS 274 (592)
T ss_pred hcCCcccCCCHHHH------hcCHhhhC
Confidence 99999999999999 78899943
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=419.20 Aligned_cols=275 Identities=49% Similarity=0.819 Sum_probs=249.8
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEcCCe-EEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC-
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ- 575 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~-vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~- 575 (782)
..+.+...++.+.+.||.|+||+||++.+.|+. ||+|++..........+.|.+|+.+|..++|||||+|+|++..+.
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 445666777888888999999999999999999 999999887776666889999999999999999999999999887
Q ss_pred ceeEEEeecCCCCHHHHHhh-cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-cEEEEecCCCc
Q 003978 576 RLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSR 653 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~-~vkL~DFGla~ 653 (782)
.++|||||+++|+|.+++.. ....+++..++.++.||++||.|||++++ ||||||||+||||+.++ ++||+|||+++
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccce
Confidence 79999999999999999987 46789999999999999999999999875 99999999999999998 99999999998
Q ss_pred ccccccccccCCCCCCcccCccccc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCC
Q 003978 654 LKHETYLTTKTGKGTPQWMAPEVLR--NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 731 (782)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~y~aPE~l~--~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 731 (782)
.............||+.|||||++. ...|+.|+||||||++||||+||+.||......++...+.....++.+|..++
T Consensus 193 ~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~ 272 (362)
T KOG0192|consen 193 EKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECP 272 (362)
T ss_pred eeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCC
Confidence 7776543444468999999999999 56899999999999999999999999999999888888888888999999999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 732 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 732 ~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
+.+..||.+||..||..||++.+++..|+.+...+.......
T Consensus 273 ~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~~~ 314 (362)
T KOG0192|consen 273 PHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGPED 314 (362)
T ss_pred HHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCccc
Confidence 999999999999999999999999999999988877544443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=405.05 Aligned_cols=258 Identities=26% Similarity=0.428 Sum_probs=230.2
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCH-HHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
..++|+++++||+|+||+||.++. +++-||+|++++..... ........|..+|..++||+||.++..|++..++|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 357899999999999999999987 46679999998876643 456778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
|+||+.||.|+.+|++.+ .+++..+..++.+|+.||.|||++| ||||||||+||||+.+|+|+|+|||+++......
T Consensus 103 Vld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 999999999999998754 7999999999999999999999999 9999999999999999999999999999777777
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHH
Q 003978 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 739 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 739 (782)
..+.+.+||+.|||||++.+..|+..+|+|||||++|+|++|.+||...+....+..+.... .+..|..++.+.++||.
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSEEARDLLK 258 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCHHHHHHHH
Confidence 77778999999999999999999999999999999999999999999999988888885322 35566679999999999
Q ss_pred HhhhhCCCCCC----CHHHHHHHHHHHHHHHhhcc
Q 003978 740 SCWHSDPQCRP----SFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 740 ~cL~~dP~~RP----s~~ell~~L~~L~~~~~~~~ 770 (782)
++|.+||++|. ++.++ -.|+||+.+
T Consensus 259 ~LL~rdp~~RLg~~~d~~~i------k~HpfF~~i 287 (357)
T KOG0598|consen 259 KLLKRDPRQRLGGPGDAEEI------KRHPFFKGI 287 (357)
T ss_pred HHhccCHHHhcCCCCChHHh------hcCcccccC
Confidence 99999999995 45554 246777543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=411.78 Aligned_cols=260 Identities=26% Similarity=0.398 Sum_probs=221.8
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHH-----HHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE-----VIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (782)
...+.|.+.+.||+|+||.|.+|.. .++.||||++++...... ......+|+++|++|.|||||+++++|+.+
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 3567899999999999999999986 578899999987654331 123356899999999999999999999999
Q ss_pred CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CcEEEEecCC
Q 003978 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH---WTVKVGDFGL 651 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~---~~vkL~DFGl 651 (782)
...||||||+.||+|++.+-.++ .+.+.....+++||+.|+.|||++| |+||||||+|||++.+ ..+||+|||+
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred CceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccch
Confidence 99999999999999999997754 5888888999999999999999999 9999999999999866 7899999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCCCC---CchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhcccccc--C
Q 003978 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPS---DEKSDVYSFGVILWELATEKIPWDNLNSMQ-VIGAVGFMNQRL--E 725 (782)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~---s~~sDIwSLG~ll~elltG~~Pf~~~~~~~-~~~~i~~~~~~~--~ 725 (782)
|+..++.. ...+.||||.|.|||++.+... ..++|||||||+||-+|+|.+||....... ..++|....... .
T Consensus 326 AK~~g~~s-fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~ 404 (475)
T KOG0615|consen 326 AKVSGEGS-FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL 404 (475)
T ss_pred hhccccce-ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence 99887544 4458899999999999987654 347899999999999999999998766555 555664333322 2
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 726 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 726 ~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
....++.+..+||.+||..||++|||+.|+ |+|+||+.++
T Consensus 405 ~w~~Iseea~dlI~~mL~VdP~~R~s~~ea------L~hpW~~~~~ 444 (475)
T KOG0615|consen 405 QWDRISEEALDLINWMLVVDPENRPSADEA------LNHPWFKDAP 444 (475)
T ss_pred hhhhhhHHHHHHHHHhhEeCcccCcCHHHH------hcChhhhccc
Confidence 334688999999999999999999999999 7899999765
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=397.09 Aligned_cols=258 Identities=26% Similarity=0.491 Sum_probs=228.2
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
..+|.+.+.||+|+|++||+|++ .+..||||.+.+..+..+..+.+..|+++|+.++|||||++++++..++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 35899999999999999999998 4677999999998888888899999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC------CcEEEEecCCCccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH------WTVKVGDFGLSRLK 655 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~------~~vkL~DFGla~~~ 655 (782)
|||+||+|.+||.+.+ .+++..+..++.||+.||++||+++ ||||||||+||||+.. -.+||+|||+|+..
T Consensus 89 EyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999998754 6999999999999999999999999 9999999999999764 46899999999987
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-cCCCCCCCHHH
Q 003978 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR-LEIPKDVDPRW 734 (782)
Q Consensus 656 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~p~~~~~~l 734 (782)
... ....+.+|+|.|||||++...+|+.|+|+||+|+++|+|++|+.||...+..+....+.+.... +.++..++..+
T Consensus 166 ~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~ 244 (429)
T KOG0595|consen 166 QPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPL 244 (429)
T ss_pred Cch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCch
Confidence 754 3455789999999999999999999999999999999999999999999998888777655443 34445677888
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 735 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
.+|+...|.++|..|-++.+. +.+++....+
T Consensus 245 ~~Ll~~ll~~~~~~~~~~~~~------~~~~~l~~~p 275 (429)
T KOG0595|consen 245 RELLISLLQRNPKDRISFEDF------FDHPFLAANP 275 (429)
T ss_pred hhhhhHHHhcCccccCchHHh------hhhhhcccCc
Confidence 899999999999999988877 4455554433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=384.84 Aligned_cols=256 Identities=25% Similarity=0.419 Sum_probs=223.9
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeee-eecCC-ce
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA-VTSPQ-RL 577 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~-~~~~~-~~ 577 (782)
....+|++.++||+|+||.||++.+ .+..+|.|.+.....+....+.+..|+.+|++|+|||||+++++ +..++ .+
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 3456899999999999999999986 67789999998777788888999999999999999999999994 44444 48
Q ss_pred eEEEeecCCCCHHHHHh---hcCCcchHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCcEEEcCCCcEEEEecCCC
Q 003978 578 CIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALDIARGVSYLHHCNPP--IIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~---~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~--ivHrDIKp~NILl~~~~~vkL~DFGla 652 (782)
+|+||||.+|+|..+++ +....+++..+|+++.|++.||..+|..-+. |+||||||.||+|+.+|.|||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 99999999999999985 3456799999999999999999999984344 999999999999999999999999999
Q ss_pred cccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC-CCCC
Q 003978 653 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP-KDVD 731 (782)
Q Consensus 653 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~~ 731 (782)
+..........+.+|||.||+||++.+.+|+.++|||||||++|||+.-.+||.+.+-.....+|... .-+++| ..++
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~~p~~~YS 254 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPPLPDEHYS 254 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCCCcHHHhh
Confidence 98877666666789999999999999999999999999999999999999999999888888888644 233455 6789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003978 732 PRWAAIVESCWHSDPQCRPSFQELVDK 758 (782)
Q Consensus 732 ~~l~~LI~~cL~~dP~~RPs~~ell~~ 758 (782)
.++..||..|+..||+.||+...++..
T Consensus 255 ~~l~~li~~ci~vd~~~RP~t~~~v~d 281 (375)
T KOG0591|consen 255 TDLRELINMCIAVDPEQRPDTVPYVQD 281 (375)
T ss_pred hHHHHHHHHHccCCcccCCCcchHHHH
Confidence 999999999999999999985444333
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=398.14 Aligned_cols=257 Identities=25% Similarity=0.458 Sum_probs=228.4
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCce
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 577 (782)
....+|++++.||+|+|++||+|+. .++.||||++.+.-. .+...+-+.+|-..|..| .||.||+||..|.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3457999999999999999999987 567899999976544 334455677899999999 899999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+|+||+++|+|.++|.+. +.|++.-+.+++.+|+.||+|||++| ||||||||+||||+.++++||+|||.|+....
T Consensus 150 YFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 9999999999999999875 47999999999999999999999999 99999999999999999999999999986543
Q ss_pred ccc-----------cc--cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc
Q 003978 658 TYL-----------TT--KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL 724 (782)
Q Consensus 658 ~~~-----------~~--~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 724 (782)
... .. .+++||..|.+||++.....+..+|||+|||+||+|+.|.+||...+....++.|. ....
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~--~l~y 304 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ--ALDY 304 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH--Hhcc
Confidence 211 12 45789999999999999999999999999999999999999999999988888874 4567
Q ss_pred CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 725 EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 725 ~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
.+|+.+++.+++||+++|..||.+|++.++| -+|+||..
T Consensus 305 ~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qI------k~HpFF~~ 343 (604)
T KOG0592|consen 305 EFPEGFPEDARDLIKKLLVRDPSDRLTSQQI------KAHPFFEG 343 (604)
T ss_pred cCCCCCCHHHHHHHHHHHccCccccccHHHH------hhCccccc
Confidence 8899999999999999999999999999998 46788854
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=376.33 Aligned_cols=254 Identities=24% Similarity=0.375 Sum_probs=221.0
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
+.|+.+.++|+|+||+||+|++ +|+-||||.|.....++...+-..+|+++|++++|+|+|.++++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 5788899999999999999987 57789999998777667777888999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
||+. ++.+-|......++.+.+..++.|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+....+....
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 9976 777888888888999999999999999999999999 9999999999999999999999999999877555555
Q ss_pred cCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc-----------------
Q 003978 663 KTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL----------------- 724 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------------- 724 (782)
...+.|.+|+|||++.| .+|+..+|||++||++.||++|.+-|.+....+.+..|....+..
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 56678999999999998 778999999999999999999999999888776665543211100
Q ss_pred CCC------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 725 EIP------------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 725 ~~p------------~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
.+| +.++.-+.+|++.||..||.+|++-+++ |.|+||
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~ql------l~H~yF 287 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQL------LHHPYF 287 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHH------hcChHH
Confidence 111 2345678999999999999999999999 567777
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=372.90 Aligned_cols=254 Identities=24% Similarity=0.443 Sum_probs=229.4
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
....+|++++.||.|+||.|.+++. .+..+|+|+++++.. ...+.+-..+|..+|+.+.||+++++++.|.+...+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 4457899999999999999999987 466799999988765 4466778889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
|||||++||.|+.++++.+ +|++..+.+++.||+.||+|||+++ |++|||||+||||+++|.+||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999999998754 7999999999999999999999999 999999999999999999999999999876554
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 738 (782)
+.+.||||.|+|||++...+|+.++|+|+|||++|||+.|.+||...+..+.+++| ......+|..+++++++||
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI--~~~~v~fP~~fs~~~kdLl 272 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI--LEGKVKFPSYFSSDAKDLL 272 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH--HhCcccCCcccCHHHHHHH
Confidence 44779999999999999999999999999999999999999999999999998888 5567889999999999999
Q ss_pred HHhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhc
Q 003978 739 ESCWHSDPQCRP-----SFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 739 ~~cL~~dP~~RP-----s~~ell~~L~~L~~~~~~~ 769 (782)
+++|+.|-.+|. ...+| ..|+||+.
T Consensus 273 ~~LL~vD~t~R~gnlknG~~dI------k~H~wF~~ 302 (355)
T KOG0616|consen 273 KKLLQVDLTKRFGNLKNGVEDI------KNHPWFKG 302 (355)
T ss_pred HHHHhhhhHhhhcCcCCCcccc------ccCccccc
Confidence 999999999993 44455 35788854
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=397.69 Aligned_cols=257 Identities=30% Similarity=0.537 Sum_probs=230.1
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCC---HHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCC
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS---DEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQ 575 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 575 (782)
...+.|.+++.||+|+||+||++.+ .+..||+|++.+.... ....+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4557899999999999999999987 5788999988775222 234567778999999999 999999999999999
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CcEEEEecCCCcc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRL 654 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~-~~vkL~DFGla~~ 654 (782)
.+|+|||||.||+|++++.. ..++.+..+..++.||+.|++|||++| |+||||||+|||++.+ +++||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 99999999999999999988 668999999999999999999999999 9999999999999999 9999999999987
Q ss_pred cccccccccCCCCCCcccCcccccCCC-CC-chhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCC-C
Q 003978 655 KHETYLTTKTGKGTPQWMAPEVLRNEP-SD-EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDV-D 731 (782)
Q Consensus 655 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~s-~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~-~ 731 (782)
.........+.+||+.|+|||++.+.. |+ .++||||+|++||-|++|..||...+.......+ ......+|..+ +
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki--~~~~~~~p~~~~S 248 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI--RKGEFKIPSYLLS 248 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH--hcCCccCCCCcCC
Confidence 743334566889999999999999977 75 7899999999999999999999998877777775 55677888888 9
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 732 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 732 ~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
++++.||.+||..||..|+++.++ +.|+||+.
T Consensus 249 ~~~~~Li~~mL~~~P~~R~t~~~i------~~h~w~~~ 280 (370)
T KOG0583|consen 249 PEARSLIEKMLVPDPSTRITLLEI------LEHPWFQK 280 (370)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHH------hhChhhcc
Confidence 999999999999999999999999 67899997
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=396.87 Aligned_cols=256 Identities=29% Similarity=0.533 Sum_probs=232.4
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
++|.+.+.||+|+||.||||+.+ .+.||||.+.+....++.++.+.+|++|++.++|||||.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57889999999999999999865 4569999999888888889999999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
||.| +|+.+|... ..++++.+..++.+++.||.|||+++ |+|||+||.|||++..|.+|+||||+|+.+.......
T Consensus 82 ~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 9966 999999875 46999999999999999999999999 9999999999999999999999999999887766566
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhh
Q 003978 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 742 (782)
....|||.|||||++.+.+|+..+|+|||||++|||++|++||......+....| ...+...|..++..+.+|+..+|
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I--~~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSI--LKDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHH--hcCCCCCcccccHHHHHHHHHHh
Confidence 6778999999999999999999999999999999999999999887777776666 34556677799999999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 743 HSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 743 ~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
.+||..|.++.++ +.|+|.+....
T Consensus 236 ~kdP~~RltW~~L------l~HpF~k~~~~ 259 (808)
T KOG0597|consen 236 IKDPAQRLTWTDL------LGHPFWKGKIN 259 (808)
T ss_pred hcChhhcccHHHH------hcChHHhhhhh
Confidence 9999999999999 66788765443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=384.05 Aligned_cols=257 Identities=32% Similarity=0.557 Sum_probs=220.0
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC--ceeEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ--RLCIV 580 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~lv 580 (782)
.+|..++.||+|+||.||++.+. +..+|||.+....... .+.+.+|+.+|+.++|||||+++|...... .+++.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 46788899999999999999985 5889999987763222 678899999999999999999999754444 68999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCcEEEEecCCCccccc--
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSRLKHE-- 657 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~-~~~vkL~DFGla~~~~~-- 657 (782)
|||+++|+|.+++.+.+..+++..+..+..||++||.|||++| ||||||||+||||+. ++.+||+|||++.....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999887668999999999999999999999999 999999999999999 79999999999986653
Q ss_pred -ccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCC-CChHHHHHHhhccccccCCCCCCCHHH
Q 003978 658 -TYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDN-LNSMQVIGAVGFMNQRLEIPKDVDPRW 734 (782)
Q Consensus 658 -~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~l 734 (782)
.........||+.|||||++.+ .....++|||||||++.||+||..||.. ......+..+......+.+|..+++++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 2223445689999999999995 3344599999999999999999999998 455555566665555678999999999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 735 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
++||.+||.+||.+|||+.++ |.|+|.+...
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eL------L~hpf~~~~~ 283 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEEL------LEHPFLKQNS 283 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHH------hhChhhhccc
Confidence 999999999999999999999 5667765543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=393.82 Aligned_cols=259 Identities=25% Similarity=0.428 Sum_probs=232.9
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCc
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQR 576 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 576 (782)
....++|.++++||+|.||+|+++..+ ++.||||++++... .++.++..+.|.+|+.... ||++++++..|+...+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345679999999999999999999985 45699999998765 5667888999999998885 9999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
+|+||||+.||++..+.. ...|++.++.+++..|+.||.|||++| |||||||.+|||+|.+|++||+|||+++...
T Consensus 444 l~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEecccccccccC
Confidence 999999999999544433 457999999999999999999999999 9999999999999999999999999998766
Q ss_pred cccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHH
Q 003978 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 736 (782)
Q Consensus 657 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 736 (782)
-....+.+++|||.|||||++.+..|+.++|+|||||+|||||.|..||.+.+..++...| .......|..++.+..+
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI--~~d~~~yP~~ls~ea~~ 597 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI--VNDEVRYPRFLSKEAIA 597 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--hcCCCCCCCcccHHHHH
Confidence 5666788999999999999999999999999999999999999999999999999999888 56677889999999999
Q ss_pred HHHHhhhhCCCCCCC-----HHHHHHHHHHHHHHHhhccc
Q 003978 737 IVESCWHSDPQCRPS-----FQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 737 LI~~cL~~dP~~RPs-----~~ell~~L~~L~~~~~~~~~ 771 (782)
+++++|.+||++|.. +.+| .+|+||+.+.
T Consensus 598 il~~ll~k~p~kRLG~~e~d~~~i------~~hpFFr~i~ 631 (694)
T KOG0694|consen 598 IMRRLLRKNPEKRLGSGERDAEDI------KKHPFFRSID 631 (694)
T ss_pred HHHHHhccCcccccCCCCCCchhh------hhCCccccCC
Confidence 999999999999974 5666 4688887664
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=391.03 Aligned_cols=262 Identities=37% Similarity=0.648 Sum_probs=236.2
Q ss_pred cccccccccceeEeeeeccCCcEEEEEEEEcCC-eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 497 CLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 497 ~~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~-~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
...|++..+.+++++.||+|.||.||+|.+++. +||+|.++...... +.|.+|+++|++|+|+|||++++++..++
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 346677788899999999999999999999887 89999998765543 46779999999999999999999999988
Q ss_pred ceeEEEeecCCCCHHHHHhh-cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 576 RLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
.+|||||||..|+|.++|+. .+..+.....+.++.|||+||+||++++ +|||||-+.||||+.+..+||+|||+|+.
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccccc
Confidence 99999999999999999986 5677899999999999999999999999 99999999999999999999999999996
Q ss_pred cccccc-cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCH
Q 003978 655 KHETYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 732 (782)
Q Consensus 655 ~~~~~~-~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 732 (782)
..+... ......-+..|+|||.+....++.|||||||||+||||+| |+.||.++...+++..+. .+.+++.|..||+
T Consensus 353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-~GyRlp~P~~CP~ 431 (468)
T KOG0197|consen 353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-RGYRLPRPEGCPD 431 (468)
T ss_pred cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-ccCcCCCCCCCCH
Confidence 555443 3334445679999999999999999999999999999999 999999999999998885 5678889999999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 733 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 733 ~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
++.+++..||..+|++|||+..+...|+++..
T Consensus 432 ~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 432 EVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred HHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 99999999999999999999999888877654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=375.04 Aligned_cols=264 Identities=29% Similarity=0.509 Sum_probs=227.3
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (782)
.|-...++|++.++||.|..++||+|++ .+..||||++..+++..+ +..+.+|+..|..++||||+.++..|..+..
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSE 98 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence 3445567899999999999999999998 577899999998887666 7899999999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
+|+||.||.+|++.++++.. ...+++..+..|++++++||.|||++| .||||||+.||||+.+|.|||+|||.+...
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeeeee
Confidence 99999999999999999653 445899999999999999999999999 999999999999999999999999987654
Q ss_pred ccccccc----cCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC----
Q 003978 656 HETYLTT----KTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE---- 725 (782)
Q Consensus 656 ~~~~~~~----~~~~Gt~~y~aPE~l~~--~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---- 725 (782)
.+..... .+.+|||.|||||++.. ..|+.|+|||||||+.+||.+|..||..+.+.+++-.. .+..++
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t--Lqn~pp~~~t 254 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT--LQNDPPTLLT 254 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH--hcCCCCCccc
Confidence 4433222 45689999999999643 55889999999999999999999999999998876443 222221
Q ss_pred ------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 726 ------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 726 ------~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
..+.++..++.||..||.+||.+|||+.++ |.|.|||.....
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskL------lkh~FFk~~k~~ 302 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKL------LKHAFFKKAKSK 302 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHH------hccHHHhhccch
Confidence 123467789999999999999999999999 678999877654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=395.73 Aligned_cols=256 Identities=33% Similarity=0.532 Sum_probs=232.1
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEecc-CCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQ-EYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.-|++++.||.|+.|.|-+|++ +|+.+|||++.+. .........+.+||-||+.+.||||+++|++|+...++|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 5689999999999999999997 7999999999876 455566778999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
||++||.|++++.+.+ ++++..++++++||+.|+.|||..+ |+|||+||+|+||+..+.|||+|||+|...... ..
T Consensus 92 Eyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-kl 167 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-KL 167 (786)
T ss_pred EecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCC-cc
Confidence 9999999999997754 7999999999999999999999998 999999999999999999999999999765443 34
Q ss_pred ccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHH
Q 003978 662 TKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 740 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~-s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 740 (782)
..+.||+|.|.+||++.|.+| +.++||||.||+||.||||++||+..+....+.++ ..+.+.+|.++++++++||.+
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV--~~G~f~MPs~Is~eaQdLLr~ 245 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV--QRGVFEMPSNISSEAQDLLRR 245 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH--HcCcccCCCcCCHHHHHHHHH
Confidence 567799999999999999998 57899999999999999999999988888887777 456788899999999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 741 CWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 741 cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
||..||..|.|..+| +.|+|+++-.+
T Consensus 246 ml~VDp~~RiT~~eI------~kHP~l~g~~~ 271 (786)
T KOG0588|consen 246 MLDVDPSTRITTEEI------LKHPFLSGYTS 271 (786)
T ss_pred HhccCccccccHHHH------hhCchhhcCCC
Confidence 999999999999999 67899866543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=352.86 Aligned_cols=262 Identities=23% Similarity=0.318 Sum_probs=226.9
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
.+|...++||+|+||.||+|++ +|+.||||.++.....+.......+||++|+.++|+||+.++++|.+...+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999997 67889999998887766666778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
||+ .+|+..++.....+....+..++.++++||+|||++. |+||||||.|+||+.+|.+||+|||+|+.........
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 995 5999999998889999999999999999999999999 9999999999999999999999999999887765555
Q ss_pred cCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc------c-----------
Q 003978 663 KTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR------L----------- 724 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~------~----------- 724 (782)
...+-|..|+|||++.|. .|+..+||||+||++.||+-|.+-|.+.+..+.+..+-...+. +
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 555789999999999874 5788999999999999999999999888877655544211110 0
Q ss_pred ---------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcCC
Q 003978 725 ---------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVG 775 (782)
Q Consensus 725 ---------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~~ 775 (782)
.+....+.++-+|+.+||..||.+|++++|+ |.++||++.+.+.-
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qa------L~~~yf~~~P~pt~ 292 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQA------LKHPYFKSLPLPTP 292 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHH------hcchhhhcCCCCCC
Confidence 0123356788999999999999999999999 67899998776554
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=384.17 Aligned_cols=258 Identities=24% Similarity=0.419 Sum_probs=223.8
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
..++|+++++||+|+||.||+|+. +|.-+|||++++... ....+.-++.|-.+|...++|+||++|..|++..++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 457899999999999999999986 677899999987665 44667788899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc--
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE-- 657 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~-- 657 (782)
||||++||++..+|.+.+ .|++..+.+++.+++.|+..||++| +|||||||+|+|||..|+|||+|||++.-...
T Consensus 219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 999999999999998754 6999999999999999999999999 99999999999999999999999999852110
Q ss_pred ---------------------ccc------c------------------ccCCCCCCcccCcccccCCCCCchhHHHHHH
Q 003978 658 ---------------------TYL------T------------------TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFG 692 (782)
Q Consensus 658 ---------------------~~~------~------------------~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG 692 (782)
... . ....+|||.|||||++.+..|+...|+||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 000 0 0123699999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCC--CCCHHHHHHHHHhhhhCCCCCC---CHHHHHHHHHHHHHHHh
Q 003978 693 VILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK--DVDPRWAAIVESCWHSDPQCRP---SFQELVDKLRDLQRQYF 767 (782)
Q Consensus 693 ~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~~~l~~LI~~cL~~dP~~RP---s~~ell~~L~~L~~~~~ 767 (782)
|+|||||.|.+||...++.++..+|..-.....+|. .+++++++||.+||. ||++|. +++|| -.|+||
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EI------K~HPfF 448 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEI------KKHPFF 448 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHH------hcCCcc
Confidence 999999999999999999999988865444455554 478999999999999 999997 47777 468999
Q ss_pred hcc
Q 003978 768 QAS 770 (782)
Q Consensus 768 ~~~ 770 (782)
+.+
T Consensus 449 ~~v 451 (550)
T KOG0605|consen 449 KGV 451 (550)
T ss_pred ccC
Confidence 654
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=367.88 Aligned_cols=264 Identities=22% Similarity=0.370 Sum_probs=227.7
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEcC--CeEEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG--SDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~--~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (782)
......+|++++.||+|.-|+||+|...+ ..+|||++.+.... .+.+.++..|-+||+.++||.++.+|..|+.++.
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 34556789999999999999999999876 56999999887653 5667788889999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
.|++||||+||+|..+++++ ...|++..+.+++.+++.||+|||..| ||+|||||+||||-++|+|.|+||.++...
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999999999999764 456999999999999999999999999 999999999999999999999999987421
Q ss_pred cc-----------------------------------c---------------------cccccCCCCCCcccCcccccC
Q 003978 656 HE-----------------------------------T---------------------YLTTKTGKGTPQWMAPEVLRN 679 (782)
Q Consensus 656 ~~-----------------------------------~---------------------~~~~~~~~Gt~~y~aPE~l~~ 679 (782)
.. . ...+..++||-.|+|||++.|
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 00 0 011234579999999999999
Q ss_pred CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCC----HHHH
Q 003978 680 EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPS----FQEL 755 (782)
Q Consensus 680 ~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs----~~el 755 (782)
..++.++|+|+|||+|||||.|..||.+.+..+.+.+|........-.+.++..+++||+++|.+||.+|.. +.||
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI 389 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHh
Confidence 999999999999999999999999999999999998885433333333467899999999999999999987 8887
Q ss_pred HHHHHHHHHHHhhccc
Q 003978 756 VDKLRDLQRQYFQASR 771 (782)
Q Consensus 756 l~~L~~L~~~~~~~~~ 771 (782)
=+|+||+-.+
T Consensus 390 ------K~HpFF~gVn 399 (459)
T KOG0610|consen 390 ------KRHPFFEGVN 399 (459)
T ss_pred ------hcCccccCCC
Confidence 4689986543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=381.32 Aligned_cols=258 Identities=28% Similarity=0.488 Sum_probs=230.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
....|...++||+|+.|.||.+.. .++.||||.+....... .+-+.+|+.+|+..+|+|||.+++.|-..+.+|+|
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 345788899999999999999986 56679999987665433 25678899999999999999999999888999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
||||+||+|-+.+... .+++.++..|++++++||+|||.+| |+|||||.+|||++.+|.|||+|||++........
T Consensus 349 MEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred EeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999999999999754 4999999999999999999999999 99999999999999999999999999987777666
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-ccCCCCCCCHHHHHHHH
Q 003978 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRWAAIVE 739 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~LI~ 739 (782)
...+.+|||.|||||++....|+.++||||||++++||+-|.+||-..++...+..|...+. .+..+..++++|++|+.
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~ 504 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLD 504 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHH
Confidence 77788999999999999999999999999999999999999999998888888877764332 55677889999999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 740 SCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 740 ~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
+||..|+.+|+++.+| |+|+||+.+..
T Consensus 505 ~cL~~dv~~RasA~eL------L~HpFl~~a~p 531 (550)
T KOG0578|consen 505 RCLVVDVEQRASAKEL------LEHPFLKMAKP 531 (550)
T ss_pred HHhhcchhcCCCHHHH------hcChhhhhcCC
Confidence 9999999999999999 67899966543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=382.52 Aligned_cols=266 Identities=26% Similarity=0.348 Sum_probs=228.8
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC--Ccee
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLC 578 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 578 (782)
..+.|+.+++||+|+||.||++++ .|+-||+|.++.....+.......+||.||++|+|||||++.+..... ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 456799999999999999999987 567799999998887777888889999999999999999999998876 6899
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
||||||+. +|..++......|++.++..++.||+.||+|||.+| |+|||||.+|||||.+|.+||+|||+|+++...
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 99999977 999999888889999999999999999999999999 999999999999999999999999999966543
Q ss_pred c-ccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--------cCCC-
Q 003978 659 Y-LTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--------LEIP- 727 (782)
Q Consensus 659 ~-~~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~--------~~~p- 727 (782)
. ......+-|++|+|||++.|. .|+.++|+||+||+|.||++|++.|.+.+..+.+..|-.+-+. ..+|
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 3 234456789999999999985 4899999999999999999999999999887766665322111 1122
Q ss_pred ------------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcCCCC
Q 003978 728 ------------------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGDS 777 (782)
Q Consensus 728 ------------------~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~~~~ 777 (782)
..++....+|+..||..||.+|.|+.+. |+++||...+.....+
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~a------L~seyF~t~p~~~~p~ 413 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSA------LQSEYFTTEPLPCDPS 413 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHH------hcCcccccCCCCCCcc
Confidence 3467788999999999999999999998 7789997666555443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=381.63 Aligned_cols=261 Identities=25% Similarity=0.381 Sum_probs=223.6
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCC-ce
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQ-RL 577 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~-~~ 577 (782)
...++|.++++||.|+||.||+|.. .+..||||.+++....-+.... .||++.|++|+ |||||++.+++.+.+ .+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 3457899999999999999999986 5778999999887766554444 46999999998 999999999998887 89
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+||||| ..+|+++++.+...|++..+..|+.||++||+|+|++| +.|||+||+||||.....|||+|||+|+....
T Consensus 86 ~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEeccccccccccc
Confidence 9999999 55999999988889999999999999999999999999 99999999999999888999999999986554
Q ss_pred ccccccCCCCCCcccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc------------
Q 003978 658 TYLTTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL------------ 724 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~-~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------ 724 (782)
...- ...+.|.+|+|||++. ...|+.+.|||++||+++|+++-++-|.+.+..+.+.+|....+.+
T Consensus 163 kpPY-TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 163 KPPY-TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred CCCc-chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 3222 2446799999999975 5668999999999999999999999999999888777764332211
Q ss_pred -----C-----------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 725 -----E-----------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 725 -----~-----------~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
. +.+.++.++.+||.+||..||.+|||+.++ |+++||+-....
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~a------l~~pffq~~~~~ 300 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQA------LQHPFFQVGRAS 300 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHH------hcCccccccccc
Confidence 1 113478899999999999999999999999 778999876654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=378.20 Aligned_cols=265 Identities=39% Similarity=0.662 Sum_probs=233.0
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
..|++..+++.+++.||+|.||+||+|.|.|. ||||++......++.++.|++|+.+|++-+|.||+-|.|++..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd-VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD-VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccc-eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 57889999999999999999999999999884 9999999988889999999999999999999999999999998877
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
.||..+|+|-+|+.+|.....+|...+.+.|+.||++||.|||.++ |||||||..||++.++++|||+|||++....-
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEecccceeeeee
Confidence 9999999999999999888889999999999999999999999999 99999999999999999999999999865432
Q ss_pred ccc--cccCCCCCCcccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc---ccccCCCCC
Q 003978 658 TYL--TTKTGKGTPQWMAPEVLRN---EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM---NQRLEIPKD 729 (782)
Q Consensus 658 ~~~--~~~~~~Gt~~y~aPE~l~~---~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~---~~~~~~p~~ 729 (782)
-.. ......|...|||||+++. .+|+..+||||||||+|||++|.+||...+..+.+..+... .....+...
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~ 620 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSN 620 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhcc
Confidence 211 1223457889999999863 55788999999999999999999999977766666555433 223334457
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 730 ~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
++.++++|+..||..++++||.+.+|+..|..+....
T Consensus 621 ~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 621 CPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred CHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 8889999999999999999999999999999988753
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=345.73 Aligned_cols=256 Identities=28% Similarity=0.471 Sum_probs=228.1
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEcCC--eEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGS--DVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~~~--~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
...++|++++.||+|-||.||+++.+.. -||+|++.+... .....+.+.+|++|...|+||||+++|++|.+...+|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 3457899999999999999999998554 489999877654 3345578999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 579 IVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|++||...|+|+..|... ..++++...+.++.|++.||.|+|.++ ||||||||+|+|++..+.+||+|||.+...+
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 999999999999999743 346999999999999999999999988 9999999999999999999999999997655
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
.....+.+||..|++||...+..++..+|+|++|++.||++.|.+||......+.+..+.. -...+|..++.++++|
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k--~~~~~p~~is~~a~dl 252 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK--VDLKFPSTISGGAADL 252 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH--ccccCCcccChhHHHH
Confidence 3455678999999999999999999999999999999999999999999888888877743 4566779999999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 738 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 738 I~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
|.+||.++|.+|....++ +.|+|.++
T Consensus 253 I~~ll~~~p~~r~~l~~v------~~hpwI~a 278 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEV------MDHPWIVA 278 (281)
T ss_pred HHHHhccCccccccHHHH------hhhHHHHh
Confidence 999999999999999999 56777654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=373.90 Aligned_cols=262 Identities=30% Similarity=0.554 Sum_probs=215.8
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeee
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAV 571 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 571 (782)
|.+..++|++.++||+|+||.||+|.+. +..||||+++... .......+.+|+.+|..+ +|||||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 4556689999999999999999999752 3469999987543 334456788999999999 899999999988
Q ss_pred ecC-CceeEEEeecCCCCHHHHHhhcC-----------------------------------------------------
Q 003978 572 TSP-QRLCIVTEFLPRGSLFRLLQRNT----------------------------------------------------- 597 (782)
Q Consensus 572 ~~~-~~~~lv~E~~~ggsL~~~l~~~~----------------------------------------------------- 597 (782)
... ..++++||||++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 45899999999999999996532
Q ss_pred --------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc--cccccCCCC
Q 003978 598 --------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET--YLTTKTGKG 667 (782)
Q Consensus 598 --------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~~~G 667 (782)
.++++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ........+
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 23677888999999999999999998 999999999999999999999999999754322 122223456
Q ss_pred CCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCC
Q 003978 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 746 (782)
Q Consensus 668 t~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP 746 (782)
++.|+|||++.+..++.++|||||||+||||++ |..||.....................+..+++.+.+||.+||..||
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDP 318 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 788999999999999999999999999999997 9999987654433333322333455677889999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHH
Q 003978 747 QCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 747 ~~RPs~~ell~~L~~L~~ 764 (782)
++|||+.++++.|+++.+
T Consensus 319 ~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 319 KERPTFSALVEILGDLLQ 336 (338)
T ss_pred hhCcCHHHHHHHHHHHHh
Confidence 999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=376.35 Aligned_cols=255 Identities=32% Similarity=0.531 Sum_probs=224.3
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
..|+..+.||+|.||.||+|.+ .++.||||++..+... +.+..+.+|+.+|..++++||.++|+.|..+..++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 3567778999999999999987 5677999999776543 446778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
||.||++.+.++... .+.+..+..++++++.||.|||.++ .+|||||+.|||+..+|.|||+|||.+..........
T Consensus 92 y~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 999999999998643 4588888999999999999999998 9999999999999999999999999998877766666
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhh
Q 003978 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 742 (782)
.+++|||.|||||++.+..|+.|+||||||++.+||.+|.+||....++.++..|. ...++.+...+++.+++||..||
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-k~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-KSAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-CCCCCccccccCHHHHHHHHHHh
Confidence 88999999999999999999999999999999999999999999998876655553 23344555678999999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 743 HSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 743 ~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
.+||+.||++.+| |+|+|.|.+
T Consensus 248 ~k~P~~RpsA~~L------LKh~FIk~a 269 (467)
T KOG0201|consen 248 DKNPEFRPSAKEL------LKHKFIKRA 269 (467)
T ss_pred hcCcccCcCHHHH------hhhHHHHhc
Confidence 9999999999999 556666653
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=380.82 Aligned_cols=260 Identities=35% Similarity=0.644 Sum_probs=231.6
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
..|++.++.+.-++-||.|+.|.||+|+..++.||||.++..+ ..+|+-|++|+||||+.|.|+|...-.+
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCcee
Confidence 4678888888888999999999999999999999999874322 3478999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|||||||..|-|+..|+.. .++.......+..+|+.||.|||.+. |||||||.-||||+.+..|||+|||.++...+
T Consensus 188 CIiMEfCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred EEeeeccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 9999999999999999864 57888888999999999999999998 99999999999999999999999999986655
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
. .+.-.++||..|||||++.+.+.+.|+|||||||||||||||..||...+....+.-+......+.+|..+|.-|+-|
T Consensus 265 ~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL 343 (904)
T KOG4721|consen 265 K-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLL 343 (904)
T ss_pred h-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHH
Confidence 4 344467899999999999999999999999999999999999999999888777666666666788999999999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHH--------HHHHhhcc
Q 003978 738 VESCWHSDPQCRPSFQELVDKLRDL--------QRQYFQAS 770 (782)
Q Consensus 738 I~~cL~~dP~~RPs~~ell~~L~~L--------~~~~~~~~ 770 (782)
|++||+.+|.+||++++++.+|+=. +..||+++
T Consensus 344 ~Kqcw~sKpRNRPSFrqil~HldIa~pell~~tee~yf~sq 384 (904)
T KOG4721|consen 344 LKQCWNSKPRNRPSFRQILLHLDIASPELLSTTEETYFKSQ 384 (904)
T ss_pred HHHHHhcCCCCCccHHHHHHHHhhcCHHHhcccHHHHHHHH
Confidence 9999999999999999999998744 45666543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=366.68 Aligned_cols=251 Identities=24% Similarity=0.417 Sum_probs=219.4
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
++|++.++||+|+||.||+|... ++.||||++..... .......+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 37899999999999999999985 77899999976443 2234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
||+.+++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 999999999999764 46889999999999999999999999 999999999999999999999999998765432
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHh
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 741 (782)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....++..+++.+++||.+|
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~ 232 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL--AGKLEFPRHLDLYAKDLIKKL 232 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCcCCCccCCHHHHHHHHHH
Confidence 224578999999999999999999999999999999999999999887776666553 334567788899999999999
Q ss_pred hhhCCCCCCC-----HHHHHHHHHHHHHHHhhc
Q 003978 742 WHSDPQCRPS-----FQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 742 L~~dP~~RPs-----~~ell~~L~~L~~~~~~~ 769 (782)
|..||.+||+ +.++ +.|+||+.
T Consensus 233 l~~dp~~R~~~~~~~~~~~------l~h~~~~~ 259 (291)
T cd05612 233 LVVDRTRRLGNMKNGADDV------KNHRWFKS 259 (291)
T ss_pred cCCCHHHccCCccCCHHHH------hcCccccC
Confidence 9999999995 8888 57888864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=372.41 Aligned_cols=248 Identities=26% Similarity=0.492 Sum_probs=214.7
Q ss_pred eeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCC
Q 003978 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg 587 (782)
+.||+|+||.||++.. .++.||||++++... .......+.+|+.+++.++||||+++++++...+.+|+||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 567899999986543 2344566788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCCC
Q 003978 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667 (782)
Q Consensus 588 sL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~G 667 (782)
+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++............+|
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence 999999764 46899999999999999999999999 999999999999999999999999998754333333345679
Q ss_pred CCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCC
Q 003978 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQ 747 (782)
Q Consensus 668 t~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~ 747 (782)
|+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..+++++.+||.+||..||+
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKDPK 235 (323)
T ss_pred CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 999999999999999999999999999999999999998877666555542 345567888999999999999999999
Q ss_pred CCC-----CHHHHHHHHHHHHHHHhhc
Q 003978 748 CRP-----SFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 748 ~RP-----s~~ell~~L~~L~~~~~~~ 769 (782)
+|| ++.++ +.|+||+.
T Consensus 236 ~R~~~~~~~~~~l------l~h~~f~~ 256 (323)
T cd05571 236 QRLGGGPEDAKEI------MEHRFFAS 256 (323)
T ss_pred HcCCCCCCCHHHH------HcCCCcCC
Confidence 999 79999 56788754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=365.40 Aligned_cols=250 Identities=26% Similarity=0.439 Sum_probs=209.3
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCH------------HHHHHHHHHHHHHHhCCCCceeE
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD------------EVIHSFRQEVSLMKRLRHPNVLL 566 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~------------~~~~~~~~Ei~il~~l~HpnIv~ 566 (782)
....++|++++.||+|.||.|.+++. .++.||||++.+..... .-++..++||.+|+++.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34568999999999999999999987 56779999997654321 12357889999999999999999
Q ss_pred EeeeeecC--CceeEEEeecCCCCHHHHHhhcCCc-chHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc
Q 003978 567 FMGAVTSP--QRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 643 (782)
Q Consensus 567 l~~~~~~~--~~~~lv~E~~~ggsL~~~l~~~~~~-l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~ 643 (782)
|+++..++ +.+|||+|||..|.+...-. ..+ +++.++++++.+++.||+|||.+| ||||||||+|+||+.+|+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCCc
Confidence 99999876 46999999998887643322 233 899999999999999999999999 999999999999999999
Q ss_pred EEEEecCCCcccccc-----cccccCCCCCCcccCcccccCCC---C-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 003978 644 VKVGDFGLSRLKHET-----YLTTKTGKGTPQWMAPEVLRNEP---S-DEKSDVYSFGVILWELATEKIPWDNLNSMQVI 714 (782)
Q Consensus 644 vkL~DFGla~~~~~~-----~~~~~~~~Gt~~y~aPE~l~~~~---~-s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~ 714 (782)
|||+|||.+...... .......+|||.|+|||++.+.. + +.+.|||||||+||.|+.|.+||-.......+
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 999999998754221 11222358999999999998732 2 57899999999999999999999999888888
Q ss_pred HHhhccccccCCCC--CCCHHHHHHHHHhhhhCCCCCCCHHHHH
Q 003978 715 GAVGFMNQRLEIPK--DVDPRWAAIVESCWHSDPQCRPSFQELV 756 (782)
Q Consensus 715 ~~i~~~~~~~~~p~--~~~~~l~~LI~~cL~~dP~~RPs~~ell 756 (782)
.+|. .....+|. .+...+++||++||.+||+.|.++.+|.
T Consensus 329 ~KIv--n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik 370 (576)
T KOG0585|consen 329 DKIV--NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIK 370 (576)
T ss_pred HHHh--cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhe
Confidence 8884 44555554 4799999999999999999999999994
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=367.40 Aligned_cols=258 Identities=26% Similarity=0.434 Sum_probs=233.9
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
...-|.+.+.||+|-|.+|.++++ .|..||||++.+.+.+.-....+.+|++.|+.++|||||++|++......+|||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 345688889999999999999986 899999999999888776677788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE-cCCCcEEEEecCCCccccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV-DKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl-~~~~~vkL~DFGla~~~~~~~ 659 (782)
+|+-++|+|++||.++...+.+..+.+++.||+.|+.|+|+.. +|||||||+||++ .+-|.|||+|||++-.+. +.
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-PG 172 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-PG 172 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCC-Cc
Confidence 9999999999999998888999999999999999999999988 9999999999887 567999999999996543 34
Q ss_pred ccccCCCCCCcccCcccccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHH
Q 003978 660 LTTKTGKGTPQWMAPEVLRNEPSD-EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~~~~s-~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 738 (782)
....+.+|+..|-|||++.|..|+ +++||||||++||.|++|.+||+..+..+.+..| +.-.+.+|..++.++++||
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI--mDCKYtvPshvS~eCrdLI 250 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI--MDCKYTVPSHVSKECRDLI 250 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh--hcccccCchhhhHHHHHHH
Confidence 556688999999999999999997 4799999999999999999999999998888777 4556788999999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 739 ~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
..||.+||++|.++++| ..+.|.|.+-
T Consensus 251 ~sMLvRdPkkRAslEeI------~s~~Wlq~~D 277 (864)
T KOG4717|consen 251 QSMLVRDPKKRASLEEI------VSTSWLQAGD 277 (864)
T ss_pred HHHHhcCchhhccHHHH------hccccccCCC
Confidence 99999999999999999 5678887653
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=371.70 Aligned_cols=253 Identities=28% Similarity=0.451 Sum_probs=220.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
..++|++.+.||+|+||.||+|.+ .++.||||++..... .......+.+|+.+++.++||||+++++++..++.+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 347899999999999999999988 467899999976543 22445678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
|||||.+++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++.......
T Consensus 96 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 99999999999999764 46888999999999999999999999 9999999999999999999999999997654322
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHH
Q 003978 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 739 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 739 (782)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..++..+++||.
T Consensus 173 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~ 247 (329)
T PTZ00263 173 ---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL--AGRLKFPNWFDGRARDLVK 247 (329)
T ss_pred ---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCcCCCCCCCHHHHHHHH
Confidence 24578999999999999999999999999999999999999998887776666553 3456677889999999999
Q ss_pred HhhhhCCCCCCC-----HHHHHHHHHHHHHHHhhc
Q 003978 740 SCWHSDPQCRPS-----FQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 740 ~cL~~dP~~RPs-----~~ell~~L~~L~~~~~~~ 769 (782)
+||..||.+||+ +.++ +.|+||+.
T Consensus 248 ~~L~~dP~~R~~~~~~~~~~l------l~hp~f~~ 276 (329)
T PTZ00263 248 GLLQTDHTKRLGTLKGGVADV------KNHPYFHG 276 (329)
T ss_pred HHhhcCHHHcCCCCCCCHHHH------hcCCccCC
Confidence 999999999996 7888 56787754
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=373.27 Aligned_cols=252 Identities=28% Similarity=0.463 Sum_probs=230.4
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc-eeEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR-LCIV 580 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~lv 580 (782)
.++|.++++||+|+||.+++++++ +..|++|.+...............|+.+++++.|||||.+++.|+.++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 468999999999999999999875 4569999998887777666788899999999999999999999999888 9999
Q ss_pred EeecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 581 TEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
|+||+||+|.+.|.+.. ..++++.+..++.|++.|+.|||+++ |+|||||+.||++++++.|||+|||+|+......
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 99999999999997654 67999999999999999999999888 9999999999999999999999999999888776
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHH
Q 003978 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 739 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 739 (782)
....+.+|||.||+||++.+.+|+.|+|||||||++|||++-+++|...+.......+.... ..++|..++.+++.||+
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~ 239 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSLVK 239 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHHHH
Confidence 56667899999999999999999999999999999999999999999999988887774333 46788899999999999
Q ss_pred HhhhhCCCCCCCHHHHHHH
Q 003978 740 SCWHSDPQCRPSFQELVDK 758 (782)
Q Consensus 740 ~cL~~dP~~RPs~~ell~~ 758 (782)
.||..+|..||++.+||..
T Consensus 240 ~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 240 SMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHhhcCCccCCCHHHHhhC
Confidence 9999999999999999876
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=357.28 Aligned_cols=251 Identities=24% Similarity=0.453 Sum_probs=222.8
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCH-HHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
..+..+|++.+.||+|+||+|.++.. .|+.||||.+++....+ .-+-.+++||+||..|+||||+++|.+|+..+.+
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 34556899999999999999999975 68899999999887744 4566789999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
+|||||..+|.|++|+...+ .+++..+..+++||+.|+.|+|.++ ++|||||.+|||++.++++||+|||++-++.+
T Consensus 129 vivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999999998754 6999999999999999999999999 99999999999999999999999999987765
Q ss_pred ccccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 736 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~-s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 736 (782)
.. ...++||+|-|.+||++.|.+| +..+|.||||++||-|+.|..||++.+......+|....+ ..+.-|.....
T Consensus 206 ~k-fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaY---rEP~~PSdA~g 281 (668)
T KOG0611|consen 206 KK-FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAY---REPETPSDASG 281 (668)
T ss_pred cc-HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccc---cCCCCCchHHH
Confidence 53 3457899999999999999998 5789999999999999999999999998888777743322 23345677899
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q 003978 737 IVESCWHSDPQCRPSFQELVDK 758 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~~ 758 (782)
||++||..||++|.|+.++..+
T Consensus 282 LIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 282 LIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred HHHHHHhcCcccchhHHHHhhh
Confidence 9999999999999999999544
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=363.70 Aligned_cols=258 Identities=27% Similarity=0.412 Sum_probs=211.3
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
....+|+++++||+|+||.||++.+. ++.||||++.... .......+.+|+++++.++|+||+++++++...+.+|+
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 34567889999999999999999874 6789999986543 34456778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
|||||.+++|.... ...+..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 150 v~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 150 LLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 99999999986532 3456778889999999999999998 9999999999999999999999999998655443
Q ss_pred ccccCCCCCCcccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH--hhccccccCCCCCCCH
Q 003978 660 LTTKTGKGTPQWMAPEVLRN-----EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGA--VGFMNQRLEIPKDVDP 732 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~-----~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~--i~~~~~~~~~p~~~~~ 732 (782)
.......||..|+|||++.. ...+.++|||||||++|+|++|+.||........... ..........+..++.
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR 302 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence 33345679999999998743 3345689999999999999999999974332221111 1112334556678899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 733 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 733 ~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
++++||.+||..||++||++.++ |+|+||......
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~el------l~hp~~~~~~~~ 337 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQL------LQHPFILRAQPG 337 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHH------hcCcccccCCcc
Confidence 99999999999999999999999 678999776544
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=354.63 Aligned_cols=248 Identities=24% Similarity=0.436 Sum_probs=215.4
Q ss_pred eeeccCCcEEEEEEEEcCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeec----CCceeEEEeecC
Q 003978 511 EQIGQGSCGTVYHAVWYGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----PQRLCIVTEFLP 585 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lv~E~~~ 585 (782)
..||+|++|.||+|.+.++.||||.++.... .....+.+.+|+.+|+.++|||||++++++.+ ...+++|||||+
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 5689999999999999999999999976544 33445788899999999999999999999866 346899999999
Q ss_pred CCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcC-CCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccC
Q 003978 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664 (782)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~-~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 664 (782)
+|+|.+++... ..+++...+.++.|++.||.|||.. + ++||||||+|||++.++.+||+|||+++...... ..
T Consensus 106 ~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~~ 179 (283)
T PHA02988 106 RGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FK 179 (283)
T ss_pred CCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhhcccc---cc
Confidence 99999999764 4688999999999999999999984 6 8899999999999999999999999987544322 24
Q ss_pred CCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhh
Q 003978 665 GKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742 (782)
Q Consensus 665 ~~Gt~~y~aPE~l~~--~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 742 (782)
..|++.|+|||++.+ ..++.++|||||||++|||++|..||...+..+....+........++..+++.+++||.+||
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 259 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACT 259 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHh
Confidence 468999999999976 678999999999999999999999999888777666664445566677789999999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHH
Q 003978 743 HSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 743 ~~dP~~RPs~~ell~~L~~L~~ 764 (782)
+.||++|||+.++++.|+.++.
T Consensus 260 ~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 260 SHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred cCCcccCcCHHHHHHHHHHHHh
Confidence 9999999999999999887753
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=368.38 Aligned_cols=257 Identities=25% Similarity=0.415 Sum_probs=221.7
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEcC---CeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG---SDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~---~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
.....++|++.+.||+|+||.||+|.+.+ ..||+|++..... .......+.+|+.+++.++|||||++++++...+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 34556789999999999999999998643 4699999876543 2344567889999999999999999999999999
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
.+|+|||||.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999999997654 6899999999999999999999999 999999999999999999999999999765
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHH
Q 003978 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735 (782)
Q Consensus 656 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 735 (782)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..+++.+.
T Consensus 182 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~ 256 (340)
T PTZ00426 182 DTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL--EGIIYFPKFLDNNCK 256 (340)
T ss_pred CCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHH
Confidence 432 234579999999999999889999999999999999999999999887766655553 334567788999999
Q ss_pred HHHHHhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhcc
Q 003978 736 AIVESCWHSDPQCRP-----SFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 736 ~LI~~cL~~dP~~RP-----s~~ell~~L~~L~~~~~~~~ 770 (782)
+||++||..||++|+ +++++ +.|+||+..
T Consensus 257 ~li~~~l~~dp~~R~~~~~~~~~~~------~~hp~f~~~ 290 (340)
T PTZ00426 257 HLMKKLLSHDLTKRYGNLKKGAQNV------KEHPWFGNI 290 (340)
T ss_pred HHHHHHcccCHHHcCCCCCCCHHHH------HcCCCcCCC
Confidence 999999999999995 89998 567887643
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=349.03 Aligned_cols=259 Identities=27% Similarity=0.477 Sum_probs=231.9
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
.+..++|..+++||+|+||+|.+|+. .++.||||+++++.. ..+.+.--..|-++|+..+||.+..+-..|+..+++
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 45678999999999999999999986 577799999988765 344455566799999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+||||..||.|+-+|.+. ..+++.+..++...|+.||.|||+++ ||+||||.+|+|++++|+|||+|||+++....
T Consensus 244 CFVMeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999999999999874 46999999999999999999999998 99999999999999999999999999987777
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
...+..+++|||.|+|||++....|+.++|+|.+|++||||+||++||...+.......| ......+|..++++++.|
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI--l~ed~kFPr~ls~eAktL 398 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI--LMEDLKFPRTLSPEAKTL 398 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH--HhhhccCCccCCHHHHHH
Confidence 778888999999999999999999999999999999999999999999998888877776 456778999999999999
Q ss_pred HHHhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhcc
Q 003978 738 VESCWHSDPQCRP-----SFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 738 I~~cL~~dP~~RP-----s~~ell~~L~~L~~~~~~~~ 770 (782)
+..+|.+||.+|. ++.|+ .+|.||..+
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi------~~h~FF~~v 430 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEI------MRHRFFASV 430 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHH------HhhhhhccC
Confidence 9999999999995 35555 567887443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=354.92 Aligned_cols=257 Identities=21% Similarity=0.297 Sum_probs=214.0
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
.|++.+.||+|+||.||++.. .++.||+|++...... ......+.+|+.+++.++|+||+++++++..++.+++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 378899999999999999986 5778999998765432 2233467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 583 FLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 583 ~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
||++++|..++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-T 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-e
Confidence 99999999888543 346899999999999999999999998 9999999999999999999999999997643322 2
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh--ccccccCCCCCCCHHHHHHHH
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVG--FMNQRLEIPKDVDPRWAAIVE 739 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~--~~~~~~~~p~~~~~~l~~LI~ 739 (782)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+. .......++..++.++.+||.
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence 234578999999999999999999999999999999999999998765432222211 122344566779999999999
Q ss_pred HhhhhCCCCCCC-----HHHHHHHHHHHHHHHhhccc
Q 003978 740 SCWHSDPQCRPS-----FQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 740 ~cL~~dP~~RPs-----~~ell~~L~~L~~~~~~~~~ 771 (782)
+||..||.+||+ +.++ ++|+||+..+
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~~------~~h~~~~~~~ 268 (285)
T cd05631 238 MLLTKNPKERLGCRGNGAAGV------KQHPIFKNIN 268 (285)
T ss_pred HHhhcCHHHhcCCCCCCHHHH------hcCHhhcCCC
Confidence 999999999997 7888 5678886643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=365.50 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=217.2
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
++|++++.||+|+||.||+|.+ .++.||||+++..... ......+..|+.++..++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 4799999999999999999998 4678999999865432 234567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
|||++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..... .
T Consensus 81 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~ 154 (333)
T cd05600 81 EYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---Y 154 (333)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCccccc---c
Confidence 999999999999754 46889999999999999999999999 99999999999999999999999999975543 2
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC------CCCCHHHH
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP------KDVDPRWA 735 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p------~~~~~~l~ 735 (782)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.........| ..++.++.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 235579999999999999999999999999999999999999999887766655553322222222 24689999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
+||.+||..+|.+||++.++ +.|+||+..
T Consensus 235 ~li~~~l~~~~~rr~s~~~l------l~h~~~~~~ 263 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDI------KNHPFFKEV 263 (333)
T ss_pred HHHHHHhhChhhhcCCHHHH------HhCcccCCC
Confidence 99999999999999999999 567777653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=364.52 Aligned_cols=248 Identities=25% Similarity=0.470 Sum_probs=212.8
Q ss_pred eeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCC
Q 003978 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg 587 (782)
+.||+|+||.||++.. .+..||+|+++.... .......+.+|+++++.++||||+++++++..++.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999987 467899999976533 2344567778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCCC
Q 003978 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667 (782)
Q Consensus 588 sL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~G 667 (782)
+|..++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++..............|
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence 999998764 36899999999999999999999998 999999999999999999999999998753332223334579
Q ss_pred CCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCC
Q 003978 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQ 747 (782)
Q Consensus 668 t~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~ 747 (782)
|+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..+++++.+||.+||..||.
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKDPK 235 (323)
T ss_pred CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 999999999999999999999999999999999999998877766555542 334567788999999999999999999
Q ss_pred CCC-----CHHHHHHHHHHHHHHHhhc
Q 003978 748 CRP-----SFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 748 ~RP-----s~~ell~~L~~L~~~~~~~ 769 (782)
+|| ++.++ +.|+||..
T Consensus 236 ~R~~~~~~~~~~~------l~h~~~~~ 256 (323)
T cd05595 236 QRLGGGPSDAKEV------MEHRFFLS 256 (323)
T ss_pred HhCCCCCCCHHHH------HcCCCcCC
Confidence 998 89998 45677754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=347.39 Aligned_cols=264 Identities=23% Similarity=0.302 Sum_probs=222.1
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeee--cCCceeE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT--SPQRLCI 579 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~l 579 (782)
.++|+.+..|++|+||.||+|+++ ++-||+|.++...-....--.-.+||.+|.+++|||||.+-.+.. .-+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 357899999999999999999984 556999999877654444455678999999999999999988865 3456999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
|||||+. +|..++.....+|....+..++.|+++||+|||.++ |+||||||+|+|++..|.+||+|||+|+.+..+.
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 9999976 999999888889999999999999999999999999 9999999999999999999999999999888775
Q ss_pred ccccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc---------------
Q 003978 660 LTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--------------- 723 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~~~-~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------- 723 (782)
......+-|..|+|||++.|.. |+.+.|+||+||++.||+++++-|.+......+..|-.....
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 5555567799999999998854 799999999999999999999999988777666554221110
Q ss_pred --------------cCCCCC-CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcCCC
Q 003978 724 --------------LEIPKD-VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGD 776 (782)
Q Consensus 724 --------------~~~p~~-~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~~~ 776 (782)
..++.. ++..-.+|+..+|..||.+|.|+.+. |.|.||...+.+..+
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~------L~h~~F~e~P~p~~P 373 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDG------LKHEYFRETPLPIDP 373 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHh------hcccccccCCCCCCh
Confidence 011111 55778999999999999999999998 778999886665543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=356.23 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=209.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.++|++.++||.|+||.||+|.. .+..||+|+++..... .....+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 35799999999999999999987 4677999998654321 22345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
||+++ +|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 99965 999999776667889999999999999999999998 999999999999999999999999998765433333
Q ss_pred ccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-----------------
Q 003978 662 TKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR----------------- 723 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~----------------- 723 (782)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+.+..+......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 344578999999999876 56789999999999999999999999877665544333111000
Q ss_pred -----------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 724 -----------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 724 -----------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
......++.++.+||.+||..||.+|||+.++ +.|+||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~------l~hp~f 288 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAA------LRHSYF 288 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHH------hcCCCC
Confidence 00113467899999999999999999999999 566775
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=369.05 Aligned_cols=255 Identities=25% Similarity=0.449 Sum_probs=219.3
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCH-HHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
++|++.+.||+|+||.||+|... ++.||||+++...... .....+..|+.++..++||||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999985 7889999998654322 45567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc--
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-- 659 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-- 659 (782)
||+.+++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 999999999999765 56899999999999999999999988 9999999999999999999999999987654332
Q ss_pred ---------------------------ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 003978 660 ---------------------------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712 (782)
Q Consensus 660 ---------------------------~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~ 712 (782)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 12234579999999999999999999999999999999999999999888766
Q ss_pred HHHHhhccccccCCCC--CCCHHHHHHHHHhhhhCCCCCCC-HHHHHHHHHHHHHHHhhc
Q 003978 713 VIGAVGFMNQRLEIPK--DVDPRWAAIVESCWHSDPQCRPS-FQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 713 ~~~~i~~~~~~~~~p~--~~~~~l~~LI~~cL~~dP~~RPs-~~ell~~L~~L~~~~~~~ 769 (782)
....+........+|. .+++++.+||.+||. ||.+||+ +.++ +.|+||+.
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~l------l~hp~~~~ 290 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEI------KSHPFFKG 290 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHH------hcCCCcCC
Confidence 6655544223333333 369999999999997 9999999 9999 56788754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=361.95 Aligned_cols=246 Identities=27% Similarity=0.430 Sum_probs=212.2
Q ss_pred eccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCCCH
Q 003978 513 IGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (782)
Q Consensus 513 IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ggsL 589 (782)
||+|+||.||++.+. ++.||+|++++... .......+.+|+.+++.++||||+++++++..++.+|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999984 66799999976432 334456778899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCCCCC
Q 003978 590 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP 669 (782)
Q Consensus 590 ~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~ 669 (782)
.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.............||+
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 81 FHHLQRE-GRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 9999764 46899999999999999999999998 99999999999999999999999999875433333334557999
Q ss_pred cccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCC
Q 003978 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 749 (782)
Q Consensus 670 ~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~R 749 (782)
.|+|||++.+..++.++|||||||++|+|++|..||...+.......+ ......++..+++++.+||.+||..||.+|
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 235 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI--LQEPLRFPDGFDRDAKDLLIGLLSRDPTRR 235 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHH--HcCCCCCCCcCCHHHHHHHHHHcCCCHHHc
Confidence 999999999999999999999999999999999999887776665554 344566788899999999999999999999
Q ss_pred CC---HHHHHHHHHHHHHHHhhc
Q 003978 750 PS---FQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 750 Ps---~~ell~~L~~L~~~~~~~ 769 (782)
|+ +.++ +.|+||+.
T Consensus 236 ~~~~~~~e~------l~hp~~~~ 252 (312)
T cd05585 236 LGYNGAQEI------KNHPFFSQ 252 (312)
T ss_pred CCCCCHHHH------HcCCCcCC
Confidence 75 6777 56777765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=364.22 Aligned_cols=248 Identities=26% Similarity=0.471 Sum_probs=212.8
Q ss_pred eeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCC
Q 003978 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg 587 (782)
+.||+|+||.||++.. .++.||||++.+... .......+.+|+++++.++||||+++++++..++.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 467899999976543 2344567888999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCCC
Q 003978 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667 (782)
Q Consensus 588 sL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~G 667 (782)
+|..++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++............+|
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence 999998764 46899999999999999999999998 999999999999999999999999998754332223334579
Q ss_pred CCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCC
Q 003978 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQ 747 (782)
Q Consensus 668 t~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~ 747 (782)
|+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+ ......+|..+++++.+||.+||..||.
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~li~~~L~~dP~ 235 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--LMEDIKFPRTLSADAKSLLSGLLIKDPN 235 (328)
T ss_pred CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh--ccCCccCCCCCCHHHHHHHHHHcCCCHH
Confidence 99999999999999999999999999999999999999887766655544 2345567888999999999999999999
Q ss_pred CCC-----CHHHHHHHHHHHHHHHhhc
Q 003978 748 CRP-----SFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 748 ~RP-----s~~ell~~L~~L~~~~~~~ 769 (782)
+|| ++.+++ .|+||..
T Consensus 236 ~R~~~~~~~~~~il------~h~~~~~ 256 (328)
T cd05593 236 KRLGGGPDDAKEIM------RHSFFTG 256 (328)
T ss_pred HcCCCCCCCHHHHh------cCCCcCC
Confidence 997 899994 5566643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=357.07 Aligned_cols=261 Identities=26% Similarity=0.361 Sum_probs=211.4
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
++|++.++||+|+||.||+|.. .++.||||++....... ....+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 6899999999999999999997 46789999987543221 22456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
|+. ++|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence 994 6888888776667899999999999999999999999 9999999999999999999999999987544333333
Q ss_pred cCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhcccccc----------------
Q 003978 663 KTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ-VIGAVGFMNQRL---------------- 724 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~-~~~~i~~~~~~~---------------- 724 (782)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .+..+......+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 45578999999999876 457889999999999999999999998764332 222211100000
Q ss_pred ---C--CC---------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcCC
Q 003978 725 ---E--IP---------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVG 775 (782)
Q Consensus 725 ---~--~p---------~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~~ 775 (782)
. .+ ..+++.+.+||.+||+.||.+|||+.++ +.|+||+.....+-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~------l~h~~f~~~~~~~~ 299 (303)
T cd07869 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAA------LSHEYFSDLPPRLW 299 (303)
T ss_pred ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHH------hcCcccccCChhhh
Confidence 0 00 1245688999999999999999999999 67999998766543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=361.91 Aligned_cols=251 Identities=24% Similarity=0.427 Sum_probs=212.5
Q ss_pred eeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHH---HhCCCCceeEEeeeeecCCceeEE
Q 003978 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLM---KRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il---~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
|++.+.||+|+||.||++.+ .++.||||++++... .......+.+|++++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67899999999999999987 467899999986542 223445666776665 456799999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
|||+.+++|..++.. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++........
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 999999999988864 35899999999999999999999998 99999999999999999999999999875433333
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHH
Q 003978 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 740 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 740 (782)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..+++.+.+||.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~ 234 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV--NDEVRYPRFLSREAISIMRR 234 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHHH
Confidence 3345679999999999999999999999999999999999999999887776665553 33455778899999999999
Q ss_pred hhhhCCCCCC-----CHHHHHHHHHHHHHHHhhc
Q 003978 741 CWHSDPQCRP-----SFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 741 cL~~dP~~RP-----s~~ell~~L~~L~~~~~~~ 769 (782)
||..||.+|| ++.++ +.|+||+.
T Consensus 235 ~L~~dP~~R~~~~~~~~~~l------~~~~~f~~ 262 (324)
T cd05589 235 LLRRNPERRLGSGEKDAEDV------KKQPFFRD 262 (324)
T ss_pred HhhcCHhHcCCCCCCCHHHH------hhCCCcCC
Confidence 9999999999 57777 45666644
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=340.25 Aligned_cols=256 Identities=23% Similarity=0.370 Sum_probs=224.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.+.|.+.+.||+|.|+.||++.+ .|+.+|+|++....+.....+.+.+|++|.+.|+|||||++.+.+......|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 35788999999999999999987 6788999999877776666788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc---CCCcEEEEecCCCcccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~---~~~~vkL~DFGla~~~~~~ 658 (782)
|+|.|++|..-|-.. ..+++..+-..+.||+.+|.|+|.++ |||||+||+|+|+. +...|||+|||+|.... .
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~ 165 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-D 165 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeC-C
Confidence 999999997655433 45889999999999999999999999 99999999999994 34569999999998776 4
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC--CCCCCCHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE--IPKDVDPRWAA 736 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~l~~ 736 (782)
......++|||.|||||++...+|+..+|||+-|++||-|+.|.+||.+.+....++.|........ ..+.++++.++
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~ 245 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS 245 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence 5556678999999999999999999999999999999999999999999888888888855444332 33578999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 737 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
||++||..||.+|.|+.|. |.|+|.+.
T Consensus 246 LvrrML~~dP~kRIta~EA------L~HpWi~~ 272 (355)
T KOG0033|consen 246 LIRRMLTVNPKKRITADEA------LKHPWICN 272 (355)
T ss_pred HHHHHhccChhhhccHHHH------hCCchhcc
Confidence 9999999999999999998 56677643
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=351.91 Aligned_cols=254 Identities=20% Similarity=0.289 Sum_probs=209.1
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
++|++.+.||+|+||.||++.+. ++.||||++............+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999984 5679999997665444556678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc-c
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-T 661 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~ 661 (782)
|+.++.+..+. .....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 99886665444 34456899999999999999999999998 99999999999999999999999999976543221 2
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-----------------c
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR-----------------L 724 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------------~ 724 (782)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...... .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 22346899999999999988999999999999999999999999877654433322111000 0
Q ss_pred -------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 725 -------------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 725 -------------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
.....++.++.+||.+||..||++|||+.++ |.|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~------l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQC------LNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHH------hcCCCC
Confidence 0112367889999999999999999999999 556775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=364.68 Aligned_cols=255 Identities=23% Similarity=0.370 Sum_probs=213.4
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
++|++++.||+|+||.||+|.. .++.||||++++... .......+..|+.++..++||||+++++.+.....+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4799999999999999999987 467899999976433 2344567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc-
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 660 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 660 (782)
|||+||+|.+++... ..+++..+..++.|++.||+|||++| |+||||||+||||+.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 999999999999764 46899999999999999999999998 99999999999999999999999999864322100
Q ss_pred ----------------------------------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 003978 661 ----------------------------------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 706 (782)
Q Consensus 661 ----------------------------------~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~ 706 (782)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 0123479999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHhhccccccCCCC--CCCHHHHHHHHHhhhhCCC---CCCCHHHHHHHHHHHHHHHhhc
Q 003978 707 NLNSMQVIGAVGFMNQRLEIPK--DVDPRWAAIVESCWHSDPQ---CRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 707 ~~~~~~~~~~i~~~~~~~~~p~--~~~~~l~~LI~~cL~~dP~---~RPs~~ell~~L~~L~~~~~~~ 769 (782)
..+.......+........+|+ .+++++++||.+|+. +|. .||++.++ +.|+||+.
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei------~~hp~f~~ 298 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEI------KTNPFFEG 298 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH------hCCCCCCC
Confidence 8887776666644333344443 478999999999764 444 46899999 56777753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=361.16 Aligned_cols=248 Identities=25% Similarity=0.413 Sum_probs=212.2
Q ss_pred eeeccCCcEEEEEEEE-----cCCeEEEEEEeccCC--CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 511 EQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~-----~~~~vAiK~~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
++||+|+||.||++.. .++.||||++++... .......+..|+.+|+.++||||+++++++..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 466799999976433 123345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccccc
Q 003978 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (782)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (782)
+.+++|.+++.... .+.+..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence 99999999997643 5788888899999999999999998 99999999999999999999999999875433333334
Q ss_pred CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhh
Q 003978 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWH 743 (782)
Q Consensus 664 ~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 743 (782)
...||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..+++++.+||.+||.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~ 236 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL--KGKLNLPPYLTPEARDLLKKLLK 236 (323)
T ss_pred ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHcc
Confidence 4579999999999999889999999999999999999999999887766665553 34556788899999999999999
Q ss_pred hCCCCCC-----CHHHHHHHHHHHHHHHhhc
Q 003978 744 SDPQCRP-----SFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 744 ~dP~~RP-----s~~ell~~L~~L~~~~~~~ 769 (782)
.||++|| ++.++ +.|+||+.
T Consensus 237 ~~p~~R~~~~~~~~~~l------~~h~~~~~ 261 (323)
T cd05584 237 RNPSSRLGAGPGDAAEV------QSHPFFRH 261 (323)
T ss_pred cCHhHcCCCCCCCHHHH------hcCCCcCC
Confidence 9999999 88888 45677643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=344.35 Aligned_cols=256 Identities=25% Similarity=0.444 Sum_probs=218.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc-----CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
..++|++.+.||+|+||.||++.+. +..||+|.++... .......+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 3568999999999999999999753 4469999987543 334456788999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
++||||+++++|.+++......+++..++.++.||+.||+|||+++ ++||||||+|||++.++.++|+|||.+.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 9999999999999999876667899999999999999999999998 99999999999999999999999998764322
Q ss_pred cc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHH
Q 003978 658 TY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735 (782)
Q Consensus 658 ~~-~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 735 (782)
.. .......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.. ......+..++..+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVED-GFRLPAPRNCPNLLH 238 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-CCCCCCCCCCCHHHH
Confidence 21 11223345678999999999999999999999999999775 9999998887766655532 234456778999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
+++.+||..+|.+||++.+|++.|.++
T Consensus 239 ~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 239 QLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=366.94 Aligned_cols=256 Identities=23% Similarity=0.389 Sum_probs=216.3
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
++|++++.||+|+||.||++.. .++.||||++..... .......+.+|+.+|..++||||+++++++..+..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4799999999999999999987 467899999976543 2345567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc-
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 660 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 660 (782)
|||.+++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++........
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999999999997643 6899999999999999999999999 99999999999999999999999999864321100
Q ss_pred -------------------------------------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCC
Q 003978 661 -------------------------------------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKI 703 (782)
Q Consensus 661 -------------------------------------~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~ 703 (782)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0112469999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhccccccCCCC--CCCHHHHHHHHHhhhhCCCCCCC---HHHHHHHHHHHHHHHhhcc
Q 003978 704 PWDNLNSMQVIGAVGFMNQRLEIPK--DVDPRWAAIVESCWHSDPQCRPS---FQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 704 Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~~~l~~LI~~cL~~dP~~RPs---~~ell~~L~~L~~~~~~~~ 770 (782)
||...+.......+........++. .+++++++||.+||. +|.+|++ +.++ +.|+||+..
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~l------l~h~~~~~~ 302 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEI------KSHPFFKGV 302 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHH------hcCCCcCCC
Confidence 9998887776665543333334443 478999999999996 9999997 9998 667887543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=358.79 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=214.2
Q ss_pred ceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCC-ceeEEeeeeecCCceeEEE
Q 003978 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHP-NVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lv~ 581 (782)
+|++++.||+|+||.||+|... ++.||||++.+... .......+..|++++..+.|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5899999999999999999875 45799999976543 234456778899999999764 6888999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 999999999999764 36889999999999999999999998 999999999999999999999999998643322223
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHh
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 741 (782)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..++.++.+||.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~ 235 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICKGL 235 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHH
Confidence 334579999999999999999999999999999999999999999888777666653 344567788999999999999
Q ss_pred hhhCCCCCCCH-----HHHHHHHHHHHHHHhhc
Q 003978 742 WHSDPQCRPSF-----QELVDKLRDLQRQYFQA 769 (782)
Q Consensus 742 L~~dP~~RPs~-----~ell~~L~~L~~~~~~~ 769 (782)
|..||.+|++. .++ +.|+||+.
T Consensus 236 l~~~P~~R~~~~~~~~~~~------~~hp~~~~ 262 (324)
T cd05587 236 LTKHPAKRLGCGPTGERDI------REHAFFRR 262 (324)
T ss_pred hhcCHHHcCCCCCCCHHHH------hcCCCcCC
Confidence 99999999976 566 45566643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=363.09 Aligned_cols=248 Identities=26% Similarity=0.484 Sum_probs=212.0
Q ss_pred eeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCC
Q 003978 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg 587 (782)
+.||+|+||.||++.+ .+..||+|++++... .......+..|+++++.++||||+++++++..+..+|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 567899999986543 2334566778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003978 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (782)
Q Consensus 588 sL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~-~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (782)
+|..++... ..+++..++.++.||+.||.|||+ .+ |+||||||+||||+.++.+||+|||+++.............
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence 999998764 468999999999999999999997 68 99999999999999999999999999875433322333457
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCC
Q 003978 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 746 (782)
Q Consensus 667 Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP 746 (782)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+ ......+|..+++++.+||.+||..||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i--~~~~~~~p~~~~~~~~~li~~~L~~dP 235 (325)
T cd05594 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--LMEEIRFPRTLSPEAKSLLSGLLKKDP 235 (325)
T ss_pred CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH--hcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 999999999999999999999999999999999999999887766655554 234556778899999999999999999
Q ss_pred CCCC-----CHHHHHHHHHHHHHHHhhc
Q 003978 747 QCRP-----SFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 747 ~~RP-----s~~ell~~L~~L~~~~~~~ 769 (782)
++|+ ++.++ +.|+||+.
T Consensus 236 ~~R~~~~~~~~~~i------l~h~~~~~ 257 (325)
T cd05594 236 KQRLGGGPDDAKEI------MQHKFFAG 257 (325)
T ss_pred HHhCCCCCCCHHHH------hcCCCcCC
Confidence 9996 89999 45667653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=354.87 Aligned_cols=256 Identities=24% Similarity=0.382 Sum_probs=213.8
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
..++|++++.||+|+||.||++.+. +..+|+|++.... .......+.+|+++|+.++||||+++++++..++.+++|
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4578999999999999999999985 6679999987542 345567889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcC-CCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~-~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
|||+++++|.+++.... .+++..+..++.|++.||.|||+. + |+|+||||+|||++.++.+||+|||++......
T Consensus 82 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 82 MEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred eecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 99999999999997643 588999999999999999999974 5 999999999999999999999999998755432
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc--------------------
Q 003978 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF-------------------- 719 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~-------------------- 719 (782)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 22345789999999999999999999999999999999999999976655433222110
Q ss_pred -------------------------cccccCC-CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 720 -------------------------MNQRLEI-PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 720 -------------------------~~~~~~~-p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
....+.. ...+++++++||.+||..||++|||+.++ +.|+||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~el------l~h~~~~~~ 307 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKML------MNHTFIKRS 307 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHH------hcChHHhhc
Confidence 0001111 12468899999999999999999999999 567888754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=359.95 Aligned_cols=255 Identities=27% Similarity=0.399 Sum_probs=213.1
Q ss_pred eeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCceeEEEeecCC
Q 003978 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~g 586 (782)
+.||+|+||.||+|..+ ++.||||++.+... .......+..|+.++..+ +||||+++++++...+.+|+|||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999874 66799999976532 233456677888888876 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003978 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (782)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (782)
++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 9999998764 46899999999999999999999998 99999999999999999999999999875433323334557
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCC
Q 003978 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 746 (782)
Q Consensus 667 Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP 746 (782)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....++..++.++.+||.+||..||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~L~~dP 235 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTWLSQDAVDILKAFMTKNP 235 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHcccCH
Confidence 9999999999999999999999999999999999999999888777666653 34456677899999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 747 QCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 747 ~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
.+||++.++...-+-+.|+||+..
T Consensus 236 ~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 236 TMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred HHCCCCCCCCCHHHHHcCCCcCCC
Confidence 999998332111122678888653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=356.47 Aligned_cols=258 Identities=26% Similarity=0.404 Sum_probs=207.3
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC-----Ccee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----QRLC 578 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~ 578 (782)
+|++.++||+|+||.||+|.. .+..||||++............+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 589999999999999999987 467899999875433333445788999999999999999999987543 2479
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
+||||| +++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELM-ESDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecC-CCCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 999999 569999987643 5899999999999999999999999 999999999999999999999999998754322
Q ss_pred c---ccccCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc--------------
Q 003978 659 Y---LTTKTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF-------------- 719 (782)
Q Consensus 659 ~---~~~~~~~Gt~~y~aPE~l~~--~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~-------------- 719 (782)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 11234578999999999876 5688999999999999999999999987654332211100
Q ss_pred ----------ccccc-----CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 720 ----------MNQRL-----EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 720 ----------~~~~~-----~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
..... ...+.+++.+.+||.+||..||++||++.++ +.|+||+.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~------l~hp~f~~~~~~ 299 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEA------LADPYFKGLAKV 299 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHH------hcCchhhhcCcc
Confidence 00000 0113467889999999999999999999999 678999776554
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=365.76 Aligned_cols=255 Identities=21% Similarity=0.319 Sum_probs=212.2
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
.|++++.||+|+||.||+|.+ .++.||||++..... .......+.+|+.+++.++|||||++++++.....+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 589999999999999999987 456799999976543 34456778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc---
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--- 659 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--- 659 (782)
||++|+|.+++.... .+++..+..++.||+.||.|||.++ |+||||||+||||+.++++||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 999999999997643 5889999999999999999999998 9999999999999999999999999875321000
Q ss_pred --------------------------------------------ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHH
Q 003978 660 --------------------------------------------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVIL 695 (782)
Q Consensus 660 --------------------------------------------~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll 695 (782)
......+||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 001234799999999999999899999999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHHhhccccccCCCC--CCCHHHHHHHHHhh--hhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 696 WELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK--DVDPRWAAIVESCW--HSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 696 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~~~l~~LI~~cL--~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
|||++|..||...+.......+........+|. .+++++.+||.+|+ ..++..||++.++ +.|+||+.
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~------l~hp~f~~ 310 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI------KAHPFFSE 310 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH------hcCcccCC
Confidence 999999999988776655544433233333443 58999999999955 5556669999999 56888865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=368.77 Aligned_cols=258 Identities=28% Similarity=0.489 Sum_probs=228.9
Q ss_pred cceeEeeeeccCCcEEEEEEEEcCCe--EEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~~~~--vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
+.|.|+..||.|+||+||++..+... .|-|++... ..+.++.+.-||+||..++||+||++++.|+.++.++|++|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 46788899999999999999876444 466776433 45667888999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
||.||-+..++-.-+..+.+..+..+++|++.||.|||+++ |||||||..|||++-+|.|+|+|||.+..........
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 99999999998877888999999999999999999999999 9999999999999999999999999987655555556
Q ss_pred cCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-ccCCCCCCCHHHHH
Q 003978 663 KTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRWAA 736 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~-----~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~ 736 (782)
.++.|||.|||||+.. ..+|++++||||||++|.||..+.+|....+++.++-.+.+... .+..|..++..+.+
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~D 267 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSD 267 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence 6889999999999864 67899999999999999999999999999999999888865433 45567789999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 737 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
|+++||.+||..||++.+| |+|+||+.+.+
T Consensus 268 fLk~cL~Knp~~Rp~aaql------l~Hpfv~~~~S 297 (1187)
T KOG0579|consen 268 FLKRCLVKNPRNRPPAAQL------LKHPFVQNAPS 297 (1187)
T ss_pred HHHHHHhcCCccCCCHHHH------hhCcccccCCc
Confidence 9999999999999999999 77899986654
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=367.12 Aligned_cols=255 Identities=23% Similarity=0.364 Sum_probs=213.3
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
++|+++++||+|+||.||++.. .++.||||++.+... .......+.+|+++++.++|||||++++++..+..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4799999999999999999987 567899999876432 3345677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc-
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 660 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 660 (782)
|||++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999999999764 46889999999999999999999999 99999999999999999999999999863211000
Q ss_pred ----------------------------------------------cccCCCCCCcccCcccccCCCCCchhHHHHHHHH
Q 003978 661 ----------------------------------------------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVI 694 (782)
Q Consensus 661 ----------------------------------------------~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~l 694 (782)
.....+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0012469999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCChHHHHHHhhccccccCCCC--CCCHHHHHHHHHhhhhCCCCC---CCHHHHHHHHHHHHHHHhhc
Q 003978 695 LWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK--DVDPRWAAIVESCWHSDPQCR---PSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 695 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~~~l~~LI~~cL~~dP~~R---Ps~~ell~~L~~L~~~~~~~ 769 (782)
+|||++|..||...+.......+........+|. .++.++++||.+||. +|.+| +++.++ +.|+||+.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~------l~hp~~~~ 310 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI------KSHPFFRG 310 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH------hcCCCcCC
Confidence 9999999999988777666555543333344444 478999999999997 67765 599999 56788764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=356.55 Aligned_cols=253 Identities=25% Similarity=0.418 Sum_probs=214.1
Q ss_pred ceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCceeEEE
Q 003978 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
+|.+.+.||+|+||.||+|.+. +..||||++++... .......+..|..++..+ .|++|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999874 45799999986543 223345567788888777 5899999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++........
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 999999999998764 36889999999999999999999998 999999999999999999999999998754333333
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHh
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 741 (782)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..++.++.+||.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~~ 235 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKEAVAICKGL 235 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCcCCHHHHHHHHHH
Confidence 345679999999999999999999999999999999999999999888777666653 334567788999999999999
Q ss_pred hhhCCCCCCCH-----HHHHHHHHHHHHHHhhc
Q 003978 742 WHSDPQCRPSF-----QELVDKLRDLQRQYFQA 769 (782)
Q Consensus 742 L~~dP~~RPs~-----~ell~~L~~L~~~~~~~ 769 (782)
|..||.+|++. .++ +.|+||+.
T Consensus 236 l~~~p~~R~~~~~~~~~~i------~~h~~~~~ 262 (323)
T cd05616 236 MTKHPGKRLGCGPEGERDI------KEHAFFRY 262 (323)
T ss_pred cccCHHhcCCCCCCCHHHH------hcCCCcCC
Confidence 99999999974 555 35666643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=360.97 Aligned_cols=239 Identities=25% Similarity=0.412 Sum_probs=207.3
Q ss_pred eeeccCCcEEEEEEEE-----cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecC
Q 003978 511 EQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 585 (782)
+.||+|+||.||++.. .++.||+|++............+..|+++++.++||||+++++++..++.+|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 46789999998654433344567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCC
Q 003978 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665 (782)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 665 (782)
+++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.............
T Consensus 82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 99999999764 46899999999999999999999999 9999999999999999999999999987654443333456
Q ss_pred CCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhC
Q 003978 666 KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSD 745 (782)
Q Consensus 666 ~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~d 745 (782)
.|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+. .....+|..+++.+.+||.+||..|
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~l~~~ 236 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQSLLRALFKRN 236 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 79999999999999889999999999999999999999999887776665553 3345677889999999999999999
Q ss_pred CCCCCCHHH
Q 003978 746 PQCRPSFQE 754 (782)
Q Consensus 746 P~~RPs~~e 754 (782)
|.+||++.+
T Consensus 237 P~~R~~a~~ 245 (318)
T cd05582 237 PANRLGAGP 245 (318)
T ss_pred HhHcCCCCC
Confidence 999999433
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=361.01 Aligned_cols=256 Identities=23% Similarity=0.404 Sum_probs=218.2
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
++|++.+.||+|+||.||++.. .++.||||+++.... ..+....+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4799999999999999999987 567899999986543 3345567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc-c
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-L 660 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~ 660 (782)
||+++++|.+++......+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++....... .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 999999999999877667999999999999999999999998 9999999999999999999999999997654322 1
Q ss_pred cccCCCCCCcccCccccc------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC--CCCCH
Q 003978 661 TTKTGKGTPQWMAPEVLR------NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP--KDVDP 732 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~------~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~ 732 (782)
......||+.|+|||++. +..++.++|||||||++|+|++|..||...........+........+| ..++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence 223457899999999987 4567789999999999999999999998887776666654333333333 35789
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 733 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 733 ~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
++.+||.+||. +|.+||++.++ +.|+||+.
T Consensus 239 ~~~~li~~ll~-~p~~R~t~~~l------~~h~~~~~ 268 (330)
T cd05601 239 DFLDLIQSLLC-GQKERLGYEGL------CCHPFFSK 268 (330)
T ss_pred HHHHHHHHHcc-ChhhCCCHHHH------hCCCCcCC
Confidence 99999999997 99999999999 67788764
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=362.35 Aligned_cols=262 Identities=25% Similarity=0.466 Sum_probs=216.6
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeee
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 570 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 570 (782)
.|....++|++++.||+|+||.||+|.+. +..||||+++.... .+....+.+|+.+++.+ +|+|||+++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 34455679999999999999999999852 23699999875443 34456788999999999 89999999999
Q ss_pred eecCCceeEEEeecCCCCHHHHHhhcC-----------------------------------------------------
Q 003978 571 VTSPQRLCIVTEFLPRGSLFRLLQRNT----------------------------------------------------- 597 (782)
Q Consensus 571 ~~~~~~~~lv~E~~~ggsL~~~l~~~~----------------------------------------------------- 597 (782)
+...+.+|+|||||.+|+|.+++....
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 999999999999999999999985421
Q ss_pred ----------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc-
Q 003978 598 ----------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 660 (782)
Q Consensus 598 ----------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 660 (782)
.++++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 24678889999999999999999998 99999999999999999999999999875433211
Q ss_pred -cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHH
Q 003978 661 -TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 661 -~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 738 (782)
......+++.|||||++.+..++.++|||||||++|+|++ |..||...........+.........+..+++++.++|
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 348 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIM 348 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHH
Confidence 1112335678999999998889999999999999999997 99999876554433333333334556667899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHH
Q 003978 739 ESCWHSDPQCRPSFQELVDKLRDLQ 763 (782)
Q Consensus 739 ~~cL~~dP~~RPs~~ell~~L~~L~ 763 (782)
.+||..||.+||++.++++.|+++.
T Consensus 349 ~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=358.50 Aligned_cols=259 Identities=28% Similarity=0.447 Sum_probs=227.4
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCH-HHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCc
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQR 576 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 576 (782)
+.....|++.+.||+|.||.||+|.. .|+.+|+|++.+..... .....+.+|+.+|+.+. |||||.++++|+....
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 34456899999999999999999987 47789999998776533 34568899999999998 9999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC----CCcEEEEecCCC
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK----HWTVKVGDFGLS 652 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~----~~~vkL~DFGla 652 (782)
+++|||+|.||.|++.+... .+++..+..++.|++.++.|||+.| |+||||||+|||+.. ++.+|++|||++
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999999999776 3999999999999999999999999 999999999999953 358999999999
Q ss_pred cccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--CCCCCC
Q 003978 653 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL--EIPKDV 730 (782)
Q Consensus 653 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~ 730 (782)
..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||...........+....... .....+
T Consensus 187 ~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~i 265 (382)
T KOG0032|consen 187 KFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDI 265 (382)
T ss_pred eEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcccc
Confidence 87776 555667899999999999999999999999999999999999999999998887777775444322 233467
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 731 DPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 731 ~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
+..+++||+.||..||..|+++.++| +|+|.+..
T Consensus 266 s~~akd~i~~ll~~dp~~R~ta~~~L------~HpWi~~~ 299 (382)
T KOG0032|consen 266 SESAKDFIRKLLEFDPRKRLTAAQAL------QHPWIKSI 299 (382)
T ss_pred CHHHHHHHHHhcccCcccCCCHHHHh------cCccccCC
Confidence 99999999999999999999999994 58998764
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=355.89 Aligned_cols=248 Identities=26% Similarity=0.440 Sum_probs=208.0
Q ss_pred eeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCceeEEEeecCC
Q 003978 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~g 586 (782)
++||+|+||.||+|.+. ++.||||+++.... .......+..|..++..+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999874 56799999986543 223344556677777654 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003978 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (782)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (782)
++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.............+
T Consensus 81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence 9999999764 36899999999999999999999998 99999999999999999999999999975433333334557
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCC
Q 003978 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 746 (782)
Q Consensus 667 Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP 746 (782)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+. ...+.+|..++.++.+||.+||..||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~ll~~~l~~~P 235 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL--NDRPHFPRWISKEAKDCLSKLFERDP 235 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 9999999999999999999999999999999999999999888777666553 34556778899999999999999999
Q ss_pred CCCCCHH-HHHHHHHHHHHHHhhc
Q 003978 747 QCRPSFQ-ELVDKLRDLQRQYFQA 769 (782)
Q Consensus 747 ~~RPs~~-ell~~L~~L~~~~~~~ 769 (782)
.+||++. ++ +.|+||+.
T Consensus 236 ~~R~~~~~~l------~~h~~~~~ 253 (316)
T cd05592 236 TKRLGVDGDI------RQHPFFRG 253 (316)
T ss_pred HHcCCChHHH------HcCcccCC
Confidence 9999864 55 34566643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=357.01 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=211.7
Q ss_pred eeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCceeEEEeecCC
Q 003978 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~g 586 (782)
++||+|+||.||+|... ++.||||++++... .......+..|++++..+ +||||+++++++..++.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999874 56799999976533 234456677889998876 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003978 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (782)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (782)
++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence 9999998764 46889999999999999999999998 99999999999999999999999999875433333334557
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCC
Q 003978 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 746 (782)
Q Consensus 667 Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP 746 (782)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..++.++.+||.+||..||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~ll~~~L~~dp 235 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL--HDDVLYPVWLSKEAVSILKAFMTKNP 235 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhccCH
Confidence 9999999999999999999999999999999999999999888777766653 33455667789999999999999999
Q ss_pred CCCC-------CHHHHHHHHHHHHHHHhhc
Q 003978 747 QCRP-------SFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 747 ~~RP-------s~~ell~~L~~L~~~~~~~ 769 (782)
++|| ++.++ +.|+||..
T Consensus 236 ~~R~~~~~~~~~~~~~------~~hp~~~~ 259 (321)
T cd05591 236 NKRLGCVASQGGEDAI------KQHPFFKE 259 (321)
T ss_pred HHcCCCCCCCCCHHHH------hcCCccCC
Confidence 9999 78888 45677743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=373.03 Aligned_cols=259 Identities=24% Similarity=0.453 Sum_probs=216.5
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEc-C-CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEee-eeec
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY-G-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMG-AVTS 573 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-~-~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~-~~~~ 573 (782)
..+++...+++|.+.|.+|+|+.||+|... + ..||+|.+-.. ++..++.+++||++|+.|. |+|||.+++ ....
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 445666778999999999999999999873 3 78999987654 5677899999999999996 999999999 3321
Q ss_pred ---C---CceeEEEeecCCCCHHHHHhh-cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEE
Q 003978 574 ---P---QRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKV 646 (782)
Q Consensus 574 ---~---~~~~lv~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL 646 (782)
+ ..++|+||||.||.|.+++.. -...|++..+++|+.|+|+|+++||.+.++|||||||-|||||+.+|++||
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEe
Confidence 1 246899999999999999964 234599999999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccccc---------cCCCCCCcccCcccc---cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 003978 647 GDFGLSRLKHETYLTT---------KTGKGTPQWMAPEVL---RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVI 714 (782)
Q Consensus 647 ~DFGla~~~~~~~~~~---------~~~~Gt~~y~aPE~l---~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~ 714 (782)
||||.++......... -...-|+.|+|||++ .+.+.+.|+|||+|||+||-||+...||......
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--- 264 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--- 264 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---
Confidence 9999987433222111 111359999999986 5788999999999999999999999999875332
Q ss_pred HHhhccccccCCC--CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 715 GAVGFMNQRLEIP--KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 715 ~~i~~~~~~~~~p--~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
+| +...+.+| +.++..+++||..||+.||.+||++-+++.++-+|++
T Consensus 265 -aI--lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 265 -AI--LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred -eE--EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 23 44445555 4789999999999999999999999999999998866
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=365.56 Aligned_cols=255 Identities=24% Similarity=0.343 Sum_probs=204.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC------
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 574 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 574 (782)
..++|+++++||+|+||.||+|.. .++.||||.+.... ....+|+.+|+.++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 346899999999999999999987 56789999885432 2234699999999999999998876432
Q ss_pred --CceeEEEeecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-cEEEEe
Q 003978 575 --QRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGD 648 (782)
Q Consensus 575 --~~~~lv~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~-~vkL~D 648 (782)
..+++|||||++ +|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++ .+||+|
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeec
Confidence 246799999964 78777643 3456899999999999999999999999 99999999999998664 699999
Q ss_pred cCCCcccccccccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----
Q 003978 649 FGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ----- 722 (782)
Q Consensus 649 FGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~----- 722 (782)
||+++...... ......||+.|+|||++.+. .++.++|||||||+||+|++|.+||........+..+.....
T Consensus 215 FGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 215 FGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99997654322 22345789999999998764 689999999999999999999999988765544433321100
Q ss_pred ----------------------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 723 ----------------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 723 ----------------------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
...+|...++++.+||.+||.+||.+|||+.++ |.|+||+..+..
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~------l~hp~f~~~~~~ 360 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEA------LADPFFDDLRDP 360 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHH------hCChhHHhhhcc
Confidence 011344578899999999999999999999999 678999876543
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=363.31 Aligned_cols=259 Identities=22% Similarity=0.351 Sum_probs=218.0
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
....++|++.++||+|+||.||++.. .+..||||++.+... .......+.+|+.+++.++||||+++++++..++.+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 34567999999999999999999987 467899999976433 223345577899999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+|||||++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999999998653 4788889999999999999999998 99999999999999999999999999876543
Q ss_pred cc-ccccCCCCCCcccCcccccCC----CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCC--CC
Q 003978 658 TY-LTTKTGKGTPQWMAPEVLRNE----PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK--DV 730 (782)
Q Consensus 658 ~~-~~~~~~~Gt~~y~aPE~l~~~----~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~ 730 (782)
.. ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+........+|. .+
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEI 274 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCC
Confidence 22 123355799999999998754 367899999999999999999999998887766666644333344444 57
Q ss_pred CHHHHHHHHHhhhhCCCC--CCCHHHHHHHHHHHHHHHhhc
Q 003978 731 DPRWAAIVESCWHSDPQC--RPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 731 ~~~l~~LI~~cL~~dP~~--RPs~~ell~~L~~L~~~~~~~ 769 (782)
+.++.+||.+||..+|.+ |+++.++ +.|+||+.
T Consensus 275 s~~~~~li~~~L~~~p~r~~R~s~~el------l~h~~~~~ 309 (370)
T cd05596 275 SKQAKDLICAFLTDREVRLGRNGVDEI------KSHPFFKN 309 (370)
T ss_pred CHHHHHHHHHHccChhhccCCCCHHHH------hcCcccCC
Confidence 999999999999999988 9999999 56788764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=347.30 Aligned_cols=255 Identities=30% Similarity=0.504 Sum_probs=210.4
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc------------------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCce
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY------------------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~------------------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI 564 (782)
...+|++.++||+|+||.||+|.+. +..||+|++.... .......+.+|+.+|..++||||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCe
Confidence 3468999999999999999999752 2259999987543 34456778899999999999999
Q ss_pred eEEeeeeecCCceeEEEeecCCCCHHHHHhhcC------------------CcchHHHHHHHHHHHHHHHHhhhcCCCCe
Q 003978 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT------------------TKLDWRRRILMALDIARGVSYLHHCNPPI 626 (782)
Q Consensus 565 v~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~------------------~~l~~~~~~~i~~qll~aL~~LH~~~~~i 626 (782)
+++++++...+..|+||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++ |
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i 159 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--F 159 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--c
Confidence 999999999999999999999999999985431 23677888999999999999999998 9
Q ss_pred eecCCCCCcEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc--CC
Q 003978 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT--EK 702 (782)
Q Consensus 627 vHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt--G~ 702 (782)
+||||||+|||++.++.+||+|||+++...... .......++..|+|||++.+..++.++|||||||++|+|++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 999999999999999999999999987543321 11223356789999999998889999999999999999986 67
Q ss_pred CCCCCCChHHHHHHhhcc------ccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003978 703 IPWDNLNSMQVIGAVGFM------NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 760 (782)
Q Consensus 703 ~Pf~~~~~~~~~~~i~~~------~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~ 760 (782)
.||......+....+... ......++.++..+.+||.+||..||++|||+.++.+.|+
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 899887766655443211 1122345678899999999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=365.88 Aligned_cols=255 Identities=21% Similarity=0.303 Sum_probs=212.5
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.+|+++++||+|+||.||++.. .++.||||++.+... .......+.+|+.+|+.++||||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3699999999999999999987 467899999875432 2234567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc---
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET--- 658 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~--- 658 (782)
|||++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 999999999999764 36888999999999999999999999 999999999999999999999999997422100
Q ss_pred ----------------------------------------cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHH
Q 003978 659 ----------------------------------------YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL 698 (782)
Q Consensus 659 ----------------------------------------~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~el 698 (782)
.......+||+.|||||++.+..++.++|||||||++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0001134799999999999999999999999999999999
Q ss_pred HcCCCCCCCCChHHHHHHhhccccccCCC--CCCCHHHHHHHHHhhhhCCCCCC---CHHHHHHHHHHHHHHHhhc
Q 003978 699 ATEKIPWDNLNSMQVIGAVGFMNQRLEIP--KDVDPRWAAIVESCWHSDPQCRP---SFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 699 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l~~LI~~cL~~dP~~RP---s~~ell~~L~~L~~~~~~~ 769 (782)
++|+.||...........+........++ ..+++++.+||.+|+ .+|.+|+ ++.++ +.|+||+.
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el------l~h~~~~~ 306 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI------KAHPFFKG 306 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH------hCCCCcCC
Confidence 99999999887766555543322233333 368999999999977 5999999 89999 56788865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=348.26 Aligned_cols=253 Identities=26% Similarity=0.360 Sum_probs=204.2
Q ss_pred cceeEeeeeccCCcEEEEEEEE---cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC---CCCceeEEeeeee-----c
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW---YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL---RHPNVLLFMGAVT-----S 573 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~-----~ 573 (782)
++|++.+.||+|+||.||+|.+ .+..||||+++...........+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3799999999999999999987 256799999876544333334555677777665 6999999999875 3
Q ss_pred CCceeEEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCC
Q 003978 574 PQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (782)
Q Consensus 574 ~~~~~lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla 652 (782)
...+++||||+. ++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEccccce
Confidence 456899999995 5999998653 345889999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc---------
Q 003978 653 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--------- 723 (782)
Q Consensus 653 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~--------- 723 (782)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||........+..+......
T Consensus 158 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 158 RIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred EeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 765433 2233456899999999999988999999999999999999999999988766655444211100
Q ss_pred ----------------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 724 ----------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 724 ----------------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
..+.+.++..+++||.+||+.||++|||+.++ |.|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~------l~hp~f 290 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA------LSHPYF 290 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHH------hcCCCC
Confidence 01123577889999999999999999999999 456765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=364.59 Aligned_cols=254 Identities=22% Similarity=0.337 Sum_probs=212.5
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
.|+++++||+|+||.||+|.. .++.||||++.+... .......+.+|+.+++.++|||||++++.+..++.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 589999999999999999987 466799999876433 33456778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc----
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET---- 658 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~---- 658 (782)
||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 99999999999764 46889999999999999999999998 999999999999999999999999997422100
Q ss_pred -------------------------------------------cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHH
Q 003978 659 -------------------------------------------YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVIL 695 (782)
Q Consensus 659 -------------------------------------------~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll 695 (782)
.......+||+.|+|||++.+..++.++|||||||+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001234699999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHHhhccccccCCC--CCCCHHHHHHHHHhhhhCCCCCCC---HHHHHHHHHHHHHHHhhc
Q 003978 696 WELATEKIPWDNLNSMQVIGAVGFMNQRLEIP--KDVDPRWAAIVESCWHSDPQCRPS---FQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 696 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l~~LI~~cL~~dP~~RPs---~~ell~~L~~L~~~~~~~ 769 (782)
|||++|..||...+.......+........+| ..+++++.+||.+|+ .+|.+|++ +.++ +.|+||+.
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei------~~hp~f~~ 310 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI------KAHPFFKT 310 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH------hcCCCcCC
Confidence 99999999999887766655554333333333 457999999999986 59999987 8888 56777755
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=363.83 Aligned_cols=268 Identities=33% Similarity=0.566 Sum_probs=239.7
Q ss_pred cccccccccceeEeeeeccCCcEEEEEEEEcC-----Ce-EEEEEEec-cCCCHHHHHHHHHHHHHHHhCCCCceeEEee
Q 003978 497 CLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-----SD-VAVKVFSR-QEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569 (782)
Q Consensus 497 ~~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-----~~-vAiK~~~~-~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 569 (782)
...|++..++..+.++||+|+||.||+|..+- .. ||+|..+. .....+....+..|.++|+.++|||||+|||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 35688888999999999999999999998732 13 89999876 3356788899999999999999999999999
Q ss_pred eeecCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEec
Q 003978 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (782)
Q Consensus 570 ~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DF 649 (782)
+......+|||||+|.||+|.++|++++..++....+.++.+.+.||+|||+++ +|||||-.+|+|++.++.+||+||
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEEeCcc
Confidence 999999999999999999999999988877999999999999999999999999 999999999999999999999999
Q ss_pred CCCccccccccccc-CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCC
Q 003978 650 GLSRLKHETYLTTK-TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIP 727 (782)
Q Consensus 650 Gla~~~~~~~~~~~-~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p 727 (782)
|+++... .+.... ...-...|+|||.+....++.++||||+||++||+++ |..||.+....++...+.....+..+|
T Consensus 307 GLs~~~~-~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~ 385 (474)
T KOG0194|consen 307 GLSRAGS-QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP 385 (474)
T ss_pred ccccCCc-ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC
Confidence 9997654 222222 2235679999999999999999999999999999999 888999999999998887778888999
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 728 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 728 ~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
...|.++..++.+||..||+.||++.++.+.|+.+....-
T Consensus 386 ~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 386 SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 9999999999999999999999999999999998866543
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=354.92 Aligned_cols=249 Identities=25% Similarity=0.402 Sum_probs=208.9
Q ss_pred eeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCceeEEEeecCC
Q 003978 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~g 586 (782)
++||+|+||.||+|.+ .+..||||+++.... .......+..|..++..+ +||||+++++++...+.+|+|||||.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999998 466799999976532 122345566788888754 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003978 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (782)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (782)
++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.............
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence 9999998764 46889999999999999999999998 99999999999999999999999999864322222333557
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCC
Q 003978 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 746 (782)
Q Consensus 667 Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP 746 (782)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. ...+.++..++.++++||.+||..||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP 235 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR--VDTPHYPRWITKESKDILEKLFERDP 235 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 9999999999999999999999999999999999999998887766665553 23456677899999999999999999
Q ss_pred CCCCCHH-HHHHHHHHHHHHHhhcc
Q 003978 747 QCRPSFQ-ELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 747 ~~RPs~~-ell~~L~~L~~~~~~~~ 770 (782)
++||++. ++ +.|+||+..
T Consensus 236 ~~R~~~~~~~------~~h~~f~~~ 254 (316)
T cd05620 236 TRRLGVVGNI------RGHPFFKTI 254 (316)
T ss_pred HHcCCChHHH------HcCCCcCCC
Confidence 9999974 55 346777554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=354.37 Aligned_cols=249 Identities=27% Similarity=0.437 Sum_probs=212.3
Q ss_pred eeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCceeEEEeecCC
Q 003978 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~g 586 (782)
+.||+|+||.||+|.+. +..||||++++... .......+..|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999884 56799999986543 233456677899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003978 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (782)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (782)
++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 9999998764 36899999999999999999999998 99999999999999999999999999865333323333457
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCC
Q 003978 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 746 (782)
Q Consensus 667 Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP 746 (782)
|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....++..++.++.+||.+||..||
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~dP 235 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL--EDEVRYPRWLSKEAKSILKSFLTKNP 235 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHccCCH
Confidence 8999999999999999999999999999999999999998887766665553 33456677899999999999999999
Q ss_pred CCCCCH-----HHHHHHHHHHHHHHhhcc
Q 003978 747 QCRPSF-----QELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 747 ~~RPs~-----~ell~~L~~L~~~~~~~~ 770 (782)
.+||++ .++ +.|+||+..
T Consensus 236 ~~R~s~~~~~~~~l------l~~~~~~~~ 258 (318)
T cd05570 236 EKRLGCLPTGEQDI------KGHPFFREI 258 (318)
T ss_pred HHcCCCCCCCHHHH------hcCCCcCCC
Confidence 999999 777 566777553
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=359.97 Aligned_cols=261 Identities=28% Similarity=0.472 Sum_probs=214.2
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeee
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 570 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 570 (782)
.++...++|+++++||+|+||.||+|.+. +..||||+++.... ....+.+.+|+.+|..+ +|||||+++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 34455668999999999999999999742 34699999875433 23346788899999999 89999999999
Q ss_pred eecCCceeEEEeecCCCCHHHHHhhcC-----------------------------------------------------
Q 003978 571 VTSPQRLCIVTEFLPRGSLFRLLQRNT----------------------------------------------------- 597 (782)
Q Consensus 571 ~~~~~~~~lv~E~~~ggsL~~~l~~~~----------------------------------------------------- 597 (782)
+......++|||||++|+|.+++....
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 999999999999999999999986422
Q ss_pred ---------------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 598 ---------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 598 ---------------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceecc
Confidence 14678888999999999999999998 9999999999999999999999999987554
Q ss_pred cccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHH
Q 003978 657 ETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733 (782)
Q Consensus 657 ~~~~--~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 733 (782)
.... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.....................+...+.+
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSE 345 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHH
Confidence 3221 1112345678999999999999999999999999999998 899998765444333332233344556678899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
+++||.+||..||++||++.++++.|++.
T Consensus 346 l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 346 MYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 99999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=355.82 Aligned_cols=253 Identities=22% Similarity=0.376 Sum_probs=210.0
Q ss_pred ceeEeeeeccCCcEEEEEEEE-----cCCeEEEEEEeccCC--CHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCce
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~-----~~~~vAiK~~~~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 577 (782)
+|+++++||+|+||.||++.. .+..||+|++.+... .......+..|+.+++.+ +||||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 589999999999999999975 467799999976432 223446678899999999 599999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+|||||.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 9999999999999999764 45899999999999999999999998 99999999999999999999999999875432
Q ss_pred c-cccccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhccccccCCCCCCC
Q 003978 658 T-YLTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNS----MQVIGAVGFMNQRLEIPKDVD 731 (782)
Q Consensus 658 ~-~~~~~~~~Gt~~y~aPE~l~~~~-~s~~sDIwSLG~ll~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~p~~~~ 731 (782)
. ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ......+ ......++..++
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 235 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--LKCDPPFPSFIG 235 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH--hcCCCCCCCCCC
Confidence 2 12223457999999999998754 78899999999999999999999964322 1222222 234456777899
Q ss_pred HHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhc
Q 003978 732 PRWAAIVESCWHSDPQCRP-----SFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 732 ~~l~~LI~~cL~~dP~~RP-----s~~ell~~L~~L~~~~~~~ 769 (782)
+.+.+||.+||..||++|| +++++ +.|+||+.
T Consensus 236 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~------l~h~~~~~ 272 (332)
T cd05614 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEI------KEHPFFKG 272 (332)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHH------HcCCCcCC
Confidence 9999999999999999999 78888 56778764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=350.73 Aligned_cols=259 Identities=23% Similarity=0.395 Sum_probs=213.9
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
+..++|++.++||+|+||.||++.+. +..+|+|++.... .......+.+|+++++.++||||+++++++..++.+|+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 34578999999999999999999984 5678999886543 34456778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcC-CCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~-~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
||||+.+++|.+++.... .+++..+..++.|++.||.|||+. + |+|+||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999999997643 588999999999999999999974 6 999999999999999999999999998754332
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh--------------------
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVG-------------------- 718 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~-------------------- 718 (782)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+.
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 1224468999999999999889999999999999999999999997654433221110
Q ss_pred -----------------------ccccccCCC-CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 719 -----------------------FMNQRLEIP-KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 719 -----------------------~~~~~~~~p-~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
.....+.++ ..++.++++||.+||..||++|||+.++ +.|+||+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~el------l~h~~~~~~~~ 307 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQL------MVHAFIKRSEA 307 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHH------hhCHHHhcCcc
Confidence 000011111 1367899999999999999999999999 67899987654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=342.85 Aligned_cols=255 Identities=34% Similarity=0.607 Sum_probs=217.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEEcC-------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~~-------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
..++|++.+.||+|+||.||+|...+ ..|++|.+.... .......+.+|+.++..++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 35689999999999999999998743 348999886443 3455667899999999999999999999999989
Q ss_pred ceeEEEeecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK 640 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~ 640 (782)
..|++|||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+||++++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~ 159 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGE 159 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcC
Confidence 9999999999999999996532 35788899999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHh
Q 003978 641 HWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAV 717 (782)
Q Consensus 641 ~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i 717 (782)
++.++|+|||++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+....+
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999987543321 12233456889999999998889999999999999999998 99999988777766555
Q ss_pred hccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003978 718 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRD 761 (782)
Q Consensus 718 ~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~ 761 (782)
. .......+..+++++.+|+.+||..||.+||++.++++.|++
T Consensus 240 ~-~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 R-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H-cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 3 223445677899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=355.94 Aligned_cols=248 Identities=26% Similarity=0.451 Sum_probs=207.8
Q ss_pred eeeccCCcEEEEEEEE--cCCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCceeEEEeecCC
Q 003978 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~g 586 (782)
++||+|+||.||++.+ .++.||||++++.... ......+..|+.+++.+ +||||+++++++...+.+|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999987 4667999999875432 34456688899999988 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003978 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (782)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (782)
++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.............
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence 9999998654 46999999999999999999999999 99999999999999999999999999874332223334567
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh--------HH-HHHHhhccccccCCCCCCCHHHHHH
Q 003978 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS--------MQ-VIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 667 Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~--------~~-~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
||+.|+|||++.+..++.++|||||||++|+|++|..||..... .. ....+ ......+|..++.++.+|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~l 235 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKASSV 235 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--HcCCCCCCCCCCHHHHHH
Confidence 99999999999999999999999999999999999999963211 11 11122 334556788899999999
Q ss_pred HHHhhhhCCCCCCC------HHHHHHHHHHHHHHHhhc
Q 003978 738 VESCWHSDPQCRPS------FQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 738 I~~cL~~dP~~RPs------~~ell~~L~~L~~~~~~~ 769 (782)
|.+||..||.+|++ +.++ +.|+||+.
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~~~i------~~hp~~~~ 267 (329)
T cd05588 236 LKGFLNKDPKERLGCHPQTGFRDI------KSHPFFRN 267 (329)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHH------hcCCCCCC
Confidence 99999999999997 6677 56788854
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=360.96 Aligned_cols=260 Identities=24% Similarity=0.386 Sum_probs=217.4
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
....++|++.+.||+|+||.||++.+. ++.||+|++.+... .......+.+|+.+++.++||||+++++++..+..+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 344578999999999999999999984 66799999975432 223345678899999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+|||||++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 9999999999999999754 4788899999999999999999998 99999999999999999999999999976543
Q ss_pred cc-ccccCCCCCCcccCcccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCC--CC
Q 003978 658 TY-LTTKTGKGTPQWMAPEVLRNEP----SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK--DV 730 (782)
Q Consensus 658 ~~-~~~~~~~Gt~~y~aPE~l~~~~----~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~ 730 (782)
.. ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+........+|. .+
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 274 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEI 274 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccC
Confidence 22 2233567999999999997643 67899999999999999999999998887766666644333444554 46
Q ss_pred CHHHHHHHHHhhhhCCCC--CCCHHHHHHHHHHHHHHHhhcc
Q 003978 731 DPRWAAIVESCWHSDPQC--RPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 731 ~~~l~~LI~~cL~~dP~~--RPs~~ell~~L~~L~~~~~~~~ 770 (782)
+..+++||..||..++.+ |+++.++ ++|+||+..
T Consensus 275 s~~~~~li~~~L~~~~~r~~R~~~~e~------l~hp~~~~~ 310 (370)
T cd05621 275 SKHAKNLICAFLTDREVRLGRNGVEEI------KQHPFFKND 310 (370)
T ss_pred CHHHHHHHHHHccCchhccCCCCHHHH------hcCcccCCC
Confidence 899999999999855543 8899999 668999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=344.92 Aligned_cols=256 Identities=26% Similarity=0.457 Sum_probs=227.3
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
+-|.++.+||+|+||.||++.+ .|..+|||.+.... -++++..|+.+|++++.|+||++||.|.....+|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3577889999999999999987 57779999876432 35778889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
||.-|++.++++....++.+..+..+++..++||+|||... -||||||..|||++.+|..||+|||.|....+.....
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 99999999999888889999999999999999999999977 7999999999999999999999999999888888888
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-ccCCCCCCCHHHHHHHHHh
Q 003978 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRWAAIVESC 741 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~LI~~c 741 (782)
.+..|||.|||||++....|+.++||||||++..||..|++||....+...+..+..... .+..|..++.++.+||++|
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C 266 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC 266 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence 888999999999999999999999999999999999999999999888776655533222 3445667899999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 742 WHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 742 L~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
|.++|++|.|+.+| ++|.|.+.+..
T Consensus 267 LiK~PE~R~TA~~L------~~H~FiknA~g 291 (502)
T KOG0574|consen 267 LIKKPEERKTALRL------CEHTFIKNAPG 291 (502)
T ss_pred hcCCHHHHHHHHHH------hhhhhhcCCCc
Confidence 99999999999999 56777765543
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=352.59 Aligned_cols=248 Identities=25% Similarity=0.419 Sum_probs=207.9
Q ss_pred eeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCceeEEEeecCC
Q 003978 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~g 586 (782)
+.||+|+||.||+|.+. ++.||||+++.... .......+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999974 56799999986532 122344566678888764 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003978 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (782)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (782)
++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 9999999764 46888999999999999999999998 99999999999999999999999999875332222333457
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCC
Q 003978 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 746 (782)
Q Consensus 667 Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP 746 (782)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.. ..+.++..++.++++||.+||..||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~~P 235 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM--DNPCYPRWLTREAKDILVKLFVREP 235 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHHHHHhccCH
Confidence 89999999999999999999999999999999999999998877766655532 2345667799999999999999999
Q ss_pred CCCCCHH-HHHHHHHHHHHHHhhc
Q 003978 747 QCRPSFQ-ELVDKLRDLQRQYFQA 769 (782)
Q Consensus 747 ~~RPs~~-ell~~L~~L~~~~~~~ 769 (782)
++||++. ++ ++|+||+.
T Consensus 236 ~~R~~~~~~l------~~h~~~~~ 253 (316)
T cd05619 236 ERRLGVKGDI------RQHPFFRE 253 (316)
T ss_pred hhcCCChHHH------HcCcccCC
Confidence 9999996 66 45677654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=354.83 Aligned_cols=252 Identities=29% Similarity=0.434 Sum_probs=208.0
Q ss_pred eeeccCCcEEEEEEEE--cCCeEEEEEEeccCCC-HHHHHHHHHHHH-HHHhCCCCceeEEeeeeecCCceeEEEeecCC
Q 003978 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~-~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 586 (782)
+.||+|+||.||++.+ .++.||||++.+.... ......+..|.. +++.++||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999998 5778999999765332 222344445544 56789999999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003978 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (782)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (782)
++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++..............
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 9999999764 46889999999999999999999998 99999999999999999999999999875433333334557
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCC
Q 003978 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 746 (782)
Q Consensus 667 Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP 746 (782)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+. .....+++.+++.+.+||.+||..||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p 235 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL--NKPLRLKPNISVSARHLLEGLLQKDR 235 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 9999999999999999999999999999999999999999887766655553 33455677889999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhc
Q 003978 747 QCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 747 ~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
.+||++.+.+..+ +.|+||..
T Consensus 236 ~~R~~~~~~~~~i--l~~~~~~~ 256 (323)
T cd05575 236 TKRLGAKDDFLEI--KNHVFFSS 256 (323)
T ss_pred HhCCCCCCCHHHH--HcCCCcCC
Confidence 9999875322221 45677743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.74 Aligned_cols=261 Identities=27% Similarity=0.360 Sum_probs=218.2
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCc-eeEEeeeeecCC-----
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-VLLFMGAVTSPQ----- 575 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~----- 575 (782)
...|..+++||+|+||+||+|+. .|+.||+|.+......+.......+|+.+|+.++|+| ||.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45677888999999999999987 5778999999766543334466788999999999999 999999998777
Q ss_pred -ceeEEEeecCCCCHHHHHhhcC---CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCC
Q 003978 576 -RLCIVTEFLPRGSLFRLLQRNT---TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (782)
Q Consensus 576 -~~~lv~E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGl 651 (782)
.+++||||+ ..+|..++.... ..++...+..++.||+.||+|||+++ |+||||||+||||+++|.+||+|||+
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccch
Confidence 799999999 459999998765 35788899999999999999999999 99999999999999999999999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc------
Q 003978 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL------ 724 (782)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~------ 724 (782)
|+....+.......++|..|+|||++.|. .|+...||||+||+++||++++.-|.+......+..|-.....+
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 99766555555567889999999999987 68899999999999999999999999988876665542211111
Q ss_pred ----------CCC------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 725 ----------EIP------------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 725 ----------~~p------------~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
.++ +..+++..+++.+||+.+|.+|.|+... |.|+||+.....
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~a------l~h~yf~~~~~~ 311 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGA------LTHPYFSELPEK 311 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHH------hcChhhcccccc
Confidence 111 1233578999999999999999999998 778999776443
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=366.48 Aligned_cols=254 Identities=28% Similarity=0.402 Sum_probs=217.0
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC----
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ---- 575 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 575 (782)
...++|.+.+.||+|+||.||++.. .++.||||++............+.+|+.++..++|+||++++..+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457999999999999999999986 5788999999877766666778889999999999999999988765332
Q ss_pred ----ceeEEEeecCCCCHHHHHhhc---CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEe
Q 003978 576 ----RLCIVTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648 (782)
Q Consensus 576 ----~~~lv~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~D 648 (782)
.+++||||+++|+|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+||||+.++.+||+|
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCCEEEEe
Confidence 368999999999999998642 346889999999999999999999998 99999999999999999999999
Q ss_pred cCCCcccccc--cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCC
Q 003978 649 FGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEI 726 (782)
Q Consensus 649 FGla~~~~~~--~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 726 (782)
||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.. .....+
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-~~~~~~ 265 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-GRYDPL 265 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCC
Confidence 9998764332 1122345799999999999999999999999999999999999999998777666555432 223456
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003978 727 PKDVDPRWAAIVESCWHSDPQCRPSFQELVDK 758 (782)
Q Consensus 727 p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~ 758 (782)
+..+++++.+||.+||..||.+||++.+++++
T Consensus 266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 78899999999999999999999999999654
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=351.91 Aligned_cols=254 Identities=24% Similarity=0.416 Sum_probs=214.8
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCceeEEE
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~ 581 (782)
+|++.+.||+|+||.||+|.. .++.||||++++... .......+..|+.++..+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 478889999999999999987 467899999976533 2334566778899998886 577888999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 999999999999764 36899999999999999999999998 999999999999999999999999998754333333
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHh
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 741 (782)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..++.++.+|+.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~ 235 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICKGL 235 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHHHHHHHHHH
Confidence 345579999999999999999999999999999999999999999888776666553 344567788999999999999
Q ss_pred hhhCCCCCCCH-----HHHHHHHHHHHHHHhhcc
Q 003978 742 WHSDPQCRPSF-----QELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 742 L~~dP~~RPs~-----~ell~~L~~L~~~~~~~~ 770 (782)
|.++|.+|++. .++ +.|+||+..
T Consensus 236 l~~~p~~R~~~~~~~~~~i------~~h~~f~~~ 263 (323)
T cd05615 236 MTKHPSKRLGCGPEGERDI------REHAFFRRI 263 (323)
T ss_pred cccCHhhCCCCCCCCHHHH------hcCcccCCC
Confidence 99999999974 444 466777653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=359.99 Aligned_cols=256 Identities=23% Similarity=0.379 Sum_probs=214.8
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
++|++++.||+|+||.||++.. .++.||||+++.... ..+....+..|+.++..++||||+++++.+...+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4689999999999999999987 467899999975432 3345667888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc--
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-- 659 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-- 659 (782)
|||+|++|.+++... ..+++..+..++.|++.||.|||++| |+||||||+||||+.++.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 999999999999764 46899999999999999999999999 9999999999999999999999999986432110
Q ss_pred ---------------------------------ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 003978 660 ---------------------------------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 706 (782)
Q Consensus 660 ---------------------------------~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~ 706 (782)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00123479999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHhhccccccCCCC--CCCHHHHHHHHHhhhhCCCCCCC---HHHHHHHHHHHHHHHhhcc
Q 003978 707 NLNSMQVIGAVGFMNQRLEIPK--DVDPRWAAIVESCWHSDPQCRPS---FQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 707 ~~~~~~~~~~i~~~~~~~~~p~--~~~~~l~~LI~~cL~~dP~~RPs---~~ell~~L~~L~~~~~~~~ 770 (782)
..+.......+........+|+ .++.++++||.+|+. ||.+|++ +.++ +.|+||+..
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei------~~hp~f~~~ 299 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEI------KSHPFFEGV 299 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHH------hcCCCCCCC
Confidence 8887776666543333334443 378999999999874 9999984 6777 678998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=342.58 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=207.7
Q ss_pred eccCCcEEEEEEEE--cCCeEEEEEEeccCCCH-HHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCCCH
Q 003978 513 IGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (782)
Q Consensus 513 IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ggsL 589 (782)
||+|+||+||++.+ .++.||+|++....... .....+..|+.+++.++||||+++++++..+..+|+|||||++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999987 46789999987654322 3345677899999999999999999999999999999999999999
Q ss_pred HHHHhh---cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003978 590 FRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (782)
Q Consensus 590 ~~~l~~---~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (782)
..++.. ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 888743 2346899999999999999999999998 99999999999999999999999999876544333334457
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHh--hccccccCCCCCCCHHHHHHHHHhhhh
Q 003978 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHS 744 (782)
Q Consensus 667 Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i--~~~~~~~~~p~~~~~~l~~LI~~cL~~ 744 (782)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+ ........++..++..+.+|+.+||..
T Consensus 159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 238 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAK 238 (280)
T ss_pred CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcC
Confidence 899999999999999999999999999999999999999765432111111 112234456677899999999999999
Q ss_pred CCCCCC-----CHHHHHHHHHHHHHHHhhccc
Q 003978 745 DPQCRP-----SFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 745 dP~~RP-----s~~ell~~L~~L~~~~~~~~~ 771 (782)
||++|| +++++ +.|+||+...
T Consensus 239 ~P~~R~~~~~~~~~~~------l~h~~~~~~~ 264 (280)
T cd05608 239 DPEKRLGFRDGNCDGL------RTHPLFRDLN 264 (280)
T ss_pred CHHHhcCCCCCCHHHH------hcChhhhcCC
Confidence 999999 67777 5689997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=369.47 Aligned_cols=265 Identities=32% Similarity=0.591 Sum_probs=230.5
Q ss_pred ccccccccccceeEeeeeccCCcEEEEEEEEcC-------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEe
Q 003978 496 DCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568 (782)
Q Consensus 496 ~~~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 568 (782)
+....++...+.++.+.||+|+||+||++...+ .-||||.++... .....+.|++|+++|..++|||||+|+
T Consensus 477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 344557778899999999999999999998632 249999987654 345678999999999999999999999
Q ss_pred eeeecCCceeEEEeecCCCCHHHHHhhc-------------CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 003978 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRN-------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN 635 (782)
Q Consensus 569 ~~~~~~~~~~lv~E~~~ggsL~~~l~~~-------------~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~N 635 (782)
|++..++.+|||+|||..|+|.++|..+ +.+++..+.+.|+.||+.||.||-++. +|||||-..|
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRN 633 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRN 633 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhh
Confidence 9999999999999999999999999643 223788999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEEecCCCccccc-cccccc-CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHH
Q 003978 636 LLVDKHWTVKVGDFGLSRLKHE-TYLTTK-TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQ 712 (782)
Q Consensus 636 ILl~~~~~vkL~DFGla~~~~~-~~~~~~-~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~ 712 (782)
+||+++..|||+|||+++.... +|.... ...-..+|||||.+...+++.+|||||+||+|||+++ |+.||.++...+
T Consensus 634 CLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E 713 (774)
T KOG1026|consen 634 CLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE 713 (774)
T ss_pred ceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH
Confidence 9999999999999999985433 233222 2234679999999999999999999999999999999 999999999999
Q ss_pred HHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 713 VIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 713 ~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
+++.+....- ..-|..+|.++++|+..||+.+|.+||++.||-..|.+...
T Consensus 714 VIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 714 VIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 9999875444 88899999999999999999999999999999888776543
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=346.33 Aligned_cols=260 Identities=23% Similarity=0.339 Sum_probs=212.8
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.++|.+.++||+|+||.||++.. .+..||+|.++..... .....+.+|+.+++.++||||+++++++..++..|+||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 36799999999999999999987 4667999998754322 22345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
||+.+ +|.+++......+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.........
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 99964 899888776667889999999999999999999998 999999999999999999999999998765443333
Q ss_pred ccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------------c
Q 003978 662 TKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-----------------R 723 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------~ 723 (782)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+..... .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 334568999999999865 4578999999999999999999999987765443332211100 0
Q ss_pred c-----------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 724 L-----------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 724 ~-----------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
. ...+.+++++++||.+||..||.+|||+.++ +.|+||+.....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~------l~h~~~~~~~~~ 295 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEA------MKHAYFRSLGTR 295 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHH------hcChhhhhcccc
Confidence 0 1113578899999999999999999999999 678999875543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.27 Aligned_cols=256 Identities=26% Similarity=0.345 Sum_probs=212.4
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec-----CCc
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-----PQR 576 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~ 576 (782)
...|..++.||.|+||.|+.+.+ .+..||||.+.......-..++..+|+++|+.++|+||+.+++++.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 35667789999999999999987 57789999987655556667888999999999999999999999865 245
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
+|+|+|+| +.+|...|+.+. .++...+..++.||++||.|+|+.+ |+||||||.|+|++.++.+||||||+|+...
T Consensus 101 vYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccccceeecc
Confidence 89999999 679999997643 5999999999999999999999999 9999999999999999999999999999775
Q ss_pred cc--cccccCCCCCCcccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc--------------
Q 003978 657 ET--YLTTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF-------------- 719 (782)
Q Consensus 657 ~~--~~~~~~~~Gt~~y~aPE~l~-~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~-------------- 719 (782)
.. .......+-|..|+|||++. ...|+.+.||||+||+|.||++|++-|.+.+....+..+..
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 32 11222446799999999875 46689999999999999999999999988876554433211
Q ss_pred ----------cccccC-----CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 720 ----------MNQRLE-----IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 720 ----------~~~~~~-----~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
....+. +.+..++.+.+|+.+||..||.+|+|++|. |.|+|+..
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eA------L~hPYl~~ 315 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEA------LAHPYLAP 315 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHH------hcChhhhh
Confidence 111111 225788999999999999999999999999 77898854
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=353.21 Aligned_cols=250 Identities=27% Similarity=0.436 Sum_probs=207.0
Q ss_pred eeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCceeEEEeecCC
Q 003978 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~g 586 (782)
+.||+|+||.||++.. .++.||+|++++... .......+..|+.++..+ +||||+++++++...+.+|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999987 456799999987543 234456678899888777 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003978 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (782)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (782)
++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.............
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence 9999988654 46899999999999999999999998 99999999999999999999999999875433333334567
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--------hHHHHHHhhccccccCCCCCCCHHHHHHH
Q 003978 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN--------SMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 667 Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~--------~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 738 (782)
||+.|+|||++.+..++.++|||||||++|+|++|..||.... ........ .......+|..++..+.+||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-i~~~~~~~p~~~~~~~~~ll 236 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV-ILEKQIRIPRSLSVKAASVL 236 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH-HhcCCCCCCCCCCHHHHHHH
Confidence 9999999999999999999999999999999999999995321 11111111 13345667888999999999
Q ss_pred HHhhhhCCCCCCCH------HHHHHHHHHHHHHHhhcc
Q 003978 739 ESCWHSDPQCRPSF------QELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 739 ~~cL~~dP~~RPs~------~ell~~L~~L~~~~~~~~ 770 (782)
.+||..||.+||++ .++ +.|+||+..
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i------~~hp~f~~~ 268 (329)
T cd05618 237 KSFLNKDPKERLGCHPQTGFADI------QGHPFFRNV 268 (329)
T ss_pred HHHhcCCHHHcCCCCCCCCHHHH------hcCCCCCCC
Confidence 99999999999984 566 567888543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=334.15 Aligned_cols=257 Identities=31% Similarity=0.562 Sum_probs=217.5
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEc-CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
|++..++|++.++||+|+||.||++... +..||+|.+..... ..+.+.+|+.+++.++|+||+++++.+...+..+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 4566789999999999999999999874 45699998765332 2467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 579 IVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
++|||+.+++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999999999999653 456788899999999999999999988 99999999999999999999999999976544
Q ss_pred cccc-ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHH
Q 003978 658 TYLT-TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735 (782)
Q Consensus 658 ~~~~-~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 735 (782)
.... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+... .....+..++.++.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 234 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMPRMENCPDELY 234 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHH
Confidence 3221 122345678999999998889999999999999999998 99999887776666555422 23344557899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
++|.+||..+|++||+++++++.|+++
T Consensus 235 ~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 235 DIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=333.90 Aligned_cols=257 Identities=24% Similarity=0.406 Sum_probs=215.4
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
++|++.++||+|+||.||++.. .++.||||.++... ........+.+|+++++.++||||+++++++...+..+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5799999999999999999987 57789999886533 34455667889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 582 EFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 582 E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 99999999988853 2345788999999999999999999998 999999999999999999999999998765543
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHhhccccccCCCCCCCHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS--MQVIGAVGFMNQRLEIPKDVDPRWAA 736 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~--~~~~~~i~~~~~~~~~p~~~~~~l~~ 736 (782)
........|++.|+|||.+.+..++.++||||||+++|+|++|..||..... ......+.........+..++..+.+
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 3333345689999999999988899999999999999999999999965432 23333332222222233467889999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003978 737 IVESCWHSDPQCRPSFQELVDKLRDLQ 763 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~~L~~L~ 763 (782)
||.+||..+|++||++.++++.|+.++
T Consensus 240 li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 240 LVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=333.85 Aligned_cols=255 Identities=35% Similarity=0.565 Sum_probs=218.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc-----CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
.++|++.+.||+|+||.||+|.+. ...||||+++... .......+.+|+.+++.++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 367999999999999999999874 2368999886543 3445567888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc-
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE- 657 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~- 657 (782)
++|||+++++|.+++......+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++.....
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 999999999999999876667899999999999999999999988 99999999999999999999999999986642
Q ss_pred -ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHH
Q 003978 658 -TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735 (782)
Q Consensus 658 -~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 735 (782)
.........+++.|+|||.+.+..++.++|||||||++|+|++ |..||...........+.. ......+..++..+.
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~ 238 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-GYRLPPPMDCPSALY 238 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHH
Confidence 1122223345678999999998889999999999999999998 9999988777666655532 223445667899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
+|+.+||..+|++||++.++++.|.++
T Consensus 239 ~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 239 QLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=333.16 Aligned_cols=250 Identities=31% Similarity=0.515 Sum_probs=214.5
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCC---HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS---DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
+.|++.+.||+|++|.||++.. .++.|+||.+...... ......+.+|+++++.++||||+++++++..+..+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4689999999999999999986 5788999998754332 2345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
+|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 999999999999997643 5888999999999999999999998 9999999999999999999999999987543321
Q ss_pred ccc---cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHH
Q 003978 660 LTT---KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 736 (782)
Q Consensus 660 ~~~---~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 736 (782)
... ....|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+........++..++..+.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHH
Confidence 111 23457889999999999989999999999999999999999998776665555554444556677889999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 003978 737 IVESCWHSDPQCRPSFQELVD 757 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~ 757 (782)
||.+||..+|.+||++.++++
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhh
Confidence 999999999999999999953
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=355.92 Aligned_cols=263 Identities=29% Similarity=0.481 Sum_probs=218.0
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEcC-------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEee
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMG 569 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~ 569 (782)
..|+...++|+++++||+|+||.||+|.+.+ ..||||+++... .....+.+.+|+++|+.+. |||||++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 4567777899999999999999999998632 259999986543 3344567889999999996 999999999
Q ss_pred eeecCCceeEEEeecCCCCHHHHHhhcC----------------------------------------------------
Q 003978 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------------------------------------------- 597 (782)
Q Consensus 570 ~~~~~~~~~lv~E~~~ggsL~~~l~~~~---------------------------------------------------- 597 (782)
++.....+|||||||++|+|.+++..+.
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 9999999999999999999999985431
Q ss_pred -------------------------------------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 003978 598 -------------------------------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 634 (782)
Q Consensus 598 -------------------------------------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~ 634 (782)
..+++..++.++.||+.||.|||+.+ |+|+||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~ 266 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAAR 266 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChH
Confidence 23677788899999999999999998 999999999
Q ss_pred cEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChH
Q 003978 635 NLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 711 (782)
Q Consensus 635 NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~ 711 (782)
|||++.++.+||+|||+++...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 9999999999999999987543321 12223457788999999999889999999999999999997 99999876544
Q ss_pred HHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003978 712 QVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 763 (782)
Q Consensus 712 ~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~ 763 (782)
............+..+..++.++.++|.+||..||++||++.+|.+.|.++.
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 347 STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 3333332233345566788999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=351.26 Aligned_cols=254 Identities=27% Similarity=0.368 Sum_probs=205.7
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC-----
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----- 575 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 575 (782)
..++|++.+.||+|+||.||++.+ .+..||||++............+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999987 4678999999766544555677889999999999999999999986543
Q ss_pred -ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 576 -RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 576 -~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
.+|+||||+.+ +|...+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 47999999955 67776642 4788889999999999999999999 99999999999999999999999999975
Q ss_pred cccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc--------------
Q 003978 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-------------- 720 (782)
Q Consensus 655 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~-------------- 720 (782)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+...
T Consensus 173 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 173 ACTNF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred cccCc-cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 43322 223457899999999999999999999999999999999999999876543322111000
Q ss_pred ------cccc--------------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 721 ------NQRL--------------------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 721 ------~~~~--------------------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
...+ ......++++++||.+||..||++|||+.++ |.|+||+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~------l~hp~~~~ 320 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA------LRHPYITV 320 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHH------hcCchhhh
Confidence 0000 0112346789999999999999999999999 56788764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=337.61 Aligned_cols=248 Identities=38% Similarity=0.682 Sum_probs=209.4
Q ss_pred eEeeeeccCCcEEEEEEEEc------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 508 TIGEQIGQGSCGTVYHAVWY------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 508 ~i~~~IG~G~~G~Vy~~~~~------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
++.+.||.|.||.||+|.+. +..|+||+++. ....+....+.+|+++++.++||||+++++++...+.+++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccc
Confidence 57789999999999999987 55699999954 334555788999999999999999999999999888899999
Q ss_pred eecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc--c
Q 003978 582 EFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE--T 658 (782)
Q Consensus 582 E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~--~ 658 (782)
|||++|+|.++|... ...+++..++.++.||+.||.|||+++ |+|+||++.||+++.++.+||+|||++..... .
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccc
Confidence 999999999999876 567999999999999999999999998 99999999999999999999999999876522 1
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
........+...|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+ ........+..++..+.++
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l 237 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSL 237 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHHH
Confidence 222233456789999999998889999999999999999999 78999999888777776 3445566778899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHH
Q 003978 738 VESCWHSDPQCRPSFQELVDKL 759 (782)
Q Consensus 738 I~~cL~~dP~~RPs~~ell~~L 759 (782)
|.+||..||++||++.++++.|
T Consensus 238 i~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 238 IQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHhcC
Confidence 9999999999999999998875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=338.73 Aligned_cols=267 Identities=33% Similarity=0.533 Sum_probs=221.7
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 572 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 572 (782)
|++..++|++.++||+|+||.||+|..+ +..||+|.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4566789999999999999999999753 23699998764432 233456788999999999999999999999
Q ss_pred cCCceeEEEeecCCCCHHHHHhhcC---------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc
Q 003978 573 SPQRLCIVTEFLPRGSLFRLLQRNT---------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 643 (782)
Q Consensus 573 ~~~~~~lv~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~ 643 (782)
.....|+||||+.+++|.+++.... ..+....++.++.||+.||.|||+++ |+||||||+||+++.++.
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~ 157 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCc
Confidence 9999999999999999999996522 23456778889999999999999998 999999999999999999
Q ss_pred EEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcc
Q 003978 644 VKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFM 720 (782)
Q Consensus 644 vkL~DFGla~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~ 720 (782)
++|+|||+++....... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+. .
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~ 236 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM-D 236 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-c
Confidence 99999999875433221 1122345778999999998889999999999999999998 799998877766554442 2
Q ss_pred ccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 721 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 721 ~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
......+..+++.++++|.+||..||++|||+.++++.|++..+++|..+
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 23345566788999999999999999999999999999999999888653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=355.62 Aligned_cols=260 Identities=23% Similarity=0.365 Sum_probs=214.8
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (782)
.+...++|++.+.||+|+||.||++.+. ++.||+|++.+... .......+.+|+.+++.++||||+++++++..+..
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3455689999999999999999999884 66799999875432 22334567889999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
+|+|||||++++|.+++... .+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 99999999999999999754 4788889999999999999999999 9999999999999999999999999997654
Q ss_pred ccc-ccccCCCCCCcccCcccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC--CC
Q 003978 657 ETY-LTTKTGKGTPQWMAPEVLRNEP----SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP--KD 729 (782)
Q Consensus 657 ~~~-~~~~~~~Gt~~y~aPE~l~~~~----~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~ 729 (782)
... ......+||+.|||||++.+.. ++.++|||||||++|+|++|..||...+.......+........+| ..
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 273 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 273 (371)
T ss_pred cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCC
Confidence 322 2233567999999999997643 6789999999999999999999999888776666664433333334 46
Q ss_pred CCHHHHHHHHHhhhhCCCC--CCCHHHHHHHHHHHHHHHhhc
Q 003978 730 VDPRWAAIVESCWHSDPQC--RPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 730 ~~~~l~~LI~~cL~~dP~~--RPs~~ell~~L~~L~~~~~~~ 769 (782)
++..+++||.+||..++.+ |+++.++ +.|+||+.
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~r~~~~ei------~~h~~~~~ 309 (371)
T cd05622 274 ISKEAKNLICAFLTDREVRLGRNGVEEI------KRHLFFKN 309 (371)
T ss_pred CCHHHHHHHHHHcCChhhhcCCCCHHHH------hcCcccCC
Confidence 8999999999999844433 7899999 45677754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.85 Aligned_cols=262 Identities=29% Similarity=0.525 Sum_probs=214.8
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeee
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAV 571 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 571 (782)
|+...++|++.+.||+|+||.||+|... ++.||+|+++... .......+..|+.++..+ +|+||+++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 4566679999999999999999999753 3569999987543 233456778899999999 799999999987
Q ss_pred ec-CCceeEEEeecCCCCHHHHHhhcC-----------------------------------------------------
Q 003978 572 TS-PQRLCIVTEFLPRGSLFRLLQRNT----------------------------------------------------- 597 (782)
Q Consensus 572 ~~-~~~~~lv~E~~~ggsL~~~l~~~~----------------------------------------------------- 597 (782)
.. ...++++|||+++++|.+++....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 64 456889999999999999985421
Q ss_pred -------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc--ccccCCCCC
Q 003978 598 -------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGT 668 (782)
Q Consensus 598 -------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt 668 (782)
..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++....... .......++
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 25788999999999999999999998 9999999999999999999999999997643221 122234567
Q ss_pred CcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCC
Q 003978 669 PQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQ 747 (782)
Q Consensus 669 ~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~ 747 (782)
..|+|||++.+..++.++|||||||++|+|++ |..||......+..............+..+++++.+++.+||+.+|+
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChh
Confidence 78999999999999999999999999999998 99999765443333222222334455667889999999999999999
Q ss_pred CCCCHHHHHHHHHHHHH
Q 003978 748 CRPSFQELVDKLRDLQR 764 (782)
Q Consensus 748 ~RPs~~ell~~L~~L~~ 764 (782)
+||++.+++++|.++.+
T Consensus 319 ~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 319 DRPTFSELVEILGDLLQ 335 (337)
T ss_pred hCcCHHHHHHHHHHHHh
Confidence 99999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.47 Aligned_cols=257 Identities=32% Similarity=0.584 Sum_probs=220.7
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc-CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
+....+|++.++||.|+||.||+|... +..+++|++..... .....+..|+.+++.++||||+++++++.....+++
T Consensus 2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 445568999999999999999999875 56799999865432 234568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 580 VTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+||+|+.++.+||+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999999999999753 345889999999999999999999998 999999999999999999999999999766544
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
........++..|++||.+.+..++.++|||||||++|+|++ |..||...+.......+. .......+..++..+.++
T Consensus 158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05148 158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKI 236 (261)
T ss_pred cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHHHH
Confidence 333334456788999999998889999999999999999998 899998887766665554 233455677899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 738 VESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 738 I~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
|.+||..||.+|||+.++++.|+.+
T Consensus 237 i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 237 MLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHcCCCchhCcCHHHHHHHHhcC
Confidence 9999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=332.06 Aligned_cols=257 Identities=34% Similarity=0.608 Sum_probs=218.2
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
|++...+|.+.++||+|+||.||+|.+. ++.|++|++.... .....+.+|+++++.++||||+++++++..+..+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 3556678999999999999999999874 6779999986533 2245688899999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 578 CIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
+++|||+++++|.+++... ...+++..++.++.|++.||+|||+++ ++|+||||+||++++++.+||+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~~ 155 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMT 155 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCccccccc
Confidence 9999999999999999654 345889999999999999999999988 9999999999999999999999999987654
Q ss_pred cccccc-cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHH
Q 003978 657 ETYLTT-KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734 (782)
Q Consensus 657 ~~~~~~-~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 734 (782)
...... ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+.. ......+..++.++
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 234 (263)
T cd05052 156 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-GYRMERPEGCPPKV 234 (263)
T ss_pred cceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHH
Confidence 332211 12234668999999999999999999999999999998 9999988776665555432 23456677899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 735 AAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
.++|.+||..||++||++.++++.|+.+
T Consensus 235 ~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 235 YELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 9999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=330.84 Aligned_cols=249 Identities=34% Similarity=0.598 Sum_probs=213.0
Q ss_pred cceeEeeeeccCCcEEEEEEEEcC-CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
++|++.+.||+|+||.||++.++. ..+|+|.+....... ..+.+|+.+++.++||||+++++++.....++++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE---EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccH---HHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 578999999999999999998854 479999886544332 4677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc-c
Q 003978 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT-T 662 (782)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~-~ 662 (782)
+++++|.+++......+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++......... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 9999999999765556899999999999999999999998 999999999999999999999999998754332221 1
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHh
Q 003978 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 741 (782)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+.. ......+...+..+.++|.+|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLYRPKLASMTVYEVMYSC 237 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHH
Confidence 22345678999999998889999999999999999999 9999998887776666543 223445667889999999999
Q ss_pred hhhCCCCCCCHHHHHHHH
Q 003978 742 WHSDPQCRPSFQELVDKL 759 (782)
Q Consensus 742 L~~dP~~RPs~~ell~~L 759 (782)
|..+|++||++.++++.|
T Consensus 238 ~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 238 WHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ccCCcccCcCHHHHHHhh
Confidence 999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=362.17 Aligned_cols=248 Identities=22% Similarity=0.355 Sum_probs=211.3
Q ss_pred cceeEeeeeccCCcEEEEEEEEc---CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
..|.+.+.||+|+||.||++... +..||+|.+... .......+.+|+.+|+.++|||||++++++..++.+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 45999999999999999999863 456888876433 2344456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 582 EFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 582 E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
||+++|+|.+++.. ...++++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999999998854 2346889999999999999999999998 999999999999999999999999999865432
Q ss_pred c--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHH
Q 003978 659 Y--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 736 (782)
Q Consensus 659 ~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 736 (782)
. ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.. .....++..+++++++
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY-GKYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCCCCccCCHHHHH
Confidence 2 123345799999999999999999999999999999999999999988777666655532 2233456678999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 003978 737 IVESCWHSDPQCRPSFQELVD 757 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~ 757 (782)
||.+||..||++||++.+++.
T Consensus 302 li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 302 LLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHhccChhhCcCHHHHHh
Confidence 999999999999999999964
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=349.21 Aligned_cols=257 Identities=21% Similarity=0.361 Sum_probs=212.5
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
++|++++.||+|+||.||++... ++.||||++.+... .......+.+|+.++..++|+||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999874 67899999975332 2334566888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc-
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 660 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 660 (782)
||+.+++|.+++......+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 999999999999876667899999999999999999999999 99999999999999999999999999865433221
Q ss_pred cccCCCCCCcccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC---CCCCH
Q 003978 661 TTKTGKGTPQWMAPEVLRN-----EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP---KDVDP 732 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~-----~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p---~~~~~ 732 (782)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+........++ ..++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence 2223468999999999873 446789999999999999999999998877666655554333333333 34789
Q ss_pred HHHHHHHHhhhhCCCC--CCCHHHHHHHHHHHHHHHhhc
Q 003978 733 RWAAIVESCWHSDPQC--RPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 733 ~l~~LI~~cL~~dP~~--RPs~~ell~~L~~L~~~~~~~ 769 (782)
.+++||.+||..++++ |+++.++ +.|+||..
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~------l~hp~~~~ 271 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDF------KDHPFFEG 271 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHH------hcCCCCCC
Confidence 9999999998654443 7899999 66788754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.85 Aligned_cols=255 Identities=22% Similarity=0.319 Sum_probs=212.6
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCH-HHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
.|++.++||+|+||.||++.. .++.||||++....... .....+.+|+.+++.++||||+++++.+..++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 488999999999999999987 46789999987644322 233556789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 583 FLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 583 ~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
|+.+++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-T 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-c
Confidence 99999999888553 346899999999999999999999998 9999999999999999999999999987643322 2
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc--cccccCCCCCCCHHHHHHHH
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF--MNQRLEIPKDVDPRWAAIVE 739 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~~l~~LI~ 739 (782)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||...........+.. ......++..++..+.+||.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICR 237 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHH
Confidence 2345789999999999998899999999999999999999999987655332222211 12234556678999999999
Q ss_pred HhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhc
Q 003978 740 SCWHSDPQCRP-----SFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 740 ~cL~~dP~~RP-----s~~ell~~L~~L~~~~~~~ 769 (782)
+||..||.+|| ++.++ +.|+||+.
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l------~~~~~~~~ 266 (285)
T cd05605 238 QLLTKDPGFRLGCRGEGAEEV------KAHPFFRT 266 (285)
T ss_pred HHccCCHHHhcCCCCCCHHHH------hcCcCccC
Confidence 99999999999 88898 56677754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=358.90 Aligned_cols=254 Identities=20% Similarity=0.280 Sum_probs=199.8
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCC------CceeEEeeeeecC
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH------PNVLLFMGAVTSP 574 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~~~~~~~ 574 (782)
..++|+++++||+|+||.||+|.+ .+..||||+++... .....+..|+++++.+.| .+|+++++++..+
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 357899999999999999999987 46679999986432 223445667777777654 4588999988754
Q ss_pred -CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCC----------
Q 003978 575 -QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHW---------- 642 (782)
Q Consensus 575 -~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~-~~~~ivHrDIKp~NILl~~~~---------- 642 (782)
.++|+|||++ |++|.+++.+. ..+++..+..++.||+.||.|||+ .| ||||||||+||||+.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccccc
Confidence 5689999998 77999988764 468999999999999999999997 58 99999999999998765
Q ss_pred ------cEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 003978 643 ------TVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGA 716 (782)
Q Consensus 643 ------~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~ 716 (782)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|++||...+....+..
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred cCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 499999998764322 22345799999999999999999999999999999999999999987776544333
Q ss_pred hhcccccc-------------------------CC-C--------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHH
Q 003978 717 VGFMNQRL-------------------------EI-P--------------KDVDPRWAAIVESCWHSDPQCRPSFQELV 756 (782)
Q Consensus 717 i~~~~~~~-------------------------~~-p--------------~~~~~~l~~LI~~cL~~dP~~RPs~~ell 756 (782)
+......+ .. + ...++.+.+||.+||..||++|||+.|+
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~- 435 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM- 435 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH-
Confidence 22111000 00 0 0124567899999999999999999999
Q ss_pred HHHHHHHHHHhhcccC
Q 003978 757 DKLRDLQRQYFQASRS 772 (782)
Q Consensus 757 ~~L~~L~~~~~~~~~~ 772 (782)
|.|+||+....
T Consensus 436 -----L~Hp~~~~~~~ 446 (467)
T PTZ00284 436 -----TTHPYVLKYYP 446 (467)
T ss_pred -----hcCccccccCC
Confidence 67899976443
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=350.19 Aligned_cols=238 Identities=32% Similarity=0.449 Sum_probs=201.1
Q ss_pred eeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHH-HHHhCCCCceeEEeeeeecCCceeEEEeecCC
Q 003978 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 586 (782)
++||+|+||.||+|.+ .++.||+|++.+... .......+..|+. +++.++||||+++++++...+.+|+|||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999998 467799999976543 2223344555554 67889999999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003978 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (782)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (782)
++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.............
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 9999988754 46888899999999999999999998 99999999999999999999999999875433333334557
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCC
Q 003978 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 746 (782)
Q Consensus 667 Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP 746 (782)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....++...+..+.++|.+||+.||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p 235 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL--HKPLQLPGGKTVAACDLLVGLLHKDQ 235 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 9999999999999999999999999999999999999999887766665553 34556777889999999999999999
Q ss_pred CCCCCHH
Q 003978 747 QCRPSFQ 753 (782)
Q Consensus 747 ~~RPs~~ 753 (782)
.+||++.
T Consensus 236 ~~R~~~~ 242 (321)
T cd05603 236 RRRLGAK 242 (321)
T ss_pred hhcCCCC
Confidence 9999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=329.08 Aligned_cols=249 Identities=28% Similarity=0.427 Sum_probs=216.6
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
+|.+.+.||+|+||.||++.. .+..|++|.+............+.+|+++++.++||||+++++.+...+.+|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 488899999999999999987 467899999877655566677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 584 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 584 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence 9999999999764 456889999999999999999999988 9999999999999999999999999987655443333
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhh
Q 003978 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 742 (782)
....|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. ......++..++.++.++|.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII-RGVFPPVSQMYSQQLAQLIDQCL 237 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCccccCHHHHHHHHHHc
Confidence 44578999999999999889999999999999999999999998877655544442 22234455578999999999999
Q ss_pred hhCCCCCCCHHHHHH
Q 003978 743 HSDPQCRPSFQELVD 757 (782)
Q Consensus 743 ~~dP~~RPs~~ell~ 757 (782)
..+|++||++.++++
T Consensus 238 ~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 238 TKDYRQRPDTFQLLR 252 (256)
T ss_pred cCCcccCcCHHHHhh
Confidence 999999999999954
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=351.73 Aligned_cols=252 Identities=29% Similarity=0.417 Sum_probs=207.8
Q ss_pred eeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHH-HHHhCCCCceeEEeeeeecCCceeEEEeecCC
Q 003978 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 586 (782)
+.||+|+||.||++.. .++.||||++.+... .......+..|.. +++.++||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999987 477899999976533 2233344555554 57789999999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003978 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (782)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (782)
++|..++... ..+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||++..............
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 9999988754 46899999999999999999999998 99999999999999999999999999875433333334557
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCC
Q 003978 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 746 (782)
Q Consensus 667 Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP 746 (782)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+++.++..+.++|.+||..||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ll~~ll~~~p 235 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL--HKPLVLRPGASLTAWSILEELLEKDR 235 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH--cCCccCCCCCCHHHHHHHHHHhccCH
Confidence 9999999999999999999999999999999999999999887766665553 23445566789999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhc
Q 003978 747 QCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 747 ~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
.+||++.+.++.+ +.|+||+.
T Consensus 236 ~~R~~~~~~~~~i--~~h~~f~~ 256 (325)
T cd05604 236 QRRLGAKEDFLEI--QEHPFFES 256 (325)
T ss_pred HhcCCCCCCHHHH--hcCCCcCC
Confidence 9999875332222 45677754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=339.25 Aligned_cols=264 Identities=30% Similarity=0.584 Sum_probs=221.4
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEcC---------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEe
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG---------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 568 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~---------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 568 (782)
.+++..++|.+++.||+|+||.||++.+.+ ..+|+|+++... .......+..|+.+++.+ +||||++++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 456777899999999999999999997632 359999987543 233456788899999999 799999999
Q ss_pred eeeecCCceeEEEeecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 003978 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (782)
Q Consensus 569 ~~~~~~~~~~lv~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp 633 (782)
+++...+.+|+||||+.+++|.+++.... ..+++..++.++.|++.||+|||+++ ++|+||||
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 168 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAA 168 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccH
Confidence 99999999999999999999999997532 24788899999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 003978 634 SNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (782)
Q Consensus 634 ~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~ 710 (782)
+|||++.++.+||+|||++........ ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+.
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 999999999999999999875543211 1122234578999999999889999999999999999998 8999987776
Q ss_pred HHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 711 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 711 ~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
......+. .......+..++.++.+||.+||..+|++||++.++++.|+++...-
T Consensus 249 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 249 EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 55554443 23345667788999999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=350.29 Aligned_cols=250 Identities=28% Similarity=0.415 Sum_probs=204.8
Q ss_pred eeeccCCcEEEEEEEEc--CCeEEEEEEeccCCC-HHHHHHHHHHH-HHHHhCCCCceeEEeeeeecCCceeEEEeecCC
Q 003978 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEV-SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~-~~~~~~~~~Ei-~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 586 (782)
+.||+|+||.||+|.+. ++.||+|++...... ......+..|. .+++.++||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999884 556999999764321 12223334444 457888999999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003978 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (782)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (782)
++|.+++... ..+.+..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 9999999764 45788888899999999999999999 99999999999999999999999999875433333334567
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCC
Q 003978 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 746 (782)
Q Consensus 667 Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP 746 (782)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+++.+++.+.++|.+||++||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p 235 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--NKPLQLKPNITNSARHLLEGLLQKDR 235 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH--hCCcCCCCCCCHHHHHHHHHHcccCH
Confidence 9999999999999999999999999999999999999999887776665552 23445667899999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHHHh
Q 003978 747 QCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 747 ~~RPs~~ell~~L~~L~~~~~ 767 (782)
.+||++.+.+..+ +.|.||
T Consensus 236 ~~R~~~~~~~~~i--~~~~~~ 254 (325)
T cd05602 236 TKRLGAKDDFMEI--KNHIFF 254 (325)
T ss_pred HHCCCCCCCHHHH--hcCccc
Confidence 9999876443322 244555
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=351.13 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=208.1
Q ss_pred eeeccCCcEEEEEEEE--cCCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCceeEEEeecCC
Q 003978 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~g 586 (782)
++||+|+||.||+|.. .++.||+|++++.... ......+..|+.++..+ .||||+++++++...+.+|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999987 4567999999875432 34556788899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003978 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (782)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (782)
++|..++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence 9999988754 36899999999999999999999998 99999999999999999999999999875333323334567
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC------hHHHHHHhhccccccCCCCCCCHHHHHHHHH
Q 003978 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN------SMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 740 (782)
Q Consensus 667 Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~------~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 740 (782)
||+.|+|||++.+..++.++|||||||++|+|++|..||.... ........ .......+|..++..+.++|.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~li~~ 236 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV-ILEKPIRIPRFLSVKASHVLKG 236 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH-HHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999999999999999999999999999999999996321 11222222 1334556788899999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 741 CWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 741 cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
||..||.+|+++......-.-+.|+||+.+
T Consensus 237 ~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 237 FLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 999999999985321111111567888654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=353.04 Aligned_cols=256 Identities=24% Similarity=0.372 Sum_probs=209.9
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC-----cee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-----RLC 578 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~ 578 (782)
+|+++++||+|+||.||++.. .++.||||.+............+.+|+.+++.++||||+++++++..+. .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999986 5788999998654434445567889999999999999999999998776 789
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999995 5888888653 46899999999999999999999998 999999999999999999999999999754332
Q ss_pred c-ccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--------------
Q 003978 659 Y-LTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-------------- 722 (782)
Q Consensus 659 ~-~~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~-------------- 722 (782)
. .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 1 122234679999999999874 478999999999999999999999988776544433311100
Q ss_pred ----------c------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 723 ----------R------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 723 ----------~------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
. ..+....++++.+||.+||..||.+|||+.++ |.|+||+..+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~------l~hp~~~~~~ 295 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADA------LAHPYLDEGR 295 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHH------hcCHhhCCCc
Confidence 0 12234568899999999999999999999999 6788987643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=335.98 Aligned_cols=252 Identities=33% Similarity=0.539 Sum_probs=210.1
Q ss_pred eeEeeeeccCCcEEEEEEEEcC--CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeec
Q 003978 507 LTIGEQIGQGSCGTVYHAVWYG--SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~~~--~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 584 (782)
|++++.||+|+||.||++...+ ..||+|++..............+|+.+++.++||||+++++++.....++++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 7899999999999999999854 46999999887655555455567999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccC
Q 003978 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664 (782)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 664 (782)
.+++|.+++.. ...+++..++.++.||+.||.+||+++ |+|+||||+||+++.++.++|+|||.+............
T Consensus 81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred ccccccccccc-ccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc
Confidence 99899999983 346899999999999999999999998 999999999999999999999999998754333334445
Q ss_pred CCCCCcccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc---ccc--cCCCCCCCHHHHHHH
Q 003978 665 GKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM---NQR--LEIPKDVDPRWAAIV 738 (782)
Q Consensus 665 ~~Gt~~y~aPE~l~-~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~---~~~--~~~p~~~~~~l~~LI 738 (782)
..+++.|+|||++. +..++.++||||||+++|+|++|..||...........+... ... .......+..+.+||
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 67899999999998 888899999999999999999999999987433322222111 111 111122348999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 739 ~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
.+||..||++||++.++ ++|+||
T Consensus 238 ~~~l~~~p~~R~~~~~l------~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEEL------LKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHH------HTSGGG
T ss_pred HHHccCChhHCcCHHHH------hcCCCC
Confidence 99999999999999999 566775
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=334.41 Aligned_cols=256 Identities=33% Similarity=0.578 Sum_probs=213.7
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEcC-------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (782)
++..++|++.+.||+|+||.||++.+.+ ..||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4556789999999999999999998643 459999886433 22344568899999999999999999999999
Q ss_pred CCceeEEEeecCCCCHHHHHhhcC---------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcE
Q 003978 574 PQRLCIVTEFLPRGSLFRLLQRNT---------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTV 644 (782)
Q Consensus 574 ~~~~~lv~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~v 644 (782)
....++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCCE
Confidence 999999999999999999996532 23567888999999999999999988 9999999999999999999
Q ss_pred EEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccc
Q 003978 645 KVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMN 721 (782)
Q Consensus 645 kL~DFGla~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~ 721 (782)
+|+|||++........ ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...........+. ..
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~ 237 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-EG 237 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cC
Confidence 9999999875433211 1122355788999999999889999999999999999999 799998887766555443 23
Q ss_pred cccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003978 722 QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 760 (782)
Q Consensus 722 ~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~ 760 (782)
....++..++..+.++|.+||+.||++||++.++++.|+
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 238 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 344567788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=354.24 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=204.1
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
+...+|++++.||+|+||.||+|.+ .++.||||.... ..+.+|+++|+.++|||||++++++..+...++
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 3456899999999999999999987 467799997532 345789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc-
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET- 658 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~- 658 (782)
+||++ +++|..++... ..+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 161 v~e~~-~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 161 ILPRY-KTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEecC-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 99999 56899888654 35889999999999999999999998 999999999999999999999999999753322
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-------HHHHHHhhc------------
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS-------MQVIGAVGF------------ 719 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~-------~~~~~~i~~------------ 719 (782)
........||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...+..+..
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 1222345799999999999999999999999999999999999987643211 000100000
Q ss_pred ------------ccccc----CCC-----CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 720 ------------MNQRL----EIP-----KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 720 ------------~~~~~----~~p-----~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
..... ..+ ..++.++.+||.+||..||.+|||+.++ |.|+||+.....
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~el------L~hp~f~~~~~~ 385 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEAL------LDFAAFQDIPDP 385 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHH------hcChhhccCCCC
Confidence 00000 000 1356789999999999999999999999 678999886543
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=330.34 Aligned_cols=257 Identities=33% Similarity=0.568 Sum_probs=217.2
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEc-CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
|++..++|++.+.||+|+||.||++.+. +..||||.++..... .+.+.+|+.+++.++||||+++++++...+..|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 3456678999999999999999999874 456999998654432 356788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
++|||+.+++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999999999997543 46899999999999999999999998 99999999999999999999999999876553
Q ss_pred ccccc-cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHH
Q 003978 658 TYLTT-KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735 (782)
Q Consensus 658 ~~~~~-~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 735 (782)
..... .....+..|+|||.+.+..++.++|||||||++|+|++ |+.||...........+.. ......+..++..+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ-GYRMPCPPGCPKELY 234 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCcCCHHHH
Confidence 32111 11223457999999999889999999999999999999 9999998877666655532 223445667899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
++|.+||..+|.+||++.++++.|+++
T Consensus 235 ~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 235 DIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=340.70 Aligned_cols=258 Identities=28% Similarity=0.507 Sum_probs=216.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCC----eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~----~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
..+|++.+.||+|+||.||+|.+ .+. .||||+++.. ......+.+.+|+.+++.++||||+++++++... ..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 45799999999999999999986 333 3899998643 2344557788999999999999999999998764 57
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
++++||+.+|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEccccccccccC
Confidence 8999999999999999877667889999999999999999999998 99999999999999999999999999986543
Q ss_pred ccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHH
Q 003978 658 TYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734 (782)
Q Consensus 658 ~~~--~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 734 (782)
... ......++..|++||++.+..++.++|||||||++|||++ |..||......+....+ ........+..++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 240 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDV 240 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hCCCCCCCCCCCCHHH
Confidence 221 1222345678999999999999999999999999999997 99999887665544333 2333445567789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 735 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
.++|.+||..||.+||++.+++..|.++.+..
T Consensus 241 ~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 241 YMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 99999999999999999999999998886643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=348.72 Aligned_cols=257 Identities=21% Similarity=0.368 Sum_probs=213.3
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
++|++.++||+|+||.||++... ++.||+|++.+... .......+..|+.++..++|+||+++++++..+..+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999874 56699999865332 2334456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc-cc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YL 660 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-~~ 660 (782)
||+.+|+|.+++.+....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 999999999999876667899999999999999999999998 999999999999999999999999998654322 22
Q ss_pred cccCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC---CCCCH
Q 003978 661 TTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP---KDVDP 732 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~-----~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p---~~~~~ 732 (782)
.....+||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..+....+........+| ..+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence 223457999999999986 3457889999999999999999999999888777776664433333333 35799
Q ss_pred HHHHHHHHhhhhCCCC--CCCHHHHHHHHHHHHHHHhhc
Q 003978 733 RWAAIVESCWHSDPQC--RPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 733 ~l~~LI~~cL~~dP~~--RPs~~ell~~L~~L~~~~~~~ 769 (782)
++++||.+||..++.+ |+++.++ ++|+||+.
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~------~~h~~f~~ 271 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDF------KQHPFFTG 271 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHH------hCCCCcCC
Confidence 9999999999765544 6899999 56777754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=348.63 Aligned_cols=257 Identities=20% Similarity=0.354 Sum_probs=212.4
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
++|++.+.||+|+||.||++... ++.||||++.+... .......+..|+.++..+.|+||+++++++..++.+|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999874 56799999875332 2334456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc-
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 660 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 660 (782)
||+.||+|.+++......+++..+..++.|++.||.|||+++ |+||||||+||||+.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 999999999999876567899999999999999999999998 99999999999999999999999999875543221
Q ss_pred cccCCCCCCcccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCC---CCCH
Q 003978 661 TTKTGKGTPQWMAPEVLRN-----EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK---DVDP 732 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~-----~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~---~~~~ 732 (782)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+........+|. .++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 2234579999999999876 4578899999999999999999999988877766666544333344443 4689
Q ss_pred HHHHHHHHhhhhCCCC--CCCHHHHHHHHHHHHHHHhhc
Q 003978 733 RWAAIVESCWHSDPQC--RPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 733 ~l~~LI~~cL~~dP~~--RPs~~ell~~L~~L~~~~~~~ 769 (782)
++++||.+||..++.+ |++++++ +.|+||+.
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~------~~h~~f~~ 271 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDF------KKHAFFEG 271 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHH------hcCCCcCC
Confidence 9999999999866544 4688888 45666643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=329.54 Aligned_cols=250 Identities=34% Similarity=0.600 Sum_probs=213.1
Q ss_pred ccceeEeeeeccCCcEEEEEEEEcCC-eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~~~-~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
.++|++.+.||+|+||.||++.+.+. .+|||.+....... ..+.+|+.+++.++||||+++++++.....+|++||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccH---HHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 35799999999999999999987654 59999887544332 467889999999999999999999998889999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc-c
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-T 661 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~ 661 (782)
|+.+++|.+++......+++..++.++.||+.||.|||+.+ |+|+||||.||+++.++.+||+|||+++....... .
T Consensus 80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999999999876557899999999999999999999998 99999999999999999999999999875443321 1
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHH
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 740 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 740 (782)
.....++..|++||.+.+..++.++|||||||++|+|++ |..||...+.......+.. ......+...+..+++++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ-GLRLYRPHLASEKVYAIMYS 236 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHH
Confidence 112345678999999998889999999999999999998 9999988877665555532 23344566788999999999
Q ss_pred hhhhCCCCCCCHHHHHHHH
Q 003978 741 CWHSDPQCRPSFQELVDKL 759 (782)
Q Consensus 741 cL~~dP~~RPs~~ell~~L 759 (782)
||..||.+||++.++++.|
T Consensus 237 cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 237 CWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred HcCCCcccCCCHHHHHHhh
Confidence 9999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=345.18 Aligned_cols=260 Identities=25% Similarity=0.388 Sum_probs=214.3
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEcC-CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCcee
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 578 (782)
.+....|+++++||+|+.+.||++...+ +.||+|.+.....+...+..+.+|+.+|.+|+ |.+||++|+|-..++.+|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 4556789999999999999999998754 55888888777778889999999999999995 999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc-
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE- 657 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~- 657 (782)
|||||- ..+|..+|++.....+.-.+..+..||+.++.++|++| |||.||||.|+|+-+. .+||+|||+|.....
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlVkG-~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLVKG-RLKLIDFGIANAIQPD 512 (677)
T ss_pred EEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEEee-eEEeeeechhcccCcc
Confidence 999998 55999999877665664578888999999999999999 9999999999999875 999999999986543
Q ss_pred -ccccccCCCCCCcccCcccccCCC-----------CCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhcccccc
Q 003978 658 -TYLTTKTGKGTPQWMAPEVLRNEP-----------SDEKSDVYSFGVILWELATEKIPWDNLNS-MQVIGAVGFMNQRL 724 (782)
Q Consensus 658 -~~~~~~~~~Gt~~y~aPE~l~~~~-----------~s~~sDIwSLG~ll~elltG~~Pf~~~~~-~~~~~~i~~~~~~~ 724 (782)
......+.+||+.||+||.+.... .+.++|||||||+||+|+.|+.||..... ...+.+|...+-.+
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~I 592 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEI 592 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccc
Confidence 334455678999999999986433 35689999999999999999999986642 23333333222234
Q ss_pred CCCCCCCHH-HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 725 EIPKDVDPR-WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 725 ~~p~~~~~~-l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
++|..-+.. +.++++.||.+||++||+..+| |+|+|.+=+
T Consensus 593 efp~~~~~~~li~~mK~CL~rdPkkR~si~eL------LqhpFl~~~ 633 (677)
T KOG0596|consen 593 EFPDIPENDELIDVMKCCLARDPKKRWSIPEL------LQHPFLQIQ 633 (677)
T ss_pred cccCCCCchHHHHHHHHHHhcCcccCCCcHHH------hcCcccccc
Confidence 555544443 9999999999999999999999 567776543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=337.99 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=207.6
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC--C---ce
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--Q---RL 577 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~---~~ 577 (782)
-.|+..+++|.|+||.||++.. .+..||||.+-.... --.+|+++|+.++|||||+++.+|... . .+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 3688899999999999999986 456799998754432 123699999999999999999888532 2 35
Q ss_pred eEEEeecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CcEEEEecCCCc
Q 003978 578 CIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSR 653 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~-~~vkL~DFGla~ 653 (782)
.+|||||+. +|++.++. .+..++.-.+..+.+||++||+|||+.| |+||||||.|+|||.+ |.+||||||.|+
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcce
Confidence 689999965 99999974 3567888899999999999999999988 9999999999999976 899999999998
Q ss_pred ccccccccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--------
Q 003978 654 LKHETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL-------- 724 (782)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------- 724 (782)
........ .+...|..|+|||++.|. .|+.+.||||.|||+.||+-|.+-|.+.+....+..+....+.+
T Consensus 175 ~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 175 VLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 76544322 355679999999999874 57999999999999999999999999887766554432221110
Q ss_pred ------------------C-CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcC
Q 003978 725 ------------------E-IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTV 774 (782)
Q Consensus 725 ------------------~-~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~ 774 (782)
. +....++++.+|+.++|..+|.+|.++.++ |.|+||++-+...
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~------l~h~fFdelr~~~ 316 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEA------LAHPFFDELRDPN 316 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHH------hcchhhHHhhCcC
Confidence 1 334678999999999999999999999999 7889998887763
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=332.50 Aligned_cols=257 Identities=34% Similarity=0.588 Sum_probs=217.9
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEcC-------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 572 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 572 (782)
|++..++|++.+.||+|+||.||++...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 45667899999999999999999998743 469999986443 2334567888999999999999999999999
Q ss_pred cCCceeEEEeecCCCCHHHHHhhcC---------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc
Q 003978 573 SPQRLCIVTEFLPRGSLFRLLQRNT---------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 643 (782)
Q Consensus 573 ~~~~~~lv~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~ 643 (782)
.....|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~ 157 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLT 157 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCC
Confidence 9999999999999999999996422 23677889999999999999999988 999999999999999999
Q ss_pred EEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcc
Q 003978 644 VKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFM 720 (782)
Q Consensus 644 vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~ 720 (782)
+||+|||+++...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+. .
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~ 236 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-D 236 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-c
Confidence 9999999987543321 12233456889999999988889999999999999999998 999998887776665554 3
Q ss_pred ccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003978 721 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 760 (782)
Q Consensus 721 ~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~ 760 (782)
.....+|..++.++.+||.+||..+|++|||+.++++.|+
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 3455677888999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=333.00 Aligned_cols=255 Identities=31% Similarity=0.575 Sum_probs=213.9
Q ss_pred cccceeEeeeeccCCcEEEEEEEE------cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~------~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (782)
.+.+|++.+.||+|+||.||+|.. .+..+++|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 346899999999999999999975 34569999986533 34445678899999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhcC----------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC
Q 003978 577 LCIVTEFLPRGSLFRLLQRNT----------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK 640 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~----------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~ 640 (782)
.|++|||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~~ 159 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGE 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEcC
Confidence 999999999999999985321 24778889999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCCcccccc--cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHh
Q 003978 641 HWTVKVGDFGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAV 717 (782)
Q Consensus 641 ~~~vkL~DFGla~~~~~~--~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i 717 (782)
++.+||+|||+++..... ........++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999999754322 112233446778999999998889999999999999999998 99999887765555444
Q ss_pred hccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003978 718 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRD 761 (782)
Q Consensus 718 ~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~ 761 (782)
. ....+..+..+++.+.++|.+||..||.+||++.++++.|+.
T Consensus 240 ~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 R-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 3 233445677889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=334.48 Aligned_cols=253 Identities=30% Similarity=0.557 Sum_probs=214.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (782)
..+|.+.+.||+|+||.||+|... +..||||+++... ..+....+.+|+++|+.++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 467899999999999999999763 3569999986543 33455788999999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhcC-------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNT-------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 643 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~-------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~ 643 (782)
.+++|||+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCCCe
Confidence 999999999999999997542 34788899999999999999999998 999999999999999999
Q ss_pred EEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcc
Q 003978 644 VKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFM 720 (782)
Q Consensus 644 vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~ 720 (782)
+||+|||++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+. .
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~-~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-Q 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-c
Confidence 9999999987543221 11223346789999999999999999999999999999998 999998877776665553 2
Q ss_pred ccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003978 721 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 760 (782)
Q Consensus 721 ~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~ 760 (782)
......+..++..+++||.+||..||.+||++.++++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 240 GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 2233455678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.65 Aligned_cols=258 Identities=30% Similarity=0.576 Sum_probs=215.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEEcC--C--eEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCcee
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWYG--S--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~~--~--~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 578 (782)
+++|++.+.||+|+||.||+|.... . .+++|.++... .....+.+.+|+.++..+ +||||+++++++.....+|
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 4689999999999999999998743 2 36888776322 334456788999999999 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc
Q 003978 579 IVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 643 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~ 643 (782)
++|||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCCe
Confidence 9999999999999996532 24788999999999999999999998 999999999999999999
Q ss_pred EEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccc
Q 003978 644 VKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQ 722 (782)
Q Consensus 644 vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~ 722 (782)
+||+|||++...... ........+..|+|||++.+..++.++|||||||++|+|++ |..||...........+.. ..
T Consensus 158 ~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~-~~ 235 (297)
T cd05089 158 SKIADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GY 235 (297)
T ss_pred EEECCcCCCccccce-eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-CC
Confidence 999999998643221 11122234567999999999889999999999999999997 9999988877666555432 23
Q ss_pred ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 723 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 723 ~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
....+..++..+.+||.+||..+|.+||++.++++.|.++...+
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 44566779999999999999999999999999999999887755
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=327.54 Aligned_cols=251 Identities=35% Similarity=0.640 Sum_probs=217.8
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
+..++|++.+.||.|+||.||++...++.||||.++.... ..+.+.+|+.+++.++|+||+++++++......|+||
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 3457899999999999999999999999999999875532 4567889999999999999999999999889999999
Q ss_pred eecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 582 EFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
||+++++|.+++.... ..+++..++.++.|++.||.|||.++ |+|+||||+||+++.++.+||+|||.+........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 9999999999997543 35899999999999999999999998 99999999999999999999999999876533221
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHH
Q 003978 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 739 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 739 (782)
...++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.. ......+..+++.+.++|.
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 233 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-GYRMEAPEGCPPEVYKVMK 233 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCCCCccCCCHHHHHHHH
Confidence 2344668999999988889999999999999999997 9999988877665554432 2244566778999999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHH
Q 003978 740 SCWHSDPQCRPSFQELVDKLRD 761 (782)
Q Consensus 740 ~cL~~dP~~RPs~~ell~~L~~ 761 (782)
+||..+|++||++.++++.|+.
T Consensus 234 ~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 234 DCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHhccChhhCcCHHHHHHHHhc
Confidence 9999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=350.52 Aligned_cols=255 Identities=22% Similarity=0.339 Sum_probs=205.8
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc----CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~----~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
....+|++++.||.|+||.||++... +..|++|.+.... ...+|+++|+.++|||||++++++.....+
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 34568999999999999999999764 3568999875432 345799999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|++||++ +++|.+++.. ...+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++....
T Consensus 162 ~lv~e~~-~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 162 CMVMPKY-KCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred EEEehhc-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9999999 4689998844 457899999999999999999999998 99999999999999999999999999875443
Q ss_pred ccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH---HHHHHhhc-cc----------
Q 003978 658 TYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM---QVIGAVGF-MN---------- 721 (782)
Q Consensus 658 ~~~--~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~---~~~~~i~~-~~---------- 721 (782)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..+..+.. ..
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 221 223457999999999999999999999999999999999999999654321 11111100 00
Q ss_pred ----------------cccCCC-----CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 722 ----------------QRLEIP-----KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 722 ----------------~~~~~p-----~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
....++ ..++.++++||.+||..||++||++.++ |.|+||+.....
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~------l~~p~f~~~~~~ 384 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDI------LSLPLFTKEPIN 384 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHH------hhCchhhccchh
Confidence 000111 1346789999999999999999999999 778999876543
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=327.09 Aligned_cols=249 Identities=27% Similarity=0.447 Sum_probs=211.9
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec-CCceeEEEe
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQRLCIVTE 582 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lv~E 582 (782)
.|++.+.||.|++|.||++.. .++.|++|.+............+.+|+++++.++|+||+++++.+.. +..+|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 489999999999999999987 45679999997766555566778899999999999999999998764 446899999
Q ss_pred ecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 583 FLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 583 ~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
|+++++|.+++... ...+++..++.++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 99999999999763 345899999999999999999999998 999999999999999999999999998765443333
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHh
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 741 (782)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.. ......+..+++.+.+||.+|
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~ 237 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-GKLPPMPKDYSPELGELIATM 237 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-cCCCCCccccCHHHHHHHHHH
Confidence 3455689999999999999899999999999999999999999987766554443321 223345667899999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 003978 742 WHSDPQCRPSFQELVD 757 (782)
Q Consensus 742 L~~dP~~RPs~~ell~ 757 (782)
|..||++||++.++++
T Consensus 238 l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 238 LSKRPEKRPSVKSILR 253 (257)
T ss_pred hccCcccCCCHHHHhc
Confidence 9999999999999943
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=329.05 Aligned_cols=255 Identities=32% Similarity=0.577 Sum_probs=215.8
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEE-cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
|++..++|+++++||+|+||.||+|.. .++.||+|.+....... ..+.+|+.+++.++|+||+++++++. ....|
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP---EAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcH---HHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 466778999999999999999999987 45779999987654432 46788999999999999999999874 45789
Q ss_pred EEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 579 IVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
++|||+.+++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 999999999999998653 346888999999999999999999998 99999999999999999999999999876542
Q ss_pred cc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHH
Q 003978 658 TY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735 (782)
Q Consensus 658 ~~-~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 735 (782)
.. .......++..|+|||++.+..++.++|||||||++|+|++ |++||...+.......+.. ......+..++.++.
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 233 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER-GYRMPRPDNCPEELY 233 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHc-CCCCCCCCCCCHHHH
Confidence 22 12223346778999999998889999999999999999999 9999988877666555432 234456677889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRD 761 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~ 761 (782)
++|.+||..+|++||++++++..|+.
T Consensus 234 ~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 234 ELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHccCChhhCCCHHHHHHHhhc
Confidence 99999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=335.86 Aligned_cols=253 Identities=21% Similarity=0.344 Sum_probs=204.1
Q ss_pred eccCCcEEEEEEEE--cCCeEEEEEEeccCCCH-HHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCCCH
Q 003978 513 IGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (782)
Q Consensus 513 IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ggsL 589 (782)
||+|+||.||++.. .++.||+|.+....... .....+..|+++++.++||||++++++++.+..+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999987 47789999987543322 2234456799999999999999999999999999999999999999
Q ss_pred HHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCCCC
Q 003978 590 FRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT 668 (782)
Q Consensus 590 ~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt 668 (782)
.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++....... ......|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCC
Confidence 9888543 345888999999999999999999998 9999999999999999999999999987654332 22234689
Q ss_pred CcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc--cccccC-CCCCCCHHHHHHHHHhhhhC
Q 003978 669 PQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF--MNQRLE-IPKDVDPRWAAIVESCWHSD 745 (782)
Q Consensus 669 ~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~-~p~~~~~~l~~LI~~cL~~d 745 (782)
+.|+|||++.+..++.++|||||||++|+|++|..||...........+.. ...... ....++.++++||.+||..|
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 237 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKK 237 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccC
Confidence 999999999998899999999999999999999999976533211111110 111111 22468999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 746 PQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 746 P~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
|++||++.++++.+ +.|+||+..
T Consensus 238 P~~R~~~~~~~~~~--~~h~~f~~~ 260 (277)
T cd05607 238 PEDRLGSREKNDDP--RKHEFFKTI 260 (277)
T ss_pred HhhCCCCccchhhh--hcChhhcCC
Confidence 99999997765443 468999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=328.10 Aligned_cols=251 Identities=33% Similarity=0.612 Sum_probs=213.9
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeee-ecCCceeEE
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV-TSPQRLCIV 580 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~lv 580 (782)
+..++|++.+.||+|+||.||++...+..+++|.++... ..+.+.+|+.+++.++|+||+++++++ ..++..|++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 445789999999999999999999999999999986432 245688899999999999999999975 455678999
Q ss_pred EeecCCCCHHHHHhhcCC-cchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 581 TEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
|||+++++|.+++..... .+++..++.++.|++.||+|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 999999999999976443 4788999999999999999999998 9999999999999999999999999987543322
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHH
Q 003978 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 738 (782)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||...........+.. ......+..+++.+.++|
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li 232 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPVVYDVM 232 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCCHHHHHHH
Confidence 23345678999999999889999999999999999997 9999987776665555532 234456678899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 739 ESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 739 ~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
.+||..+|++|||+.++++.|+++
T Consensus 233 ~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 233 KQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHhcCChhhCcCHHHHHHHHhcC
Confidence 999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=348.53 Aligned_cols=254 Identities=27% Similarity=0.343 Sum_probs=207.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC------
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 574 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 574 (782)
..++|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 357899999999999999999987 467799999976554455567788899999999999999999987543
Q ss_pred CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
..+|+||||++ ++|.+++.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 35799999995 478887753 4788889999999999999999998 99999999999999999999999999976
Q ss_pred cccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc------------
Q 003978 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------ 722 (782)
Q Consensus 655 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~------------ 722 (782)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.....
T Consensus 176 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 176 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred cCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 54432 22345789999999999999999999999999999999999999987766544333211000
Q ss_pred --------cc--------------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 723 --------RL--------------------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 723 --------~~--------------------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
.+ ......+..+++||.+||..||.+|||+.++ |+|+||+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~------L~hp~~~~ 323 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA------LQHPYINV 323 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHH------hcCccccc
Confidence 00 0111234678999999999999999999999 67888864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=339.28 Aligned_cols=257 Identities=23% Similarity=0.346 Sum_probs=210.8
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.++|++.++||.|+||.||++.+ .+..||+|.++..... .....+.+|+.+++.++||||+++++++..++.+|+||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 46899999999999999999987 4677999998654322 22345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
||+. ++|.+++......+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.........
T Consensus 84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 9996 5999998776667899999999999999999999998 999999999999999999999999998765433333
Q ss_pred ccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------------c
Q 003978 662 TKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-----------------R 723 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------~ 723 (782)
.....+++.|+|||++.+. .++.++|||||||++|+|++|.+||...+.......+..... .
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 3344678999999998764 478899999999999999999999987765443322211000 0
Q ss_pred c-----------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 724 L-----------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 724 ~-----------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
. .....+++.+++||.+||..||.+|||+.++ ++|+||++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ei------l~h~~f~~~ 292 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEA------MKHPYFHCL 292 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHH------hcCcccccc
Confidence 0 1123578899999999999999999999999 678998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=372.53 Aligned_cols=266 Identities=24% Similarity=0.397 Sum_probs=215.2
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec--C
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--P 574 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~ 574 (782)
..+....+|+++++||.|+||.||+|.+. +..||+|++............+..|+.+|+.|.|||||+++++|.. .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 34566789999999999999999999984 5569999998766666667788999999999999999999998854 4
Q ss_pred CceeEEEeecCCCCHHHHHhhc---CCcchHHHHHHHHHHHHHHHHhhhcCC-----CCeeecCCCCCcEEEcC------
Q 003978 575 QRLCIVTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCN-----PPIIHRDLKSSNLLVDK------ 640 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qll~aL~~LH~~~-----~~ivHrDIKp~NILl~~------ 640 (782)
..+|||||||++++|.++|... ...+++..++.|+.||+.||.|||..+ .+||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 5689999999999999999652 346899999999999999999999843 34999999999999964
Q ss_pred -----------CCcEEEEecCCCcccccccccccCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 003978 641 -----------HWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWDN 707 (782)
Q Consensus 641 -----------~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~s~~sDIwSLG~ll~elltG~~Pf~~ 707 (782)
.+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||+||+|++|..||..
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESM-AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccccCCCCceEEccCCcccccccccc-ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 23589999999976543322 234579999999999864 4578899999999999999999999987
Q ss_pred CChHHHHHHhhccccccCCC-CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 708 LNSMQVIGAVGFMNQRLEIP-KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 708 ~~~~~~~~~i~~~~~~~~~p-~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
.+....+.... ...+.++ ...+.++.+||.+||..+|.+||++.++| .++|++.....
T Consensus 246 ~~~~~qli~~l--k~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL------~h~~ik~i~~p 304 (1021)
T PTZ00266 246 ANNFSQLISEL--KRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCL------GYQIIKNVGPP 304 (1021)
T ss_pred CCcHHHHHHHH--hcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHh------ccHHHhhcCCC
Confidence 66544332221 1122222 45789999999999999999999999994 56888755443
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=335.12 Aligned_cols=258 Identities=29% Similarity=0.484 Sum_probs=216.6
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.+.|+++++||.|+||.||++... +..+++|++... .....+.+.+|+.+++.++||||+++++.+..++.+|+||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 367999999999999999999874 577999998653 3455677888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
||+++++|..++......+++..++.++.|++.+|.|||+++ |+|+||||+||+++.++.+||+|||++.........
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 999999999888765667899999999999999999999998 999999999999999999999999998754433333
Q ss_pred ccCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-cccCCCCCCCHHHH
Q 003978 662 TKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QRLEIPKDVDPRWA 735 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~-----~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~~l~ 735 (782)
.....+++.|+|||++. ...++.++|||||||++|+|++|..||...+.......+.... .....+..++.++.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHH
Confidence 33456889999999985 3446789999999999999999999998776655444432211 12334567889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
+||.+||..||++||++.++ +.|+||+...
T Consensus 247 ~li~~~l~~~p~~Rp~~~~i------l~~~~~~~~~ 276 (292)
T cd06644 247 DFLKTALDKHPETRPSAAQL------LEHPFVSSVT 276 (292)
T ss_pred HHHHHHhcCCcccCcCHHHH------hcCccccccc
Confidence 99999999999999999999 5678886544
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=347.93 Aligned_cols=253 Identities=28% Similarity=0.356 Sum_probs=206.0
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC------
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 574 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 574 (782)
..++|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457999999999999999999986 467899999976655555567788899999999999999999988643
Q ss_pred CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
...|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++| |+||||||+||||+.++.+||+|||+++.
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCccccc
Confidence 347999999955 77777753 4788889999999999999999998 99999999999999999999999999976
Q ss_pred cccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-------------
Q 003978 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN------------- 721 (782)
Q Consensus 655 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~------------- 721 (782)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+....
T Consensus 169 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 169 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred CCCcc-ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 54432 2234578999999999999999999999999999999999999998766443322110000
Q ss_pred -------c--------------------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003978 722 -------Q--------------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 722 -------~--------------------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~ 768 (782)
. ....+...+.++++||.+||..||++|||+.++ |+|+||+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~el------l~hp~~~ 315 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA------LQHPYIN 315 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHH------hcCcchh
Confidence 0 000112245678999999999999999999999 5678875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=356.49 Aligned_cols=250 Identities=31% Similarity=0.509 Sum_probs=218.8
Q ss_pred eeeccCCcEEEEEEEEcCC--eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCCC
Q 003978 511 EQIGQGSCGTVYHAVWYGS--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGS 588 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~~~--~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ggs 588 (782)
-+||+|+||+||-|++... ..|||.+.... ....+-+..||.+-+.|+|.|||+++|.+..++.+-|.||-++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 3799999999999998555 46888775433 3445778999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCcc--hHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCcEEEEecCCCcccccccccccCC
Q 003978 589 LFRLLQRNTTKL--DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHETYLTTKTG 665 (782)
Q Consensus 589 L~~~l~~~~~~l--~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~ 665 (782)
|.++|...=+++ ++.+.-++.+||++||.|||++. |||||||-+||||+ -.|.+||.|||.++........+.++
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence 999998765566 88899999999999999999998 99999999999997 47899999999998776666677889
Q ss_pred CCCCcccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccccCCCCCCCHHHHHHHHHhh
Q 003978 666 KGTPQWMAPEVLRNE--PSDEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742 (782)
Q Consensus 666 ~Gt~~y~aPE~l~~~--~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 742 (782)
.||..|||||++... .|+.++|||||||++.||.||++||..+... ..+.++......+++|..++.+++.||.+|+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 999999999999754 4788999999999999999999999877654 4556677777789999999999999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 743 HSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 743 ~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
..||..||++.++ |.++|.+-.
T Consensus 817 epd~~~R~sA~~L------L~DpFlq~~ 838 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDL------LQDPFLQHN 838 (1226)
T ss_pred CCCcccCccHHHh------ccCcccccC
Confidence 9999999999999 567776433
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.42 Aligned_cols=253 Identities=31% Similarity=0.536 Sum_probs=213.9
Q ss_pred eeEeeeeccCCcEEEEEEEEc-----CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc-----
Q 003978 507 LTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR----- 576 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----- 576 (782)
|++++.||+|+||.||+|... +..||||.++...........+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 578899999999999999863 2569999998766555666788999999999999999999998765543
Q ss_pred -eeEEEeecCCCCHHHHHhhc-----CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecC
Q 003978 577 -LCIVTEFLPRGSLFRLLQRN-----TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650 (782)
Q Consensus 577 -~~lv~E~~~ggsL~~~l~~~-----~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFG 650 (782)
.+++|||+++++|..++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECCcc
Confidence 79999999999999998432 235889999999999999999999988 9999999999999999999999999
Q ss_pred CCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCC
Q 003978 651 LSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIP 727 (782)
Q Consensus 651 la~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p 727 (782)
+++...... .......++..|++||.+.+..++.++|||||||++|||++ |..||......+....+.. ......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 237 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH-GNRLKQP 237 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCC
Confidence 987543321 11222335678999999998889999999999999999999 9999988877766655532 3345567
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 728 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 728 ~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
..++.++.++|.+||..||.+||++.++++.|.++
T Consensus 238 ~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 238 EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 78999999999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=329.22 Aligned_cols=253 Identities=30% Similarity=0.505 Sum_probs=210.2
Q ss_pred eeEeeeeccCCcEEEEEEEEcCC----eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC------Cc
Q 003978 507 LTIGEQIGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------QR 576 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~~~~----~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~ 576 (782)
|.++++||+|+||.||+|..... .+|+|.++...........+..|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678999999999999987432 589999876655566678889999999999999999999976432 24
Q ss_pred eeEEEeecCCCCHHHHHhh-----cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCC
Q 003978 577 LCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~-----~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGl 651 (782)
.+++|||+.+++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCCCc
Confidence 6899999999999988742 2344789999999999999999999988 99999999999999999999999999
Q ss_pred Ccccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCC
Q 003978 652 SRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPK 728 (782)
Q Consensus 652 a~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 728 (782)
++....... ......+++.|++||.+.+..++.++|||||||++|+|++ |..||...........+.. ......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~ 237 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ-GNRLKQPP 237 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CCCCCCCC
Confidence 886543221 1223346788999999999989999999999999999999 8999988776665554432 23345567
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 729 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 729 ~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
.++..+.++|.+||..||++|||+.++++.|+++
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 7899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=328.30 Aligned_cols=250 Identities=34% Similarity=0.610 Sum_probs=212.4
Q ss_pred ccceeEeeeeccCCcEEEEEEEEcC-CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
..+|++.+.||+|+||.||++.+.+ ..+|+|++....... ..+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 3578899999999999999998754 469999986544332 356779999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
|+++++|.+++......+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999999999776667899999999999999999999998 9999999999999999999999999987654322111
Q ss_pred -cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHH
Q 003978 663 -KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 740 (782)
Q Consensus 663 -~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 740 (782)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+. .......+..++.++.+++.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHH
Confidence 11223457999999999889999999999999999999 899998877666555543 233455667789999999999
Q ss_pred hhhhCCCCCCCHHHHHHHH
Q 003978 741 CWHSDPQCRPSFQELVDKL 759 (782)
Q Consensus 741 cL~~dP~~RPs~~ell~~L 759 (782)
||..+|++|||+.++++.|
T Consensus 237 cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HhcCChhhCcCHHHHHHHh
Confidence 9999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=326.71 Aligned_cols=246 Identities=32% Similarity=0.559 Sum_probs=208.0
Q ss_pred eeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCCC
Q 003978 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGS 588 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ggs 588 (782)
+.||+|+||.||++.. .++.||+|.+... ...+....+.+|+++++.++||||+++++++.....+|+||||+.+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 4699999999999987 5778999987643 344556778899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc--cCCC
Q 003978 589 LFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT--KTGK 666 (782)
Q Consensus 589 L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~--~~~~ 666 (782)
|.+++......+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.+||+|||++.......... ....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 99999766667899999999999999999999998 9999999999999999999999999987543321111 1112
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhC
Q 003978 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSD 745 (782)
Q Consensus 667 Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~d 745 (782)
++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.. ......+..++..+.+||.+||..+
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~ 236 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-GVRLPCPELCPDAVYRLMERCWEYD 236 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-CCCCCCcccCCHHHHHHHHHHcCCC
Confidence 3457999999998889999999999999999997 9999987776655544432 2344566778999999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 003978 746 PQCRPSFQELVDKLR 760 (782)
Q Consensus 746 P~~RPs~~ell~~L~ 760 (782)
|++|||+.++++.|+
T Consensus 237 p~~Rps~~~~~~~l~ 251 (252)
T cd05084 237 PGQRPSFSTVHQELQ 251 (252)
T ss_pred hhhCcCHHHHHHHHh
Confidence 999999999988775
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=372.60 Aligned_cols=263 Identities=31% Similarity=0.594 Sum_probs=229.2
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc---CC----eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY---GS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~---~~----~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (782)
......++...||+|.||.||.|.+. +. .||||.+++.. +......|.+|..+|+.++|||||+++|++...
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 33567889999999999999999874 22 27888776543 456678899999999999999999999999999
Q ss_pred CceeEEEeecCCCCHHHHHhhc------CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEe
Q 003978 575 QRLCIVTEFLPRGSLFRLLQRN------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~~------~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~D 648 (782)
...+|++|||.||+|..+|+.. ...+.....+.++.||++|+.||++++ +|||||-..|+||+....|||+|
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEcc
Confidence 9999999999999999999887 667899999999999999999999988 99999999999999999999999
Q ss_pred cCCCcc-cccccccccCC-CCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccC
Q 003978 649 FGLSRL-KHETYLTTKTG-KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLE 725 (782)
Q Consensus 649 FGla~~-~~~~~~~~~~~-~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~ 725 (782)
||+|+. ....+...... .-...|||||.+....++.|+|||||||+|||+|+ |..||...+..+++..+. ...++.
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~-~ggRL~ 924 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL-EGGRLD 924 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH-hCCccC
Confidence 999993 33333333222 34569999999999999999999999999999999 999999999999887554 344999
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003978 726 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 726 ~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~ 768 (782)
.|..||..+.++|.+||+.+|++||++..|++.+..+......
T Consensus 925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 9999999999999999999999999999999988888765543
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.10 Aligned_cols=245 Identities=27% Similarity=0.518 Sum_probs=208.4
Q ss_pred eeccCCcEEEEEEEE----cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCC
Q 003978 512 QIGQGSCGTVYHAVW----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (782)
Q Consensus 512 ~IG~G~~G~Vy~~~~----~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg 587 (782)
+||+|+||.||+|.+ .+..+|+|+++...........+..|+.+++.++||||+++++++. ....++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 3567999998766555566778899999999999999999999875 45678999999999
Q ss_pred CHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc---cccC
Q 003978 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL---TTKT 664 (782)
Q Consensus 588 sL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~ 664 (782)
+|.+++... ..+++..++.++.|++.||.|||+++ |+|+||||.||+++.++.+||+|||++........ ....
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 999999754 46899999999999999999999998 99999999999999999999999999876543221 1122
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhh
Q 003978 665 GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWH 743 (782)
Q Consensus 665 ~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 743 (782)
..+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+.. ......|..+++++.+||.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~~~ 236 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-GERMECPQRCPPEMYDLMKLCWT 236 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHHhc
Confidence 344679999999988888999999999999999998 9999998877666655543 23456778899999999999999
Q ss_pred hCCCCCCCHHHHHHHHHH
Q 003978 744 SDPQCRPSFQELVDKLRD 761 (782)
Q Consensus 744 ~dP~~RPs~~ell~~L~~ 761 (782)
.||++||++.+|.+.|++
T Consensus 237 ~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 237 YGVDERPGFAVVELRLRN 254 (257)
T ss_pred cCchhCcCHHHHHHHHhc
Confidence 999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=334.48 Aligned_cols=261 Identities=31% Similarity=0.597 Sum_probs=220.2
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEcC-------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeee
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 570 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 570 (782)
.++...++|++.+.||+|+||.||++...+ ..+|+|.+.... .......+.+|+.+++.+ +|+||++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 345566789999999999999999998643 458999987543 334456788999999999 79999999999
Q ss_pred eecCCceeEEEeecCCCCHHHHHhhc---------------CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 003978 571 VTSPQRLCIVTEFLPRGSLFRLLQRN---------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN 635 (782)
Q Consensus 571 ~~~~~~~~lv~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~N 635 (782)
+..++.++++|||+.+++|..++... ...+++..++.++.|++.||.|||+.+ |+|+||||+|
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~N 162 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARN 162 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceee
Confidence 99999999999999999999999642 345889999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHH
Q 003978 636 LLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQ 712 (782)
Q Consensus 636 ILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~ 712 (782)
|+++.++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 9999999999999999976543221 1222345678999999999889999999999999999997 999998887766
Q ss_pred HHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003978 713 VIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 763 (782)
Q Consensus 713 ~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~ 763 (782)
....+. .......+..++..+.+||.+||..||++|||+.++++.|+++.
T Consensus 243 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKLLK-EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 655543 23344566778999999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.29 Aligned_cols=249 Identities=25% Similarity=0.435 Sum_probs=213.9
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
+|++.++||.|+||.||++.. .+..+|+|.++.... ....+.+..|+.+++.++||||+++++.+...+.+|++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 588999999999999999987 467799999875442 33456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 584 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 584 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
+++++|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++..........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence 9999999988653 345789999999999999999999998 9999999999999999999999999987655433333
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhh
Q 003978 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 742 (782)
....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+. ......++..++..+.+||.+||
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 236 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELRSLIKQMF 236 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHH
Confidence 34568999999999999889999999999999999999999998877665554443 22334466778999999999999
Q ss_pred hhCCCCCCCHHHHHHH
Q 003978 743 HSDPQCRPSFQELVDK 758 (782)
Q Consensus 743 ~~dP~~RPs~~ell~~ 758 (782)
..||++||++.+++..
T Consensus 237 ~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 237 KRNPRSRPSATTILSR 252 (255)
T ss_pred hCCcccCCCHHHHhhc
Confidence 9999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=336.39 Aligned_cols=252 Identities=28% Similarity=0.345 Sum_probs=200.5
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC---CCCceeEEeeeeec-----CC
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL---RHPNVLLFMGAVTS-----PQ 575 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~-----~~ 575 (782)
+|++.+.||+|+||.||+|.+ .++.||+|+++...........+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 588999999999999999987 467799999876443322223445677766655 79999999998764 24
Q ss_pred ceeEEEeecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
.++++|||+. ++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++..
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 5799999996 48988886543 35899999999999999999999998 99999999999999999999999999876
Q ss_pred cccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc---c--------
Q 003978 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ---R-------- 723 (782)
Q Consensus 655 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~---~-------- 723 (782)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+..... .
T Consensus 158 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 158 YSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred ccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 54322 22234689999999999998899999999999999999999999987766544433321100 0
Q ss_pred --------------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 724 --------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 724 --------------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
....+.++..+.+||.+||..||++|||+.++ +.|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~------l~hp~f 288 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRA------LQHPFF 288 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHH------hcCCCC
Confidence 01123567889999999999999999999999 456765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=349.62 Aligned_cols=263 Identities=29% Similarity=0.486 Sum_probs=218.9
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEcC-------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEee
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMG 569 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~ 569 (782)
..|++..++|.++++||+|+||.||+|++.+ ..||||+++.... ....+.+.+|+++|..+. |||||++++
T Consensus 30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 3477788899999999999999999998643 4699999975433 334457889999999997 999999999
Q ss_pred eeecCCceeEEEeecCCCCHHHHHhhcC----------------------------------------------------
Q 003978 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------------------------------------------- 597 (782)
Q Consensus 570 ~~~~~~~~~lv~E~~~ggsL~~~l~~~~---------------------------------------------------- 597 (782)
++.....+++|||||.+|+|.+++..+.
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 9999999999999999999999996532
Q ss_pred ---------------------------------------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 003978 598 ---------------------------------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLK 632 (782)
Q Consensus 598 ---------------------------------------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIK 632 (782)
..+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlk 266 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLA 266 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCC
Confidence 13566778889999999999999988 9999999
Q ss_pred CCcEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 003978 633 SSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (782)
Q Consensus 633 p~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~ 709 (782)
|+|||++.++.+||+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999997543221 11223357889999999998889999999999999999998 899998766
Q ss_pred hHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003978 710 SMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 763 (782)
Q Consensus 710 ~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~ 763 (782)
.............++..|..++.++.+||.+||..+|.+||++.+|++.|+++.
T Consensus 347 ~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 347 MNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred chHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 555443332233345567788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=317.58 Aligned_cols=261 Identities=23% Similarity=0.339 Sum_probs=211.6
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC---
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ--- 575 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--- 575 (782)
.+..++|++.+.||+|+|+-||++.. .+..||+|.+.... .+..+...+|++..++++||||++++++...+.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 35567999999999999999999985 66779999987655 345678889999999999999999999875443
Q ss_pred --ceeEEEeecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecC
Q 003978 576 --RLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650 (782)
Q Consensus 576 --~~~lv~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFG 650 (782)
..||+++|...|+|.+.+.. .+..+++.++++++.+|++||.+||+..++++||||||.|||+++.+.++|.|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 38999999999999999854 3456899999999999999999999998889999999999999999999999999
Q ss_pred CCcccccccc---------cccCCCCCCcccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh
Q 003978 651 LSRLKHETYL---------TTKTGKGTPQWMAPEVLRN---EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVG 718 (782)
Q Consensus 651 la~~~~~~~~---------~~~~~~Gt~~y~aPE~l~~---~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~ 718 (782)
.++....... .......|..|+|||++.- ...+.++|||||||+||.|+.|..||...-....--.+.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA 254 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA 254 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence 8865432111 1122357999999999864 445889999999999999999999996432211101112
Q ss_pred ccccccCCC--CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003978 719 FMNQRLEIP--KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 763 (782)
Q Consensus 719 ~~~~~~~~p--~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~ 763 (782)
..+..+.+| ..++..+.+||++||+.||.+||++.+++..+++|.
T Consensus 255 v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 255 VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 223333333 348899999999999999999999999999998874
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=353.47 Aligned_cols=250 Identities=27% Similarity=0.358 Sum_probs=209.2
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-C-----CceeEEeeeeecCC
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-H-----PNVLLFMGAVTSPQ 575 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~~~~~~~~ 575 (782)
.-+|.+.+.||+|+||.|.+|.+ +++.||||+++... ........|+.+|..|+ | -|||+++++|...+
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 34899999999999999999997 46779999997654 44556677999999996 4 38999999999999
Q ss_pred ceeEEEeecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC--CCcEEEEecCCC
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK--HWTVKVGDFGLS 652 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~--~~~vkL~DFGla 652 (782)
++|||+|++ ..+|+++|+.+. ..++...++.|+.||+.||.+||+.+ |||+|||||||||.. ...|||+|||.|
T Consensus 262 HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 262 HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecccc
Confidence 999999999 669999998653 45899999999999999999999998 999999999999964 347999999999
Q ss_pred cccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--------
Q 003978 653 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL-------- 724 (782)
Q Consensus 653 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------- 724 (782)
+....... +.+.+..|+|||++.|.+|+.+.|||||||+++||++|.+-|.+.+..+.+..|....+.+
T Consensus 339 c~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 339 CFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 87765433 5567999999999999999999999999999999999999999888776665542111000
Q ss_pred ------------------------------------------CCCC-----------CCCHHHHHHHHHhhhhCCCCCCC
Q 003978 725 ------------------------------------------EIPK-----------DVDPRWAAIVESCWHSDPQCRPS 751 (782)
Q Consensus 725 ------------------------------------------~~p~-----------~~~~~l~~LI~~cL~~dP~~RPs 751 (782)
..|. .-...+.+||++||..||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 0110 11235789999999999999999
Q ss_pred HHHHHHHHHHHHHHHhh
Q 003978 752 FQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 752 ~~ell~~L~~L~~~~~~ 768 (782)
+.+. |+|+|+.
T Consensus 496 p~qa------l~Hpfl~ 506 (586)
T KOG0667|consen 496 PAQA------LNHPFLT 506 (586)
T ss_pred HHHH------hcCcccc
Confidence 9998 7889986
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=325.82 Aligned_cols=246 Identities=35% Similarity=0.626 Sum_probs=215.1
Q ss_pred eeeccCCcEEEEEEEEc-----CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecC
Q 003978 511 EQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 585 (782)
++||+|+||.||++... +..|++|+++...... ....+.+|+++++.++|+||+++++++.....++++|||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 46999999999999885 6679999987654433 46788899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhc--------CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 586 RGSLFRLLQRN--------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 586 ggsL~~~l~~~--------~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
+++|.+++... ...+++..++.++.|++.||+|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999999875 467899999999999999999999988 99999999999999999999999999976554
Q ss_pred cc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHH
Q 003978 658 TY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734 (782)
Q Consensus 658 ~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 734 (782)
.. .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+....+.. ......+..++.++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDEL 236 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCChHH
Confidence 32 22334567899999999998889999999999999999999 6999998877776666643 44556778889999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003978 735 AAIVESCWHSDPQCRPSFQELVDKLR 760 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RPs~~ell~~L~ 760 (782)
.++|.+||..+|++|||+.++++.|+
T Consensus 237 ~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 237 YELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHccCCcccCcCHHHHHHhhC
Confidence 99999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=330.19 Aligned_cols=257 Identities=24% Similarity=0.413 Sum_probs=214.6
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.+|++.+.||.|+||.||++.. .+..++||.+..... .......+.+|+.+++.+.||||+++++.+..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5788999999999999999986 577899998865433 3345567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 582 EFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 582 E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
||+++++|.+++.. ....+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999999998864 2345889999999999999999999998 999999999999999999999999998765443
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHhhccccccCCCCCCCHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM--QVIGAVGFMNQRLEIPKDVDPRWAA 736 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~--~~~~~i~~~~~~~~~p~~~~~~l~~ 736 (782)
........|++.|+|||.+.+..++.++||||||+++|+|++|..||...... .....+.........+..++..+++
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 33333456899999999999888999999999999999999999999754332 2222222222222233458899999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003978 737 IVESCWHSDPQCRPSFQELVDKLRDLQ 763 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~~L~~L~ 763 (782)
||.+||..||++|||+.++++.+.+++
T Consensus 240 li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 240 LVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=332.03 Aligned_cols=257 Identities=32% Similarity=0.531 Sum_probs=216.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
...+|.+.+.||+|+||.||++... ...+++|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 3467999999999999999999753 2347888875432 333467889999999999999999999999999
Q ss_pred ceeEEEeecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK 640 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~ 640 (782)
..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+|+||||+|||++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~ 158 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGA 158 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEcc
Confidence 9999999999999999996532 34788999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHh
Q 003978 641 HWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAV 717 (782)
Q Consensus 641 ~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i 717 (782)
++.++|+|||++....... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999987543321 11223456889999999999999999999999999999998 99999888776665554
Q ss_pred hccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 718 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 718 ~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
. .......+..++..+.+||.+||..||++||++.++++.|+++..
T Consensus 239 ~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 239 T-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred h-CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 3 233344566789999999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=328.04 Aligned_cols=255 Identities=32% Similarity=0.543 Sum_probs=215.6
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--C---CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--G---SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~---~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
..+|++.+.||+|+||.||+|... + ..+|+|.++... .......+.+|+.+++.++||||+++++++..++..|
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357899999999999999999863 2 258999886543 3445678889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
+||||+++++|.+++......+++..++.++.|++.||.|||+++ ++|+||||+|||++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 999999999999999876667899999999999999999999998 999999999999999999999999998765432
Q ss_pred cc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHH
Q 003978 659 YL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734 (782)
Q Consensus 659 ~~---~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 734 (782)
.. ......++..|++||.+.+..++.++|+|||||++|++++ |..||......+....+... .....+..+++.+
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPAPMDCPAAL 238 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcCCCCCCCCHHH
Confidence 21 1112234568999999998889999999999999999886 99999887766555554322 2344556789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 735 AAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
.+++.+||..+|.+||++.++++.|+++
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 239 HQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 9999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=330.27 Aligned_cols=257 Identities=30% Similarity=0.538 Sum_probs=217.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
.+.+|.+.+.||+|+||.||++... +..+|+|.+... .......+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 4568999999999999999999752 234888887543 2445567889999999999999999999999999
Q ss_pred ceeEEEeecCCCCHHHHHhhcC------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNT------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 643 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~ 643 (782)
.++++|||+++++|.+++.... ..+++..++.++.||+.||+|||+++ ++||||||+|||++.++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLL 158 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCCc
Confidence 9999999999999999996432 24899999999999999999999998 999999999999999999
Q ss_pred EEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcc
Q 003978 644 VKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFM 720 (782)
Q Consensus 644 vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~ 720 (782)
+||+|||++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+..
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~- 237 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ- 237 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-
Confidence 9999999987543221 11223345788999999999989999999999999999998 9999988877666555532
Q ss_pred ccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 721 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 721 ~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
......+..++.++.+|+.+||..||.+|||+.++++.|+++.+
T Consensus 238 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 238 GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 22344566789999999999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=335.62 Aligned_cols=265 Identities=29% Similarity=0.560 Sum_probs=216.9
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCe--EEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCce
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~--vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 577 (782)
.+++|++.+.||+|+||.||+|.+. +.. +++|.++.. ........+.+|+.++..+ +||||+++++++...+.+
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 4578999999999999999999874 333 566665432 2344556788899999999 899999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 003978 578 CIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~ 642 (782)
|+||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~~ 161 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY 161 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCCC
Confidence 99999999999999996532 24788999999999999999999998 99999999999999999
Q ss_pred cEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccc
Q 003978 643 TVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMN 721 (782)
Q Consensus 643 ~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~ 721 (782)
.+||+|||++...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+. ..
T Consensus 162 ~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~ 239 (303)
T cd05088 162 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QG 239 (303)
T ss_pred cEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cC
Confidence 9999999998643221 11222344678999999988889999999999999999998 999998777666554442 22
Q ss_pred cccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 722 QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 722 ~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
.....+..+++++.+||.+||..+|++||++.+++..|.++...-....+.
T Consensus 240 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~~ 290 (303)
T cd05088 240 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT 290 (303)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhhh
Confidence 234455668899999999999999999999999999998886655444443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=325.58 Aligned_cols=256 Identities=25% Similarity=0.447 Sum_probs=214.8
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
++|++.+.||+|+||.||+|.. .++.||+|.++.... .......+.+|+++++.++|+||+++++.+...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999988 478899999875433 3344678889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 582 EFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 582 E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
||+++++|..++.. ....+++..++.++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999999999864 2345889999999999999999999998 999999999999999999999999998755433
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHhhccccccCCCC-CCCHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS--MQVIGAVGFMNQRLEIPK-DVDPRWA 735 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~--~~~~~~i~~~~~~~~~p~-~~~~~l~ 735 (782)
........|++.|+|||.+.+..++.++|||||||++|+|++|..||..... ......+.. ......+. .++..+.
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-CDYPPLPADHYSEELR 238 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-CCCCCCChhhcCHHHH
Confidence 2223345688999999999998899999999999999999999999965432 222222221 12223333 6888999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDLQ 763 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L~ 763 (782)
++|.+||..+|++||++.++++.|+.++
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 9999999999999999999999998774
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=334.48 Aligned_cols=262 Identities=29% Similarity=0.577 Sum_probs=220.4
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEc---------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEe
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 568 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~---------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 568 (782)
.|++...+|.+.+.||+|+||.||++.+. +..||+|++.... .......+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 45667789999999999999999999752 2358999886432 334457788999999999 899999999
Q ss_pred eeeecCCceeEEEeecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 003978 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (782)
Q Consensus 569 ~~~~~~~~~~lv~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp 633 (782)
+++......|++|||+.+++|.+++.... ..+++..++.++.||+.||.|||++| |+|+||||
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp 165 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAA 165 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 99999999999999999999999997532 24678889999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 003978 634 SNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (782)
Q Consensus 634 ~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~ 710 (782)
+||+++.++.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 999999999999999999976543221 2223456788999999999889999999999999999998 8999988777
Q ss_pred HHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 711 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 711 ~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
......+. .......+..++.++.+||.+||..+|.+||++.++++.|+++..
T Consensus 246 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 246 EELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 66655553 233445667889999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.00 Aligned_cols=255 Identities=22% Similarity=0.334 Sum_probs=211.2
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
.|++.+.||+|+||.||++.+ .++.||||.+...... ......+..|+.+++.++|+||+.+++.+...+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 377889999999999999987 4678999998765433 2334567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 583 FLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 583 ~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
|+.+++|.+++... ...+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-T 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-c
Confidence 99999999988543 345899999999999999999999988 9999999999999999999999999987543322 2
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHH---HHHhhccccccCCCCCCCHHHHHHH
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQV---IGAVGFMNQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~---~~~i~~~~~~~~~p~~~~~~l~~LI 738 (782)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||........ ...+. .......+..+++++.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHHHHH
Confidence 2244789999999999999999999999999999999999999986543211 11111 1112345667899999999
Q ss_pred HHhhhhCCCCCCC-----HHHHHHHHHHHHHHHhhcc
Q 003978 739 ESCWHSDPQCRPS-----FQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 739 ~~cL~~dP~~RPs-----~~ell~~L~~L~~~~~~~~ 770 (782)
.+||..||++||| +.++ +.|+||+..
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~------~~h~~~~~~ 267 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREV------KEHPLFKQI 267 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHH------HcChhhhcc
Confidence 9999999999999 8888 577888754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=329.65 Aligned_cols=258 Identities=31% Similarity=0.558 Sum_probs=215.6
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCC----eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~----~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
..+|++.++||+|+||.||+|.+ .+. .||+|+++... .......+.+|+.+++.+.||||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 46899999999999999999986 333 48999986543 34445678899999999999999999999875 457
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
+++|||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 8999999999999999876667899999999999999999999998 99999999999999999999999999876543
Q ss_pred cccc--ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHH
Q 003978 658 TYLT--TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734 (782)
Q Consensus 658 ~~~~--~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 734 (782)
.... .....+++.|++||.+.+..++.++|||||||++|||++ |..||...........+. .......+..++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 240 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGERLPQPPICTIDV 240 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCccCCHHH
Confidence 2211 122345678999999999889999999999999999998 999998776655544443 233445566789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 735 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
.++|.+||..||++||++.++++.|.++...+
T Consensus 241 ~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 241 YMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 99999999999999999999999888775543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=327.05 Aligned_cols=259 Identities=35% Similarity=0.621 Sum_probs=218.0
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEcC-----CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
++..++|.+.++||+|+||.||+|.+.. ..|+||.+.... .....+.+.+|+.+++.+.||||+++++++.. .
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 4456789999999999999999998643 258899875433 24456788899999999999999999998875 5
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
..|+||||+++++|.+++......+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeeec
Confidence 678999999999999999876667899999999999999999999998 999999999999999999999999998754
Q ss_pred ccccc-cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHH
Q 003978 656 HETYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733 (782)
Q Consensus 656 ~~~~~-~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 733 (782)
..... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...........+. .......+..++..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPT 236 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHH
Confidence 43321 1122334578999999988889999999999999999986 999998887766554443 23345667789999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
+.++|.+||..+|.+|||+.++++.|.++..
T Consensus 237 ~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 237 LYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=331.82 Aligned_cols=255 Identities=30% Similarity=0.572 Sum_probs=214.2
Q ss_pred ceeEeeeeccCCcEEEEEEEEcC-------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~~~-------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
+|++.+.||+|+||.||+|.... ..+++|++.... .......+.+|+.+++.+.||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 47889999999999999998642 348888876543 2334567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhc-----------------------CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 003978 579 IVTEFLPRGSLFRLLQRN-----------------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN 635 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~-----------------------~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~N 635 (782)
++|||+.+++|.+++... ...+++..++.++.|++.||.|||+++ |+|+||||+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~n 157 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARN 157 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhhe
Confidence 999999999999998642 134788899999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHH
Q 003978 636 LLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQ 712 (782)
Q Consensus 636 ILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~ 712 (782)
||+++++.+||+|||+++...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999987543221 12223346778999999998889999999999999999998 999998877666
Q ss_pred HHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 713 VIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 713 ~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
....+. .......+..++.++.+||.+||..+|.+||++.++++.|+++.+
T Consensus 238 ~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 LFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHh-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 554443 223445567789999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=346.88 Aligned_cols=262 Identities=33% Similarity=0.602 Sum_probs=233.1
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEc----CC--eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY----GS--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~----~~--~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 571 (782)
.+|++..+..++.++||.|.||.||+|.+. |. .||||.++.+.. .+..+.|..|.-+|+.++|||||+++|++
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 467778888899999999999999999983 33 388998876544 33478899999999999999999999999
Q ss_pred ecCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCC
Q 003978 572 TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (782)
Q Consensus 572 ~~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGl 651 (782)
.. ...|||||+++.|.|..+|+.+...++......++.||+.||+|||+.+ +|||||-..||||.....|||+|||+
T Consensus 461 ~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 461 VE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred ec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccch
Confidence 75 5789999999999999999999999999999999999999999999988 99999999999999999999999999
Q ss_pred Ccccccc-cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCC
Q 003978 652 SRLKHET-YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKD 729 (782)
Q Consensus 652 a~~~~~~-~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 729 (782)
+++..+. +.......-...|||||.+.-..++.++|||-||++|||++. |..||.+....+++..+. .+.+++.|++
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE-nGeRlP~P~n 616 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE-NGERLPCPPN 616 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec-CCCCCCCCCC
Confidence 9986554 444444555779999999999999999999999999999876 999999998888776664 4568889999
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 730 ~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
||+.++.|+.+||.++|.+||.+.++...|.++.+
T Consensus 617 CPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 617 CPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 99999999999999999999999999999988866
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=333.23 Aligned_cols=257 Identities=30% Similarity=0.489 Sum_probs=219.0
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.++|++.+.||.|+||.||++.. .+..+|+|++... .......+..|+++++.++||||+++++.+..+..+|+||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 35799999999999999999987 4677999998643 3445577889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
||+++++|.+++......+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.........
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999999999999876667999999999999999999999998 999999999999999999999999998765443333
Q ss_pred ccCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-cccCCCCCCCHHHH
Q 003978 662 TKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QRLEIPKDVDPRWA 735 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~-----~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~~l~ 735 (782)
.....|++.|++||++. +..++.++|||||||++|+|++|..||...+.......+.... .....+..++.++.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence 34456899999999975 3446779999999999999999999998887666554443221 12334567899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
+||.+||..+|.+||++.++ ++|+||+..
T Consensus 240 ~li~~~l~~~p~~Rps~~~i------l~~~~~~~~ 268 (280)
T cd06611 240 DFLKSCLVKDPDDRPTAAEL------LKHPFVSDQ 268 (280)
T ss_pred HHHHHHhccChhhCcCHHHH------hcChhhccc
Confidence 99999999999999999999 678998765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=326.23 Aligned_cols=255 Identities=34% Similarity=0.597 Sum_probs=212.5
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEcC-CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
++..++|++.++||+|+||.||++.+.+ ..||||+++...... ..+.+|+++++.++||||+++++.+.. ...|+
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l 77 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 77 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCH---HHHHHHHHHHHhCCCCCcceEEEEECC-CCcEE
Confidence 4556789999999999999999998754 469999987544332 467889999999999999999998754 56899
Q ss_pred EEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 580 VTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 99999999999999753 345788999999999999999999988 999999999999999999999999999765433
Q ss_pred ccc-ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHH
Q 003978 659 YLT-TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 736 (782)
Q Consensus 659 ~~~-~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 736 (782)
... .....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.. ......+..++..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ 234 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHD 234 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-CCCCCCccccCHHHHH
Confidence 221 123346778999999988889999999999999999999 8999988776665555432 2233445678999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 737 IVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
||.+||+.||.+||++.++++.|+++
T Consensus 235 li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 235 LMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHHHccCCcccCCCHHHHHHHHHHh
Confidence 99999999999999999998887653
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=332.70 Aligned_cols=248 Identities=28% Similarity=0.353 Sum_probs=202.7
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
+|++.+.||+|+||.||+|.. .+..||||+++...........+.+|+.+++.++||||+++++++..+..+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 588999999999999999987 467899999876543333446678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC--CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 584 LPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 584 ~~ggsL~~~l~~~~--~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
+. ++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 96 58988886432 56899999999999999999999998 999999999999999999999999998755433322
Q ss_pred ccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-------------------
Q 003978 662 TKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN------------------- 721 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~------------------- 721 (782)
.....+++.|+|||++.+. .++.++|||||||++|+|++|..||...........+....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 3344678999999998764 46889999999999999999999998765433222210000
Q ss_pred --------cccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHH
Q 003978 722 --------QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELV 756 (782)
Q Consensus 722 --------~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell 756 (782)
........+++++.+||.+||..||.+|||+.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll 280 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKAL 280 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 00011235789999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=334.85 Aligned_cols=263 Identities=30% Similarity=0.591 Sum_probs=219.8
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEc---------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEe
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 568 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~---------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 568 (782)
.+....++|.++++||+|+||.||++... ...+|+|+++... .......+..|+.+++.+ +||||++++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 34556679999999999999999999752 2358999887543 344466788899999999 699999999
Q ss_pred eeeecCCceeEEEeecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 003978 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (782)
Q Consensus 569 ~~~~~~~~~~lv~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp 633 (782)
+++.....+|++|||+.+++|.+++.... ..+++..+..++.||+.||.|||++| |+|+||||
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 162 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAA 162 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 99998899999999999999999996532 34788899999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 003978 634 SNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (782)
Q Consensus 634 ~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~ 710 (782)
+|||++.++.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999976543211 1122334568999999999889999999999999999999 8999988777
Q ss_pred HHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 711 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 711 ~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
......+.. ......+..++.++++||.+||..||++||++.++++.|.++...
T Consensus 243 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 243 EELFKLLRE-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 666655532 234456778899999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=324.89 Aligned_cols=256 Identities=34% Similarity=0.597 Sum_probs=217.1
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEcC-CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
|++..++|++.++||+|+||.||++...+ ..++||.+...... ...+.+|+.+++.++|+||+++++++......+
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 35667899999999999999999998743 56999998765433 356788999999999999999999999888999
Q ss_pred EEEeecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
++|||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+|+||||+||+|+.++.+||+|||++.....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999999999997643 46899999999999999999999998 99999999999999999999999999876543
Q ss_pred cc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHH
Q 003978 658 TY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735 (782)
Q Consensus 658 ~~-~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 735 (782)
.. .......++..|+|||.+.+..++.++|||||||++|+|++ |+.||...........+.. ......+...+.++.
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER-GYRMPRPPNCPEELY 234 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHH
Confidence 21 11122234678999999999889999999999999999998 9999988777666655532 223455667799999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRD 761 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~ 761 (782)
+++.+||..+|++||++.++++.|+.
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 235 DLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHcccCcccCCCHHHHHHHHhc
Confidence 99999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=342.34 Aligned_cols=262 Identities=29% Similarity=0.508 Sum_probs=213.2
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEE-------cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeee
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVW-------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAV 571 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 571 (782)
|+...++|++++.||+|+||.||+|.+ .++.||||+++.... ......+.+|+.+|..+ +||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 455667999999999999999999974 346799999875443 33456788899999999 689999999987
Q ss_pred ecC-CceeEEEeecCCCCHHHHHhhcC-----------------------------------------------------
Q 003978 572 TSP-QRLCIVTEFLPRGSLFRLLQRNT----------------------------------------------------- 597 (782)
Q Consensus 572 ~~~-~~~~lv~E~~~ggsL~~~l~~~~----------------------------------------------------- 597 (782)
... ..++++||||++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 56789999999999999986421
Q ss_pred -------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc--ccc
Q 003978 598 -------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTT 662 (782)
Q Consensus 598 -------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~ 662 (782)
..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 23577788899999999999999998 9999999999999999999999999987543221 112
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHh
Q 003978 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 741 (782)
....+++.|+|||++.+..++.++|||||||++|+|++ |..||.....................|..+++++.+++.+|
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c 318 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence 22345678999999999889999999999999999997 99999876543333233223334556677889999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHHHH
Q 003978 742 WHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 742 L~~dP~~RPs~~ell~~L~~L~~ 764 (782)
|..||++||++.+++++|..+.+
T Consensus 319 l~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 319 WHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=334.05 Aligned_cols=261 Identities=28% Similarity=0.490 Sum_probs=216.9
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeee
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 570 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 570 (782)
.+....++|.+.+.||+|+||.||++... +..||+|+++... .....+.+.+|+.+++.+ +||||++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 44566779999999999999999999752 2358999886543 234456788999999999 79999999999
Q ss_pred eecCCceeEEEeecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEec
Q 003978 571 VTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (782)
Q Consensus 571 ~~~~~~~~lv~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DF 649 (782)
+...+.+|++|||+.+++|.+++.... ..+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.++|+||
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCC
Confidence 999999999999999999999997543 34899999999999999999999998 999999999999999999999999
Q ss_pred CCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCC
Q 003978 650 GLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEI 726 (782)
Q Consensus 650 Gla~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~ 726 (782)
|++........ ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.....................
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 265 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCC
Confidence 99875433211 1222346788999999999889999999999999999998 99999877655444333222223445
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 727 PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 727 p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
+...++++.+||.+||..+|++||++.++++.|.++
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 567889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=332.76 Aligned_cols=255 Identities=26% Similarity=0.482 Sum_probs=214.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
...+|++.++||+|+||.||+|... +..||||+++... .......+..|+.++..++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 3457888999999999999999864 3569999987543 3344567889999999999999999999999999
Q ss_pred ceeEEEeecCCCCHHHHHhhc---------------CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC
Q 003978 576 RLCIVTEFLPRGSLFRLLQRN---------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK 640 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~ 640 (782)
..++++||+.+++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||+++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~~ 159 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFD 159 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEecC
Confidence 999999999999999998532 134788889999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHh
Q 003978 641 HWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAV 717 (782)
Q Consensus 641 ~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i 717 (782)
++.+||+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+....+
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999987543321 11223456789999999988889999999999999999998 89999888777666555
Q ss_pred hccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003978 718 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRD 761 (782)
Q Consensus 718 ~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~ 761 (782)
.. ......+..++..+.+|+.+||+.+|.+||++.+++..|+.
T Consensus 240 ~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 RN-RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred Hc-CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 42 22345567899999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=332.39 Aligned_cols=252 Identities=23% Similarity=0.438 Sum_probs=218.6
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
++|++.+.||+|+||.||++.+ .++.||+|+++.... .......+.+|+++++.++||||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4799999999999999999987 467899999876543 2345577889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||+|.||+|+.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 999999999999765 46899999999999999999999998 999999999999999999999999998765443
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHh
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 741 (782)
.....|++.|++||.+.+...+.++||||||+++|+|++|..||...........+. .....++..++..++++|.+|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~ 232 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIRNL 232 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHHHH
Confidence 234468999999999988888999999999999999999999998877655554442 445667788899999999999
Q ss_pred hhhCCCCCC-----CHHHHHHHHHHHHHHHhhcc
Q 003978 742 WHSDPQCRP-----SFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 742 L~~dP~~RP-----s~~ell~~L~~L~~~~~~~~ 770 (782)
|..||.+|+ ++.++ +.|+||+..
T Consensus 233 l~~~p~~R~~~~~~~~~~l------~~~~~~~~~ 260 (290)
T cd05580 233 LQVDLTKRLGNLKNGVNDI------KNHPWFAGI 260 (290)
T ss_pred ccCCHHHccCcccCCHHHH------HcCcccccC
Confidence 999999999 78888 456877543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=347.11 Aligned_cols=246 Identities=26% Similarity=0.422 Sum_probs=202.7
Q ss_pred eccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhC---CCCceeEEeeeeecCCceeEEEeecCC
Q 003978 513 IGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL---RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (782)
Q Consensus 513 IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~lv~E~~~g 586 (782)
||+|+||.||+|.. .++.||||++.+... .......+..|..++..+ .||||+++++++.....+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999987 467899999975433 222334455566776655 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003978 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (782)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (782)
++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++..............
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 9999998764 46899999999999999999999999 99999999999999999999999999875433333334567
Q ss_pred CCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC-CCCCHHHHHHHHHhhhh
Q 003978 667 GTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP-KDVDPRWAAIVESCWHS 744 (782)
Q Consensus 667 Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~~~~l~~LI~~cL~~ 744 (782)
||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+... ...++ ..+++++.+||.+||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~li~~~L~~ 235 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG--KVRFPKNVLSDEGRQFVKGLLNR 235 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC--CCCCCCccCCHHHHHHHHHHcCC
Confidence 99999999998764 4789999999999999999999999887776666555332 23333 35799999999999999
Q ss_pred CCCCCC----CHHHHHHHHHHHHHHHhhc
Q 003978 745 DPQCRP----SFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 745 dP~~RP----s~~ell~~L~~L~~~~~~~ 769 (782)
||.+|| ++.++ +.|+||+.
T Consensus 236 ~P~~R~~~~~~~~~l------l~h~~~~~ 258 (330)
T cd05586 236 NPQHRLGAHRDAVEL------KEHPFFAD 258 (330)
T ss_pred CHHHCCCCCCCHHHH------hcCccccC
Confidence 999998 56676 46788754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=325.74 Aligned_cols=255 Identities=34% Similarity=0.602 Sum_probs=214.2
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEc-CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
|++..++|++.++||+|+||.||++... +..+|+|.+....... ..+.+|+.+++.++|+||+++++++. ....|
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 3456678999999999999999999874 4579999987654433 46788999999999999999999875 45689
Q ss_pred EEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 579 IVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
++|||+.+++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999999999999999753 345889999999999999999999998 99999999999999999999999999876543
Q ss_pred ccc-cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHH
Q 003978 658 TYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735 (782)
Q Consensus 658 ~~~-~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 735 (782)
... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+.. ......+...+..+.
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 233 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER-GYRMPCPQDCPISLH 233 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCcCCHHHH
Confidence 221 1122345678999999988889999999999999999999 9999988777666655532 234456677899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRD 761 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~ 761 (782)
+||.+||..+|++|||+.++.+.|++
T Consensus 234 ~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 234 ELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHHHHhc
Confidence 99999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=344.19 Aligned_cols=256 Identities=26% Similarity=0.350 Sum_probs=208.0
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC------
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 574 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 574 (782)
..++|++++.||.|+||.||+|.. .+..||||++............+.+|+.+|+.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 357899999999999999999986 456799999876543334456677899999999999999999987543
Q ss_pred CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
..+|++|+++ +++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCCcccee
Confidence 3478999998 7799988864 35899999999999999999999998 99999999999999999999999999976
Q ss_pred cccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------
Q 003978 655 KHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ----------- 722 (782)
Q Consensus 655 ~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~----------- 722 (782)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.....
T Consensus 168 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 168 ADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred cCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 5432 224578999999999977 5678999999999999999999999987665443332211000
Q ss_pred ----------ccC--------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 723 ----------RLE--------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 723 ----------~~~--------~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
... .....++.+.+||.+||..||.+|||+.++ |.|+||+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~el------l~hp~~~~~~~ 306 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEA------LAHPYFSQYHD 306 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHH------hcCcchhccCC
Confidence 000 112356778999999999999999999999 57899976543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=331.45 Aligned_cols=261 Identities=28% Similarity=0.462 Sum_probs=220.4
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
+.....+|++.+.||.|+||.||++.. .++.|+||.+...... ....+.+|+.+++.++||||+++++++.....+
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 14 IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDEL 91 (296)
T ss_pred cCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence 334456899999999999999999986 5778999998754432 245678899999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+||||+.+++|..++... .+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 92 ~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999999999998753 5899999999999999999999998 99999999999999999999999999875443
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-ccccCCCCCCCHHHHH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLEIPKDVDPRWAA 736 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~l~~ 736 (782)
.........|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+... ......+..+++.+.+
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06655 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD 247 (296)
T ss_pred ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHH
Confidence 322223446889999999999888999999999999999999999999887765544333221 1223455678999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 737 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
||.+||..||.+||++.++ +.++||+..+.
T Consensus 248 li~~~l~~dp~~Rpt~~~i------l~~~~~~~~~~ 277 (296)
T cd06655 248 FLNRCLEMDVEKRGSAKEL------LQHPFLKLAKP 277 (296)
T ss_pred HHHHHhhcChhhCCCHHHH------hhChHhhhccc
Confidence 9999999999999999999 68899987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=324.25 Aligned_cols=249 Identities=24% Similarity=0.431 Sum_probs=215.0
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
+|++.+.||+|+||.||++.. .++.|++|.+............+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 589999999999999999987 567899999876555555567888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 584 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 584 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
+.+++|.+++... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh
Confidence 9999999998654 335788999999999999999999998 9999999999999999999999999987655433333
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhh
Q 003978 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 742 (782)
....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+. .......+..++.++.++|.+||
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 237 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQLF 237 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-cCCCCCCcccCCHHHHHHHHHHh
Confidence 34568899999999999888999999999999999999999998776665554442 23344567788999999999999
Q ss_pred hhCCCCCCCHHHHHH
Q 003978 743 HSDPQCRPSFQELVD 757 (782)
Q Consensus 743 ~~dP~~RPs~~ell~ 757 (782)
..+|.+||++.++++
T Consensus 238 ~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 238 KRNPRDRPSVNSILE 252 (256)
T ss_pred hCChhhCcCHHHHhh
Confidence 999999999999943
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=327.80 Aligned_cols=256 Identities=26% Similarity=0.484 Sum_probs=212.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCC----eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~----~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
..+|++.+.||+|+||.||+|.+ .++ .+++|.+... ........+..|+.++..+.||||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~ 83 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL 83 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence 35789999999999999999987 344 3677776432 223445677888889999999999999998754 567
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
++++||+++++|.+++......+++..++.++.||+.||.|||+++ ++|+||||+|||++.++.+||+|||+++....
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 8999999999999999876667899999999999999999999988 99999999999999999999999999975432
Q ss_pred cc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHH
Q 003978 658 TY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734 (782)
Q Consensus 658 ~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 734 (782)
.. .......++..|++||.+.+..++.++|||||||++|||++ |..||...........+. .......+..++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 240 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQPQICTIDV 240 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCCCCCHHH
Confidence 21 12223456778999999998889999999999999999998 999998877655443332 333445566788899
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 735 AAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
.+++.+||..||.+|||+.++++.|..+..
T Consensus 241 ~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 241 YMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=352.95 Aligned_cols=256 Identities=31% Similarity=0.518 Sum_probs=218.8
Q ss_pred ceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccC--CCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc--eeE
Q 003978 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR--LCI 579 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--~~l 579 (782)
-.+...+||+|+|-+||+|.+. |-.||.-.++... .....+++|..|+.+|+.|+|||||++|+.|.+..+ +.+
T Consensus 41 y~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~ 120 (632)
T KOG0584|consen 41 YLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF 120 (632)
T ss_pred eeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence 3456678999999999999874 4456654443332 245667999999999999999999999999987665 789
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCcEEEEecCCCcccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~-~~~vkL~DFGla~~~~~~ 658 (782)
|+|++..|+|..|+++.+ .++.+.+..|++||++||.|||++.++|||||||-+||+|+. .|.|||+|+|+|......
T Consensus 121 iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred eeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999999998865 689999999999999999999999999999999999999975 589999999999987776
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHhhccccccCCCCCCCHHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL-NSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
... ..+|||.|||||++. ..|+..+||||||++|+||.|+.+||... +..+.+.++.....+-.+.+.-+++.++|
T Consensus 200 ~ak--svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~f 276 (632)
T KOG0584|consen 200 HAK--SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREF 276 (632)
T ss_pred ccc--eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHH
Confidence 544 368999999999998 77999999999999999999999999765 45566666665555556667779999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 738 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 738 I~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
|.+||.. ..+|||+.|| |.++||..-.-
T Consensus 277 IekCl~~-~~~R~sa~eL------L~d~Ff~~d~g 304 (632)
T KOG0584|consen 277 IEKCLAT-KSERLSAKEL------LKDPFFDEDGG 304 (632)
T ss_pred HHHHhcC-chhccCHHHH------hhChhhccccc
Confidence 9999999 9999999999 67899987533
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=323.76 Aligned_cols=254 Identities=34% Similarity=0.598 Sum_probs=212.2
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEcC-CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
++..++|.+.++||+|+||.||++...+ ..+|+|.+...... ...+.+|+++++.++||||+++++++. .+..++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 4455789999999999999999998755 46999987654332 356788999999999999999999875 456899
Q ss_pred EEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 580 VTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
+|||+.+++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 99999999999999753 334788999999999999999999998 999999999999999999999999999765432
Q ss_pred ccc-ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHH
Q 003978 659 YLT-TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 736 (782)
Q Consensus 659 ~~~-~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 736 (782)
... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.. ......+..++..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-GYRMPCPQGCPESLHE 234 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHHHH
Confidence 211 122345678999999998889999999999999999999 9999988777665555432 2334556778999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHH
Q 003978 737 IVESCWHSDPQCRPSFQELVDKLRD 761 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~~L~~ 761 (782)
||.+||..||.+||+++++++.|++
T Consensus 235 li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 235 LMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHccCCcccCcCHHHHHHHHhc
Confidence 9999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=324.22 Aligned_cols=246 Identities=26% Similarity=0.535 Sum_probs=206.8
Q ss_pred eeccCCcEEEEEEEEc----CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCC
Q 003978 512 QIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (782)
Q Consensus 512 ~IG~G~~G~Vy~~~~~----~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg 587 (782)
.||+|+||.||+|.+. +..||+|++.... .....+.+.+|+.+++.++||||+++++++.. ...++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 4899999999999763 3358999986543 34455678899999999999999999998864 5789999999999
Q ss_pred CHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc---cccC
Q 003978 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL---TTKT 664 (782)
Q Consensus 588 sL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~ 664 (782)
+|.+++......+++..++.++.|++.||.|||+++ ++|+||||+|||++.++.+||+|||++........ ....
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 999999766667899999999999999999999998 99999999999999999999999999875433211 1112
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhh
Q 003978 665 GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWH 743 (782)
Q Consensus 665 ~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 743 (782)
..+++.|+|||.+.+..++.++|||||||++|+|++ |..||...........+. .......+..+++++.++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c~~ 236 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCWI 236 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHcC
Confidence 234678999999998889999999999999999996 999999887776665553 233456777889999999999999
Q ss_pred hCCCCCCCHHHHHHHHHHH
Q 003978 744 SDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 744 ~dP~~RPs~~ell~~L~~L 762 (782)
.||++||++.++++.|+++
T Consensus 237 ~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 237 YKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CChhhCcCHHHHHHHHhhh
Confidence 9999999999998887653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=333.83 Aligned_cols=253 Identities=25% Similarity=0.334 Sum_probs=204.5
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
+|++.+.||.|+||.||+|.+ .+..|++|.++...........+.+|+.+++.++||||+++++++.....+|+++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 588999999999999999998 577899999876544333445677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccccc
Q 003978 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (782)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (782)
+. ++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++...........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 96 5888888765667999999999999999999999998 99999999999999999999999999876544333333
Q ss_pred CCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCC-CChHHHHHHhhccc---------------c---c
Q 003978 664 TGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDN-LNSMQVIGAVGFMN---------------Q---R 723 (782)
Q Consensus 664 ~~~Gt~~y~aPE~l~~~~-~s~~sDIwSLG~ll~elltG~~Pf~~-~~~~~~~~~i~~~~---------------~---~ 723 (782)
...+++.|+|||++.+.. ++.++|||||||++|+|++|..||.. .+.......+.... . .
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 456789999999987754 68899999999999999999888643 33222222111000 0 0
Q ss_pred ---------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 724 ---------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 724 ---------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
....+.+++++++||.+||..||.+|||+.+++ .|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il------~h~~f 284 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEAL------QHPYF 284 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHh------cCCCC
Confidence 011235788999999999999999999999994 45665
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=327.54 Aligned_cols=254 Identities=28% Similarity=0.516 Sum_probs=211.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEEcC-------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~~-------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
..++|++.+.||+|+||.||+|.+.+ ..|++|.+.... .......+..|+.+++.++|+||+++++++....
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 45689999999999999999998854 458888775433 2334456888999999999999999999999888
Q ss_pred ceeEEEeecCCCCHHHHHhhcC------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---cEEE
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNT------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKV 646 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~---~vkL 646 (782)
..+++|||+.+++|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++ .+||
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999997543 25889999999999999999999998 99999999999998654 5999
Q ss_pred EecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccc
Q 003978 647 GDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQR 723 (782)
Q Consensus 647 ~DFGla~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~ 723 (782)
+|||+++....... .......+..|+|||++.+..++.++|||||||++|+|++ |..||...........+. ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~ 239 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-GGGR 239 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCc
Confidence 99999876532211 1112234568999999999889999999999999999997 999998877666554443 2334
Q ss_pred cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003978 724 LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 760 (782)
Q Consensus 724 ~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~ 760 (782)
...+..++..+.+||.+||..+|++||++.+++++|.
T Consensus 240 ~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 240 LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 5567788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=346.39 Aligned_cols=251 Identities=26% Similarity=0.445 Sum_probs=226.0
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
......|.+.+.||+|.|+.|.++++ ++..||||++.+.......++.+.+|+++|+.++|||||+++.+.+....+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 34456899999999999999999987 6788999999988888777778999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
+||||+.+|.+++++.+++. ..+..+..++.|+++|++|||+++ |||||||++||||+.+.++||+|||++.... .
T Consensus 132 lV~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-~ 207 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTFFD-Y 207 (596)
T ss_pred EEEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccceeec-c
Confidence 99999999999999988764 555888899999999999999998 9999999999999999999999999998766 3
Q ss_pred cccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~-s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
.....+.+|++.|.|||++.|..| .+.+|+||||++||-|++|.+||.+.+.......+ ....+.+|..++.++.++
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv--l~gk~rIp~~ms~dce~l 285 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV--LRGKYRIPFYMSCDCEDL 285 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh--eeeeecccceeechhHHH
Confidence 455678899999999999999888 56899999999999999999999988776655554 455677888899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHH
Q 003978 738 VESCWHSDPQCRPSFQELVD 757 (782)
Q Consensus 738 I~~cL~~dP~~RPs~~ell~ 757 (782)
|+++|..+|.+|++.+++.+
T Consensus 286 Lrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred HHHhhccCccccCCHHHhhh
Confidence 99999999999999999944
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.54 Aligned_cols=253 Identities=28% Similarity=0.452 Sum_probs=208.0
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecC------
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSP------ 574 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~------ 574 (782)
.+.|++.+.||+|+||.||+|.. .++.||+|++...... ...+..|+.+++.+ +||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc---HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35688899999999999999987 4667999998654322 24677899999998 699999999998643
Q ss_pred CceeEEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 575 QRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
..+|++|||+.+++|.+++... ...+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCCce
Confidence 4589999999999999999764 346889999999999999999999998 9999999999999999999999999987
Q ss_pred ccccccccccCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCC
Q 003978 654 LKHETYLTTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 728 (782)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 728 (782)
.............|++.|+|||++. +..++.++|||||||++|+|++|..||...........+.........+.
T Consensus 160 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06637 160 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK 239 (272)
T ss_pred ecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCC
Confidence 6544333334567899999999986 34578899999999999999999999987665554444332223333445
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 729 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 729 ~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
.++..+.+||.+||..||.+||++.++ +.|+||
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rpt~~~i------l~~~~~ 272 (272)
T cd06637 240 KWSKKFQSFIESCLVKNHSQRPTTEQL------MKHPFI 272 (272)
T ss_pred CcCHHHHHHHHHHcCCChhhCCCHHHH------hhCCCC
Confidence 688999999999999999999999999 556664
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=330.08 Aligned_cols=256 Identities=21% Similarity=0.300 Sum_probs=212.6
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCH-HHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
.|+..++||.|+||.||++.+ .++.||+|++....... .....+.+|+++|+.++|+||+.+++.+..++.+|++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 377889999999999999987 46789999987654432 234557789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 583 FLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 583 ~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
|+.+++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-S 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-c
Confidence 99999999888643 346899999999999999999999998 9999999999999999999999999986543221 1
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc--cccccCCCCCCCHHHHHHHH
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF--MNQRLEIPKDVDPRWAAIVE 739 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~~l~~LI~ 739 (782)
.....|++.|+|||++.+..++.++|+|||||++|+|++|..||...........+.. ......++..++.++.+||.
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK 237 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence 2345789999999999998899999999999999999999999987765433333211 22233456678999999999
Q ss_pred HhhhhCCCCCCC-----HHHHHHHHHHHHHHHhhcc
Q 003978 740 SCWHSDPQCRPS-----FQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 740 ~cL~~dP~~RPs-----~~ell~~L~~L~~~~~~~~ 770 (782)
+||..||++||+ +.++ +.|+||+..
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l------~~~~~~~~~ 267 (285)
T cd05632 238 MLLTKDPKQRLGCQEEGAGEV------KRHPFFRNM 267 (285)
T ss_pred HHccCCHhHcCCCcccChHHH------HcChhhhcC
Confidence 999999999999 7777 567777554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=319.83 Aligned_cols=258 Identities=25% Similarity=0.428 Sum_probs=219.7
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccC------CCHHHHHHHHHHHHHHHhC-CCCceeEEeeeee
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQE------YSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVT 572 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~------~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 572 (782)
-.+..|...+.||.|..+.|-++.+ .+..+|+|++.... ...+..+.-.+|+.||+++ .||+|+.+.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3456788899999999999999987 56779999885321 1235667788899999998 6999999999999
Q ss_pred cCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCC
Q 003978 573 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (782)
Q Consensus 573 ~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla 652 (782)
.+..+++|+|.|+.|.|+|+|.. ...++++....|++|++.|+.|||.++ ||||||||+|||++++.+|||+|||+|
T Consensus 94 s~sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEecccee
Confidence 99999999999999999999976 456999999999999999999999999 999999999999999999999999999
Q ss_pred cccccccccccCCCCCCcccCcccccC------CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCC
Q 003978 653 RLKHETYLTTKTGKGTPQWMAPEVLRN------EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEI 726 (782)
Q Consensus 653 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 726 (782)
+..... ......||||.|+|||.+.. ..|+..+|+|++|++||-|+.|-+||......-.+..|...+....-
T Consensus 171 ~~l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s 249 (411)
T KOG0599|consen 171 CQLEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS 249 (411)
T ss_pred eccCCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC
Confidence 876554 34456799999999999853 44677899999999999999999999877766666666544443333
Q ss_pred C--CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 727 P--KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 727 p--~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
| ..++...++||.+||+.||++|.|+.|+ |.|+||+.
T Consensus 250 peWadis~~~KdLIsrlLqVdp~~Ritake~------LaHpff~q 288 (411)
T KOG0599|consen 250 PEWADISATVKDLISRLLQVDPTKRITAKEA------LAHPFFIQ 288 (411)
T ss_pred cchhhccccHHHHHHHHHeeCchhcccHHHH------hcChHHHH
Confidence 3 3578889999999999999999999999 67899843
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=330.54 Aligned_cols=255 Identities=29% Similarity=0.458 Sum_probs=214.2
Q ss_pred ceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
.|++.+.||.|+||.||++... +..+++|.+... .......+.+|+++++.++||||+++++++..++..|+||||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 4688899999999999999985 456788887543 244567788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccccc
Q 003978 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (782)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (782)
+++++|..++.....++++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++...........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 9999999988765567899999999999999999999998 99999999999999999999999999876544333334
Q ss_pred CCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-ccccCCCCCCCHHHHHH
Q 003978 664 TGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 664 ~~~Gt~~y~aPE~l~-----~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~l~~L 737 (782)
...|++.|+|||++. +..++.++|||||||++|+|++|..||...+.......+... ......+..++.++.+|
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence 457899999999984 445678999999999999999999999887765554444222 22334556788999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 738 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 738 I~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
|.+||..||.+||++.++ ++|+||+..
T Consensus 242 i~~~l~~~p~~Rp~~~~i------l~~~~~~~~ 268 (282)
T cd06643 242 LKKCLEKNVDARWTTTQL------LQHPFVTVN 268 (282)
T ss_pred HHHHccCChhhCcCHHHH------hcCCCEecc
Confidence 999999999999999999 678888754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=322.18 Aligned_cols=250 Identities=25% Similarity=0.415 Sum_probs=216.8
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
+|++.+.||.|+||.||.+.. .+..+++|.+............+.+|+++++.++|+||+++++++...+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 589999999999999988876 567799999877666666667888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 584 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 584 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
|++++|.+++... ...+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEcccccccc
Confidence 9999999999764 456899999999999999999999998 9999999999999999999999999987654443233
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhh
Q 003978 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 742 (782)
....|++.|+|||.+.+..++.++|||||||++|+|++|..||...........+.. ......+..++.++.++|.+||
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ-GNYTPVVSVYSSELISLVHSLL 237 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-CCCCCCccccCHHHHHHHHHHc
Confidence 445789999999999988889999999999999999999999988776665555532 2233345678899999999999
Q ss_pred hhCCCCCCCHHHHHHH
Q 003978 743 HSDPQCRPSFQELVDK 758 (782)
Q Consensus 743 ~~dP~~RPs~~ell~~ 758 (782)
..+|.+||++.+++++
T Consensus 238 ~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 238 QQDPEKRPTADEVLDQ 253 (256)
T ss_pred ccCcccCCCHHHHhhC
Confidence 9999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=331.51 Aligned_cols=262 Identities=27% Similarity=0.445 Sum_probs=218.3
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (782)
.+.....+|++.+.||+|+||.||++.. .+..|++|.+....... ...+.+|+.+++.+.||||+++++.+.....
T Consensus 14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~ 91 (296)
T cd06654 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDE 91 (296)
T ss_pred ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch--HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCE
Confidence 3344557999999999999999999986 56789999987654332 3667889999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
.|+||||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++....
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 92 LWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred EEEeecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 99999999999999998643 4788899999999999999999998 9999999999999999999999999987543
Q ss_pred cccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-ccccCCCCCCCHHHH
Q 003978 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLEIPKDVDPRWA 735 (782)
Q Consensus 657 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~l~ 735 (782)
..........|++.|+|||.+.+..++.++|||||||++|+|++|..||...........+... ......+..++..+.
T Consensus 168 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 247 (296)
T cd06654 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (296)
T ss_pred ccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHH
Confidence 3322223456899999999999888899999999999999999999999876654433222211 112234567889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
+||.+||..||++||++.++ +.++||...++
T Consensus 248 ~li~~~l~~~p~~Rpt~~ei------l~~~~~~~~~~ 278 (296)
T cd06654 248 DFLNRCLDMDVEKRGSAKEL------LQHQFLKIAKP 278 (296)
T ss_pred HHHHHHCcCCcccCcCHHHH------hhChhhhccCC
Confidence 99999999999999999999 56888876654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=334.18 Aligned_cols=259 Identities=23% Similarity=0.393 Sum_probs=216.7
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCH-HHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
++|++.+.||+|+||.||+|... +..||||.+....... .....+..|+++++.++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999874 6789999998765443 45677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 582 EFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 582 E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
||+.+++|.+++... ...+++..++.++.|++.||.|||..+ ++|+||||+||+|+.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999999999753 356899999999999999999999998 99999999999999999999999998864322110
Q ss_pred -----------------------------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH
Q 003978 661 -----------------------------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (782)
Q Consensus 661 -----------------------------~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~ 711 (782)
......|+..|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 111236889999999999988999999999999999999999999888766
Q ss_pred HHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCC----HHHHHHHHHHHHHHHhhccc
Q 003978 712 QVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPS----FQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 712 ~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs----~~ell~~L~~L~~~~~~~~~ 771 (782)
.....+............++..+++||.+||..||++||+ +.++ +.|+||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~l------l~~~~~~~~~ 296 (316)
T cd05574 239 ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI------KQHPFFRGVN 296 (316)
T ss_pred HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHH------HcCchhhcCC
Confidence 6555443222222222237999999999999999999999 7887 5678987754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=348.40 Aligned_cols=245 Identities=32% Similarity=0.461 Sum_probs=216.6
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
.|.=++.||.|+||.||-+++ +...||||.+..... ..+..+.+..|++.|+.++|||+|.+-++|-.+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 455567899999999999987 456699999876543 45677889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
|| -|+-.|++.-...++-+..+..|+.+.+.||+|||+++ .||||||..|||+++.|.|||+|||.|......
T Consensus 107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---- 179 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---- 179 (948)
T ss_pred HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcCch----
Confidence 99 56999999888888999999999999999999999999 999999999999999999999999988755432
Q ss_pred cCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHH
Q 003978 663 KTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 739 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~---~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 739 (782)
.+++|||.|||||++. ...|+-++|||||||+..||...++|+-+++.+..+..|.....+......++..+++|+.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd 259 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 259 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHH
Confidence 4789999999999985 4668999999999999999999999999999998888886544444445679999999999
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 003978 740 SCWHSDPQCRPSFQELVD 757 (782)
Q Consensus 740 ~cL~~dP~~RPs~~ell~ 757 (782)
.||++-|.+|||..++++
T Consensus 260 ~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 260 SCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHhhCcccCCcHHHHhh
Confidence 999999999999999943
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=325.00 Aligned_cols=255 Identities=32% Similarity=0.569 Sum_probs=215.6
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--C---CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--G---SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~---~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
..+|++.+.||+|+||.||+|... + ..||||++... ........+..|+.+++.+.||||+++++++.....++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 357899999999999999999874 2 24999998653 34555678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
+||||+++++|.+++......+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999999999876667899999999999999999999998 999999999999999999999999998754332
Q ss_pred ccc---c--cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCH
Q 003978 659 YLT---T--KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 732 (782)
Q Consensus 659 ~~~---~--~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 732 (782)
... . .....+..|++||.+.+..++.++|||||||++|||++ |..||...........+.. ......+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~ 238 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-DYRLPPPMDCPT 238 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-CCcCCCcccCCH
Confidence 111 1 11112457999999999889999999999999999886 9999988877766655532 234445567899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 733 RWAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 733 ~l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
.+.+++.+||..+|.+||++.+++..|+++
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 239 ALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=338.72 Aligned_cols=254 Identities=24% Similarity=0.399 Sum_probs=204.6
Q ss_pred EeeeeccC--CcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeec
Q 003978 509 IGEQIGQG--SCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (782)
Q Consensus 509 i~~~IG~G--~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 584 (782)
++++||+| +|++||++.. .++.||||.+............+.+|+.+++.++||||+++++++..++.+|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 6789999987 4678999999876655666778889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc---
Q 003978 585 PRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL--- 660 (782)
Q Consensus 585 ~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~--- 660 (782)
++++|.+++..+ ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999999654 345889999999999999999999998 99999999999999999999999986543211110
Q ss_pred ----cccCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc------------
Q 003978 661 ----TTKTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------ 722 (782)
Q Consensus 661 ----~~~~~~Gt~~y~aPE~l~~--~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~------------ 722 (782)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||.................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 1122356788999999976 4588999999999999999999999986654432222110000
Q ss_pred --------------------------------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 723 --------------------------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 723 --------------------------------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
.......+++.+.+||.+||+.||++|||+.++ ++|+||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~el------l~~p~f~~~ 313 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTL------LNHSFFKQI 313 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHH------hcChhhhhc
Confidence 001112357789999999999999999999999 678888764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=344.00 Aligned_cols=249 Identities=27% Similarity=0.353 Sum_probs=200.8
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
...|.+.+.||+|+||.||++.+. ++.||||.... ..+.+|+++|+.++|+|||++++++...+..|+||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 457999999999999999999984 56799996422 23567999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc-
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 660 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 660 (782)
|++ .++|..++......+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.......
T Consensus 240 e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 240 PKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred Ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 999 56999998776667999999999999999999999998 99999999999999999999999999976433211
Q ss_pred -cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--------hHHHHHHhhccccc-cCC----
Q 003978 661 -TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN--------SMQVIGAVGFMNQR-LEI---- 726 (782)
Q Consensus 661 -~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~--------~~~~~~~i~~~~~~-~~~---- 726 (782)
......||+.|+|||++.+..++.++|||||||+||||++|..|+-... ..+....+...... ..+
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 1223569999999999999999999999999999999999876542211 12222222111100 000
Q ss_pred -----------------C----------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 727 -----------------P----------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 727 -----------------p----------~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
+ ..++.++.+||.+||..||.+|||+.|+ |.|+||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~el------L~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAEL------LRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHH------hhCcccCC
Confidence 0 1345689999999999999999999999 77899975
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=331.65 Aligned_cols=254 Identities=33% Similarity=0.560 Sum_probs=212.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEcC------------------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcee
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWYG------------------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~~------------------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 565 (782)
..+|++++.||+|+||.||++.... ..||+|++.... .......+.+|+++++.++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 4689999999999999999997643 348999887543 334567888999999999999999
Q ss_pred EEeeeeecCCceeEEEeecCCCCHHHHHhhcC----------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 003978 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT----------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN 635 (782)
Q Consensus 566 ~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~----------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~N 635 (782)
++++++..+...+++|||+.+++|.+++.... ..+++..++.++.|++.||.|||+++ |+|+||||+|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRN 160 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhc
Confidence 99999999999999999999999999997643 26899999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCChH
Q 003978 636 LLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT--EKIPWDNLNSM 711 (782)
Q Consensus 636 ILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt--G~~Pf~~~~~~ 711 (782)
|+++.++.++|+|||++....... .......+++.|+|||.+.+..++.++|||||||++|+|++ +..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999999987543321 12223456789999999998889999999999999999998 78899887766
Q ss_pred HHHHHhhcc------ccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003978 712 QVIGAVGFM------NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 760 (782)
Q Consensus 712 ~~~~~i~~~------~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~ 760 (782)
..+..+... ......+..++.++.+||.+||..||.+|||+.+|++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 665554322 1112344567899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=322.74 Aligned_cols=246 Identities=30% Similarity=0.550 Sum_probs=207.8
Q ss_pred eeeccCCcEEEEEEEEcC-----CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecC
Q 003978 511 EQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 585 (782)
++||+|+||.||+|.+.. ..+|+|.+...... .....+.+|+++++.+.|||||++++++. ....+++|||+.
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 469999999999998632 46999998765543 44567889999999999999999999876 456899999999
Q ss_pred CCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc---c
Q 003978 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT---T 662 (782)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~---~ 662 (782)
+++|.+++.... .+++..++.++.|++.||.|||..+ ++|+||||+|||++.++.+||+|||+++........ .
T Consensus 79 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 79 LGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 999999997654 6899999999999999999999998 999999999999999999999999998755332211 1
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHh
Q 003978 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 741 (782)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+.. ......+..++..++++|.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES-GERLPRPEECPQEIYSIMLSC 234 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHH
Confidence 12234568999999999889999999999999999998 9999998877666555532 334456778899999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHH
Q 003978 742 WHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 742 L~~dP~~RPs~~ell~~L~~L 762 (782)
|..+|++||++.++++.|.++
T Consensus 235 l~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 235 WKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred hcCChhhCcCHHHHHHHHHhc
Confidence 999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=328.45 Aligned_cols=250 Identities=28% Similarity=0.446 Sum_probs=206.0
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
++|++.++||+|+||.||++.+ .+..||||++.... .......+.+|+++++.++||||+++++.+..++..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 4688899999999999999986 56779999987543 34445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
|+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++....... .
T Consensus 80 ~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--~ 150 (279)
T cd06619 80 FMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--A 150 (279)
T ss_pred cCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--c
Confidence 99999986552 4678888899999999999999998 9999999999999999999999999987554332 2
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-------HHHHHhhccccccCCCCCCCHHHH
Q 003978 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM-------QVIGAVGFMNQRLEIPKDVDPRWA 735 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~-------~~~~~i~~~~~~~~~p~~~~~~l~ 735 (782)
....|++.|+|||++.+..++.++|||||||++|+|++|..||...... .....+.............++++.
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence 3457899999999999988999999999999999999999999653321 111111111111112335788999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
+||.+||..+|.+||++.++ +.++||+..
T Consensus 231 ~li~~~l~~~P~~Rp~~~ei------l~~~~~~~~ 259 (279)
T cd06619 231 HFITQCMRKQPKERPAPENL------MDHPFIVQY 259 (279)
T ss_pred HHHHHHhhCChhhCCCHHHH------hcCcccccc
Confidence 99999999999999999999 567888654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=325.43 Aligned_cols=248 Identities=31% Similarity=0.532 Sum_probs=210.5
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCC-------HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-------DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~-------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (782)
+|.+.+.||.|+||.||+|.. .++.+|+|.+...... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477889999999999999987 4678999988654322 2345678899999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
.+++|||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 99999999999999999764 46888999999999999999999998 9999999999999999999999999987654
Q ss_pred cccc------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCC
Q 003978 657 ETYL------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 730 (782)
Q Consensus 657 ~~~~------~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 730 (782)
.... ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+.. ...+.++..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 236 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPEIPSNI 236 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCCcCCccc
Confidence 2111 11123578999999999988889999999999999999999999988766555444432 3345667788
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003978 731 DPRWAAIVESCWHSDPQCRPSFQELVD 757 (782)
Q Consensus 731 ~~~l~~LI~~cL~~dP~~RPs~~ell~ 757 (782)
+..+.++|.+||+.||.+||++.++++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 237 SSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 999999999999999999999999943
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=332.50 Aligned_cols=256 Identities=23% Similarity=0.407 Sum_probs=211.5
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
++|++.+.||+|+||.||++.+. +..+|+|.+.... .......+.+|+++++.++||||+++++.+..++.+|++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 36999999999999999999874 5668889886532 34556678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~-~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
|+++++|.+++... ..+++..+..++.|++.||.|||+ ++ ++|+||||+|||++.++.+||+|||++.......
T Consensus 80 y~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 80 HMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 99999999999765 468899999999999999999997 57 9999999999999999999999999987554332
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc--------------------
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-------------------- 721 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~-------------------- 721 (782)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 234578999999999998889999999999999999999999997655433322221100
Q ss_pred ---------------cccCCC-CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 722 ---------------QRLEIP-KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 722 ---------------~~~~~p-~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
..+.+| ..++.++++||.+||..||++||++.++ ++++||+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l------l~~~~~~~~~~ 295 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKEL------TKHPFIKRAEL 295 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHH------hcChhhhhccc
Confidence 011111 1367889999999999999999999999 67899876433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=327.62 Aligned_cols=255 Identities=33% Similarity=0.536 Sum_probs=217.4
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
++|++.+.||.|+||.||++.. .++.|++|++.... .......+.+|+++++.++|+||+++++.+..+..+|+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 3688899999999999999987 46789999987543 23344667889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
|+++++|.+++... ++++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 99999999999764 6899999999999999999999988 9999999999999999999999999997665443333
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCC-CCHHHHHHHHHh
Q 003978 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKD-VDPRWAAIVESC 741 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~-~~~~l~~LI~~c 741 (782)
....+++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+... ....++.. ++.++.++|.+|
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-NPPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-CCCCCcccccCHHHHHHHHHH
Confidence 4557889999999999988999999999999999999999999877655554443322 23333444 889999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 742 WHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 742 L~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
|..+|++||++.++ +.++||+...
T Consensus 235 l~~~p~~Rpt~~~i------l~~~~~~~~~ 258 (274)
T cd06609 235 LNKDPKERPSAKEL------LKHKFIKKAK 258 (274)
T ss_pred hhCChhhCcCHHHH------hhChhhcCCC
Confidence 99999999999999 5689987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=324.42 Aligned_cols=246 Identities=31% Similarity=0.529 Sum_probs=211.9
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
++|++.++||.|+||.||++... +..+++|.++.... ...+.+|+++++.++||||+++++.+.....+|+++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 57999999999999999999985 57899999865321 5788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
|+.+++|.+++......+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..........
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 99999999999876677899999999999999999999998 9999999999999999999999999987655443333
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-ccccCCCCCCCHHHHHHHHHh
Q 003978 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLEIPKDVDPRWAAIVESC 741 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~l~~LI~~c 741 (782)
....|+..|+|||.+.+..++.++|||||||++|+|++|..||...........+... ......+..++.++.+||.+|
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHH
Confidence 3456889999999999998999999999999999999999999877665444333211 122334456788999999999
Q ss_pred hhhCCCCCCCHHHHH
Q 003978 742 WHSDPQCRPSFQELV 756 (782)
Q Consensus 742 L~~dP~~RPs~~ell 756 (782)
|..||++|||+.+++
T Consensus 237 l~~~P~~Rps~~~il 251 (256)
T cd06612 237 LVKDPEERPSAIQLL 251 (256)
T ss_pred HhcChhhCcCHHHHh
Confidence 999999999999994
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=322.75 Aligned_cols=256 Identities=30% Similarity=0.527 Sum_probs=215.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CC---eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GS---DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~---~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
...+|+..+.||+|+||.||+|... +. .++||.++... .....+.+..|+++++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 3457889999999999999999873 22 58999886543 344456788999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+||||+++++|.+++......+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999999999876667899999999999999999999998 99999999999999999999999999875543
Q ss_pred ccccc---cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHH
Q 003978 658 TYLTT---KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733 (782)
Q Consensus 658 ~~~~~---~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 733 (782)
..... .....++.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+.. ......+..++..
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~ 238 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-GFRLPAPMDCPSA 238 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-CCCCCCCCCCCHH
Confidence 22111 11223567999999998888999999999999999997 9999988777666655542 2233445568899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
+.+||.+||..+|++||++.++++.|+++
T Consensus 239 ~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 239 VYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=323.30 Aligned_cols=250 Identities=32% Similarity=0.503 Sum_probs=212.2
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.++|++.+.||.|+||.||++.. .+..+++|++..... ...+.+.+|+.+++.++||||+++++.+.....+|++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 36899999999999999999987 456799999875532 24578889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
||+.+++|.+++......+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 999999999999876567999999999999999999999998 999999999999999999999999998765443323
Q ss_pred ccCCCCCCcccCcccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc---ccCCCCCCCHHHH
Q 003978 662 TKTGKGTPQWMAPEVLRNE---PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ---RLEIPKDVDPRWA 735 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~---~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~---~~~~p~~~~~~l~ 735 (782)
.....++..|++||.+.+. .++.++|||||||++|+|++|..||...........+..... ....+..++.++.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence 3345788999999999877 788999999999999999999999988776555444332211 1122345678899
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 003978 736 AIVESCWHSDPQCRPSFQELVD 757 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~ 757 (782)
+||.+||..+|.+||++.+++.
T Consensus 238 ~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 238 DFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHhc
Confidence 9999999999999999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=327.38 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=205.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
..+|++.++||+|+||.||++.. .++.||+|++...... ....+.+|+.+++.++||||+++++.+..+..+|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD--DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc--hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 45899999999999999999987 5677999998654322 2346778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.........
T Consensus 86 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 86 EYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 999999999998654 46899999999999999999999998 999999999999999999999999998765433222
Q ss_pred ccCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc---cCCCCCCCHHHH
Q 003978 662 TKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR---LEIPKDVDPRWA 735 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~---~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~---~~~p~~~~~~l~ 735 (782)
.....|++.|+|||.+. ...++.++|||||||++|+|++|..||...........+...... ...+..++..+.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence 33456889999999985 344678999999999999999999999766544332222111111 112235788999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHH
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKL 759 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L 759 (782)
+||.+||..+|++||++.+++++|
T Consensus 243 ~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 243 NFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHhhCChhhCcCHHHHhcCC
Confidence 999999999999999999997653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=326.97 Aligned_cols=254 Identities=30% Similarity=0.520 Sum_probs=205.4
Q ss_pred cce-eEeeeeccCCcEEEEEEEE------cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC--C
Q 003978 505 EDL-TIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--Q 575 (782)
Q Consensus 505 ~~y-~i~~~IG~G~~G~Vy~~~~------~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~ 575 (782)
++| ++.+.||+|+||+||++.+ .+..||+|+++... .......+.+|+++|+.++||||+++++++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 344 8999999999999998764 35569999987543 233456788899999999999999999987643 4
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
.+|++|||+.+++|.+++... .+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.+||+|||++...
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeeccccccc
Confidence 589999999999999999754 4899999999999999999999998 999999999999999999999999998765
Q ss_pred ccccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH--HH------------HHhh
Q 003978 656 HETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ--VI------------GAVG 718 (782)
Q Consensus 656 ~~~~~---~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~--~~------------~~i~ 718 (782)
..... ......++..|+|||.+.+..++.++|||||||++|+|++|..||......- .. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 43221 1122345677999999998889999999999999999999999986543210 00 0000
Q ss_pred ccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003978 719 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 763 (782)
Q Consensus 719 ~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~ 763 (782)
........+..++.++.+++.+||..+|++|||++++++.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111223345678899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=340.72 Aligned_cols=248 Identities=24% Similarity=0.361 Sum_probs=198.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
...|++++.||+|+||.||+|... +..||+|+..... ...|+.+++.++||||+++++++......|+||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 347999999999999999999984 4579999854322 245899999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
||+ .++|.+++......+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++...... .
T Consensus 137 e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~ 212 (357)
T PHA03209 137 PHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-A 212 (357)
T ss_pred Ecc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccccCc-c
Confidence 999 56999998776778999999999999999999999998 9999999999999999999999999987543322 2
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCC-CCCChH----------HHHHHhhcccc-ccCCC--
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW-DNLNSM----------QVIGAVGFMNQ-RLEIP-- 727 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf-~~~~~~----------~~~~~i~~~~~-~~~~p-- 727 (782)
.....||+.|+|||++.+..++.++|||||||++|||+++..|+ ...... .....+..... ...++
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 292 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD 292 (357)
T ss_pred cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence 22456899999999999999999999999999999999865444 332111 01100100000 00011
Q ss_pred ----------------------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 728 ----------------------------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 728 ----------------------------~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
..++.++.+||.+||..||.+|||+.++ |.|+||+.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~------l~hp~f~~ 356 (357)
T PHA03209 293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEI------LNYPMFAQ 356 (357)
T ss_pred CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHH------hcCchhcc
Confidence 1456678889999999999999999999 77899975
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=324.71 Aligned_cols=254 Identities=30% Similarity=0.509 Sum_probs=213.0
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC---CHHHHHHHHHHHHHHHhCCCCceeEEeeeeec--CCce
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY---SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRL 577 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 577 (782)
.+|++.+.||+|+||.||++.. .+..|++|++..... .......+.+|+.+++.++||||+++++.+.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688999999999999999986 467899999875432 22455678899999999999999999998865 3568
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
+++|||+++++|.+++.... .+++...+.++.|++.||+|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 89999999999999997643 5888999999999999999999988 99999999999999999999999999875432
Q ss_pred cc---ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHH
Q 003978 658 TY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734 (782)
Q Consensus 658 ~~---~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 734 (782)
.. .......++..|+|||.+.+..++.++|||||||++|+|++|..||...........+......+.++..+++.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHA 238 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHH
Confidence 11 111234578999999999998899999999999999999999999987766655555444444566677889999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003978 735 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~ 768 (782)
++|| +||..+|++||++.++ +.|+||+
T Consensus 239 ~~li-~~~~~~p~~Rp~~~ei------l~hp~~~ 265 (266)
T cd06651 239 RDFL-GCIFVEARHRPSAEEL------LRHPFAQ 265 (266)
T ss_pred HHHH-HHhcCChhhCcCHHHH------hcCcccc
Confidence 9999 6888999999999999 6788875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=327.35 Aligned_cols=253 Identities=32% Similarity=0.555 Sum_probs=212.8
Q ss_pred cccceeEeeeeccCCcEEEEEEEE-------cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW-------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
.+.+|.+.++||+|+||.||++.. .+..+++|.+... .......+.+|+++++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 456889999999999999999964 2346888887543 3444567899999999999999999999999999
Q ss_pred ceeEEEeecCCCCHHHHHhhcC--------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNT--------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 641 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~--------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~ 641 (782)
..+++|||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+|+||||+|||++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~~ 158 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQG 158 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcCC
Confidence 9999999999999999997543 24788999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhh
Q 003978 642 WTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVG 718 (782)
Q Consensus 642 ~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~ 718 (782)
+.+||+|||++....... .......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...........+.
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 999999999987543221 11223345788999999999999999999999999999998 999998877766655553
Q ss_pred ccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003978 719 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 760 (782)
Q Consensus 719 ~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~ 760 (782)
. ......+..+++.+.+||.+||..||.+||++.++++.|+
T Consensus 239 ~-~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 Q-GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred c-CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 2 2334566788999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=342.36 Aligned_cols=258 Identities=35% Similarity=0.574 Sum_probs=207.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEEcC-CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC-ceeEE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-RLCIV 580 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~lv 580 (782)
-.++|.-...||+|+||.||+|...+ +.||||.+....... ..+|.+|+.++..++|||+|+++|+|.+.+ ..+||
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 34688888999999999999999865 889999876654432 345999999999999999999999999888 49999
Q ss_pred EeecCCCCHHHHHhhcCC-cchHHHHHHHHHHHHHHHHhhhcC-CCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc-
Q 003978 581 TEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE- 657 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qll~aL~~LH~~-~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~- 657 (782)
+|||+.|+|.++|..... +++|..+++|+.++++||+|||.. .++||||||||+|||+|.++..||+|||+|+....
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 999999999999977655 899999999999999999999984 34799999999999999999999999999976654
Q ss_pred ccccccCC-CCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---hHHHHHH----hhc--c--ccccC
Q 003978 658 TYLTTKTG-KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN---SMQVIGA----VGF--M--NQRLE 725 (782)
Q Consensus 658 ~~~~~~~~-~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~---~~~~~~~----i~~--~--~~~~~ 725 (782)
... .... .||..|++||.+.....+.|+||||+|++|+||++|+.|..... ....... +.. . .-.+.
T Consensus 231 ~~~-~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~ 309 (361)
T KOG1187|consen 231 DTS-VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPR 309 (361)
T ss_pred ccc-eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCC
Confidence 211 1122 79999999999998889999999999999999999998876432 1111111 100 0 00122
Q ss_pred CC-CCCC--H---HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003978 726 IP-KDVD--P---RWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 763 (782)
Q Consensus 726 ~p-~~~~--~---~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~ 763 (782)
+. ...+ . .+..+..+|++.+|.+||++.++++.|+.+.
T Consensus 310 l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 310 LKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred ccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 22 2333 2 3567888999999999999999988885554
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=330.41 Aligned_cols=255 Identities=31% Similarity=0.514 Sum_probs=210.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEEcC----------------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWYG----------------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~~----------------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 566 (782)
...+|++.++||+|+||.||++...+ ..||||+++... .......+.+|+++++.++||||++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 45689999999999999999997632 238999987543 3455667889999999999999999
Q ss_pred EeeeeecCCceeEEEeecCCCCHHHHHhhcC-----------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 003978 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-----------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN 635 (782)
Q Consensus 567 l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~-----------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~N 635 (782)
+++++......++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||||+|
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~N 159 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRN 159 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhh
Confidence 9999999999999999999999999986432 13678888999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCChH
Q 003978 636 LLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT--EKIPWDNLNSM 711 (782)
Q Consensus 636 ILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt--G~~Pf~~~~~~ 711 (782)
|+++.++.+||+|||++....... .......+++.|+|||++.+..++.++|||||||++|+|++ +..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 999999999999999987543321 11122345778999999998889999999999999999988 77899887766
Q ss_pred HHHHHhhccc------cccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003978 712 QVIGAVGFMN------QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 760 (782)
Q Consensus 712 ~~~~~i~~~~------~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~ 760 (782)
+....+.... .....++.+++.+.+||.+||..||++||++.++++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 5554432111 123345668899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=328.55 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=207.7
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
++|++.+.||+|+||.||++... ++.||+|++..........+.+.+|+.+++.++||||+++++++.....+++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47999999999999999999874 6789999987554333334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
|++++.|..++.. ...+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 9998888777654 346899999999999999999999998 9999999999999999999999999997655443233
Q ss_pred cCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------------cc
Q 003978 663 KTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-----------------RL 724 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------~~ 724 (782)
....++..|+|||++.+ ..++.++|||||||++|+|++|..||......+....+..... ..
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34467889999999876 4578899999999999999999999987766544433211000 00
Q ss_pred C------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 725 E------------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 725 ~------------~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
. ....++..+.+||.+||..+|++||++.++ +.|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei------l~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL------LEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHH------hcCCCC
Confidence 0 012467889999999999999999999999 556665
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=323.87 Aligned_cols=253 Identities=30% Similarity=0.501 Sum_probs=212.4
Q ss_pred ceeEeeeeccCCcEEEEEEEE-cCCeEEEEEEeccCC----CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEY----SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~-~~~~vAiK~~~~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
+|++.+.||.|+||.||++.. .++.+|+|.+..... .......+.+|+++++.++|+||+++++++...+.+|++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478899999999999999976 667799999875432 223456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc--
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-- 658 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-- 658 (782)
|||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 9999999999999764 35889999999999999999999998 999999999999999999999999998653211
Q ss_pred ----cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-ccccCCCCCCCHH
Q 003978 659 ----YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLEIPKDVDPR 733 (782)
Q Consensus 659 ----~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~ 733 (782)
........|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+... ...+.++..++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHH
Confidence 11122346899999999999988999999999999999999999999877655544333222 2234567789999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
+.+||.+||..+|.+||++.++ +.|+||
T Consensus 238 ~~~~i~~~l~~~p~~Rp~~~~~------l~~~~~ 265 (265)
T cd06631 238 AIDFVTSCLTRDQHERPSALQL------LRHDFL 265 (265)
T ss_pred HHHHHHHHhcCCcccCCCHHHH------hcCCCC
Confidence 9999999999999999999999 455654
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=322.59 Aligned_cols=246 Identities=33% Similarity=0.579 Sum_probs=211.6
Q ss_pred eeeccCCcEEEEEEEEcC---C--eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecC
Q 003978 511 EQIGQGSCGTVYHAVWYG---S--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~~---~--~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 585 (782)
++||+|+||.||++.+.. + .||||.+...... ...+.+.+|+.+++.++||||+++++.+.. ..++++|||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999998632 2 5899998776544 566789999999999999999999999988 88999999999
Q ss_pred CCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc---cc
Q 003978 586 RGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY---LT 661 (782)
Q Consensus 586 ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~---~~ 661 (782)
+++|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++....... ..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 999999997654 56899999999999999999999998 9999999999999999999999999987654321 11
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHH
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 740 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 740 (782)
.....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+.........+..++..+.+++.+
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 223457789999999999889999999999999999998 9999988877776666654444555667789999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHH
Q 003978 741 CWHSDPQCRPSFQELVDKLR 760 (782)
Q Consensus 741 cL~~dP~~RPs~~ell~~L~ 760 (782)
||..+|++||++.++++.|.
T Consensus 237 ~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 237 CWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HCCCCcccCCCHHHHHHHhc
Confidence 99999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=331.98 Aligned_cols=260 Identities=27% Similarity=0.448 Sum_probs=217.4
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
....+|++.+.||.|+||.||++.. .++.||||.+....... ...+.+|+.+++.++||||+++++++......|+
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 3457899999999999999999986 57789999987544332 3567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
||||+++++|.+++... .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 94 VMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred eecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 99999999999999653 4788899999999999999999998 9999999999999999999999999987544332
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-ccccCCCCCCCHHHHHHH
Q 003978 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~l~~LI 738 (782)
.......+++.|++||.+.+..++.++|||||||++|+|++|..||...+.......+... ......+..++..+++||
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFL 249 (297)
T ss_pred cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHH
Confidence 2233456889999999999988999999999999999999999999776554332222111 112234567889999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 739 ~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
.+||..||++||++.++ +.|+||+..+..
T Consensus 250 ~~~l~~~p~~Rps~~~i------l~~~~~~~~~~~ 278 (297)
T cd06656 250 NRCLEMDVDRRGSAKEL------LQHPFLKLAKPL 278 (297)
T ss_pred HHHccCChhhCcCHHHH------hcCchhcccccc
Confidence 99999999999999999 678999866554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=321.25 Aligned_cols=255 Identities=31% Similarity=0.577 Sum_probs=214.6
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEE-cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
|++..++|++.++||+|+||.||++.. .+..+++|.+.... .....+.+|+++++.++|+||+++++.+.. ...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 567788999999999999999999986 44569999876432 234678889999999999999999999887 7789
Q ss_pred EEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 579 IVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
++|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999999999999999753 345788889999999999999999988 99999999999999999999999999875443
Q ss_pred ccc-cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHH
Q 003978 658 TYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735 (782)
Q Consensus 658 ~~~-~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 735 (782)
... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...+.......+. .......+...+.++.
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELY 233 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCcccCCHHHH
Confidence 221 1222345678999999998889999999999999999998 999998877766555443 2223445567889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRD 761 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~ 761 (782)
+++.+||..+|++||++.++++.|+.
T Consensus 234 ~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 234 NIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHHHHhc
Confidence 99999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=334.33 Aligned_cols=263 Identities=32% Similarity=0.586 Sum_probs=220.1
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEcC---------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEE
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG---------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLF 567 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~---------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l 567 (782)
..|+....+|++++.||+|+||.||++.+.+ ..||+|+++.. ........+.+|+++++.+ +||||+++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 3566777789999999999999999997522 25899987643 2344567888999999999 79999999
Q ss_pred eeeeecCCceeEEEeecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 003978 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLK 632 (782)
Q Consensus 568 ~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIK 632 (782)
++++...+.+|++|||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|||||
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlk 161 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLA 161 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccc
Confidence 999999999999999999999999996532 24678888999999999999999998 9999999
Q ss_pred CCcEEEcCCCcEEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 003978 633 SSNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (782)
Q Consensus 633 p~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~ 709 (782)
|+|||++.++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999875543221 1222344678999999999999999999999999999998 899998887
Q ss_pred hHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 710 SMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 710 ~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
.......+. .......+..++.++.+||.+||..+|.+||++.++++.|+++..
T Consensus 242 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 242 VEELFKLLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 766655543 223445667788999999999999999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=317.75 Aligned_cols=246 Identities=30% Similarity=0.570 Sum_probs=208.5
Q ss_pred eeeccCCcEEEEEEEE-cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCCCH
Q 003978 511 EQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ggsL 589 (782)
++||+|+||.||++.. .+..+|+|++.... .......+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3689999999999986 45679999886543 344455788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc-cCCCCC
Q 003978 590 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT-KTGKGT 668 (782)
Q Consensus 590 ~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~Gt 668 (782)
.+++......+++..++.++.|++.+|.|||+++ ++|+||||+||+++.++.+||+|||++.......... ....++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 9999766667889999999999999999999998 9999999999999999999999999987543322111 122346
Q ss_pred CcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCC
Q 003978 669 PQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQ 747 (782)
Q Consensus 669 ~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~ 747 (782)
+.|+|||++.+..++.++|||||||++|+|++ |..||...........+. .......+..++..+.+|+.+||..+|+
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKPE 236 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence 77999999998889999999999999999998 999998877666555543 2334456677899999999999999999
Q ss_pred CCCCHHHHHHHHH
Q 003978 748 CRPSFQELVDKLR 760 (782)
Q Consensus 748 ~RPs~~ell~~L~ 760 (782)
+||++.++++.|.
T Consensus 237 ~Rp~~~~l~~~l~ 249 (250)
T cd05085 237 NRPKFSELQKELA 249 (250)
T ss_pred cCCCHHHHHHHhc
Confidence 9999999988764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.69 Aligned_cols=259 Identities=29% Similarity=0.487 Sum_probs=216.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEEcC------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec-CC
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWYG------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQ 575 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~~------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~ 575 (782)
..++|++.+.||+|+||.||+|.+.. ..|++|.+... ........+.+|+.+++.+.||||+++++++.. +.
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 45789999999999999999998754 56899987643 344556778899999999999999999998765 56
Q ss_pred ceeEEEeecCCCCHHHHHhhcC-------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEe
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNT-------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~-------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~D 648 (782)
..+++++|+.+++|.+++.... ..+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEECC
Confidence 7899999999999999996532 45889999999999999999999998 99999999999999999999999
Q ss_pred cCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccC
Q 003978 649 FGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLE 725 (782)
Q Consensus 649 FGla~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~ 725 (782)
||+++....... ......++..|+|||++.+..++.++|||||||++|++++ |+.||...+.......+.. .....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~ 239 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD-GYRLA 239 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc-CCCCC
Confidence 999975432211 1122345778999999999889999999999999999999 9999988776665544432 22334
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 726 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 726 ~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
.+..+++++.+++.+||..||++|||+.++++.|.++...
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 4556789999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.54 Aligned_cols=249 Identities=29% Similarity=0.466 Sum_probs=214.0
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec--CCceeEEE
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRLCIVT 581 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~ 581 (782)
+|++.+.||.|+||.||++.+ .+..||+|++..........+.+..|+++++.++||||+++++++.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588999999999999999987 56779999998766666667788899999999999999999997753 45689999
Q ss_pred eecCCCCHHHHHhhc---CCcchHHHHHHHHHHHHHHHHhhh-----cCCCCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 582 EFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLH-----HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 582 E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qll~aL~~LH-----~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
||+++++|.+++... ..++++..++.++.||+.||.||| +.+ |+|+||||+||+++.++.+||+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEecccccc
Confidence 999999999999653 456899999999999999999999 777 9999999999999999999999999988
Q ss_pred ccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHH
Q 003978 654 LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733 (782)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 733 (782)
.............|++.|++||.+.+..++.++|+||||+++|+|++|..||...+.......+. ......++..++..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 237 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIPYRYSSE 237 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh-cCCCCCCccccCHH
Confidence 66544332334578999999999999889999999999999999999999999877555554443 22334567788999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHH
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVD 757 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~ 757 (782)
+.+++.+||..+|.+||++.++++
T Consensus 238 ~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 238 LNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred HHHHHHHHccCCcccCCCHHHHhh
Confidence 999999999999999999999954
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=328.49 Aligned_cols=258 Identities=23% Similarity=0.436 Sum_probs=214.5
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
++|++++.||+|+||.||++... +..||+|.++.. ........+.+|+.+++.++||||+++++.+..++.+|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 36889999999999999999984 778999988654 234445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc--CCcchHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 583 FLPRGSLFRLLQRN--TTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 583 ~~~ggsL~~~l~~~--~~~l~~~~~~~i~~qll~aL~~LH~-~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
|+++++|..++... ...+++..+..++.||+.||.|||+ ++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999998753 2368999999999999999999996 47 9999999999999999999999999987553322
Q ss_pred ccccCCCCCCcccCcccccCCC------CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc--cccccCCCCCCC
Q 003978 660 LTTKTGKGTPQWMAPEVLRNEP------SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF--MNQRLEIPKDVD 731 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~~~------~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~ 731 (782)
.....+++.|+|||.+.+.. ++.++|||||||++|+|++|..||...........+.. ......++..++
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS 235 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccC
Confidence 23446888999999986543 47899999999999999999999976655443333221 223455677799
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 732 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 732 ~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
.++.+||.+||..+|++||++.++ +.++||...+..
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~l------~~~~~~~~~~~~ 271 (286)
T cd06622 236 DDAQDFVAKCLNKIPNRRPTYAQL------LEHPWLVKYKNA 271 (286)
T ss_pred HHHHHHHHHHcccCcccCCCHHHH------hcChhhhhccCC
Confidence 999999999999999999999999 567888665544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=326.96 Aligned_cols=254 Identities=28% Similarity=0.513 Sum_probs=212.9
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
..++|++.+.||+|+||.||++... +..||+|++.... .......+.+|+.+++.+.||||+++++++..+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 3468999999999999999999863 4569999986433 3445567889999999999999999999999999
Q ss_pred ceeEEEeecCCCCHHHHHhhcC---------------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNT---------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 634 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~---------------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~ 634 (782)
..|++|||+++++|.+++.... ..+++..++.++.||+.||.|||.++ ++|+||||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~ 159 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATR 159 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHh
Confidence 9999999999999999996432 24678889999999999999999998 999999999
Q ss_pred cEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChH
Q 003978 635 NLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSM 711 (782)
Q Consensus 635 NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~ 711 (782)
||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999987543221 11223345678999999998889999999999999999997 88999887776
Q ss_pred HHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003978 712 QVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 760 (782)
Q Consensus 712 ~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~ 760 (782)
+....+.. ......+..++.++.+||.+||..||.+||++.++++.|+
T Consensus 240 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 EVIYYVRD-GNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 66555432 2233456678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=332.18 Aligned_cols=263 Identities=26% Similarity=0.337 Sum_probs=214.4
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC--CceeE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLCI 579 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~l 579 (782)
.++|++.+.||+|+||.||++.. .+..||+|+++...........+.+|+.+++.++|+||+++++++... +.+|+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46899999999999999999987 477899999876543333334456799999999999999999998754 46899
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
||||+. ++|.+++......+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999995 5899998776667899999999999999999999999 9999999999999999999999999987654432
Q ss_pred ccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc----------------
Q 003978 660 LTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ---------------- 722 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~---------------- 722 (782)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+....+..+.....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence 22223346888999999876 4578999999999999999999999988877665544432110
Q ss_pred -ccCC-----------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcCC
Q 003978 723 -RLEI-----------PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVG 775 (782)
Q Consensus 723 -~~~~-----------p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~~ 775 (782)
...+ ....++++.+||.+||..||++|||+.++ +.|+||+.....+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~i------l~h~~f~~~~~~~~ 301 (309)
T cd07845 243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEA------LESSYFKEKPLPCE 301 (309)
T ss_pred ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHH------hcChhhccCCCCCC
Confidence 0000 12357889999999999999999999999 67899987766544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.27 Aligned_cols=256 Identities=29% Similarity=0.557 Sum_probs=217.6
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CC----eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~----~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
..+|++.+.||+|+||.||+|... +. .+|+|.+..... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 468999999999999999999863 22 488998765443 4455778899999999999999999999887 788
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
+++|||+.+++|.+++......+++..++.++.||+.||+|||+++ |+|+||||+||+++.++.+||+|||+++....
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999999999877667999999999999999999999988 99999999999999999999999999976543
Q ss_pred ccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHH
Q 003978 658 TYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734 (782)
Q Consensus 658 ~~~--~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 734 (782)
... ......++..|++||.+.+..++.++|||||||++|+|++ |..||...........+. .......+..++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 240 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICTIDV 240 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCHHH
Confidence 211 1112234678999999988889999999999999999998 999999887766555553 333455667788999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 735 AAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
.+++.+||..||.+||++.++++.|+++.+
T Consensus 241 ~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 241 YMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 999999999999999999999999998855
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=325.02 Aligned_cols=253 Identities=29% Similarity=0.501 Sum_probs=213.5
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
++|++.+.||.|+||.||++.+. ++.+++|.+..... ......+.+|+++++.+.||||+++++.+...+.++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 36788899999999999999985 67899999876543 3455678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~-~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
|+.+++|.+++......+++..+..++.|++.||+|||+ .+ ++|+||||+||+++.++.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 999999999998765678999999999999999999999 88 999999999999999999999999998655332221
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----hHHHHHHhhccccccCCCCC-CCHHHH
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN-----SMQVIGAVGFMNQRLEIPKD-VDPRWA 735 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~-----~~~~~~~i~~~~~~~~~p~~-~~~~l~ 735 (782)
...++..|+|||.+.+..++.++|||||||++|+|++|..||.... .......+. ....+.++.. ++.++.
T Consensus 158 --~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (265)
T cd06605 158 --TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPPRLPSGKFSPDFQ 234 (265)
T ss_pred --cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCCCCCChhhcCHHHH
Confidence 2578899999999999999999999999999999999999997652 222222221 1223334444 889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
+||.+||..||++|||+.++ +.++||+.
T Consensus 235 ~li~~~l~~~p~~Rpt~~~l------l~~~~~~~ 262 (265)
T cd06605 235 DFVNLCLIKDPRERPSYKEL------LEHPFIKK 262 (265)
T ss_pred HHHHHHcCCCchhCcCHHHH------hhCchhhc
Confidence 99999999999999999999 67899864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=327.91 Aligned_cols=254 Identities=32% Similarity=0.539 Sum_probs=208.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc------------------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcee
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY------------------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~------------------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 565 (782)
.++|++.++||+|+||.||++.+. +..+|+|++.... .......+.+|+.+++.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 467999999999999999998643 2248999886543 344556788999999999999999
Q ss_pred EEeeeeecCCceeEEEeecCCCCHHHHHhhcC----------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 003978 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT----------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN 635 (782)
Q Consensus 566 ~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~----------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~N 635 (782)
++++++......|++|||+.+++|.+++.... ..+++..++.++.||+.||+|||+++ |+|+||||+|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~N 160 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRN 160 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhe
Confidence 99999999999999999999999999996532 23667889999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCChH
Q 003978 636 LLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT--EKIPWDNLNSM 711 (782)
Q Consensus 636 ILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt--G~~Pf~~~~~~ 711 (782)
||++.++.++|+|||++........ ......+++.|++||+..+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999875433211 1112234678999999888889999999999999999998 78999877665
Q ss_pred HHHHHhhc------cccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003978 712 QVIGAVGF------MNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 760 (782)
Q Consensus 712 ~~~~~i~~------~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~ 760 (782)
+....... .......+..+++.+.+||.+||..||.+||++.++++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 54433211 11123345668899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.94 Aligned_cols=249 Identities=33% Similarity=0.621 Sum_probs=212.1
Q ss_pred cceeEeeeeccCCcEEEEEEEEc-CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
.+|++.+.||.|+||.||++.+. +..+|+|++....... ..+.+|+++++.+.||||+++++++......|++|||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 57899999999999999999875 6789999987654433 4577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc-c
Q 003978 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT-T 662 (782)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~-~ 662 (782)
+.+++|.+++......+++..++.++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++......... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 9999999999876667899999999999999999999998 999999999999999999999999998754332211 1
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHh
Q 003978 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 741 (782)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.. ......+...+..+.+|+.+|
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~ 237 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA-GFRLYKPRLASQSVYELMQHC 237 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-CCCCCCCCCCCHHHHHHHHHH
Confidence 12235678999999998889999999999999999998 9999987776665555432 223344566889999999999
Q ss_pred hhhCCCCCCCHHHHHHHH
Q 003978 742 WHSDPQCRPSFQELVDKL 759 (782)
Q Consensus 742 L~~dP~~RPs~~ell~~L 759 (782)
|..+|++||++.++++.|
T Consensus 238 l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 238 WKERPEDRPSFSLLLHQL 255 (256)
T ss_pred cccChhhCCCHHHHHHhh
Confidence 999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.74 Aligned_cols=246 Identities=33% Similarity=0.592 Sum_probs=209.0
Q ss_pred eeeccCCcEEEEEEEEc-CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCCCH
Q 003978 511 EQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ggsL 589 (782)
++||+|+||.||++... ++.|++|++...... .....+.+|+++++.++|+||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 46999999999999875 788999998765443 4556788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc--cCCCC
Q 003978 590 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT--KTGKG 667 (782)
Q Consensus 590 ~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~--~~~~G 667 (782)
.+++......+++..++.++.+++.+|.|||+++ ++|+||||+||+++.++.++|+|||++.......... ....+
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 9999766667889999999999999999999998 9999999999999999999999999987554221111 12234
Q ss_pred CCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCC
Q 003978 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 746 (782)
Q Consensus 668 t~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP 746 (782)
+..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.. ......+..++.++.++|.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-GYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-CCCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999998889999999999999999999 8999987776555444432 23445567789999999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 003978 747 QCRPSFQELVDKLR 760 (782)
Q Consensus 747 ~~RPs~~ell~~L~ 760 (782)
.+||++.++++.|+
T Consensus 237 ~~Rp~~~ell~~l~ 250 (251)
T cd05041 237 ENRPSFSEIYNELQ 250 (251)
T ss_pred hhCcCHHHHHHHhh
Confidence 99999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=324.90 Aligned_cols=249 Identities=28% Similarity=0.427 Sum_probs=205.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.++|++.++||+|+||.||++.. .++.||+|+++.... .....+.+|+.+++.++||||+++++.+...+.+|++|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 35889999999999999999987 467899999875432 23356778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++.........
T Consensus 86 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 86 EFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred eccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 9999999999987643 6899999999999999999999998 999999999999999999999999998755443333
Q ss_pred ccCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC-C--CCCCCHHHH
Q 003978 662 TKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE-I--PKDVDPRWA 735 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~---~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-~--p~~~~~~l~ 735 (782)
.....|++.|+|||++. ...++.++|||||||++|+|++|..||..................+. . ...++..+.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence 34557899999999974 45578899999999999999999999976654433322221111111 1 124678999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 003978 736 AIVESCWHSDPQCRPSFQELVD 757 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~ 757 (782)
+||.+||..+|++||++.++++
T Consensus 243 ~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 243 HFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhc
Confidence 9999999999999999999954
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=324.99 Aligned_cols=253 Identities=26% Similarity=0.359 Sum_probs=210.7
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
+|++.+.||.|+||.||+|.+ .++.|++|++............+.+|+.+++.++||||+++++++.....+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 589999999999999999987 567899999987665455567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc-cc
Q 003978 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-TT 662 (782)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~ 662 (782)
+ +++|.+++......+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 9 99999999776677999999999999999999999998 99999999999999999999999999876544321 12
Q ss_pred cCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc------------------
Q 003978 663 KTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR------------------ 723 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~-~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~------------------ 723 (782)
....|+..|+|||.+.+.. ++.++|||||||++|+|++|.+||...........+......
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 3456899999999987644 588999999999999999999888776654433322110000
Q ss_pred ----------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 724 ----------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 724 ----------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
....+..+..+.+||.+||..||.+||++.++ |.|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~------l~h~~~ 285 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEA------LRHPYF 285 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHH------hhCcCc
Confidence 01123567899999999999999999999999 566776
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.39 Aligned_cols=247 Identities=33% Similarity=0.609 Sum_probs=210.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
..++|++.+.||+|+||.||++...++.||+|+++... ....+.+|+.+++.++||||+++++++..+ ..+++||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 34689999999999999999999999999999986432 235678899999999999999999998754 5799999
Q ss_pred ecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 583 FLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
|+.+++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 999999999997543 35789999999999999999999998 9999999999999999999999999987543321
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHH
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 740 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 740 (782)
.....+..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+.. ...+..+..++..+.+||.+
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ 232 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-GYRMEPPEGCPADVYVLMTS 232 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-CCCCCCCCcCCHHHHHHHHH
Confidence 12234678999999998889999999999999999997 9999988877665555432 23444566789999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHH
Q 003978 741 CWHSDPQCRPSFQELVDKLR 760 (782)
Q Consensus 741 cL~~dP~~RPs~~ell~~L~ 760 (782)
||..+|++||++.++++.|+
T Consensus 233 ~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 233 CWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HcCCChhhCcCHHHHHHHHc
Confidence 99999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=310.50 Aligned_cols=255 Identities=26% Similarity=0.436 Sum_probs=209.8
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEcC--CeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCC
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG--SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~--~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 575 (782)
.+....++++++..||.|+.|.|+++++.. .-.|||.+.+... .+..+++...+.++... +.|+||+++|+|..+.
T Consensus 86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~ 164 (391)
T KOG0983|consen 86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT 164 (391)
T ss_pred ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence 344556778889999999999999999855 6789999987654 34456677777766555 5899999999999999
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
.+++.||.| ..-+..++++-..++++..+-++...++.||.||.++. +||||||||+|||++..|+|||||||++...
T Consensus 165 dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 165 DVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred hHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEccCCCEEeeccccccee
Confidence 999999999 44667777777778999999999999999999998642 4999999999999999999999999999877
Q ss_pred ccccccccCCCCCCcccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhccccccCCCC--C
Q 003978 656 HETYLTTKTGKGTPQWMAPEVLRN---EPSDEKSDVYSFGVILWELATEKIPWDNLN-SMQVIGAVGFMNQRLEIPK--D 729 (782)
Q Consensus 656 ~~~~~~~~~~~Gt~~y~aPE~l~~---~~~s~~sDIwSLG~ll~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~p~--~ 729 (782)
.+....+ ...|-+.|||||.+.. ..|+.++||||||++++||.||..||...+ ..+++..+.. ..++.++. .
T Consensus 243 vdSkAht-rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~g 320 (391)
T KOG0983|consen 243 VDSKAHT-RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMG 320 (391)
T ss_pred ecccccc-cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccC
Confidence 6655444 3468899999999964 467899999999999999999999998754 4566656543 22344443 4
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003978 730 VDPRWAAIVESCWHSDPQCRPSFQELVDK 758 (782)
Q Consensus 730 ~~~~l~~LI~~cL~~dP~~RPs~~ell~~ 758 (782)
+++.+.+|+..||.+|+.+||.+.+|+++
T Consensus 321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 321 FSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 89999999999999999999999999543
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=321.19 Aligned_cols=248 Identities=31% Similarity=0.572 Sum_probs=205.5
Q ss_pred eeeccCCcEEEEEEEEcC--C--eEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCceeEEEeecC
Q 003978 511 EQIGQGSCGTVYHAVWYG--S--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLP 585 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~~--~--~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~ 585 (782)
+.||+|+||.||++...+ . .+++|.++.. ........+.+|+.++..+ +||||+++++++...+.+|++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 368999999999998743 2 3678877632 2344456788999999999 79999999999999999999999999
Q ss_pred CCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecC
Q 003978 586 RGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650 (782)
Q Consensus 586 ggsL~~~l~~~~---------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFG 650 (782)
+++|.+++.... ..+++..++.++.|++.||+|||+++ ++|+||||+|||++.++.+||+|||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEECCCC
Confidence 999999996532 24788999999999999999999988 9999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCC
Q 003978 651 LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKD 729 (782)
Q Consensus 651 la~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 729 (782)
++...... ........++.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+.. ......+..
T Consensus 158 l~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~ 235 (270)
T cd05047 158 LSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEKPLN 235 (270)
T ss_pred Cccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC-CCCCCCCCc
Confidence 98633221 11222334667999999998889999999999999999997 9999987776665554432 234456667
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003978 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 763 (782)
Q Consensus 730 ~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~ 763 (782)
++.++.+|+.+||..||.+|||+.++++.|.++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 236 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 8899999999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.26 Aligned_cols=247 Identities=24% Similarity=0.394 Sum_probs=213.6
Q ss_pred eccCCcEEEEEEEEc--CCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCCCH
Q 003978 513 IGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (782)
Q Consensus 513 IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ggsL 589 (782)
||.|+||.||++... +..|++|++.+.... ....+.+.+|+.+++.++||||+++++.+..+..+|++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999986 788999999765542 34557789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCCCCC
Q 003978 590 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP 669 (782)
Q Consensus 590 ~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~ 669 (782)
.+++.+.. .+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++....... ......|++
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~ 156 (262)
T cd05572 81 WTILRDRG-LFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTP 156 (262)
T ss_pred HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCc
Confidence 99997643 5889999999999999999999998 9999999999999999999999999987654432 223446899
Q ss_pred cccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCC
Q 003978 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN--SMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQ 747 (782)
Q Consensus 670 ~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~ 747 (782)
.|++||.+.+..++.++|+|||||++|+|++|..||.... .......+........+|..+++++.+||.+||..||+
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 9999999988889999999999999999999999998776 55555454433456667777899999999999999999
Q ss_pred CCCC-----HHHHHHHHHHHHHHHhhc
Q 003978 748 CRPS-----FQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 748 ~RPs-----~~ell~~L~~L~~~~~~~ 769 (782)
+||+ +.++ ++|+||+.
T Consensus 237 ~R~~~~~~~~~~l------~~~~~~~~ 257 (262)
T cd05572 237 ERLGNLKGGIKDI------KKHKWFNG 257 (262)
T ss_pred hCcCCcccCHHHH------hcChhhhC
Confidence 9999 8888 56899974
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.66 Aligned_cols=249 Identities=33% Similarity=0.563 Sum_probs=203.6
Q ss_pred eeeccCCcEEEEEEEEc-----CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeee-cCCceeEEEeec
Q 003978 511 EQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT-SPQRLCIVTEFL 584 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lv~E~~ 584 (782)
+.||+|+||.||+|... ...||||.+.... .......+.+|+.+++.++||||+++++++. .++..+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 36899999999999863 2358999875432 3344577888999999999999999999765 455689999999
Q ss_pred CCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc----c
Q 003978 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY----L 660 (782)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~----~ 660 (782)
.+++|.+++......+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++...... .
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999999776556777888899999999999999988 9999999999999999999999999987543211 1
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHH
Q 003978 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 739 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 739 (782)
......+++.|+|||.+.+..++.++|||||||++|||++ |.+||...+.......+. ....+..+..++..+.+++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 236 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGRRLLQPEYCPDPLYEVML 236 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHHHHH
Confidence 1123346778999999988889999999999999999999 567787766655544442 22334455668899999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHHH
Q 003978 740 SCWHSDPQCRPSFQELVDKLRDLQ 763 (782)
Q Consensus 740 ~cL~~dP~~RPs~~ell~~L~~L~ 763 (782)
+||..+|++||++.++++.|+++.
T Consensus 237 ~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 237 SCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HHcCCChhhCCCHHHHHHHHHHHh
Confidence 999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=322.37 Aligned_cols=254 Identities=34% Similarity=0.554 Sum_probs=205.5
Q ss_pred cceeEeeeeccCCcEEEEEEEE------cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec--CCc
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQR 576 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~------~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~ 576 (782)
.+|++.+.||+|+||.||++.+ .+..||||.+.... ....+.+.+|+++++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 4789999999999999999975 36679999986442 4445778899999999999999999997643 346
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
+++||||+++++|.+++......+++..++.++.||+.||+|||+++ |+|+||||+||+|+.++.+||+|||++....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 89999999999999999776667899999999999999999999998 9999999999999999999999999998654
Q ss_pred cccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHH---------------HHHhh
Q 003978 657 ETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQV---------------IGAVG 718 (782)
Q Consensus 657 ~~~~---~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~---------------~~~i~ 718 (782)
.... ......++..|+|||++.+..++.++|||||||++|||++|..|+........ ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 3211 11122345569999999998899999999999999999998777643321100 00111
Q ss_pred ccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 719 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 719 ~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
........+..++.++.+||.+||..+|++|||+.++++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11123344567889999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=319.77 Aligned_cols=248 Identities=31% Similarity=0.515 Sum_probs=207.2
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC---CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC--Cce
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY---SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRL 577 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 577 (782)
.+|++.+.||+|+||.||++.. .++.|+||.+..... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4799999999999999999987 467899998864322 234567889999999999999999999988653 467
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
+++|||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 8999999999999999764 35788889999999999999999998 99999999999999999999999999875432
Q ss_pred cc---ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHH
Q 003978 658 TY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734 (782)
Q Consensus 658 ~~---~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 734 (782)
.. .......|+..|+|||++.+..++.++|||||||++|+|++|..||...........+........+|..++..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHC 238 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHH
Confidence 11 112234588999999999988889999999999999999999999987765555444433333455677788899
Q ss_pred HHHHHHhhhhCCCCCCCHHHHH
Q 003978 735 AAIVESCWHSDPQCRPSFQELV 756 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RPs~~ell 756 (782)
.++|.+||. +|.+||++.+++
T Consensus 239 ~~~i~~~l~-~p~~Rp~~~~il 259 (265)
T cd06652 239 RDFLKRIFV-EAKLRPSADELL 259 (265)
T ss_pred HHHHHHHhc-ChhhCCCHHHHh
Confidence 999999995 999999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.80 Aligned_cols=248 Identities=33% Similarity=0.572 Sum_probs=213.4
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC---CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY---SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
+|+..+.||+|+||.||+|.. .+..|++|.+..... ..+..+.+.+|+.+++.++|+||+++++++.....+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 477789999999999999987 477899999865432 245567889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
|||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 99999999999997653 5889999999999999999999998 9999999999999999999999999987654332
Q ss_pred cccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHH
Q 003978 661 TTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 739 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~~~-~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 739 (782)
......|++.|++||.+.... ++.++|+|||||++|+|++|..||...........+........++..+++.+.+||.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 236 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFIL 236 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHH
Confidence 223456899999999988776 8899999999999999999999998777655555554434455677789999999999
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 003978 740 SCWHSDPQCRPSFQELVD 757 (782)
Q Consensus 740 ~cL~~dP~~RPs~~ell~ 757 (782)
+||..+|.+||++.+++.
T Consensus 237 ~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 237 KCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHhhcCcccCcCHHHHhc
Confidence 999999999999999953
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=324.14 Aligned_cols=253 Identities=28% Similarity=0.440 Sum_probs=204.8
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeee-----
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVT----- 572 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~----- 572 (782)
....++|++.+.||+|+||.||++.. .++.+|+|++..... ....+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 34567999999999999999999987 467899998764322 224577899999999 6999999999873
Q ss_pred cCCceeEEEeecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEec
Q 003978 573 SPQRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (782)
Q Consensus 573 ~~~~~~lv~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DF 649 (782)
....+++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCCEEEccC
Confidence 34568999999999999998753 2346888899999999999999999988 999999999999999999999999
Q ss_pred CCCcccccccccccCCCCCCcccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-cc
Q 003978 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLRN-----EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QR 723 (782)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~-~~ 723 (782)
|++..............|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.... ..
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (286)
T cd06638 169 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPT 248 (286)
T ss_pred CceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCc
Confidence 998765443333334578999999999853 446889999999999999999999998776544433322111 12
Q ss_pred cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003978 724 LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDK 758 (782)
Q Consensus 724 ~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~ 758 (782)
...+..++..+.+||.+||..||++|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 22445678899999999999999999999999543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=325.53 Aligned_cols=252 Identities=31% Similarity=0.528 Sum_probs=212.2
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
+.|+..+.||.|+||.||+|.+ .+..||+|++..... ......+.+|+.+++.++||||+++++.+..++..|+|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 4577788999999999999987 466799999865432 3455788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
|+++++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 83 YLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred ccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 9999999999864 35889999999999999999999988 9999999999999999999999999987654433333
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhh
Q 003978 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 742 (782)
....|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........+. ......++..++.++.+||.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYSKPFKEFVEACL 237 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-cCCCCCCCcccCHHHHHHHHHHc
Confidence 34468899999999999889999999999999999999999998766554443332 12233455568899999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003978 743 HSDPQCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 743 ~~dP~~RPs~~ell~~L~~L~~~~~~ 768 (782)
..+|++||++.+++ .|+||+
T Consensus 238 ~~~p~~Rp~~~~il------~~~~~~ 257 (277)
T cd06642 238 NKDPRFRPTAKELL------KHKFIT 257 (277)
T ss_pred cCCcccCcCHHHHH------HhHHHH
Confidence 99999999999995 456664
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.43 Aligned_cols=248 Identities=27% Similarity=0.440 Sum_probs=212.5
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
+|++.+.||+|+||.||++.. .+..+|||.+............+.+|+++++.++||||+++++.+...+.+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588999999999999999987 566799999987665556678899999999999999999999999989999999999
Q ss_pred cCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CcEEEEecCCCccccccccc
Q 003978 584 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 584 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~-~~vkL~DFGla~~~~~~~~~ 661 (782)
+++++|.+++... ...+++..++.++.+++.+|+|||+++ |+|+||||+||+++.+ +.+||+|||++....... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-K 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-c
Confidence 9999999999764 345889999999999999999999998 9999999999999865 458999999987654432 2
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHh
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 741 (782)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.. .....++..++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~ 236 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-GTFAPISDRYSPDLRQLILSM 236 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh-cCCCCCCCCcCHHHHHHHHHH
Confidence 2235688999999999988889999999999999999999999987766554444422 223456677899999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 003978 742 WHSDPQCRPSFQELVD 757 (782)
Q Consensus 742 L~~dP~~RPs~~ell~ 757 (782)
|..+|.+|||+.++++
T Consensus 237 l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 237 LNLDPSKRPQLSQIMA 252 (256)
T ss_pred ccCChhhCCCHHHHhh
Confidence 9999999999999943
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=375.07 Aligned_cols=258 Identities=28% Similarity=0.481 Sum_probs=221.0
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
+|.-+.+||.|.||.||.+.. +|.-.|+|-++.+.........+.+|..+|..++|||+|++||+-.+.+.++|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 677788999999999999986 677789999877666666677888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc----
Q 003978 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY---- 659 (782)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~---- 659 (782)
|.+|+|.+.+... +-.++.....+..|++.|++|||++| ||||||||+||+++.+|.+|++|||.|.......
T Consensus 1316 C~~GsLa~ll~~g-ri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHG-RIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred hccCcHHHHHHhc-chhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 9999999999753 45677777788899999999999999 9999999999999999999999999998655432
Q ss_pred ccccCCCCCCcccCcccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccccCCCCCCCHHHH
Q 003978 660 LTTKTGKGTPQWMAPEVLRNEP---SDEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFMNQRLEIPKDVDPRWA 735 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~~~---~s~~sDIwSLG~ll~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~~~~l~ 735 (782)
......+||+.|||||++.+.. ...+.||||||||+.||+||+.||..++.. +.+..+ .+...+.+|..++.+-+
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V-~~gh~Pq~P~~ls~~g~ 1471 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV-AAGHKPQIPERLSSEGR 1471 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH-hccCCCCCchhhhHhHH
Confidence 1233557999999999998644 567999999999999999999999988654 444444 36667889999999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
+||.+||..||+.|+++.||+ .+.|.+....+
T Consensus 1472 dFle~Cl~~dP~~Rw~~~qll------e~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1472 DFLEHCLEQDPKMRWTASQLL------EHAFGKSCTDE 1503 (1509)
T ss_pred HHHHHHHhcCchhhhHHHHHH------Hhhcccccccc
Confidence 999999999999999999994 45666554443
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=359.73 Aligned_cols=257 Identities=25% Similarity=0.346 Sum_probs=209.0
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
++|++.++||+|+||.||+|.+ .++.||||++..... .......+.+|+++++.++||||+++++++..++..|++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5899999999999999999987 467899999875433 2345567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhc----------CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCC
Q 003978 582 EFLPRGSLFRLLQRN----------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (782)
Q Consensus 582 E~~~ggsL~~~l~~~----------~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGl 651 (782)
||++|++|.+++... ...++...++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEecCc
Confidence 999999999998642 123456677889999999999999998 99999999999999999999999999
Q ss_pred Cccccccc------------------ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 003978 652 SRLKHETY------------------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQV 713 (782)
Q Consensus 652 a~~~~~~~------------------~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~ 713 (782)
++...... ......+||+.|||||++.+..++.++|||||||++|+|++|..||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 97541100 011124699999999999999999999999999999999999999987554433
Q ss_pred HHHhhccccccC--CCCCCCHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHHHH
Q 003978 714 IGAVGFMNQRLE--IPKDVDPRWAAIVESCWHSDPQCRP-SFQELVDKLRDLQR 764 (782)
Q Consensus 714 ~~~i~~~~~~~~--~p~~~~~~l~~LI~~cL~~dP~~RP-s~~ell~~L~~L~~ 764 (782)
.... ....... ....+++.+.+++.+||..||++|| +++++++.|..+.+
T Consensus 240 ~~~~-~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 240 SYRD-VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhh-hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 2221 1111111 1246889999999999999999997 57777777776644
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=319.72 Aligned_cols=248 Identities=30% Similarity=0.489 Sum_probs=203.4
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
+.+.....||+|+||.||++.+. +..|++|.+.... ....+.+.+|+.+++.++|+||+++++++..++..+++||
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 34444568999999999999864 5569999876543 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcc--hHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCcEEEEecCCCccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKL--DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l--~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~-~~~vkL~DFGla~~~~~~~ 659 (782)
|+++++|.+++......+ ++..+..++.||+.||+|||+.+ |+|+||||+||+++. ++.++|+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 999999999997654445 78888899999999999999988 999999999999976 6789999999987544332
Q ss_pred ccccCCCCCCcccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhccccccCCCCCCCHHHHH
Q 003978 660 LTTKTGKGTPQWMAPEVLRNEP--SDEKSDVYSFGVILWELATEKIPWDNLNSMQ-VIGAVGFMNQRLEIPKDVDPRWAA 736 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~~~--~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~p~~~~~~l~~ 736 (782)
.......|++.|+|||.+.+.. ++.++||||||+++|+|++|..||....... ...........+.++..+++++.+
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKN 243 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHH
Confidence 2233446899999999986643 6789999999999999999999997654322 222222233345677789999999
Q ss_pred HHHHhhhhCCCCCCCHHHHH
Q 003978 737 IVESCWHSDPQCRPSFQELV 756 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell 756 (782)
||.+||..+|.+||++.+++
T Consensus 244 li~~~l~~~p~~Rpt~~~ll 263 (268)
T cd06624 244 FILRCFEPDPDKRASAHDLL 263 (268)
T ss_pred HHHHHcCCCchhCCCHHHHH
Confidence 99999999999999999994
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=325.12 Aligned_cols=248 Identities=28% Similarity=0.444 Sum_probs=203.0
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeec------C
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS------P 574 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~------~ 574 (782)
.+.|++.+.||.|+||.||++.+ .++.+|+|++.... .....+..|+.+++.+ +|+||+++++++.. .
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 46889999999999999999997 46679999986532 2335677899999998 69999999999853 4
Q ss_pred CceeEEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 575 QRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
..+|++|||+.+++|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++.
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 5789999999999999999653 345788889999999999999999998 9999999999999999999999999987
Q ss_pred ccccccccccCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCC
Q 003978 654 LKHETYLTTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 728 (782)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 728 (782)
.............|++.|+|||++. +..++.++|||||||++|+|++|..||...........+...........
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 249 (282)
T cd06636 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSK 249 (282)
T ss_pred hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCccc
Confidence 5543333334557899999999986 34577899999999999999999999977665444433322222222334
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHH
Q 003978 729 DVDPRWAAIVESCWHSDPQCRPSFQELV 756 (782)
Q Consensus 729 ~~~~~l~~LI~~cL~~dP~~RPs~~ell 756 (782)
.++.++.+||.+||..||.+||++.+++
T Consensus 250 ~~~~~~~~li~~cl~~~p~~Rp~~~ell 277 (282)
T cd06636 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLL 277 (282)
T ss_pred ccCHHHHHHHHHHhCCChhhCcCHHHHh
Confidence 6889999999999999999999999994
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=322.94 Aligned_cols=256 Identities=30% Similarity=0.526 Sum_probs=216.7
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
..|+..+.||.|+||.||++.+ .+..||||++..... ......+.+|+.+++.+.||||+++++.+..+...|+|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 4578889999999999999987 467899999875432 3445788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
|+++++|.+++.. .++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 83 YLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 9999999999875 35888899999999999999999988 9999999999999999999999999987554333223
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhh
Q 003978 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 742 (782)
....++..|+|||++.+..++.++|+|||||++|+|++|..||...........+. ....+.++..++..+.+||.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-cCCCCCCchhhhHHHHHHHHHHc
Confidence 34467889999999998889999999999999999999999998777655444332 22234555678899999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 743 HSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 743 ~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
..+|++||++.++ +.++||.....
T Consensus 238 ~~~p~~Rp~~~~i------l~~~~~~~~~~ 261 (277)
T cd06640 238 NKDPSFRPTAKEL------LKHKFIVKNAK 261 (277)
T ss_pred ccCcccCcCHHHH------HhChHhhhcch
Confidence 9999999999999 56777765544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=326.01 Aligned_cols=261 Identities=24% Similarity=0.314 Sum_probs=214.7
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCC---HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS---DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
+|++.+.||.|+||.||+|.. .++.|+||.++..... ......+..|+++++.++|+||+++++++...+.+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488899999999999999987 4678999999765543 33455677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
|||+ +++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 9999 88999999765557899999999999999999999999 99999999999999999999999999976554433
Q ss_pred cccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------------
Q 003978 661 TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ----------------- 722 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~----------------- 722 (782)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||........+..+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 3334457889999999865 4568899999999999999999888876665443333211000
Q ss_pred ---------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcCC
Q 003978 723 ---------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVG 775 (782)
Q Consensus 723 ---------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~~ 775 (782)
........+.++.+||.+||..||++|||+.++ +.++||+.......
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~------l~~~~~~~~~~~~~ 293 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQA------LEHPYFSNDPAPTP 293 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHH------hhCccccCCCCCCC
Confidence 000123457889999999999999999999999 67899988766654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.22 Aligned_cols=253 Identities=31% Similarity=0.515 Sum_probs=211.7
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
++|++++.||.|+||.||+|.. .+..+++|++....... ....+.+|+++++.++|+||+++++.+...+..|++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4799999999999999999987 46679999987655433 56788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc--CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 583 FLPRGSLFRLLQRN--TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 583 ~~~ggsL~~~l~~~--~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
++++++|.+++... ...+++..+..++.|++.||.|||+++ |+|+||||+||++++++.++|+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999999754 246899999999999999999999998 99999999999999999999999999875543322
Q ss_pred c----ccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC-----CCC
Q 003978 661 T----TKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP-----KDV 730 (782)
Q Consensus 661 ~----~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p-----~~~ 730 (782)
. .....|++.|++||.+... .++.++|+|||||++|+|++|+.||...+............ ...++ ..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 236 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-PPSLETGADYKKY 236 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC-CCCcCCccccccc
Confidence 1 1234689999999998776 78899999999999999999999998777655444432221 11111 357
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 731 DPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 731 ~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
+..+.+||.+||..||++||++.++ +.|+||
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~l------l~~p~~ 267 (267)
T cd06610 237 SKSFRKMISLCLQKDPSKRPTAEEL------LKHKFF 267 (267)
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHH------hhCCCC
Confidence 8899999999999999999999999 456665
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.26 Aligned_cols=255 Identities=29% Similarity=0.487 Sum_probs=207.1
Q ss_pred cceeEeeeeccCCcEEEEEEEE------cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC--Cc
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QR 576 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~------~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~ 576 (782)
+-|++++.||+|+||.||++.+ .+..||+|.++... .......+.+|+.+++.+.||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3578999999999999999974 35679999986543 344556789999999999999999999998765 56
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
.+++|||++|++|.+++......+++..++.++.||+.||+|||+++ |+|+||||+||+++.++.++|+|||++....
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCccccccc
Confidence 89999999999999999776556899999999999999999999998 9999999999999999999999999987654
Q ss_pred cccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh--------------HHHHHHhhc
Q 003978 657 ETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS--------------MQVIGAVGF 719 (782)
Q Consensus 657 ~~~~---~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~--------------~~~~~~i~~ 719 (782)
.... ......++..|+|||++.+..++.++|||||||++|+|+++..|+..... .........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 3221 11234567789999999988899999999999999999998765432110 000001111
Q ss_pred cccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 720 MNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 720 ~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
.......+..++..+.+||.+||+.||++||++.++++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1223445667899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.65 Aligned_cols=245 Identities=24% Similarity=0.367 Sum_probs=189.0
Q ss_pred eeeeccCCcEEEEEEEEc----CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec--CCceeEEEee
Q 003978 510 GEQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRLCIVTEF 583 (782)
Q Consensus 510 ~~~IG~G~~G~Vy~~~~~----~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~E~ 583 (782)
+++||+|+||.||+|... +..||+|.+...... ..+.+|+.+|+.++||||+++++++.. ...+|++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999863 456999998654432 346689999999999999999998854 4568999999
Q ss_pred cCCCCHHHHHhhc--------CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----cCCCcEEEEecCC
Q 003978 584 LPRGSLFRLLQRN--------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGL 651 (782)
Q Consensus 584 ~~ggsL~~~l~~~--------~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl----~~~~~vkL~DFGl 651 (782)
+. ++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 94 5898887532 235889999999999999999999999 9999999999999 4567899999999
Q ss_pred Cccccccc---ccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChH---------HHHHHhh
Q 003978 652 SRLKHETY---LTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSM---------QVIGAVG 718 (782)
Q Consensus 652 a~~~~~~~---~~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~---------~~~~~i~ 718 (782)
++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...... ..+..+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 97654322 122345789999999999874 5789999999999999999999999643321 1111110
Q ss_pred c-cccc-------------------------c----------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 719 F-MNQR-------------------------L----------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 719 ~-~~~~-------------------------~----------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
. .... . ......+.++.+||.+||..||.+|||+.++ |
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~------l 312 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA------M 312 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHH------h
Confidence 0 0000 0 0011235678999999999999999999999 5
Q ss_pred HHHHh
Q 003978 763 QRQYF 767 (782)
Q Consensus 763 ~~~~~ 767 (782)
+|+||
T Consensus 313 ~hp~f 317 (317)
T cd07868 313 QDPYF 317 (317)
T ss_pred cCCCC
Confidence 67776
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=320.55 Aligned_cols=254 Identities=28% Similarity=0.523 Sum_probs=213.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (782)
.++|++.+.||.|+||.||++..+ ...+++|.+.... .......+.+|+++++.++|+||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 368999999999999999999863 3458999875433 23356778999999999999999999999998899
Q ss_pred eeEEEeecCCCCHHHHHhhcC--------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEe
Q 003978 577 LCIVTEFLPRGSLFRLLQRNT--------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~--------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~D 648 (782)
.|+||||+++++|.+++.... ..+++..+..++.||+.||+|||+++ |+|+||||+||+++.++.++|+|
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEEcc
Confidence 999999999999999997543 15899999999999999999999998 99999999999999999999999
Q ss_pred cCCCcccccc-cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCC
Q 003978 649 FGLSRLKHET-YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEI 726 (782)
Q Consensus 649 FGla~~~~~~-~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~ 726 (782)
||++...... ........++..|++||.+.+..++.++|||||||++|+|++ |..||...........+.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence 9998643221 222233456778999999988888899999999999999998 89999877766666555433333445
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003978 727 PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 760 (782)
Q Consensus 727 p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~ 760 (782)
+..++..+.++|.+||..+|++||++.++++.|.
T Consensus 241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 6678999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=322.94 Aligned_cols=255 Identities=30% Similarity=0.446 Sum_probs=208.4
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecC-----
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSP----- 574 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~----- 574 (782)
..++|++.+.||+|+||.||++.. .++.+|+|++..... ....+.+|+.+++.+ +||||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 457899999999999999999987 467899999865332 234567889999998 799999999998643
Q ss_pred CceeEEEeecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCC
Q 003978 575 QRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGl 651 (782)
..+|+||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEeeccc
Confidence 358999999999999998853 3456899999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCCC-----CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-ccccC
Q 003978 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNEP-----SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLE 725 (782)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-----~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~ 725 (782)
+..............|+..|+|||++.... ++.++|||||||++|+|++|+.||...........+... .....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (291)
T cd06639 175 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL 254 (291)
T ss_pred chhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCC
Confidence 876544333333456899999999986433 578999999999999999999999887765554443221 11223
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003978 726 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 726 ~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~ 768 (782)
.+..++..+.+||.+||..+|++||++.++ ++|+||+
T Consensus 255 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~i------l~~~~~~ 291 (291)
T cd06639 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHL------LEHPFIK 291 (291)
T ss_pred cccccCHHHHHHHHHHhhcChhhCcCHHHH------hcCcccC
Confidence 345677899999999999999999999999 5678774
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=326.33 Aligned_cols=254 Identities=26% Similarity=0.346 Sum_probs=207.4
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
++|++.++||+|+||.||+|.+. ++.||+|++............+.+|+++++.++||||+++++++..+...|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47899999999999999999984 6789999986654444445678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
|+++++|..+.... ..+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 99998888876543 35899999999999999999999998 9999999999999999999999999987654433333
Q ss_pred cCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-------------------
Q 003978 663 KTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------------- 722 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~------------------- 722 (782)
....++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 34567899999999876 4467899999999999999999999976554333222211000
Q ss_pred -c---------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 723 -R---------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 723 -~---------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
. ....+.++..+.+||.+||..+|++||++.++ ++|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i------l~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL------LHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHH------hcCCCC
Confidence 0 01124578899999999999999999999999 556665
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=351.13 Aligned_cols=258 Identities=19% Similarity=0.283 Sum_probs=193.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEEcCC---eEEEEE--------------E-eccCCCHHHHHHHHHHHHHHHhCCCCce
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWYGS---DVAVKV--------------F-SRQEYSDEVIHSFRQEVSLMKRLRHPNV 564 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~~~---~vAiK~--------------~-~~~~~~~~~~~~~~~Ei~il~~l~HpnI 564 (782)
..++|+++++||+|+||.||+|..+.. .+++|. + +...........+.+|+.+|+.++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 457899999999999999999875321 122221 1 1111122345668899999999999999
Q ss_pred eEEeeeeecCCceeEEEeecCCCCHHHHHhhcC----CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC
Q 003978 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT----TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK 640 (782)
Q Consensus 565 v~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~----~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~ 640 (782)
|++++++...+..|++|+++ +++|..++.... .......++.++.||+.||.|||+++ ||||||||+||||+.
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~ 302 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNC 302 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECC
Confidence 99999999999999999999 558888775432 12345667789999999999999998 999999999999999
Q ss_pred CCcEEEEecCCCcccccccc-cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCC-CCCCCC--h-HHHHH
Q 003978 641 HWTVKVGDFGLSRLKHETYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKI-PWDNLN--S-MQVIG 715 (782)
Q Consensus 641 ~~~vkL~DFGla~~~~~~~~-~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~-Pf~~~~--~-~~~~~ 715 (782)
++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||+||||++|.. ||.... . .+...
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 99999999999976543321 2234579999999999999999999999999999999999875 443322 1 11111
Q ss_pred Hhhccc---c---------------------ccCC-----CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 716 AVGFMN---Q---------------------RLEI-----PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 716 ~i~~~~---~---------------------~~~~-----p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
.+.... . ...+ ...++.++.++|.+||..||.+|||+.|+ |.|+|
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~el------L~hp~ 456 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAEL------LALPL 456 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHH------hhChh
Confidence 111000 0 0000 11356678889999999999999999999 66888
Q ss_pred hhc
Q 003978 767 FQA 769 (782)
Q Consensus 767 ~~~ 769 (782)
|+.
T Consensus 457 f~~ 459 (501)
T PHA03210 457 FSA 459 (501)
T ss_pred hhc
Confidence 865
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=321.80 Aligned_cols=256 Identities=29% Similarity=0.484 Sum_probs=204.2
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHH-HHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSL-MKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
++|++.+.||+|+||.||++.+ .+..||||.++........ ..+..|+.+ ++.++||||+++++++..++..|++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 4789999999999999999987 4778999998765443333 334445554 66778999999999999999999999
Q ss_pred eecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHhhhcC-CCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 582 EFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 582 E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qll~aL~~LH~~-~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
||++ ++|.+++.. ....+++..++.++.||+.||+|||++ + ++|+||||+||+++.++.+||+|||++.....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9995 688887754 234689999999999999999999986 7 99999999999999999999999999876543
Q ss_pred ccccccCCCCCCcccCcccccC----CCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhccccccCCC-CCCC
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRN----EPSDEKSDVYSFGVILWELATEKIPWDNLN-SMQVIGAVGFMNQRLEIP-KDVD 731 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~----~~~s~~sDIwSLG~ll~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~p-~~~~ 731 (782)
... .....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.... ....+..+. ......++ ..++
T Consensus 157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (283)
T cd06617 157 SVA-KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAEKFS 234 (283)
T ss_pred ccc-cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCCCCCccccC
Confidence 221 123467899999999865 446789999999999999999999997533 222222221 12222333 3578
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 732 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 732 ~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
.++.+||.+||..+|.+||++.++ +.++||+....
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~i------l~~~~~~~~~~ 269 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPEL------LQHPFFELHLS 269 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHH------hcCchhhhccc
Confidence 999999999999999999999999 66899877653
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=316.24 Aligned_cols=255 Identities=31% Similarity=0.485 Sum_probs=217.7
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
++|++.+.||.|++|.||++... +..|+||++...... .....+.+|+.++..++|+||+++++.+.....++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 36889999999999999999884 678999998765432 456788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~-~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
|+++++|.+++... ..+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 99999999999765 568999999999999999999999 88 999999999999999999999999998765544333
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHhhccccccCCCCC-CCHHHHHH
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN---SMQVIGAVGFMNQRLEIPKD-VDPRWAAI 737 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~~p~~-~~~~l~~L 737 (782)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+....+. ......++.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHHHH
Confidence 334467899999999999889999999999999999999999998774 333333332 2233445555 88999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 738 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 738 I~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
|.+||..+|++||++.++ +.++|++..
T Consensus 236 i~~~l~~~p~~R~~~~~l------l~~~~~~~~ 262 (264)
T cd06623 236 ISACLQKDPKKRPSAAEL------LQHPFIKKA 262 (264)
T ss_pred HHHHccCChhhCCCHHHH------HhCHHHHhc
Confidence 999999999999999999 567888754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=322.79 Aligned_cols=244 Identities=24% Similarity=0.345 Sum_probs=211.1
Q ss_pred ceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
+|++.+.||.|+||.||+|... +..||+|++.+.... ....+.+.+|+++++.++||||+++++.+..+...|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4899999999999999999874 778999999865443 3556788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
|+.+++|.+++... .++++..+..++.||+.||.|||+++ ++|+||||+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 156 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LT 156 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cc
Confidence 99999999999765 46899999999999999999999998 9999999999999999999999999987654432 22
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHhhccccccCCCCCCCHHHHHHHH
Q 003978 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS---MQVIGAVGFMNQRLEIPKDVDPRWAAIVE 739 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 739 (782)
....|+..|+|||.+.+..++.++|+|||||++|+|++|..||..... ....... .......+..++..+.++|.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ--ETADVLYPATWSTEAIDAIN 234 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh--ccccccCcccCcHHHHHHHH
Confidence 345688999999999988899999999999999999999999987764 2222222 11455677789999999999
Q ss_pred HhhhhCCCCCCCH--HHH
Q 003978 740 SCWHSDPQCRPSF--QEL 755 (782)
Q Consensus 740 ~cL~~dP~~RPs~--~el 755 (782)
+||..||.+||++ +++
T Consensus 235 ~~l~~~p~~R~~~~~~~l 252 (258)
T cd05578 235 KLLERDPQKRLGDNLKDL 252 (258)
T ss_pred HHccCChhHcCCccHHHH
Confidence 9999999999999 776
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=315.35 Aligned_cols=249 Identities=39% Similarity=0.687 Sum_probs=212.2
Q ss_pred eeEeeeeccCCcEEEEEEEEcC------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 507 LTIGEQIGQGSCGTVYHAVWYG------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~~~------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
+++.+.||.|+||.||++.... ..||+|++..... ......+..|+.+++.++|+||+++++++...+..|++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 4577899999999999998854 6799999865432 33567888999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCc-chHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~-l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
|||+++++|.+++...... +++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999999765444 899999999999999999999998 9999999999999999999999999987654431
Q ss_pred cc-ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHH
Q 003978 660 LT-TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 660 ~~-~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
.. .....+++.|++||.+.+..++.++|||||||++|+|++ |..||...+.......+.. ......+..++.++.++
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK-GYRLPKPENCPPEIYKL 236 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCcCCHHHHHH
Confidence 11 112346789999999988889999999999999999998 8999988777666655543 23445666789999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHH
Q 003978 738 VESCWHSDPQCRPSFQELVDKL 759 (782)
Q Consensus 738 I~~cL~~dP~~RPs~~ell~~L 759 (782)
+.+||..||++|||+.++++.|
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHCcCChhhCcCHHHHHhhC
Confidence 9999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.35 Aligned_cols=254 Identities=31% Similarity=0.514 Sum_probs=211.6
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC----CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY----SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
+|+..+.||+|+||.||++.. .+..||+|+++.... .......+.+|+++++.++|+||+++++++...+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999986 577899999875432 12356788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-cEEEEecCCCcccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHET 658 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~-~vkL~DFGla~~~~~~ 658 (782)
||||+.+++|.+++... .++++..++.++.||+.||.|||+++ ++|+||||+||+++.++ .+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999999999999764 46889999999999999999999998 99999999999998775 5999999998755432
Q ss_pred cc----cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH---HHHHHhhccccccCCCCCCC
Q 003978 659 YL----TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM---QVIGAVGFMNQRLEIPKDVD 731 (782)
Q Consensus 659 ~~----~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~p~~~~ 731 (782)
.. ......|+..|+|||.+.+..++.++|||||||++|+|++|..||...... .....+........++..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 11 112346789999999999888999999999999999999999999754432 22222222334556777889
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003978 732 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 732 ~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~ 768 (782)
+++.++|.+||..+|.+||++.++ +.|+||+
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~l------l~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSREL------LKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHH------hcCcccC
Confidence 999999999999999999999999 5677764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=317.47 Aligned_cols=249 Identities=27% Similarity=0.483 Sum_probs=210.8
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
+|++.+.||+|+||.||++.. .+..+|+|.+............+.+|+.+++.++|+||+++++.+.....+|+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 588999999999999999987 467799999876544444456778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc-EEEEecCCCccccccccc
Q 003978 584 LPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-VKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 584 ~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~-vkL~DFGla~~~~~~~~~ 661 (782)
+.+++|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++. +||+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 99999999996543 35789999999999999999999998 999999999999998764 699999998765543333
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHh
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 741 (782)
.....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+. .......++.++.++.++|.+|
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~ 237 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC-QGYFAPISPNFSRDLRSLISQL 237 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-cccCCCCCCCCCHHHHHHHHHH
Confidence 334468999999999988889999999999999999999999998776655544432 2223345567889999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 003978 742 WHSDPQCRPSFQELVD 757 (782)
Q Consensus 742 L~~dP~~RPs~~ell~ 757 (782)
|..+|++|||+.++++
T Consensus 238 l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 238 FKVSPRDRPSITSILK 253 (257)
T ss_pred hccChhhCcCHHHHhh
Confidence 9999999999999943
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=324.45 Aligned_cols=259 Identities=29% Similarity=0.550 Sum_probs=214.9
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCC----eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~----~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
.++|+..+.||+|+||.||++.+ .+. .+|+|++.... .......+.+|+.+++.+.||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 45789999999999999999986 333 46888876433 233345688899999999999999999998754 46
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
++++||+++|+|.+++......+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++....
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEccccccccccC
Confidence 7999999999999999876667899999999999999999999998 99999999999999999999999999976443
Q ss_pred ccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHH
Q 003978 658 TYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734 (782)
Q Consensus 658 ~~~--~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 734 (782)
... ......++..|++||.+.+..++.++|||||||++|+|++ |..||...........+. .......+..++..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 240 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-KGERLPQPPICTIDV 240 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHH
Confidence 221 1223345778999999999999999999999999999997 999998776555443332 333445566788999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 735 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
.++|.+||..+|++||++.++++.|.++.+...
T Consensus 241 ~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 241 YMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 999999999999999999999999999876654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=313.23 Aligned_cols=253 Identities=34% Similarity=0.579 Sum_probs=218.6
Q ss_pred ceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC--CceeEEE
Q 003978 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLCIVT 581 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv~ 581 (782)
+|.+.+.||+|++|.||+|... +..|++|++............+.+|+.+++.++||||+++++.+... ..++++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999985 77899999877665556678899999999999999999999999888 8899999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc-
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 660 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 660 (782)
||+++++|.+++.... .+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999999999997655 7899999999999999999999988 99999999999999999999999999876655432
Q ss_pred -cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhccccccCCCCCCCHHHHHHH
Q 003978 661 -TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN-SMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 661 -~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 738 (782)
......++..|++||.+.+...+.++||||||+++|+|++|..||.... .......+........++..++..+.+||
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 237 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence 1334578999999999998889999999999999999999999998776 23333333323445667788899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 739 ~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
.+||..||.+||++.++ +.|+||
T Consensus 238 ~~~l~~~p~~Rp~~~~l------l~~~~~ 260 (260)
T cd06606 238 RKCLRRDPKKRPTADEL------LQHPFL 260 (260)
T ss_pred HHhCcCChhhCCCHHHH------hhCCCC
Confidence 99999999999999999 556664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=318.57 Aligned_cols=256 Identities=31% Similarity=0.528 Sum_probs=216.0
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
+-|++.+.||.|+||.||++.. .+..||||++..... ......+.+|+.+++.++||||+++++.+..+...|+|||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 3477889999999999999986 467899999865432 3445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
|+++++|.+++.. ..+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 83 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence 9999999999864 35889999999999999999999988 9999999999999999999999999987554432223
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhh
Q 003978 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 742 (782)
....++..|++||.+.+...+.++|+|||||++|+|++|..||...........+. ......++..++.++.++|.+||
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l 237 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEACL 237 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHc
Confidence 34568899999999988888999999999999999999999998776655444442 22344566678999999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 743 HSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 743 ~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
..+|.+||++.++ +.|+||+....
T Consensus 238 ~~~p~~Rp~~~~~------l~~~~~~~~~~ 261 (277)
T cd06641 238 NKEPSFRPTAKEL------LKHKFIVRFAK 261 (277)
T ss_pred cCChhhCcCHHHH------HhCHHHhhhhh
Confidence 9999999999999 45678765543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=323.53 Aligned_cols=253 Identities=25% Similarity=0.371 Sum_probs=206.0
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
+|++++.||.|++|.||++.. .+..||||.++...........+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 488999999999999999987 467899999875544344446788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 584 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 584 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
+. ++|..++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence 95 5898888653 346889999999999999999999998 9999999999999999999999999987554333233
Q ss_pred cCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-------------------
Q 003978 663 KTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------------- 722 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~-~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~------------------- 722 (782)
....+++.|+|||++.+.. ++.++|||||||++|+|+||+.||...+.......+.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 3445788999999987644 58899999999999999999999987665433322211000
Q ss_pred --------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 723 --------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 723 --------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
...+.+.+++++++||.+||..||.+||++.++ +.|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~------l~~~~f 284 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAA------LAHPFF 284 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHH------hcCCCC
Confidence 001123578899999999999999999999999 456665
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=316.79 Aligned_cols=247 Identities=32% Similarity=0.586 Sum_probs=209.2
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
+|++.+.||+|+||.||++.. .++.|++|+++...........+.+|+.+++.++|+||+++++.+...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588999999999999999986 567899999987665556778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc-
Q 003978 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT- 662 (782)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~- 662 (782)
+++++|.+++... ..+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 9999999999764 35788999999999999999999998 9999999999999999999999999987654332211
Q ss_pred ---cCCCCCCcccCcccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhccccccCCCCC--CCHH
Q 003978 663 ---KTGKGTPQWMAPEVLRNEP---SDEKSDVYSFGVILWELATEKIPWDNLNS-MQVIGAVGFMNQRLEIPKD--VDPR 733 (782)
Q Consensus 663 ---~~~~Gt~~y~aPE~l~~~~---~s~~sDIwSLG~ll~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~p~~--~~~~ 733 (782)
....+++.|++||++.+.. ++.++|||||||++|+|++|..||..... ......+.. .....+|.. ++..
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 236 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLSPE 236 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcccccCHH
Confidence 1246789999999998766 78899999999999999999999976643 222222322 334444544 4899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHH
Q 003978 734 WAAIVESCWHSDPQCRPSFQELV 756 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell 756 (782)
+.+||.+||..+|.+||++.+++
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~i~ 259 (264)
T cd06626 237 GKDFLDRCLESDPKKRPTASELL 259 (264)
T ss_pred HHHHHHHHccCCcccCCCHHHHh
Confidence 99999999999999999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=327.92 Aligned_cols=260 Identities=30% Similarity=0.519 Sum_probs=222.6
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEcC-CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
.+.......++++||+|-||.|.+|...+ ..||+|.++.... ......|.+|+++|.+|+|||||+++++|..++.++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 35566788999999999999999999876 8899999976653 344688999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcc-hHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKL-DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l-~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
+|+|||+.|+|.+++..+..+. .-.....|+.||+.||+||.+.+ +|||||.+.|+|++.++++||+|||+++....
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCccccccccc
Confidence 9999999999999998874443 55566779999999999999999 99999999999999999999999999984332
Q ss_pred -cc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCChHHHHHHhhcccc------ccCCC
Q 003978 658 -TY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT--EKIPWDNLNSMQVIGAVGFMNQ------RLEIP 727 (782)
Q Consensus 658 -~~-~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt--G~~Pf~~~~~~~~~~~i~~~~~------~~~~p 727 (782)
.+ ......+-..+|||||.+...+++.++|+|++|+++||+++ ...||..+...++.+....+.. -+..|
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence 22 22223345789999999999999999999999999999765 7899999999888877654332 24577
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 728 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 728 ~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
..++..+.++|.+||..+.++||+++++...|.+.
T Consensus 770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 770 PACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 88999999999999999999999999997776654
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=320.85 Aligned_cols=255 Identities=31% Similarity=0.524 Sum_probs=210.5
Q ss_pred cceeEeeeeccCCcEEEEEEEEc------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec--CCc
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQR 576 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~ 576 (782)
++|++.+.||+|+||.||++.+. +..+|||+++..... .....+.+|+++++.+.||||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 57888999999999999999864 457999998765443 456788999999999999999999999877 557
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
.+++|||+++++|.+++......+++..++.++.||+.||+|||+++ |+|+||||+||+++.++.++|+|||++....
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 89999999999999999876667999999999999999999999998 9999999999999999999999999998655
Q ss_pred cccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH--------------HHHHhhc
Q 003978 657 ETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ--------------VIGAVGF 719 (782)
Q Consensus 657 ~~~~---~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~--------------~~~~i~~ 719 (782)
.... ......++..|++||.+.+..++.++|||||||++|+|++|..||....... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 3211 1112345667999999998889999999999999999999999986532211 0111111
Q ss_pred cccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 720 MNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 720 ~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
.......+..++.++.+|+.+||..+|.+||++.++++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1223344566789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=323.71 Aligned_cols=259 Identities=24% Similarity=0.361 Sum_probs=211.9
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
++|++.+.||+|+||.||++.+. ++.|+||.+...... ......+.+|+++++.++||||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36899999999999999999874 567999998765432 234567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc--
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-- 659 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-- 659 (782)
||++|++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 999999999999765 46889999999999999999999998 9999999999999999999999999886321110
Q ss_pred -------------ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-ccC
Q 003978 660 -------------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLE 725 (782)
Q Consensus 660 -------------~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~ 725 (782)
.......|+..|+|||.+.+..++.++|||||||++|+|++|..||.+....+....+..... .+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 011123578899999999988899999999999999999999999987776665555432221 222
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 726 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 726 ~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
....++.++.+||.+||..||++||+..++++. +.++||..
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~l---l~~~~~~~ 278 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEV---KQHRFFLG 278 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHH---HhCccccC
Confidence 233688999999999999999999985444332 56788744
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=324.78 Aligned_cols=254 Identities=25% Similarity=0.340 Sum_probs=209.0
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC--CceeEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLCIV 580 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv 580 (782)
++|++.+.||.|+||.||+|.+. ++.+++|.++...........+.+|+.++..++||||+++++++... ..+|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57899999999999999999984 67799999976554444445667899999999999999999998877 889999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
|||+. ++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++........
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 99996 5999999776667899999999999999999999998 99999999999999999999999999876554433
Q ss_pred cccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------------
Q 003978 661 TTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ----------------- 722 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~~~-~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~----------------- 722 (782)
......+++.|+|||.+.+.. ++.++|||||||++|+|++|..||...........+.....
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 333456789999999987654 58899999999999999999999987766554433211000
Q ss_pred ------------ccCCCCC-CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 723 ------------RLEIPKD-VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 723 ------------~~~~p~~-~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
...++.. +++.+.+||.+||..+|++|||+.++ +.++||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~el------l~~~~f 293 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDA------LKHPYF 293 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHH------hcCCCC
Confidence 0112222 58889999999999999999999999 455665
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=313.44 Aligned_cols=249 Identities=30% Similarity=0.503 Sum_probs=218.2
Q ss_pred ceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
+|.+.+.||.|+||.||++.+. +..|++|++............+.+|+++++.++|||++++++.+......+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5889999999999999999985 77899999987666556677888999999999999999999999998999999999
Q ss_pred cCCCCHHHHHhhc---CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 584 LPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 584 ~~ggsL~~~l~~~---~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
+++++|.+++... ...+++..++.++.+++.||.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 9999999999764 367899999999999999999999998 99999999999999999999999999876555432
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHH
Q 003978 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 740 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 740 (782)
......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+......... ......++..++..+.++|.+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~ 237 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-KGQYPPIPSQYSSELRNLVSS 237 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHH
Confidence 3334578999999999999889999999999999999999999998877665555443 223455667889999999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 003978 741 CWHSDPQCRPSFQELVD 757 (782)
Q Consensus 741 cL~~dP~~RPs~~ell~ 757 (782)
||..+|++||++.++++
T Consensus 238 ~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 238 LLQKDPEERPSIAQILQ 254 (258)
T ss_pred HcCCChhhCcCHHHHhc
Confidence 99999999999999943
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=322.01 Aligned_cols=249 Identities=25% Similarity=0.347 Sum_probs=205.5
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
++|++.++||+|+||.||+|.+. ++.|+||+++...........+.+|+++++.+.|+||+++++.+..++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36999999999999999999874 6779999987655445556788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc-c
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-T 661 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~ 661 (782)
|++++.+..++. ....+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 998766655554 3456899999999999999999999998 99999999999999999999999999876554332 2
Q ss_pred ccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc------------------
Q 003978 662 TKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------------ 722 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~------------------ 722 (782)
.....+++.|+|||++.+. .++.++|||||||++|+|++|..||...........+.....
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 2345678999999999888 788999999999999999999999987655443322211000
Q ss_pred ------------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHH
Q 003978 723 ------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELV 756 (782)
Q Consensus 723 ------------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell 756 (782)
....+..++.++.+||.+||..+|++||++.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 283 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHh
Confidence 0012334588999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=318.17 Aligned_cols=249 Identities=29% Similarity=0.548 Sum_probs=205.6
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC--------CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY--------SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~--------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
+|.+.+.||.|+||.||+|.. .++.+|+|.++.... .....+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588899999999999999976 577899998864321 1123467888999999999999999999999999
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 999999999999999999765 46889999999999999999999998 999999999999999999999999998754
Q ss_pred ccccc--cccCCCCCCcccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC----
Q 003978 656 HETYL--TTKTGKGTPQWMAPEVLRNEP--SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP---- 727 (782)
Q Consensus 656 ~~~~~--~~~~~~Gt~~y~aPE~l~~~~--~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p---- 727 (782)
..... ......|+..|+|||++.... ++.++|+||||+++|+|++|..||...........+........++
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 33211 122346889999999987654 7889999999999999999999997666554443332222222222
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003978 728 KDVDPRWAAIVESCWHSDPQCRPSFQELVD 757 (782)
Q Consensus 728 ~~~~~~l~~LI~~cL~~dP~~RPs~~ell~ 757 (782)
..++.++.+||.+||..+|++||++.++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 356899999999999999999999999943
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=322.93 Aligned_cols=258 Identities=28% Similarity=0.461 Sum_probs=214.9
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
...+|++.+.||+|+||.||++.. .+..|++|.+..... .....+.+|+.+++.++||||+++++.+...+..|+|
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 347899999999999999999986 567799999864332 2346678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
+||+++++|.+++... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 95 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred EecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 9999999999999753 4788899999999999999999998 99999999999999999999999998865443333
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-ccccCCCCCCCHHHHHHHH
Q 003978 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLEIPKDVDPRWAAIVE 739 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~l~~LI~ 739 (782)
......|++.|++||.+.+..++.++|+|||||++|+|++|..||...+.......+... ......+..++..+++||.
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 250 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 250 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHH
Confidence 333446889999999998888899999999999999999999999876554332222111 1112233457889999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 740 SCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 740 ~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
+||..+|++||++.++ +.|+||+..+.
T Consensus 251 ~~l~~~p~~Rp~~~~i------l~h~~~~~~~~ 277 (293)
T cd06647 251 RCLEMDVEKRGSAKEL------LQHPFLKIAKP 277 (293)
T ss_pred HHccCChhhCcCHHHH------hcCHHHhcCcc
Confidence 9999999999999999 68899987774
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=311.60 Aligned_cols=247 Identities=30% Similarity=0.587 Sum_probs=216.6
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
+|++.+.||+|++|.||++.. .++.|++|.+............+.+|++++..++||||+++++++...+.++++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 588999999999999999987 466899999987766556678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccccc
Q 003978 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (782)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (782)
+++++|.+++... ..+++..++.++.|++.+|.|||+.+ |+|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 9999999999765 56899999999999999999999998 99999999999999999999999999986655443334
Q ss_pred CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhh
Q 003978 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWH 743 (782)
Q Consensus 664 ~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 743 (782)
...++..|++||.+.+..++.++|||+||+++|+|++|..||...........+. ......++..++..+.++|.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHHh
Confidence 4568999999999988888999999999999999999999998777655444443 234456677889999999999999
Q ss_pred hCCCCCCCHHHHH
Q 003978 744 SDPQCRPSFQELV 756 (782)
Q Consensus 744 ~dP~~RPs~~ell 756 (782)
.+|++||++.+++
T Consensus 237 ~~p~~R~~~~~~l 249 (254)
T cd06627 237 KDPNLRPTAKQLL 249 (254)
T ss_pred CChhhCcCHHHHh
Confidence 9999999999994
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=322.50 Aligned_cols=254 Identities=25% Similarity=0.376 Sum_probs=202.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.++|++.+.||+|+||.||++.. .++.||||.+....... ....+.+|+.+++.++||||+++++++..+...|+||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 36899999999999999999987 46789999987543221 1234567999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
||+.+ +|.+++......+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||+++........
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 99964 999999876667899999999999999999999998 999999999999999999999999998754433222
Q ss_pred ccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhcc-cc----------------
Q 003978 662 TKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNS-MQVIGAVGFM-NQ---------------- 722 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~-~~~~~~i~~~-~~---------------- 722 (782)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|..||..... .+....+... ..
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 233457889999999876 4578899999999999999999999976552 1111111000 00
Q ss_pred --cc---------CCCCCCC--HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 723 --RL---------EIPKDVD--PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 723 --~~---------~~p~~~~--~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
.. .....++ .++.++|.+||..+|++||++.++ +.++||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~------l~~~~f 291 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEA------MKHPYF 291 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHH------hcCCCC
Confidence 00 0001234 788999999999999999999999 455665
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=322.64 Aligned_cols=256 Identities=32% Similarity=0.456 Sum_probs=213.0
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
..+.|.+.+.||+|+||.||++.. .++.||+|++..... ..+....+.+|+.+++.++||||+++++++...+..|+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 345799999999999999999987 477899999865433 34555678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
||||+. ++|.+++......+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 93 VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred EHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 999996 5888887665567899999999999999999999998 999999999999999999999999998654322
Q ss_pred ccccCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHH
Q 003978 660 LTTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 736 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~---~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 736 (782)
....+++.|+|||++. ...++.++||||||+++|+|++|..||...+.......+.........+..++..+.+
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRN 245 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 2346788999999974 3557889999999999999999999998877666554443222222223457889999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 737 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
+|.+||..||++||++.++ +.++||+...
T Consensus 246 li~~~l~~~p~~Rp~~~~i------l~~~~~~~~~ 274 (307)
T cd06607 246 FVDSCLQKIPQDRPSSEEL------LKHRFVLRER 274 (307)
T ss_pred HHHHHhcCChhhCcCHHHH------hcChhhcccC
Confidence 9999999999999999999 4567876544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=361.80 Aligned_cols=257 Identities=24% Similarity=0.398 Sum_probs=225.5
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
...++|.++++||+|+||.|.+++++ ++-||||++.+... ......-|+.|-.+|...+.+=||+++.+|.++.++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 34579999999999999999999985 55699999977432 2233456888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc-c
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH-E 657 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~-~ 657 (782)
+|||||+||+|-.++.+.. ++++..+++++..|+.||..||+.| +|||||||+||||+..|+|||+|||.+-... +
T Consensus 152 lVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 9999999999999998877 8999999999999999999999999 9999999999999999999999999776555 5
Q ss_pred ccccccCCCCCCcccCccccc----C-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC--CCC
Q 003978 658 TYLTTKTGKGTPQWMAPEVLR----N-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP--KDV 730 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~----~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~ 730 (782)
....+...+|||.|.+||++. + ..|+.-.|+|||||++|||++|..||....-...+.+|......+.+| ..+
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~V 308 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDV 308 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccccc
Confidence 556677789999999999985 3 457889999999999999999999999988889999987777777888 568
Q ss_pred CHHHHHHHHHhhhhCCCCCCC---HHHHHHHHHHHHHHHhh
Q 003978 731 DPRWAAIVESCWHSDPQCRPS---FQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 731 ~~~l~~LI~~cL~~dP~~RPs---~~ell~~L~~L~~~~~~ 768 (782)
|.++++||.+.+. +|+.|.. +.++ -.|+||.
T Consensus 309 SeeakdLI~~ll~-~~e~RLgrngiedi------k~HpFF~ 342 (1317)
T KOG0612|consen 309 SEEAKDLIEALLC-DREVRLGRNGIEDI------KNHPFFE 342 (1317)
T ss_pred CHHHHHHHHHHhc-ChhhhcccccHHHH------HhCcccc
Confidence 9999999999776 6888877 8888 4678883
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=318.17 Aligned_cols=249 Identities=31% Similarity=0.486 Sum_probs=204.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCC-----
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQ----- 575 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~----- 575 (782)
.++|++.+.||.|+||.||+|.. .++.+++|++..... ....+.+|+.+++.+ .|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 47899999999999999999998 456799999875442 235788999999999 6999999999986544
Q ss_pred -ceeEEEeecCCCCHHHHHhhc---CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCC
Q 003978 576 -RLCIVTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (782)
Q Consensus 576 -~~~lv~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGl 651 (782)
.+|++|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999999998653 357899999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccccccCCCCCCcccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-ccC
Q 003978 652 SRLKHETYLTTKTGKGTPQWMAPEVLRN-----EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLE 725 (782)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~ 725 (782)
+..............|++.|+|||++.. ..++.++|||||||+||+|++|..||...........+..... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd06608 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLK 239 (275)
T ss_pred ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCC
Confidence 8765443333345568999999998754 3457789999999999999999999987655544444322111 222
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003978 726 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVD 757 (782)
Q Consensus 726 ~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~ 757 (782)
.+..++.++++||.+||..||++|||+.++++
T Consensus 240 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 240 SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 23347889999999999999999999999953
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=325.09 Aligned_cols=257 Identities=28% Similarity=0.435 Sum_probs=213.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.+.|.....||+|+||.||++.. .+..||||.+.... ......+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 34566667899999999999987 46789999886432 334566889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
||+++++|.+++.. ..+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++.........
T Consensus 99 e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 99 EFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred eCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence 99999999998864 35888999999999999999999998 999999999999999999999999998754333322
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-ccccCCCCCCCHHHHHHHHH
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLEIPKDVDPRWAAIVES 740 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~l~~LI~~ 740 (782)
.....|++.|+|||.+.+..++.++|||||||++|+|++|..||...........+... .........++..+.+||.+
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL 254 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence 33456899999999999888999999999999999999999999877766554443221 11222233578899999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 741 CWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 741 cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
||..||.+|||+.++ ++++||+...+
T Consensus 255 ~l~~~P~~Rpt~~~i------l~~~~~~~~~~ 280 (292)
T cd06658 255 MLVREPSQRATAQEL------LQHPFLKLAGP 280 (292)
T ss_pred HccCChhHCcCHHHH------hhChhhhccCC
Confidence 999999999999999 56899975443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=322.11 Aligned_cols=253 Identities=29% Similarity=0.448 Sum_probs=209.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.++|++.+.||+|+||.||++... +..||+|++.... .......+.+|+++++.++||||+++++.+.....+|+||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 468999999999999999999875 7789999986543 2445577889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~-~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
||+++++|.+++... ..+++..+..++.+++.+|.|||+ ++ ++|+||||+||++++++.++|+|||++.......
T Consensus 83 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 83 EFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred ecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 999999999998764 368999999999999999999997 57 9999999999999999999999999986543221
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-----------HHHHHhhccccccCCCC-
Q 003978 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM-----------QVIGAVGFMNQRLEIPK- 728 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~-----------~~~~~i~~~~~~~~~p~- 728 (782)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||...... .....+. ......++.
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 236 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-QEPPPRLPSS 236 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-hccCCCCCch
Confidence 22457899999999998888899999999999999999999999865442 1111111 111222333
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 729 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 729 ~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
.++.++.+||.+||..||++||++.++ +.++||..
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~------~~~~~~~~ 271 (284)
T cd06620 237 DFPEDLRDFVDACLLKDPTERPTPQQL------CAMPPFIQ 271 (284)
T ss_pred hcCHHHHHHHHHHhcCCcccCcCHHHH------hcCccccc
Confidence 378899999999999999999999999 45566644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=322.58 Aligned_cols=255 Identities=25% Similarity=0.319 Sum_probs=204.6
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCc-----
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQR----- 576 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~----- 576 (782)
++|++.+.||+|+||.||++.+ .++.||||+++...........+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4689999999999999999987 4678999998665433333456788999999995 6999999999877665
Q ss_pred eeEEEeecCCCCHHHHHhhc----CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCcEEEEecCC
Q 003978 577 LCIVTEFLPRGSLFRLLQRN----TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGL 651 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~----~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~-~~~vkL~DFGl 651 (782)
+|++|||+++ +|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+||+++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeeccc
Confidence 8999999975 898888543 235799999999999999999999998 999999999999998 88999999999
Q ss_pred CcccccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--------
Q 003978 652 SRLKHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-------- 722 (782)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~-------- 722 (782)
+..............+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 8755433222233457889999998865 4568999999999999999999999987765554333211100
Q ss_pred ------------------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003978 723 ------------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 723 ------------------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~ 768 (782)
.....+.++.++.+||.+||..||.+||++.++ +.|+||+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~ei------l~~~~~~ 295 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAA------LTHPYFD 295 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHH------hcCCCcC
Confidence 000113578899999999999999999999999 6678774
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=331.15 Aligned_cols=253 Identities=26% Similarity=0.358 Sum_probs=205.4
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC------
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 574 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 574 (782)
..++|++.+.||+|+||.||++.. .++.||||++.+..........+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999987 577899999876544445556777899999999999999999988644
Q ss_pred CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
...|+||||+. ++|.+.+... ++...+..++.|++.||+|||.++ |+|+||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 34799999995 5888888643 888899999999999999999998 99999999999999999999999999986
Q ss_pred cccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc------------
Q 003978 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------ 722 (782)
Q Consensus 655 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~------------ 722 (782)
...... .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 168 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 168 AGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred CCCCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 544322 2344688999999999999999999999999999999999999987664332222210000
Q ss_pred --------cc---------------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003978 723 --------RL---------------------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 723 --------~~---------------------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~ 768 (782)
.. ..+...+..+.+||.+||..||.+|||+.++ |.|+||+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ei------L~~~~~~ 315 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDA------LQHPYIN 315 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHH------hcChhHh
Confidence 00 0012346678999999999999999999999 5677775
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=318.28 Aligned_cols=255 Identities=28% Similarity=0.505 Sum_probs=212.5
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC---CCceeEEeeeeecCCceeEE
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lv 580 (782)
.|++.+.||.|+||.||+|.+ .+..|++|++.... .......+.+|+.+++.+. ||||+++++++......|++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 478889999999999999997 46789999986543 2334567788999999996 99999999999998999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
|||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 81 MEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 9999999999998653 6889999999999999999999998 99999999999999999999999999876554433
Q ss_pred cccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCC-CCCHHHHHHH
Q 003978 661 TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK-DVDPRWAAIV 738 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~~l~~LI 738 (782)
......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+... ....++. .++.++.+||
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i 235 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLEDNGYSKLLREFV 235 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCCcccCCHHHHHHH
Confidence 3344578999999998865 45688999999999999999999999877665544333211 2223333 3788999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 739 ~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
.+||..||++||++.++ +.++||+....
T Consensus 236 ~~~l~~~p~~R~~~~~i------l~~~~~~~~~~ 263 (277)
T cd06917 236 AACLDEEPKERLSAEEL------LKSKWIKAHSK 263 (277)
T ss_pred HHHcCCCcccCcCHHHH------hhChHhhcccc
Confidence 99999999999999999 56899976553
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=319.40 Aligned_cols=256 Identities=29% Similarity=0.503 Sum_probs=217.0
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
..+.|++.+.||+|+||.||++.+. +..+++|++..... ....+..|+++++.++|+||+++++.+......|++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 4567889999999999999999985 77899999875443 446788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
|||+++++|.+++......+++..++.++.|++.||.|||+.| |+|+||||+||+++.++.++|+|||++........
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 9999999999999876557899999999999999999999988 99999999999999999999999998865443322
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-ccCCCCCCCHHHHHHHH
Q 003978 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRWAAIVE 739 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~LI~ 739 (782)
......+++.|++||.+.+..++.++|+|||||++|+|++|..||...+.......+..... ....+..++..+++||.
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence 23344678899999999988899999999999999999999999987776554444322111 12223348899999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 740 SCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 740 ~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
+||..+|.+||++.++ +.++||+.
T Consensus 252 ~~l~~~p~~Rpt~~~i------l~~~~~~~ 275 (286)
T cd06614 252 KCLVKDPEKRPSAEEL------LQHPFLKK 275 (286)
T ss_pred HHhccChhhCcCHHHH------hhChHhhc
Confidence 9999999999999999 56788865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=317.12 Aligned_cols=245 Identities=32% Similarity=0.589 Sum_probs=204.7
Q ss_pred eeccCCcEEEEEEEEcC--------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 512 QIGQGSCGTVYHAVWYG--------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 512 ~IG~G~~G~Vy~~~~~~--------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
.||+|+||.||++.... ..++||.+.... .......+.+|+.+++.++||||+++++++......+++|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 68999999999998643 468999876433 223456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc------CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-----cEEEEecCCC
Q 003978 584 LPRGSLFRLLQRN------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-----TVKVGDFGLS 652 (782)
Q Consensus 584 ~~ggsL~~~l~~~------~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~-----~vkL~DFGla 652 (782)
+++++|.+++... ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++ .++|+|||++
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999999642 234788899999999999999999988 99999999999999877 8999999998
Q ss_pred ccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCC
Q 003978 653 RLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKD 729 (782)
Q Consensus 653 ~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 729 (782)
....... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+. .......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-cCCccCCccc
Confidence 7543221 11223345788999999999889999999999999999998 999998877666554442 2334556677
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003978 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLR 760 (782)
Q Consensus 730 ~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~ 760 (782)
++..+.+||.+||..+|.+||++.++++.|+
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 8999999999999999999999999988875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.70 Aligned_cols=253 Identities=31% Similarity=0.540 Sum_probs=209.9
Q ss_pred eeEeeeeccCCcEEEEEEEEc-----CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC------
Q 003978 507 LTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------ 575 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 575 (782)
|++.+.||+|+||.||+|... +..||||++..........+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677889999999999999753 467999999876666666778889999999999999999999876432
Q ss_pred ceeEEEeecCCCCHHHHHhhc-----CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecC
Q 003978 576 RLCIVTEFLPRGSLFRLLQRN-----TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~-----~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFG 650 (782)
..++++||+.+++|.+++... ...++...++.++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECccc
Confidence 247889999999999887432 234788899999999999999999988 9999999999999999999999999
Q ss_pred CCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCC
Q 003978 651 LSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIP 727 (782)
Q Consensus 651 la~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p 727 (782)
+++...... .......+++.|++||.+.+..++.++|||||||++|+|++ |..||...+.......+.. ......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 237 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK-GNRLKQP 237 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCcCCCC
Confidence 987543221 12223345678999999998889999999999999999999 8999988776655544432 2234455
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 728 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 728 ~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
...+..+.+++.+||..+|++||++.++++.|+++
T Consensus 238 ~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 67889999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.18 Aligned_cols=252 Identities=25% Similarity=0.425 Sum_probs=209.7
Q ss_pred ceeEeeeeccCCcEEEEEEEEcC---CeEEEEEEeccC--------CCHHHHHHHHHHHHHHHh-CCCCceeEEeeeeec
Q 003978 506 DLTIGEQIGQGSCGTVYHAVWYG---SDVAVKVFSRQE--------YSDEVIHSFRQEVSLMKR-LRHPNVLLFMGAVTS 573 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~~~---~~vAiK~~~~~~--------~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~ 573 (782)
.|++.+.||+|+||.||++...+ ..+|+|.+.... ........+..|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999854 679999875432 233455667788888875 799999999999999
Q ss_pred CCceeEEEeecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCcEEEEec
Q 003978 574 PQRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (782)
Q Consensus 574 ~~~~~lv~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qll~aL~~LH~-~~~~ivHrDIKp~NILl~~~~~vkL~DF 649 (782)
++..+++|||+++++|.+++.. ....+++..++.++.|++.+|.|||. .+ |+|+||||+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988743 34568999999999999999999996 66 999999999999999999999999
Q ss_pred CCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCC
Q 003978 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKD 729 (782)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 729 (782)
|++....... ......|+..|++||.+.+..++.++||||||+++|+|++|..||...........+......+.....
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCccc
Confidence 9987654432 233456899999999999888999999999999999999999999877766555554332222222336
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003978 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLR 760 (782)
Q Consensus 730 ~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~ 760 (782)
+++.+.+||.+||..||++||++.++...+.
T Consensus 238 ~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 238 YSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 7899999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.05 Aligned_cols=245 Identities=30% Similarity=0.511 Sum_probs=194.9
Q ss_pred eeeccCCcEEEEEEEEc----CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCC
Q 003978 511 EQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~----~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 586 (782)
+.||+|+||.||+|... ...+++|.+.... .......+.+|+.+++.++||||+++++.+.....+|+||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 36899999999999753 2357777765432 334456778899999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCC----cchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc--cc
Q 003978 587 GSLFRLLQRNTT----KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET--YL 660 (782)
Q Consensus 587 gsL~~~l~~~~~----~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~--~~ 660 (782)
++|.+++..... ..++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999976432 2457778899999999999999998 999999999999999999999999998643221 11
Q ss_pred cccCCCCCCcccCcccccC-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccc----ccCCCC
Q 003978 661 TTKTGKGTPQWMAPEVLRN-------EPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQ----RLEIPK 728 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~-------~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~----~~~~p~ 728 (782)
......+++.|+|||++.. ..++.++|||||||++|+|++ |..||...........+..... .+.++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL 237 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccc
Confidence 1223346778999999743 456789999999999999999 8899988776655444322211 223445
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003978 729 DVDPRWAAIVESCWHSDPQCRPSFQELVDKL 759 (782)
Q Consensus 729 ~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L 759 (782)
.++..+.+++..|| .||++||++.++++.|
T Consensus 238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 238 KYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 68899999999999 5999999999998775
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=315.98 Aligned_cols=238 Identities=21% Similarity=0.413 Sum_probs=194.2
Q ss_pred eeeccCCcEEEEEEEEc--------------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc
Q 003978 511 EQIGQGSCGTVYHAVWY--------------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~--------------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (782)
+.||+|+||.||++... ...+++|++.... ......+.+|+.+++.++||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 46899999999999752 1247888865432 3345678889999999999999999999999889
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc-------EEEEec
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-------VKVGDF 649 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~-------vkL~DF 649 (782)
.+++|||+++++|..++......+++..++.++.||+.||+|||+++ |+||||||+||||+.++. ++++||
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 99999999999999998766667899999999999999999999998 999999999999987654 899999
Q ss_pred CCCcccccccccccCCCCCCcccCccccc-CCCCCchhHHHHHHHHHHHHH-cCCCCCCCCChHHHHHHhhccccccCCC
Q 003978 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELA-TEKIPWDNLNSMQVIGAVGFMNQRLEIP 727 (782)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~s~~sDIwSLG~ll~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~~~p 727 (782)
|++...... ....++..|+|||++. +..++.++|||||||++|+|+ +|..||............ .......
T Consensus 157 g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~---~~~~~~~ 229 (262)
T cd05077 157 GIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY---EGQCMLV 229 (262)
T ss_pred CCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH---hcCccCC
Confidence 988644321 2345788999999987 566889999999999999997 589999776544332211 1222233
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003978 728 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 759 (782)
Q Consensus 728 ~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L 759 (782)
...+.++.+||.+||..||.+||++.+|++.|
T Consensus 230 ~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 230 TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 44568899999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=320.33 Aligned_cols=253 Identities=26% Similarity=0.364 Sum_probs=200.7
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
++|++.+.||+|+||.||+|.. .+..|+||++...... .....+.+|+.+++.++|+||+++++++..+...|+|||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 5799999999999999999986 4778999998654322 222355689999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
|+. ++|.+++......+++..+..++.|++.||.|||+++ |+|+||||+|||++.++.+||+|||+++.........
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 995 6888777665556788888999999999999999998 9999999999999999999999999987544333333
Q ss_pred cCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhc-cc------------------
Q 003978 663 KTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQ-VIGAVGF-MN------------------ 721 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~-~~~~i~~-~~------------------ 721 (782)
....+++.|+|||.+.+. .++.++|||||||++|+|++|..||....... .+..+.. ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence 344678999999998764 47889999999999999999999997655321 1111100 00
Q ss_pred c--ccCCC---------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 722 Q--RLEIP---------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 722 ~--~~~~p---------~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
. ....+ ...++.+.+||.+||..||.+|||+.++ +.|+||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~------l~h~~~ 291 (291)
T cd07870 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDA------LLHPYF 291 (291)
T ss_pred hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHH------hcCCCC
Confidence 0 00000 0135789999999999999999999999 556665
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.16 Aligned_cols=258 Identities=25% Similarity=0.357 Sum_probs=207.9
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
++|++.+.||.|.+|.||++.. .++.||||.+............+.+|+++++.++||||+++++++.....+|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 5799999999999999999987 46789999986654433445677889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCcEEEEecCCCcccccccc
Q 003978 583 FLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~-~~~vkL~DFGla~~~~~~~~ 660 (782)
|++ ++|.+++.... ..+++..++.++.||+.||+|||+++ |+|+||||+||+++. ++.+||+|||++........
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 995 58888875433 33678888899999999999999998 999999999999985 56799999999975543322
Q ss_pred cccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc----------------
Q 003978 661 TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR---------------- 723 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------- 723 (782)
......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 2234467899999999876 45788999999999999999999999876654443332110000
Q ss_pred -----------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 724 -----------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 724 -----------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
....+.+++++.++|.+||..+|++||++.++ +.++||....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~------l~~~~~~~~~ 291 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAA------LEHEYFKDLG 291 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHH------hcCchHhHHh
Confidence 00124578899999999999999999999999 5689987654
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=313.43 Aligned_cols=245 Identities=30% Similarity=0.441 Sum_probs=194.7
Q ss_pred eeeccCCcEEEEEEEEcC----CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCC
Q 003978 511 EQIGQGSCGTVYHAVWYG----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~~----~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 586 (782)
+.||+|+||.||+|...+ ..+++|.++.... ......+.+|+.+++.++||||+++++++.....+++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 368999999999998643 3589998765543 23335678899999999999999999999998999999999999
Q ss_pred CCHHHHHhhcC----CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc--c
Q 003978 587 GSLFRLLQRNT----TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--L 660 (782)
Q Consensus 587 gsL~~~l~~~~----~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~ 660 (782)
++|.+++.... ...++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999996432 23566778889999999999999998 9999999999999999999999999987543321 1
Q ss_pred cccCCCCCCcccCcccccCC-------CCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcc-cc---ccCCCC
Q 003978 661 TTKTGKGTPQWMAPEVLRNE-------PSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFM-NQ---RLEIPK 728 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~~-------~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~-~~---~~~~p~ 728 (782)
......+++.|+|||++.+. .++.++|||||||++|+|++ |..||......+........ .. .+.+..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence 22234578899999998643 34779999999999999996 99999877665543332111 11 122233
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003978 729 DVDPRWAAIVESCWHSDPQCRPSFQELVDKL 759 (782)
Q Consensus 729 ~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L 759 (782)
..+..+.++|.+|| .+|++|||+++|+..|
T Consensus 238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred CCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 57789999999999 6899999999998765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=313.34 Aligned_cols=236 Identities=25% Similarity=0.443 Sum_probs=194.6
Q ss_pred eeeccCCcEEEEEEEEcCCe------------EEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 511 EQIGQGSCGTVYHAVWYGSD------------VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~~~~------------vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
+.||+|+||.||++...... +++|++...... ...+.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46999999999999885433 677776543321 5678889999999999999999999887 7789
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-------cEEEEecCC
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-------TVKVGDFGL 651 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~-------~vkL~DFGl 651 (782)
+||||+.+++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++.++ .+||+|||+
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999999876657899999999999999999999988 99999999999999887 799999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCC--CCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCC
Q 003978 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNE--PSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPK 728 (782)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~y~aPE~l~~~--~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 728 (782)
+..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||............. .....+.
T Consensus 155 a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~~~~~~~ 227 (259)
T cd05037 155 PITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---DQHRLPM 227 (259)
T ss_pred cccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---cCCCCCC
Confidence 875443 2234567889999999876 78899999999999999999 688887775433322221 2222233
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003978 729 DVDPRWAAIVESCWHSDPQCRPSFQELVDKL 759 (782)
Q Consensus 729 ~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L 759 (782)
.....+.+||.+||..+|.+||++.++++.|
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 228 PDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 3348999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=325.51 Aligned_cols=245 Identities=25% Similarity=0.371 Sum_probs=187.9
Q ss_pred eeeeccCCcEEEEEEEEc----CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeee--cCCceeEEEee
Q 003978 510 GEQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT--SPQRLCIVTEF 583 (782)
Q Consensus 510 ~~~IG~G~~G~Vy~~~~~----~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lv~E~ 583 (782)
+.+||+|+||.||+|... +..||+|.+...... ..+.+|+.+++.++||||+++++++. .+..+|++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 468999999999999864 356999998654432 34678999999999999999999885 35678999999
Q ss_pred cCCCCHHHHHhhc--------CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----cCCCcEEEEecCC
Q 003978 584 LPRGSLFRLLQRN--------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGL 651 (782)
Q Consensus 584 ~~ggsL~~~l~~~--------~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl----~~~~~vkL~DFGl 651 (782)
+. ++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 95 5888877432 234788899999999999999999998 9999999999999 4567899999999
Q ss_pred Ccccccccc---cccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChH----------HHHHHh
Q 003978 652 SRLKHETYL---TTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSM----------QVIGAV 717 (782)
Q Consensus 652 a~~~~~~~~---~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~----------~~~~~i 717 (782)
++....... ......||+.|+|||++.+. .++.++|||||||++|+|+||.+||...... +....+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 976543321 12244689999999998774 5789999999999999999999999643321 000000
Q ss_pred hccc-------------------------c----------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 718 GFMN-------------------------Q----------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 718 ~~~~-------------------------~----------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
.... . ........+..+.+||.+||..||.+|||+.|+ |
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~------l 312 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQA------L 312 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHH------h
Confidence 0000 0 000111245678899999999999999999999 5
Q ss_pred HHHHh
Q 003978 763 QRQYF 767 (782)
Q Consensus 763 ~~~~~ 767 (782)
+|+||
T Consensus 313 ~hp~f 317 (317)
T cd07867 313 QDPYF 317 (317)
T ss_pred cCCCC
Confidence 66765
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=331.74 Aligned_cols=244 Identities=27% Similarity=0.426 Sum_probs=209.7
Q ss_pred eeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCC
Q 003978 510 GEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (782)
Q Consensus 510 ~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg 587 (782)
.+.||.|.||+||-|.+ .|+.||||++.+.++..+....+++|+.||+.+.||.||.+...|+..+++++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 37899999999999976 6889999999998887766788999999999999999999999999999999999999665
Q ss_pred CHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CcEEEEecCCCcccccccccccC
Q 003978 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH---WTVKVGDFGLSRLKHETYLTTKT 664 (782)
Q Consensus 588 sL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~---~~vkL~DFGla~~~~~~~~~~~~ 664 (782)
-|.-+|.....++++....+++.||+.||.|||.++ |+|+||||+|||+... -++||||||+|+..++..... +
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr-s 725 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR-S 725 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhhhhh-h
Confidence 555556666788999999999999999999999999 9999999999999754 469999999999888765443 5
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhh
Q 003978 665 GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHS 744 (782)
Q Consensus 665 ~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~ 744 (782)
.+|||.|+|||++.++.|+..-|+||+|+++|--+.|..||.........-+-.....++.....+++++.+||..+|+.
T Consensus 726 VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqV 805 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQV 805 (888)
T ss_pred hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHH
Confidence 68999999999999999999999999999999999999999765443221111222334444457899999999999999
Q ss_pred CCCCCCCHHHHH
Q 003978 745 DPQCRPSFQELV 756 (782)
Q Consensus 745 dP~~RPs~~ell 756 (782)
+-.+|.|++..+
T Consensus 806 km~kRysvdk~l 817 (888)
T KOG4236|consen 806 KMRKRYSVDKSL 817 (888)
T ss_pred HHHHhcchHhhc
Confidence 999999998873
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=317.43 Aligned_cols=238 Identities=24% Similarity=0.443 Sum_probs=197.1
Q ss_pred eeeccCCcEEEEEEEEcC---------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 511 EQIGQGSCGTVYHAVWYG---------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~~---------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
+.||.|+||.||+|.... ..+++|.+.... ......+..|+.+++.+.||||+++++++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 369999999999997632 237778764322 334567888999999999999999999999989999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc--------EEEEecCCCc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT--------VKVGDFGLSR 653 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~--------vkL~DFGla~ 653 (782)
||+++++|..++..+...+++..++.++.||+.||+|||+++ |+||||||+||+++.++. ++++|||++.
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999999876667899999999999999999999998 999999999999987654 6999999886
Q ss_pred ccccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhccccccCCCCCCC
Q 003978 654 LKHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 731 (782)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 731 (782)
.... .....+++.|+|||++.+ ..++.++|||||||++|+|++| ..||........... ......+|...+
T Consensus 157 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 229 (258)
T cd05078 157 TVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF---YEDRHQLPAPKW 229 (258)
T ss_pred ccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH---HHccccCCCCCc
Confidence 4432 123467889999999986 4578899999999999999998 577766655443322 223455666778
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003978 732 PRWAAIVESCWHSDPQCRPSFQELVDKL 759 (782)
Q Consensus 732 ~~l~~LI~~cL~~dP~~RPs~~ell~~L 759 (782)
.++.+||.+||+.||++|||+.++++.|
T Consensus 230 ~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 230 TELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 8999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=321.87 Aligned_cols=255 Identities=27% Similarity=0.425 Sum_probs=212.3
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
..|.....||+|+||.||++.. .++.||||++...... ....+.+|+.+++.++||||+++++.+..++..|++||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 3455566899999999999987 4778999998654322 23567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
|+++++|..++.. ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..........
T Consensus 99 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 174 (297)
T cd06659 99 FLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 174 (297)
T ss_pred cCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence 9999999998864 35889999999999999999999998 9999999999999999999999999987544433333
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-cccCCCCCCCHHHHHHHHHh
Q 003978 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QRLEIPKDVDPRWAAIVESC 741 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~~l~~LI~~c 741 (782)
....|++.|+|||++.+..++.++|||||||++|+|++|..||...........+.... .....+..++..+.++|.+|
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence 34578999999999998889999999999999999999999998776655554443211 12233456788999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 742 WHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 742 L~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
|..+|.+||++.++ ++++||....
T Consensus 255 l~~~P~~Rps~~~l------l~~~~~~~~~ 278 (297)
T cd06659 255 LTREPQERATAQEL------LDHPFLLQTG 278 (297)
T ss_pred hcCCcccCcCHHHH------hhChhhccCC
Confidence 99999999999999 5568876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.33 Aligned_cols=255 Identities=28% Similarity=0.449 Sum_probs=213.2
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
.|...+.||+|++|.||++.. .++.+++|++.... ......+.+|+.+++.+.||||+++++++...+..|+++||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 455567999999999999986 46779999886432 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccccc
Q 003978 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (782)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (782)
+.+++|.+++.. .++++..+..++.|++.||+|||+++ |+|+||||+||+++.++.++|+|||++...........
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 999999999976 45889999999999999999999998 99999999999999999999999998765443322233
Q ss_pred CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-ccCCCCCCCHHHHHHHHHhh
Q 003978 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRWAAIVESCW 742 (782)
Q Consensus 664 ~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~LI~~cL 742 (782)
...|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+..... ....+..++..+.+||.+||
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence 45689999999999988899999999999999999999999987776655554432211 12223347899999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 743 HSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 743 ~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
..+|++||++.++ +.|+||+..+.
T Consensus 254 ~~~p~~Rpt~~~i------l~~~~~~~~~~ 277 (285)
T cd06648 254 VRDPAQRATAAEL------LNHPFLAKAGP 277 (285)
T ss_pred ccChhhCcCHHHH------ccCcccccCCC
Confidence 9999999999999 57899977664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=321.06 Aligned_cols=259 Identities=22% Similarity=0.300 Sum_probs=204.6
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC--
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-- 575 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 575 (782)
+....++|++.++||+|+||.||++.. .+..||||.+............+.+|+++++.++||||+++++++....
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 334456899999999999999999987 4678999998755433333345667999999999999999999876544
Q ss_pred ------ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEec
Q 003978 576 ------RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (782)
Q Consensus 576 ------~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DF 649 (782)
..|+||||+. ++|.+++......+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 87 YNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred ccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECcC
Confidence 3599999995 5898888766557899999999999999999999998 999999999999999999999999
Q ss_pred CCCcccccccc----cccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-
Q 003978 650 GLSRLKHETYL----TTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR- 723 (782)
Q Consensus 650 Gla~~~~~~~~----~~~~~~Gt~~y~aPE~l~~~~-~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~- 723 (782)
|++........ ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99875433221 112345788999999887644 688999999999999999999999877655443332221110
Q ss_pred ----------------cCCC-------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 724 ----------------LEIP-------------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 724 ----------------~~~p-------------~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
..++ ...+..+.+||.+||..||.+|||+.++ |.|+||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~------l~h~~f 310 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTA------LNHDFF 310 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHH------hcCCCC
Confidence 0011 1235678899999999999999999999 556665
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=318.28 Aligned_cols=247 Identities=27% Similarity=0.353 Sum_probs=202.6
Q ss_pred eeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeec
Q 003978 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 584 (782)
|++.+.||.|++|.||++.+ .+..|++|++............+.+|+++++.++||||+++++++...+..|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67789999999999999987 5788999998765444444456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccccc
Q 003978 585 PRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (782)
Q Consensus 585 ~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (782)
+ ++|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence 4 69999987644 46899999999999999999999988 99999999999999999999999999875543322223
Q ss_pred CCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc---------------------
Q 003978 664 TGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN--------------------- 721 (782)
Q Consensus 664 ~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~--------------------- 721 (782)
...+++.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+....
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 34568899999988764 46889999999999999999999998766543332221100
Q ss_pred ------cccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHH
Q 003978 722 ------QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELV 756 (782)
Q Consensus 722 ------~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell 756 (782)
......+.++..+.+||.+||..||.+||++.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il 278 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAAL 278 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 00112345778999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.34 Aligned_cols=249 Identities=24% Similarity=0.373 Sum_probs=205.2
Q ss_pred eccCCcEEEEEEEE--cCCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCCCH
Q 003978 513 IGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (782)
Q Consensus 513 IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ggsL 589 (782)
||+|+||.||+|.. .++.||+|++...... ......+..|+++++.++||||+++++.+...+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999986 4778999998764432 23345667899999999999999999999999999999999999999
Q ss_pred HHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCCCC
Q 003978 590 FRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT 668 (782)
Q Consensus 590 ~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt 668 (782)
.+++.... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++...... .......++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCC
Confidence 99986543 36899999999999999999999998 999999999999999999999999998754432 222344678
Q ss_pred CcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh--ccccccCCCCCCCHHHHHHHHHhhhhCC
Q 003978 669 PQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVG--FMNQRLEIPKDVDPRWAAIVESCWHSDP 746 (782)
Q Consensus 669 ~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~--~~~~~~~~p~~~~~~l~~LI~~cL~~dP 746 (782)
..|++||.+.+..++.++|||||||++|+|++|+.||...........+. ........+..+++.+.++|.+||..||
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDP 237 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCCh
Confidence 89999999988889999999999999999999999997664421111111 1223455667789999999999999999
Q ss_pred CCCC-----CHHHHHHHHHHHHHHHhhcc
Q 003978 747 QCRP-----SFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 747 ~~RP-----s~~ell~~L~~L~~~~~~~~ 770 (782)
.+|| ++.++ +.|+||+..
T Consensus 238 ~~R~~~~~~~~~~l------l~h~~~~~~ 260 (277)
T cd05577 238 EKRLGCRGGSADEV------REHPLFKDL 260 (277)
T ss_pred hHccCCCcccHHHH------HhChhhhcC
Confidence 9999 66667 468888543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=305.30 Aligned_cols=246 Identities=33% Similarity=0.558 Sum_probs=210.7
Q ss_pred ceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
+|.+.+.||+|++|.||++... +..+++|++..... .....+.+|+.+++.++|+||+++++++..+...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4788999999999999999985 67899999876543 3457788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccccc
Q 003978 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (782)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (782)
+++++|.+++......+++..+..++.|++.+|.|||..+ ++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 155 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RN 155 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccccc-cc
Confidence 9999999999876567899999999999999999999988 99999999999999999999999999876554322 33
Q ss_pred CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCC--CCCHHHHHHHHHh
Q 003978 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK--DVDPRWAAIVESC 741 (782)
Q Consensus 664 ~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~~~l~~LI~~c 741 (782)
...++..|++||.+.+..++.++||||||+++|+|++|..||...+.......+.. ......+. .++..+.+||.+|
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~ 234 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKC 234 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHH
Confidence 45688999999999988889999999999999999999999988765555444432 22222332 3489999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 003978 742 WHSDPQCRPSFQELVD 757 (782)
Q Consensus 742 L~~dP~~RPs~~ell~ 757 (782)
|..||++|||+.++++
T Consensus 235 l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 235 LQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccCChhhCCCHHHHhc
Confidence 9999999999999964
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=317.90 Aligned_cols=248 Identities=24% Similarity=0.401 Sum_probs=198.7
Q ss_pred eeccCCcEEEEEEEE--cCCeEEEEEEeccCCCH-HHHHHHHHHHHHH---HhCCCCceeEEeeeeecCCceeEEEeecC
Q 003978 512 QIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLM---KRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585 (782)
Q Consensus 512 ~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il---~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 585 (782)
.||+|+||.||++.. .++.+|+|++....... .....+.+|..++ ...+||||+.+++++..++..|+||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999987 46789999987654322 1122233444333 34479999999999999999999999999
Q ss_pred CCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCC
Q 003978 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665 (782)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 665 (782)
+++|.+++.... .+++..+..++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||++....... ....
T Consensus 81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (279)
T cd05633 81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHAS 155 (279)
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceeccccC--ccCc
Confidence 999999987643 6899999999999999999999999 9999999999999999999999999986543321 2234
Q ss_pred CCCCcccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH--HHHHhhccccccCCCCCCCHHHHHHHHHhh
Q 003978 666 KGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ--VIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742 (782)
Q Consensus 666 ~Gt~~y~aPE~l~-~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~--~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 742 (782)
.|++.|+|||.+. +..++.++|||||||++|+|++|..||....... ..... .......++..+++++++||.+||
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l 234 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTVNVELPDSFSPELKSLLEGLL 234 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hhcCCcCCccccCHHHHHHHHHHh
Confidence 6899999999986 4667899999999999999999999997543221 11111 123345677789999999999999
Q ss_pred hhCCCCCC-----CHHHHHHHHHHHHHHHhhccc
Q 003978 743 HSDPQCRP-----SFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 743 ~~dP~~RP-----s~~ell~~L~~L~~~~~~~~~ 771 (782)
..||.+|| ++.++ ++|+||+..+
T Consensus 235 ~~~p~~R~~~~~~~~~~~------~~h~~~~~~~ 262 (279)
T cd05633 235 QRDVSKRLGCLGRGAQEV------KEHVFFKGID 262 (279)
T ss_pred cCCHHHhcCCCCCCHHHH------HhCccccCCC
Confidence 99999999 59988 6778887644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=316.65 Aligned_cols=247 Identities=27% Similarity=0.492 Sum_probs=213.1
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCceeEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv 580 (782)
++|.+.+.||.|+||.||++.. .+..|++|++..... .......+.+|+.+++.+. ||||+++++++...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4799999999999999999987 577899999876443 3344567888999999998 99999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc-
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY- 659 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~- 659 (782)
|||+.+++|.+++.... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999999999997654 6999999999999999999999998 9999999999999999999999999987544322
Q ss_pred -------------------ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc
Q 003978 660 -------------------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM 720 (782)
Q Consensus 660 -------------------~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~ 720 (782)
.......|+..|++||++.+..++.++|||||||++|+|++|..||...........+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-- 235 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL-- 235 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH--
Confidence 12223457899999999988888999999999999999999999999887655554442
Q ss_pred ccccCCCCCCCHHHHHHHHHhhhhCCCCCCCH----HHHH
Q 003978 721 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSF----QELV 756 (782)
Q Consensus 721 ~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~----~ell 756 (782)
.....++..+++.+.+||.+||..+|.+||++ .+++
T Consensus 236 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 236 KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 34456777889999999999999999999999 8883
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=326.80 Aligned_cols=262 Identities=24% Similarity=0.326 Sum_probs=209.9
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC-----Cc
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----QR 576 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 576 (782)
.++|++.+.||+|+||.||++.. .+..||||.+............+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35799999999999999999987 467899999875433333445677899999999999999999987644 34
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
+|++|||+. ++|.+++... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 799999995 6899998764 46899999999999999999999998 9999999999999999999999999997654
Q ss_pred cccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc---------------
Q 003978 657 ETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM--------------- 720 (782)
Q Consensus 657 ~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~--------------- 720 (782)
..........++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 43222334467899999998865 45889999999999999999999999766543322211100
Q ss_pred ---------cc-----ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcCC
Q 003978 721 ---------NQ-----RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVG 775 (782)
Q Consensus 721 ---------~~-----~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~~ 775 (782)
.. .....+.+++++.+||.+||..+|.+|||+.++ +.|+||+..+..-.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~el------l~h~~~~~~~~~~~ 302 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA------LAHPYLASLHDPSD 302 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHH------HcCcchhhhcCccc
Confidence 00 011234678999999999999999999999999 67788876554433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=326.72 Aligned_cols=260 Identities=24% Similarity=0.347 Sum_probs=218.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCH-HHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
..+.|..-++||+|+||.||-+.. +|+-||+|.+.+..... .-.....+|.+||..+..++||.+-.+|+..+.+|+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 456788889999999999998865 67789999887665433 233456789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 580 VTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
||..|+||+|.-+|...+ ..|++.++++++.+|+.||++||+.+ ||+||+||+|||+|+.|+|.|+|+|+|....+.
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 999999999988885543 45999999999999999999999988 999999999999999999999999999876654
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh--ccccccCCCCCCCHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVG--FMNQRLEIPKDVDPRWAA 736 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~--~~~~~~~~p~~~~~~l~~ 736 (782)
.. ....+||..|||||++.+..|+...|+|||||+||||+.|+.||.........+.+. .....-+++...++++++
T Consensus 341 ~~-~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaks 419 (591)
T KOG0986|consen 341 KP-IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKS 419 (591)
T ss_pred Cc-cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHH
Confidence 32 234589999999999999999999999999999999999999998665433222221 134456677889999999
Q ss_pred HHHHhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhccc
Q 003978 737 IVESCWHSDPQCRP-----SFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 737 LI~~cL~~dP~~RP-----s~~ell~~L~~L~~~~~~~~~ 771 (782)
|...+|.+||.+|. .++++ -.|+||+..+
T Consensus 420 lc~~LL~Kdp~~RLGcrg~ga~ev------k~HpfFk~ln 453 (591)
T KOG0986|consen 420 LCEGLLTKDPEKRLGCRGEGAQEV------KEHPFFKDLN 453 (591)
T ss_pred HHHHHHccCHHHhccCCCcCcchh------hhCcccccCC
Confidence 99999999999986 45566 3678887643
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=325.09 Aligned_cols=262 Identities=26% Similarity=0.354 Sum_probs=216.4
Q ss_pred ceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC-----cee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-----RLC 578 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~ 578 (782)
+|++.+.||.|+||.||+|... +..|+||++..........+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5899999999999999999974 678999998765433445577889999999999999999999988775 789
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
++|||+. ++|.+++.... .+++..++.++.||+.||.|||+.| |+|+||||.|||++.++.++|+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999996 58999987644 7999999999999999999999998 999999999999999999999999999865543
Q ss_pred c---ccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-----------
Q 003978 659 Y---LTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR----------- 723 (782)
Q Consensus 659 ~---~~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~----------- 723 (782)
. .......+++.|+|||.+.+. .++.++|||||||++|+|++|..||...+.......+......
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 2 122344678999999999887 7899999999999999999999999877665443332211100
Q ss_pred ------------------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcCCCC
Q 003978 724 ------------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGDS 777 (782)
Q Consensus 724 ------------------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~~~~ 777 (782)
....+.++.++.+||.+||..+|.+||++.++ +.|+||+..+....+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l------l~~~~~~~~~~~~~~~ 302 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEA------LAHPYLAQLHDPEDEP 302 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHH------HhCccHHhhcccccCC
Confidence 01123468899999999999999999999999 6789998777664443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=317.13 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=204.1
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
+|++.++||.|++|.||+|.. .+..||||+++..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 588999999999999999997 4678999998754322 2234567799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC--CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 584 LPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 584 ~~ggsL~~~l~~~~--~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
+.+ +|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.........
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 975 8988886543 45899999999999999999999998 999999999999999999999999998755443333
Q ss_pred ccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc------------------c
Q 003978 662 TKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN------------------Q 722 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~------------------~ 722 (782)
.....+++.|++||++.+. .++.++|||||||++|+|++|..||...+..+....+.... .
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 3344678999999998664 46889999999999999999999998766544333221000 0
Q ss_pred ---------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 723 ---------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 723 ---------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
...+.+.++..++++|.+||+.||.+||++.++ +.++||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~------l~~~~f 284 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDA------LQHPWF 284 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHH------hcCCCC
Confidence 001123467889999999999999999999999 455665
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.74 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=199.7
Q ss_pred eeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecC--CceeEEE
Q 003978 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSP--QRLCIVT 581 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~lv~ 581 (782)
|++.++||+|+||.||++.. .+..||+|+++......... ...+|+.++..+. |+||+++++++... +.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 67899999999999999987 46779999987543332222 3346888888885 99999999999887 8899999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
||+. ++|.+++......+++..++.++.|++.||.|||+.+ ++|+||||+||+++. +.+||+|||++........
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 80 ELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred ecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 9996 5888888765567899999999999999999999998 999999999999999 9999999999876543322
Q ss_pred ccCCCCCCcccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc----------------cc
Q 003978 662 TKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ----------------RL 724 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~-~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~----------------~~ 724 (782)
.....+++.|+|||++. +..++.++|||||||++|+|++|..||...+.......+..... ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 12345789999999765 45568899999999999999999999987765543333211000 01
Q ss_pred C-----------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 725 E-----------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 725 ~-----------~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
. +...++..+.+||.+||.++|++||++.++ ++|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~------l~~~~~ 282 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQA------LRHPYF 282 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHH------hhCCCC
Confidence 1 123567899999999999999999999999 556665
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=312.75 Aligned_cols=250 Identities=26% Similarity=0.435 Sum_probs=210.2
Q ss_pred eccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCCCH
Q 003978 513 IGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (782)
Q Consensus 513 IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ggsL 589 (782)
||.|+||.||++.+. ++.+++|++..... .......+.+|+++++.++||||+++++.+......|++|||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999984 78899999876543 234567888999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc--------c
Q 003978 590 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL--------T 661 (782)
Q Consensus 590 ~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~--------~ 661 (782)
.+++.... .+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 99997654 6899999999999999999999998 99999999999999999999999999875433211 2
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCC--CHHHHHHHH
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDV--DPRWAAIVE 739 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~--~~~l~~LI~ 739 (782)
.....++..|++||.+.+...+.++||||||+++|+|++|..||...........+.. .....+..+ +..+.+||.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~ 235 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKIEWPEDVEVSDEAIDLIS 235 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCcCCCccccCCHHHHHHHH
Confidence 2334678899999999888889999999999999999999999988877666655533 233344444 899999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 740 SCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 740 ~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
+||..+|.+||++..+.+. +.++||+.+
T Consensus 236 ~~l~~~p~~Rpt~~~~~~~---l~~~~~~~~ 263 (265)
T cd05579 236 KLLVPDPEKRLGAKSIEEI---KNHPFFKGI 263 (265)
T ss_pred HHhcCCHhhcCCCccHHHH---hcCccccCC
Confidence 9999999999999333322 668999765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.82 Aligned_cols=237 Identities=22% Similarity=0.407 Sum_probs=194.5
Q ss_pred eeccCCcEEEEEEEEc--------------------------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcee
Q 003978 512 QIGQGSCGTVYHAVWY--------------------------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565 (782)
Q Consensus 512 ~IG~G~~G~Vy~~~~~--------------------------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 565 (782)
+||+|+||.||++... ...|++|++.... ......+.+|+.+++.+.||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 6999999999998641 1237888875432 33456788899999999999999
Q ss_pred EEeeeeecCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---
Q 003978 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW--- 642 (782)
Q Consensus 566 ~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~--- 642 (782)
++++++..+...|+||||+++++|..++......+++..+..++.||+.||+|||+++ |+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCccc
Confidence 9999999999999999999999999999776667899999999999999999999988 99999999999997643
Q ss_pred ----cEEEEecCCCcccccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHH-cCCCCCCCCChHHHHHH
Q 003978 643 ----TVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELA-TEKIPWDNLNSMQVIGA 716 (782)
Q Consensus 643 ----~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~ell-tG~~Pf~~~~~~~~~~~ 716 (782)
.+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||...........
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred CccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 4899999987543221 23357888999998875 55789999999999999985 69999987765543322
Q ss_pred hhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003978 717 VGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 759 (782)
Q Consensus 717 i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L 759 (782)
. .....++...++.+.++|.+||..+|++||++.++++.|
T Consensus 234 ~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 234 Y---EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred H---HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 2 223344555678999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.85 Aligned_cols=254 Identities=27% Similarity=0.414 Sum_probs=202.1
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~ 581 (782)
++|+..++||+|+||.||++.+ .++.||||.+...... .....+.+|+.++..+. ||||+++++++..+...+++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 4677788999999999999987 4678999998754433 44567788999999996 999999999999999999999
Q ss_pred eecCCCCHHHHHh----hcCCcchHHHHHHHHHHHHHHHHhhhcC-CCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 582 EFLPRGSLFRLLQ----RNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 582 E~~~ggsL~~~l~----~~~~~l~~~~~~~i~~qll~aL~~LH~~-~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
||+. ++|.++.. .....+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++....
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9995 46655432 1235689999999999999999999974 7 9999999999999999999999999987544
Q ss_pred cccccccCCCCCCcccCcccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccccC----CCC
Q 003978 657 ETYLTTKTGKGTPQWMAPEVLRNE---PSDEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFMNQRLE----IPK 728 (782)
Q Consensus 657 ~~~~~~~~~~Gt~~y~aPE~l~~~---~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~----~p~ 728 (782)
.... .....|++.|+|||++.+. .++.++|||||||++|+|++|+.||...... .....+.. ...+. .+.
T Consensus 160 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (288)
T cd06616 160 DSIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK-GDPPILSNSEER 237 (288)
T ss_pred cCCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcC-CCCCcCCCcCCC
Confidence 3322 2234688999999999876 6789999999999999999999999765421 12112111 11111 223
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 729 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 729 ~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
.++.++.+||.+||..||++|||+.++ +.++||+..
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i------~~~~~~~~~ 273 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKEL------LEHPFIKDY 273 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHH------hcChhhhch
Confidence 478999999999999999999999999 677888653
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=308.59 Aligned_cols=249 Identities=30% Similarity=0.513 Sum_probs=210.1
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccC---CCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC--Cce
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQE---YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRL 577 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 577 (782)
.+|.+.+.||+|+||.||++.. .+..|++|++.... ........+.+|+.+++.++|+||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4799999999999999999986 56789999875432 2234567889999999999999999999998654 458
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
+++|||+++++|.+++.... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 89999999999999997643 4788899999999999999999998 99999999999999999999999999875432
Q ss_pred cc---ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHH
Q 003978 658 TY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734 (782)
Q Consensus 658 ~~---~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 734 (782)
.. .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........+........+|..+++.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 238 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDAC 238 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHH
Confidence 11 111234688999999999998889999999999999999999999988766665555544444566788899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH
Q 003978 735 AAIVESCWHSDPQCRPSFQELVD 757 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RPs~~ell~ 757 (782)
.++|.+||. +|..||++.+++.
T Consensus 239 ~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 239 RDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHHHhc-CcccCccHHHHhc
Confidence 999999999 5799999999854
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=312.65 Aligned_cols=256 Identities=25% Similarity=0.435 Sum_probs=207.8
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec--CCceeEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRLCIV 580 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv 580 (782)
++|+..+.||.|++|.||++.. .++.+|+|.+..... ......+.+|+++++.++||||+++++++.. .+.+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 3688999999999999999998 467799999875433 3445778899999999999999999998854 3468999
Q ss_pred EeecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 581 TEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999988753 3456889999999999999999999998 99999999999999999999999999865433
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----hHHHHHHhhccccccCCC-----
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN-----SMQVIGAVGFMNQRLEIP----- 727 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~-----~~~~~~~i~~~~~~~~~p----- 727 (782)
... ....++..|++||.+.+..++.++|||||||++|+|++|..||.... ..+....+... ....++
T Consensus 158 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (287)
T cd06621 158 SLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-PNPELKDEPGN 234 (287)
T ss_pred ccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-CchhhccCCCC
Confidence 221 23457889999999999889999999999999999999999997652 22333222211 111111
Q ss_pred -CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 728 -KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 728 -~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
..+++.+.+||.+||..+|.+|||+.++ +.|+||+....
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~ei------l~~~~~~~~~~ 274 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDM------LEHPWIKAQMK 274 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHH------HhCcccccccc
Confidence 2356789999999999999999999999 67788866544
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=318.32 Aligned_cols=248 Identities=31% Similarity=0.459 Sum_probs=209.0
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
.+.|...+.||+|+||.||++.. .+..+|+|++..... ..+....+..|+++++.++||||+++++++..+...|+|
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 34588899999999999999987 467899999875433 345566788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
|||+. |+|.+++.....++++..+..++.||+.||.|||+++ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 104 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 104 MEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred EeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 99996 4888888766667899999999999999999999998 99999999999999999999999998864432
Q ss_pred cccCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHH
Q 003978 661 TTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~---~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
.....|++.|+|||.+. +..++.++|||||||++|+|++|..||...........+.........+..+++.+++|
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 256 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHH
Confidence 22446889999999974 45678899999999999999999999988766655555543333333445688999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHH
Q 003978 738 VESCWHSDPQCRPSFQELVDK 758 (782)
Q Consensus 738 I~~cL~~dP~~RPs~~ell~~ 758 (782)
|.+||..+|.+||++.+++++
T Consensus 257 i~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 257 VDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred HHHHccCCcccCcCHHHHHhC
Confidence 999999999999999999654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=306.79 Aligned_cols=247 Identities=28% Similarity=0.482 Sum_probs=213.7
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
+|++.++||+|+||.||++.. .+..+++|.+............+.+|+++++.++|+||+++++++......|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 588999999999999999987 466799999987655555567788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc---CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 584 LPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 584 ~~ggsL~~~l~~~---~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|.||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 9999999998652 345889999999999999999999998 999999999999999999999999998766544
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHH
Q 003978 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 740 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 740 (782)
......+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+.......+. ......++..++.+++++|.+
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPIYSQDLQNFIRS 235 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCchhhCHHHHHHHHH
Confidence 2234568899999999999989999999999999999999999998887665544442 233345566789999999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 003978 741 CWHSDPQCRPSFQELVD 757 (782)
Q Consensus 741 cL~~dP~~RPs~~ell~ 757 (782)
||..+|++||++.++++
T Consensus 236 ~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 236 MLQVKPKLRPNCDKILA 252 (256)
T ss_pred HcCCCcccCCCHHHHhc
Confidence 99999999999999964
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=308.64 Aligned_cols=250 Identities=26% Similarity=0.366 Sum_probs=203.5
Q ss_pred eeeccCCcEEEEEEEE--cCCeEEEEEEeccCCC-HHHHHHHHHHHHHH-HhCCCCceeEEeeeeecCCceeEEEeecCC
Q 003978 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLM-KRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 586 (782)
+.||.|+||.||+|.. .++.||||++++.... ......+..|..++ ...+|+||+++++++...+.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999987 5678999998754432 22233444555544 445899999999999999999999999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003978 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (782)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (782)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..... .....
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~ 154 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFV 154 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc----cccCC
Confidence 9999999764 36899999999999999999999998 99999999999999999999999998875432 22446
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--ccCCCCCCCHHHHHHHHHhhhh
Q 003978 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ--RLEIPKDVDPRWAAIVESCWHS 744 (782)
Q Consensus 667 Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~~~~l~~LI~~cL~~ 744 (782)
|++.|++||.+.+..++.++||||||+++|+|++|..||...+.......+..... .......+++.+.++|.+||..
T Consensus 155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 88999999999988889999999999999999999999988777665555432221 2233446899999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 745 DPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 745 dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
||++||++..+.+. +.|+||+.+
T Consensus 235 ~p~~R~~~~~~~~~---l~~~~~~~~ 257 (260)
T cd05611 235 DPAKRLGANGYQEI---KSHPFFKSI 257 (260)
T ss_pred CHHHccCCCcHHHH---HcChHhhcC
Confidence 99999966544332 678999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=330.22 Aligned_cols=256 Identities=21% Similarity=0.359 Sum_probs=230.9
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEcCCe--EEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~--vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
....+++++..||-|+||.|-++..+++. +|+|++++... .....+-+..|-.||..++.|+||++|-.|.+..++|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 34567888899999999999999988776 89999987654 4455566788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
++||-|-||.|..+|...+ .|+...+.+++.-+++|++|||++| ||+|||||+|+|++.+|-+||.|||+|+.....
T Consensus 497 mLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999999998754 6999999999999999999999999 999999999999999999999999999987765
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 738 (782)
.. +-+++|||.|.|||++.+..++.++|.||||+++||||+|.+||.+.+++..+..|.+....+.+|..++....+||
T Consensus 574 ~K-TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 574 RK-TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI 652 (732)
T ss_pred Cc-eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence 44 44789999999999999999999999999999999999999999999999999999888888999999999999999
Q ss_pred HHhhhhCCCCCCC-----HHHHHHHHHHHHHHHh
Q 003978 739 ESCWHSDPQCRPS-----FQELVDKLRDLQRQYF 767 (782)
Q Consensus 739 ~~cL~~dP~~RPs-----~~ell~~L~~L~~~~~ 767 (782)
+++...+|.+|.. +.+| -+|.||
T Consensus 653 k~LCr~~P~ERLG~~~~gI~DI------kkH~Wf 680 (732)
T KOG0614|consen 653 KKLCRDNPTERLGYQKGGINDI------KKHRWF 680 (732)
T ss_pred HHHHhcCcHhhhccccCChHHH------Hhhhhh
Confidence 9999999999975 4555 256787
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.55 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=206.2
Q ss_pred eeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeec
Q 003978 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 584 (782)
|++.+.||.|++|.||++.. .+..+++|.+............+.+|+.+++.++|+||+++++++..+..+++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56788999999999999987 4777999998766555445577888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccC
Q 003978 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664 (782)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 664 (782)
++ +|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++............
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 65 898888776567899999999999999999999998 999999999999999999999999998766544322233
Q ss_pred CCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--------------------
Q 003978 665 GKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR-------------------- 723 (782)
Q Consensus 665 ~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------------- 723 (782)
..++..|+|||.+.+. .++.++|||||||++|+|++|+.||...+..+....+......
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 4678899999999876 6889999999999999999999999877655443332110000
Q ss_pred --------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHH
Q 003978 724 --------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELV 756 (782)
Q Consensus 724 --------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell 756 (782)
..+.+.++.++.+||.+||..||.+||++.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll 278 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQAL 278 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHh
Confidence 012234688999999999999999999999994
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.87 Aligned_cols=244 Identities=28% Similarity=0.444 Sum_probs=216.8
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEcCCe--EEEEEEeccCC-CHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCce
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~--vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 577 (782)
+...+|.++.+||+|+||+|.++..+|+. ||||++++... +++-.+--+.|-++|... +-|.+++++..|+..+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 44568899999999999999999987764 99999988754 333334445677787766 468999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+||||+.||+|--+|++- .++.+..+.+++.+|+-||-|||++| ||+||||.+|||++.+|+|||+|||+++...-
T Consensus 426 yFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred eeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999999998888764 46888999999999999999999999 99999999999999999999999999987666
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
...++.+.+|||.|+|||++..++|+..+|+||+|++||||+.|.+||.+.+..++...| +...-..|+.++.++..+
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI--~ehnvsyPKslSkEAv~i 580 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI--MEHNVSYPKSLSKEAVAI 580 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--HHccCcCcccccHHHHHH
Confidence 677788999999999999999999999999999999999999999999999999998888 445567889999999999
Q ss_pred HHHhhhhCCCCCC
Q 003978 738 VESCWHSDPQCRP 750 (782)
Q Consensus 738 I~~cL~~dP~~RP 750 (782)
++..|.+.|.+|.
T Consensus 581 ckg~ltK~P~kRL 593 (683)
T KOG0696|consen 581 CKGLLTKHPGKRL 593 (683)
T ss_pred HHHHhhcCCcccc
Confidence 9999999999995
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.98 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=199.1
Q ss_pred ceeEeeeeccCCcEEEEEEEE----cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC--Ccee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW----YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLC 578 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~----~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 578 (782)
+|.+.++||+|+||.||+|.. .+..||||++..... .......+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 488999999999999999997 457899999876431 223345677899999999999999999999887 7899
Q ss_pred EEEeecCCCCHHHHHhhc----CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC----CCcEEEEecC
Q 003978 579 IVTEFLPRGSLFRLLQRN----TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK----HWTVKVGDFG 650 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~----~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~----~~~vkL~DFG 650 (782)
+||||+++ +|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 99999964 777776432 236889999999999999999999998 999999999999999 8999999999
Q ss_pred CCcccccccc---cccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHH---------HHHHh
Q 003978 651 LSRLKHETYL---TTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQ---------VIGAV 717 (782)
Q Consensus 651 la~~~~~~~~---~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~---------~~~~i 717 (782)
++........ ......+++.|+|||++.+. .++.++|||||||++|+|++|..||....... .+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9876543322 22334678999999988764 57889999999999999999999997554321 00000
Q ss_pred -hc-----------------------cccccCCC-----------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 718 -GF-----------------------MNQRLEIP-----------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 718 -~~-----------------------~~~~~~~p-----------~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
.. .......+ ...+.++.++|.+||..||++|||+.++ +
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ei------l 311 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEA------L 311 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHH------h
Confidence 00 00000111 1567789999999999999999999999 5
Q ss_pred HHHHh
Q 003978 763 QRQYF 767 (782)
Q Consensus 763 ~~~~~ 767 (782)
.|+||
T Consensus 312 ~~~~f 316 (316)
T cd07842 312 EHPYF 316 (316)
T ss_pred cCCCC
Confidence 56665
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=315.73 Aligned_cols=254 Identities=31% Similarity=0.467 Sum_probs=211.1
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
+.|...++||+|+||.||+|.. .+..|+||++..... .......+.+|+.+++.++||||+++++++......|+||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 3477778899999999999986 567899999875543 3345567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
||+. ++|.+++.....++++..++.++.||+.+|.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 101 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 101 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 9995 5888888766667899999999999999999999998 99999999999999999999999998864322
Q ss_pred ccCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHH
Q 003978 662 TKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~---~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 738 (782)
.....|+..|+|||++. +..++.++|||||||++|+|++|..||...+.......+............++..+++||
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 253 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFV 253 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 22456889999999984 455788999999999999999999999887766555554333222233345788999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 739 ~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
.+||+.+|.+||++.++ +.++||...+
T Consensus 254 ~~~l~~~P~~Rp~~~~~------l~~~~~~~~~ 280 (313)
T cd06633 254 DYCLQKIPQERPASAEL------LRHDFVRRDR 280 (313)
T ss_pred HHHccCChhhCcCHHHH------hcCcccCCCc
Confidence 99999999999999999 5667776543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=316.88 Aligned_cols=253 Identities=25% Similarity=0.326 Sum_probs=204.8
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC----
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ---- 575 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 575 (782)
...++|++.+.||+|+||.||+|.. .++.||||+++...........+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4457899999999999999999998 4678999998765433333456778999999999999999999987654
Q ss_pred ------ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEec
Q 003978 576 ------RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (782)
Q Consensus 576 ------~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DF 649 (782)
.+|++|||+++ +|...+......+++..++.++.||+.||+|||+.+ |+|+||||+||++++++.+||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEEeCcc
Confidence 78999999965 888888766567899999999999999999999998 999999999999999999999999
Q ss_pred CCCcccccccc-cccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc---
Q 003978 650 GLSRLKHETYL-TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL--- 724 (782)
Q Consensus 650 Gla~~~~~~~~-~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~--- 724 (782)
|++........ ......++..|++||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+.......
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 99876543321 1122356788999998865 446889999999999999999999998776655443332211000
Q ss_pred -------------------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003978 725 -------------------------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVD 757 (782)
Q Consensus 725 -------------------------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~ 757 (782)
.....++..+.+||.+||..||.+||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 012346899999999999999999999999943
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=311.41 Aligned_cols=249 Identities=24% Similarity=0.374 Sum_probs=199.3
Q ss_pred eeccCCcEEEEEEEE--cCCeEEEEEEeccCCCH-HHHHHHHHH---HHHHHhCCCCceeEEeeeeecCCceeEEEeecC
Q 003978 512 QIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQE---VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585 (782)
Q Consensus 512 ~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~-~~~~~~~~E---i~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 585 (782)
.||+|+||.||++.. .++.||||++.+..... .....+..| +++++...||||+.+++++..+..+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999987 46789999987654322 111122233 344555679999999999999999999999999
Q ss_pred CCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCC
Q 003978 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665 (782)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 665 (782)
|++|..++... ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...... .....
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 155 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHAS 155 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCc
Confidence 99999998754 46899999999999999999999998 999999999999999999999999998754332 22245
Q ss_pred CCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH-HhhccccccCCCCCCCHHHHHHHHHhhh
Q 003978 666 KGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIG-AVGFMNQRLEIPKDVDPRWAAIVESCWH 743 (782)
Q Consensus 666 ~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~-~i~~~~~~~~~p~~~~~~l~~LI~~cL~ 743 (782)
.|+..|+|||++.+ ..++.++||||+||++|+|++|..||.......... ..........++..++.++.++|.+||.
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~ 235 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 235 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhh
Confidence 78999999999875 467899999999999999999999997663221111 1111233456777789999999999999
Q ss_pred hCCCCCC-----CHHHHHHHHHHHHHHHhhccc
Q 003978 744 SDPQCRP-----SFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 744 ~dP~~RP-----s~~ell~~L~~L~~~~~~~~~ 771 (782)
.+|.+|| ++.++ +.++||+...
T Consensus 236 ~~p~~R~~~~~~~~~~l------l~~~~~~~~~ 262 (278)
T cd05606 236 RDVNRRLGCLGRGAQEV------KEHPFFRSLD 262 (278)
T ss_pred cCHHhccCCCCCCHHHH------HhCccccCCC
Confidence 9999999 99999 4678886543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=320.49 Aligned_cols=256 Identities=26% Similarity=0.375 Sum_probs=209.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC-----
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----- 575 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 575 (782)
..++|++.+.||+|+||.||++.. .+..||||++............+.+|+.+|+.++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 457899999999999999999986 4678999998655444445567889999999999999999999987654
Q ss_pred -ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 576 -RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 576 -~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
.+++||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 358999999 7799988864 35899999999999999999999998 99999999999999999999999999875
Q ss_pred cccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------
Q 003978 655 KHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ----------- 722 (782)
Q Consensus 655 ~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~----------- 722 (782)
.... .....+++.|++||.+.+ ..++.++|+|||||++|+|++|..||...+.......+.....
T Consensus 168 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 168 TDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred cccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 5432 223467899999999876 4578899999999999999999999987665433322211000
Q ss_pred ------------------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 723 ------------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 723 ------------------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
...+...+++.+.++|.+||..||.+|||+.++ +.|+||+..+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~------l~~~~~~~~~~ 306 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEA------LAHPYFEEFHD 306 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHH------hcCccHhhhcC
Confidence 001224678899999999999999999999999 56899977644
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=313.50 Aligned_cols=261 Identities=27% Similarity=0.457 Sum_probs=207.8
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCC
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 575 (782)
.+....++|++.+.||.|+||.||++.+. +..||||+++...... ....+..|+.++... .||||+++++++....
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 34456688999999999999999999986 7889999997654332 345556677766666 5999999999999999
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~-~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
..|++|||+ +++|.+++......+++..+..++.|++.||+|||+ ++ |+|+||+|+||+++.++.+||+|||++..
T Consensus 88 ~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 88 DVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred eEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECccccchh
Confidence 999999999 458888876655678999999999999999999997 57 99999999999999999999999999875
Q ss_pred cccccccccCCCCCCcccCcccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhccccccCCC--
Q 003978 655 KHETYLTTKTGKGTPQWMAPEVLRNEP----SDEKSDVYSFGVILWELATEKIPWDNLNS-MQVIGAVGFMNQRLEIP-- 727 (782)
Q Consensus 655 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~----~s~~sDIwSLG~ll~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~p-- 727 (782)
....... ....+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||..... .+.+..+... ....++
T Consensus 165 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 242 (296)
T cd06618 165 LVDSKAK-TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE-EPPSLPPN 242 (296)
T ss_pred ccCCCcc-cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC-CCCCCCCC
Confidence 5433222 2335788999999987654 68899999999999999999999976433 2333232211 112222
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 728 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 728 ~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
..++.++.+||.+||..||.+||++.++ +.++||+-.+
T Consensus 243 ~~~~~~l~~li~~~l~~~p~~Rp~~~~i------l~~~~~~~~~ 280 (296)
T cd06618 243 EGFSPDFCSFVDLCLTKDHRKRPKYREL------LQHPFIRRYE 280 (296)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHH------hcChhhhccc
Confidence 3478999999999999999999999999 5667776543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.46 Aligned_cols=244 Identities=27% Similarity=0.456 Sum_probs=193.0
Q ss_pred eeccCCcEEEEEEEEc-CC---eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCC
Q 003978 512 QIGQGSCGTVYHAVWY-GS---DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (782)
Q Consensus 512 ~IG~G~~G~Vy~~~~~-~~---~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg 587 (782)
.||+|+||.||++... +. .+++|.+.... .......+.+|+.+++.++||||+++++.+......|+||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 6999999999999753 32 24556554432 2334567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcC---CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc--cccc
Q 003978 588 SLFRLLQRNT---TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET--YLTT 662 (782)
Q Consensus 588 sL~~~l~~~~---~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~--~~~~ 662 (782)
+|.+++.... ..+++..++.++.||+.||+|||+.+ |+|+||||+|||++.++.++|+|||++...... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999997532 33566778889999999999999988 999999999999999999999999997642221 1122
Q ss_pred cCCCCCCcccCcccccC-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccc----cccCCCCCC
Q 003978 663 KTGKGTPQWMAPEVLRN-------EPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMN----QRLEIPKDV 730 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~-------~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~----~~~~~p~~~ 730 (782)
....++..|+|||++.. ..++.++|||||||++|+|++ |..||........+..+.... ..+.++..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 34567899999999753 234678999999999999997 578998777665555432211 123444568
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003978 731 DPRWAAIVESCWHSDPQCRPSFQELVDKL 759 (782)
Q Consensus 731 ~~~l~~LI~~cL~~dP~~RPs~~ell~~L 759 (782)
++.+.+++..|| .+|++||++.++++.|
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 899999999999 6799999999998776
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=320.36 Aligned_cols=255 Identities=26% Similarity=0.424 Sum_probs=203.1
Q ss_pred eeeccC--CcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCC
Q 003978 511 EQIGQG--SCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (782)
Q Consensus 511 ~~IG~G--~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 586 (782)
..||.| +||+||++.+ .++.||||++.......+..+.+.+|+.+++.++||||+++++++.....+|+||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999987 678899999987665666678899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc-----
Q 003978 587 GSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL----- 660 (782)
Q Consensus 587 gsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~----- 660 (782)
++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++++||+.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 99999987642 35888999999999999999999988 99999999999999999999999986432211110
Q ss_pred --cccCCCCCCcccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--------------
Q 003978 661 --TTKTGKGTPQWMAPEVLRNE--PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-------------- 722 (782)
Q Consensus 661 --~~~~~~Gt~~y~aPE~l~~~--~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~-------------- 722 (782)
......++..|++||++.+. .++.++|||||||++|+|++|..||.................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 01112356779999999764 467899999999999999999999987655433322110000
Q ss_pred -------------------------------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 723 -------------------------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 723 -------------------------------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
....+..+++.+.+||.+||..||++|||+.++ ++|+||+.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~------l~~~~~~~~~ 315 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSL------LSHAFFKQVK 315 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHH------hhCHHHHHHH
Confidence 001123356789999999999999999999999 6788887665
Q ss_pred Cc
Q 003978 772 ST 773 (782)
Q Consensus 772 ~~ 773 (782)
..
T Consensus 316 ~~ 317 (328)
T cd08226 316 EQ 317 (328)
T ss_pred Hh
Confidence 44
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=336.77 Aligned_cols=264 Identities=33% Similarity=0.552 Sum_probs=236.8
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEc--C---CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY--G---SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 572 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~---~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 572 (782)
+..|+.....+|.++||.|-||.||+|+.+ + ..||||.++. .+.++....|..|+.||-+++||||++|.|+..
T Consensus 622 FakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 622 FAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeecc-CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 344666778999999999999999999873 3 3499999864 456777889999999999999999999999999
Q ss_pred cCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCC
Q 003978 573 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (782)
Q Consensus 573 ~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla 652 (782)
....++||.|||+.|+|..+|+.+...|...+..-+++.|+.||.||-+.+ +|||||-..||||+.+...|++|||++
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccce
Confidence 999999999999999999999999999999999999999999999999999 999999999999999999999999999
Q ss_pred cccccccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCC
Q 003978 653 RLKHETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPK 728 (782)
Q Consensus 653 ~~~~~~~~---~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 728 (782)
+...+... ++....-..+|.|||.+...+++.++||||+||+|||.++ |..||..+...+++..+. ...+++.|.
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-~gyRLPpPm 857 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-QGYRLPPPM 857 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-hccCCCCCC
Confidence 97755432 2223344579999999999999999999999999999776 999999999999998885 566778888
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 729 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 729 ~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
.+|..|.+|+..||++|-.+||.+.+|+..|++|..+
T Consensus 858 DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 858 DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 9999999999999999999999999999999999764
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=310.17 Aligned_cols=244 Identities=21% Similarity=0.355 Sum_probs=198.7
Q ss_pred cceeEeeee--ccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCceeE
Q 003978 505 EDLTIGEQI--GQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 505 ~~y~i~~~I--G~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 579 (782)
++|++.+.+ |.|+||.||++.. .+..+|+|++........ |+.....+ +||||+++++.+..++.+|+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 466666666 9999999999987 467799999876543221 22222222 69999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-cEEEEecCCCcccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHET 658 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~-~vkL~DFGla~~~~~~ 658 (782)
||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++ .++|+|||++......
T Consensus 87 v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 999999999999997654 7899999999999999999999998 99999999999999988 9999999998755432
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHH--HHHhhccccccCCCCCCCHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQV--IGAVGFMNQRLEIPKDVDPRWAA 736 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~--~~~i~~~~~~~~~p~~~~~~l~~ 736 (782)
....|+..|+|||++.+..++.++|||||||++|+|++|..||........ .............++.+++.+++
T Consensus 164 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAND 239 (267)
T ss_pred ----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHH
Confidence 234689999999999998899999999999999999999999975543221 11111123344555679999999
Q ss_pred HHHHhhhhCCCCCCC-HHHHHHHHHHHHHHHhh
Q 003978 737 IVESCWHSDPQCRPS-FQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 737 LI~~cL~~dP~~RPs-~~ell~~L~~L~~~~~~ 768 (782)
||.+||+.||.+||+ ++++ |+|+||+
T Consensus 240 li~~~l~~~p~~R~~~~~~~------l~h~~~~ 266 (267)
T PHA03390 240 FVQSMLKYNINYRLTNYNEI------IKHPFLK 266 (267)
T ss_pred HHHHHhccChhhCCchHHHH------hcCCccc
Confidence 999999999999995 6999 6788886
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=322.54 Aligned_cols=261 Identities=34% Similarity=0.590 Sum_probs=229.5
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEcC--CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG--SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~--~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
-.||+...++.+..+||-|.||.||.|.|+. -.||||.++... ..+++|..|..+|+.++|||+|+++++|..+-
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 4677777889999999999999999999864 458999886543 34578999999999999999999999999999
Q ss_pred ceeEEEeecCCCCHHHHHhhcCC-cchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
.+|||.|||..|+|.+||..+.. .++.-..+.++.||..||+||..++ +|||||-..|+||..+..||++|||++++
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchhhh
Confidence 99999999999999999987543 3666677889999999999999988 99999999999999999999999999998
Q ss_pred cccccccc-cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCH
Q 003978 655 KHETYLTT-KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 732 (782)
Q Consensus 655 ~~~~~~~~-~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 732 (782)
+.....+. ....-...|.|||.+....++.|+|||+||++|||+.| |-.||.+.+..+++..+. ...+++.|..||+
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-kgyRM~~PeGCPp 493 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-KGYRMDGPEGCPP 493 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-ccccccCCCCCCH
Confidence 76543332 22234668999999999999999999999999999998 999999999999987775 5678899999999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 733 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 733 ~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
..++|+..||+.+|.+||++.++-+.|+.+-+
T Consensus 494 kVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 494 KVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 99999999999999999999999999887743
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=322.32 Aligned_cols=259 Identities=22% Similarity=0.359 Sum_probs=207.8
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec----CCcee
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----PQRLC 578 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~ 578 (782)
.+|++.+.||+|+||.||++.. .+..||+|++............+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6899999999999999999986 47789999987654333445677789999999999999999998753 34689
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++......
T Consensus 85 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999995 6899998654 35899999999999999999999998 999999999999999999999999998754332
Q ss_pred ccc----ccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-------------
Q 003978 659 YLT----TKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM------------- 720 (782)
Q Consensus 659 ~~~----~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~------------- 720 (782)
... .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 211 123468899999999865 45788999999999999999999999776544322221110
Q ss_pred -----------ccccC-----CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 721 -----------NQRLE-----IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 721 -----------~~~~~-----~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
..... +.+..+.++.+||.+||+.+|.+||++.++ +.|+||+.....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~------l~~~~~~~~~~~ 303 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQA------LQHPFLAQYHDP 303 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHH------HhChhhhhccCC
Confidence 00111 124568899999999999999999999999 678999654443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=316.08 Aligned_cols=255 Identities=24% Similarity=0.372 Sum_probs=202.0
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC------
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------ 575 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 575 (782)
.++|++.++||.|+||.||++.+ .++.++||++............+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47899999999999999999987 4677999998765433333345678999999999999999999875433
Q ss_pred --ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 576 --RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 576 --~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
.+|+||||+. ++|...+......+++..+..++.||+.||.|||+++ |+|+||||+||++++++.++|+|||++.
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCccch
Confidence 4699999995 4788887765667999999999999999999999998 9999999999999999999999999987
Q ss_pred cccccccc-----------ccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc
Q 003978 654 LKHETYLT-----------TKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN 721 (782)
Q Consensus 654 ~~~~~~~~-----------~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~ 721 (782)
........ .....+++.|+|||.+.+. .++.++|||||||++|+|++|.+||...+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 54332211 1123568889999988654 57889999999999999999999998777655443321110
Q ss_pred cc---------------------cCC-------CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 722 QR---------------------LEI-------PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 722 ~~---------------------~~~-------p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
.. ... ...+++.+.+||.+||..||.+|||+.++ +.|+||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~el------l~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDA------LEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHH------hcCCCC
Confidence 00 000 12345788999999999999999999999 556665
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=317.44 Aligned_cols=257 Identities=24% Similarity=0.366 Sum_probs=207.1
Q ss_pred eeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCC
Q 003978 507 LTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 586 (782)
|.+++.+|.|+++.||++...++.||||++............+.+|+.+++.++||||+++++++...+..|++|||+++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 45666677778888888888889999999987655566678899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc-----
Q 003978 587 GSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL----- 660 (782)
Q Consensus 587 gsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~----- 660 (782)
++|.+++... ...+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999999753 345889999999999999999999998 99999999999999999999999998864322111
Q ss_pred --cccCCCCCCcccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc---------------
Q 003978 661 --TTKTGKGTPQWMAPEVLRNE--PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN--------------- 721 (782)
Q Consensus 661 --~~~~~~Gt~~y~aPE~l~~~--~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~--------------- 721 (782)
......++..|+|||++.+. .++.++|||||||++|+|++|..||................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 12234577889999998763 47889999999999999999999998765443321110000
Q ss_pred -----------------cccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 722 -----------------QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 722 -----------------~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
.....+..++.++.+||.+||..||++|||+.++ |.|+||+..+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l------l~~p~~~~~~ 302 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQL------LNHSFFKQCK 302 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHH------hcCchHhhhc
Confidence 0001112234678999999999999999999999 6789998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=311.42 Aligned_cols=255 Identities=17% Similarity=0.207 Sum_probs=189.9
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEcCC-----eEEEEEEeccCCCH--HH-------HHHHHHHHHHHHhCCCCceeE
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSD--EV-------IHSFRQEVSLMKRLRHPNVLL 566 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~-----~vAiK~~~~~~~~~--~~-------~~~~~~Ei~il~~l~HpnIv~ 566 (782)
++..++|++.++||+|+||.||+|.+.+. .+++|+........ +. ......+...+..+.|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 34557899999999999999999987543 46777643322111 10 011222334455678999999
Q ss_pred EeeeeecCC----ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 003978 567 FMGAVTSPQ----RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642 (782)
Q Consensus 567 l~~~~~~~~----~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~ 642 (782)
+++.+.... ..+++|+++ ..++.+.+... ...++..++.++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGNN 163 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCC
Confidence 998765443 346788887 44777777543 34577888999999999999999998 99999999999999999
Q ss_pred cEEEEecCCCccccccc-------ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHH
Q 003978 643 TVKVGDFGLSRLKHETY-------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM-QVI 714 (782)
Q Consensus 643 ~vkL~DFGla~~~~~~~-------~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~-~~~ 714 (782)
.++|+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 99999999997543211 1112346999999999999999999999999999999999999999877332 211
Q ss_pred HH-----hhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003978 715 GA-----VGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 759 (782)
Q Consensus 715 ~~-----i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L 759 (782)
.. +.........++.+++.+.+++..||..+|++||++.++++.|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11 1111111122356789999999999999999999999998765
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=319.51 Aligned_cols=257 Identities=24% Similarity=0.409 Sum_probs=203.2
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC-----Cc
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----QR 576 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 576 (782)
.++|++.++||+|+||.||+|.+ .+..||||+++... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 36899999999999999999987 56789999986432 223456677899999999999999999886543 35
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
.|++|||+. ++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 799999995 588888864 35899999999999999999999999 9999999999999999999999999987543
Q ss_pred cccc---cccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc------------
Q 003978 657 ETYL---TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM------------ 720 (782)
Q Consensus 657 ~~~~---~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~------------ 720 (782)
.... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 3211 1123468999999998755 56789999999999999999999999766543322111000
Q ss_pred ------------ccccC-----CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 721 ------------NQRLE-----IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 721 ------------~~~~~-----~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
..... ..+..++++.+||.+||..||++||++.++ +.|+||+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~------l~hp~~~~~~~ 300 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEA------LAHPYLEQYHD 300 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHH------hcCccccccCC
Confidence 00000 113467889999999999999999999999 66788876543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=327.04 Aligned_cols=253 Identities=34% Similarity=0.591 Sum_probs=222.7
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc---CC--eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY---GS--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~---~~--~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (782)
+..++.++.++||+|.||.|++|.|+ |+ .||||+++...... ....|.+|+.+|.+|+|||+|++||+.-+ ..
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 44567888899999999999999984 32 48999998766544 56789999999999999999999999887 77
Q ss_pred eeEEEeecCCCCHHHHHhh-cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 577 LCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
+.||||++++|+|.+.|.+ ....|.....-.++.||+.||.||..++ +|||||-..||||-....|||+|||+.+-.
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccceecc
Confidence 8999999999999999977 5556888888899999999999999988 999999999999998889999999999865
Q ss_pred ccc---cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCC
Q 003978 656 HET---YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 731 (782)
Q Consensus 656 ~~~---~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 731 (782)
... |.......-...|+|||.+....++.++|+|++||+|||||+ |.-||.+....+++..+. ...++..|+.|+
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~cs 341 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYCS 341 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCCh
Confidence 443 222333345678999999999999999999999999999999 799999999999999887 777889999999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 003978 732 PRWAAIVESCWHSDPQCRPSFQELVDKL 759 (782)
Q Consensus 732 ~~l~~LI~~cL~~dP~~RPs~~ell~~L 759 (782)
.++++++++||..+|.+||++..|.+.+
T Consensus 342 edIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 342 EDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHHHHHHHhccCCccccccHHHHHHhH
Confidence 9999999999999999999999996543
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.21 Aligned_cols=257 Identities=23% Similarity=0.384 Sum_probs=207.8
Q ss_pred ceeEeeeeccCCcEEEEEEEE-----cCCeEEEEEEeccCCC--HHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCce
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~-----~~~~vAiK~~~~~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 577 (782)
+|++.+.||.|+||.||++.. .+..||+|+++..... ....+.+.+|+++++.+ +|+||+++++.++.+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 488999999999999999986 5678999998754321 23346678899999999 599999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 9999999999999999764 46888999999999999999999998 99999999999999999999999999875433
Q ss_pred cc-ccccCCCCCCcccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHh--hccccccCCCCCCCH
Q 003978 658 TY-LTTKTGKGTPQWMAPEVLRNE--PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDP 732 (782)
Q Consensus 658 ~~-~~~~~~~Gt~~y~aPE~l~~~--~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i--~~~~~~~~~p~~~~~ 732 (782)
.. .......|+..|++||.+.+. .++.++|||||||++|+|++|..||...........+ .........+..+++
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCH
Confidence 21 112234689999999998753 4678899999999999999999999643321111111 112234456777899
Q ss_pred HHHHHHHHhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhccc
Q 003978 733 RWAAIVESCWHSDPQCRP-----SFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 733 ~l~~LI~~cL~~dP~~RP-----s~~ell~~L~~L~~~~~~~~~ 771 (782)
.+.+||.+||..||++|| ++.++ +.++||+...
T Consensus 238 ~~~~ll~~~l~~~p~~R~~~~~~~~~~l------~~~~~~~~~~ 275 (290)
T cd05613 238 LAKDIIQRLLMKDPKKRLGCGPSDADEI------KKHPFFQKIN 275 (290)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHH------HcCcccccCC
Confidence 999999999999999997 78888 5667776554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=306.67 Aligned_cols=247 Identities=28% Similarity=0.470 Sum_probs=204.7
Q ss_pred ceeEeeeeccCCcEEEEEEEEcC--CeEEEEEEeccC---CCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 506 DLTIGEQIGQGSCGTVYHAVWYG--SDVAVKVFSRQE---YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~~~--~~vAiK~~~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
+|.+.++||+|+||.||++.... ..+++|+++... ........+..|+.+++.++||||+++++++......+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58899999999999999998743 346666665422 2223334566799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 581 TEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++. +.++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999999998853 3456899999999999999999999998 999999999999975 5799999999876544
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
.........|++.|++||.+.+..++.++|+||||+++|+|++|..||...........+. ....+.++..++.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHHH
Confidence 4333445568999999999988888999999999999999999999998766555444432 233445567788999999
Q ss_pred HHHhhhhCCCCCCCHHHHH
Q 003978 738 VESCWHSDPQCRPSFQELV 756 (782)
Q Consensus 738 I~~cL~~dP~~RPs~~ell 756 (782)
|.+||..||++||++.+++
T Consensus 237 i~~~l~~~p~~Rp~~~~il 255 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEIL 255 (260)
T ss_pred HHHHhcCChhhCcCHHHHh
Confidence 9999999999999999994
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.44 Aligned_cols=238 Identities=29% Similarity=0.452 Sum_probs=206.8
Q ss_pred eccCCcEEEEEEEEc--CCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCCCH
Q 003978 513 IGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (782)
Q Consensus 513 IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ggsL 589 (782)
||.|+||.||++... ++.+++|++...... ......+..|+.+++.++||||+++++.++.+..+|++|||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999874 678999998766442 34566788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCCCCC
Q 003978 590 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP 669 (782)
Q Consensus 590 ~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~ 669 (782)
.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..............++.
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 99997653 5899999999999999999999988 99999999999999999999999999876544322334456889
Q ss_pred cccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCC
Q 003978 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 749 (782)
Q Consensus 670 ~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~R 749 (782)
.|++||.+.+...+.++|+||||+++|+|++|..||...+.......+.. ....++..++..+.++|.+||..||++|
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R 235 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKR 235 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence 99999999988889999999999999999999999987776555545432 4567788889999999999999999999
Q ss_pred CCH---HHH
Q 003978 750 PSF---QEL 755 (782)
Q Consensus 750 Ps~---~el 755 (782)
|++ .++
T Consensus 236 ~~~~~~~~l 244 (250)
T cd05123 236 LGSGGAEEI 244 (250)
T ss_pred CCcccHHHH
Confidence 999 666
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=282.73 Aligned_cols=255 Identities=25% Similarity=0.351 Sum_probs=214.6
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
+|.-.++||+|+||+||+++. .++-||+|.++....++.......+|+-+|+.++|.|||+++++...++.+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 466678999999999999986 455699999988776666677888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccccc
Q 003978 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (782)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (782)
|.. +|..+.......++.+.+..++.|+++||.|+|+++ +.|||+||.|+||+.+|.+||+|||+++..+.+-....
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 954 999999887788999999999999999999999999 99999999999999999999999999998777655555
Q ss_pred CCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccc------c---CCC-----
Q 003978 664 TGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQR------L---EIP----- 727 (782)
Q Consensus 664 ~~~Gt~~y~aPE~l~~~~-~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~------~---~~p----- 727 (782)
..+-|..|++|.++.|.. |+...|+||-||++.|+.. |++-|.+.+....+..|-..... + .+|
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 667899999999998866 6788999999999999988 77778887766655444221111 1 011
Q ss_pred -------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 728 -------------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 728 -------------~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
+.++..-++|+.++|.-+|..|.++++. ++|+||.-
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaa------lqhpyf~d 288 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAA------LQHPYFSD 288 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHH------hcCccccc
Confidence 1223345899999999999999999998 78899854
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.00 Aligned_cols=263 Identities=24% Similarity=0.331 Sum_probs=209.2
Q ss_pred ccee-EeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHH------------HHHHHHHHHHHHHhCCCCceeEEee
Q 003978 505 EDLT-IGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE------------VIHSFRQEVSLMKRLRHPNVLLFMG 569 (782)
Q Consensus 505 ~~y~-i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~------------~~~~~~~Ei~il~~l~HpnIv~l~~ 569 (782)
++|. +.+.||.|+||.||++.. .++.||||+++....... ....+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 557799999999999986 467899999865432210 0124678999999999999999999
Q ss_pred eeecCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEec
Q 003978 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (782)
Q Consensus 570 ~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DF 649 (782)
++......|++|||+. ++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEECCc
Confidence 9999999999999996 5999998653 45899999999999999999999998 999999999999999999999999
Q ss_pred CCCcccccc--------------cccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 003978 650 GLSRLKHET--------------YLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVI 714 (782)
Q Consensus 650 Gla~~~~~~--------------~~~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~ 714 (782)
|++...... ........+++.|+|||.+.+. .++.++|||||||++|+|++|..||...+.....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 998754411 1111233568899999998764 4688999999999999999999999887765544
Q ss_pred HHhhcccccc--------------------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003978 715 GAVGFMNQRL--------------------------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 715 ~~i~~~~~~~--------------------------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~ 768 (782)
..+......+ ......+.++.+||.+||..+|++||++.++ +.++||+
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~------l~~~~~~ 317 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEA------LKHEYFK 317 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHH------hcCcccC
Confidence 4332111000 1123457889999999999999999999999 6789998
Q ss_pred cccCcCCCC
Q 003978 769 ASRSTVGDS 777 (782)
Q Consensus 769 ~~~~~~~~~ 777 (782)
.-...+.+.
T Consensus 318 ~~~~~~~~~ 326 (335)
T PTZ00024 318 SDPLPCDPS 326 (335)
T ss_pred CCCCCCCcc
Confidence 776665543
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=319.44 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=204.9
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC------
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------ 575 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 575 (782)
..+|.+.+.||+|+||.||+|.. .++.||||++.+..........+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46899999999999999999986 4778999998765434444566788999999999999999999986543
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
.+|+||||+. .+|..++. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 94 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred eEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 4689999995 47777653 35888999999999999999999998 999999999999999999999999998754
Q ss_pred ccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc------------
Q 003978 656 HETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------ 722 (782)
Q Consensus 656 ~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~------------ 722 (782)
... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 168 DAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 332 223467889999999876 4578899999999999999999999987765443332211000
Q ss_pred ---------cc--------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 723 ---------RL--------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 723 ---------~~--------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
.. ...+..++.+.+||.+||..||.+||++.++ +.|+||+..+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~------l~h~~f~~~~~ 305 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEA------LEHPYFDSFRD 305 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHH------hcCcchhhccc
Confidence 00 0113467889999999999999999999999 66788877654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.65 Aligned_cols=247 Identities=26% Similarity=0.348 Sum_probs=202.2
Q ss_pred eeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC--CceeEEEe
Q 003978 507 LTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLCIVTE 582 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv~E 582 (782)
|++.++||.|+||.||++... +..+|+|++............+.+|+.+++.++||||+++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678999999999999999874 57899999986643344456778899999999999999999999887 88999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc-c
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-T 661 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~ 661 (782)
|+++ +|..++......+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.++|+|||++........ .
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 9964 899998766567999999999999999999999998 99999999999999999999999999876544321 1
Q ss_pred ccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-----------------
Q 003978 662 TKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR----------------- 723 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~----------------- 723 (782)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+......
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 223356889999998765 45788999999999999999999999877765443332111000
Q ss_pred ------------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHH
Q 003978 724 ------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELV 756 (782)
Q Consensus 724 ------------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell 756 (782)
..+...++..+.++|.+||..+|.+||++.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l 282 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQAL 282 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 001112388999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=307.21 Aligned_cols=251 Identities=27% Similarity=0.351 Sum_probs=202.3
Q ss_pred eeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC---CCCceeEEeeeeecCCc-----
Q 003978 507 LTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL---RHPNVLLFMGAVTSPQR----- 576 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~----- 576 (782)
|++.+.||+|+||.||++.+. +..||+|+++...........+.+|+.+++.+ .||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678999999999999999984 67899999975544333345566788777666 59999999999987776
Q ss_pred eeEEEeecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
++++|||+.+ +|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCcceec
Confidence 8999999964 8999886643 35899999999999999999999998 999999999999999999999999998765
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc---c---------
Q 003978 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ---R--------- 723 (782)
Q Consensus 656 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~---~--------- 723 (782)
..... .....+++.|+|||++.+..++.++|||||||++|+|++|.+||......+....+..... .
T Consensus 158 ~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 158 SFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred cCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 43321 1233578899999999998899999999999999999999999987776554443321000 0
Q ss_pred -------------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 724 -------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 724 -------------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
....+.+++.+.+||.+||..||.+||++.++ +.|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~i------l~~~~~ 287 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA------LQHPYF 287 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHH------hcCcCC
Confidence 00112346788999999999999999999999 456665
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.73 Aligned_cols=250 Identities=27% Similarity=0.430 Sum_probs=208.2
Q ss_pred eeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCC
Q 003978 510 GEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (782)
Q Consensus 510 ~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg 587 (782)
..+||+|+||.||++.. .+..||||.+.... ......+.+|+.+++.++|+||+++++.+..++..|++|||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 46799999999999987 56789999875432 234466888999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCCC
Q 003978 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667 (782)
Q Consensus 588 sL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~G 667 (782)
+|.+++.. ..+++..++.++.|++.+|+|||+.+ |+|+||||+||+++.++.++|+|||++..............|
T Consensus 103 ~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 103 ALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred cHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 99998864 35788999999999999999999998 999999999999999999999999988654332222234568
Q ss_pred CCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-ccccCCCCCCCHHHHHHHHHhhhhCC
Q 003978 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLEIPKDVDPRWAAIVESCWHSDP 746 (782)
Q Consensus 668 t~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~l~~LI~~cL~~dP 746 (782)
++.|++||.+.+..++.++|+|||||++|+|++|..||...........+... .........+++.+.++|.+||..||
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P 258 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDP 258 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCc
Confidence 89999999998888899999999999999999999999877665554443221 11222334678999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 747 QCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 747 ~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
.+||++.++ +.|+||....
T Consensus 259 ~~R~~~~~l------l~~~~~~~~~ 277 (292)
T cd06657 259 AQRATAAEL------LKHPFLAKAG 277 (292)
T ss_pred ccCcCHHHH------hcChHHhccC
Confidence 999999999 5689986544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=315.40 Aligned_cols=259 Identities=26% Similarity=0.349 Sum_probs=207.8
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC-----
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP----- 574 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 574 (782)
...++|.+.+.||+|+||.||++.. .+..||+|++............+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 3457899999999999999999986 567899999876543444456778899999999999999999987543
Q ss_pred -CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 575 -QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 575 -~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
...|++++++ +++|.+++... .+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++.
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCCCEEEecccccc
Confidence 3478888888 78999888643 5889999999999999999999998 9999999999999999999999999987
Q ss_pred ccccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc----------
Q 003978 654 LKHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ---------- 722 (782)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~---------- 722 (782)
..... .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.....
T Consensus 169 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 169 HTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred ccccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 54332 223467899999999876 5678899999999999999999999976665443322211000
Q ss_pred -----------ccC--------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcC
Q 003978 723 -----------RLE--------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTV 774 (782)
Q Consensus 723 -----------~~~--------~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~ 774 (782)
... .....++++.+||.+||..||.+||++.++ +.|+||+......
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~------l~h~~f~~~~~~~ 310 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA------LAHAYFAQYHDPD 310 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHH------hcChhhhhcCCCC
Confidence 000 112357889999999999999999999999 6789998654433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=309.50 Aligned_cols=259 Identities=23% Similarity=0.346 Sum_probs=210.4
Q ss_pred ceeEeeeeccCCcEEEEEEEE-----cCCeEEEEEEeccCCC--HHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCce
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~-----~~~~vAiK~~~~~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 577 (782)
+|++.+.||+|+||.||++.. .++.||||++++.... ......+..|++++..+ +||||+++++.+..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 488999999999999999975 3567999998754321 23445678899999999 599999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+||||+.+++|.+++... ..+++..+..++.|++.+|.|||+.+ ++|+||||.||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 9999999999999998754 46888999999999999999999988 99999999999999999999999999875433
Q ss_pred cc-ccccCCCCCCcccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCChH----HHHHHhhccccccCCCCCC
Q 003978 658 TY-LTTKTGKGTPQWMAPEVLRNEP--SDEKSDVYSFGVILWELATEKIPWDNLNSM----QVIGAVGFMNQRLEIPKDV 730 (782)
Q Consensus 658 ~~-~~~~~~~Gt~~y~aPE~l~~~~--~s~~sDIwSLG~ll~elltG~~Pf~~~~~~----~~~~~i~~~~~~~~~p~~~ 730 (782)
.. .......|++.|++||.+.+.. .+.++||||||+++|+|++|..||...... .....+ .......+..+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI--LKSKPPFPKTM 235 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH--HccCCCCCccc
Confidence 22 1122346899999999987765 678999999999999999999999643221 111111 23345567778
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 731 DPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 731 ~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
++.+.+||.+||..||++|||+.++.+. +.++||+....
T Consensus 236 ~~~l~~li~~~l~~~p~~R~t~~~~~~~---l~~~~~~~~~~ 274 (288)
T cd05583 236 SAEARDFIQKLLEKDPKKRLGANGADEI---KNHPFFQGIDW 274 (288)
T ss_pred CHHHHHHHHHHhcCCHhhccCcchHHHH---hcCcccccCCH
Confidence 9999999999999999999997766554 66789877643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.89 Aligned_cols=256 Identities=25% Similarity=0.355 Sum_probs=208.5
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCC--C----ceeEEeeeee
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH--P----NVLLFMGAVT 572 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~H--p----nIv~l~~~~~ 572 (782)
+.+.++|++.+.+|+|+||.|-.+.+. +..||||+++.- ....++.+-|+++|+++.+ | -+|++.+||.
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 456789999999999999999999874 557999998643 3445667779999999942 2 3788999999
Q ss_pred cCCceeEEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc------------
Q 003978 573 SPQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD------------ 639 (782)
Q Consensus 573 ~~~~~~lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~------------ 639 (782)
-.+++|||+|.+ |-|++++|..+ ..+++...+..|++||+++++|||+.+ ++|.||||+|||+.
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCC
Confidence 999999999999 77999999764 467899999999999999999999998 99999999999983
Q ss_pred --------CCCcEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH
Q 003978 640 --------KHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (782)
Q Consensus 640 --------~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~ 711 (782)
++..|+|+|||.|+..++.. ...+.|..|+|||++.|-.++.+.||||+||+|+|+++|..-|+..+..
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 13469999999998766543 3557799999999999999999999999999999999999999887755
Q ss_pred HHHHHhhccccc-------------------cCCCCC-------------------------CCHHHHHHHHHhhhhCCC
Q 003978 712 QVIGAVGFMNQR-------------------LEIPKD-------------------------VDPRWAAIVESCWHSDPQ 747 (782)
Q Consensus 712 ~~~~~i~~~~~~-------------------~~~p~~-------------------------~~~~l~~LI~~cL~~dP~ 747 (782)
+-+..+....++ ...+.. --.+|.+||.+||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 533322211110 110100 012589999999999999
Q ss_pred CCCCHHHHHHHHHHHHHHHhhccc
Q 003978 748 CRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 748 ~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
+|+|+.|+ |.|+||+-..
T Consensus 396 ~RiTl~EA------L~HpFF~~~~ 413 (415)
T KOG0671|consen 396 RRITLREA------LSHPFFARLT 413 (415)
T ss_pred ccccHHHH------hcCHHhhcCC
Confidence 99999999 7899998654
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.94 Aligned_cols=257 Identities=22% Similarity=0.330 Sum_probs=204.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecC--Cce
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSP--QRL 577 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~--~~~ 577 (782)
..++|++.+.||+|+||.||+|.. .+..+|||.+............+.+|+.+++.+ +||||+++++++... ..+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 456899999999999999999987 467899998865433334445677899999999 999999999988643 368
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+||||+. ++|..++... .+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 99999996 5999998754 6788899999999999999999988 99999999999999999999999999875433
Q ss_pred ccc-----cccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc----------
Q 003978 658 TYL-----TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN---------- 721 (782)
Q Consensus 658 ~~~-----~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~---------- 721 (782)
... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 1223468999999998765 457889999999999999999999997665443322211100
Q ss_pred -------------------cccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 722 -------------------QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 722 -------------------~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
......+.++.++.+||.+||+.||.+|||+.+++ .++|++.-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il------~~~~~~~~ 301 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEAL------EHPYVAQF 301 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHh------hChhhhhh
Confidence 00112234789999999999999999999999994 56777543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=311.80 Aligned_cols=253 Identities=31% Similarity=0.443 Sum_probs=208.1
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
.+.|...+.||+|+||.||++.. .+..++||.+..... .......+.+|+++++.++|+||+++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 34688889999999999999987 466799999875432 334456788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
|||+. ++|.+++......+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 99995 5888888665667899999999999999999999988 999999999999999999999999998654332
Q ss_pred cccCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHH
Q 003978 661 TTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~---~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
....|++.|+|||.+. ...++.++|||||||++|+|++|..||...+.......+.........+..++..+.+|
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHH
Confidence 2346789999999975 34578899999999999999999999987765554444332222222344688999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 738 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 738 I~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
|.+||..+|.+||++.+++ .++|+..
T Consensus 247 i~~cl~~~P~~Rp~~~~ll------~~~~~~~ 272 (308)
T cd06634 247 VDSCLQKIPQDRPTSEVLL------KHRFVLR 272 (308)
T ss_pred HHHHhhCCcccCCCHHHHh------hCccccc
Confidence 9999999999999999994 5566543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.76 Aligned_cols=252 Identities=26% Similarity=0.382 Sum_probs=207.1
Q ss_pred eeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeec
Q 003978 507 LTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 584 (782)
|++.+.||+|.||.||++... ++.|++|++............+..|+.+++.++|+||+++++++.....+++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 567889999999999999884 678999999765433444566778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccC
Q 003978 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664 (782)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 664 (782)
. ++|.+++......+++..++.++.|++.||+|||+++ |+|+||+|+||+++.++.++|+|||++............
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 6 5999999876557999999999999999999999998 999999999999999999999999998765443322233
Q ss_pred CCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc----------------c----
Q 003978 665 GKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ----------------R---- 723 (782)
Q Consensus 665 ~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~----------------~---- 723 (782)
..++..|+|||.+.+. .++.++|||||||++|+|++|..||...+.......+..... .
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 4567889999998776 788999999999999999999999987765443332211000 0
Q ss_pred -------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 724 -------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 724 -------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
....+.++..+.++|.+||..||++||++.++ +.++||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~------l~~p~~ 282 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEA------LKHPYF 282 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHH------hhCcCC
Confidence 01112357899999999999999999999999 556665
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=312.80 Aligned_cols=260 Identities=27% Similarity=0.386 Sum_probs=208.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec-CCceeE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQRLCI 579 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~l 579 (782)
..++|++.+.||.|+||.||++.. .+..||||.+.+........+.+..|+.+++.++||||+++++++.. ....|+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 346899999999999999999986 46679999886544334445677889999999999999999999865 457899
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
+|||+ +++|..++.. ..+++..+..++.||+.||.|||+.+ |+|+||||.||+++.++.++|+|||++......
T Consensus 88 v~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 88 VTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred Eeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 99999 6689988864 34788888899999999999999998 999999999999999999999999998754332
Q ss_pred ccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc-------------------
Q 003978 660 LTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF------------------- 719 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~------------------- 719 (782)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...........+..
T Consensus 162 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 162 --MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred --cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 123467889999999866 5688999999999999999999999977654322211110
Q ss_pred -----cccccC-----CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcCCC
Q 003978 720 -----MNQRLE-----IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGD 776 (782)
Q Consensus 720 -----~~~~~~-----~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~~~ 776 (782)
...... ..+.++.++.++|.+||..+|++||++.++ +.++||+.......+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~el------l~~~~~~~~~~~~~~ 300 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEA------LAHPYLAPYHDPTDE 300 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHH------hcCCccccccCCccc
Confidence 000001 113578899999999999999999999999 678898766655443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=317.90 Aligned_cols=257 Identities=26% Similarity=0.369 Sum_probs=210.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc----
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR---- 576 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---- 576 (782)
..++|++.+.||.|+||.||++... +..||||++............+.+|+.+++.++||||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999884 6779999987654444455677889999999999999999998876554
Q ss_pred --eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 577 --LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 577 --~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
+|+|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEcccccccc
Confidence 89999999 6799999875 35899999999999999999999998 99999999999999999999999999876
Q ss_pred cccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc----------
Q 003978 655 KHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR---------- 723 (782)
Q Consensus 655 ~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~---------- 723 (782)
.... .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+......
T Consensus 168 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 168 TDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred cccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 5432 224467899999999865 46788999999999999999999999876655443332111000
Q ss_pred -------------------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 724 -------------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 724 -------------------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
......++..+.+||.+||..||++|||+.++ +.|+||+.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~el------l~h~~~~~~~~~ 307 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA------LAHPYLAEYHDP 307 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHH------hcCCCccccCCC
Confidence 01123468899999999999999999999999 678998765444
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=312.88 Aligned_cols=256 Identities=24% Similarity=0.310 Sum_probs=202.2
Q ss_pred ceeEeeeeccCCcEEEEEEEEc----CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeec----CCc
Q 003978 506 DLTIGEQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS----PQR 576 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~~----~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----~~~ 576 (782)
+|++.+.||+|+||.||++... +..||||.+..........+.+.+|+.+++.+ .||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4889999999999999999985 45799999875433334456778899999999 59999999987532 245
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
+|++|+|+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 789999994 6899988653 46899999999999999999999998 9999999999999999999999999997544
Q ss_pred cccc----cccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc----------
Q 003978 657 ETYL----TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN---------- 721 (782)
Q Consensus 657 ~~~~----~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~---------- 721 (782)
.... ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+....
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 3211 1223468999999998765 567899999999999999999999998765433222211000
Q ss_pred --------------c-----ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 722 --------------Q-----RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 722 --------------~-----~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
. .....+.++..+.+||.+||+.||.+|||+.++ +.++|+..-+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~l------l~~~~~~~~~ 299 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEA------LEHPYLAIWH 299 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHH------hcChhhhhhc
Confidence 0 001123467899999999999999999999999 5778886443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=338.88 Aligned_cols=147 Identities=28% Similarity=0.445 Sum_probs=133.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
.++|.++++||+|+||.||+|.+. ++.||||+++.... .......+..|+.+++.++||||+++++++.....+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 468999999999999999999986 78899999976543 445567788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
|||+.+++|.+++.... .+++..++.++.||+.||.|||.++ ||||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999997643 5888999999999999999999998 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=315.84 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=201.8
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC-------
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------- 574 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------- 574 (782)
..+|++.+.||.|+||.||+|.. .+..||+|++..... ...+.+.+|+++++.++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 36899999999999999999987 467899999866543 3346678899999999999999999876543
Q ss_pred -------CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCcEEE
Q 003978 575 -------QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKV 646 (782)
Q Consensus 575 -------~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~-~~~vkL 646 (782)
..+|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||+++. ++.+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEE
Confidence 35789999996 599888864 35889999999999999999999998 999999999999974 557899
Q ss_pred EecCCCcccccccc---cccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc--
Q 003978 647 GDFGLSRLKHETYL---TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-- 720 (782)
Q Consensus 647 ~DFGla~~~~~~~~---~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~-- 720 (782)
+|||++........ ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+...
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999875432211 1122357889999998754 55788999999999999999999999876654433222100
Q ss_pred ---------------------ccc-----cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 721 ---------------------NQR-----LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 721 ---------------------~~~-----~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
... ..+.+.++.++.+||.+||..||.+||++.++ +.|+||+.-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el------l~h~~~~~~ 306 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEA------LMHPYMSCY 306 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHH------hCCCccccc
Confidence 000 01224578899999999999999999999999 678999743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=300.66 Aligned_cols=258 Identities=26% Similarity=0.384 Sum_probs=202.6
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec-CCc
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQR 576 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~ 576 (782)
...|++++.||+|+||.||++..+ ...+|||.++..+.....-....+|+.+++.++|||||.+..+|-. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 357899999999999999999653 2258999998764444445677889999999999999999999876 788
Q ss_pred eeEEEeecCCCCHHHHHhhc----CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC----CcEEEEe
Q 003978 577 LCIVTEFLPRGSLFRLLQRN----TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH----WTVKVGD 648 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~----~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~----~~vkL~D 648 (782)
+++++||.+. +|..+|.-+ ...++...+..|++||+.|+.|||++. |+||||||.||||..+ |.|||+|
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeec
Confidence 9999999976 898888543 245889999999999999999999999 9999999999999877 8999999
Q ss_pred cCCCcccccccc---cccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCh-------HH--HHH
Q 003978 649 FGLSRLKHETYL---TTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNS-------MQ--VIG 715 (782)
Q Consensus 649 FGla~~~~~~~~---~~~~~~Gt~~y~aPE~l~~~~-~s~~sDIwSLG~ll~elltG~~Pf~~~~~-------~~--~~~ 715 (782)
||+++.+..+.. .....+-|..|+|||++.|.. |+.+.|||++||++.||++-.+-|.+... .+ .+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 999998776532 223345689999999999855 68899999999999999998877743321 11 111
Q ss_pred Hhhc-ccc-----cc---CCC--------------------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003978 716 AVGF-MNQ-----RL---EIP--------------------------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 760 (782)
Q Consensus 716 ~i~~-~~~-----~~---~~p--------------------------~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~ 760 (782)
+|-. +.. ++ .+| +.-++...+|+.+||..||.+|.|+.+.
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA----- 334 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA----- 334 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH-----
Confidence 1100 000 00 011 1124457899999999999999999998
Q ss_pred HHHHHHhhcc
Q 003978 761 DLQRQYFQAS 770 (782)
Q Consensus 761 ~L~~~~~~~~ 770 (782)
|.|+||.+-
T Consensus 335 -leh~yF~~d 343 (438)
T KOG0666|consen 335 -LEHPYFTED 343 (438)
T ss_pred -hcccccccC
Confidence 678999765
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=295.99 Aligned_cols=249 Identities=26% Similarity=0.412 Sum_probs=213.7
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCH-HHHHHHHHHHHHHHhC-CCCceeEEeeeeec
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS 573 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 573 (782)
..+.....+|.++.+||+|+|.+|.+++++ .+-||+|+++++-..+ +-+.=...|..+.... +||.+|-++.+|..
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 445566789999999999999999999875 4459999998876543 3344455566666665 69999999999999
Q ss_pred CCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 574 ~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
+..+++|.||++||+|--++++. .+++++.+.++...|+.||.|||++| ||+||||.+||||+..|++||+|+|+++
T Consensus 323 esrlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred cceEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccchhh
Confidence 99999999999999998888764 47999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-------ChHHHHHHhhccccccCC
Q 003978 654 LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL-------NSMQVIGAVGFMNQRLEI 726 (782)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~-------~~~~~~~~i~~~~~~~~~ 726 (782)
..-.+...+.+++|||.|.|||++.|..|+..+|+|+||++|+||+.|+.||.-. +....+.++ .....+.+
T Consensus 400 e~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv-ilekqiri 478 (593)
T KOG0695|consen 400 EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV-ILEKQIRI 478 (593)
T ss_pred cCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH-Hhhhcccc
Confidence 7777777888999999999999999999999999999999999999999999521 222333333 24556788
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCCC
Q 003978 727 PKDVDPRWAAIVESCWHSDPQCRP 750 (782)
Q Consensus 727 p~~~~~~l~~LI~~cL~~dP~~RP 750 (782)
|..++-....+++.-|.+||.+|.
T Consensus 479 prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 479 PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cceeehhhHHHHHHhhcCCcHHhc
Confidence 999999999999999999999984
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=326.13 Aligned_cols=253 Identities=31% Similarity=0.500 Sum_probs=216.8
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeee-----cCCc
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVT-----SPQR 576 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~-----~~~~ 576 (782)
.-|++.+.||.|.+|.||+++. .++..|+|++......+ .++..|..+|+.+ .|||++.+|++|. .++.
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 4688999999999999999975 67889999987655433 4556788899888 5999999999985 3467
Q ss_pred eeEEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
+|||||||.||++-|+++.. +..+.|..+..|++.++.||.+||.+. ++|||||-.|||++.++.|||+|||.+...
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 99999999999999999643 567899999999999999999999988 999999999999999999999999999888
Q ss_pred ccccccccCCCCCCcccCcccccCC-----CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-ccCCCCC
Q 003978 656 HETYLTTKTGKGTPQWMAPEVLRNE-----PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKD 729 (782)
Q Consensus 656 ~~~~~~~~~~~Gt~~y~aPE~l~~~-----~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~ 729 (782)
...-....+.+|||.|||||++... .|+.++|+||||++..||--|.+|+..+.+...+..|..... .+..|+.
T Consensus 174 dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~k 253 (953)
T KOG0587|consen 174 DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKK 253 (953)
T ss_pred ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhh
Confidence 7777777788999999999998643 356789999999999999999999999988887766643322 2334677
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003978 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 730 ~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~ 768 (782)
++.++.+||..||.+|.++||++.++ |.|+|.+
T Consensus 254 Ws~~FndFIs~cL~Kd~e~RP~~~~l------l~hpFi~ 286 (953)
T KOG0587|consen 254 WSKKFNDFISTCLVKDYEQRPSTEEL------LKHPFIT 286 (953)
T ss_pred HHHHHHHHHHHHHhhccccCcchhhh------ccCCccc
Confidence 89999999999999999999999999 4556655
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.98 Aligned_cols=245 Identities=25% Similarity=0.374 Sum_probs=197.3
Q ss_pred eeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCceeEEEee
Q 003978 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
|++.+.||+|+||.||+|.. .++.|+||.+.......+ .....+|+..++.++ ||||+++++++..++..|+||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 67889999999999999998 467799999865433222 223456899999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 584 LPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 584 ~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
+ +++|.+++.... ..+++..++.++.|++.+|.|||+++ ++|+||||+||+++.++.++|+|||++........ .
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 155 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-Y 155 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-c
Confidence 9 789999887643 46899999999999999999999998 99999999999999999999999999875543221 2
Q ss_pred cCCCCCCcccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc------------------
Q 003978 663 KTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR------------------ 723 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~-~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~------------------ 723 (782)
....++..|+|||++. +..++.++|+||||+++|+|++|..||...........+......
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 2346789999999885 445788999999999999999999999776554433222111000
Q ss_pred ----------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHH
Q 003978 724 ----------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELV 756 (782)
Q Consensus 724 ----------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell 756 (782)
....+..+..+.+||.+||..+|.+||++.+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~ 278 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQAL 278 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHh
Confidence 001122368899999999999999999999994
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=323.05 Aligned_cols=255 Identities=24% Similarity=0.401 Sum_probs=204.6
Q ss_pred eeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC------cee
Q 003978 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------RLC 578 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------~~~ 578 (782)
|...+.||+|+||.||++++ .|+.||||.++.... ..-.+...+|+++|++++|||||+++++-+... ...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcc-cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 45567899999999999986 688899999976542 233567789999999999999999999876554 457
Q ss_pred EEEeecCCCCHHHHHhh--cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc--CCCc--EEEEecCCC
Q 003978 579 IVTEFLPRGSLFRLLQR--NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD--KHWT--VKVGDFGLS 652 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~--~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~--~~~~--vkL~DFGla 652 (782)
++||||.||+|+..|.+ +...+++...+.++.+++.||.|||++| ||||||||.||++- .+|+ .||+|||+|
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999975 3456999999999999999999999999 99999999999984 3344 799999999
Q ss_pred cccccccccccCCCCCCcccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH----HHHHhhcc-------
Q 003978 653 RLKHETYLTTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ----VIGAVGFM------- 720 (782)
Q Consensus 653 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~----~~~~i~~~------- 720 (782)
+-..+.. ...+.+||+.|++||++. ...|+..+|.||+||++|++.||.+||....... ....+...
T Consensus 172 rel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 172 RELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred ccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence 9777655 455779999999999998 4888999999999999999999999997654432 22222111
Q ss_pred ------cc------ccCCCCCCCHHH----HHHHHHhhhhCCCCCC--CHHHHHHHHHHHHHH
Q 003978 721 ------NQ------RLEIPKDVDPRW----AAIVESCWHSDPQCRP--SFQELVDKLRDLQRQ 765 (782)
Q Consensus 721 ------~~------~~~~p~~~~~~l----~~LI~~cL~~dP~~RP--s~~ell~~L~~L~~~ 765 (782)
+. .+++|-.+++.+ -..+..+|..+|.+|. .+.++...+..+.+.
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 11 122334455544 4467778899999999 888888888887653
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=296.00 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=205.1
Q ss_pred eeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCceeEEEeecCCC
Q 003978 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~E~~~gg 587 (782)
+.||+|+|+.|-.+.. ++..||||++.+.. .....++.+|++++.+.+ |+||++++++|+++..+|||||.|.||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 5799999999998875 78889999998764 345678889999999995 999999999999999999999999999
Q ss_pred CHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CcEEEEecCCCcccccc------
Q 003978 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH---WTVKVGDFGLSRLKHET------ 658 (782)
Q Consensus 588 sL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~---~~vkL~DFGla~~~~~~------ 658 (782)
.|..+|.+.. .|++..+..+.++|+.||.|||.+| |.||||||+|||...- ..||||||.+..-....
T Consensus 162 plLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 162 PLLSHIQKRK-HFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred hHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 9999998754 6999999999999999999999999 9999999999999643 46999999987532211
Q ss_pred -cccccCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---------------HHHHHHh
Q 003978 659 -YLTTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNS---------------MQVIGAV 717 (782)
Q Consensus 659 -~~~~~~~~Gt~~y~aPE~l~-----~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~---------------~~~~~~i 717 (782)
.....+.+|+..|||||+.. ...|+.+-|.||||++||-||.|.+||.+... ...++.|
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI 318 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI 318 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence 11223557999999999863 34578899999999999999999999976532 1222233
Q ss_pred hccccccCCCC----CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 718 GFMNQRLEIPK----DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 718 ~~~~~~~~~p~----~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
+ ...+++|. .++.+.++||..+|.+|+.+|.++.++ +.|+|++-...+
T Consensus 319 Q--EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~v------lnhPw~~~~~~e 370 (463)
T KOG0607|consen 319 Q--EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQV------LNHPWVQRCAPE 370 (463)
T ss_pred h--ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhc------cCCccccccchh
Confidence 2 23456664 478999999999999999999999998 677888655443
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=294.17 Aligned_cols=255 Identities=27% Similarity=0.389 Sum_probs=202.1
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHH-HHHhCCCCceeEEeeeeecCC
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~ 575 (782)
.++...++++-+..||.|+||+|+|..++ |+..|||.++.... +...+++..|.+ +++.-+.||||++||+...++
T Consensus 58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG 136 (361)
T KOG1006|consen 58 LHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG 136 (361)
T ss_pred ccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence 44455567777889999999999999984 66789999987665 333456666776 455557999999999999999
Q ss_pred ceeEEEeecCCCCHHHHHh----hcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCC
Q 003978 576 RLCIVTEFLPRGSLFRLLQ----RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~----~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGl 651 (782)
-.||.||+| ..+|..+.+ .....+++..+-.|..-.+.||.||-.. ..||||||||+|||++..|.|||||||+
T Consensus 137 dcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~G~vKLCDFGI 214 (361)
T KOG1006|consen 137 DCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILLDRHGDVKLCDFGI 214 (361)
T ss_pred ceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEEecCCCEeeecccc
Confidence 999999999 457755543 2345689999999999999999999864 3499999999999999999999999999
Q ss_pred CcccccccccccCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhcccc-ccCCC
Q 003978 652 SRLKHETYLTTKTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFMNQ-RLEIP 727 (782)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~-~~~~~i~~~~~-~~~~p 727 (782)
+....+....+ ...|-..|||||.+.. ..|+.++|+||||++|||+.||+.||+..+.. +.+..+..... .+..+
T Consensus 215 cGqLv~SiAkT-~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~ 293 (361)
T KOG1006|consen 215 CGQLVDSIAKT-VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFD 293 (361)
T ss_pred hHhHHHHHHhh-hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCc
Confidence 87766655444 4478889999999964 45889999999999999999999999887652 22223322211 12222
Q ss_pred C---CCCHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003978 728 K---DVDPRWAAIVESCWHSDPQCRPSFQELVD 757 (782)
Q Consensus 728 ~---~~~~~l~~LI~~cL~~dP~~RPs~~ell~ 757 (782)
. .++..+..||..||.+|-..||.+.+|++
T Consensus 294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 2 37889999999999999999999999954
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=307.48 Aligned_cols=260 Identities=24% Similarity=0.365 Sum_probs=211.0
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-----CHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-----SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (782)
..+.++|-++.+||+|+|+.||++.+ ..+.||||+-...+. .....+-..+|.+|-+.|+||.||++|++|.-
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 34556899999999999999999986 567799998654332 12344567889999999999999999999964
Q ss_pred -CCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc---CCCcEEEEec
Q 003978 574 -PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDF 649 (782)
Q Consensus 574 -~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~---~~~~vkL~DF 649 (782)
.+.+|-|+|||+|.+|.-+|+.+. .+++..+..|+.||+.||.||.+..++|||-||||.|||+- ..|.|||+||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 467899999999999999998754 68999999999999999999999999999999999999995 4588999999
Q ss_pred CCCccccccccc-------ccCCCCCCcccCcccccC----CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH-h
Q 003978 650 GLSRLKHETYLT-------TKTGKGTPQWMAPEVLRN----EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGA-V 717 (782)
Q Consensus 650 Gla~~~~~~~~~-------~~~~~Gt~~y~aPE~l~~----~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~-i 717 (782)
|+++.+.+.... +.-+.||.+|++||++.- ...+.|+||||+||++|.++.|+.||...-..+.+-. -
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 999987654332 334579999999999853 3358899999999999999999999986654433222 1
Q ss_pred hcccc---ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 718 GFMNQ---RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 718 ~~~~~---~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
..+.. .++.-+.++.+.+.||++||.+..++|.++.+| ..++||
T Consensus 698 TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qL------A~dpyl 744 (775)
T KOG1151|consen 698 TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQL------ACDPYL 744 (775)
T ss_pred chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHH------ccCccc
Confidence 11111 233335789999999999999999999999988 456776
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=290.67 Aligned_cols=251 Identities=27% Similarity=0.406 Sum_probs=205.2
Q ss_pred cccceeEe-eeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeec----C
Q 003978 503 LWEDLTIG-EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS----P 574 (782)
Q Consensus 503 ~~~~y~i~-~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----~ 574 (782)
..++|.+. ++||-|-.|+|-.|.+ +++++|+|++... ...++|+++--.. .|||||+++++|+. .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 34567665 5689999999999987 5778999997542 3567788876555 59999999999864 2
Q ss_pred CceeEEEeecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCcEEEEecC
Q 003978 575 QRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFG 650 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~---~~~vkL~DFG 650 (782)
..+.+|||.|+||.|+..++..+ ..|++..+..|+.||+.|+.|||+.+ |.||||||+|+|... +..+||+|||
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccc
Confidence 45779999999999999997654 45999999999999999999999999 999999999999964 5679999999
Q ss_pred CCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH----HHHHHhhccccccCC
Q 003978 651 LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM----QVIGAVGFMNQRLEI 726 (782)
Q Consensus 651 la~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~----~~~~~i~~~~~~~~~ 726 (782)
+|+..... ....+.+-||.|.|||++..+.|+..-|+|||||+||-||+|.+||...... ....+| ....+.+
T Consensus 210 FAK~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI--~~gqy~F 286 (400)
T KOG0604|consen 210 FAKETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRI--RTGQYEF 286 (400)
T ss_pred cccccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHh--hccCccC
Confidence 99865543 3445678899999999999999999999999999999999999999766432 222333 2333444
Q ss_pred CC----CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 727 PK----DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 727 p~----~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
|. .++...+++|+.+|..+|++|.|+.++ +.|+|....+
T Consensus 287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~------m~hpwi~~~~ 329 (400)
T KOG0604|consen 287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEV------MDHPWINQYE 329 (400)
T ss_pred CChhHhHHHHHHHHHHHHHhcCCchhheeHHHh------hcCchhcccc
Confidence 42 478899999999999999999999999 6778875543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=314.30 Aligned_cols=242 Identities=24% Similarity=0.348 Sum_probs=203.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCceeE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 579 (782)
..+.|++...+|.|+|+.|-.+.+ +++..++|++.+... ...+|+.++... .||||+++.+.+.+..+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeee
Confidence 456888999999999999999987 566799999987632 223466555444 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE-cCCCcEEEEecCCCcccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV-DKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl-~~~~~vkL~DFGla~~~~~~ 658 (782)
|||++.|+.|.+.+.... .....+..|+.+|+.|+.|||.+| ||||||||+|||+ +..++++|+|||.++.....
T Consensus 394 v~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999998888876543 222677789999999999999988 9999999999999 68899999999999866554
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccccCCCCCCCHHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
..+.+-|..|.|||++....|+.+.||||||++||+||+|..||...... +....+ ..+++...+|.++++|
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s~~vS~~AKdL 542 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFSECVSDEAKDL 542 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccccccCHHHHHH
Confidence 23445688999999999999999999999999999999999999887766 332222 3444558899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 738 VESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 738 I~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
|.+||+.||.+||++.++ ..|+||
T Consensus 543 l~~LL~~dP~~Rl~~~~i------~~h~w~ 566 (612)
T KOG0603|consen 543 LQQLLQVDPALRLGADEI------GAHPWF 566 (612)
T ss_pred HHHhccCChhhCcChhhh------ccCcch
Confidence 999999999999999999 567888
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=330.81 Aligned_cols=244 Identities=30% Similarity=0.511 Sum_probs=191.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeee----------
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV---------- 571 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~---------- 571 (782)
..+|+.++.||+|+||.||+|+. .|+.||||.+.... .......+.+|+.+|.+|+|||||++|..|
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 45788889999999999999987 68999999998766 677788899999999999999999998331
Q ss_pred --------------------------------------------------e------c----------------------
Q 003978 572 --------------------------------------------------T------S---------------------- 573 (782)
Q Consensus 572 --------------------------------------------------~------~---------------------- 573 (782)
. .
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0 0
Q ss_pred -------------------------------CCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcC
Q 003978 574 -------------------------------PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622 (782)
Q Consensus 574 -------------------------------~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~ 622 (782)
...+||-||||+..+|.+++.++...-.....|.++++|+.||.|+|+.
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0126899999998888888876542224678899999999999999999
Q ss_pred CCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc------c------------ccccccCCCCCCcccCcccccCCC---
Q 003978 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH------E------------TYLTTKTGKGTPQWMAPEVLRNEP--- 681 (782)
Q Consensus 623 ~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~------~------------~~~~~~~~~Gt~~y~aPE~l~~~~--- 681 (782)
| ||||||||.||+++.++.|||+|||+|+... + ........+||.-|+|||++.+..
T Consensus 717 g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 717 G--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred c--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9 9999999999999999999999999997511 0 011223457999999999998755
Q ss_pred CCchhHHHHHHHHHHHHHcCCCCCC-CCChHHHHHHhhccccccCCCCC---C---CHHHHHHHHHhhhhCCCCCCCHHH
Q 003978 682 SDEKSDVYSFGVILWELATEKIPWD-NLNSMQVIGAVGFMNQRLEIPKD---V---DPRWAAIVESCWHSDPQCRPSFQE 754 (782)
Q Consensus 682 ~s~~sDIwSLG~ll~elltG~~Pf~-~~~~~~~~~~i~~~~~~~~~p~~---~---~~~l~~LI~~cL~~dP~~RPs~~e 754 (782)
|+.|+|||||||+|+||+. ||. .+.....+..+. ...+|.. . -+.-+.+|.+||+.||.+|||+.+
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR----~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR----KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc----cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 8999999999999999984 453 223333333332 2222222 2 234578999999999999999999
Q ss_pred HHH
Q 003978 755 LVD 757 (782)
Q Consensus 755 ll~ 757 (782)
||+
T Consensus 868 LL~ 870 (1351)
T KOG1035|consen 868 LLN 870 (1351)
T ss_pred Hhh
Confidence 964
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=289.96 Aligned_cols=227 Identities=19% Similarity=0.238 Sum_probs=186.4
Q ss_pred CCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCCCHHHHH
Q 003978 516 GSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL 593 (782)
Q Consensus 516 G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ggsL~~~l 593 (782)
|.||.||++.+ .++.||+|.++... ...+|...+....||||+++++++......|++|||+++++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 89999999987 56779999986543 1223445555567999999999999999999999999999999999
Q ss_pred hhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCCCCCcccC
Q 003978 594 QRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 673 (782)
Q Consensus 594 ~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~a 673 (782)
.... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||.+....... ....++..|+|
T Consensus 77 ~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y~a 150 (237)
T cd05576 77 SKFL-NIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMYCA 150 (237)
T ss_pred HHhc-CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCccccC
Confidence 7643 5899999999999999999999998 9999999999999999999999999876544321 23356778999
Q ss_pred cccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCH-
Q 003978 674 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSF- 752 (782)
Q Consensus 674 PE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~- 752 (782)
||.+.+..++.++||||+||++|+|++|..||...... + .......+|..+++.+++||.+||+.||.+||++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 99998888899999999999999999999887643221 1 0112345677889999999999999999999985
Q ss_pred ----HHHHHHHHHHHHHHh
Q 003978 753 ----QELVDKLRDLQRQYF 767 (782)
Q Consensus 753 ----~ell~~L~~L~~~~~ 767 (782)
.++ +.|+||
T Consensus 225 ~~~~~~~------~~h~~~ 237 (237)
T cd05576 225 VAGVEDI------KSHPFF 237 (237)
T ss_pred ccchHHH------HcCCCC
Confidence 666 455664
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=322.16 Aligned_cols=262 Identities=32% Similarity=0.611 Sum_probs=225.8
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEc---------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEe
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 568 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~---------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 568 (782)
.|++..++.++.+.||+|.||.|+++... ...||||.++..... ...+.+..|+++|+.+ +|+|||.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 67888888899999999999999999753 235899998766554 6678899999999999 599999999
Q ss_pred eeeecCCceeEEEeecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 003978 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (782)
Q Consensus 569 ~~~~~~~~~~lv~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp 633 (782)
+++...+.+++|+|||..|+|..++..++ ..++....+.++.||+.||+||++.. +|||||-.
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAa 446 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAA 446 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhh
Confidence 99999999999999999999999998766 34888999999999999999999987 99999999
Q ss_pred CcEEEcCCCcEEEEecCCCccccc-ccccccCCCC--CCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 003978 634 SNLLVDKHWTVKVGDFGLSRLKHE-TYLTTKTGKG--TPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (782)
Q Consensus 634 ~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~~G--t~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~ 709 (782)
.||||+++..+||+|||+++.... .+.......| ...|||||.+....++.++||||+|++||||++ |..||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 999999999999999999985433 2222222233 446999999999999999999999999999999 899999866
Q ss_pred -hHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 710 -SMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 710 -~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
...... ....+.++..|..+++++.++++.||+.+|++||++.++.+.|..+..
T Consensus 527 ~~~~l~~-~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 PTEELLE-FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred cHHHHHH-HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 444433 444666889999999999999999999999999999999999999654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=307.79 Aligned_cols=257 Identities=20% Similarity=0.318 Sum_probs=207.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
...|..++.||-|+||.|.++... ...||+|.+.+... ....+.-.+.|-.||...+.+-||+||..|.+.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 346889999999999999999764 44599999876543 445566778899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCc---cccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR---LKHE 657 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~---~~~~ 657 (782)
|+|++||++-.+|.+.+ .|++..+.+++.+|..|+++.|..| +|||||||+|||||.+|+|||+|||++. +.++
T Consensus 708 MdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred EeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccceeccc
Confidence 99999999999987654 6999999999999999999999999 9999999999999999999999999974 1111
Q ss_pred c---------------------------------------cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHH
Q 003978 658 T---------------------------------------YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWEL 698 (782)
Q Consensus 658 ~---------------------------------------~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~el 698 (782)
. -......+||+.|+|||++....|+.--|+||.||+||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 0 0001133699999999999999999999999999999999
Q ss_pred HcCCCCCCCCChHHHHHHhhccccccCC--CCCCCHHHHHHHHHhhhhCCCCCC---CHHHHHHHHHHHHHHHhhcc
Q 003978 699 ATEKIPWDNLNSMQVIGAVGFMNQRLEI--PKDVDPRWAAIVESCWHSDPQCRP---SFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 699 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~--p~~~~~~l~~LI~~cL~~dP~~RP---s~~ell~~L~~L~~~~~~~~ 770 (782)
+.|..||......+...++..-...+.+ ..++++++.+||.++.. +++.|. .+++| -.|+||+.+
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~v------KaHpfFkgI 934 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQV------KAHPFFKGI 934 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhhcccchhhh------hcCcccccc
Confidence 9999999887776655444322222333 35799999999998554 567775 34444 246777554
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=289.10 Aligned_cols=264 Identities=21% Similarity=0.296 Sum_probs=210.1
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC-----
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP----- 574 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 574 (782)
.....|+-..+||+|.||.||+++. .++.||+|++-.+......-....+|+++|..++|+|++.++++|...
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 4446778888999999999999987 456788887644333333334567899999999999999999887432
Q ss_pred ---CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCC
Q 003978 575 ---QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (782)
Q Consensus 575 ---~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGl 651 (782)
..+|+||.+|+. +|..+|.....+++...+..++.+++.||.|+|+.. |+|||+||+|+||+.+|.+||+|||+
T Consensus 94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeecccc
Confidence 348999999966 999999877788999999999999999999999998 99999999999999999999999999
Q ss_pred Ccccccc----cccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc---
Q 003978 652 SRLKHET----YLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--- 723 (782)
Q Consensus 652 a~~~~~~----~~~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~--- 723 (782)
++..... .......+-|..|++||.+.|. .|+.+.|||.-||+|.||+++.+-+.+....+.+..|...-+.
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 9754322 1112244569999999999875 4788999999999999999999999988887766654321110
Q ss_pred --------------c---CCC-------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 724 --------------L---EIP-------------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 724 --------------~---~~p-------------~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
+ +++ -.-+++..+|+.++|..||.+|++++++ +.|.||..-+.+
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~a------lnh~~F~kdp~p 324 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQA------LNHDFFWKDPMP 324 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhh------hchhhhhcCCcc
Confidence 0 011 1124578899999999999999999999 667888766554
Q ss_pred C
Q 003978 774 V 774 (782)
Q Consensus 774 ~ 774 (782)
.
T Consensus 325 q 325 (376)
T KOG0669|consen 325 Q 325 (376)
T ss_pred h
Confidence 3
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=288.56 Aligned_cols=260 Identities=33% Similarity=0.596 Sum_probs=206.5
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC--CCCceeEEeeeeecCC
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL--RHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~~~~ 575 (782)
+.......+..+.+.||+|.||.||+|.+.|..||||+|.... .....+|.+|++.+ +|+||+.|++.-..++
T Consensus 204 LVQRTiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 204 LVQRTIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred HhHHhhhheeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 3445566789999999999999999999999999999996533 25678899998875 8999999999876543
Q ss_pred ----ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhc-----C-CCCeeecCCCCCcEEEcCCCcEE
Q 003978 576 ----RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-----C-NPPIIHRDLKSSNLLVDKHWTVK 645 (782)
Q Consensus 576 ----~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~-----~-~~~ivHrDIKp~NILl~~~~~vk 645 (782)
.+|||.+|-+.|||+|||.+ ..++....++++..++.||++||. + .+.|.|||||..||||.+++...
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 58999999999999999986 458899999999999999999995 2 35699999999999999999999
Q ss_pred EEecCCCcccccc----cccccCCCCCCcccCcccccCCCC-----C-chhHHHHHHHHHHHHHc-----C-----CCCC
Q 003978 646 VGDFGLSRLKHET----YLTTKTGKGTPQWMAPEVLRNEPS-----D-EKSDVYSFGVILWELAT-----E-----KIPW 705 (782)
Q Consensus 646 L~DFGla~~~~~~----~~~~~~~~Gt~~y~aPE~l~~~~~-----s-~~sDIwSLG~ll~ellt-----G-----~~Pf 705 (782)
|+|+|+|...... .......+||.+|||||++...-. + ..+||||||.++||+.. | .+||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 9999999754332 233456789999999999864321 2 35999999999999876 2 5788
Q ss_pred CCCC----hHHHHHHh-hccccccCCCCCCC--H---HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 706 DNLN----SMQVIGAV-GFMNQRLEIPKDVD--P---RWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 706 ~~~~----~~~~~~~i-~~~~~~~~~p~~~~--~---~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
...- ..+.+..+ .....++.+|..+. + .+..|++.||..||.-|.|+-.+.+.|.++.+
T Consensus 437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 5442 22333333 33334555555432 3 45678999999999999999999999888864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=291.54 Aligned_cols=256 Identities=34% Similarity=0.553 Sum_probs=206.8
Q ss_pred cceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC--CCCceeEEeeeeecCC----cee
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL--RHPNVLLFMGAVTSPQ----RLC 578 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~~~~----~~~ 578 (782)
...++.++||+|.||.||+|...++.||||+++.. ..+.+..|.+|+... +|+||++|+++-.... .++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~-----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ-----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhccCceeEEEecCHH-----HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 45677889999999999999999999999998643 357788888888765 7999999999876554 789
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcC-------CCCeeecCCCCCcEEEcCCCcEEEEecCC
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-------NPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~-------~~~ivHrDIKp~NILl~~~~~vkL~DFGl 651 (782)
||++|-+.|+|.++|+.+ .++|.....++.-|++||+|||+- .++|+|||||..||||.+|++..|+|||+
T Consensus 285 LVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999999865 589999999999999999999962 36799999999999999999999999999
Q ss_pred Ccccccc--cccccCCCCCCcccCcccccCCCC-C-----chhHHHHHHHHHHHHHcC------------CCCCC-----
Q 003978 652 SRLKHET--YLTTKTGKGTPQWMAPEVLRNEPS-D-----EKSDVYSFGVILWELATE------------KIPWD----- 706 (782)
Q Consensus 652 a~~~~~~--~~~~~~~~Gt~~y~aPE~l~~~~~-s-----~~sDIwSLG~ll~elltG------------~~Pf~----- 706 (782)
|...... .......+||.+|||||++.|.-. . .+.||||+|.|||||++. ..||.
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 9865432 223334689999999999987432 1 368999999999999883 12343
Q ss_pred CCChHHHHHHhhccccccCCCCCC-----CHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 707 NLNSMQVIGAVGFMNQRLEIPKDV-----DPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 707 ~~~~~~~~~~i~~~~~~~~~p~~~-----~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
.....++...+.....++.+|..+ ..-+++.|..||..|++-|.|+.=+-+.+.++.+.+-
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 111223333444455666666543 3468899999999999999999999999999988764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=273.16 Aligned_cols=236 Identities=33% Similarity=0.505 Sum_probs=196.3
Q ss_pred CcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCCCHHHHHh
Q 003978 517 SCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ 594 (782)
Q Consensus 517 ~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~ 594 (782)
+||.||++... +..+++|++........ ...+.+|++.++.++|+||+++++.+......+++|||+.+++|..++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999985 57899999876543322 5788899999999999999999999999899999999999989999997
Q ss_pred hcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCCCCCcccCc
Q 003978 595 RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAP 674 (782)
Q Consensus 595 ~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aP 674 (782)
.... +++..++.++.+++.+|.|||+.+ ++|+||+|.||+++.++.++|+|||++....... ......++..|++|
T Consensus 80 ~~~~-~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~p 155 (244)
T smart00220 80 KRGR-LSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAP 155 (244)
T ss_pred hccC-CCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCH
Confidence 6443 888999999999999999999998 9999999999999999999999999987665432 23345688999999
Q ss_pred ccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CChHHHHHHhhccccccCCCCC-CCHHHHHHHHHhhhhCCCCCCCH
Q 003978 675 EVLRNEPSDEKSDVYSFGVILWELATEKIPWDN-LNSMQVIGAVGFMNQRLEIPKD-VDPRWAAIVESCWHSDPQCRPSF 752 (782)
Q Consensus 675 E~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~-~~~~l~~LI~~cL~~dP~~RPs~ 752 (782)
|.+.+..++.++|||+||+++|+|++|..||.. .........+............ ++.++.+++.+||..+|++||++
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~ 235 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTA 235 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCH
Confidence 999988889999999999999999999999987 3433333333211111111111 88999999999999999999999
Q ss_pred HHHHH
Q 003978 753 QELVD 757 (782)
Q Consensus 753 ~ell~ 757 (782)
.++++
T Consensus 236 ~~~~~ 240 (244)
T smart00220 236 EEALQ 240 (244)
T ss_pred HHHhh
Confidence 99954
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=333.07 Aligned_cols=247 Identities=24% Similarity=0.399 Sum_probs=191.4
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
...|...+.||+|+||.||+|.. .+..||||.+...... ...|+++++.++|||||++++++..+...|+||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 34567778999999999999986 5678999988643321 124688899999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcC-CCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~-~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
|||++|+|.+++. .+++..+..++.|++.||+|||.. .++|+||||||+||+++.++..++. ||.......
T Consensus 763 Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 763 EYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred eCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 9999999999995 378899999999999999999943 2339999999999999998887775 665543221
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHhh--ccc------cccCCCC--
Q 003978 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM--QVIGAVG--FMN------QRLEIPK-- 728 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~--~~~~~i~--~~~------~~~~~p~-- 728 (782)
.....||+.|||||++.+..++.++|||||||++|||++|+.||...... ....... ... ..+.+..
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 12336889999999999999999999999999999999999998532110 1111000 000 0011111
Q ss_pred ----CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 729 ----DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 729 ----~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
....++.+++.+||..||++||++.++++.|+++...
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 1123577899999999999999999999999887653
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=300.45 Aligned_cols=254 Identities=31% Similarity=0.561 Sum_probs=220.3
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCC----eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~----~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
..+..++||.|+||+||+|.+ ++. +||||++..... .+.-.++..|+-+|.+++|||++++++++.... +.|
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 345568999999999999987 333 589999865543 334567888999999999999999999998765 889
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
|++||++|.|.++++.++..+-.+..+.|..||++||.|||.++ +|||||-..||||..-.+|||.|||+++......
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999999999998889999999999999999999999988 9999999999999999999999999998754432
Q ss_pred --ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHH
Q 003978 660 --LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 736 (782)
Q Consensus 660 --~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 736 (782)
.......-.+.|||-|.+....|+.++||||+||++||++| |..||.+....++-..+. ...++..|+.++.++..
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-~geRLsqPpiCtiDVy~ 931 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-KGERLSQPPICTIDVYM 931 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-ccccCCCCCCccHHHHH
Confidence 22333445678999999999999999999999999999998 999999988776655543 55678999999999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 737 IVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
++.+||..|+..||+++++...|.++..
T Consensus 932 ~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 932 VMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred HHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 9999999999999999999999988754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=305.15 Aligned_cols=257 Identities=19% Similarity=0.223 Sum_probs=175.1
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeee-----
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA----- 570 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~----- 570 (782)
...++|++.++||+|+||.||+|.+. +..||||.+......+ ....+ .+....+.+++.++..
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e----~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE----IWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH----HHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 35679999999999999999999874 5679999875432111 11111 1122222233322222
Q ss_pred -eecCCceeEEEeecCCCCHHHHHhhcCCcc-------------------hHHHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 003978 571 -VTSPQRLCIVTEFLPRGSLFRLLQRNTTKL-------------------DWRRRILMALDIARGVSYLHHCNPPIIHRD 630 (782)
Q Consensus 571 -~~~~~~~~lv~E~~~ggsL~~~l~~~~~~l-------------------~~~~~~~i~~qll~aL~~LH~~~~~ivHrD 630 (782)
...+..+++||||+.+++|.+++....... ....+..++.||+.||.|||+++ |+|||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRD 280 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRD 280 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCc
Confidence 234567899999999999999987543221 23345678999999999999998 99999
Q ss_pred CCCCcEEEcC-CCcEEEEecCCCcccccc-cccccCCCCCCcccCcccccCCC----------------------CCchh
Q 003978 631 LKSSNLLVDK-HWTVKVGDFGLSRLKHET-YLTTKTGKGTPQWMAPEVLRNEP----------------------SDEKS 686 (782)
Q Consensus 631 IKp~NILl~~-~~~vkL~DFGla~~~~~~-~~~~~~~~Gt~~y~aPE~l~~~~----------------------~s~~s 686 (782)
|||+||||+. ++.+||+|||+|+..... ........+|+.|||||.+.... ++.++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999985 579999999999754322 12233567899999999764322 23456
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------c--------cCCCCCCCHHHHHHHHHhhhhCCC
Q 003978 687 DVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-----------R--------LEIPKDVDPRWAAIVESCWHSDPQ 747 (782)
Q Consensus 687 DIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~-----------~--------~~~p~~~~~~l~~LI~~cL~~dP~ 747 (782)
|||||||+||||+++..|+.... ......+..... . ..+....+....+||.+||.+||.
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 99999999999999877754321 111111110000 0 001111233456899999999999
Q ss_pred CCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 748 CRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 748 ~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
+|||+.++ |+|+||+.....
T Consensus 440 kR~ta~e~------L~Hpff~~~~~~ 459 (566)
T PLN03225 440 QRISAKAA------LAHPYFDREGLL 459 (566)
T ss_pred cCCCHHHH------hCCcCcCCCCcc
Confidence 99999999 678999765543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=304.63 Aligned_cols=245 Identities=29% Similarity=0.463 Sum_probs=193.7
Q ss_pred eeEeeeeccCCcEE-EEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCceeEEEeec
Q 003978 507 LTIGEQIGQGSCGT-VYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFL 584 (782)
Q Consensus 507 y~i~~~IG~G~~G~-Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~E~~ 584 (782)
|.-.+.+|.|+.|+ ||+|.+.++.||||.+-. +....+.+|+.+|+.- .|||||++|+.-.+....||++|+|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 44456789999986 999999999999997643 3345678899999988 4999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCcchH---HHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---C--CcEEEEecCCCcccc
Q 003978 585 PRGSLFRLLQRNTTKLDW---RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---H--WTVKVGDFGLSRLKH 656 (782)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~---~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~---~--~~vkL~DFGla~~~~ 656 (782)
..+|.+++......+.. -..+.++.|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++...
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 55999999864111111 344678889999999999988 999999999999975 3 468999999998654
Q ss_pred cc---cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhcccc-ccCCCCCCC
Q 003978 657 ET---YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVD 731 (782)
Q Consensus 657 ~~---~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG-~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~ 731 (782)
.. .....+..||-.|+|||++.......++|||||||++|+.++| .+||...-..+. .|..... ...+.+..+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d 740 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPD 740 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCch
Confidence 32 2234566799999999999998888999999999999999996 999986544332 2221121 112222333
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 732 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 732 ~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
.++.+||.+|+..+|..||++.++ |.|++|
T Consensus 741 ~eA~dLI~~ml~~dP~~RPsa~~V------L~HPlF 770 (903)
T KOG1027|consen 741 CEAKDLISRMLNPDPQLRPSATDV------LNHPLF 770 (903)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHH------hCCCcc
Confidence 389999999999999999999999 455655
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=279.28 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=197.9
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-----C---CceeEEeeeeec-
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-----H---PNVLLFMGAVTS- 573 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-----H---pnIv~l~~~~~~- 573 (782)
.+|.+.++||.|-|++||++.+. .+.||||+++.. ....+....||++|+.++ | ..||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 69999999999999999999984 566999998643 345567888999999984 3 469999999964
Q ss_pred ---CCceeEEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc----------
Q 003978 574 ---PQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---------- 639 (782)
Q Consensus 574 ---~~~~~lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~---------- 639 (782)
..++|||+|++ |.+|..+|... ...++...+..|++||+.||.|||+. .+|||.||||+|||+-
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceeeeeccccchhhhh
Confidence 35799999999 77999988664 44589999999999999999999974 3499999999999983
Q ss_pred --------------------------------------------------------------------------------
Q 003978 640 -------------------------------------------------------------------------------- 639 (782)
Q Consensus 640 -------------------------------------------------------------------------------- 639 (782)
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence
Q ss_pred ------------------------CC----------------------------------------------------Cc
Q 003978 640 ------------------------KH----------------------------------------------------WT 643 (782)
Q Consensus 640 ------------------------~~----------------------------------------------------~~ 643 (782)
+. -+
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 00 03
Q ss_pred EEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh------HH----H
Q 003978 644 VKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS------MQ----V 713 (782)
Q Consensus 644 vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~------~~----~ 713 (782)
|||+|||.|++.+..+. ....|..|+|||++.|..|+..+||||++|++|||.||...|..... .. .
T Consensus 393 vKIaDlGNACW~~khFT---~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i 469 (590)
T KOG1290|consen 393 VKIADLGNACWVHKHFT---EDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI 469 (590)
T ss_pred EEEeeccchhhhhhhhc---hhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence 68888888887666543 33579999999999999999999999999999999999998864432 11 1
Q ss_pred HHHhhccc---------------cc---------------------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003978 714 IGAVGFMN---------------QR---------------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVD 757 (782)
Q Consensus 714 ~~~i~~~~---------------~~---------------------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~ 757 (782)
++.+..+. .+ +.++..-..++.+||.-||+.+|++|||+.++
T Consensus 470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c-- 547 (590)
T KOG1290|consen 470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC-- 547 (590)
T ss_pred HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH--
Confidence 11111000 00 01111122468899999999999999999999
Q ss_pred HHHHHHHHHhhcccC
Q 003978 758 KLRDLQRQYFQASRS 772 (782)
Q Consensus 758 ~L~~L~~~~~~~~~~ 772 (782)
|+|+|++...-
T Consensus 548 ----l~hPwLn~~~~ 558 (590)
T KOG1290|consen 548 ----LKHPWLNPVAG 558 (590)
T ss_pred ----hcCccccCCCC
Confidence 67899986544
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=264.57 Aligned_cols=254 Identities=19% Similarity=0.369 Sum_probs=203.2
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCC--cee
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQ--RLC 578 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~--~~~ 578 (782)
.++|++.+++|+|.|+.||.|.. .+++++||++++.+ .+.+++|++||+.|. ||||+.++++..++. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 46899999999999999999984 67889999987543 367899999999996 999999999998764 467
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CcEEEEecCCCccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHE 657 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~-~~vkL~DFGla~~~~~ 657 (782)
||+||++..+...+.. .++.-.+..++.+++.||.|||+.| |+|||+||.|+||+.. -.++|+|+|+|...+.
T Consensus 112 LiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999998877665553 3677788999999999999999999 9999999999999864 5699999999987765
Q ss_pred ccccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCC-CCChHHHHHHhhcccc-----------cc
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWD-NLNSMQVIGAVGFMNQ-----------RL 724 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~-~~~~~~~~~~i~~~~~-----------~~ 724 (782)
.. .....+.+..|.-||++..- .|++.-|+|||||+|..|++.+-||- +.+..+.+..+....+ .+
T Consensus 186 ~~-eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 186 GK-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred Cc-eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 43 33455678899999998764 47899999999999999999988873 3333333323221100 01
Q ss_pred CCC------------------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcCC
Q 003978 725 EIP------------------------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVG 775 (782)
Q Consensus 725 ~~p------------------------~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~~ 775 (782)
.++ ...++++.+|+.++|..|-.+|+|+.|. +.|+||...+....
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEa------m~HpyF~~~~~~~~ 333 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEA------MAHPYFAPVREAES 333 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHH------hcCchHHHHHHHhh
Confidence 111 1246899999999999999999999998 78999987765443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=290.31 Aligned_cols=255 Identities=23% Similarity=0.350 Sum_probs=207.1
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC------CCceeEEeeeee
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR------HPNVLLFMGAVT 572 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~l~~~~~ 572 (782)
|.+-.+|.+....|+|-|+.|..|.+ .+..||||++....... +.=..|++||++|. --++++|+-.|.
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~---KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH---KTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh---hhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 55667999999999999999999987 46689999998755422 34457999999995 247999999999
Q ss_pred cCCceeEEEeecCCCCHHHHHhhcCC--cchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CcEEEEec
Q 003978 573 SPQRLCIVTEFLPRGSLFRLLQRNTT--KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDF 649 (782)
Q Consensus 573 ~~~~~~lv~E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~-~~vkL~DF 649 (782)
..+++|||||-+ ..+|.++|++.+. .|....+..++.||+.||..|-.+| |+|.||||+||||+.. ..+|||||
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccC
Confidence 999999999999 6799999987543 3677889999999999999999999 9999999999999865 46899999
Q ss_pred CCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC----
Q 003978 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE---- 725 (782)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---- 725 (782)
|.|....+...+.. .-+..|.|||++.|.+|++..|+||+||+||||+||+.-|.+....+++....-+.+.++
T Consensus 582 GSA~~~~eneitPY--LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 582 GSASFASENEITPY--LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred ccccccccccccHH--HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 99977666544332 236789999999999999999999999999999999999998887776654211111000
Q ss_pred ------------------------------------CC-----------CCCC-------HHHHHHHHHhhhhCCCCCCC
Q 003978 726 ------------------------------------IP-----------KDVD-------PRWAAIVESCWHSDPQCRPS 751 (782)
Q Consensus 726 ------------------------------------~p-----------~~~~-------~~l~~LI~~cL~~dP~~RPs 751 (782)
-| ..++ ..|++|+.+||..||++|.|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 00 0111 25789999999999999999
Q ss_pred HHHHHHHHHHHHHHHhhc
Q 003978 752 FQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 752 ~~ell~~L~~L~~~~~~~ 769 (782)
..+. |.|+||+.
T Consensus 740 ~nqA------L~HpFi~~ 751 (752)
T KOG0670|consen 740 VNQA------LKHPFITE 751 (752)
T ss_pred HHHH------hcCCcccC
Confidence 9998 67888864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=293.54 Aligned_cols=258 Identities=19% Similarity=0.243 Sum_probs=186.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEE------------------cCCeEEEEEEeccCCC--HH----------HHHHHHHH
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW------------------YGSDVAVKVFSRQEYS--DE----------VIHSFRQE 552 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~------------------~~~~vAiK~~~~~~~~--~~----------~~~~~~~E 552 (782)
..++|++.++||+|+||.||+|.. .++.||||.+...... .+ ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 456899999999999999999963 2456999998643211 01 11223446
Q ss_pred HHHHHhCCCCce-----eEEeeeeec--------CCceeEEEeecCCCCHHHHHhhcC----------------------
Q 003978 553 VSLMKRLRHPNV-----LLFMGAVTS--------PQRLCIVTEFLPRGSLFRLLQRNT---------------------- 597 (782)
Q Consensus 553 i~il~~l~HpnI-----v~l~~~~~~--------~~~~~lv~E~~~ggsL~~~l~~~~---------------------- 597 (782)
+.++..++|.++ ++++++|.. ....+|||||+.+++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 667777643 356899999999999999986421
Q ss_pred -CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc-ccccCCCCCCcccCcc
Q 003978 598 -TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-LTTKTGKGTPQWMAPE 675 (782)
Q Consensus 598 -~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~Gt~~y~aPE 675 (782)
..+++..++.++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++....... .......+|+.|+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 12345678889999999999999988 9999999999999999999999999986543321 1122334589999999
Q ss_pred cccCCCC----------------------CchhHHHHHHHHHHHHHcCCC-CCCCCChHHHHHH-----------hhccc
Q 003978 676 VLRNEPS----------------------DEKSDVYSFGVILWELATEKI-PWDNLNSMQVIGA-----------VGFMN 721 (782)
Q Consensus 676 ~l~~~~~----------------------s~~sDIwSLG~ll~elltG~~-Pf~~~~~~~~~~~-----------i~~~~ 721 (782)
++..... ..+.||||+||++|+|++|.+ ||........... +....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 9864321 124699999999999999986 7764332211110 00011
Q ss_pred cccCCCCCCCHHHHHHHHHhhhhCC---CCCCCHHHHHHHHHHHHHHHhh
Q 003978 722 QRLEIPKDVDPRWAAIVESCWHSDP---QCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 722 ~~~~~p~~~~~~l~~LI~~cL~~dP---~~RPs~~ell~~L~~L~~~~~~ 768 (782)
.........++..++||.+||..+| .+|+|+.++ |.|+||.
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~ea------L~Hp~f~ 504 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQA------LSHRFFL 504 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHH------hCCCCcC
Confidence 1223335678999999999999876 689999999 6789884
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=268.90 Aligned_cols=262 Identities=27% Similarity=0.451 Sum_probs=218.0
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEcCC-------eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS-------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~-------~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (782)
.+...++++..++-+|+||.||.|.+..+ .|.+|.++... .+-.+..+..|--++..+.|||+..+.++...
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 34456788899999999999999966432 35666664333 44456678888888999999999999998754
Q ss_pred -CCceeEEEeecCCCCHHHHHhhc-------CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEE
Q 003978 574 -PQRLCIVTEFLPRGSLFRLLQRN-------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 645 (782)
Q Consensus 574 -~~~~~lv~E~~~ggsL~~~l~~~-------~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vk 645 (782)
....++++.++.-|+|..+|... ...++..+...++.|++.||+|||.++ |||.||-..|++|++.-+||
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhheeEE
Confidence 45678899999999999999732 234677788889999999999999999 99999999999999999999
Q ss_pred EEecCCCccccc-ccccc-cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccc
Q 003978 646 VGDFGLSRLKHE-TYLTT-KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQ 722 (782)
Q Consensus 646 L~DFGla~~~~~-~~~~~-~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~ 722 (782)
|+|-.+++-.-. ++... ...-....||+||.+.+..|+.++|+||||++||||+| |+.||...++.++...+ +.++
T Consensus 437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl-kdGy 515 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL-KDGY 515 (563)
T ss_pred eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH-hccc
Confidence 999999984322 22111 12234668999999999999999999999999999999 99999999999887666 3677
Q ss_pred ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 723 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 723 ~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
+...|-++|+++..++.-||...|++||+++++...|.++..+.
T Consensus 516 RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 516 RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 88999999999999999999999999999999999999887654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=253.73 Aligned_cols=215 Identities=25% Similarity=0.395 Sum_probs=174.4
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHH-hCCCCceeEEeeeeecCCc
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMK-RLRHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~ 576 (782)
+++..+++..+..||+|+||.|-+.++ .|.-.|+|.+..... ....+++.+|+.+.. ...+|++|.|||.+.....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 455666777888999999999888876 677789999865443 344456667777654 4479999999999999999
Q ss_pred eeEEEeecCCCCHHHHHh---hcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 577 LCIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~---~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
++|.||.| ..+|..+.. ..+..+++..+-+|+..+++||.|||++ ..|||||+||.||||+.+|+||+||||.+-
T Consensus 120 vwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 120 VWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999999 447766543 3466789999999999999999999986 359999999999999999999999999998
Q ss_pred ccccccccccCCCCCCcccCcccccC----CCCCchhHHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHhh
Q 003978 654 LKHETYLTTKTGKGTPQWMAPEVLRN----EPSDEKSDVYSFGVILWELATEKIPWDNL-NSMQVIGAVG 718 (782)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~y~aPE~l~~----~~~s~~sDIwSLG~ll~elltG~~Pf~~~-~~~~~~~~i~ 718 (782)
...+....+ ...|-..|||||.+.. ..|+.++||||||++++||.++++||... .+.+.+.++.
T Consensus 198 ~L~dSiAkt-~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 198 YLVDSIAKT-MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred eehhhhHHH-HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 776654433 2467788999999864 46788999999999999999999999754 4556555553
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-29 Score=258.30 Aligned_cols=257 Identities=18% Similarity=0.298 Sum_probs=217.6
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCcee
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 578 (782)
+..-.|+++++||+|+||..+.|.. ++.+||||.-++... ...+..|.+.++.|. .++|...|.+.....+..
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 3445899999999999999999974 899999998765443 245677888888884 799999999999888999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-----CcEEEEecCCCc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-----WTVKVGDFGLSR 653 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~-----~~vkL~DFGla~ 653 (782)
||||++ |.+|.|++.-++..|+.+++..++.||+.-++|+|++. +|+|||||+|+||..- ..|.|+|||+|+
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 999999 88999999999999999999999999999999999998 9999999999999743 359999999998
Q ss_pred cccc-------ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHhhccccc
Q 003978 654 LKHE-------TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ---VIGAVGFMNQR 723 (782)
Q Consensus 654 ~~~~-------~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~---~~~~i~~~~~~ 723 (782)
.+.+ ++....+..||.+||+-..+.|...+.+.|+-|||.+++++|-|.+||.++.... .+++|......
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 6543 3445566789999999999999999999999999999999999999999875443 44444322221
Q ss_pred ---cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 724 ---LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 724 ---~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
..+...+|.++...+...-..+..+-|+++-+...|.++...
T Consensus 258 T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 258 TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 123456889999999999999999999999998888887653
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=268.43 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=202.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC------
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------ 575 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 575 (782)
..+|.-++.+|.|.- .|..+.+ .+++||+|.+..........++..+|..++..+.|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 357888899999998 6666654 6889999988766444445678889999999999999999999986543
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
..|+|||+| ..+|...+. ..++-.++.++..|++.|+.|||+.| |+||||||+||++..++.+||.|||+|+..
T Consensus 95 e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchhhccc
Confidence 479999999 559988886 34778899999999999999999999 999999999999999999999999999876
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-------------
Q 003978 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------- 722 (782)
Q Consensus 656 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~------------- 722 (782)
... ......+.|..|+|||++.+..+...+||||+||++.||++|..-|.+.+......++....+
T Consensus 169 ~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 169 DTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred Ccc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 665 333455789999999999999999999999999999999999999987654332222110000
Q ss_pred -------c-----cC----CC-----------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003978 723 -------R-----LE----IP-----------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 723 -------~-----~~----~p-----------~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~ 768 (782)
+ .. +| +.-...+++++.+||..||++|.|++++ |+|+|++
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~da------L~HPY~~ 314 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDA------LRHPYIK 314 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHH------hcCCeee
Confidence 0 00 11 0112357899999999999999999999 7889996
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-31 Score=266.50 Aligned_cols=249 Identities=26% Similarity=0.406 Sum_probs=197.7
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC-----cee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-----RLC 578 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~ 578 (782)
+.+..+.||.|+||.||-+++ .++.||+|.+..-...--..+.+.+|+++|..++|.|++..+++..-.+ .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 455567899999999999987 6888999988654333345577889999999999999999988876543 478
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
++.|+| ..+|..+|-. ...++...+..++.||++||.|||+.+ |.||||||.|+|++.+..+||||||+++.....
T Consensus 134 V~TELm-QSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHH-Hhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccccchh
Confidence 899999 5588888865 457899999999999999999999999 999999999999999999999999999875443
Q ss_pred cc-cccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-------------
Q 003978 659 YL-TTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR------------- 723 (782)
Q Consensus 659 ~~-~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~------------- 723 (782)
.. .....+-|..|+|||+++|. .|+.+.||||+||++.||+-.+.-|...++.+.+..|....+.
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 22 12223458899999999985 4789999999999999999999999888776655544221111
Q ss_pred --------cCCC-----------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003978 724 --------LEIP-----------KDVDPRWAAIVESCWHSDPQCRPSFQELVDK 758 (782)
Q Consensus 724 --------~~~p-----------~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~ 758 (782)
.+.| ..-..+...++.+||..||++|.+..+.+.+
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 1111 1223467889999999999999998888543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=244.04 Aligned_cols=210 Identities=40% Similarity=0.656 Sum_probs=185.4
Q ss_pred eccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCCCHH
Q 003978 513 IGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 590 (782)
Q Consensus 513 IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ggsL~ 590 (782)
||.|.+|.||++... +..+++|++....... ....+.+|++.++.+.|++|+++++++......+++|||+.+++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999986 7889999987655332 3467889999999999999999999999989999999999989999
Q ss_pred HHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCcEEEEecCCCcccccccccccCCCCCC
Q 003978 591 RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSRLKHETYLTTKTGKGTP 669 (782)
Q Consensus 591 ~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~Gt~ 669 (782)
+++......++...++.++.+++.+|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+..............+..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 999865456889999999999999999999998 999999999999999 89999999999876554432233456788
Q ss_pred cccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCC
Q 003978 670 QWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQC 748 (782)
Q Consensus 670 ~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~ 748 (782)
.|++||.+... .++.++|+|+||+++|+| ..+.+++.+||..||++
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~ 204 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEK 204 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCccc
Confidence 99999999887 778999999999999999 78899999999999999
Q ss_pred CCCHHHHHHH
Q 003978 749 RPSFQELVDK 758 (782)
Q Consensus 749 RPs~~ell~~ 758 (782)
||++.++++.
T Consensus 205 R~~~~~l~~~ 214 (215)
T cd00180 205 RPSAKEILEH 214 (215)
T ss_pred CcCHHHHhhC
Confidence 9999999764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=285.95 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=216.9
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
...++|+++..+|.|+||.|||+++ +++..|+|+++..... ....+..|+-+++..+|||||.+++.|-....+++
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--cccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 3456899999999999999999987 5778999999876543 24567789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
+||||.||+|.+.-.-. .++++.++..+++..++||+|||+.| =+|||||-.|||+++.|.|||.|||.+..+....
T Consensus 90 cMEycgggslQdiy~~T-gplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred EEEecCCCcccceeeec-ccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhhhh
Confidence 99999999999887653 47999999999999999999999998 8999999999999999999999999998877777
Q ss_pred ccccCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc---cCCCCCCCHH
Q 003978 660 LTTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR---LEIPKDVDPR 733 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~---~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~---~~~p~~~~~~ 733 (782)
.....+.|||.|||||+-. ...|....|||++|++..|+-.-..|--....++.+..+.+.... .+-+..+++-
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~ 246 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEF 246 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHH
Confidence 7778889999999999863 455888999999999999999888887777777776665443332 2233468899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHH
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVD 757 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~ 757 (782)
+-+|++.||.++|++||+++.+|.
T Consensus 247 fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhhee
Confidence 999999999999999999999854
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=275.31 Aligned_cols=199 Identities=25% Similarity=0.431 Sum_probs=172.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEcCC--eEEEEEEeccCCCHH------HHHHHHHHHHHHHhCC---CCceeEEeeeee
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWYGS--DVAVKVFSRQEYSDE------VIHSFRQEVSLMKRLR---HPNVLLFMGAVT 572 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~~~--~vAiK~~~~~~~~~~------~~~~~~~Ei~il~~l~---HpnIv~l~~~~~ 572 (782)
+.+|..++.+|.|+||.|++|.++.. .|+||.+.+++.-.+ .+-.+..||+||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 45799999999999999999998543 589999887654221 2234556999999997 999999999999
Q ss_pred cCCceeEEEeec-CCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCC
Q 003978 573 SPQRLCIVTEFL-PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (782)
Q Consensus 573 ~~~~~~lv~E~~-~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGl 651 (782)
+++.+||+||.- +|.+|+++|...+ .+++..+..|+.|++.|+++||++| |||||||-+||+++.+|.+||+|||.
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEeeccc
Confidence 999999999964 5679999998754 6999999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCC
Q 003978 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDN 707 (782)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-s~~sDIwSLG~ll~elltG~~Pf~~ 707 (782)
|.+....+. ..++||..|.|||++.|.+| +..-|||+||++||-++....||.+
T Consensus 717 aa~~ksgpf--d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKSGPF--DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcCCCc--ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 876555433 35689999999999999888 5678999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=236.45 Aligned_cols=202 Identities=36% Similarity=0.590 Sum_probs=173.8
Q ss_pred eeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeec
Q 003978 507 LTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 584 (782)
|.+.+.||.|++|.||++... +..++||.+...... .....+.+|++.++.++|+||+++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 567899999999999999985 578999998765433 24678889999999999999999999999889999999999
Q ss_pred CCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc-cccc
Q 003978 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-LTTK 663 (782)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~ 663 (782)
++++|.+++......+++..++.++.+++.+|.+||.++ ++|+||+|.||+++.++.++|+|||++....... ....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 999999999765433789999999999999999999998 9999999999999999999999999987655432 1122
Q ss_pred CCCCCCcccCcccc-cCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CChH
Q 003978 664 TGKGTPQWMAPEVL-RNEPSDEKSDVYSFGVILWELATEKIPWDN-LNSM 711 (782)
Q Consensus 664 ~~~Gt~~y~aPE~l-~~~~~s~~sDIwSLG~ll~elltG~~Pf~~-~~~~ 711 (782)
...++..|++||.+ ....++.++|+|+||+++|+|++|+.||.. .+..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~ 207 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT 207 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence 34678899999998 667778899999999999999999999977 3443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=226.62 Aligned_cols=257 Identities=21% Similarity=0.301 Sum_probs=212.5
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCce
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 577 (782)
.+....|+++++||.|+||.+|++.. .|..||||+-+.....+ .+..|.++++.|+ -..|+.+..++.....-
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 45678999999999999999999986 68899999976554433 3556888888886 46788888888888888
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCcEEEEecCCCcc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFGLSRL 654 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~---~~~vkL~DFGla~~ 654 (782)
.+||+++ |.+|.+++.-+...++..+++-++-|++.-++|+|.++ +|||||||+|+|..- ...+.|+|||+|+.
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhh
Confidence 9999999 89999999988889999999999999999999999998 999999999999963 34699999999985
Q ss_pred ccc-------ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHH---HHHhhcccc--
Q 003978 655 KHE-------TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQV---IGAVGFMNQ-- 722 (782)
Q Consensus 655 ~~~-------~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~---~~~i~~~~~-- 722 (782)
..+ ++.......||.+|.+-..+.+...+.+.|+-|+|.+|.++.-|.+||++...... ++.|....-
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 433 34445566899999999999999899999999999999999999999998865443 333321111
Q ss_pred -ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 723 -RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 723 -~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
.-.+.+.+|.++...+..|-..-.++-|++.-+.+.|.-|..
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 112446789999999999999999999999988777765533
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=239.14 Aligned_cols=244 Identities=21% Similarity=0.333 Sum_probs=186.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEcCC--eEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeee-eecCCceeE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWYGS--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA-VTSPQRLCI 579 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~~~--~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~-~~~~~~~~l 579 (782)
.+.|.|.+.||+|.||.+-++.++++ .+++|.+++... ....|.+|...--.| .|.||+.-|++ |+..+.+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 46899999999999999999999654 599999876543 346677777654445 58999988764 677788889
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc--CCCcEEEEecCCCccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD--KHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~--~~~~vkL~DFGla~~~~~ 657 (782)
++||++.|+|..-+... .+-+.....++.|+++|+.|||+.+ +||||||.+||||- +.-+|||||||+++..+.
T Consensus 100 ~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred eeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999999999988754 4788888999999999999999999 99999999999994 334799999999876554
Q ss_pred ccccccCCCCCCcccCcccccCCC-----CCchhHHHHHHHHHHHHHcCCCCCCCCChHH--HHHHhhccc-cccCCC--
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEP-----SDEKSDVYSFGVILWELATEKIPWDNLNSMQ--VIGAVGFMN-QRLEIP-- 727 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~-----~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~--~~~~i~~~~-~~~~~p-- 727 (782)
.-.. ..-+..|.+||++.... .++.+|||.||+++|.+|||.+||+...... ......+.. ..+..|
T Consensus 176 tV~~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~ 252 (378)
T KOG1345|consen 176 TVKY---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK 252 (378)
T ss_pred eehh---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchh
Confidence 3221 12356799999875432 2567999999999999999999998543221 111222222 223333
Q ss_pred -CCCCHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003978 728 -KDVDPRWAAIVESCWHSDPQCRPSFQELVD 757 (782)
Q Consensus 728 -~~~~~~l~~LI~~cL~~dP~~RPs~~ell~ 757 (782)
..+++.+..++++-|..+|++|--..+..+
T Consensus 253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred hcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 457889999999999999999955444433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-25 Score=242.22 Aligned_cols=255 Identities=22% Similarity=0.314 Sum_probs=203.1
Q ss_pred ceeEeeeeccCCcEEEEEEEEcCC---eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCC----CceeEEeeee-ecCCce
Q 003978 506 DLTIGEQIGQGSCGTVYHAVWYGS---DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH----PNVLLFMGAV-TSPQRL 577 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~~~~---~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~H----pnIv~l~~~~-~~~~~~ 577 (782)
+|++.++||+|+||.||+|..... .+|+|+......... ..+..|+.++..+.. +++..+++.+ ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 899999999999999999997554 589998765432211 156678888888862 5899999998 577788
Q ss_pred eEEEeecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-----CcEEEEecCC
Q 003978 578 CIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-----WTVKVGDFGL 651 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~-----~~vkL~DFGl 651 (782)
||||+.+ |.+|.++..... ..++..+++.++.|++.+|.+||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 9999999 889999986655 78999999999999999999999999 9999999999999865 4699999999
Q ss_pred Cc--ccc-cc------ccc-ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc
Q 003978 652 SR--LKH-ET------YLT-TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN 721 (782)
Q Consensus 652 a~--~~~-~~------~~~-~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~ 721 (782)
++ ... .. ... .....||..|+++.++.+...+.+.|+|||+.++.+|+.|.+||...........+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98 321 11 111 223469999999999999999999999999999999999999998776543333332222
Q ss_pred cccC---CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 722 QRLE---IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 722 ~~~~---~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
.... .....+.++..+...+-..+...+|.+..+...|..+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 2211 3345667888888888889999999999998886665443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=282.97 Aligned_cols=200 Identities=22% Similarity=0.246 Sum_probs=146.9
Q ss_pred CCC-CceeEEeeee-------ecCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 003978 559 LRH-PNVLLFMGAV-------TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRD 630 (782)
Q Consensus 559 l~H-pnIv~l~~~~-------~~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrD 630 (782)
+.| +||+++++++ .....++++|||+ +++|+++|......+++..++.++.||+.||.|||++| |||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHrD 105 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVHN 105 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeecc
Confidence 345 5777888877 2334678889988 66999999766667999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCC-------------------cEEEEecCCCccccccc----------------ccccCCCCCCcccCcc
Q 003978 631 LKSSNLLVDKHW-------------------TVKVGDFGLSRLKHETY----------------LTTKTGKGTPQWMAPE 675 (782)
Q Consensus 631 IKp~NILl~~~~-------------------~vkL~DFGla~~~~~~~----------------~~~~~~~Gt~~y~aPE 675 (782)
|||+||||+..+ .+||+|||+++...... ......+||+.|||||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 999999996544 45556666654321100 0011235889999999
Q ss_pred cccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHH
Q 003978 676 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQEL 755 (782)
Q Consensus 676 ~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~el 755 (782)
++.+..++.++|||||||+||||++|..||..... ....+...... .......+....++.+||.++|.+||++.++
T Consensus 186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ei 262 (793)
T PLN00181 186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLP-PQILLNWPKEASFCLWLLHPEPSCRPSMSEL 262 (793)
T ss_pred hhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcC-hhhhhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence 99999999999999999999999999988764321 11122111111 1111224567889999999999999999999
Q ss_pred HHHHHHHHHHHhhcc
Q 003978 756 VDKLRDLQRQYFQAS 770 (782)
Q Consensus 756 l~~L~~L~~~~~~~~ 770 (782)
++|+||+..
T Consensus 263 ------l~h~~~~~~ 271 (793)
T PLN00181 263 ------LQSEFINEP 271 (793)
T ss_pred ------hhchhhhhh
Confidence 557777653
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=246.27 Aligned_cols=252 Identities=24% Similarity=0.377 Sum_probs=195.2
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE-----cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecC
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSP 574 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 574 (782)
..+.+.|.++++||+|+|++||++.. ..+.||+|.+..... ..++..|+++|..+. +.||+.+.+++..+
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34567899999999999999999975 345699998865432 346788999999994 99999999999999
Q ss_pred CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCcEEEEecCCCc
Q 003978 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSR 653 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~-~~~vkL~DFGla~ 653 (782)
+...+||||++.....+++.. ++...+..+++.++.||.++|.+| ||||||||.|||.+. .++-.|+|||+|.
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred CeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHH
Confidence 999999999999988888763 567888999999999999999999 999999999999985 4678999999986
Q ss_pred ccc---------------ccc-----------------------------ccccCCCCCCcccCcccccCCC-CCchhHH
Q 003978 654 LKH---------------ETY-----------------------------LTTKTGKGTPQWMAPEVLRNEP-SDEKSDV 688 (782)
Q Consensus 654 ~~~---------------~~~-----------------------------~~~~~~~Gt~~y~aPE~l~~~~-~s~~sDI 688 (782)
... ... .......||+.|+|||++...+ .+.++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 100 000 0011235999999999987655 4789999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCh-HHHHHHh------------hccccc---------------------c----------
Q 003978 689 YSFGVILWELATEKIPWDNLNS-MQVIGAV------------GFMNQR---------------------L---------- 724 (782)
Q Consensus 689 wSLG~ll~elltG~~Pf~~~~~-~~~~~~i------------~~~~~~---------------------~---------- 724 (782)
||.|++++.++++.+||-.... ...+..+ ....+. .
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 9999999999999999843321 1111110 000000 0
Q ss_pred ------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003978 725 ------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 725 ------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~ 768 (782)
......+..+.+|+.+||..||.+|.|+++. |+|+||.
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeA------LkHpFF~ 385 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDA------LKHPFFD 385 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHH------hcCcCCc
Confidence 0001234578999999999999999999998 6778885
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=220.03 Aligned_cols=163 Identities=23% Similarity=0.318 Sum_probs=130.1
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003978 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (782)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (782)
|+|.+++......+++..++.++.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-----cCC
Confidence 6899999876667999999999999999999999875 999999999999999 9998765432 236
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhcccccc-----CCCCCCCH--HHHHHH
Q 003978 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ-VIGAVGFMNQRL-----EIPKDVDP--RWAAIV 738 (782)
Q Consensus 667 Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~-~~~~i~~~~~~~-----~~p~~~~~--~l~~LI 738 (782)
||+.|||||++.+..++.++|||||||++|||++|..||....... ....+....... ..+..++. ++.+||
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 8999999999999999999999999999999999999997654322 222221111111 11122333 699999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 739 ESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 739 ~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
.+||..||.+||++.++++++..+..
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHHH
Confidence 99999999999999999887766643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.9e-23 Score=216.53 Aligned_cols=249 Identities=29% Similarity=0.442 Sum_probs=203.7
Q ss_pred eeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHH-HHHHHHHHHHHHHhCCCC-ceeEEeeeeecCCceeEEEeec
Q 003978 507 LTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRHP-NVLLFMGAVTSPQRLCIVTEFL 584 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~-~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lv~E~~ 584 (782)
|.+.+.||.|+||.||++... ..+++|.+........ ....+.+|+.++..+.|+ +|+++++.+......+++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 788899999999999999988 7789999877665443 677899999999999988 7999999998777789999999
Q ss_pred CCCCHHHHHhhcC--CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-cEEEEecCCCcccccccc-
Q 003978 585 PRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHETYL- 660 (782)
Q Consensus 585 ~ggsL~~~l~~~~--~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~-~vkL~DFGla~~~~~~~~- 660 (782)
.++++.+++.... ..+.......++.|++.++.|+|+.+ ++||||||+||+++..+ .++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999997776544 26889999999999999999999999 99999999999999988 799999999875444321
Q ss_pred -----cccCCCCCCcccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhccccc-cC--
Q 003978 661 -----TTKTGKGTPQWMAPEVLRN---EPSDEKSDVYSFGVILWELATEKIPWDNLNS----MQVIGAVGFMNQR-LE-- 725 (782)
Q Consensus 661 -----~~~~~~Gt~~y~aPE~l~~---~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~----~~~~~~i~~~~~~-~~-- 725 (782)
......|+..|++||.+.+ ...+...|+|++|++++++++|..||..... ......+...... ..
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 2356689999999999988 5778899999999999999999999877763 3333333222212 11
Q ss_pred CCCCC----CHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003978 726 IPKDV----DPRWAAIVESCWHSDPQCRPSFQELVDK 758 (782)
Q Consensus 726 ~p~~~----~~~l~~LI~~cL~~dP~~RPs~~ell~~ 758 (782)
..... ...+.+++..|+..+|..|.+..+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11111 2578999999999999999998887554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-24 Score=251.96 Aligned_cols=259 Identities=24% Similarity=0.324 Sum_probs=201.6
Q ss_pred eEeeeeccCCcEEEEEEEEc--CCeEEEEEEe----ccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFS----RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 508 ~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~----~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.....+|.|++|.|+.+... ...++.|.+. ...........+..|+.+-..+.||||+..+..+.+....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999988877642 2334444433 11112233333667788888889999998888887776666669
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc--
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-- 659 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-- 659 (782)
|||++ +|+.++... ..+....+-.++.|++.||.|||..| |.||||||+|+++..+|.+||+|||.+.......
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 99999 999999864 36888899999999999999999999 9999999999999999999999999987654433
Q ss_pred --ccccCCCCCCcccCcccccCCCCCc-hhHHHHHHHHHHHHHcCCCCCCCCChHHHH--HHhhc-----cccccCCCCC
Q 003978 660 --LTTKTGKGTPQWMAPEVLRNEPSDE-KSDVYSFGVILWELATEKIPWDNLNSMQVI--GAVGF-----MNQRLEIPKD 729 (782)
Q Consensus 660 --~~~~~~~Gt~~y~aPE~l~~~~~s~-~sDIwSLG~ll~elltG~~Pf~~~~~~~~~--~~i~~-----~~~~~~~p~~ 729 (782)
......+|+..|+|||++.+..|+. ..||||.|++++.|.+|+.||......+.. ..... ......+...
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSL 556 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHh
Confidence 2345668999999999999999976 589999999999999999999766544332 11111 1111223345
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcCCC
Q 003978 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGD 776 (782)
Q Consensus 730 ~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~~~ 776 (782)
++.+.+.+|.+||+.||.+|.|+.+| ++.+||+++.-|+-+
T Consensus 557 lp~~~~~~~~~~l~~~P~~R~ti~~i------~~d~W~~~i~~c~v~ 597 (601)
T KOG0590|consen 557 LPRETRIIIYRMLQLDPTKRITIEQI------LNDEWIRSIECCHVD 597 (601)
T ss_pred chhhHHHHHHHHccCChhheecHHHH------hhChHhhhcceEEec
Confidence 78889999999999999999999999 788999999887654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-23 Score=224.47 Aligned_cols=167 Identities=18% Similarity=0.141 Sum_probs=129.9
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE---cCCeEEEEEEeccCC---CHHHHHHHHHHHHHHHhCCCCceeE-Eeeeeec
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW---YGSDVAVKVFSRQEY---SDEVIHSFRQEVSLMKRLRHPNVLL-FMGAVTS 573 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~---~~~~vAiK~~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~-l~~~~~~ 573 (782)
.....+|.+.+.||+|+||+||+|.+ .++.+|||++..... .......+.+|+++|+.++|+||+. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 45667899999999999999999987 355679998753311 2344567999999999999999985 5442
Q ss_pred CCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCCcEEEcCCCcEEEEecCCC
Q 003978 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDL-KSSNLLVDKHWTVKVGDFGLS 652 (782)
Q Consensus 574 ~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDI-Kp~NILl~~~~~vkL~DFGla 652 (782)
+..|+|||||+|++|... .. .. ...++.+++.+|.|||++| |+|||| ||+|||++.++.+||+|||+|
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 457999999999999732 11 11 1356789999999999998 999999 999999999999999999999
Q ss_pred cccccccc--------cccCCCCCCcccCcccccCCC
Q 003978 653 RLKHETYL--------TTKTGKGTPQWMAPEVLRNEP 681 (782)
Q Consensus 653 ~~~~~~~~--------~~~~~~Gt~~y~aPE~l~~~~ 681 (782)
+....... ......+++.|++||.+....
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 85543321 112446888999999986543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=210.08 Aligned_cols=252 Identities=29% Similarity=0.619 Sum_probs=211.5
Q ss_pred cceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeec
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 584 (782)
.++.+.-+|.+...|..|+|++.|..++.|++............|..|.-.|+-+.||||..+++.+..+.++.+|..||
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 34555667889999999999999999999998776666666677888888899999999999999999999999999999
Q ss_pred CCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEE--ecCCCccccccccc
Q 003978 585 PRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVG--DFGLSRLKHETYLT 661 (782)
Q Consensus 585 ~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~--DFGla~~~~~~~~~ 661 (782)
+.|+|+..|... ...++..++..++.++++|++|||+..+-|----|....++|+++.+.+|. |--++. .
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf-------q 342 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-------Q 342 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-------e
Confidence 999999999654 334677889999999999999999986433344588889999998776653 222211 1
Q ss_pred ccCCCCCCcccCcccccCCCCC---chhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHH
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSD---EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s---~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 738 (782)
.....-.|.||+||.+...+.+ .+.|+|||.+++|||.|...||....+.+..-++.....+..+|+.+++.+..|+
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm 422 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLM 422 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHH
Confidence 1123347899999999877664 4789999999999999999999999999888888888889999999999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHH
Q 003978 739 ESCWHSDPQCRPSFQELVDKLRDLQ 763 (782)
Q Consensus 739 ~~cL~~dP~~RPs~~ell~~L~~L~ 763 (782)
.-||.-||.+||.++.++--|++++
T Consensus 423 ~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 423 NICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHhcCCCCcCCCcceehhhHHHhc
Confidence 9999999999999999988887764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-24 Score=238.33 Aligned_cols=242 Identities=24% Similarity=0.393 Sum_probs=197.3
Q ss_pred eeccCCcEEEEEEEE-----cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCceeEEEeecC
Q 003978 512 QIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEFLP 585 (782)
Q Consensus 512 ~IG~G~~G~Vy~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~E~~~ 585 (782)
.+|+|+||.|+++.. .+.-+|+|+.++.............|..++..++ ||.+|++...++.+..+++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998864 3455899998765443222224556888888887 9999999999999999999999999
Q ss_pred CCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCC
Q 003978 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665 (782)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 665 (782)
||.|+..+.... .+.+.....+...++.+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-+....
T Consensus 81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---- 153 (612)
T ss_pred cchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence 999999987644 5777777888889999999999999 999999999999999999999999999865443322
Q ss_pred CCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhC
Q 003978 666 KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSD 745 (782)
Q Consensus 666 ~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~d 745 (782)
+||..|||||++. .+..++|+||+|+++|+|++|..||.. +....| ....+.+|..++..+++++.+++.++
T Consensus 154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I--l~~~~~~p~~l~~~a~~~~~~l~~r~ 225 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI--LKAELEMPRELSAEARSLFRQLFKRN 225 (612)
T ss_pred ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH--hhhccCCchhhhHHHHHHHHHHHhhC
Confidence 8999999999998 567789999999999999999999987 333333 33467788999999999999999999
Q ss_pred CCCCCCH--HHHHHHHHHHHHHHhhccc
Q 003978 746 PQCRPSF--QELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 746 P~~RPs~--~ell~~L~~L~~~~~~~~~ 771 (782)
|.+|.-. +.+.+ -.+|++|+.+.
T Consensus 226 p~nrLg~~~~~~~e---ik~h~f~~~i~ 250 (612)
T KOG0603|consen 226 PENRLGAGPDGVDE---IKQHEFFQSID 250 (612)
T ss_pred HHHHhccCcchhHH---Hhccchheeee
Confidence 9999643 33322 25677776553
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.6e-21 Score=197.28 Aligned_cols=175 Identities=13% Similarity=0.122 Sum_probs=137.3
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCH-HHHHH------HHHHHHHHHhCCCCceeEEeeeeec
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSD-EVIHS------FRQEVSLMKRLRHPNVLLFMGAVTS 573 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~-~~~~~------~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (782)
.++.++|++.++||.|+||.||++...+..+|||++....... ..... +.+|++.+.++.|++|+.+.+++..
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3567899999999999999999988778889999997654433 33333 5789999999999999999888653
Q ss_pred C--------CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEE
Q 003978 574 P--------QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 645 (782)
Q Consensus 574 ~--------~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vk 645 (782)
. ...+|+|||++|.+|.++.. +++ ....+++.+|..||+.| ++|+||||.||+++.+| ++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-EE
Confidence 3 35789999999999988742 222 23558999999999999 99999999999999998 99
Q ss_pred EEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHH
Q 003978 646 VGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELA 699 (782)
Q Consensus 646 L~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ell 699 (782)
|+|||........... ...+....++.++|+|+||+++..+.
T Consensus 175 liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999987644322111 11334555678999999999987654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-20 Score=199.28 Aligned_cols=255 Identities=25% Similarity=0.366 Sum_probs=180.3
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEcC------------------------------C-------eEEEEEEeccC-
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG------------------------------S-------DVAVKVFSRQE- 540 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~------------------------------~-------~vAiK~~~~~~- 540 (782)
+.....++|++++.||+|....||.+.... + +.|||.+-.-.
T Consensus 151 dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~ 230 (598)
T KOG4158|consen 151 DSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEH 230 (598)
T ss_pred hcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccccc
Confidence 334556799999999999999999774310 0 14566543211
Q ss_pred --CCHHHHHHHHHHH------HH--------HHh--------CCCCceeEEeeeeec-----------------------
Q 003978 541 --YSDEVIHSFRQEV------SL--------MKR--------LRHPNVLLFMGAVTS----------------------- 573 (782)
Q Consensus 541 --~~~~~~~~~~~Ei------~i--------l~~--------l~HpnIv~l~~~~~~----------------------- 573 (782)
.....++...+|. .+ .+. -+|||||++..+|.+
T Consensus 231 ~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~ 310 (598)
T KOG4158|consen 231 DSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPS 310 (598)
T ss_pred CCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccc
Confidence 1223333333332 11 111 259999999887632
Q ss_pred ----CCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc--CCC--cEE
Q 003978 574 ----PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD--KHW--TVK 645 (782)
Q Consensus 574 ----~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~--~~~--~vk 645 (782)
+..+|+||..+.. +|..++-.+ ..+......++.|+++|+.|||++| |.|||+|.+||||. +++ .+.
T Consensus 311 g~g~~~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LV 385 (598)
T KOG4158|consen 311 GAGEPKTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLV 385 (598)
T ss_pred ccCCCceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEE
Confidence 2357999998854 999999754 3667777888899999999999999 99999999999994 333 478
Q ss_pred EEecCCCccccc-----cccc-ccCCCCCCcccCcccccCCCC------CchhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 003978 646 VGDFGLSRLKHE-----TYLT-TKTGKGTPQWMAPEVLRNEPS------DEKSDVYSFGVILWELATEKIPWDNLNSMQV 713 (782)
Q Consensus 646 L~DFGla~~~~~-----~~~~-~~~~~Gt~~y~aPE~l~~~~~------s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~ 713 (782)
|+|||++--... ++.. ....-|.-..||||+....+= -.|+|.|+.|.+.||++.-..||........
T Consensus 386 vaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L 465 (598)
T KOG4158|consen 386 VADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL 465 (598)
T ss_pred EcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee
Confidence 999998743222 1111 122347888999999864331 2589999999999999999999987443332
Q ss_pred HHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003978 714 IGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDK 758 (782)
Q Consensus 714 ~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~ 758 (782)
-.........+.+|..+++.+++++..+|+.||.+|++.+=....
T Consensus 466 ~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 466 DTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred chhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhH
Confidence 222222334677888999999999999999999999987654443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-21 Score=222.61 Aligned_cols=260 Identities=20% Similarity=0.232 Sum_probs=192.3
Q ss_pred ceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCC--CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
+|...+.||.+.|=+|.++.+..-.|+||++-+... .-.-..+...|++ ...++|||++.+.-+.+.+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 688889999999999999998666699999866542 2222233334555 6667999999999998888899999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc--cc-cc
Q 003978 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH--ET-YL 660 (782)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~--~~-~~ 660 (782)
+.. +|+|.|..++ -+..-+..+|+.||+.||.-+|..| |+|+|||.+||||+.-.-+.|+||..-+... ++ +.
T Consensus 103 vkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred Hhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 954 9999997644 4677788889999999999999999 9999999999999998899999998654321 11 11
Q ss_pred c----ccCCCCCCcccCcccccCCC-----------CCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhh--cccc
Q 003978 661 T----TKTGKGTPQWMAPEVLRNEP-----------SDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVG--FMNQ 722 (782)
Q Consensus 661 ~----~~~~~Gt~~y~aPE~l~~~~-----------~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~--~~~~ 722 (782)
. ..+...-..|.|||.+.... .+++-||||+||+++||++ |.+||.- .+.+.... ....
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---SQL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---SQLLAYRSGNADDP 255 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---HHHHhHhccCccCH
Confidence 1 01122345799999986411 3568899999999999998 6888842 11111110 0000
Q ss_pred ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHH---------HHHHHHHHhhcccCc
Q 003978 723 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDK---------LRDLQRQYFQASRST 773 (782)
Q Consensus 723 ~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~---------L~~L~~~~~~~~~~~ 773 (782)
..-+.+--+..+++||..|++.||.+|.+++++|+. |..+.+.||..-+..
T Consensus 256 e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~yFy~FL~~Y~~~~~~~ 315 (1431)
T KOG1240|consen 256 EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPEYFYSFLYDYLDRFVPL 315 (1431)
T ss_pred HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhhccccHHHHHHHHHHHHHhcCCc
Confidence 111122245689999999999999999999999987 677788887654443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-20 Score=196.85 Aligned_cols=233 Identities=20% Similarity=0.309 Sum_probs=152.7
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhCC----------CCceeEEeeee
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLR----------HPNVLLFMGAV 571 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~----------HpnIv~l~~~~ 571 (782)
..+..+..||.|+++.||.+++. ++++|||++...... ....+.+++|.-....+. |-.++-.++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 35778899999999999999994 588999998655432 234566666654443332 11222222222
Q ss_pred ec---------C---C-----ceeEEEeecCCCCHHHHHhh---cC---CcchHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 003978 572 TS---------P---Q-----RLCIVTEFLPRGSLFRLLQR---NT---TKLDWRRRILMALDIARGVSYLHHCNPPIIH 628 (782)
Q Consensus 572 ~~---------~---~-----~~~lv~E~~~ggsL~~~l~~---~~---~~l~~~~~~~i~~qll~aL~~LH~~~~~ivH 628 (782)
.. . . +.+++|+-+ .++|.+++.. .. ..+.....+.+..|+++.+++||.+| |||
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVH 168 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVH 168 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEe
Confidence 11 1 1 346788888 5588877632 11 22445555677789999999999999 999
Q ss_pred cCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCCCCCcccCcccccC--------CCCCchhHHHHHHHHHHHHHc
Q 003978 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN--------EPSDEKSDVYSFGVILWELAT 700 (782)
Q Consensus 629 rDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~--------~~~s~~sDIwSLG~ll~ellt 700 (782)
+||||+||+++.+|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|+||+++|.|+|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 999999999999999999999987666554332 233578999998743 245789999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCC
Q 003978 701 EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 749 (782)
Q Consensus 701 G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~R 749 (782)
|.+||.......... ........+|..++.||..+|+.||.+|
T Consensus 246 ~~lPf~~~~~~~~~~------~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPE------WDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSG------GGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCcccccc------ccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999998664332111 0233334788999999999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=181.57 Aligned_cols=187 Identities=16% Similarity=0.170 Sum_probs=142.9
Q ss_pred eEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCH--HHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCceeEEEeec
Q 003978 508 TIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSD--EVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEFL 584 (782)
Q Consensus 508 ~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~E~~ 584 (782)
-+...|++|+||+||.+...+.+++.+.+.....-. -....+.+|+++|+.|. |++|++++++ +..|++|||+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 356789999999999888888888877776544311 12235789999999995 5889999886 3469999999
Q ss_pred CCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCCcEEEcCCCcEEEEecCCCcccccccc---
Q 003978 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDL-KSSNLLVDKHWTVKVGDFGLSRLKHETYL--- 660 (782)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDI-Kp~NILl~~~~~vkL~DFGla~~~~~~~~--- 660 (782)
.|.+|...+... ...++.|++.+|.+||++| |+|||| ||+|||++.++.++|+|||++...+....
T Consensus 81 ~G~~L~~~~~~~--------~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 81 AGAAMYQRPPRG--------DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred cCccHHhhhhhh--------hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 999987654211 1346779999999999999 999999 79999999999999999999985443321
Q ss_pred --c--------ccCCCCCCcccCcccccCC-CCC-chhHHHHHHHHHHHHHcCCCCCCCC
Q 003978 661 --T--------TKTGKGTPQWMAPEVLRNE-PSD-EKSDVYSFGVILWELATEKIPWDNL 708 (782)
Q Consensus 661 --~--------~~~~~Gt~~y~aPE~l~~~-~~s-~~sDIwSLG~ll~elltG~~Pf~~~ 708 (782)
. ..-...++.|+.|+...-. ..+ .+.++++.|+-+|.|+|+..|+...
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 1112367888888875432 233 5789999999999999999886543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.1e-20 Score=186.35 Aligned_cols=141 Identities=20% Similarity=0.219 Sum_probs=107.8
Q ss_pred eeeeccCCcEEEEEEEE-cCCeEEEEEEeccCCCHHH------------------------HHHHHHHHHHHHhCCCCce
Q 003978 510 GEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEV------------------------IHSFRQEVSLMKRLRHPNV 564 (782)
Q Consensus 510 ~~~IG~G~~G~Vy~~~~-~~~~vAiK~~~~~~~~~~~------------------------~~~~~~Ei~il~~l~HpnI 564 (782)
...||+|+||.||+|.. .|+.||||+++........ ......|++++..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999987 5889999999764321100 1223459999999987776
Q ss_pred eEEeeeeecCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhh-hcCCCCeeecCCCCCcEEEcCCCc
Q 003978 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL-HHCNPPIIHRDLKSSNLLVDKHWT 643 (782)
Q Consensus 565 v~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~L-H~~~~~ivHrDIKp~NILl~~~~~ 643 (782)
.....+.. ...+|||||++|+++...+.. ...++...+..++.|++.+|.+| |+.| |+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-CCc
Confidence 43333222 223899999988777655333 34688999999999999999999 6888 99999999999998 478
Q ss_pred EEEEecCCCcccc
Q 003978 644 VKVGDFGLSRLKH 656 (782)
Q Consensus 644 vkL~DFGla~~~~ 656 (782)
++|+|||+|....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.3e-20 Score=212.03 Aligned_cols=219 Identities=28% Similarity=0.433 Sum_probs=158.5
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
.+|..++.|-.|+||.||.++++ .+++|+|+= ++... +++ ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~li------lRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNLI------LRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhccc-ccchh------hhc---cccccCCccee-----------------
Confidence 46788899999999999999886 677999543 22210 000 33333444444
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc----
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET---- 658 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~---- 658 (782)
|+-...++. ..+++. +++.+++|||+.+ |+|||+||+|++|+.-|++|++|||+++..-..
T Consensus 136 ----gDc~tllk~-~g~lPv--------dmvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ----GDCATLLKN-IGPLPV--------DMVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ----chhhhhccc-CCCCcc--------hhhHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 233333332 223332 2377899999988 999999999999999999999999998642211
Q ss_pred ----cc-------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc-cccccCC
Q 003978 659 ----YL-------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF-MNQRLEI 726 (782)
Q Consensus 659 ----~~-------~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~-~~~~~~~ 726 (782)
++ .....+|||.|.|||++.-+.|+..+|+|+||+++|+++.|..||.+....+.+..+.. ...+++-
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE 280 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence 11 12234799999999999999999999999999999999999999999988887766532 2234444
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003978 727 PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 727 p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~ 768 (782)
...++++++++|.++|+.+|..|--...- ++--+|.||+
T Consensus 281 dea~p~Ea~dli~~LL~qnp~~Rlgt~ga---~evk~h~ff~ 319 (1205)
T KOG0606|consen 281 DEALPPEAQDLIEQLLRQNPLCRLGTGGA---LEVKQHGFFQ 319 (1205)
T ss_pred CcCCCHHHHHHHHHHHHhChHhhcccchh---hhhhhcccee
Confidence 56789999999999999999999632221 2224667764
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.5e-19 Score=178.84 Aligned_cols=141 Identities=21% Similarity=0.208 Sum_probs=110.1
Q ss_pred eeeeccCCcEEEEEEEE-cCCeEEEEEEeccCCC----------------------H--HHHHHHHHHHHHHHhCCCCce
Q 003978 510 GEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYS----------------------D--EVIHSFRQEVSLMKRLRHPNV 564 (782)
Q Consensus 510 ~~~IG~G~~G~Vy~~~~-~~~~vAiK~~~~~~~~----------------------~--~~~~~~~~Ei~il~~l~HpnI 564 (782)
...||+|+||.||+|.. .|+.||||+++..... . .....+..|.+.+..+.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999987 4889999999765211 0 012234678999999999887
Q ss_pred eEEeeeeecCCceeEEEeecCCCCHHHH-HhhcCCcchHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCC
Q 003978 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRL-LQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHW 642 (782)
Q Consensus 565 v~l~~~~~~~~~~~lv~E~~~ggsL~~~-l~~~~~~l~~~~~~~i~~qll~aL~~LH~-~~~~ivHrDIKp~NILl~~~~ 642 (782)
.....+... ..||||||++|+++... +.. ..++...+..++.|++.+|.+||. .| |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-CC
Confidence 544443332 24899999988755433 432 357788899999999999999999 88 99999999999999 78
Q ss_pred cEEEEecCCCccccc
Q 003978 643 TVKVGDFGLSRLKHE 657 (782)
Q Consensus 643 ~vkL~DFGla~~~~~ 657 (782)
.++|+|||++.....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=207.11 Aligned_cols=255 Identities=24% Similarity=0.315 Sum_probs=189.4
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEE-cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC---CCceeEEeeeeecC
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVLLFMGAVTSP 574 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~ 574 (782)
..+...+.|.|-+.||+|+||+||+|.. +++.||||+-+.....+=.+ -.+++.+|+ -+.|..+..++.-.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI-----~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI-----CLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee-----hHHHHHhhchhhhcchHHHHHHHccC
Confidence 4456678999999999999999999986 57789999976654322111 112222232 23466666666677
Q ss_pred CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-------CCcEEEE
Q 003978 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-------HWTVKVG 647 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~-------~~~vkL~ 647 (782)
+..+||+||.+.|+|.+++.. ...+++..+.++..||+..++.||.++ |||+||||+|+||.. .--++|+
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred CcceeeeeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEE
Confidence 788999999999999999984 456899999999999999999999999 999999999999953 2359999
Q ss_pred ecCCCcccc--cccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC
Q 003978 648 DFGLSRLKH--ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE 725 (782)
Q Consensus 648 DFGla~~~~--~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~ 725 (782)
|||.+--+. ....+....++|-.+-.+|+..|+++++..|.|.|..+++-||+|++- + + .......
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~-------q----~-~~g~~~~ 911 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM-------E----V-KNGSSWM 911 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-------H----h-cCCccee
Confidence 999985321 112233455789999999999999999999999999999999999641 1 1 1111111
Q ss_pred ----CCCCCCH-HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 726 ----IPKDVDP-RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 726 ----~p~~~~~-~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
++..+.. -|..|+..+|..|=..=|.+.+|...|++...+-|+..+..
T Consensus 912 ~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~~~~~~ 964 (974)
T KOG1166|consen 912 VKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFTGLREA 964 (974)
T ss_pred ccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHHHHHHH
Confidence 2222322 36789999999554455888898888888877777654433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.8e-17 Score=167.99 Aligned_cols=136 Identities=26% Similarity=0.392 Sum_probs=114.8
Q ss_pred eeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHH------HHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeec
Q 003978 511 EQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDE------VIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 584 (782)
+.||+|++|.||+|.+.+..+++|+......... ....+.+|+.++..+.|++|+....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5799999999999999999999998764433211 2245778999999999998877777776777889999999
Q ss_pred CCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
+|++|.+++.... . ....++.+++.+|.+||..+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999986532 1 77788999999999999998 99999999999999 78999999998864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=170.68 Aligned_cols=133 Identities=16% Similarity=0.228 Sum_probs=102.3
Q ss_pred EeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-----CCCceeEEeeeeecCC---cee-E
Q 003978 509 IGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-----RHPNVLLFMGAVTSPQ---RLC-I 579 (782)
Q Consensus 509 i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~---~~~-l 579 (782)
-.++||+|+||.||.-..... .+||++...... ....+.+|+.+++.+ .||||++++++++++. .++ +
T Consensus 6 ~~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 6 EQSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CcceecCCCceEEEECCCCcC-eEEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 346899999999996222233 478888654322 235789999999999 5799999999998874 333 7
Q ss_pred EEee--cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHH-HhhhcCCCCeeecCCCCCcEEEcCC----CcEEEEecC
Q 003978 580 VTEF--LPRGSLFRLLQRNTTKLDWRRRILMALDIARGV-SYLHHCNPPIIHRDLKSSNLLVDKH----WTVKVGDFG 650 (782)
Q Consensus 580 v~E~--~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL-~~LH~~~~~ivHrDIKp~NILl~~~----~~vkL~DFG 650 (782)
|||| +.+++|.+++.+. .+++. ..++.+++.++ +|||+++ ||||||||+|||++.. +.++|+||+
T Consensus 83 I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 8999 4578999999763 35555 34567888777 9999999 9999999999999743 479999944
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.7e-17 Score=166.57 Aligned_cols=133 Identities=25% Similarity=0.355 Sum_probs=108.8
Q ss_pred eeccCCcEEEEEEEEcCCeEEEEEEeccCCCH------HHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecC
Q 003978 512 QIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSD------EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585 (782)
Q Consensus 512 ~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 585 (782)
.||+|+||.||++.+.+.++++|+........ .....+.+|++++..+.|+++.....++......+++|||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 48999999999999999999999975543211 123567889999999988876554444555667899999999
Q ss_pred CCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
|++|.+++..... .++.+++.+|.+||+.+ ++|+|+||.||+++ ++.++++|||++...
T Consensus 81 g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGND--------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998864321 67889999999999998 99999999999999 789999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.4e-17 Score=182.35 Aligned_cols=208 Identities=34% Similarity=0.577 Sum_probs=163.6
Q ss_pred HHhCCCCceeEEeeeeecCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 003978 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN 635 (782)
Q Consensus 556 l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~N 635 (782)
|+.+.|.|+.+|++.+.....+++|.+||..|+|.+.+......+++.....++++|+.||.|||..-. ..|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPI-GYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeecccc
Confidence 356789999999999999999999999999999999998877889999999999999999999998652 3999999999
Q ss_pred EEEcCCCcEEEEecCCCcccccc--cccccCCCCCCcccCcccccCCC-------CCchhHHHHHHHHHHHHHcCCCCCC
Q 003978 636 LLVDKHWTVKVGDFGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEP-------SDEKSDVYSFGVILWELATEKIPWD 706 (782)
Q Consensus 636 ILl~~~~~vkL~DFGla~~~~~~--~~~~~~~~Gt~~y~aPE~l~~~~-------~s~~sDIwSLG~ll~elltG~~Pf~ 706 (782)
++++..+.+||+|||+....... ........-..-|.|||.+.+.. .+.+.||||+|++++|+++...||.
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 99999999999999998765321 00111112245789999998742 2557999999999999999999997
Q ss_pred CCC----hHHHHHHhhcccc---ccCCC--CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 707 NLN----SMQVIGAVGFMNQ---RLEIP--KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 707 ~~~----~~~~~~~i~~~~~---~~~~p--~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
... ..+.+..+..... ++.+. ...++++..++.+||..+|..||++..+...++.+..
T Consensus 160 ~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 160 LRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 532 2234444433122 22222 1456689999999999999999999999887776644
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=3e-16 Score=183.01 Aligned_cols=139 Identities=23% Similarity=0.313 Sum_probs=115.1
Q ss_pred cceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCC-H-----HHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYS-D-----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~-~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
..|...++||+|+||.||++.+.+..+++|+....... . .....+.+|+++++.++|++|+..+.++......+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 34566889999999999999998888777764332221 1 12356889999999999999988877777777889
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
+||||++|++|.+++. ....++.+++.+|.+||+.+ |+||||||+|||+ .++.++|+|||+++..
T Consensus 413 lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999999999885 34568889999999999998 9999999999999 5779999999998653
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.4e-16 Score=164.47 Aligned_cols=144 Identities=24% Similarity=0.236 Sum_probs=111.0
Q ss_pred ceeEeeeeccCCcEEEEEEE-E--cCCeEEEEEEeccCCC--------------------H--HHHHHHHHHHHHHHhCC
Q 003978 506 DLTIGEQIGQGSCGTVYHAV-W--YGSDVAVKVFSRQEYS--------------------D--EVIHSFRQEVSLMKRLR 560 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~-~--~~~~vAiK~~~~~~~~--------------------~--~~~~~~~~Ei~il~~l~ 560 (782)
-|.+.+.||+|+||.||+|. . .++.||||+++..... . .....+..|+.+++.+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 3 6889999998754311 0 11234678999999997
Q ss_pred CC--ceeEEeeeeecCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 003978 561 HP--NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV 638 (782)
Q Consensus 561 Hp--nIv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl 638 (782)
+. .+++++++ ...++||||++|.+|...+... ..+....+..++.||+.+|.+||.+| .|+|+||||+||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEE
Confidence 53 34455543 2358999999988887665332 34566677889999999999999865 49999999999999
Q ss_pred cCCCcEEEEecCCCcccc
Q 003978 639 DKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 639 ~~~~~vkL~DFGla~~~~ 656 (782)
+ ++.++|+|||++....
T Consensus 183 ~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred E-CCCEEEEEChhhhccC
Confidence 9 8899999999886443
|
|
| >PF13426 PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_B 3P7N_B 1LL8_A 3MJQ_A 3BWL_A 4EET_B 4EEP_A | Back alignment and domain information |
|---|
Probab=99.68 E-value=7.3e-16 Score=137.54 Aligned_cols=104 Identities=27% Similarity=0.522 Sum_probs=95.2
Q ss_pred CceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEcCCCCEEEEEE
Q 003978 140 GQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVA 219 (782)
Q Consensus 140 ~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~v~~ 219 (782)
|+||+++|.+|+|+++|++|++++||++++++|+++.+++++.........+.+++..+..+..++.+++++|..+|+.+
T Consensus 1 p~~i~i~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~~~~ 80 (104)
T PF13426_consen 1 PDGIFILDPDGRILYVNPAFERLFGYSREELIGKSISDFFPEEDRPEFEEQIERALEEGGSWSGEVRLRRKDGETFWVEV 80 (104)
T ss_dssp -SEEEEEETTSBEEEE-HHHHHHHTS-HHHHTTSBGGGGCSTTSCHHHHHHHHHHHHHTSSEEEEEEEEETTSEEEEEEE
T ss_pred CEEEEEECCcCcEEehhHHHHHHHCcCHHHHcCCCcccccCcccchhhHHHHHHHHhcCCceeEEEEEEcCCCCEEEEEE
Confidence 68999999999999999999999999999999999999998776666677888999999999999999999999999999
Q ss_pred EEEEEECCCCCEEEEEEEEEehhH
Q 003978 220 TNTPFYDDDGTLVGIVCVSTDSRP 243 (782)
Q Consensus 220 ~~~Pi~d~~G~v~g~v~i~rDITe 243 (782)
++.|+.+++|++.+++++++|||+
T Consensus 81 ~~~~i~~~~g~~~~~i~~~~DiTe 104 (104)
T PF13426_consen 81 SASPIRDEDGEITGIIGIFRDITE 104 (104)
T ss_dssp EEEEEEETTSSEEEEEEEEEEEHH
T ss_pred EEEEEECCCCCEEEEEEEEEECCC
Confidence 999999999999999999999996
|
... |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.2e-16 Score=157.42 Aligned_cols=138 Identities=24% Similarity=0.218 Sum_probs=107.5
Q ss_pred ceeEeeeeccCCcEEEEEEEE-cCCeEEEEEEeccCCCH--------------------HHHHHHHHHHHHHHhCCCCc-
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSD--------------------EVIHSFRQEVSLMKRLRHPN- 563 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~-~~~~vAiK~~~~~~~~~--------------------~~~~~~~~Ei~il~~l~Hpn- 563 (782)
.|.+.+.||+|+||.||++.. .++.||||++....... .....+..|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 377889999999999999987 58899999976532110 11123667899999887774
Q ss_pred -eeEEeeeeecCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 003978 564 -VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642 (782)
Q Consensus 564 -Iv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~ 642 (782)
++.+++. ...+++|||++|++|..+... .....++.+++.++.++|+.+ |+|+||||+||+|+.++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCCC
Confidence 4455442 345899999999998766431 234567889999999999988 99999999999999999
Q ss_pred cEEEEecCCCcccc
Q 003978 643 TVKVGDFGLSRLKH 656 (782)
Q Consensus 643 ~vkL~DFGla~~~~ 656 (782)
.++|+|||++....
T Consensus 163 ~~~liDfg~~~~~~ 176 (198)
T cd05144 163 KIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEEECCccccCC
Confidence 99999999985443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.4e-17 Score=176.54 Aligned_cols=166 Identities=27% Similarity=0.399 Sum_probs=127.5
Q ss_pred ceeEEEeecCCCCHHHHHhhc--CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRN--TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~--~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
++||.|++|...+|.++|... ....++...+.++.|++.|+.| ++ .+|+|+||.||++..+..+||.|||+..
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhee
Confidence 578999999999999999643 3446777888899999999999 66 9999999999999999999999999986
Q ss_pred cccccc------ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCC
Q 003978 654 LKHETY------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEI 726 (782)
Q Consensus 654 ~~~~~~------~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~ 726 (782)
...... ......+||+.||+||.+.+..|+.++|||+||++|+|++. -..+|... ..+..+. ...+
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r----~g~i 477 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIR----DGII 477 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---Hhhhhhh----cCCC
Confidence 544332 23334579999999999999999999999999999999997 33333211 1111221 1222
Q ss_pred CC---CCCHHHHHHHHHhhhhCCCCCCCHH
Q 003978 727 PK---DVDPRWAAIVESCWHSDPQCRPSFQ 753 (782)
Q Consensus 727 p~---~~~~~l~~LI~~cL~~dP~~RPs~~ 753 (782)
|+ .=.++-..|+.+||.+.|.+||++-
T Consensus 478 p~~~~~d~p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 478 PPEFLQDYPEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred ChHHhhcCcHHHHHHHHhcCCCcccCchHH
Confidence 21 1224556899999999999999433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.5e-17 Score=194.02 Aligned_cols=248 Identities=25% Similarity=0.359 Sum_probs=196.2
Q ss_pred ceeEeeeeccCCcEEEEEEEEc---CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCceeEEE
Q 003978 506 DLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.|.+.+.||+|+|+.|-..... ...+|+|.+...............|..+-+.+. |+|++.+++........++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4666777999999999988653 233677776655434445566667888888886 999999999999999999999
Q ss_pred eecCCCCHHHHH-hhcCCcchHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEEcCCC-cEEEEecCCCccccc-
Q 003978 582 EFLPRGSLFRLL-QRNTTKLDWRRRILMALDIARGVSYLH-HCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHE- 657 (782)
Q Consensus 582 E~~~ggsL~~~l-~~~~~~l~~~~~~~i~~qll~aL~~LH-~~~~~ivHrDIKp~NILl~~~~-~vkL~DFGla~~~~~- 657 (782)
+|..|+++++.+ .......+...+..++.|+..++.|+| ..+ +.|+||||+|.+++..+ .+++.|||+|.....
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999999999999 443325666777788899999999999 888 99999999999999999 999999999976544
Q ss_pred --ccccccCCCC-CCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH--hhcccc-ccCCCCCC
Q 003978 658 --TYLTTKTGKG-TPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGA--VGFMNQ-RLEIPKDV 730 (782)
Q Consensus 658 --~~~~~~~~~G-t~~y~aPE~l~~~~-~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~--i~~~~~-~~~~p~~~ 730 (782)
........+| ++.|+|||.+.+.. .....|+||.|+++.-+++|..||........... +..... .......+
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSI 258 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccC
Confidence 2233445578 99999999999854 46789999999999999999999976654432111 111101 23344568
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHH
Q 003978 731 DPRWAAIVESCWHSDPQCRPSFQEL 755 (782)
Q Consensus 731 ~~~l~~LI~~cL~~dP~~RPs~~el 755 (782)
+....+++.+++..+|..|.+.+++
T Consensus 259 ~~~~~~~l~k~l~~~~~~r~s~~~~ 283 (601)
T KOG0590|consen 259 SDQAHDLLHKILKENPSNRLSIEEL 283 (601)
T ss_pred ChhhhhcccccccCCchhccccccc
Confidence 8899999999999999999999988
|
|
| >PF08448 PAS_4: PAS fold; InterPro: IPR013656 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.4e-14 Score=130.81 Aligned_cols=110 Identities=24% Similarity=0.357 Sum_probs=98.6
Q ss_pred HHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEcCCCCEE
Q 003978 136 LQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERV 215 (782)
Q Consensus 136 le~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~ 215 (782)
|++++++|+++|.+|+|+++|+++++++|++.++++|+++.+++++.........+.+++..+.....+..... +|..+
T Consensus 1 l~~~p~~i~v~D~~~~i~~~N~~~~~~~~~~~~~~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 79 (110)
T PF08448_consen 1 LDSSPDGIFVIDPDGRIVYANQAAAELFGVSPEELIGRSLFDLLPPEDREEFQAALRRALAGGEPVFFEEILLR-DGEER 79 (110)
T ss_dssp HHHCSSEEEEEETTSBEEEE-HHHHHHHTSTHHHHTTSBHHHHSCCGCHHHHHHHHHHHHHHTSEEEEEEEECT-TSCEE
T ss_pred CCCCCceeEEECCCCEEEEEHHHHHHHhCCCHHHHhhccchhccccchhhhhHHHHHHhhccCceEEEEEEEee-cCCcE
Confidence 68999999999999999999999999999999999999999999887655566677888888888776666555 89999
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEEehhHHHH
Q 003978 216 LVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246 (782)
Q Consensus 216 ~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~ 246 (782)
|+.+++.|++|.+|++.|++++++|||++|+
T Consensus 80 ~~~~~~~Pi~~~~g~~~g~~~~~~DiT~~rr 110 (110)
T PF08448_consen 80 WFEVSISPIFDEDGEVVGVLVIIRDITERRR 110 (110)
T ss_dssp EEEEEEEEEECTTTCEEEEEEEEEEECCHHH
T ss_pred EEEEEEEEeEcCCCCEEEEEEEEEECchhhC
Confidence 9999999999999999999999999999985
|
The PAS fold appears in archaea, eubacteria and eukarya. ; PDB: 3K3D_A 3K3C_B 3KX0_X 3FC7_B 3LUQ_D 3MXQ_A 3BWL_C 3FG8_A. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.1e-15 Score=148.25 Aligned_cols=138 Identities=25% Similarity=0.230 Sum_probs=97.7
Q ss_pred eeeeccCCcEEEEEEEEc-CCeEEEEEEeccCCCHHHHHH----------------------HHHHHHHHHhCCCC--ce
Q 003978 510 GEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHS----------------------FRQEVSLMKRLRHP--NV 564 (782)
Q Consensus 510 ~~~IG~G~~G~Vy~~~~~-~~~vAiK~~~~~~~~~~~~~~----------------------~~~Ei~il~~l~Hp--nI 564 (782)
++.||+|+||.||++... ++.||||++............ ...|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 567999999999999876 888999998764322111111 13466666666433 24
Q ss_pred eEEeeeeecCCceeEEEeecCCCCHH-HHHhhcCCcchHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCC
Q 003978 565 LLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHW 642 (782)
Q Consensus 565 v~l~~~~~~~~~~~lv~E~~~ggsL~-~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~-~~~~ivHrDIKp~NILl~~~~ 642 (782)
.++++. ...+++|||++++.+. ..+.... .. ..+..++.+++.++.++|. ++ |+|+||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-CC
Confidence 445543 2458999999884332 1121111 11 5667888999999999999 88 99999999999999 88
Q ss_pred cEEEEecCCCccccc
Q 003978 643 TVKVGDFGLSRLKHE 657 (782)
Q Consensus 643 ~vkL~DFGla~~~~~ 657 (782)
.++|+|||.+.....
T Consensus 152 ~~~liDfg~a~~~~~ 166 (187)
T cd05119 152 KVYIIDVPQAVEIDH 166 (187)
T ss_pred cEEEEECcccccccC
Confidence 999999999864443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.2e-14 Score=152.02 Aligned_cols=136 Identities=20% Similarity=0.221 Sum_probs=105.8
Q ss_pred eeec-cCCcEEEEEEEEcCCeEEEEEEeccCC-----------CHHHHHHHHHHHHHHHhCCCCce--eEEeeeeecCCc
Q 003978 511 EQIG-QGSCGTVYHAVWYGSDVAVKVFSRQEY-----------SDEVIHSFRQEVSLMKRLRHPNV--LLFMGAVTSPQR 576 (782)
Q Consensus 511 ~~IG-~G~~G~Vy~~~~~~~~vAiK~~~~~~~-----------~~~~~~~~~~Ei~il~~l~HpnI--v~l~~~~~~~~~ 576 (782)
..|| .|+.|+||.+...+..++||.+..... .......+.+|+.++..+.|++| +..+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4576 788888998888899999999865332 11233567889999999998775 677766443222
Q ss_pred ----eeEEEeecCC-CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCC
Q 003978 577 ----LCIVTEFLPR-GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (782)
Q Consensus 577 ----~~lv~E~~~g-gsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGl 651 (782)
.++|||+++| .+|.+++... .+++.. +.+|+.+|.+||++| |+|+||||.|||++.++.++|+|||.
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA--PLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC--CCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEECCC
Confidence 3599999987 6899988653 344432 468999999999999 99999999999999988999999998
Q ss_pred Ccc
Q 003978 652 SRL 654 (782)
Q Consensus 652 a~~ 654 (782)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-14 Score=138.57 Aligned_cols=135 Identities=19% Similarity=0.169 Sum_probs=111.8
Q ss_pred EeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCC--CceeEEeeeeecCCceeEEEeecCC
Q 003978 509 IGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH--PNVLLFMGAVTSPQRLCIVTEFLPR 586 (782)
Q Consensus 509 i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lv~E~~~g 586 (782)
+.+.||.|.++.||++...+..+++|++..... ...+..|+.+++.+.| .++++++.+....+..+++|||+.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 457899999999999999888899999865432 3567889999999976 5899999988888889999999988
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCC-CCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN-PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~-~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
..+..+ +......++.+++.+|++||... .+++|+|++|.||++++.+.++++|||.+...
T Consensus 78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 776544 34455667889999999999841 23999999999999999899999999988643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PF00989 PAS: PAS fold; InterPro: IPR013767 PAS domains are involved in many signalling proteins where they are used as a signal sensor domain [] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2e-14 Score=130.37 Aligned_cols=112 Identities=25% Similarity=0.438 Sum_probs=95.8
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeE-EEEEEEE
Q 003978 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW-TGQFPAK 208 (782)
Q Consensus 130 ~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~-~~e~~~~ 208 (782)
++|+.++++++++|+++|.+|+|+|+|++|+++|||+.++++|+++.+++++.........+...+..+... ..+....
T Consensus 1 e~~~~i~~~~~~~i~~~d~~g~I~~~N~a~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (113)
T PF00989_consen 1 ERYRAILENSPDGIFVIDEDGRILYVNQAAEELLGYSREELIGKSLFDLIHPEDRRELRERLRQALSQGESGESFEVRFR 80 (113)
T ss_dssp HHHHHHHHCSSSEEEEEETTSBEEEECHHHHHHHSS-HHHHTTSBGGGGCSGGGHHHHHHHHHHHHHHCCHECEEEEEEE
T ss_pred CHHHHHHhcCCceEEEEeCcCeEEEECHHHHHHHccCHHHHcCCcHHHhcCchhhHHHHHHHHHHHHcCCCceeEEEEEE
Confidence 579999999999999999999999999999999999999999999999998776444455677777777754 3344444
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEeh
Q 003978 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDS 241 (782)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDI 241 (782)
.++|..+|+.+.+.|+++.+|++.|++++++||
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~DI 113 (113)
T PF00989_consen 81 LRDGRPRWVEVRASPVRDEDGQIIGILVIFRDI 113 (113)
T ss_dssp ETTSCEEEEEEEEEEEEETTEEEEEEEEEEEE-
T ss_pred ecCCcEEEEEEEEEEEEeCCCCEEEEEEEEEeC
Confidence 579999999999999999999999999999997
|
PAS domains appear in archaea, bacteria and eukaryotes. Several PAS-domain proteins are known to detect their signal by way of an associated cofactor. Haeme, flavin, and a 4-hydroxycinnamyl chromophore are used in different proteins. The PAS domain was named after three proteins that it occurs in: Per- period circadian protein Arnt- Ah receptor nuclear translocator protein Sim- single-minded protein. PAS domains are often associated with PAC domains IPR001610 from INTERPRO. It appears that these domains are directly linked, and that together they form the conserved 3D PAS fold. The division between the PAS and PAC domains is caused by major differences in sequences in the region connecting these two motifs []. In human PAS kinase, this region has been shown to be very flexible, and adopts different conformations depending on the bound ligand []. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels [].; GO: 0006355 regulation of transcription, DNA-dependent; PDB: 2GJ3_A 4F3L_B 1XFN_A 1OTD_A 2PYR_A 1KOU_A 1XFQ_A 2ZOI_A 2ZOH_A 1OTA_A .... |
| >PRK11091 aerobic respiration control sensor protein ArcB; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.6e-13 Score=167.65 Aligned_cols=150 Identities=16% Similarity=0.158 Sum_probs=131.2
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEE
Q 003978 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (782)
Q Consensus 129 ~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~ 208 (782)
.++++.++++++++|+++|.+|+|+++|++|++++||+.++++|+++.+++++.............+..+..+..+....
T Consensus 154 ~~~l~~il~~~~~~i~~~D~~g~i~~~N~a~~~l~G~~~~eliG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 233 (779)
T PRK11091 154 SSLLRSFLDASPDLVYYRNEDGEFSGCNRAMELLTGKSEKQLIGLTPKDVYSPEAAEKVIETDEKVFRHNVSLTYEQWLD 233 (779)
T ss_pred HHHHHHHHhcCcceEEEECCCCcEEeEcHHHHHHhCcCHHHHcCCChHHhCCHHHHHHHHHHHHHHHhcCCCeEEEEEEE
Confidence 46799999999999999999999999999999999999999999999999887654444444566777788888888899
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhhccccccccCCchhHHHHHhCCCchhHHHHHHH
Q 003978 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIA 287 (782)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~i~~~~~gl~~~l~~d~~qpL~~~i~ 287 (782)
+++|..+|+.++..|+++.+|++.|++++++|||++|+++++++.... .+..|++.++||++.||+.++.
T Consensus 234 ~~~G~~~~~~~~~~pi~~~~g~~~g~v~~~~DITe~k~~e~~l~~a~~---------~~~~~~a~isHelrtPL~~I~g 303 (779)
T PRK11091 234 YPDGRKACFELRKVPFYDRVGKRHGLMGFGRDITERKRYQDALEKASR---------DKTTFISTISHELRTPLNGIVG 303 (779)
T ss_pred cCCCCEEEEEEEeeeEEcCCCCEEEEEEEEeehhHHHHHHHHHHHHHH---------HHHHHHHHhhHhhcCcHHHHHH
Confidence 999999999999999999999999999999999999999998876532 2445999999999999987643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=4.5e-14 Score=158.34 Aligned_cols=246 Identities=22% Similarity=0.168 Sum_probs=186.5
Q ss_pred ccceeEeeeecc--CCcEEEEEEEE----cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCc
Q 003978 504 WEDLTIGEQIGQ--GSCGTVYHAVW----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQR 576 (782)
Q Consensus 504 ~~~y~i~~~IG~--G~~G~Vy~~~~----~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 576 (782)
-..+.+.+.+|. |.+|.||.+.. .+..+|+|.-+...........-.+|+...+.++ |+|.|+.+..|+..+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 346778889999 99999999876 3456888763322221111223345666666664 9999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHH----HHHhhhcCCCCeeecCCCCCcEEEcCC-CcEEEEecCC
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR----GVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGL 651 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~----aL~~LH~~~~~ivHrDIKp~NILl~~~-~~vkL~DFGl 651 (782)
+|+-+|+| +.+|..+.......++...++....+... ||.++|..+ ++|-|+||+||++..+ ...+++|||+
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred ceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcce
Confidence 99999999 57888888776666888899999999999 999999999 9999999999999999 7789999999
Q ss_pred CcccccccccccCC-----CCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC--ChHHHHHHhhcccccc
Q 003978 652 SRLKHETYLTTKTG-----KGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL--NSMQVIGAVGFMNQRL 724 (782)
Q Consensus 652 a~~~~~~~~~~~~~-----~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~--~~~~~~~~i~~~~~~~ 724 (782)
.............. .|...|++||+..+. ++...|||+||.++.+..++..++... +....+... ....
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~---~ip~ 345 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG---YIPL 345 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc---cCch
Confidence 88766554333222 688999999998776 668999999999999999987665433 111111111 1223
Q ss_pred CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHH
Q 003978 725 EIPKDVDPRWAAIVESCWHSDPQCRPSFQELV 756 (782)
Q Consensus 725 ~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell 756 (782)
++....+.++...+.+||..+|..|++.+.+.
T Consensus 346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred hhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 33345567788899999999999999988774
|
|
| >PRK13557 histidine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.5e-13 Score=155.87 Aligned_cols=150 Identities=18% Similarity=0.230 Sum_probs=128.7
Q ss_pred HHHHHHHHHHcCceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEE
Q 003978 129 DRQYLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQF 205 (782)
Q Consensus 129 ~~~~~~ile~~~d~I~v~D~---dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~ 205 (782)
..+|+.+++.++++|+++|. +|+|+|+|++|++++||+.+|++|+++.+++++.........++..+..+..+..++
T Consensus 29 ~~~~~~~~~~~~~~i~v~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 108 (540)
T PRK13557 29 SDIFFAAVETTRMPMIVTDPNQPDNPIVFANRAFLEMTGYAAEEIIGNNCRFLQGPETDRATVAEVRDAIAERREIATEI 108 (540)
T ss_pred hHHHHHHHHhCcCcEEEEcCCCCCCCEEEEcHHHHHHhCCCHHHhcCCChHhhcCCCCCHHHHHHHHHHHHcCCCceEEE
Confidence 47899999999999999995 789999999999999999999999999999887665555667788888888888888
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhhccccccccCCchhHHHHHhCCCchhHHHHH
Q 003978 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQAT 285 (782)
Q Consensus 206 ~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~i~~~~~gl~~~l~~d~~qpL~~~ 285 (782)
..++++|..+|+.+++.|+++.+|.+++++++.+|||+++++++++....... ....+...++|+.+.||+..
T Consensus 109 ~~~~~~G~~~~~~~~~~~i~~~~g~~~~~~~~~~dit~~~~~e~~l~~~~~~~-------~l~~~~~~i~h~l~~pl~~i 181 (540)
T PRK13557 109 LNYRKDGSSFWNALFVSPVYNDAGDLVYFFGSQLDVSRRRDAEDALRQAQKME-------ALGQLTGGIAHDFNNLLQVM 181 (540)
T ss_pred EEEeCCCCEEEEEEEEEEeECCCCCEEEEEEEecChHHHHHHHHHHHHHHHHH-------HhhhhhhhhhHHhhhHHHHH
Confidence 88899999999999999999999999999999999999999988876543221 12236777889999998753
|
|
| >PRK13559 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=6.1e-13 Score=147.38 Aligned_cols=144 Identities=19% Similarity=0.170 Sum_probs=120.7
Q ss_pred HHHHHHHHHHcCceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEE
Q 003978 129 DRQYLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQF 205 (782)
Q Consensus 129 ~~~~~~ile~~~d~I~v~D~---dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~ 205 (782)
.+.|+.+++.++++|+++|. +|.|+++|++|++++||+.++++|+++..+..+.........+...+..+..+..+.
T Consensus 42 ~~~~~~~~e~~~~~i~i~D~~~~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~ 121 (361)
T PRK13559 42 GRLFEQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFLQGAATDPIAVAKIRAAIAAEREIVVEL 121 (361)
T ss_pred hhHHHHHHHhCCCcEEEecCCCCCCcEEEEchHHHHHhCCCHHHHcCCChhhhcCCCCCHHHHHHHHHHhccCCceEEEE
Confidence 36688999999999999997 578999999999999999999999999877765544444455677788888888888
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhhccccccccCCchhHHHHHhCCCchhHHHHH
Q 003978 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQAT 285 (782)
Q Consensus 206 ~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~i~~~~~gl~~~l~~d~~qpL~~~ 285 (782)
..+++||..+|+.++..|+++.+|.+.+++++++|||+++++++.++.. ..++..++|+.+.||..+
T Consensus 122 ~~~~~dG~~~~~~~~~~~i~d~~G~~~~~v~~~~DITerk~~e~~~~~~-------------~~l~~~l~H~~~n~L~~i 188 (361)
T PRK13559 122 LNYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQWDVTDIRAVRALEAHE-------------RRLAREVDHRSKNVFAVV 188 (361)
T ss_pred EEEcCCCCEEEEEEEEEEEEcCCCCEEEeeeeeeehhcchhhHHHHHHH-------------HHHHHHHHHhhhhHHHHH
Confidence 8899999999999999999999999999999999999999887654332 226667788888888653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=5e-12 Score=143.13 Aligned_cols=222 Identities=21% Similarity=0.296 Sum_probs=147.5
Q ss_pred cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCCCCHHHHHhhcCCcchHHHHH
Q 003978 527 YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRI 606 (782)
Q Consensus 527 ~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~ 606 (782)
.+.+|.|++++.... .......+-++.|+.++||||+++++.++..+.+|||+|-+. -|..+++.. ....+.
T Consensus 36 ~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----~~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----GKEEVC 107 (690)
T ss_pred cCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----HHHHHH
Confidence 567788888876554 445567778899999999999999999999999999999983 677777643 255566
Q ss_pred HHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCch
Q 003978 607 LMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 685 (782)
Q Consensus 607 ~i~~qll~aL~~LH~-~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~ 685 (782)
..+.||+.||.|||. ++ ++|++|+-..|+|+..|.+||++|.++..............---.|..|+.+.... ..
T Consensus 108 ~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s 183 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WS 183 (690)
T ss_pred HHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cc
Confidence 678899999999984 55 99999999999999999999999988754333221111112223466666554332 45
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh-----ccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003978 686 SDVYSFGVILWELATEKIPWDNLNSMQVIGAVG-----FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 760 (782)
Q Consensus 686 sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~-----~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~ 760 (782)
.|.|-|||++++++.|..+ ..........+. .......-.....+...+++..|...-+--|-.+-+++..|.
T Consensus 184 ~D~~~Lg~li~el~ng~~~--~~~~~~~~~~ipk~~~~~~~k~~~~~~~~r~n~~~~~~~~~~~~gff~n~fvd~~~fLe 261 (690)
T KOG1243|consen 184 IDSWGLGCLIEELFNGSLL--TKTDLSNTGKIPKALIELYCKKLGATELKRPNKLRFILECRLLGGFFRNDFVDTLLFLE 261 (690)
T ss_pred hhhhhHHHHHHHHhCcccC--cchhhhccCccchhHHHHHHHHhccccccccchhhHHHHHHhccccccchHHHHHHHHH
Confidence 7999999999999999332 111110000000 000000000111122556667777666666666666666666
Q ss_pred HH
Q 003978 761 DL 762 (782)
Q Consensus 761 ~L 762 (782)
+|
T Consensus 262 el 263 (690)
T KOG1243|consen 262 EL 263 (690)
T ss_pred hc
Confidence 65
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.9e-11 Score=131.14 Aligned_cols=260 Identities=15% Similarity=0.214 Sum_probs=177.0
Q ss_pred ceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeee------ec-CCce
Q 003978 506 DLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAV------TS-PQRL 577 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~------~~-~~~~ 577 (782)
-...++.||+|+-+.+|-.-.-+..| -|++........ . .-+..|... .||-+-.-+.|- -. ...+
T Consensus 12 ~i~~gr~LgqGgea~ly~l~e~~d~V-AKIYh~Pppa~~--a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 12 PIPPGRPLGQGGEADLYTLGEVRDQV-AKIYHAPPPAAQ--A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred ccCCCccccCCccceeeecchhhchh-heeecCCCchHH--H---HHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 34567889999999999764433334 477765543221 1 112333333 466433212221 11 2237
Q ss_pred eEEEeecCCCCH-HHHHh-----hcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCC
Q 003978 578 CIVTEFLPRGSL-FRLLQ-----RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (782)
Q Consensus 578 ~lv~E~~~ggsL-~~~l~-----~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGl 651 (782)
.++|..+.|..- ..++. +....+.|...+.+++.|+.+.+.||..| .+-+|+.++|+||++++.|.|+|-..
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEcccc
Confidence 789999877633 22221 12234788999999999999999999999 89999999999999999999998764
Q ss_pred CcccccccccccCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcC-CCCCCCCCh-----HHHHHHhhc-
Q 003978 652 SRLKHETYLTTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATE-KIPWDNLNS-----MQVIGAVGF- 719 (782)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~s~~sDIwSLG~ll~elltG-~~Pf~~~~~-----~~~~~~i~~- 719 (782)
-.. +.........+|.+.|.+||... +..-+...|.|.||+++|+++.| ++||.+... ......|..
T Consensus 164 fqi-~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 164 FQI-NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred eee-ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 332 23333344568999999999865 33346679999999999999987 999975421 001111111
Q ss_pred ------ccc------ccCCC-CCCCHHHHHHHHHhhhh--CCCCCCCHHHHHHHHHHHHHHHhhcccCcC
Q 003978 720 ------MNQ------RLEIP-KDVDPRWAAIVESCWHS--DPQCRPSFQELVDKLRDLQRQYFQASRSTV 774 (782)
Q Consensus 720 ------~~~------~~~~p-~~~~~~l~~LI~~cL~~--dP~~RPs~~ell~~L~~L~~~~~~~~~~~~ 774 (782)
... ...+| ..+++.+..|+.+|+.. ++.-|||++.++..|.++.++.-+|+++.+
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~ 312 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAM 312 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhccc
Confidence 011 11122 24789999999999973 467899999999999999999999988764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=6.1e-13 Score=155.92 Aligned_cols=251 Identities=21% Similarity=0.231 Sum_probs=189.1
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (782)
|....+.+.+.+.+-.|.++.++.+.-. +.-.++|+...... .....+....+-.++-...+|.++....-+.....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 5666778899999999999999988643 22234443322111 11112333334444444567888877777777788
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
.+|+++|+.+++|...|...+ ..+..........++.+++|||... ++|+|++|.|+++..+|+.++.|||......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred cchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999999999997654 4555555566668889999999977 8999999999999999999999998432111
Q ss_pred cc-------------------------------cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 003978 657 ET-------------------------------YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705 (782)
Q Consensus 657 ~~-------------------------------~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf 705 (782)
.. ........||+.|.+||.+.+......+|+|++|+++++.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 01122346999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHhhccc-cccCCCCCCCHHHHHHHHHhhhhCCCCCCCHH
Q 003978 706 DNLNSMQVIGAVGFMN-QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQ 753 (782)
Q Consensus 706 ~~~~~~~~~~~i~~~~-~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ 753 (782)
......++.+.+.... .++.-+...+++.++++.+.|..+|.+|..+.
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999888887774322 24455567899999999999999999998765
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.33 E-value=7.2e-12 Score=142.13 Aligned_cols=147 Identities=22% Similarity=0.246 Sum_probs=98.1
Q ss_pred ccceeEeeeeccCCcEEEEEEEE-cCCeEEEEEEeccCCCH--------------------------------HHHH---
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSD--------------------------------EVIH--- 547 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~-~~~~vAiK~~~~~~~~~--------------------------------~~~~--- 547 (782)
+..|. .+.||.|++|.||+|+. .|+.||||+.++..... +...
T Consensus 117 F~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~ 195 (437)
T TIGR01982 117 FAEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLR 195 (437)
T ss_pred HhhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHH
Confidence 34444 36799999999999987 68899999986532100 0000
Q ss_pred ---HHHHHHHHHHhCC-----CCceeEEeeeeecCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHH-HHHh
Q 003978 548 ---SFRQEVSLMKRLR-----HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR-GVSY 618 (782)
Q Consensus 548 ---~~~~Ei~il~~l~-----HpnIv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~-aL~~ 618 (782)
.+.+|.+.+..+. +++|.-..-++......+|||||++|++|.++......... ...++..++. .+..
T Consensus 196 ~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 196 RELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQ 272 (437)
T ss_pred HHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHH
Confidence 1344555555542 34432221122223456899999999999887653222222 2334555555 4678
Q ss_pred hhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 619 LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
+|..| ++|+|+||.||+++.++.++|+|||++....
T Consensus 273 l~~~g--~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 273 VLRDG--FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHhCC--ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 89888 9999999999999999999999999987554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.6e-12 Score=133.62 Aligned_cols=199 Identities=24% Similarity=0.392 Sum_probs=142.9
Q ss_pred HHHHhCCCCceeEEeeeeecCC-----ceeEEEeecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHhhhcCCCC
Q 003978 554 SLMKRLRHPNVLLFMGAVTSPQ-----RLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPP 625 (782)
Q Consensus 554 ~il~~l~HpnIv~l~~~~~~~~-----~~~lv~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ 625 (782)
.-|-.+.|.|||+++.+|.+.. ...++.|||.-|+|..+|++ +...+......+|+-||+.||.|||+..++
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3444557999999999986543 47889999999999999964 445578888889999999999999999999
Q ss_pred eeecCCCCCcEEEcCCCcEEEEecCCCcccccc-----cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc
Q 003978 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-----YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700 (782)
Q Consensus 626 ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-----~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt 700 (782)
|+|+++..+.|++..+|-||+.--.... .+.. ........+-+.|.+||.=.....+.++|||++|+..++|.-
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 9999999999999999999874221111 1110 111222346788999998666667789999999999999988
Q ss_pred CCCC-CCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 003978 701 EKIP-WDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDK 758 (782)
Q Consensus 701 G~~P-f~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~ 758 (782)
+..- -.......+...+.... ...-+..-+++|.+||+..|..||++++++-+
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i-----~~len~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVI-----IGLENGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCCcceeehhhhhhhhe-----eeccCccccCcCcccccCCCCCCcchhhhhcC
Confidence 7653 22222222222221111 11112333678999999999999999998654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.3e-12 Score=146.74 Aligned_cols=146 Identities=21% Similarity=0.234 Sum_probs=94.6
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC---------------------------C-----HHHH
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY---------------------------S-----DEVI 546 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~---------------------------~-----~~~~ 546 (782)
+..+..|.. +.||.|++|.||+|+.+ |+.||||+.++... . .+..
T Consensus 116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 116 EEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred HHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 445667887 89999999999999973 78999999975421 0 0122
Q ss_pred HHHHHHHHH------HHhCC----CCceeEEeeee-ecCCceeEEEeecCCCCHHHH--HhhcCC---cchHHHHHHHHH
Q 003978 547 HSFRQEVSL------MKRLR----HPNVLLFMGAV-TSPQRLCIVTEFLPRGSLFRL--LQRNTT---KLDWRRRILMAL 610 (782)
Q Consensus 547 ~~~~~Ei~i------l~~l~----HpnIv~l~~~~-~~~~~~~lv~E~~~ggsL~~~--l~~~~~---~l~~~~~~~i~~ 610 (782)
+.+.+|+.+ +..+. +.+.+.+-.++ .--...+||||||+|+.|.++ +...+. .+....+..++.
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 233334333 33331 22222222222 112345799999999999775 333221 244444455555
Q ss_pred HHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----cEEEEecCCCcccc
Q 003978 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFGLSRLKH 656 (782)
Q Consensus 611 qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~----~vkL~DFGla~~~~ 656 (782)
|++ ..| ++|+|+||.||+|+.++ .++++|||++....
T Consensus 275 Qif-------~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 275 QVF-------RDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHH-------hCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 554 467 99999999999999888 99999999986543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.3e-12 Score=144.71 Aligned_cols=246 Identities=19% Similarity=0.143 Sum_probs=178.2
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc---CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCcee
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 578 (782)
...+|.++..||.|.|+.||++... +..|++|.+.........-..-..|+.+...+ -|.+++.++..|......|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 4568999999999999999998753 45588887765544332222333466666666 4889999999888888889
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CcEEEEecCCCccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHE 657 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~-~~vkL~DFGla~~~~~ 657 (782)
+-.|||.++++...+. -...+.+...+.+..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|||+.....-
T Consensus 343 ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred CchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccccccce
Confidence 9999999998876662 2334777888899999999999999988 9999999999999886 7789999998764211
Q ss_pred ccccccCCCCCCcc-cCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHH
Q 003978 658 TYLTTKTGKGTPQW-MAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 736 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y-~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 736 (782)
. .......+..| .++.......+..+.|++|||..+.+.+++..--...... ...........+....++..
T Consensus 420 ~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-----~~i~~~~~p~~~~~~~~~q~ 492 (524)
T KOG0601|consen 420 S--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-----LTIRSGDTPNLPGLKLQLQV 492 (524)
T ss_pred e--cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc-----eeeecccccCCCchHHhhhh
Confidence 1 11111223344 3555666677788999999999999999986532222211 11122223333444488899
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q 003978 737 IVESCWHSDPQCRPSFQELVDK 758 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~~ 758 (782)
+.+.++..++..||.+.++..+
T Consensus 493 ~~kv~~~~~~~~~~l~~~l~~~ 514 (524)
T KOG0601|consen 493 LLKVMINPDRKRRPSAVELSLH 514 (524)
T ss_pred hhhhhcCCccccchhhhhhccc
Confidence 9999999999999998888544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=9.7e-12 Score=122.18 Aligned_cols=129 Identities=16% Similarity=0.101 Sum_probs=95.7
Q ss_pred eeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCce-eEEeeeeecCCceeEEEeecCCCC
Q 003978 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV-LLFMGAVTSPQRLCIVTEFLPRGS 588 (782)
Q Consensus 510 ~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lv~E~~~ggs 588 (782)
++.|+.|.++.||++...+..|++|+...... ....+..|+.+++.+.+.++ ++++.+.. ...++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 46789999999999999999999999755431 11245678888888865443 45555443 34589999999987
Q ss_pred HHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCC---CeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 589 LFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP---PIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 589 L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~---~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
+.... . ....++.+++.+|+.||..+. .++|+|++|.||+++ ++.++|+|||.+.
T Consensus 78 l~~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 75430 0 112345689999999998761 249999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR02938 nifL_nitrog nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.4e-11 Score=139.27 Aligned_cols=126 Identities=18% Similarity=0.298 Sum_probs=111.1
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEE
Q 003978 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (782)
Q Consensus 129 ~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~ 208 (782)
.+.|+.+++.++++|+++|.+|+|+|+|+++++++||++++++|++...+..+.........++..+..+..+..+....
T Consensus 3 ~~~~~~i~~~~~~~i~~~d~~g~~~~~N~~~~~~~G~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (494)
T TIGR02938 3 PEAYRQTVDQAPLAISITDLKANILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKLLNR 82 (494)
T ss_pred hHHHHHHHHhCCceEEEECCCCcEEEEchhheeecCCCHHHHhCCCchhhcCCCCCHHHHHHHHHHHHhCCcccceeecc
Confidence 46799999999999999999999999999999999999999999987777665554444556677777888888888888
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHh
Q 003978 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (782)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~ 254 (782)
+++|..+|+...+.|+++.+|.+.+++++++|||++++++++|+..
T Consensus 83 ~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIt~~k~~e~~l~~~ 128 (494)
T TIGR02938 83 RKDGELYLAELTVAPVLNEAGETTHFLGMHRDITELHRLEQVVANQ 128 (494)
T ss_pred CCCccchhhheeeEEEECCCCCEEEEEEehhhhhHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999999887653
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes. |
| >TIGR00229 sensory_box PAS domain S-box | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.1e-10 Score=101.67 Aligned_cols=120 Identities=23% Similarity=0.396 Sum_probs=97.4
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCC-eEEEEEEEE
Q 003978 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGE-RWTGQFPAK 208 (782)
Q Consensus 130 ~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~-~~~~e~~~~ 208 (782)
+.++.+++.++++++++|.+|.|+++|+++++++|++..+++|+.+..++++.........+...+..+. .......+.
T Consensus 3 ~~~~~~~~~~~~~~~~~d~~~~i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (124)
T TIGR00229 3 ERYRAIFESSPDAIIVIDLEGNILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERLLEGEREPVSEERRVR 82 (124)
T ss_pred hHHHHHHhhCCceEEEEcCCCcEEEEchHHHHHhCCChHHhcCcchhhhcChhhhHHHHHHHHHHHcCCCCCcceEeeeE
Confidence 5688999999999999999999999999999999999999999999887766554333333444454332 234445556
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHH
Q 003978 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAA 250 (782)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~ 250 (782)
.++|..+|+..+..|+. .+|.+.++++++.|||++++++++
T Consensus 83 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~dit~~~~~~~~ 123 (124)
T TIGR00229 83 RKDGSEIWVEVSVSPIR-TNGGELGVVGIVRDITERKQAEEA 123 (124)
T ss_pred cCCCCEEEEEEEEeehh-hCCCeeEEEEEeeehhHHHHHHhc
Confidence 88999999999999998 788899999999999999988764
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. |
| >PRK13560 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.4e-10 Score=141.70 Aligned_cols=127 Identities=15% Similarity=0.134 Sum_probs=105.8
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEE
Q 003978 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (782)
Q Consensus 129 ~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~ 208 (782)
.+.|+.++++++++|+++|.+|+|+++|+++++++||+.+|++|+++.+++++.............+..+.....+..+.
T Consensus 203 ~~~l~~l~e~~~~~i~~~d~~g~i~~~N~~~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 282 (807)
T PRK13560 203 LHFLQQLLDNIADPAFWKDEDAKVFGCNDAACLACGFRREEIIGMSIHDFAPAQPADDYQEADAAKFDADGSQIIEAEFQ 282 (807)
T ss_pred HHHHHHHHhhCCCeEEEEcCCCCEEEEhHHHHHHhCCCHHHHcCCcchhcCCcchhHHHHHHHHHHhccCCceEEEEEEE
Confidence 45688999999999999999999999999999999999999999999998876543222223345556666677788889
Q ss_pred cCCCCEEEEEE--EEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhh
Q 003978 209 TKTEERVLVVA--TNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTK 255 (782)
Q Consensus 209 ~kdG~~~~v~~--~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~ 255 (782)
++||..+|+.+ +..|+.+.+|.+.|++++++|||++|++|++|+...
T Consensus 283 ~~dG~~~~~~~~~~~~~~~~~~g~~~g~~~~~~DITerk~~e~~L~~se 331 (807)
T PRK13560 283 NKDGRTRPVDVIFNHAEFDDKENHCAGLVGAITDISGRRAAERELLEKE 331 (807)
T ss_pred cCCCCEEEEEEEecceEEEcCCCCEEEEEEEEEechHHHHHHHHHHHHH
Confidence 99999996655 456778999999999999999999999999986543
|
|
| >PRK10060 RNase II stability modulator; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.7e-10 Score=136.52 Aligned_cols=133 Identities=17% Similarity=0.230 Sum_probs=106.8
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCcccccccccc-ccHHHHHHHHHHcCCeEEEEEEE
Q 003978 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD-FDVAYDIVHRIKMGERWTGQFPA 207 (782)
Q Consensus 129 ~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~-~~~~~~l~~~l~~g~~~~~e~~~ 207 (782)
..+++.+++.++++|+++|.+|+|+++|+++++++||+.++++|+++.+++.+... ......+...+..+..+..+.++
T Consensus 110 ~~~~~~v~~~~~~gI~i~D~~g~I~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 189 (663)
T PRK10060 110 LSFAEQVVSEANSVIVILDSRGNIQRFNRLCEEYTGLKEHDVIGQSVFKLFMSRREAAASRRNIRGFFRSGNAYEVERWI 189 (663)
T ss_pred HHHHHHHHhhCCceEEEEeCCCCEEEEcHHHHHHHCcCHHHHcCCCHHHHhCChhhHHHHHHHHHHHHhcCCceEEEEEE
Confidence 35677899999999999999999999999999999999999999999887654432 22333456677888889999999
Q ss_pred EcCCCCEEEEEEEEEEEECCCC-CEEEEEEEEEehhHHHHHHHHHHHhhccccccc
Q 003978 208 KTKTEERVLVVATNTPFYDDDG-TLVGIVCVSTDSRPFQETRAALWDTKNSDTDSN 262 (782)
Q Consensus 208 ~~kdG~~~~v~~~~~Pi~d~~G-~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~ 262 (782)
.+++|..+|+.....+ .+.+| ...+++++.+|||++++++++|+.....+..+.
T Consensus 190 ~~~~G~~~~~~~~~~~-~~~~g~~~~~~i~~~~DITe~k~~e~~l~~~a~~D~LTG 244 (663)
T PRK10060 190 KTRKGQRLFLFRNKFV-HSGSGKNEIFLICSGTDITEERRAQERLRILANTDSITG 244 (663)
T ss_pred EeCCCCEEEEEeeeEE-EcCCCCceEEEEEEEEechHHHHHHHHHHHHhhcCccCC
Confidence 9999999987765544 44444 446788999999999999999988766555443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.7e-10 Score=112.63 Aligned_cols=133 Identities=26% Similarity=0.350 Sum_probs=103.2
Q ss_pred eeeccCCcEEEEEEEEcCCeEEEEEEeccCCC-HH-----HHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeec
Q 003978 511 EQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYS-DE-----VIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~-~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 584 (782)
..|++|+-+.+|.+.+.+.++++|.=.++.+. ++ ...+..+|.+++..++--.|.-.+=+..++....|+|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 35789999999999999988888875444442 21 2345677999999886555544444555667788999999
Q ss_pred CCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
+|..|.+.+... ...++..+-.-+.-||..| |||+||.++||++..++ +.++|||++..
T Consensus 82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA--------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 998999899765 1345666777788899999 99999999999999874 99999999863
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.6e-10 Score=116.45 Aligned_cols=138 Identities=20% Similarity=0.179 Sum_probs=98.2
Q ss_pred eeeccCCcEEEEEEEEc--------CCeEEEEEEeccCC--------------------CHHHHHH----HHHHHHHHHh
Q 003978 511 EQIGQGSCGTVYHAVWY--------GSDVAVKVFSRQEY--------------------SDEVIHS----FRQEVSLMKR 558 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~--------~~~vAiK~~~~~~~--------------------~~~~~~~----~~~Ei~il~~ 558 (782)
..||.|--+.||.|... +..+|||+++.... ...-.+. ..+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999754 36899999853110 0011222 3379999998
Q ss_pred CCC--CceeEEeeeeecCCceeEEEeecCCCCHHH-HHhhcCCcchHHHHHHHHHHHHHHHHhh-hcCCCCeeecCCCCC
Q 003978 559 LRH--PNVLLFMGAVTSPQRLCIVTEFLPRGSLFR-LLQRNTTKLDWRRRILMALDIARGVSYL-HHCNPPIIHRDLKSS 634 (782)
Q Consensus 559 l~H--pnIv~l~~~~~~~~~~~lv~E~~~ggsL~~-~l~~~~~~l~~~~~~~i~~qll~aL~~L-H~~~~~ivHrDIKp~ 634 (782)
+.. -+++.++++ ...+|||||+.+..+.. .+.. ..++......+..+++.+|..| |..| |||+||++.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence 853 456667764 45689999997644422 2222 1344455667788999999999 8888 999999999
Q ss_pred cEEEcCCCcEEEEecCCCccccc
Q 003978 635 NLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 635 NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|||+.. +.++|+|||.+.....
T Consensus 155 NIL~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 155 NMLWHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred HEEEEC-CcEEEEECCCceeCCC
Confidence 999974 6899999998865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR02040 PpsR-CrtJ transcriptional regulator PpsR | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.1e-10 Score=130.94 Aligned_cols=114 Identities=14% Similarity=0.004 Sum_probs=91.1
Q ss_pred HHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCC-hhhHcCCCccccccccccccHHHHHHHHHHc-CCeEEEEEEEE
Q 003978 131 QYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYS-AEEALGQDAIELLTDGRDFDVAYDIVHRIKM-GERWTGQFPAK 208 (782)
Q Consensus 131 ~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys-~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~-g~~~~~e~~~~ 208 (782)
.|+.++++++++|+++|.+|+|+++|++|++|+||+ .++++|+++.+++.+... ....+...+.. |.....+....
T Consensus 253 ~~~~l~e~~~d~I~v~D~~G~I~~~N~a~~~l~G~~~~~~l~G~~~~~~~~~~~~--~~~~~~~~~~~~g~~~~~~~~~~ 330 (442)
T TIGR02040 253 NLARLYHEAPDAIVFSDADGTIRGANEAFLELTDSSSLEAVRGRTLDRWLGRGGV--DLRVLLSNVRRTGQVRLYATTLT 330 (442)
T ss_pred HHHHHHHhCCceEEEEcCCCcEEehhHHHHHHhCCCChHHHcCCCHHHHhCCCcc--cHHHHHHHHhhcCceEEEEEEEE
Confidence 589999999999999999999999999999999997 578999999887764322 12333444443 44444566778
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHH
Q 003978 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETR 248 (782)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E 248 (782)
+++|..+|+.+++.|+.+.++ ..++++++|||+|++.+
T Consensus 331 ~~~G~~~~ve~s~~~i~~~~~--~~~~~v~rDITeR~~~~ 368 (442)
T TIGR02040 331 GEFGAQTEVEISAAWVDQGER--PLIVLVIRDISRRLTMR 368 (442)
T ss_pred cCCCCEEEEEEEEEEeccCCc--eEEEEEEecchhhccCC
Confidence 999999999999999986555 45788999999998774
|
This model represents the transcriptional regulator PpsR which is strictly associated with photosynthetic proteobacteria and found in photosynthetic operons. PpsR has been reported to be a repressor. These proteins contain a Helix-Turn_Helix motif of the "fis" type (pfam02954). |
| >PRK11073 glnL nitrogen regulation protein NR(II); Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.5e-10 Score=127.55 Aligned_cols=144 Identities=15% Similarity=0.070 Sum_probs=113.2
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEE
Q 003978 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (782)
Q Consensus 129 ~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~ 208 (782)
...++.+|+++++||+++|.+|+|+++|++|++++||+.++++|+++.++++.... ....+...+..+..+......+
T Consensus 6 ~~~~~~il~~~~~gi~~~d~~~~i~~~N~a~~~~~g~~~~~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 83 (348)
T PRK11073 6 LPDAGQILNSLINSILLLDDDLAIHYANPAAQQLLAQSSRKLFGTPLPELLSYFSL--NIELMRESLQAGQGFTDNEVTL 83 (348)
T ss_pred cchHHHHHhcCcCeEEEECCCCeEeeEcHHHHHHhCCCHHHHcCCCHHHHcCcchh--hHHHHHHHHHcCCcccccceEE
Confidence 35689999999999999999999999999999999999999999999998865331 1234456677776655444555
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhhccccccccCCchhHHHHHhCCCchhHHHHHH
Q 003978 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATI 286 (782)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~i~~~~~gl~~~l~~d~~qpL~~~i 286 (782)
.++|..+|+.++..|+. . .+++..++|||+++++++++....... ....+...++||++.||..+.
T Consensus 84 ~~~g~~~~~~~~~~~~~--~---~~~~~~~~dit~~~~~~~~~~~~~~~~-------~~~~~~~~iaHelr~pL~~i~ 149 (348)
T PRK11073 84 VIDGRSHILSLTAQRLP--E---GMILLEMAPMDNQRRLSQEQLQHAQQV-------AARDLVRGLAHEIKNPLGGLR 149 (348)
T ss_pred EECCceEEEEEEEEEcc--C---ceeEEEEechhHHHHHHHHHHHHHHHH-------HHHHHHHhhhHhhcChHHHHH
Confidence 67999999999999987 2 246778999999999888775543321 123488899999999998754
|
|
| >PRK13558 bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.4e-10 Score=136.02 Aligned_cols=127 Identities=22% Similarity=0.259 Sum_probs=112.0
Q ss_pred HHHHHHHHHcCceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEE
Q 003978 130 RQYLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (782)
Q Consensus 130 ~~~~~ile~~~d~I~v~D~---dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~ 206 (782)
+.++.+++..+++|+++|. +|.|+|+|+++++++||+.++++|+++..++++.........+...+..+..+..+++
T Consensus 148 r~~~~~~~~~~~gi~~~d~~~~dg~i~~~N~~~~~l~G~~~eel~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 227 (665)
T PRK13558 148 RLKERALDEAPVGITIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERPTSVELR 227 (665)
T ss_pred HHHHHHHhcCCccEEEEcCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHHHhcCCCccHHHHHHHHHHHhcCCCeEEEEE
Confidence 3467899999999999984 7999999999999999999999999998888766554455567778888888888999
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhhc
Q 003978 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKN 256 (782)
Q Consensus 207 ~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~ 256 (782)
.++++|..+|+.++..|+++.+|.+.+++++++|||++|++|++++....
T Consensus 228 ~~~~dG~~~~~~~~~~pi~d~~G~~~~~vgi~~DITerk~~E~~L~~~~~ 277 (665)
T PRK13558 228 NYRKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTERKEAELALQRERR 277 (665)
T ss_pred EECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEeCcHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999876443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=8e-10 Score=107.47 Aligned_cols=145 Identities=23% Similarity=0.210 Sum_probs=108.2
Q ss_pred EeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCH------HHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 509 IGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSD------EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 509 i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
.+..|-+|+-+.|+++.+.|+.+.||.=..+.+.. -..++.++|+++|.++.--.|.-..-++.+...-.|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 45678899999999999999999998744433322 234577889999998864444444444555566788999
Q ss_pred ecCC-CCHHHHHhhcCCcc-hHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---cEEEEecCCCccc
Q 003978 583 FLPR-GSLFRLLQRNTTKL-DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRLK 655 (782)
Q Consensus 583 ~~~g-gsL~~~l~~~~~~l-~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~---~vkL~DFGla~~~ 655 (782)
|++| .++.+++......- .......++..|-..+.-||..+ |||+||..+||++..++ .+.|+|||++...
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9977 47888886543332 33333678889999999999999 99999999999997654 3589999998643
|
|
| >PRK09776 putative diguanylate cyclase; Provisional | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.3e-09 Score=138.10 Aligned_cols=134 Identities=20% Similarity=0.199 Sum_probs=110.0
Q ss_pred CHHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCcccccccccc--ccHHHHHHHHHHcCCe--EEE
Q 003978 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD--FDVAYDIVHRIKMGER--WTG 203 (782)
Q Consensus 128 ~~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~--~~~~~~l~~~l~~g~~--~~~ 203 (782)
.++.++.++++++++|+++|.+|+|+++|+++++++||+.+|++|+++.++++.... ......+......+.. ...
T Consensus 534 ~~~~l~~~l~~~~~~i~~~D~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 613 (1092)
T PRK09776 534 EKERLHITLDSIGEAVVCTDMAMKVTFMNPVAEKMTGWTQEEALGVPLLTVLHITFGDNGPLMENIYSCLTSRSAAYLEQ 613 (1092)
T ss_pred HHHHHHHHHhccccEEEEECCCCeEEEEcHHHHHHhCCCHHHHcCCCHHHHcccccCCcchhhHHHHHHHhcCCCccccc
Confidence 356688899999999999999999999999999999999999999999887754322 1222234444444443 456
Q ss_pred EEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhhcccccc
Q 003978 204 QFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDS 261 (782)
Q Consensus 204 e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~ 261 (782)
+....+++|..+|+.++..|+++.+|++.|++++++|||++|+.+++|......+..+
T Consensus 614 ~~~~~~~~G~~~~~~~~~~pi~~~~g~~~g~v~~~~DITe~k~~e~~L~~~a~~D~lT 671 (1092)
T PRK09776 614 DVVLHCRSGGSYDVHYSITPLSTLDGENIGSVLVIQDVTESRKMLRQLSYSASHDALT 671 (1092)
T ss_pred eEEEEeCCCcEEEEEEEeeeeecCCCCEEEEEEEEEecchHHHHHHHHHhhcCCCccc
Confidence 7778899999999999999999999999999999999999999999998776554443
|
|
| >PRK09776 putative diguanylate cyclase; Provisional | Back alignment and domain information |
|---|
Probab=99.10 E-value=4.6e-10 Score=142.23 Aligned_cols=129 Identities=13% Similarity=0.098 Sum_probs=109.2
Q ss_pred CHHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcC-CeEEEEEE
Q 003978 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMG-ERWTGQFP 206 (782)
Q Consensus 128 ~~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g-~~~~~e~~ 206 (782)
.++.++.++++++++|+++|.+|+|+++|+++++++||+.+|++|+++.+++++++.......+...+..+ ..+..+.+
T Consensus 281 ~e~r~~~l~e~~~~~i~~~d~dG~i~~~N~~~~~l~G~~~~el~g~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~e~~ 360 (1092)
T PRK09776 281 SETRFRNAMEYSAIGMALVGTEGQWLQVNKALCQFLGYSQEELRGLTFQQLTWPEDLNKDLQQVEKLLSGEINSYSMEKR 360 (1092)
T ss_pred HHHHHHHHHHhCCceEEEEcCCCcEEehhHHHHHHhCCCHHHHccCCceeccCcchhHhHHHHHHHHHcCCccceeeeeE
Confidence 35678999999999999999999999999999999999999999999999888776433333333333332 23677888
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhhc
Q 003978 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKN 256 (782)
Q Consensus 207 ~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~ 256 (782)
..++||+.+|+..+..|+++.+|++.+++++++|||++|++|+++++..+
T Consensus 361 ~~~~dG~~~~~~~~~~~~~~~~g~~~~~i~~~~DITerk~~e~~l~~~~~ 410 (1092)
T PRK09776 361 YYRRDGEVVWALLAVSLVRDTDGTPLYFIAQIEDINELKRTEQVNERLME 410 (1092)
T ss_pred EEcCCCCEEEEEEEEEEEECCCCCEeeehhhHHhhHHHHHHHHHHHHHHH
Confidence 89999999999999999999999999999999999999999999876543
|
|
| >TIGR02966 phoR_proteo phosphate regulon sensor kinase PhoR | Back alignment and domain information |
|---|
Probab=99.09 E-value=7.3e-10 Score=120.10 Aligned_cols=128 Identities=16% Similarity=0.251 Sum_probs=102.1
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEE
Q 003978 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (782)
Q Consensus 129 ~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~ 208 (782)
.+.|+.++++++++|+++|.+|+|+|+|++|++++||++++++|+++.+++.+.. +...+..+.. ...+...
T Consensus 5 ~~~l~~~~~~~~~~i~~~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~-------~~~~l~~~~~-~~~~~~~ 76 (333)
T TIGR02966 5 LSRFRAAAQALPDAVVVLDEEGQIEWCNPAAERLLGLRWPDDLGQRITNLIRHPE-------FVEYLAAGRF-SEPLELP 76 (333)
T ss_pred HHHHHHHHHhCcCcEEEECCCCcEEEEcHHHHHHhCCChHHHcCCcHHHHccCHH-------HHHHHHhccc-CCCeEee
Confidence 4678999999999999999999999999999999999999999999998875432 3444444333 2235555
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhhccccccccCCchhHHHHHhCCCchhHHHHH
Q 003978 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQAT 285 (782)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~i~~~~~gl~~~l~~d~~qpL~~~ 285 (782)
.++|..+|+.+...|+.+.+ ++.+++|||+++++++... .+...++|+.++||..+
T Consensus 77 ~~~~~~~~~~~~~~p~~~~~-----~~~~~~dit~~~~~~~~~~----------------~~~~~l~h~l~~pL~~i 132 (333)
T TIGR02966 77 SPINSERVLEIRIAPYGEEQ-----KLLVARDVTRLRRLEQMRR----------------DFVANVSHELRTPLTVL 132 (333)
T ss_pred cCCCCceEEEEEEEEcCCCc-----eEEEEeCchHHHHHHHHHH----------------HHHHhhhhhhcccHHHH
Confidence 68888999999999987543 6788999999998766532 26778889999998764
|
Members of this protein family are the regulatory histidine kinase PhoR associated with the phosphate ABC transporter in most Proteobacteria. Related proteins from Gram-positive organisms are not included in this model. The phoR gene usually is adjacent to the response regulator phoB gene (TIGR02154). |
| >PRK11360 sensory histidine kinase AtoS; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.8e-09 Score=126.96 Aligned_cols=146 Identities=16% Similarity=0.226 Sum_probs=119.1
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeE-EEEEEEE
Q 003978 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW-TGQFPAK 208 (782)
Q Consensus 130 ~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~-~~e~~~~ 208 (782)
..++.++++++++|+++|.+|+|+++|+++++++||+.++++|+++.+++++... ....+.+.+..+... ..++...
T Consensus 262 ~~~~~i~~~~~~~i~~~d~~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 339 (607)
T PRK11360 262 SLNELILESIADGVIAIDRQGKITTMNPAAEVITGLQRHELVGKPYSELFPPNTP--FASPLLDTLEHGTEHVDLEISFP 339 (607)
T ss_pred HHHHHHHHhccCeEEEEcCCCCEEEECHHHHHHhCCChHHhcCCcHHHHcCCchh--HHHHHHHHHhcCCCccceEEEEE
Confidence 4577899999999999999999999999999999999999999999998875432 233455666666553 4456677
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhhccccccccCCchhHHHHHhCCCchhHHHHH
Q 003978 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQAT 285 (782)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~i~~~~~gl~~~l~~d~~qpL~~~ 285 (782)
.++|..+ +.++..|+++.+|++.|++++++|||++++++++++...... ....++..++|++++||...
T Consensus 340 ~~~~~~~-~~~~~~~i~~~~g~~~~~i~~~~Dite~~~~e~~l~~~~~~~-------~l~~~~~~~~hel~~~l~~i 408 (607)
T PRK11360 340 GRDRTIE-LSVSTSLLHNTHGEMIGALVIFSDLTERKRLQRRVARQERLA-------ALGELVAGVAHEIRNPLTAI 408 (607)
T ss_pred cCCCcEE-EEEEEeeEEcCCCCEEEEEEEEeechHHHHHHHHHHHHHHHH-------HHHHHHHHHHHHhhhHHHHH
Confidence 8888776 889999999999999999999999999999999987654321 13347888899999999764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.06 E-value=9.7e-10 Score=112.55 Aligned_cols=141 Identities=21% Similarity=0.247 Sum_probs=103.0
Q ss_pred eeeccCCcEEEEEEEEcC-CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCC--CceeEEeeeeecC---CceeEEEeec
Q 003978 511 EQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH--PNVLLFMGAVTSP---QRLCIVTEFL 584 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~---~~~~lv~E~~ 584 (782)
+.|+.|.++.||++...+ ..+++|+....... .....+..|+++++.+.+ .++++++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998865 88999997654321 123467889999999865 3456777776553 3678999999
Q ss_pred CCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcC------------------------------------------
Q 003978 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC------------------------------------------ 622 (782)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~------------------------------------------ 622 (782)
+|.++.+.+.. ..+++.....++.+++.+|..||+.
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99887665431 2355555556666666666666642
Q ss_pred ------------CCCeeecCCCCCcEEEcC--CCcEEEEecCCCcc
Q 003978 623 ------------NPPIIHRDLKSSNLLVDK--HWTVKVGDFGLSRL 654 (782)
Q Consensus 623 ------------~~~ivHrDIKp~NILl~~--~~~vkL~DFGla~~ 654 (782)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF13596 PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.3e-09 Score=97.33 Aligned_cols=106 Identities=22% Similarity=0.319 Sum_probs=78.0
Q ss_pred HHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEcCC
Q 003978 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKT 211 (782)
Q Consensus 132 ~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kd 211 (782)
++.+|++++.+++++|.+++|.|+|+++.++|+... ..+|+++.++.++.. ......+.+.+..|+....+... ..+
T Consensus 1 L~~il~s~~~~i~~vD~~~~I~~~n~~a~~~f~~~~-~~iGr~l~~~~~~~~-~~~l~~~i~~~~~~~~~~~~~~~-~~~ 77 (106)
T PF13596_consen 1 LNNILDSMPIGIIFVDRNLRIRYFNPAAARLFNLSP-SDIGRPLFDIHPPLS-YPNLKKIIEQVRSGKEEEFEIVI-PNG 77 (106)
T ss_dssp HHHHHHHSSSEEEEEETTSBEEEE-SCGC-SS---G-GGTTSBCCCSS-HHH-HHHHHHHHHHHHTTSBSEEEEEE-EET
T ss_pred ChHHHhcCCCCEEEEcCCCeEEEeChhHhhhcCCCh-HHCCCCHHHcCCccc-hHHHHHHHHHHHcCCCceEEEEe-cCC
Confidence 468999999999999999999999999999999765 558999999987643 33445567777888864444333 244
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEehh
Q 003978 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (782)
Q Consensus 212 G~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (782)
| .|+.+...|+++.+|++.|++.++.|||
T Consensus 78 ~--~~~~~~~~P~~~~~g~~~G~v~~~~DIT 106 (106)
T PF13596_consen 78 G--RWYLVRYRPYRDEDGEYAGAVITFQDIT 106 (106)
T ss_dssp T--EEEEEEEEEEE-TTS-EEEEEEEEEE-G
T ss_pred C--EEEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 4 4668899999999999999999999998
|
|
| >COG5002 VicK Signal transduction histidine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=7.9e-09 Score=108.46 Aligned_cols=132 Identities=20% Similarity=0.290 Sum_probs=109.3
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEc
Q 003978 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (782)
Q Consensus 130 ~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~ 209 (782)
+.+..+|-.+.|||+.+|..|+|+.+|..|.+++|.+.++++|+++.+++.-++... +.+.+........+..
T Consensus 111 ~kL~SvlayMtDGViATdRrG~iI~iN~~A~k~L~~~~E~~~~~~i~elL~i~d~y~----~~dL~e~~~s~lld~~--- 183 (459)
T COG5002 111 RKLDSVLAYMTDGVIATDRRGKIILINKPALKMLGVSKEDALGRSILELLKIEDTYT----FEDLVEKNDSLLLDSS--- 183 (459)
T ss_pred HHHHHHHHHHcCceEeecCCCcEEEeccHHHHHhCcCHHHHhcccHHHHhCCcccee----HHHHHhcCCcEEEeec---
Confidence 558889999999999999999999999999999999999999999999987666432 3444444443333322
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhhccccccccCCchhHHHHHhCCCchhHHHH
Q 003978 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQA 284 (782)
Q Consensus 210 kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~i~~~~~gl~~~l~~d~~qpL~~ 284 (782)
.+++.+.+.++.+.+.-+.|-+.|+|+++.|+||+.+.|++.+. +.+.++|+++.||.+
T Consensus 184 ~~~E~~~lrv~Fs~i~rEsGfisGlIaVlhDvTEqek~e~ErRe----------------fvanvSHElRTPlts 242 (459)
T COG5002 184 DEEEGYVLRVNFSVIQRESGFISGLIAVLHDVTEQEKVERERRE----------------FVANVSHELRTPLTS 242 (459)
T ss_pred CCCccEEEEEEEEEEeecccccceeEEEEecccHHHHHHHHHHH----------------HHHhcchhhcCchHH
Confidence 26777788888889999999999999999999999999888643 678899999999977
|
|
| >PRK11359 cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Probab=98.95 E-value=5.5e-09 Score=128.02 Aligned_cols=125 Identities=23% Similarity=0.273 Sum_probs=104.9
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCcccccccccc-ccHHHHHHHHHHcCCeEEEEEEE
Q 003978 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD-FDVAYDIVHRIKMGERWTGQFPA 207 (782)
Q Consensus 129 ~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~-~~~~~~l~~~l~~g~~~~~e~~~ 207 (782)
.+.+..++++++++|+++|.+|+|+++|+++++++||+.++++|+++.+++++... ......+...+..+..+..+.+.
T Consensus 135 ~~~~~~~~~~~~~~i~~~d~~g~i~~~N~~~~~l~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 214 (799)
T PRK11359 135 TRQLIIAVDHLDRPVIVLDPERRIVQCNRAFTEMFGYCISEASGMQPDTLLNIPEFPADNRIRLQQLLWKTARDQDEFLL 214 (799)
T ss_pred HHHHHHHHhcCCCcEEEEcCCCcEEEEChhhHhhhCCCHHHHCCCChHHhcCCCCCcHHHHHHHHHhhccCCCCcceeEE
Confidence 34566789999999999999999999999999999999999999999887654333 22333455666666677778888
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHH
Q 003978 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWD 253 (782)
Q Consensus 208 ~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~ 253 (782)
.+++|..+|+.++..|+.+.+|.+.+++++++|||+++++++..+.
T Consensus 215 ~~~dG~~~~~~~~~~~v~d~~g~~~~~~~~~~DITerk~~e~~~~~ 260 (799)
T PRK11359 215 LTRTGEKIWIKASISPVYDVLAHLQNLVMTFSDITEERQIRQLEGN 260 (799)
T ss_pred eCCCCCEEEEEeeeeeeecCCCceeEEEEEeehhhhHHHHHHHHHH
Confidence 8999999999999999999999999999999999999988765543
|
|
| >PRK13560 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=8.7e-09 Score=126.06 Aligned_cols=146 Identities=10% Similarity=0.096 Sum_probs=116.0
Q ss_pred HHHHHHHcCceeEEEcCC-CcEEEecHHHHHHhCCChhhHcC--CCccccccccccccHHHHHHHHHHcCC-eEEEEEEE
Q 003978 132 YLNILQSMGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALG--QDAIELLTDGRDFDVAYDIVHRIKMGE-RWTGQFPA 207 (782)
Q Consensus 132 ~~~ile~~~d~I~v~D~d-G~Ii~vN~aae~l~Gys~eEliG--~~~~~l~~~~~~~~~~~~l~~~l~~g~-~~~~e~~~ 207 (782)
.+.++++.+++++..+.+ |..+.+|.....++||+++++++ ..+..++++++.......+...+..+. .+..++++
T Consensus 475 ~~~~~e~~~~~i~~~~~~~~~~~~~~~~~~~~~G~~~~e~~~~~~~~~~~~~p~d~~~~~~~~~~~~~~g~~~~~~e~r~ 554 (807)
T PRK13560 475 ANLIVENSPLVLFRWKAEEGWPVELVSKNITQFGYEPDEFISGKRMFAAIIHPADLEQVAAEVAEFAAQGVDRFEQEYRI 554 (807)
T ss_pred HHHHHhcCCceEEEEecCCCceEEEecchhhhcCCCHHHhhcccchHhhhcChhhHHHHHHHHHHHHhcCCccceeEEEE
Confidence 456789999999887754 55666677778899999999986 334456666654444444555555554 46778999
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhhccccccccCCchhHHHHHhCCCchhHHHHHH
Q 003978 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATI 286 (782)
Q Consensus 208 ~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~i~~~~~gl~~~l~~d~~qpL~~~i 286 (782)
.++||..+|+.....|++|.+|++.+++++++|||++|++|++|+....+ +..|+..++||++.||+.+.
T Consensus 555 ~~~dG~~~w~~~~~~~~~d~~G~~~~~~g~~~DITerK~aE~~L~~a~~~---------~~~~l~~isHelrnpL~~I~ 624 (807)
T PRK13560 555 LGKGGAVCWIDDQSAAERDEEGQISHFEGIVIDISERKHAEEKIKAALTE---------KEVLLKEIHHRVKNNLQIIS 624 (807)
T ss_pred EcCCCCEEEEEecceeeeCCCCCEEEEEEEEechHHHHHHHHHHHHHHHH---------HHHHHHHhHHHHhChHHHHH
Confidence 99999999999999999999999999999999999999999998765432 44588999999999998753
|
|
| >cd00130 PAS PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.1e-08 Score=81.74 Aligned_cols=102 Identities=28% Similarity=0.455 Sum_probs=85.5
Q ss_pred CceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEcCCCCEEEEEE
Q 003978 140 GQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVA 219 (782)
Q Consensus 140 ~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~v~~ 219 (782)
+++++++|.+|.++++|+++++++|++..+++|+.+..++++.........+...+..+.....+......+|...|+.+
T Consensus 2 ~~~i~~~d~~~~~~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (103)
T cd00130 2 PDGVIVLDLDGRILYANPAAEQLLGYSPEELIGKSLLDLIHPEDREELRERLENLLSGGEPVTLEVRLRRKDGSVIWVLV 81 (103)
T ss_pred CceEEEECCCCcEEEECHHHHHHhCCCHHHHcCccHHHhcCCccchHHHHHHHHHHhcCcCeEEEEEEEccCCCEEEEEE
Confidence 57899999999999999999999999999999999988887766443333445555555667777888888899999999
Q ss_pred EEEEEECCCCCEEEEEEEEEeh
Q 003978 220 TNTPFYDDDGTLVGIVCVSTDS 241 (782)
Q Consensus 220 ~~~Pi~d~~G~v~g~v~i~rDI 241 (782)
...++.+.+|...+++++++||
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~di 103 (103)
T cd00130 82 SLTPIRDEGGEVIGLLGVVRDI 103 (103)
T ss_pred EEEEEecCCCCEEEEEEEEecC
Confidence 9999998888999999999886
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. |
| >PF08447 PAS_3: PAS fold; InterPro: IPR013655 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.4e-08 Score=88.78 Aligned_cols=86 Identities=26% Similarity=0.471 Sum_probs=72.1
Q ss_pred EEEecHHHHHHhCCChhhHcCCC----ccccccccccccHHHHHHH-HHHcCCeEEEEEEEEcCCCCEEEEEEEEEEEEC
Q 003978 152 IIYWNRSAELLYGYSAEEALGQD----AIELLTDGRDFDVAYDIVH-RIKMGERWTGQFPAKTKTEERVLVVATNTPFYD 226 (782)
Q Consensus 152 Ii~vN~aae~l~Gys~eEliG~~----~~~l~~~~~~~~~~~~l~~-~l~~g~~~~~e~~~~~kdG~~~~v~~~~~Pi~d 226 (782)
|+|+|+.+++|+||+++++ +.. +..+++|++.......+.. .+..+..+..+++++++||+.+|+.+...+++|
T Consensus 1 ~i~~s~~~~~i~G~~~~~~-~~~~~~~~~~~ihpdD~~~~~~~~~~~~~~~~~~~~~e~R~~~~~G~~~wi~~~~~~~~d 79 (91)
T PF08447_consen 1 IIYWSDNFYEIFGYSPEEI-GKPDFEEWLERIHPDDRERVRQAIQQAALQNGEPFEIEYRIRRKDGEYRWIEVRGRPIFD 79 (91)
T ss_dssp -EEE-THHHHHHTS-HHHH-TCBEHHHHHHHB-TTTHHHHHHHHHHHHHHTT-EEEEEEEEEGTTSTEEEEEEEEEEEET
T ss_pred CEEEeHHHHHHhCCCHHHh-ccCCHHHHHhhcCHHHHHHHHHHHHHHhhccCcceEEEEEEECCCCCEEEEEEEEEEEEC
Confidence 7899999999999999999 777 7788999987777677777 677788999999999999999999999999999
Q ss_pred CCCCEEEEEEEE
Q 003978 227 DDGTLVGIVCVS 238 (782)
Q Consensus 227 ~~G~v~g~v~i~ 238 (782)
.+|+++.++++.
T Consensus 80 ~~g~~~~~~Gv~ 91 (91)
T PF08447_consen 80 ENGKPIRIIGVI 91 (91)
T ss_dssp TTS-EEEEEEEE
T ss_pred CCCCEEEEEEEC
Confidence 999999998874
|
The PAS fold appears in archaea, eubacteria and eukarya. The PAS domain contains a sensory box, or S-box domain that occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include haem in the oxygen sensor FixL [], FAD in the redox potential sensor NifL [], and a 4-hydroxycinnamyl chromophore in photoactive yellow protein []. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. This domain has been found in the gene product of the madA gene of the filamentous zygomycete fungus Phycomyces blakesleeanus. It has been shown that MadA encodes a blue-light photoreceptor for phototropism and other light responses. The gene is involved in the phototropic responses associated with sporangiophore growth; they exhibit phototropism by bending toward near-UV and blue wavelengths and away from far-UV wavelengths in a manner that is physiologically similar to plant phototropic responses [].; GO: 0005515 protein binding; PDB: 3NJA_D 3H9W_A 3GDI_B 3ICY_A 3EEH_A 3MR0_B. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.3e-08 Score=106.03 Aligned_cols=138 Identities=18% Similarity=0.133 Sum_probs=97.7
Q ss_pred eccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHH----------HHHHHHHHHHhCCCCc--eeEEeeeeec-----CC
Q 003978 513 IGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIH----------SFRQEVSLMKRLRHPN--VLLFMGAVTS-----PQ 575 (782)
Q Consensus 513 IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~----------~~~~Ei~il~~l~Hpn--Iv~l~~~~~~-----~~ 575 (782)
+-.-....|+++...|+.|.||........ +..+ .+.+|...+..|..-+ ++.++++++. ..
T Consensus 30 v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFELAGKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEECCEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 333444457788888889999976433311 1111 3678888887774222 2344444432 23
Q ss_pred ceeEEEeecCCC-CHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-------CCcEEE
Q 003978 576 RLCIVTEFLPRG-SLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-------HWTVKV 646 (782)
Q Consensus 576 ~~~lv~E~~~gg-sL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~-------~~~vkL 646 (782)
..+||||++++. +|.+++... ....+......++.+++..+.-||..| |+|+|+++.||||+. +..+.|
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~L 186 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSV 186 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEE
Confidence 478999999876 899998642 234556677788999999999999999 999999999999975 468999
Q ss_pred EecCCCc
Q 003978 647 GDFGLSR 653 (782)
Q Consensus 647 ~DFGla~ 653 (782)
+||+.+.
T Consensus 187 IDl~r~~ 193 (268)
T PRK15123 187 IDLHRAQ 193 (268)
T ss_pred EECCccc
Confidence 9999775
|
|
| >COG3829 RocR Transcriptional regulator containing PAS, AAA-type ATPase, and DNA-binding domains [Transcription / Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.7e-08 Score=112.87 Aligned_cols=116 Identities=23% Similarity=0.453 Sum_probs=94.9
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEc
Q 003978 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (782)
Q Consensus 130 ~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~ 209 (782)
+.|+.|++.+.++|+++|.+|.|+++|.++..++|++.++++|+++.+++.... ...+..++..+++.......+.
T Consensus 117 ~~l~~il~~~~~~l~vvD~~G~~i~~N~~~~~~~gl~~e~~~gk~~~~v~~~~~----~s~~l~vl~~~kp~~~~~~~~~ 192 (560)
T COG3829 117 QRLEAILDSIDDGLLVVDEDGIIIYYNKAYAKLLGLSPEEVLGKHLLDVVSAGE----DSTLLEVLRTGKPIRDVVQTYN 192 (560)
T ss_pred HHHHHHHhhccCceEEEcCCCcEEEEcHHHHHHhCCCHHHHcCCcHHHHHhccC----CceehhhhhcCCcceeeeeeec
Confidence 668899999999999999999999999999999999999999999999871111 1126788999998877766655
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHh
Q 003978 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (782)
Q Consensus 210 kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~ 254 (782)
.+.. ..+..|++ .+|.+.|+|.+++|+++.+.+..++...
T Consensus 193 ~~~~----i~~~~pv~-~~g~l~G~v~~~~~~~~l~~l~~~~~~~ 232 (560)
T COG3829 193 GNKI----IVNVAPVY-ADGQLIGVVGISKDVSELERLTRELEES 232 (560)
T ss_pred CCce----eEeeccEe-cCCcEEEEEEeecchHHHHHHHHHHHHH
Confidence 4432 56677877 5679999999999999999887776544
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.86 E-value=8.3e-08 Score=106.18 Aligned_cols=212 Identities=18% Similarity=0.208 Sum_probs=151.4
Q ss_pred CcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeee----cCCceeEEEeecCC-CCH
Q 003978 517 SCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT----SPQRLCIVTEFLPR-GSL 589 (782)
Q Consensus 517 ~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~----~~~~~~lv~E~~~g-gsL 589 (782)
.-.+.|++.. .|..|++|.+...+... ......-++.++++.|+|||+|.++|. .+..+++|++|.++ ++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 3457899986 57789999884332211 011122477899999999999999886 45678999999876 478
Q ss_pred HHHHhhc--------------CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 590 FRLLQRN--------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 590 ~~~l~~~--------------~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
+++...+ +...++..+|.++.||..||.++|+.| +..+-|.|.+||++.+.+|+|...|.....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeee
Confidence 7776321 334688999999999999999999999 888999999999999989999877765443
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCC-CCCCCChHHHHHHhhccccccCCCCCCCHHH
Q 003978 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKI-PWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734 (782)
Q Consensus 656 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~-Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 734 (782)
..... +.+.+. .+-|.=.||.+++.|.||.. -|........ . ...+...++.++
T Consensus 444 ~~d~~--------------~~le~~---Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s--~------~~~I~~~yS~D~ 498 (655)
T KOG3741|consen 444 QEDPT--------------EPLESQ---QQNDLRDLGLLLLALATGTENSNRTDSTQSS--H------LTRITTTYSTDL 498 (655)
T ss_pred cCCCC--------------cchhHH---hhhhHHHHHHHHHHHhhcccccccccchHHH--H------HHHhhhhhhHHH
Confidence 33210 112221 46799999999999999943 2322222221 0 112345688999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q 003978 735 AAIVESCWHSDPQCRPSFQELVDK 758 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RPs~~ell~~ 758 (782)
+++|......++.+ -++.+++..
T Consensus 499 rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 499 RNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHhcCccc-ccHHHHHHH
Confidence 99999999999887 577777655
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.1e-09 Score=122.65 Aligned_cols=145 Identities=17% Similarity=0.302 Sum_probs=107.4
Q ss_pred HHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc-------cc--cccCCCCCCcccCcccccCCC
Q 003978 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-------YL--TTKTGKGTPQWMAPEVLRNEP 681 (782)
Q Consensus 611 qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-------~~--~~~~~~Gt~~y~aPE~l~~~~ 681 (782)
+++.||.|+|.. .++||++|.|++|.++..+.+||+.|+++...... +. ......-...|.|||++.+..
T Consensus 107 ~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred cccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 455899999986 35999999999999999999999999987543321 00 011113456899999999988
Q ss_pred CCchhHHHHHHHHHHHHH-cCCCCCCCCChHHHHHHh--hccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHH
Q 003978 682 SDEKSDVYSFGVILWELA-TEKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELV 756 (782)
Q Consensus 682 ~s~~sDIwSLG~ll~ell-tG~~Pf~~~~~~~~~~~i--~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell 756 (782)
.+.++|+|||||++|-++ .|+.-+............ ............+|.++++=+.+++..++..||++..++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 889999999999999999 566655544332222111 111123445578999999999999999999999888773
|
|
| >PRK11086 sensory histidine kinase DcuS; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=1e-07 Score=111.30 Aligned_cols=136 Identities=16% Similarity=0.239 Sum_probs=101.5
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCC---hhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEE
Q 003978 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYS---AEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (782)
Q Consensus 130 ~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys---~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~ 206 (782)
+.++.+++++++||+++|.+|+|+++|++|++++|++ ..+.+|+.+..+.+.. .+...+..+........
T Consensus 221 ~~~~~il~~~~~gIi~~D~~g~I~~~N~~a~~llg~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~ 293 (542)
T PRK11086 221 EQRQAMLQSIKEGVIAVDDRGEVTLINDEAKRLFNYKKGLEDDPLGTDVESWMPVS-------RLKEVLRTGTPRRDEEI 293 (542)
T ss_pred HHHHHHHHHhcCcEEEECCCCeEEEEhHHHHHHhCCCcCCcccccCCcHHHhCCch-------hHHHHHhcCCCccceEE
Confidence 3357899999999999999999999999999999875 3467888877766532 24556667665433222
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhhccccccccCCchhHHHHHhCCCchhHHHHHH
Q 003978 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATI 286 (782)
Q Consensus 207 ~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~i~~~~~gl~~~l~~d~~qpL~~~i 286 (782)
..+|. ++.+...|+.+ +|.+.|++.+++|+|+.+++++++...... ...+...+||.+.||+.+.
T Consensus 294 --~~~g~--~~~~~~~pi~~-~g~~~g~v~~~rDite~~~l~~~l~~~~~~----------~~~l~~~sHel~npL~~I~ 358 (542)
T PRK11086 294 --NINGR--LLLTNTVPVRV-NGEIIGAIATFRDKTEVRQLAQRLDGMVNY----------ADALRAQSHEFMNKLHVIL 358 (542)
T ss_pred --EECCE--EEEEEEEEEeE-CCEEEEEEEEEEEchHHHHHHHHHHHHHHH----------HHHHHhhchhhcCHHHHHH
Confidence 22453 45566789987 889999999999999999998888655422 1245667899999998764
Q ss_pred H
Q 003978 287 A 287 (782)
Q Consensus 287 ~ 287 (782)
.
T Consensus 359 g 359 (542)
T PRK11086 359 G 359 (542)
T ss_pred H
Confidence 3
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=5.7e-08 Score=97.47 Aligned_cols=127 Identities=29% Similarity=0.308 Sum_probs=81.5
Q ss_pred EEEEEEE-cCCeEEEEEEecc---------------C--------CC-HHHHHHHHHHHHHHHhCCCC--ceeEEeeeee
Q 003978 520 TVYHAVW-YGSDVAVKVFSRQ---------------E--------YS-DEVIHSFRQEVSLMKRLRHP--NVLLFMGAVT 572 (782)
Q Consensus 520 ~Vy~~~~-~~~~vAiK~~~~~---------------~--------~~-~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~ 572 (782)
.||.|.. .+..+|||+.+.. . .. ........+|.+.|..+..- ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899987 6778999998531 0 01 12335677899999999755 466777653
Q ss_pred cCCceeEEEeecC--CCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHh-hhcCCCCeeecCCCCCcEEEcCCCcEEEEec
Q 003978 573 SPQRLCIVTEFLP--RGSLFRLLQRNTTKLDWRRRILMALDIARGVSY-LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (782)
Q Consensus 573 ~~~~~~lv~E~~~--ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~-LH~~~~~ivHrDIKp~NILl~~~~~vkL~DF 649 (782)
..+|||||++ |..+..+.... ++......++.+++..+.. +|..| |||+|+.+.|||++.+ .+.|+||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEEEEec
Confidence 3479999998 65554443321 1123344556677775555 57888 9999999999999988 9999999
Q ss_pred CCCcccc
Q 003978 650 GLSRLKH 656 (782)
Q Consensus 650 Gla~~~~ 656 (782)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9876443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK10820 DNA-binding transcriptional regulator TyrR; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=6.1e-08 Score=112.63 Aligned_cols=106 Identities=18% Similarity=0.255 Sum_probs=81.9
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEc
Q 003978 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (782)
Q Consensus 130 ~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~ 209 (782)
..++.||+++++||+++|.+|+|+++|++|+++||++.++++|+++.++++... +.+.++.+....... ...
T Consensus 80 ~~L~aIL~sm~eGVi~vD~~G~I~~iN~aA~~Llg~~~eel~Gk~i~eli~~~~-------l~~~le~~~~~~~~~-~v~ 151 (520)
T PRK10820 80 RALSALLEALPEPVLSIDMKGKVELANPASCQLFGQSEEKLRNHTAAQLINGFN-------FLRWLESEPQDSHNE-HVV 151 (520)
T ss_pred HHHHHHHHhCCCcEEEECCCCeeeHhHHHHHHHHCcCHHHHCCCcHHHHcCcch-------HHHHHHcCCCccceE-EEE
Confidence 558899999999999999999999999999999999999999999999987543 445566665421111 223
Q ss_pred CCCCEEEEEEEEEEEE--CCCCCE--EEEEEEEEehhHHH
Q 003978 210 KTEERVLVVATNTPFY--DDDGTL--VGIVCVSTDSRPFQ 245 (782)
Q Consensus 210 kdG~~~~v~~~~~Pi~--d~~G~v--~g~v~i~rDITerk 245 (782)
.+|..++ +.+.|+. +++|.. +|+|.+++|+++..
T Consensus 152 ~~g~~~~--v~~~PI~~~d~~g~~~~~GaVivlrd~~~l~ 189 (520)
T PRK10820 152 INGQDFL--MEITPVYLQDENDQHVLVGAVVMLRSTARMG 189 (520)
T ss_pred ECCEEEE--EEEEeeeecCCCCceeEEEEEEEeccHHHHH
Confidence 4576555 5566776 666654 89999999998754
|
|
| >PRK11006 phoR phosphate regulon sensor protein; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=6.2e-08 Score=110.24 Aligned_cols=127 Identities=17% Similarity=0.255 Sum_probs=92.8
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEE
Q 003978 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (782)
Q Consensus 129 ~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~ 208 (782)
.+.|+.++++++++|+++|.+|+|+++|++|++++||+.++++|+++.+++.... +...+.... ........
T Consensus 97 ~~~~~~~~~~~~~~i~~~d~~g~i~~~N~~a~~l~g~~~~~~~g~~~~~~~~~~~-------~~~~~~~~~-~~~~~~~~ 168 (430)
T PRK11006 97 IKRFRSGAESLPDAVVLTTEEGNIFWCNGLAQQLLGFRWPEDNGQNILNLLRYPE-------FTQYLKTRD-FSRPLTLV 168 (430)
T ss_pred HHHHHHHHHhCCCeEEEEcCCCceeHHHHHHHHHhCCCChHhCCCcHHHHhcCHH-------HHHHHHhcc-cCCCeEEE
Confidence 4668899999999999999999999999999999999999999999988775432 122222222 11222333
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhhccccccccCCchhHHHHHhCCCchhHHHHHH
Q 003978 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATI 286 (782)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~i~~~~~gl~~~l~~d~~qpL~~~i 286 (782)
..+|. ++.+...|+.+ + +.+.+++|||+++++++..+ .|++.++||++.||..+.
T Consensus 169 ~~~~~--~~~~~~~~~~~--~---~~~~~~~dit~~~~~e~~~~----------------~~~~~isHelrtPL~~i~ 223 (430)
T PRK11006 169 LNNGR--HLEIRVMPYTE--G---QLLMVARDVTQMHQLEGARR----------------NFFANVSHELRTPLTVLQ 223 (430)
T ss_pred cCCCC--EEEEEEEEcCC--C---cEEEEEehhhHHHHHHHHHH----------------HHHHHhHHHhcchHHHHH
Confidence 45554 45566667642 3 25678999999998876543 278889999999997743
|
|
| >PRK11359 cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=9.4e-08 Score=117.21 Aligned_cols=124 Identities=16% Similarity=0.236 Sum_probs=98.5
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCe----EEEE
Q 003978 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQ 204 (782)
Q Consensus 129 ~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~----~~~e 204 (782)
+..+..+++..+++++++|.+|+|+++|+++++++||+.+|++|+++.+++++.........+......+.. +..+
T Consensus 11 ~~~~~~~le~~~~~i~~~d~~g~i~~~N~~~~~l~G~s~eeliG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 90 (799)
T PRK11359 11 DGIFFPALEQNMMGAVLINENDEVLFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMSRE 90 (799)
T ss_pred hhhHHHHHHhhcCcEEEEcCCCeEEEEcHHHHHHhCCCHHHHcCCCHHHhcCccccccchHHHhhhhccCCcccccccee
Confidence 455778899999999999999999999999999999999999999999998876654333334444444332 3457
Q ss_pred EEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHh
Q 003978 205 FPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (782)
Q Consensus 205 ~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~ 254 (782)
++.+++||..+|+.++..|+. .+|. .+++++.+|||++++++++++..
T Consensus 91 ~~~~~~dG~~~~v~~~~~~~~-~~g~-~~~~~~~~DiT~~~~~~~~~~~~ 138 (799)
T PRK11359 91 LQLEKKDGSKIWTRFALSKVS-AEGK-VYYLALVRDASVEMAQKEQTRQL 138 (799)
T ss_pred eEEecCCcCEEEEEEEeeeec-cCCc-eEEEEEEeeccchhhhHHHHHHH
Confidence 888999999999999998874 4565 45788999999998877765443
|
|
| >PF12860 PAS_7: PAS fold | Back alignment and domain information |
|---|
Probab=98.67 E-value=6.9e-08 Score=88.88 Aligned_cols=105 Identities=24% Similarity=0.351 Sum_probs=75.3
Q ss_pred HHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhH-cCCCccccccccc------cccHHHHHHHHH---HcCCeEEEEE
Q 003978 136 LQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEA-LGQDAIELLTDGR------DFDVAYDIVHRI---KMGERWTGQF 205 (782)
Q Consensus 136 le~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEl-iG~~~~~l~~~~~------~~~~~~~l~~~l---~~g~~~~~e~ 205 (782)
|+++++||+++|.+|+++++|++|.+|+|++.+.+ .|.++.+++.... .......+.+.+ ...... .+
T Consensus 1 Ld~l~~Gv~v~D~~~rl~~~N~~~~~l~~~~~~~~~~G~~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~--~~ 78 (115)
T PF12860_consen 1 LDSLPQGVAVFDSDGRLVFWNQRFRELFGLPPEMLRPGASFRDLLRRLAERGEFPPGDPEAWVRQRLARLRRRQPR--SF 78 (115)
T ss_pred CCCcCceEEEEcCCCeEEeEcHHHHHHhCCCHHHhcCCCCHHHHHHHHHHcCCCCCCCHHHHHHHHHHHHhcCCCc--ee
Confidence 57899999999999999999999999999999998 7999887753210 111122233333 333322 33
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHH
Q 003978 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRA 249 (782)
Q Consensus 206 ~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~ 249 (782)
.....|| .|+.+...|+- +| |+|.++.|||+++++|+
T Consensus 79 ~~~~~dg--r~l~~~~~~~~--~G---g~v~~~~DVT~~~~~E~ 115 (115)
T PF12860_consen 79 ELRLPDG--RWLEVRAQPLP--DG---GFVLTFTDVTERRRAEE 115 (115)
T ss_pred EEECCCC--EEEEEEeEECC--CC---CEEEEEEeCCHHHHhcC
Confidence 3456777 46678888873 45 57899999999998874
|
|
| >TIGR02040 PpsR-CrtJ transcriptional regulator PpsR | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.8e-07 Score=105.31 Aligned_cols=118 Identities=18% Similarity=0.263 Sum_probs=87.2
Q ss_pred HHHHHHHHHHcCceeEEEcC-CCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEE
Q 003978 129 DRQYLNILQSMGQSVHIFDL-SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPA 207 (782)
Q Consensus 129 ~~~~~~ile~~~d~I~v~D~-dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~ 207 (782)
++.|+.+++.++++|+++|. +|+|+++|+++++|+||+.++++|+++.+++++.........+......|.....++.
T Consensus 132 e~r~~~l~e~~~~~i~~~d~~~g~i~~~N~a~~~l~G~~~~el~g~~~~~~~~~~~~~~~~~~l~~~~~~g~~~~~~~~- 210 (442)
T TIGR02040 132 ETRYRVVLEVSSDAVLLVDMSTGRIVEANSAAAALLGGVGQSLVGRAFPQEFEGRRREELMLTLRNVRATGSAAPVRIL- 210 (442)
T ss_pred HHHHHHHHhhCCceEEEEECCCCEEEEEcHHHHHHhCcCHHHHcCCCHHHhCCHHHHHHHHHHHHHHHhcCCCcceEEE-
Confidence 46789999999999999998 7999999999999999999999999999988776544334445555666665544444
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHH
Q 003978 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAAL 251 (782)
Q Consensus 208 ~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L 251 (782)
..++|.. | .+.+.++.. +|. ..+++.++|||+++++++++
T Consensus 211 ~~~~~~~-~-~~~~~~~~~-~~~-~~~l~~~~dit~~~~~e~~~ 250 (442)
T TIGR02040 211 LRRSQKR-L-LVVVSVFRQ-DGE-SLFLCQLSPAGATQPVGDEL 250 (442)
T ss_pred EcCCCeE-E-EEEEEEEEe-CCc-eEEEEEEcccchhhhhhHHH
Confidence 3344433 3 345556653 343 35677899999998877654
|
This model represents the transcriptional regulator PpsR which is strictly associated with photosynthetic proteobacteria and found in photosynthetic operons. PpsR has been reported to be a repressor. These proteins contain a Helix-Turn_Helix motif of the "fis" type (pfam02954). |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=3e-07 Score=95.28 Aligned_cols=135 Identities=27% Similarity=0.252 Sum_probs=96.5
Q ss_pred eeEeeeeccCCcEEEEEEEE-cCCeEEEEEEecc-------C-----------CC--HHHHHHHHHHHHHHHhCCCC--c
Q 003978 507 LTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQ-------E-----------YS--DEVIHSFRQEVSLMKRLRHP--N 563 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~-~~~~vAiK~~~~~-------~-----------~~--~~~~~~~~~Ei~il~~l~Hp--n 563 (782)
+.++.+||.|--+.||.|.. ++.++|||.=+.. + .+ .-......+|.++|..|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45788999999999999998 5899999974211 0 00 12335678899999999644 6
Q ss_pred eeEEeeeeecCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc
Q 003978 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 643 (782)
Q Consensus 564 Iv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~ 643 (782)
|++.+++ +...+||||++|-.|+..-- .....-.++..|+.-+.-+-..| |||+|+.+-||+++++|.
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecCCC
Confidence 7777775 45689999999877765431 12222233334444444444567 999999999999999999
Q ss_pred EEEEecCCCc
Q 003978 644 VKVGDFGLSR 653 (782)
Q Consensus 644 vkL~DFGla~ 653 (782)
+.++||--+.
T Consensus 241 ~~vIDwPQ~v 250 (304)
T COG0478 241 IVVIDWPQAV 250 (304)
T ss_pred EEEEeCcccc
Confidence 9999996554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.53 E-value=1e-06 Score=90.10 Aligned_cols=105 Identities=30% Similarity=0.304 Sum_probs=80.7
Q ss_pred HHHHHHHHHHHhCCCC--ceeEEeeeeecC----CceeEEEeecCCC-CHHHHHhhcCCcchHHHHHHHHHHHHHHHHhh
Q 003978 547 HSFRQEVSLMKRLRHP--NVLLFMGAVTSP----QRLCIVTEFLPRG-SLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619 (782)
Q Consensus 547 ~~~~~Ei~il~~l~Hp--nIv~l~~~~~~~----~~~~lv~E~~~gg-sL~~~l~~~~~~l~~~~~~~i~~qll~aL~~L 619 (782)
.+..+|...+..|..- .++..+++.+.. ...+||+|++++. +|.+++..... .+......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 4567788877776422 234555555432 2458999999874 79999876332 55667778889999999999
Q ss_pred hcCCCCeeecCCCCCcEEEcCCC---cEEEEecCCCcc
Q 003978 620 HHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRL 654 (782)
Q Consensus 620 H~~~~~ivHrDIKp~NILl~~~~---~vkL~DFGla~~ 654 (782)
|..| |+|+|+++.||||+.++ .+.|+||+-++.
T Consensus 135 H~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999 99999999999999887 899999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02938 nifL_nitrog nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.6e-07 Score=107.57 Aligned_cols=153 Identities=8% Similarity=0.032 Sum_probs=100.7
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEE-EEEEE
Q 003978 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT-GQFPA 207 (782)
Q Consensus 129 ~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~-~e~~~ 207 (782)
...++.++++++++|+++|.+|+|+++|+++++++|+...+..+..+..++.+.... .+......+..+. .+...
T Consensus 129 ~~~~~~~~~~~~~~i~~~d~~~~i~~~N~~~~~~~g~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 204 (494)
T TIGR02938 129 KLLIESVVDAAPVAFVLLDPTGRVILDNQEYKKLATDLRVKEPAHTVLDLLREAWRE----ALAENWPQQLAFSNREARF 204 (494)
T ss_pred HHHHHHHHhcccceEEEEcCCCCEEEechhHHHhhchhhhhHHHHHHHHHhhHHhhh----hhhhcchhhhccccceeee
Confidence 356789999999999999999999999999999999998888777665555433211 1111111222222 23344
Q ss_pred EcCCCC-EEEEEEEEEEEECCCCCE---------EEEEEEEEehhHHHHHHHHHHHhhccc---cccccCCchhHHHHHh
Q 003978 208 KTKTEE-RVLVVATNTPFYDDDGTL---------VGIVCVSTDSRPFQETRAALWDTKNSD---TDSNINRPRNTVTAKL 274 (782)
Q Consensus 208 ~~kdG~-~~~v~~~~~Pi~d~~G~v---------~g~v~i~rDITerk~~E~~L~~~~~~~---~~~~i~~~~~gl~~~l 274 (782)
...+|. .+|+.....|+.+.+|.+ .+++++++|||++|+.|++++....++ .........+ ++...
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~DITe~k~~ee~l~~~al~~~~~~~~~~~~l~~-~~~~~ 283 (494)
T TIGR02938 205 DRGGGRPARWLSCTGSVIGMESDCADSFFCAAEQPYLLLTIADISNLREEQERARLSALQALMAEEERLEAIRE-TLSAA 283 (494)
T ss_pred ccCCCceeeEEEecCceEEeecchhhheeccCCCchheehHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-HHHHH
Confidence 445554 789999888887666543 345678999999999998775432221 1111112222 45566
Q ss_pred CCCchhHHHHHH
Q 003978 275 GLDSQQPLQATI 286 (782)
Q Consensus 275 ~~d~~qpL~~~i 286 (782)
.|++++||+.+.
T Consensus 284 ~h~lr~pL~~i~ 295 (494)
T TIGR02938 284 IHRLQGPMNLIS 295 (494)
T ss_pred HHHHhcHHHHHH
Confidence 699999997743
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.7e-06 Score=85.29 Aligned_cols=138 Identities=17% Similarity=0.097 Sum_probs=100.5
Q ss_pred ccCCcEEEEEEEEcCCeEEEEEEeccCC---C-HHHHHHHHHHHHHHHhCCCC--ceeEEeeeee--cC--CceeEEEee
Q 003978 514 GQGSCGTVYHAVWYGSDVAVKVFSRQEY---S-DEVIHSFRQEVSLMKRLRHP--NVLLFMGAVT--SP--QRLCIVTEF 583 (782)
Q Consensus 514 G~G~~G~Vy~~~~~~~~vAiK~~~~~~~---~-~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~--~~--~~~~lv~E~ 583 (782)
|+|+.+.|+...+.|..+-+|.-..... . +--...|.+|+..|+.|..- .+++++.... .+ ...+||+|-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 6799999999998888888886531100 0 11236788899998888422 2444442211 11 235799998
Q ss_pred cCC-CCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc--EEEEecCCCc
Q 003978 584 LPR-GSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT--VKVGDFGLSR 653 (782)
Q Consensus 584 ~~g-gsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~--vkL~DFGla~ 653 (782)
++| -+|.+++.... .+.+......++.+++..+.-||+.| +.|+|+-+.||+++.++. |+++||.-++
T Consensus 107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 854 48999886532 34567777788999999999999999 999999999999986667 9999998665
|
|
| >COG3852 NtrB Signal transduction histidine kinase, nitrogen specific [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.2e-06 Score=88.07 Aligned_cols=137 Identities=20% Similarity=0.155 Sum_probs=105.0
Q ss_pred HHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEE-EEEEEcCC
Q 003978 133 LNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTG-QFPAKTKT 211 (782)
Q Consensus 133 ~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~-e~~~~~kd 211 (782)
..+|+++..+|+++|.+|.|.|+|++|+.+||.+...+.|..+..+++.... ...-+.++...+.++.. ++.+. .+
T Consensus 10 ~~~Ln~~~~pVl~vd~~~~i~yaN~aAe~~~~~Sa~~L~~~~l~~l~~~gs~--ll~ll~q~~~~~~~~~~~~v~l~-~~ 86 (363)
T COG3852 10 GAILNNLINPVLLVDDELAIHYANPAAEQLLAVSARRLAGTRLSELLPFGSL--LLSLLDQVLERGQPVTEYEVTLV-IL 86 (363)
T ss_pred HhHHhccCCceEEEcCCCcEEecCHHHHHHHHHHHHHHhcCChHHHcCCCcH--HHHHHHHHHHhcCCcccceeeee-ec
Confidence 4689999999999999999999999999999999999999999999987754 23345667777776533 44444 78
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhhccccccccCCchhHHHHHhCCCchhHH
Q 003978 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPL 282 (782)
Q Consensus 212 G~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~i~~~~~gl~~~l~~d~~qpL 282 (782)
|....+++++.|+-...|- ++..+..+....++.+++.+.... .+..++...++|+++.||
T Consensus 87 g~~~~v~~~v~~v~~~~G~---vlle~~~~~~~~ridre~~q~a~~-------~a~~~L~r~LAHEIKNPL 147 (363)
T COG3852 87 GRSHIVDLTVAPVPEEPGS---VLLEFHPRDMQRRLDREQTQHAQQ-------RAVKGLVRGLAHEIKNPL 147 (363)
T ss_pred CccceEEEEEeeccCCCCe---EEEEechhHHHhHhhHHHHHHHHH-------HHHHHHHHHHHHHhcCcc
Confidence 9999999999999876764 567788888777777765443221 233456777777776666
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.38 E-value=4.2e-06 Score=85.20 Aligned_cols=140 Identities=16% Similarity=0.140 Sum_probs=94.6
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCH-HHHHH------HHHHHHHHHhC---CCCceeEEeeee
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSD-EVIHS------FRQEVSLMKRL---RHPNVLLFMGAV 571 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~-~~~~~------~~~Ei~il~~l---~HpnIv~l~~~~ 571 (782)
+...+|++.+.+-......|.+....+..+++|..+...... ..... ..+.+..+..+ .-..++.++.+.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 455789999999888888999999999999999876543221 11111 22233333333 222333333333
Q ss_pred ec-----CCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEE
Q 003978 572 TS-----PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKV 646 (782)
Q Consensus 572 ~~-----~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL 646 (782)
+. -...+|+|||++|..|.++.. +++ .+...+..++.-||+.| ++|+|..|.|++++++ .+++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~-~i~i 175 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNN-GIRI 175 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECC-cEEE
Confidence 22 234568999999988866542 222 13345677889999999 9999999999999976 5999
Q ss_pred EecCCCc
Q 003978 647 GDFGLSR 653 (782)
Q Consensus 647 ~DFGla~ 653 (782)
+||+..+
T Consensus 176 ID~~~k~ 182 (229)
T PF06176_consen 176 IDTQGKR 182 (229)
T ss_pred EECcccc
Confidence 9998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.37 E-value=4e-06 Score=86.98 Aligned_cols=136 Identities=15% Similarity=0.205 Sum_probs=83.9
Q ss_pred eeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCc--eeEEeeeeecCCceeEEEeecCCCC
Q 003978 511 EQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN--VLLFMGAVTSPQRLCIVTEFLPRGS 588 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lv~E~~~ggs 588 (782)
.+||.|..+.||+. .+..+++|+..... .. ..+.+|.++++.+..-. +++.+.+....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-~~---~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-DK---ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC-CH---HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 56899999999984 36678899876533 22 34577999998875332 4677777777777889999998863
Q ss_pred -HHHHH--------------hh-----cCC---cchHHHHHH-HHH----------HHHH-HHHhh--hcCCCCeeecCC
Q 003978 589 -LFRLL--------------QR-----NTT---KLDWRRRIL-MAL----------DIAR-GVSYL--HHCNPPIIHRDL 631 (782)
Q Consensus 589 -L~~~l--------------~~-----~~~---~l~~~~~~~-i~~----------qll~-aL~~L--H~~~~~ivHrDI 631 (782)
+...+ .. +.. ......... +.. .+.. ...+| +.....++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 00 000 001000000 000 0001 11111 222334799999
Q ss_pred CCCcEEEcCCCcEEEEecCCCc
Q 003978 632 KSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 632 Kp~NILl~~~~~vkL~DFGla~ 653 (782)
.|.||+++.++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999988 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.1e-06 Score=86.99 Aligned_cols=140 Identities=18% Similarity=0.219 Sum_probs=82.7
Q ss_pred eeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCC--ceeEEeeeee---cCCceeEEEeec
Q 003978 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP--NVLLFMGAVT---SPQRLCIVTEFL 584 (782)
Q Consensus 510 ~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~---~~~~~~lv~E~~ 584 (782)
++.|+.|..+.||++...+..+++|+.... .....+.+|..+++.+... .+++++.... .....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 467999999999999998889999997543 3446677888888887422 3556665432 223468999999
Q ss_pred CCCCHHH----------------HHh---hc--C-CcchH-H--------HHHHH------------HHHHHH-HHHhhh
Q 003978 585 PRGSLFR----------------LLQ---RN--T-TKLDW-R--------RRILM------------ALDIAR-GVSYLH 620 (782)
Q Consensus 585 ~ggsL~~----------------~l~---~~--~-~~l~~-~--------~~~~i------------~~qll~-aL~~LH 620 (782)
+|..+.. .+. .. . ..+.. . ..... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9987777 111 00 0 00000 0 00000 011111 223333
Q ss_pred c-----CCCCeeecCCCCCcEEEc-CCCcEEEEecCCCc
Q 003978 621 H-----CNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSR 653 (782)
Q Consensus 621 ~-----~~~~ivHrDIKp~NILl~-~~~~vkL~DFGla~ 653 (782)
. ....++|+|+.|.|||++ .++.|.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1 223499999999999999 66777899998775
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG3290 CitA Signal transduction histidine kinase regulating citrate/malate metabolism [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=2.4e-06 Score=95.81 Aligned_cols=114 Identities=21% Similarity=0.314 Sum_probs=93.8
Q ss_pred HHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChh--hHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEc
Q 003978 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAE--EALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (782)
Q Consensus 132 ~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~e--EliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~ 209 (782)
-.++|+++.+||+.+|+.|.|..+|.+|++|+|+... +.+|+++.++++|..+ +...++.+++...+...+
T Consensus 217 r~A~l~si~EGviAvd~~G~It~~N~~A~~ll~~~~~~~~~ig~~i~~v~~p~~~------l~~vl~~~~~~~~~e~~~- 289 (537)
T COG3290 217 RQAMLQSIKEGVIAVDKKGVITLINQAAQKLLGLRQPSGDPIGRSIVEVLPPDSD------LPEVLETGKPQHDEEIRI- 289 (537)
T ss_pred HHHHHHHhhceEEEECCCCeEeehhHHHHHHhcccCcCcccccccceEeeccccC------cHHHHhcCCcccchhhhc-
Confidence 3467899999999999999999999999999999765 7999999999997544 556678888765544322
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhhc
Q 003978 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKN 256 (782)
Q Consensus 210 kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~ 256 (782)
+| .++.++..||+ .+|+++|+|..|||-|+.+++-++|...++
T Consensus 290 -ng--~~~i~nr~pI~-~~~~~~GaI~tFRdktei~~L~eqLt~vr~ 332 (537)
T COG3290 290 -NG--RLLVANRVPIR-SGGQIVGAIITFRDKTEIKKLTEQLTGVRQ 332 (537)
T ss_pred -CC--eEEEEEeccEE-ECCEEeEEEEEEecHHHHHHHHHHHHHHHH
Confidence 34 46678888998 678999999999999999999999976554
|
|
| >KOG0501 consensus K+-channel KCNQ [Inorganic ion transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.2e-06 Score=94.93 Aligned_cols=117 Identities=15% Similarity=0.185 Sum_probs=97.1
Q ss_pred HHHHHHHHHcC--ceeEEEc-C---CCcEEEecHHHHHHhCCChhhHcCCCcc--ccccccccccHHHHHHHHHHcCCeE
Q 003978 130 RQYLNILQSMG--QSVHIFD-L---SDRIIYWNRSAELLYGYSAEEALGQDAI--ELLTDGRDFDVAYDIVHRIKMGERW 201 (782)
Q Consensus 130 ~~~~~ile~~~--d~I~v~D-~---dG~Ii~vN~aae~l~Gys~eEliG~~~~--~l~~~~~~~~~~~~l~~~l~~g~~~ 201 (782)
-+++.|+.-.. |.-+++. . |-.|+|+|+.||++.||.+.|+..++|. .+++...+......+.+.++.-+.-
T Consensus 14 TFLENiiRRsn~~dtsFlL~NAQiVD~PiVY~NdgFcKlsGY~RAevMQKs~tc~FMyGEltdk~ti~k~~~t~eN~~~~ 93 (971)
T KOG0501|consen 14 TFLENIIRRSNNADTSFLLANAQIVDWPIVYCNDGFCKLSGYHRAEVMQKSCTCSFMYGELTDKGTIEKVRQTLENYETN 93 (971)
T ss_pred hHHHHHHhhccCCCcceeeccceeeccceEEecCcchhccCccHHHHhcccceeeeeeccccchhhHHHHHHHHHhhhhc
Confidence 45777766554 5545433 2 5789999999999999999999998865 3445555566777888889888888
Q ss_pred EEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHH
Q 003978 202 TGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246 (782)
Q Consensus 202 ~~e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~ 246 (782)
..++.++.|+....|+.+.+.||+++...|+-+++.|+|||..|+
T Consensus 94 qfEillyKKN~TPvW~~vqiAPIrNe~d~VVLfLctFkDIT~~KQ 138 (971)
T KOG0501|consen 94 QFEILLYKKNRTPVWLLVQIAPIRNEKDKVVLFLCTFKDITALKQ 138 (971)
T ss_pred ceeeEeeecCCCceEEEEEeecccCCCceEEEEEeecccchhhcC
Confidence 889999999999999999999999999999999999999999874
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.7e-06 Score=97.72 Aligned_cols=151 Identities=23% Similarity=0.264 Sum_probs=94.3
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc-CCeEEEEEEeccC---------------------------CC-----HHHHH
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQE---------------------------YS-----DEVIH 547 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~-~~~vAiK~~~~~~---------------------------~~-----~~~~~ 547 (782)
+..+..|.. +.|+.++-|.||+|+.. |+.||||+.++.- +. ++..+
T Consensus 122 ee~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 122 EELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred HHHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 334444542 68999999999999986 8999999975421 11 11112
Q ss_pred H------HHHHHHHHHhCC-----CCceeEEeeeeecCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHH
Q 003978 548 S------FRQEVSLMKRLR-----HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 616 (782)
Q Consensus 548 ~------~~~Ei~il~~l~-----HpnIv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL 616 (782)
. +.+|...+..++ .++|.-..=+++--..-.|+|||++|..+.+...-....++...+.....++.-
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~-- 278 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFL-- 278 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHH--
Confidence 2 333444444442 344433223333334558999999999888885322233443433333322221
Q ss_pred HhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 617 ~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
..+=..| ++|.|..|.||+++.+|++.+.|||+.....
T Consensus 279 ~q~~~dg--ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 279 RQLLRDG--FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHHhcC--ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 2222347 9999999999999999999999999976443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.7e-07 Score=106.05 Aligned_cols=234 Identities=20% Similarity=0.217 Sum_probs=153.5
Q ss_pred eeeccCCcEEEEEEEEcCCe-EEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCc-eeEEeeeeecCCceeEEEeecCCC-
Q 003978 511 EQIGQGSCGTVYHAVWYGSD-VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-VLLFMGAVTSPQRLCIVTEFLPRG- 587 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~~~~-vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lv~E~~~gg- 587 (782)
..+++|+++++||.+...+. ...+++... ....-++++|.+++||| .+..++-++.+...++.|+++.++
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 44689999999998754332 224444322 33455899999999999 777777777788899999999876
Q ss_pred CHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCCC
Q 003978 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667 (782)
Q Consensus 588 sL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~G 667 (782)
+....+......+..-....+.+.-++++++||+.- =+|+| ||+..+ +.+++.||+......... ...+..+
T Consensus 321 s~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~~~ 392 (829)
T KOG0576|consen 321 SSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRTAIG 392 (829)
T ss_pred cccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCccc-ccccCCC
Confidence 332222222222334444556667778999999863 48888 777766 589999999876555443 4456789
Q ss_pred CCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCC--CCCHHHH-HHHHHhhhh
Q 003978 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK--DVDPRWA-AIVESCWHS 744 (782)
Q Consensus 668 t~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~~~l~-~LI~~cL~~ 744 (782)
++.+++||+.....+....|.|++|.-..+|--|.+|-... ......+......+.+.. .+++... ++...|+..
T Consensus 393 ~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g 470 (829)
T KOG0576|consen 393 TPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNG 470 (829)
T ss_pred CCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCC--ccccCCCCCCCCccccchhhhcCcccccCCcccccCC
Confidence 99999999999999999999999999888888887775431 111111111110111111 1112222 366777887
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHh
Q 003978 745 DPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 745 dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
-|..|+..-.. +.+++|
T Consensus 471 ~P~~pkv~mga------cfsKvf 487 (829)
T KOG0576|consen 471 LPPTPKVHMGA------CFSKVF 487 (829)
T ss_pred CCCCCcchhhH------HHHHHh
Confidence 78777776655 445555
|
|
| >PRK15053 dpiB sensor histidine kinase DpiB; Provisional | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.9e-05 Score=92.57 Aligned_cols=114 Identities=19% Similarity=0.203 Sum_probs=82.6
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCCh--hhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEE
Q 003978 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSA--EEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPA 207 (782)
Q Consensus 130 ~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~--eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~ 207 (782)
+.++.+++++.+||+++|.+|+|+++|++|++++|+.. ++++|+++.+++++... +..... .......
T Consensus 222 ~~~~~il~~~~egii~~D~~g~I~~~N~~a~~ll~~~~~~~~~~g~~~~~~~~~~~~------~~~~~~-~~~~~~~--- 291 (545)
T PRK15053 222 RQQEALFSSVYEGLIAVDPHGYITAINRNARKMLGLSSPGRQWLGKPIAEVVRPADF------FTEQID-EKRQDVV--- 291 (545)
T ss_pred HHHHHHHHHhCceEEEECCCCeEEeecHHHHHHhCCCCcchhhcCCcHHHhCCCchh------hhhhcC-CcccceE---
Confidence 34567899999999999999999999999999999975 57999999888764321 111111 1111111
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhhc
Q 003978 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKN 256 (782)
Q Consensus 208 ~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~ 256 (782)
...+| ..+.++..|+.. +|++.|++.+++|+|+.++++.++.....
T Consensus 292 ~~~~~--~~~~~~~~~i~~-~~~~~G~v~~~~d~te~~~l~~~l~~~~~ 337 (545)
T PRK15053 292 ANFNG--LSVIANREAIRS-GDDLLGAIISFRSKDEISTLNAQLTQIKQ 337 (545)
T ss_pred EEECC--EEEEEEeeeEEE-CCeEEEEEEEEEchHHHHHHHHHHHHHHH
Confidence 12244 345577788875 56788999999999999998888766543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.9e-05 Score=82.68 Aligned_cols=136 Identities=18% Similarity=0.187 Sum_probs=84.2
Q ss_pred eccCCc-EEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCceeEEEeecCCCCHH
Q 003978 513 IGQGSC-GTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 590 (782)
Q Consensus 513 IG~G~~-G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~E~~~ggsL~ 590 (782)
|-.|.+ ..||++...+..+.||+..... ...+.+|+++++.+. +--+++++++....+..++|||+++|.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 444555 7899998777788999875442 234567888888874 334667888777667789999999987765
Q ss_pred HHHh----------------h-cC-----CcchHH--HHHHH-----------------------HHHHHHHHHhhh--c
Q 003978 591 RLLQ----------------R-NT-----TKLDWR--RRILM-----------------------ALDIARGVSYLH--H 621 (782)
Q Consensus 591 ~~l~----------------~-~~-----~~l~~~--~~~~i-----------------------~~qll~aL~~LH--~ 621 (782)
.... + +. .++... ..+.. ..++...|.... .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4320 0 00 011100 00000 111111111110 1
Q ss_pred CCCCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 622 ~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
....++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12348999999999999998778899999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF14598 PAS_11: PAS domain; PDB: 1P97_A 3F1O_A 2A24_A 3H7W_A 3F1P_A 3H82_A 3F1N_A 4F3L_B 4DJ3_A 2KDK_A | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.6e-05 Score=70.61 Aligned_cols=95 Identities=22% Similarity=0.307 Sum_probs=78.2
Q ss_pred EEcCCCcEEEecHH-HHHHhCCChhhHcCCCcccccccccccc-HHHHHHHHHHcCCeEEEEEEEEcCCCCEEEEEEEEE
Q 003978 145 IFDLSDRIIYWNRS-AELLYGYSAEEALGQDAIELLTDGRDFD-VAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNT 222 (782)
Q Consensus 145 v~D~dG~Ii~vN~a-ae~l~Gys~eEliG~~~~~l~~~~~~~~-~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~v~~~~~ 222 (782)
-.+.+|+|+++-.. ...++||.++|++|+.+.+++++++... ........+..|+....-+++..++|..+|+.....
T Consensus 7 rhs~dgki~~~d~~~v~~~lgy~~~eLvG~s~y~~~H~~D~~~~~~~~~~~~~~~g~~~~~~yR~~~k~g~~vwvqt~~~ 86 (111)
T PF14598_consen 7 RHSLDGKITYVDSRAVSSLLGYLPEELVGRSIYDFVHPDDLQRVLKQHHREVLQKGQSVSPYYRFRTKNGGYVWVQTKAT 86 (111)
T ss_dssp EEETTSBEEEEETTHHHHHHSS-HHHHTTSBGGGGBSCCTHHHHHHHHHHHHHHHSSEEEEEEEEE-TTSSEEEEEEEEE
T ss_pred EECCCcEEEEEcCccChhhcCCCcHHHcCCchHHhCCHhhhhhHHHHHHHHHhhCCCcCcceEEEEecCCcEEEEEEEEE
Confidence 36789999999999 5999999999999999999999998764 555677888999988888999999999999999999
Q ss_pred EEECC-CCCEEEEEEEEE
Q 003978 223 PFYDD-DGTLVGIVCVST 239 (782)
Q Consensus 223 Pi~d~-~G~v~g~v~i~r 239 (782)
++.+. .+++..++++-+
T Consensus 87 ~~~n~~~~~~~~Iv~~n~ 104 (111)
T PF14598_consen 87 LFYNPWTSKPEFIVCTNT 104 (111)
T ss_dssp EEEETTTTCEEEEEEEEE
T ss_pred EEECCCCCCccEEEEEEE
Confidence 99864 446666665544
|
... |
| >PRK09959 hybrid sensory histidine kinase in two-component regulatory system with EvgA; Provisional | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.1e-05 Score=101.14 Aligned_cols=155 Identities=10% Similarity=0.040 Sum_probs=90.0
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCcccccccccc-ccHHHHHHHHHHcCCeEEEEEEEE
Q 003978 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD-FDVAYDIVHRIKMGERWTGQFPAK 208 (782)
Q Consensus 130 ~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~-~~~~~~l~~~l~~g~~~~~e~~~~ 208 (782)
++++.++++++++|+++|.+|+|+++|++|++++|+......+........+-.. .................. .....
T Consensus 576 ~~~~~i~~~~~~~i~~~d~~g~i~~~N~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 654 (1197)
T PRK09959 576 SFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIY-TQVFE 654 (1197)
T ss_pred HHHHHHHhhCCCcEEEEcCCCcEEEehHHHHHHhCcccccccccccccccCchhhhHhHHHHHHHHHhhccccc-eeeEe
Confidence 4578899999999999999999999999999999987543333222211111000 000001111111111111 11222
Q ss_pred cCCCCEEEEEE-EEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhhccccccccCCchhHHHHHhCCCchhHHHHHHH
Q 003978 209 TKTEERVLVVA-TNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIA 287 (782)
Q Consensus 209 ~kdG~~~~v~~-~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~~~~i~~~~~gl~~~l~~d~~qpL~~~i~ 287 (782)
..+|...++.. ...+.....+...++++.++|||++++++++++...++.... ......++..++||++.||..++.
T Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dite~~~~~~~l~~~~~~~~~~--~~~~~~~~~~isHelrtPL~~i~~ 732 (1197)
T PRK09959 655 IDNGIEKRCINHWHTLCNLPASDHAVYICGWQDITETRDLIHALEVERNKAINA--TVAKSQFLATMSHEIRTPISSIMG 732 (1197)
T ss_pred eecCccceeeeeeeeeeccCCCCceEEEEEEEehhHHHHHHHHHHHHHHHHHHH--HHHHHHHHHhcChhhCccHHHHHH
Confidence 33343322222 222222223344678888999999999998887665543222 123455899999999999987543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.4e-05 Score=80.54 Aligned_cols=138 Identities=21% Similarity=0.175 Sum_probs=89.0
Q ss_pred eeccCCcEEEEEEEE-cCCeEEEEEEeccCCC--------------------HHHH--HHHHHHHHHHHhCC--CCceeE
Q 003978 512 QIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYS--------------------DEVI--HSFRQEVSLMKRLR--HPNVLL 566 (782)
Q Consensus 512 ~IG~G~~G~Vy~~~~-~~~~vAiK~~~~~~~~--------------------~~~~--~~~~~Ei~il~~l~--HpnIv~ 566 (782)
.|..|--..||+|.. .+..+|+|+++..... ...+ .=...|+..|+++. +-.+++
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 566677778999886 5788999998643211 1111 11234666676663 334455
Q ss_pred EeeeeecCCceeEEEeecCCCC-HHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCcE
Q 003978 567 FMGAVTSPQRLCIVTEFLPRGS-LFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTV 644 (782)
Q Consensus 567 l~~~~~~~~~~~lv~E~~~ggs-L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~-~~~~ivHrDIKp~NILl~~~~~v 644 (782)
.+.+. ...|||||+.... -.-.|+ ..++....+..+..++++.+.-|-. .+ +||+||..-|||+. ++.+
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-CCeE
Confidence 55554 3479999995431 111111 1123333556666778888877766 66 99999999999999 7799
Q ss_pred EEEecCCCcccccc
Q 003978 645 KVGDFGLSRLKHET 658 (782)
Q Consensus 645 kL~DFGla~~~~~~ 658 (782)
.|+|||-|....++
T Consensus 206 ~iID~~QaV~~~hp 219 (268)
T COG1718 206 YIIDVSQAVTIDHP 219 (268)
T ss_pred EEEECccccccCCC
Confidence 99999988755543
|
|
| >PRK11388 DNA-binding transcriptional regulator DhaR; Provisional | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.3e-05 Score=93.90 Aligned_cols=107 Identities=19% Similarity=0.198 Sum_probs=82.0
Q ss_pred HHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEcCCC
Q 003978 133 LNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTE 212 (782)
Q Consensus 133 ~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG 212 (782)
..+++++.+||+++|.+|+|+++|+++++++|++.++++|+++.++++... .+..++..+............+|
T Consensus 206 ~~il~~~~~gVl~vD~~G~I~~~N~aa~~llg~s~~~l~G~~i~~l~~~~~------~l~~vl~~~~~~~~~~~~l~~~g 279 (638)
T PRK11388 206 NALLESMDDGVIAWDEQGNLQFLNAQAARLLRLDATASQGRAITELLTLPA------VLQQAIKQAHPLKHVEVTFESQG 279 (638)
T ss_pred HHHHhccCCcEEEECCCCeEehhhHHHHHHhCcCHHHHCCCcHHHHhccch------HHHHHHhcCCceeeEEEEEecCC
Confidence 448899999999999999999999999999999999999999999875321 24556777776544333334567
Q ss_pred CEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHH
Q 003978 213 ERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQET 247 (782)
Q Consensus 213 ~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~ 247 (782)
..+++.+++.|+.+..| .+++.+++|++..++.
T Consensus 280 ~~~~~~v~~~Pi~~~~g--~~~v~~l~~~~~~~~~ 312 (638)
T PRK11388 280 QFIDAVITLKPIIEGQG--TSFILLLHPVEQMRQL 312 (638)
T ss_pred ceEEEEEEEEeecccCc--eEEEEEehhhHHHHHH
Confidence 77788999999975444 3466677888776543
|
|
| >COG2202 AtoS FOG: PAS/PAC domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=7e-05 Score=71.33 Aligned_cols=116 Identities=25% Similarity=0.442 Sum_probs=89.5
Q ss_pred HHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHc--CCeEEEEEEEE
Q 003978 131 QYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKM--GERWTGQFPAK 208 (782)
Q Consensus 131 ~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~--g~~~~~e~~~~ 208 (782)
.++.++++++++++++|.+|.|+++|+++++++||+..+.++.....+................... ......+....
T Consensus 113 ~~~~~~~~~~~~~~~~d~~~~~~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (232)
T COG2202 113 RLRALLEASPDGIWVLDEDGRILYANPAAEELLGYSPEEELGRGLSDLIHPEDEERRELELARALAEGRGGPLEIEYRVR 192 (232)
T ss_pred HHHHHHhhCCceEEEEeCCCCEEEeCHHHHHHhCCChHHhcCCChhheEecCCCchhhHHHHHHhhccCCCCcceEEEEE
Confidence 3778999999999999999999999999999999998888888877776544432111122233333 33467788888
Q ss_pred cCCCCE-EEEEEEEEEEECCCCCEEEEEEEEEehhHHHHH
Q 003978 209 TKTEER-VLVVATNTPFYDDDGTLVGIVCVSTDSRPFQET 247 (782)
Q Consensus 209 ~kdG~~-~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~ 247 (782)
.++|.. .++.....+... +|.+.+++....|++++++.
T Consensus 193 ~~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~~~~~~ 231 (232)
T COG2202 193 RKDGERVRWILSRISPVRD-DGEIVGVVGIARDITERKQA 231 (232)
T ss_pred ecCCCEEEEEEeeeeEecC-CCceEEEEEEEechHHHhhc
Confidence 999996 888888777764 78899999999999998764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 782 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-94 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-94 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-44 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-43 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-43 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-43 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-40 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-40 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-40 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-40 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-40 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-40 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-40 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-40 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-40 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-39 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-39 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-37 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-36 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-36 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-36 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-36 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-36 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-35 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-35 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-35 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-35 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-35 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-35 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-35 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-35 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-35 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-35 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-35 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-35 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-35 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-35 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-35 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-35 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-34 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-34 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-34 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-34 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-34 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-34 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-34 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-34 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-34 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-34 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-34 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-34 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-33 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-33 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-33 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-33 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-33 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-33 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-33 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-33 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-33 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-33 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-33 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-33 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-33 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-33 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-33 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-33 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-33 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-33 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-33 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-33 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-33 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-33 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-33 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-33 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-33 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-33 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-33 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-33 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-32 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-32 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-32 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-32 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-32 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-32 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-32 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-32 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-32 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-32 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-32 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-32 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-32 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-32 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-32 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-32 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-32 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-32 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-32 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-32 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-32 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-32 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-32 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-31 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-31 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-31 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-31 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-31 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-30 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-30 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-30 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-30 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-30 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-30 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-30 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-30 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-30 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-30 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-30 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-30 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-30 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-30 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-30 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-30 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-29 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-29 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-29 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-29 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-29 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-29 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-29 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-29 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-29 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-29 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-29 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-29 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-29 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-29 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-29 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-29 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-29 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-29 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-29 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-29 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-29 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-29 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-29 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-29 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-29 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-29 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-29 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-29 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-29 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-29 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-29 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-29 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-29 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-29 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-29 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-29 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-29 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-28 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-28 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-28 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-28 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-28 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-28 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-28 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-28 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-28 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-28 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-28 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-28 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-28 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-28 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-28 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-28 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-28 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-28 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-28 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-28 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-28 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-28 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-28 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-28 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-28 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-28 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-28 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-28 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-28 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-28 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-27 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-27 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-27 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-27 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-27 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-27 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-27 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-27 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-27 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-27 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-27 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-27 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-27 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-27 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-27 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-27 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-27 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-27 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-27 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-27 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-27 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-27 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-27 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-27 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-27 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-27 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-27 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-27 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-27 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-27 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-27 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-27 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-27 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-26 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-26 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-26 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-26 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-26 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-26 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-26 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-26 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-26 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-26 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-26 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-26 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-26 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-26 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-26 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-26 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-26 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-26 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-26 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-26 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-25 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-25 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-25 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-25 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-25 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-25 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-25 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-25 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-25 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-25 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-25 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-25 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-25 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-25 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-25 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-25 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-25 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-25 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-25 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-25 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-25 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-24 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-24 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-24 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-24 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-24 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-24 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-24 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-24 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-24 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-24 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-24 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-24 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-24 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-24 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-24 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-24 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-24 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-24 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-24 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-24 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-24 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-24 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-24 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-24 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-24 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-24 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-24 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-24 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-24 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-24 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-23 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-23 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-23 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-23 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-23 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-23 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-23 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-23 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-23 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-23 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-23 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-23 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-23 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-23 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-23 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-23 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-23 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-23 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-23 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-23 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-23 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-23 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-23 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-23 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-23 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-23 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-22 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-22 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-22 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-22 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-22 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-22 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-22 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-22 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-22 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-22 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-22 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-22 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-22 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-22 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-22 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-22 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-22 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-22 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-22 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-22 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-22 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-22 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-22 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-22 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-22 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-22 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-22 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-22 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-22 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-22 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-22 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-22 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-21 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-21 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-21 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-21 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-21 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-21 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-21 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-21 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-21 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-21 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-21 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-21 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-21 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-21 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-21 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-21 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-21 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-21 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-21 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-21 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-21 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-21 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-21 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-21 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-21 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-21 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-21 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-21 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-21 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-21 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-21 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-21 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-21 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-21 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-21 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-21 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-21 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-21 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-21 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-21 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-21 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-21 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-21 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-21 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-21 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-21 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-21 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-21 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-21 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-21 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-21 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-21 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-21 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-21 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-21 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-21 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-20 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-20 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-20 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-20 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-20 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-20 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-20 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-20 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-20 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-20 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-20 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-20 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-20 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-20 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-20 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-20 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-20 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-20 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-20 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-20 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-20 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-19 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-19 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-19 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-19 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-19 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-19 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-19 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-19 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-19 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-19 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-19 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-19 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-19 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-19 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-18 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-18 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-18 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-18 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-18 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-18 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-18 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-18 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-18 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-18 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-18 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-18 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-18 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-17 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-17 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-17 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-17 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-17 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-17 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-17 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-17 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-17 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-16 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-16 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-16 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-16 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-16 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-16 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-16 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-16 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-15 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-15 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-15 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-15 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-15 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-15 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-15 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-15 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-14 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-14 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-14 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-14 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-14 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-14 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-14 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-14 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-14 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-14 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-14 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-13 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-13 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-13 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-13 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-13 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-13 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-13 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-13 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-13 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-13 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-12 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-11 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-11 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-11 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-10 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 9e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 464 bits (1197), Expect = e-160
Identities = 166/296 (56%), Positives = 219/296 (73%), Gaps = 3/296 (1%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEY 541
++ D D +I W DL I E+IG GS GTV+ A W+GSDVAVK+ Q++
Sbjct: 14 DIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF 73
Query: 542 SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-- 599
E ++ F +EV++MKRLRHPN++LFMGAVT P L IVTE+L RGSL+RLL ++ +
Sbjct: 74 HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ 133
Query: 600 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659
LD RRR+ MA D+A+G++YLH+ NPPI+HR+LKS NLLVDK +TVKV DFGLSRLK T+
Sbjct: 134 LDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193
Query: 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF 719
L++K+ GTP+WMAPEVLR+EPS+EKSDVYSFGVILWELAT + PW NLN QV+ AVGF
Sbjct: 194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF 253
Query: 720 MNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF-QASRSTV 774
+RLEIP++++P+ AAI+E CW ++P RPSF ++D LR L + +RS +
Sbjct: 254 KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 430 bits (1107), Expect = e-147
Identities = 77/271 (28%), Positives = 138/271 (50%), Gaps = 11/271 (4%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
I ++ L ++ + G ++ W G+D+ VKV +++S F +E ++
Sbjct: 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 561 HPNVLLFMGAVTSP--QRLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVS 617
HPNVL +GA SP ++T ++P GSL+ +L T +D + + ALD+ARG++
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL 677
+LH P I L S ++++D+ T ++ + P W+APE L
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-----GRMYAPAWVAPEAL 180
Query: 678 RNEPSD---EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734
+ +P D +D++SF V+LWEL T ++P+ +L++M++ V R IP + P
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV 240
Query: 735 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765
+ +++ C + DP RP F +V L +Q +
Sbjct: 241 SKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 426 bits (1097), Expect = e-145
Identities = 104/273 (38%), Positives = 148/273 (54%), Gaps = 15/273 (5%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVF--SRQEYSDEVIHSFRQEVSLMKR 558
EI + +LT+ E IG G G VY A W G +VAVK E + I + RQE L
Sbjct: 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
L+HPN++ G LC+V EF G L R+L ++ + A+ IARG++Y
Sbjct: 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNY 120
Query: 619 LHHCNP-PIIHRDLKSSNLLVDK--------HWTVKVGDFGLSRLKHETYLTTKTGKGTP 669
LH PIIHRDLKSSN+L+ + + +K+ DFGL+R H T T + G
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAAGAY 178
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKD 729
WMAPEV+R + SDV+S+GV+LWEL T ++P+ ++ + V V L IP
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238
Query: 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
+A ++E CW+ DP RPSF ++D+L +
Sbjct: 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 412 bits (1060), Expect = e-139
Identities = 89/280 (31%), Positives = 138/280 (49%), Gaps = 21/280 (7%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-----EVIHSFRQ 551
+ ++ +QIG+G G V+ S VA+K + E F++
Sbjct: 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD 611
EV +M L HPN++ G + +P +V EF+P G L+ L + W ++ + LD
Sbjct: 73 EVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDK-----HWTVKVGDFGLSRLKHETYLTTKTGK 666
IA G+ Y+ + NPPI+HRDL+S N+ + KV DFGLS+ +
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLL 187
Query: 667 GTPQWMAPEVL--RNEPSDEKSDVYSFGVILWELATEKIPWDNLNS--MQVIGAVGFMNQ 722
G QWMAPE + E EK+D YSF +IL+ + T + P+D + ++ I +
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247
Query: 723 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
R IP+D PR ++E CW DP+ RP F +V +L +L
Sbjct: 248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 411 bits (1059), Expect = e-139
Identities = 103/276 (37%), Positives = 165/276 (59%), Gaps = 13/276 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
D+EI +T+G++IG GS GTVY W+G DVAVK+ + + + + +F+ EV ++++
Sbjct: 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRK 76
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
RH N+LLFMG T+PQ L IVT++ SL+ L + TK + ++ I +A ARG+ Y
Sbjct: 77 TRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEV 676
LH + IIHRDLKS+N+ + + TVK+GDFGL+ K + G+ WMAPEV
Sbjct: 136 LHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193
Query: 677 LRNE---PSDEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFMNQR---LEIPKD 729
+R + P +SDVY+FG++L+EL T ++P+ N+N+ Q+I VG + ++ +
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253
Query: 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765
R ++ C RPSF ++ ++ +L R+
Sbjct: 254 CPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 409 bits (1052), Expect = e-138
Identities = 87/311 (27%), Positives = 155/311 (49%), Gaps = 22/311 (7%)
Query: 474 TSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAV 533
S +S+ ++ + L +++I +E L IGE IG+G G VYH W+G +VA+
Sbjct: 6 LSLLSARSFPRKASQTSIFLQ----EWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAI 60
Query: 534 KVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL 593
++ + +++ + +F++EV ++ RH NV+LFMGA SP L I+T +L+ ++
Sbjct: 61 RLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV 120
Query: 594 QRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+ LD + +A +I +G+ YLH I+H+DLKS N+ D + V + DFGL
Sbjct: 121 RDAKIVLDVNKTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NGKVVITDFGLFS 177
Query: 654 LKHETYLTTKTGK-----GTPQWMAPEVLRN---------EPSDEKSDVYSFGVILWELA 699
+ + K G +APE++R P + SDV++ G I +EL
Sbjct: 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237
Query: 700 TEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 759
+ P+ + +I +G + + + I+ CW + + RP+F +L+D L
Sbjct: 238 AREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297
Query: 760 RDLQRQYFQAS 770
L ++ + S
Sbjct: 298 EKLPKRNRRLS 308
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 403 bits (1038), Expect = e-136
Identities = 85/272 (31%), Positives = 133/272 (48%), Gaps = 14/272 (5%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 559
+ I ++++ + E +G+G+ G V A W DVA+K + F E+ + R+
Sbjct: 3 HMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKA----FIVELRQLSRV 58
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL--QRNTTKLDWRRRILMALDIARGVS 617
HPN++ GA +P +C+V E+ GSL+ +L + L ++GV+
Sbjct: 59 NHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 618 YLHHCNP-PIIHRDLKSSNLLVDKHWTV-KVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
YLH P +IHRDLK NLL+ TV K+ DFG + KG+ WMAPE
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPE 173
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN-SMQVIGAVGFMNQRLEIPKDVDPRW 734
V EK DV+S+G+ILWE+ T + P+D + I R + K++
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 735 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766
+++ CW DP RPS +E+V + L R +
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 399 bits (1027), Expect = e-134
Identities = 87/280 (31%), Positives = 131/280 (46%), Gaps = 17/280 (6%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
DL GE +G+G G + + + + +E +F +EV +M+ L
Sbjct: 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE 65
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
HPNVL F+G + +RL +TE++ G+L +++ ++ W +R+ A DIA G++YLH
Sbjct: 66 HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--------------KHETYLTTKTGK 666
N IIHRDL S N LV ++ V V DFGL+RL K T
Sbjct: 126 SMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLE 725
G P WMAPE++ DEK DV+SFG++L E+ + + +
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY 243
Query: 726 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765
P + P + I C DP+ RPSF +L L L+
Sbjct: 244 CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 365 bits (940), Expect = e-121
Identities = 86/334 (25%), Positives = 137/334 (41%), Gaps = 52/334 (15%)
Query: 473 STSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVA 532
S S S S + L + + + + +QIG+G G V+ W G VA
Sbjct: 12 RDLIEQSQSSGSGSGLPL-------LVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVA 64
Query: 533 VKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----RLCIVTEFLPRGS 588
VKVF E + E+ +RH N+L F+ A +L ++T++ GS
Sbjct: 65 VKVFFTTEEASWF---RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGS 121
Query: 589 LFRLLQRNTTKLDWRRRILMALDIARGVSYLH------HCNPPIIHRDLKSSNLLVDKHW 642
L+ L+ T LD + + +A G+ +LH P I HRDLKS N+LV K+
Sbjct: 122 LYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179
Query: 643 TVKVGDFGLSRL----KHETYLTTKTGKGTPQWMAPEVL------RNEPSDEKSDVYSFG 692
T + D GL+ +E + T GT ++M PEVL + S +D+YSFG
Sbjct: 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239
Query: 693 VILWELATE----------KIPWDNLNSMQ-----VIGAVGFMNQRLEIPK-----DVDP 732
+ILWE+A ++P+ +L + V R P +
Sbjct: 240 LILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLR 299
Query: 733 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766
+ ++ CW +P R + + L +
Sbjct: 300 QMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 353 bits (908), Expect = e-116
Identities = 83/302 (27%), Positives = 137/302 (45%), Gaps = 45/302 (14%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
+ D+T+ E +G+G G V+ W G +VAVK+FS ++ E+ LR
Sbjct: 4 RTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWF---RETELYNTVMLR 60
Query: 561 HPNVLLFMGAVT----SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 616
H N+L F+ + S +L ++T + GSL+ LQ T LD + + L IA G+
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGL 118
Query: 617 SYLH------HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY----LTTKTGK 666
++LH P I HRDLKS N+LV K+ + D GL+ + ++ +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 667 GTPQWMAPEVLRNEP------SDEKSDVYSFGVILWELATE----------KIPWDNLNS 710
GT ++MAPEVL S ++ D+++FG++LWE+A K P+ ++
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238
Query: 711 -----MQVIGAVGFMNQRLEIPKDVD-----PRWAAIVESCWHSDPQCRPSFQELVDKLR 760
+ V QR IP A +++ CW+ +P R + + L
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
Query: 761 DL 762
+
Sbjct: 299 KI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 348 bits (894), Expect = e-114
Identities = 86/311 (27%), Positives = 137/311 (44%), Gaps = 45/311 (14%)
Query: 496 DCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSL 555
L + + + E IG+G G V+ W G +VAVK+FS +E E+
Sbjct: 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWF---REAEIYQ 89
Query: 556 MKRLRHPNVLLFMGAVT----SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD 611
LRH N+L F+ A + +L +V+++ GSLF L R T + I +AL
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALS 147
Query: 612 IARGVSYLH------HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT--- 662
A G+++LH P I HRDLKS N+LV K+ T + D GL+ T
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 207
Query: 663 -KTGKGTPQWMAPEVLRNE------PSDEKSDVYSFGVILWELAT----------EKIPW 705
GT ++MAPEVL + S +++D+Y+ G++ WE+A ++P+
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267
Query: 706 DNLNSM-----QVIGAVGFMNQRLEIPK-----DVDPRWAAIVESCWHSDPQCRPSFQEL 755
+L ++ V R IP + A I+ CW+++ R + +
Sbjct: 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327
Query: 756 VDKLRDLQRQY 766
L L +Q
Sbjct: 328 KKTLSQLSQQE 338
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 336 bits (864), Expect = e-110
Identities = 83/326 (25%), Positives = 131/326 (40%), Gaps = 47/326 (14%)
Query: 481 GSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQE 540
G + VDL + L L + E +G G V+ A VAVK+F Q+
Sbjct: 2 GHHHHHHSSGVDLGTENL--YFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD 59
Query: 541 YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP----QRLCIVTEFLPRGSLFRLLQRN 596
EV + ++H N+L F+GA L ++T F +GSL L+ N
Sbjct: 60 KQSWQ---NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN 116
Query: 597 TTKLDWRRRILMALDIARGVSYLHH--------CNPPIIHRDLKSSNLLVDKHWTVKVGD 648
+ W +A +ARG++YLH P I HRD+KS N+L+ + T + D
Sbjct: 117 V--VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 649 FGLSRLKH--ETYLTTKTGKGTPQWMAPEVLRNEP-----SDEKSDVYSFGVILWELATE 701
FGL+ ++ T GT ++MAPEVL + + D+Y+ G++LWELA+
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234
Query: 702 KIPWDNLNS----------------MQVIGAVGFMNQRLEIPKDVDP-----RWAAIVES 740
D + V +R + +E
Sbjct: 235 CTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEE 294
Query: 741 CWHSDPQCRPSFQELVDKLRDLQRQY 766
CW D + R S + +++ +QR
Sbjct: 295 CWDHDAEARLSAGCVGERITQMQRLT 320
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = e-103
Identities = 83/327 (25%), Positives = 132/327 (40%), Gaps = 60/327 (18%)
Query: 493 LDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQE 552
++ + + ++L + E IG+G G VY VAVKVFS +F E
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR-----QNFINE 55
Query: 553 --VSLMKRLRHPNVLLFMGA-----VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR 605
+ + + H N+ F+ +V E+ P GSL + L +T DW
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSS 113
Query: 606 ILMALDIARGVSYLH-------HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658
+A + RG++YLH H P I HRDL S N+LV T + DFGLS
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 659 YL--------TTKTGKGTPQWMAPEVLRN-------EPSDEKSDVYSFGVILWELA---T 700
L + GT ++MAPEVL E + ++ D+Y+ G+I WE+ T
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 701 EKIPWDNLNSMQV---------------IGAVGFMNQRLEIPKDVDPRW------AAIVE 739
+ P +++ Q+ V QR + P+ +E
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 740 SCWHSDPQCRPSFQELVDKLRDLQRQY 766
CW D + R + Q +++ +L +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIW 320
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 8e-79
Identities = 79/280 (28%), Positives = 132/280 (47%), Gaps = 17/280 (6%)
Query: 489 NKVDLDNDCLDYEILWEDLT-----IGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY 541
N+ D + L+ + + +IG+GS TVY + +VA ++
Sbjct: 5 NQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL 64
Query: 542 SDEVIHSFRQEVSLMKRLRHPNVLLFMGA----VTSPQRLCIVTEFLPRGSLFRLLQRNT 597
+ F++E ++K L+HPN++ F + V + + +VTE + G+L L+R
Sbjct: 65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK 124
Query: 598 TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKH 656
+ + I +G+ +LH PPIIHRDLK N+ + +VK+GD GL+ LK
Sbjct: 125 -VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183
Query: 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVI-G 715
+ K GTP++MAPE+ + DE DVY+FG+ + E+AT + P+ + I
Sbjct: 184 AS--FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR 240
Query: 716 AVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQEL 755
V + K P I+E C + R S ++L
Sbjct: 241 RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 280
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 2e-75
Identities = 86/275 (31%), Positives = 136/275 (49%), Gaps = 13/275 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS--DVAVKVFSRQEYSDEVIHSFRQEVSLM 556
+ + EDL +GEQIG+G+ G V+ VAVK R+ ++ F QE ++
Sbjct: 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARIL 166
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 616
K+ HPN++ +G T Q + IV E + G L+ +L + + M D A G+
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGM 226
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT-P-QWMAP 674
YL IHRDL + N LV + +K+ DFG+SR + + G P +W AP
Sbjct: 227 EYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284
Query: 675 EVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVD 731
E L +SDV+SFG++LWE + P+ NL++ Q V G RL P+
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG---RLPCPELCP 341
Query: 732 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766
++E CW +P RPSF + +L+ +++++
Sbjct: 342 DAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 2e-72
Identities = 81/272 (29%), Positives = 134/272 (49%), Gaps = 13/272 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
+EI +DLT +++G G G V + W G DVA+K+ ++ E F +E +M
Sbjct: 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSE--DEFIEEAKVMM 74
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVS 617
L H ++ G T + + I+TE++ G L L+ + ++ + M D+ +
Sbjct: 75 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 134
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 676
YL +HRDL + N LV+ VKV DFGLSR + T+ G P +W PEV
Sbjct: 135 YLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 192
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPR 733
L KSD+++FGV++WE+ + K+P++ + + + G RL P +
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL---RLYRPHLASEK 249
Query: 734 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765
I+ SCWH RP+F+ L+ + D+ +
Sbjct: 250 VYTIMYSCWHEKADERPTFKILLSNILDVMDE 281
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 4e-72
Identities = 88/270 (32%), Positives = 141/270 (52%), Gaps = 13/270 (4%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 559
E+ E++T+ +++G G G V W G DVAVK+ ++ E F QE M +L
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSE--DEFFQEAQTMMKL 60
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
HP ++ F G + + IVTE++ G L L+ + L+ + + M D+ G+++L
Sbjct: 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVLR 678
IHRDL + N LVD+ VKV DFG++R + + G P +W APEV
Sbjct: 121 ESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFH 178
Query: 679 NEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWA 735
KSDV++FG+++WE+ + K+P+D + +V+ V G RL P
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH---RLYRPHLASDTIY 235
Query: 736 AIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765
I+ SCWH P+ RP+FQ+L+ + L+ +
Sbjct: 236 QIMYSCWHELPEKRPTFQQLLSSIEPLREK 265
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 5e-72
Identities = 87/273 (31%), Positives = 138/273 (50%), Gaps = 13/273 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+ I +LT ++IG G G V+ W VA+K R+ E F +E +M +
Sbjct: 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSE--EDFIEEAEVMMK 59
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
L HP ++ G +C+VTEF+ G L L+ + M LD+ G++Y
Sbjct: 60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVL 677
L +IHRDL + N LV ++ +KV DFG++R + T+ TG P +W +PEV
Sbjct: 120 LEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 177
Query: 678 RNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRW 734
KSDV+SFGV++WE+ +E KIP++N ++ +V+ + GF RL P+
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---RLYKPRLASTHV 234
Query: 735 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767
I+ CW P+ RP+F L+ +L ++
Sbjct: 235 YQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 7e-71
Identities = 88/276 (31%), Positives = 133/276 (48%), Gaps = 16/276 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEV 553
Y I ED+ + +G+G G VY V+ VAVK +++ + + F E
Sbjct: 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEA 64
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
+MK L HP+++ +G + + I+ E P G L L+RN L +L +L I
Sbjct: 65 VIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 123
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWM 672
+ ++YL N +HRD+ N+LV VK+GDFGLSR ++ E Y + +WM
Sbjct: 124 KAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKD 729
+PE + SDV+ F V +WE+ + K P+ L + VIG + G RL P
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD---RLPKPDL 238
Query: 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765
P ++ CW DP RP F ELV L D+ +
Sbjct: 239 CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 9e-71
Identities = 84/310 (27%), Positives = 130/310 (41%), Gaps = 31/310 (10%)
Query: 473 STSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-- 530
S S NK++ D I L +G+ +G+G G+V D
Sbjct: 8 HHHSSGLVPRGSEELQNKLE------DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGT 61
Query: 531 ---VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT-----SPQRLCIVTE 582
VAVK S I F E + MK HPNV+ +G + ++
Sbjct: 62 SLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILP 121
Query: 583 FLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSN 635
F+ G L L + + + +DIA G+ YL + +HRDL + N
Sbjct: 122 FMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNF----LHRDLAARN 177
Query: 636 LLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGV 693
++ TV V DFGLS+ + + P +W+A E L + KSDV++FGV
Sbjct: 178 CMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGV 237
Query: 694 ILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSF 752
+WE+AT P+ + + ++ + RL+ P+D I+ SCW +DP RP+F
Sbjct: 238 TMWEIATRGMTPYPGVQNHEMYDYLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTF 296
Query: 753 QELVDKLRDL 762
L +L L
Sbjct: 297 SVLRLQLEKL 306
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 1e-70
Identities = 92/291 (31%), Positives = 148/291 (50%), Gaps = 27/291 (9%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQ 551
++E+ E +T+ ++GQGS G VY V G VA+K + S F
Sbjct: 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLN 77
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------TTKLDW 602
E S+MK +V+ +G V+ Q ++ E + RG L L+
Sbjct: 78 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 603 RRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660
+ I MA +IA G++YL + +HRDL + N +V + +TVK+GDFG++R +ET
Sbjct: 138 SKMIQMAGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193
Query: 661 TTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV 717
K GKG P +WM+PE L++ SDV+SFGV+LWE+AT + P+ L++ QV+ V
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253
Query: 718 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
L+ P + ++ CW +P+ RPSF E++ +++ F+
Sbjct: 254 -MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 303
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 2e-70
Identities = 80/294 (27%), Positives = 129/294 (43%), Gaps = 30/294 (10%)
Query: 492 DLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVI 546
+L D I + T+G +G+G G+V A D VAVK+ + I
Sbjct: 10 ELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI 69
Query: 547 HSFRQEVSLMKRLRHPNVLLFMGAVT------SPQRLCIVTEFLPRGSLFRLLQ-----R 595
F +E + MK HP+V +G ++ F+ G L L
Sbjct: 70 EEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE 129
Query: 596 NTTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
N L + + +DIA G+ YL + IHRDL + N ++ + TV V DFGLSR
Sbjct: 130 NPFNLPLQTLVRFMVDIACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSR 185
Query: 654 LKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNS 710
+ + P +W+A E L + SDV++FGV +WE+ T + P+ + +
Sbjct: 186 KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN 245
Query: 711 MQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
++ + G RL+ P + ++ CW +DP+ RPSF L +L ++
Sbjct: 246 AEIYNYLIGG---NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 2e-70
Identities = 76/283 (26%), Positives = 132/283 (46%), Gaps = 20/283 (7%)
Query: 495 NDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHS 548
N L + + + +G G+ GTVY +W VA+K R+ S +
Sbjct: 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKE 63
Query: 549 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 608
E +M + +P+V +G + + ++T+ +P G L ++ + + + +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGK 666
+ IA+G++YL ++HRDL + N+LV VK+ DFGL++L E + GK
Sbjct: 123 CVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 667 GTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQ 722
P +WMA E + + +SDV+S+GV +WEL T P+D + + ++ + G
Sbjct: 181 -VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--- 236
Query: 723 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765
RL P I+ CW D RP F+EL+ + + R
Sbjct: 237 RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 1e-69
Identities = 89/276 (32%), Positives = 136/276 (49%), Gaps = 16/276 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEV 553
DYEI E + +G IG+G G V+ ++ + VA+K + SD V F QE
Sbjct: 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEA 67
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
M++ HP+++ +G +T + I+ E G L LQ LD IL A ++
Sbjct: 68 LTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 126
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWM 672
++YL +HRD+ + N+LV + VK+GDFGLSR ++ TY GK +WM
Sbjct: 127 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 184
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKD 729
APE + SDV+ FGV +WE+ P+ + + VIG + G RL +P +
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPN 241
Query: 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765
P +++ CW DP RP F EL +L + +
Sbjct: 242 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 2e-69
Identities = 90/286 (31%), Positives = 134/286 (46%), Gaps = 15/286 (5%)
Query: 495 NDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEY--SDEVIH 547
L I +DL + E++G GS G V W VAVK + + E +
Sbjct: 8 LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-KPDVLSQPEAMD 66
Query: 548 SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 607
F +EV+ M L H N++ G V +P + +VTE P GSL L+++
Sbjct: 67 DFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR 125
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTG 665
A+ +A G+ YL IHRDL + NLL+ VK+GDFGL R +++ + +
Sbjct: 126 YAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 183
Query: 666 KGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQR 723
+ P W APE L+ SD + FGV LWE+ T + PW LN Q++ + +R
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 243
Query: 724 LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769
L P+D ++ CW P+ RP+F L D L + Q +A
Sbjct: 244 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRA 289
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 3e-69
Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 25/290 (8%)
Query: 492 DLDNDCL----DYEIL--WEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQE 540
DLD+ L D I IG+G G VYH + A+K +
Sbjct: 2 DLDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRI 60
Query: 541 YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-RLCIVTEFLPRGSLFRLLQRNTTK 599
+ + +F +E LM+ L HPNVL +G + P+ ++ ++ G L + ++
Sbjct: 61 TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN 120
Query: 600 LDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657
+ I L +ARG+ YL +HRDL + N ++D+ +TVKV DFGL+R +
Sbjct: 121 PTVKDLISFGLQVARGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILD 176
Query: 658 T--YLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQ 712
Y + P +W A E L+ KSDV+SFGV+LWEL T P+ +++
Sbjct: 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236
Query: 713 VIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
+ + +RL P+ +++ CW +DP RP+F+ LV ++ +
Sbjct: 237 LTHFLA-QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 3e-69
Identities = 86/272 (31%), Positives = 147/272 (54%), Gaps = 17/272 (6%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+ + ++L + + IG+G G V + G+ VAVK + + + + +F E S+M +
Sbjct: 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI-KNDATAQ---AFLAEASVMTQ 70
Query: 559 LRHPNVLLFMGAVTSPQ-RLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARGV 616
LRH N++ +G + + L IVTE++ +GSL L+ R + L + +LD+ +
Sbjct: 71 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEV 676
YL N +HRDL + N+LV + KV DFGL++ E T TGK +W APE
Sbjct: 131 EYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEA 185
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPR 733
LR + KSDV+SFG++LWE+ + ++P+ + V+ V G+ +++ P P
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPPA 242
Query: 734 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765
++++CWH D RPSF +L ++L ++
Sbjct: 243 VYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 6e-69
Identities = 84/277 (30%), Positives = 137/277 (49%), Gaps = 18/277 (6%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS------DVAVKVFSRQEYSDEVIHSFRQEV 553
EI +T + IG G G VY + S VA+K + Y+++ F E
Sbjct: 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEA 97
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
+M + H N++ G ++ + + I+TE++ G+L + L+ + + + M IA
Sbjct: 98 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 157
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT--P-Q 670
G+ YL + N +HRDL + N+LV+ + KV DFGLSR+ + T T G P +
Sbjct: 158 AGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIP 727
W APE + SDV+SFG+++WE+ T + P+ L++ +V+ A+ GF RL P
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF---RLPTP 272
Query: 728 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764
D ++ CW + RP F ++V L L R
Sbjct: 273 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 1e-68
Identities = 87/275 (31%), Positives = 130/275 (47%), Gaps = 17/275 (6%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSDEVIHSFRQEVSL 555
EI + I + IG G G V + VA+K + Y++ F E S+
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSEASI 103
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
M + HPN++ G VT + IVTE++ GSL L+ + + + + M + G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWM 672
+ YL +HRDL + N+LVD + KV DFGLSR+ + TT GK +W
Sbjct: 164 MRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT 221
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKD 729
APE + SDV+SFGV++WE+ + P+ N+ + VI +V G+ RL P
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY---RLPAPMG 278
Query: 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764
++ CWH D RP F ++V L L R
Sbjct: 279 CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 2e-68
Identities = 84/325 (25%), Positives = 141/325 (43%), Gaps = 25/325 (7%)
Query: 466 SSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDY------EILWEDLTIGEQIGQGSCG 519
S+S+ + S ++ ++ L+ + + + E IG+G G
Sbjct: 44 STSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFG 103
Query: 520 TVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574
VYH +D AVK + + F E +MK HPNVL +G
Sbjct: 104 CVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162
Query: 575 QR-LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDL 631
+ +V ++ G L ++ T + I L +A+G+ +L +HRDL
Sbjct: 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF----VHRDL 218
Query: 632 KSSNLLVDKHWTVKVGDFGLSRLKHET--YLTTKTGKGT-P-QWMAPEVLRNEPSDEKSD 687
+ N ++D+ +TVKV DFGL+R ++ P +WMA E L+ + KSD
Sbjct: 219 AARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSD 278
Query: 688 VYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDP 746
V+SFGV+LWEL T P+ ++N+ + + +RL P+ ++ CWH
Sbjct: 279 VWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKA 337
Query: 747 QCRPSFQELVDKLRDLQRQYFQASR 771
+ RPSF ELV ++ + +
Sbjct: 338 EMRPSFSELVSRISAIFSTFIGEHY 362
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 3e-68
Identities = 83/294 (28%), Positives = 138/294 (46%), Gaps = 32/294 (10%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEV 553
+ L +Q+G+G+ G+V + VAVK Q ++E + F +E+
Sbjct: 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREI 93
Query: 554 SLMKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD 611
++K L+H N++ + G S R L ++ E+LP GSL LQ++ ++D + +
Sbjct: 94 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 153
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP 669
I +G+ YL IHRDL + N+LV+ VK+GDFGL+++ + + Y K +P
Sbjct: 154 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 670 -QWMAPEVLRNEPSDEKSDVYSFGVILWELAT----------------EKIPWDNLNSMQ 712
W APE L SDV+SFGV+L+EL T +
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271
Query: 713 VIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766
+I + N RL P I+ CW+++ RPSF++L ++ ++ Q
Sbjct: 272 LIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 3e-68
Identities = 81/293 (27%), Positives = 137/293 (46%), Gaps = 32/293 (10%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEVS 554
+ L +Q+G+G+ G+V + VAVK Q ++E + F +E+
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 63
Query: 555 LMKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDI 612
++K L+H N++ + G S R L ++ E+LP GSL LQ++ ++D + + I
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP- 669
+G+ YL IHRDL + N+LV+ VK+GDFGL+++ + + + K +P
Sbjct: 124 CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI 181
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELAT----------------EKIPWDNLNSMQV 713
W APE L SDV+SFGV+L+EL T + +
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241
Query: 714 IGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766
I + N RL P I+ CW+++ RPSF++L ++ ++
Sbjct: 242 IELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 7e-68
Identities = 84/292 (28%), Positives = 131/292 (44%), Gaps = 21/292 (7%)
Query: 492 DLDNDCLDYEIL--WEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDE 544
+L I + E IG+G G VYH +D AVK +
Sbjct: 10 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIG 68
Query: 545 VIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR-LCIVTEFLPRGSLFRLLQRNTTKLDWR 603
+ F E +MK HPNVL +G + +V ++ G L ++ T +
Sbjct: 69 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 128
Query: 604 RRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET--Y 659
I L +A+G+ YL +HRDL + N ++D+ +TVKV DFGL+R ++ Y
Sbjct: 129 DLIGFGLQVAKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184
Query: 660 LTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGA 716
P +WMA E L+ + KSDV+SFGV+LWEL T P+ ++N+ +
Sbjct: 185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 244
Query: 717 VGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
+ +RL P+ ++ CWH + RPSF ELV ++ + +
Sbjct: 245 LL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 7e-68
Identities = 83/276 (30%), Positives = 137/276 (49%), Gaps = 17/276 (6%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEVSL 555
E+ +++I + +G G G V VA+K + Y+++ F E S+
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASI 99
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
M + HPN++ G VT + + IVTE++ GSL L+++ + + + M IA G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWM 672
+ YL +HRDL + N+L++ + KV DFGL R+ E TT+ GK +W
Sbjct: 160 MKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKD 729
+PE + SDV+S+G++LWE+ + + P+ +++ VI AV G+ RL P D
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPPPMD 274
Query: 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765
++ CW D RP F+++V L L R
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 8e-68
Identities = 84/291 (28%), Positives = 136/291 (46%), Gaps = 34/291 (11%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQEV 553
I D+ + ++G+G+ G V+ A Y VAVK ++ + F++E
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARKDFQREA 68
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------------TT 598
L+ L+H +++ F G L +V E++ G L + L+ +
Sbjct: 69 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 599 KLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656
+L + + +A IA G+ YL H +HRDL + N LV + VK+GDFG+SR +
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRDVY 184
Query: 657 ETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQV 713
T G P +WM PE + +SDV+SFGVILWE+ T K PW L++ +V
Sbjct: 185 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 244
Query: 714 IGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764
I + + LE P+ ++ CW +PQ R + +E+ L L +
Sbjct: 245 IECIT-QGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGK 294
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 8e-68
Identities = 89/274 (32%), Positives = 140/274 (51%), Gaps = 15/274 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS--DVAVKVFSRQEYSDEVIHSFRQEVSLM 556
+E+ D+T+ ++G G G VY VW VAVK +++ + F +E ++M
Sbjct: 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEV--EEFLKEAAVM 63
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARG 615
K ++HPN++ +G T I+TEF+ G+L L+ N ++ + MA I+
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAP 674
+ YL N IHRDL + N LV ++ VKV DFGLSRL T G P +W AP
Sbjct: 124 MEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
Query: 675 EVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVD 731
E L KSDV++FGV+LWE+AT P+ ++ QV + + R+E P+
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---RMERPEGCP 238
Query: 732 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765
+ ++ +CW +P RPSF E+ + ++
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 9e-68
Identities = 91/324 (28%), Positives = 151/324 (46%), Gaps = 37/324 (11%)
Query: 471 VNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWE----DLTIGEQIGQGSCGTVYHAVW 526
+ S SS+S S + + + D+ + ++G+G+ G V+ A
Sbjct: 3 MGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAEC 62
Query: 527 YGSD-------VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579
+ VAVK +E S+ F++E L+ L+H +++ F G T + L +
Sbjct: 63 HNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120
Query: 580 VTEFLPRGSLFRLLQRN--------------TTKLDWRRRILMALDIARGVSYL--HHCN 623
V E++ G L R L+ + L + + +A +A G+ YL H
Sbjct: 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF- 179
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEP 681
+HRDL + N LV + VK+GDFG+SR + T G+ P +WM PE +
Sbjct: 180 ---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK 236
Query: 682 SDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 740
+SDV+SFGV+LWE+ T K PW L++ + I + + LE P+ P AI+
Sbjct: 237 FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT-QGRELERPRACPPEVYAIMRG 295
Query: 741 CWHSDPQCRPSFQELVDKLRDLQR 764
CW +PQ R S +++ +L+ L +
Sbjct: 296 CWQREPQQRHSIKDVHARLQALAQ 319
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 1e-67
Identities = 88/278 (31%), Positives = 145/278 (52%), Gaps = 19/278 (6%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
++E+ E L + E++G G G V+ + G VAVK +Q +F E +LMK
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSP--DAFLAEANLMK 63
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGV 616
+L+H ++ VT + + I+TE++ GSL L+ + KL + + MA IA G+
Sbjct: 64 QLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPE 675
+++ N IHRDL+++N+LV + K+ DFGL+RL + T + G P +W APE
Sbjct: 123 AFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 676 VLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDP 732
+ KSDV+SFG++L E+ T +IP+ + + +VI + G+ R+ P +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---RMVRPDNCPE 237
Query: 733 RWAAIVESCWHSDPQCRPSFQELVDKLRDL----QRQY 766
++ CW P+ RP+F L L D + QY
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQY 275
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 2e-67
Identities = 70/292 (23%), Positives = 131/292 (44%), Gaps = 18/292 (6%)
Query: 499 DYEILWEDLTIGE-QIGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIHSFRQEV 553
+ ++L I + ++G G+ G+V V+ DVA+KV +Q +E
Sbjct: 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREA 61
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
+M +L +P ++ +G + L +V E G L + L ++ + ++
Sbjct: 62 QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP-Q 670
G+ YL N +HRDL + N+L+ K+ DFGLS+ ++Y T ++ P +
Sbjct: 121 MGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKD 729
W APE + +SDV+S+GV +WE + + P+ + +V+ + +R+E P +
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 237
Query: 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGDSTQKE 781
P A++ CW + RP F + ++R + + S V
Sbjct: 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRA----CYYSLASKVEGHHHHH 285
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 5e-67
Identities = 79/290 (27%), Positives = 125/290 (43%), Gaps = 33/290 (11%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQEV 553
EI + E++G+ G VY +G VA+K + + + FR E
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEA 63
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------------TT 598
L RL+HPNV+ +G VT Q L ++ + G L L +
Sbjct: 64 MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 599 KLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656
L+ + + IA G+ YL HH +H+DL + N+LV VK+ D GL R +
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 657 ETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQV 713
G P +WMAPE + SD++S+GV+LWE+ + P+ ++ V
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 239
Query: 714 IGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 763
+ + Q L P D A++ CW+ P RP F+++ +LR
Sbjct: 240 VEMIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 288
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 5e-67
Identities = 79/290 (27%), Positives = 128/290 (44%), Gaps = 30/290 (10%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVS 554
L +G+G G V + G VAVK + E I ++E+
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIE 75
Query: 555 LMKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDI 612
+++ L H N++ + G T + ++ EFLP GSL L +N K++ ++++ A+ I
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP- 669
+G+ YL +HRDL + N+LV+ VK+GDFGL++ + Y T K + +P
Sbjct: 136 CKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV 193
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELAT---------------EKIPWDNLNSMQVI 714
W APE L SDV+SFGV L EL T + +++
Sbjct: 194 FWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253
Query: 715 GAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764
+ +RL P + ++ CW P R SFQ L++ L +
Sbjct: 254 NTLK-EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 1e-66
Identities = 73/280 (26%), Positives = 127/280 (45%), Gaps = 24/280 (8%)
Query: 501 EILWE----DLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFR 550
+ +L + +G G GTV+ VW V +KV + + +
Sbjct: 5 VLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVT 63
Query: 551 QEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
+ + L H +++ +G L +VT++LP GSL ++++ L + + +
Sbjct: 64 DHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV 122
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGT 668
IA+G+ YL ++HR+L + N+L+ V+V DFG++ L + L K T
Sbjct: 123 QIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAK-T 179
Query: 669 P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRL 724
P +WMA E + +SDV+S+GV +WEL T P+ L +V + G RL
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE---RL 236
Query: 725 EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764
P+ ++ CW D RP+F+EL ++ + R
Sbjct: 237 AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 1e-66
Identities = 76/283 (26%), Positives = 132/283 (46%), Gaps = 20/283 (7%)
Query: 495 NDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHS 548
N L + + + +G G+ GTVY +W VA+K R+ S +
Sbjct: 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKE 63
Query: 549 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 608
E +M + +P+V +G + + ++T+ +P G L ++ + + + +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGK 666
+ IA+G++YL ++HRDL + N+LV VK+ DFGL++L E + GK
Sbjct: 123 CVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 667 GTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQ 722
P +WMA E + + +SDV+S+GV +WEL T P+D + + ++ + G
Sbjct: 181 -VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--- 236
Query: 723 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765
RL P I+ CW D RP F+EL+ + + R
Sbjct: 237 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-66
Identities = 75/292 (25%), Positives = 133/292 (45%), Gaps = 32/292 (10%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEVS 554
L +G+G G V + ++ VAVK + + + ++QE+
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEID 85
Query: 555 LMKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDI 612
+++ L H +++ + G L +V E++P GSL L R+ + + +L A I
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQI 143
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP- 669
G++YLH + IHRDL + N+L+D VK+GDFGL++ + Y + +P
Sbjct: 144 CEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 201
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELAT---------------EKIPWDNLNSMQVI 714
W APE L+ SDV+SFGV L+EL T I + +++
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261
Query: 715 GAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766
+ +RL P ++++CW ++ RP+F+ L+ L+ + +Y
Sbjct: 262 ELLE-RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 2e-66
Identities = 85/271 (31%), Positives = 147/271 (54%), Gaps = 17/271 (6%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+ + ++L + + IG+G G V + G+ VAVK + + + + +F E S+M +
Sbjct: 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI-KNDATAQ---AFLAEASVMTQ 242
Query: 559 LRHPNVLLFMGAVTSPQ-RLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARGV 616
LRH N++ +G + + L IVTE++ +GSL L+ R + L + +LD+ +
Sbjct: 243 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 302
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEV 676
YL N +HRDL + N+LV + KV DFGL++ E T TGK +W APE
Sbjct: 303 EYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEA 357
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPR 733
LR + KSDV+SFG++LWE+ + ++P+ + V+ V G+ +++ P P
Sbjct: 358 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPPA 414
Query: 734 WAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764
++++CWH D RP+F +L ++L ++
Sbjct: 415 VYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 3e-66
Identities = 89/276 (32%), Positives = 136/276 (49%), Gaps = 16/276 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEV 553
DYEI E + +G IG+G G V+ ++ + VA+K + SD V F QE
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEA 442
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
M++ HP+++ +G +T + I+ E G L LQ LD IL A ++
Sbjct: 443 LTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLS 501
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWM 672
++YL +HRD+ + N+LV + VK+GDFGLSR ++ TY GK +WM
Sbjct: 502 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 559
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKD 729
APE + SDV+ FGV +WE+ P+ + + VIG + G RL +P +
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPN 616
Query: 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765
P +++ CW DP RP F EL +L + +
Sbjct: 617 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 3e-66
Identities = 96/316 (30%), Positives = 155/316 (49%), Gaps = 23/316 (7%)
Query: 474 TSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS--DV 531
T+ + + V + D +E+ D+T+ ++G G G VY VW V
Sbjct: 191 TTLHYPAPKRNKPTIYGVSPNYD--KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTV 248
Query: 532 AVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFR 591
AVK +++ + F +E ++MK ++HPN++ +G T I+TEF+ G+L
Sbjct: 249 AVKTL-KEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 305
Query: 592 LLQ-RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
L+ N ++ + MA I+ + YL N IHR+L + N LV ++ VKV DFG
Sbjct: 306 YLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFG 363
Query: 651 LSRLKHETYLTTKTGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNL 708
LSRL T G P +W APE L KSDV++FGV+LWE+AT P+ +
Sbjct: 364 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423
Query: 709 NSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766
+ QV + + R+E P+ + ++ +CW +P RPSF E+ + ++
Sbjct: 424 DLSQVYELLEKDY---RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE- 479
Query: 767 FQASRSTVGDSTQKEL 782
S++ D +KEL
Sbjct: 480 -----SSISDEVEKEL 490
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 1e-65
Identities = 74/287 (25%), Positives = 129/287 (44%), Gaps = 31/287 (10%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQEV 553
E+ +++T+ +G G+ G VY G VAVK + S++ F E
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEA 84
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------TTKLDWRRRIL 607
++ + H N++ +G I+ E + G L L+ + L +
Sbjct: 85 LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 608 MALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRLKHETYLTT 662
+A DIA G YL +H IHRD+ + N L+ K+GDFG++R +
Sbjct: 145 VARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 663 KTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV-- 717
K G P +WM PE K+D +SFGV+LWE+ + +P+ + ++ +V+ V
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260
Query: 718 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764
G R++ PK+ I+ CW P+ RP+F +++++ +
Sbjct: 261 GG---RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 2e-65
Identities = 89/269 (33%), Positives = 145/269 (53%), Gaps = 15/269 (5%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E L + ++GQG G V+ W G+ VA+K + +F QE +MK+
Sbjct: 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSP--EAFLQEAQVMKK 235
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVS 617
LRH ++ V+ + + IVTE++ +GSL L+ T K L + + MA IA G++
Sbjct: 236 LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 676
Y+ N +HRDL+++N+LV ++ KV DFGL+RL + T + G P +W APE
Sbjct: 295 YVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 352
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPR 733
KSDV+SFG++L EL T+ ++P+ + + +V+ V G+ R+ P +
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---RMPCPPECPES 409
Query: 734 WAAIVESCWHSDPQCRPSFQELVDKLRDL 762
++ CW +P+ RP+F+ L L D
Sbjct: 410 LHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 2e-65
Identities = 78/312 (25%), Positives = 135/312 (43%), Gaps = 49/312 (15%)
Query: 493 LDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEV 545
L+ L E ++ IG+G+ G V+ A G VAVK+ ++E S ++
Sbjct: 35 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADM 93
Query: 546 IHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR 605
F++E +LM +PN++ +G + +C++ E++ G L L+ +
Sbjct: 94 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 153
Query: 606 -----------------------ILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDK 640
+ +A +A G++YL +HRDL + N LV +
Sbjct: 154 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGE 209
Query: 641 HWTVKVGDFGLSRLKHET--YLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILW 696
+ VK+ DFGLSR + Y G P +WM PE + +SDV+++GV+LW
Sbjct: 210 NMVVKIADFGLSRNIYSADYY--KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 267
Query: 697 ELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQ 753
E+ + P+ + +VI V G L P++ ++ CW P RPSF
Sbjct: 268 EIFSYGLQPYYGMAHEEVIYYVRDG---NILACPENCPLELYNLMRLCWSKLPADRPSFC 324
Query: 754 ELVDKLRDLQRQ 765
+ L+ + +
Sbjct: 325 SIHRILQRMCER 336
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 5e-65
Identities = 66/295 (22%), Positives = 123/295 (41%), Gaps = 34/295 (11%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD---------VAVKVFSRQEYSDEVIHSFR 550
++I EDL E +GQG+ ++ V V +KV + SF
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL--DKAHRNYSESFF 60
Query: 551 QEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
+ S+M +L H +++L G +V EF+ GSL L++N ++ ++ +A
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 611 DIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWT--------VKVGDFGLSRLKHETYL 660
+A + +L + IH ++ + N+L+ + +K+ D G+S +
Sbjct: 121 QLAAAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI 176
Query: 661 TTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVG 718
+ W+ PE + N + + +D +SFG LWE+ + P L+S + +
Sbjct: 177 LQERIP----WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232
Query: 719 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773
+L PK A ++ +C +P RPSF+ ++ L L S
Sbjct: 233 -DRHQLPAPK--AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSH 284
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 7e-65
Identities = 84/292 (28%), Positives = 129/292 (44%), Gaps = 31/292 (10%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEVS 554
L Q+G+G+ G+V + VAVK Q + F++E+
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQ 76
Query: 555 LMKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDI 612
++K L ++ + G P R L +V E+LP G L LQR+ +LD R +L + I
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI 136
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP- 669
+G+ YL +HRDL + N+LV+ VK+ DFGL++L + Y + +P
Sbjct: 137 CKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 194
Query: 670 QWMAPEVLRNEPSDEKSDVYSFGVILWELAT---------------EKIPWDNLNSMQVI 714
W APE L + +SDV+SFGV+L+EL T D +++
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254
Query: 715 GAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766
+ QRL P +++ CW PQ RPSF L +L L
Sbjct: 255 ELLE-EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 1e-64
Identities = 74/287 (25%), Positives = 129/287 (44%), Gaps = 31/287 (10%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQEV 553
E+ +++T+ +G G+ G VY G VAVK + S++ F E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEA 125
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------TTKLDWRRRIL 607
++ + H N++ +G I+ E + G L L+ + L +
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 608 MALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRLKHETYLTT 662
+A DIA G YL +H IHRD+ + N L+ K+GDFG++R +
Sbjct: 186 VARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR 241
Query: 663 KTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV-- 717
K G P +WM PE K+D +SFGV+LWE+ + +P+ + ++ +V+ V
Sbjct: 242 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301
Query: 718 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764
G R++ PK+ I+ CW P+ RP+F +++++ +
Sbjct: 302 GG---RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 5e-64
Identities = 85/308 (27%), Positives = 153/308 (49%), Gaps = 41/308 (13%)
Query: 487 AVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD---------VAVKVFS 537
V++ +L D +E + LT+G+ +G+G+ G V A G D VAVK+
Sbjct: 18 GVSEYELPED-PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML- 75
Query: 538 RQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN 596
+ + +++ + E+ +MK + +H N++ +GA T L ++ E+ +G+L L+
Sbjct: 76 KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
Query: 597 ---------------TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVD 639
++ ++ + +ARG+ YL C IHRDL + N+LV
Sbjct: 136 RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVT 191
Query: 640 KHWTVKVGDFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWE 697
++ +K+ DFGL+R + KT G P +WMAPE L + +SDV+SFGV++WE
Sbjct: 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 251
Query: 698 LATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQE 754
+ T P+ + ++ + G R++ P + ++ CWH+ P RP+F++
Sbjct: 252 IFTLGGSPYPGIPVEELFKLLKEGH---RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQ 308
Query: 755 LVDKLRDL 762
LV+ L +
Sbjct: 309 LVEDLDRI 316
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 1e-63
Identities = 83/270 (30%), Positives = 143/270 (52%), Gaps = 15/270 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
+EI E L + +++G G G V+ A + VAVK + +F E ++MK
Sbjct: 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSV--EAFLAEANVMK 238
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGV 616
L+H ++ VT + + I+TEF+ +GSL L+ + +K + I + IA G+
Sbjct: 239 TLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPE 675
+++ N IHRDL+++N+LV K+ DFGL+R+ + T + G P +W APE
Sbjct: 298 AFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 355
Query: 676 VLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDP 732
+ KSDV+SFG++L E+ T +IP+ +++ +VI A+ G+ R+ P++
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY---RMPRPENCPE 412
Query: 733 RWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
I+ CW + P+ RP+F+ + L D
Sbjct: 413 ELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 1e-63
Identities = 70/282 (24%), Positives = 127/282 (45%), Gaps = 14/282 (4%)
Query: 499 DYEILWEDLTIGEQ-IGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIHSFRQEV 553
+ + + LT+ ++ +G G+ GTV + VAVK+ + + E
Sbjct: 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 69
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
++M++L +P ++ +G + + +V E G L + LQ+N + + I + ++
Sbjct: 70 NVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVS 127
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP-Q 670
G+ YL N +HRDL + N+L+ K+ DFGLS+ E Y +T P +
Sbjct: 128 MGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKD 729
W APE + KSDV+SFGV++WE + + P+ + +V + +R+ P
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 244
Query: 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771
++ CW D + RP F + +LR+
Sbjct: 245 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 286
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-63
Identities = 79/301 (26%), Positives = 134/301 (44%), Gaps = 45/301 (14%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQ 551
+E ++L +G+ +G+G G V A + VAVK+ ++ S +
Sbjct: 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLS 75
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN--------------- 596
E +++K++ HP+V+ GA + L ++ E+ GSL L+ +
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 597 --------TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKV 646
L I A I++G+ YL +HRDL + N+LV + +K+
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKI 191
Query: 647 GDFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KI 703
DFGLSR +E K +G P +WMA E L + +SDV+SFGV+LWE+ T
Sbjct: 192 SDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 704 PWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRD 761
P+ + ++ + G R+E P + ++ CW +P RP F ++ L
Sbjct: 252 PYPGIPPERLFNLLKTGH---RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308
Query: 762 L 762
+
Sbjct: 309 M 309
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 1e-63
Identities = 86/319 (26%), Positives = 156/319 (48%), Gaps = 37/319 (11%)
Query: 474 TSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--- 530
T S+ + + V++ +L D +E + LT+G+ +G+G G V A G D
Sbjct: 51 TRLSSTADTPMLAGVSEYELPED-PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDK 109
Query: 531 ------VAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEF 583
VAVK+ + + +++ + E+ +MK + +H N++ +GA T L ++ E+
Sbjct: 110 PKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 168
Query: 584 LPRGSLFRLLQRN---------------TTKLDWRRRILMALDIARGVSYL--HHCNPPI 626
+G+L L+ ++ ++ + +ARG+ YL C
Sbjct: 169 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---- 224
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDE 684
IHRDL + N+LV ++ +K+ DFGL+R + KT G P +WMAPE L +
Sbjct: 225 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 284
Query: 685 KSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWH 743
+SDV+SFGV++WE+ T P+ + ++ + R++ P + ++ CWH
Sbjct: 285 QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWH 343
Query: 744 SDPQCRPSFQELVDKLRDL 762
+ P RP+F++LV+ L +
Sbjct: 344 AVPSQRPTFKQLVEDLDRI 362
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 220 bits (561), Expect = 3e-63
Identities = 89/269 (33%), Positives = 145/269 (53%), Gaps = 15/269 (5%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E L + ++GQG G V+ W G+ VA+K + +F QE +MK+
Sbjct: 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSP--EAFLQEAQVMKK 318
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVS 617
LRH ++ V+ + + IVTE++ +GSL L+ T K L + + MA IA G++
Sbjct: 319 LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 377
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP-QWMAPEV 676
Y+ N +HRDL+++N+LV ++ KV DFGL+RL + T + G P +W APE
Sbjct: 378 YVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 435
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPR 733
KSDV+SFG++L EL T+ ++P+ + + +V+ V G+ R+ P +
Sbjct: 436 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---RMPCPPECPES 492
Query: 734 WAAIVESCWHSDPQCRPSFQELVDKLRDL 762
++ CW +P+ RP+F+ L L D
Sbjct: 493 LHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-62
Identities = 77/297 (25%), Positives = 130/297 (43%), Gaps = 41/297 (13%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQ 551
+E L+ G+ +G G+ G V A YG VAVK+ + +
Sbjct: 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMS 75
Query: 552 EVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN-------------- 596
E+ ++ L H N++ +GA T ++TE+ G L L+R
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 597 ---TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651
LD + + +A+G+++L +C IHRDL + N+L+ K+ DFGL
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGL 191
Query: 652 SRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNL 708
+R G P +WMAPE + N +SDV+S+G+ LWEL + P+ +
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 709 -NSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
+ + GF R+ P+ I+++CW +DP RP+F+++V +
Sbjct: 252 PVDSKFYKMIKEGF---RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 2e-62
Identities = 85/300 (28%), Positives = 144/300 (48%), Gaps = 48/300 (16%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG---------SDVAVKV----FSRQEYSDEV 545
+E+ + L +G+ +G+G+ G V A G + VAVK+ + ++ SD
Sbjct: 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-- 120
Query: 546 IHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSL--------------- 589
E+ +MK + +H N++ +GA T L ++ E+ +G+L
Sbjct: 121 ---LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 177
Query: 590 FRLLQRNTTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVG 647
+ +L + + A +ARG+ YL C IHRDL + N+LV + +K+
Sbjct: 178 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIA 233
Query: 648 DFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIP 704
DFGL+R H KT G P +WMAPE L + +SDV+SFGV+LWE+ T P
Sbjct: 234 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
Query: 705 WDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
+ + ++ + G R++ P + ++ CWH+ P RP+F++LV+ L +
Sbjct: 294 YPGVPVEELFKLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-62
Identities = 83/304 (27%), Positives = 141/304 (46%), Gaps = 37/304 (12%)
Query: 489 NKVDLDNDCLDY-EILWEDLTIGEQIGQGSCGTVYHAVWYGSD----VAVKVFSRQEYSD 543
+ + D Y + W D+ + IG+G+ G V A A+K ++ S
Sbjct: 8 HHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASK 66
Query: 544 EVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------ 596
+ F E+ ++ +L HPN++ +GA L + E+ P G+L L+++
Sbjct: 67 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 126
Query: 597 ---------TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVK 645
+ L ++ + A D+ARG+ YL IHRDL + N+LV +++ K
Sbjct: 127 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAK 182
Query: 646 VGDFGLSRLKHETYLTTKTGKGTP-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KI 703
+ DFGLSR E Y+ G+ P +WMA E L SDV+S+GV+LWE+ +
Sbjct: 183 IADFGLSR-GQEVYVKKTMGR-LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 240
Query: 704 PWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRD 761
P+ + ++ + G+ RLE P + D ++ CW P RPSF +++ L
Sbjct: 241 PYCGMTCAELYEKLPQGY---RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297
Query: 762 LQRQ 765
+ +
Sbjct: 298 MLEE 301
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 2e-61
Identities = 76/324 (23%), Positives = 146/324 (45%), Gaps = 38/324 (11%)
Query: 474 TSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG----- 528
+ S S + ++ L + +E +L G+ +G G+ G V A +G
Sbjct: 16 WKIIESYEGNSYTFIDPTQLPYN-EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKED 74
Query: 529 --SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLP 585
VAVK+ + + + E+ +M L +H N++ +GA T + ++TE+
Sbjct: 75 AVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 133
Query: 586 RGSLFRLLQRN-------------TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRD 630
G L L+R + R + + +A+G+++L +C IHRD
Sbjct: 134 YGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC----IHRD 189
Query: 631 LKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDV 688
+ + N+L+ K+GDFGL+R G P +WMAPE + + +SDV
Sbjct: 190 VAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 249
Query: 689 YSFGVILWELATE-KIPWDNLNS-MQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHS 744
+S+G++LWE+ + P+ + + V G+ ++ P +I+++CW
Sbjct: 250 WSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY---QMAQPAFAPKNIYSIMQACWAL 306
Query: 745 DPQCRPSFQELVDKLRDLQRQYFQ 768
+P RP+FQ++ L++ ++ +
Sbjct: 307 EPTHRPTFQQICSFLQEQAQEDRR 330
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 9e-61
Identities = 83/299 (27%), Positives = 138/299 (46%), Gaps = 40/299 (13%)
Query: 496 DCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHS 548
D +E + L +G+ +G+G+ G V A +G D VAVK+ ++ + +
Sbjct: 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRA 76
Query: 549 FRQEVSLMKRL-RHPNVLLFMGAVTSPQR-LCIVTEFLPRGSLFRLLQRN---------- 596
E+ ++ + H NV+ +GA T P L ++ EF G+L L+
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 597 -----TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649
L I + +A+G+ +L C IHRDL + N+L+ + VK+ DF
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDF 192
Query: 650 GLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWD 706
GL+R ++ + G P +WMAPE + + +SDV+SFGV+LWE+ + P+
Sbjct: 193 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252
Query: 707 NLNS-MQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
+ + + G R+ P P + CWH +P RP+F ELV+ L +L
Sbjct: 253 GVKIDEEFCRRLKEGT---RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 215 bits (548), Expect = 1e-60
Identities = 71/295 (24%), Positives = 134/295 (45%), Gaps = 22/295 (7%)
Query: 499 DYEILWEDLTIGE-QIGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIHSFRQEV 553
+ ++L I + ++G G+ G+V V+ DVA+KV +Q +E
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREA 387
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
+M +L +P ++ +G + L +V E G L + L ++ + ++
Sbjct: 388 QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 446
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTP-Q 670
G+ YL N +HR+L + N+L+ K+ DFGLS+ ++Y T ++ P +
Sbjct: 447 MGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAV--GFMNQRLEIP 727
W APE + +SDV+S+GV +WE + + P+ + +V+ + G R+E P
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECP 561
Query: 728 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGDSTQKEL 782
+ P A++ CW + RP F + ++R + + S V + E+
Sbjct: 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA----CYYSLASKVEGGSALEV 612
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 4e-60
Identities = 70/290 (24%), Positives = 139/290 (47%), Gaps = 27/290 (9%)
Query: 489 NKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVI 546
+ VDL + L ++ + E ++IG+GS G G +K + S +
Sbjct: 9 SGVDLGTENLYFQSM-EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER 67
Query: 547 HSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK------- 599
R+EV+++ ++HPN++ + + L IV ++ G LF+ +
Sbjct: 68 EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI 127
Query: 600 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659
LDW +I +AL ++H I+HRD+KS N+ + K TV++GDFG++R+ + T
Sbjct: 128 LDWFVQICLALK------HVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179
Query: 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF 719
+ GTP +++PE+ N+P + KSD+++ G +L+EL T K ++ + ++ +
Sbjct: 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI-- 237
Query: 720 MNQRLE-IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
++ + ++V + +P+ RPS + L++ +
Sbjct: 238 ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI------LEKGFIA 281
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-59
Identities = 82/313 (26%), Positives = 134/313 (42%), Gaps = 47/313 (15%)
Query: 488 VNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQE 540
V+ + + D L +E E+L G+ +G G+ G V +A YG VAVK+ +++
Sbjct: 29 VDFREYEYD-LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEK 86
Query: 541 YSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN--- 596
+ E+ +M +L H N++ +GA T + ++ E+ G L L+
Sbjct: 87 ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREK 146
Query: 597 -------------------TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSN 635
L + + A +A+G+ +L C +HRDL + N
Sbjct: 147 FSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARN 202
Query: 636 LLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT-P-QWMAPEVLRNEPSDEKSDVYSFGV 693
+LV VK+ DFGL+R G P +WMAPE L KSDV+S+G+
Sbjct: 203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 262
Query: 694 ILWELATE-KIPWDNL-NSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 749
+LWE+ + P+ + + GF +++ P I++SCW D + R
Sbjct: 263 LLWEIFSLGVNPYPGIPVDANFYKLIQNGF---KMDQPFYATEEIYIIMQSCWAFDSRKR 319
Query: 750 PSFQELVDKLRDL 762
PSF L L
Sbjct: 320 PSFPNLTSFLGCQ 332
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 7e-59
Identities = 71/287 (24%), Positives = 121/287 (42%), Gaps = 38/287 (13%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
DYE+L IG GS G G + K ++ EV+L+
Sbjct: 7 DYEVL-------YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL 59
Query: 557 KRLRHPNVLLFMGAV--TSPQRLCIVTEFLPRGSLFRLLQRNTTK---------LDWRRR 605
+ L+HPN++ + + + L IV E+ G L ++ + T + L +
Sbjct: 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 606 ILMALDIARGVSYLHHCNPP---IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
+ +AL H + ++HRDLK +N+ +D VK+GDFGL+R+ +
Sbjct: 120 LTLALK------ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173
Query: 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ 722
KT GTP +M+PE + +EKSD++S G +L+EL P+ + ++ G +
Sbjct: 174 KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI--REG 231
Query: 723 RLE-IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
+ IP I+ + RPS +E+ L+
Sbjct: 232 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI------LENPLIL 272
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 8e-59
Identities = 76/281 (27%), Positives = 133/281 (47%), Gaps = 14/281 (4%)
Query: 484 SSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY 541
S + + D ++D L+Y+ +++ +G+G+ G VY +A+K +
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-- 58
Query: 542 SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD 601
+E++L K L+H N++ ++G+ + + I E +P GSL LL+ L
Sbjct: 59 DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK 118
Query: 602 WRRRILM--ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHET 658
+ + I G+ YLH I+HRD+K N+L++ + +K+ DFG S+
Sbjct: 119 DNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176
Query: 659 YLTTKTGKGTPQWMAPEVLRNEPS--DEKSDVYSFG-VILWELATEKIPWDNL-NSMQVI 714
T+T GT Q+MAPE++ P + +D++S G I+ E+AT K P+ L +
Sbjct: 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTII-EMATGKPPFYELGEPQAAM 235
Query: 715 GAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQEL 755
VG EIP+ + A + C+ DP R +L
Sbjct: 236 FKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDL 276
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 3e-55
Identities = 67/267 (25%), Positives = 117/267 (43%), Gaps = 26/267 (9%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEV-IHSFRQEVSLMKRLRH 561
+ I ++IG+G VY A G VA+K + D +E+ L+K+L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---------LDWRRRILMALDI 612
PNV+ + + L IV E G L R+++ + + ++ AL+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE- 150
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM 672
++H ++HRD+K +N+ + VK+GD GL R + GTP +M
Sbjct: 151 -----HMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 203
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATEKIPW--DNLNSMQVIGAVGFMNQRLE-IPKD 729
+PE + + KSD++S G +L+E+A + P+ D +N + + +P D
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI--EQCDYPPLPSD 261
Query: 730 V-DPRWAAIVESCWHSDPQCRPSFQEL 755
+V C + DP+ RP +
Sbjct: 262 HYSEELRQLVNMCINPDPEKRPDVTYV 288
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 8e-54
Identities = 63/296 (21%), Positives = 115/296 (38%), Gaps = 61/296 (20%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
D++ + E IG G G V+ A G +K +EV +
Sbjct: 12 DFKEI-------ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKAL 58
Query: 557 KRLRHPNVLLFMGA----------------VTSPQRLCIVTEFLPRGSLFRLLQRNTTK- 599
+L H N++ + G + + L I EF +G+L + +++ +
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 600 ------LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
L+ +I +D Y+H +I+RDLK SN+ + VK+GDFGL
Sbjct: 119 LDKVLALELFEQITKGVD------YIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVT 170
Query: 654 -LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
LK++ T G T ++M+PE + ++ ++ D+Y+ G+IL EL +
Sbjct: 171 SLKNDGKRTRSKG--TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF 228
Query: 713 VIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
+ I D + +++ P+ RP+ E+ L+
Sbjct: 229 T------DLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEI------LRTLTVW 272
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-53
Identities = 68/328 (20%), Positives = 129/328 (39%), Gaps = 35/328 (10%)
Query: 447 ESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWED 506
S + + A + + SSSA + + Y I
Sbjct: 7 SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGR--IYSI---- 60
Query: 507 LTIGEQIGQGSCGTVYHAV-WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-- 563
+QIG G V+ + A+K + +E ++ + S+R E++ + +L+ +
Sbjct: 61 ---LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 564 -VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHH 621
+ L+ + Q + +V E L L++ + R+ ++ V +H
Sbjct: 118 IIRLY-DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLEAVHTIHQ 173
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRN 679
I+H DLK +N L+ +K+ DFG++ T + + G +M PE +++
Sbjct: 174 HG--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 680 EPS-----------DEKSDVYSFGVILWELATEKIPWDNL-NSMQVIGAVGFMNQRLEIP 727
S KSDV+S G IL+ + K P+ + N + + A+ N +E P
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290
Query: 728 KDVDPRWAAIVESCWHSDPQCRPSFQEL 755
+ +++ C DP+ R S EL
Sbjct: 291 DIPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-53
Identities = 62/267 (23%), Positives = 118/267 (44%), Gaps = 26/267 (9%)
Query: 508 TIGEQIGQGSCGTVYHAV-WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN--- 563
+I +QIG G V+ + A+K + +E ++ + S+R E++ + +L+ +
Sbjct: 31 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHC 622
+ L+ + Q + +V E L L++ + R+ ++ V +H
Sbjct: 91 IRLY-DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLEAVHTIHQH 146
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRNE 680
I+H DLK +N L+ +K+ DFG++ T + + GT +M PE +++
Sbjct: 147 G--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 681 PS-----------DEKSDVYSFGVILWELATEKIPWDNL-NSMQVIGAVGFMNQRLEIPK 728
S KSDV+S G IL+ + K P+ + N + + A+ N +E P
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 263
Query: 729 DVDPRWAAIVESCWHSDPQCRPSFQEL 755
+ +++ C DP+ R S EL
Sbjct: 264 IPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 2e-53
Identities = 57/312 (18%), Positives = 106/312 (33%), Gaps = 17/312 (5%)
Query: 447 ESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWED 506
H + N + S + + + S + + +
Sbjct: 5 HHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPE------SFFQQS 58
Query: 507 LTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPN 563
++G GS G V+ G AVK + + S K +HP
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
+ A L + TE SL + + L + D +++LH
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG 177
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSD 683
++H D+K +N+ + K+GDFGL + +G P++MAPE+L
Sbjct: 178 --LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGEVQEGDPRYMAPELL-QGSYG 233
Query: 684 EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWH 743
+DV+S G+ + E+A Q + G++ E + +++
Sbjct: 234 TAADVFSLGLTILEVACNMELPHGGEGWQQLRQ-GYL--PPEFTAGLSSELRSVLVMMLE 290
Query: 744 SDPQCRPSFQEL 755
DP+ R + + L
Sbjct: 291 PDPKLRATAEAL 302
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-53
Identities = 62/267 (23%), Positives = 118/267 (44%), Gaps = 26/267 (9%)
Query: 508 TIGEQIGQGSCGTVYHAV-WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN--- 563
+I +QIG G V+ + A+K + +E ++ + S+R E++ + +L+ +
Sbjct: 12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHC 622
+ L+ + Q + +V E L L++ + R+ ++ V +H
Sbjct: 72 IRLY-DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLEAVHTIHQH 127
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRNE 680
I+H DLK +N L+ +K+ DFG++ T + + GT +M PE +++
Sbjct: 128 G--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 681 PS-----------DEKSDVYSFGVILWELATEKIPWDNL-NSMQVIGAVGFMNQRLEIPK 728
S KSDV+S G IL+ + K P+ + N + + A+ N +E P
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244
Query: 729 DVDPRWAAIVESCWHSDPQCRPSFQEL 755
+ +++ C DP+ R S EL
Sbjct: 245 IPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-52
Identities = 71/303 (23%), Positives = 116/303 (38%), Gaps = 24/303 (7%)
Query: 462 WGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTV 521
W S S+ + + + G + + VD + Y +T ++G+GS G V
Sbjct: 20 WSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYE-----YREEVHWMTHQPRVGRGSFGEV 74
Query: 522 YHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579
+ G AVK + + +E+ L P ++ GAV + I
Sbjct: 75 HRMKDKQTGFQCAVKKVRLEVFRV-------EELVACAGLSSPRIVPLYGAVREGPWVNI 127
Query: 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD 639
E L GSL +L+ + L R + G+ YLH I+H D+K+ N+L+
Sbjct: 128 FMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLS 184
Query: 640 KH-WTVKVGDFGLSR-----LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGV 693
+ DFG + ++ LT GT MAPEV+ +P D K D++S
Sbjct: 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCC 244
Query: 694 ILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRWAAIVESCWHSDPQCRPSF 752
++ + PW + + EIP P A ++ +P R S
Sbjct: 245 MMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASA 304
Query: 753 QEL 755
EL
Sbjct: 305 MEL 307
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-51
Identities = 74/291 (25%), Positives = 114/291 (39%), Gaps = 55/291 (18%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
D +GQG+ G V A A+K ++E + + EV L+ L H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQ 62
Query: 563 NVLLFMGA-------------VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD----WR-- 603
V+ + A V L I E+ G+L+ L+ WR
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT- 662
R+IL AL Y+H IIHRDLK N+ +D+ VK+GDFGL++ H +
Sbjct: 123 RQILEALS------YIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 663 -------------KTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNL 708
+ GT ++A EVL +EK D+YS G+I +E+ +
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGM 232
Query: 709 NSMQVIGAVGFMNQRLEIPKDVDPRWAA----IVESCWHSDPQCRPSFQEL 755
+ ++ + + +E P D D I+ DP RP + L
Sbjct: 233 ERVNILKKL--RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-50
Identities = 63/295 (21%), Positives = 109/295 (36%), Gaps = 46/295 (15%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKV--FSRQEYSDEVIHSFRQEVSLMKRLR 560
D + +G+G G V+ A + A+K +E + E +EV + +L
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE---KVMREVKALAKLE 61
Query: 561 HPNVLLFMGA------------VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 608
HP ++ + A + L I + + +L + T + R + +
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 609 --ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT-- 664
L IA V +LH ++HRDLK SN+ VKVGDFGL +
Sbjct: 122 HIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 665 ----------GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVI 714
GT +M+PE + K D++S G+IL+EL + ++ +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTL 237
Query: 715 GAVGFMNQRL-EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
V N + + P +V+ P RP + ++ F+
Sbjct: 238 TDV--RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI------IENAVFE 284
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 4e-50
Identities = 78/206 (37%), Positives = 120/206 (58%), Gaps = 17/206 (8%)
Query: 513 IGQGSCGTVYHAV-WYGSDVAVKV---FSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+G G VY G+ VAVK Q + F+ EV ++ H N+L
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ----FQTEVEMISMAVHRNLLRLR 93
Query: 569 G-AVTSPQRLCIVTEFLPRGSL-FRLLQRNTTK--LDWRRRILMALDIARGVSYLH-HCN 623
G +T +RL +V ++ GS+ L +R ++ LDW +R +AL ARG++YLH HC+
Sbjct: 94 GFCMTPTERL-LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRNEP 681
P IIHRD+K++N+L+D+ + VGDFGL++L +T++TT +GT +APE L
Sbjct: 153 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV-RGTIGHIAPEYLSTGK 211
Query: 682 SDEKSDVYSFGVILWELATEKIPWDN 707
S EK+DV+ +GV+L EL T + +D
Sbjct: 212 SSEKTDVFGYGVMLLELITGQRAFDL 237
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 9e-50
Identities = 77/270 (28%), Positives = 134/270 (49%), Gaps = 29/270 (10%)
Query: 513 IGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571
IG G G VY V G+ VA+K + + S + I F E+ + RHP+++ +G
Sbjct: 47 IGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 572 TSPQRLCIVTEFLPRGSLFRLL---QRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ ++ +++ G+L R L T + W +R+ + + ARG+ YLH IIH
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIH 162
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHE---TYLTTKTGKGTPQWMAPE-VLRNEPSDE 684
RD+KS N+L+D+++ K+ DFG+S+ E T+L+T KGT ++ PE ++ + E
Sbjct: 163 RDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV-KGTLGYIDPEYFIKGRLT-E 220
Query: 685 KSDVYSFGVILWELATEKIPWDNLNSMQVIGAV---GFMNQRLEIPKDVDP--------- 732
KSDVYSFGV+L+E+ + +++ + ++ + VDP
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE 280
Query: 733 ---RWAAIVESCWHSDPQCRPSFQELVDKL 759
++ C + RPS +++ KL
Sbjct: 281 SLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-49
Identities = 57/283 (20%), Positives = 107/283 (37%), Gaps = 39/283 (13%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
Y + E+IG G G+V+ V G A+K + + +EV
Sbjct: 8 RYTTEFH---ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAH 64
Query: 557 KRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALDI 612
L +H +V+ + A + I E+ GSL + R + + L +
Sbjct: 65 AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKH-------------------WTVKVGDFGLSR 653
RG+ Y+H + ++H D+K SN+ + + K+GD G
Sbjct: 125 GRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 654 LKHETYLTTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ +G +++A EVL+ N K+D+++ + + A + N +
Sbjct: 183 RISS----PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH 238
Query: 713 VIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQEL 755
I + IP+ + + +++ H DP+ RPS L
Sbjct: 239 EI----RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMAL 277
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-49
Identities = 82/271 (30%), Positives = 134/271 (49%), Gaps = 24/271 (8%)
Query: 513 IGQGSCGTVYHAVWYGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570
+G+G G VY + VAVK + ++E+ F QE+ +M + +H N++ +G
Sbjct: 39 MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF 98
Query: 571 VTSPQRLCIVTEFLPRGSL-FRLLQRNTTK-LDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ LC+V ++P GSL RL + T L W R +A A G+++LH IH
Sbjct: 99 SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIH 156
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHE---TYLTTKTGKGTPQWMAPEVLRNEPSDEK 685
RD+KS+N+L+D+ +T K+ DFGL+R + T +T++ GT +MAPE LR E + K
Sbjct: 157 RDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRI-VGTTAYMAPEALRGEIT-PK 214
Query: 686 SDVYSFGVILWELATEKIPWDNLNSMQ--VIGAVGFMNQRLEIPKDVDP----------- 732
SD+YSFGV+L E+ T D Q + ++ I +D
Sbjct: 215 SDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVE 274
Query: 733 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 763
++ C H RP +++ L+++
Sbjct: 275 AMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 2e-49
Identities = 63/284 (22%), Positives = 113/284 (39%), Gaps = 32/284 (11%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+ +++G+G V + G A+K E D ++E + + HP
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR--EEAQREADMHRLFNHP 86
Query: 563 NVLLFMGA----VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDW--RRRIL-MALDIARG 615
N+L + + ++ F RG+L+ ++R K ++ +IL + L I RG
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK---------TGK 666
+ +H HRDLK +N+L+ + D G ++ +
Sbjct: 147 LEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 667 GTPQWMAPEVL---RNEPSDEKSDVYSFGVILWELATEKIPWD--NLNSMQVIGAVGFMN 721
T + APE+ + DE++DV+S G +L+ + + P+D V AV
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV---Q 261
Query: 722 QRLEIPKD--VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 763
+L IP+ ++ S DP RP L+ +L LQ
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-48
Identities = 70/255 (27%), Positives = 111/255 (43%), Gaps = 14/255 (5%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRHPNVL 565
G +G+G + A K+ + E+S+ + L H +V+
Sbjct: 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 78
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
F G + +V E R SL L +R + R + I G YLH
Sbjct: 79 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNR-- 135
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 685
+IHRDLK NL +++ VK+GDFGL+ K GTP ++APEVL + +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 686 SDVYSFGVILWELATEKIPWD--NLNSM-QVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742
DV+S G I++ L K P++ L I + IPK ++P A++++
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-----SIPKHINPVAASLIQKML 250
Query: 743 HSDPQCRPSFQELVD 757
+DP RP+ EL++
Sbjct: 251 QTDPTARPTINELLN 265
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-48
Identities = 71/253 (28%), Positives = 114/253 (45%), Gaps = 10/253 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRH 561
ED IG +G+G G VY A +A+KV + + V H R+EV + LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
PN+L G R+ ++ E+ P G+++R LQ+ + + R + +A +SY H
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE-LANALSYCHS 127
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
+IHRD+K NLL+ +K+ DFG S H GT ++ PE++
Sbjct: 128 KR--VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEGRM 183
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741
DEK D++S GV+ +E K P++ + + P V ++
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRL 241
Query: 742 WHSDPQCRPSFQE 754
+P RP +E
Sbjct: 242 LKHNPSQRPMLRE 254
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-47
Identities = 70/255 (27%), Positives = 111/255 (43%), Gaps = 14/255 (5%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRHPNVL 565
G +G+G + A K+ + E+S+ + L H +V+
Sbjct: 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 104
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
F G + +V E R SL L +R + R + I G YLH
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNR-- 161
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 685
+IHRDLK NL +++ VK+GDFGL+ K GTP ++APEVL + +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 686 SDVYSFGVILWELATEKIPWD--NLNSM-QVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742
DV+S G I++ L K P++ L I + IPK ++P A++++
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-----SIPKHINPVAASLIQKML 276
Query: 743 HSDPQCRPSFQELVD 757
+DP RP+ EL++
Sbjct: 277 QTDPTARPTINELLN 291
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-47
Identities = 71/256 (27%), Positives = 119/256 (46%), Gaps = 16/256 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRH 561
+D IG +G+G G VY A +A+KV + + + V H R+E+ + LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
PN+L +R+ ++ EF PRG L++ LQ++ + R M ++A + Y H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME-ELADALHYCHE 132
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
+IHRD+K NLL+ +K+ DFG S H L +T GT ++ PE++ +
Sbjct: 133 RK--VIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRTMCGTLDYLPPEMIEGKT 188
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQV---IGAVGFMNQRLEIPKDVDPRWAAIV 738
DEK D++ GV+ +E P+D+ + + I V L+ P + ++
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----DLKFPPFLSDGSKDLI 243
Query: 739 ESCWHSDPQCRPSFQE 754
P R +
Sbjct: 244 SKLLRYHPPQRLPLKG 259
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-47
Identities = 89/284 (31%), Positives = 144/284 (50%), Gaps = 27/284 (9%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQ 539
+ S + N D E L+ L E+IG+GS G V+ + VA+K+ +
Sbjct: 2 AHSPVQSGLPGMQNLKADPEELFTKL---EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE 58
Query: 540 EYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK 599
E DE I +QE++++ + P V + G+ +L I+ E+L GS LL+
Sbjct: 59 EAEDE-IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD 117
Query: 600 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659
IL +I +G+ YLH IHRD+K++N+L+ +H VK+ DFG++ +T
Sbjct: 118 ETQIATILR--EILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173
Query: 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF 719
+ T GTP WMAPEV++ D K+D++S G+ ELA + P L+ M+V+ F
Sbjct: 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL----F 229
Query: 720 MNQRLEIPKDVDPR----WAAI----VESCWHSDPQCRPSFQEL 755
+ IPK+ P ++ VE+C + +P RP+ +EL
Sbjct: 230 L-----IPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKEL 268
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 7e-47
Identities = 65/266 (24%), Positives = 116/266 (43%), Gaps = 22/266 (8%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSL 555
D+++ G +G+GS VY A + G +VA+K+ ++ Y ++ + EV +
Sbjct: 12 DFKV-------GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD-WRRRILMALDIAR 614
+L+HP++L + +V E G + R L+ R M I
Sbjct: 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIIT 123
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAP 674
G+ YLH I+HRDL SNLL+ ++ +K+ DFGL+ + T GTP +++P
Sbjct: 124 GMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISP 181
Query: 675 EVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQV---IGAVGFMNQRLEIPKDVD 731
E+ +SDV+S G + + L + P+D + + E+P +
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY-----EMPSFLS 236
Query: 732 PRWAAIVESCWHSDPQCRPSFQELVD 757
++ +P R S ++D
Sbjct: 237 IEAKDLIHQLLRRNPADRLSLSSVLD 262
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-46
Identities = 77/307 (25%), Positives = 135/307 (43%), Gaps = 40/307 (13%)
Query: 494 DNDCLDYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQ 551
D+ L + I +D + E IG G+ V A VA+K + ++ + +
Sbjct: 4 DSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLK 62
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD 611
E+ M + HPN++ + + L +V + L GS+ +++ K + + +L
Sbjct: 63 EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 612 IA-------RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664
IA G+ YLH IHRD+K+ N+L+ + +V++ DFG+S T+
Sbjct: 123 IATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180
Query: 665 GK-----GTPQWMAPEVL-RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVG 718
GTP WMAPEV+ + D K+D++SFG+ ELAT P+ M+V+
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---- 236
Query: 719 FMNQRLEIPKDVDPRWAAI------------VESCWHSDPQCRPSFQELVDKLRDLQRQY 766
+ + + P + C DP+ RP+ EL L+ ++
Sbjct: 237 MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL------LRHKF 290
Query: 767 FQASRST 773
FQ +++
Sbjct: 291 FQKAKNK 297
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-46
Identities = 54/264 (20%), Positives = 107/264 (40%), Gaps = 29/264 (10%)
Query: 476 SVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKV 535
+ S S+ N + L+ + + D I + QG + A+K
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKK 61
Query: 536 FSRQE---------------YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580
+ + F+ E+ ++ +++ L G +T+ + I+
Sbjct: 62 YEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYII 121
Query: 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR--------GVSYLHHCNPPIIHRDLK 632
E++ S+ + + LD + + + + SY+H+ I HRD+K
Sbjct: 122 YEYMENDSILKFDEYFF-VLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVK 179
Query: 633 SSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP--SDEKSDVYS 690
SN+L+DK+ VK+ DFG S ++ K +GT ++M PE NE + K D++S
Sbjct: 180 PSNILMDKNGRVKLSDFGES--EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWS 237
Query: 691 FGVILWELATEKIPWDNLNSMQVI 714
G+ L+ + +P+ S+ +
Sbjct: 238 LGICLYVMFYNVVPFSLKISLVEL 261
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 5e-46
Identities = 76/322 (23%), Positives = 132/322 (40%), Gaps = 47/322 (14%)
Query: 472 NSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHA--VWYGS 529
S + G S V + E+ L + + +G VY A V G
Sbjct: 3 GPGSLGGASGRDQSDFVGQT--------VELGELRLRVRRVLAEGGFAFVYEAQDVGSGR 54
Query: 530 DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGA-------VTSPQRLCIVT 581
+ A+K E + QEV MK+L HPN++ F A + Q ++
Sbjct: 55 EYALKRLLSNEEEKN--RAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL 112
Query: 582 EFLPRGSLFRLL--QRNTTKLDWRRRIL-MALDIARGVSYLHHCNPPIIHRDLKSSNLLV 638
L +G L L + L +L + R V ++H PPIIHRDLK NLL+
Sbjct: 113 TELCKGQLVEFLKKMESRGPLS-CDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL 171
Query: 639 DKHWTVKVGDFGLSRLKHETYLTTKTGK------------GTPQWMAPEVL---RNEPSD 683
T+K+ DFG + + + + TP + PE++ N P
Sbjct: 172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG 231
Query: 684 EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKD--VDPRWAAIVESC 741
EK D+++ G IL+ L + P+++ ++++ N + IP + +++ +
Sbjct: 232 EKQDIWALGCILYLLCFRQHPFEDGAKLRIV------NGKYSIPPHDTQYTVFHSLIRAM 285
Query: 742 WHSDPQCRPSFQELVDKLRDLQ 763
+P+ R S E+V +L+++
Sbjct: 286 LQVNPEERLSIAEVVHQLQEIA 307
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-45
Identities = 66/290 (22%), Positives = 116/290 (40%), Gaps = 25/290 (8%)
Query: 481 GSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHA-VWYGSDVAVKVFSRQ 539
GS+ S + D + + + + +G G+ GT+ + ++ DVAVK +
Sbjct: 2 GSSPSLEQDDGDEETSVVIVGKI--SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE 59
Query: 540 EYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT 598
+S +EV L++ HPNV+ + Q I E +L +++
Sbjct: 60 CFSFA-----DREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDF 113
Query: 599 KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV-----DKHWTVKVGDFGLSR 653
I + G+++LH N I+HRDLK N+L+ + DFGL +
Sbjct: 114 AHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 654 L---KHETYLTTKTGKGTPQWMAPEVLRNEPS---DEKSDVYSFGVILWELATE-KIPWD 706
++ GT W+APE+L + D++S G + + + +E P+
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231
Query: 707 NLNSMQVIGAVGFMN-QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQEL 755
Q +G + L K D ++E DPQ RPS + +
Sbjct: 232 KSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 5e-44
Identities = 77/281 (27%), Positives = 135/281 (48%), Gaps = 20/281 (7%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQ 539
+ + K+D D+ E +++ L E++G+GS G+VY A G VA+K +
Sbjct: 9 NPPRRQLKKLDEDSLTKQPEEVFDVL---EKLGEGSYGSVYKAIHKETGQIVAIKQVPVE 65
Query: 540 EYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK 599
E+I +E+S+M++ P+V+ + G+ L IV E+ GS+ +++
Sbjct: 66 SDLQEII----KEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT 121
Query: 600 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659
L + +G+ YLH IHRD+K+ N+L++ K+ DFG++ +T
Sbjct: 122 LTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179
Query: 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF 719
T GTP WMAPEV++ + +D++S G+ E+A K P+ +++ M+ I F
Sbjct: 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI----F 235
Query: 720 MNQRLEIPKDVDP-RWAAI----VESCWHSDPQCRPSFQEL 755
M P P W+ V+ C P+ R + +L
Sbjct: 236 MIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQL 276
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-43
Identities = 50/226 (22%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV- 564
+ + +GQG+ V+ G A+KVF+ + V +E ++K+L H N+
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV-DVQMREFEVLKKLNHKNIV 70
Query: 565 -LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR----RRILMALDIARGVSYL 619
L + T+ + ++ EF P GSL+ +L+ + +L D+ G+++L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR--DVVGGMNHL 128
Query: 620 HHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAP 674
I+HR++K N++ D K+ DFG +R L+ + + GT +++ P
Sbjct: 129 RENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL--YGTEEYLHP 184
Query: 675 EVLR--------NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
++ + D++S GV + AT +P+ +
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-43
Identities = 75/270 (27%), Positives = 132/270 (48%), Gaps = 23/270 (8%)
Query: 498 LDYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSL 555
LD +WE + ++G G+ G VY A G+ A KV + S+E + + E+ +
Sbjct: 15 LDPNEVWEIV---GELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEI 69
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
+ HP ++ +GA +L I+ EF P G++ ++ L + ++ +
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 129
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
+++LH IIHRDLK+ N+L+ +++ DFG+S +T + GTP WMAPE
Sbjct: 130 LNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187
Query: 676 VLRNEPS-----DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 730
V+ E D K+D++S G+ L E+A + P LN M+V+ + + P +
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL----LKIAKSDPPTLL 243
Query: 731 DP-RWAAI----VESCWHSDPQCRPSFQEL 755
P +W+ ++ +P+ RPS +L
Sbjct: 244 TPSKWSVEFRDFLKIALDKNPETRPSAAQL 273
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 7e-43
Identities = 70/264 (26%), Positives = 125/264 (47%), Gaps = 20/264 (7%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
D + + E+IGQG+ GTVY A V G +VA++ + Q+ E+ +M
Sbjct: 17 DPKKKYTRF---EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVM 71
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 616
+ ++PN++ ++ + L +V E+L GSL ++ + + + +
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC--RECLQAL 129
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEV 676
+LH +IHRD+KS N+L+ +VK+ DFG T GTP WMAPEV
Sbjct: 130 EFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 677 LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP-RWA 735
+ + K D++S G++ E+ + P+ N N ++ + ++ P+ +P + +
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL----YLIATNGTPELQNPEKLS 243
Query: 736 AI----VESCWHSDPQCRPSFQEL 755
AI + C D + R S +EL
Sbjct: 244 AIFRDFLNRCLEMDVEKRGSAKEL 267
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 2e-42
Identities = 50/226 (22%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV- 564
+ + +GQG+ V+ G A+KVF+ + V +E ++K+L H N+
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV-DVQMREFEVLKKLNHKNIV 70
Query: 565 -LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR----RRILMALDIARGVSYL 619
L + T+ + ++ EF P GSL+ +L+ + +L D+ G+++L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR--DVVGGMNHL 128
Query: 620 HHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAP 674
I+HR++K N++ D K+ DFG +R L+ + + GT +++ P
Sbjct: 129 RENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL--YGTEEYLHP 184
Query: 675 EVLR--------NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
++ + D++S GV + AT +P+ +
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-42
Identities = 82/296 (27%), Positives = 142/296 (47%), Gaps = 36/296 (12%)
Query: 482 STSSSAVNKVDLDNDCL-DYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSR 538
++ S A + ++D L D ++E + E +G G+ G VY G A+KV
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELV---ELVGNGTYGQVYKGRHVKTGQLAAIKV--- 56
Query: 539 QEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA------VTSPQRLCIVTEFLPRGSLFR 591
+ + + +QE++++K+ H N+ + GA +L +V EF GS+
Sbjct: 57 MDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 116
Query: 592 LLQRNTTKL---DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648
L++ +W I +I RG+S+LH +IHRD+K N+L+ ++ VK+ D
Sbjct: 117 LIKNTKGNTLKEEWIAYIC--REILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVD 172
Query: 649 FGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS-----DEKSDVYSFGVILWELATEKI 703
FG+S T T GTP WMAPEV+ + + D KSD++S G+ E+A
Sbjct: 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
Query: 704 PWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI----VESCWHSDPQCRPSFQEL 755
P +++ M+ + F+ R P+ +W+ +ESC + RP+ ++L
Sbjct: 233 PLCDMHPMRAL----FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQL 284
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 4e-42
Identities = 88/287 (30%), Positives = 134/287 (46%), Gaps = 28/287 (9%)
Query: 482 STSSSAVNKVDLDNDCL--DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFS 537
+ ++ D+ D E L+ DL +IG GS G VY A V VA+K S
Sbjct: 32 GGRAGSLKDPDVAELFFKDDPEKLFSDL---REIGHGSFGAVYFARDVRNSEVVAIKKMS 88
Query: 538 -RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN 596
+ S+E +EV +++LRHPN + + G +V E+ GS LL+ +
Sbjct: 89 YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH 147
Query: 597 TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656
L + +G++YLH N +IHRD+K+ N+L+ + VK+GDFG +
Sbjct: 148 KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSA---- 201
Query: 657 ETYLT-TKTGKGTPQWMAPEVLRNEPS---DEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ + + GTP WMAPEV+ D K DV+S G+ ELA K P N+N+M
Sbjct: 202 -SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 260
Query: 713 VIGAVGFMNQRLEIPKDVDPRWAAI----VESCWHSDPQCRPSFQEL 755
+ + + E P W+ V+SC PQ RP+ + L
Sbjct: 261 AL----YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 303
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-42
Identities = 66/258 (25%), Positives = 118/258 (45%), Gaps = 17/258 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
L +IG+GS G V A G VAVK+ ++ EV +M+ +H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR--ELLFNEVVIMRDYQHF 102
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
NV+ + + L ++ EFL G+L ++ + + + + + ++YLH
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVC--EAVLQALAYLHAQ 160
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 682
+IHRD+KS ++L+ VK+ DFG + K+ GTP WMAPEV+
Sbjct: 161 G--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 683 DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP-RWAAI---- 737
+ D++S G+++ E+ + P+ + + +Q + + PK + + + +
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM----KRLRDSPPPKLKNSHKVSPVLRDF 274
Query: 738 VESCWHSDPQCRPSFQEL 755
+E DPQ R + QEL
Sbjct: 275 LERMLVRDPQERATAQEL 292
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 6e-42
Identities = 56/308 (18%), Positives = 107/308 (34%), Gaps = 38/308 (12%)
Query: 487 AVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHA-----------VWYGSDVAVKV 535
A+ ++ L N L E + ++ ++ ++A + +
Sbjct: 35 AIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDES 94
Query: 536 FSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR 595
S + + ++ M N + + + L I + + +L + R
Sbjct: 95 TDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR 154
Query: 596 NTTKLDWRRRILMAL--DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+ D + + + IA V +LH ++HRDLK SN+ VKVGDFGL
Sbjct: 155 RCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVT 212
Query: 654 LKHETYLTTKT------------GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE 701
+ GT +M+PE + K D++S G+IL+EL
Sbjct: 213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
Query: 702 KIPWDNLNSMQVIGAVGFMNQRL-EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 760
++I V N + + P+ +V+ P RP ++
Sbjct: 273 FSTQMERV--RIITDV--RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI----- 323
Query: 761 DLQRQYFQ 768
++ F+
Sbjct: 324 -IENAIFE 330
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 8e-42
Identities = 60/289 (20%), Positives = 103/289 (35%), Gaps = 56/289 (19%)
Query: 508 TIGEQIGQGSCGTVYHA-VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVL 565
+ +G GS GTV + G VAVK E+ L+ HPNV+
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC-----DIALMEIKLLTESDDHPNVI 72
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRR------RILMALDIARGVSY 618
+ + T+ + L I E +L + +N + + + L+ IA GV++
Sbjct: 73 RYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLL-RQIASGVAH 130
Query: 619 LHHCNPPIIHRDLKSSNLLVD-------------KHWTVKVGDFGLSRL----KHETYLT 661
LH IIHRDLK N+LV ++ + + DFGL + +
Sbjct: 131 LHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 662 TKTGKGTPQWMAPEVLRN-------EPSDEKSDVYSFGVILWELATEKIP--WDNLNSMQ 712
GT W APE+L D++S G + + + ++ D +
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248
Query: 713 VIGAVGFMNQRLEIPKDVDPRWAAI-------VESCWHSDPQCRPSFQE 754
I + + + ++ + DP RP+ +
Sbjct: 249 NI-----IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMK 292
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-41
Identities = 62/302 (20%), Positives = 121/302 (40%), Gaps = 53/302 (17%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
E+ +D ++G G+ G V+ G +A K+ E + + +E+ ++
Sbjct: 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLH 86
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL--MALDIARG 615
P ++ F GA S + I E + GSL ++L++ +IL +++ + +G
Sbjct: 87 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKG 143
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
++YL I+HRD+K SN+LV+ +K+ DFG+S ++ + GT +M+PE
Sbjct: 144 LTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPE 200
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV------------------ 717
L+ +SD++S G+ L E+A + P ++ ++
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260
Query: 718 ---------------GFMNQRLEIPKDVDPRWAAI---------VESCWHSDPQCRPSFQ 753
I + P+ + V C +P R +
Sbjct: 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 320
Query: 754 EL 755
+L
Sbjct: 321 QL 322
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 161 bits (407), Expect = 1e-41
Identities = 65/268 (24%), Positives = 104/268 (38%), Gaps = 23/268 (8%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ E++G G G V + G VA+K RQE S + + E+ +MK+L HPNV+
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQC-RQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 566 -LF-----MGAVTSPQRLCIVTEFLPRGSLFRLLQR--NTTKL--DWRRRILMALDIARG 615
+ + + E+ G L + L + N L R +L DI+
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS--DISSA 133
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQW 671
+ YLH IIHRDLK N+++ + K+ D G ++ L T GT Q+
Sbjct: 134 LRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF--VGTLQY 189
Query: 672 MAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 731
+APE+L + D +SFG + +E T P+ I D
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249
Query: 732 PRWAAIVESCWHSDPQCRPSFQELVDKL 759
A S + +++
Sbjct: 250 LTGAVKFSSVLPTPNHLSGILAGKLERW 277
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 70/278 (25%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVS-LM 556
E+ +DL ++G+G+ G V V G +AVK R + + ++ M
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISM 60
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRI------LMAL 610
+ + P + F GA+ + I E + SL + ++ K + I +A+
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDK---GQTIPEDILGKIAV 116
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK---- 666
I + + +LH +IHRD+K SN+L++ VK+ DFG+S YL K
Sbjct: 117 SIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISG-----YLVDDVAKDIDA 170
Query: 667 GTPQWMAPEVLRNEPS----DEKSDVYSFGVILWELATEKIPWDNLNS-MQVIGAVGFMN 721
G +MAPE + E + KSD++S G+ + ELA + P+D+ + Q + V
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV---- 226
Query: 722 QRLEIPKDVDPRWAAI----VESCWHSDPQCRPSFQEL 755
P+ +++A C + + RP++ EL
Sbjct: 227 VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 264
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 77/299 (25%), Positives = 130/299 (43%), Gaps = 44/299 (14%)
Query: 484 SSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEY 541
S + K+ + + ++ EDL +IG+G+ G+V G +AVK R
Sbjct: 2 SIESSGKLKISPE-QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTV 59
Query: 542 SDEVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL 600
++ ++ +M+ P ++ F GA+ I E + S + + + L
Sbjct: 60 DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVL 118
Query: 601 DWR--RRIL--MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656
D IL + L + +++L N IIHRD+K SN+L+D+ +K+ DFG+S
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGIS---- 173
Query: 657 ETYLTTKTGK----GTPQWMAPEVLRNEPS----DEKSDVYSFGVILWELATEKIPWDNL 708
L K G +MAPE + S D +SDV+S G+ L+ELAT + P+
Sbjct: 174 -GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232
Query: 709 NSMQVIGAVGFMNQRLEIPKDVDPR--------WAAI----VESCWHSDPQCRPSFQEL 755
NS+ +Q ++ K P+ ++ V C D RP ++EL
Sbjct: 233 NSV--------FDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKEL 283
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 3e-41
Identities = 54/245 (22%), Positives = 98/245 (40%), Gaps = 29/245 (11%)
Query: 505 EDLTIGEQIGQG--SCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
+ IG+G TV A G V V+ + + S+E++ + E+ + K
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL---DWRRRILMALDIARGVS 617
HPN++ + + L +VT F+ GS L+ + IL + + +
Sbjct: 85 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYIL--QGVLKALD 142
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK-------GTPQ 670
Y+HH +HR +K+S++L+ V + + +
Sbjct: 143 YIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 671 WMAPEVLRNEPS--DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 728
W++PEVL+ D KSD+YS G+ ELA +P+ ++ + Q++ LE
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML---------LEKLN 251
Query: 729 DVDPR 733
P
Sbjct: 252 GTVPC 256
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 66/298 (22%), Positives = 120/298 (40%), Gaps = 40/298 (13%)
Query: 481 GSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSR 538
GS+ SS L Y+ DL ++G G+CG V+ G +AVK R
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-R 59
Query: 539 QEYSDEVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRN 596
+ + E ++ ++K P ++ G + + I E + + + +
Sbjct: 60 RSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG 119
Query: 597 TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656
++ + I + + YL + +IHRD+K SN+L+D+ +K+ DFG+S
Sbjct: 120 PIPERILGKM--TVAIVKALYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGIS---- 172
Query: 657 ETYLTTKTGK----GTPQWMAPEVLRNEPS-----DEKSDVYSFGVILWELATEKIPWDN 707
L K G +MAPE + D ++DV+S G+ L ELAT + P+ N
Sbjct: 173 -GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231
Query: 708 LNSMQVIGAVGFMNQRLEIPKD------VDPRWAAI----VESCWHSDPQCRPSFQEL 755
+ ++ ++ ++ V+ C D + RP + +L
Sbjct: 232 CKTD--------FEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKL 281
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 69/256 (26%), Positives = 110/256 (42%), Gaps = 39/256 (15%)
Query: 508 TIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQ------------------------EY 541
T+ ++IG+GS G V A + A+KV S++
Sbjct: 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 542 SDEVIHSFRQEVSLMKRLRHPNVL-LF--MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT 598
I QE++++K+L HPNV+ L + L +V E + +G + +
Sbjct: 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNE-DHLYMVFELVNQGPVMEVPTLKPL 134
Query: 599 KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658
D R D+ +G+ YLH+ IIHRD+K SNLLV + +K+ DFG+S +
Sbjct: 135 SEDQARFYFQ--DLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 659 YLTTKTGKGTPQWMAPEVLRNEPSD---EKSDVYSFGVILWELATEKIPWDNLNSMQVIG 715
GTP +MAPE L + DV++ GV L+ + P+ + M +
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS 250
Query: 716 AVGFMNQRLEIPKDVD 731
+ +Q LE P D
Sbjct: 251 KI--KSQALEFPDQPD 264
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 16/195 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
E +G G+ V+ G A+K + + S E++++K+++H N++
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIAVLKKIKHENIV 69
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 623
S +V + + G LF R+L+R T+ D I + V YLH
Sbjct: 70 TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ---VLSAVKYLHENG 126
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 680
I+HRDLK NLL +++ + + DFGLS+++ ++T G TP ++APEVL +
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACG--TPGYVAPEVLAQK 182
Query: 681 PSDEKSDVYSFGVIL 695
P + D +S GVI
Sbjct: 183 PYSKAVDCWSIGVIT 197
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-40
Identities = 66/253 (26%), Positives = 118/253 (46%), Gaps = 13/253 (5%)
Query: 508 TIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ + IG+G+ V A + G +VA+K+ + + + + +EV +MK L HPN++
Sbjct: 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ + + L ++ E+ G +F L+ K R I V Y H
Sbjct: 78 KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR--QIVSAVQYCHQKR- 134
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETYLTTKTGKGTPQWMAPEVLRNEPSD 683
I+HRDLK+ NLL+D +K+ DFG S L G P + APE+ + + D
Sbjct: 135 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGAPPYAAPELFQGKKYD 191
Query: 684 -EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742
+ DV+S GVIL+ L + +P+D N ++ V + + IP + +++
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV--LRGKYRIPFYMSTDCENLLKRFL 249
Query: 743 HSDPQCRPSFQEL 755
+P R + +++
Sbjct: 250 VLNPIKRGTLEQI 262
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 5e-40
Identities = 72/272 (26%), Positives = 124/272 (45%), Gaps = 22/272 (8%)
Query: 509 IGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSD--EVIHSFRQEVSLMKRLRHPN- 563
+GE +G G V+ A DVAVKV R + + FR+E L HP
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 564 VLLF-MGAVTSPQRLC--IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
V ++ G +P IV E++ +L ++ + +R I + D + +++ H
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH 133
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT-TKTGK--GTPQWMAPEVL 677
IIHRD+K +N+++ VKV DFG++R ++ + T+T GT Q+++PE
Sbjct: 134 QNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 678 RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR---- 733
R + D +SDVYS G +L+E+ T + P+ + + V A + + P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHVREDPIPPSARHEGLSAD 249
Query: 734 WAAIVESCWHSDPQCRP-SFQELVDKLRDLQR 764
A+V +P+ R + E+ L +
Sbjct: 250 LDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-40
Identities = 67/268 (25%), Positives = 125/268 (46%), Gaps = 19/268 (7%)
Query: 509 IGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSD--EVIHSFRQEVSLMKRLRHPNV 564
I +++G G TVY A VA+K + E + F +EV +L H N+
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ + +V E++ +L ++ + L I I G+ + H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMR- 131
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK--GTPQWMAPEVLRNEPS 682
I+HRD+K N+L+D + T+K+ DFG+++ ET LT T GT Q+ +PE + E +
Sbjct: 132 -IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGEAT 189
Query: 683 DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL-----EIPKDVDPRWAAI 737
DE +D+YS G++L+E+ + P++ ++ + A+ + + ++ KD+ + +
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIKHIQDSVPNVTTDVRKDIPQSLSNV 247
Query: 738 VESCWHSDPQCRP-SFQELVDKLRDLQR 764
+ D R + QE+ D L +
Sbjct: 248 ILRATEKDKANRYKTIQEMKDDLSSVLH 275
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 8e-40
Identities = 51/196 (26%), Positives = 94/196 (47%), Gaps = 15/196 (7%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ E++G+G+ V V G + A K+ + ++ S +E + ++L+HPN++
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 623
++ +V + + G LF ++ R ++ D I ++Y H
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESIAYCHSNG 125
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRN 679
I+HR+LK NLL+ K VK+ DFGL+ + GTP +++PEVL+
Sbjct: 126 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEVLKK 181
Query: 680 EPSDEKSDVYSFGVIL 695
+P + D+++ GVIL
Sbjct: 182 DPYSKPVDIWACGVIL 197
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 43/309 (13%), Positives = 91/309 (29%), Gaps = 37/309 (11%)
Query: 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFR 550
++++ + + + +G+G+ VY A + +KV + +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE--FYIGT 115
Query: 551 QEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR----NTTKLDWRRRI 606
Q + +K + F A +V E G+L + + I
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 607 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLV-----------DKHWTVKVGDFGLSRLK 655
A+ + + +H C IIH D+K N ++ D + + D G S
Sbjct: 176 SFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233
Query: 656 --HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQV 713
T + E+L N+P + + D + ++ + +
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293
Query: 714 IGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773
+D W + +D LR ++ FQ +
Sbjct: 294 -----KPEGLFRRLPHLDM-WNEFFHVMLNIPDCHHLP---SLDLLRQKLKKVFQQHYTN 344
Query: 774 VGDSTQKEL 782
+ + L
Sbjct: 345 KIRALRNRL 353
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
+ + +G+G+ G V A VAVK+ + D + + E+ + K L H NV+
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVK 69
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
F G + E+ G LF R+ +R L +A GV YLH
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL-MA-GVVYLHGIG-- 125
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRL----KHETYLTTKTGKGTPQWMAPEVLRNEP 681
I HRD+K NLL+D+ +K+ DFGL+ + E L GT ++APE+L+
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTLPYVAPELLKRRE 183
Query: 682 SD-EKSDVYSFGVILWELATEKIPWD 706
E DV+S G++L + ++PWD
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 65/196 (33%), Positives = 101/196 (51%), Gaps = 16/196 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
I +G+GS G V + AVKV ++ ++ + +EV L+K+L HPN++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 623
+ IV E G LF +++R ++ D R + + G++Y+H N
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN 141
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRN 679
I+HRDLK N+L+ +K +K+ DFGLS + T + + GT ++APEVLR
Sbjct: 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLR- 196
Query: 680 EPSDEKSDVYSFGVIL 695
DEK DV+S GVIL
Sbjct: 197 GTYDEKCDVWSAGVIL 212
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 60/260 (23%), Positives = 115/260 (44%), Gaps = 20/260 (7%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSD--EVIHSFRQEVSLMKRLRHPNV 564
+G+ +G+GS G V AVK+ +++ + ++E+ L++RLRH NV
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 565 L-LF--MGAVTSPQRLCIVTEFLPRGS--LFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
+ L + Q++ +V E+ G + + + + G+ YL
Sbjct: 69 IQLVDVLYNEE-KQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFC--QLIDGLEYL 125
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT--KTGKGTPQWMAPEVL 677
H I+H+D+K NLL+ T+K+ G++ H +T +G+P + PE+
Sbjct: 126 HSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 678 RNEP--SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735
S K D++S GV L+ + T P++ N ++ +G IP D P +
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG--KGSYAIPGDCGPPLS 241
Query: 736 AIVESCWHSDPQCRPSFQEL 755
+++ +P R S +++
Sbjct: 242 DLLKGMLEYEPAKRFSIRQI 261
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 4e-38
Identities = 76/356 (21%), Positives = 137/356 (38%), Gaps = 86/356 (24%)
Query: 493 LDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEV 545
L D +E + L +G+ +G+G+ G V A +G D VAVK+ ++ +
Sbjct: 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSE 68
Query: 546 IHSFRQEVSL---------------------------MKRLRHPNVLLF----------- 567
+ E+ + ++ + N+ +
Sbjct: 69 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128
Query: 568 ---------------MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR------- 605
V +RL +T S + +++ + ++
Sbjct: 129 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKD 188
Query: 606 -------ILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KH 656
I + +A+G+ +L IHRDL + N+L+ + VK+ DFGL+R K
Sbjct: 189 FLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNL-NSMQVI 714
Y+ + +WMAPE + + +SDV+SFGV+LWE+ + P+ + +
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 306
Query: 715 GAV--GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
+ G R+ P P + CWH +P RP+F ELV+ L +L + Q
Sbjct: 307 RRLKEGT---RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 359
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-38
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
+ + +G+G+ G V A VAVK+ + D + + E+ + K L H NV+
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVK 69
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
F G + E+ G LF R+ +R L +A GV YLH
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL-MA-GVVYLHGIG-- 125
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRL----KHETYLTTKTGKGTPQWMAPEVLRNEP 681
I HRD+K NLL+D+ +K+ DFGL+ + E L GT ++APE+L+
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTLPYVAPELLKRRE 183
Query: 682 SD-EKSDVYSFGVILWELATEKIPWD 706
E DV+S G++L + ++PWD
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-37
Identities = 51/196 (26%), Positives = 94/196 (47%), Gaps = 15/196 (7%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ E++G+G+ V V G + A K+ + ++ S +E + ++L+HPN++
Sbjct: 32 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 623
++ +V + + G LF ++ R ++ D I ++Y H
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESIAYCHSNG 148
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRN 679
I+HR+LK NLL+ K VK+ DFGL+ + GTP +++PEVL+
Sbjct: 149 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEVLKK 204
Query: 680 EPSDEKSDVYSFGVIL 695
+P + D+++ GVIL
Sbjct: 205 DPYSKPVDIWACGVIL 220
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 10/210 (4%)
Query: 508 TIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRHPNV 564
+G+ +G G+ G V G VAVK+ +RQ+ S +V+ ++E+ +K RHP++
Sbjct: 14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
+ +++P +V E++ G LF + + + RR+ I V Y H
Sbjct: 74 IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ--QILSAVDYCHRHM 131
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSD 683
++HRDLK N+L+D H K+ DFGLS + + +T G+P + APEV+
Sbjct: 132 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTSCGSPNYAAPEVISGRLYA 188
Query: 684 -EKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ D++S GVIL+ L +P+D+ +
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPT 218
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-37
Identities = 64/271 (23%), Positives = 120/271 (44%), Gaps = 36/271 (13%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYS------DEVIHSFRQEVSLMKRL 559
+ + +G G+CG V A VA+++ S+++++ + + E+ ++K+L
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSY 618
HP ++ + IV E + G LF +++ +L L + V Y
Sbjct: 198 NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQY 254
Query: 619 LHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAP 674
LH IIHRDLK N+L+ ++ +K+ DFG S+ L + + T GTP ++AP
Sbjct: 255 LHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLAP 310
Query: 675 EVLRNEPS---DEKSDVYSFGVILWELATEKIP-WDNLNSMQVIGAVGFMNQRLEIPKDV 730
EVL + + + D +S GVIL+ + P ++ + + + + +
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI--TSGKYNFI--- 365
Query: 731 DPRWAAI-------VESCWHSDPQCRPSFQE 754
WA + V+ DP+ R + +E
Sbjct: 366 PEVWAEVSEKALDLVKKLLVVDPKARFTTEE 396
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-37
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQ------EYSDEVIHSFRQEVSLMKRL 559
+ + +G G+CG V A VA+K+ S++ + + E+ ++K+L
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSY 618
HP ++ + IV E + G LF +++ +L L + V Y
Sbjct: 73 NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQY 129
Query: 619 LHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
LH IIHRDLK N+L+ ++ +K+ DFG S++ ET L +T GTP ++APE
Sbjct: 130 LHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLAPE 186
Query: 676 VLRNEPS---DEKSDVYSFGVIL 695
VL + + + D +S GVIL
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 18/200 (9%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFS----RQEYSDEVIHSFRQEVSLMKRLRH 561
IGE++G G V G + A K R +EVS+++++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLH 620
NV+ + + ++ E + G LF L Q+ L I GV+YLH
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLH 132
Query: 621 HCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPE 675
I H DLK N+++ +K+ DFGL+ ++ G TP+++APE
Sbjct: 133 TKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG--TPEFVAPE 188
Query: 676 VLRNEPSDEKSDVYSFGVIL 695
++ EP ++D++S GVI
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-37
Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSR-------QEYSDEVIHSFRQEVSLMKR 558
E +G+G V + + AVK+ E E+ + +EV ++++
Sbjct: 20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 559 L-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARG 615
+ HPN++ + +V + + +G LF L ++ T ++ + R+ + +
Sbjct: 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK---IMRALLEV 136
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAP 674
+ LH N I+HRDLK N+L+D +K+ DFG S L L GTP ++AP
Sbjct: 137 ICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC--GTPSYLAP 192
Query: 675 EVLRNEPS------DEKSDVYSFGVIL 695
E++ + ++ D++S GVI+
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-36
Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 12/195 (6%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ E++G+G+ V V G + A + + ++ S +E + + L+HPN++
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 623
+++ ++ + + G LF ++ R ++ D I V + H
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH---CIQQILEAVLHCHQMG 130
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 680
++HR+LK NLL+ K VK+ DFGL+ GTP +++PEVLR +
Sbjct: 131 --VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD 188
Query: 681 PSDEKSDVYSFGVIL 695
P + D+++ GVIL
Sbjct: 189 PYGKPVDLWACGVIL 203
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 49/200 (24%), Positives = 87/200 (43%), Gaps = 18/200 (9%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFS----RQEYSDEVIHSFRQEVSLMKRLRH 561
+GE++G G V G + A K +EV++++ +RH
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLH 620
PN++ + + ++ E + G LF L ++ L I GV YLH
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLH 125
Query: 621 HCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPE 675
I H DLK N+++ + +K+ DFG++ ++ G TP+++APE
Sbjct: 126 SKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFG--TPEFVAPE 181
Query: 676 VLRNEPSDEKSDVYSFGVIL 695
++ EP ++D++S GVI
Sbjct: 182 IVNYEPLGLEADMWSIGVIT 201
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 55/206 (26%), Positives = 102/206 (49%), Gaps = 25/206 (12%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSR------QEYSDEVIHSFRQEVSLMKRL 559
+ IG+G V V G + AVK+ E +EV + R+E +++++
Sbjct: 97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156
Query: 560 R-HPNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGV 616
HP+++ + + S + +V + + +G LF L ++ ++ + R + + V
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRS---IMRSLLEAV 213
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPE 675
S+LH N I+HRDLK N+L+D + +++ DFG S L+ L GTP ++APE
Sbjct: 214 SFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC--GTPGYLAPE 269
Query: 676 VLRNEPS------DEKSDVYSFGVIL 695
+L+ ++ D+++ GVIL
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEV---IHSFRQEVSLMKRLRHP 562
+ E IG+G V + G AVK+ +++ ++E S+ L+HP
Sbjct: 27 ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHP 86
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDW--RRRILMALDIARGVSYL 619
+++ + +S L +V EF+ L +++R + I + Y
Sbjct: 87 HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 620 HHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEV 676
H N IIHRD+K +L+ + VK+G FG++ E+ L GTP +MAPEV
Sbjct: 147 HDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204
Query: 677 LRNEPSDEKSDVYSFGVIL 695
++ EP + DV+ GVIL
Sbjct: 205 VKREPYGKPVDVWGCGVIL 223
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-36
Identities = 45/315 (14%), Positives = 98/315 (31%), Gaps = 51/315 (16%)
Query: 507 LTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLR--- 560
L G +GQ A G V V E I ++EV ++ LR
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 561 -------------------HPNVLLFMGAVTSPQRLCIVTEFL----PRGSLFRLLQ--- 594
P + + + +++ F + +L +
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 595 ---RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651
L R+ + L + R ++ LHH ++H L+ ++++D+ V + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 652 SRLKHETYLT-TKTGKGTPQWMAPEVLRNEPSDEK-----SDVYSFGVILWELATEKIPW 705
+ ++ G P+ A +L D ++ G+ ++ + +P
Sbjct: 258 LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317
Query: 706 DNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDK--LRDLQ 763
+ ++ + IP+ V A++E + R + ++ L+
Sbjct: 318 TDDAALGGSEWI--FRSCKNIPQPV----RALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371
Query: 764 RQYFQASRSTVGDST 778
+ A D
Sbjct: 372 TELSAALPLYQTDGE 386
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 57/268 (21%), Positives = 103/268 (38%), Gaps = 25/268 (9%)
Query: 508 TIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSD--EVIHSFRQEVSLMKRLRHPN 563
+ +G+G G VY A VA+K+ + S ++E RL+ P+
Sbjct: 37 RLRRLVGRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 564 VLLFMGAV----TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
V+ + +L + + L +L+R L R + + I +
Sbjct: 96 VV----PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAA 150
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT-TKTGKGTPQWMAPEVLR 678
H HRD+K N+LV + DFG++ + LT GT +MAPE
Sbjct: 151 HAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS 208
Query: 679 NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR----W 734
+ ++D+Y+ +L+E T P+ + + V +NQ + P V P +
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPPYQG-DQLSV--MGAHINQAIPRPSTVRPGIPVAF 265
Query: 735 AAIVESCWHSDPQCR-PSFQELVDKLRD 761
A++ +P+ R + +L
Sbjct: 266 DAVIARGMAKNPEDRYVTCGDLSAAAHA 293
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 64/252 (25%), Positives = 115/252 (45%), Gaps = 23/252 (9%)
Query: 452 EGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGE 511
+ S + +++S ++ ++ G+ S +D N + L + +
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSN----RDALSDFFEVES 59
Query: 512 QIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
++G+G+ VY G+ A+KV + R E+ ++ RL HPN++
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKE 115
Query: 570 AVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPII 627
+P + +V E + G LF R++++ ++ D I V+YLH I+
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAAD---AVKQILEAVAYLHENG--IV 170
Query: 628 HRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRNEPSD 683
HRDLK NLL +K+ DFGLS+ ++H+ + T G TP + APE+LR
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCG--TPGYCAPEILRGCAYG 228
Query: 684 EKSDVYSFGVIL 695
+ D++S G+I
Sbjct: 229 PEVDMWSVGIIT 240
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 28/218 (12%)
Query: 508 TIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ IG G+ G VAVK R DE + ++E+ + LRHPN++
Sbjct: 23 DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV---QREIINHRSLRHPNIV 79
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR--------GVS 617
F + +P L I+ E+ G L+ + R + D AR GVS
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERICNA------GR---FSEDEARFFFQQLLSGVS 130
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWT--VKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
Y H I HRDLK N L+D +K+ DFG S+ K+ GTP ++APE
Sbjct: 131 YCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPE 187
Query: 676 VLRNEPSD-EKSDVYSFGVILWELATEKIPWDNLNSMQ 712
VL + D + +DV+S GV L+ + P+++ +
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR 225
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 18/204 (8%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
Y + +++G+G V + G + A K ++ + E+++++
Sbjct: 30 YILT------SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLE 83
Query: 558 RLRH-PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARG 615
+ P V+ + + ++ E+ G +F L + I + I G
Sbjct: 84 LAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEG 143
Query: 616 VSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQW 671
V YLH N I+H DLK N+L+ +K+ DFG+SR + H L G TP++
Sbjct: 144 VYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMG--TPEY 199
Query: 672 MAPEVLRNEPSDEKSDVYSFGVIL 695
+APE+L +P +D+++ G+I
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIA 223
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-36
Identities = 44/316 (13%), Positives = 97/316 (30%), Gaps = 67/316 (21%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLR-- 560
L G +GQ A G V V E I ++EV ++ LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 561 --------------------HPNVLLFMGAVTSPQRLCIVTEFL----PRGSLFRLLQ-- 594
P + + + +++ F + +L +
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 595 ----RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
L R+ + L + R ++ LHH ++H L+ ++++D+ V + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFE 251
Query: 651 LSRLKHETYLTTKTGKGTPQWMAPEVL-----------RNEPSDEKSDVYSFGVILWELA 699
+++ + + PE+ R D ++ G++++ +
Sbjct: 252 HLVRDGARVVSS----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 700 TEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPS-------- 751
+P ++ + IP+ V A++E + R
Sbjct: 308 CADLPITKDAALGGSEWI--FRSCKNIPQPV----RALLEGFLRYPKEDRLLPLQAMETP 361
Query: 752 -FQELVDKLRDLQRQY 766
+++L +L Y
Sbjct: 362 EYEQLRTELSAALPLY 377
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 139 bits (350), Expect = 6e-36
Identities = 30/315 (9%), Positives = 72/315 (22%), Gaps = 61/315 (19%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRHP 562
L + E + G V+ D A+KVF+ + + + RL
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 563 NVLLFMGA--------------------------VTSPQRLCIVTEFLPRGSLFRLLQR- 595
+ + ++ L L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTL 181
Query: 596 -----NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
++ + R + L ++H NL + + +GD
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVS 239
Query: 651 LSRLKHETYLTTKTGKGTPQWMAPEVL---RNEPSDEKSDVYSFGVILWELATEKIPWDN 707
+ P AP + + G+ ++ + +P+
Sbjct: 240 ALWKVGTRGPAS----SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295
Query: 708 LNS-------MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPS--------- 751
+ + G + + ++ + D + R
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355
Query: 752 FQELVDKLRDLQRQY 766
F +L +++
Sbjct: 356 FLQLQNEISSSLSTG 370
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-36
Identities = 66/304 (21%), Positives = 119/304 (39%), Gaps = 29/304 (9%)
Query: 466 SSSVNVNSTSSVSSCGSTSSSAVNKVDLDND-CLDYEILWEDLTIGEQIGQGSCGTVYHA 524
SS + + +S + GS + + + E L +G +G G G+VY
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62
Query: 525 --VWYGSDVAVKVFSRQEYSDEVIHSF----RQEVSLMKRLRH--PNVLLFMGAVTSPQR 576
V VA+K + SD EV L+K++ V+ + P
Sbjct: 63 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122
Query: 577 LCIVTEF-LPRGSLFRLLQRNTTKLDWR--RRILMALDIARGVSYLHHCNPPIIHRDLKS 633
++ E P LF + L R + V + H+C ++HRD+K
Sbjct: 123 FVLILERPEPVQDLFDFITERG-ALQEELARSFFW--QVLEAVRHCHNCG--VLHRDIKD 177
Query: 634 SNLLVD-KHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSD-EKSDVYSF 691
N+L+D +K+ DFG L +T T GT + PE +R + V+S
Sbjct: 178 ENILIDLNRGELKLIDFGSGALLKDTVYTDFD--GTRVYSPPEWIRYHRYHGRSAAVWSL 235
Query: 692 GVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPS 751
G++L+++ IP+++ + + ++ + V ++ C P RP+
Sbjct: 236 GILLYDMVCGDIPFEHDEEI--------IRGQVFFRQRVSSECQHLIRWCLALRPSDRPT 287
Query: 752 FQEL 755
F+E+
Sbjct: 288 FEEI 291
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 61/263 (23%), Positives = 106/263 (40%), Gaps = 30/263 (11%)
Query: 508 TIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSR----QEYSDEVIHSFRQEVSLMKRLR- 560
+G +G+G GTV+ + VA+KV R + EV+L+ ++
Sbjct: 34 RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 561 ---HPNVLLFMGAVTSPQRLCIVTEF-LPRGSLFRLLQRNTTKLDWR--RRILMALDIAR 614
HP V+ + + + +V E LP LF + L R +
Sbjct: 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFG--QVVA 150
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 673
+ + H ++HRD+K N+L+D + K+ DFG L H+ T GT +
Sbjct: 151 AIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD--GTRVYSP 206
Query: 674 PEVLRNEPSD-EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 732
PE + + V+S G++L+++ IP++ + + L P V P
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI--------LEAELHFPAHVSP 258
Query: 733 RWAAIVESCWHSDPQCRPSFQEL 755
A++ C P RPS +E+
Sbjct: 259 DCCALIRRCLAPKPSSRPSLEEI 281
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 52/200 (26%), Positives = 84/200 (42%), Gaps = 18/200 (9%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFS----RQEYSDEVIHSFRQEVSLMKRLRH 561
GE++G G V G A K + +EVS++K ++H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLH 620
PNV+ + + ++ E + G LF L ++ L I GV YLH
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLH 131
Query: 621 HCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPE 675
I H DLK N+++ +K+ DFGL+ + G TP+++APE
Sbjct: 132 SLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG--TPEFVAPE 187
Query: 676 VLRNEPSDEKSDVYSFGVIL 695
++ EP ++D++S GVI
Sbjct: 188 IVNYEPLGLEADMWSIGVIT 207
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFS----RQEYSDEVIHSFRQEVSLMKRLRH 561
IGE++G G V G + A K R +EVS+++++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLH 620
PN++ + + ++ E + G LF L Q+ L I GV+YLH
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLH 132
Query: 621 HCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPE 675
I H DLK N+++ +K+ DFGL+ ++ G TP+++APE
Sbjct: 133 TKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG--TPEFVAPE 188
Query: 676 VLRNEPSDEKSDVYSFGVIL 695
++ EP ++D++S GVI
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 71/306 (23%), Positives = 117/306 (38%), Gaps = 66/306 (21%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSR---QEYSDEVIHSFRQEVSLMKRLRHP 562
+ IGQGS G V A+ + A+K+ ++ ++ + + + + EV LMK+L HP
Sbjct: 29 HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMAL----------- 610
N+ Q +C+V E G L +L ++
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 611 ---------------------------DIARGVSYLHHCNPPIIHRDLKSSNLLV--DKH 641
I + YLH+ I HRD+K N L +K
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKS 206
Query: 642 WTVKVGDFGLSRL----KHETYLTTKTGKGTPQWMAPEVLR--NEPSDEKSDVYSFGVIL 695
+ +K+ DFGLS+ + Y T GTP ++APEVL NE K D +S GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 696 WELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI-------VESCWHSDPQC 748
L +P+ +N I V +N++L +P + + + + + +
Sbjct: 267 HLLLMGAVPFPGVNDADTISQV--LNKKLCFE---NPNYNVLSPLARDLLSNLLNRNVDE 321
Query: 749 RPSFQE 754
R
Sbjct: 322 RFDAMR 327
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 75/253 (29%), Positives = 126/253 (49%), Gaps = 15/253 (5%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRHPNVL 565
I E +G+GS G V A VA+K SRQ ++ +E+S +K LRHP+++
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+T+P + +V E+ G LF ++++ D RR I + Y H
Sbjct: 73 KLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQ--QIICAIEYCHRHK- 128
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETYLTTKTGKGTPQWMAPEVLRNEPSD 683
I+HRDLK NLL+D + VK+ DFGLS + +L KT G+P + APEV+ +
Sbjct: 129 -IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL--KTSCGSPNYAAPEVINGKLYA 185
Query: 684 -EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742
+ DV+S G++L+ + ++P+D+ + V + +P + P +++
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLIRRMI 243
Query: 743 HSDPQCRPSFQEL 755
+DP R + QE+
Sbjct: 244 VADPMQRITIQEI 256
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 61/263 (23%), Positives = 112/263 (42%), Gaps = 28/263 (10%)
Query: 508 TIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE------YSDEVIHSFRQEVSLMKRL 559
+ +G G+ G V+ A +V VK +++ D + E++++ R+
Sbjct: 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGS-LFRLLQRNTTKLDWR--RRILMALDIARGV 616
H N++ + + +V E G LF + R+ +LD I + V
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFR--QLVSAV 143
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETYLTTKTGKGTPQWMAPE 675
YL + IIHRD+K N+++ + +T+K+ DFG + + T GT ++ APE
Sbjct: 144 GYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTFCGTIEYCAPE 199
Query: 676 VLRNEPSD-EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734
VL P + +++S GV L+ L E+ P+ L + + P V
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------VEAAIHPPYLVSKEL 251
Query: 735 AAIVESCWHSDPQCRPSFQELVD 757
++V P+ R + ++LV
Sbjct: 252 MSLVSGLLQPVPERRTTLEKLVT 274
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 44/194 (22%), Positives = 88/194 (45%), Gaps = 14/194 (7%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
I E +G+G G V+ V K + ++ ++E+S++ RH N+L
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV---KKEISILNIARHRNIL 64
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ S + L ++ EF+ +F R+ +L+ R + + + +LH N
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLHSHN- 122
Query: 625 PIIHRDLKSSNLLV--DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRNEP 681
I H D++ N++ + T+K+ +FG +R LK P++ APEV +++
Sbjct: 123 -IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT--APEYYAPEVHQHDV 179
Query: 682 SDEKSDVYSFGVIL 695
+D++S G ++
Sbjct: 180 VSTATDMWSLGTLV 193
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-35
Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 13/194 (6%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
I E++G G+ G V+ V G K + D ++ + E+S+M +L HP ++
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLI 111
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
A + ++ EFL G LF R+ + K+ I G+ ++H +
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMHEHS- 169
Query: 625 PIIHRDLKSSNLLV--DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRNEP 681
I+H D+K N++ K +VK+ DFGL+ L + + T T ++ APE++ EP
Sbjct: 170 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA--TAEFAAPEIVDREP 226
Query: 682 SDEKSDVYSFGVIL 695
+D+++ GV+
Sbjct: 227 VGFYTDMWAIGVLG 240
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 59/196 (30%), Positives = 90/196 (45%), Gaps = 18/196 (9%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
T+ IG+GS G V AV A K + D + F+QE+ +MK L HPN++
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNII 69
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 623
+ +V E G LF R++ + + D R + D+ V+Y H N
Sbjct: 70 RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---IMKDVLSAVAYCHKLN 126
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRN 679
+ HRDLK N L +K+ DFGL+ K + TK GTP +++P+VL
Sbjct: 127 --VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVLEG 182
Query: 680 EPSDEKSDVYSFGVIL 695
+ D +S GV++
Sbjct: 183 -LYGPECDEWSAGVMM 197
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-35
Identities = 65/210 (30%), Positives = 109/210 (51%), Gaps = 12/210 (5%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRHPNVL 565
+G+ +G G+ G V G VAVK+ +RQ+ S +V+ R+E+ +K RHP+++
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+++P + +V E++ G LF + + RR+ I GV Y H
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ--QILSGVDYCHRHM- 136
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETYLTTKTGKGTPQWMAPEVLRNEPSD 683
++HRDLK N+L+D H K+ DFGLS + +L +T G+P + APEV+
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAAPEVISGRLYA 193
Query: 684 -EKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ D++S GVIL+ L +P+D+ +
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPT 223
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-34
Identities = 71/261 (27%), Positives = 119/261 (45%), Gaps = 26/261 (9%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+++G G+ G V + A+K+ + S +EV+++K L HPN++
Sbjct: 40 QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ +V E G LF ++ R K + ++ + GV+YLH N
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHN- 156
Query: 625 PIIHRDLKSSNLLV---DKHWTVKVGDFGLSRL-KHETYLTTKTGKGTPQWMAPEVLRNE 680
I+HRDLK NLL+ +K +K+ DFGLS + +++ + + GT ++APEVLR +
Sbjct: 157 -IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEVLR-K 212
Query: 681 PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI--- 737
DEK DV+S GVIL+ L P+ +++ V + P W +
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV--EKGKYTFD---SPEWKNVSEG 267
Query: 738 ----VESCWHSDPQCRPSFQE 754
++ D Q R S Q+
Sbjct: 268 AKDLIKQMLQFDSQRRISAQQ 288
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-34
Identities = 74/264 (28%), Positives = 120/264 (45%), Gaps = 30/264 (11%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
I +G+GS G V + AVKV ++ ++ + +EV L+K+L HPN++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 623
+ IV E G LF +++R ++ D R + + G++Y+H N
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN 141
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRL-KHETYLTTKTGKGTPQWMAPEVLRN 679
I+HRDLK N+L+ +K +K+ DFGLS + T + + GT ++APEVLR
Sbjct: 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLR- 196
Query: 680 EPSDEKSDVYSFGVILWELATEKIP-WDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI- 737
DEK DV+S GVIL+ L + P + N ++ V + P+W I
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPFYGK-NEYDILKRV--ETGKYAFD---LPQWRTIS 250
Query: 738 ------VESCWHSDPQCRPSFQEL 755
+ P R + +
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQC 274
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 56/196 (28%), Positives = 92/196 (46%), Gaps = 13/196 (6%)
Query: 506 DLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
++ E +G G G V+ G +A K+ + D + E+S+M +L H N
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD--KEEVKNEISVMNQLDHAN 147
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
++ A S + +V E++ G LF R++ + L IL I G+ ++H
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY-NLTELDTILFMKQICEGIRHMHQM 206
Query: 623 NPPIIHRDLKSSNLLVDKHWT--VKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRN 679
I+H DLK N+L +K+ DFGL+R K L G TP+++APEV+
Sbjct: 207 Y--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG--TPEFLAPEVVNY 262
Query: 680 EPSDEKSDVYSFGVIL 695
+ +D++S GVI
Sbjct: 263 DFVSFPTDMWSVGVIA 278
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 59/256 (23%), Positives = 116/256 (45%), Gaps = 22/256 (8%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLR 560
ED G+ +G+GS TV A + A+K+ ++ ++V + +E +M RL
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV-TRERDVMSRLD 88
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR-----ILMALDIARG 615
HP + ++L + G L + +++ + + R I+ AL+
Sbjct: 89 HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE---- 144
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMA 673
YLH IIHRDLK N+L+++ +++ DFG +++ + GT Q+++
Sbjct: 145 --YLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200
Query: 674 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733
PE+L + + + SD+++ G I+++L P+ N + + + + P+ P+
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFPK 258
Query: 734 WAAIVESCWHSDPQCR 749
+VE D R
Sbjct: 259 ARDLVEKLLVLDATKR 274
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 48/197 (24%), Positives = 89/197 (45%), Gaps = 20/197 (10%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNV 564
+ E IG GS + + AVK+ + + +E+ ++ R +HPN+
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK------RDPTEEIEILLRYGQHPNI 78
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHC 622
+ + + +VTE + G L ++L++ ++ + + I + V YLH
Sbjct: 79 ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA---VLFTITKTVEYLHAQ 135
Query: 623 NPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 678
++HRDLK SN+L ++++ DFG ++ T T ++APEVL
Sbjct: 136 G--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLE 193
Query: 679 NEPSDEKSDVYSFGVIL 695
+ D D++S GV+L
Sbjct: 194 RQGYDAACDIWSLGVLL 210
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 64/277 (23%), Positives = 114/277 (41%), Gaps = 37/277 (13%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
Y++ + +G+GS V AVK+ S++ ++ ++E++ +
Sbjct: 9 HYDLD----LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEAN-----TQKEITAL 59
Query: 557 KRLR-HPNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIA 613
K HPN++ +V E L G LF R+ ++ ++ + + +
Sbjct: 60 KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY---IMRKLV 116
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ 670
VS++H ++HRDLK NLL + + +K+ DFG +RLK KT T
Sbjct: 117 SAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLH 174
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIP-WDNLNSMQVIGAVGFMNQ----RLE 725
+ APE+L DE D++S GVIL+ + + ++P + S+ AV M +
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS 234
Query: 726 IPKDVDPRWAAI-------VESCWHSDPQCRPSFQEL 755
W + ++ DP R L
Sbjct: 235 FE---GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-34
Identities = 56/268 (20%), Positives = 98/268 (36%), Gaps = 33/268 (12%)
Query: 509 IGEQIGQGSCGTVYHA---VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-V 564
+ I G G +Y A G V +K E E + + HP+ V
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 565 LLF----MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
+F IV E++ SL R + KL I L+I +SYLH
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH 199
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK--GTPQWMAPEVLR 678
+++ DLK N+++ + +K+ D G G GTP + APE++R
Sbjct: 200 SIG--LVYNDLKPENIMLTEE-QLKLIDLGAVSR------INSFGYLYGTPGFQAPEIVR 250
Query: 679 NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738
P+ +D+Y+ G L L + + + + + ++
Sbjct: 251 TGPTV-ATDIYTVGRTLAALTLDLPTRNGRYVDGL--------PEDDPVLKTYDSYGRLL 301
Query: 739 ESCWHSDPQCRP-SFQELVDKLRDLQRQ 765
DP+ R + +E+ +L + R+
Sbjct: 302 RRAIDPDPRQRFTTAEEMSAQLTGVLRE 329
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-34
Identities = 71/263 (26%), Positives = 114/263 (43%), Gaps = 27/263 (10%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEV-IHSFRQEVSLMKRLRHPNV 564
+G+GS G V G + AVKV S+++ + S +EV L+K+L HPN+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
+ +V E G LF ++ R + + + G++Y+H
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNK 146
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRL-KHETYLTTKTGKGTPQWMAPEVLRN 679
I+HRDLK NLL+ K +++ DFGLS + + K GT ++APEVL
Sbjct: 147 --IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPEVLH- 201
Query: 680 EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI-- 737
DEK DV+S GVIL+ L + P++ N ++ V + P+W +
Sbjct: 202 GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV--EKGKYTFE---LPQWKKVSE 256
Query: 738 -----VESCWHSDPQCRPSFQEL 755
+ P R S ++
Sbjct: 257 SAKDLIRKMLTYVPSMRISARDA 279
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 28/208 (13%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
DY++ + +G G G V G A+K+ RQEV
Sbjct: 29 DYQLS------KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHH 75
Query: 557 KRL-RHPNVLLFMGA----VTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMAL 610
+ P+++ + + L I+ E + G LF R+ +R R +
Sbjct: 76 WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 135
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKG 667
DI + +LH N I HRD+K NLL +K +K+ DFG ++ + L T
Sbjct: 136 DIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY-- 191
Query: 668 TPQWMAPEVLRNEPSDEKSDVYSFGVIL 695
TP ++APEVL E D+ D++S GVI+
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-33
Identities = 66/276 (23%), Positives = 100/276 (36%), Gaps = 37/276 (13%)
Query: 432 NESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKV 491
+ S Q P P ++ + V S +A+
Sbjct: 3 SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID- 61
Query: 492 DLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSF 549
DY++ + +G G G V A+K+
Sbjct: 62 -------DYKVT------SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KA 101
Query: 550 RQEVSLMKRL-RHPNVLLFMGA----VTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWR 603
R+EV L R + P+++ + + L IV E L G LF R+ R R
Sbjct: 102 RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 161
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETY 659
+ I + YLH N I HRD+K NLL + +K+ DFG ++
Sbjct: 162 EASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219
Query: 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVIL 695
LTT TP ++APEVL E D+ D++S GVI+
Sbjct: 220 LTTPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 47/197 (23%), Positives = 84/197 (42%), Gaps = 15/197 (7%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
++G G+ G V+ G + +K ++ + E+ ++K L HPN++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-MEQIEAEIEVLKSLDHPNII 83
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTK--LDWRRRILMALDIARGVSYLHHC 622
+ IV E G L R++ L + + ++Y H
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 623 NPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLR 678
+ ++H+DLK N+L H +K+ DFGL+ K + + T GT +MAPEV +
Sbjct: 144 H--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYMAPEVFK 199
Query: 679 NEPSDEKSDVYSFGVIL 695
K D++S GV++
Sbjct: 200 -RDVTFKCDIWSAGVVM 215
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-32
Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 13/194 (6%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
I E++G G+ G V+ G++ A K SD + R+E+ M LRHP ++
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLV 217
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
A + ++ EF+ G LF ++ + K+ + + +G+ ++H N
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN- 275
Query: 625 PIIHRDLKSSNLLV--DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRNEP 681
+H DLK N++ + +K+ DFGL+ L + + TG T ++ APEV +P
Sbjct: 276 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG--TAEFAAPEVAEGKP 332
Query: 682 SDEKSDVYSFGVIL 695
+D++S GV+
Sbjct: 333 VGYYTDMWSVGVLS 346
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-31
Identities = 72/304 (23%), Positives = 121/304 (39%), Gaps = 42/304 (13%)
Query: 481 GSTSSSAVNKVDLDNDCL---DYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKV 535
+ + ++ + E ++G G+ G V S+ A+KV
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68
Query: 536 FSRQ-----------EYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584
+ + ++ E+SL+K L HPN++ + +VTEF
Sbjct: 69 IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128
Query: 585 PRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DK 640
G LF +++ R+ K D + I G+ YLH N I+HRD+K N+L+ +
Sbjct: 129 EGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNS 184
Query: 641 HWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELA 699
+K+ DFGLS + L + GT ++APEVL+ + +EK DV+S GVI++ L
Sbjct: 185 LLNIKIVDFGLSSFFSKDYKLRDRL--GTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILL 241
Query: 700 TEKIP-WDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI-------VESCWHSDPQCRPS 751
P N +I V + W I ++ D R +
Sbjct: 242 CGYPPFGGQ-NDQDIIKKV--EKGKYYFD---FNDWKNISDEAKELIKLMLTYDYNKRCT 295
Query: 752 FQEL 755
+E
Sbjct: 296 AEEA 299
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 27/205 (13%)
Query: 511 EQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLF 567
+ +G+G+ V + + AVK+ +Q +EV ++ + + H NVL
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR--SRVFREVEMLYQCQGHRNVLEL 76
Query: 568 MGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPP 625
+ R +V E + GS+ + +R +L+ + D+A + +LH+
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLHNKG-- 131
Query: 626 IIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGK-------GTPQWMAPE 675
I HRDLK N+L ++ VK+ DF L + G+ ++MAPE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 676 VLRNEPS-----DEKSDVYSFGVIL 695
V+ D++ D++S GVIL
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 55/254 (21%), Positives = 115/254 (45%), Gaps = 23/254 (9%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLR 560
+ + +G GS G V S A+K+ +Q+ ++ H+ E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVN 99
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR-----ILMALDIARG 615
P ++ + L +V E++ G +F L+R + R I++ +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE---- 155
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
YLH + +I+RDLK NLL+D+ ++V DFG ++ T T GTP+ +APE
Sbjct: 156 --YLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTLCGTPEALAPE 208
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735
++ ++ ++ D ++ GV+++E+A P+ +Q+ + ++ ++ P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--VSGKVRFPSHFSSDLK 266
Query: 736 AIVESCWHSDPQCR 749
++ + D R
Sbjct: 267 DLLRNLLQVDLTKR 280
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-29
Identities = 72/308 (23%), Positives = 138/308 (44%), Gaps = 20/308 (6%)
Query: 446 PESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWE 505
+ + A S + + S + + ++V ++ ++E L
Sbjct: 100 TTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMN----EFEYL-- 153
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSDV--AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRH 561
+ +G+G+ G V + A+K+ ++ DEV H+ E +++ RH
Sbjct: 154 -----KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRH 207
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
P + + + RLC V E+ G LF L R + R R A +I + YLH
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHS 266
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
+++RDLK NL++DK +K+ DFGL + + T KT GTP+++APEVL +
Sbjct: 267 EKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741
D + GV+++E+ ++P+ N + ++ + + + + P+ + P +++
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--LMEEIRFPRTLGPEAKSLLSGL 383
Query: 742 WHSDPQCR 749
DP+ R
Sbjct: 384 LKKDPKQR 391
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 64/240 (26%), Positives = 106/240 (44%), Gaps = 22/240 (9%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLR 560
ED + + IG+G+ G V + A+K+ S+ E + F +E +M
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFAN 127
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR----RILMALDIARGV 616
P V+ A + L +V E++P G L L+ W R +++ALD
Sbjct: 128 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALD----- 182
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPE 675
+H IHRD+K N+L+DK +K+ DFG ++ E + T GTP +++PE
Sbjct: 183 -AIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 239
Query: 676 VLRNEPSDEK----SDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 731
VL+++ D D +S GV L+E+ P+ + + + L P D D
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 299
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-29
Identities = 55/244 (22%), Positives = 109/244 (44%), Gaps = 25/244 (10%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLR 560
ED I + IG+G+ G V +D A+K+ ++ E E FR+E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC-FREERDVLVNGD 132
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL--DWRR----RILMALDIAR 614
+ A L +V ++ G L LL + +L + R +++A+D
Sbjct: 133 SKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID--- 189
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMA 673
+H + +HRD+K N+L+D + +++ DFG +L + + + GTP +++
Sbjct: 190 ---SVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 674 PEVLRNEPSDEKS-----DVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 728
PE+L+ + D +S GV ++E+ + P+ + ++ G + +R + P
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304
Query: 729 DVDP 732
V
Sbjct: 305 QVTD 308
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-29
Identities = 44/234 (18%), Positives = 97/234 (41%), Gaps = 17/234 (7%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+G+ V + A+K+ ++ + EV FR+E ++ +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC-FREERDVLVNGDRRWITQLH 127
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
A L +V E+ G L LL + ++ +I + +H +H
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVH 185
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSD 687
RD+K N+L+D+ +++ DFG +L+ + + + GTP +++PE+L+ +
Sbjct: 186 RDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTG 245
Query: 688 VY-------SFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734
Y + GV +E+ + P+ ++ + G + ++ + + +
Sbjct: 246 SYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI--VHYKEHLSLPLVDEG 297
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 66/241 (27%), Positives = 119/241 (49%), Gaps = 10/241 (4%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+G+ G V + A+K+ ++ DEV H+ E +++ RHP +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHPFLTALK 71
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
A + RLC V E+ G LF L R + R R A +I + YLH + +++
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLHSRD--VVY 128
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RD+K NL++DK +K+ DFGL + T KT GTP+++APEVL + D
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 689 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQC 748
+ GV+++E+ ++P+ N + ++ + + + + P+ + P +++ DP+
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRTLSPEAKSLLAGLLKKDPKQ 246
Query: 749 R 749
R
Sbjct: 247 R 247
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 64/254 (25%), Positives = 124/254 (48%), Gaps = 23/254 (9%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLR 560
+D I +G GS G V+ + A+KV ++ +V H+ E ++ +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-NDERLMLSIVT 64
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR-----ILMALDIARG 615
HP ++ G Q++ ++ +++ G LF LL+++ + + + +AL+
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE---- 120
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
YLH + II+RDLK N+L+DK+ +K+ DFG ++ + T T GTP ++APE
Sbjct: 121 --YLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPE 173
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735
V+ +P ++ D +SFG++++E+ P+ + N+M+ + +N L P +
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--LNAELRFPPFFNEDVK 231
Query: 736 AIVESCWHSDPQCR 749
++ D R
Sbjct: 232 DLLSRLITRDLSQR 245
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 65/250 (26%), Positives = 114/250 (45%), Gaps = 23/250 (9%)
Query: 513 IGQGSCGTVYHA------VWYGSDVAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNV 564
IG+GS G V Y A+K ++Q+ +EV + F+ E+ +M+ L HP +
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMY----AMKYMNKQKCVERNEVRNVFK-ELQIMQGLEHPFL 77
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ + + + +V + L G L LQ+N + ++ + ++ + YL +
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYLQNQR- 135
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPEVLRNEPSD 683
IIHRD+K N+L+D+H V + DF ++ L ET +TT GT +MAPE+ +
Sbjct: 136 -IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYMAPEMFSSRKGA 192
Query: 684 EKS---DVYSFGVILWELATEKIPWDNLNSMQVIGAV-GFMNQRLEIPKDVDPRWAAIVE 739
S D +S GV +EL + P+ +S V F + P ++++
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLK 252
Query: 740 SCWHSDPQCR 749
+P R
Sbjct: 253 KLLEPNPDQR 262
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 35/220 (15%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHS--FRQEVS 554
YE L E+IG+G+ GTV+ A VA+K R + DE + S R E+
Sbjct: 3 KYEKL-------EKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALR-EIC 53
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIA 613
L+K L+H N++ + S ++L +V EF + L + LD + + +
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFL-FQLL 111
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH---ETYLTTKTGKGTPQ 670
+G+ + H N ++HRDLK NLL++++ +K+ +FGL+R Y + +
Sbjct: 112 KGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--------SAE 161
Query: 671 ----WM-APEVLRNEPS-DEKSDVYSFGVILWELATEKIP 704
W P+VL D++S G I ELA P
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 61/241 (25%), Positives = 113/241 (46%), Gaps = 9/241 (3%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+GS G V+ A + ++ A+K + D+V + ++ L HP +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + L V E+L G L +Q K D R A +I G+ +LH I++
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKG--IVY 141
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK N+L+DK +K+ DFG+ + T T GTP ++APE+L + + D
Sbjct: 142 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDW 201
Query: 689 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQC 748
+SFGV+L+E+ + P+ + ++ ++ P+ ++ ++ + +P+
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLEKEAKDLLVKLFVREPEK 259
Query: 749 R 749
R
Sbjct: 260 R 260
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-27
Identities = 71/337 (21%), Positives = 140/337 (41%), Gaps = 25/337 (7%)
Query: 417 KTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSS 476
K W ++ E P G++ + + + ++
Sbjct: 269 KAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIG-----QGTKAPEEKTA 323
Query: 477 VSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAVK 534
+ ++ +++ L D+ L +G+GS G V + G+D AVK
Sbjct: 324 NTISKFDNNGNRDRMKLT----DFNFL-------MVLGKGSFGKVMLSERKGTDELYAVK 372
Query: 535 VFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL 592
+ + D+V + ++ L + P + + RL V E++ G L
Sbjct: 373 ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYH 432
Query: 593 LQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
+Q+ + + A +IA G+ +L II+RDLK N+++D +K+ DFG+
Sbjct: 433 IQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMC 489
Query: 653 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ 712
+ +TTKT GTP ++APE++ +P + D ++FGV+L+E+ + P++ + +
Sbjct: 490 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549
Query: 713 VIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 749
+ ++ M + PK + AI + P R
Sbjct: 550 LFQSI--MEHNVAYPKSMSKEAVAICKGLMTKHPGKR 584
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-27
Identities = 56/245 (22%), Positives = 116/245 (47%), Gaps = 14/245 (5%)
Query: 513 IGQGSCGTVY---HAVWYGSDV--AVKVFSRQ---EYSDEVIHSFRQEVSLMKRLRHPNV 564
+G+G G V+ + A+KV + + + H+ + E ++++ ++HP +
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNILEEVKHPFI 83
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ + A + +L ++ E+L G LF L+R ++ +A +I+ + +LH
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA-EISMALGHLHQKG- 141
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDE 684
II+RDLK N++++ VK+ DFGL + T T GT ++MAPE+L +
Sbjct: 142 -IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNR 200
Query: 685 KSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHS 744
D +S G +++++ T P+ N + I + + +L +P + +++
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI--LKCKLNLPPYLTQEARDLLKKLLKR 258
Query: 745 DPQCR 749
+ R
Sbjct: 259 NAASR 263
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 6e-27
Identities = 71/278 (25%), Positives = 123/278 (44%), Gaps = 20/278 (7%)
Query: 476 SVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAV 533
S ++ N++ +D ++E + +G+GS G V A + AV
Sbjct: 5 SSKEGNGIGVNSSNRLGID----NFEFI-------RVLGKGSFGKVMLARVKETGDLYAV 53
Query: 534 KVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFR 591
KV + D+V + ++ L HP + +P RL V EF+ G L
Sbjct: 54 KVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMF 113
Query: 592 LLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651
+Q+ + + D R A +I + +LH II+RDLK N+L+D K+ DFG+
Sbjct: 114 HIQK-SRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGM 170
Query: 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711
+ +TT T GTP ++APE+L+ D ++ GV+L+E+ P++ N
Sbjct: 171 CKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED 230
Query: 712 QVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 749
+ A+ +N + P + I++S +P R
Sbjct: 231 DLFEAI--LNDEVVYPTWLHEDATGILKSFMTKNPTMR 266
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 35/218 (16%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHS--FRQEVS 554
YE + +IG+GS G V+ G VA+K F + D VI R E+
Sbjct: 4 KYEKI-------GKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALR-EIR 54
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIA 613
++K+L+HPN++ + +RL +V E+ ++ L R + + +
Sbjct: 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSIT-WQTL 112
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR---LKHETYLTTKTGKGTPQ 670
+ V++ H N IHRD+K N+L+ KH +K+ DFG +R + Y +
Sbjct: 113 QAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--------DDE 162
Query: 671 ----WM-APEVLRNEPSDEKS-DVYSFGVILWELATEK 702
W +PE+L + DV++ G + EL +
Sbjct: 163 VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 63/274 (22%), Positives = 128/274 (46%), Gaps = 23/274 (8%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVY---HAVWYGSDV--AVKVF 536
K D +E+L + +GQGS G V+ + A+KV
Sbjct: 12 HHVKEGHEKADPS----QFELL-------KVLGQGSFGKVFLVKKISGSDARQLYAMKVL 60
Query: 537 SRQE-YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR 595
+ + + + + E ++ + HP ++ A + +L ++ +FL G LF L +
Sbjct: 61 KKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK 119
Query: 596 NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655
+ + +A ++A + +LH II+RDLK N+L+D+ +K+ DFGLS+
Sbjct: 120 EVMFTEEDVKFYLA-ELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKES 176
Query: 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIG 715
+ + GT ++MAPEV+ + +D +SFGV+++E+ T +P+ + + +
Sbjct: 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT 236
Query: 716 AVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 749
+ + +L +P+ + P +++ + +P R
Sbjct: 237 MI--LKAKLGMPQFLSPEAQSLLRMLFKRNPANR 268
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 69/281 (24%), Positives = 131/281 (46%), Gaps = 22/281 (7%)
Query: 473 STSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-- 530
+T++VS ++ +++ L D+ L +G+GS G V + G+D
Sbjct: 1 TTNTVSK--FDNNGNRDRMKLT----DFNFL-------MVLGKGSFGKVMLSERKGTDEL 47
Query: 531 VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGS 588
AVK+ + D+V + ++ L + P + + RL V E++ G
Sbjct: 48 YAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD 107
Query: 589 LFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648
L +Q+ + + A +IA G+ +L II+RDLK N+++D +K+ D
Sbjct: 108 LMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIAD 164
Query: 649 FGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708
FG+ + +TTKT GTP ++APE++ +P + D ++FGV+L+E+ + P++
Sbjct: 165 FGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224
Query: 709 NSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 749
+ ++ ++ M + PK + AI + P R
Sbjct: 225 DEDELFQSI--MEHNVAYPKSMSKEAVAICKGLMTKHPGKR 263
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 78/288 (27%), Positives = 132/288 (45%), Gaps = 20/288 (6%)
Query: 466 SSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAV 525
+ N + S + S+ D+ L + IG+GS G V A
Sbjct: 10 LMNANPAPPPAPSQQINLGPSSNPHAKPS----DFHFL-------KVIGKGSFGKVLLAR 58
Query: 526 WYGSDV--AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581
+V AVKV ++ E H + L+K ++HP ++ + + +L V
Sbjct: 59 HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118
Query: 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 641
+++ G LF LQR L+ R R A +IA + YLH N I++RDLK N+L+D
Sbjct: 119 DYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLHSLN--IVYRDLKPENILLDSQ 175
Query: 642 WTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE 701
+ + DFGL + E TT T GTP+++APEVL +P D D + G +L+E+
Sbjct: 176 GHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235
Query: 702 KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR 749
P+ + N+ ++ + +N+ L++ ++ ++E D R
Sbjct: 236 LPPFYSRNTAEMYDNI--LNKPLQLKPNITNSARHLLEGLLQKDRTKR 281
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 34/217 (15%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV-WYGSDVAVKVFSRQEYSDEVIHS--FRQEVSL 555
Y L E+IG+G+ G VY A YG A+K R E DE I S R E+S+
Sbjct: 3 KYHGL-------EKIGEGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTIR-EISI 53
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIAR 614
+K L+H N++ + + +RL +V E L + L +LL L+ + + L +
Sbjct: 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFL-LQLLN 111
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH---ETYLTTKTGKGTPQ- 670
G++Y H ++HRDLK NLL+++ +K+ DFGL+R Y T +
Sbjct: 112 GIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--------THEI 161
Query: 671 ---WM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
W AP+VL D++S G I E+
Sbjct: 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV-WYGSDVAVKVFSRQEYSDEVIHS--FRQEVSL 555
Y+ L E++G+G+ G VY A G VA+K R + DE I S R E+SL
Sbjct: 22 KYQKL-------EKVGEGTYGVVYKAKDSQGRIVALKRI-RLDAEDEGIPSTAIR-EISL 72
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIAR 614
+K L HPN++ + + S + L +V EF+ + L ++L N T L + +I + + R
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYL-YQLLR 130
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH---ETYLTTKTGKGTPQ- 670
GV++ H I+HRDLK NLL++ +K+ DFGL+R +Y T +
Sbjct: 131 GVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--------THEV 180
Query: 671 ---WM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
W AP+VL D++S G I E+ T K
Sbjct: 181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 29/215 (13%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHS--FRQEVS 554
YE L +G+GS G V G VA+K F + D+++ R E+
Sbjct: 26 KYENL-------GLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMR-EIK 76
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIA 613
L+K+LRH N++ + +R +V EF+ ++ L+ LD++ + + I
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYL-FQII 134
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ--- 670
G+ + H N IIHRD+K N+LV + VK+ DFG +R L +
Sbjct: 135 NGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFAR-----TLAAPGEVYDDEVAT 187
Query: 671 -WM-APEVLRNEPSDEKS-DVYSFGVILWELATEK 702
W APE+L + K+ DV++ G ++ E+ +
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 64/253 (25%), Positives = 121/253 (47%), Gaps = 24/253 (9%)
Query: 513 IGQGSCGTVYHAVWYGSDV--AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+GS V +D A+KV ++ +++ ++ + HP ++
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ RL V E++ G L +QR + R A +I+ ++YLH II+
Sbjct: 77 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERG--IIY 133
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDV 688
RDLK N+L+D +K+ D+G+ + TT T GTP ++APE+LR E D
Sbjct: 134 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 193
Query: 689 YSFGVILWELATEKIPW-----------DNLNSM-QVIGAVGFMNQRLEIPKDVDPRWAA 736
++ GV+++E+ + P+ + + + QVI + +++ IP+ + + A+
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-----LEKQIRIPRSLSVKAAS 248
Query: 737 IVESCWHSDPQCR 749
+++S + DP+ R
Sbjct: 249 VLKSFLNKDPKER 261
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 51/208 (24%), Positives = 75/208 (36%), Gaps = 48/208 (23%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
DY++ + +G G G V A+K+ R+EV L
Sbjct: 18 DYKVT------SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELH 64
Query: 557 KRL-RHPNVLLFMGA----VTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMAL 610
R + P+++ + + L IV E L G LF R+ R R +
Sbjct: 65 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 124
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKG 667
I + YLH N I HRD+K NLL + +K+ DFG
Sbjct: 125 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF---------------- 166
Query: 668 TPQWMAPEVLRNEPSDEKSDVYSFGVIL 695
A E E D+ D++S GVI+
Sbjct: 167 -----AKETTG-EKYDKSCDMWSLGVIM 188
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 55/205 (26%), Positives = 102/205 (49%), Gaps = 27/205 (13%)
Query: 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEV-IHSFRQEVSLMKRLRHPNVLLF 567
+++G+G+ TVY + VA+K R E+ + + R EVSL+K L+H N++
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEI-RLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 65
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIARGVSYLHHCNPPI 626
+ + + L +V E+L + L + L ++ ++ + + RG++Y H +
Sbjct: 66 HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFL-FQLLRGLAYCHRQK--V 121
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKH---ETYLTTKTGKGTPQ----WM-APEVLR 678
+HRDLK NLL+++ +K+ DFGL+R K +TY + W P++L
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--------DNEVVTLWYRPPDILL 173
Query: 679 NEPS-DEKSDVYSFGVILWELATEK 702
+ D++ G I +E+AT +
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 36/220 (16%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVA---VKVFSRQEYSDEV-IHSFRQE 552
YE L + +G+G TVY A VA +K+ R E D + + R E
Sbjct: 11 RYEKL-------DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-E 62
Query: 553 VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALD 611
+ L++ L HPN++ + A + +V +F+ L +++ N+ L + M L
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYM-LM 120
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK---HETYLTTKTGKGT 668
+G+ YLH I+HRDLK +NLL+D++ +K+ DFGL++ + Y T
Sbjct: 121 TLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--------T 170
Query: 669 PQ----WM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
Q W APE+L D+++ G IL EL
Sbjct: 171 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 7e-25
Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 39/222 (17%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEV-IHSFRQEVSL 555
++ L E++G G+ TVY G VA+K + + + + R E+SL
Sbjct: 6 QFKQL-------EKLGNGTYATVYKGLNKTTGVYVALKEV-KLDSEEGTPSTAIR-EISL 56
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR------RILMA 609
MK L+H N++ + + +L +V EF+ L + + T R +
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQ- 114
Query: 610 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH---ETYLTTKTGK 666
+ +G+++ H I+HRDLK NLL++K +K+GDFGL+R T+
Sbjct: 115 WQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF------- 165
Query: 667 GTPQ----WM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
+ + W AP+VL + D++S G IL E+ T K
Sbjct: 166 -SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 69/319 (21%), Positives = 139/319 (43%), Gaps = 36/319 (11%)
Query: 447 ESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWED 506
H ++ + + + + + S A + + L D+++L
Sbjct: 6 HHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMN-TRESGKASSSLGLQ----DFDLL--- 57
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSDV--AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHP 562
IG+GS V +D A++V ++ +++ ++ + HP
Sbjct: 58 ----RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
++ + RL V E++ G L +QR + R A +I+ ++YLH
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHER 172
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 682
II+RDLK N+L+D +K+ D+G+ + TT T GTP ++APE+LR E
Sbjct: 173 G--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 683 DEKSDVYSFGVILWELATEKIPW-----------DNLNSM-QVIGAVGFMNQRLEIPKDV 730
D ++ GV+++E+ + P+ + + + QVI + +++ IP+ +
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-----LEKQIRIPRSL 285
Query: 731 DPRWAAIVESCWHSDPQCR 749
+ A++++S + DP+ R
Sbjct: 286 SVKAASVLKSFLNKDPKER 304
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 31/251 (12%), Positives = 62/251 (24%), Gaps = 40/251 (15%)
Query: 509 IGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHS-FRQEVSLMKRLRHPNVL 565
+ G + A+ VA+ Q + + + R+ P V
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
+ V + +V E++ GSL + + I +A H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG-- 149
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 685
+ S + V V + ++ +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATMP---------------------------DANPQ 182
Query: 686 SDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF-MNQRLEIPKDVDPR----WAAIVES 740
D+ G L+ L + P + + P D+D +A+
Sbjct: 183 DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAAR 242
Query: 741 CWHSDPQCRPS 751
D R +
Sbjct: 243 SVQGDGGIRSA 253
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 54/222 (24%), Positives = 91/222 (40%), Gaps = 39/222 (17%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHS--FRQEVS 554
Y + ++G+G+ G VY A VA+K R E+ +E + R EVS
Sbjct: 35 RYRRI-------TKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIR-EVS 85
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR 614
L+K L+H N++ + RL ++ E+ L + + +N + + +
Sbjct: 86 LLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFL-YQLIN 143
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWT-----VKVGDFGLSRLK---HETYLTTKTGK 666
GV++ H +HRDLK NLL+ +K+GDFGL+R +
Sbjct: 144 GVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF------- 194
Query: 667 GTPQ----WM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
T + W PE+L D++S I E+ +
Sbjct: 195 -THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 57/246 (23%), Positives = 97/246 (39%), Gaps = 12/246 (4%)
Query: 513 IGQGSCGTVYHAVWYGSDV--AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+G G V+ + A K +++ + E ++ ++ ++
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA-MVEKKILAKVHSRFIVSLA 251
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---LDWRRRILMALDIARGVSYLHHCNPP 625
A + LC+V + G + + R I I G+ +LH N
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 685
II+RDLK N+L+D V++ D GL+ TK GTP +MAPE+L E D
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFS 369
Query: 686 SDVYSFGVILWELATEKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWH 743
D ++ GV L+E+ + P+ + + Q + P P E+
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQ 429
Query: 744 SDPQCR 749
DP+ R
Sbjct: 430 KDPEKR 435
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 55/245 (22%), Positives = 96/245 (39%), Gaps = 13/245 (5%)
Query: 513 IGQGSCGTVYHAVWYGSDV--AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+G G V + A K ++ + E +++++ V+
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKVNSRFVVSLA 250
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
A + LC+V + G L + R + A +I G+ LH I+
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IV 308
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-LTTKTGKGTPQWMAPEVLRNEPSDEKS 686
+RDLK N+L+D H +++ D GL+ H T K GT +MAPEV++NE
Sbjct: 309 YRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP 366
Query: 687 DVYSFGVILWELATEKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIVESCWHS 744
D ++ G +L+E+ + P+ V E + P+ ++
Sbjct: 367 DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCK 426
Query: 745 DPQCR 749
DP R
Sbjct: 427 DPAER 431
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 63/326 (19%), Positives = 132/326 (40%), Gaps = 43/326 (13%)
Query: 448 SHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVN------KVDLDNDCLDYE 501
+H + + + G+ +S + N KV ++ ++E
Sbjct: 2 AHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIE----NFE 57
Query: 502 ILWEDLTIGEQIGQGSCGTVY---HAVWYGSDV--AVKVFSRQ---EYSDEVIHSFRQEV 553
+L + +G G+ G V+ + + A+KV + + + H+ +
Sbjct: 58 LL-------KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 110
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
L + P ++ A + +L ++ +++ G LF L + + +I + +I
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG-EIV 169
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK-HETYLTTKTGKGTPQWM 672
+ +LH II+RD+K N+L+D + V + DFGLS+ + GT ++M
Sbjct: 170 LALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 673 APEVLRNEPS--DEKSDVYSFGVILWELATEKIPWDNLNS-------MQVIGAVGFMNQR 723
AP+++R S D+ D +S GV+++EL T P+ + I +
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI-----LKSE 282
Query: 724 LEIPKDVDPRWAAIVESCWHSDPQCR 749
P+++ +++ DP+ R
Sbjct: 283 PPYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-22
Identities = 55/247 (22%), Positives = 106/247 (42%), Gaps = 17/247 (6%)
Query: 513 IGQGSCGTVYHAVWYGSDV--AVKVFSRQE--YSDEVIHSF--RQEVSLMKRLRHPNVLL 566
IG+G G VY + A+K ++ + R +SL+ P ++
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
A +P +L + + + G L L ++ A +I G+ ++H+ +
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRF--V 313
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKS 686
++RDLK +N+L+D+H V++ D GL+ + GT +MAPEVL+ + + S
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 687 -DVYSFGVILWELATEKIPWDNLNSM---QVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742
D +S G +L++L P+ + ++ + +E+P P +++E
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELRSLLEGLL 429
Query: 743 HSDPQCR 749
D R
Sbjct: 430 QRDVNRR 436
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 37/224 (16%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVK---VFSRQEYSDEVIHSFRQEVS 554
+++ +G+G+ G V A G VA+K F + ++ + + R E+
Sbjct: 13 FQLK-------SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA---LRTLR-EIK 61
Query: 555 LMKRLRHPNVLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMA 609
++K +H N++ + I+ E + L R++ D + +
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFI-- 118
Query: 610 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTP 669
R V LH N +IHRDLK SNLL++ + +KV DFGL+R+ E+ G
Sbjct: 119 YQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 670 QWM----------APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
M APEV+ DV+S G IL EL +
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 49/223 (21%), Positives = 89/223 (39%), Gaps = 47/223 (21%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVK-VFSRQEYSDEVIHSFR--QEVSLMKRLRHP 562
+ GQG+ GTV G VA+K V + R Q + + L HP
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI------QDPRFRNRELQIMQDLAVLHHP 79
Query: 563 NVLLFMGAVTSPQR-------LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD---- 611
N++ + L +V E++P +L R + +RR++
Sbjct: 80 NIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC-----RNYYRRQVAPPPILIKV 133
Query: 612 ----IARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHET-----YLT 661
+ R + LH + + HRD+K N+LV++ T+K+ DFG ++ + Y+
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193
Query: 662 TKTGKGTPQWM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
++ + APE++ D++S G I E+ +
Sbjct: 194 SR-------YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 48/226 (21%), Positives = 82/226 (36%), Gaps = 41/226 (18%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV-WYGSDVAVKVFSRQEYSDEVIHSFRQ------- 551
Y + I GS G V V G VA+K ++
Sbjct: 24 YTVQ-------RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRV 76
Query: 552 --EVSLMKRLRHPNVLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQRNTTKL-DWR 603
E+ L+ HPN+L + L +VTE + L +++ +
Sbjct: 77 LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQH 135
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET----- 658
+ M I G+ LH ++HRDL N+L+ + + + DF L+R
Sbjct: 136 IQYFM-YHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH 192
Query: 659 YLTTKTGKGTPQWM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
Y+T +W APE++ + D++S G ++ E+ K
Sbjct: 193 YVTH-------RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDE--VIHSFRQEVS 554
YE L +IGQG+ G V+ A G VA+K E E I + R E+
Sbjct: 18 KYEKL-------AKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALR-EIK 68
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLC--------IVTEFLPRGSLFRLLQRNTTKLDWRRRI 606
+++ L+H NV+ + + +V +F L LL K
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK 127
Query: 607 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666
+ + G+ Y+H I+HRD+K++N+L+ + +K+ DFGL+R ++ +
Sbjct: 128 RVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLA-KNSQPNR 184
Query: 667 GTPQ----WM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
T + W PE+L E D++ G I+ E+ T
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 5e-22
Identities = 66/227 (29%), Positives = 93/227 (40%), Gaps = 43/227 (18%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSF-----RQ 551
YE + +IG G+ GTVY A G VA+K R R
Sbjct: 10 RYEPV-------AEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVR- 60
Query: 552 EVSLMKRLR---HPNVLLFMGAVTSPQ-----RLCIVTEFLPRGSLFRLL-QRNTTKLDW 602
EV+L++RL HPNV+ M + + ++ +V E + + L L + L
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 119
Query: 603 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE--TYL 660
+ RG+ +LH I+HRDLK N+LV TVK+ DFGL+R+
Sbjct: 120 ETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL- 176
Query: 661 TTKTGKGTPQ----WM-APEVLRNEPSDEKSDVYSFGVILWELATEK 702
TP W APEVL D++S G I E+ K
Sbjct: 177 -------TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 6e-22
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRH 561
+ IG G+ G V A +VA+K F Q ++ ++R E+ LMK + H
Sbjct: 28 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA---KRAYR-ELVLMKCVNH 83
Query: 562 PNVLLFMGAVTSPQRLC------IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
N++ + T + L IV E + +L +++Q R L+ + G
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELD--HERMSYLL-YQMLCG 139
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
+ +LH IIHRDLK SN++V T+K+ DFGL+R +++ T T + APE
Sbjct: 140 IKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-YVVTRYYRAPE 196
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEK 702
V+ E D++S G I+ E+
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 6e-22
Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 47/220 (21%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVK-VFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
T + IG GS G VY A G VA+K V + + R E+ +M++L H N+
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------NR-ELQIMRKLDHCNI 109
Query: 565 LLFMGAVTSPQR------LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD------- 611
+ S L +V +++P +++R+ + R + + +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVA-----RHYSRAKQTLPVIYVKLYMY 163
Query: 612 -IARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHET-----YLTTKT 664
+ R ++Y+H I HRD+K NLL+D +K+ DFG ++ Y+ ++
Sbjct: 164 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR- 220
Query: 665 GKGTPQWM-APEVLRNEPSDEKS-DVYSFGVILWELATEK 702
+ APE++ S DV+S G +L EL +
Sbjct: 221 ------YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} Length = 124 | Back alignment and structure |
|---|
Score = 90.6 bits (226), Expect = 7e-22
Identities = 28/112 (25%), Positives = 55/112 (49%), Gaps = 2/112 (1%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+Q + ++ + DL II WN+ +E LYGYS E+A+GQ + +L D +
Sbjct: 7 KQRAKAFDYVFDAIVVTDLQGFIIDWNKGSETLYGYSKEQAIGQP-VNMLHVPGDTEHIT 65
Query: 190 -DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+++ ++ +WTG+ K + + P Y ++ +VG + ++ D
Sbjct: 66 SEVISAVENQGKWTGEIRMLHKDGHIGWIESMCVPIYGENYQMVGALGINRD 117
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-22
Identities = 54/209 (25%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRH 561
+G G+ G+V A+ G VA+K F + ++ ++R E+ L+K ++H
Sbjct: 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFA---KRAYR-ELLLLKHMQH 82
Query: 562 PNVLLFMGAVTSPQRLC------IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
NV+ + T L +V F+ L +++ + + + + L+ + +G
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFS--EEKIQYLV-YQMLKG 138
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQW-MAP 674
+ Y+H ++HRDLK NL V++ +K+ DFGL+R TG +W AP
Sbjct: 139 LKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVVTRWYRAP 192
Query: 675 EVLRNEPS-DEKSDVYSFGVILWELATEK 702
EV+ + ++ D++S G I+ E+ T K
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-21
Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 50/221 (22%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGSD-VAVK-VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
T + IG GS G V+ A SD VA+K V + + R E+ +M+ ++HPNV+
Sbjct: 43 TNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK------NR-ELQIMRIVKHPNVV 95
Query: 566 LFMGAVTSPQR------LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD-------- 611
S L +V E++P +++R + + + M +
Sbjct: 96 DLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHY-----AKLKQTMPMLLIKLYMYQ 149
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSR--LKHET---YLTTKTG 665
+ R ++Y+H I HRD+K NLL+D +K+ DFG ++ + E Y+ ++
Sbjct: 150 LLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR-- 205
Query: 666 KGTPQWM-APEVLRNEPSDEKS---DVYSFGVILWELATEK 702
+ APE++ + + D++S G ++ EL +
Sbjct: 206 -----YYRAPELIFG--ATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 56/242 (23%), Positives = 105/242 (43%), Gaps = 41/242 (16%)
Query: 499 DYEIL---WE---DLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFR 550
DYE W D + ++G+G V+ A+ V VK+ + ++
Sbjct: 24 DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-KPVKKKKIK---- 78
Query: 551 QEVSLMKRLR-HPNVLLFMGAVTSPQ--RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 607
+E+ +++ LR PN++ V P +V E + +L Q T D+ R
Sbjct: 79 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT---DYDIRFY 135
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHET-----YLT 661
M +I + + Y H I+HRD+K N+++D +H +++ D+GL+ H +
Sbjct: 136 M-YEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 192
Query: 662 TKTGKGTPQWM-APEVLRNEPSDEKS-DVYSFGVILWELATEKIPW----DNLNSMQVIG 715
++ + PE+L + + S D++S G +L + K P+ DN + + I
Sbjct: 193 SR-------YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 245
Query: 716 AV 717
V
Sbjct: 246 KV 247
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 2e-21
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 35/214 (16%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRH 561
+ IG G+ G V A +VA+K F Q ++ ++R E+ LMK + H
Sbjct: 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYR-ELVLMKCVNH 120
Query: 562 PNVLLFMGAVTSPQRLC------IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
N++ + T + L +V E + +L +++Q R L+ + G
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELD--HERMSYLL-YQMLCG 176
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-----YLTTKTGKGTPQ 670
+ +LH IIHRDLK SN++V T+K+ DFGL+R + Y+ T +
Sbjct: 177 IKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT-------R 227
Query: 671 WM-APEVLRNEPSDEKSDVYSFGVILWELATEKI 703
+ APEV+ E D++S G I+ E+ KI
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 60/225 (26%), Positives = 94/225 (41%), Gaps = 41/225 (18%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHS--FRQEV 553
YE + +IG+G+ G V+ A G VA+K R + +E + R EV
Sbjct: 12 QYECV-------AEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIR-EV 62
Query: 554 SLMKRLR---HPNVLLFMGAVTSPQ-----RLCIVTEFLPRGSLFRLL-QRNTTKLDWRR 604
++++ L HPNV+ T + +L +V E + + L L + +
Sbjct: 63 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET 121
Query: 605 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE--TYLTT 662
M + RG+ +LH ++HRDLK N+LV +K+ DFGL+R+
Sbjct: 122 IKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--- 176
Query: 663 KTGKGTPQ----WM-APEVLRNEPSDEKSDVYSFGVILWELATEK 702
T W APEVL D++S G I E+ K
Sbjct: 177 -----TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 33/209 (15%)
Query: 511 EQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+G G+ G+V A G VAVK F ++ ++R E+ L+K ++H NV
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYR-ELRLLKHMKHENV 90
Query: 565 LLFMGAVTSPQRLC------IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
+ + T + L +VT + L +++ D + ++ I RG+ Y
Sbjct: 91 IGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIY--QILRGLKY 147
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET---YLTTKTGKGTPQW-MAP 674
+H + IIHRDLK SNL V++ +K+ DFGL+R + Y+ T +W AP
Sbjct: 148 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT-------RWYRAP 198
Query: 675 EVLRNEPS-DEKSDVYSFGVILWELATEK 702
E++ N ++ D++S G I+ EL T +
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 511 EQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+ +G G+ G V AV G+ VA+K F + ++ ++R E+ L+K +RH NV
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA---KRAYR-ELRLLKHMRHENV 86
Query: 565 LLFMGAVTSPQRLC------IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
+ + T + L +V F+ L +L++ KL R + + +G+ Y
Sbjct: 87 IGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE--KLGEDRIQFLVYQMLKGLRY 143
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM-APEVL 677
+H IIHRDLK NL V++ +K+ DFGL+R + TG +W APEV+
Sbjct: 144 IHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR----QADSEMTGYVVTRWYRAPEVI 197
Query: 678 RNEPS-DEKSDVYSFGVILWELATEK 702
N + D++S G I+ E+ T K
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-20
Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 29/216 (13%)
Query: 509 IGEQIGQGSCGTVYHA----VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
G ++G+G+ G VY A D A+K S +E++L++ L+HPNV
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----REIALLRELKHPNV 80
Query: 565 LLFMGAVTSPQ--RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD--------IAR 614
+ S ++ ++ ++ L+ +++ + ++ + + I
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSRL--KHETYLTTKTGKGT 668
G+ YLH ++HRDLK +N+LV + VK+ D G +RL L
Sbjct: 140 GIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 669 PQWM-APEVLRNEPSDEKS-DVYSFGVILWELATEK 702
W APE+L K+ D+++ G I EL T +
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 6e-20
Identities = 49/232 (21%), Positives = 97/232 (41%), Gaps = 53/232 (22%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVF-SRQEYSDEVIHSFRQEVSLM 556
Y ++ ++G G TV+ A + VA+K+ + Y++ E+ L+
Sbjct: 21 YILV-------RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED----EIKLL 69
Query: 557 KRLR--------HPNV-----LL--FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-- 599
+R+ LL F + + +V E L +L L+++ +
Sbjct: 70 QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGI 128
Query: 600 -LDWRRRILMALDIARGVSYLH-HCNPPIIHRDLKSSNLLVD------KHWTVKVGDFGL 651
L + ++I + + G+ Y+H C IIH D+K N+L++ +K+ D G
Sbjct: 129 PLIYVKQI--SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGN 184
Query: 652 SRLKHE---TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
+ E + T+ ++ +PEVL P +D++S +++EL T
Sbjct: 185 ACWYDEHYTNSIQTR------EYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 39/226 (17%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVK--VFSRQEYSDEVIHSFRQEVSL 555
Y L + +G G G V+ AV VA+K V + + H+ R E+ +
Sbjct: 13 YMDL-------KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSV---KHALR-EIKI 61
Query: 556 MKRLRHPNVLLFMGAVTSPQRLC--------------IVTEFLPRGSLFRLLQRNTTKLD 601
++RL H N++ + IV E++ L +L++ +
Sbjct: 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEE 120
Query: 602 WRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHETYL 660
R + + RG+ Y+H N ++HRDLK +NL ++ +K+GDFGL+R+ Y
Sbjct: 121 HARLFMY--QLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 661 TTK--TGKGTPQWM-APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
+ +W +P +L + + + D+++ G I E+ T K
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVK---VFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
T IG+G+ G V A VA+K F Q Y + R E+ ++ R RH
Sbjct: 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC---QRTLR-EIKILLRFRHE 85
Query: 563 NVLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVS 617
N++ + +P + IV + + L++LL+ D L I RG+
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLY--QILRGLK 142
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK--TGKGTPQWM-AP 674
Y+H N ++HRDLK SNLL++ +K+ DFGL+R+ + T T +W AP
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 675 EVLRNEPS-DEKSDVYSFGVILWELATEK 702
E++ N + D++S G IL E+ + +
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 54/233 (23%), Positives = 92/233 (39%), Gaps = 49/233 (21%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEV 553
Y I IG+GS G VY A +VA+K +F R E+
Sbjct: 28 YIIK-------HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC---KRILR-EI 76
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLC-----IVTEFLPRGSLFRLLQRNTTKLDWRRRILM 608
+++ RL+ ++ + L IV E L +L + + + ++
Sbjct: 77 TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTIL 135
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR------------LKH 656
++ G +++H IIHRDLK +N L+++ +VKV DFGL+R
Sbjct: 136 -YNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 657 ETYLTTKTGKGTPQWM----------APEVLRNEPS-DEKSDVYSFGVILWEL 698
E K + + APE++ + + + D++S G I EL
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 63/243 (25%), Positives = 104/243 (42%), Gaps = 43/243 (17%)
Query: 483 TSSSAVNKVDLDNDCLDY-----EILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKV 535
+ N D+D Y + + + + IG+GS G V A VA+K+
Sbjct: 70 GMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKM 129
Query: 536 F-SRQEYSDEVIHSFRQ---EVSLMKRLRH------PNVLLFMGAVTSPQRLCIVTEFLP 585
+ + + RQ E+ +++ LR NV+ + T +C+ E L
Sbjct: 130 VRNEKRF-------HRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL- 181
Query: 586 RGSLFRLLQRNTTK---LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV--DK 640
+L+ L+++N + L R+ A I + + LH IIH DLK N+L+
Sbjct: 182 SMNLYELIKKNKFQGFSLPLVRKF--AHSILQCLDALHKNR--IIHCDLKPENILLKQQG 237
Query: 641 HWTVKVGDFGLSRLKHE---TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWE 697
+KV DFG S +H+ TY+ ++ + APEV+ D++S G IL E
Sbjct: 238 RSGIKVIDFGSSCYEHQRVYTYIQSR------FYRAPEVILGARYGMPIDMWSLGCILAE 291
Query: 698 LAT 700
L T
Sbjct: 292 LLT 294
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 2e-18
Identities = 61/277 (22%), Positives = 100/277 (36%), Gaps = 48/277 (17%)
Query: 461 AWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGT 520
+ + V+ + S+ + D++I + I IG GS G
Sbjct: 10 QQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIP-DRYEIRHLIGTGSYGH 68
Query: 521 VYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574
V A VA+K VF R E++++ RL H +V+ + V
Sbjct: 69 VCEAYDKLEKRVVAIKKILRVFEDLIDC---KRILR-EIAILNRLNHDHVVKVLDIVIPK 124
Query: 575 QRLC-----IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHR 629
+V E +L + + + L+ ++ GV Y+H I+HR
Sbjct: 125 DVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLL-YNLLVGVKYVHSAG--ILHR 180
Query: 630 DLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM----------------- 672
DLK +N LV++ +VKV DFGL+R +P+
Sbjct: 181 DLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQL 240
Query: 673 ----------APEVLRNEPS-DEKSDVYSFGVILWEL 698
APE++ + + E DV+S G I EL
Sbjct: 241 TGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 9e-18
Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 35/229 (15%)
Query: 494 DNDCLDY-----EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVF-SRQEYSDEV 545
D+D DY E + I IG+GS G V A VA+K+ +++ + ++
Sbjct: 38 DDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA 97
Query: 546 IHSFRQEVSLMKRLRHP------NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK 599
+ EV L++ + ++ LC+V E L +L+ LL+ +
Sbjct: 98 ----QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFR 152
Query: 600 ---LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV--DKHWTVKVGDFGLSRL 654
L+ R+ A + + +L IIH DLK N+L+ K +K+ DFG S
Sbjct: 153 GVSLNLTRKF--AQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210
Query: 655 KHE---TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
+ Y+ ++ + +PEVL P D D++S G IL E+ T
Sbjct: 211 LGQRIYQYIQSR------FYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 53/252 (21%), Positives = 91/252 (36%), Gaps = 79/252 (31%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVK-VFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
++G+ +G GS G V G A+K V Y R E+ +MK L H N+
Sbjct: 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK------NR-ELDIMKVLDHVNI 62
Query: 565 ---------------------------------LLFMGAVTSPQR-----LCIVTEFLPR 586
+ L ++ E++P
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP- 121
Query: 587 GSLFRLLQRNTTKLDWRRRILMALD--------IARGVSYLHHCNPPIIHRDLKSSNLLV 638
+L ++L K R + ++ + R V ++H I HRD+K NLLV
Sbjct: 122 DTLHKVL-----KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLV 174
Query: 639 D-KHWTVKVGDFGLSRLKHET-----YLTTKTGKGTPQWM-APEVLRNEPS-DEKSDVYS 690
+ K T+K+ DFG ++ + Y+ ++ + APE++ D++S
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAYICSR-------FYRAPELMLGATEYTPSIDLWS 227
Query: 691 FGVILWELATEK 702
G + EL K
Sbjct: 228 IGCVFGELILGK 239
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 52/234 (22%), Positives = 103/234 (44%), Gaps = 47/234 (20%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEV 553
YE++ +++G+G+ G V+ ++ G VAVK F + +FR E+
Sbjct: 11 YELV-------KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDA---QRTFR-EI 59
Query: 554 SLMKRLR-HPNVLLFMGAVTSP--QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
++ L H N++ + + + + + +V +++ L +++ N + ++ ++
Sbjct: 60 MILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVV--Y 116
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-----------LKHETY 659
+ + + YLH ++HRD+K SN+L++ VKV DFGLSR +
Sbjct: 117 QLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 660 LTTKTGKGTPQWM----------APEVLRNEPS-DEKSDVYSFGVILWELATEK 702
T+ + APE+L + D++S G IL E+ K
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 28/98 (28%), Positives = 41/98 (41%)
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT 202
V I DL RI+Y N + + Y EE +GQD + + D+ I G W
Sbjct: 2 VSITDLQGRILYANDNFCAVSRYGREELVGQDHRIVNSGYHGKAYIRDMWRTISRGNIWQ 61
Query: 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
G+F + K R V +T P D+ G + + D
Sbjct: 62 GEFCNRRKDGTRYWVDSTIVPLMDNAGKPRQYISIRRD 99
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 9e-15
Identities = 25/122 (20%), Positives = 46/122 (37%), Gaps = 8/122 (6%)
Query: 126 NFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDF 185
+ + + + + + D + RIIY N + G + E LGQ +L
Sbjct: 107 EAQLARLKQAMDANSEMILLTDRAGRIIYANPALCRFSGMAEGELLGQS-PSILDSPLAD 165
Query: 186 DVAY-DIVHRIKMGERWTGQFPAKTKTE------ERVLVVATNTPFYDDDGTLVGIVCVS 238
+ ++ G+ W+G+ + +T E + TP + D LVG V +
Sbjct: 166 QETLAAMQEALQAGQPWSGRLLNRRRTGPAPHDAEDYWAEISTTPIHTDGNGLVGYVQIQ 225
Query: 239 TD 240
D
Sbjct: 226 HD 227
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-14
Identities = 55/247 (22%), Positives = 106/247 (42%), Gaps = 63/247 (25%)
Query: 495 NDCLD--YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVF-SRQEYSDEVIHSF 549
L+ + ++ ++G G+ G V AVKV + ++Y+ S
Sbjct: 30 GMLLNNAFLVI-------RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTR----SA 78
Query: 550 RQEVSLMKRLRH-----PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---LD 601
+ E ++K++++ N++ + G +C++ E L SL+ ++ RN ++
Sbjct: 79 KIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIE 137
Query: 602 WRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN-LLVDKHWT----------------- 643
+ ++I + ++YL + + H DLK N LL D ++
Sbjct: 138 DIKLY--CIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193
Query: 644 -------VKVGDFGLSRLKHE---TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGV 693
+K+ DFG + K + + + T+ Q+ APEV+ N D SD++SFG
Sbjct: 194 YRTKSTGIKLIDFGCATFKSDYHGSIINTR------QYRAPEVILNLGWDVSSDMWSFGC 247
Query: 694 ILWELAT 700
+L EL T
Sbjct: 248 VLAELYT 254
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 56/243 (23%), Positives = 96/243 (39%), Gaps = 59/243 (24%)
Query: 495 NDCLD--YEILWEDLTIGEQIGQGSCGTVYHAV---WYGSDVAVKVF-SRQEYSDEVIHS 548
D L YEI+ +G+G+ G V + S VA+K+ + +Y +
Sbjct: 14 GDWLQERYEIV-------GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA--- 63
Query: 549 FRQEVSLMKRLRHP------NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK--- 599
R E++++K+++ +L +CI E L + F L+ N +
Sbjct: 64 -RLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYP 121
Query: 600 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN-LLVD------------------K 640
L R + A + + +LH + H DLK N L V+ K
Sbjct: 122 LPHVRHM--AYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177
Query: 641 HWTVKVGDFGLSRLKHE---TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWE 697
+ +++V DFG + HE T + T+ + PEV+ + DV+S G IL+E
Sbjct: 178 NTSIRVADFGSATFDHEHHTTIVATR------HYRPPEVILELGWAQPCDVWSIGCILFE 231
Query: 698 LAT 700
Sbjct: 232 YYR 234
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 60/243 (24%), Positives = 96/243 (39%), Gaps = 59/243 (24%)
Query: 495 NDCLD--YEILWEDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVF-SRQEYSDEVIHS 548
D L YEI+ + +G+G+ G V + + G VAVK+ + Y +
Sbjct: 9 GDVLSARYEIV-------DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA--- 58
Query: 549 FRQEVSLMKRLRHP------NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK--- 599
R E+ +++ L + + +CIV E L S + ++ N
Sbjct: 59 -RSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFR 116
Query: 600 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN-LLVDKHWT--------------- 643
LD R++ A I + V++LH + H DLK N L V +T
Sbjct: 117 LDHIRKM--AYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172
Query: 644 ---VKVGDFGLSRLKHE---TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWE 697
+KV DFG + E T ++T+ + APEV+ + DV+S G IL E
Sbjct: 173 NPDIKVVDFGSATYDDEHHSTLVSTR------HYRAPEVILALGWSQPCDVWSIGCILIE 226
Query: 698 LAT 700
Sbjct: 227 YYL 229
|
| >3a0s_A Sensor protein; PAS-fold, kinase, phosphoprotein, transferase, two-component regulatory system; HET: PG4 PGE; 1.47A {Thermotoga maritima} PDB: 3a0v_A* Length = 96 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 2e-13
Identities = 23/102 (22%), Positives = 38/102 (37%), Gaps = 7/102 (6%)
Query: 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMG 198
M ++ RI WN+ AE L+G E LG+ +L ++ +
Sbjct: 1 METAIITLSKDGRITEWNKKAEQLFGLKKENVLGRRLKDLPDFE---EIGSVAESVFENK 57
Query: 199 ERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
E F K ER + +PF + L+ V ++ D
Sbjct: 58 EPVFLNF---YKFGERYFNI-RFSPFRNAKTQLLEGVIITID 95
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 53/274 (19%), Positives = 102/274 (37%), Gaps = 80/274 (29%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVF-SRQEYSDEVIHSFRQEVSLMK 557
++ + ++G G TV+ + + VA+KV S + Y++ + E+ L+K
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD----EIRLLK 88
Query: 558 RLR-----HPN-----VLLFMGAVTSP--QRLCIVTEFLPRGSLFRLLQRNTTK---LDW 602
+R PN LL ++ +C+V E L L + + ++ + L
Sbjct: 89 SVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPC 147
Query: 603 RRRILMALDIARGVSYLH-HCNPPIIHRDLKSSNLLV----------------------- 638
++I+ + +G+ YLH C IIH D+K N+L+
Sbjct: 148 VKKIIQ--QVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP 203
Query: 639 --------------------------DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWM 672
+ VK+ D G + H+ + T Q+
Sbjct: 204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ---TRQYR 260
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 706
+ EVL + +D++S + +ELAT ++
Sbjct: 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294
|
| >3a0r_A Sensor protein; four helix bundle, PAS fold, kinase, phosphoprotein, transfe two-component regulatory system; 3.80A {Thermotoga maritima} Length = 349 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 25/112 (22%), Positives = 43/112 (38%), Gaps = 7/112 (6%)
Query: 130 RQYL-NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVA 188
R + +IL+S+ ++ RI WN+ AE L+G E LG+ +L DF+
Sbjct: 7 RNFSESILESLETAIITLSKDGRITEWNKKAEQLFGLKKENVLGRRLKDLP----DFEEI 62
Query: 189 YDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ + + F K ER + + L G++ D
Sbjct: 63 GSVAESVFENKE--PVFLNFYKFGERYFNIRFSPFRNAKTQLLEGVIITIDD 112
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 68/284 (23%), Positives = 105/284 (36%), Gaps = 35/284 (12%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH----P 562
+G +IG GS G +Y + G +VA+K E E + K ++ P
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIK----LECVKTKHPQLHIESKIYKMMQGGVGIP 68
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
+ G +V E L SL L + K + +L+A + + Y+H
Sbjct: 69 TIRWC-G--AEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 623 NPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRL-------KHETYLTTKTGKGTPQWM 672
N IHRD+K N L+ K V + DFGL++ +H Y K GT ++
Sbjct: 125 N--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 673 APEV-LRNEPSDEKSDVYSFGVILWELATEKIPWDNL---NSMQVIGAVGFMNQRLEIP- 727
+ L E S + D+ S G +L +PW L Q + I
Sbjct: 183 SINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241
Query: 728 --KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL-QRQYFQ 768
K +A + C +P + L R+L RQ F
Sbjct: 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 6e-12
Identities = 43/264 (16%), Positives = 71/264 (26%), Gaps = 63/264 (23%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKV------FSRQEYSDEVIHSFRQEVSLMKR 558
E L E+IG+G G V+ + + VA+K+ + E+ + K
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKE 79
Query: 559 L---------RHPNVLLFMGA------------------------------VTSPQRLCI 579
L R + +L I
Sbjct: 80 LSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFI 139
Query: 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD 639
V EF G L Q T + + ++ + HRDL N+L+
Sbjct: 140 VLEFEFGGID--LEQMRTKLSSLATAKSILHQLTASLAVAEA-SLRFEHRDLHWGNVLLK 196
Query: 640 KH-----------WTVKVGDFGLSRLKHETYLTTKTGKGTPQWM---APEVLRNEPSDEK 685
K + + GL + L+ G + E L D +
Sbjct: 197 KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQ 256
Query: 686 SDVYSF-GVILWELATEKIPWDNL 708
D+Y E P+ N+
Sbjct: 257 FDIYRLMKKENNNRWGEYHPYSNV 280
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 68.0 bits (165), Expect = 8e-12
Identities = 72/518 (13%), Positives = 151/518 (29%), Gaps = 154/518 (29%)
Query: 312 MDREGGSGDSHHSD--HGFSDAALSDHREDGMSSGASTPRGDVPPCPFGVFS--HVDEKS 367
MD E G + D F DA + + D DV P + S +D
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNF--DCK---------DVQDMPKSILSKEEIDH-- 53
Query: 368 PGKSVRDSGDESEGKPAIHKIITSK----AEQWMG---KKGLSW---PWKGNEREGSDAK 417
+ S D G + + SK ++++ + + P K E+
Sbjct: 54 ----IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIK-TEQRQPSMM 108
Query: 418 TARFAWPWSHGDQDNESVQQKSPSYGTKPESHMY--EGNRSVNNEAWGSWSSSVNVNSTS 475
T + D+ Q + ++ + ++ + + V ++
Sbjct: 109 TRMYI---EQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN------VLIDG-- 157
Query: 476 SVSSCGSTS--SSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAV 533
V G T + +D++I W L + + + + Y D
Sbjct: 158 -VLGSGKTWVALDVCLSYKVQ-CKMDFKIFW--LNLKNCNSPETVLEMLQKLLYQIDPNW 213
Query: 534 KVFSRQEYSDEV-IHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFR 591
S + ++ IHS + E+ L+K + N LL +
Sbjct: 214 TSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL------------V------------ 249
Query: 592 LLQRNTTKLD--WRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLL---VDKHWTVKV 646
L + A ++ C + R + ++ L H ++
Sbjct: 250 --------LLNVQNAKAWNAFNL--------SCKILLTTRFKQVTDFLSAATTTHISLDH 293
Query: 647 GDFGLSRLKHET------YLTTKTG-------KGTPQWMA--PEVLRNEPSDEKSDVYSF 691
L+ E YL + P+ ++ E +R+ +
Sbjct: 294 HSMTLT--PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLA--------- 342
Query: 692 GVILWELATEKIPWDNLNSMQVIGAVG-FMN-----------QRLEI-PKDVD-PRWAAI 737
W+ W ++N ++ + +N RL + P P +
Sbjct: 343 ---TWD------NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIP--TIL 391
Query: 738 VESCWHSDPQCRPSFQELVDKLRD---LQRQYFQASRS 772
+ W + +V+KL +++Q +++ S
Sbjct: 392 LSLIWFDVIKSDV--MVVVNKLHKYSLVEKQPKESTIS 427
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 52/220 (23%), Positives = 85/220 (38%), Gaps = 30/220 (13%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH----P 562
+G +IG+GS G ++ + VA+K E R E K L P
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIK----FEPRRSDAPQLRDEYRTYKLLAGCTGIP 69
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
NV F G +V + L SL LL K + + A + V +H
Sbjct: 70 NVYYF-G--QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 623 NPPIIHRDLKSSNLLVDKHWT-----VKVGDFGLSRL-------KHETYLTTKTGKGTPQ 670
+ +++RD+K N L+ + + + V DFG+ + +H Y K GT +
Sbjct: 126 S--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 671 WMAPEV-LRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709
+M+ L E S + D+ + G + +PW L
Sbjct: 184 YMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLK 222
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 50/222 (22%), Positives = 85/222 (38%), Gaps = 34/222 (15%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH----P 562
+G++IG G+ G + ++ VA+K+ E E K+L P
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKL----EPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 563 NVLLFMGAVTSPQRL--CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
V F P +V E L SL L + +++A+ + + Y+H
Sbjct: 69 QVYYF-----GPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH 122
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVG-----DFGLSRL-------KHETYLTTKTGKGT 668
N +I+RD+K N L+ + DF L++ KH Y K+ GT
Sbjct: 123 SKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT 180
Query: 669 PQWMAPEV-LRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709
++M+ L E S + D+ + G + +PW L
Sbjct: 181 ARYMSINTHLGKEQS-RRDDLEALGHMFMYFLRGSLPWQGLK 221
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} Length = 115 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 4e-11
Identities = 20/99 (20%), Positives = 38/99 (38%), Gaps = 2/99 (2%)
Query: 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH 193
IL +M + I D I Y N +AELL+ SA+ + Q +L+ +
Sbjct: 11 AILNNMVTATLILDDGLAIRYANPAAELLFSQSAKRIVEQSLSQLIQHASLDLAL--LTQ 68
Query: 194 RIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLV 232
++ G+ T +++ T +P ++
Sbjct: 69 PLQSGQSITDSDVTFVVDGRPLMLEVTVSPITWQRQLML 107
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} Length = 126 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 8e-11
Identities = 18/103 (17%), Positives = 40/103 (38%), Gaps = 2/103 (1%)
Query: 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH 193
N L+++ + I + R++Y N + GY+ EE + I +T I+
Sbjct: 3 NFLETIEDMILIINREGRLLYANTAVPKKLGYTHEELMSMH-ILTITSAGKMAEGEKILA 61
Query: 194 RIKMGERWTGQFPAKTKTEERVLVVATNTPF-YDDDGTLVGIV 235
+ G++ + + K + A + ++ L I+
Sbjct: 62 ELFAGKKESLPLSLEKKEGTSIPAKARIWQGKWHNEPCLFAII 104
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} Length = 114 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 2e-10
Identities = 17/112 (15%), Positives = 38/112 (33%), Gaps = 3/112 (2%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+ + ++ +FD R + +R YG + LG ++ + + +
Sbjct: 3 ERLRLFTEHAPAALAMFDREMRYLAVSRRWREDYGLGDGDILGMSHYDIFPEIGEEWKSV 62
Query: 190 DIVHRIKMGERWTG-QFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
R GE + + P+Y+ +G + G+V + D
Sbjct: 63 H--RRGLAGEVIRVEEDCFVRADGRTQWLRWEVRPWYEGEGRVGGVVIFTED 112
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 46/214 (21%), Positives = 81/214 (37%), Gaps = 20/214 (9%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVL 565
+G +IG GS G +Y + +VA+K E E + + L+ +
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLLYESKIYRILQGGTGIP 66
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
+V + L SL L + KL + +++A + V ++H +
Sbjct: 67 NVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS-- 123
Query: 626 IIHRDLKSSNLLVDKHWT---VKVGDFGLSRL-------KHETYLTTKTGKGTPQWMAPE 675
+HRD+K N L+ V + DFGL++ +H Y K GT ++ +
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVN 183
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN 709
+ D+ S G +L +PW L
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 44/229 (19%), Positives = 81/229 (35%), Gaps = 35/229 (15%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
+G++IG G G +Y A A V + + + S E+ +R+ + +
Sbjct: 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS---ELKFYQRVAKKDCIK 97
Query: 567 FMGAVTSPQRLCIVT-----EFLPRGSLFR-----LLQRNTTKL-DWRRR-----ILM-A 609
L I +G +R L + K+ +L
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLG 157
Query: 610 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKV--GDFGLSRL-------KHETYL 660
+ + + Y+H +H D+K++NLL+ +V D+GLS K
Sbjct: 158 IRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215
Query: 661 TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNL 708
K GT ++ + + + S +SDV G + K+PW+
Sbjct: 216 PRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQN 263
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 42/234 (17%), Positives = 82/234 (35%), Gaps = 42/234 (17%)
Query: 509 IGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHS----FRQEVSLMKRLRHPN 563
+G IGQG G +Y A V +V S E+ +R P
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSD----APCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 564 VLLFMGAVTSPQRLCI-------------------VTEFLPRGSLFRLLQRNTTKLDWRR 604
+ + L + + + L ++ + N + +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRKT 153
Query: 605 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKV--GDFGLSRL-------K 655
+ ++L I + Y+H +H D+K+SNLL++ +V D+GL+ K
Sbjct: 154 VLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
Query: 656 HETYLTTKTGKGTPQWMAPEV-LRNEPSDEKSDVYSFGVILWELATEKIPWDNL 708
+ GT ++ + + PS + D+ G + + T +PW++
Sbjct: 212 AYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDN 264
|
| >3mxq_A Sensor protein; PSI2, MCSG, structural genomics, protein structure initiativ midwest center for structural genomics; 2.78A {Vibrio cholerae o1 biovar el tor} Length = 152 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 1e-08
Identities = 21/128 (16%), Positives = 41/128 (32%), Gaps = 11/128 (8%)
Query: 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183
A + +L + ++ I I+ N E + E G++ +EL +
Sbjct: 16 AMAKSRLLLSELLDQLSFALCIVRNDYVIVKVNEYFESRVIFDGETMQGKNILELFPESA 75
Query: 184 DF------DVAYDIVHRIKMGERWTGQFPAK-----TKTEERVLVVATNTPFYDDDGTLV 232
D+ E+ P K + EE++ P + +DGT+
Sbjct: 76 DYLKRKIDTALVIESSSFSSWEQKPHLLPFKSSRPVSGEEEQMYQNLEVIPIHSEDGTIE 135
Query: 233 GIVCVSTD 240
+ D
Sbjct: 136 HVCLCVYD 143
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} Length = 117 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 1e-08
Identities = 23/106 (21%), Positives = 41/106 (38%), Gaps = 3/106 (2%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
Y + + + I D + N + GY+ +E L D +L+ G D A
Sbjct: 11 NAYRALFEHAIDGIFIMDAEGHYLDVNPAICSAIGYTRDEFLALD-WGVLSRGVDSGWAA 69
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIV 235
+ RI GE + T+ +++ V + DG ++GI
Sbjct: 70 ASLARIVGGEPLREERTVWTRNGDQLTVELSAHLL--PDGKILGIA 113
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 42/232 (18%), Positives = 85/232 (36%), Gaps = 38/232 (16%)
Query: 509 IGEQIGQGSCGTVYHAV----------WYGSDVAVKVFSRQ-----EYSDEVIHSFRQEV 553
+ + + G +Y A ++K+ ++ E + + +V
Sbjct: 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 554 SLMKRLRH------PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 607
+ K+L P + F G R +V L R SL L + + R +L
Sbjct: 106 NKWKKLYSTPLLAIPTCMGF-GVHQDKYR-FLVLPSLGR-SLQSALDVSPKHVLSERSVL 162
Query: 608 M-ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKV--GDFGLSRL-----KHETY 659
A + + +LH +H ++ + N+ VD +V +G + KH Y
Sbjct: 163 QVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220
Query: 660 LTTKTGK--GTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNL 708
+ G ++++ ++ + PS +SD+ S G + + +PW N
Sbjct: 221 VEGSRSPHEGDLEFISMDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTNC 271
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A Length = 120 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 5e-08
Identities = 13/91 (14%), Positives = 24/91 (26%), Gaps = 2/91 (2%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYD-IVHRIKMGERWTGQFPAKT 209
I N ++ + + +G+ L +F+ + I + + K
Sbjct: 23 VIEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERIGERISPVMIAHGSYADDRIMKR 82
Query: 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
E T D L V D
Sbjct: 83 AGGELFWCHVTGRAL-DRTAPLAAGVWTFED 112
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} Length = 125 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-08
Identities = 13/111 (11%), Positives = 29/111 (26%), Gaps = 6/111 (5%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+++ +++ + + I+ N S G + +GQ ++
Sbjct: 19 KKFESLVSDSPDGIVHLTTNGTILSVNPSMAGRLGADPDTLVGQQLSAVMDSEAANQRLE 78
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
++ G + R P D VS D
Sbjct: 79 AGKSAVENGTATRSE----DAVGGRHYHN-QYIPV-DSHRKSDTFQLVSRD 123
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} Length = 126 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 6e-08
Identities = 16/111 (14%), Positives = 34/111 (30%), Gaps = 3/111 (2%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+ + ++ + + D I N+ GY E LG+ E D +
Sbjct: 17 SRLEALFENSPDMIDVLDADGTICEVNQRFCAELGYDESEVLGRSIWEFDLM-FDAEDVQ 75
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ + ER + + + + V F + + +S D
Sbjct: 76 TQLSGFSVDERRKFEGLYERRDGSTMSVEVHLLRFNLEGEDR--FLAISRD 124
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} Length = 120 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 7e-08
Identities = 25/112 (22%), Positives = 50/112 (44%), Gaps = 2/112 (1%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR-DFDVA 188
+ ++ ++ I DL I+Y NR+ + GY +EE LG++ +L++G V
Sbjct: 5 EIFRQTVEHAPIAISITDLKANILYANRAFRTITGYGSEEVLGKNE-SILSNGTTPRLVY 63
Query: 189 YDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ R+ + W+G + K + L T P ++ G + + + D
Sbjct: 64 QALWGRLAQKKPWSGVLVNRRKDKTLYLAELTVAPVLNEAGETIYYLGMHRD 115
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} Length = 118 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 8e-08
Identities = 15/111 (13%), Positives = 40/111 (36%), Gaps = 7/111 (6%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+ ++ + ++ + + +Y N + + YS E+ L + ++ D D A
Sbjct: 13 KFAHYLINNAVEASFCLGDNWQFLYVNDATCRMTEYSREQLLSMNLQDI-----DVDFAL 67
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
I+ +T + ++++ LV + T D + +
Sbjct: 68 HDWEEIRQKNNYTFKTRYRSQSGRIFLVEMSLTFLEDQERRF--SCVFVRE 116
|
| >2jhe_A Transcription regulator TYRR; aromatic hydrocarbons catabolism, TYRR protei nucleotide-binding, transcription regulation, activator; HET: PG4; 2.30A {Escherichia coli} Length = 190 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 21/116 (18%), Positives = 41/116 (35%), Gaps = 22/116 (18%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+L+++ + V D+ ++ N ++ L+G + A +L+ F+
Sbjct: 80 LALSALLEALPEPVLSVDMKSKVDMANPASCQLFGQKLDRLRNHTAAQLI---NGFNF-- 134
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVL----VVATNTPFY----DDDGTLVGIVCV 237
RW P + E V+ + TP Y +D L G V +
Sbjct: 135 ---------LRWLESEPQDSHNEHVVINGQNFLMEITPVYLQDENDQHVLTGAVVM 181
|
| >3mfx_A Sensory BOX/ggdef family protein; alpha-beta protein, structural genomics, PSI-2, protein structure initiative; 2.40A {Shewanella oneidensis} Length = 129 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-07
Identities = 16/119 (13%), Positives = 40/119 (33%), Gaps = 11/119 (9%)
Query: 126 NFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDF 185
+ + +Q + +++ + + + I N+ + L GQD LT+
Sbjct: 3 HSSLETIELFIQHLTEAMILVNANGFIRSCNQRSAELLDCPQVSLKGQDWRNFLTEHHQA 62
Query: 186 DVAYDIVHRIKMGERWTGQFPAKTKTEERVL---------VVATNTPFYDDDGTLVGIV 235
+ H +++G P + +E L V + + + V ++
Sbjct: 63 RYDNLLSHDVQLGTN--CGQPVQHPAQETTLICASGKAKDVELSISYIPGHEPMFVMVM 119
|
| >1d06_A Nitrogen fixation regulatory protein FIXL; oxygen sensor, histidine kinase, PAS, high-resolution, two-C system, signaling protein; HET: HEM; 1.40A {Sinorhizobium meliloti} SCOP: d.110.3.2 PDB: 1ew0_A* Length = 130 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 2e-06
Identities = 12/45 (26%), Positives = 25/45 (55%), Gaps = 1/45 (2%)
Query: 135 ILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL 179
IL ++ + + I+ +N +A +GY+ EE +GQ+ + +L
Sbjct: 21 ILDTVPDATVVSATDGTIVSFNAAAVRQFGYAEEEVIGQN-LRIL 64
|
| >2vv6_A FIXL, sensor protein FIXL; signaling protein, transferase, phosphoprotein, nitrogen FIX PER-ARNT-SIM, metal-binding, PAS, iron, heme; HET: HEM; 1.5A {Bradyrhizobium japonicum} PDB: 1xj6_A* 1xj4_A* 2vv7_A* 2vv8_A* 1lsw_A* 1dp8_A* 1dp9_A* 1drm_A* 1lsv_A* 1dp6_A* 1lsx_A* 1lt0_A* 1y28_A* 2cmn_A* 1xj3_A* 1xj2_A* 2owh_A* 2owj_A* Length = 119 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 4e-06
Identities = 12/35 (34%), Positives = 22/35 (62%), Gaps = 1/35 (2%)
Query: 145 IFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL 179
+ D I ++ +AE L+G+S EA+GQ+ + +L
Sbjct: 8 VIDGHGIIQLFSTAAERLFGWSELEAIGQN-VNIL 41
|
| >1v9y_A Heme PAS sensor protein; signaling protein; HET: HEM; 1.32A {Escherichia coli} SCOP: d.110.3.2 PDB: 1v9z_A* 1vb6_A* 1s67_L* 1s66_L* Length = 167 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 7e-06
Identities = 16/56 (28%), Positives = 31/56 (55%), Gaps = 1/56 (1%)
Query: 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL 179
A N D + L+ + + +D ++++N +AE L+GY EE +G + I++L
Sbjct: 34 ADNAADGIFFPALEQNMMGAVLINENDEVMFFNPAAEKLWGYKREEVIGNN-IDML 88
|
| >1ll8_A PAS kinase; PAS domain, ligand binding, ligand screening, kinase regulation, transferase; NMR {Homo sapiens} SCOP: d.110.3.5 Length = 114 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 8e-06
Identities = 13/103 (12%), Positives = 31/103 (30%), Gaps = 5/103 (4%)
Query: 135 ILQSMGQSVHIFDLSD-RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH 193
+ +++ D I+ N A L GYS+++ +GQ + V
Sbjct: 3 MDPEFNKAIFTVDAKTTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEE 62
Query: 194 RIKMGERWT----GQFPAKTKTEERVLVVATNTPFYDDDGTLV 232
++ +++ E++ V +
Sbjct: 63 HMEADGHAAVVFGTVVDIISRSGEKIPVSVWMKRMRQERRLCC 105
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} Length = 258 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 26/163 (15%), Positives = 56/163 (34%), Gaps = 2/163 (1%)
Query: 152 IIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKT 211
+I N++ L GYS EE +G++ L G + + I ++ + + K
Sbjct: 88 LIAINQAFTDLTGYSEEECVGRNCRFLAGSGTEPWLTDKIRQGVREHKPVLVEILNYKKD 147
Query: 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVT 271
P YDDD L+ + + Q + ++ ++ + VT
Sbjct: 148 GTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDDQPNMGMARRERAAEMLKTLSPRQLEVT 207
Query: 272 AKLGLDSQQPLQATI--ASKISNLATKVSNKVKSRIRTGDNFM 312
+ + A S+ + + K ++T + +
Sbjct: 208 TLVASGLRNKEVAARLGLSEKTVKMHRGLVMEKLNLKTSADLV 250
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} Length = 128 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 2e-05
Identities = 20/90 (22%), Positives = 33/90 (36%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210
I++ N + L GY A+E +G++ L G D I I + K
Sbjct: 21 PIVFANPAFLKLTGYEADEVMGRNCRFLQGHGTDPAHVRAIKSAIAAEKPIDIDIINYKK 80
Query: 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ E +P ++ +G L V D
Sbjct: 81 SGEAFWNRLHISPVHNANGRLQHFVSSQLD 110
|
| >3fg8_A Uncharacterized protein RHA05790; PAS domain, structural genomics, PS protein structure initiative, midwest center for structural genomics, MCSG; HET: 3PB; 1.80A {Rhodococcus SP} Length = 118 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-05
Identities = 18/62 (29%), Positives = 22/62 (35%), Gaps = 2/62 (3%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL--TDGRDFDV 187
N+ G D RIIY N S +E LG+ E+L T G FD
Sbjct: 12 SGRENLYFQGGLGFMALDEDLRIIYVNSGCLRHVRRSRDELLGRVVTEVLPETQGSYFDA 71
Query: 188 AY 189
Sbjct: 72 LC 73
|
| >3vol_A Aerotaxis transducer AER2; heme, oxygen sensor protein, PAS, HAMP, cyanoMet, CN-bound, protein; HET: HEM; 2.40A {Pseudomonas aeruginosa} Length = 233 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 3e-05
Identities = 28/180 (15%), Positives = 61/180 (33%), Gaps = 7/180 (3%)
Query: 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTD---GRDFDVAY- 189
+ L ++ +V I D IIY NR+ + G + + + + G + DV +
Sbjct: 26 SALDNVSANVMIADNDLNIIYMNRTVSEMLGRAEAD-IRKQLPNFDAGRLMGANIDVFHK 84
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRA 249
+ H+ + TG A+ R + P ++D +G TD
Sbjct: 85 NPAHQRHLLANLTGVHKAELNLGGRRFSL-DVVPVFNDANERLGSAVQWTDRTEEHRAEQ 143
Query: 250 ALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISNLATKVSNKVKSRIRTGD 309
+ + + ++ R K G + ++ + +++ + GD
Sbjct: 144 EVSQLVQAAAAGDFSK-RVEEAGKEGFFLRLAKDLNSLVDTADRGLRDVSRMLGALAQGD 202
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} Length = 162 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 4e-05
Identities = 23/90 (25%), Positives = 30/90 (33%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210
+IY N + E L GYS +E L QD L D RD I + G K
Sbjct: 49 ILIYVNAAFEYLTGYSRDEILYQDCRFLQGDDRDQLGRARIRKAMAEGRPCREVLRNYRK 108
Query: 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ TP D + + D
Sbjct: 109 DGSAFWNELSITPVKSDFDQRTYFIGIQKD 138
|
| >3k3c_A Protein RV1364C/MT1410; sensor, PAS, signal transduction, fatty-acid binding, sigma regulator, signaling protein; HET: PLM; 1.62A {Mycobacterium tuberculosis} PDB: 3k3d_A Length = 158 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 19/118 (16%), Positives = 39/118 (33%), Gaps = 10/118 (8%)
Query: 130 RQYLNILQSMGQSVHIFDLSD-RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVA 188
I + + + + D R + N + + +GQ A E+ + +
Sbjct: 17 EDVRRIFEHIPAILVGLEGPDHRFVAVNAAYRGFSP--LLDTVGQPAREVYPELEGQQIY 74
Query: 189 YDIVHRI------KMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+++ R+ + G W Q E TP DG++ G+ + D
Sbjct: 75 -EMLDRVYQTGEPQSGSEWRLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDD 131
|
| >3kx0_X Uncharacterized protein RV1364C/MT1410; PAS domain, sensory domain, mycobacteium tuberculos molecule binding domain; 2.30A {Mycobacterium tuberculosis} Length = 185 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 19/118 (16%), Positives = 39/118 (33%), Gaps = 10/118 (8%)
Query: 130 RQYLNILQSMGQSVHIFDLSD-RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVA 188
I + + + + D R + N + + +GQ A E+ + +
Sbjct: 37 EDVRRIFEHIPAILVGLEGPDHRFVAVNAAYRGFSP--LLDTVGQPAREVYPELEGQQIY 94
Query: 189 YDIVHRI------KMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+++ R+ + G W Q E TP DG++ G+ + D
Sbjct: 95 -EMLDRVYQTGEPQSGSEWRLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDD 151
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* Length = 132 | Back alignment and structure |
|---|
Score = 41.7 bits (99), Expect = 1e-04
Identities = 22/85 (25%), Positives = 31/85 (36%), Gaps = 1/85 (1%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210
I+Y N+ + GY EE LG++ L D +I ++ E T Q K
Sbjct: 23 PIVYVNQGFVQMTGYETEEILGKNCRFLQGKHTDPAEVDNIRTALQNKEPVTVQIQNYKK 82
Query: 211 TEERVLVVATNTPFYDDDGTL-VGI 234
P +D T VGI
Sbjct: 83 DGTMFWNELNIDPMEIEDKTYFVGI 107
|
| >2qkp_A Uncharacterized protein; structural genomics, unknown function, PSI-2, protein struct initiative; 1.75A {Streptococcus mutans} Length = 151 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 1e-04
Identities = 21/128 (16%), Positives = 47/128 (36%), Gaps = 6/128 (4%)
Query: 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSA---ELLYGYSAEEALGQDAIELLTDGR 183
+ Q IL + + + D Y+N S E+++ + +G++ +
Sbjct: 16 LSVEQANLILNHLPLEITFVNKDDIFQYYNDSVPAAEMVFKRT-PSQVGRNVELCHPP-K 73
Query: 184 DFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243
D + ++ G+R +++ + + V T D G G++ D +P
Sbjct: 74 VLDKVKKVFELLRNGQRDKVNMWFQSERLGKFVYV-TYAAVRDQAGDFQGVLEYVQDIKP 132
Query: 244 FQETRAAL 251
F E +
Sbjct: 133 FFELDSEF 140
|
| >2vlg_A Sporulation kinase A; histidine kinase, two-component regulatory system, two-component signal transduction, transferase, phosphorylation, SCOD; 1.7A {Bacillus subtilis} Length = 111 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 2e-04
Identities = 18/107 (16%), Positives = 30/107 (28%), Gaps = 5/107 (4%)
Query: 135 ILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL-TDGRDFDVAYDIVH 193
LQ+ + + RIIY + +++L GY E +G L + D +
Sbjct: 4 PLQTKTDIHAVLASNGRIIYISANSKLHLGYLQGEMIGSFLKTFLHEE----DQFLVESY 59
Query: 194 RIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
F K V V A + +
Sbjct: 60 FYNEHHLMPCTFRFIKKDHTIVWVEAAVEIVTTRAERTEREIILKMK 106
|
| >2w0n_A Sensor protein DCUS; signal transduction, two-component regulatory system, PAS, kinase, membrane, transferase, solid state cell inner membrane; NMR {Escherichia coli} Length = 118 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 4e-04
Identities = 18/106 (16%), Positives = 39/106 (36%), Gaps = 15/106 (14%)
Query: 135 ILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAE---EALGQDAIELLTDGRDFDVAYDI 191
+LQS+ + V D + N +A+ L Y E L + +V
Sbjct: 20 MLQSIKEGVVAVDDRGEVTLINDAAQELLNYRKSQDDEKLSTLSHSWSQVVDVSEV---- 75
Query: 192 VHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCV 237
++ G + + ++R+L++ P +G ++G +
Sbjct: 76 ---LRDGTPRRDE---EITIKDRLLLI-NTVPVR-SNGVIIGAIST 113
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* Length = 166 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 19/90 (21%), Positives = 31/90 (34%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210
I+Y +R L GYS ++ LG++ L D I + I G + +
Sbjct: 59 PIVYASRGFLTLTGYSLDQILGRNCRFLQGPETDPRAVDKIRNAITKGVDTSVCLLNYRQ 118
Query: 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ D G +V V V +
Sbjct: 119 DGTTFWNLFFVAGLRDSKGNIVNYVGVQSK 148
|
| >3cax_A Uncharacterized protein PF0695; structural genomics, unknown function, PSI-2, protein struct initiative; 2.43A {Pyrococcus furiosus dsm 3638} Length = 369 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 24/167 (14%), Positives = 58/167 (34%), Gaps = 10/167 (5%)
Query: 80 PDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNSGPSAFNFTDRQYLNILQSM 139
P+ T + + Q + + +G + I +++
Sbjct: 193 PELNVEQLLTLPKEVQQALRGQPLEFDKTQLKREEDIDLGTG----YLNIEELKAIFEAL 248
Query: 140 GQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGE 199
V D DR+ +++ E ++ + LG+ + V I+ K G
Sbjct: 249 PVDVTFIDKDDRVRFFSP-GERIFTRT-PSVLGRPVQLCHPP-KSVYVVNKILKAFKEGR 305
Query: 200 RWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246
+ F + E+ V + P +++ G +G + ++ D P+++
Sbjct: 306 KKEATFWLR-LREKYVYI--KYVPLFNEKGEYIGTLEMTMDIAPYKK 349
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* Length = 146 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 8e-04
Identities = 23/90 (25%), Positives = 33/90 (36%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210
II+ + S L YS EE LG++ L D I I T Q TK
Sbjct: 26 PIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRATVRKIRDAIDNQTEVTVQLINYTK 85
Query: 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ ++ + P D G + + V D
Sbjct: 86 SGKKFWNLFHLQPMRDQKGDVQYFIGVQLD 115
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 782 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 2gj3_A | 120 | Nitrogen fixation regulatory protein; PAS domain, | 99.77 | |
| 4hia_A | 176 | LOV protein; PAS, HTH, signaling protein; HET: FMN | 99.75 | |
| 2pr5_A | 132 | Blue-light photoreceptor; light-oxygen-voltage, LO | 99.74 | |
| 1n9l_A | 109 | PHOT-LOV1, putative blue light receptor; phototrop | 99.71 | |
| 3p7n_A | 258 | Sensor histidine kinase; LOV domain, light-activat | 99.7 | |
| 3ue6_A | 166 | Aureochrome1; PAS/LOV domain, FMN-binding blue-lig | 99.69 | |
| 3sw1_A | 162 | Sensory box protein; light-oxygen-voltage, LOV, PA | 99.68 | |
| 3t50_A | 128 | Blue-light-activated histidine kinase; PAS superfa | 99.68 | |
| 3f1p_B | 121 | ARYL hydrocarbon receptor nuclear translocator; PA | 99.66 | |
| 3k3c_A | 158 | Protein RV1364C/MT1410; sensor, PAS, signal transd | 99.64 | |
| 2vv6_A | 119 | FIXL, sensor protein FIXL; signaling protein, tran | 99.64 | |
| 4eet_B | 115 | Phototropin-2; LOV, blue light photoreceptor, sign | 99.63 | |
| 3mqq_A | 120 | Transcriptional regulator, LUXR family; PAS domain | 99.62 | |
| 3mr0_A | 142 | Sensory box histidine kinase/response regulator; P | 99.62 | |
| 3lyx_A | 124 | Sensory BOX/ggdef domain protein; structural genom | 99.61 | |
| 3f1p_A | 117 | Endothelial PAS domain-containing protein 1; PAS d | 99.61 | |
| 2z6d_A | 130 | Phototropin-2; PAS-fold, LOV-fold, alternative spl | 99.61 | |
| 2r78_A | 117 | Sensor protein; sensory box sensor histidine kinas | 99.6 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.6 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 99.59 | |
| 3nja_A | 125 | Probable ggdef family protein; structural genomics | 99.59 | |
| 3luq_A | 114 | Sensor protein; PAS, histidine, kinase, PSI, MCSG, | 99.57 | |
| 3mxq_A | 152 | Sensor protein; PSI2, MCSG, structural genomics, p | 99.57 | |
| 3kx0_X | 185 | Uncharacterized protein RV1364C/MT1410; PAS domain | 99.56 | |
| 2wkq_A | 332 | NPH1-1, RAS-related C3 botulinum toxin substrate 1 | 99.55 | |
| 1d06_A | 130 | Nitrogen fixation regulatory protein FIXL; oxygen | 99.54 | |
| 3vol_A | 233 | Aerotaxis transducer AER2; heme, oxygen sensor pro | 99.53 | |
| 2v0u_A | 146 | NPH1-1, LOV2; kinase, transferase, ATP-binding, se | 99.52 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 99.5 | |
| 3h9w_A | 115 | Diguanylate cyclase with PAS/PAC sensor; alpha-bet | 99.49 | |
| 3mjq_A | 126 | Uncharacterized protein; NESG, structural genomics | 99.48 | |
| 3olo_A | 118 | Two-component sensor histidine kinase; structural | 99.48 | |
| 3icy_A | 118 | Sensor protein; sensory box histidine kinase/respo | 99.47 | |
| 2qkp_A | 151 | Uncharacterized protein; structural genomics, unkn | 99.46 | |
| 3mfx_A | 129 | Sensory BOX/ggdef family protein; alpha-beta prote | 99.44 | |
| 2l0w_A | 138 | Potassium voltage-gated channel, subfamily H (EAG | 99.43 | |
| 3eeh_A | 125 | Putative light and redox sensing histidine kinase; | 99.43 | |
| 1byw_A | 110 | Protein (human ERG potassium channel); PAS domain, | 99.42 | |
| 1v9y_A | 167 | Heme PAS sensor protein; signaling protein; HET: H | 99.42 | |
| 2kdk_A | 121 | ARYL hydrocarbon receptor nuclear translocator-LI | 99.42 | |
| 3d72_A | 149 | Vivid PAS protein VVD; circadian, photoreceptor, b | 99.4 | |
| 4hi4_A | 121 | Aerotaxis transducer AER2; PAS domain, diatomic GA | 99.38 | |
| 3b33_A | 115 | Sensor protein; structural genomics, PAS domain, n | 99.38 | |
| 3bwl_A | 126 | Sensor protein; structural genomics, APC87707.1, P | 99.36 | |
| 3fc7_A | 125 | HTR-like protein, sensor protein; APC87712.1, HTR- | 99.31 | |
| 3fg8_A | 118 | Uncharacterized protein RHA05790; PAS domain, stru | 99.3 | |
| 4eho_A | 635 | Bacteriophytochrome, PAS/PAC sensor; photoreceptor | 99.27 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 2vlg_A | 111 | Sporulation kinase A; histidine kinase, two-compon | 99.21 | |
| 3cax_A | 369 | Uncharacterized protein PF0695; structural genomic | 99.2 | |
| 4f3l_A | 361 | Mclock, circadian locomoter output cycles protein | 99.17 | |
| 3a0r_A | 349 | Sensor protein; four helix bundle, PAS fold, kinas | 99.17 | |
| 1ll8_A | 114 | PAS kinase; PAS domain, ligand binding, ligand scr | 99.12 | |
| 1nwz_A | 125 | PYP, photoactive yellow protein; PAS, LOV, GAF, do | 99.07 | |
| 3a0s_A | 96 | Sensor protein; PAS-fold, kinase, phosphoprotein, | 99.06 | |
| 4f3l_B | 387 | BMAL1B; BHLH, PAS, circadian rhythm proteins, tran | 99.05 | |
| 1mzu_A | 129 | PPR; photoactive yellow protein, PAS, PYP, signali | 99.04 | |
| 2w0n_A | 118 | Sensor protein DCUS; signal transduction, two-comp | 99.02 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.0 | |
| 2jhe_A | 190 | Transcription regulator TYRR; aromatic hydrocarbon | 99.0 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.99 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.87 | |
| 3rty_A | 339 | Period circadian protein; PAS domain, signalling, | 98.68 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.67 | |
| 2ykf_A | 305 | Pdtas, probable sensor histidine kinase pdtas; tra | 98.05 | |
| 4dj3_A | 317 | Period circadian protein homolog 3; PAS domain, ci | 98.46 | |
| 3gdi_A | 309 | Period circadian protein homolog 2; tandem PAS dom | 98.43 | |
| 4dj2_A | 320 | Period circadian protein homolog 1; PAS domains, c | 98.39 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.32 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.27 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.19 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.07 | |
| 4f3l_A | 361 | Mclock, circadian locomoter output cycles protein | 97.98 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.96 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.95 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.9 | |
| 4f3l_B | 387 | BMAL1B; BHLH, PAS, circadian rhythm proteins, tran | 97.8 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.63 | |
| 3rty_A | 339 | Period circadian protein; PAS domain, signalling, | 97.58 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.58 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.47 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.19 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.16 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.13 | |
| 1oj5_A | 132 | Steroid receptor coactivator 1A; transcriptional c | 97.12 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.06 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.73 | |
| 4dj2_A | 320 | Period circadian protein homolog 1; PAS domains, c | 96.63 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.48 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.41 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.37 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.28 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.26 | |
| 4dj3_A | 317 | Period circadian protein homolog 3; PAS domain, ci | 96.12 | |
| 3gdi_A | 309 | Period circadian protein homolog 2; tandem PAS dom | 95.82 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.18 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.14 | |
| 2ool_A | 337 | Sensor protein; bacteriophytochrome, photoconversi | 90.53 | |
| 4dah_A | 217 | Sporulation kinase D; alpha-beta-alpha structure, | 90.16 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.0 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.19 | |
| 1p0z_A | 131 | Sensor kinase CITA; transferase; HET: FLC MO7; 1.6 | 83.99 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.9 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.48 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=480.20 Aligned_cols=257 Identities=24% Similarity=0.420 Sum_probs=225.6
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.++|+++++||+|+||+||+|++. ++.||||++.+........+.+.+|+++|+.++|||||++++++++++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 478999999999999999999984 788999999988777777889999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 582 EFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 582 E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
|||+||+|.++|... ...+++..++.++.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+.......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 999999999999754 345789999999999999999999999 99999999999999999999999999987655433
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHH
Q 003978 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 740 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 740 (782)
...+.+||+.|||||++.+..|+.++|||||||+||||+||+.||...+..+.+..+... ..+.++..+++++++||.+
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-~~~~~~~~~s~~~~~li~~ 259 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLVSQ 259 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCCCCCTTSCHHHHHHHHH
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-CCCCCCccCCHHHHHHHHH
Confidence 344567999999999999999999999999999999999999999999888877776432 2345677899999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 741 CWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 741 cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
||.+||++|||+.++ |+|+||+.
T Consensus 260 ~L~~dP~~R~s~~e~------l~hp~~~~ 282 (350)
T 4b9d_A 260 LFKRNPRDRPSVNSI------LEKGFIAK 282 (350)
T ss_dssp HTCSSGGGSCCHHHH------HTSHHHHT
T ss_pred HccCChhHCcCHHHH------hcCHHhhc
Confidence 999999999999999 56788864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-56 Score=476.53 Aligned_cols=263 Identities=22% Similarity=0.379 Sum_probs=232.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
.++|+++++||+|+||+||+|++ .++.||||++.+... .....+.+.+|+++|+.++|||||+++++|++++.+|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35799999999999999999998 477899999986543 223356789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc--
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-- 658 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-- 658 (782)
||||+||+|.++|.+. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.....
T Consensus 111 mEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 9999999999999765 46999999999999999999999999 999999999999999999999999999865432
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 738 (782)
.....+.+||+.|||||++.+..|+.++|||||||+||+|++|.+||...+....+..+. ...+.+|..+++++++||
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dli 265 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII--KLEYDFPEKFFPKARDLV 265 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTCCCCCTTCCHHHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCcccCHHHHHHH
Confidence 223456789999999999999999999999999999999999999999988888877774 345677889999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 739 ~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
.+||.+||++|||+.|++.+-.=++|+||+.+.
T Consensus 266 ~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 266 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp HHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 999999999999999976554446799998753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-55 Score=475.38 Aligned_cols=257 Identities=26% Similarity=0.407 Sum_probs=227.6
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.+.|+++++||+|+||+||+|.+ .++.||||++....... .+.+.+|+.+|+.++|||||+++++|++++.+||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46799999999999999999998 47789999997654322 346788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
|||+||+|.+++... .+++..++.++.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+........
T Consensus 151 Ey~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 151 EFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp CCCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred eCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 999999999999753 5999999999999999999999999 999999999999999999999999999876655445
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-cccCCCCCCCHHHHHHHHH
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QRLEIPKDVDPRWAAIVES 740 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~~l~~LI~~ 740 (782)
..+.+||+.|||||++.+..|+.++|||||||+||||++|.+||...+..+.+..+.... .....+..+++++++||.+
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 567799999999999999999999999999999999999999999988888777664322 2334445789999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 741 CWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 741 cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
||.+||++|||+.|+ |+|+||+....
T Consensus 307 ~L~~dP~~R~ta~e~------l~Hp~~~~~~~ 332 (346)
T 4fih_A 307 LLVRDPAQRATAAEL------LKHPFLAKAGP 332 (346)
T ss_dssp HSCSSTTTSCCHHHH------TTCGGGGGCCC
T ss_pred HcCCChhHCcCHHHH------hcCHhhcCCCC
Confidence 999999999999999 67899987543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-54 Score=463.66 Aligned_cols=266 Identities=36% Similarity=0.591 Sum_probs=227.0
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
..|++..++|+++++||+|+||+||+|.+.+ .||||+++......+..+.|.+|+.+|+.++|||||++++++.. +.+
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 4578888999999999999999999998765 69999998776677778899999999999999999999998764 578
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|||||||+||+|.++|.....++++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999999999877778999999999999999999999998 99999999999999999999999999986543
Q ss_pred c--cccccCCCCCCcccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-c---ccCCCC
Q 003978 658 T--YLTTKTGKGTPQWMAPEVLRN---EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-Q---RLEIPK 728 (782)
Q Consensus 658 ~--~~~~~~~~Gt~~y~aPE~l~~---~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~-~---~~~~p~ 728 (782)
. .......+||+.|||||++.+ .+|+.++|||||||+||||+||+.||...+....+..+.... . ...++.
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 264 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYK 264 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCT
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Confidence 2 223345689999999999964 358999999999999999999999998876654443332221 1 234567
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 729 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 729 ~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
.+++++.+||.+||+.||++|||+.++++.|+.|+|++.
T Consensus 265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 265 NCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 899999999999999999999999999999999988754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=455.39 Aligned_cols=254 Identities=31% Similarity=0.524 Sum_probs=219.0
Q ss_pred eeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec----CCceeEE
Q 003978 507 LTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----PQRLCIV 580 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lv 580 (782)
|++.++||+|+||.||+|.+. +..||||++..........+.+.+|+++|+.++|||||+++++|+. +..+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 578889999999999999984 6679999998877777778899999999999999999999999865 3568999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCcEEEEecCCCccccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~-~~~~vkL~DFGla~~~~~~~ 659 (782)
||||+||+|.+++.+. ..+++..++.++.||+.||+|||+++++||||||||+||||+ .+|.+||+|||+|+.....
T Consensus 108 mEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~- 185 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence 9999999999999764 469999999999999999999999877799999999999997 4799999999999865443
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccccCCCCCCCHHHHHHH
Q 003978 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFMNQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~~~~l~~LI 738 (782)
...+.+||+.|||||++.+ .|+.++|||||||+||||+||+.||...... .....+.....+..++..+++++++||
T Consensus 186 -~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li 263 (290)
T 3fpq_A 186 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 263 (290)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred -ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHH
Confidence 2345689999999999876 5999999999999999999999999876544 444444433334456677899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 739 ~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
.+||.+||++|||+.++ |+|+||+..
T Consensus 264 ~~~L~~dP~~R~s~~e~------l~Hp~~~~~ 289 (290)
T 3fpq_A 264 EGCIRQNKDERYSIKDL------LNHAFFQEE 289 (290)
T ss_dssp HHHSCSSGGGSCCHHHH------HTSGGGC--
T ss_pred HHHccCChhHCcCHHHH------hcCccccCC
Confidence 99999999999999999 678999753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=451.91 Aligned_cols=253 Identities=29% Similarity=0.519 Sum_probs=210.7
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
++|++++.||+|+||+||+|.+ .++.||||++.+.... ......+.+|+++|+.++|||||++++++++++.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999987 4788999999876543 344567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
||| +|+|.+++.+. .++++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+|+...... .
T Consensus 93 Ey~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-~ 167 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-F 167 (275)
T ss_dssp ECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred eCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCCCC-c
Confidence 999 67999999764 46999999999999999999999999 9999999999999999999999999998655432 2
Q ss_pred ccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHH
Q 003978 662 TKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 740 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~-s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 740 (782)
..+.+||+.|||||++.+..+ +.++|||||||++|+|+||+.||...+.......+. .....+|..+++++++||.+
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~ 245 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS--NGVYTLPKFLSPGAAGLIKR 245 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHHHHH
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHH
Confidence 345689999999999999876 579999999999999999999999888777776663 34566788999999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 741 CWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 741 cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
||.+||++|||+.|+ ++|+|||.-
T Consensus 246 ~L~~dP~~R~s~~ei------l~hpw~k~~ 269 (275)
T 3hyh_A 246 MLIVNPLNRISIHEI------MQDDWFKVD 269 (275)
T ss_dssp HSCSSGGGSCCHHHH------HHCHHHHTT
T ss_pred HccCChhHCcCHHHH------HcCcccccC
Confidence 999999999999999 678999853
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-54 Score=466.36 Aligned_cols=254 Identities=26% Similarity=0.319 Sum_probs=219.8
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
+....+.|++.++||+|+||.||+|+++ ++.||||+++..... .+|+.+|+.++|||||++++++.+++.+
T Consensus 53 ~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~ 125 (336)
T 4g3f_A 53 YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWV 125 (336)
T ss_dssp CCBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred hhcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3344568999999999999999999984 778999999875532 3699999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-cEEEEecCCCcccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKH 656 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~-~vkL~DFGla~~~~ 656 (782)
|||||||+||+|.++|...+ .+++..++.++.||+.||+|||+++ ||||||||+||||+.+| ++||+|||+|+...
T Consensus 126 ~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp EEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred EEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 99999999999999997654 6999999999999999999999999 99999999999999987 69999999998654
Q ss_pred ccc-----ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-ccCCCCCC
Q 003978 657 ETY-----LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDV 730 (782)
Q Consensus 657 ~~~-----~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~ 730 (782)
... ......+||+.|||||++.+..|+.++|||||||+||||+||.+||...+.......+..... ...+++.+
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 282 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC 282 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTS
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccC
Confidence 322 122345799999999999999999999999999999999999999988776666656543332 24578899
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003978 731 DPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 763 (782)
Q Consensus 731 ~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~ 763 (782)
++++++||.+||.+||.+|||+.||+++|.+..
T Consensus 283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 999999999999999999999999999987764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-53 Score=459.86 Aligned_cols=260 Identities=32% Similarity=0.562 Sum_probs=223.5
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 572 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 572 (782)
..+..++|.+.++||+|+||+||+|.+. ++.||||+++.. .....+.|.+|+++|+.++|||||++++++.
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3456678999999999999999999874 457999999643 4556688999999999999999999999999
Q ss_pred cCCceeEEEeecCCCCHHHHHhhcC--------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 003978 573 SPQRLCIVTEFLPRGSLFRLLQRNT--------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV 638 (782)
Q Consensus 573 ~~~~~~lv~E~~~ggsL~~~l~~~~--------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl 638 (782)
+.+.+|||||||++|+|.++|.... .++++..++.++.||+.||+|||+++ ||||||||+||||
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl 191 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLV 191 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEE
Confidence 9999999999999999999997532 35899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEecCCCcccccc--cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 003978 639 DKHWTVKVGDFGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIG 715 (782)
Q Consensus 639 ~~~~~vkL~DFGla~~~~~~--~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~ 715 (782)
+.++.+||+|||+|+..... .......+||+.|||||++.+..++.++|||||||+||||+| |+.||...+..+.+.
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999999865432 222334579999999999999999999999999999999999 999999998888777
Q ss_pred HhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 716 AVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 716 ~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
.+.. ..++.+|..+++++.+||.+||+.||++|||+.+|+++|+.|.+
T Consensus 272 ~i~~-g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 272 CITQ-GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHH-TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHc-CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 6643 34677888999999999999999999999999999999988864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-55 Score=467.32 Aligned_cols=256 Identities=23% Similarity=0.396 Sum_probs=219.4
Q ss_pred ccceeEeeeeccCCcEEEEEEEE-----cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
.++|++++.||+|+||+||+|++ .++.||||++++..........+.+|+++|+.++|||||++++++++++.+|
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 36899999999999999999987 3567999999765432222345778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
||||||+||+|.+++.+.. .+++..+..++.||+.||+|||++| ||||||||+|||++.+|.+||+|||+|+.....
T Consensus 103 ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 9999999999999998654 6999999999999999999999999 999999999999999999999999999865554
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 738 (782)
.....+.+||+.|||||++.+..|+.++|||||||+||||+||..||...+..+.+..+. ...+.+|..+++++++||
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li 257 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQSLL 257 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHH
T ss_pred CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH--cCCCCCCCcCCHHHHHHH
Confidence 444556789999999999999999999999999999999999999999998888877764 345677889999999999
Q ss_pred HHhhhhCCCCCCC-----HHHHHHHHHHHHHHHhhcc
Q 003978 739 ESCWHSDPQCRPS-----FQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 739 ~~cL~~dP~~RPs-----~~ell~~L~~L~~~~~~~~ 770 (782)
.+||.+||++||| ++|+ +.|+||+.+
T Consensus 258 ~~~L~~dP~~R~ta~~~~~~ei------l~Hp~f~~i 288 (304)
T 3ubd_A 258 RMLFKRNPANRLGAGPDGVEEI------KRHSFFSTI 288 (304)
T ss_dssp HHHTCSSGGGSTTCSTTTHHHH------HTSGGGTTC
T ss_pred HHHcccCHHHCCCCCcCCHHHH------HcCccccCC
Confidence 9999999999998 4677 678999765
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-53 Score=473.15 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=228.4
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.+.|+++++||+|+||.||+|.+. ++.||||++....... .+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 467999999999999999999984 7789999997654322 356789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
|||+||+|.+++... .+++..+..++.||+.||+|||++| ||||||||+||||+.+|.|||+|||+|+........
T Consensus 228 Ey~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 228 EFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp ECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred eCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 999999999999753 5999999999999999999999999 999999999999999999999999999876655445
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-cccCCCCCCCHHHHHHHHH
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QRLEIPKDVDPRWAAIVES 740 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~~l~~LI~~ 740 (782)
..+.+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+....+..+.... .....+..+++++++||.+
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence 557789999999999999999999999999999999999999999988888777664322 2344556799999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 741 CWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 741 cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
||.+||++|||+.|+ |+|+||+....
T Consensus 384 ~L~~dP~~R~ta~el------l~Hp~~~~~~~ 409 (423)
T 4fie_A 384 LLVRDPAQRATAAEL------LKHPFLAKAGP 409 (423)
T ss_dssp HSCSSTTTSCCHHHH------TTCGGGGGCCC
T ss_pred HcCCChhHCcCHHHH------hcCHHhcCCCC
Confidence 999999999999999 67899987543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-53 Score=453.98 Aligned_cols=260 Identities=30% Similarity=0.535 Sum_probs=227.1
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 572 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 572 (782)
.++..++|.+.++||+|+||.||+|.+. +..||||+++.. .....+.|.+|+++|+.++|||||++++++.
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 3556689999999999999999999864 456999998643 4556788999999999999999999999999
Q ss_pred cCCceeEEEeecCCCCHHHHHhhcC------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC
Q 003978 573 SPQRLCIVTEFLPRGSLFRLLQRNT------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK 640 (782)
Q Consensus 573 ~~~~~~lv~E~~~ggsL~~~l~~~~------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~ 640 (782)
+++.+|||||||++|+|.++|.... ..+++..++.++.||+.||+|||+++ ||||||||+||||+.
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~ 163 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGE 163 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECC
Confidence 9999999999999999999997542 46899999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHh
Q 003978 641 HWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAV 717 (782)
Q Consensus 641 ~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i 717 (782)
++.+||+|||+|+...... .......||+.|||||++.+..++.++|||||||+||||+| |+.||...+..++...+
T Consensus 164 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999998654332 22233468999999999999999999999999999999998 99999999988887776
Q ss_pred hccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 718 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 718 ~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
.. ...+..|..+|+++.+||.+||+.||++|||+.++.+.|+++.+
T Consensus 244 ~~-~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 244 TQ-GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Hc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 43 34567888999999999999999999999999999988887653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=449.82 Aligned_cols=257 Identities=29% Similarity=0.522 Sum_probs=225.3
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (782)
++...+++++++||+|+||+||+|.+. ++.||||+++... .....+.|.+|+.+|+.++|||||++++++..
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 456678999999999999999999863 4579999987543 33445789999999999999999999999999
Q ss_pred CCceeEEEeecCCCCHHHHHhhc---------------CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 003978 574 PQRLCIVTEFLPRGSLFRLLQRN---------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV 638 (782)
Q Consensus 574 ~~~~~lv~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl 638 (782)
++.+|||||||++|+|.++|... ...+++..++.++.||+.||+|||+++ ||||||||+||||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl 178 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLV 178 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEE
Confidence 99999999999999999999643 235899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEecCCCcccccc--cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 003978 639 DKHWTVKVGDFGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIG 715 (782)
Q Consensus 639 ~~~~~vkL~DFGla~~~~~~--~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~ 715 (782)
+.++.+||+|||+|+..... .......+||+.|||||++.+..++.++|||||||+||||+| |..||.+.+..++..
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999999865432 223345679999999999999999999999999999999998 899999999888877
Q ss_pred HhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003978 716 AVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRD 761 (782)
Q Consensus 716 ~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~ 761 (782)
.+. ....++.|..+|+++.+||.+||..||++|||+.+|++.|++
T Consensus 259 ~i~-~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 259 MIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHH-cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 764 344567788999999999999999999999999999998864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=451.05 Aligned_cols=264 Identities=30% Similarity=0.535 Sum_probs=228.5
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEcC-------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCC-CceeEEee
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH-PNVLLFMG 569 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~ 569 (782)
..||+..++|+++++||+|+||.||+|.+.+ +.||||+++... .....+.+.+|+++|..+.| ||||++++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 4578889999999999999999999999754 359999987544 34456789999999999975 89999999
Q ss_pred eeecC-CceeEEEeecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 003978 570 AVTSP-QRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (782)
Q Consensus 570 ~~~~~-~~~~lv~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp 633 (782)
+|..+ +.+|||||||++|+|.++|.... ..+++..++.++.||+.||+|||+++ ||||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~ 213 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 213 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCc
Confidence 98664 56899999999999999997532 34889999999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEecCCCcccccc--cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 003978 634 SNLLVDKHWTVKVGDFGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (782)
Q Consensus 634 ~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~ 710 (782)
+||||+.++.+||+|||+|+..... .......+||+.|||||++.+..|+.++|||||||+||||+| |..||...+.
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999865432 223345578999999999999999999999999999999998 9999998775
Q ss_pred HHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 711 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 711 ~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
...+..+.....++..|..+++++.+||.+||+.||++|||+.+|+++|.++.+
T Consensus 294 ~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 294 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 554444444556778889999999999999999999999999999999998865
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-50 Score=446.10 Aligned_cols=258 Identities=21% Similarity=0.342 Sum_probs=219.6
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec------CC
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS------PQ 575 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~ 575 (782)
.++|+++++||+|+||+||+|.+ .|+.||||+++.........+.+.+|+++|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 46899999999999999999998 47889999998776666667888999999999999999999998753 36
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
.+|||||||+ |+|.+++... ..+++..+..++.||+.||.|||++| ||||||||+||||+.+|.+||+|||+|+..
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecceeeec
Confidence 7899999995 6899999764 47999999999999999999999999 999999999999999999999999999865
Q ss_pred ccc----cccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc------
Q 003978 656 HET----YLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL------ 724 (782)
Q Consensus 656 ~~~----~~~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~------ 724 (782)
... .....+.+||+.|||||++.+. .++.++|||||||++|||++|++||.+.+....+..+......+
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 332 1223456899999999999885 46899999999999999999999999988877666653221111
Q ss_pred -----------------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 725 -----------------------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 725 -----------------------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
.+.+.+++++.+||.+||..||.+|||+.|+ |+|+||+...
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~------L~Hp~f~~~~ 352 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA------LRHPFLAKYH 352 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHH------TTSGGGTTTC
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHH------hcCHhhCcCC
Confidence 0123578999999999999999999999999 7789998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=431.49 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=197.9
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC-------
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------- 575 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------- 575 (782)
++|++++.||+|+||+||+|+++ ++.||||+++... .....+.+.+|+++|+.++|||||+++++|...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 57999999999999999999984 7789999997654 3455678899999999999999999999987544
Q ss_pred -----ceeEEEeecCCCCHHHHHhhcCC--cchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEe
Q 003978 576 -----RLCIVTEFLPRGSLFRLLQRNTT--KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648 (782)
Q Consensus 576 -----~~~lv~E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~D 648 (782)
.+|||||||+||+|.+++..... ..++..++.++.||+.||+|||++| ||||||||+||||+.++.+||+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEcc
Confidence 37999999999999999976432 2445678899999999999999999 99999999999999999999999
Q ss_pred cCCCcccccccc------------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHH
Q 003978 649 FGLSRLKHETYL------------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS-MQVIG 715 (782)
Q Consensus 649 FGla~~~~~~~~------------~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~-~~~~~ 715 (782)
||+|+....... ...+.+||+.|||||++.+..|+.++|||||||+||||++ ||..... ...+.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 999986543211 1234579999999999999999999999999999999996 7764322 12222
Q ss_pred HhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 716 AVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 716 ~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
.+.. ...+..+...++.+.+||.+||++||.+|||+.++ |+|+||+...
T Consensus 239 ~~~~-~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei------l~h~~~~~~~ 287 (299)
T 4g31_A 239 DVRN-LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI------IENAVFEDLD 287 (299)
T ss_dssp HHHT-TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHH------HTSGGGCCC-
T ss_pred HHhc-CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHH------hcCHhhCCCC
Confidence 2211 11111223456778999999999999999999999 5689998754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=422.67 Aligned_cols=255 Identities=32% Similarity=0.498 Sum_probs=200.7
Q ss_pred cceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC----ceeEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----RLCIV 580 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lv 580 (782)
++|.+.++||+|+||.||+|.++|+.||||+++... .....+..|+..+..++|||||++++++..++ .+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 579999999999999999999999999999996543 11122334666667889999999999997654 57999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcC------CCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC------NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~------~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
||||++|+|.++|... .+++..++.++.|++.||+|||++ .++||||||||+||||+.++.+||+|||+|+.
T Consensus 80 ~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 9999999999999764 589999999999999999999986 12399999999999999999999999999986
Q ss_pred cccccc----cccCCCCCCcccCcccccCC------CCCchhHHHHHHHHHHHHHcCCCCCCC----------CC-----
Q 003978 655 KHETYL----TTKTGKGTPQWMAPEVLRNE------PSDEKSDVYSFGVILWELATEKIPWDN----------LN----- 709 (782)
Q Consensus 655 ~~~~~~----~~~~~~Gt~~y~aPE~l~~~------~~s~~sDIwSLG~ll~elltG~~Pf~~----------~~----- 709 (782)
...... .....+||+.|||||++.+. .++.++|||||||+||||+||..||.. ..
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 544322 12245799999999999865 356799999999999999999766532 11
Q ss_pred hHHHHHHhhccccccCCCCC-----CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 710 SMQVIGAVGFMNQRLEIPKD-----VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 710 ~~~~~~~i~~~~~~~~~p~~-----~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
.......+.....++.+|.. ++..+.+||.+||..||++|||+.++++.|++|.+
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 12222223222334444432 23578999999999999999999999999998865
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=424.45 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=206.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc-----CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCc
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 576 (782)
..++|+++++||+|+||+||+|+++ ++.||||++..... ...+.+|+++|+.+ +|||||+++++|.++++
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 4568999999999999999999863 45699999865432 24577899999998 69999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CcEEEEecCCCccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLK 655 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~-~~vkL~DFGla~~~ 655 (782)
+|||||||+|++|.+++. .+++..+..++.||+.||+|||++| ||||||||+||||+.+ +.+||+|||+|+..
T Consensus 95 ~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 999999999999999984 4889999999999999999999999 9999999999999876 79999999999754
Q ss_pred ccccc----------------------------cccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCC
Q 003978 656 HETYL----------------------------TTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWD 706 (782)
Q Consensus 656 ~~~~~----------------------------~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~ 706 (782)
..... ...+.+||+.|||||++.+. .++.++||||+||++|+|++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 33211 12245799999999999876 48999999999999999999999995
Q ss_pred CCC-hHHHHHHhhccc----------------------------------------------------cccCCCCCCCHH
Q 003978 707 NLN-SMQVIGAVGFMN----------------------------------------------------QRLEIPKDVDPR 733 (782)
Q Consensus 707 ~~~-~~~~~~~i~~~~----------------------------------------------------~~~~~p~~~~~~ 733 (782)
... ....+..+.... ........++++
T Consensus 249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~ 328 (361)
T 4f9c_A 249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE 328 (361)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence 443 333322221100 001122457899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
+++||.+||..||.+|||+.|+ |+|+||+..+
T Consensus 329 a~DLl~~lL~~dP~~R~ta~ea------L~Hp~f~~i~ 360 (361)
T 4f9c_A 329 AYDLLDKLLDLNPASRITAEEA------LLHPFFKDMS 360 (361)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHH------HTSGGGTTC-
T ss_pred HHHHHHHHCcCChhHCcCHHHH------hcCcccCCCC
Confidence 9999999999999999999999 7899998764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=448.37 Aligned_cols=256 Identities=23% Similarity=0.404 Sum_probs=217.7
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC----CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY----SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
+..++|+++++||+|+||.||+|++ .++.||||++.+... ..........++.+++.++|||||+++++|++++
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 3457899999999999999999998 477899999976432 2233334445567777889999999999999999
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
.+|||||||+||+|.++|.+. ..+++..+..++.||+.||+|||++| ||||||||+||||+.+|+|||+|||+|+..
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 999999999999999999865 46999999999999999999999999 999999999999999999999999999865
Q ss_pred ccccccccCCCCCCcccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHhhccccccCCCCCCC
Q 003978 656 HETYLTTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNS---MQVIGAVGFMNQRLEIPKDVD 731 (782)
Q Consensus 656 ~~~~~~~~~~~Gt~~y~aPE~l~-~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~~~ 731 (782)
... ...+.+||+.|||||++. +..|+.++|||||||+||||++|.+||...+. ......+ ......+|..++
T Consensus 343 ~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i--~~~~~~~p~~~S 418 (689)
T 3v5w_A 343 SKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFS 418 (689)
T ss_dssp SSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH--HHCCCCCCTTSC
T ss_pred CCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh--cCCCCCCCccCC
Confidence 443 334678999999999996 56799999999999999999999999975432 2222222 344567888999
Q ss_pred HHHHHHHHHhhhhCCCCCCC-----HHHHHHHHHHHHHHHhhcc
Q 003978 732 PRWAAIVESCWHSDPQCRPS-----FQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 732 ~~l~~LI~~cL~~dP~~RPs-----~~ell~~L~~L~~~~~~~~ 770 (782)
+++++||.+||.+||.+|++ +.++ +.|+||+.+
T Consensus 419 ~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei------~~HpfF~~i 456 (689)
T 3v5w_A 419 PELRSLLEGLLQRDVNRRLGCLGRGAQEV------KESPFFRSL 456 (689)
T ss_dssp HHHHHHHHHHTCSCGGGCTTCSSSTHHHH------TTSGGGTTC
T ss_pred HHHHHHHHHHccCCHhHCCCCCCCCHHHH------hcCccccCC
Confidence 99999999999999999997 7888 678999654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=447.85 Aligned_cols=260 Identities=22% Similarity=0.377 Sum_probs=228.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
..++|++++.||+|+||.||+|.+ .++.||||++.... ....+.+.+|+.+|+.++|||||+++++|+++..+|||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 457899999999999999999998 47789999997643 33456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC--CcEEEEecCCCcccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH--WTVKVGDFGLSRLKHET 658 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~--~~vkL~DFGla~~~~~~ 658 (782)
||||+||+|.++|......+++..+..++.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||+|+.....
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999999999766678999999999999999999999999 9999999999999854 89999999999876543
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--cCCCCCCCHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--LEIPKDVDPRWAA 736 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~~~~l~~ 736 (782)
. .....+||+.|||||++.+..|+.++|||||||+||+|++|.+||...+..+.+..+...... ...+..+++++++
T Consensus 311 ~-~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d 389 (573)
T 3uto_A 311 Q-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 389 (573)
T ss_dssp S-EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred C-ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 2 233558999999999999999999999999999999999999999999988888777544332 2334578999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 737 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
||.+||..||.+|||+.|+ |+|+||+.....
T Consensus 390 li~~~L~~dp~~R~t~~e~------l~Hpw~~~~~~~ 420 (573)
T 3uto_A 390 FIRKLLLADPNTRMTIHQA------LEHPWLTPGNAP 420 (573)
T ss_dssp HHHTTSCSSGGGSCCHHHH------HHSTTTSCCCCT
T ss_pred HHHHHccCChhHCcCHHHH------hcCcCcCCCCCC
Confidence 9999999999999999999 678999865543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=402.86 Aligned_cols=268 Identities=61% Similarity=1.043 Sum_probs=230.5
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
..+++...+|++.+.||+|+||.||+|.+.++.||||++............+.+|+++++.++||||+++++++.....+
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 35567788999999999999999999999999999999988777777778899999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCC--cchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTT--KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
++|||||++++|.+++..... .+++..++.++.||+.||+|||+++.+|+||||||+||||+.++.+||+|||+++..
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999999976432 389999999999999999999998767999999999999999999999999999866
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHH
Q 003978 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735 (782)
Q Consensus 656 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 735 (782)
...........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+........++..+++++.
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 269 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 269 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred cccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence 55544445668999999999999999999999999999999999999999999888887777666677788899999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
+||.+||..||.+|||+.++++.|+.+...
T Consensus 270 ~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 270 AIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999998877654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=398.74 Aligned_cols=259 Identities=25% Similarity=0.441 Sum_probs=231.2
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
....++|++++.||+|+||.||+|.+ .++.||||++..........+.+.+|+++|+.++||||+++++++...+.+|
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 34457899999999999999999997 5788999999887777777888999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
+|||||++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999999999765 46899999999999999999999999 999999999999999999999999999765443
Q ss_pred cccccCCCCCCcccCcccccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSD-EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s-~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
. .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+. .....+|..+++++.+|
T Consensus 168 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~l 244 (328)
T 3fe3_A 168 G-KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL--RGKYRIPFYMSTDCENL 244 (328)
T ss_dssp C-GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHH
T ss_pred C-ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHH
Confidence 2 33456899999999999988875 79999999999999999999999988877766663 34556778899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 738 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 738 I~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
|.+||..||.+|||+.++ ++|+||+...
T Consensus 245 i~~~L~~dP~~R~t~~ei------l~h~~~~~~~ 272 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTLEQI------MKDRWINAGH 272 (328)
T ss_dssp HHHHCCSSTTTSCCHHHH------TTCTTTTTTC
T ss_pred HHHHCCCChhHCcCHHHH------hcCHhhcCCC
Confidence 999999999999999999 6789997654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=398.04 Aligned_cols=257 Identities=25% Similarity=0.451 Sum_probs=225.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
..++|++++.||+|+||.||+|... ++.||||++++... .......+.+|+.+|+.++||||+++++++...+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 4578999999999999999999984 77899999976432 12234567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
|||||+||+|..++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|.+||+|||+++......
T Consensus 83 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 99999999999999764 46899999999999999999999999 9999999999999999999999999998654444
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHH
Q 003978 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 739 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 739 (782)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..+++++++||.
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~ 237 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEAKSLLA 237 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHH
Confidence 44556789999999999999999999999999999999999999999888777666653 3455678889999999999
Q ss_pred HhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhcc
Q 003978 740 SCWHSDPQCRP-----SFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 740 ~cL~~dP~~RP-----s~~ell~~L~~L~~~~~~~~ 770 (782)
+||..||.+|| ++.++ +.|+||+.+
T Consensus 238 ~lL~~dP~~R~g~~~~~~~ei------~~h~~f~~~ 267 (337)
T 1o6l_A 238 GLLKKDPKQRLGGGPSDAKEV------MEHRFFLSI 267 (337)
T ss_dssp HHTCSSTTTSTTCSTTTHHHH------HTSGGGTTC
T ss_pred HHhhcCHHHhcCCCCCCHHHH------HcCCCcCCC
Confidence 99999999999 89999 667888543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=397.82 Aligned_cols=263 Identities=29% Similarity=0.576 Sum_probs=228.1
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEcC---------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEe
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG---------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 568 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~---------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 568 (782)
.++...++|++++.||+|+||.||+|.+.+ ..||||+++... .......+.+|+.+|+.+ +|||||+++
T Consensus 75 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 75 KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred cccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 345667899999999999999999998732 359999987543 455667899999999999 899999999
Q ss_pred eeeecCCceeEEEeecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 003978 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (782)
Q Consensus 569 ~~~~~~~~~~lv~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp 633 (782)
+++...+.+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp 231 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAA 231 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccch
Confidence 99999999999999999999999997643 24789999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 003978 634 SNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (782)
Q Consensus 634 ~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~ 710 (782)
+||||+.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999999999998554322 22334567899999999999999999999999999999999 9999998877
Q ss_pred HHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 711 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 711 ~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
......+. .......+..++.++.+||.+||..||.+||++.++++.|+++...
T Consensus 312 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 312 EELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp GGHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 76665543 3345667788999999999999999999999999999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=387.66 Aligned_cols=259 Identities=27% Similarity=0.452 Sum_probs=226.4
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
...++|++.++||+|+||.||+|.+ .++.||||++....... .+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 3457899999999999999999986 57789999997654332 3567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
|||||.+++|.+++... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.......
T Consensus 95 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp EEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 99999999999999764 5899999999999999999999999 9999999999999999999999999998766554
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-ccccCCCCCCCHHHHHHH
Q 003978 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~l~~LI 738 (782)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+... ......+..+++.+.+||
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 250 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHH
T ss_pred cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHH
Confidence 4555668999999999999999999999999999999999999999988776655554322 223445677999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 739 ~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
.+||..||.+|||+.++ ++|+||+....
T Consensus 251 ~~~l~~dp~~Rps~~el------l~h~~~~~~~~ 278 (297)
T 3fxz_A 251 NRCLEMDVEKRGSAKEL------LQHQFLKIAKP 278 (297)
T ss_dssp HHHSCSSTTTSCCHHHH------TTCGGGGGCCC
T ss_pred HHHccCChhHCcCHHHH------hhChhhcccCc
Confidence 99999999999999999 67899987654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=388.56 Aligned_cols=263 Identities=26% Similarity=0.360 Sum_probs=219.8
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE-cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
+.+.++|+++++||+|+||.||+|.+ .++.||||++............+.+|+++++.++||||+++++++..+..+|+
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 45668999999999999999999998 57789999997665545556778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
|||||++ +|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9999964 899999877777999999999999999999999999 9999999999999999999999999998765544
Q ss_pred ccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc---------------
Q 003978 660 LTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--------------- 723 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------- 723 (782)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+......
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 44455678999999999987 56799999999999999999999999877665544443211110
Q ss_pred -------------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 724 -------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 724 -------------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
..+.+.+++++.+||.+||..||.+|||+.++ |+|+||+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el------l~hp~f~~~~~ 309 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA------MNHPYFKDLDP 309 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHH------HTSGGGTTSCT
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHH------hcCcccccCCc
Confidence 01224578899999999999999999999999 67899997654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=401.47 Aligned_cols=258 Identities=27% Similarity=0.415 Sum_probs=220.5
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCce
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 577 (782)
...++|+++++||+|+||.||+|.+. ++.||||++++... .......+.+|+.+++.+ +||||+++++++...+.+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 44578999999999999999999984 67899999976432 223346678899999988 699999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+|||||+|++|..++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 100 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 9999999999999999765 46999999999999999999999999 99999999999999999999999999986544
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..+++++.+|
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~l 254 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTWLHEDATGI 254 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHH
T ss_pred CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHH
Confidence 4445556789999999999999999999999999999999999999999988888777763 34566788899999999
Q ss_pred HHHhhhhCCCCCCCH------HHHHHHHHHHHHHHhhcc
Q 003978 738 VESCWHSDPQCRPSF------QELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 738 I~~cL~~dP~~RPs~------~ell~~L~~L~~~~~~~~ 770 (782)
|.+||.+||.+||++ .++ ++|+||+..
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~i------l~hp~f~~~ 287 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAI------LRHPFFKEI 287 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHH------HTSGGGTTC
T ss_pred HHHHhhhCHHHccCCcccCCHHHH------hhCCcccCC
Confidence 999999999999998 777 678999754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=375.52 Aligned_cols=259 Identities=30% Similarity=0.601 Sum_probs=231.1
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC--Ccee
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLC 578 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 578 (782)
++..++|++.+.||+|+||.||+|.+.++.||||++..........+.+.+|+.+++.++||||+++++++... ..++
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 45668999999999999999999999999999999988777777778899999999999999999999999877 7889
Q ss_pred EEEeecCCCCHHHHHhhcCC-cchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
+||||+++++|.+++..... .+++..++.++.||+.||.|||+++..|+|+||||+|||++.++.++|+|||++.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999999976543 58999999999999999999999877799999999999999999999999998754322
Q ss_pred ccccccCCCCCCcccCcccccCCCCCc---hhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDE---KSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~---~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 734 (782)
....||+.|+|||++.+..++. ++|||||||++|+|++|..||...........+......+.++..+++++
T Consensus 166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (271)
T 3kmu_A 166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV 240 (271)
T ss_dssp -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHH
T ss_pred -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHH
Confidence 2456899999999998866544 89999999999999999999999888877766665666777888999999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 735 AAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
.+||.+||..||.+|||+.++++.|+++++
T Consensus 241 ~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 241 SKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 999999999999999999999999998753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=397.78 Aligned_cols=258 Identities=26% Similarity=0.428 Sum_probs=220.2
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCce
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 577 (782)
...++|+++++||+|+||.||+|++. ++.||||++++.... ......+..|..+|..+ +|||||++++++.....+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 44578999999999999999999984 567999999876543 33445677899999887 899999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+|||||+||+|..++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+++....
T Consensus 129 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 9999999999999999764 46999999999999999999999999 99999999999999999999999999986444
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---------hHHHHHHhhccccccCCCC
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN---------SMQVIGAVGFMNQRLEIPK 728 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~---------~~~~~~~i~~~~~~~~~p~ 728 (782)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......+ ......+|.
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~ 283 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPR 283 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH--HHCCCCCCT
T ss_pred CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH--hccccCCCC
Confidence 4445567789999999999999999999999999999999999999996432 11122222 344567888
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCH------HHHHHHHHHHHHHHhhcc
Q 003978 729 DVDPRWAAIVESCWHSDPQCRPSF------QELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 729 ~~~~~l~~LI~~cL~~dP~~RPs~------~ell~~L~~L~~~~~~~~ 770 (782)
.+++++++||.+||..||.+||++ .++ +.|+||+..
T Consensus 284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei------~~Hpff~~i 325 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADI------QGHPFFRNV 325 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHH------HHSTTTTTC
T ss_pred cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHH------hcCccccCC
Confidence 999999999999999999999985 566 678999654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=386.60 Aligned_cols=258 Identities=23% Similarity=0.363 Sum_probs=214.5
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE-----cCCeEEEEEEeccCCC--HHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~-----~~~~vAiK~~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (782)
+..++|++++.||+|+||.||++.. .++.||||++++.... ......+.+|+.+|+.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 4457899999999999999999987 4678999999765432 23445678899999999999999999999999
Q ss_pred CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
+.+|+|||||++++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred CEEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999997643 6889999999999999999999999 99999999999999999999999999976
Q ss_pred cccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHH
Q 003978 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734 (782)
Q Consensus 655 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 734 (782)
............||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..+++++
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~ 248 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL--KCKLNLPPYLTQEA 248 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HTCCCCCTTSCHHH
T ss_pred cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHH
Confidence 4443333445679999999999999999999999999999999999999999888777666653 33456778899999
Q ss_pred HHHHHHhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhcc
Q 003978 735 AAIVESCWHSDPQCRP-----SFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RP-----s~~ell~~L~~L~~~~~~~~ 770 (782)
.+||.+||..||.+|| ++.++ +.|+||+..
T Consensus 249 ~~li~~~L~~dp~~R~~~~~~~~~e~------l~hp~f~~~ 283 (327)
T 3a62_A 249 RDLLKKLLKRNAASRLGAGPGDAGEV------QAHPFFRHI 283 (327)
T ss_dssp HHHHHHHSCSCGGGSTTSSTTTHHHH------HHSGGGSSC
T ss_pred HHHHHHHHhcCHhhccCCCCCCHHHH------HcCCcccCC
Confidence 9999999999999999 78888 678999654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=388.48 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=221.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCcee
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 578 (782)
..++|++++.||+|+||.||+|.++ ++.||||++++... .......+.+|+.+++.+ +|||||++++++.....+|
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 4578999999999999999999985 67799999987654 445667788999999988 8999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
+|||||+|++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 87 lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 999999999999999764 36899999999999999999999999 999999999999999999999999999864444
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC---------ChHHHHHHhhccccccCCCCC
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL---------NSMQVIGAVGFMNQRLEIPKD 729 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~~~p~~ 729 (782)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||... ........+ ......+|..
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~~ 241 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPRS 241 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH--HHCCCCCCTT
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH--HcCCCCCCCC
Confidence 44455678999999999999999999999999999999999999999652 112222222 2345667888
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCH------HHHHHHHHHHHHHHhhcc
Q 003978 730 VDPRWAAIVESCWHSDPQCRPSF------QELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 730 ~~~~l~~LI~~cL~~dP~~RPs~------~ell~~L~~L~~~~~~~~ 770 (782)
++.++++||.+||..||.+||++ .++ +.|+||+..
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i------~~hp~f~~~ 282 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADI------QGHPFFRNV 282 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHH------HTSGGGTTC
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHH------hcCCccCCC
Confidence 99999999999999999999985 566 678999643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=383.83 Aligned_cols=263 Identities=32% Similarity=0.514 Sum_probs=227.6
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEc-----CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (782)
..++..++|++.+.||+|+||.||+|.+. +..||||+++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 34566789999999999999999999983 3349999997543 45566789999999999999999999999999
Q ss_pred CCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 574 ~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
.+.+|+|||||++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCccc
Confidence 99999999999999999999877678999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCC
Q 003978 654 LKHETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKD 729 (782)
Q Consensus 654 ~~~~~~~---~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 729 (782)
....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.. ......+..
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 278 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE-GYRLPAPMG 278 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-TCCCCCCTT
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-CCCCCCCCC
Confidence 6544321 2223456889999999999999999999999999999999 9999999888877766643 345567778
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 730 ~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
+++.+.+||.+||..||.+|||+.++++.|+++...
T Consensus 279 ~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 279 CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 999999999999999999999999999999988653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=371.34 Aligned_cols=260 Identities=30% Similarity=0.574 Sum_probs=229.1
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEE-cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
.|.+..++|++.+.||+|+||.||++.+ .+..||+|++....... +.+.+|+++++.++||||+++++++.....+
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 4566778999999999999999999998 56679999998765544 4678899999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+||||+++++|.+++......+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEeccccccccccc
Confidence 9999999999999999877777999999999999999999999999 99999999999999999999999999976544
Q ss_pred cc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHH
Q 003978 658 TY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735 (782)
Q Consensus 658 ~~-~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 735 (782)
.. .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.. ......+..+++.+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 237 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHVY 237 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTTSCHHHH
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc-CccCCCCCcCCHHHH
Confidence 32 22334467889999999999999999999999999999999 9999999888777666643 334556777899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
+||.+||..||.+||++.+++++|+++..
T Consensus 238 ~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 238 QIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999998864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=377.85 Aligned_cols=258 Identities=24% Similarity=0.337 Sum_probs=218.5
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
++|+++++||+|+||.||+|.+ .++.||||++............+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 6899999999999999999998 46789999998776666666788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
||++ +|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.........
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 9965 777777666677999999999999999999999999 9999999999999999999999999998765554445
Q ss_pred cCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCC-CCCCChHHHHHHhhcccc------------------
Q 003978 663 KTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIP-WDNLNSMQVIGAVGFMNQ------------------ 722 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~-~s~~sDIwSLG~ll~elltG~~P-f~~~~~~~~~~~i~~~~~------------------ 722 (782)
....||+.|+|||++.+.. ++.++|||||||++|+|++|..| |...+.......+.....
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 5668899999999998766 79999999999999999998777 455554444444321110
Q ss_pred ---------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 723 ---------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 723 ---------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
.....+.+++++++||.+||..||++|||+.++ ++|+||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~------l~hp~f~~~~ 290 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA------LQHPYFSDFC 290 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH------HTSGGGTTC-
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHH------hcCcccccCC
Confidence 011224578999999999999999999999999 6789998643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=401.40 Aligned_cols=259 Identities=22% Similarity=0.333 Sum_probs=225.3
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
...++|+++++||+|+||.||+|.+ .++.||+|++..........+.+.+|+.+++.++|||||++++++...+.+|+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3457899999999999999999987 57789999998877666667789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc---CCCcEEEEecCCCcccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~---~~~~vkL~DFGla~~~~ 656 (782)
|||||.|++|.+++... ..+++..+..++.||+.||.|||++| |+||||||+||||+ .++.+||+|||++....
T Consensus 88 v~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 99999999999999765 46999999999999999999999999 99999999999998 46789999999998765
Q ss_pred cccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCC--CCCCCHHH
Q 003978 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEI--PKDVDPRW 734 (782)
Q Consensus 657 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--p~~~~~~l 734 (782)
..........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+......... ...+++++
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 5444445668999999999999999999999999999999999999999998887777776543333222 24689999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 735 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
++||.+||..||.+|||+.++ |+|+||+.
T Consensus 245 ~~li~~~L~~dP~~Rpta~e~------L~hp~~~~ 273 (444)
T 3soa_A 245 KDLINKMLTINPSKRITAAEA------LKHPWISH 273 (444)
T ss_dssp HHHHHHHSCSSTTTSCCHHHH------HHSCTTHH
T ss_pred HHHHHHHcCCChhHCCCHHHH------hcCccccC
Confidence 999999999999999999999 55677754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=385.99 Aligned_cols=253 Identities=25% Similarity=0.445 Sum_probs=223.0
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
..++|++++.||+|+||.||+|.. .++.||||++++.... ......+.+|+.+++.++||||+++++++.+...+|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 357899999999999999999998 4778999999764321 1234567789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
|||||+|++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|.+||+|||+++.....
T Consensus 84 v~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp EECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 99999999999999764 46899999999999999999999999 999999999999999999999999999865432
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHH
Q 003978 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 739 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 739 (782)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..+++++.+||.
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~ 235 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL--NAELRFPPFFNEDVKDLLS 235 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHHH
T ss_pred --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHH
Confidence 335689999999999999999999999999999999999999999888777766663 3345678889999999999
Q ss_pred HhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhc
Q 003978 740 SCWHSDPQCRP-----SFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 740 ~cL~~dP~~RP-----s~~ell~~L~~L~~~~~~~ 769 (782)
+||..||.+|| ++.++ +.|+||+.
T Consensus 236 ~lL~~dp~~R~~~~~~~~~~i------~~hp~f~~ 264 (318)
T 1fot_A 236 RLITRDLSQRLGNLQNGTEDV------KNHPWFKE 264 (318)
T ss_dssp HHTCSCTTTCTTSSTTTTHHH------HTSGGGSS
T ss_pred HHhccCHHHcCCCcCCCHHHH------hcCccccC
Confidence 99999999999 89999 67899864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=381.30 Aligned_cols=257 Identities=25% Similarity=0.367 Sum_probs=214.0
Q ss_pred cceeEeeeeccCCcEEEEEEEEc-CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
++|++++.||+|+||.||+|.+. ++.||||++............+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 68999999999999999999984 77899999976544333346678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccccc
Q 003978 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (782)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (782)
+++ +|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 965 999999876677999999999999999999999998 99999999999999999999999999976554333334
Q ss_pred CCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-------------------
Q 003978 664 TGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR------------------- 723 (782)
Q Consensus 664 ~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~------------------- 723 (782)
...||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+......
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence 55789999999999764 5799999999999999999999999988776655444211000
Q ss_pred --------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 724 --------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 724 --------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
..+...+++++.+||.+||..||.+|||+.++ +.|+||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~------l~hp~f~~~ 287 (288)
T 1ob3_A 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA------LEHAYFKEN 287 (288)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHH------HTSGGGGC-
T ss_pred ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHH------hcCcchhhc
Confidence 01224578999999999999999999999999 678999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=394.69 Aligned_cols=258 Identities=25% Similarity=0.426 Sum_probs=223.3
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCce
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 577 (782)
...++|++.+.||+|+||.||+|.++ ++.||||++++... .......+..|..++..+ +||||+++++++.....+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 45579999999999999999999984 67799999976432 112245677899999877 899999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|.+||+|||+++....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 9999999999999999764 36899999999999999999999999 99999999999999999999999999986543
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.. ....+|..+++++++|
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~l 248 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRWLEKEAKDL 248 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHH
T ss_pred CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh--CCCCCCcccCHHHHHH
Confidence 33344567899999999999999999999999999999999999999998888777766643 3456778899999999
Q ss_pred HHHhhhhCCCCCCCHH-HHHHHHHHHHHHHhhcc
Q 003978 738 VESCWHSDPQCRPSFQ-ELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 738 I~~cL~~dP~~RPs~~-ell~~L~~L~~~~~~~~ 770 (782)
|.+||..||.+||++. ++ ++|+||+..
T Consensus 249 i~~lL~~dp~~R~~~~~~i------~~hp~f~~~ 276 (345)
T 1xjd_A 249 LVKLFVREPEKRLGVRGDI------RQHPLFREI 276 (345)
T ss_dssp HHHHSCSSGGGSBTTBSCG------GGSGGGTTC
T ss_pred HHHHhcCCHhHcCCChHHH------HcCccccCC
Confidence 9999999999999997 77 567888654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=380.48 Aligned_cols=256 Identities=26% Similarity=0.413 Sum_probs=213.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCH------------------------HHHHHHHHHHHHH
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD------------------------EVIHSFRQEVSLM 556 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~------------------------~~~~~~~~Ei~il 556 (782)
..++|++.+.||+|+||.||+|.+ .++.||||++....... ...+.+.+|+++|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 347899999999999999999987 46779999997654221 1245688999999
Q ss_pred HhCCCCceeEEeeeeec--CCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 003978 557 KRLRHPNVLLFMGAVTS--PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 634 (782)
Q Consensus 557 ~~l~HpnIv~l~~~~~~--~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~ 634 (782)
+.++||||+++++++.. ...+|+||||+++++|.+++. ...+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~ 166 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPS 166 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHH
Confidence 99999999999999986 567899999999999988654 346899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEEecCCCcccccccccccCCCCCCcccCcccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCChH
Q 003978 635 NLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP---SDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (782)
Q Consensus 635 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~---~s~~sDIwSLG~ll~elltG~~Pf~~~~~~ 711 (782)
||||+.++.+||+|||+++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||......
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 99999999999999999987655443344568999999999998765 377899999999999999999999988776
Q ss_pred HHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003978 712 QVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 712 ~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~ 768 (782)
.....+............+++++.+||.+||..||.+|||+.++ ++|+||+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~------l~hp~~~ 297 (298)
T 2zv2_A 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI------KLHPWVT 297 (298)
T ss_dssp HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHH------TTCHHHH
T ss_pred HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHH------hcCcccc
Confidence 66655543333333445789999999999999999999999999 6789986
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=391.01 Aligned_cols=258 Identities=23% Similarity=0.366 Sum_probs=222.7
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCH----HHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
...++|++++.||+|+||.||+|.+. ++.||||++++..... ...+.+.+|+.+|+.++||||+++++++....
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 44578999999999999999999984 7789999998754321 12467889999999999999999999999999
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----cEEEEecCC
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFGL 651 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~----~vkL~DFGl 651 (782)
.+|+|||||+|++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 999999999999999999764 46999999999999999999999999 99999999999998776 799999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--cCCCCC
Q 003978 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--LEIPKD 729 (782)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~ 729 (782)
+....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+...... ...+..
T Consensus 166 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (361)
T 2yab_A 166 AHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244 (361)
T ss_dssp CEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred ceEcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccC
Confidence 98655432 234567999999999999999999999999999999999999999998887777666433221 122357
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 730 ~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
+++++++||.+||..||.+|||+.++ +.|+||+.
T Consensus 245 ~s~~~~~li~~~L~~dP~~R~t~~e~------l~hp~~~~ 278 (361)
T 2yab_A 245 TSELAKDFIRKLLVKETRKRLTIQEA------LRHPWITP 278 (361)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHH------HTSTTTSC
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHH------hcCcCcCC
Confidence 89999999999999999999999999 56788864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=392.75 Aligned_cols=257 Identities=24% Similarity=0.398 Sum_probs=223.2
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCce
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 577 (782)
...++|++++.||+|+||.||+|.+. ++.||||++++... .......+..|..+|..+ +||||+++++++...+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 45679999999999999999999985 46799999976432 112345677899999888 799999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+|||||+||+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||||+.+|.+||+|||+++....
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999999997643 6899999999999999999999999 99999999999999999999999999986444
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
........+||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+. .....+|..+++++.+|
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~l 251 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKEAVAI 251 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHH
T ss_pred CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHH
Confidence 4444556789999999999999999999999999999999999999999888877776664 34566788999999999
Q ss_pred HHHhhhhCCCCCCC-----HHHHHHHHHHHHHHHhhc
Q 003978 738 VESCWHSDPQCRPS-----FQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 738 I~~cL~~dP~~RPs-----~~ell~~L~~L~~~~~~~ 769 (782)
|.+||..||.+||+ +.++ +.|+||+.
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i------~~h~~f~~ 282 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDI------KEHAFFRY 282 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHH------HTSGGGTT
T ss_pred HHHHhhcCHHHcCCCCCCCHHHH------hcCccccC
Confidence 99999999999995 5777 56788864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=384.96 Aligned_cols=258 Identities=21% Similarity=0.327 Sum_probs=223.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
..++|++++.||+|+||.||+|.+. +..||+|++.... .....+.+|+.+|+.++||||+++++++...+.+|+|
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 4578999999999999999999984 6679999986432 3345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC--CCcEEEEecCCCcccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK--HWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~--~~~vkL~DFGla~~~~~~ 658 (782)
||||+|++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||++......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999999999876667999999999999999999999999 999999999999987 789999999999865443
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--CCCCCCCHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL--EIPKDVDPRWAA 736 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~~~~l~~ 736 (782)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+....... .....++.++.+
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T 1tki_A 158 D-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp C-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred C-ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence 2 2234568999999999999888999999999999999999999999888877766664322211 122478999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 737 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
||.+||..||.+|||+.++ |+|+||+....
T Consensus 237 li~~~L~~dp~~Rpt~~e~------l~hp~~~~~~~ 266 (321)
T 1tki_A 237 FVDRLLVKERKSRMTASEA------LQHPWLKQKIE 266 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHH------HHSHHHHSCGG
T ss_pred HHHHHcCCChhHCcCHHHH------hcChhhccCcc
Confidence 9999999999999999999 67899986543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=389.87 Aligned_cols=258 Identities=22% Similarity=0.396 Sum_probs=224.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
..++|++.+.||+|+||.||+|.+. +..||||++..........+.+.+|+.+++.++|||||++++++...+.+|+|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3568999999999999999999984 77899999988777777778899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CcEEEEecCCCccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH---WTVKVGDFGLSRLKHE 657 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~---~~vkL~DFGla~~~~~ 657 (782)
||||.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||++.....
T Consensus 107 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp ECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 9999999999999764 46899999999999999999999999 9999999999999764 4599999999986654
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC--CCCCHHHH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP--KDVDPRWA 735 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l~ 735 (782)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.........+ ..++++++
T Consensus 184 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 262 (362)
T 2bdw_A 184 SE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 262 (362)
T ss_dssp CC-SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred Cc-ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 32 2334679999999999999999999999999999999999999999888777766664333222222 35799999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
+||.+||..||.+||++.++ |.|+||+..
T Consensus 263 ~li~~~L~~dP~~R~t~~e~------l~hp~~~~~ 291 (362)
T 2bdw_A 263 SLIDSMLTVNPKKRITADQA------LKVPWICNR 291 (362)
T ss_dssp HHHHHHSCSSGGGSCCHHHH------TTSHHHHTH
T ss_pred HHHHHHcCCChhhCcCHHHH------hcCcccCCC
Confidence 99999999999999999999 567887643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=393.90 Aligned_cols=262 Identities=27% Similarity=0.387 Sum_probs=216.5
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCC-HHHHHHHHHHHHH-HHhCCCCceeEEeeeeecCCce
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSL-MKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~-~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~ 577 (782)
...++|++++.||+|+||.||+|.++ +..||||++++.... ......+..|..+ ++.++|||||++++++...+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 34578999999999999999999984 567999999876543 3334556667776 5778999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++....
T Consensus 115 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 9999999999999999764 36889999999999999999999999 99999999999999999999999999986544
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
........+||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+. .....++..++.++++|
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~l 269 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--NKPLQLKPNITNSARHL 269 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHH--HSCCCCCSSSCHHHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--hcccCCCCCCCHHHHHH
Confidence 4444556789999999999999999999999999999999999999999888877776663 34556778899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 738 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 738 I~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
|.+||..||.+||++.+.++.+ +.|+||+.+
T Consensus 270 i~~lL~~dp~~R~~~~~~~~~i--~~h~~f~~~ 300 (373)
T 2r5t_A 270 LEGLLQKDRTKRLGAKDDFMEI--KSHVFFSLI 300 (373)
T ss_dssp HHHHTCSSGGGSTTTTTTHHHH--HTSGGGTTC
T ss_pred HHHHcccCHHhCCCCCCCHHHH--hCCccccCC
Confidence 9999999999999875332222 467888643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=394.03 Aligned_cols=263 Identities=31% Similarity=0.545 Sum_probs=230.4
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (782)
.|++..++|++++.||+|+||.||+|.+. ++.||||+++.. ...+....+.+|+++|+.++|||||++++++...+.
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 45677789999999999999999999984 778999998754 345556778899999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
+|+|||||++++|.+++......+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 99999999999999999877777999999999999999999999999 9999999999999999999999999997654
Q ss_pred ccccccc--CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHH
Q 003978 657 ETYLTTK--TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733 (782)
Q Consensus 657 ~~~~~~~--~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 733 (782)
....... ...+++.|+|||++.+..++.++|||||||++|||++ |..||......+....+. .......|..++++
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 343 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPDA 343 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 4322211 2235678999999998889999999999999999998 999999988777665553 34456678889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
+.+||.+||..||.+|||+.++++.|+++...
T Consensus 344 l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 99999999999999999999999999998764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=405.15 Aligned_cols=259 Identities=25% Similarity=0.453 Sum_probs=217.1
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
....++|+++++||+|+||.||+|.+ .++.||||+++.... .......+.+|+.+++.++||||+++++++...+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 34567899999999999999999997 467899999976532 234456678899999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~-~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
|+|||||++++|.+++.... .+++..++.++.||+.||+|||+ ++ ||||||||+||||+.++.+||+|||+++...
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEEEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999999997644 68999999999999999999998 88 9999999999999999999999999998654
Q ss_pred cccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHH
Q 003978 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 736 (782)
Q Consensus 657 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 736 (782)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....+|..+++++.+
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~ 378 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLGPEAKS 378 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHH
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHHHHH
Confidence 44444556789999999999999999999999999999999999999999888877766663 3455678889999999
Q ss_pred HHHHhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhcc
Q 003978 737 IVESCWHSDPQCRP-----SFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 737 LI~~cL~~dP~~RP-----s~~ell~~L~~L~~~~~~~~ 770 (782)
||.+||..||.+|| ++.++ ++|+||+..
T Consensus 379 li~~~L~~dP~~R~~~~~~t~~el------l~hp~f~~~ 411 (446)
T 4ejn_A 379 LLSGLLKKDPKQRLGGGSEDAKEI------MQHRFFAGI 411 (446)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHH------HTSGGGTTC
T ss_pred HHHHHcccCHHHhCCCCCCCHHHH------HhCccccCC
Confidence 99999999999999 99999 678998654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=368.37 Aligned_cols=267 Identities=21% Similarity=0.365 Sum_probs=231.9
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
..++|++.+.||+|+||.||+|.+. ++.||+|++............+.+|+.+++.++||||+++++++......|+|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3478999999999999999999884 67899999988777777778899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc---EEEEecCCCccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT---VKVGDFGLSRLKHE 657 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~---vkL~DFGla~~~~~ 657 (782)
|||+.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+|+.++. +||+|||++.....
T Consensus 84 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 9999999999998765 46899999999999999999999999 999999999999986655 99999999976554
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC--CCCCCCHHHH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE--IPKDVDPRWA 735 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~l~ 735 (782)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+........ ....+++++.
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 3kk8_A 161 SE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239 (284)
T ss_dssp SC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred Cc-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence 33 22345799999999999999999999999999999999999999998888777766643333222 2347899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcCCCCCc
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGDSTQ 779 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~~~~~~ 779 (782)
+||.+||..||.+|||+.++ +.|+||+..........+
T Consensus 240 ~li~~~l~~dp~~Rps~~~~------l~h~~~~~~~~~~~~~~~ 277 (284)
T 3kk8_A 240 SLIDSMLTVNPKKRITADQA------LKVPWICNRERVASAIHR 277 (284)
T ss_dssp HHHHHHSCSSTTTSCCHHHH------TTSHHHHSCCCGGGSCCC
T ss_pred HHHHHHcccChhhCCCHHHH------hcCccccCChhHHhHhhc
Confidence 99999999999999999999 678999887766655544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=379.20 Aligned_cols=262 Identities=34% Similarity=0.533 Sum_probs=221.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
..++|+++++||+|+||.||++.+. +..||+|++.. ........+.+|+++++.++||||+++++++..+..+++|
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 3578999999999999999999984 77899998854 3456678899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
||||++++|.+++......+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999999887778999999999999999999999999 99999999999999999999999999976543322
Q ss_pred c--------------ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHh-hccccccC
Q 003978 661 T--------------TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV-GFMNQRLE 725 (782)
Q Consensus 661 ~--------------~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i-~~~~~~~~ 725 (782)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||............ ........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY 243 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc
Confidence 1 11457999999999999999999999999999999999999998754321110000 00011234
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003978 726 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 726 ~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~ 768 (782)
.+..+++.+.+||.+||..||++|||+.++++.|++++...-.
T Consensus 244 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 244 CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 5678999999999999999999999999999999999876543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=386.89 Aligned_cols=269 Identities=29% Similarity=0.520 Sum_probs=228.6
Q ss_pred CccccccccccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeE
Q 003978 495 NDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLL 566 (782)
Q Consensus 495 ~~~~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~ 566 (782)
.+...|++..++|+++++||+|+||.||+|.+. ++.||||+++... .....+.+.+|+++++.+ +|||||+
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceee
Confidence 334567788899999999999999999999853 2569999997543 445567889999999999 7999999
Q ss_pred EeeeeecCCc-eeEEEeecCCCCHHHHHhhcCC-----------------------------------------------
Q 003978 567 FMGAVTSPQR-LCIVTEFLPRGSLFRLLQRNTT----------------------------------------------- 598 (782)
Q Consensus 567 l~~~~~~~~~-~~lv~E~~~ggsL~~~l~~~~~----------------------------------------------- 598 (782)
+++++...+. +++|||||++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999887554 8999999999999999976432
Q ss_pred ------------------cchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc--
Q 003978 599 ------------------KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-- 658 (782)
Q Consensus 599 ------------------~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-- 658 (782)
.+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 1889999999999999999999999 999999999999999999999999999755332
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||.....................+..+++++.+|
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 328 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 328 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 222334568899999999999999999999999999999998 9999988765554444444455667788899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 738 VESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 738 I~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
|.+||..||.+|||+.+++++|+++....
T Consensus 329 i~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 329 MLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 99999999999999999999999987643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=370.69 Aligned_cols=261 Identities=30% Similarity=0.547 Sum_probs=226.2
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEcCC-eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~-~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (782)
..+++..++|++++.||+|+||.||++.+.+. .||||++....... ..+.+|+++++.++||||+++++++...+.
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 93 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence 45567778999999999999999999998654 69999998765544 457889999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
+|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||||+.++.+||+|||+++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 99999999999999999876667999999999999999999999999 9999999999999999999999999997654
Q ss_pred ccc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHH
Q 003978 657 ETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734 (782)
Q Consensus 657 ~~~-~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 734 (782)
... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.. ......+..+++.+
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 250 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKV 250 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHH
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhc-ccCCCCCCcCCHHH
Confidence 432 22234457889999999999899999999999999999998 9999999888777666542 33455667789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 735 AAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
.+||.+||..||.+|||+.+++++|.++..
T Consensus 251 ~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 251 YTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 999999999999999999999999998865
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=369.07 Aligned_cols=259 Identities=33% Similarity=0.604 Sum_probs=226.8
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEcCC-eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~-~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
+++..++|++.+.||+|+||.||++.+.+. .||||+++...... ..+.+|+++++.++||||+++++++.....+|
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 355678999999999999999999988654 69999998765544 45788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 999999999999999877667999999999999999999999999 999999999999999999999999999765443
Q ss_pred c-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHH
Q 003978 659 Y-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 736 (782)
Q Consensus 659 ~-~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 736 (782)
. .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+. .......+..+++.+.+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~ 236 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIYQ 236 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTSCHHHHH
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCCCCCCcChHHHHH
Confidence 2 22334457788999999999889999999999999999999 999999888777665553 23345566778999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 737 IVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
||.+||..||.+|||+.++++.|+.++.
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 237 IMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 9999999999999999999999988743
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=388.68 Aligned_cols=254 Identities=22% Similarity=0.369 Sum_probs=224.2
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
...++|++++.||+|+||.||+|.+. ++.||||++.+.... ......+.+|+.+|+.++||||+++++++.....+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34579999999999999999999984 778999999764321 123467888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
+|||||+|++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||||+.+|.+||+|||+++.....
T Consensus 118 lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 9999999999999997653 6899999999999999999999999 999999999999999999999999999865432
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 738 (782)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.. ....+|..+++++.+||
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li 269 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--GKVRFPSHFSSDLKDLL 269 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTCCHHHHHHH
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHH
Confidence 2355799999999999999999999999999999999999999998888777766643 35667888999999999
Q ss_pred HHhhhhCCCCCCC-----HHHHHHHHHHHHHHHhhc
Q 003978 739 ESCWHSDPQCRPS-----FQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 739 ~~cL~~dP~~RPs-----~~ell~~L~~L~~~~~~~ 769 (782)
.+||..||.+||+ +.++ +.|+||+.
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei------~~h~~f~~ 299 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDI------KNHKWFAT 299 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHH------HTSGGGTT
T ss_pred HHHhhcCHHhccCCccCCHHHH------HhCcCcCC
Confidence 9999999999998 8888 67899864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=370.60 Aligned_cols=264 Identities=33% Similarity=0.586 Sum_probs=217.4
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEcC-----CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 572 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 572 (782)
..+++..++|++++.||+|+||.||+|.+.. ..||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 3467778899999999999999999998742 348999876532 4556678999999999999999999999985
Q ss_pred cCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCC
Q 003978 573 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (782)
Q Consensus 573 ~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla 652 (782)
++..|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC----
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECccccc
Confidence 56789999999999999999877667999999999999999999999998 999999999999999999999999999
Q ss_pred ccccccc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCC
Q 003978 653 RLKHETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 730 (782)
Q Consensus 653 ~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 730 (782)
+...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.. .....++..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~ 242 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERLPMPPNC 242 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TCCCCCCTTC
T ss_pred cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc-CCCCCCCCCC
Confidence 7654432 12234467889999999999999999999999999999997 9999998877766655542 2345677889
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 731 DPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 731 ~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
++.+.+||.+||..||.+|||+.++++.|.++..+.
T Consensus 243 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 243 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999999987654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=369.38 Aligned_cols=258 Identities=40% Similarity=0.701 Sum_probs=214.5
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCC--HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
++..++|++.+.||+|+||.||++.+.++.||||+++..... ....+.+.+|+++++.++||||+++++++...+.+|
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 345679999999999999999999999999999998764332 234567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCC-CeeecCCCCCcEEEcC--------CCcEEEEec
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP-PIIHRDLKSSNLLVDK--------HWTVKVGDF 649 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~-~ivHrDIKp~NILl~~--------~~~vkL~DF 649 (782)
+||||+++++|.+++.. ..+++..++.++.||+.||.|||+++. +|+|+||||+|||++. ++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999999964 468999999999999999999999873 3889999999999986 678999999
Q ss_pred CCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCC
Q 003978 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKD 729 (782)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 729 (782)
|++........ ....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+........++..
T Consensus 161 g~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3dtc_A 161 GLAREWHRTTK--MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238 (271)
T ss_dssp CC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTT
T ss_pred Ccccccccccc--cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcc
Confidence 99976544322 2457899999999999999999999999999999999999999998887777666655556677889
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 730 ~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
+++.+.+||.+||..||.+|||+.+++++|++|
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 999999999999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=382.33 Aligned_cols=266 Identities=27% Similarity=0.490 Sum_probs=228.6
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEcC-------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeee
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 570 (782)
..++...++|++++.||+|+||.||+|.+.+ +.||||+++... .......+.+|+.+++.++||||++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3456677899999999999999999999864 679999987543 45566789999999999999999999999
Q ss_pred eecCCceeEEEeecCCCCHHHHHhhcC-----------------------CcchHHHHHHHHHHHHHHHHhhhcCCCCee
Q 003978 571 VTSPQRLCIVTEFLPRGSLFRLLQRNT-----------------------TKLDWRRRILMALDIARGVSYLHHCNPPII 627 (782)
Q Consensus 571 ~~~~~~~~lv~E~~~ggsL~~~l~~~~-----------------------~~l~~~~~~~i~~qll~aL~~LH~~~~~iv 627 (782)
+...+.+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--iv 196 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FV 196 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 999999999999999999999997642 56899999999999999999999999 99
Q ss_pred ecCCCCCcEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCC
Q 003978 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIP 704 (782)
Q Consensus 628 HrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~P 704 (782)
||||||+||||+.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 99999999999999999999999997543321 22334568899999999999899999999999999999999 9999
Q ss_pred CCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 705 WDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 705 f~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
|...........+.. ......+..+++++.+||.+||..||.+|||+.++++.|+++...+.
T Consensus 277 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 277 YYGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCCCChHHHHHHHhC-CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 998887776665532 33456778899999999999999999999999999999998876554
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=382.28 Aligned_cols=265 Identities=25% Similarity=0.353 Sum_probs=205.3
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
++|+++++||+|+||.||+|.+. ++.||||+++.... ......+.+|+.+++.++|||||++++++..++.+|+|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 57999999999999999999874 77899999976542 2223567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcC-----CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 583 FLPRGSLFRLLQRNT-----TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~-----~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
||+ ++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 997 59999986532 35889999999999999999999998 99999999999999999999999999987654
Q ss_pred ccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--------------
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-------------- 722 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~-------------- 722 (782)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.....
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (317)
T 2pmi_A 161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240 (317)
T ss_dssp CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence 4334445678999999999987 4689999999999999999999999998887665554422110
Q ss_pred ------------------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcCCCCCc
Q 003978 723 ------------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGDSTQ 779 (782)
Q Consensus 723 ------------------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~~~~~~ 779 (782)
....+..++.++.+||.+||..||.+|||+.++ |+|+||+........+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~------l~hp~f~~~~~~~~~~~~ 309 (317)
T 2pmi_A 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA------LHHPWFAEYYHHASMGGS 309 (317)
T ss_dssp TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHH------TTSGGGGGGCC-------
T ss_pred hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHH------hCChhhhcccchhhcccc
Confidence 011223578899999999999999999999999 678999988877766554
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=387.14 Aligned_cols=259 Identities=24% Similarity=0.353 Sum_probs=215.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC---CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY---SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
..++|++.+.||+|+||.||+|.+ .++.||||++..... .....+.+.+|+.+++.++|||||++++++...+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 346899999999999999999998 477899999865321 111246788999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhc---CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc---EEEEecCC
Q 003978 578 CIVTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT---VKVGDFGL 651 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~---vkL~DFGl 651 (782)
|+|||||+|++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++. +||+|||+
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999999888543 235899999999999999999999999 999999999999986554 99999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--cCCCCC
Q 003978 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--LEIPKD 729 (782)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~ 729 (782)
+.............+||+.|+|||++.+..++.++|||||||++|+|++|..||.... ......+...... ......
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTT
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcccccc
Confidence 9876655444456689999999999999999999999999999999999999998753 3333333221111 111256
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 730 ~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
++.++++||.+||..||.+|||+.++ |.|+||+..
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~------l~hp~~~~~ 293 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEA------LNHPWLKER 293 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHH------HTSHHHHTH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHH------hcChhhcCC
Confidence 89999999999999999999999999 567888654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=380.15 Aligned_cols=260 Identities=25% Similarity=0.371 Sum_probs=222.2
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCH----HHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (782)
+...++|++.+.||+|+||.||+|.+. +..||||++....... .....+.+|+.+|+.++||||+++++++...
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 344578999999999999999999984 7789999997654321 1246788999999999999999999999999
Q ss_pred CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----cEEEEecC
Q 003978 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFG 650 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~----~vkL~DFG 650 (782)
..+|+|||||++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred CEEEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999999999754 46999999999999999999999999 99999999999999877 89999999
Q ss_pred CCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--cCCCC
Q 003978 651 LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--LEIPK 728 (782)
Q Consensus 651 la~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~ 728 (782)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...... ...+.
T Consensus 164 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 164 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp TCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred CCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence 998654332 223457999999999999999999999999999999999999999988877766655432221 12235
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 729 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 729 ~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
.++..+.+||.+||..||.+|||+.++ |+|+||+..
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~------l~hp~~~~~ 278 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDS------LQHPWIKPK 278 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHH------HHSTTTSCC
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHH------hcCCCccCC
Confidence 789999999999999999999999999 567888643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=384.58 Aligned_cols=264 Identities=31% Similarity=0.574 Sum_probs=230.6
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEcC---------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEe
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG---------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 568 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~---------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 568 (782)
.+++..++|+++++||+|+||.||+|.+.+ ..||||+++... .......+.+|+++++.+ +|||||+++
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 456777899999999999999999998743 359999997653 455667889999999999 899999999
Q ss_pred eeeecCCceeEEEeecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 003978 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (782)
Q Consensus 569 ~~~~~~~~~~lv~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp 633 (782)
+++..++.+|+|||||++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp 219 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAA 219 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCc
Confidence 99999999999999999999999997643 35899999999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 003978 634 SNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (782)
Q Consensus 634 ~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~ 710 (782)
+||||+.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998654332 22334567889999999999999999999999999999999 9999998887
Q ss_pred HHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 711 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 711 ~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
......+. .......+..+++++.+||.+||..||.+|||+.++++.|+++....
T Consensus 300 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 300 EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 77665553 33456677889999999999999999999999999999999997543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=386.97 Aligned_cols=264 Identities=23% Similarity=0.367 Sum_probs=219.4
Q ss_pred cccccceeEeeeeccC--CcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc
Q 003978 501 EILWEDLTIGEQIGQG--SCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G--~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (782)
....++|+++++||+| +||.||+|.+. ++.||||++............+.+|+.+++.++|||||++++++...+.
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 3445789999999999 99999999985 7789999999887777788899999999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
+|+|||||++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++...
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999999764 356899999999999999999999999 999999999999999999999999988643
Q ss_pred cccc-------ccccCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-----
Q 003978 656 HETY-------LTTKTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN----- 721 (782)
Q Consensus 656 ~~~~-------~~~~~~~Gt~~y~aPE~l~~--~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~----- 721 (782)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+....
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 2211 11223478999999999988 678999999999999999999999998765544332221100
Q ss_pred ---------------------------------------cccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 722 ---------------------------------------QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 722 ---------------------------------------~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
.....+..+++++.+||.+||..||.+|||+.++ |
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el------l 332 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL------L 332 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH------T
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH------h
Confidence 0112345688999999999999999999999999 6
Q ss_pred HHHHhhcccC
Q 003978 763 QRQYFQASRS 772 (782)
Q Consensus 763 ~~~~~~~~~~ 772 (782)
+|+||+....
T Consensus 333 ~hp~f~~~~~ 342 (389)
T 3gni_B 333 NHSFFKQIKR 342 (389)
T ss_dssp TSGGGGGC--
T ss_pred cCHHHHHHhh
Confidence 7899987654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=397.10 Aligned_cols=261 Identities=19% Similarity=0.328 Sum_probs=222.5
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
....++|+++++||+|+||.||+|.+ .++.||||++++... .......+.+|+.++..++||||+++++++.+.+.+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 34568999999999999999999998 477899999975332 112234578899999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+|||||+||+|.+++.+....+++..++.++.||+.||.|||+++ ||||||||+||||+.++++||+|||+++....
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 9999999999999999876667999999999999999999999999 99999999999999999999999999976544
Q ss_pred ccc-cccCCCCCCcccCccccc-------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCC---
Q 003978 658 TYL-TTKTGKGTPQWMAPEVLR-------NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEI--- 726 (782)
Q Consensus 658 ~~~-~~~~~~Gt~~y~aPE~l~-------~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--- 726 (782)
... .....+||+.|+|||++. +..++.++|||||||++|||++|..||...+.......+........+
T Consensus 215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 294 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV 294 (412)
T ss_dssp TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcc
Confidence 322 233568999999999997 356889999999999999999999999998888777766543333333
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCC---CCHHHHHHHHHHHHHHHhhcc
Q 003978 727 PKDVDPRWAAIVESCWHSDPQCR---PSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 727 p~~~~~~l~~LI~~cL~~dP~~R---Ps~~ell~~L~~L~~~~~~~~ 770 (782)
+..+++++++||.+||. +|.+| |++.++ +.|+||+.+
T Consensus 295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei------~~Hpff~~i 334 (412)
T 2vd5_A 295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDF------RTHPFFFGL 334 (412)
T ss_dssp --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHH------HTSGGGTTC
T ss_pred ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH------hcCCCcCCC
Confidence 35799999999999999 99998 589999 678999764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=397.65 Aligned_cols=260 Identities=23% Similarity=0.363 Sum_probs=222.7
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
....++|+++++||+|+||.||+|.+. ++.||||++++.... ......+.+|+.+++.++|||||++++++.+...+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 345679999999999999999999984 667999999753211 01123467899999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+|||||+||+|.+++... .+++..++.++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+++....
T Consensus 145 ~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 9999999999999999753 5899999999999999999999999 99999999999999999999999999976544
Q ss_pred cc-ccccCCCCCCcccCcccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC--CCC
Q 003978 658 TY-LTTKTGKGTPQWMAPEVLRNEP----SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP--KDV 730 (782)
Q Consensus 658 ~~-~~~~~~~Gt~~y~aPE~l~~~~----~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~ 730 (782)
.. ......+||+.|+|||++.+.. ++.++|||||||+||+|++|..||...+.......+........+| ..+
T Consensus 221 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 300 (410)
T 3v8s_A 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 300 (410)
T ss_dssp TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCC
T ss_pred CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccc
Confidence 32 2344678999999999998766 7789999999999999999999999988888777775433333444 479
Q ss_pred CHHHHHHHHHhhhhCCCC--CCCHHHHHHHHHHHHHHHhhcc
Q 003978 731 DPRWAAIVESCWHSDPQC--RPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 731 ~~~l~~LI~~cL~~dP~~--RPs~~ell~~L~~L~~~~~~~~ 770 (782)
++++++||.+||..+|.+ ||++.++ +.|+||+..
T Consensus 301 s~~~~~li~~lL~~~~~rlgR~~~~ei------~~Hp~f~~~ 336 (410)
T 3v8s_A 301 SKEAKNLICAFLTDREVRLGRNGVEEI------KRHLFFKND 336 (410)
T ss_dssp CHHHHHHHHHHSSCGGGCTTSSCHHHH------HTSGGGCCS
T ss_pred cHHHHHHHHHHccChhhhCCCCCHHHH------hcCccccCC
Confidence 999999999999999988 9999999 678999865
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=378.23 Aligned_cols=259 Identities=27% Similarity=0.423 Sum_probs=228.0
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
...++|.+++.||+|+||.||++.+. ++.||+|++..... .......+.+|+.+++.++||||+++++++...+.+|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34578999999999999999999984 56799999986644 4456678899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
+|||||.+++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+||||+.++.+||+|||++......
T Consensus 118 lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 999999999999998764 46899999999999999999999999 999999999999999999999999999866544
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 738 (782)
........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. .....++..+++.+.+||
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li 272 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASLI 272 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHHH
T ss_pred cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh--cCCCCCCccCCHHHHHHH
Confidence 444445679999999999999999999999999999999999999999887766555543 334567788999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 739 ~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
.+||..||.+|||+.++ +.|+||+...
T Consensus 273 ~~~l~~dp~~Rps~~el------l~~~~~~~~~ 299 (335)
T 2owb_A 273 QKMLQTDPTARPTINEL------LNDEFFTSGY 299 (335)
T ss_dssp HHHTCSSGGGSCCGGGG------GGSHHHHTSC
T ss_pred HHHccCChhHCcCHHHH------hcCccccCCC
Confidence 99999999999999999 6789997654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=400.46 Aligned_cols=262 Identities=20% Similarity=0.351 Sum_probs=223.7
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCH-HHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
....++|+++++||+|+||.||+|.+. ++.||||++++..... .....+.+|+.++..++|||||++++++.+...+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 345679999999999999999999985 5679999997532111 1123477899999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+|||||+||+|.+++......+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++....
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 9999999999999999876667999999999999999999999999 99999999999999999999999999976543
Q ss_pred cc-ccccCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC---C
Q 003978 658 TY-LTTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP---K 728 (782)
Q Consensus 658 ~~-~~~~~~~Gt~~y~aPE~l~-----~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p---~ 728 (782)
.. ......+||+.|+|||++. +..++.++|||||||++|||++|..||...+..+....+........+| .
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 307 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT 307 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCC
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccc
Confidence 32 2334468999999999997 5568999999999999999999999999988888777765433334444 4
Q ss_pred CCCHHHHHHHHHhhhhCCCC--CCCHHHHHHHHHHHHHHHhhcc
Q 003978 729 DVDPRWAAIVESCWHSDPQC--RPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 729 ~~~~~l~~LI~~cL~~dP~~--RPs~~ell~~L~~L~~~~~~~~ 770 (782)
.+++++++||.+||..+|++ ||++.++ +.|+||+.+
T Consensus 308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~ei------l~Hpff~~i 345 (437)
T 4aw2_A 308 DVSENAKDLIRRLICSREHRLGQNGIEDF------KKHPFFSGI 345 (437)
T ss_dssp CSCHHHHHHHHTTSSCGGGCTTTTTTHHH------HTSGGGTTC
T ss_pred cCCHHHHHHHHHHhcccccccCCCCHHHH------hCCCccCCC
Confidence 58999999999999888888 9999999 678999754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=374.49 Aligned_cols=261 Identities=24% Similarity=0.367 Sum_probs=215.0
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.++|+++++||+|+||.||+|.+. ++.||||++..........+.+.+|+++++.++||||+++++++...+.+++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 468999999999999999999984 778999999877666667788899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
|||++++|.+++... ..+++..++.++.||+.||.|||++| |+|+||||+|||++.++.+||+|||++.........
T Consensus 82 e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp ECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 999998998888654 46899999999999999999999999 999999999999999999999999999876544444
Q ss_pred ccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc------------------
Q 003978 662 TKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------------ 722 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~------------------ 722 (782)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 445678999999999986 5679999999999999999999999998877665544321100
Q ss_pred -ccC----------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 723 -RLE----------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 723 -~~~----------~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
... ..+.++.++.+||.+||..||.+|||+.++ ++|+||+..+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el------l~hp~f~~~~~~ 294 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQL------LHHPYFENIREI 294 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHH------HTSGGGTTCC--
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHH------hcChHHHhccCH
Confidence 000 014578899999999999999999999999 678999876543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=370.84 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=217.4
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
+...++|++++.||+|+||.||++.+ .+..||||++..... .....+.+.+|+.+++.++||||+++++++...+.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 34567999999999999999999997 467899999866543 456678899999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+||||++|++|.+++.... ++++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999999997654 6899999999999999999999999 99999999999999999999999999986544
Q ss_pred cc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc---ccCCCCCCCHH
Q 003978 658 TY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ---RLEIPKDVDPR 733 (782)
Q Consensus 658 ~~-~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~---~~~~p~~~~~~ 733 (782)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..||................. ....+..+++.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHH
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHH
Confidence 32 223345799999999999999999999999999999999999999998877655433321111 12355779999
Q ss_pred HHHHHHHhhhhCCCCCC-CHHHHHHHHHHH
Q 003978 734 WAAIVESCWHSDPQCRP-SFQELVDKLRDL 762 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RP-s~~ell~~L~~L 762 (782)
+.++|.+||..||.+|| +++++.+.|.++
T Consensus 244 l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 244 LSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred HHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 99999999999999999 888888777654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=371.15 Aligned_cols=262 Identities=37% Similarity=0.636 Sum_probs=212.5
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
..+++..++|++.++||+|+||.||++.+.+ .||||+++.........+.+.+|+.+++.++||||++++++. ....+
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 4567788899999999999999999998755 599999987777777788999999999999999999999965 45678
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
++|||||.+++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceecccccc
Confidence 9999999999999999877778999999999999999999999999 99999999999999999999999999975432
Q ss_pred c--cccccCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh-cccc---ccCCCC
Q 003978 658 T--YLTTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVG-FMNQ---RLEIPK 728 (782)
Q Consensus 658 ~--~~~~~~~~Gt~~y~aPE~l~---~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~-~~~~---~~~~p~ 728 (782)
. ........||+.|+|||++. +..++.++|||||||++|+|++|..||............. .... ...+..
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS 252 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCT
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccc
Confidence 1 12223456899999999987 6667889999999999999999999998766554333332 1111 223445
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003978 729 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 763 (782)
Q Consensus 729 ~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~ 763 (782)
.+++.+.+||.+||..||.+|||+.++++.|+++.
T Consensus 253 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 253 NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 78999999999999999999999999999998764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=372.33 Aligned_cols=262 Identities=29% Similarity=0.549 Sum_probs=227.3
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 571 (782)
.++...++|++.+.||+|+||.||++.+. +..||||++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 45666789999999999999999999873 2569999987543 455667899999999999999999999999
Q ss_pred ecCCceeEEEeecCCCCHHHHHhhcC-----------------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 003978 572 TSPQRLCIVTEFLPRGSLFRLLQRNT-----------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIH 628 (782)
Q Consensus 572 ~~~~~~~lv~E~~~ggsL~~~l~~~~-----------------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivH 628 (782)
...+.+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH 173 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVH 173 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccc
Confidence 99999999999999999999997643 24899999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCC
Q 003978 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPW 705 (782)
Q Consensus 629 rDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf 705 (782)
|||||+||||+.++.+||+|||++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999997654322 22334567889999999999889999999999999999999 99999
Q ss_pred CCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 706 DNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 706 ~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
...........+. .......+..+++++.+||.+||..||.+||++.++++.|+++..
T Consensus 254 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 254 PGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp TTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHhh-cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9887766655543 233556778899999999999999999999999999999998864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=371.32 Aligned_cols=262 Identities=30% Similarity=0.502 Sum_probs=216.6
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE------cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec-
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS- 573 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~------~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~- 573 (782)
+...++|+++++||+|+||.||+|.+ .++.||||++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 34567999999999999999999985 4667999998643 35566789999999999999999999999854
Q ss_pred -CCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCC
Q 003978 574 -PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (782)
Q Consensus 574 -~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla 652 (782)
...+++|||||++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCccc
Confidence 35689999999999999999887777999999999999999999999998 999999999999999999999999999
Q ss_pred ccccccc---ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH---------------HH
Q 003978 653 RLKHETY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ---------------VI 714 (782)
Q Consensus 653 ~~~~~~~---~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~---------------~~ 714 (782)
....... .......+++.|+|||++.+..++.++|||||||++|+|++|..||....... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 8654332 12233457788999999999999999999999999999999999986542211 00
Q ss_pred HHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 715 GAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 715 ~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
............+..+++++.+||.+||..||.+|||+.++++.|+++...+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 1111123355667889999999999999999999999999999999987643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=368.72 Aligned_cols=263 Identities=29% Similarity=0.487 Sum_probs=223.8
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCH-HHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
...++|++++.||+|+||.||+|.+. +..||||++....... .....+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 44579999999999999999999985 4569999987543221 22456888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+||||+.++.+||+|||++......
T Consensus 86 lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 999999999999999764 46899999999999999999999998 999999999999999999999999998654433
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 738 (782)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .....++..++..+.+||
T Consensus 163 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li 238 (279)
T 3fdn_A 163 R--RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDLI 238 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHHH
T ss_pred c--ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH--hCCCCCCCcCCHHHHHHH
Confidence 2 234578999999999999999999999999999999999999999888777666553 334567788999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcCCCC
Q 003978 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGDS 777 (782)
Q Consensus 739 ~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~~~~ 777 (782)
.+||..||.+|||+.++ +.|+||+.....-...
T Consensus 239 ~~~l~~~p~~Rps~~e~------l~h~~~~~~~~~~~~~ 271 (279)
T 3fdn_A 239 SRLLKHNPSQRPMLREV------LEHPWITANSSKPSNC 271 (279)
T ss_dssp HHHCCSSGGGSCCHHHH------HHCHHHHHHCSSCCCC
T ss_pred HHHhccChhhCCCHHHH------hhCccccCCccCcccc
Confidence 99999999999999999 6789998766554433
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=393.21 Aligned_cols=256 Identities=32% Similarity=0.616 Sum_probs=224.0
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC-ce
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-RL 577 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~ 577 (782)
.+++..++|++.++||+|+||.||++.+.++.||||+++... ..+.+.+|+.+|+.++|||||++++++.... .+
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence 456778899999999999999999999999999999997654 2356889999999999999999999986654 79
Q ss_pred eEEEeecCCCCHHHHHhhcCC-cchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
|+|||||++|+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 999999999999999986543 3689999999999999999999999 9999999999999999999999999997543
Q ss_pred cccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHH
Q 003978 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735 (782)
Q Consensus 657 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 735 (782)
.. .....+++.|+|||++.+..++.++|||||||+||||++ |..||......+....+. ...++..|..+++++.
T Consensus 341 ~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~ 416 (450)
T 1k9a_A 341 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVY 416 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCHHHH
T ss_pred cc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHH
Confidence 32 223467899999999999999999999999999999998 999999887776665553 3345677889999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
+||.+||..||.+|||+.++++.|+++..
T Consensus 417 ~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 417 DVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999988764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=362.02 Aligned_cols=259 Identities=31% Similarity=0.581 Sum_probs=227.4
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEE-cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
|.+..++|++.+.||+|+||.||++.+ .+..||+|++....... +.+.+|+.+++.++||||+++++++...+.+|
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred eEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 456678999999999999999999998 45679999998765443 46788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEcccccccccccc
Confidence 999999999999999877677999999999999999999999999 999999999999999999999999999765432
Q ss_pred c-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHH
Q 003978 659 Y-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 736 (782)
Q Consensus 659 ~-~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 736 (782)
. .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+.. ......+..++..+.+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~ 236 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHVYQ 236 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTTSCHHHHH
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc-CCcCCCCccCcHHHHH
Confidence 2 22234467889999999998889999999999999999999 8999998887776666542 2344566778999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 737 IVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
||.+||..||.+||++.++++.|+++..
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 237 IMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998865
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=388.39 Aligned_cols=258 Identities=22% Similarity=0.372 Sum_probs=218.4
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
++..++|++++.||+|+||.||+|.+. ++.||||++.+... .......+.+|+.+|+.++|||||++++++.....+
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456689999999999999999999984 56799999976432 122346788899999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+|||||.||+|..++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|.+||+|||+++....
T Consensus 91 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp EEEECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999999999764 46999999999999999999999999 99999999999999999999999999986543
Q ss_pred ccccccCCCCCCcccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHhhccccccCCCCCCC
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRN---EPSDEKSDVYSFGVILWELATEKIPWDNLNS---MQVIGAVGFMNQRLEIPKDVD 731 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~---~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~~~ 731 (782)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+ ......+|..++
T Consensus 168 ~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~p~~~s 244 (384)
T 4fr4_A 168 E-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--ETTVVTYPSAWS 244 (384)
T ss_dssp T-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH--HHCCCCCCTTSC
T ss_pred C-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH--hhcccCCCCcCC
Confidence 3 23346689999999999974 4588999999999999999999999975432 2222222 234566778899
Q ss_pred HHHHHHHHHhhhhCCCCCCC-HHHHHHHHHHHHHHHhhcc
Q 003978 732 PRWAAIVESCWHSDPQCRPS-FQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 732 ~~l~~LI~~cL~~dP~~RPs-~~ell~~L~~L~~~~~~~~ 770 (782)
+++.+||.+||..||.+||+ +.++ +.|+||+..
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l------~~hp~f~~~ 278 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDV------QNFPYMNDI 278 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHH------HTSGGGTTC
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHH------HcChhhhcC
Confidence 99999999999999999998 7777 467888643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=378.61 Aligned_cols=265 Identities=28% Similarity=0.461 Sum_probs=222.9
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEee
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMG 569 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 569 (782)
..+++..++|++++.||+|+||.||+|.+. +..||||++.... .......+.+|+.+++.+ +||||+++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 456778899999999999999999999972 3469999997543 233456788999999999 8999999999
Q ss_pred eeecCCceeEEEeecCCCCHHHHHhhcCC----------------------cchHHHHHHHHHHHHHHHHhhhcCCCCee
Q 003978 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTT----------------------KLDWRRRILMALDIARGVSYLHHCNPPII 627 (782)
Q Consensus 570 ~~~~~~~~~lv~E~~~ggsL~~~l~~~~~----------------------~l~~~~~~~i~~qll~aL~~LH~~~~~iv 627 (782)
++...+.+|+|||||++++|.+++..... .+++..++.++.||+.||.|||+++ |+
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iv 194 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CV 194 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence 99999999999999999999999976532 3788999999999999999999999 99
Q ss_pred ecCCCCCcEEEcCCCcEEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCC
Q 003978 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIP 704 (782)
Q Consensus 628 HrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~P 704 (782)
||||||+||||+.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999976543321 2223457889999999999999999999999999999998 9999
Q ss_pred CCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 705 WDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 705 f~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
|...........+.........+..+++++.+||.+||..||.+|||+.+++++|..+...
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 9887655544444334445667788999999999999999999999999999999887543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=387.97 Aligned_cols=255 Identities=28% Similarity=0.481 Sum_probs=217.7
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCH-HHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
..++|++.+.||+|+||.||+|.+ .++.||||++.+..... .....+.+|+.+++.++||||+++++++.....+|+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 457899999999999999999998 57789999997543211 123568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
||||+ +|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 87 v~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 99999 78999998764 36899999999999999999999999 9999999999999999999999999998655432
Q ss_pred ccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHH
Q 003978 660 LTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~~~~-s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 738 (782)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+ ......+|..+++++.+||
T Consensus 163 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li 239 (336)
T 3h4j_B 163 -FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLI 239 (336)
T ss_dssp -TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHHHH
T ss_pred -ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHHHH
Confidence 2345689999999999998876 68999999999999999999999876543322222 2234557788999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 739 ~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
.+||..||.+|||+.++ ++|+||+..
T Consensus 240 ~~~L~~dP~~Rpt~~ei------l~hp~~~~~ 265 (336)
T 3h4j_B 240 RRMIVADPMQRITIQEI------RRDPWFNVN 265 (336)
T ss_dssp HTTSCSSGGGSCCHHHH------TTCHHHHTT
T ss_pred HHHcCCChhHCcCHHHH------HhChhhccC
Confidence 99999999999999999 678999754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=370.70 Aligned_cols=265 Identities=27% Similarity=0.469 Sum_probs=227.0
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEee
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMG 569 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 569 (782)
..++...++|++++.||+|+||.||+|.+. +..||||+++... .....+.+.+|+.+++.+ +||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 456777889999999999999999999862 3579999997543 344567889999999999 8999999999
Q ss_pred eeecCCceeEEEeecCCCCHHHHHhhcCC-----------------cchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 003978 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTT-----------------KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLK 632 (782)
Q Consensus 570 ~~~~~~~~~lv~E~~~ggsL~~~l~~~~~-----------------~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIK 632 (782)
++...+..++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+|+|||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlk 172 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLA 172 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCc
Confidence 99999999999999999999999976542 4899999999999999999999998 9999999
Q ss_pred CCcEEEcCCCcEEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 003978 633 SSNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (782)
Q Consensus 633 p~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~ 709 (782)
|+||||+.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999999999976544322 2223457889999999999999999999999999999999 999998876
Q ss_pred hHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 710 SMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 710 ~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
.................+..++.++.+||.+||..||.+|||+.++++.|+++...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 55444444333445556778999999999999999999999999999999887664
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=364.17 Aligned_cols=270 Identities=24% Similarity=0.467 Sum_probs=230.8
Q ss_pred cccccceeEee-eeccCCcEEEEEEEE----cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 501 EILWEDLTIGE-QIGQGSCGTVYHAVW----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 501 e~~~~~y~i~~-~IG~G~~G~Vy~~~~----~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
....++|.+.+ .||+|+||.||+|.+ .+..||||+++... .....+.+.+|+++++.++||||+++++++. .+
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 82 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AE 82 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CC
Confidence 34557888887 999999999999986 45679999997643 4556778999999999999999999999994 56
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
.+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||||+.++.+||+|||++...
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccceeee
Confidence 789999999999999999876677999999999999999999999999 999999999999999999999999999765
Q ss_pred cccc---ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCC
Q 003978 656 HETY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 731 (782)
Q Consensus 656 ~~~~---~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 731 (782)
.... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+. ......++..++
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~ 239 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECP 239 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTCC
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-cCCcCCCCCCcC
Confidence 4322 12233457899999999998889999999999999999998 999999888777665553 234566778999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcCC
Q 003978 732 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVG 775 (782)
Q Consensus 732 ~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~~ 775 (782)
+++.+||.+||..||.+||++.+++++|.++....-......+.
T Consensus 240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~~ 283 (287)
T 1u59_A 240 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHH 283 (287)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSCCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCCcc
Confidence 99999999999999999999999999999998777655544433
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=381.47 Aligned_cols=258 Identities=26% Similarity=0.368 Sum_probs=204.0
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
+...++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.+|+.++||||+++++++.....+|
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 445678999999999999999999985 5679999997543 2356778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCcEEEEecCCCccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFGLSRLK 655 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~---~~~vkL~DFGla~~~ 655 (782)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+. ++.+||+|||+++..
T Consensus 125 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 999999999999999764 46899999999999999999999998 999999999999975 889999999999865
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhccccc--cCCCCCCCH
Q 003978 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ-VIGAVGFMNQR--LEIPKDVDP 732 (782)
Q Consensus 656 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~-~~~~i~~~~~~--~~~p~~~~~ 732 (782)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+...... ......++.
T Consensus 202 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 202 EHQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred Cccc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 4432 2234579999999999999999999999999999999999999998766544 33333222211 223356899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 733 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 733 ~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
++.+||.+||..||++|||+.++ |+|+||+....
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~------l~hp~~~~~~~ 314 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQA------LQHPWVTGKAA 314 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHH------HHSTTTTSTTC
T ss_pred HHHHHHHHHccCChhhCcCHHHH------hcCcccCCCcc
Confidence 99999999999999999999999 67899976554
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=377.03 Aligned_cols=263 Identities=24% Similarity=0.385 Sum_probs=217.8
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE-cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCC--CceeEEeeeeecCCce
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH--PNVLLFMGAVTSPQRL 577 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~ 577 (782)
.+..++|++++.||+|+||.||++.. .++.||||++............+.+|+.+|+.+.| |||+++++++..+..+
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 34567899999999999999999987 46679999998877777778889999999999986 9999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+|||++ +++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+ ++.+||+|||+++....
T Consensus 85 ~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 85 YMVMECG-NIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEECCC-SEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEEeCC-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 9999955 78999999864 46899999999999999999999999 99999999999997 57899999999986543
Q ss_pred ccc--cccCCCCCCcccCcccccC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhccccc
Q 003978 658 TYL--TTKTGKGTPQWMAPEVLRN-----------EPSDEKSDVYSFGVILWELATEKIPWDNLNS-MQVIGAVGFMNQR 723 (782)
Q Consensus 658 ~~~--~~~~~~Gt~~y~aPE~l~~-----------~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~-~~~~~~i~~~~~~ 723 (782)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+......
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence 321 2235579999999999865 6678899999999999999999999987543 2333344333445
Q ss_pred cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcC
Q 003978 724 LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTV 774 (782)
Q Consensus 724 ~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~ 774 (782)
..++...+.++.+||.+||..||.+|||+.++ |.|+||+......
T Consensus 240 ~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~------l~hp~~~~~~~~~ 284 (343)
T 3dbq_A 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL------LAHPYVQIQTHPV 284 (343)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH------HTSHHHHSCCC--
T ss_pred cCCcccCCHHHHHHHHHHcCCChhHCCCHHHH------HhCccccccCCcc
Confidence 66778889999999999999999999999999 6789998765543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=381.40 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=211.9
Q ss_pred eEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecC
Q 003978 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585 (782)
Q Consensus 508 ~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 585 (782)
...+.||+|+||.||+|.. .++.||+|+++... ....+.+.+|+++|+.++|||||++++++...+.+|+|||||+
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 3367899999999999987 47789999997644 2345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE--cCCCcEEEEecCCCccccccccccc
Q 003978 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV--DKHWTVKVGDFGLSRLKHETYLTTK 663 (782)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl--~~~~~vkL~DFGla~~~~~~~~~~~ 663 (782)
+++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++...... ...
T Consensus 170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~~ 246 (373)
T 2x4f_A 170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLK 246 (373)
T ss_dssp TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BCC
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-ccc
Confidence 99999999776667999999999999999999999999 9999999999999 567899999999998654432 233
Q ss_pred CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--cCCCCCCCHHHHHHHHHh
Q 003978 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--LEIPKDVDPRWAAIVESC 741 (782)
Q Consensus 664 ~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~~~~l~~LI~~c 741 (782)
...||+.|+|||++.+..++.++|||||||++|+|++|..||...+....+..+...... ......+++++.+||.+|
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 326 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKL 326 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTT
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHH
Confidence 457999999999999999999999999999999999999999988887766665432221 122356899999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 742 WHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 742 L~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
|..||.+|||+.++ |+|+||+..
T Consensus 327 L~~dp~~Rps~~e~------l~hp~~~~~ 349 (373)
T 2x4f_A 327 LIKEKSWRISASEA------LKHPWLSDH 349 (373)
T ss_dssp SCSSGGGSCCHHHH------HHSHHHHCH
T ss_pred cCCChhhCCCHHHH------hcCcCcCCC
Confidence 99999999999999 567888643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=371.80 Aligned_cols=260 Identities=25% Similarity=0.433 Sum_probs=198.8
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
..++|++.+.||+|+||.||+|.. .++.||||++...... ......+.+|+.+++.++||||+++++++...+.+|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 346899999999999999999997 5778999999754321 1234678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
||||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 99999999999999877678999999999999999999999999 9999999999999999999999999998665443
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHH
Q 003978 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 739 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 739 (782)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+ ......++..++.++.+||.
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~ 244 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--VLADYEMPSFLSIEAKDLIH 244 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C--CSSCCCCCTTSCHHHHHHHH
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH--hhcccCCccccCHHHHHHHH
Confidence 3334567899999999999988999999999999999999999999877655444333 22344567789999999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 740 SCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 740 ~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
+||..||.+|||+.++ +.|+||+....
T Consensus 245 ~~l~~dp~~Rps~~~~------l~h~~~~~~~~ 271 (278)
T 3cok_A 245 QLLRRNPADRLSLSSV------LDHPFMSRNSS 271 (278)
T ss_dssp HHSCSSGGGSCCHHHH------TTSTTTC----
T ss_pred HHcccCHhhCCCHHHH------hcCccccCCCC
Confidence 9999999999999999 67899876544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=375.12 Aligned_cols=274 Identities=32% Similarity=0.535 Sum_probs=235.3
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 571 (782)
.+++..++|++.+.||+|+||.||+|.+. +..||||++.... .......+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 55677789999999999999999999865 4679999987543 344556788999999999999999999999
Q ss_pred ecCCceeEEEeecCCCCHHHHHhhcC---------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 003978 572 TSPQRLCIVTEFLPRGSLFRLLQRNT---------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642 (782)
Q Consensus 572 ~~~~~~~lv~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~ 642 (782)
...+..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTC
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCCC
Confidence 99999999999999999999996532 34688999999999999999999999 99999999999999999
Q ss_pred cEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhc
Q 003978 643 TVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGF 719 (782)
Q Consensus 643 ~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~ 719 (782)
.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~- 254 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM- 254 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH-
Confidence 99999999997554332 22234467899999999999999999999999999999999 899999888777665553
Q ss_pred cccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcCCC
Q 003978 720 MNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGD 776 (782)
Q Consensus 720 ~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~~~ 776 (782)
.......+..++..+.+||.+||..||.+|||+.++++.|+++..++|+.......+
T Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~~~~ 311 (322)
T 1p4o_A 255 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSE 311 (322)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCSTTST
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccccccccc
Confidence 233455677899999999999999999999999999999999988888776655443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=366.67 Aligned_cols=256 Identities=35% Similarity=0.638 Sum_probs=216.9
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCH--HHH---HHHHHHHHHHHhCCCCceeEEeeeeecC
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD--EVI---HSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~--~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (782)
...++|++.+.||+|+||.||+|.+ .++.||||++....... ... +.+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 3447899999999999999999998 57789999987654322 211 6788999999999999999999998765
Q ss_pred CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc-----EEEEec
Q 003978 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-----VKVGDF 649 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~-----vkL~DF 649 (782)
. ++||||+++++|.+++......+++..++.++.||+.||.|||+++.+|+|+||||+||||+.++. +||+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 4 799999999999999987777899999999999999999999998766999999999999988776 999999
Q ss_pred CCCcccccccccccCCCCCCcccCccccc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHH--HHHhhccccccC
Q 003978 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLR--NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQV--IGAVGFMNQRLE 725 (782)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~y~aPE~l~--~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~--~~~i~~~~~~~~ 725 (782)
|+++..... .....||+.|+|||++. +..++.++|||||||++|+|++|..||........ ...+........
T Consensus 174 g~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 4f0f_A 174 GLSQQSVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250 (287)
T ss_dssp TTCBCCSSC---EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred Ccccccccc---ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence 999754432 23457999999999984 45568899999999999999999999987654433 333434445667
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 726 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 726 ~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
++..+++++.+||.+||..||.+|||+.++++.|++|
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 7889999999999999999999999999999998753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=383.24 Aligned_cols=262 Identities=26% Similarity=0.465 Sum_probs=225.1
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (782)
++..++|+++++||+|+||.||+|.+. +..||||+++... .......+.+|+.+++.++|||||++++++..
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 455689999999999999999999853 3469999986433 44555678899999999999999999999999
Q ss_pred CCceeEEEeecCCCCHHHHHhhcC------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---cE
Q 003978 574 PQRLCIVTEFLPRGSLFRLLQRNT------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TV 644 (782)
Q Consensus 574 ~~~~~lv~E~~~ggsL~~~l~~~~------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~---~v 644 (782)
....|+|||||++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++ .+
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceE
Confidence 999999999999999999997643 35899999999999999999999999 99999999999999555 59
Q ss_pred EEEecCCCcccccc--cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccc
Q 003978 645 KVGDFGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMN 721 (782)
Q Consensus 645 kL~DFGla~~~~~~--~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~ 721 (782)
||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+. ..
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~-~~ 302 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 302 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TT
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cC
Confidence 99999999754322 122234467999999999999999999999999999999998 999999988877776654 33
Q ss_pred cccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 722 QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 722 ~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
.....+..++..+.+||.+||..||.+|||+.+++++|+.+....
T Consensus 303 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 303 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 355667889999999999999999999999999999999887654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=383.78 Aligned_cols=264 Identities=30% Similarity=0.526 Sum_probs=218.2
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEc-----CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (782)
..++...+|++.+.||+|+||.||+|.+. +..||||+++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 34566679999999999999999999864 5569999986543 45566789999999999999999999999999
Q ss_pred CCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 574 ~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
...+|+|||||++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 99999999999999999999877777999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCC
Q 003978 654 LKHETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKD 729 (782)
Q Consensus 654 ~~~~~~~---~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 729 (782)
....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||...........+.. ......+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~ 274 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYRLPPPMD 274 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT-TEECCCCTT
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcc
Confidence 6544321 1223346788999999999999999999999999999998 9999998887776665532 334556678
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 730 ~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
++..+.+||.+||..||.+||++.++++.|+++....
T Consensus 275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp CBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 9999999999999999999999999999999987644
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=375.24 Aligned_cols=266 Identities=29% Similarity=0.468 Sum_probs=210.7
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEcCC-----eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~-----~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (782)
...+..++|++++.||+|+||.||+|.+... .||||+++.........+.+.+|+++++.++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 4456678999999999999999999986432 69999998765555667889999999999999999999999987
Q ss_pred CCce------eEEEeecCCCCHHHHHhhcC-----CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 003978 574 PQRL------CIVTEFLPRGSLFRLLQRNT-----TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642 (782)
Q Consensus 574 ~~~~------~lv~E~~~ggsL~~~l~~~~-----~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~ 642 (782)
.... ++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDM 174 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTS
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCCC
Confidence 7655 99999999999999996432 25899999999999999999999999 99999999999999999
Q ss_pred cEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhc
Q 003978 643 TVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGF 719 (782)
Q Consensus 643 ~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~ 719 (782)
.+||+|||+++...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+.
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~- 253 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI- 253 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh-
Confidence 99999999997654322 12223457889999999999999999999999999999999 999999888776665553
Q ss_pred cccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH-HHh
Q 003978 720 MNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR-QYF 767 (782)
Q Consensus 720 ~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~-~~~ 767 (782)
.......+..+++++.+||.+||..||.+|||+.++++.|+++.. +|+
T Consensus 254 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 254 GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 233556778899999999999999999999999999999999955 444
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=372.72 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=219.9
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
.|...++||+|+||.||+|.. .++.||||++...... ..+.+.+|+.+++.++||||+++++++......|+||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 478888999999999999998 4788999999765432 235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccccc
Q 003978 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (782)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (782)
+++++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++...........
T Consensus 124 ~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 124 LQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp CCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred CCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence 999999999875 35899999999999999999999998 99999999999999999999999999986655443445
Q ss_pred CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-ccCCCCCCCHHHHHHHHHhh
Q 003978 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRWAAIVESCW 742 (782)
Q Consensus 664 ~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~LI~~cL 742 (782)
...||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..... ....+..+++.+.+||.+||
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 66899999999999999999999999999999999999999998877766655533221 22233468899999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 743 HSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 743 ~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
..||.+|||+.++ +.|+||+...
T Consensus 280 ~~dp~~Rps~~el------l~hp~~~~~~ 302 (321)
T 2c30_A 280 VRDPQERATAQEL------LDHPFLLQTG 302 (321)
T ss_dssp CSSTTTSCCHHHH------HTSGGGGGCC
T ss_pred cCChhhCcCHHHH------hcChhhccCC
Confidence 9999999999999 6689997653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=378.67 Aligned_cols=258 Identities=25% Similarity=0.383 Sum_probs=213.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.++|++++.||+|+||.||+|.+. ++.||||++..... ....+.+.+|+.+++.++|||||++++++...+..|+||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 478999999999999999999884 77899999975543 223466889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc--c
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET--Y 659 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~--~ 659 (782)
|||++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..... .
T Consensus 85 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 85 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999999999999754 46899999999999999999999999 999999999999999999999999999754322 1
Q ss_pred ccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccccCCCCCCCHHHHHH
Q 003978 660 LTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~~~~-s~~sDIwSLG~ll~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ..................+++.+.+|
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 22335679999999999988775 77899999999999999999999866543 22222222222223335689999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 738 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 738 I~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
|.+||..||.+|||+.++ ++|+||+...
T Consensus 242 i~~~L~~dP~~R~t~~ei------l~h~~~~~~~ 269 (323)
T 3tki_A 242 LHKILVENPSARITIPDI------KKDRWYNKPL 269 (323)
T ss_dssp HHHHSCSSTTTSCCHHHH------TTCTTTTCCC
T ss_pred HHHHccCChhhCcCHHHH------hhChhhcccc
Confidence 999999999999999999 6789997543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=379.28 Aligned_cols=263 Identities=22% Similarity=0.330 Sum_probs=213.1
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
++|+++++||+|+||.||+|.+. ++.||||++..... ......+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 68999999999999999999984 67899999865432 1112234579999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
||+ ++|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.........
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 996 5999999887778999999999999999999999999 9999999999999999999999999998665444444
Q ss_pred cCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc-----------------
Q 003978 663 KTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL----------------- 724 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------------- 724 (782)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+......+
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 45678999999999987 567999999999999999999999999888776655543211110
Q ss_pred -----------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcCCCC
Q 003978 725 -----------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGDS 777 (782)
Q Consensus 725 -----------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~~~~ 777 (782)
...+.+++++.+||.+||..||.+|||+.++ |+|+||+.........
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~------l~hp~f~~~~~~~~~~ 295 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA------MKHPFFLSLGERIHKL 295 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHH------TTSGGGGGGCSTTSSS
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHH------hcChhhhhcccccccC
Confidence 1123578999999999999999999999999 6789998776655443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=384.11 Aligned_cols=259 Identities=21% Similarity=0.377 Sum_probs=223.1
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
...++|++++.||+|+||.||+|.+. ++.||+|++.... ......+.+|+.+|+.++|||||++++++.....+|+
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence 34578999999999999999999984 6779999987543 2334578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC--CCcEEEEecCCCccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK--HWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~--~~~vkL~DFGla~~~~~ 657 (782)
|||||.+++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+. .+.+||+|||+++....
T Consensus 126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999999999876667999999999999999999999999 999999999999974 57899999999986544
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--ccCCCCCCCHHHH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ--RLEIPKDVDPRWA 735 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~~~~l~ 735 (782)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..... .......+++++.
T Consensus 204 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 204 DEI-VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp TSC-EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred Ccc-eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 322 2234789999999999999999999999999999999999999998887776666543322 2233457899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
+||.+||..||.+|||+.++ |.|+||+...
T Consensus 283 ~li~~~L~~dP~~Rpt~~el------l~hp~~~~~~ 312 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDA------LEHPWLKGDH 312 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHH------HTSTTTSSCC
T ss_pred HHHHHHcCCChhHCcCHHHH------hhCccccCCc
Confidence 99999999999999999999 5678887543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=379.08 Aligned_cols=256 Identities=27% Similarity=0.410 Sum_probs=204.6
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
...++|++++.||+|+||.||++.+ .++.||||++....... ..+.+|+.+++.++|||||++++++.....+|+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 3456899999999999999999998 47789999997654333 457789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc--EEEEecCCCccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT--VKVGDFGLSRLKHE 657 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~--vkL~DFGla~~~~~ 657 (782)
|||||.+++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||||+.++. +||+|||+++....
T Consensus 94 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 94 IMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999999997643 6999999999999999999999999 999999999999987765 99999999974332
Q ss_pred ccccccCCCCCCcccCcccccCCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhccccccCCCCCCCH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEK-SDVYSFGVILWELATEKIPWDNLNS----MQVIGAVGFMNQRLEIPKDVDP 732 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~-sDIwSLG~ll~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~p~~~~~ 732 (782)
.. ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||..... ......+............+++
T Consensus 171 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (361)
T 3uc3_A 171 HS-QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred cC-CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence 22 2234579999999999988887655 8999999999999999999986543 2333333222223333346899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 733 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 733 ~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
++.+||.+||..||.+|||+.++ +.|+||+..
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~el------l~hp~f~~~ 281 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEI------KTHSWFLKN 281 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHH------HTSHHHHTT
T ss_pred HHHHHHHHHccCChhHCcCHHHH------HhCcchhcC
Confidence 99999999999999999999999 678999554
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=364.75 Aligned_cols=262 Identities=31% Similarity=0.501 Sum_probs=220.6
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec---
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--- 573 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--- 573 (782)
........|++.+.||+|+||.||+|.+. +..||+|++..........+.+.+|+.+++.++||||+++++++..
T Consensus 20 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (290)
T 1t4h_A 20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp EECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred hcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence 33445567999999999999999999984 5679999998877777778899999999999999999999998864
Q ss_pred -CCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCcEEEEecCC
Q 003978 574 -PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGL 651 (782)
Q Consensus 574 -~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~-~~~~vkL~DFGl 651 (782)
...+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+++.+|+|+||||+||||+ .++.+||+|||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 100 GKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred CCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 35589999999999999999764 468999999999999999999999776699999999999997 789999999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccccCCCCCC
Q 003978 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFMNQRLEIPKDV 730 (782)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~ 730 (782)
+....... .....||+.|+|||++.+. ++.++|||||||++|+|++|..||...... .....+........++..+
T Consensus 179 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (290)
T 1t4h_A 179 ATLKRASF--AKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 255 (290)
T ss_dssp GGGCCTTS--BEESCSSCCCCCGGGGGTC-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCC
T ss_pred cccccccc--cccccCCcCcCCHHHHhcc-CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCC
Confidence 97554432 2345789999999998754 889999999999999999999999875544 3333443333344556678
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 731 DPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 731 ~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
++++.+||.+||..||.+|||+.++ +.|+||+..
T Consensus 256 ~~~l~~li~~~l~~dp~~Rps~~el------l~h~~f~~~ 289 (290)
T 1t4h_A 256 IPEVKEIIEGCIRQNKDERYSIKDL------LNHAFFQEE 289 (290)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHH------HTSGGGC--
T ss_pred CHHHHHHHHHHccCChhhCCCHHHH------hhCcccccC
Confidence 8999999999999999999999999 678999753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=370.74 Aligned_cols=268 Identities=29% Similarity=0.510 Sum_probs=226.1
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEee
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMG 569 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 569 (782)
..++...++|++++.||+|+||.||+|.+. ++.||||+++... .......+.+|+.+++.+ +||||+++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 456677889999999999999999999863 3569999997543 445567889999999999 6999999999
Q ss_pred eeecCC-ceeEEEeecCCCCHHHHHhhcCCc---------------chHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 003978 570 AVTSPQ-RLCIVTEFLPRGSLFRLLQRNTTK---------------LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (782)
Q Consensus 570 ~~~~~~-~~~lv~E~~~ggsL~~~l~~~~~~---------------l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp 633 (782)
++...+ .+|+|||||++++|.+++...... +++..++.++.||+.||.|||+++ |+||||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp 176 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 176 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCcc
Confidence 987654 589999999999999999765432 899999999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 003978 634 SNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (782)
Q Consensus 634 ~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~ 710 (782)
+||||+.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 99999999999999999997654322 22233457889999999999999999999999999999998 9999987765
Q ss_pred HHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003978 711 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 711 ~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~ 768 (782)
................+..+++++.++|.+||..||.+|||+.+++++|+++.+...+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 314 (316)
T 2xir_A 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314 (316)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred hHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcc
Confidence 4433333333445667788999999999999999999999999999999999876543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=376.11 Aligned_cols=260 Identities=30% Similarity=0.443 Sum_probs=210.5
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc--
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR-- 576 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-- 576 (782)
++....++|+++++||+|+||.||+|.+.++.||||++.... .......+|+.+++.++|||||++++++.....
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred ccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 344566799999999999999999999999999999996543 233455668999999999999999999987543
Q ss_pred --eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcC----------CCCeeecCCCCCcEEEcCCCcE
Q 003978 577 --LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC----------NPPIIHRDLKSSNLLVDKHWTV 644 (782)
Q Consensus 577 --~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~----------~~~ivHrDIKp~NILl~~~~~v 644 (782)
+|+|||||++++|.+++... .+++..++.++.||+.||.|||+. + |+||||||+||||+.++.+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTTCCE
T ss_pred ceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCCCeE
Confidence 69999999999999999764 489999999999999999999998 8 9999999999999999999
Q ss_pred EEEecCCCcccccccc--cccCCCCCCcccCcccccCC-----CCCchhHHHHHHHHHHHHHcCCCCCCCCCh-------
Q 003978 645 KVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNE-----PSDEKSDVYSFGVILWELATEKIPWDNLNS------- 710 (782)
Q Consensus 645 kL~DFGla~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~-----~~s~~sDIwSLG~ll~elltG~~Pf~~~~~------- 710 (782)
||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.....
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 9999999976543322 23345799999999999874 345688999999999999999999965321
Q ss_pred ---------HHHHHHhhccccccCCCC-----CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 711 ---------MQVIGAVGFMNQRLEIPK-----DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 711 ---------~~~~~~i~~~~~~~~~p~-----~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
......+......+.++. ..+.++.+||.+||..||.+|||+.++++.|++|+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 112222221222222222 1235699999999999999999999999999998753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=375.80 Aligned_cols=267 Identities=27% Similarity=0.355 Sum_probs=219.8
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC---CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY---SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
....++|++++.||+|+||.||+|.+ .+..||||++..... .......+.+|+++++.++|||||++++++...+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 34567999999999999999999988 456799999976432 3345678899999999999999999999999999
Q ss_pred ceeEEEeecCCCCHHHHHhhc---------------------------------------CCcchHHHHHHHHHHHHHHH
Q 003978 576 RLCIVTEFLPRGSLFRLLQRN---------------------------------------TTKLDWRRRILMALDIARGV 616 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~qll~aL 616 (782)
.+|+|||||++++|.+++... ...+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999998521 22357888899999999999
Q ss_pred HhhhcCCCCeeecCCCCCcEEEcCCC--cEEEEecCCCccccccc----ccccCCCCCCcccCcccccC--CCCCchhHH
Q 003978 617 SYLHHCNPPIIHRDLKSSNLLVDKHW--TVKVGDFGLSRLKHETY----LTTKTGKGTPQWMAPEVLRN--EPSDEKSDV 688 (782)
Q Consensus 617 ~~LH~~~~~ivHrDIKp~NILl~~~~--~vkL~DFGla~~~~~~~----~~~~~~~Gt~~y~aPE~l~~--~~~s~~sDI 688 (782)
.|||+++ |+||||||+||||+.++ .+||+|||++....... .......||+.|+|||++.+ ..++.++||
T Consensus 182 ~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 182 HYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 9999998 99999999999998766 89999999997543321 12335579999999999975 678899999
Q ss_pred HHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC--CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 689 YSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP--KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 689 wSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
|||||++|+|++|..||...........+.........+ ..+++++.+||.+||..||.+||++.++ |+|+|
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~------l~hp~ 333 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA------LQHPW 333 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH------HHSHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHH------hcChh
Confidence 999999999999999999988877766664333222222 3489999999999999999999999999 67899
Q ss_pred hhcccCcCC
Q 003978 767 FQASRSTVG 775 (782)
Q Consensus 767 ~~~~~~~~~ 775 (782)
|+.....+.
T Consensus 334 ~~~~~~~~~ 342 (345)
T 3hko_A 334 ISQFSDKIY 342 (345)
T ss_dssp HHTTSSCSS
T ss_pred hccChHhhE
Confidence 988765543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=364.35 Aligned_cols=259 Identities=27% Similarity=0.423 Sum_probs=228.0
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
...++|++++.||+|+||.||++.+. ++.||+|++..... .......+.+|+.+++.++||||+++++++...+.+|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 44578999999999999999999985 66799999977654 4456678899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++......
T Consensus 92 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 999999999999998764 36899999999999999999999998 999999999999999999999999999866544
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 738 (782)
........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. .....++..+++.+.+||
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li 246 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASLI 246 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHH
T ss_pred ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hccCCCccccCHHHHHHH
Confidence 334445679999999999999989999999999999999999999999887766655543 334567788999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 739 ~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
.+||..||.+|||+.++ +.|+||+...
T Consensus 247 ~~~l~~~p~~Rps~~~l------l~~~~~~~~~ 273 (294)
T 2rku_A 247 QKMLQTDPTARPTINEL------LNDEFFTSGY 273 (294)
T ss_dssp HHHTCSSGGGSCCGGGG------GGSHHHHTSC
T ss_pred HHHcccChhhCcCHHHH------hhChheecCC
Confidence 99999999999999999 6789997654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=368.00 Aligned_cols=271 Identities=30% Similarity=0.483 Sum_probs=220.2
Q ss_pred CCCCccccccccccceeEeeeeccCCcEEEEEEEEcC-----CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeE
Q 003978 492 DLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566 (782)
Q Consensus 492 ~~~~~~~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 566 (782)
++......+.+..++|++++.||+|+||.||+|.+.. ..||||+++...........+.+|+.+++.++||||++
T Consensus 21 el~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 100 (313)
T 3brb_A 21 ELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100 (313)
T ss_dssp ---CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred hhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeee
Confidence 3444455666778899999999999999999998743 36999999877667777788999999999999999999
Q ss_pred EeeeeecCC-----ceeEEEeecCCCCHHHHHhh-----cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 003978 567 FMGAVTSPQ-----RLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNL 636 (782)
Q Consensus 567 l~~~~~~~~-----~~~lv~E~~~ggsL~~~l~~-----~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NI 636 (782)
+++++.... ..|+||||+.+++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 101 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NI 178 (313)
T 3brb_A 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNC 178 (313)
T ss_dssp CCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGE
T ss_pred eeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceE
Confidence 999987654 35999999999999999943 2356899999999999999999999998 99999999999
Q ss_pred EEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 003978 637 LVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQV 713 (782)
Q Consensus 637 Ll~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~ 713 (782)
||+.++.+||+|||++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 179 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 258 (313)
T 3brb_A 179 MLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258 (313)
T ss_dssp EECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence 99999999999999997654322 22233457889999999999999999999999999999999 9999998877666
Q ss_pred HHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 714 IGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 714 ~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
...+. .......+..+++++.+||.+||..||.+|||+.++++.|+++...
T Consensus 259 ~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 259 YDYLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp HHHHH-TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHH-cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 55543 2335567788999999999999999999999999999999998764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=378.61 Aligned_cols=259 Identities=22% Similarity=0.308 Sum_probs=207.2
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
..++|+++++||+|+||.||+|.+ .++.||||+++...........+.+|+.+++.++||||+++++++.....+|+|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 346899999999999999999987 467899999977665555567788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-----CCCcEEEEecCCCccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-----KHWTVKVGDFGLSRLK 655 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~-----~~~~vkL~DFGla~~~ 655 (782)
||||+ ++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+++..
T Consensus 112 ~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 99996 49999997654 5899999999999999999999999 99999999999994 4556999999999866
Q ss_pred ccccccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC---------
Q 003978 656 HETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE--------- 725 (782)
Q Consensus 656 ~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------- 725 (782)
...........||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+......+.
T Consensus 188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 5444444456789999999999874 479999999999999999999999998887766555432111100
Q ss_pred -------------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 726 -------------------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 726 -------------------~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
++..+++++.+||.+||..||.+|||+.++ |+|+||+...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~------l~hp~f~~~~ 326 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA------LEHPYFSHND 326 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHH------HTSGGGSSSC
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHH------hCCcccCCCC
Confidence 011268899999999999999999999999 6789998653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=371.30 Aligned_cols=254 Identities=20% Similarity=0.224 Sum_probs=210.2
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCcee
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 578 (782)
...++|++.++||+|+||.||+|.+. ++.||||++...............|+..+..+ +||||+++++++...+.+|
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 34578999999999999999999984 77899999876655554445555566655555 8999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
+||||| +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++......
T Consensus 134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999999 77999999887778999999999999999999999998 999999999999999999999999998765443
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 738 (782)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+........++..+++++.+||
T Consensus 211 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li 285 (311)
T 3p1a_A 211 G-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVL 285 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHH
T ss_pred C-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHH
Confidence 2 2334579999999999987 689999999999999999999766654322 2223222223345567899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 739 ~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
.+||..||++|||+.++ |.|+||++
T Consensus 286 ~~~L~~dP~~Rpt~~el------l~hp~~~~ 310 (311)
T 3p1a_A 286 VMMLEPDPKLRATAEAL------LALPVLRQ 310 (311)
T ss_dssp HHHSCSSTTTSCCHHHH------HTSGGGSC
T ss_pred HHHcCCChhhCcCHHHH------HhCccccC
Confidence 99999999999999999 67899975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=376.32 Aligned_cols=255 Identities=31% Similarity=0.453 Sum_probs=221.1
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
.+.|++++.||+|+||.||+|.. .++.||||++...... ....+.+.+|+++++.++|||||++++++...+..|+|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 45799999999999999999997 5778999999866443 34567889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
||||. |+|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++......
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 99996 6899988766678999999999999999999999999 999999999999999999999999999765432
Q ss_pred cccCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHH
Q 003978 661 TTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~---~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
....||+.|+|||++. +..++.++|||||||++|+|++|..||...+.......+.........+..++..+.+|
T Consensus 208 --~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 285 (348)
T 1u5q_A 208 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 285 (348)
T ss_dssp --CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred --CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 2457999999999985 56688999999999999999999999998887766655544433444556789999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 738 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 738 I~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
|.+||..||.+|||+.++ +.|+||...+
T Consensus 286 i~~~l~~dP~~Rps~~~l------l~h~~~~~~~ 313 (348)
T 1u5q_A 286 VDSCLQKIPQDRPTSEVL------LKHRFVLRER 313 (348)
T ss_dssp HHHHTCSSGGGSCCHHHH------TTCHHHHSCC
T ss_pred HHHHcccChhhCcCHHHH------hhChhhhccC
Confidence 999999999999999999 5678876544
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=390.81 Aligned_cols=259 Identities=25% Similarity=0.289 Sum_probs=198.4
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec-----CCc
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-----PQR 576 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~ 576 (782)
.++|+++++||+|+||.||+|.+ .++.||||++..........+.+.+|+.+|+.++|||||++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 47899999999999999999987 47789999997765566667889999999999999999999999843 356
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
+|+||||+ +++|.+++... ..+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++...
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 89999999 56999999754 46999999999999999999999999 9999999999999999999999999998654
Q ss_pred ccc---------------------------ccccCCCCCCcccCcccc-cCCCCCchhHHHHHHHHHHHHHc--------
Q 003978 657 ETY---------------------------LTTKTGKGTPQWMAPEVL-RNEPSDEKSDVYSFGVILWELAT-------- 700 (782)
Q Consensus 657 ~~~---------------------------~~~~~~~Gt~~y~aPE~l-~~~~~s~~sDIwSLG~ll~ellt-------- 700 (782)
... ......+||+.|+|||++ .+..++.++|||||||+||||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 221 112345789999999986 56678999999999999999999
Q ss_pred ---CCCCCCCCChH--------------------HHHHHhhcc------------------------c-----cccCCCC
Q 003978 701 ---EKIPWDNLNSM--------------------QVIGAVGFM------------------------N-----QRLEIPK 728 (782)
Q Consensus 701 ---G~~Pf~~~~~~--------------------~~~~~i~~~------------------------~-----~~~~~p~ 728 (782)
|.++|.+.... ..+..+... . ......+
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 66777554311 111111000 0 0011234
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 729 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 729 ~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
.+++++.+||.+||..||.+|||+.++ |.|+||+....
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~------L~Hp~f~~~~~ 405 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINEC------LAHPFFKEVRI 405 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHH------HHSGGGTTTCC
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHH------hcCHhhhhcCC
Confidence 568999999999999999999999999 67999987654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=370.23 Aligned_cols=265 Identities=31% Similarity=0.513 Sum_probs=223.0
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEcCC------eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~------~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 571 (782)
+..++...+|++.+.||+|+||.||+|.+... .||||+++... .......+.+|+.+++.++||||+++++++
T Consensus 37 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 115 (333)
T 1mqb_A 37 FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 115 (333)
T ss_dssp -CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34466778999999999999999999987432 49999987543 455567789999999999999999999999
Q ss_pred ecCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCC
Q 003978 572 TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (782)
Q Consensus 572 ~~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGl 651 (782)
...+.+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCc
Confidence 9999999999999999999999877677999999999999999999999999 99999999999999999999999999
Q ss_pred Ccccccccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCC
Q 003978 652 SRLKHETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIP 727 (782)
Q Consensus 652 a~~~~~~~~---~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p 727 (782)
++....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.. ......+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~-~~~~~~~ 272 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-GFRLPTP 272 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCC
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHC-CCcCCCc
Confidence 986543321 1223456889999999999999999999999999999999 9999998887776665542 2345567
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 728 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 728 ~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
..++..+.+||.+||..||.+||++.++++.|+++....
T Consensus 273 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 273 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 789999999999999999999999999999999887644
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=370.36 Aligned_cols=266 Identities=29% Similarity=0.555 Sum_probs=229.0
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEc---------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEE
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLF 567 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~---------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l 567 (782)
..++...++|++++.||+|+||.||+|.+. +..||||+++... .......+.+|+.+++.+ +||||+++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 345667789999999999999999999863 4569999987543 455567889999999999 89999999
Q ss_pred eeeeecCCceeEEEeecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 003978 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLK 632 (782)
Q Consensus 568 ~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIK 632 (782)
++++...+.+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+|||
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk 184 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLA 184 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCc
Confidence 999999999999999999999999997643 24889999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 003978 633 SSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLN 709 (782)
Q Consensus 633 p~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~ 709 (782)
|+||||+.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 999999999999999999997654432 22334467889999999998889999999999999999999 999999888
Q ss_pred hHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 710 SMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 710 ~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
.......+. .......+..++.++.+||.+||..||.+|||+.++++.|+++.....
T Consensus 265 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 265 VEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 776665543 233456778899999999999999999999999999999999976543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=394.21 Aligned_cols=257 Identities=27% Similarity=0.540 Sum_probs=224.5
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCH-HHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
...++|.+++.||+|+||.||+|.+. ++.||||++....... +....+.+|+.+|+.++||||+++++++.....+|
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45578999999999999999999984 7889999997643211 23467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
+|||||++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++......
T Consensus 93 lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 999999999999999764 46999999999999999999999998 999999999999999999999999999865443
Q ss_pred cccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~-s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+. ......|..+++++.+|
T Consensus 170 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~L 246 (476)
T 2y94_A 170 E-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC--DGIFYTPQYLNPSVISL 246 (476)
T ss_dssp C-CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH--TTCCCCCTTCCHHHHHH
T ss_pred c-cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCcCCCccCCHHHHHH
Confidence 2 2345689999999999998776 689999999999999999999999887777666653 33456677899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 738 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 738 I~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
|.+||..||.+|||+.++ +.|+||+..
T Consensus 247 i~~~L~~dP~~Rpt~~ei------l~hp~~~~~ 273 (476)
T 2y94_A 247 LKHMLQVDPMKRATIKDI------REHEWFKQD 273 (476)
T ss_dssp HHHHTCSSTTTSCCHHHH------HTCHHHHTT
T ss_pred HHHHcCCCchhCcCHHHH------HhCHHhhhc
Confidence 999999999999999999 668999764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=361.83 Aligned_cols=261 Identities=33% Similarity=0.568 Sum_probs=221.5
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEcCC-----eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~-----~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (782)
+.+..++|++.+.||+|+||.||+|.+.+. .||+|++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE- 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-
Confidence 455668999999999999999999987432 39999987643 44556789999999999999999999999875
Q ss_pred CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
+..|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++..
T Consensus 85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 4678999999999999999877777999999999999999999999999 99999999999999999999999999976
Q ss_pred ccccc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCH
Q 003978 655 KHETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 732 (782)
Q Consensus 655 ~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 732 (782)
..... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+. .......+..+++
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 241 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCPP 241 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-HTCCCCCCTTCCH
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-cCCCCCCCCCCCH
Confidence 54432 12234467889999999999999999999999999999998 999998777666555443 2334556778999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 733 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 733 ~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
.+.+||.+||..||.+||++.++++.|+++...
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 242 VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999999999988653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=380.15 Aligned_cols=260 Identities=23% Similarity=0.384 Sum_probs=216.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc-CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC--CCceeEEeeeeecCCceeE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR--HPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~l 579 (782)
...+|++++.||+|+||.||++... ++.||||++............+.+|+.+|+.+. |||||++++++..++.+|+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 3467999999999999999999874 677999999887777777888999999999996 5999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
|||+ .+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||||+ ++.+||+|||+++......
T Consensus 134 v~E~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 134 VMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEC-CSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEec-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9995 5789999998754 6888899999999999999999998 99999999999995 5799999999998654322
Q ss_pred --ccccCCCCCCcccCcccccC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhccccccC
Q 003978 660 --LTTKTGKGTPQWMAPEVLRN-----------EPSDEKSDVYSFGVILWELATEKIPWDNLNS-MQVIGAVGFMNQRLE 725 (782)
Q Consensus 660 --~~~~~~~Gt~~y~aPE~l~~-----------~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~ 725 (782)
......+||+.|+|||++.+ ..++.++|||||||+||+|++|..||..... ...+..+........
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 288 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence 12335579999999999976 3678899999999999999999999987543 334444433344556
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 726 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 726 ~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
++...+.++.+||.+||..||.+|||+.++ |.|+||+.....
T Consensus 289 ~~~~~~~~~~~li~~~L~~dP~~Rps~~el------l~hp~~~~~~~~ 330 (390)
T 2zmd_A 289 FPDIPEKDLQDVLKCCLKRDPKQRISIPEL------LAHPYVQIQTHP 330 (390)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHH------HTSHHHHSCC--
T ss_pred CCccchHHHHHHHHHHcccChhhCCCHHHH------hhCcCccccCcc
Confidence 777789999999999999999999999999 678999765443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=366.45 Aligned_cols=265 Identities=25% Similarity=0.355 Sum_probs=206.6
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
+++..++|++++.||+|+||.||++.+ .++.||||+++...........+.++..+++.++||||+++++++...+..
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 356678999999999999999999998 677899999976654444455566666678888999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHhhhcC-CCCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 578 CIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qll~aL~~LH~~-~~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
|+||||++ ++|.+++.. ....+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+|||++.
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 99999996 488887754 355799999999999999999999997 8 9999999999999999999999999997
Q ss_pred ccccccccccCCCCCCcccCcccc----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhccccccCCCC
Q 003978 654 LKHETYLTTKTGKGTPQWMAPEVL----RNEPSDEKSDVYSFGVILWELATEKIPWDNLN-SMQVIGAVGFMNQRLEIPK 728 (782)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~y~aPE~l----~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~p~ 728 (782)
....... .....||+.|+|||++ .+..++.++|||||||++|+|++|..||.... .................+.
T Consensus 159 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T 3fme_A 159 YLVDDVA-KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred ccccccc-ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence 6544322 2344789999999996 56678899999999999999999999998643 3333333322222333345
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcC
Q 003978 729 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTV 774 (782)
Q Consensus 729 ~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~ 774 (782)
.+++++.+||.+||..||.+|||+.++ ++|+||+...+..
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~------l~hp~f~~~~~~~ 277 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTYPEL------MQHPFFTLHESKG 277 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHH------TTSHHHHHHHHSC
T ss_pred cCCHHHHHHHHHHhhcChhhCcCHHHH------HhCcccccCcccc
Confidence 789999999999999999999999999 6789998765443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=364.57 Aligned_cols=263 Identities=33% Similarity=0.579 Sum_probs=229.1
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
..|++..++|++.+.||+|+||.||+|.+. +..||||++..... ..+.+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST---HHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 466778899999999999999999999985 67799999875432 3467889999999999999999999999999
Q ss_pred ceeEEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
.+|+||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++..
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 999999999999999999763 345899999999999999999999999 99999999999999999999999999986
Q ss_pred cccccc-cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCH
Q 003978 655 KHETYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 732 (782)
Q Consensus 655 ~~~~~~-~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 732 (782)
...... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+. .......+..+++
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 239 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPE 239 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCH
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-ccCCCCCCCCCCH
Confidence 554322 2223356889999999999999999999999999999999 999999888776665553 2335566788999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 733 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 733 ~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
.+.+||.+||..||.+|||+.++++.|+++..+.
T Consensus 240 ~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999886653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=364.70 Aligned_cols=259 Identities=29% Similarity=0.470 Sum_probs=215.4
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE------cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC-
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP- 574 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~------~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~- 574 (782)
...+.|+++++||+|+||.||+|.+ .++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 3346799999999999999999985 46779999987543 222346788999999999999999999999876
Q ss_pred -CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 575 -QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 575 -~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
..+++||||+++++|.+++......+++..++.++.||+.||+|||+++ |+|+||||+||||+.++.+||+|||++.
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECcccccc
Confidence 6689999999999999999777778999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccc---ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--------------hHHHHHH
Q 003978 654 LKHETY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN--------------SMQVIGA 716 (782)
Q Consensus 654 ~~~~~~---~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~--------------~~~~~~~ 716 (782)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 654432 22334568889999999999989999999999999999999998864321 1111112
Q ss_pred hhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003978 717 VGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 763 (782)
Q Consensus 717 i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~ 763 (782)
..........+..+++++.+||.+||..||.+|||+.++++.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 22233455677889999999999999999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=363.03 Aligned_cols=262 Identities=24% Similarity=0.399 Sum_probs=209.8
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
..++|++.+.||+|+||.||+|.. .++.||||++..... .......+.+|+.+++.++||||+++++++...+.+++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 456899999999999999999997 577899999976443 45667788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 580 VTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+||||+.++.+||+|||++....
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999999864 3456899999999999999999999999 9999999999999999999999999987655
Q ss_pred cccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHhhccccccCCCCCCCHHH
Q 003978 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN--SMQVIGAVGFMNQRLEIPKDVDPRW 734 (782)
Q Consensus 657 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~~l 734 (782)
..........|++.|+|||++.+..++.++|||||||++|+|++|..||.... .......+.........+..++.++
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence 44333345578999999999999999999999999999999999999997543 2333333332222333346789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 735 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
.+||.+||..||.+|||+.++++.|++|+...
T Consensus 268 ~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 268 RQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 99999999999999999999999999987654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=382.35 Aligned_cols=259 Identities=21% Similarity=0.314 Sum_probs=207.3
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCC--c
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQ--R 576 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~--~ 576 (782)
...++|+++++||+|+||.||+|.+ .++.||||++............+.+|+.+|+.+. |||||++++++..++ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3457999999999999999999987 4778999999766556666778889999999997 999999999997544 6
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
+|+|||||+ ++|..++... .+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 899999996 5999999763 5889999999999999999999999 9999999999999999999999999997543
Q ss_pred cc---------------------cccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 003978 657 ET---------------------YLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVI 714 (782)
Q Consensus 657 ~~---------------------~~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~ 714 (782)
.. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 21 111234579999999999987 67899999999999999999999999988876655
Q ss_pred HHhhcccccc---------------------------------------------CCCCCCCHHHHHHHHHhhhhCCCCC
Q 003978 715 GAVGFMNQRL---------------------------------------------EIPKDVDPRWAAIVESCWHSDPQCR 749 (782)
Q Consensus 715 ~~i~~~~~~~---------------------------------------------~~p~~~~~~l~~LI~~cL~~dP~~R 749 (782)
..+......+ ..+..+++++.+||.+||..||.+|
T Consensus 241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 5542111100 1123678999999999999999999
Q ss_pred CCHHHHHHHHHHHHHHHhhccc
Q 003978 750 PSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 750 Ps~~ell~~L~~L~~~~~~~~~ 771 (782)
||+.++ |.|+||+...
T Consensus 321 ~t~~e~------l~Hp~~~~~~ 336 (388)
T 3oz6_A 321 ISANDA------LKHPFVSIFH 336 (388)
T ss_dssp CCHHHH------TTSTTTTTTC
T ss_pred CCHHHH------hCCHHHHHhc
Confidence 999999 6789986543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=376.27 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=214.1
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-----CCceeEEeeeee
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-----HPNVLLFMGAVT 572 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~~~~~ 572 (782)
.....++|+++++||+|+||.||+|.+ .++.||||+++. .......+..|+.+++.+. |||||++++++.
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 345678999999999999999999998 577899999864 2344567788999999996 999999999999
Q ss_pred cCCceeEEEeecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-----------
Q 003978 573 SPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK----------- 640 (782)
Q Consensus 573 ~~~~~~lv~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~----------- 640 (782)
..+.+|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~ 183 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVR 183 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchh
Confidence 999999999999 889999997653 35899999999999999999999999 999999999999975
Q ss_pred --------------CCcEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 003978 641 --------------HWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 706 (782)
Q Consensus 641 --------------~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~ 706 (782)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp CTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 789999999999764432 235578999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHhhcccccc------------------------CCC--------------------CCCCHHHHHHHHHhh
Q 003978 707 NLNSMQVIGAVGFMNQRL------------------------EIP--------------------KDVDPRWAAIVESCW 742 (782)
Q Consensus 707 ~~~~~~~~~~i~~~~~~~------------------------~~p--------------------~~~~~~l~~LI~~cL 742 (782)
..+.......+....... ..| ...++.+.+||.+||
T Consensus 261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 340 (360)
T 3llt_A 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL 340 (360)
T ss_dssp CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence 887766555442211110 011 112477889999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003978 743 HSDPQCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 743 ~~dP~~RPs~~ell~~L~~L~~~~~~ 768 (782)
..||.+|||+.++ |+|+|||
T Consensus 341 ~~dP~~Rpta~el------L~hp~f~ 360 (360)
T 3llt_A 341 QIDPTLRPSPAEL------LKHKFLE 360 (360)
T ss_dssp CSSGGGSCCHHHH------TTSGGGC
T ss_pred cCChhhCCCHHHH------hcCcccC
Confidence 9999999999999 6788885
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=377.19 Aligned_cols=255 Identities=27% Similarity=0.380 Sum_probs=212.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC------
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------ 575 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 575 (782)
.++|++++.||+|+||.||+|.+ .++.||||++..........+.+.+|+++|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 47899999999999999999997 4778999999776556666788999999999999999999999997653
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
.+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 469999999 8899999976 35899999999999999999999999 999999999999999999999999999865
Q ss_pred ccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc------------
Q 003978 656 HETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------ 722 (782)
Q Consensus 656 ~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~------------ 722 (782)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+.....
T Consensus 179 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 179 DSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp CSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred ccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 432 234578999999999987 6789999999999999999999999998877655544321110
Q ss_pred -----------------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 723 -----------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 723 -----------------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
...+...+++.+.+||.+||..||.+|||+.++ |.|+||+....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~------l~hp~f~~~~~ 316 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA------LAHPYFESLHD 316 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH------HHSGGGTTTC-
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHH------hcChHHHhhcC
Confidence 112345679999999999999999999999999 67899987544
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=371.43 Aligned_cols=267 Identities=26% Similarity=0.485 Sum_probs=227.6
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEcC-------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeee
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 570 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 570 (782)
.++...++|++.+.||+|+||.||+|.+.+ ..||+|++.... .......+.+|+.+++.+ +||||++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 466777899999999999999999999743 369999987543 345567889999999999 89999999999
Q ss_pred eecCCceeEEEeecCCCCHHHHHhhc-------------CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 003978 571 VTSPQRLCIVTEFLPRGSLFRLLQRN-------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLL 637 (782)
Q Consensus 571 ~~~~~~~~lv~E~~~ggsL~~~l~~~-------------~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NIL 637 (782)
+...+.+|+|||||++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl 196 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVL 196 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEE
Confidence 99999999999999999999999653 235789999999999999999999998 999999999999
Q ss_pred EcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 003978 638 VDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVI 714 (782)
Q Consensus 638 l~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~ 714 (782)
|+.++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 9999999999999997554322 12233457889999999999999999999999999999998 99999877655544
Q ss_pred HHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003978 715 GAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 715 ~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~ 768 (782)
..+.........+..+++.+.+||.+||..||.+|||+.++++.|+++..+.-+
T Consensus 277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 330 (333)
T 2i1m_A 277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR 330 (333)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhc
Confidence 444434445566778899999999999999999999999999999998776533
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=362.82 Aligned_cols=258 Identities=32% Similarity=0.605 Sum_probs=216.7
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec-CCce
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQRL 577 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~ 577 (782)
.+.+..++|++.+.||+|+||.||++.+.++.||||+++... ..+.+.+|+.+++.++||||+++++++.. .+.+
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence 455667899999999999999999999999999999987543 34678899999999999999999998654 4578
Q ss_pred eEEEeecCCCCHHHHHhhcCC-cchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
|+||||+++++|.+++..... .+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 999999999999999976432 3788999999999999999999999 9999999999999999999999999987554
Q ss_pred cccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHH
Q 003978 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735 (782)
Q Consensus 657 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 735 (782)
... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+. .......+..+++.+.
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 244 (278)
T 1byg_A 169 STQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVY 244 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHH
T ss_pred ccc---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCcccCCHHHH
Confidence 332 23467899999999999999999999999999999998 999999887766655553 2334567788999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
+||.+||..||.+|||+.++++.|++++...
T Consensus 245 ~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 245 EVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 9999999999999999999999999987653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=363.23 Aligned_cols=259 Identities=27% Similarity=0.473 Sum_probs=224.2
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCH-HHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
...++|++.+.||+|+||.||+|.+. +..||||++....... .....+.+|+.+++.++||||+++++++...+.+|
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 44578999999999999999999985 5579999987543211 12357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
+||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999999999997654 6899999999999999999999998 999999999999999999999999998655432
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 738 (782)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+. .....++..++.++++||
T Consensus 168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li 243 (284)
T 2vgo_A 168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDLKFPPFLSDGSKDLI 243 (284)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHH
T ss_pred --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh--ccccCCCCcCCHHHHHHH
Confidence 2235578999999999999999999999999999999999999999887776655553 334567788999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 739 ~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
.+||..||.+||++.++ +.|+||+.....
T Consensus 244 ~~~l~~~p~~Rps~~~l------l~h~~~~~~~~~ 272 (284)
T 2vgo_A 244 SKLLRYHPPQRLPLKGV------MEHPWVKANSRR 272 (284)
T ss_dssp HHHSCSSGGGSCCHHHH------HTCHHHHHHCCC
T ss_pred HHHhhcCHhhCCCHHHH------hhCHHHHhhccc
Confidence 99999999999999999 668999765543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=362.19 Aligned_cols=259 Identities=18% Similarity=0.279 Sum_probs=218.8
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCce
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 577 (782)
....++|++.+.||+|+||.||+|.+ .++.||||++...... ..+.+|+.+++.+ +|+||+++++++......
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 34567899999999999999999996 5778999998754432 3467799999999 799999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc-----EEEEecCCC
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-----VKVGDFGLS 652 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~-----vkL~DFGla 652 (782)
|+||||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++. +||+|||++
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 9999999 99999999877767999999999999999999999998 999999999999987765 999999999
Q ss_pred cccccccc-------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHhhcc--
Q 003978 653 RLKHETYL-------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN---SMQVIGAVGFM-- 720 (782)
Q Consensus 653 ~~~~~~~~-------~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~---~~~~~~~i~~~-- 720 (782)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 86544321 2345579999999999999999999999999999999999999998753 33333332211
Q ss_pred -ccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 721 -NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 721 -~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
.....+...+++++.+||.+||..||.+||++.+|++.|+++....
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 1122344578999999999999999999999999999999887654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=363.36 Aligned_cols=257 Identities=22% Similarity=0.401 Sum_probs=212.5
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
..++|.+.++||+|+||.||++... +..||+|++...... .....+.+|+++++.++||||+++++++.....+|+|
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 3468999999999999999999984 678999999765432 2246788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhc---CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCcEEEEecCCCcc
Q 003978 581 TEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRL 654 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl---~~~~~vkL~DFGla~~ 654 (782)
||||++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||++..
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 9999999999998542 356899999999999999999999999 9999999999999 4567899999999976
Q ss_pred cccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC-CCCCCCHH
Q 003978 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE-IPKDVDPR 733 (782)
Q Consensus 655 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-~p~~~~~~ 733 (782)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+........ ....++++
T Consensus 177 ~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (285)
T 3is5_A 177 FKSDE-HSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQ 254 (285)
T ss_dssp -----------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHH
T ss_pred cCCcc-cCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHH
Confidence 54432 2335578999999999864 578999999999999999999999998887776655543332222 22347899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
+.+||.+||..||.+|||+.++ |.|+||+.+
T Consensus 255 ~~~li~~~L~~dP~~Rps~~e~------l~hp~f~~a 285 (285)
T 3is5_A 255 AVDLLKQMLTKDPERRPSAAQV------LHHEWFKQA 285 (285)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHH------HTSGGGGC-
T ss_pred HHHHHHHHccCChhhCcCHHHH------hcCHHhhcC
Confidence 9999999999999999999999 678999863
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=373.60 Aligned_cols=260 Identities=25% Similarity=0.349 Sum_probs=216.1
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
...++|++++.||+|+||.||+|.+. ++.||||++............+.+|+.+++.++||||+++++++...+.+|+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 34579999999999999999999985 7789999998777667777788899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+|+||||+||||+.++.+||+|||+++......
T Consensus 102 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 102 VFEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EEECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999998888887654 346899999999999999999999999 9999999999999999999999999998665544
Q ss_pred ccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc---------------
Q 003978 660 LTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--------------- 723 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------- 723 (782)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+......
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 444556799999999999875 6799999999999999999999999988776655443211000
Q ss_pred --c------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 724 --L------------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 724 --~------------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
. ...+.+++.+.+||.+||..||.+|||+.++ |+|+||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el------l~hp~f~~~ 313 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL------LHHDFFQMD 313 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGG------GGSHHHHGG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHH------hcCchhccC
Confidence 0 0113578999999999999999999999999 668999754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=361.79 Aligned_cols=262 Identities=26% Similarity=0.473 Sum_probs=221.4
Q ss_pred cccccceeEee-eeccCCcEEEEEEEEc----CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 501 EILWEDLTIGE-QIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 501 e~~~~~y~i~~-~IG~G~~G~Vy~~~~~----~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
....++|++.+ .||+|+||.||+|.+. +..||||+++.........+.+.+|+.+++.++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 34557899998 9999999999999653 45699999987655556678899999999999999999999999 567
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
.+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+||||+.++.+||+|||++...
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 789999999999999999764 46899999999999999999999999 999999999999999999999999999765
Q ss_pred ccccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCC
Q 003978 656 HETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 731 (782)
Q Consensus 656 ~~~~~---~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 731 (782)
..... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+. .......+..++
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 246 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCP 246 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCC
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 43321 1223456789999999998888999999999999999999 999999988877665554 334566778899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 732 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 732 ~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
+++.+||.+||..||.+||++.++++.|+++...--
T Consensus 247 ~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 247 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999998866543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=358.51 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=219.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
..++|++.++||+|+||.||++.+. +..||+|++....... ...+.+|+++++.++||||+++++++.....+|+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 3468999999999999999999985 4579999987654322 45788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCcEEEEecCCCccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl---~~~~~vkL~DFGla~~~~~ 657 (782)
|||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||+ +.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 85 MELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred EeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999999999999764 45899999999999999999999999 9999999999999 7888999999999976544
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC----CCCCHH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP----KDVDPR 733 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p----~~~~~~ 733 (782)
.. ......||+.|+|||++.+. ++.++|||||||++|+|++|..||...........+... ...++ ..+++.
T Consensus 162 ~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 237 (277)
T 3f3z_A 162 GK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG--TFTFPEKDWLNVSPQ 237 (277)
T ss_dssp TS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCHHHHTTSCHH
T ss_pred cc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCchhhhcCCHH
Confidence 32 33355799999999998775 889999999999999999999999988877766665332 22223 268999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
+.+||.+||..||.+|||+.++ |+|+||+....
T Consensus 238 ~~~li~~~l~~dp~~R~s~~~~------l~h~~~~~~~~ 270 (277)
T 3f3z_A 238 AESLIRRLLTKSPKQRITSLQA------LEHEWFEKQLS 270 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHH------TTSHHHHHHHC
T ss_pred HHHHHHHHccCChhhCcCHHHH------hcCHHHhcccc
Confidence 9999999999999999999999 67899977544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=358.36 Aligned_cols=262 Identities=32% Similarity=0.562 Sum_probs=224.7
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEcC-CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
.|++..++|++++.||+|+||.||+|.+.+ ..||||++...... ...+.+|+++++.++||||+++++++. .+..
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 82 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPI 82 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCc
Confidence 467778899999999999999999999865 47999999765543 356888999999999999999999987 4568
Q ss_pred eEEEeecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++....
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 99999999999999996532 25899999999999999999999999 9999999999999999999999999998655
Q ss_pred cccc-cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHH
Q 003978 657 ETYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734 (782)
Q Consensus 657 ~~~~-~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 734 (782)
.... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+.. ......+..++.++
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 239 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPDNCPEEL 239 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHH
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc-ccCCCCcccccHHH
Confidence 4322 2234457889999999998889999999999999999999 9999998887776665532 23455677899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 735 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
.+||.+||..||++|||+.++++.|+++.....
T Consensus 240 ~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 999999999999999999999999988866543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=371.95 Aligned_cols=256 Identities=18% Similarity=0.269 Sum_probs=214.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCceeE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 579 (782)
..++|++++.||+|+||.||+|.+ .++.||||++...... ..+.+|+.+++.+ +||||+++++++......|+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 457899999999999999999996 5778999998765432 3577899999999 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc-----EEEEecCCCcc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-----VKVGDFGLSRL 654 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~-----vkL~DFGla~~ 654 (782)
||||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++. +||+|||+++.
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99999 99999999876678999999999999999999999998 999999999999998887 99999999986
Q ss_pred cccccc-------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH---HHHHHhhccccc-
Q 003978 655 KHETYL-------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM---QVIGAVGFMNQR- 723 (782)
Q Consensus 655 ~~~~~~-------~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~---~~~~~i~~~~~~- 723 (782)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..+..+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 543221 124567999999999999999999999999999999999999999875432 223332111111
Q ss_pred --cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 724 --LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 724 --~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
..+...+| ++.+||.+||..||.+||++.+|++.|+++....
T Consensus 240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 11123355 9999999999999999999999999999886653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=380.43 Aligned_cols=253 Identities=24% Similarity=0.372 Sum_probs=201.2
Q ss_pred ccccceeEe-eeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHH-HhCCCCceeEEeeeeec----
Q 003978 502 ILWEDLTIG-EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLM-KRLRHPNVLLFMGAVTS---- 573 (782)
Q Consensus 502 ~~~~~y~i~-~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~---- 573 (782)
...++|.+. ++||+|+||.||++.+. ++.||||++... ..+.+|+.++ +..+||||+++++++..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 345678877 78999999999999984 678999998642 3456788877 45589999999999865
Q ss_pred CCceeEEEeecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCcEEEEec
Q 003978 574 PQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDF 649 (782)
Q Consensus 574 ~~~~~lv~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~---~~~vkL~DF 649 (782)
...+|||||||+||+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+. ++.+||+||
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEec
Confidence 567899999999999999997643 45899999999999999999999999 999999999999987 789999999
Q ss_pred CCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH----HHHHhhcccccc-
Q 003978 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ----VIGAVGFMNQRL- 724 (782)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~----~~~~i~~~~~~~- 724 (782)
|+++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+.......
T Consensus 209 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~ 287 (400)
T 1nxk_A 209 GFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 287 (400)
T ss_dssp TTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred ccccccCCCC-ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence 9998654322 2335678999999999999999999999999999999999999997654321 122222111111
Q ss_pred -CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 725 -EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 725 -~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
.....++.++.+||.+||..||.+|||+.++ +.|+||+..
T Consensus 288 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ei------l~hp~~~~~ 328 (400)
T 1nxk_A 288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF------MNHPWIMQS 328 (400)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH------HHSHHHHTT
T ss_pred CcccccCCHHHHHHHHHHCCCChhHCcCHHHH------hcCccccCC
Confidence 1225689999999999999999999999999 678998754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=368.81 Aligned_cols=259 Identities=23% Similarity=0.350 Sum_probs=221.7
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCH----HHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
...++|++++.||+|+||.||+|.+. ++.||||++....... .....+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 34578999999999999999999984 7789999997654321 12467889999999999999999999999999
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----cEEEEecCC
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFGL 651 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~----~vkL~DFGl 651 (782)
.+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++ .+||+|||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 999999999999999999764 46899999999999999999999998 99999999999999887 799999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--cCCCCC
Q 003978 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--LEIPKD 729 (782)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~ 729 (782)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...... ..++..
T Consensus 166 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (321)
T 2a2a_A 166 AHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244 (321)
T ss_dssp CEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred ceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcc
Confidence 97655432 223457999999999999999999999999999999999999999988877766665432221 122357
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 730 ~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
++..+.+||.+||..||.+|||+.++ +.|+||+..
T Consensus 245 ~~~~~~~li~~~l~~dp~~Rps~~e~------l~hp~~~~~ 279 (321)
T 2a2a_A 245 TSELAKDFIRKLLVKETRKRLTIQEA------LRHPWITPV 279 (321)
T ss_dssp CCHHHHHHHHTTSCSSTTTSCCHHHH------HHSTTTSCS
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHH------hcCccccCC
Confidence 89999999999999999999999999 567887543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=392.41 Aligned_cols=261 Identities=28% Similarity=0.452 Sum_probs=221.8
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
...++|+++++||+|+||.||+|.+. ++.||||++.+..........+.+|+.+|+.++|||||++++++.....+|+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 34578999999999999999999984 7789999997543322234678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc---CCCcEEEEecCCCcccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~---~~~~vkL~DFGla~~~~ 656 (782)
|||||.+++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+ .++.+||+|||+++...
T Consensus 99 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 99999999999998765 46899999999999999999999999 99999999999995 45679999999997654
Q ss_pred cccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC--CCCCHHH
Q 003978 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP--KDVDPRW 734 (782)
Q Consensus 657 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l 734 (782)
... .....+||+.|+|||++.+. ++.++|||||||++|+|++|..||...+.......+.........+ ..+++++
T Consensus 176 ~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 253 (486)
T 3mwu_A 176 QNT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253 (486)
T ss_dssp CC-----CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHH
T ss_pred CCC-ccCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHH
Confidence 432 23355799999999999874 8899999999999999999999999988888777765443333322 4689999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 735 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
++||.+||..||.+|||+.++ |.|+||+.....
T Consensus 254 ~~li~~~L~~dp~~R~t~~~~------l~hp~~~~~~~~ 286 (486)
T 3mwu_A 254 KDLIRKMLTFHPSLRITATQC------LEHPWIQKYSSE 286 (486)
T ss_dssp HHHHHHHTCSSTTTSCCHHHH------HHCHHHHHTCCC
T ss_pred HHHHHHHcCCChhhCcCHHHH------hcCHhhccCccc
Confidence 999999999999999999999 678999876543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=392.58 Aligned_cols=263 Identities=27% Similarity=0.433 Sum_probs=221.3
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCH-----------HHHHHHHHHHHHHHhCCCCceeEEe
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-----------EVIHSFRQEVSLMKRLRHPNVLLFM 568 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~-----------~~~~~~~~Ei~il~~l~HpnIv~l~ 568 (782)
...++|+++++||+|+||.||+|.+. +..||||++....... ...+.+.+|+.+|+.++|||||+++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35678999999999999999999984 5679999997654321 2346788999999999999999999
Q ss_pred eeeecCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---cEE
Q 003978 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVK 645 (782)
Q Consensus 569 ~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~---~vk 645 (782)
+++.....+|+|||||++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++ .+|
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEE
Confidence 9999999999999999999999999764 46999999999999999999999999 99999999999998775 699
Q ss_pred EEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC
Q 003978 646 VGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE 725 (782)
Q Consensus 646 L~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~ 725 (782)
|+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+.......+........
T Consensus 190 l~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 267 (504)
T 3q5i_A 190 IVDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267 (504)
T ss_dssp ECCCTTCEECCTTS-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred EEECCCCEEcCCCC-ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99999998665432 2335679999999999875 588999999999999999999999999888887777654332222
Q ss_pred --CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcCC
Q 003978 726 --IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVG 775 (782)
Q Consensus 726 --~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~~ 775 (782)
....+++++++||.+||..||.+|||+.++ |.|+||+.......
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~------l~h~~~~~~~~~~~ 313 (504)
T 3q5i_A 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEA------LNSRWIKKYANNIN 313 (504)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH------HTSHHHHHTCCCCC
T ss_pred ccccCCCCHHHHHHHHHHcCCChhHCCCHHHH------hcCHhhhhchhccc
Confidence 225789999999999999999999999999 67899987665543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=367.79 Aligned_cols=260 Identities=28% Similarity=0.433 Sum_probs=212.9
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeec----
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS---- 573 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~---- 573 (782)
....++|++++.||+|+||.||+|.+ .++.||||++...... ...+.+|+.+++.+ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 34567899999999999999999998 6778999999765433 25677899999999 79999999999976
Q ss_pred --CCceeEEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecC
Q 003978 574 --PQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650 (782)
Q Consensus 574 --~~~~~lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFG 650 (782)
...+|+||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+||||+.++.+||+|||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEEEeeCc
Confidence 46789999999999999999764 346899999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC
Q 003978 651 LSRLKHETYLTTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE 725 (782)
Q Consensus 651 la~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~ 725 (782)
++..............||+.|+|||++. +..++.++|||||||++|+|++|..||...........+........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 254 (326)
T 2x7f_A 175 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 254 (326)
T ss_dssp TTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred CceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccC
Confidence 9986654433344557999999999997 56678999999999999999999999998887766555543333334
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 726 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 726 ~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
.+..++..+.+||.+||..||.+||++.++ +.|+||+...
T Consensus 255 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l------l~hp~~~~~~ 294 (326)
T 2x7f_A 255 KSKKWSKKFQSFIESCLVKNHSQRPATEQL------MKHPFIRDQP 294 (326)
T ss_dssp SCSCSCHHHHHHHHHHCCSSGGGSCCHHHH------HTSHHHHCCT
T ss_pred CccccCHHHHHHHHHHhccChhhCCCHHHH------hhChHHhhCc
Confidence 456789999999999999999999999999 5678887654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=363.92 Aligned_cols=263 Identities=25% Similarity=0.408 Sum_probs=221.2
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeee--cCCceeE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT--SPQRLCI 579 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~l 579 (782)
.++|++++.||+|+||.||++.+ .++.||+|++..........+.+.+|+.+++.++||||+++++++. ....+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46899999999999999999998 4678999999887777777788999999999999999999999874 4678999
Q ss_pred EEeecCCCCHHHHHhhc---CCcchHHHHHHHHHHHHHHHHhhhcCC---CCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 580 VTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCN---PPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qll~aL~~LH~~~---~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ .+|+|+||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999653 234899999999999999999999876 339999999999999999999999999987
Q ss_pred ccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHH
Q 003978 654 LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733 (782)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 733 (782)
.............||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.. .....++..++.+
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~ 243 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSDE 243 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-TCCCCCCTTSCHH
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh-cccccCCcccCHH
Confidence 654432222334689999999999999999999999999999999999999998887766655532 2334667789999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
+.+||.+||..||.+||++.++ +.+.|+.+....
T Consensus 244 l~~li~~~l~~~p~~Rps~~~l------l~~~~~~~~~~~ 277 (279)
T 2w5a_A 244 LNEIITRMLNLKDYHRPSVEEI------LENPLILEHHHH 277 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHH------HTSTTCCGGGSC
T ss_pred HHHHHHHHcCCCcccCCCHHHH------HhChhhhhhccc
Confidence 9999999999999999999999 456666655443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=370.47 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=206.5
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce-
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL- 577 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~- 577 (782)
...++|++.+.||+|+||.||++.+ .++.||||+++.... .......+.+|+.+++.++||||+++++++......
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 4557899999999999999999997 567899999987544 445667889999999999999999999998766544
Q ss_pred ---eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 578 ---CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 578 ---~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
|+|||||++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 99999999999999997643 6899999999999999999999999 99999999999999999999999999976
Q ss_pred ccccc---ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--ccCCCCC
Q 003978 655 KHETY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ--RLEIPKD 729 (782)
Q Consensus 655 ~~~~~---~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~ 729 (782)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||................. .......
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence 54322 122345689999999999999999999999999999999999999998887665544432221 1123356
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHH
Q 003978 730 VDPRWAAIVESCWHSDPQCRPSFQEL 755 (782)
Q Consensus 730 ~~~~l~~LI~~cL~~dP~~RPs~~el 755 (782)
+++++.+||.+||..||.+||+..++
T Consensus 246 ~~~~l~~li~~~l~~dP~~R~~~~~~ 271 (311)
T 3ork_A 246 LSADLDAVVLKALAKNPENRYQTAAE 271 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred CCHHHHHHHHHHHhcCHhhChhhHHH
Confidence 89999999999999999999976666
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=364.24 Aligned_cols=258 Identities=27% Similarity=0.459 Sum_probs=218.2
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
...++|++.+.||+|+||.||+|.+. ++.||||++..... ...+.+|+.+++.++||||+++++++...+.+|+
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 44578999999999999999999985 77899999976543 2467789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
||||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999999999866677999999999999999999999999 9999999999999999999999999997665544
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-cccCCCCCCCHHHHHHH
Q 003978 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~~l~~LI 738 (782)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.... .....+..++..+.+||
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 259 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFV 259 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHH
Confidence 44455679999999999999999999999999999999999999999887766554443221 12334556899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 739 ~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
.+||..||.+|||+.++ +.|+||+...
T Consensus 260 ~~~l~~dp~~Rpt~~~l------l~~~~~~~~~ 286 (314)
T 3com_A 260 KQCLVKSPEQRATATQL------LQHPFVRSAK 286 (314)
T ss_dssp HHHTCSCTTTSCCHHHH------TTSHHHHTCC
T ss_pred HHHccCChhhCcCHHHH------HhCHHHhcCC
Confidence 99999999999999999 6689997654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=408.78 Aligned_cols=259 Identities=24% Similarity=0.397 Sum_probs=225.4
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCc
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 576 (782)
....++|+++++||+|+||.||+|.+. ++.||||++++... .......+..|..+|..+ +||||+++++++...+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 455679999999999999999999984 56699999976432 112345677899999887 69999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
+||||||++||+|.+++.... .+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++...
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999999998653 6999999999999999999999999 9999999999999999999999999998654
Q ss_pred cccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHH
Q 003978 657 ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 736 (782)
Q Consensus 657 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 736 (782)
.........+||+.|+|||++.+..++.++|||||||+||||++|..||...+.......+. .....+|..+++++.+
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~ 571 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKEAVA 571 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--SSCCCCCTTSCHHHHH
T ss_pred cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHHHHH
Confidence 44445557789999999999999999999999999999999999999999988888777773 4456778899999999
Q ss_pred HHHHhhhhCCCCCCCH-----HHHHHHHHHHHHHHhhcc
Q 003978 737 IVESCWHSDPQCRPSF-----QELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~-----~ell~~L~~L~~~~~~~~ 770 (782)
||.+||.+||.+||++ .+| +.|+||+.+
T Consensus 572 li~~lL~~dP~~R~~~~~~~~~ei------~~h~ff~~i 604 (674)
T 3pfq_A 572 ICKGLMTKHPGKRLGCGPEGERDI------KEHAFFRYI 604 (674)
T ss_dssp HHHHHSCSSSTTCTTCSTTHHHHH------HSSGGGSSC
T ss_pred HHHHHccCCHHHCCCCCCCcHHHH------hcCccccCC
Confidence 9999999999999987 777 568898653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=396.77 Aligned_cols=258 Identities=24% Similarity=0.363 Sum_probs=221.1
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCH-HHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
...++|++.+.||+|+||.||+|.+ .++.||||++.+..... .....+.+|+.+|+.++|||||++++++.....+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 3457899999999999999999998 47789999997643211 23456788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhc---CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 579 IVTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
+|||||+||+|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||||+.+|.+||+|||+++..
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 999999999999999754 346899999999999999999999999 999999999999999999999999999876
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHhhccccccCCCCCCC
Q 003978 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLN----SMQVIGAVGFMNQRLEIPKDVD 731 (782)
Q Consensus 656 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~----~~~~~~~i~~~~~~~~~p~~~~ 731 (782)
..........+||+.|+|||++.+..++.++|||||||++|||++|..||.... .......+ ......+|..++
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i--~~~~~~~p~~~s 417 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV--LEQAVTYPDKFS 417 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH--HHCCCCCCTTSC
T ss_pred cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH--hhcccCCCcccC
Confidence 554434445689999999999999999999999999999999999999997653 23333333 234556778899
Q ss_pred HHHHHHHHHhhhhCCCCCCCH-----HHHHHHHHHHHHHHhhc
Q 003978 732 PRWAAIVESCWHSDPQCRPSF-----QELVDKLRDLQRQYFQA 769 (782)
Q Consensus 732 ~~l~~LI~~cL~~dP~~RPs~-----~ell~~L~~L~~~~~~~ 769 (782)
+++++||.+||..||.+||++ .++ +.|+||+.
T Consensus 418 ~~~~~li~~lL~~dP~~R~~~~~~~a~ei------~~Hpff~~ 454 (543)
T 3c4z_A 418 PASKDFCEALLQKDPEKRLGFRDGSCDGL------RTHPLFRD 454 (543)
T ss_dssp HHHHHHHHHHSCSSGGGSCCCBTTBSHHH------HTSGGGTT
T ss_pred HHHHHHHHHhccCCHhHCCCCcccCHHHH------HcCccccC
Confidence 999999999999999999964 677 57899975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=377.19 Aligned_cols=252 Identities=24% Similarity=0.387 Sum_probs=212.0
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCceeE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 579 (782)
..++|++.+.||+|+||.||+|.++ ++.||||++.+.... ..+|++++..+ +||||+++++++.+...+|+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 3568999999999999999999984 677999999765432 34578888877 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC----CcEEEEecCCCccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH----WTVKVGDFGLSRLK 655 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~----~~vkL~DFGla~~~ 655 (782)
|||||.||+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||+..+ +.+||+|||+++..
T Consensus 94 v~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999999999764 46899999999999999999999999 9999999999998543 35999999999866
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC---ChHHHHHHhhccccc--cCCCCCC
Q 003978 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL---NSMQVIGAVGFMNQR--LEIPKDV 730 (782)
Q Consensus 656 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~---~~~~~~~~i~~~~~~--~~~p~~~ 730 (782)
..........+||+.|+|||++.+..++.++|||||||++|+|++|..||... ........+...... ...+..+
T Consensus 171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 250 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred cCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence 55444445668999999999999888899999999999999999999999763 334444444322221 2233578
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 731 DPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 731 ~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
++++++||.+||..||.+||++.++ ++|+||+.
T Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~i------l~hp~~~~ 283 (342)
T 2qr7_A 251 SDTAKDLVSKMLHVDPHQRLTAALV------LRHPWIVH 283 (342)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHH------TTSHHHHT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHH------hcCCeecC
Confidence 9999999999999999999999999 67899854
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=368.95 Aligned_cols=259 Identities=27% Similarity=0.322 Sum_probs=208.1
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCC---HHHHHHHHHHHHHHHhC---CCCceeEEeeeeec
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS---DEVIHSFRQEVSLMKRL---RHPNVLLFMGAVTS 573 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~---~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~ 573 (782)
...++|+++++||+|+||.||+|.+ .++.||||++...... ......+.+|+.+++.+ .||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3457899999999999999999996 5778999998754321 11123455677766665 59999999999876
Q ss_pred CC-----ceeEEEeecCCCCHHHHHhhcCC-cchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEE
Q 003978 574 PQ-----RLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVG 647 (782)
Q Consensus 574 ~~-----~~~lv~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~ 647 (782)
.. .++++|||+. ++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEEEC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEEe
Confidence 55 4799999996 599999976543 3899999999999999999999999 9999999999999999999999
Q ss_pred ecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc---
Q 003978 648 DFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL--- 724 (782)
Q Consensus 648 DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~--- 724 (782)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+......+
T Consensus 163 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 163 DFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp SCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 999997654332 2234578999999999999999999999999999999999999999888777665543211100
Q ss_pred ----------------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 725 ----------------------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 725 ----------------------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
.+.+.+++++.+||.+||..||.+|||+.++ |+|+||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~------l~h~~~~~~ 303 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA------LQHSYLHKD 303 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHH------HTSTTC---
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHH------hcCccccCC
Confidence 1124578999999999999999999999999 678999764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=388.36 Aligned_cols=258 Identities=31% Similarity=0.575 Sum_probs=224.0
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEc-CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (782)
..+++..++|++.++||+|+||.||+|.+. +..||||+++..... .+.+.+|+.+|+.++|||||++++++. ...
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 346778889999999999999999999985 567999999765433 467889999999999999999999987 567
Q ss_pred eeEEEeecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
+|+|||||.+|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 899999999999999997542 35788899999999999999999998 999999999999999999999999999865
Q ss_pred ccccc-cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHH
Q 003978 656 HETYL-TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733 (782)
Q Consensus 656 ~~~~~-~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 733 (782)
..... ......+++.|+|||++.+..++.++|||||||+||||++ |..||......+....+. ...+...|..++++
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 413 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEE 413 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTSCHH
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 44321 2233456889999999998899999999999999999999 999999988887776664 23455667889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
+.+||.+||..||++|||+.+|++.|+++
T Consensus 414 l~~li~~cl~~dp~~RPt~~~i~~~L~~~ 442 (454)
T 1qcf_A 414 LYNIMMRCWKNRPEERPTFEYIQSVLDDF 442 (454)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 99999999999999999999999887765
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=391.01 Aligned_cols=257 Identities=28% Similarity=0.410 Sum_probs=215.2
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
..++|+++++||+|+||.||+|.+ .+..||||++.+..........+.+|+.+|+.++|||||++++++.....+|+|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 456899999999999999999998 467899999987654443456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCcEEEEecCCCccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~---~~~vkL~DFGla~~~~~ 657 (782)
||||.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+. ++.+||+|||++.....
T Consensus 115 ~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 9999999999998764 46899999999999999999999999 999999999999976 45599999999986654
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCC--CCCCCHHHH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEI--PKDVDPRWA 735 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--p~~~~~~l~ 735 (782)
.. .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+......... ...+++.++
T Consensus 192 ~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 269 (494)
T 3lij_A 192 QK-KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269 (494)
T ss_dssp TB-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred Cc-cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence 32 2335679999999999875 5899999999999999999999999999888877776543333222 246899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
+||.+||..||.+|||+.++ |+|+||+..
T Consensus 270 ~li~~~L~~dp~~R~s~~e~------l~hp~~~~~ 298 (494)
T 3lij_A 270 DLIKQMLQFDSQRRISAQQA------LEHPWIKEM 298 (494)
T ss_dssp HHHHHHTCSSTTTSCCHHHH------HTCHHHHHH
T ss_pred HHHHHHCCCChhhCccHHHH------hcCcccccC
Confidence 99999999999999999999 567888653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=363.13 Aligned_cols=261 Identities=31% Similarity=0.527 Sum_probs=219.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEEcCC-----eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeee-ecCCc
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV-TSPQR 576 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~~~-----~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~ 576 (782)
...+|++.++||+|+||.||+|.+... .||+|.+.... .....+.+.+|+.+++.++||||+++++++ ..++.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 345799999999999999999986322 47888886533 445667889999999999999999999985 55668
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
.|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECccccccccc
Confidence 89999999999999999876777899999999999999999999999 9999999999999999999999999997654
Q ss_pred ccc----ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCC
Q 003978 657 ETY----LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 731 (782)
Q Consensus 657 ~~~----~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 731 (782)
... .......||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+.......+. .......+..++
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 258 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCP 258 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTCCCCCCTTCC
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCCCCCCCccCC
Confidence 322 12233457889999999999999999999999999999999 677887776665554443 233455677899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 732 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 732 ~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
..+.+||.+||..||.+|||+.++++.|+++...++
T Consensus 259 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 259 DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 999999999999999999999999999999887654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=370.28 Aligned_cols=259 Identities=27% Similarity=0.523 Sum_probs=215.4
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCe----EEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSD----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~----vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
...++|+++++||+|+||.||+|.+. ++. ||+|.+.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-
Confidence 34578999999999999999999873 333 5777765332 233456788999999999999999999999875
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
..++||||+.+++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 478999999999999999887778999999999999999999999998 999999999999999999999999999765
Q ss_pred cccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCH
Q 003978 656 HETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 732 (782)
Q Consensus 656 ~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 732 (782)
.... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+. .......+..++.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 246 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTI 246 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBCH
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-cCCCCCCCccCCH
Confidence 4322 22234457889999999999999999999999999999999 999999887766555443 3335566778999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 733 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 733 ~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
++.+||.+||..||.+||++.++++.|.++...
T Consensus 247 ~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 247 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 999999999999999999999999999998653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=367.05 Aligned_cols=261 Identities=29% Similarity=0.495 Sum_probs=217.8
Q ss_pred ceeEeeeeccCCcEEEEEEEE------cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC--Cce
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRL 577 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~------~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 577 (782)
.|+++++||+|+||.||++.+ .++.||||+++... .......+.+|+++|+.++||||+++++++... ..+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 459999999999999999875 46679999997653 455667899999999999999999999999874 568
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
++||||+++++|.+++... .+++..++.++.||+.||.|||+++ |+|+||||+||||+.++.+||+|||++.....
T Consensus 111 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 9999999999999999764 4899999999999999999999999 99999999999999999999999999986544
Q ss_pred cc---ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH--------------HHHHhhcc
Q 003978 658 TY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ--------------VIGAVGFM 720 (782)
Q Consensus 658 ~~---~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~--------------~~~~i~~~ 720 (782)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ........
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 32 12334568889999999999889999999999999999999999997543211 01111122
Q ss_pred ccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 721 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 721 ~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
......+..+++++.+||.+||..||.+|||+.++++.|+++...|-...+
T Consensus 267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p 317 (318)
T 3lxp_A 267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317 (318)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence 334566788999999999999999999999999999999999988865443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=366.56 Aligned_cols=254 Identities=25% Similarity=0.454 Sum_probs=215.4
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEcC---------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG---------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~~---------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 571 (782)
++..++|++.+.||+|+||.||+|.+.. ..||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 3456799999999999999999998743 459999986543 23346788999999999999999999999
Q ss_pred ecCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc--------
Q 003978 572 TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-------- 643 (782)
Q Consensus 572 ~~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~-------- 643 (782)
..++..|+|||||++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccce
Confidence 9999999999999999999999887767999999999999999999999999 999999999999998877
Q ss_pred EEEEecCCCcccccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccc
Q 003978 644 VKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMN 721 (782)
Q Consensus 644 vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~ 721 (782)
+||+|||++....... ...||+.|+|||++.+ ..++.++|||||||++|+|++ +.+||............ .
T Consensus 160 ~kl~Dfg~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~---~ 232 (289)
T 4fvq_A 160 IKLSDPGISITVLPKD----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY---E 232 (289)
T ss_dssp EEECCCCSCTTTSCHH----HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---H
T ss_pred eeeccCcccccccCcc----ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh---h
Confidence 9999999987544322 2346889999999987 678999999999999999999 46666665554433322 3
Q ss_pred cccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 722 QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 722 ~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
....++...++++.+||.+||..||.+|||+.+++++|+++..+
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 233 DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 35566777889999999999999999999999999999887553
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=390.88 Aligned_cols=259 Identities=33% Similarity=0.588 Sum_probs=226.6
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
..+++...+|++.++||+|+||.||+|.+. +..||||+++..... .+.+.+|+.+|+.++|||||++++++....
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 346777889999999999999999999986 678999999765433 467889999999999999999999999999
Q ss_pred ceeEEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
.+|||||||.+|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeeccccee
Confidence 999999999999999999763 345899999999999999999999999 99999999999999999999999999986
Q ss_pred ccccc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCH
Q 003978 655 KHETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 732 (782)
Q Consensus 655 ~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 732 (782)
..... .......+++.|+|||++.+..++.++|||||||+||||++ |..||...+..+....+. ...+...+..+++
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 446 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPE 446 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCH
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 54332 22233456789999999999889999999999999999999 999999888776665553 3345667888999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 733 RWAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 733 ~l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
++.+||.+||..||.+|||+.+|++.|+.+
T Consensus 447 ~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 447 KVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 999999999999999999999999988765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=360.06 Aligned_cols=259 Identities=30% Similarity=0.567 Sum_probs=220.4
Q ss_pred ceeEeeeeccCCcEEEEEEEEc--CC---eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce-eE
Q 003978 506 DLTIGEQIGQGSCGTVYHAVWY--GS---DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL-CI 579 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~~--~~---~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~-~l 579 (782)
.|.+.++||+|+||.||+|.+. +. .||+|++.... .....+.+.+|+.+++.++||||+++++++...+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 6778899999999999999873 22 58999986533 445667889999999999999999999999876665 99
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
+|||+.+++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 99999999999999876777999999999999999999999999 9999999999999999999999999997543321
Q ss_pred ----ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHH
Q 003978 660 ----LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734 (782)
Q Consensus 660 ----~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 734 (782)
.......+|+.|+|||.+.+..++.++|||||||++|+|++ |.+||...+.......+. .......+..+++.+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 257 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLPQPEYCPDSL 257 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-TTCCCCCCTTCCHHH
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-cCCCCCCCccchHHH
Confidence 22234467899999999999999999999999999999999 556666666655554443 333456677899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003978 735 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~ 768 (782)
.+||.+||..||.+|||+.++++.|+++...+..
T Consensus 258 ~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 258 YQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999887654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=363.40 Aligned_cols=252 Identities=33% Similarity=0.574 Sum_probs=204.1
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHh--CCCCceeEEeeeeec----CC
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR--LRHPNVLLFMGAVTS----PQ 575 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~----~~ 575 (782)
...++|++.+.||+|+||.||+|.+.++.||||++.... ...+.+|.+++.. ++||||+++++++.. ..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 456799999999999999999999999999999986532 2445667777777 789999999998643 34
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhh--------cCCCCeeecCCCCCcEEEcCCCcEEEE
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH--------HCNPPIIHRDLKSSNLLVDKHWTVKVG 647 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH--------~~~~~ivHrDIKp~NILl~~~~~vkL~ 647 (782)
.+|+||||+++++|.+++.. ..+++..++.++.||+.||.||| +++ |+||||||+||||+.++.+||+
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTTSCEEEC
T ss_pred eeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCCCCEEEe
Confidence 58999999999999999964 36899999999999999999999 888 9999999999999999999999
Q ss_pred ecCCCccccccccc----ccCCCCCCcccCcccccCC------CCCchhHHHHHHHHHHHHHcC----------CCCCCC
Q 003978 648 DFGLSRLKHETYLT----TKTGKGTPQWMAPEVLRNE------PSDEKSDVYSFGVILWELATE----------KIPWDN 707 (782)
Q Consensus 648 DFGla~~~~~~~~~----~~~~~Gt~~y~aPE~l~~~------~~s~~sDIwSLG~ll~elltG----------~~Pf~~ 707 (782)
|||+++........ .....||+.|+|||++.+. .++.++|||||||++|+|++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999754433221 2334799999999999876 345689999999999999999 888865
Q ss_pred CCh----HHHHHH-hhccccccCCCC-----CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 708 LNS----MQVIGA-VGFMNQRLEIPK-----DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 708 ~~~----~~~~~~-i~~~~~~~~~p~-----~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
... ...... +......+.++. .+++++.+||.+||..||.+|||+.++++.|++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 321 222222 222222333332 2457899999999999999999999999999876
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=361.78 Aligned_cols=261 Identities=34% Similarity=0.547 Sum_probs=216.1
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc---CC--eEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY---GS--DVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~---~~--~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (782)
.+..++|++++.||+|+||.||+|.+. +. .||||+++.... .....+.+.+|+++++.++||||+++++++..+
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 344578999999999999999999863 22 489999876543 335667899999999999999999999999876
Q ss_pred CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
. .++||||+.+++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++..
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEcccccccc
Confidence 4 89999999999999999876667999999999999999999999998 99999999999999999999999999976
Q ss_pred cccccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCC
Q 003978 655 KHETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 730 (782)
Q Consensus 655 ~~~~~~---~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 730 (782)
...... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+.......+.........+..+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 250 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCc
Confidence 543321 2234467889999999998888999999999999999999 999999998888777776555566677889
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 731 DPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 731 ~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
+.++.++|.+||..||.+|||+.++++.|.+++.
T Consensus 251 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 251 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 9999999999999999999999999999988754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=359.53 Aligned_cols=259 Identities=24% Similarity=0.396 Sum_probs=219.0
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCH----HHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
.++|++++.||+|+||.||++.+. ++.||+|+++...... ...+.+.+|+.+++.++||||+++++++.....+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 468999999999999999999985 7789999998654322 1246788999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----cEEEEecCCCc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFGLSR 653 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~----~vkL~DFGla~ 653 (782)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+||+++.++ .+||+|||++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 9999999999999999764 46899999999999999999999998 99999999999998877 89999999997
Q ss_pred ccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--cCCCCCCC
Q 003978 654 LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--LEIPKDVD 731 (782)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~~ 731 (782)
...... ......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+...... ...+..++
T Consensus 161 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T 3bhy_A 161 KIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239 (283)
T ss_dssp ECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred eccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCC
Confidence 654432 223457899999999999999999999999999999999999999988877766655432221 22335789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 732 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 732 ~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
..+.+||.+||..||.+||++.++ +.|+||+..+.
T Consensus 240 ~~~~~li~~~l~~dp~~Rps~~~~------l~h~~~~~~~~ 274 (283)
T 3bhy_A 240 ELAKDFIRRLLVKDPKRRMTIAQS------LEHSWIKAIRR 274 (283)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHH------HHCHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHH------HhCHHHHHHHH
Confidence 999999999999999999999999 56788876543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=374.50 Aligned_cols=263 Identities=17% Similarity=0.230 Sum_probs=209.4
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCH----HHH-----HHHHHHHHHHHhCCCCce
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSD----EVI-----HSFRQEVSLMKRLRHPNV 564 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~----~~~-----~~~~~Ei~il~~l~HpnI 564 (782)
+...++|+++++||+|+||.||+|.+. ++.||||++....... ... ..+..|+..+..++||||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 455679999999999999999999874 3679999987653210 000 123345566777889999
Q ss_pred eEEeeeeecC----CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-
Q 003978 565 LLFMGAVTSP----QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD- 639 (782)
Q Consensus 565 v~l~~~~~~~----~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~- 639 (782)
+++++++... ..+||||||| +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNY 187 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEES
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEec
Confidence 9999998764 4589999999 99999999887678999999999999999999999998 99999999999999
Q ss_pred -CCCcEEEEecCCCccccccccc-------ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH
Q 003978 640 -KHWTVKVGDFGLSRLKHETYLT-------TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (782)
Q Consensus 640 -~~~~vkL~DFGla~~~~~~~~~-------~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~ 711 (782)
.++.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8899999999999765432211 12345999999999999999999999999999999999999999854322
Q ss_pred HHHHHhhccc---------cccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 712 QVIGAVGFMN---------QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 712 ~~~~~i~~~~---------~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
.......... ........++.++.+||..||..||.+||++.+|++.|.++....
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 2211111000 011123678999999999999999999999999999999887653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=372.53 Aligned_cols=260 Identities=23% Similarity=0.284 Sum_probs=213.2
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCC---HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS---DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
..++|++++.||+|+||.||+|.+. ++.||||++...... ......+.+|+.+++.++||||+++++++.....+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999974 778999998754322 12234678899999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
++||||+++ +|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 999999975 999999877777899999999999999999999999 99999999999999999999999999987655
Q ss_pred ccccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc------------
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL------------ 724 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------ 724 (782)
.........||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+....+..+......+
T Consensus 165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244 (346)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence 44444556899999999999764 47899999999999999999999999888776655543211100
Q ss_pred --------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 725 --------------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 725 --------------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
.+...++.++.+||.+||..||.+|||+.++ |+|+||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el------l~h~~f~~~~ 299 (346)
T 1ua2_A 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA------LKMKYFSNRP 299 (346)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHH------HTSGGGTSSS
T ss_pred ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHH------hcChhhhcCC
Confidence 0114567899999999999999999999999 6789997654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=367.44 Aligned_cols=265 Identities=31% Similarity=0.456 Sum_probs=217.7
Q ss_pred cccceeEeeeeccCCcEEEEEEEE------cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeee--cC
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT--SP 574 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~------~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~ 574 (782)
..++|++++.||+|+||.||+|.+ .+..||||++... .....+.+.+|+++++.++||||+++++++. ..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 357999999999999999999985 4567999998654 3455677899999999999999999999886 45
Q ss_pred CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
..+|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||||+.++.+||+|||++..
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEccccccee
Confidence 6689999999999999999876667999999999999999999999998 99999999999999999999999999986
Q ss_pred ccccc---ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH--------------HHHHHh
Q 003978 655 KHETY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM--------------QVIGAV 717 (782)
Q Consensus 655 ~~~~~---~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~--------------~~~~~i 717 (782)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 54322 1233456889999999999998999999999999999999999998654322 111112
Q ss_pred hccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 718 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 718 ~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
.........+..+++++.+||.+||..||.+|||+.+++++|+.+......+..
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 310 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET 310 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccc
Confidence 222334566788999999999999999999999999999999988766554443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=358.37 Aligned_cols=259 Identities=25% Similarity=0.499 Sum_probs=215.2
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
....++|++++.||+|+||.||+|.+. ++.||||++...... .+....+.+|+.+++.++||||+++++++.....+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 345679999999999999999999984 788999999754321 12346788999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999999997653 5899999999999999999999999 99999999999999999999999999876544
Q ss_pred ccccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 736 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~-s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 736 (782)
.. ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+. .....++..++..+.+
T Consensus 164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 164 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR--GGVFYIPEYLNRSVAT 240 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHH
T ss_pred Cc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh--cCcccCchhcCHHHHH
Confidence 32 2234578999999999988766 689999999999999999999999887766665553 2344567789999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 737 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
||.+||..||.+|||+.++ +.|+||+...
T Consensus 241 li~~~l~~~p~~Rps~~~~------l~h~~~~~~~ 269 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDI------REHEWFKQDL 269 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHH------HHSHHHHTTC
T ss_pred HHHHHccCChhhCCCHHHH------HhChhhccCc
Confidence 9999999999999999999 5689997643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=370.09 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=204.0
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC------
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------ 575 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 575 (782)
.++|++++.||+|+||.||+|.+ .++.||||+++... .....+.+.+|+++|+.++|||||++++++....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 46899999999999999999998 47789999997654 3334577899999999999999999999885443
Q ss_pred ---------------------------------------------------ceeEEEeecCCCCHHHHHhhcCC--cchH
Q 003978 576 ---------------------------------------------------RLCIVTEFLPRGSLFRLLQRNTT--KLDW 602 (782)
Q Consensus 576 ---------------------------------------------------~~~lv~E~~~ggsL~~~l~~~~~--~l~~ 602 (782)
.+|+|||||++++|.+++..... ..++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 27999999999999999976432 2455
Q ss_pred HHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc------------ccccCCCCCCc
Q 003978 603 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY------------LTTKTGKGTPQ 670 (782)
Q Consensus 603 ~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~------------~~~~~~~Gt~~ 670 (782)
..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...... .......||+.
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 678899999999999999999 9999999999999999999999999998655432 12234579999
Q ss_pred ccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCC
Q 003978 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRP 750 (782)
Q Consensus 671 y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RP 750 (782)
|+|||++.+..++.++|||||||++|+|++|..|+... ......+. ....+..+...++++.+||.+||..||.+||
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 318 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPTERP 318 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHH-TTCCCHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhh-ccCCCcccccCChhHHHHHHHHccCCCCcCC
Confidence 99999999999999999999999999999987765321 11111111 1111112234568899999999999999999
Q ss_pred CHHHHHHHHHHHHHHHhhc
Q 003978 751 SFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 751 s~~ell~~L~~L~~~~~~~ 769 (782)
|+.++ ++|+||+.
T Consensus 319 s~~~~------l~~~~f~~ 331 (332)
T 3qd2_B 319 EATDI------IENAIFEN 331 (332)
T ss_dssp CHHHH------HHSTTCCC
T ss_pred CHHHH------hhchhhhc
Confidence 99999 67888875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=372.46 Aligned_cols=258 Identities=28% Similarity=0.487 Sum_probs=216.5
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCe----EEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSD----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~----vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
...++|+++++||+|+||.||+|.+. +.. ||+|++..... ......+.+|+.+++.++||||+++++++. ..
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 34578999999999999999999974 343 77777654321 122345667999999999999999999886 56
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
..++||||+.+++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCccccc
Confidence 789999999999999999876667999999999999999999999999 999999999999999999999999999865
Q ss_pred cccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCH
Q 003978 656 HETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 732 (782)
Q Consensus 656 ~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 732 (782)
.... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+. .......+..++.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 244 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQICTI 244 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-TTCBCCCCTTBCT
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCCCcCcH
Confidence 4332 12234567889999999999999999999999999999999 999999887766665553 3345566778899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 733 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 733 ~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
++.+||.+||..||.+||++.++++.|+++..
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 245 DVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999998854
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=371.95 Aligned_cols=260 Identities=23% Similarity=0.369 Sum_probs=218.7
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
++..++|++.+.||+|+||.||++.+. +..||+|++.... .......+.+|+.+++.++||||+++++++..++.+|
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 445679999999999999999999985 7789999997653 4556678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcC-CCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~-~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
+|||||++++|.+++.... .+++..++.++.||+.||.|||+. + |+|+||||+||||+.++.+||+|||++.....
T Consensus 108 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999999997653 689999999999999999999985 8 99999999999999999999999999975433
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh-------------------
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVG------------------- 718 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~------------------- 718 (782)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.
T Consensus 185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 185 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp H--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred c--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 2 2234578999999999999999999999999999999999999998776544322211
Q ss_pred -----------------------ccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 719 -----------------------FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 719 -----------------------~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
...........++.++.+||.+||..||.+|||+.++ |+|+||+....
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el------l~hp~~~~~~~ 333 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL------MVHAFIKRSDA 333 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHH------HTSHHHHHHHH
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHH------hhChHhhcchH
Confidence 0111111223478999999999999999999999999 67899976543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=363.56 Aligned_cols=253 Identities=33% Similarity=0.623 Sum_probs=209.5
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
+..++|++.+.||+|+||.||++.+.++.||||++... ...+.+.+|+++++.++||||+++++++. +..|+||
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~ 78 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVM 78 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEE
Confidence 34578999999999999999999999999999998643 23467889999999999999999999887 4589999
Q ss_pred eecCCCCHHHHHhhcCC--cchHHHHHHHHHHHHHHHHhhhc---CCCCeeecCCCCCcEEEcCCCc-EEEEecCCCccc
Q 003978 582 EFLPRGSLFRLLQRNTT--KLDWRRRILMALDIARGVSYLHH---CNPPIIHRDLKSSNLLVDKHWT-VKVGDFGLSRLK 655 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~qll~aL~~LH~---~~~~ivHrDIKp~NILl~~~~~-vkL~DFGla~~~ 655 (782)
||+++++|.+++..... .+++..++.++.|++.||.|||+ ++ |+||||||+||||+.++. +||+|||++...
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 99999999999976432 36788999999999999999999 67 999999999999998886 799999999754
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHhhccccccCCCCCCCHH
Q 003978 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM--QVIGAVGFMNQRLEIPKDVDPR 733 (782)
Q Consensus 656 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~--~~~~~i~~~~~~~~~p~~~~~~ 733 (782)
.... ....||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+ ........+..++..
T Consensus 157 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (307)
T 2eva_A 157 QTHM---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV-HNGTRPPLIKNLPKP 232 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHH-HTTCCCCCBTTCCHH
T ss_pred cccc---ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHH-hcCCCCCcccccCHH
Confidence 4321 2346899999999999999999999999999999999999999865432 222222 233455667789999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
+.+||.+||..||.+|||+.++++.|+.+...+
T Consensus 233 l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 233 IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 999999999999999999999999999886544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=360.68 Aligned_cols=256 Identities=31% Similarity=0.520 Sum_probs=223.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.+.|++++.||+|+||.||+|.+ .++.||||++...... .....+.+|+.+++.++||||+++++++.....+|+||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 35799999999999999999987 4678999999765432 23567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
||+++++|.+++.. ..+++..++.++.||+.||.|||+++ |+|+||||+||+|+.++.+||+|||++.........
T Consensus 100 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 100 EYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp ECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred EeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 99999999999975 46899999999999999999999999 999999999999999999999999999876554444
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHh
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 741 (782)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.. .....++..++..+.+||.+|
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~ 254 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK-NNPPTLEGNYSKPLKEFVEAC 254 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SCCCCCCSSCCHHHHHHHHHH
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc-CCCCCCccccCHHHHHHHHHH
Confidence 4566799999999999999999999999999999999999999998887766655432 234456778999999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 742 WHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 742 L~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
|..||.+|||+.++ +.|+||+...
T Consensus 255 l~~dp~~Rps~~~l------l~~~~~~~~~ 278 (303)
T 3a7i_A 255 LNKEPSFRPTAKEL------LKHKFILRNA 278 (303)
T ss_dssp CCSSGGGSCCHHHH------TTCHHHHHHC
T ss_pred cCCChhhCcCHHHH------hhChhhhcCC
Confidence 99999999999999 5567775443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=371.41 Aligned_cols=252 Identities=24% Similarity=0.422 Sum_probs=193.1
Q ss_pred ccceeEe---eeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCce
Q 003978 504 WEDLTIG---EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 504 ~~~y~i~---~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 577 (782)
.++|.+. ++||+|+||.||+|.+. ++.||||++.... ...+.+|+.+++.+. ||||+++++++......
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-----EANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh-----hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 3566664 78999999999999984 6789999997542 356678999999997 99999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---cEEEEecCCCcc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRL 654 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~---~vkL~DFGla~~ 654 (782)
|+|||||++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++ .+||+|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp EEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 9999999999999999764 46999999999999999999999999 99999999999998765 899999999986
Q ss_pred cccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-------HHHHHHhhccccccCCC
Q 003978 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS-------MQVIGAVGFMNQRLEIP 727 (782)
Q Consensus 655 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~p 727 (782)
...........+||+.|+|||++.+..++.++|||||||++|+|++|..||...+. ......+.. ....++
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~--~~~~~~ 236 (325)
T 3kn6_A 159 KPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK--GDFSFE 236 (325)
T ss_dssp CCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT--TCCCCC
T ss_pred cCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc--CCCCCC
Confidence 65544444566789999999999999999999999999999999999999976543 233333322 122222
Q ss_pred ----CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 728 ----KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 728 ----~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
..+++++++||.+||..||.+|||+.++ ++|+||+...
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~el------l~h~w~~~~~ 278 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL------RYNEWLQDGS 278 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTS------TTCGGGCTTC
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHH------hcChhhccCc
Confidence 3589999999999999999999999999 6789997653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=358.21 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=212.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCceeEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv 580 (782)
.++|++++.||+|+||.||+|.+. ++.||||++............+.+|+.++..+ +||||+++++++..++.+|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 468999999999999999999984 78899999987665555567788999999999 899999999999999999999
Q ss_pred EeecCCCCHHHHHhhcC---CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC----------------
Q 003978 581 TEFLPRGSLFRLLQRNT---TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH---------------- 641 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~---------------- 641 (782)
|||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999999999997542 45899999999999999999999999 9999999999999844
Q ss_pred ---CcEEEEecCCCcccccccccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHh
Q 003978 642 ---WTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV 717 (782)
Q Consensus 642 ---~~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i 717 (782)
..+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|..|+....... .+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~ 240 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH---EI 240 (289)
T ss_dssp --CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH---HH
T ss_pred CCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH---HH
Confidence 47999999999765443 234689999999999876 55679999999999999999998876543322 22
Q ss_pred hccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 718 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 718 ~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
. ......++..+++++.+||.+||..||.+|||+.++ ++|+||+..
T Consensus 241 ~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l------l~h~~~~~~ 286 (289)
T 1x8b_A 241 R-QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMAL------VKHSVLLSA 286 (289)
T ss_dssp H-TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHH------HTCTTC---
T ss_pred H-cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHH------hhChHhhhh
Confidence 1 233456778899999999999999999999999999 678998764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=388.66 Aligned_cols=254 Identities=26% Similarity=0.364 Sum_probs=208.0
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC-----
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----- 575 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 575 (782)
..++|+++++||+|+||.||+|.+ .++.||||++..........+.+.+|+.+|+.++|||||++++++....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999987 4678999999876656677788999999999999999999999996553
Q ss_pred -ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 576 -RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 576 -~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
.+|+|||||++ +|.+.+.. .+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++.
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred CeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 46999999965 67777753 4889999999999999999999999 99999999999999999999999999986
Q ss_pred cccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc----------
Q 003978 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL---------- 724 (782)
Q Consensus 655 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------- 724 (782)
..... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+......+
T Consensus 214 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 214 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp ---CC-CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred cCCCc-ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence 65432 2335689999999999999999999999999999999999999999887766554442211100
Q ss_pred ----------C---------CCCC-----------CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 725 ----------E---------IPKD-----------VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 725 ----------~---------~p~~-----------~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
. ++.. .++++.+||.+||..||++|||+.++ |+|+||+.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~------L~Hp~~~~ 361 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA------LQHPYINV 361 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH------HTSTTTGG
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHH------hcChhhhh
Confidence 0 0000 15679999999999999999999999 67899974
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=369.45 Aligned_cols=258 Identities=28% Similarity=0.527 Sum_probs=214.4
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCe----EEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSD----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~----vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
...++|+++++||+|+||.||+|.+. ++. |++|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 44578999999999999999999973 444 4666664332 2233467889999999999999999999998754
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
.++||||+.+++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 78999999999999999887778999999999999999999999999 999999999999999999999999999865
Q ss_pred cccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCH
Q 003978 656 HETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 732 (782)
Q Consensus 656 ~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 732 (782)
.... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+. .......+..++.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 246 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTI 246 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBCH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCH
Confidence 4322 22234457889999999999999999999999999999999 999999887776655543 3345566788999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 733 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 733 ~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
++.+||.+||..||.+||++.++++.|.++..
T Consensus 247 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 247 DVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999999974
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=361.82 Aligned_cols=266 Identities=28% Similarity=0.479 Sum_probs=217.1
Q ss_pred cccccccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 003978 497 CLDYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (782)
Q Consensus 497 ~~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (782)
...+....++|.....||+|+||.||+|.+ .+..||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 91 (295)
T 2clq_A 14 LLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN 91 (295)
T ss_dssp CCCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred cccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC
Confidence 345555566777777999999999999998 46679999987653 23456788999999999999999999999999
Q ss_pred CceeEEEeecCCCCHHHHHhhcC--CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCcEEEEecCC
Q 003978 575 QRLCIVTEFLPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGL 651 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~-~~~vkL~DFGl 651 (782)
+.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+||+|+. ++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~ 169 (295)
T 2clq_A 92 GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGT 169 (295)
T ss_dssp TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeeccc
Confidence 99999999999999999997653 34568889999999999999999998 999999999999987 89999999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhccccccCCCC
Q 003978 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNEP--SDEKSDVYSFGVILWELATEKIPWDNLNSMQ-VIGAVGFMNQRLEIPK 728 (782)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~--~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~p~ 728 (782)
+..............||+.|+|||++.+.. ++.++|||||||++|+|++|..||....... .............++.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (295)
T 2clq_A 170 SKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPE 249 (295)
T ss_dssp CEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCT
T ss_pred ccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccc
Confidence 986554333344567999999999997644 7889999999999999999999997654332 2222222334556778
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 729 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 729 ~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
.+++++.+||.+||..||++||++.++ |.|+||+....
T Consensus 250 ~~~~~~~~li~~~l~~dp~~Rps~~~l------l~~~~~~~~~~ 287 (295)
T 2clq_A 250 SMSAEAKAFILKCFEPDPDKRACANDL------LVDEFLKVSSK 287 (295)
T ss_dssp TSCHHHHHHHHHTTCSSTTTSCCHHHH------HTSGGGCC---
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHH------hcChhhhhccc
Confidence 899999999999999999999999999 67899976543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=366.80 Aligned_cols=259 Identities=19% Similarity=0.357 Sum_probs=209.9
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC--ce
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ--RL 577 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~ 577 (782)
...++|++.++||+|+||.||+|.+. ++.||||++...... .....+.+|+++|+.++||||+++++++.... .+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 34578999999999999999999985 778999999754422 12456778999999999999999999987655 78
Q ss_pred eEEEeecCCCCHHHHHhhcCC--cchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----cCCCcEEEEecCC
Q 003978 578 CIVTEFLPRGSLFRLLQRNTT--KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGL 651 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl----~~~~~vkL~DFGl 651 (782)
|+|||||++++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 999999999999999976433 3899999999999999999999999 9999999999999 7788899999999
Q ss_pred CcccccccccccCCCCCCcccCccccc--------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhc
Q 003978 652 SRLKHETYLTTKTGKGTPQWMAPEVLR--------NEPSDEKSDVYSFGVILWELATEKIPWDNLNS----MQVIGAVGF 719 (782)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~----~~~~~~i~~ 719 (782)
++...... ......||+.|+|||++. +..++.++|||||||++|+|++|..||..... ......+..
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 98655433 223457999999999986 57788999999999999999999999975432 222222211
Q ss_pred ccc-------------------c----cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 720 MNQ-------------------R----LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 720 ~~~-------------------~----~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
... . ..++..++..+.+||.+||..||++|||+.+++++..+-.|
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 110 0 01222345678999999999999999999999988776543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=395.88 Aligned_cols=258 Identities=23% Similarity=0.329 Sum_probs=220.2
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
...++|++.+.||+|+||.||+|.+ .++.||||++.+.... ......+.+|+.+|+.++|||||++++++...+.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 4457899999999999999999998 4778999999764321 122356788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
+|||||+||+|.+++.... ..+++..++.++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+++....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999999997643 34899999999999999999999999 99999999999999999999999999986544
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhccccccCCCCCCCHH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS----MQVIGAVGFMNQRLEIPKDVDPR 733 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~p~~~~~~ 733 (782)
.. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+ ......++..++++
T Consensus 339 ~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i--~~~~~~~p~~~s~~ 415 (576)
T 2acx_A 339 GQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV--KEVPEEYSERFSPQ 415 (576)
T ss_dssp TC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH--HHCCCCCCTTSCHH
T ss_pred Cc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh--hcccccCCccCCHH
Confidence 32 22345899999999999999999999999999999999999999987532 2333333 22345667889999
Q ss_pred HHHHHHHhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhcc
Q 003978 734 WAAIVESCWHSDPQCRP-----SFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RP-----s~~ell~~L~~L~~~~~~~~ 770 (782)
+++||.+||..||.+|| ++.++ +.|+||+..
T Consensus 416 ~~dLI~~lL~~dP~~R~g~~~~sa~ei------l~HpfF~~i 451 (576)
T 2acx_A 416 ARSLCSQLLCKDPAERLGCRGGSAREV------KEHPLFKKL 451 (576)
T ss_dssp HHHHHHHHTCSSGGGSTTCSSSHHHHH------HTSGGGTTC
T ss_pred HHHHHHHhccCCHHHcCCCCCCCHHHH------HhChhhccC
Confidence 99999999999999999 78999 678999753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=370.95 Aligned_cols=261 Identities=21% Similarity=0.290 Sum_probs=215.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec-------
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS------- 573 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------- 573 (782)
..++|+++++||+|+||.||+|.+ .++.||||++............+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 347899999999999999999998 47789999987665444444567789999999999999999999876
Q ss_pred -CCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCC
Q 003978 574 -PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (782)
Q Consensus 574 -~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla 652 (782)
.+.+|+|||||.+ +|.+.+......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 3468999999965 888888776677999999999999999999999999 999999999999999999999999999
Q ss_pred cccccc----cccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC--
Q 003978 653 RLKHET----YLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE-- 725 (782)
Q Consensus 653 ~~~~~~----~~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-- 725 (782)
+..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+........
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 764421 122234578999999999986 4579999999999999999999999998887766655532221111
Q ss_pred CCCC----------------------------CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 726 IPKD----------------------------VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 726 ~p~~----------------------------~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
..+. .++.+.+||.+||..||.+|||+.++ |+|+||+....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~------l~hp~f~~~~~ 320 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA------LNHDFFWSDPM 320 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHH------HTSGGGGSSSC
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHH------hCCCCcCCCCC
Confidence 1011 26789999999999999999999999 67899976443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=391.66 Aligned_cols=260 Identities=29% Similarity=0.435 Sum_probs=223.8
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
...++|++.++||+|+||.||+|.+ .++.||||++...... ......+.+|+.+|+.++|||||++++++...+.+|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4457899999999999999999998 4778999999765432 233567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCcEEEEecCCCccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl---~~~~~vkL~DFGla~~~ 655 (782)
+|||||.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 999999999999999764 46999999999999999999999999 9999999999999 56789999999999765
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC--CCCCHH
Q 003978 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP--KDVDPR 733 (782)
Q Consensus 656 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~ 733 (782)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||...+.......+.........+ ..++++
T Consensus 180 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 257 (484)
T 3nyv_A 180 EASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 257 (484)
T ss_dssp CCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred cccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence 4432 2234479999999999987 58899999999999999999999999998888777775444333333 468999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
+++||.+||..||.+|||+.++ |.|+||+....
T Consensus 258 ~~~li~~~L~~dp~~R~s~~e~------l~h~~~~~~~~ 290 (484)
T 3nyv_A 258 AKDLIRKMLTYVPSMRISARDA------LDHEWIQTYTK 290 (484)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHH------HTSHHHHHHTC
T ss_pred HHHHHHHHCCCChhHCcCHHHH------hhChhhccccc
Confidence 9999999999999999999999 67899876543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=365.37 Aligned_cols=260 Identities=28% Similarity=0.469 Sum_probs=217.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
..++|++++.||+|+||.||+|.+. +..||+|++..... .....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 4578999999999999999999985 67899999865432 2346788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
||||++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++........
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 9999999999999876677999999999999999999999998 99999999999999999999999998764433322
Q ss_pred cccCCCCCCcccCcccc-----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-ccCCCCCCCHHH
Q 003978 661 TTKTGKGTPQWMAPEVL-----RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRW 734 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l-----~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l 734 (782)
......||+.|+|||++ .+..++.++|||||||++|+|++|..||...+.......+..... ....+..++..+
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEF 252 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHH
Confidence 33355789999999998 467788999999999999999999999998887766655533222 223456789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 735 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
.+||.+||..||.+|||+.++ +.|+||+....
T Consensus 253 ~~li~~~l~~dp~~Rps~~~l------l~h~~~~~~~~ 284 (302)
T 2j7t_A 253 RDFLKIALDKNPETRPSAAQL------LEHPFVSSITS 284 (302)
T ss_dssp HHHHHHHSCSCTTTSCCHHHH------TTSTTTTTCCC
T ss_pred HHHHHHHcccChhhCCCHHHH------hcChHHhhhcc
Confidence 999999999999999999999 56788876543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=360.20 Aligned_cols=259 Identities=22% Similarity=0.366 Sum_probs=219.8
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
..++|++.+.||+|+||.||++.+ .++.||||+++.... .....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 457899999999999999999998 477899999976432 2235678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCcEEEEecCCCccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl---~~~~~vkL~DFGla~~~~~ 657 (782)
|||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+|+||||+||++ +.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 85 MQLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp ECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999999999997643 6899999999999999999999998 9999999999999 7788999999999875443
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--ccCCCCCCCHHHH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ--RLEIPKDVDPRWA 735 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~~~~l~ 735 (782)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..... ....+..+++++.
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (304)
T 2jam_A 162 GI--MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK 239 (304)
T ss_dssp BT--THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred Cc--cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence 22 2233589999999999999999999999999999999999999998887776666543322 2234467899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcC
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTV 774 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~ 774 (782)
+||.+||..||.+|||+.++ +.|+||+......
T Consensus 240 ~li~~~l~~dp~~Rps~~~~------l~h~~~~~~~~~~ 272 (304)
T 2jam_A 240 DFICHLLEKDPNERYTCEKA------LSHPWIDGNTALH 272 (304)
T ss_dssp HHHHHHHCSSTTTSCCHHHH------HTSHHHHSSCSCC
T ss_pred HHHHHHcCCChhHCcCHHHH------hcCccccCCCccc
Confidence 99999999999999999999 6789998765443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=366.63 Aligned_cols=261 Identities=30% Similarity=0.573 Sum_probs=219.7
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCe--EEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCc
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~--vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 576 (782)
..+++|++.+.||+|+||.||+|.+. +.. +|+|.++... .......+.+|+++++.+ +||||+++++++...+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 34579999999999999999999874 443 4889886432 333456788999999999 89999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 003978 577 LCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 641 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~ 641 (782)
+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.+
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcCC
Confidence 999999999999999997643 36899999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcc
Q 003978 642 WTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFM 720 (782)
Q Consensus 642 ~~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~ 720 (782)
+.+||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+..
T Consensus 179 ~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~- 256 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ- 256 (327)
T ss_dssp GCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-
T ss_pred CeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc-
Confidence 99999999998743322 22234467899999999998889999999999999999998 9999998887776665532
Q ss_pred ccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 721 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 721 ~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
......+..+++++.+||.+||..||.+|||+.++++.|.++....-
T Consensus 257 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 257 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 23455677899999999999999999999999999999999877543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=384.22 Aligned_cols=258 Identities=33% Similarity=0.587 Sum_probs=218.9
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEcC-CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (782)
..+++..++|++.++||+|+||.||+|.+.+ ..||||+++...... +.+.+|+++|+.++||||+++++++.. +.
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence 3567788899999999999999999999865 469999998655433 568899999999999999999999876 67
Q ss_pred eeEEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
+|+|||||++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccceec
Confidence 89999999999999999753 345899999999999999999999999 999999999999999999999999999865
Q ss_pred cccc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHH
Q 003978 656 HETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733 (782)
Q Consensus 656 ~~~~-~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 733 (782)
.... .......+++.|+|||++.+..++.++|||||||++|||++ |..||......+....+. ...+...|..+++.
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 409 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 409 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCHH
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 4332 22233457889999999999899999999999999999999 999999988877776664 33456677889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
+.+||.+||..||++|||+.++++.|+++
T Consensus 410 l~~li~~cl~~dP~~Rpt~~~l~~~L~~~ 438 (452)
T 1fmk_A 410 LHDLMCQCWRKEPEERPTFEYLQAFLEDY 438 (452)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999998877654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=377.99 Aligned_cols=261 Identities=23% Similarity=0.322 Sum_probs=208.4
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC-----C
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----Q 575 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~ 575 (782)
..++|++++.||+|+||.||+|.+. ++.||||++..........+.+.+|+.+|+.++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4579999999999999999999984 56799999987655666678899999999999999999999999766 5
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 6899999995 5999999764 46999999999999999999999999 999999999999999999999999999865
Q ss_pred ccccc----------------------cccCCCCCCcccCcccc-cCCCCCchhHHHHHHHHHHHHHcCCCC--------
Q 003978 656 HETYL----------------------TTKTGKGTPQWMAPEVL-RNEPSDEKSDVYSFGVILWELATEKIP-------- 704 (782)
Q Consensus 656 ~~~~~----------------------~~~~~~Gt~~y~aPE~l-~~~~~s~~sDIwSLG~ll~elltG~~P-------- 704 (782)
..... .....+||+.|+|||++ .+..++.++|||||||++|||++|..|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 259 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence 43221 12456899999999986 566689999999999999999985444
Q ss_pred ---CCCCCh-----------------HHHHHH------------------------hhccccccC-----CCCCCCHHHH
Q 003978 705 ---WDNLNS-----------------MQVIGA------------------------VGFMNQRLE-----IPKDVDPRWA 735 (782)
Q Consensus 705 ---f~~~~~-----------------~~~~~~------------------------i~~~~~~~~-----~p~~~~~~l~ 735 (782)
|.+.+. ...+.. +........ ..+.+++++.
T Consensus 260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 339 (432)
T 3n9x_A 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI 339 (432)
T ss_dssp CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence 333220 000000 100011111 1146899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
+||.+||..||.+|||+.++ |.|+||+..+..
T Consensus 340 dLl~~mL~~dP~~R~ta~e~------L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 340 NLLESMLKFNPNKRITIDQA------LDHPYLKDVRKK 371 (432)
T ss_dssp HHHHHHSCSSTTTSCCHHHH------HTCGGGTTTCCT
T ss_pred HHHHHHhcCCcccCCCHHHH------hcChhhhhccCc
Confidence 99999999999999999999 678999876543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=373.32 Aligned_cols=251 Identities=24% Similarity=0.403 Sum_probs=214.9
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHH------HHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE------VIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (782)
..++|++++.||+|+||.||+|.+ .++.||||++........ ....+.+|+.+|+.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999987 567799999987643221 234567799999999999999999999999
Q ss_pred CceeEEEeecCCC-CHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 575 QRLCIVTEFLPRG-SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 575 ~~~~lv~E~~~gg-sL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
+.+++||||+.+| +|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeecccce
Confidence 9999999998766 9999997643 6999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCH
Q 003978 654 LKHETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 732 (782)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 732 (782)
....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ........+..+++
T Consensus 179 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~~~ 249 (335)
T 3dls_A 179 YLERGKL-FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------TVEAAIHPPYLVSK 249 (335)
T ss_dssp ECCTTCC-BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------GTTTCCCCSSCCCH
T ss_pred ECCCCCc-eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------HHhhccCCCcccCH
Confidence 6554322 234579999999999998877 7899999999999999999999976332 12234455667999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 733 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 733 ~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
++.+||.+||..||.+|||+.++ ++|+||+...
T Consensus 250 ~l~~li~~~L~~dP~~Rps~~el------l~hp~~~~~~ 282 (335)
T 3dls_A 250 ELMSLVSGLLQPVPERRTTLEKL------VTDPWVTQPV 282 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHH------HHCTTTTCCC
T ss_pred HHHHHHHHHccCChhhCcCHHHH------hcCccccCCc
Confidence 99999999999999999999999 6789987643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=369.71 Aligned_cols=263 Identities=22% Similarity=0.374 Sum_probs=221.6
Q ss_pred ccccccceeEe-eeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCC
Q 003978 500 YEILWEDLTIG-EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQ 575 (782)
Q Consensus 500 ~e~~~~~y~i~-~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 575 (782)
.+...++|.+. ++||+|+||.||+|.+. ++.||||++............+.+|+.+++.+. ||||+++++++....
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34556788887 89999999999999985 778999999876554444567889999999995 699999999999999
Q ss_pred ceeEEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCcEEEEecCC
Q 003978 576 RLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFGL 651 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~---~~~vkL~DFGl 651 (782)
.+|+|||||.+++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||||+. ++.+||+|||+
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 999999999999999998543 356899999999999999999999999 999999999999987 78999999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--ccCCCCC
Q 003978 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ--RLEIPKD 729 (782)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~ 729 (782)
++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..... ....+..
T Consensus 181 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 259 (327)
T 3lm5_A 181 SRKIGHACE-LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSS 259 (327)
T ss_dssp CEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred ccccCCccc-cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcc
Confidence 986554322 2345799999999999999999999999999999999999999998888776665543332 3334467
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 730 ~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
+++.+.+||.+||..||.+|||+.++ |+|+||+...
T Consensus 260 ~~~~~~~li~~~L~~dP~~Rpt~~~l------l~h~~~~~~~ 295 (327)
T 3lm5_A 260 VSQLATDFIQSLLVKNPEKRPTAEIC------LSHSWLQQWD 295 (327)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHH------TTCGGGCCCC
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHH------hCCHhhcccc
Confidence 89999999999999999999999999 6789997653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=394.12 Aligned_cols=261 Identities=25% Similarity=0.485 Sum_probs=219.6
Q ss_pred cccccceeEee-eeccCCcEEEEEEEEc----CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 501 EILWEDLTIGE-QIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 501 e~~~~~y~i~~-~IG~G~~G~Vy~~~~~----~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
.+..+++.+.+ +||+|+||.||+|.+. +..||||+++.... ....+.+.+|+++|+.++|||||++++++.. +
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 44456677777 8999999999999874 34599999976532 2345678899999999999999999999976 5
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
.+|+|||||.+|+|.+++......+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 699999999999999999877777999999999999999999999998 999999999999999999999999999865
Q ss_pred cccc---ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCC
Q 003978 656 HETY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 731 (782)
Q Consensus 656 ~~~~---~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 731 (782)
.... .......+++.|+|||++.+..++.++|||||||+||||++ |..||...+..+....+. ...++..|..++
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~ 565 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECP 565 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-TTCCCCCCTTCC
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCC
Confidence 4321 11223356789999999999999999999999999999998 999999988887776664 344667788899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 732 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 732 ~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
+++.+||.+||..||.+||++.+|++.|+.+....
T Consensus 566 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 566 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999887764443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=369.01 Aligned_cols=257 Identities=24% Similarity=0.433 Sum_probs=218.8
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC--C----HHHHHHHHHHHHHHHhC-CCCceeEEeeeee
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY--S----DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVT 572 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~--~----~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 572 (782)
...++|++.+.||+|+||.||+|.+. ++.||||++..... . ....+.+.+|+.+++.+ +||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 34578999999999999999999984 78899999976542 2 23356788999999999 7999999999999
Q ss_pred cCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCC
Q 003978 573 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (782)
Q Consensus 573 ~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla 652 (782)
.....|+|||||+|++|.+++... ..+++..++.++.||+.||.|||++| |+|+||||+||||+.++.+||+|||++
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEEecCcc
Confidence 999999999999999999999764 46899999999999999999999999 999999999999999999999999999
Q ss_pred cccccccccccCCCCCCcccCcccccC------CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC-
Q 003978 653 RLKHETYLTTKTGKGTPQWMAPEVLRN------EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE- 725 (782)
Q Consensus 653 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~- 725 (782)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+........
T Consensus 248 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 326 (365)
T 2y7j_A 248 CHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS 326 (365)
T ss_dssp EECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred cccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 7654432 2335679999999999863 3578899999999999999999999998877766655533222221
Q ss_pred -CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003978 726 -IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 726 -~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~ 768 (782)
....++..+.+||.+||..||.+|||+.++ |+|+||+
T Consensus 327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~el------l~hp~f~ 364 (365)
T 2y7j_A 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQA------LQHPFFE 364 (365)
T ss_dssp HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHH------HHSGGGC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHH------hcCcccC
Confidence 124688999999999999999999999999 6789986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=375.80 Aligned_cols=262 Identities=31% Similarity=0.527 Sum_probs=213.6
Q ss_pred cceeEeeeeccCCcEEEEEEEEcC-----CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeee-cCCcee
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT-SPQRLC 578 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~ 578 (782)
..|++.++||+|+||.||+|.+.. ..||+|.++... .......+.+|+.+++.++||||+++++++. .++..|
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 468899999999999999998632 248999886533 3455678899999999999999999999864 456789
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeecccccccccc
Confidence 999999999999999877777899999999999999999999999 999999999999999999999999999754332
Q ss_pred cc----cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHH
Q 003978 659 YL----TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733 (782)
Q Consensus 659 ~~----~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 733 (782)
.. ......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...+..+....+. .......|..++..
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-~~~~~~~p~~~~~~ 324 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDP 324 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-TTCCCCCCTTCCHH
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 11 1223457889999999999999999999999999999999 788998776655554443 23345567789999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
+.+||.+||..||.+|||+.++++.|+++...+....
T Consensus 325 l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 325 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 9999999999999999999999999999988776443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=370.44 Aligned_cols=262 Identities=28% Similarity=0.453 Sum_probs=214.3
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEc-CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
+.+...++|++.+.||+|+||.||+|.+. ++.||||++..... ...+.+.+|+.+++.++||||+++++++...+.+
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 34456689999999999999999999974 77899998865433 3356788999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcC---CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 578 CIVTEFLPRGSLFRLLQRNT---TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeecccccc
Confidence 99999999999999986543 35899999999999999999999998 99999999999999999999999999975
Q ss_pred ccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHH---HHH----hhc--ccc-
Q 003978 655 KHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQV---IGA----VGF--MNQ- 722 (782)
Q Consensus 655 ~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~---~~~----i~~--~~~- 722 (782)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ... ... ...
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 43321 122334589999999999988999999999999999999999999975433211 000 000 000
Q ss_pred -cc----CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 723 -RL----EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 723 -~~----~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
.. .++..++..+.+||.+||..||++|||+.+++++|+.+.+
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 11 1223345678999999999999999999999999998764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=363.86 Aligned_cols=262 Identities=26% Similarity=0.456 Sum_probs=220.2
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE-------cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW-------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (782)
++..++|++++.||+|+||.||+|.+ .+..||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 35567999999999999999999984 35579999986433 44556678899999999999999999999999
Q ss_pred CCceeEEEeecCCCCHHHHHhhcC------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCcE
Q 003978 574 PQRLCIVTEFLPRGSLFRLLQRNT------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTV 644 (782)
Q Consensus 574 ~~~~~lv~E~~~ggsL~~~l~~~~------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~---~~~v 644 (782)
....|+|||||++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+. +..+
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceE
Confidence 999999999999999999997653 34889999999999999999999999 999999999999984 4469
Q ss_pred EEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccc
Q 003978 645 KVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMN 721 (782)
Q Consensus 645 kL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~ 721 (782)
||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+. ..
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~ 261 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 261 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TT
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh-cC
Confidence 999999987543221 12223467899999999999899999999999999999998 999999888776665553 23
Q ss_pred cccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 722 QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 722 ~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
.....+..++..+.+||.+||..||.+||++.+++++|..+....
T Consensus 262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 355667789999999999999999999999999999999887644
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=358.45 Aligned_cols=261 Identities=24% Similarity=0.440 Sum_probs=216.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCC--HHHHHHHHHHHHHHHhCCCCceeEEeeee--ecCCc
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLRHPNVLLFMGAV--TSPQR 576 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~--~~~~~ 576 (782)
..++|++++.||+|+||.||++.+ .+..||||++...... ......+.+|+.+++.++||||+++++++ .....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 357899999999999999999998 4668999999764321 23456788999999999999999999998 44567
Q ss_pred eeEEEeecCCCCHHHHHhh-cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 577 LCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
+|+|||||.++ |.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++...
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 89999999765 7777754 3456899999999999999999999999 999999999999999999999999999765
Q ss_pred ccc--cccccCCCCCCcccCcccccCCCC--CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCC
Q 003978 656 HET--YLTTKTGKGTPQWMAPEVLRNEPS--DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 731 (782)
Q Consensus 656 ~~~--~~~~~~~~Gt~~y~aPE~l~~~~~--s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 731 (782)
... ........||+.|+|||++.+... +.++|||||||++|+|++|..||...+.......+. .....++..++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~--~~~~~~~~~~~ 237 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG--KGSYAIPGDCG 237 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HCCCCCCSSSC
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHh--cCCCCCCCccC
Confidence 422 222335579999999999987544 779999999999999999999999888777666553 23456778899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcC
Q 003978 732 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTV 774 (782)
Q Consensus 732 ~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~ 774 (782)
+.+.+||.+||..||.+|||+.++ ++|+||+......
T Consensus 238 ~~l~~li~~~l~~dp~~Rps~~~l------l~~~~~~~~~~~~ 274 (305)
T 2wtk_C 238 PPLSDLLKGMLEYEPAKRFSIRQI------RQHSWFRKKHPPA 274 (305)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHH------HHSHHHHSCCCC-
T ss_pred HHHHHHHHHHccCChhhCCCHHHH------hcCcccccCCCCc
Confidence 999999999999999999999999 6789998765543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=368.25 Aligned_cols=254 Identities=26% Similarity=0.342 Sum_probs=205.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC-----
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----- 575 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 575 (782)
..++|++++.||+|+||.||+|.+ .++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 457999999999999999999987 4678999999876666667788899999999999999999999987655
Q ss_pred -ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 576 -RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 576 -~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
.+|+|||||+ ++|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred cceEEEEEcCC-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 6799999996 488888853 4889999999999999999999999 99999999999999999999999999976
Q ss_pred cccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-----------
Q 003978 655 KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR----------- 723 (782)
Q Consensus 655 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~----------- 723 (782)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+......
T Consensus 177 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 177 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred ccccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 54432 223457899999999999999999999999999999999999999988776655444221110
Q ss_pred ---------cC--------------CCC------CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 724 ---------LE--------------IPK------DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 724 ---------~~--------------~p~------~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
+. ++. ..+.++++||.+||..||.+|||+.++ |+|+||+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~------l~hp~~~~ 324 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA------LQHPYINV 324 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHH------HHSHHHHT
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHH------hCCcchhh
Confidence 00 000 015689999999999999999999999 67899964
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=371.78 Aligned_cols=257 Identities=21% Similarity=0.249 Sum_probs=202.8
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEc-----CCeEEEEEEeccCCCH----H-----HHHHHHHHHHHHHhCCCCcee
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSD----E-----VIHSFRQEVSLMKRLRHPNVL 565 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-----~~~vAiK~~~~~~~~~----~-----~~~~~~~Ei~il~~l~HpnIv 565 (782)
.+...++|++++.||+|+||.||+|.+. +..||||++....... . ....+.+|+.+++.++||||+
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence 3455679999999999999999999984 4679999987653211 0 112356788999999999999
Q ss_pred EEeeeeec----CCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 003978 566 LFMGAVTS----PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 641 (782)
Q Consensus 566 ~l~~~~~~----~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~ 641 (782)
++++++.. ...+|+||||| +++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||||+.+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYK 187 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESS
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccC
Confidence 99999877 67899999999 999999997655 7999999999999999999999998 9999999999999887
Q ss_pred C--cEEEEecCCCcccccccc-------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC--Ch
Q 003978 642 W--TVKVGDFGLSRLKHETYL-------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL--NS 710 (782)
Q Consensus 642 ~--~vkL~DFGla~~~~~~~~-------~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~--~~ 710 (782)
+ .+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||... +.
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 999999999976533211 113457999999999999999999999999999999999999999642 22
Q ss_pred HHHHHHhhccccccCCC---------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 711 MQVIGAVGFMNQRLEIP---------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 711 ~~~~~~i~~~~~~~~~p---------~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
....... ......++ ..++.++.+||.+||..||.+||++.+|++.|+++
T Consensus 268 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 268 VAVQTAK--TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHH--HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHHH--HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 2221111 11111122 27899999999999999999999999999887754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=365.80 Aligned_cols=260 Identities=30% Similarity=0.462 Sum_probs=202.9
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHH--HHhCCCCceeEEeeeee-----c
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSL--MKRLRHPNVLLFMGAVT-----S 573 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~i--l~~l~HpnIv~l~~~~~-----~ 573 (782)
.+..++|+++++||+|+||.||+|.+.++.||||++..... ..+..|.++ +..++||||+++++.+. .
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR-----QNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred CcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 34567999999999999999999999999999999975431 233334444 45589999999997543 2
Q ss_pred CCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcC---------CCCeeecCCCCCcEEEcCCCcE
Q 003978 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC---------NPPIIHRDLKSSNLLVDKHWTV 644 (782)
Q Consensus 574 ~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~---------~~~ivHrDIKp~NILl~~~~~v 644 (782)
...+|+|||||++++|.+++.... +++..++.++.||+.||.|||++ + |+||||||+||||+.++.+
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTTSCE
T ss_pred CceEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCCCcE
Confidence 335789999999999999997644 58888999999999999999998 8 9999999999999999999
Q ss_pred EEEecCCCcccccc--------cccccCCCCCCcccCcccccC-------CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 003978 645 KVGDFGLSRLKHET--------YLTTKTGKGTPQWMAPEVLRN-------EPSDEKSDVYSFGVILWELATEKIPWDNLN 709 (782)
Q Consensus 645 kL~DFGla~~~~~~--------~~~~~~~~Gt~~y~aPE~l~~-------~~~s~~sDIwSLG~ll~elltG~~Pf~~~~ 709 (782)
||+|||+++..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 99999999765432 112224479999999999987 345678999999999999999977663221
Q ss_pred h------------------HHHHHHhhccccccCCCCC------CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 710 S------------------MQVIGAVGFMNQRLEIPKD------VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 710 ~------------------~~~~~~i~~~~~~~~~p~~------~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
. ......+......+.++.. +++++.+||.+||..||.+|||+.++++.|++|.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 1 1111112222233444443 345899999999999999999999999999999998
Q ss_pred Hhhc
Q 003978 766 YFQA 769 (782)
Q Consensus 766 ~~~~ 769 (782)
|-+.
T Consensus 320 ~~~~ 323 (336)
T 3g2f_A 320 WERN 323 (336)
T ss_dssp CCC-
T ss_pred HHhc
Confidence 8643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=375.14 Aligned_cols=258 Identities=22% Similarity=0.369 Sum_probs=212.5
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE-----cCCeEEEEEEeccCC--CHHHHHHHHHHHHHHHhC-CCCceeEEeeeeec
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS 573 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~-----~~~~vAiK~~~~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 573 (782)
...++|+++++||+|+||.||++.. .++.||||+++.... .......+.+|+++|+.+ .||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 4457999999999999999999998 577899999865321 111224566799999999 69999999999999
Q ss_pred CCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 574 ~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
...+|+|||||++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred CceEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 999999999999999999997643 6899999999999999999999998 9999999999999999999999999997
Q ss_pred ccccc-cccccCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhccccccCC
Q 003978 654 LKHET-YLTTKTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWDNLNS----MQVIGAVGFMNQRLEI 726 (782)
Q Consensus 654 ~~~~~-~~~~~~~~Gt~~y~aPE~l~~--~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~ 726 (782)
..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+ ......+
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~ 285 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPY 285 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HHCCCCC
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH--hccCCCC
Confidence 54332 222334579999999999986 3468899999999999999999999974432 2222222 2345567
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhcc
Q 003978 727 PKDVDPRWAAIVESCWHSDPQCRP-----SFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 727 p~~~~~~l~~LI~~cL~~dP~~RP-----s~~ell~~L~~L~~~~~~~~ 770 (782)
+..++..+.+||.+||..||.+|| ++.++ +.|+||+..
T Consensus 286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~el------l~h~~f~~~ 328 (355)
T 1vzo_A 286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI------KEHLFFQKI 328 (355)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHH------HTSGGGTTC
T ss_pred CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHH------HcCcchhcC
Confidence 788999999999999999999999 99999 567888643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=362.81 Aligned_cols=250 Identities=21% Similarity=0.354 Sum_probs=206.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeec--CCcee
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTS--PQRLC 578 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~--~~~~~ 578 (782)
.++|+++++||+|+||.||+|.+ .++.||||+++... .+.+.+|+.+++.+. ||||+++++++.. ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 47899999999999999999987 57789999987433 356889999999997 9999999999987 56789
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-cEEEEecCCCccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHE 657 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~-~vkL~DFGla~~~~~ 657 (782)
+||||+.+++|.+++. .+++..++.++.||+.||.|||+++ |+||||||+||||+.++ .+||+|||+++....
T Consensus 110 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999999885 3788999999999999999999999 99999999999999776 899999999976544
Q ss_pred ccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhcccc-------------
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLN-SMQVIGAVGFMNQ------------- 722 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~-~~~~~~~i~~~~~------------- 722 (782)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ....+..+.....
T Consensus 184 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 184 GQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp TC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 32 2335578999999999987 668999999999999999999999995432 2222211110000
Q ss_pred ----------------------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 723 ----------------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 723 ----------------------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
....+..+++++.+||.+||..||.+|||+.++ |+|+||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~------l~hp~f~~~~ 327 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA------MEHPYFYTVV 327 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHH------HTSGGGTTCC
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHH------hcCccHhhhc
Confidence 001122378999999999999999999999999 6789998764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=370.49 Aligned_cols=266 Identities=31% Similarity=0.557 Sum_probs=220.4
Q ss_pred cccccccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc
Q 003978 497 CLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 497 ~~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (782)
...+++..++|++.+.||+|+||.||+|.+.+ .+|+|+++.........+.+.+|+.+++.++||||+++++++.....
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 35667778999999999999999999999866 59999987654433334567789999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++ ++.+||+|||++....
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 99999999999999999876667999999999999999999999999 99999999999998 6799999999987543
Q ss_pred cc-----cccccCCCCCCcccCcccccC---------CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc
Q 003978 657 ET-----YLTTKTGKGTPQWMAPEVLRN---------EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ 722 (782)
Q Consensus 657 ~~-----~~~~~~~~Gt~~y~aPE~l~~---------~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~ 722 (782)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 260 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK 260 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC
Confidence 21 112233468999999999875 4468899999999999999999999998887777666644333
Q ss_pred ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 723 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 723 ~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
....+..++.++.+||.+||..||.+|||+.++++.|+++....
T Consensus 261 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 33334468899999999999999999999999999999887654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=359.97 Aligned_cols=257 Identities=19% Similarity=0.260 Sum_probs=209.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
..++|++.+.||+|+||.||++.+ .++.||||++..... .......+.+|+.+++.++||||+++++++..++.+|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 357899999999999999999997 467799999976543 34556789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+||||+.++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 99999999999999764 36899999999999999999999999 9999999999999999999999999987654432
Q ss_pred -ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-cccCCCCCCCHHHHHH
Q 003978 660 -LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QRLEIPKDVDPRWAAI 737 (782)
Q Consensus 660 -~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~~l~~L 737 (782)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+.... .....+..+++++.+|
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 268 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAV 268 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHH
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHH
Confidence 22234578999999999999999999999999999999999999998876654433332222 2234567899999999
Q ss_pred HHHhhhhCCCCCC-CHHHHHHHHHHH
Q 003978 738 VESCWHSDPQCRP-SFQELVDKLRDL 762 (782)
Q Consensus 738 I~~cL~~dP~~RP-s~~ell~~L~~L 762 (782)
|.+||..||++|| ++.++++.|+++
T Consensus 269 i~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 269 IARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred HHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 9999999999999 999998887755
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=359.07 Aligned_cols=262 Identities=25% Similarity=0.425 Sum_probs=200.7
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
..|....++|++++.||+|+||.||+|.+. ++.||||++............+..+..+++.++||||+++++++..+.
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 456677889999999999999999999984 788999999876554444555666667788889999999999999999
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcC-CCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~-~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
.+|+||||+ ++.+..++......+++..++.++.||+.||.|||+. + |+|+||||+|||++.++.+||+|||++..
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 999999999 6677777766566799999999999999999999985 8 99999999999999999999999999976
Q ss_pred cccccccccCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhccccccCCC-
Q 003978 655 KHETYLTTKTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLN-SMQVIGAVGFMNQRLEIP- 727 (782)
Q Consensus 655 ~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~p- 727 (782)
..... ......||+.|+|||++. +..++.++|||||||++|+|++|..||.... .......+.. .....++
T Consensus 175 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~ 252 (318)
T 2dyl_A 175 LVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ-EEPPLLPG 252 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH-SCCCCCCS
T ss_pred ccCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc-cCCCCCCc
Confidence 54432 223457899999999994 5567889999999999999999999998743 3333333322 2222222
Q ss_pred -CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 728 -KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 728 -~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
..+++++.+||.+||..||.+||++.+++ .|+||+..
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll------~h~~~~~~ 290 (318)
T 2dyl_A 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLL------EHSFIKRY 290 (318)
T ss_dssp SSCCCHHHHHHHHHHTCSCTTTSCCHHHHT------TSHHHHHH
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHh------hCHHHHhc
Confidence 46899999999999999999999999994 56676543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=354.47 Aligned_cols=259 Identities=25% Similarity=0.386 Sum_probs=216.4
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.++|++++.||+|+||.||+|.+. ++.||||++...... .....+.+|+.+++.++||||+++++++...+..|+||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 468999999999999999999984 778999999765432 34567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc--
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-- 659 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-- 659 (782)
||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 85 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 999999999998653 46899999999999999999999999 9999999999999999999999999997543321
Q ss_pred ccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccccCCCCCCCHHHHHH
Q 003978 660 LTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~~~~-s~~sDIwSLG~ll~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ..................+++.+.+|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHH
Confidence 22335578999999999988765 67899999999999999999999876543 22222221222222335689999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 738 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 738 I~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
|.+||..||.+|||+.++ +.|+||+....
T Consensus 242 i~~~l~~~p~~Rps~~~i------l~~~~~~~~~~ 270 (276)
T 2yex_A 242 LHKILVENPSARITIPDI------KKDRWYNKPLK 270 (276)
T ss_dssp HHHHSCSSTTTSCCHHHH------TTCTTTTCCCC
T ss_pred HHHHCCCCchhCCCHHHH------hcCccccChhh
Confidence 999999999999999999 56899986643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=374.79 Aligned_cols=257 Identities=23% Similarity=0.304 Sum_probs=212.9
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC------CCCceeEEeeeee
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL------RHPNVLLFMGAVT 572 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~~~~~ 572 (782)
+....+|+++++||+|+||.||+|.+. ++.||||+++.. ......+.+|+++++.+ .|+||+++++++.
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 455678999999999999999999884 577999999653 34446677888888877 5779999999999
Q ss_pred cCCceeEEEeecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc--EEEEec
Q 003978 573 SPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT--VKVGDF 649 (782)
Q Consensus 573 ~~~~~~lv~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~--vkL~DF 649 (782)
....+|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||+++ ||||||||+||||+.++. +||+||
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeec
Confidence 9999999999995 69999997654 35899999999999999999999999 999999999999999887 999999
Q ss_pred CCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc-----
Q 003978 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL----- 724 (782)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~----- 724 (782)
|+++..... ....+||+.|+|||++.+..++.++|||||||+||+|++|..||...+....+..+......+
T Consensus 247 G~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~ 323 (429)
T 3kvw_A 247 GSSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323 (429)
T ss_dssp TTCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 999765433 235578999999999999999999999999999999999999999887766554432110000
Q ss_pred ----------------------------------------------------CCCCCCCHHHHHHHHHhhhhCCCCCCCH
Q 003978 725 ----------------------------------------------------EIPKDVDPRWAAIVESCWHSDPQCRPSF 752 (782)
Q Consensus 725 ----------------------------------------------------~~p~~~~~~l~~LI~~cL~~dP~~RPs~ 752 (782)
.++...++++.+||.+||..||.+|||+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta 403 (429)
T 3kvw_A 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403 (429)
T ss_dssp HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence 0122347889999999999999999999
Q ss_pred HHHHHHHHHHHHHHhhcccC
Q 003978 753 QELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 753 ~ell~~L~~L~~~~~~~~~~ 772 (782)
.++ |+|+||+....
T Consensus 404 ~e~------L~Hpw~~~~~~ 417 (429)
T 3kvw_A 404 GQA------LRHPWLRRRLP 417 (429)
T ss_dssp HHH------HTSTTTC----
T ss_pred HHH------hCChhhccCCC
Confidence 999 67899987543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=360.61 Aligned_cols=261 Identities=26% Similarity=0.431 Sum_probs=197.9
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeee---
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVT--- 572 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~--- 572 (782)
..+....+|++.++||+|+||.||++.+ .++.||||++... .......+.+|+.+++.+. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 3455567999999999999999999998 6778999998654 3455677889999999996 999999999983
Q ss_pred -----cCCceeEEEeecCCCCHHHHHhh--cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEE
Q 003978 573 -----SPQRLCIVTEFLPRGSLFRLLQR--NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 645 (782)
Q Consensus 573 -----~~~~~~lv~E~~~ggsL~~~l~~--~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vk 645 (782)
....++++|||+. |+|.+++.. ....+++..++.++.||+.||.|||+++.+|+||||||+||||+.++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEE
Confidence 3445899999995 699998864 34569999999999999999999999776699999999999999999999
Q ss_pred EEecCCCcccccccc------------cccCCCCCCcccCcccc---cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 003978 646 VGDFGLSRLKHETYL------------TTKTGKGTPQWMAPEVL---RNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (782)
Q Consensus 646 L~DFGla~~~~~~~~------------~~~~~~Gt~~y~aPE~l---~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~ 710 (782)
|+|||+++....... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 999999976543221 11134689999999998 567788999999999999999999999976554
Q ss_pred HHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 711 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 711 ~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
...... ......+..++..+.+||.+||..||.+|||+.+++++|.++....
T Consensus 259 ~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 259 LRIVNG----KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp -----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHhhcC----cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 332221 2233445667888999999999999999999999999999887643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=372.66 Aligned_cols=255 Identities=22% Similarity=0.334 Sum_probs=208.3
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec------
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS------ 573 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------ 573 (782)
...++|++++.||+|+||.||+|.+ .++.||||++..... ...+|+++|+.++|||||++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 4457899999999999999999987 577899999875532 12369999999999999999999843
Q ss_pred --------------------------------CCceeEEEeecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHh
Q 003978 574 --------------------------------PQRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSY 618 (782)
Q Consensus 574 --------------------------------~~~~~lv~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qll~aL~~ 618 (782)
...+++|||||+ ++|.+.+.. ....+++..++.++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 334889999997 588777753 34579999999999999999999
Q ss_pred hhcCCCCeeecCCCCCcEEEc-CCCcEEEEecCCCcccccccccccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHH
Q 003978 619 LHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILW 696 (782)
Q Consensus 619 LH~~~~~ivHrDIKp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~s~~sDIwSLG~ll~ 696 (782)
||++| |+||||||+||||+ .++.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|
T Consensus 157 LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 157 IHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 99998 99999999999997 68899999999998654432 233557899999999988754 899999999999999
Q ss_pred HHHcCCCCCCCCChHHHHHHhhcccc---------------------------ccCCCCCCCHHHHHHHHHhhhhCCCCC
Q 003978 697 ELATEKIPWDNLNSMQVIGAVGFMNQ---------------------------RLEIPKDVDPRWAAIVESCWHSDPQCR 749 (782)
Q Consensus 697 elltG~~Pf~~~~~~~~~~~i~~~~~---------------------------~~~~p~~~~~~l~~LI~~cL~~dP~~R 749 (782)
+|++|..||...+....+..+..... ...++..+++++.+||.+||..||.+|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 99999999998887765555432111 111456689999999999999999999
Q ss_pred CCHHHHHHHHHHHHHHHhhcccC
Q 003978 750 PSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 750 Ps~~ell~~L~~L~~~~~~~~~~ 772 (782)
||+.++ |+|+||+..+.
T Consensus 314 ~t~~e~------l~hp~f~~~~~ 330 (383)
T 3eb0_A 314 INPYEA------MAHPFFDHLRN 330 (383)
T ss_dssp CCHHHH------HTSGGGHHHHH
T ss_pred CCHHHH------hcCHHHHHHHh
Confidence 999999 56788876543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=361.10 Aligned_cols=256 Identities=30% Similarity=0.530 Sum_probs=205.8
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC--CCCceeEEeeeeecC----
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL--RHPNVLLFMGAVTSP---- 574 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~~~---- 574 (782)
....++|+++++||+|+||.||+|.+.++.||||++.... ...+.+|.+++..+ +||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred cccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 4556799999999999999999999999999999986543 13344556665554 899999999998876
Q ss_pred CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcC--------CCCeeecCCCCCcEEEcCCCcEEE
Q 003978 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC--------NPPIIHRDLKSSNLLVDKHWTVKV 646 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~--------~~~ivHrDIKp~NILl~~~~~vkL 646 (782)
..+|+|||||++++|.+++... .+++..++.++.|++.||.|||++ + |+||||||+||||+.++.+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTTSCEEE
T ss_pred CceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCCCCEEE
Confidence 6789999999999999999754 589999999999999999999988 7 999999999999999999999
Q ss_pred EecCCCccccccccc----ccCCCCCCcccCcccccCCCCCch------hHHHHHHHHHHHHHcC----------CCCCC
Q 003978 647 GDFGLSRLKHETYLT----TKTGKGTPQWMAPEVLRNEPSDEK------SDVYSFGVILWELATE----------KIPWD 706 (782)
Q Consensus 647 ~DFGla~~~~~~~~~----~~~~~Gt~~y~aPE~l~~~~~s~~------sDIwSLG~ll~elltG----------~~Pf~ 706 (782)
+|||+++........ .....||+.|+|||++.+.....+ +|||||||++|+|++| ..||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 999999755432221 224579999999999988766554 9999999999999999 77776
Q ss_pred CCCh-----HHHHHHhhccccccCCCC-----CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 707 NLNS-----MQVIGAVGFMNQRLEIPK-----DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 707 ~~~~-----~~~~~~i~~~~~~~~~p~-----~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
.... ......+........++. .+++++.+||.+||..||.+|||+.+++++|+++...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 5421 122222222222333332 4567899999999999999999999999999988653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=389.24 Aligned_cols=257 Identities=33% Similarity=0.595 Sum_probs=223.4
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEcC-CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
.|++..++|++.++||+|+||.||+|.+.+ ..||||+++...... +.+.+|+++|+.++|||||++++++.. ..+
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 467778899999999999999999999865 469999998655433 568899999999999999999999876 678
Q ss_pred eEEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 578 CIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
|||||||.+++|.+++... ...+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++...
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 9999999999999999753 345899999999999999999999999 9999999999999999999999999998654
Q ss_pred ccc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHH
Q 003978 657 ETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734 (782)
Q Consensus 657 ~~~-~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l 734 (782)
... .......++..|+|||++.+..++.++|||||||+||||++ |..||......+....+. ...+...+..++..+
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l 493 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESL 493 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHH
T ss_pred CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHH
Confidence 432 12234457889999999999899999999999999999999 999999988877776664 334566778899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 735 AAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 735 ~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
.+||.+||..||++|||+.+|++.|+++
T Consensus 494 ~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 494 HDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 9999999999999999999999887654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=354.61 Aligned_cols=259 Identities=24% Similarity=0.401 Sum_probs=220.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC---C----HHHHHHHHHHHHHHHhCC-CCceeEEeeeee
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY---S----DEVIHSFRQEVSLMKRLR-HPNVLLFMGAVT 572 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~---~----~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~ 572 (782)
..++|++.+.||+|+||.||+|.+ .++.||||++..... . ......+.+|+++++.+. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 457899999999999999999998 467899999976531 1 234567889999999995 999999999999
Q ss_pred cCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCC
Q 003978 573 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (782)
Q Consensus 573 ~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla 652 (782)
....+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEecccch
Confidence 999999999999999999999764 46899999999999999999999999 999999999999999999999999999
Q ss_pred cccccccccccCCCCCCcccCccccc------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCC
Q 003978 653 RLKHETYLTTKTGKGTPQWMAPEVLR------NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEI 726 (782)
Q Consensus 653 ~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 726 (782)
....... ......|++.|+|||++. ...++.++|||||||++|+|++|..||...+.......+.........
T Consensus 172 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 172 CQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp EECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred hhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 7654332 233457899999999985 456788999999999999999999999988877666555433322222
Q ss_pred C--CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 727 P--KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 727 p--~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
+ ..++..+.+||.+||..||.+|||+.++ ++|+||+...
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l------l~h~~~~~~~ 291 (298)
T 1phk_A 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA------LAHPFFQQYV 291 (298)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH------TTSGGGCTTC
T ss_pred ccccccCHHHHHHHHHHccCCcccCCCHHHH------HhChHhhhcc
Confidence 2 4689999999999999999999999999 6789997653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=369.24 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=214.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce---
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL--- 577 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~--- 577 (782)
+.++|.+.+.||+|+||.||+|.+. ++.||||++............+.+|+.+++.++||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3479999999999999999999874 77899999987766677778899999999999999999999999877655
Q ss_pred ---eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 578 ---CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 578 ---~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
|+||||+. ++|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999996 68888874 34899999999999999999999999 99999999999999999999999999976
Q ss_pred cccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc----------
Q 003978 655 KHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR---------- 723 (782)
Q Consensus 655 ~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~---------- 723 (782)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+......
T Consensus 194 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 194 ADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred cccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 5433 234578999999999987 67899999999999999999999999988776655544221110
Q ss_pred -------------------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 724 -------------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 724 -------------------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
...++.+++++.+||.+||..||.+|||+.++ |+|+||+..+.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el------l~hp~f~~~~~ 332 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA------LTHPFFEPFRD 332 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHH------HTSGGGTTTCC
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHH------hcCcccccCCC
Confidence 11234678999999999999999999999999 67899986543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=356.58 Aligned_cols=267 Identities=24% Similarity=0.378 Sum_probs=216.0
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEE-cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC--CCceeEEeeeeecCCc
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR--HPNVLLFMGAVTSPQR 576 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~ 576 (782)
..+..++|++++.||+|+||.||++.+ .++.||||++............+.+|+.+++.+. ||||+++++++.....
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 345667899999999999999999987 4677999999877777777888999999999997 5999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
+|+|||++ +++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||+++ +.+||+|||++....
T Consensus 103 ~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 103 IYMVMECG-NIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEEEECCC-SEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEEEEecC-CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 99999954 78999999864 46899999999999999999999998 999999999999965 799999999997654
Q ss_pred cccc--cccCCCCCCcccCcccccC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhcccc
Q 003978 657 ETYL--TTKTGKGTPQWMAPEVLRN-----------EPSDEKSDVYSFGVILWELATEKIPWDNLNS-MQVIGAVGFMNQ 722 (782)
Q Consensus 657 ~~~~--~~~~~~Gt~~y~aPE~l~~-----------~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~-~~~~~~i~~~~~ 722 (782)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+.....
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 257 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 257 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc
Confidence 3221 2234578999999999976 4678899999999999999999999987643 233333333334
Q ss_pred ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcCCCC
Q 003978 723 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGDS 777 (782)
Q Consensus 723 ~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~~~~ 777 (782)
...++..++.++.+||.+||..||.+||++.++ +.|+||+.......+.
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el------l~h~~~~~~~~~~~~~ 306 (313)
T 3cek_A 258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL------LAHPYVQIQTHPVNQM 306 (313)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH------HTSHHHHCC-------
T ss_pred ccCCcccchHHHHHHHHHHccCCcccCcCHHHH------hcCccccCCCCchhhh
Confidence 556777889999999999999999999999999 6789998877665554
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=360.67 Aligned_cols=261 Identities=30% Similarity=0.502 Sum_probs=218.5
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE------cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~------~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
...++|++++.||+|+||.||++.+ .++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 3457899999999999999999985 4667999998753 3455678899999999999999999999987654
Q ss_pred --ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 576 --RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 576 --~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
.+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||||+.++.+||+|||++.
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 789999999999999999887677999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH---------------HHH
Q 003978 654 LKHETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ---------------VIG 715 (782)
Q Consensus 654 ~~~~~~~---~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~---------------~~~ 715 (782)
....... ......++..|+|||++.+..++.++|||||||++|+|++|..||......- .+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 6544321 1223457888999999999889999999999999999999999986431110 001
Q ss_pred HhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 716 AVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 716 ~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
...........+..+++++.+||.+||..||.+|||+.++++.|++++.++
T Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 111122345567789999999999999999999999999999999998875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=377.23 Aligned_cols=254 Identities=23% Similarity=0.307 Sum_probs=206.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC------C
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------Q 575 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~ 575 (782)
..+|++++.||+|+||.||+|.+ .++.||||++..... ...+|+++|+.++|||||++++++... .
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 35799999999999999999998 477899999875432 234699999999999999999988432 2
Q ss_pred ceeEEEeecCCCCHHHHHh---hcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-CcEEEEecCC
Q 003978 576 RLCIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGL 651 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~---~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~-~~vkL~DFGl 651 (782)
.+++||||+++ +|.+++. .....+++..++.++.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||+
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchh
Confidence 36799999965 7776664 23457899999999999999999999998 9999999999999965 5789999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--------
Q 003978 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-------- 722 (782)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~-------- 722 (782)
++...... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||...+....+..+.....
T Consensus 204 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 204 AKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 98654332 22345789999999999775 689999999999999999999999998876655444322100
Q ss_pred -------ccC------------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 723 -------RLE------------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 723 -------~~~------------~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
... ++..+++++.+||.+||..||.+||++.++ +.|+||+..+..
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~------l~hp~f~~~~~~ 346 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA------CAHSFFDELRDP 346 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH------HTSGGGGGGGCT
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHH------hCCHhhcccccc
Confidence 011 234678999999999999999999999999 678999876544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=373.01 Aligned_cols=255 Identities=26% Similarity=0.358 Sum_probs=199.4
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC------C
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------Q 575 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~ 575 (782)
.++|++++.||+|+||.||+|.+ .++.||||++............+.+|+.+|+.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999987 467899999977655666678889999999999999999999998654 5
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
.+|++|||+ +++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC-------
T ss_pred eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 679999999 7899999875 46899999999999999999999999 999999999999999999999999999765
Q ss_pred ccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-----------
Q 003978 656 HETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR----------- 723 (782)
Q Consensus 656 ~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~----------- 723 (782)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+......
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 183 ADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred ccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 432 234578999999999987 67899999999999999999999999988776555443221100
Q ss_pred ----------c--------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 724 ----------L--------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 724 ----------~--------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
. .+...+++.+.+||.+||..||.+|||+.++ |.|+||+....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~------L~hp~~~~~~~ 320 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA------LAHAYFAQYHD 320 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHH------HTSGGGTTTCC
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHH------hcChhhhhccC
Confidence 0 1123568899999999999999999999999 67899986544
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=380.20 Aligned_cols=249 Identities=16% Similarity=0.185 Sum_probs=200.4
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHH---HHHhCCCCceeEEe-------ee
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVS---LMKRLRHPNVLLFM-------GA 570 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~---il~~l~HpnIv~l~-------~~ 570 (782)
.++|++.+.||+|+||.||+|.+ .++.||||++..... .....+.+.+|+. +|+.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 47899999999999999999986 478899999986533 3345678889994 55555899999998 55
Q ss_pred eecCC-----------------ceeEEEeecCCCCHHHHHhhcC------CcchHHHHHHHHHHHHHHHHhhhcCCCCee
Q 003978 571 VTSPQ-----------------RLCIVTEFLPRGSLFRLLQRNT------TKLDWRRRILMALDIARGVSYLHHCNPPII 627 (782)
Q Consensus 571 ~~~~~-----------------~~~lv~E~~~ggsL~~~l~~~~------~~l~~~~~~~i~~qll~aL~~LH~~~~~iv 627 (782)
++.++ ..||+|||| +|+|.+++.... ..+++..++.++.||+.||+|||+++ |+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iv 228 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LV 228 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 55443 278999999 679999997542 23445888889999999999999999 99
Q ss_pred ecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCCCCCcccCcccccCC-----------CCCchhHHHHHHHHHH
Q 003978 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE-----------PSDEKSDVYSFGVILW 696 (782)
Q Consensus 628 HrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-----------~~s~~sDIwSLG~ll~ 696 (782)
||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||++|
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 999999999999999999999999985443 2335567 999999999887 8999999999999999
Q ss_pred HHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 697 ELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 697 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
+|++|..||......... ......+..+++++.+||.+||..||.+|||+.++ ++|+||+...
T Consensus 305 elltg~~Pf~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~------l~hp~f~~~~ 367 (377)
T 3byv_A 305 WIWCADLPITKDAALGGS------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQA------METPEYEQLR 367 (377)
T ss_dssp HHHHSSCCC------CCS------GGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHH------HTSHHHHHHH
T ss_pred HHHHCCCCCcccccccch------hhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHH------hhChHHHHHH
Confidence 999999999765433221 11223346789999999999999999999999999 5567776544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=351.68 Aligned_cols=257 Identities=22% Similarity=0.312 Sum_probs=212.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeee-ecCCceeE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV-TSPQRLCI 579 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~l 579 (782)
..++|++.+.||+|+||.||+|.+ .++.||||++...... ..+.+|+.+++.+.|++++..+.++ ......++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 347899999999999999999996 5778999998765443 2477899999999988766655554 56677899
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc---CCCcEEEEecCCCcccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~---~~~~vkL~DFGla~~~~ 656 (782)
||||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||++....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99999 89999999866678999999999999999999999999 99999999999994 78899999999998654
Q ss_pred cccc-------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHhhc---cccc
Q 003978 657 ETYL-------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS---MQVIGAVGF---MNQR 723 (782)
Q Consensus 657 ~~~~-------~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~---~~~~~~i~~---~~~~ 723 (782)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+.. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 4322 12455799999999999999999999999999999999999999986432 122222211 1111
Q ss_pred cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 724 LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 724 ~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
..++..+++++.+||.+||..||.+|||+.++++.|+++....
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 2234678999999999999999999999999999998886654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=391.53 Aligned_cols=259 Identities=26% Similarity=0.478 Sum_probs=218.6
Q ss_pred cccceeEe-eeeccCCcEEEEEEEEc----CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 503 LWEDLTIG-EQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 503 ~~~~y~i~-~~IG~G~~G~Vy~~~~~----~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
....+.+. ++||+|+||.||+|.+. ++.||||+++.........+.+.+|+++|+.++|||||++++++.. ..+
T Consensus 366 ~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~ 444 (635)
T 4fl3_A 366 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESW 444 (635)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred cchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCE
Confidence 33445554 48999999999999763 3569999998765555566789999999999999999999999974 568
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
++|||||.+++|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++....
T Consensus 445 ~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 445 MLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred EEEEEccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 9999999999999999764 46899999999999999999999999 99999999999999999999999999976543
Q ss_pred cc---ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHH
Q 003978 658 TY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733 (782)
Q Consensus 658 ~~---~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 733 (782)
.. .......+|+.|+|||++.+..++.++|||||||+||||++ |..||...+.......+. .......+..++++
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~ 600 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPRE 600 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 22 12233457889999999999999999999999999999998 999999998887776664 34456778889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
+.+||.+||..||++||++.+|++.|+++...+
T Consensus 601 l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 601 MYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999999988776554
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=365.55 Aligned_cols=256 Identities=24% Similarity=0.365 Sum_probs=213.4
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC-----Cc
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----QR 576 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 576 (782)
..+|+++++||+|+||.||+|.+ .+..||||++.... .......+.+|+++|+.++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 36899999999999999999987 46679999987533 445567888999999999999999999998654 36
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
+|+||||+. ++|.+++... .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 899999996 5999999753 5899999999999999999999999 9999999999999999999999999998654
Q ss_pred ccccc---ccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc---------
Q 003978 657 ETYLT---TKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--------- 723 (782)
Q Consensus 657 ~~~~~---~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~--------- 723 (782)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+....+..+......
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 33221 234579999999998754 55899999999999999999999999887766555443211100
Q ss_pred --------------------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 724 --------------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 724 --------------------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
..+.+.+++++.+||.+||..||.+|||+.++ |.|+||+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~------l~hp~~~~~~ 321 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA------LAHPYLEQYY 321 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHH------HTSGGGTTTC
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHH------hcCcchhhcc
Confidence 11225678999999999999999999999999 6789998753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=351.39 Aligned_cols=256 Identities=22% Similarity=0.313 Sum_probs=208.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeee-ecCCceeEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV-TSPQRLCIV 580 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~lv 580 (782)
.++|++.+.||+|+||.||+|.+ .++.||||++...... ..+.+|+.+++.+.|++++..+..+ ......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 46899999999999999999996 5678999987654332 3467899999999988777666555 666778999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCcEEEEecCCCccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl---~~~~~vkL~DFGla~~~~~ 657 (782)
|||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 9999 89999999876677999999999999999999999999 9999999999999 7889999999999986544
Q ss_pred ccc-------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH---HHHHHhhc---ccccc
Q 003978 658 TYL-------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM---QVIGAVGF---MNQRL 724 (782)
Q Consensus 658 ~~~-------~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~---~~~~~i~~---~~~~~ 724 (782)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+.. .....
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 321 223557999999999999999999999999999999999999999765332 12212111 11112
Q ss_pred CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 725 EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 725 ~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
.....+++++.+||.+||..||++|||+.++++.|+++....
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 233678999999999999999999999999999999887765
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=360.29 Aligned_cols=255 Identities=23% Similarity=0.351 Sum_probs=204.5
Q ss_pred ccceeEe-eeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCceeE
Q 003978 504 WEDLTIG-EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 504 ~~~y~i~-~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 579 (782)
.+.|++. +.||+|+||.||+|.+ .++.||||++...... ....+.+|++++..+ +||||+++++++...+.+|+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH--IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC--CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch--hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 3578885 7899999999999987 5778999999765432 245778899999985 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc---EEEEecCCCcccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT---VKVGDFGLSRLKH 656 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~---vkL~DFGla~~~~ 656 (782)
|||||++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++. +||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999999765 46899999999999999999999998 999999999999988765 9999999987543
Q ss_pred ccc-------ccccCCCCCCcccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh--------------
Q 003978 657 ETY-------LTTKTGKGTPQWMAPEVLRN-----EPSDEKSDVYSFGVILWELATEKIPWDNLNS-------------- 710 (782)
Q Consensus 657 ~~~-------~~~~~~~Gt~~y~aPE~l~~-----~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~-------------- 710 (782)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 211 11223469999999999975 4578899999999999999999999976542
Q ss_pred -HHHHHHhhccccccCCC----CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 711 -MQVIGAVGFMNQRLEIP----KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 711 -~~~~~~i~~~~~~~~~p----~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
......+. .....++ ..+++++++||.+||..||.+|||+.++ ++|+||+...
T Consensus 246 ~~~~~~~i~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~------l~hp~~~~~~ 303 (316)
T 2ac3_A 246 QNMLFESIQ--EGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQV------LQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHH--HCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH------HHSTTCC---
T ss_pred HHHHHHHHh--ccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHH------hcChhhcCCC
Confidence 12222222 1222333 4689999999999999999999999999 6789997653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=359.40 Aligned_cols=262 Identities=26% Similarity=0.340 Sum_probs=215.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc---CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC---CCCceeEEeeeee-----
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL---RHPNVLLFMGAVT----- 572 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~----- 572 (782)
.++|++++.||+|+||.||+|.+. ++.||||++............+.+|+.+++.+ .||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 468999999999999999999983 56799999876543322223455677766665 8999999999987
Q ss_pred cCCceeEEEeecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCC
Q 003978 573 SPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (782)
Q Consensus 573 ~~~~~~lv~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGl 651 (782)
....+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++| |+|+||||+||||+.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEEEecCcc
Confidence 5567899999996 59999997643 34899999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc---------
Q 003978 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ--------- 722 (782)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~--------- 722 (782)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.....
T Consensus 167 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (326)
T 1blx_A 167 ARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245 (326)
T ss_dssp CCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred cccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence 97654332 23356789999999999999999999999999999999999999998887665554421100
Q ss_pred ----------------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcCC
Q 003978 723 ----------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVG 775 (782)
Q Consensus 723 ----------------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~~ 775 (782)
...+...++..+.+||.+||..||.+|||+.++ +.|+||+....+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~------l~hp~~~~~~~~~~ 308 (326)
T 1blx_A 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA------LSHPYFQDLERCKE 308 (326)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH------HTSGGGTTCCCCCC
T ss_pred ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHH------hcCccccccchhhh
Confidence 112345689999999999999999999999999 67899987765543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=354.36 Aligned_cols=261 Identities=27% Similarity=0.429 Sum_probs=221.0
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
....++|++++.||+|+||.||+|.. .++.||||++............+.+|+++++.++||||+++++++.....+|
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 44567999999999999999999998 4778999999766544444567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC---CcEEEEecCCCccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH---WTVKVGDFGLSRLK 655 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~---~~vkL~DFGla~~~ 655 (782)
+||||+.+++|.+++.... .+++..++.++.||+.||.|||+++ |+|+||||+||+|+.+ +.+||+|||++...
T Consensus 98 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 9999999999999987643 6899999999999999999999998 9999999999999754 47999999998765
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCC--CCCCCHH
Q 003978 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEI--PKDVDPR 733 (782)
Q Consensus 656 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--p~~~~~~ 733 (782)
..... .....||+.|+|||++.+. ++.++|||||||++|+|++|..||...+.......+......... ...++++
T Consensus 175 ~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T 2wei_A 175 QQNTK-MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (287)
T ss_dssp CCCSS-CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHH
T ss_pred cCCCc-cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHH
Confidence 43321 2233578999999998875 889999999999999999999999988877766665433322222 2568999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
+.+||.+||..||.+|||+.++ +.|+||+....
T Consensus 253 ~~~li~~~l~~dp~~Rps~~el------l~hp~~~~~~~ 285 (287)
T 2wei_A 253 AKDLIRKMLTFHPSLRITATQC------LEHPWIQKYSS 285 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHH------HHSHHHHHHCC
T ss_pred HHHHHHHHcccChhhCcCHHHH------hcCHHHhcccc
Confidence 9999999999999999999999 67899986543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=351.33 Aligned_cols=254 Identities=25% Similarity=0.369 Sum_probs=211.5
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec------
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS------ 573 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------ 573 (782)
....+|++++.||+|+||.||+|.+. ++.||||++.... ..+.+|+++++.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 34578999999999999999999985 7889999997653 346689999999999999999998854
Q ss_pred ----------CCceeEEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 003978 574 ----------PQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642 (782)
Q Consensus 574 ----------~~~~~lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~ 642 (782)
...+|+||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.++
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTK 159 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETT
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCCC
Confidence 34589999999999999999754 356899999999999999999999998 99999999999999999
Q ss_pred cEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc
Q 003978 643 TVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ 722 (782)
Q Consensus 643 ~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~ 722 (782)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||... ......+ .
T Consensus 160 ~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~----~ 232 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDL----R 232 (284)
T ss_dssp EEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHH----H
T ss_pred CEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHh----h
Confidence 99999999997655432 223457899999999999999999999999999999999999887432 1122122 1
Q ss_pred ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 723 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 723 ~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
...++..++..+.+||.+||..||.+|||+.++++.|..+.+..-+..
T Consensus 233 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~ 280 (284)
T 2a19_B 233 DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE 280 (284)
T ss_dssp TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC------
T ss_pred cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCccc
Confidence 234567789999999999999999999999999999988866544433
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=369.49 Aligned_cols=259 Identities=22% Similarity=0.382 Sum_probs=219.2
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCH---------------HHHHHHHHHHHHHHhCCCCcee
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSD---------------EVIHSFRQEVSLMKRLRHPNVL 565 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~---------------~~~~~~~~Ei~il~~l~HpnIv 565 (782)
....++|++++.||+|+||.||+|.+.++.||||++....... .....+.+|+.+++.++||||+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 3456799999999999999999999988999999987543211 1126788999999999999999
Q ss_pred EEeeeeecCCceeEEEeecCCCCHHHH------Hhhc-CCcchHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEE
Q 003978 566 LFMGAVTSPQRLCIVTEFLPRGSLFRL------LQRN-TTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLL 637 (782)
Q Consensus 566 ~l~~~~~~~~~~~lv~E~~~ggsL~~~------l~~~-~~~l~~~~~~~i~~qll~aL~~LH~-~~~~ivHrDIKp~NIL 637 (782)
++++++...+.+|+||||+++++|.++ +... ...+++..++.++.||+.||.|||+ +| |+|+||||+|||
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil 184 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNIL 184 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEE
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEE
Confidence 999999999999999999999999998 5442 4578999999999999999999998 88 999999999999
Q ss_pred EcCCCcEEEEecCCCcccccccccccCCCCCCcccCcccccCC-CCCc-hhHHHHHHHHHHHHHcCCCCCCCCCh-HHHH
Q 003978 638 VDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE-PSDE-KSDVYSFGVILWELATEKIPWDNLNS-MQVI 714 (782)
Q Consensus 638 l~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~-~sDIwSLG~ll~elltG~~Pf~~~~~-~~~~ 714 (782)
|+.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||..... ....
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 999999999999999865443 23455789999999999887 5665 99999999999999999999988766 5555
Q ss_pred HHhhccccccCCC-------------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 715 GAVGFMNQRLEIP-------------------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 715 ~~i~~~~~~~~~p-------------------~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
..+... ...++ ..+++++.+||.+||..||.+|||+.++ ++|+||+...
T Consensus 263 ~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~------l~hp~f~~~~ 330 (348)
T 2pml_X 263 NNIRTK--NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA------LKHEWLADTN 330 (348)
T ss_dssp HHHTSC--CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHH------HTSGGGTTCC
T ss_pred HHHhcc--CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHH------hcCccccCCC
Confidence 454322 22333 5689999999999999999999999999 5678887654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=360.26 Aligned_cols=261 Identities=25% Similarity=0.337 Sum_probs=214.4
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC-----C
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----Q 575 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~ 575 (782)
..++|++.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 4578999999999999999999985 7789999996433 345567788999999999999999999987654 6
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
..|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++...
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 7899999996 599999976 35899999999999999999999999 999999999999999999999999999765
Q ss_pred ccccc----------cccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-
Q 003978 656 HETYL----------TTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR- 723 (782)
Q Consensus 656 ~~~~~----------~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~- 723 (782)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 43211 1123478999999998765 67899999999999999999999999988765544332211000
Q ss_pred -----------------------------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcC
Q 003978 724 -----------------------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTV 774 (782)
Q Consensus 724 -----------------------------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~ 774 (782)
...++.+++++.+||.+||..||.+|||+.++ ++|+||+......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el------l~hp~~~~~~~~~ 316 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA------LEHPYLQTYHDPN 316 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHH------HTSGGGTTTCCTT
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHH------hcCccccccCCcc
Confidence 01124688999999999999999999999999 6789998776544
Q ss_pred C
Q 003978 775 G 775 (782)
Q Consensus 775 ~ 775 (782)
.
T Consensus 317 ~ 317 (353)
T 2b9h_A 317 D 317 (353)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=374.71 Aligned_cols=257 Identities=12% Similarity=0.078 Sum_probs=194.0
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhC--CCCceeEEe-------eee
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL--RHPNVLLFM-------GAV 571 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l--~HpnIv~l~-------~~~ 571 (782)
..+|+++++||+|+||.||+|.+ .++.||||++...... ......+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34699999999999999999997 4677999999886653 34566777885544444 699988865 333
Q ss_pred ecC-----------------CceeEEEeecCCCCHHHHHhhcCCcchHHHH------HHHHHHHHHHHHhhhcCCCCeee
Q 003978 572 TSP-----------------QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR------ILMALDIARGVSYLHHCNPPIIH 628 (782)
Q Consensus 572 ~~~-----------------~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~------~~i~~qll~aL~~LH~~~~~ivH 628 (782)
..+ ..+|||||||+ ++|.+++......+++..+ +.++.||+.||+|||+++ |+|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivH 217 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVH 217 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--Ccc
Confidence 322 33799999997 7999999875444555555 677799999999999999 999
Q ss_pred cCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCC
Q 003978 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWD 706 (782)
Q Consensus 629 rDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~s~~sDIwSLG~ll~elltG~~Pf~ 706 (782)
|||||+||||+.++.+||+|||+++....... ...+|+.|+|||++.+ ..++.++|||||||+||+|++|..||.
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP---ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEEE---GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCcc---CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999986543321 3356799999999987 778999999999999999999999998
Q ss_pred CCChHHHH--HH---hhcc--ccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 707 NLNSMQVI--GA---VGFM--NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 707 ~~~~~~~~--~~---i~~~--~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
........ .. .... ......+..+++.+.+||.+||..||++|||+.++ |+|+||+....
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~------l~hp~f~~~~~ 361 (371)
T 3q60_A 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA------METPEFLQLQN 361 (371)
T ss_dssp BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHH------TTSHHHHHHHH
T ss_pred CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHH------hcCHHHHHHHH
Confidence 76432110 00 0001 11122335789999999999999999999999999 67888876543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=361.69 Aligned_cols=265 Identities=29% Similarity=0.493 Sum_probs=197.3
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
..+.+..++|++.+.||+|+||.||++.+ .++.||||++..... ......+.+|+.+++.++||||+++++++...+
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSS
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence 34566778999999999999999999986 678899999865432 233467788999999999999999999999999
Q ss_pred ceeEEEeecCCCCHHHHHhh-------cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEe
Q 003978 576 RLCIVTEFLPRGSLFRLLQR-------NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~-------~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~D 648 (782)
..|+||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~d 164 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIAD 164 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEe
Confidence 99999999999999999964 2345899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccccccc-----ccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc
Q 003978 649 FGLSRLKHETY-----LTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ 722 (782)
Q Consensus 649 FGla~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~ 722 (782)
||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.................
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 244 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC
Confidence 99987543321 11234578999999999876 5688999999999999999999999988766554433221111
Q ss_pred --------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 723 --------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 723 --------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
.......++.++.+||.+||..||.+||++.++ ++|+||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l------l~h~~~~~~~ 295 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL------LRHKFFQKAK 295 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHH------HTSTTC----
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHH------hhChhhhcCC
Confidence 122345688999999999999999999999999 6678887654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=359.33 Aligned_cols=257 Identities=24% Similarity=0.349 Sum_probs=214.5
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE---cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCC------ceeEEeeee
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW---YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP------NVLLFMGAV 571 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~Hp------nIv~l~~~~ 571 (782)
+...++|++++.||+|+||.||+|.+ .++.||||+++.. ......+.+|+.+++.++|+ +|+++++++
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 45567999999999999999999987 4677999998643 34557788899999988655 599999999
Q ss_pred ecCCceeEEEeecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC----------
Q 003978 572 TSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---------- 640 (782)
Q Consensus 572 ~~~~~~~lv~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~---------- 640 (782)
...+.+|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC--
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCc
Confidence 9999999999999 889999997654 36889999999999999999999999 999999999999987
Q ss_pred ---------CCcEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH
Q 003978 641 ---------HWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (782)
Q Consensus 641 ---------~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~ 711 (782)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 668999999999765432 23457899999999999999999999999999999999999999988766
Q ss_pred HHHHHhhccccc------------------------------------------cCCCCCCCHHHHHHHHHhhhhCCCCC
Q 003978 712 QVIGAVGFMNQR------------------------------------------LEIPKDVDPRWAAIVESCWHSDPQCR 749 (782)
Q Consensus 712 ~~~~~i~~~~~~------------------------------------------~~~p~~~~~~l~~LI~~cL~~dP~~R 749 (782)
.....+...... ...+...++++.+||.+||..||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 544433211110 01112235789999999999999999
Q ss_pred CCHHHHHHHHHHHHHHHhhcccC
Q 003978 750 PSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 750 Ps~~ell~~L~~L~~~~~~~~~~ 772 (782)
||+.++ ++|+||+..+.
T Consensus 321 pt~~el------l~hp~f~~~~~ 337 (339)
T 1z57_A 321 ITLREA------LKHPFFDLLKK 337 (339)
T ss_dssp CCHHHH------TTSGGGGGGGC
T ss_pred cCHHHH------hcCHHHHHHhc
Confidence 999999 67899987654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=365.26 Aligned_cols=262 Identities=20% Similarity=0.291 Sum_probs=210.9
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE-cCCeEEEEEEeccCC---------CHHHHHHHHHHHHHHHhCCCCceeEEeee
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEY---------SDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~-~~~~vAiK~~~~~~~---------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 570 (782)
....++|++++.||+|+||.||+|.+ .+..||||++..... .....+.+.+|+.+++.++||||++++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 45668999999999999999999986 577899999865322 23445788999999999999999999999
Q ss_pred eec-----CCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEE
Q 003978 571 VTS-----PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 645 (782)
Q Consensus 571 ~~~-----~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vk 645 (782)
+.. ...+|+||||+. ++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||||+.++.+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEE
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCCCCEE
Confidence 843 346899999996 6999998877677999999999999999999999999 99999999999999999999
Q ss_pred EEecCCCcccccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-
Q 003978 646 VGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR- 723 (782)
Q Consensus 646 L~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~- 723 (782)
|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+......
T Consensus 175 l~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 175 ICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp ECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99999997544332 2234578999999999987 67899999999999999999999999988766655444211110
Q ss_pred -----------------------------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 724 -----------------------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 724 -----------------------------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
...++.+++.+.+||.+||..||.+|||+.++ |+|+||+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el------l~hp~f~~~~~ 325 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA------LRHPYFESLFD 325 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHH------HTSGGGTTTCC
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHH------HcCchhhhccC
Confidence 11234578899999999999999999999999 67899987643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=356.86 Aligned_cols=254 Identities=31% Similarity=0.527 Sum_probs=209.6
Q ss_pred eeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccC--CCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeec
Q 003978 507 LTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 584 (782)
|..+++||+|+||.||+|.+.++.||||++.... ......+.+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 4455899999999999999999999999987543 23345678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc--CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc--c
Q 003978 585 PRGSLFRLLQRN--TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--L 660 (782)
Q Consensus 585 ~ggsL~~~l~~~--~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~ 660 (782)
++++|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+||||+.++.+||+|||++....... .
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 999999999643 345899999999999999999999998 9999999999999999999999999997654322 1
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH----HHhhccc---------cccCCC
Q 003978 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVI----GAVGFMN---------QRLEIP 727 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~----~~i~~~~---------~~~~~p 727 (782)
......||+.|+|||++.+. ++.++|||||||++|+|++|..||......... ..+.... .....+
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD 269 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCC
T ss_pred cccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccc
Confidence 23345799999999998764 788999999999999999999999865432211 1111000 011122
Q ss_pred CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003978 728 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 763 (782)
Q Consensus 728 ~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~ 763 (782)
..++..+.+||.+||..||.+|||+.++++.|+++.
T Consensus 270 ~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 270 STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 334567999999999999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=363.95 Aligned_cols=259 Identities=17% Similarity=0.207 Sum_probs=212.3
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEE-------EcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC---CCceeEE
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAV-------WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVLLF 567 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~-------~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l 567 (782)
..++...++|++.++||+|+||.||+|. ..++.||||+++... ...+..|+++++.+. |+||+++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 3455667899999999999999999993 357789999986543 245677888888886 9999999
Q ss_pred eeeeecCCceeEEEeecCCCCHHHHHhh----cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---
Q 003978 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQR----NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK--- 640 (782)
Q Consensus 568 ~~~~~~~~~~~lv~E~~~ggsL~~~l~~----~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~--- 640 (782)
++++...+..|+|||||++|+|.+++.. ....+++..++.++.||+.||+|||+++ ||||||||+||||+.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGT
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEeccccc
Confidence 9999999999999999999999999975 3456999999999999999999999998 999999999999998
Q ss_pred --------CCcEEEEecCCCcccc--cccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 003978 641 --------HWTVKVGDFGLSRLKH--ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS 710 (782)
Q Consensus 641 --------~~~vkL~DFGla~~~~--~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~ 710 (782)
++.+||+|||+++... .........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 8999999999997543 122233456799999999999999999999999999999999999999964432
Q ss_pred HHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCC-CCHHHHHHHHHHHHHHHhhc
Q 003978 711 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCR-PSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 711 ~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~R-Ps~~ell~~L~~L~~~~~~~ 769 (782)
.. ............+..+.+++..||..+|.+| |++.++.+.|+++...-+..
T Consensus 291 ~~------~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~~ 344 (365)
T 3e7e_A 291 GE------CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTN 344 (365)
T ss_dssp TE------EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTTT
T ss_pred Cc------eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhhh
Confidence 11 0000111111346789999999999999998 57889888888877665543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=368.61 Aligned_cols=260 Identities=30% Similarity=0.486 Sum_probs=208.5
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEE-cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
..+...++|++.+.||+|+||.||+|.. .++.||||++....... ....+.+|+++++.++||||+++++++......
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 3455678999999999999999999986 47789999987543221 123578899999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcC---CcchHHHHHHHHHHHHHHHHhhhcC---CCCeeecCCCCCcEEEcCCCcEEEEecCC
Q 003978 578 CIVTEFLPRGSLFRLLQRNT---TKLDWRRRILMALDIARGVSYLHHC---NPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~qll~aL~~LH~~---~~~ivHrDIKp~NILl~~~~~vkL~DFGl 651 (782)
++|||||.+++|.+++.... ..+++..++.++.||+.||.|||++ + |+||||||+||||+.++.+||+|||+
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 180 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDFGL 180 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTTCCEEECCCSS
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCCCCEEeccCcc
Confidence 99999999999999997543 3489999999999999999999998 8 99999999999999999999999999
Q ss_pred Cccccccc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-----ChHHHHHHhhccccc--
Q 003978 652 SRLKHETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL-----NSMQVIGAVGFMNQR-- 723 (782)
Q Consensus 652 a~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~-----~~~~~~~~i~~~~~~-- 723 (782)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||... ........+......
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (326)
T 3uim_A 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260 (326)
T ss_dssp CEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC
T ss_pred ccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh
Confidence 98654322 2233456999999999999888999999999999999999999999521 111111111100000
Q ss_pred ----------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003978 724 ----------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRD 761 (782)
Q Consensus 724 ----------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~ 761 (782)
...+...+..+.+||.+||..||.+|||+.+++++|+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 11112234679999999999999999999999998864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=377.06 Aligned_cols=257 Identities=27% Similarity=0.432 Sum_probs=202.2
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCC------HHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS------DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (782)
...++|.+.++||+|+||.||+|.+. ++.||||++...... ......+.+|+.+|+.++|||||++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45678999999999999999999984 578999999865421 1223457889999999999999999999864
Q ss_pred CCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC---cEEEEecC
Q 003978 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFG 650 (782)
Q Consensus 574 ~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~---~vkL~DFG 650 (782)
..+|+|||||++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++ .+||+|||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred -CceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecc
Confidence 4589999999999999988654 46899999999999999999999998 99999999999997544 59999999
Q ss_pred CCcccccccccccCCCCCCcccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhccc--ccc
Q 003978 651 LSRLKHETYLTTKTGKGTPQWMAPEVLRN---EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ-VIGAVGFMN--QRL 724 (782)
Q Consensus 651 la~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~-~~~~i~~~~--~~~ 724 (782)
+++...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ....+.... ..+
T Consensus 288 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~ 366 (419)
T 3i6u_A 288 HSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366 (419)
T ss_dssp TTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred cceecCCCc-cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence 998765432 2335679999999999864 567889999999999999999999997654332 222221111 112
Q ss_pred CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 725 EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 725 ~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
.....+++.+.+||.+||..||.+|||+.++ |+|+||+.
T Consensus 367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~------l~hp~~~~ 405 (419)
T 3i6u_A 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEA------LRHPWLQD 405 (419)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH------HHSGGGCC
T ss_pred hhhcccCHHHHHHHHHHccCChhHCcCHHHH------hCCcccCC
Confidence 2235689999999999999999999999999 67899864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=357.37 Aligned_cols=258 Identities=22% Similarity=0.296 Sum_probs=209.1
Q ss_pred cccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeee----cC
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT----SP 574 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~----~~ 574 (782)
.+..++|++++.||+|+||.||++.. .++.||||++... .......+.+|+.+++.++||||+++++++. ..
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 34567899999999999999999997 5778999998653 3455678899999999999999999999986 34
Q ss_pred CceeEEEeecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCC
Q 003978 575 QRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGl 651 (782)
..+|+||||+.+++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+||||+.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEecCc
Confidence 578999999999999999975 3567899999999999999999999998 99999999999999999999999999
Q ss_pred Ccccccccc---------cccCCCCCCcccCcccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHh
Q 003978 652 SRLKHETYL---------TTKTGKGTPQWMAPEVLRNEP---SDEKSDVYSFGVILWELATEKIPWDNLNS--MQVIGAV 717 (782)
Q Consensus 652 a~~~~~~~~---------~~~~~~Gt~~y~aPE~l~~~~---~s~~sDIwSLG~ll~elltG~~Pf~~~~~--~~~~~~i 717 (782)
+........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ......+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 260 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence 875432111 011235799999999998664 58899999999999999999999953211 0111111
Q ss_pred hccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003978 718 GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 763 (782)
Q Consensus 718 ~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~ 763 (782)
. .......+..++.++.+||.+||..||.+|||+.+++++|++++
T Consensus 261 ~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 261 Q-NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp H-CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred h-ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 1 12233445678999999999999999999999999999988774
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=369.50 Aligned_cols=257 Identities=22% Similarity=0.303 Sum_probs=207.3
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc-CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc---
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR--- 576 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--- 576 (782)
+....+|+++++||+|+||.||+|.+. +..||+|.+..... ...+|+++|+.++|||||++++++.....
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 344568999999999999999999984 44588888765432 12369999999999999999999854433
Q ss_pred ---eeEEEeecCCCCHHHHHh---hcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCcEEEEec
Q 003978 577 ---LCIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDF 649 (782)
Q Consensus 577 ---~~lv~E~~~ggsL~~~l~---~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~-~~~~vkL~DF 649 (782)
+|+|||||++ ++...+. .....+++..++.++.||+.||.|||++| |+||||||+||||+ .++.+||+||
T Consensus 110 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 110 EVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp CEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCC
T ss_pred ceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 7899999976 5544432 23456899999999999999999999999 99999999999999 7999999999
Q ss_pred CCCcccccccccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-----
Q 003978 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR----- 723 (782)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~----- 723 (782)
|+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+....+..+......
T Consensus 187 G~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 187 GSAKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp TTCEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCcccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9998654332 23355789999999999775 4899999999999999999999999988776655443221100
Q ss_pred ----------------------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 724 ----------------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 724 ----------------------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
..++..+++++.+||.+||..||.+|||+.++ +.|+||+..+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~------l~hp~f~~~~~~ 331 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEA------LCHPFFDELRTG 331 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH------HTSGGGSTTTSS
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHH------hcChhhhhhccc
Confidence 01334588999999999999999999999999 679999876553
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=362.64 Aligned_cols=256 Identities=14% Similarity=0.190 Sum_probs=210.1
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc----------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeE-----
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY----------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL----- 566 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~----------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~----- 566 (782)
...++|++.+.||+|+||.||+|.+. ++.||||++... ..+.+|+++++.++||||++
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~ 111 (352)
T 2jii_A 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKL 111 (352)
T ss_dssp TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhh
Confidence 34579999999999999999999874 568999998754 35778999999999999988
Q ss_pred ----------Eeeeeec-CCceeEEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 003978 567 ----------FMGAVTS-PQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 634 (782)
Q Consensus 567 ----------l~~~~~~-~~~~~lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~ 634 (782)
+++++.. ...+|+||||| +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~ 188 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAE 188 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGG
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHH
Confidence 5556554 67889999999 99999999865 357999999999999999999999998 999999999
Q ss_pred cEEEcCCC--cEEEEecCCCcccccccc-------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 003978 635 NLLVDKHW--TVKVGDFGLSRLKHETYL-------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPW 705 (782)
Q Consensus 635 NILl~~~~--~vkL~DFGla~~~~~~~~-------~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf 705 (782)
||||+.++ .+||+|||+++....... ......||+.|+|||++.+..++.++|||||||+||+|++|..||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 899999999976543221 113347999999999999999999999999999999999999999
Q ss_pred CCCC--hHHHHHHhhc-cccccCCC------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHh
Q 003978 706 DNLN--SMQVIGAVGF-MNQRLEIP------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767 (782)
Q Consensus 706 ~~~~--~~~~~~~i~~-~~~~~~~p------~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~ 767 (782)
.... .......... ......++ ..++.++.+||.+||..||.+|||+.++++.|+++....-
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 8764 2222222211 11111111 2568999999999999999999999999999999877654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=369.62 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=204.7
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC--------CCceeEEeeee
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR--------HPNVLLFMGAV 571 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~--------HpnIv~l~~~~ 571 (782)
...++|+++++||+|+||.||+|.+ .++.||||++... ......+.+|+.+|+.+. |+||+++++++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 4457899999999999999999987 4677999998643 445577889999999985 78899999998
Q ss_pred e----cCCceeEEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcC-CCCeeecCCCCCcEEEcCCC---
Q 003978 572 T----SPQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHW--- 642 (782)
Q Consensus 572 ~----~~~~~~lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~-~~~ivHrDIKp~NILl~~~~--- 642 (782)
. ....+|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++ | |+||||||+||||+.++
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhh
Confidence 7 556799999999 66777666543 35699999999999999999999998 8 99999999999998775
Q ss_pred ----------------------------------------------cEEEEecCCCcccccccccccCCCCCCcccCccc
Q 003978 643 ----------------------------------------------TVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEV 676 (782)
Q Consensus 643 ----------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~ 676 (782)
.+||+|||+++..... .....||+.|+|||+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChh
Confidence 7999999999865543 234578999999999
Q ss_pred ccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh------HHHHHHhhcccc----------------------------
Q 003978 677 LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS------MQVIGAVGFMNQ---------------------------- 722 (782)
Q Consensus 677 l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~------~~~~~~i~~~~~---------------------------- 722 (782)
+.+..++.++|||||||+||+|++|..||...+. ......+.....
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 9999999999999999999999999999976542 111111110000
Q ss_pred ------------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 723 ------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 723 ------------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
....+...++.+.+||.+||..||.+|||+.++ |+|+||+.
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~------l~hp~~~~ 397 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC------LRHPWLNS 397 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHH------HTSGGGGC
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHH------hhCccccC
Confidence 001122335678999999999999999999999 67899863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=358.66 Aligned_cols=256 Identities=32% Similarity=0.551 Sum_probs=211.1
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHh--CCCCceeEEeeeeecCC---
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR--LRHPNVLLFMGAVTSPQ--- 575 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~--- 575 (782)
....++|++.+.||+|+||.||++.+.++.||||++.... ...+.+|+++++. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 4556799999999999999999999999999999986432 3566788999988 68999999999998776
Q ss_pred -ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhh--------cCCCCeeecCCCCCcEEEcCCCcEEE
Q 003978 576 -RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH--------HCNPPIIHRDLKSSNLLVDKHWTVKV 646 (782)
Q Consensus 576 -~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH--------~~~~~ivHrDIKp~NILl~~~~~vkL 646 (782)
.+|+||||+++++|.+++... .+++..++.++.||+.||.||| +++ |+||||||+||||+.++.+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTTSCEEE
T ss_pred ceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCCCCEEE
Confidence 789999999999999999754 5899999999999999999999 778 999999999999999999999
Q ss_pred EecCCCcccccccc----cccCCCCCCcccCcccccCCCC------CchhHHHHHHHHHHHHHcC----------CCCCC
Q 003978 647 GDFGLSRLKHETYL----TTKTGKGTPQWMAPEVLRNEPS------DEKSDVYSFGVILWELATE----------KIPWD 706 (782)
Q Consensus 647 ~DFGla~~~~~~~~----~~~~~~Gt~~y~aPE~l~~~~~------s~~sDIwSLG~ll~elltG----------~~Pf~ 706 (782)
+|||++........ ......||+.|+|||++.+... +.++|||||||++|+|++| ..||.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 99999976544321 2234579999999999987632 3689999999999999999 88997
Q ss_pred CCCh-----HHHHHHhhccccccCCCC-----CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 707 NLNS-----MQVIGAVGFMNQRLEIPK-----DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 707 ~~~~-----~~~~~~i~~~~~~~~~p~-----~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
.... ......+......+.++. .++..+.+||.+||..||.+|||+.+++++|+++..+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 6532 222223322222333332 2346899999999999999999999999999998764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=360.94 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=212.9
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc----
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR---- 576 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---- 576 (782)
..++|.+.+.||+|+||.||+|.+. ++.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 3478999999999999999999984 7789999998766666677889999999999999999999999987654
Q ss_pred --eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 577 --LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 577 --~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
+|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999996 58887774 34899999999999999999999999 99999999999999999999999999976
Q ss_pred cccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc------------
Q 003978 655 KHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN------------ 721 (782)
Q Consensus 655 ~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~------------ 721 (782)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+....+..+....
T Consensus 176 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 176 ADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred CCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 5432 234578999999999987 678999999999999999999999999887665544432110
Q ss_pred -----------------cccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 722 -----------------QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 722 -----------------~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
....++..+++++.+||.+||..||.+|||+.++ +.|+||+..+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~------l~hp~f~~~~~ 314 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA------LTHPFFEPFRD 314 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHH------HTSGGGTTTCC
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHH------hcCcchhhccC
Confidence 0112335679999999999999999999999999 67899986554
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=359.30 Aligned_cols=250 Identities=28% Similarity=0.442 Sum_probs=200.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCC------HHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS------DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (782)
..++|++.+.||+|+||.||+|.+. ++.||||++...... ......+.+|+.+|+.++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4578999999999999999999984 568999999764321 12334678899999999999999999998765
Q ss_pred CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc---EEEEecCC
Q 003978 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT---VKVGDFGL 651 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~---vkL~DFGl 651 (782)
. +|+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++. +||+|||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred c-eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 4 89999999999999999754 46899999999999999999999999 999999999999987654 99999999
Q ss_pred CcccccccccccCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhcc--ccccC
Q 003978 652 SRLKHETYLTTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFM--NQRLE 725 (782)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~-~~~~~i~~~--~~~~~ 725 (782)
+........ .....||+.|+|||++. +..++.++|||||||++|+|++|..||...... .....+... .....
T Consensus 164 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T 2ycf_A 164 SKILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242 (322)
T ss_dssp CEECCCCHH-HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHH
T ss_pred ceecccccc-cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCch
Confidence 986544321 12346899999999974 566789999999999999999999999765432 122222111 11122
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003978 726 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVD 757 (782)
Q Consensus 726 ~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~ 757 (782)
.+..++.++.+||.+||..||.+||++.++++
T Consensus 243 ~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 33568999999999999999999999999953
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=351.85 Aligned_cols=259 Identities=22% Similarity=0.343 Sum_probs=207.4
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeee-------
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT------- 572 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~------- 572 (782)
...++|++++.||+|+||.||+|.+. ++.||||++... .....+.+.+|+++++.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 34578999999999999999999985 678999998754 3556678899999999999999999998873
Q ss_pred -------cCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCcE
Q 003978 573 -------SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTV 644 (782)
Q Consensus 573 -------~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~-~~~~v 644 (782)
....+|+||||+. ++|.+++.. ..+++..++.++.||+.||+|||+++ |+|+||||+|||++ .++.+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEE
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeE
Confidence 3467899999996 599999975 45889999999999999999999999 99999999999997 56799
Q ss_pred EEEecCCCccccccc---ccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc
Q 003978 645 KVGDFGLSRLKHETY---LTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM 720 (782)
Q Consensus 645 kL~DFGla~~~~~~~---~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~ 720 (782)
||+|||+++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999998654321 11223457999999998865 67899999999999999999999999988776655443211
Q ss_pred cc----------------------------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 721 NQ----------------------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 721 ~~----------------------------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
.. ....++.++.++.+||.+||..||.+|||+.++ +.|+||+...-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el------l~hp~~~~~~~ 314 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA------LSHPYMSIYSF 314 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHH------HTSHHHHTTCC
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHH------hCCcccccccC
Confidence 10 011235689999999999999999999999999 67899987654
Q ss_pred c
Q 003978 773 T 773 (782)
Q Consensus 773 ~ 773 (782)
.
T Consensus 315 p 315 (320)
T 2i6l_A 315 P 315 (320)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=385.87 Aligned_cols=263 Identities=33% Similarity=0.590 Sum_probs=224.9
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEcC-----CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeee
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 572 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 572 (782)
..+++..++|++++.||+|+||.||+|.+.. ..||||+++.. ......+.+.+|+.+++.++|||||++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3566777899999999999999999998842 34889987643 24556678999999999999999999999985
Q ss_pred cCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCC
Q 003978 573 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (782)
Q Consensus 573 ~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla 652 (782)
++.+|+|||||++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred -cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecCCC
Confidence 46789999999999999999877667999999999999999999999998 999999999999999999999999999
Q ss_pred ccccccc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCC
Q 003978 653 RLKHETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 730 (782)
Q Consensus 653 ~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 730 (782)
+...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+.. .....++..+
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~ 617 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERLPMPPNC 617 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH-TCCCCCCTTC
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-CCCCCCCccc
Confidence 8654432 22234467889999999999999999999999999999997 9999999888777666643 3355678889
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 731 DPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 731 ~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
++.+.+||.+||..||.+|||+.++++.|.++..+
T Consensus 618 ~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999998654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=358.75 Aligned_cols=263 Identities=21% Similarity=0.234 Sum_probs=201.3
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc--
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR-- 576 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-- 576 (782)
....++|++.+.||+|+||.||+|.+. +..||||++....... ....++++.+..++||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---HHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 345679999999999999999999984 7789999986543322 345567888888999999999999865433
Q ss_pred -----eeEEEeecCCCCHHHHHh---hcCCcchHHHHHHHHHHHHHHHHhhh--cCCCCeeecCCCCCcEEEcC-CCcEE
Q 003978 577 -----LCIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALDIARGVSYLH--HCNPPIIHRDLKSSNLLVDK-HWTVK 645 (782)
Q Consensus 577 -----~~lv~E~~~ggsL~~~l~---~~~~~l~~~~~~~i~~qll~aL~~LH--~~~~~ivHrDIKp~NILl~~-~~~vk 645 (782)
+++||||+++ +|...+. .....+++..++.++.||+.||.||| +++ |+||||||+||||+. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEE
Confidence 7899999976 6655543 23456889999999999999999999 877 999999999999996 89999
Q ss_pred EEecCCCcccccccccccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--
Q 003978 646 VGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-- 722 (782)
Q Consensus 646 L~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~-- 722 (782)
|+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+.....
T Consensus 173 l~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp ECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 99999998655432 233557899999999997654 79999999999999999999999998887665555422110
Q ss_pred ----------------------------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcC
Q 003978 723 ----------------------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTV 774 (782)
Q Consensus 723 ----------------------------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~ 774 (782)
....+...++++.+||.+||..||.+|||+.++ |+|+||+......
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~------l~hp~f~~~~~~~ 325 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA------LCHPYFDELHDPA 325 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHH------TTSGGGGGGGCTT
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHH------hcCccccccCCcc
Confidence 011223367899999999999999999999999 6799998876554
Q ss_pred CC
Q 003978 775 GD 776 (782)
Q Consensus 775 ~~ 776 (782)
..
T Consensus 326 ~~ 327 (360)
T 3e3p_A 326 TK 327 (360)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=348.86 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=203.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec--------
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-------- 573 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-------- 573 (782)
.++|++++.||+|+||.||+|.+ .++.||||++... ......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 36899999999999999999997 5778999998643 3456788899999999999999999998754
Q ss_pred -----CCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEe
Q 003978 574 -----PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648 (782)
Q Consensus 574 -----~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~D 648 (782)
...+|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||||+.++.+||+|
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEEee
Confidence 35689999999999999999877767889999999999999999999999 99999999999999999999999
Q ss_pred cCCCcccccc--------------cccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC-hHH
Q 003978 649 FGLSRLKHET--------------YLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLN-SMQ 712 (782)
Q Consensus 649 FGla~~~~~~--------------~~~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~-~~~ 712 (782)
||++...... ........||+.|+|||++.+. .++.++|||||||++|+|++ ||.... ...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 9999765422 1122345689999999999865 68899999999999999998 564322 222
Q ss_pred HHHHhhccc--cccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 713 VIGAVGFMN--QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 713 ~~~~i~~~~--~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
....+.... ....++...++.+.+||.+||..||.+|||+.++ +.|+||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l------l~h~~~~~~ 290 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL------LNSGWLPVK 290 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHH------HHSSCSCCC
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHH------hCCCCcCCC
Confidence 333332211 1233455678889999999999999999999999 568888643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=369.63 Aligned_cols=260 Identities=19% Similarity=0.363 Sum_probs=210.1
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC--ce
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ--RL 577 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~ 577 (782)
...++|++.++||+|+||.||+|.+. ++.||||++...... .....+.+|+++|+.++||||+++++++.... ..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 34578999999999999999999985 778999999754321 22456778999999999999999999987655 68
Q ss_pred eEEEeecCCCCHHHHHhhcCC--cchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----cCCCcEEEEecCC
Q 003978 578 CIVTEFLPRGSLFRLLQRNTT--KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGL 651 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl----~~~~~vkL~DFGl 651 (782)
|+|||||++++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 999999999999999976432 3899999999999999999999999 9999999999999 7778899999999
Q ss_pred CcccccccccccCCCCCCcccCcccccC--------CCCCchhHHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHhhc
Q 003978 652 SRLKHETYLTTKTGKGTPQWMAPEVLRN--------EPSDEKSDVYSFGVILWELATEKIPWDNLN----SMQVIGAVGF 719 (782)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~y~aPE~l~~--------~~~s~~sDIwSLG~ll~elltG~~Pf~~~~----~~~~~~~i~~ 719 (782)
++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ....+..+..
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp CEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred ceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 98655433 2334579999999999875 456789999999999999999999996432 2233333321
Q ss_pred ccc-------------------cc----CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 720 MNQ-------------------RL----EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 720 ~~~-------------------~~----~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
... .. .++..++..+.+||.+||..||++||++.++++.+.++.+.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 110 00 11123456789999999999999999999999999887653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=355.12 Aligned_cols=262 Identities=26% Similarity=0.415 Sum_probs=191.3
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHH-HHHhCCCCceeEEeeeeecC
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSP 574 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~ 574 (782)
..++...++|++++.||+|+||.||+|.+. ++.||||++..... ......+..|+. +++.++||||+++++++..+
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~ 93 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 93 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence 455667789999999999999999999985 77899999976543 333445555655 77778999999999999999
Q ss_pred CceeEEEeecCCCCHHHHHhh----cCCcchHHHHHHHHHHHHHHHHhhhcC-CCCeeecCCCCCcEEEcCCCcEEEEec
Q 003978 575 QRLCIVTEFLPRGSLFRLLQR----NTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~----~~~~l~~~~~~~i~~qll~aL~~LH~~-~~~ivHrDIKp~NILl~~~~~vkL~DF 649 (782)
+..|+||||+.+ +|.+++.. ....+++..++.++.|++.||.|||+. + |+||||||+||||+.++.+||+||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~Df 170 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDF 170 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECCC
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEccC
Confidence 999999999965 88887753 245689999999999999999999998 8 999999999999999999999999
Q ss_pred CCCcccccccccccCCCCCCcccCcccc----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhcccccc
Q 003978 650 GLSRLKHETYLTTKTGKGTPQWMAPEVL----RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ-VIGAVGFMNQRL 724 (782)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~y~aPE~l----~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~-~~~~i~~~~~~~ 724 (782)
|+++....... .....||+.|+|||++ .+..++.++|||||||++|+|++|..||....... ....+. .....
T Consensus 171 g~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~ 248 (327)
T 3aln_A 171 GISGQLVDSIA-KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV-KGDPP 248 (327)
T ss_dssp SSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC-CSCCC
T ss_pred CCceecccccc-cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh-cCCCC
Confidence 99976544322 2234789999999998 46668899999999999999999999998754321 111111 11122
Q ss_pred CC----CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 725 EI----PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 725 ~~----p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
.+ ...+++.+.+||.+||..||.+|||+.++ ++|+||+...
T Consensus 249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el------l~hp~~~~~~ 293 (327)
T 3aln_A 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKEL------LKHPFILMYE 293 (327)
T ss_dssp CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHH------TTSHHHHHHH
T ss_pred CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHH------HhChHHHHhH
Confidence 22 24689999999999999999999999999 5677875443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=361.72 Aligned_cols=258 Identities=24% Similarity=0.314 Sum_probs=209.6
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CC-----ceeEEeeeee
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HP-----NVLLFMGAVT 572 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~l~~~~~ 572 (782)
+...++|++.++||+|+||.||+|.+. ++.||||+++.. ......+..|+.+++.+. |+ +|+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 445689999999999999999999884 667999999643 344567778899988885 44 4999999999
Q ss_pred cCCceeEEEeecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc--CCCcEEEEec
Q 003978 573 SPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD--KHWTVKVGDF 649 (782)
Q Consensus 573 ~~~~~~lv~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~--~~~~vkL~DF 649 (782)
..+.+|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||.+..+||||||||+||||+ .++.+||+||
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999999995 59999997653 458999999999999999999995333399999999999995 4778999999
Q ss_pred CCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc-----
Q 003978 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL----- 724 (782)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~----- 724 (782)
|+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+....+..+......+
T Consensus 206 G~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 206 GSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp TTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999866443 234578999999999999999999999999999999999999999888766655443211100
Q ss_pred -----------CCC------------------CC----------------------------CCHHHHHHHHHhhhhCCC
Q 003978 725 -----------EIP------------------KD----------------------------VDPRWAAIVESCWHSDPQ 747 (782)
Q Consensus 725 -----------~~p------------------~~----------------------------~~~~l~~LI~~cL~~dP~ 747 (782)
.++ +. .++++.+||.+||..||.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 000 00 014789999999999999
Q ss_pred CCCCHHHHHHHHHHHHHHHhhccc
Q 003978 748 CRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 748 ~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
+|||+.++ |+|+||+...
T Consensus 363 ~Rpta~e~------L~hp~f~~~~ 380 (382)
T 2vx3_A 363 TRIQPYYA------LQHSFFKKTA 380 (382)
T ss_dssp TSCCHHHH------TTSGGGCC--
T ss_pred hCCCHHHH------hcCcccccCC
Confidence 99999999 6789998654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=368.80 Aligned_cols=259 Identities=22% Similarity=0.327 Sum_probs=192.9
Q ss_pred cccceeE-eeeeccCCcEEEEEEEEc----CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeee--cCC
Q 003978 503 LWEDLTI-GEQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT--SPQ 575 (782)
Q Consensus 503 ~~~~y~i-~~~IG~G~~G~Vy~~~~~----~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~ 575 (782)
..+.|++ +++||+|+||.||+|.+. +..||||++...... ..+.+|+.+|+.++|||||++++++. ...
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 3456776 568999999999999974 567999999765543 35678999999999999999999994 467
Q ss_pred ceeEEEeecCCCCHHHHHhhc--------CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----cCCCc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRN--------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWT 643 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~--------~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl----~~~~~ 643 (782)
.+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTC
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCc
Confidence 8999999995 5888888532 124899999999999999999999999 9999999999999 67789
Q ss_pred EEEEecCCCccccccc---ccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChH--------
Q 003978 644 VKVGDFGLSRLKHETY---LTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSM-------- 711 (782)
Q Consensus 644 vkL~DFGla~~~~~~~---~~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~-------- 711 (782)
+||+|||+++...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 9999999998654321 223345799999999999874 4899999999999999999999999755431
Q ss_pred -HHHHHhhcccccc------------------------------------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHH
Q 003978 712 -QVIGAVGFMNQRL------------------------------------EIPKDVDPRWAAIVESCWHSDPQCRPSFQE 754 (782)
Q Consensus 712 -~~~~~i~~~~~~~------------------------------------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~e 754 (782)
..+..+......+ ......++.+.+||.+||..||.+|||+.+
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 1111111000000 011123778999999999999999999999
Q ss_pred HHHHHHHHHHHHhhcccCcC
Q 003978 755 LVDKLRDLQRQYFQASRSTV 774 (782)
Q Consensus 755 ll~~L~~L~~~~~~~~~~~~ 774 (782)
+ |+|+||+..+...
T Consensus 331 ~------L~hp~f~~~~~~~ 344 (405)
T 3rgf_A 331 A------MQDPYFLEDPLPT 344 (405)
T ss_dssp H------HTSGGGTSSSCCC
T ss_pred H------hcChhhccCCCCc
Confidence 9 7789998765443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=371.21 Aligned_cols=256 Identities=20% Similarity=0.302 Sum_probs=213.3
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCC-CceeEEeeeeecCCcee
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH-PNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~ 578 (782)
...++|+++++||+|+||.||+|.+. ++.||||++....... .+.+|+++++.+.| ++|+.+..++......|
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 34578999999999999999999974 7789999987654332 46779999999986 55666666677778889
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---cCCCcEEEEecCCCccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl---~~~~~vkL~DFGla~~~ 655 (782)
|||||| +++|.+++......+++..++.++.||+.||.|||+++ ||||||||+|||| +.++.+||+|||+++..
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 999999 89999999876778999999999999999999999999 9999999999999 58899999999999865
Q ss_pred ccccc-------cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHhhcc---cc
Q 003978 656 HETYL-------TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS---MQVIGAVGFM---NQ 722 (782)
Q Consensus 656 ~~~~~-------~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~---~~~~~~i~~~---~~ 722 (782)
..... ......||+.|+|||++.+..++.++|||||||+||+|++|..||..... ...+..+... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 44321 22356799999999999999999999999999999999999999987543 2222222111 11
Q ss_pred ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 723 RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 723 ~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
...++..++.++.+||.+||..||++||++.+|++.|+++..
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 223346789999999999999999999999999999998865
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=353.37 Aligned_cols=256 Identities=23% Similarity=0.344 Sum_probs=210.9
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc--C-CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCc------eeEEeeee
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--G-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN------VLLFMGAV 571 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~-~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~~~ 571 (782)
+...++|++++.||+|+||.||+|.+. + ..||||+++.. ......+.+|+.+++.+.|++ |+.+++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 345689999999999999999999974 3 57999998643 344567888999999987655 99999999
Q ss_pred ecCCceeEEEeecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE------------
Q 003978 572 TSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV------------ 638 (782)
Q Consensus 572 ~~~~~~~lv~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl------------ 638 (782)
...+.+|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC
T ss_pred eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccccc
Confidence 9999999999999 667777776543 56899999999999999999999998 9999999999999
Q ss_pred -------cCCCcEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH
Q 003978 639 -------DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM 711 (782)
Q Consensus 639 -------~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~ 711 (782)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56789999999999764433 23457999999999999999999999999999999999999999988766
Q ss_pred HHHHHhhcccccc------------------------------------------CCCCCCCHHHHHHHHHhhhhCCCCC
Q 003978 712 QVIGAVGFMNQRL------------------------------------------EIPKDVDPRWAAIVESCWHSDPQCR 749 (782)
Q Consensus 712 ~~~~~i~~~~~~~------------------------------------------~~p~~~~~~l~~LI~~cL~~dP~~R 749 (782)
.....+....... ......++++.+||.+||..||.+|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 5444332211100 0111224589999999999999999
Q ss_pred CCHHHHHHHHHHHHHHHhhccc
Q 003978 750 PSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 750 Ps~~ell~~L~~L~~~~~~~~~ 771 (782)
||+.++ |.|+||+...
T Consensus 326 pt~~e~------l~hp~f~~~~ 341 (355)
T 2eu9_A 326 ITLAEA------LLHPFFAGLT 341 (355)
T ss_dssp CCHHHH------TTSGGGGGCC
T ss_pred cCHHHH------hcChhhcCCC
Confidence 999999 6789998654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=352.38 Aligned_cols=257 Identities=25% Similarity=0.445 Sum_probs=203.5
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCH----HHHHHHHHHHHHHHhC----CCCceeEEe
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRL----RHPNVLLFM 568 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~----~~~~~~~~Ei~il~~l----~HpnIv~l~ 568 (782)
..+...++|++++.||+|+||.||+|.+ .++.||||++....... .....+.+|+.+++.+ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3455668999999999999999999987 56789999997654322 1233456799999998 899999999
Q ss_pred eeeecCCceeEEEee-cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCcEEE
Q 003978 569 GAVTSPQRLCIVTEF-LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKV 646 (782)
Q Consensus 569 ~~~~~~~~~~lv~E~-~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~-~~~~vkL 646 (782)
+++...+..++|||| +.+++|.+++.... .+++..++.++.||+.||.|||+++ |+|+||||+||+++ .++.+||
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEE
Confidence 999999999999999 78899999997643 6899999999999999999999999 99999999999999 8899999
Q ss_pred EecCCCcccccccccccCCCCCCcccCcccccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC
Q 003978 647 GDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSD-EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE 725 (782)
Q Consensus 647 ~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s-~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~ 725 (782)
+|||++....... .....||+.|+|||++.+..+. .++|||||||++|+|++|..||..... . ......
T Consensus 182 ~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~------~~~~~~ 251 (312)
T 2iwi_A 182 IDFGSGALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--I------LEAELH 251 (312)
T ss_dssp CCCSSCEECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--H------HHTCCC
T ss_pred EEcchhhhcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--H------hhhccC
Confidence 9999998665432 2345789999999999876664 589999999999999999999975321 1 123455
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcC
Q 003978 726 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTV 774 (782)
Q Consensus 726 ~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~ 774 (782)
++..++.++.+||.+||..||++|||+.++ ++|+||+......
T Consensus 252 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~------l~~~~~~~~~~~~ 294 (312)
T 2iwi_A 252 FPAHVSPDCCALIRRCLAPKPSSRPSLEEI------LLDPWMQTPAEDV 294 (312)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSCCHHHH------HHSTTTCC-----
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCHHHH------hcChhhcCchhcc
Confidence 678899999999999999999999999999 6789998765443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=353.86 Aligned_cols=253 Identities=22% Similarity=0.347 Sum_probs=181.9
Q ss_pred cccceeEee-eeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec----CC
Q 003978 503 LWEDLTIGE-QIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----PQ 575 (782)
Q Consensus 503 ~~~~y~i~~-~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~ 575 (782)
..++|.+.+ .||+|+||.||+|.+. ++.||||++.... . ........++.+.||||+++++++.. ..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 446899865 6999999999999985 7889999986532 1 12223344667799999999999875 44
Q ss_pred ceeEEEeecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCcEEEEecCC
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFGL 651 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~---~~~vkL~DFGl 651 (782)
.+|+|||||++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+. ++.+||+|||+
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 5899999999999999997653 46999999999999999999999999 999999999999976 45599999999
Q ss_pred CcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH----hhccc--cccC
Q 003978 652 SRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGA----VGFMN--QRLE 725 (782)
Q Consensus 652 a~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~----i~~~~--~~~~ 725 (782)
++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........... +.... ....
T Consensus 178 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T 3fhr_A 178 AKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255 (336)
T ss_dssp CEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred ceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence 9765433 22345789999999999888889999999999999999999999976654432211 11111 1122
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 726 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 726 ~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
....+++++.+||.+||..||.+|||+.++ +.|+||+...
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~el------l~hp~~~~~~ 295 (336)
T 3fhr_A 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQF------MNHPWINQSM 295 (336)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHH------HHSHHHHTGG
T ss_pred hhccCCHHHHHHHHHHCCCChhHCcCHHHH------hcCccccccc
Confidence 225689999999999999999999999999 6789998654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=353.12 Aligned_cols=253 Identities=23% Similarity=0.412 Sum_probs=212.3
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCH----HHHHHHHHHHHHHHhCC--CCceeEEeeee
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLR--HPNVLLFMGAV 571 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~----~~~~~~~~Ei~il~~l~--HpnIv~l~~~~ 571 (782)
.+...++|++++.||+|+||.||+|.+ .++.||||++....... .....+.+|+.+++.+. ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 345668999999999999999999987 56789999997654321 11245667999999996 59999999999
Q ss_pred ecCCceeEEEeecCC-CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCcEEEEec
Q 003978 572 TSPQRLCIVTEFLPR-GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDF 649 (782)
Q Consensus 572 ~~~~~~~lv~E~~~g-gsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~-~~~~vkL~DF 649 (782)
..++.+++|||++.+ ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+ .++.+||+||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999999976 8999999764 46899999999999999999999999 99999999999999 7889999999
Q ss_pred CCCcccccccccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCC
Q 003978 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPK 728 (782)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 728 (782)
|+++...... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... . ......++.
T Consensus 195 g~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~------~~~~~~~~~ 264 (320)
T 3a99_A 195 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--I------IRGQVFFRQ 264 (320)
T ss_dssp TTCEECCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--H------HHCCCCCSS
T ss_pred cccccccccc--ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--h------hcccccccc
Confidence 9998665432 234578999999999987665 6789999999999999999999975321 1 122345667
Q ss_pred CCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 729 DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 729 ~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
.+++++.+||.+||..||.+|||+.++ ++++||+...
T Consensus 265 ~~~~~~~~li~~~l~~dp~~Rps~~~l------l~hp~~~~~~ 301 (320)
T 3a99_A 265 RVSSECQHLIRWCLALRPSDRPTFEEI------QNHPWMQDVL 301 (320)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHH------HTSGGGSSCC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHH------hcCHhhcCcc
Confidence 899999999999999999999999999 6788987654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=355.90 Aligned_cols=256 Identities=19% Similarity=0.314 Sum_probs=205.6
Q ss_pred ccccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-----------CCceeEEe
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-----------HPNVLLFM 568 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~ 568 (782)
...++|++++.||+|+||.||+|.+ .++.||||++... ......+.+|+.+++.+. ||||++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 3457899999999999999999997 5778999998643 334567788999998886 89999999
Q ss_pred eeeecCC----ceeEEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcC-CCCeeecCCCCCcEEEc---
Q 003978 569 GAVTSPQ----RLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVD--- 639 (782)
Q Consensus 569 ~~~~~~~----~~~lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~-~~~ivHrDIKp~NILl~--- 639 (782)
+++...+ .++++|||+ +++|.+++... ...+++..++.++.||+.||.|||++ + |+||||||+||||+
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEE
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccC
Confidence 9987654 789999999 88999999763 34589999999999999999999997 8 99999999999994
Q ss_pred ---CCCcEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh------
Q 003978 640 ---KHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS------ 710 (782)
Q Consensus 640 ---~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~------ 710 (782)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 3448999999999765543 2345789999999999999999999999999999999999999986542
Q ss_pred HHHHHHhhc-c---------------------------------------ccccCCCCCCCHHHHHHHHHhhhhCCCCCC
Q 003978 711 MQVIGAVGF-M---------------------------------------NQRLEIPKDVDPRWAAIVESCWHSDPQCRP 750 (782)
Q Consensus 711 ~~~~~~i~~-~---------------------------------------~~~~~~p~~~~~~l~~LI~~cL~~dP~~RP 750 (782)
......+.. . .....++..++.++.+||.+||..||.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 111111110 0 001123344567899999999999999999
Q ss_pred CHHHHHHHHHHHHHHHhhcccC
Q 003978 751 SFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 751 s~~ell~~L~~L~~~~~~~~~~ 772 (782)
|+.++ |.|+||+....
T Consensus 327 t~~el------l~hp~f~~~~~ 342 (373)
T 1q8y_A 327 DAGGL------VNHPWLKDTLG 342 (373)
T ss_dssp CHHHH------HTCGGGTTCTT
T ss_pred CHHHH------hhChhhhcccC
Confidence 99999 67899987543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=366.42 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=197.0
Q ss_pred ccccceeEeeeeccCCcEE-EEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCceeE
Q 003978 502 ILWEDLTIGEQIGQGSCGT-VYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~-Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 579 (782)
+...+|.+.++||+|+||. ||++...++.||||++..... ..+.+|+++|+.+ +|||||++++++.....+|+
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 4445799999999999998 555666889999999865432 2345799999999 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-----CCcEEEEecCCCcc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-----HWTVKVGDFGLSRL 654 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~-----~~~vkL~DFGla~~ 654 (782)
|||||. ++|.+++......+.+..++.++.||+.||.|||+++ |+||||||+||||+. ...+||+|||+++.
T Consensus 96 v~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 999995 5999999876656666677889999999999999999 999999999999953 23588999999976
Q ss_pred ccccc---ccccCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccc-cCC
Q 003978 655 KHETY---LTTKTGKGTPQWMAPEVLR---NEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQR-LEI 726 (782)
Q Consensus 655 ~~~~~---~~~~~~~Gt~~y~aPE~l~---~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~-~~~ 726 (782)
..... .......||+.|+|||++. +..++.++|||||||++|+|++ |..||...........+...... ...
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 252 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHP 252 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCT
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCc
Confidence 54321 2233457999999999998 4566789999999999999999 99999766554443332211111 112
Q ss_pred CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003978 727 PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 727 p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~ 768 (782)
+...+..+.+||.+||..||.+|||+.+++ +|+||+
T Consensus 253 ~~~~~~~~~~li~~~L~~dP~~Rps~~evl------~hp~f~ 288 (432)
T 3p23_A 253 EKHEDVIARELIEKMIAMDPQKRPSAKHVL------KHPFFW 288 (432)
T ss_dssp TCHHHHHHHHHHHHHSCSSGGGSCCHHHHH------TSTTTC
T ss_pred cccccHHHHHHHHHHHhCCHhhCCCHHHHH------hCcccc
Confidence 233456789999999999999999999994 566664
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=330.40 Aligned_cols=231 Identities=16% Similarity=0.137 Sum_probs=192.6
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
...++|++.+.||+|+||.||+|.+. ++.||||++..... .......+.+|+.++..++||||+++++++...+.+|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 45578999999999999999999985 77899999987654 3566788999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
+|||||+|++|.+++... .....+..++.||+.||.|||++| |+||||||+||||+.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 999999999999999643 344567889999999999999999 9999999999999999999997443
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH-hhcccc----ccCCCCCCCHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGA-VGFMNQ----RLEIPKDVDPR 733 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~-i~~~~~----~~~~p~~~~~~ 733 (782)
|++ +++.++|||||||++|+|++|+.||...+....+.. ...... ...+...++++
T Consensus 175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T 3uqc_A 175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ 235 (286)
T ss_dssp ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHH
T ss_pred ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHH
Confidence 333 368899999999999999999999987654321100 000111 11234678999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
+.+||.+||..||.+| |+.++++.|.++...
T Consensus 236 l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 236 ISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp HHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred HHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 9999999999999999 999999999988643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=350.76 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=189.3
Q ss_pred ccceeEeeeeccCCcEEEEEE-EEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHA-VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~-~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.+.|.+.+.||+|+||+||.+ ...++.||||++.... ...+.+|+.+|+.+ +|||||++++++.....+|+||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 345677899999999999755 4478899999987543 24567899999876 8999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcc------hHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC-------------C
Q 003978 582 EFLPRGSLFRLLQRNTTKL------DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-------------W 642 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l------~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~-------------~ 642 (782)
|||. ++|.+++....... .+..++.++.||+.||+|||+++ |+||||||+||||+.+ +
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCce
Confidence 9995 59999997643211 22345679999999999999999 9999999999999754 4
Q ss_pred cEEEEecCCCcccccccc----cccCCCCCCcccCcccccC-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 003978 643 TVKVGDFGLSRLKHETYL----TTKTGKGTPQWMAPEVLRN-------EPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (782)
Q Consensus 643 ~vkL~DFGla~~~~~~~~----~~~~~~Gt~~y~aPE~l~~-------~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~ 710 (782)
.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 899999999986544321 1224579999999999976 568899999999999999999 9999976544
Q ss_pred HHHHHHhhccccccCC----CCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003978 711 MQVIGAVGFMNQRLEI----PKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 711 ~~~~~~i~~~~~~~~~----p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~ 768 (782)
.... .+......... +..+++++.+||.+||..||.+|||+.+++ +|+||+
T Consensus 246 ~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil------~hp~f~ 300 (434)
T 2rio_A 246 RESN-IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL------RHPLFW 300 (434)
T ss_dssp HHHH-HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH------TSGGGS
T ss_pred hHHH-HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHH------hCCccC
Confidence 3321 11111111111 113457899999999999999999999994 566664
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=327.30 Aligned_cols=235 Identities=23% Similarity=0.387 Sum_probs=189.4
Q ss_pred ccccceeEe-eeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHH-HhCCCCceeEEeeeeec----
Q 003978 502 ILWEDLTIG-EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLM-KRLRHPNVLLFMGAVTS---- 573 (782)
Q Consensus 502 ~~~~~y~i~-~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~---- 573 (782)
...++|.+. +.||+|+||.||++.+ .++.||||++... ..+.+|+.++ +.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 345678877 7899999999999998 5678999998642 3456788887 66689999999999876
Q ss_pred CCceeEEEeecCCCCHHHHHhhcC-CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCcEEEEec
Q 003978 574 PQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDF 649 (782)
Q Consensus 574 ~~~~~lv~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~---~~~vkL~DF 649 (782)
...+|+|||||++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+. ++.+||+||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEecc
Confidence 677899999999999999997653 46999999999999999999999999 999999999999998 788999999
Q ss_pred CCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc--ccccCCC
Q 003978 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM--NQRLEIP 727 (782)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~p 727 (782)
|++.... +..++.++|||||||++|+|++|..||...........+... .....++
T Consensus 165 g~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 222 (299)
T 3m2w_A 165 GFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 222 (299)
T ss_dssp TTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSC
T ss_pred ccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCC
Confidence 9985432 234678999999999999999999999876554332221111 1112222
Q ss_pred ----CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 728 ----KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 728 ----~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
..+++++.+||.+||..||.+|||+.++ +.|+||+.....
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~------l~hp~~~~~~~~ 266 (299)
T 3m2w_A 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF------MNHPWIMQSTKV 266 (299)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH------HTSHHHHTGGGS
T ss_pred chhcccCCHHHHHHHHHHcccChhhCCCHHHH------hcChhhcccccC
Confidence 5689999999999999999999999999 678999776543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=349.93 Aligned_cols=241 Identities=16% Similarity=0.163 Sum_probs=188.4
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCC-Ccee--------------
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRH-PNVL-------------- 565 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~H-pnIv-------------- 565 (782)
...|++++.||+|+||.||+|.+. ++.||||++..... .....+.+.+|+.+++.+.| +|+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 356899999999999999999985 88999999874332 22345678899999999976 2211
Q ss_pred -------EEeeeeec-----CCceeEEEeecCCCCHHHHHh------hcCCcchHHHHHHHHHHHHHHHHhhhcCCCCee
Q 003978 566 -------LFMGAVTS-----PQRLCIVTEFLPRGSLFRLLQ------RNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627 (782)
Q Consensus 566 -------~l~~~~~~-----~~~~~lv~E~~~ggsL~~~l~------~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~iv 627 (782)
.++.++.. ...++++|+++ +++|.+++. .....+++..++.++.||+.||+|||+++ ||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ii 233 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LV 233 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence 11111111 22467788877 679999984 22456888999999999999999999999 99
Q ss_pred ecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCCCCCcccCcccc----------cCCCCCchhHHHHHHHHHHH
Q 003978 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL----------RNEPSDEKSDVYSFGVILWE 697 (782)
Q Consensus 628 HrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l----------~~~~~s~~sDIwSLG~ll~e 697 (782)
||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++|+
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 9999999999999999999999998765543 335577 999999999 55567889999999999999
Q ss_pred HHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 003978 698 LATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVD 757 (782)
Q Consensus 698 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~ 757 (782)
|++|+.||...+....... .......+++++.+||.+||..||.+||++.++++
T Consensus 310 lltg~~Pf~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSEW------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHSSCCCCTTGGGSCSGG------GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHCCCCCCCcchhhhHHH------HHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999987654332211 12233468899999999999999999999999854
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=350.91 Aligned_cols=246 Identities=20% Similarity=0.223 Sum_probs=191.9
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCC------CHHHHHHHHHHHHHHHhCC---------CCceeE
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEY------SDEVIHSFRQEVSLMKRLR---------HPNVLL 566 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~------~~~~~~~~~~Ei~il~~l~---------HpnIv~ 566 (782)
+..++|+++++||+|+||.||+|+++++.||||++..... .....+.+.+|+.+|+.++ |||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 4457899999999999999999999999999999986542 2223467888999998886 555555
Q ss_pred Eee-----------------eeec-------------CCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHH
Q 003978 567 FMG-----------------AVTS-------------PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 616 (782)
Q Consensus 567 l~~-----------------~~~~-------------~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL 616 (782)
+++ ++.. ...+|||||||++|++.+.+.+ ..+++..++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 544 4443 6789999999999977666643 4589999999999999999
Q ss_pred Hhhh-cCCCCeeecCCCCCcEEEcCCC--------------------cEEEEecCCCcccccccccccCCCCCCcccCcc
Q 003978 617 SYLH-HCNPPIIHRDLKSSNLLVDKHW--------------------TVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675 (782)
Q Consensus 617 ~~LH-~~~~~ivHrDIKp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE 675 (782)
.||| +++ ||||||||+||||+.++ .+||+|||+|+..... ..+||+.|+|||
T Consensus 175 ~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE 247 (336)
T 2vuw_A 175 AVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSG
T ss_pred HHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChh
Confidence 9999 899 99999999999999887 8999999999866543 337899999999
Q ss_pred cccCCCCCchhHHHHHHHH-HHHHHcCCCCCCCCChHH-HHHHhh-ccccc----cCCCCCCCHHHHHHHHHhhhhCCCC
Q 003978 676 VLRNEPSDEKSDVYSFGVI-LWELATEKIPWDNLNSMQ-VIGAVG-FMNQR----LEIPKDVDPRWAAIVESCWHSDPQC 748 (782)
Q Consensus 676 ~l~~~~~s~~sDIwSLG~l-l~elltG~~Pf~~~~~~~-~~~~i~-~~~~~----~~~p~~~~~~l~~LI~~cL~~dP~~ 748 (782)
++.+.. +.++|||||+++ .+++++|..||....... ....+. ..... ...+..+++++++||.+||.+|
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--- 323 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--- 323 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence 999877 899999998777 778889999985421111 111111 01111 1112347889999999999976
Q ss_pred CCCHHHHHHHHHHH-HHHHhh
Q 003978 749 RPSFQELVDKLRDL-QRQYFQ 768 (782)
Q Consensus 749 RPs~~ell~~L~~L-~~~~~~ 768 (782)
|+.++ | +|+||+
T Consensus 324 --sa~e~------l~~Hp~f~ 336 (336)
T 2vuw_A 324 --SATDL------LCQHSLFK 336 (336)
T ss_dssp --SHHHH------HHHCGGGC
T ss_pred --CHHHH------HhcCCCcC
Confidence 99999 6 688885
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=365.91 Aligned_cols=248 Identities=22% Similarity=0.263 Sum_probs=198.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec------CC
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS------PQ 575 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~ 575 (782)
.++|++.++||+|+||.||++.+ .++.||||++... ........+.+|+++++.++||||+++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 36899999999999999999987 5778999998654 345666789999999999999999999998765 67
Q ss_pred ceeEEEeecCCCCHHHHHhhcC--CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCc---EEEEecC
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT---VKVGDFG 650 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~---vkL~DFG 650 (782)
..|+|||||+|++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++. +||+|||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 7899999999999999997643 25889999999999999999999999 999999999999997665 9999999
Q ss_pred CCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH---------HHhhc--
Q 003978 651 LSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVI---------GAVGF-- 719 (782)
Q Consensus 651 la~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~---------~~i~~-- 719 (782)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..+..
T Consensus 170 ~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 170 YAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred ccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 998665433 233567999999999999999999999999999999999999999765332210 00000
Q ss_pred -ccc----------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHH
Q 003978 720 -MNQ----------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQEL 755 (782)
Q Consensus 720 -~~~----------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~el 755 (782)
... ...++..+++.+.+||.+||..||.+|||+.++
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000 011223367899999999999999999999997
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=361.14 Aligned_cols=247 Identities=23% Similarity=0.317 Sum_probs=201.8
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc---CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc-
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR- 576 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~- 576 (782)
+...++|++.++||+|+||.||++.+. ++.||||++.... .......+.+|+++++.++|||||++++++...+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 455689999999999999999999984 6789999986532 45556788899999999999999999999987665
Q ss_pred ----eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCC
Q 003978 577 ----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (782)
Q Consensus 577 ----~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla 652 (782)
.|||||||+|++|.+++.. .+++..++.++.||+.||.|||++| ||||||||+||||+.+ .+||+|||++
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred CCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999988754 6899999999999999999999999 9999999999999986 9999999999
Q ss_pred cccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCH
Q 003978 653 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 732 (782)
Q Consensus 653 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 732 (782)
+..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||....... . .........++
T Consensus 229 ~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------~-~~~~~~~~~~~ 295 (681)
T 2pzi_A 229 SRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-------L-PEDDPVLKTYD 295 (681)
T ss_dssp EETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-------C-CTTCHHHHHCH
T ss_pred hhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-------c-cccccccccCH
Confidence 865443 3457999999999998764 889999999999999999999886421100 0 00000012357
Q ss_pred HHHHHHHHhhhhCCCCCC-CHHHHHHHHHHHHHHHh
Q 003978 733 RWAAIVESCWHSDPQCRP-SFQELVDKLRDLQRQYF 767 (782)
Q Consensus 733 ~l~~LI~~cL~~dP~~RP-s~~ell~~L~~L~~~~~ 767 (782)
.+.+||.+||..||.+|| +++++...|..+.....
T Consensus 296 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~ 331 (681)
T 2pzi_A 296 SYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVV 331 (681)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHhh
Confidence 899999999999999999 57788888877765543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-30 Score=299.14 Aligned_cols=184 Identities=16% Similarity=0.123 Sum_probs=132.3
Q ss_pred eeccCCcEEEEEEE--EcCCeEEEEEEeccCC----C----HHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCceeEE
Q 003978 512 QIGQGSCGTVYHAV--WYGSDVAVKVFSRQEY----S----DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 512 ~IG~G~~G~Vy~~~--~~~~~vAiK~~~~~~~----~----~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv 580 (782)
.++.|++|.++.++ +.|+.|+||++.+... . +...+.+.+|+++|+++ .|+||+++++++++++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 56788888777765 4799999999976532 1 23456799999999999 699999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
||||+|++|.++|...+ ++++. .|+.||+.||+|||++| ||||||||+||||+.+|.|||+|||+|+.......
T Consensus 321 MEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred EecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 99999999999998654 56654 47889999999999999 99999999999999999999999999987665544
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCC
Q 003978 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEK 702 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~ 702 (782)
...+.+||+.|||||++.+. +..++|+||+|+++++|.++.
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp CSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred cccCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence 44556899999999999875 567899999999988775553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=268.53 Aligned_cols=186 Identities=18% Similarity=0.189 Sum_probs=148.5
Q ss_pred eEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCH------HHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 508 TIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSD------EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 508 ~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
...++||+|+||.||++...+..+++|......... ...+.+.+|+++|+.++||||+++..++......||||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 446789999999999998899999999876544322 12456899999999999999996555555677889999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
|||+|++|.+++.. ++.++.||+.||.|||+++ |+||||||+|||++. .+||+|||+++........
T Consensus 419 E~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 419 SYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp ECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred ECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 99999999999975 5678999999999999999 999999999999999 9999999999876543221
Q ss_pred -------ccCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCC
Q 003978 662 -------TKTGKGTPQWMAPEVLRN--EPSDEKSDVYSFGVILWELATEKIPWD 706 (782)
Q Consensus 662 -------~~~~~Gt~~y~aPE~l~~--~~~s~~sDIwSLG~ll~elltG~~Pf~ 706 (782)
.....||+.|||||++.+ ..|+...|+|+..+-.++.+.++-+|.
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 134579999999999987 556778899999999999888887774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2e-22 Score=214.40 Aligned_cols=146 Identities=22% Similarity=0.208 Sum_probs=115.9
Q ss_pred cceeEeeeeccCCcEEEEEEEE-cCCeEEEEEEeccCCCH----------------HHHHHHHHHHHHHHhCCCCceeEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSD----------------EVIHSFRQEVSLMKRLRHPNVLLF 567 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~-~~~~vAiK~~~~~~~~~----------------~~~~~~~~Ei~il~~l~HpnIv~l 567 (782)
..|.+++.||+|+||.||+|.+ .++.||||+++...... .....+.+|+.+|+.++ | +++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 3466779999999999999998 46789999986432211 24567889999999998 4 566
Q ss_pred eeeeecCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEE
Q 003978 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVG 647 (782)
Q Consensus 568 ~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~ 647 (782)
++++.. +..|+|||||+|++|.+ +.. .....++.||+.||.|||++| |+||||||+||||+ ++.+||+
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TTEEEEC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CCcEEEE
Confidence 665443 56799999999999988 421 123468999999999999999 99999999999999 9999999
Q ss_pred ecCCCcccccccccccCCCCCCcccCccccc
Q 003978 648 DFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 678 (782)
Q Consensus 648 DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~ 678 (782)
|||+++. +..|+|||.+.
T Consensus 235 DFG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 235 DFPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp CCTTCEE-------------TTSTTHHHHHH
T ss_pred ECCCCeE-------------CCCCCHHHHHH
Confidence 9999852 34578899864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=3.7e-19 Score=186.57 Aligned_cols=138 Identities=20% Similarity=0.214 Sum_probs=107.8
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCe--EEEEEEeccCCC----------------------HHHHHHHHHHHHHHHhC
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSD--VAVKVFSRQEYS----------------------DEVIHSFRQEVSLMKRL 559 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~--vAiK~~~~~~~~----------------------~~~~~~~~~Ei~il~~l 559 (782)
-|.+.+.||+|+||.||+|.+ .|+. ||||+++..... ......+.+|+.+|+.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999988 7888 999997543211 01224678899999999
Q ss_pred CCCce--eEEeeeeecCCceeEEEeecCC-C----CHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhh-cCCCCeeecCC
Q 003978 560 RHPNV--LLFMGAVTSPQRLCIVTEFLPR-G----SLFRLLQRNTTKLDWRRRILMALDIARGVSYLH-HCNPPIIHRDL 631 (782)
Q Consensus 560 ~HpnI--v~l~~~~~~~~~~~lv~E~~~g-g----sL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH-~~~~~ivHrDI 631 (782)
.|++| +.+++. ...+|||||+.+ | +|.++... .++..+..++.||+.+|.||| ++| ||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE--LVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCC
Confidence 87754 344432 367899999942 3 77776532 234567788999999999999 988 999999
Q ss_pred CCCcEEEcCCCcEEEEecCCCccc
Q 003978 632 KSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 632 Kp~NILl~~~~~vkL~DFGla~~~ 655 (782)
||+|||++. .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999643
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} | Back alignment and structure |
|---|
Probab=99.77 E-value=5.5e-18 Score=154.38 Aligned_cols=118 Identities=20% Similarity=0.320 Sum_probs=106.7
Q ss_pred CHHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEE
Q 003978 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPA 207 (782)
Q Consensus 128 ~~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~ 207 (782)
.++.|+.++++++++|+++|.+|+|+|+|++|++++||+.+|++|+++..+.++.........++..+..+..+..++..
T Consensus 3 ~~~~~~~~~~~~~~~i~~~d~~g~i~~~N~a~~~~~G~~~~elig~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 82 (120)
T 2gj3_A 3 LPEIFRQTVEHAPIAISITDLKANILYANRAFRTITGYGSEEVLGKNESILSNGTTPRLVYQALWGRLAQKKPWSGVLVN 82 (120)
T ss_dssp CHHHHHHHHHHCSSEEEEECTTCBEEEECHHHHHHHCCCTTGGGGCBGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEE
T ss_pred hHHHHHHHHHhCCCeEEEECCCCCEEeehHHHHHHHCcCHHHHcCCCHHHcCCCCCCHHHHHHHHHHHHcCCCEEEEEEE
Confidence 35789999999999999999999999999999999999999999999998877665444445678888899999999999
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHH
Q 003978 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQ 245 (782)
Q Consensus 208 ~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk 245 (782)
+++||..+|+.+++.|++|.+|++.+++++++|||++|
T Consensus 83 ~~~dG~~~~~~~~~~pi~~~~g~~~~~v~~~~DITe~k 120 (120)
T 2gj3_A 83 RRKDKTLYLAELTVAPVLNEAGETIYYLGMHRDTSELH 120 (120)
T ss_dssp ECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCSCC
T ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEeccCcccC
Confidence 99999999999999999999999999999999999864
|
| >4hia_A LOV protein; PAS, HTH, signaling protein; HET: FMN; 1.95A {Rhodobacter sphaeroides} PDB: 4hnb_A* 4hj4_A* 4hj6_A* 4hj3_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2.8e-18 Score=166.77 Aligned_cols=121 Identities=13% Similarity=0.131 Sum_probs=112.9
Q ss_pred HHHHHHHHHcCceeEEEcCC---CcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEE
Q 003978 130 RQYLNILQSMGQSVHIFDLS---DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (782)
Q Consensus 130 ~~~~~ile~~~d~I~v~D~d---G~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~ 206 (782)
+.|+.++++++++|+++|.+ |+|+|+|++|++++||+.++++|+++..++++.........+...+..+..+..++.
T Consensus 7 ~~~~~~~~~~~~~i~~~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 86 (176)
T 4hia_A 7 EKIRAVFDRSGVALTLVDMSLPEQPVVLANPPFLRMTGYTEGQILGFNCRFLQRGDENAQARADIRDALKLGRELQVVLR 86 (176)
T ss_dssp HHHHHHHHHCSSCCEEEETTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEE
T ss_pred HHHHHHHhcCCCcEEEEecCCCCCcEEEECHHHHHHHCcCHHHHcCCCcceeeCCCCCHHHHHHHHHHHHcCCceEEEEE
Confidence 56889999999999999999 999999999999999999999999999998877766666678888999999999999
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHH
Q 003978 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAA 250 (782)
Q Consensus 207 ~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~ 250 (782)
.+++||..+|+.+++.|+++.+|.+.+++++++|||++|++|++
T Consensus 87 ~~~~dG~~~~~~~~~~pi~~~~g~~~~~~~~~~DITe~k~~e~~ 130 (176)
T 4hia_A 87 NYRANDEPFDNLLFLHPVGGRPDAPDYFLGSQFELGRSGNSEEA 130 (176)
T ss_dssp EECTTCCEEEEEEEEEEESSBTTBCSEEEEEEEEESSSGGGHHH
T ss_pred EEcCCCCEEEEEEEEEEeeCCCCCeEEEEEEEEECcHhhHHHHH
Confidence 99999999999999999999999999999999999999999988
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=2.4e-17 Score=152.69 Aligned_cols=122 Identities=22% Similarity=0.173 Sum_probs=105.0
Q ss_pred HHHHHcCceeEEEcCCC---cEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEcC
Q 003978 134 NILQSMGQSVHIFDLSD---RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210 (782)
Q Consensus 134 ~ile~~~d~I~v~D~dG---~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~k 210 (782)
.++++++++|+++|.+| +|+|+|++|++|+||+.+|++|+++..+.++.........+...+..+..+..++..+++
T Consensus 3 ~~~~~~~~~i~~~d~~g~~~~i~~~N~a~~~~~G~~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~k 82 (132)
T 2pr5_A 3 HMLDHVRVGVVITDPALEDNPIVYVNQGFVQMTGYETEEILGKNCRFLQGKHTDPAEVDNIRTALQNKEPVTVQIQNYKK 82 (132)
T ss_dssp ---CCCCCEEEEECTTSTTCCEEEECHHHHHHHSCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECT
T ss_pred hHHhcCCCcEEEEeCCCCCCcEEEECHHHHHHhCcCHHHHcCCChhhhCCCCCCHHHHHHHHHHHHcCCCeEEEEEEEec
Confidence 57899999999999976 999999999999999999999999988776655444455677888888889999999999
Q ss_pred CCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhhcc
Q 003978 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNS 257 (782)
Q Consensus 211 dG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~ 257 (782)
||..+|+.+++.|+++.+ +.+++++++|||++|++|++|++...+
T Consensus 83 dG~~~~~~~~~~~~~~~~--~~~~~~~~~DITe~k~~e~~l~~~~~~ 127 (132)
T 2pr5_A 83 DGTMFWNELNIDPMEIED--KTYFVGIQNDITKQKEYEKLLEDSLTE 127 (132)
T ss_dssp TSCEEEEEEEEEEEEETT--EEEEEEEEEECHHHHHHHHHHHHHHHH
T ss_pred CCCeeeeEEEEEeccCCC--eeEEEEEEEeCcHHHHHHHHHHHHHHH
Confidence 999999999999998765 889999999999999999999776543
|
| >1n9l_A PHOT-LOV1, putative blue light receptor; phototropin, flavin, electron transport; HET: FMN; 1.90A {Chlamydomonas reinhardtii} SCOP: d.110.3.6 PDB: 1n9n_A* 1n9o_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.1e-16 Score=143.93 Aligned_cols=105 Identities=23% Similarity=0.287 Sum_probs=95.6
Q ss_pred cCceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEcCCCCEE
Q 003978 139 MGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERV 215 (782)
Q Consensus 139 ~~d~I~v~D~---dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~ 215 (782)
++++|+++|. +|+|+|+|++|++|+||+.+|++|+++..+.++.........+++++..++.+..++..++|||+.+
T Consensus 2 ~~~~i~i~d~~~~~g~i~~~N~a~~~l~Gy~~~e~~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~ 81 (109)
T 1n9l_A 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGTPF 81 (109)
T ss_dssp CSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEE
T ss_pred CccEEEEEcCCCCCCeEEEEchHHHHHHCcCHHHHcCCCchhcCCCCCCHHHHHHHHHHHHcCCcEEEEEEEEcCCCCEE
Confidence 6789999994 7999999999999999999999999988877766544455678899999999999999999999999
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEEehhH
Q 003978 216 LVVATNTPFYDDDGTLVGIVCVSTDSRP 243 (782)
Q Consensus 216 ~v~~~~~Pi~d~~G~v~g~v~i~rDITe 243 (782)
|+.+++.|++|++|++.+++++++|||+
T Consensus 82 ~~~~~~~pi~d~~G~~~~~v~~~~DITe 109 (109)
T 1n9l_A 82 WNLLTVTPIKTPDGRVSKFVGVQVDVTS 109 (109)
T ss_dssp EEEEEEEEEECTTSCEEEEEEEEEECCC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEeCCC
Confidence 9999999999999999999999999984
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.3e-16 Score=166.09 Aligned_cols=126 Identities=18% Similarity=0.163 Sum_probs=108.7
Q ss_pred CcCHHHHHHHHHHcCceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEE
Q 003978 126 NFTDRQYLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT 202 (782)
Q Consensus 126 ~l~~~~~~~ile~~~d~I~v~D~---dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~ 202 (782)
.-.++.|+.++++++++|+++|. +|+|+|||++|++++||+.+|++|+++.+++++.........+...+..+..+.
T Consensus 59 ~~~~~~~~~i~~~~~~~i~~~d~~~~~g~i~~~N~a~~~l~G~~~~el~g~~~~~l~~~~~~~~~~~~~~~~l~~~~~~~ 138 (258)
T 3p7n_A 59 QPPAQWVLDLIEASPIASVVSDPRLADNPLIAINQAFTDLTGYSEEECVGRNCRFLAGSGTEPWLTDKIRQGVREHKPVL 138 (258)
T ss_dssp --CCHHHHHHHHTCSSEEEEECTTSTTCCEEEECHHHHHHHCCCGGGTTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEE
T ss_pred HhHHHHHHHHHhcCCccEEEEcCCCCCCcEEEEhHHHHHHcCCCHHHHCCCChhhccCCCCchhHHHHHHHHHHcCCCeE
Confidence 34457899999999999999999 899999999999999999999999999999888776666667888899999999
Q ss_pred EEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHH--HHHHHH
Q 003978 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQ--ETRAAL 251 (782)
Q Consensus 203 ~e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk--~~E~~L 251 (782)
.++..+++||..+|+.+++.|++|.+|.+.+++++++|||++| +.+.++
T Consensus 139 ~e~~~~~~dG~~~~~~~~~~pi~d~~g~~~~~v~~~~DITerk~~~~e~~~ 189 (258)
T 3p7n_A 139 VEILNYKKDGTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDDQPNMGMARR 189 (258)
T ss_dssp EEEEEECTTSCEEEEEEEEEEEECTTSCSEEEEEEEEEC-------CHHHH
T ss_pred EEEEEEcCCCCEEEEeeEEEEEEcCCCCEEEEEEEeeecchhhhhhhHHHH
Confidence 9999999999999999999999999999999999999999994 444443
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=4.9e-16 Score=148.24 Aligned_cols=125 Identities=20% Similarity=0.147 Sum_probs=113.2
Q ss_pred CHHHHHHHHHHcCceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEE
Q 003978 128 TDRQYLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQ 204 (782)
Q Consensus 128 ~~~~~~~ile~~~d~I~v~D~---dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e 204 (782)
..+.++.++++++++|+++|. +|+|+|+|++|++++||+.++++|+++..++++.........+...+..+..+..+
T Consensus 33 ~~~~~~~~~~~~~~~i~~~d~~~~~g~i~~~N~~~~~l~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e 112 (166)
T 3ue6_A 33 PDYSLVKALQMAQQNFVITDASLPDNPIVYASRGFLTLTGYSLDQILGRNCRFLQGPETDPRAVDKIRNAITKGVDTSVC 112 (166)
T ss_dssp CCCHHHHHHHHTTSCEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHHTCCEEEE
T ss_pred HHHHHHHHHhcCCceEEEEEccCCCCcEEEECHHHHHHhCcCHHHHcCCCHhheeCCCCCHHHHHHHHHHHhcCCceEEE
Confidence 346799999999999999999 79999999999999999999999999998888776555566778888899999999
Q ss_pred EEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHH
Q 003978 205 FPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALW 252 (782)
Q Consensus 205 ~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~ 252 (782)
+...+++|..+|+.+++.|+++.+|.+.|++++++|||++|+.+...+
T Consensus 113 ~~~~~~~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DITe~k~~~~~~e 160 (166)
T 3ue6_A 113 LLNYRQDGTTFWNLFFVAGLRDSKGNIVNYVGVQSKVSEDYAKLLVNE 160 (166)
T ss_dssp EEEECTTSCEEEEEEEEEEEECTTSCEEEEEEECCBCCHHHHHHHHHH
T ss_pred EEEEcCCCCEEEEEEEEEeeeCCCCCEEEEEEEEEechHHHHHHHHHh
Confidence 999999999999999999999999999999999999999998876643
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.1e-15 Score=145.46 Aligned_cols=133 Identities=19% Similarity=0.155 Sum_probs=120.6
Q ss_pred cCcCHHHHHHHHHHcCceeEEEcCCC---cEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeE
Q 003978 125 FNFTDRQYLNILQSMGQSVHIFDLSD---RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW 201 (782)
Q Consensus 125 ~~l~~~~~~~ile~~~d~I~v~D~dG---~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~ 201 (782)
.....+.++.++++++++|+++|.+| +|+++|+++++++||+.++++|+++..++++.........+...+..+..+
T Consensus 20 ~~~~~~~~~~i~~~~~~~i~~~d~~~~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (162)
T 3sw1_A 20 HMINAQLLQSMVDASNDGIVVAEKEGDDTILIYVNAAFEYLTGYSRDEILYQDCRFLQGDDRDQLGRARIRKAMAEGRPC 99 (162)
T ss_dssp -CCCHHHHHHHHHTCSSEEEEEEEETTEEEEEEECHHHHHHHTCCHHHHTTSBGGGGTTTCCCCHHHHHHHHHHHHTCCE
T ss_pred ccchHHHHHHHHhhccCcEEEEeCCCCccEEEEECHHHHHHHCCCHHHHcCCCcceecCCCcCHHHHHHHHHHHhcCCCC
Confidence 44567899999999999999999999 999999999999999999999999998888776666666778888999999
Q ss_pred EEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhhcc
Q 003978 202 TGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNS 257 (782)
Q Consensus 202 ~~e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~ 257 (782)
..++...+++|..+|+.+++.|+.+.+|.+.+++++++|||++++++++|+.....
T Consensus 100 ~~~~~~~~~~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DiTe~k~~e~~l~~~~~~ 155 (162)
T 3sw1_A 100 REVLRNYRKDGSAFWNELSITPVKSDFDQRTYFIGIQKDVSRQVELERELAELRAR 155 (162)
T ss_dssp EEEEEEECTTCCEEEEEEEEEEEECSSSSCEEEEEEEEECHHHHHHHHHHHHHTC-
T ss_pred cceEEEECCCCCEEEEEEEEEEeecCCCCEEEEEEEEEeCcHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999877654
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} | Back alignment and structure |
|---|
Probab=99.68 E-value=3e-16 Score=142.89 Aligned_cols=119 Identities=19% Similarity=0.143 Sum_probs=103.2
Q ss_pred HHHHcCceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEcCC
Q 003978 135 ILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKT 211 (782)
Q Consensus 135 ile~~~d~I~v~D~---dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kd 211 (782)
++++++++|+++|. +|+|+++|++|++++||+.++++|+++.+++++.........+...+..+..+..++...+++
T Consensus 2 ~~~~~~~~i~~~d~~~~~g~i~~~N~~~~~l~g~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~ 81 (128)
T 3t50_A 2 ASEFTLMPMLITNPHLPDNPIVFANPAFLKLTGYEADEVMGRNCRFLQGHGTDPAHVRAIKSAIAAEKPIDIDIINYKKS 81 (128)
T ss_dssp CCCCCSSCEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEECTT
T ss_pred ccccCcccEEEecCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHhhhcCCccCHHHHHHHHHHHHcCCCceeEEEEEcCC
Confidence 46788999999999 999999999999999999999999999998877766555667788888999999999999999
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHH
Q 003978 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWD 253 (782)
Q Consensus 212 G~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~ 253 (782)
|..+|+.+++.|+.+.+|.+.+++++++|||++|++|++..+
T Consensus 82 g~~~~~~~~~~~i~~~~g~~~~~~~~~~DITe~k~~e~~~~~ 123 (128)
T 3t50_A 82 GEAFWNRLHISPVHNANGRLQHFVSSQLDVTLELVPRGSLEH 123 (128)
T ss_dssp CCEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHC-------
T ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEEcchhhhhhhhhhh
Confidence 999999999999999999999999999999999999887644
|
| >3f1p_B ARYL hydrocarbon receptor nuclear translocator; PAS domain, heterodimer, internal cavity, activator, angiogenesis, congenital erythrocytosis; 1.17A {Homo sapiens} SCOP: d.110.3.0 PDB: 3f1o_B* 3f1n_B 3h7w_B* 3h82_B* 1x0o_A 2hv1_A 4h6j_B 2b02_A* 2k7s_A 2a24_B | Back alignment and structure |
|---|
Probab=99.66 E-value=1.6e-16 Score=144.47 Aligned_cols=117 Identities=13% Similarity=0.192 Sum_probs=97.8
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHH-cCCeEEEEEEEE
Q 003978 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIK-MGERWTGQFPAK 208 (782)
Q Consensus 130 ~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~-~g~~~~~e~~~~ 208 (782)
+++..+++++++.|+++|.+|+|+|+|+++++++||+++|++|+++.+++++++.......+..++. .+..+..+++++
T Consensus 2 ~~~~ll~e~~~d~i~~~d~~g~i~~~n~~~~~~~G~~~~el~g~~~~~~i~p~d~~~~~~~~~~~~~~~~~~~~~e~r~~ 81 (121)
T 3f1p_B 2 EFKGLNVCQPTRFISRHNIEGIFTFVDHRCVATVGYQPQELLGKNIVEFCHPEDQQLLRDSFQQVVKLKGQVLSVMFRFR 81 (121)
T ss_dssp ------CCCCCEEEEEECTTSBEEEECTTHHHHHSCCGGGTTTSBGGGGBCTTTHHHHHHHHHHHTTSTTCCEEEEEEEE
T ss_pred CcccceecCCCceEEEECCCceEEEECcchhhhhCCChHHHcCCCHHHeECHHHHHHHHHHHHHHHhcCCCcccEEEEEE
Confidence 4567789999999999999999999999999999999999999999999998876554455556664 455688899999
Q ss_pred cCCCCEEEEEEEEEEEECC-CCCEEEEEEEEEehhHHHH
Q 003978 209 TKTEERVLVVATNTPFYDD-DGTLVGIVCVSTDSRPFQE 246 (782)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~-~G~v~g~v~i~rDITerk~ 246 (782)
++||..+|+.++..|++|. +|++.+++++.+|||++|+
T Consensus 82 ~~dG~~~w~~~~~~~~~~~~~g~~~~iv~~~~DIT~~kq 120 (121)
T 3f1p_B 82 SKNQEWLWMRTSSFTFQNPYSDEIEYIICTNTNVKNSSQ 120 (121)
T ss_dssp CTTSCEEEEEEEEEEECCTTCCCCCEEEEEEEECCCC--
T ss_pred ecCCCEEEEEEEEEEEECCCCCceeEEEEEeEEcccccC
Confidence 9999999999999999987 7899999999999999875
|
| >3k3c_A Protein RV1364C/MT1410; sensor, PAS, signal transduction, fatty-acid binding, sigma regulator, signaling protein; HET: PLM; 1.62A {Mycobacterium tuberculosis} PDB: 3k3d_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.8e-15 Score=143.92 Aligned_cols=128 Identities=15% Similarity=0.101 Sum_probs=108.3
Q ss_pred CHHHHHHHHHHcCceeEEEc-CCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEE
Q 003978 128 TDRQYLNILQSMGQSVHIFD-LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (782)
Q Consensus 128 ~~~~~~~ile~~~d~I~v~D-~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~ 206 (782)
..+.|+.++++++++|+++| .+|+|+++|+++++++|++ +++|+++.+++++.........+.+++..|++...+..
T Consensus 15 ~~~~~~~~~~~~~~~i~~~d~~~~~i~~~N~~~~~~~g~~--~~~G~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~ 92 (158)
T 3k3c_A 15 AAEDVRRIFEHIPAILVGLEGPDHRFVAVNAAYRGFSPLL--DTVGQPAREVYPELEGQQIYEMLDRVYQTGEPQSGSEW 92 (158)
T ss_dssp CHHHHHHHHHHCSSEEEEEETTTTEEEEECHHHHHHCTTC--CSTTSBHHHHSGGGGGTTHHHHHHHHHHHCCCEEEEEE
T ss_pred HHHHHHHHHhcCCceEEEEECCCcEeHHHHHHHHHHcCCc--hhcCCcHHHhCCchhHHHHHHHHHHHHHhCCcccccce
Confidence 35789999999999999999 9999999999999999999 99999999999876655555667788888887544322
Q ss_pred -E--EcC-C-CCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhhcc
Q 003978 207 -A--KTK-T-EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNS 257 (782)
Q Consensus 207 -~--~~k-d-G~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~ 257 (782)
. .+. + |..+|+.++..|+++.+|.+.|++++++|||++|++|++|+....+
T Consensus 93 ~~~~~~~~~~g~~~~~~~~~~pi~~~~g~~~g~~~~~~DITe~k~~e~~l~~~~~~ 148 (158)
T 3k3c_A 93 RLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDDVTSRVRARQAAEARVEE 148 (158)
T ss_dssp EEEEESSSSCEEEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHHHHHHHHHHHHH
T ss_pred eEEeccCCCCcceEEEEEEEEEeECCCCCEEEEEEEEEehhHHHHHHHHHHHHHHH
Confidence 2 232 2 7789999999999999999999999999999999999998765543
|
| >2vv6_A FIXL, sensor protein FIXL; signaling protein, transferase, phosphoprotein, nitrogen FIX PER-ARNT-SIM, metal-binding, PAS, iron, heme; HET: HEM; 1.5A {Bradyrhizobium japonicum} PDB: 1xj6_A* 1xj4_A* 2vv7_A* 2vv8_A* 1lsw_A* 1dp8_A* 1dp9_A* 1drm_A* 1lsv_A* 1dp6_A* 1lsx_A* 1lt0_A* 1y28_A* 2cmn_A* 1xj3_A* 1xj2_A* 2owh_A* 2owj_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=1.2e-15 Score=138.33 Aligned_cols=113 Identities=17% Similarity=0.140 Sum_probs=81.1
Q ss_pred cCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCe----EEEEEEEEcCCCCE
Q 003978 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQFPAKTKTEER 214 (782)
Q Consensus 139 ~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~----~~~e~~~~~kdG~~ 214 (782)
++++|+++|.+|+|+++|++|++|+||+++|++|+++..++++.........+...+..+.. ...++..+++||..
T Consensus 2 ~~d~i~~~d~~g~i~~~N~a~~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dG~~ 81 (119)
T 2vv6_A 2 IPDAMIVIDGHGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRRDGTT 81 (119)
T ss_dssp CCCEEEEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECTTSCE
T ss_pred CcceEEEECCCCeEEEEhHHHHHHhCCCHHHHcCCCHHHhCCchHHHHHHHHHHHHhcCCCcccCCCceEEEEEeCCCCE
Confidence 67899999999999999999999999999999999999888765432222233344444443 23467788999999
Q ss_pred EEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHH
Q 003978 215 VLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWD 253 (782)
Q Consensus 215 ~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~ 253 (782)
+|+.+++.|+.+.+ ..+++++++|||++|++|++|++
T Consensus 82 ~~~~~~~~~~~~~~--~~~~~~~~~DITerk~~e~~l~~ 118 (119)
T 2vv6_A 82 FPMHLSIGEMQSGG--EPYFTGFVRDLTEHQQTQARLQE 118 (119)
T ss_dssp EEEEEEEEEEEETT--EEEEEEEEEECC-----------
T ss_pred EEEEEEEEEEEECC--eEEEEEEEEEcHHHHHHHHHHHh
Confidence 99999999998643 35689999999999999998864
|
| >4eet_B Phototropin-2; LOV, blue light photoreceptor, signaling protein, flavoprote; HET: FMN; 1.20A {Arabidopsis thaliana} PDB: 4ees_A* 4eer_A* 4eep_A* 4eeu_A* 1jnu_A* 1g28_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=2.6e-15 Score=132.82 Aligned_cols=110 Identities=24% Similarity=0.197 Sum_probs=98.7
Q ss_pred HHHHcCceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEcCC
Q 003978 135 ILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKT 211 (782)
Q Consensus 135 ile~~~d~I~v~D~---dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kd 211 (782)
.+++++++|+++|. +|+|+|+|++|++++||+.++++|+++..++++.........+...+..+..+..++...+++
T Consensus 2 ~l~~~~~~i~~~d~~~~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (115)
T 4eet_B 2 SPEFIEKNFVITDPRLPDNPIIFASDGFLELTEYSREEILGRNARFLQGPETDQATVQKIRDAIRDQRETTVQLINYTKS 81 (115)
T ss_dssp ---CCCCSEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEECTT
T ss_pred ccccCCCcEEEEcCCCCCCcEEEEcHHHHHHHCcCHHHHhCCCHHHhcCCCCChHHHHHHHHHHHcCCCcceEEEEecCC
Confidence 47889999999999 999999999999999999999999999888877765555566788888999998899999999
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEehhHH
Q 003978 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (782)
Q Consensus 212 G~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITer 244 (782)
|..+|+.+++.|+++.+|.+.+++++++|||++
T Consensus 82 g~~~~~~~~~~~~~~~~g~~~~~~~~~~DITer 114 (115)
T 4eet_B 82 GKKFWNLLHLQPVRDQKGELQYFIGVQLDGSDH 114 (115)
T ss_dssp CCEEEEEEEEEEEECTTSCEEEEEEEEEECSCC
T ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEeeccc
Confidence 999999999999999999999999999999975
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A | Back alignment and structure |
|---|
Probab=99.62 E-value=9e-16 Score=139.21 Aligned_cols=114 Identities=11% Similarity=0.074 Sum_probs=94.1
Q ss_pred HHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCcccccccccc-ccHHHHHHHHHHcCCeEEEEEEEEcC
Q 003978 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD-FDVAYDIVHRIKMGERWTGQFPAKTK 210 (782)
Q Consensus 132 ~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~-~~~~~~l~~~l~~g~~~~~e~~~~~k 210 (782)
|+.++++++++|+ +|.+|+|+++|++|++|+||+.++++|+++..++++... ......+...+..+..+..+..+.++
T Consensus 5 ~~~~~~~~~~~i~-~~~~g~i~~~N~a~~~l~G~~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 83 (120)
T 3mqq_A 5 YKTAFHLAPIGLV-LSRDRVIEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERIGERISPVMIAHGSYADDRIMKRA 83 (120)
T ss_dssp HHHHHHHCSSEEE-EEETTEEEEECHHHHHHTTSCHHHHTTCBGGGGSSSHHHHHHHHHHHHHHHHHHSCEEEEEEEECT
T ss_pred HHHHHhcCCceEE-EecCCEEHHHHHHHHHHhCcCHHHhCCCchhhccCChhhHHHHHHHHHHHHhcCCcceEEEEEEeC
Confidence 8899999999996 578999999999999999999999999999988765433 22333456667778888889999999
Q ss_pred CCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHH
Q 003978 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQET 247 (782)
Q Consensus 211 dG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~ 247 (782)
||..+|+.++..|+ +.+|.+.+++++++|||++|++
T Consensus 84 dG~~~~~~~~~~~~-~~~~~~~~~v~~~~DITerk~~ 119 (120)
T 3mqq_A 84 GGELFWCHVTGRAL-DRTAPLAAGVWTFEDLSATRRV 119 (120)
T ss_dssp TSCEEEEEEEEEES-STTSTTSSEEEEEEESCC----
T ss_pred CCCEEEEEEEEEEC-CCCCCceeEEEEEEcccHhhcc
Confidence 99999999999998 5566667899999999999976
|
| >3mr0_A Sensory box histidine kinase/response regulator; PAS fold, structural genomics, PSI-2; HET: PG5; 1.49A {Burkholderia thailandensis} | Back alignment and structure |
|---|
Probab=99.62 E-value=5.9e-15 Score=138.75 Aligned_cols=130 Identities=9% Similarity=0.166 Sum_probs=112.8
Q ss_pred cCHHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcC--CCccccccccccccHHHHHHHHHHcCCeEEEE
Q 003978 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALG--QDAIELLTDGRDFDVAYDIVHRIKMGERWTGQ 204 (782)
Q Consensus 127 l~~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG--~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e 204 (782)
.+++.|+.++++++++++.+|.++.++|+|+++++++||+.+++.+ ..+..+++|++.......+..++..+..+..+
T Consensus 6 ~se~rl~~~~~~~~~g~w~~d~~~~~~~~s~~~~~~~G~~~~~~~~~~~~~~~~ihpdD~~~~~~~~~~~~~~~~~~~~e 85 (142)
T 3mr0_A 6 ASEERFQLAVSGASAGLWDWNPKTGAMYLSPHFKKIMGYEDHELPDEITGHRESIHPDDRARVLAALKAHLEHRDTYDVE 85 (142)
T ss_dssp ---CCHHHHHHHTTCEEEEECTTTCCEEECHHHHHHTTCCGGGSCSEEC---CCBCTTTHHHHHHHHHHHHHHCCCEEEE
T ss_pred HHHHHHHHHHHhCCcEEEEEEcCCCeEEECHHHHHHhCCCccccCCCHHHHHhhcCHHHHHHHHHHHHHHHhCCCceEEE
Confidence 3456699999999999999999999999999999999999999877 34667888887666666677788888889999
Q ss_pred EEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhhc
Q 003978 205 FPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKN 256 (782)
Q Consensus 205 ~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~ 256 (782)
+++.++||..+|+.....|++|.+|++++++++++|||++|++|++|+...+
T Consensus 86 ~r~~~~~G~~~w~~~~~~~~~d~~g~~~~~~G~~~DITerk~~E~~L~~~~~ 137 (142)
T 3mr0_A 86 YRVRTRSGDFRWIQSRGQALWNSAGEPYRMVGWIMDVTDRKRDEDALRVSRE 137 (142)
T ss_dssp EEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHHHHHHHHHHHH
T ss_pred EEEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEcCchHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999999999999977654
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} | Back alignment and structure |
|---|
Probab=99.61 E-value=5.6e-15 Score=130.97 Aligned_cols=119 Identities=24% Similarity=0.415 Sum_probs=104.8
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEE
Q 003978 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (782)
Q Consensus 129 ~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~ 208 (782)
.+.++.++++++++|+++|.+|+|+++|+++++++|++.++++|+++..+.++.........+...+..+..+..+....
T Consensus 6 ~~~~~~~~~~~~~~i~~~d~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (124)
T 3lyx_A 6 LKQRAKAFDYVFDAIVVTDLQGFIIDWNKGSETLYGYSKEQAIGQPVNMLHVPGDTEHITSEVISAVENQGKWTGEIRML 85 (124)
T ss_dssp HHHHHHGGGTCSSEEEEEETTCBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTTHHHHHHHHHHHHHHTSCEEEEEEEE
T ss_pred HHHHHHHHhhcCceEEEECCCCcEeehhhHHHHHhCCCHHHHcCCCHHHhcCcchhhHHHHHHHHHHHcCCcccceEEEE
Confidence 46789999999999999999999999999999999999999999999966665554444456778888899898899999
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHH
Q 003978 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQET 247 (782)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~ 247 (782)
.++|..+|+.++..|+.+.+|.+.|++++++|||+++++
T Consensus 86 ~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~l 124 (124)
T 3lyx_A 86 HKDGHIGWIESMCVPIYGENYQMVGALGINRDITKRKKE 124 (124)
T ss_dssp CTTSCEEEEEEEEEEEECSTTCEEEEEEEEEECSCC---
T ss_pred ccCCCEEEEEEEEEEEECCCCCEEEEEEEEecchhhhcC
Confidence 999999999999999999999999999999999998753
|
| >3f1p_A Endothelial PAS domain-containing protein 1; PAS domain, heterodimer, internal cavity, activator, angiogenesis, congenital erythrocytosis; 1.17A {Homo sapiens} SCOP: d.110.3.7 PDB: 3f1o_A* 3f1n_A 3h7w_A* 3h82_A* 1p97_A 2a24_A 4h6j_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.2e-15 Score=137.45 Aligned_cols=108 Identities=19% Similarity=0.228 Sum_probs=97.5
Q ss_pred cCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEcCCCCEEEEE
Q 003978 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVV 218 (782)
Q Consensus 139 ~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~v~ 218 (782)
.++.|+++|.+|+|+|+|+++++++||+++|++|+++.+++++++.......+..++..+..+..+++++++||..+|+.
T Consensus 8 ~~~~i~~~d~~g~i~~~n~~~~~~~Gy~~~el~g~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~~~w~~ 87 (117)
T 3f1p_A 8 SKTFLSEHSMDMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGGYVWLE 87 (117)
T ss_dssp GGEEEEEECTTCBEEEECTHHHHHHCCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHHHHSEEECCCEEEECTTSSEEEEE
T ss_pred CccEEEEECCCceEEEECcChhhhhCCCHHHHcCCchhheECHHHHHHHHHHHHHHHhCCCeeeeEEEEEecCCCEEEEE
Confidence 45789999999999999999999999999999999999999988866555567777888888888999999999999999
Q ss_pred EEEEEEECC-CCCEEEEEEEEEehhHHHH
Q 003978 219 ATNTPFYDD-DGTLVGIVCVSTDSRPFQE 246 (782)
Q Consensus 219 ~~~~Pi~d~-~G~v~g~v~i~rDITerk~ 246 (782)
++..|++|. +|.+.+++++.+|||++++
T Consensus 88 ~~~~~~~d~~~g~~~~iv~~~~DITer~~ 116 (117)
T 3f1p_A 88 TQGTVIYNPRNLQPQCIMCVNYVLSEIEK 116 (117)
T ss_dssp EEEEEEEETTTTEEEEEEEEEEECSCCBC
T ss_pred EeeEEEECCCCCCceEEEEEeeecccccc
Confidence 999999987 8899999999999998864
|
| >2z6d_A Phototropin-2; PAS-fold, LOV-fold, alternative splicing, ATP-binding, chromophore, flavoprotein, FMN, kinase, membrane, nucleotide-binding; HET: FMN; 2.00A {Arabidopsis thaliana} PDB: 2z6c_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=8.8e-15 Score=130.56 Aligned_cols=122 Identities=20% Similarity=0.278 Sum_probs=105.7
Q ss_pred HHHHHHHHHHcCceeEEEc---CCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEE
Q 003978 129 DRQYLNILQSMGQSVHIFD---LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQF 205 (782)
Q Consensus 129 ~~~~~~ile~~~d~I~v~D---~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~ 205 (782)
++.++.++++++++|+++| .+|.|+++|+++++++|++.++++|+++..++++.........+...+..+..+..++
T Consensus 5 ~~~~~~~~~~~~~~i~~~d~~d~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (130)
T 2z6d_A 5 SQELKTALSTLQQTFVVSDATQPHCPIVYASSGFFTMTGYSSKEIVGRNCRFLQGPDTDKNEVAKIRDCVKNGKSYCGRL 84 (130)
T ss_dssp --CHHHHHHHTTCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEE
T ss_pred HHHHHHHHHhcccceeeeeccCCCCcEEEecHHHHHHhCcCHHHHcCCChhhccCCCCCchHHHHHHHHHHcCCcceeEE
Confidence 3568999999999999999 9999999999999999999999999999988877665555566778888888888888
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHH
Q 003978 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAA 250 (782)
Q Consensus 206 ~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~ 250 (782)
...+++|..+|+.+...|+.+.+|.+.+++++++|||++++++++
T Consensus 85 ~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~~e~e 129 (130)
T 2z6d_A 85 LNYKKDGTPFWNLLTVTPIKDDQGNTIKFIGMQVEVSKYTEGVND 129 (130)
T ss_dssp EEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCTTC-----
T ss_pred EEEcCCCcEEEEEEEEEEEECCCCCeeEEEEEEecchHHHHhhcc
Confidence 889999999999999999999999999999999999999987654
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} | Back alignment and structure |
|---|
Probab=99.60 E-value=7.7e-15 Score=133.31 Aligned_cols=114 Identities=19% Similarity=0.198 Sum_probs=92.3
Q ss_pred CccCcCHHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEE
Q 003978 123 SAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT 202 (782)
Q Consensus 123 ~a~~l~~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~ 202 (782)
..+...++.|+.++++++++|+++|.+|+|+++|+++++|+||+++|++|+++..+.++.. ......++..+..+..+.
T Consensus 4 ~~l~~se~~~~~l~e~~~d~i~~~d~~g~i~~vN~a~~~l~Gy~~~el~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 82 (117)
T 2r78_A 4 ENLYFQSNAYRALFEHAIDGIFIMDAEGHYLDVNPAICSAIGYTRDEFLALDWGVLSRGVD-SGWAAASLARIVGGEPLR 82 (117)
T ss_dssp CSHHHHHHHHHHHHHHCSSEEEEECTTSBEEEECHHHHHHHCCCHHHHTTCBTTTTTTCST-TSHHHHHHHHHHTTCCEE
T ss_pred hHHHHhHHHHHHHHhcCCceEEEECCCCCEEEecHHHHHHHCcCHHHHcCCCHHHhCCccc-hhHHHHHHHHHHcCCcEE
Confidence 3344567889999999999999999999999999999999999999999999876654332 222334566677787788
Q ss_pred EEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehh
Q 003978 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (782)
Q Consensus 203 ~e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (782)
.+.+.+++||+.+|+.+++.|+. +|+ ++++++|||
T Consensus 83 ~e~~~~~kdG~~~~v~~~~~~~~--~g~---~~~i~~DIT 117 (117)
T 2r78_A 83 EERTVWTRNGDQLTVELSAHLLP--DGK---ILGIARDVS 117 (117)
T ss_dssp EEEEEECTTSCEEEEEEEEEECT--TSC---EEEEEEC--
T ss_pred EEEEEEecCCCEEEEEEEEEEec--CCe---EEEEEEeCC
Confidence 88999999999999999999985 566 567899997
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.60 E-value=9.4e-16 Score=168.64 Aligned_cols=136 Identities=17% Similarity=0.154 Sum_probs=98.4
Q ss_pred eeEeeeeccCCcEEEEEEEE-cCCeEEEEEEeccCC---------------CHH-----HHHHHHHHHHHHHhCCCCcee
Q 003978 507 LTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEY---------------SDE-----VIHSFRQEVSLMKRLRHPNVL 565 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~-~~~~vAiK~~~~~~~---------------~~~-----~~~~~~~Ei~il~~l~HpnIv 565 (782)
|.++++||.|+||.||+|.. .|+.||||+++.... ... ......+|...|..+.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 89999999999999999986 678999999753211 000 011223567777777544432
Q ss_pred --EEeeeeecCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-
Q 003978 566 --LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW- 642 (782)
Q Consensus 566 --~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~- 642 (782)
..++. ...+|||||++|++|.++... .....++.||+.+|.+||++| ||||||||.||||++++
T Consensus 177 vp~p~~~----~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 177 VPEPIAQ----SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CCCEEEE----ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEEC
T ss_pred CCeeeec----cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCCC
Confidence 22322 234799999998887554321 123457789999999999999 99999999999998776
Q ss_pred ---------cEEEEecCCCccc
Q 003978 643 ---------TVKVGDFGLSRLK 655 (782)
Q Consensus 643 ---------~vkL~DFGla~~~ 655 (782)
.+.|+||+-+...
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEET
T ss_pred cccccccccceEEEEeCCcccC
Confidence 3899999977543
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} | Back alignment and structure |
|---|
Probab=99.59 E-value=9.7e-15 Score=149.01 Aligned_cols=113 Identities=27% Similarity=0.342 Sum_probs=102.9
Q ss_pred eeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEcCCCCEEEEEEEE
Q 003978 142 SVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATN 221 (782)
Q Consensus 142 ~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~v~~~~ 221 (782)
.|+++|.+|+|+|+|++|++|+||+++|++|+++..+.++.........+++.+..+..+..++..+++||..+|+.+++
T Consensus 1 ~i~i~D~~g~i~~~N~a~~~l~Gy~~~el~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~ 80 (227)
T 3ewk_A 1 LVSITDLQGRILYANDNFCAVSRYGREELVGQDHRIVNSGYHGKAYIRDMWRTISRGNIWQGEFCNRRKDGTRYWVDSTI 80 (227)
T ss_dssp CEEEEETTCBEEEECHHHHHHTTCCHHHHTTSBGGGGCCSCSCHHHHHHHHHHHTTTCCEEEEEEEECSSSCEEEEEEEE
T ss_pred CEEEECCCCcEEehHHHHHHHHCcCHHHHcCCCHHHcCCCCCCHHHHHHHHHHHHcCCeEEEEEEEEcCCCCEEeeeeEE
Confidence 37899999999999999999999999999999998887665555555677888999999999999999999999999999
Q ss_pred EEEECCCCCEEEEEEEEEehhHHHHHHHHHHHh
Q 003978 222 TPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (782)
Q Consensus 222 ~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~ 254 (782)
.|++|.+|++.+++++.+|||++|++|++|+..
T Consensus 81 ~p~~d~~g~~~~~~~~~~DIT~~k~~e~~l~~~ 113 (227)
T 3ewk_A 81 VPLMDNAGKPRQYISIRRDITAQKEAEAQLARL 113 (227)
T ss_dssp EEEECSSSCEEEEEEEEEECTTTTHHHHHHHHH
T ss_pred EEEEcCCCCEEEEEEEEEehhhHHHHHHHHHHH
Confidence 999999999999999999999999999988654
|
| >3nja_A Probable ggdef family protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; 2.37A {Chromobacterium violaceum} | Back alignment and structure |
|---|
Probab=99.59 E-value=6.1e-15 Score=132.42 Aligned_cols=120 Identities=6% Similarity=0.101 Sum_probs=93.7
Q ss_pred cCHHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcC--CCccccccccccccHHHHHHHHHHcCCeEEEE
Q 003978 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALG--QDAIELLTDGRDFDVAYDIVHRIKMGERWTGQ 204 (782)
Q Consensus 127 l~~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG--~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e 204 (782)
..++.|+.++++++++|+++|.+|.++++|+++++++||+.++++| ..+..++++++.......+..++..+..+..+
T Consensus 4 ~~~~~l~~~~~~~~~~i~~~d~~~~~~~~n~~~~~~~G~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~e 83 (125)
T 3nja_A 4 MAEKLLHTAESDAGIGSWVLHMESGRLEWSQAVHDIFGTDSATFDATEDAYFQRVHPDDRARVRRELDRHVLGDRPFDVE 83 (125)
T ss_dssp -------------CCEEEEEETTTTEEEECHHHHHHHTCCTTTCCCBHHHHHHHBCTTTHHHHHHHHHHHHHSCCCEEEE
T ss_pred HHHHHHHHHHHhCCeeEEEEEcCCCcEEECHHHHHHhCCCcccccccHHHHHhhcChhHHHHHHHHHHHHHhcCCCceEE
Confidence 3457799999999999999999999999999999999999999999 66667777776555555667778888888889
Q ss_pred EEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHH
Q 003978 205 FPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246 (782)
Q Consensus 205 ~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~ 246 (782)
+++.+++|..+|+.+...|+.+.+|.+.+++++++|||++|+
T Consensus 84 ~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~g~~~DITe~k~ 125 (125)
T 3nja_A 84 YRIVRPDGQVRELLERNHIQRQASGQVDHLWGTVIDMTEHKQ 125 (125)
T ss_dssp EEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCC---
T ss_pred EEEECCCCCEEEEEEeeEEEECCCCCEEEEEEEEEecccccC
Confidence 999999999999999999999999999999999999999874
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} | Back alignment and structure |
|---|
Probab=99.57 E-value=2e-14 Score=127.06 Aligned_cols=112 Identities=16% Similarity=0.164 Sum_probs=92.4
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEE-EEE
Q 003978 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQ-FPA 207 (782)
Q Consensus 129 ~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e-~~~ 207 (782)
++.|+.++++++++|+++|.+|+|+++|+++++++|++.++++|+++.++++ +... ........+..+.....+ ...
T Consensus 2 e~~~~~~~~~~~~~i~~~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~ 79 (114)
T 3luq_A 2 DERLRLFTEHAPAALAMFDREMRYLAVSRRWREDYGLGDGDILGMSHYDIFP-EIGE-EWKSVHRRGLAGEVIRVEEDCF 79 (114)
T ss_dssp CHHHHHHHHTCSSEEEEEETTCBEEEECHHHHHHTTCCSSCCTTCBHHHHCT-TCCH-HHHHHHHHHHTTCCEEEEEEEE
T ss_pred hHHHHHHHhcCCceEEEEcCCcEEEEECHHHHHHHCCCHHHHcCCcHHHHCC-ccHH-HHHHHHHHHhcCCcceeeeeEE
Confidence 3679999999999999999999999999999999999999999999999884 3322 233344444455554444 477
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehh
Q 003978 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (782)
Q Consensus 208 ~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (782)
.+++|..+|+.++..|+++.+|.+.|++++++|||
T Consensus 80 ~~~~g~~~~~~~~~~p~~~~~g~~~~~~~~~~DIT 114 (114)
T 3luq_A 80 VRADGRTQWLRWEVRPWYEGEGRVGGVVIFTEDIT 114 (114)
T ss_dssp EC--CCEEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EcCCCcEEEEEEEEEEeECCCCCEEEEEEEEeeCC
Confidence 89999999999999999999999999999999997
|
| >3mxq_A Sensor protein; PSI2, MCSG, structural genomics, protein structure initiativ midwest center for structural genomics; 2.78A {Vibrio cholerae o1 biovar el tor} | Back alignment and structure |
|---|
Probab=99.57 E-value=5.3e-15 Score=142.32 Aligned_cols=117 Identities=15% Similarity=0.140 Sum_probs=93.3
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEE-----
Q 003978 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQ----- 204 (782)
Q Consensus 130 ~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e----- 204 (782)
..++.||+++++||+++|.+|+|++||+++++++|++.++++|+++.++++. ........+..++..|.+....
T Consensus 22 ~~l~~il~~~~~gi~v~D~~g~I~~~N~a~~~~~G~~~~eviG~~~~~~~p~-~~~~~~~~l~~vl~~G~~~~~~~~~~~ 100 (152)
T 3mxq_A 22 LLLSELLDQLSFALCIVRNDYVIVKVNEYFESRVIFDGETMQGKNILELFPE-SADYLKRKIDTALVIESSSFSSWEQKP 100 (152)
T ss_dssp HHHHHHHHHHCCEEEEEETTSBEEEECHHHHHTSSSCHHHHTTSBHHHHSGG-GHHHHHHHHHHHHHHTSCEEEECCSSS
T ss_pred HHHHHHHhcCCCCEEEEcCCCEEEEECHHHHHHHCcCHHHHCCCCHHHhcCC-hHHHHHHHHHHHHhcCCceeeeccccc
Confidence 3578999999999999999999999999999999999999999999999987 4333444678888888763321
Q ss_pred ----EEE---EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHH
Q 003978 205 ----FPA---KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQET 247 (782)
Q Consensus 205 ----~~~---~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~ 247 (782)
+.. ..++|..++..+++.|++|.+|++.|++.+++|||+++.+
T Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~ti~Pl~d~~G~v~gv~~ii~DVTe~~~a 150 (152)
T 3mxq_A 101 HLLPFKSSRPVSGEEEQMYQNLEVIPIHSEDGTIEHVCLCVYDVTIQASQ 150 (152)
T ss_dssp CSSCC----------CCEEEEEEEEEEECTTSCEEEEEEEEEEEECC---
T ss_pred ccccccccCCCCCCCcEEEEEEEEEEEECCCCCEEEEEEEEEECCHHHhc
Confidence 111 2356778889999999999999999999999999998764
|
| >3kx0_X Uncharacterized protein RV1364C/MT1410; PAS domain, sensory domain, mycobacteium tuberculos molecule binding domain; 2.30A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.8e-14 Score=142.08 Aligned_cols=124 Identities=15% Similarity=0.094 Sum_probs=101.7
Q ss_pred CHHHHHHHHHHcCceeEEEc-CCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEE
Q 003978 128 TDRQYLNILQSMGQSVHIFD-LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (782)
Q Consensus 128 ~~~~~~~ile~~~d~I~v~D-~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~ 206 (782)
..+.|+.++++++++|+++| .+|+|+|+|++|++++||+ +++|+++.+++++.........+..++..|+....+..
T Consensus 35 ~~~~l~~l~~~~~~~i~~~d~~~g~i~~~N~a~~~l~G~~--~~~G~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~ 112 (185)
T 3kx0_X 35 AAEDVRRIFEHIPAILVGLEGPDHRFVAVNAAYRGFSPLL--DTVGQPAREVYPELEGQQIYEMLDRVYQTGEPQSGSEW 112 (185)
T ss_dssp CHHHHHHHHHHCSSEEEEEETTTTEEEEECHHHHHHCCCC--SCTTSBHHHHCTTSCSSSSHHHHHHHHHHCCCEEEEEE
T ss_pred hHHHHHHHHhcCCceEEEEECCCcEEEEEcHHHHHHcCCc--cccCCcHHHHCCchhhhhHHHHHHHHHHcCCcccccce
Confidence 35789999999999999999 9999999999999999999 99999999999876655455567788888888655433
Q ss_pred EE---cCC--CCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHH
Q 003978 207 AK---TKT--EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWD 253 (782)
Q Consensus 207 ~~---~kd--G~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~ 253 (782)
.+ +++ |..+|+.++..|+++.+|.+.|++++++|||++|++|+++..
T Consensus 113 ~~~~~~~~~gg~~~~~~~~~~pi~~~~g~~~g~~~~~~DITerk~~e~~~~~ 164 (185)
T 3kx0_X 113 RLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDDVTSRVRARQAAEA 164 (185)
T ss_dssp EEC--------CCEEEEEEEEEEECTTSCEEEEEEEEEECHHHHTTCC----
T ss_pred eEEeeccCCCCccEEEEEEEEEEECCCCCEEEEEEEEEeCCHHHHHHHHHHH
Confidence 22 222 778999999999999999999999999999999999888433
|
| >2wkq_A NPH1-1, RAS-related C3 botulinum toxin substrate 1; transferase, cell adhesion, nucleotide-binding, protein engineering, RAS superfamily LOV2; HET: GTP FMN; 1.60A {Avena sativa} PDB: 2wkr_A* 2wkp_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=1.8e-14 Score=155.50 Aligned_cols=117 Identities=24% Similarity=0.209 Sum_probs=108.0
Q ss_pred HHHHcCceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEcCC
Q 003978 135 ILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKT 211 (782)
Q Consensus 135 ile~~~d~I~v~D~---dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kd 211 (782)
++++++++|+++|. +|+|+|+|++|++|+||+++|++|+++.+++++.........+...+..+..+..+.+.+++|
T Consensus 16 ~~~~~~~~i~~~D~~~~~g~i~~~N~a~~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~d 95 (332)
T 2wkq_A 16 TLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNARFLQGPETDRATVRKIRDAIDNQTEVTVQLINYTKS 95 (332)
T ss_dssp CGGGCCSEEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTT
T ss_pred HhhcCCCcEEEecCCCCCCCEEEeehHHHHHhCCCHHHHcCCCchhhcCCCCCHHHHHHHHHHHHcCCeeEEEEEEEcCC
Confidence 47899999999999 999999999999999999999999999999887766556667888999999999999999999
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHH
Q 003978 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAAL 251 (782)
Q Consensus 212 G~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L 251 (782)
|..+|+.+++.|++|.+|++.|++++++|||+++++++++
T Consensus 96 G~~~~~~~~~~pi~d~~g~~~~~v~~~~DITe~k~~e~~~ 135 (332)
T 2wkq_A 96 GKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVRDAAER 135 (332)
T ss_dssp CCEEEEEEEEEEEECTTSCEEEEEEEEEEESSCCCHHHHH
T ss_pred CCEEEEeeEEEEeEcCCCCEEEEEEEeccCchhhhhhhhc
Confidence 9999999999999999999999999999999998887665
|
| >1d06_A Nitrogen fixation regulatory protein FIXL; oxygen sensor, histidine kinase, PAS, high-resolution, two-C system, signaling protein; HET: HEM; 1.40A {Sinorhizobium meliloti} SCOP: d.110.3.2 PDB: 1ew0_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=3.8e-14 Score=130.60 Aligned_cols=110 Identities=15% Similarity=0.162 Sum_probs=88.8
Q ss_pred HHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCe----EEEEEE
Q 003978 131 QYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQFP 206 (782)
Q Consensus 131 ~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~----~~~e~~ 206 (782)
.|+.++++++++|+++|.+|+|+++|++|++|+||+.+|++|+++..++++.........+...+..+.. ...++.
T Consensus 17 ~~~~l~~~~~d~i~~~d~~g~i~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 96 (130)
T 1d06_A 17 HLRSILDTVPDATVVSATDGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQRYMATGEKRIIGIDRVVS 96 (130)
T ss_dssp CHHHHHTTCSSEEEEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTSCEEEE
T ss_pred HHHHHHhhCcCeEEEECCCCeEEEEcHHHHHHHCCCHHHHcCCcHHHHCCchhHHHHHHHHHHHHhcCCccccCCeeEEE
Confidence 4889999999999999999999999999999999999999999999988765532222333444444443 234677
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehh
Q 003978 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (782)
Q Consensus 207 ~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (782)
.+++||+.+|+.+++.|+.+.+ ..+++++++|||
T Consensus 97 ~~~kdG~~~~~~~~~~~~~~~~--~~~~~~~~~DIT 130 (130)
T 1d06_A 97 GQRKDGSTFPMKLAVGEMRSGG--ERFFTGFIRDLT 130 (130)
T ss_dssp EECTTSCEEEEEEEEEEEEETT--EEEEEEEEEECC
T ss_pred EEeCCCCEEEEEEEEEEEEECC--eEEEEEEEEECc
Confidence 8899999999999999998633 356889999997
|
| >3vol_A Aerotaxis transducer AER2; heme, oxygen sensor protein, PAS, HAMP, cyanoMet, CN-bound, protein; HET: HEM; 2.40A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.53 E-value=3.9e-14 Score=146.05 Aligned_cols=129 Identities=13% Similarity=0.142 Sum_probs=98.8
Q ss_pred CCCccCcCHHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHh------------CCChhhHcCCCccccccccccccHH
Q 003978 121 GPSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLY------------GYSAEEALGQDAIELLTDGRDFDVA 188 (782)
Q Consensus 121 ~~~a~~l~~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~------------Gys~eEliG~~~~~l~~~~~~~~~~ 188 (782)
|-.+.....++++.+|++++++|+++|.+|+|+|+|++|++|+ ||+.++++|+++.++++... ..
T Consensus 13 ~~~~~~~e~~~l~~iLd~~~~~vii~D~~g~I~~~N~a~~~ll~~~~~~~~~~l~G~~~~eliG~~~~~~~~~~~---~~ 89 (233)
T 3vol_A 13 GLVPRGSHMARIKSALDNVSANVMIADNDLNIIYMNRTVSEMLGRAEADIRKQLPNFDAGRLMGANIDVFHKNPA---HQ 89 (233)
T ss_dssp -----CTHHHHHHHHHTTSSSEEEEEETTSBEEEECHHHHHHHHHTHHHHHTTCTTCCTTSCTTCBGGGGSSSHH---HH
T ss_pred cCCchHHHHHHHHHHHhcCCCcEEEECCCCcEEEecHHHHHHHHHHHHHHHhhcCCCCHHHHcCCCHHHHcCCHH---HH
Confidence 3334444557799999999999999999999999999999999 89999999999998876422 12
Q ss_pred HHHHHHHHcCCeEEEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhhcccc
Q 003978 189 YDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDT 259 (782)
Q Consensus 189 ~~l~~~l~~g~~~~~e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~~~~~ 259 (782)
..++..+. ..+..++. .+| .|+.++++|++|.+|++.|++++++|||+++++|++++.......
T Consensus 90 ~~~~~~~~--~~~~~~~~---~~g--~~~~~~~~Pi~d~~G~~~g~v~~~~DITe~~~~e~ei~~l~~a~~ 153 (233)
T 3vol_A 90 RHLLANLT--GVHKAELN---LGG--RRFSLDVVPVFNDANERLGSAVQWTDRTEEHRAEQEVSQLVQAAA 153 (233)
T ss_dssp HHHHHTCC--SCEEEEEE---ETT--EEEEEEEEEEECTTCCEEEEEEEEEECHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhcc--cceeEEEE---ECC--EEEEEEEEEEECCCCCEEEEEEEEehhhHHHHHHHHHHHHHHHHh
Confidence 22333322 23444433 355 367899999999999999999999999999999999987766533
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=5.9e-14 Score=128.32 Aligned_cols=116 Identities=22% Similarity=0.205 Sum_probs=105.2
Q ss_pred HHHHHHHcCceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEE
Q 003978 132 YLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (782)
Q Consensus 132 ~~~ile~~~d~I~v~D~---dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~ 208 (782)
++.++++++++|+++|. +|.|+++|+++++++||+.++++|+++..++++.........+...+..+..+..++...
T Consensus 4 l~~~~~~~~~~i~~~d~~~~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (146)
T 2v0u_A 4 LATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRATVRKIRDAIDNQTEVTVQLINY 83 (146)
T ss_dssp CCCTGGGSSSCEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEE
T ss_pred HHHHHhcCCCcEEEEcCCCCCceEEEEcHHHHHHHCcCHHHHcCCCHHHhcCCcCChHHHHHHHHHHhcCCCcceEEEEE
Confidence 45678999999999999 999999999999999999999999999988877765555566788888899888899999
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHH
Q 003978 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQET 247 (782)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~ 247 (782)
+++|..+|+.++..|+.+.+|.+.+++++++|||++++.
T Consensus 84 ~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~~ 122 (146)
T 2v0u_A 84 TKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVRD 122 (146)
T ss_dssp CTTCCEEEEEEEEEEEECTTSCEEEEEEEEEEESSCCCH
T ss_pred ecCCcEEEEEEEEEEeECCCCCEEEEEEEEeechHHHHH
Confidence 999999999999999999999999999999999999873
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.5e-13 Score=140.07 Aligned_cols=111 Identities=23% Similarity=0.336 Sum_probs=102.7
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEc
Q 003978 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (782)
Q Consensus 130 ~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~ 209 (782)
+.++.++++++++|+++|.+|+|+|+|++|++++||+.+|++|+++..+.++.........+++++..+..+..++..++
T Consensus 111 ~~~~~~~~~~~~~i~~~d~~g~i~~~N~~~~~~~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 190 (227)
T 3ewk_A 111 ARLKQAMDANSEMILLTDRAGRIIYANPALCRFSGMAEGELLGQSPSILDSPLADQETLAAMQEALQAGQPWSGRLLNRR 190 (227)
T ss_dssp HHHHHHHHTCCSEEEEECTTSCEEEECHHHHHHHTCCTHHHHSSCGGGGBCTTSCHHHHHHHHHHHHHTCCEECCEEEEE
T ss_pred HHHHHHHhcCcCeEEEEcCCCcEEEEchHHHHHhCCCHHHHcCCChhhccCCCCCHHHHHHHHHHHHcCCceeEEEEEEC
Confidence 45778899999999999999999999999999999999999999999988877766666778999999999999999999
Q ss_pred CCCC------EEEEEEEEEEEECCCCCEEEEEEEEEe
Q 003978 210 KTEE------RVLVVATNTPFYDDDGTLVGIVCVSTD 240 (782)
Q Consensus 210 kdG~------~~~v~~~~~Pi~d~~G~v~g~v~i~rD 240 (782)
++|. .+|+.+++.|++|.+|++++++++++|
T Consensus 191 k~G~~~~dg~~~~~~~~~~pi~d~~g~~~~~v~i~~D 227 (227)
T 3ewk_A 191 RTGPAPHDAEDYWAEISTTPIHTDGNGLVGYVQIQHD 227 (227)
T ss_dssp ECCSSSSCEEEEEEEEEEEEEECSSSCEEEEEEEEEC
T ss_pred CCCCcCcccceEEEEEEEEEEECCCCCEEEEEEEecC
Confidence 9997 899999999999999999999999987
|
| >3h9w_A Diguanylate cyclase with PAS/PAC sensor; alpha-beta protein., structural genomics, PSI-2, protein STR initiative; 1.90A {Marinobacter aquaeolei} | Back alignment and structure |
|---|
Probab=99.49 E-value=7.8e-14 Score=125.29 Aligned_cols=111 Identities=12% Similarity=0.048 Sum_probs=95.0
Q ss_pred cCceeEEEc-CCCcEEEecHHHHHHhCCChhhHcCCC-ccccccccccccHHHHHHHHHHcCCeEEEEEEEEcCCCCEEE
Q 003978 139 MGQSVHIFD-LSDRIIYWNRSAELLYGYSAEEALGQD-AIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVL 216 (782)
Q Consensus 139 ~~d~I~v~D-~dG~Ii~vN~aae~l~Gys~eEliG~~-~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~ 216 (782)
++++|+.+| .+|+++|+|+++++|+||+.++++|.. +..+++|++.......+..++..+..+..+++++++||..+|
T Consensus 2 a~~giw~~d~~~~~~~~~n~~~~~l~G~~~~e~~~~~~~~~~ihpdd~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~~~w 81 (115)
T 3h9w_A 2 TKAIPWKINWQTMAFEYIGPQIEALLGWPQGSWKSVEDWATRMHPEDQEWVVNFCVKQSECGVDHEADYRALHRDGHYVW 81 (115)
T ss_dssp -CCEEEEEETTTTEEEEECTHHHHHHCSCGGGCCBHHHHHHSBCHHHHHHHHHHHHHHHHTTCCEEEEEEEECTTSCEEE
T ss_pred cceEEEEEEcCCCcEEEEChhHHHHhCCChHHccCHHHHHHhcCHHHHHHHHHHHHHHHhcCCcccEEEEEEcCCCCEEE
Confidence 467899999 679999999999999999999999842 345777777655556677788888888999999999999999
Q ss_pred EEEEEEEEECCCCCEEEEEEEEEehhHHHHHHH
Q 003978 217 VVATNTPFYDDDGTLVGIVCVSTDSRPFQETRA 249 (782)
Q Consensus 217 v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~ 249 (782)
+.+...|++|.+|++++++++..|||++|++|+
T Consensus 82 ~~~~~~~~~d~~G~~~~~~G~~~Dit~~k~~~~ 114 (115)
T 3h9w_A 82 IRDVVHVVRDDSGEVEALIGFMFDISLEHHHHH 114 (115)
T ss_dssp EEEEEEEEECTTSCEEEEEEEEEECGGGGC---
T ss_pred EEEEEEEEECCCCCEEEEEEEEeccCccccccc
Confidence 999999999999999999999999999998875
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} | Back alignment and structure |
|---|
Probab=99.48 E-value=8.5e-14 Score=125.48 Aligned_cols=120 Identities=12% Similarity=0.098 Sum_probs=87.7
Q ss_pred HHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEcCCC
Q 003978 133 LNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTE 212 (782)
Q Consensus 133 ~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG 212 (782)
+.++++++++|+++|.+|+|+++|+++++++||+.++++|+++.+++++.........+...+..+. ...++...+++|
T Consensus 2 ~~l~~~~~~~i~~~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~g 80 (126)
T 3mjq_A 2 KNFLETIEDMILIINREGRLLYANTAVPKKLGYTHEELMSMHILTITSAGKMAEGEKILAELFAGKK-ESLPLSLEKKEG 80 (126)
T ss_dssp CTTGGGCSSEEEEEETTSBEEEECTHHHHHHSCCHHHHHHSBHHHHHCTTCHHHHHHHHHHHHHTCC-SEEEEEEECTTS
T ss_pred hhHHhhCCceEEEEeCCCcEEEEcHHHHHHHCCCHHHHcCCCHHHHcCchhHHHHHHHHHHHHhCCC-ceeEEEEEccCC
Confidence 4578999999999999999999999999999999999999999999876654333333444444444 467788889999
Q ss_pred CEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHhh
Q 003978 213 ERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTK 255 (782)
Q Consensus 213 ~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~~ 255 (782)
..+|+.++..|+... ...+++++++|||+++++++++....
T Consensus 81 ~~~~~~~~~~~~~~~--~~~~~~~~~~DITe~k~a~~~~~~~~ 121 (126)
T 3mjq_A 81 TSIPAKARIWQGKWH--NEPCLFAIIKDLSKEERASSPPFLEH 121 (126)
T ss_dssp CEEEEEEEEEEEESS--SSEEEEEEEEECC-------------
T ss_pred CEEEEEEEEEeeeEC--CceEEEEEEEechHHHHhhcccchhh
Confidence 999999999987653 35689999999999999988876543
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} | Back alignment and structure |
|---|
Probab=99.48 E-value=4.9e-13 Score=119.15 Aligned_cols=107 Identities=13% Similarity=0.069 Sum_probs=89.9
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEE
Q 003978 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (782)
Q Consensus 129 ~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~ 208 (782)
.+.++.++++++++|+++|.+|+|+++|+++++++||++++++|+++.++++...... +..+..+..+..+....
T Consensus 12 ~~~~~~~~~~~~~~i~~~d~~g~i~~~N~~~~~l~G~~~~el~g~~~~~~~~~~~~~~-----~~~~~~~~~~~~e~~~~ 86 (118)
T 3olo_A 12 FKFAHYLINNAVEASFCLGDNWQFLYVNDATCRMTEYSREQLLSMNLQDIDVDFALHD-----WEEIRQKNNYTFKTRYR 86 (118)
T ss_dssp HHHHHHHHHHCSSEEEEECTTSBEEEECHHHHHHHCCCHHHHTTCBGGGTBTTGGGSC-----HHHHHHHSEEEEEEEEE
T ss_pred HHHHHHHHhcCCceEEEECCCCcEEEEHHHHHHHHCCCHHHHhCCChhhcccccCHHH-----HHHHHhcCcEEEEEEEE
Confidence 3567889999999999999999999999999999999999999999999886544322 44455667788888999
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehh
Q 003978 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (782)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (782)
+++|..+|+.++..|+.+.+ ..+++++++|||
T Consensus 87 ~~~g~~~~~~~~~~~~~~~~--~~~~~~~~~DIT 118 (118)
T 3olo_A 87 SQSGRIFLVEMSLTFLEDQE--RRFSCVFVREKS 118 (118)
T ss_dssp CTTCCEEEEEEEEEEEEETT--EEEEEEEEEEC-
T ss_pred ccCCCEEEEEEEEEEEEECC--ccEEEEEEEeCC
Confidence 99999999999999997643 346789999997
|
| >3icy_A Sensor protein; sensory box histidine kinase/response regulator domain, kinase, chlorobium tepidum TLS, PSI-2; 2.68A {Chlorobaculum tepidum} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.1e-13 Score=123.53 Aligned_cols=115 Identities=11% Similarity=0.119 Sum_probs=102.9
Q ss_pred CHHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCc--cccccccccccHHHHHHHHHHcCCeEEEEE
Q 003978 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDA--IELLTDGRDFDVAYDIVHRIKMGERWTGQF 205 (782)
Q Consensus 128 ~~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~--~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~ 205 (782)
+++.|+.++++++++|+.+|.+|.++++|+++++++||+.+++++... ..++++++.......+...+..+..+..++
T Consensus 2 s~~~~~~l~~~~~~~i~~~d~~~~~~~~n~~~~~~~G~~~~~~~~~~~~~~~~i~p~d~~~~~~~~~~~~~~~~~~~~e~ 81 (118)
T 3icy_A 2 NAEELQALVDNIPAAIYHLDVSGQATIRFRPPAFLKTLVSEHAGTTRLNTLSMIHHDDRHMLSNAYSKLREAKHSLTLVY 81 (118)
T ss_dssp HHHHHHHHHTTCCCCCEEECTTSCEEECCCCCGGGGGGEEEETTEEEEGGGGGBCGGGHHHHHHHHHHHHHSCCEEEEEE
T ss_pred cHHHHHHHHhcCCceEEEEEcCCCceEEechhHhhcCCCHHHccCChhHHHHHcCHHHHHHHHHHHHHHHhcCCCceEEE
Confidence 357899999999999999999999999999999999999999988754 567777776555556677778888889999
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehh
Q 003978 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (782)
Q Consensus 206 ~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (782)
++.+++|..+|+.....|+++.+|.+++++++++|||
T Consensus 82 r~~~~~g~~~w~~~~~~~~~~~~g~~~~~~g~~~DIT 118 (118)
T 3icy_A 82 RIVTPEGKLHWIEDHMRSSFSDDGLFSGIDGILCEVT 118 (118)
T ss_dssp EEECTTCCEEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 9999999999999999999999999999999999997
|
| >2qkp_A Uncharacterized protein; structural genomics, unknown function, PSI-2, protein struct initiative; 1.75A {Streptococcus mutans} | Back alignment and structure |
|---|
Probab=99.46 E-value=9.9e-14 Score=133.27 Aligned_cols=122 Identities=18% Similarity=0.258 Sum_probs=100.6
Q ss_pred cCHHHHHHHHHHcCceeEEEcCCCcEEEecHH---HHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEE
Q 003978 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRS---AELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTG 203 (782)
Q Consensus 127 l~~~~~~~ile~~~d~I~v~D~dG~Ii~vN~a---ae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~ 203 (782)
++.+.+..||++++++|+++|.+|+|+|+|++ +++++| ..++++|+++.+++++.. ....+.+..++++|+....
T Consensus 16 l~~~~l~~IL~~~~~gI~~vD~~g~I~~~N~a~~~~~~i~g-~~~~~iGr~v~~~~~~~~-~~~v~~i~~~l~~g~~~~~ 93 (151)
T 2qkp_A 16 LSVEQANLILNHLPLEITFVNKDDIFQYYNDSVPAAEMVFK-RTPSQVGRNVELCHPPKV-LDKVKKVFELLRNGQRDKV 93 (151)
T ss_dssp ECHHHHHHHHHHSSSEEEEEETTSBEEEECCCSCGGGCSSC-CCGGGTTSBGGGSSCHHH-HHHHHHHHHHHHTTSBSEE
T ss_pred ecHHHHHHHHHhCCCceEEEcCCCeEEEEeCCCchhhhhcC-CCHHHcCCCHHHhCCHHH-HHHHHHHHHHHHcCCccEE
Confidence 56688999999999999999999999999999 999999 567899999999876443 3345678888999988766
Q ss_pred EEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHH
Q 003978 204 QFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAAL 251 (782)
Q Consensus 204 e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L 251 (782)
++.....+ ...++.++..||+|++|+++|++.+++|||+.++++++.
T Consensus 94 ~~~~~~~~-~~~~v~v~~~Pi~d~~G~~~G~vev~~Dit~l~~le~~r 140 (151)
T 2qkp_A 94 NMWFQSER-LGKFVYVTYAAVRDQAGDFQGVLEYVQDIKPFFELDSEF 140 (151)
T ss_dssp EEEEEETT-TTEEEEEEEEEEECTTCCEEEEEEEEEECGGGGGGGGC-
T ss_pred EEEEecCC-CCeEEEEEEEEEECCCCCEEEEEEEEEECHHHHhhhhhh
Confidence 66654332 124678899999999999999999999999998776653
|
| >3mfx_A Sensory BOX/ggdef family protein; alpha-beta protein, structural genomics, PSI-2, protein structure initiative; 2.40A {Shewanella oneidensis} | Back alignment and structure |
|---|
Probab=99.44 E-value=5e-13 Score=124.74 Aligned_cols=112 Identities=13% Similarity=0.073 Sum_probs=84.6
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCC-------eEE
Q 003978 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGE-------RWT 202 (782)
Q Consensus 130 ~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~-------~~~ 202 (782)
+.++.++++++++|+++|.+|+|+++|++|++|+||+.++++|+++.+++++.........+......+. ...
T Consensus 7 ~~l~~i~~~~~d~i~~~D~~g~I~~~N~aa~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (129)
T 3mfx_A 7 ETIELFIQHLTEAMILVNANGFIRSCNQRSAELLDCPQVSLKGQDWRNFLTEHHQARYDNLLSHDVQLGTNCGQPVQHPA 86 (129)
T ss_dssp HHHHHHHTTCSSEEEEEETTSBEEEECHHHHHHTTSCHHHHTTSBGGGGBCTTCCGGGGCTTC----------CCSCEEE
T ss_pred HHHHHHHhcCCceEEEECCCCEEEeEhHHHHHHHCcCHHHHcCCcHHHHcChHhHHHHHHHHHHHHhcCcccccccCCCc
Confidence 5688999999999999999999999999999999999999999999999987654221111111112221 245
Q ss_pred EEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHH
Q 003978 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (782)
Q Consensus 203 ~e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITer 244 (782)
.++.++++||+.+|+.++++|+.+ ++. -++++++|+...
T Consensus 87 ~E~~~~rkdG~~~~velsis~i~~-~~~--~~v~~~~~~~~~ 125 (129)
T 3mfx_A 87 QETTLICASGKAKDVELSISYIPG-HEP--MFVMVMHDLEHH 125 (129)
T ss_dssp EEEEEECTTSCEEEEEEEEEEECS-SSC--EEEEEEEEC---
T ss_pred eEEEEEcCCCCEEEEEEEEEEecC-CCc--EEEEEEechhhh
Confidence 788899999999999999999983 322 278889998643
|
| >2l0w_A Potassium voltage-gated channel, subfamily H (EAG member 2, isoform CRA_B; HERG, PAS domain, voltage-gated potassium channel, membrane; NMR {Homo sapiens} PDB: 2l1m_A 2l4r_A | Back alignment and structure |
|---|
Probab=99.43 E-value=1.1e-12 Score=118.85 Aligned_cols=113 Identities=16% Similarity=0.135 Sum_probs=95.0
Q ss_pred HHHHHHHcCceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCC--ccccccccccccHHHHHHHHHHcCCeEEEEEE
Q 003978 132 YLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQD--AIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (782)
Q Consensus 132 ~~~ile~~~d~I~v~D~---dG~Ii~vN~aae~l~Gys~eEliG~~--~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~ 206 (782)
+...+++++++|+++|. +|+|+|+|+++++++||+.++++|++ +..+.++.........+...+..+..+..+..
T Consensus 21 ~~~~~~~~~~~i~~~d~~~~~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (138)
T 2l0w_A 21 IIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIA 100 (138)
T ss_dssp HHHHHTTTTSEEEEEESSSTTCBEEEECSHHHHHHSCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHTTCSSCEEEEEE
T ss_pred HHHHHhcCCCCEEEEecCCCCCEEEEeCHHHHHHhCCCHHHHcCCCCcccccCCcccchhHHHHHHHHHhhcCCceeEEE
Confidence 44445559999999999 99999999999999999999999999 45455544433334556777777888888888
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHH
Q 003978 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (782)
Q Consensus 207 ~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITer 244 (782)
..+++|..+|+.+++.|+.+.+|.+.+++++++|||++
T Consensus 101 ~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~ 138 (138)
T 2l0w_A 101 FYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEK 138 (138)
T ss_dssp EECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEEEEEC
T ss_pred EECCCCCEEEEEEEEEEEeCCCCCEEEEEEEEEeccCC
Confidence 89999999999999999999999999999999999863
|
| >3eeh_A Putative light and redox sensing histidine kinase; structural genomic MCSG, protein structure initiative, midwest center for STRU genomics; HET: PG5; 1.95A {Haloarcula marismortui} | Back alignment and structure |
|---|
Probab=99.43 E-value=5.4e-13 Score=118.62 Aligned_cols=114 Identities=14% Similarity=0.163 Sum_probs=97.8
Q ss_pred CHHHHHHHHHHcCceeEEEcCC-CcEEEecHHHHHHhCCChhhHcCCC--ccccccccccccHHHHHHHHHHcCCeEEEE
Q 003978 128 TDRQYLNILQSMGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQD--AIELLTDGRDFDVAYDIVHRIKMGERWTGQ 204 (782)
Q Consensus 128 ~~~~~~~ile~~~d~I~v~D~d-G~Ii~vN~aae~l~Gys~eEliG~~--~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e 204 (782)
.++.|+.++++++++|+++|.+ |.|+++|+++++++||+.++++|+. +..+++++.... ....+..+..+..+..+
T Consensus 9 ~~~~~~~~~~~~~~~i~~~d~~~~~i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e 87 (125)
T 3eeh_A 9 SERRVRELTEATNDILWEFTADLSEVLVINSAYEDIWGRSVAKLRENPHDFLNGIHPEDREL-MKDTMQSLMDGESADVE 87 (125)
T ss_dssp -CHHHHHHHSCCCCEEEEEETTSSCEEEECTHHHHHHSSCHHHHHHCGGGGGGGBCHHHHHH-HHHHHHHHHTTCCEEEE
T ss_pred HHHHHHHHHhcCCceEEEEEcCCCcEEEecHHHHHHHCCCHHHHccCcHHHHHhcCHHHHHH-HHHHHHHHHcCCCccEE
Confidence 4478999999999999999999 9999999999999999999999988 556666655332 23334446778888889
Q ss_pred EEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehh
Q 003978 205 FPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (782)
Q Consensus 205 ~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (782)
+++.+++|..+|+.++..|+.+.+|.+.+++++++|||
T Consensus 88 ~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIT 125 (125)
T 3eeh_A 88 CRVNATEEYQRWVWIQGEPITNDAGETVRVAGFARDIT 125 (125)
T ss_dssp EEECGGGTTCEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EEEEcCCCCEEEEEEecEEEECCCCCEEEEEEEEEecC
Confidence 99999999999999999999999999999999999997
|
| >1byw_A Protein (human ERG potassium channel); PAS domain, potassium channel domain, membrane protein; 2.60A {Homo sapiens} SCOP: d.110.3.6 | Back alignment and structure |
|---|
Probab=99.42 E-value=1.9e-12 Score=111.85 Aligned_cols=104 Identities=17% Similarity=0.132 Sum_probs=88.2
Q ss_pred ceeEEEcC---CCcEEEecHHHHHHhCCChhhHcCCC--ccccccccccccHHHHHHHHHHcCCeEEEEEEEEcCCCCEE
Q 003978 141 QSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQD--AIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERV 215 (782)
Q Consensus 141 d~I~v~D~---dG~Ii~vN~aae~l~Gys~eEliG~~--~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~ 215 (782)
++|+++|. +|+|+|+|+++++++||+.++++|++ +..+.++.........+...+..+..+..+....+++|..+
T Consensus 2 ~~i~i~d~~~~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~ 81 (110)
T 1byw_A 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCF 81 (110)
T ss_dssp CEEEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEE
T ss_pred CCEEEEeccCCCCcEEEECHHHHHHhCCCHHHHccCCCccccccCCcCCHHHHHHHHHHHhcCCCceEEEEEEcCCCCEE
Confidence 58999997 59999999999999999999999998 34444443333334567778888888888888899999999
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEEehhHH
Q 003978 216 LVVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (782)
Q Consensus 216 ~v~~~~~Pi~d~~G~v~g~v~i~rDITer 244 (782)
|+.++..|+.+.+|.+.+++++++|||++
T Consensus 82 ~~~~~~~~~~~~~g~~~~~~~~~~DiTe~ 110 (110)
T 1byw_A 82 LCLVDVVPVKNEDGAVIMFILNFEVVMEK 110 (110)
T ss_dssp EEEEEEEEEECTTCCEEEEEEEEEEEEEC
T ss_pred EEEEEEEEeecCCCCEEEEEEEEEeccCC
Confidence 99999999999999999999999999963
|
| >1v9y_A Heme PAS sensor protein; signaling protein; HET: HEM; 1.32A {Escherichia coli} SCOP: d.110.3.2 PDB: 1v9z_A* 1vb6_A* 1s67_L* 1s66_L* | Back alignment and structure |
|---|
Probab=99.42 E-value=5.8e-13 Score=126.19 Aligned_cols=123 Identities=15% Similarity=0.227 Sum_probs=86.6
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCe----EEEEE
Q 003978 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQF 205 (782)
Q Consensus 130 ~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~----~~~e~ 205 (782)
+.|+.++++++++|+++|.+|.|+++|+++++++||+.++++|+++.+++++.........+......+.. +..++
T Consensus 40 ~~~~~~l~~~~~~i~~~d~~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (167)
T 1v9y_A 40 GIFFPALEQNMMGAVLINENDEVMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMSREL 119 (167)
T ss_dssp CCHHHHHHTCSSEEEEECTTSBEEEECHHHHHHHSCCGGGTTTSBGGGGSCGGGTTTHHHHHHHHHC----------CEE
T ss_pred HHHHHHHHhCCCCEEEECCCCcEEEECHHHHHHhCCCHHHHcCCChhhccCccccchHHHHHHHHhhcCCCcccccceEE
Confidence 45899999999999999999999999999999999999999999999988876544333333444443333 44577
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHHh
Q 003978 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (782)
Q Consensus 206 ~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~~ 254 (782)
...+++|..+|+.++..|+ +.+|.+ +++++++|||++++++++|+.+
T Consensus 120 ~~~~~~g~~~~~~~~~~~~-~~~g~~-~~~~~~~DiT~~~~~e~~l~~l 166 (167)
T 1v9y_A 120 QLEKKDGSKIWTRFALSKV-SAEGKV-YYLALVRDASVEMAQKEQTRQL 166 (167)
T ss_dssp EEECTTSCEEEEEEEEEEE-EETTEE-EEEEEEEC--------------
T ss_pred EEEcCCCcEEEEEEEEEEE-ecCCCE-EEEEEEecCcHHHHHHHHHHhh
Confidence 7889999999999999999 456666 4899999999999999887653
|
| >2kdk_A ARYL hydrocarbon receptor nuclear translocator-LI 2; circadian clock, PAS domain, transcription, activator, biolo rhythms, DNA-binding, nucleus; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=5.3e-13 Score=120.45 Aligned_cols=110 Identities=18% Similarity=0.215 Sum_probs=92.3
Q ss_pred HHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHc-CCeEEEEEEEEcCCCC
Q 003978 135 ILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKM-GERWTGQFPAKTKTEE 213 (782)
Q Consensus 135 ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~-g~~~~~e~~~~~kdG~ 213 (782)
++++++++|+++|.+|+|+|+|+++++++||+.+|++|+++.+++++++.......+...+.. +.....+++++++||.
T Consensus 8 ~~~~~~~~i~~~d~~g~i~~~N~~~~~~~G~~~~el~g~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~ 87 (121)
T 2kdk_A 8 INVKPTEFITRFAVNGKFVYVDQRATAILGYLPQELLGTSCYEYFHQDDHNNLTDKHKAVLQSKEKILTDSYKFRAKDGS 87 (121)
T ss_dssp CCCCSSEEEEEECTTSBEEEECTHHHHHTCCCTTTSBTSBTTTTBCSSSHHHHHHHHHHHHTSSSCEEEEEEEEECSSSC
T ss_pred cccCCccEEEEECCCeeEEEEChhHHHHHCCCHHHHcCCcHHHeeCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCC
Confidence 567789999999999999999999999999999999999999998877654444444555655 3446778899999999
Q ss_pred EEEEEEEEEEEECCC-CCEEEEEEEEEehhHH
Q 003978 214 RVLVVATNTPFYDDD-GTLVGIVCVSTDSRPF 244 (782)
Q Consensus 214 ~~~v~~~~~Pi~d~~-G~v~g~v~i~rDITer 244 (782)
.+|+.++..|++|.+ +.+.+++++.+||++.
T Consensus 88 ~~~~~~~~~~~~d~~~~~~~~~v~~~~~i~~~ 119 (121)
T 2kdk_A 88 FVTLKSQWFSFTNPDTKELEYIVSVNTLVLGH 119 (121)
T ss_dssp EEEEEEEEEEEECCSSSCEEEEEEEEECCSSC
T ss_pred EEEEEEEEEEEECCCCCeeeEEEEEEEecccc
Confidence 999999999999876 5677788999999864
|
| >3d72_A Vivid PAS protein VVD; circadian, photoreceptor, blue-light, LOV, signaling protein; HET: FAD; 1.65A {Neurospora crassa} PDB: 3is2_A* 2pd8_A* 3hjk_A* 2pdr_A* 2pd7_A* 2pdt_A* 3hji_A* 3rh8_B* | Back alignment and structure |
|---|
Probab=99.40 E-value=1.4e-12 Score=122.11 Aligned_cols=105 Identities=17% Similarity=0.199 Sum_probs=92.1
Q ss_pred HHHHcCceeEEEc---CCCcEEEecHHHHHHhCCChhhHcCCCccccccccc-----------cccHHHHHHHHHHcCCe
Q 003978 135 ILQSMGQSVHIFD---LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR-----------DFDVAYDIVHRIKMGER 200 (782)
Q Consensus 135 ile~~~d~I~v~D---~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~-----------~~~~~~~l~~~l~~g~~ 200 (782)
++++. ++|+++| .+|+|+|+|+++++|+||+.+|++|+++..++++.. .......+...+..+..
T Consensus 31 ~~~~~-~~i~~~d~~d~~g~i~~~N~a~~~l~G~~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 109 (149)
T 3d72_A 31 PVDTS-VALILCDLKQKDTPIVYASEAFLYMTGYSNAEVLGRNCRFLQSPDGMVKPKSTRKYVDSNTINTMRKAIDRNAE 109 (149)
T ss_dssp SCCTT-SCEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGGSTTSCCCTTCCCSSSCHHHHHHHHHHHHHTCC
T ss_pred hhcCC-ccEEEEeccCCCCcEEEECHHHHHHHCcCHHHHcCCChhHhCCccccccccccccccChHHHHHHHHHHHCCCc
Confidence 34553 8999999 799999999999999999999999999998887663 34445567788888988
Q ss_pred EEEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEe
Q 003978 201 WTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240 (782)
Q Consensus 201 ~~~e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rD 240 (782)
+..+...+++||..+|+.+++.|+++.+|++.+++++++|
T Consensus 110 ~~~e~~~~~~dG~~~~~~~~~~~i~~~~g~~~~~v~~~~D 149 (149)
T 3d72_A 110 VQVEVVNFKKNGQRFVNFLTMIPVRDETGEYRYSMGFQCE 149 (149)
T ss_dssp EEEEEEEECTTCCEEEEEEEEEEEECTTSSEEEEEEECCC
T ss_pred eEEEEEEECCCCCEEEEEEEEEEEEcCCCCEEEEEEEEeC
Confidence 9899999999999999999999999999999999999877
|
| >4hi4_A Aerotaxis transducer AER2; PAS domain, diatomic GAS sensor, signaling protein; HET: HEM GOL; 2.30A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.9e-12 Score=118.25 Aligned_cols=105 Identities=16% Similarity=0.220 Sum_probs=80.9
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhC------------CChhhHcCCCccccccccccccHHHHHHHHHHc
Q 003978 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYG------------YSAEEALGQDAIELLTDGRDFDVAYDIVHRIKM 197 (782)
Q Consensus 130 ~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~G------------ys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~ 197 (782)
.+++.+|++++++|+++|.+|+|+|+|++|++|+| |+.++++|+++.++++... ....++..+.
T Consensus 5 ~rl~~il~~~~~gviv~D~~g~I~~~N~a~~~llg~~~~~i~~~~~g~~~~~~~G~~~~~~~~~~~---~~~~~~~~~~- 80 (121)
T 4hi4_A 5 ARIASALDNVSANVMIADNDLNIIYMNRTVSEMLGRAEADIRKQLPNFDAGRLMGANIDVFHKNPA---HQRHLLANLT- 80 (121)
T ss_dssp HHHHHHHTTSSSEEEEEETTCBEEEECHHHHHHHHHTHHHHHHHCTTCCGGGCTTCBGGGGCSSHH---HHHHHHHHCS-
T ss_pred HHHHHHHhcCCccEEEEcCCCeEEEecHHHHHHHHHHHHHHHHhcCCCChHHhcCCCHHHhcCCHH---HHHHHHhCcC-
Confidence 56899999999999999999999999999999996 8999999999998875321 1222333222
Q ss_pred CCeEEEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHH
Q 003978 198 GERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (782)
Q Consensus 198 g~~~~~e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITer 244 (782)
..+..++. .+|. ++.++++|++|.+|++.|++++++|||+.
T Consensus 81 -~~~~~~~~---~~~~--~~~~~~~pi~~~~g~~~g~v~~~~DiTee 121 (121)
T 4hi4_A 81 -GVHKAELN---LGGR--RFSLDVVPVFNDANARLGSAVQWTDRTEE 121 (121)
T ss_dssp -SCEEEEEE---ETTE--EEEEEEEEEECTTSCEEEEEEEEEECC--
T ss_pred -CCcEEEEE---ECCE--EEEEEEEEEECCCCCEEEEEEEEEEecCC
Confidence 23443333 2453 45789999999999999999999999974
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} | Back alignment and structure |
|---|
Probab=99.38 E-value=2.5e-12 Score=115.03 Aligned_cols=108 Identities=18% Similarity=0.146 Sum_probs=88.6
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeE-EEEEEEE
Q 003978 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW-TGQFPAK 208 (782)
Q Consensus 130 ~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~-~~e~~~~ 208 (782)
.....++++++++|+++|.+|+|+|+|++|++++|++.++++|+++.+++++... ....+.+++..+... ..+..+.
T Consensus 7 ~l~~~il~~~~~~i~~~D~~g~I~~~N~aa~~l~g~~~~~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 84 (115)
T 3b33_A 7 SLPSAILNNMVTATLILDDGLAIRYANPAAELLFSQSAKRIVEQSLSQLIQHASL--DLALLTQPLQSGQSITDSDVTFV 84 (115)
T ss_dssp CHHHHHHHHCSSEEEEECTTCBEEEECHHHHHHTTSCHHHHTTCBHHHHCSEEEC--CTHHHHHHHHHCCCEEEEEEEEE
T ss_pred ccHHHHHhhcCceEEEECCCCcEEEECHHHHHHhCCCHHHHhCCCHHHHhCccch--hhHHHHHHHHcCCcccCCceEEe
Confidence 4567799999999999999999999999999999999999999999998765432 123355667777664 3455555
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehh
Q 003978 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (782)
Q Consensus 209 ~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (782)
++|..+|+.+++.|+.+ +|. .+++.+++||+
T Consensus 85 -~~g~~~~~~~~~~pi~~-~g~-~~~l~~~~Di~ 115 (115)
T 3b33_A 85 -VDGRPLMLEVTVSPITW-QRQ-LMLLVEMRKID 115 (115)
T ss_dssp -ETTEEEEEEEEEEEEEE-TTE-EEEEEEEEEC-
T ss_pred -cCCCEEEEEEEEEEeec-CCc-eEEEEEEEeCC
Confidence 78999999999999998 776 68999999985
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} | Back alignment and structure |
|---|
Probab=99.36 E-value=5.6e-12 Score=114.48 Aligned_cols=109 Identities=13% Similarity=0.109 Sum_probs=82.0
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhH--cCCCccccccccccccHHHHHHHHHHcCCeEEEEEE
Q 003978 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEA--LGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (782)
Q Consensus 129 ~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEl--iG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~ 206 (782)
++.|+.++++++++|+++|.+|+|+++|+++++++||+.+|+ +|+++.++++ .. ......+.....+.....+..
T Consensus 16 ~~~~~~l~e~~~~~i~~~d~~g~i~~~N~a~~~~~G~~~~el~g~g~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~e~~ 92 (126)
T 3bwl_A 16 SSRLEALFENSPDMIDVLDADGTICEVNQRFCAELGYDESEVLGRSIWEFDLMF--DA-EDVQTQLSGFSVDERRKFEGL 92 (126)
T ss_dssp HHHHHHHHHHCSSEEEEECTTCBEEEECHHHHHHHTCCGGGTTTSBGGGTBTTC--CH-HHHHHHHHTCCTTCEEEEEEE
T ss_pred HHHHHHHHhhCCcEEEEEcCCCCEEEEcHHHHHHhCCCHHHHhhCCCchhhccC--CH-HHHHHHHHHHhcCCCcceEEE
Confidence 467899999999999999999999999999999999999999 5787777766 21 111111111223344555667
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehh
Q 003978 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (782)
Q Consensus 207 ~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (782)
..++||..+|+.++..++.+ +|.. +++++++|||
T Consensus 93 ~~~~dG~~~~~~~~~~~~~~-~~~~-~~~~~~~DIT 126 (126)
T 3bwl_A 93 YERRDGSTMSVEVHLLRFNL-EGED-RFLAISRDIT 126 (126)
T ss_dssp EECTTSCEEEEEEEEEEEEE-TTEE-EEEEEEEEC-
T ss_pred EEeCCCCEEEEEEEeEEEec-CCcE-EEEEEEEeCC
Confidence 78999999999999888753 4443 5788999997
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} | Back alignment and structure |
|---|
Probab=99.31 E-value=1.3e-12 Score=117.77 Aligned_cols=108 Identities=11% Similarity=0.064 Sum_probs=77.0
Q ss_pred CHHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEE
Q 003978 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPA 207 (782)
Q Consensus 128 ~~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~ 207 (782)
.++.|+.++++++++|+++|.+|+|+++|++|++++||+.++++|+++.+++++.............+..+...
T Consensus 17 ~~~~~~~i~~~~~~~i~~~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 90 (125)
T 3fc7_A 17 TRKKFESLVSDSPDGIVHLTTNGTILSVNPSMAGRLGADPDTLVGQQLSAVMDSEAANQRLEAGKSAVENGTAT------ 90 (125)
T ss_dssp ---------CCSCCEEEEEETTSBEEEECHHHHHHHTSCHHHHTTSBGGGSSCHHHHHHHHHHHHHHHHHTSCE------
T ss_pred HHHHHHHHHhcCCCeEEEEcCCCeEEEECHHHHHHhCCCHHHHcCccHHHhCCHHHHHHHHHHHHHHhcCCCeE------
Confidence 34679999999999999999999999999999999999999999999999884332222222224555666544
Q ss_pred EcCCCC-EEEEEEEEEEEECCCCCEEEEEEEEEehh
Q 003978 208 KTKTEE-RVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (782)
Q Consensus 208 ~~kdG~-~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (782)
..++|. .+|+.+++.|+.+. |.+.|++++++|||
T Consensus 91 ~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~~DIT 125 (125)
T 3fc7_A 91 RSEDAVGGRHYHNQYIPVDSH-RKSDTFQLVSRDIT 125 (125)
T ss_dssp EEEEEETTEEEEEEEEESSTT-TTTTEEEEEEEECC
T ss_pred EeEcCCCcEEEEEEEEeEecC-CCeEEEEEEEecCC
Confidence 223444 67899999998764 66678999999997
|
| >3fg8_A Uncharacterized protein RHA05790; PAS domain, structural genomics, PS protein structure initiative, midwest center for structural genomics, MCSG; HET: 3PB; 1.80A {Rhodococcus SP} | Back alignment and structure |
|---|
Probab=99.30 E-value=1.5e-12 Score=118.10 Aligned_cols=107 Identities=17% Similarity=0.079 Sum_probs=86.4
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEc
Q 003978 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (782)
Q Consensus 130 ~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~ 209 (782)
.+.+.++++++++|+++|.+|+|+++|+++++++|++.++++|+++.+++++.........+.+++..++....++....
T Consensus 12 ~~~~~il~~~~~~i~~~D~~g~i~~~N~a~~~l~g~~~~e~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (118)
T 3fg8_A 12 SGRENLYFQGGLGFMALDEDLRIIYVNSGCLRHVRRSRDELLGRVVTEVLPETQGSYFDALCRKVLATGREQQTRVDSLY 91 (118)
T ss_dssp -CCCCSSSCTTCEEEEECTTCBEEEECHHHHHHHTCCHHHHTTSBHHHHCGGGTTSHHHHHHHHHHHHCCCEEEEEECSS
T ss_pred chHHHHHhhCCceEEEECCCCeEEEECHHHHHHhCCCHHHHcCCcHHHHcCccchHHHHHHHHHHHHcCCceEEEEEEEc
Confidence 44677899999999999999999999999999999999999999999998766544445567788888988776443333
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHH
Q 003978 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (782)
Q Consensus 210 kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITer 244 (782)
.+| .|+.+++.|+.+ |++++++|||++
T Consensus 92 ~~g--~~~~~~~~p~~~------g~v~~~~DITer 118 (118)
T 3fg8_A 92 SPG--MTIEVTAAADSG------ALVVHFRDVTAE 118 (118)
T ss_dssp STT--CEEEEEEEEETT------EEEEEEEECSCC
T ss_pred CCC--eEEEEEEEEcCC------cEEEEEEeccCC
Confidence 466 577888889753 378889999974
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=1.7e-11 Score=127.64 Aligned_cols=142 Identities=15% Similarity=0.026 Sum_probs=110.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCceeEEEe
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~E 582 (782)
...|++...++.|+++.||++...+..+++|+........ ...+.+|+.+++.+. +..++++++++...+..|+|||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3578899999999999999998888899999987532111 135778999999884 6778899999988888999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCC---------------------------------------
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN--------------------------------------- 623 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~--------------------------------------- 623 (782)
|++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 91 ~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 91 EADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp CCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred ecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 9999998776321 1122356778888999999810
Q ss_pred ------------------CCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 624 ------------------PPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 624 ------------------~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 238999999999999876556799999774
|
| >2vlg_A Sporulation kinase A; histidine kinase, two-component regulatory system, two-component signal transduction, transferase, phosphorylation, SCOD; 1.7A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=99.21 E-value=2.9e-11 Score=109.65 Aligned_cols=92 Identities=21% Similarity=0.160 Sum_probs=68.6
Q ss_pred HHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHc-CCeEEEEEEEEcCCC
Q 003978 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKM-GERWTGQFPAKTKTE 212 (782)
Q Consensus 134 ~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~-g~~~~~e~~~~~kdG 212 (782)
.+|+++++.|+++|.+|+|+|+|+++++++||+.+|++|+++.++++|++.... ...+.. +.....++++++|||
T Consensus 3 ~lle~~~d~i~v~d~~G~i~yvn~~~~~~lGy~~~el~G~~~~~~ihp~D~~~~----~~~~~~~~~~~~~e~r~~~kdG 78 (111)
T 2vlg_A 3 FPLQTKTDIHAVLASNGRIIYISANSKLHLGYLQGEMIGSFLKTFLHEEDQFLV----ESYFYNEHHLMPCTFRFIKKDH 78 (111)
T ss_dssp ------CCEEEEECTTSBEEEECTTHHHHHSCCHHHHTTSBGGGGBCGGGHHHH----HHHHHCSCCSSCEEEEEECTTS
T ss_pred chhhcCCCEEEEEcCCCeEEEEChHHHHHhCCCHHHHcCCcHHHeECHhHHHHH----HHHHhccCCCccEEEEEEcCCC
Confidence 478999999999999999999999999999999999999999999998875332 233332 233455788899999
Q ss_pred CEEEEEEEEEEEECCCC
Q 003978 213 ERVLVVATNTPFYDDDG 229 (782)
Q Consensus 213 ~~~~v~~~~~Pi~d~~G 229 (782)
+.+|+.+++.++.+.++
T Consensus 79 ~~~wve~~~~~v~~~~~ 95 (111)
T 2vlg_A 79 TIVWVEAAVEIVTTRAE 95 (111)
T ss_dssp CEEEEEEEEEEC-----
T ss_pred CEEEEEEEEEEEecccC
Confidence 99999999999987654
|
| >3cax_A Uncharacterized protein PF0695; structural genomics, unknown function, PSI-2, protein struct initiative; 2.43A {Pyrococcus furiosus dsm 3638} | Back alignment and structure |
|---|
Probab=99.20 E-value=2.2e-11 Score=134.08 Aligned_cols=118 Identities=17% Similarity=0.331 Sum_probs=98.8
Q ss_pred cCHHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEE
Q 003978 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (782)
Q Consensus 127 l~~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~ 206 (782)
+..+.+..||+++++||+++|.+|+|+|+|++ ++++ ++.++++|+++.+++++.. ....+.+..++++|+....+..
T Consensus 236 ~~~~~l~~IL~~l~dgIivvD~~g~I~~~N~a-e~i~-~~~~e~iGr~v~~~~p~~~-~~~~~~l~~~l~~g~~~~~~~~ 312 (369)
T 3cax_A 236 LNIEELKAIFEALPVDVTFIDKDDRVRFFSPG-ERIF-TRTPSVLGRPVQLCHPPKS-VYVVNKILKAFKEGRKKEATFW 312 (369)
T ss_dssp ECHHHHHHHHHHSSSEEEEECTTSBEEEECCS-SCSS-CCCGGGTTCBTTTSSCGGG-HHHHHHHHHHHHHTSCSCEEEE
T ss_pred hhHHHHHHHHHhCCCcEEEECCCCcEEEEcCH-HHcc-CChHHHcCCcHHHHCChhh-HHHHHHHHHHHHcCCceEEEEE
Confidence 55688999999999999999999999999999 9999 9999999999999887543 2334567788888887655554
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHH
Q 003978 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAA 250 (782)
Q Consensus 207 ~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~ 250 (782)
.. .+| .++.++..||+|.+|+++|++.+++|||+++++++.
T Consensus 313 ~~-~~g--~~v~v~~~PI~d~~G~~~G~v~v~~DITe~~~le~~ 353 (369)
T 3cax_A 313 LR-LRE--KYVYIKYVPLFNEKGEYIGTLEMTMDIAPYKKIEGE 353 (369)
T ss_dssp EE-ETT--EEEEEEEEEEECTTSCEEEEEEEEEECHHHHTCCSC
T ss_pred Ee-eCC--EEEEEEEEEEECCCCCEEEEEEEEEcCHHHHHHHHH
Confidence 43 346 578899999999999999999999999999876543
|
| >4f3l_A Mclock, circadian locomoter output cycles protein kaput; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.17 E-value=6.5e-11 Score=129.99 Aligned_cols=109 Identities=16% Similarity=0.138 Sum_probs=97.6
Q ss_pred CceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEcCCCCEEEEEE
Q 003978 140 GQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVA 219 (782)
Q Consensus 140 ~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~v~~ 219 (782)
.+.++..|.+|+|+|+|++++.++||+++|++|+++.+++++++.......+...+..|+....+++++++||..+|+..
T Consensus 251 ~~f~~~~~~dg~~~~vn~~~~~ilGY~~eEl~g~~~~~~iHpdD~~~~~~~~~~~l~~g~~~~~eyR~~~kdG~~vWv~~ 330 (361)
T 4f3l_A 251 EEFTSRHSLEWKFLFLDHRAPPIIGYLPFEVLGTSGYDYYHVDDLENLAKCHEHLMQYGKGKSCYYRFLTKGQQWIWLQT 330 (361)
T ss_dssp CEEEEEECTTSBEEEECTTSHHHHCCCHHHHTTSBGGGGBCHHHHHHHHHHHHHHHHHSEEECCCEEEECTTSEEEEEEE
T ss_pred ceeEEEEcCCceEEEECChhhhhhCcCHHHHcCCCHHHeECHHHHHHHHHHHHHHHhCCCcceEEEEEEecCCCEEEEEE
Confidence 34566789999999999999999999999999999999999988765556677888888877778999999999999999
Q ss_pred EEEEEECC-CCCEEEEEEEEEehhHHHHHH
Q 003978 220 TNTPFYDD-DGTLVGIVCVSTDSRPFQETR 248 (782)
Q Consensus 220 ~~~Pi~d~-~G~v~g~v~i~rDITerk~~E 248 (782)
+..|++|. +|++.+++++.+|||+++..+
T Consensus 331 ~~~~v~~~~~g~~~~iv~~~~dITe~~~~~ 360 (361)
T 4f3l_A 331 HYYITYHQWNSRPEFIVCTHTVVSYAEVRA 360 (361)
T ss_dssp EEEEEECTTTCCEEEEEEEEEECCHHHHHH
T ss_pred EEEEEEcCCCCCeeEEEEEEEECChhHhhc
Confidence 99999998 799999999999999998764
|
| >3a0r_A Sensor protein; four helix bundle, PAS fold, kinase, phosphoprotein, transfe two-component regulatory system; 3.80A {Thermotoga maritima} | Back alignment and structure |
|---|
Probab=99.17 E-value=2.2e-12 Score=139.72 Aligned_cols=144 Identities=17% Similarity=0.178 Sum_probs=107.4
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEc
Q 003978 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (782)
Q Consensus 130 ~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~ 209 (782)
++++.++++++++|+++|.+|+|+++|++|++++||+.++++|+++.++..... ....+...+..+...... .
T Consensus 8 ~~~~~i~~~~~~~i~~~d~~g~i~~~N~a~~~l~G~~~~e~~G~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~----~ 80 (349)
T 3a0r_A 8 NFSESILESLETAIITLSKDGRITEWNKKAEQLFGLKKENVLGRRLKDLPDFEE---IGSVAESVFENKEPVFLN----F 80 (349)
T ss_dssp -CCCSSGGGSSSEEEEEESSSBCSCBCHHHHHHHSCCSTTTTTCBSTTSTTTTH---HHHHHHHHHHHCCCCEEE----C
T ss_pred HHHHHHHhhhcCeEEEECCCCCEEeeHHHHHHHhCCCHHHHcCcCHHHCcChhH---HHHHHHHHHhcCCceeec----c
Confidence 456789999999999999999999999999999999999999999998833222 223345556666654322 1
Q ss_pred CCCCEEEEEEEEEEEECCCCCE-EEEEEEEEehhHHHHHHHHHHHhhccccccccCCchhHHHHHhCCCchhHHHHHHH
Q 003978 210 KTEERVLVVATNTPFYDDDGTL-VGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIA 287 (782)
Q Consensus 210 kdG~~~~v~~~~~Pi~d~~G~v-~g~v~i~rDITerk~~E~~L~~~~~~~~~~~i~~~~~gl~~~l~~d~~qpL~~~i~ 287 (782)
..+...|+.++..|+.+.+|.+ .|++++++|||++++++++++..... .....+++.++||+++||..+..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~DiTe~~~~e~~~~~~~~~-------~~~~~~~~~i~Helr~pL~~i~~ 152 (349)
T 3a0r_A 81 YKFGERYFNIRFSPFRNAKTQLLEGVIITIDDVTELYKYEEERKRRERL-------SILGEMTARVAHEIRNPITIIGG 152 (349)
T ss_dssp CCBTTBCCEEEEEEECCTTTTSSCEEEEEEECCSTTTTTTTTTTHHHHH-------HHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccCceEEEEEEEEEEcCCCceeeEEEEEEEechHHHHHHHHHHHHHHH-------HHHHHHHHHHHHHhcchHHHHHH
Confidence 2223357888999999888765 58999999999999887766443211 12334888899999999977543
|
| >1ll8_A PAS kinase; PAS domain, ligand binding, ligand screening, kinase regulation, transferase; NMR {Homo sapiens} SCOP: d.110.3.5 | Back alignment and structure |
|---|
Probab=99.12 E-value=1.8e-11 Score=109.56 Aligned_cols=101 Identities=17% Similarity=0.235 Sum_probs=76.1
Q ss_pred cCceeEEEcCC-CcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHH-HHc-CCeE---EEEEEEEcCCC
Q 003978 139 MGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHR-IKM-GERW---TGQFPAKTKTE 212 (782)
Q Consensus 139 ~~d~I~v~D~d-G~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~-l~~-g~~~---~~e~~~~~kdG 212 (782)
.+++|+++|.+ |+|+++|++|++||||+.+|++|+++.+++++... .....+... +.. +... ..++..+++||
T Consensus 7 ~~~~i~~~d~~~g~I~~~N~aa~~l~G~~~~el~g~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dG 85 (114)
T 1ll8_A 7 FNKAIFTVDAKTTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDS-DVVEALSEEHMEADGHAAVVFGTVVDIISRSG 85 (114)
T ss_dssp TTCEEEEEETTTCBEEEECTTHHHHHTCCTTTTTTSBGGGGSSCTTT-HHHHHTTSSTTSSSSCSSCCCSSSEEECCTTC
T ss_pred CCceEEEEECCCCeEEEehHHHHHHhCCCHHHHcCCCHHHhcCcchh-HHHHHHHHHhhccCCcceeccCcEEEEEecCC
Confidence 45799999999 99999999999999999999999999999887542 111122211 111 1111 23466789999
Q ss_pred CEEEEEEEEEEEECCCCCEEEEEEEEEehh
Q 003978 213 ERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (782)
Q Consensus 213 ~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (782)
..+|+.++++|+.+.++ .+++++++|++
T Consensus 86 ~~~~v~~~~~~~~~~~~--~~~v~~~~~~~ 113 (114)
T 1ll8_A 86 EKIPVSVWMKRMRQERR--LCCVVVLEPVE 113 (114)
T ss_dssp CCEEEECCEECCBSSSS--BEEEEEEEECC
T ss_pred CEEEEEEEEEeeccCCc--cEEEEEEeecC
Confidence 99999999999987654 36788999975
|
| >1nwz_A PYP, photoactive yellow protein; PAS, LOV, GAF, domains fold, signaling protein; HET: HC4; 0.82A {Halorhodospira halophila} SCOP: d.110.3.1 PDB: 1kou_A* 1ot9_A* 1otb_A* 1s4r_A* 1s4s_A* 1ts0_A* 1ts6_A* 1ts7_A* 1ts8_A* 1uwn_X* 1uwp_X* 2d01_A* 2phy_A* 2pyp_A* 2pyr_A* 2qj5_A* 2qj7_A* 2qws_A* 2zoh_A* 2zoi_A* ... | Back alignment and structure |
|---|
Probab=99.07 E-value=1.4e-09 Score=99.99 Aligned_cols=101 Identities=9% Similarity=-0.039 Sum_probs=80.0
Q ss_pred HHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccc-cccccccHHHHHHHHHHcCCeEEEEEEEEcCC
Q 003978 133 LNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL-TDGRDFDVAYDIVHRIKMGERWTGQFPAKTKT 211 (782)
Q Consensus 133 ~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~-~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kd 211 (782)
..+++++++||+++|.+|+|++||+++++++||++++++|+++.+.+ +....+.....+.+.++.|..........+++
T Consensus 20 ~~~ld~l~~Gii~lD~~g~I~~~N~~~e~~sG~~~~eviGk~~f~~~~~~~~~~~f~~rf~~~~~~g~l~~~~~~v~~~~ 99 (125)
T 1nwz_A 20 DGQLDGLAFGAIQLDGDGNILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGNLNTMFEYTFDYQ 99 (125)
T ss_dssp HHHHTTCSSEEEEEETTCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTCCEEEEEEEECTT
T ss_pred HHHHhccCceEEEECCCCEEEEEHHHHHHHhCCCHHHHcCCchhhhccchhcccHHHHHHHHHHhcCceeEEEEEEEcCC
Confidence 44799999999999999999999999999999999999999998754 44444555556788888888433444445999
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEE
Q 003978 212 EERVLVVATNTPFYDDDGTLVGIV 235 (782)
Q Consensus 212 G~~~~v~~~~~Pi~d~~G~v~g~v 235 (782)
|. ++.+.+.+..+.+|..++++
T Consensus 100 ~~--p~~v~i~l~~~~~~~~~~i~ 121 (125)
T 1nwz_A 100 MT--PTKVKVHMKKALSGDSYWVF 121 (125)
T ss_dssp SC--CEEEEEEEEECSSSSEEEEE
T ss_pred CC--EEEEEEEEEEcCCCCEEEEE
Confidence 98 55666667778888877664
|
| >3a0s_A Sensor protein; PAS-fold, kinase, phosphoprotein, transferase, two-component regulatory system; HET: PG4 PGE; 1.47A {Thermotoga maritima} PDB: 3a0v_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=1e-09 Score=92.13 Aligned_cols=95 Identities=21% Similarity=0.263 Sum_probs=72.9
Q ss_pred cCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEcCCCCEEEEE
Q 003978 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVV 218 (782)
Q Consensus 139 ~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~v~ 218 (782)
++++|+++|.+|+|+++|+++++++|++.++++|+++.++ +. . ......+...+..+..+... .. +|...|+.
T Consensus 1 ~~~~i~~~d~~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~-~~-~-~~~~~~~~~~~~~~~~~~~~--~~--~~~~~~~~ 73 (96)
T 3a0s_A 1 METAIITLSKDGRITEWNKKAEQLFGLKKENVLGRRLKDL-PD-F-EEIGSVAESVFENKEPVFLN--FY--KFGERYFN 73 (96)
T ss_dssp CCCEEEEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGGS-TT-C-HHHHHHHHHHHHHTCCEEEE--EE--EETTEEEE
T ss_pred CCceEEEEcCCCCEeehhHHHHHHhCCCHHHhcCCCHHHC-cc-h-HHHHHHHHHHhccCCeEEEE--EE--cCCcEEEE
Confidence 4689999999999999999999999999999999999988 32 2 22233455666666665322 22 34446899
Q ss_pred EEEEEEECCCCC-EEEEEEEEEe
Q 003978 219 ATNTPFYDDDGT-LVGIVCVSTD 240 (782)
Q Consensus 219 ~~~~Pi~d~~G~-v~g~v~i~rD 240 (782)
+++.|+.+.+|. +.|++++++|
T Consensus 74 ~~~~p~~~~~~~~~~g~v~~~~D 96 (96)
T 3a0s_A 74 IRFSPFRNAKTQLLEGVIITIDD 96 (96)
T ss_dssp EEEEEEECTTTCCEEEEEEEEEC
T ss_pred EEEEEeEcCCCCeeeEEEEEecC
Confidence 999999988665 6799999887
|
| >4f3l_B BMAL1B; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.05 E-value=3.8e-10 Score=125.01 Aligned_cols=108 Identities=15% Similarity=0.112 Sum_probs=89.5
Q ss_pred cCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCe-EEEEEEEEcCCCCEEEE
Q 003978 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER-WTGQFPAKTKTEERVLV 217 (782)
Q Consensus 139 ~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~-~~~e~~~~~kdG~~~~v 217 (782)
..+-++..|.+|+|+|+|++++.++||+++|++|+++.++++|++.......+...+..+.. ...+++++++||..+|+
T Consensus 277 ~~~fi~~~~~dg~~~~vn~~~~~ilGY~~eEl~g~~~~~~iHpdD~~~~~~~~~~~l~~~~~~~~~eyR~~~kdG~~vWv 356 (387)
T 4f3l_B 277 SMEYVSRHAIDGKFVFVDQRATAILAYLPQELLGTSCYEYFHQDDIGHLAECHRQVLQTREKITTNCYKFKIKDGSFITL 356 (387)
T ss_dssp CCEEEEEECTTSBEEEECTHHHHHHCCCHHHHTTSBGGGTBCHHHHHHHHHHHHHHTTCSSCEECCCEEEECTTSCEEEE
T ss_pred CceEEEEECCCCEEEEECCCcccccCCCHHHHcCCcHHHeeCHHHHHHHHHHHHHHHhcCCCeeeEEEEEEccCCCEEEE
Confidence 44567779999999999999999999999999999999999988765444445555655544 56689999999999999
Q ss_pred EEEEEEEECC-CCCEEEEEEEEEehhHHHH
Q 003978 218 VATNTPFYDD-DGTLVGIVCVSTDSRPFQE 246 (782)
Q Consensus 218 ~~~~~Pi~d~-~G~v~g~v~i~rDITerk~ 246 (782)
..+..+++|. +|++.++|++.+|||+||.
T Consensus 357 ~~~~~~~~~~~~g~~~~ivg~~~dIT~Rk~ 386 (387)
T 4f3l_B 357 RSRWFSFMNPWTKEVEYIVSTNTVVLANVL 386 (387)
T ss_dssp EEEEEEEEETTTTEEEEEEEEEEECC----
T ss_pred EEEEEEEECCCCCCEEEEEEEEEEcchhhc
Confidence 9999999987 7899999999999999974
|
| >1mzu_A PPR; photoactive yellow protein, PAS, PYP, signaling protein; HET: HC4; 2.00A {Rhodospirillum centenum} SCOP: d.110.3.1 | Back alignment and structure |
|---|
Probab=99.04 E-value=1.9e-09 Score=99.38 Aligned_cols=100 Identities=12% Similarity=-0.063 Sum_probs=79.0
Q ss_pred HHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccc-cccccccHHHHHHHHHHcCCeEEEEEEEEcCCC
Q 003978 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL-TDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTE 212 (782)
Q Consensus 134 ~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~-~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG 212 (782)
.+|+++++||+++|.+|+|++||.++++++||++++++|+++.+.+ +....+.....+.+.++.|..........+++|
T Consensus 26 ~~ld~l~~GiivlD~dg~I~~~N~~~e~isG~s~eeviGk~~f~~~~p~~~~~~f~grf~~~~~~G~l~~~~~yv~~~~~ 105 (129)
T 1mzu_A 26 AEFDALPVGAIQVDGSGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGTLDARFDFVFDFQM 105 (129)
T ss_dssp TTGGGCSSEEEEEETTCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSCCEEEEEEEEECSS
T ss_pred HHHhccCceEEEECCCCeEEEEHHHHHHHhCCCHHHHcCCchhhhccchhcccHHHHHHHHHHhcCceeEEEEEEEcCCC
Confidence 3699999999999999999999999999999999999999998754 444445555567888887774333444458899
Q ss_pred CEEEEEEEEEEEECCCCCEEEEE
Q 003978 213 ERVLVVATNTPFYDDDGTLVGIV 235 (782)
Q Consensus 213 ~~~~v~~~~~Pi~d~~G~v~g~v 235 (782)
. ++.+.+.+..+.+|..++++
T Consensus 106 ~--p~~v~i~l~~~~~~~~~~i~ 126 (129)
T 1mzu_A 106 A--PVRVQIRMQNAGVPDRYWIF 126 (129)
T ss_dssp C--EEEEEEEEEECSSTTEEEEE
T ss_pred C--EEEEEEEEEEcCCCCEEEEE
Confidence 8 55666667778888877664
|
| >2w0n_A Sensor protein DCUS; signal transduction, two-component regulatory system, PAS, kinase, membrane, transferase, solid state cell inner membrane; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.02 E-value=5e-11 Score=105.71 Aligned_cols=105 Identities=18% Similarity=0.215 Sum_probs=83.7
Q ss_pred CcCHHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCC---ChhhHcCCCccccccccccccHHHHHHHHHHcCCeEE
Q 003978 126 NFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGY---SAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT 202 (782)
Q Consensus 126 ~l~~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gy---s~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~ 202 (782)
....+.++.++++++++|+++|.+|+|+++|++|++++|| +.++++|+++.+++++.. +...+..+....
T Consensus 11 ~~~~~~~~~il~~~~~~i~~~d~~g~i~~~N~~~~~~~g~~~~~~~~~~g~~~~~~~~~~~-------~~~~~~~~~~~~ 83 (118)
T 2w0n_A 11 STLFEQRQAMLQSIKEGVVAVDDRGEVTLINDAAQELLNYRKSQDDEKLSTLSHSWSQVVD-------VSEVLRDGTPRR 83 (118)
T ss_dssp CTTHHHHHHHHHCCCCCCEEEBTTTBCCCBCHHHHHHHCSCTTTTTSSCCCTTCCCSCTHH-------HHHHHHTTCCCC
T ss_pred HHHHHHHHHHHhhccccEEEECCCCcEeehhHHHHHHhCCCccChhhhhccCcccccCchh-------HHHHhccCceec
Confidence 3446778999999999999999999999999999999998 889999999998876532 455566665432
Q ss_pred EEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehh
Q 003978 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (782)
Q Consensus 203 ~e~~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (782)
... ...+| .|+.++..|+.+ +|++.|++++++|||
T Consensus 84 ~~~--~~~~~--~~~~~~~~p~~~-~g~~~g~v~~~~DiT 118 (118)
T 2w0n_A 84 DEE--ITIKD--RLLLINTVPVRS-NGVIIGAISTFRDKT 118 (118)
T ss_dssp CCC--EESSS--CEECCCEECCCC-SSCCCCEEECCCCCC
T ss_pred cEE--EEECC--EEEEEeeceeee-CCEEEEEEEEEEeCC
Confidence 221 12355 467888899987 888889999999997
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.00 E-value=5.5e-10 Score=122.08 Aligned_cols=146 Identities=19% Similarity=0.242 Sum_probs=107.4
Q ss_pred eeEeeeeccCCcEEEEEEEEcCCeEEEEEEe--ccCCCHHHHHHHHHHHHHHHhCC--CCceeEEeeeeecC---CceeE
Q 003978 507 LTIGEQIGQGSCGTVYHAVWYGSDVAVKVFS--RQEYSDEVIHSFRQEVSLMKRLR--HPNVLLFMGAVTSP---QRLCI 579 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~--~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~---~~~~l 579 (782)
...++.|+.|.++.||++...+..+++|+.. ..... .....+.+|+.+++.+. +..+++++.++.+. +..|+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred CceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 3346789999999999999888889999876 33211 12346778999999996 44578888888766 45899
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcC-------------------------------------
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC------------------------------------- 622 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~------------------------------------- 622 (782)
||||++|..+.+.. ...++......++.+++..|..||..
T Consensus 119 vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999987664321 12356777778888999999999972
Q ss_pred -------------------CCCeeecCCCCCcEEEcCCCc--EEEEecCCCcccc
Q 003978 623 -------------------NPPIIHRDLKSSNLLVDKHWT--VKVGDFGLSRLKH 656 (782)
Q Consensus 623 -------------------~~~ivHrDIKp~NILl~~~~~--vkL~DFGla~~~~ 656 (782)
...++|+|++|.|||++.++. +.|+||+.+...+
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 134999999999999997753 6899999987543
|
| >2jhe_A Transcription regulator TYRR; aromatic hydrocarbons catabolism, TYRR protei nucleotide-binding, transcription regulation, activator; HET: PG4; 2.30A {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.00 E-value=2.5e-10 Score=112.35 Aligned_cols=105 Identities=14% Similarity=0.203 Sum_probs=82.0
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCC-e-EEEEEE
Q 003978 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGE-R-WTGQFP 206 (782)
Q Consensus 129 ~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~-~-~~~e~~ 206 (782)
.+.++.+++++++||+++|.+|+|+++|++|++++|++.++++|+++.++++... +...+..+. . ...++.
T Consensus 79 ~~~l~~il~~~~~gvi~~D~~g~I~~~N~aa~~llg~~~~~~~g~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 151 (190)
T 2jhe_A 79 HLALSALLEALPEPVLSVDMKSKVDMANPASCQLFGQKLDRLRNHTAAQLINGFN-------FLRWLESEPQDSHNEHVV 151 (190)
T ss_dssp HHHHHHHHHHCSSCEEEECTTCBEEEECHHHHHHHTSCHHHHTTSBGGGTSTTCC-------HHHHHHTCCCSCEEEEEE
T ss_pred HHHHHHHHHhCCCcEEEEcCCCCEEEEcHHHHHHhCCCHHHhcCccHHHHhCCCC-------HHHHHhcCCCCCcceEEE
Confidence 3578999999999999999999999999999999999999999999999887543 233455554 2 333333
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCC----EEEEEEEEEehhHHH
Q 003978 207 AKTKTEERVLVVATNTPFYDDDGT----LVGIVCVSTDSRPFQ 245 (782)
Q Consensus 207 ~~~kdG~~~~v~~~~~Pi~d~~G~----v~g~v~i~rDITerk 245 (782)
. +|. ++.+.+.|+.+.+|+ +.|++.+++|||+++
T Consensus 152 ~---~g~--~~~~~~~pi~~~~~~~~~~~~g~v~~~~DiTe~~ 189 (190)
T 2jhe_A 152 I---NGQ--NFLMEITPVYLQDENDQHVLTGAVVMLRSTIRMG 189 (190)
T ss_dssp E---TTE--EEEEEEEEETTTTEEEEEEEE-HHHHHHHHTTTC
T ss_pred E---CCe--EEEEEEEEEEecCCCCcceEEeEEEEEeccchhc
Confidence 2 664 456778899875665 789999999999864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.99 E-value=4.2e-10 Score=116.22 Aligned_cols=137 Identities=16% Similarity=0.092 Sum_probs=97.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc-CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCc--eeEEeeeeecCCceeEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN--VLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lv 580 (782)
...|.+....+.|..+.||++... +..+++|+..... ...+.+|+.+++.+.+.+ +++++++....+..++|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 345665554456677999999764 5679999976542 134677899998885434 56788888887889999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCC-------------------------------------
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN------------------------------------- 623 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~------------------------------------- 623 (782)
|||++|.+|. ... ... ..++.+++..|..||+..
T Consensus 94 ~e~i~G~~l~--~~~----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 94 LGEVPGQDLL--SSH----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp EECCSSEETT--TSC----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEecCCcccC--cCc----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 9999998873 211 111 134556666777777532
Q ss_pred -------------------CCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 624 -------------------PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 624 -------------------~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 1299999999999998776677999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.87 E-value=2e-09 Score=114.81 Aligned_cols=185 Identities=20% Similarity=0.194 Sum_probs=119.1
Q ss_pred eeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCc--eeEEeeeeecCC---ceeEEEee
Q 003978 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPN--VLLFMGAVTSPQ---RLCIVTEF 583 (782)
Q Consensus 510 ~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-Hpn--Iv~l~~~~~~~~---~~~lv~E~ 583 (782)
++.++.|.+..||++. ..+++|+.... .....+.+|+++|+.+. +.. +++++....... ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 3568999999999873 67999986432 44567889999998873 322 445555544333 34899999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcC-----------------------------------------
Q 003978 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC----------------------------------------- 622 (782)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~----------------------------------------- 622 (782)
++|.+|...... .++......++.+++..|..||+.
T Consensus 98 i~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 98 IKGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred cCCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 999877643321 245555566666777777666641
Q ss_pred ---------------CCCeeecCCCCCcEEEcC--CCcEEEEecCCCcccccccccccCCCCCCcccCccccc------C
Q 003978 623 ---------------NPPIIHRDLKSSNLLVDK--HWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR------N 679 (782)
Q Consensus 623 ---------------~~~ivHrDIKp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~------~ 679 (782)
...++|+|++|.||+++. ...+.|+||+.+...+.......... ...-..|+... +
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~-~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLME-DDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCC-TTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHh-hccccCHHHHHHHHHHcC
Confidence 123899999999999998 45678999999875433211111100 00002233211 1
Q ss_pred CCC--------CchhHHHHHHHHHHHHHcCCCCC
Q 003978 680 EPS--------DEKSDVYSFGVILWELATEKIPW 705 (782)
Q Consensus 680 ~~~--------s~~sDIwSLG~ll~elltG~~Pf 705 (782)
... ....+.|+++.++|.+.+|..+|
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 100 12368999999999999998876
|
| >3rty_A Period circadian protein; PAS domain, signalling, timeless, circadian clock protein; 2.85A {Drosophila melanogaster} PDB: 1wa9_A 3gec_A | Back alignment and structure |
|---|
Probab=98.68 E-value=7.2e-08 Score=104.47 Aligned_cols=105 Identities=12% Similarity=0.033 Sum_probs=88.1
Q ss_pred CceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCe-----EEEEEEEEcCCCCE
Q 003978 140 GQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER-----WTGQFPAKTKTEER 214 (782)
Q Consensus 140 ~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~-----~~~e~~~~~kdG~~ 214 (782)
.+.|+..|.+|+|+|+|+++..++||.++|++|+++.+++++++.......+...+..|+. ...+++++++||..
T Consensus 154 ~~fi~r~~~dG~~~yvn~~~~~lLGY~peELiG~s~~~~vHPdD~~~~~~~~~~~l~~G~~~~~~~~s~~yR~~~kdG~~ 233 (339)
T 3rty_A 154 PKFAIRHTATGIISHVDSAAVSALGYLPQDLIGRSIMDFYHHEDLSVMKETYETVMKKGQTAGASFCSKPYRFLIQNGCY 233 (339)
T ss_dssp CEEEEEEETTCBEEEECTTHHHHHCCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHHHHTTSTTCCCBCCCEEEECTTSCE
T ss_pred ceEEEEECCCCeEEEcChhhhcccCCCHHHHcCCcHHHEECHHHHHHHHHHHHHHHHcCCcccccccceEEEEEccCCCE
Confidence 4677789999999999999999999999999999999999998865555566777777774 35689999999999
Q ss_pred EEEEEEEEEEECCC-CCEEEEEEEEEehhHH
Q 003978 215 VLVVATNTPFYDDD-GTLVGIVCVSTDSRPF 244 (782)
Q Consensus 215 ~~v~~~~~Pi~d~~-G~v~g~v~i~rDITer 244 (782)
+|+..+..+++|.. +++.++|++-+.|+..
T Consensus 234 vWlet~~~~~~np~s~~~~~II~~h~vi~~p 264 (339)
T 3rty_A 234 VLLETEWTSFVNPWSRKLEFVVGHHRVFQGP 264 (339)
T ss_dssp EEEEEEEEEEECTTTCSEEEEEEEEEEEECC
T ss_pred EEEEEEEEEEECCCCCCeeEEEEEEEECCCC
Confidence 99999999999865 5677777777765543
|
| >2ykf_A Pdtas, probable sensor histidine kinase pdtas; transferase, two-component system, GAF domain, PAS domain; 2.00A {Mycobacterium tuberculosis} PDB: 2ykh_A | Back alignment and structure |
|---|
Probab=98.05 E-value=4.1e-09 Score=112.85 Aligned_cols=112 Identities=16% Similarity=0.132 Sum_probs=80.7
Q ss_pred HHHHcCceeEEEcCCCcEEEecHHHHHHhC---CChhhHcCCCcccccccc---cc-c-cHHHHHHHHHHc-CCeEEEEE
Q 003978 135 ILQSMGQSVHIFDLSDRIIYWNRSAELLYG---YSAEEALGQDAIELLTDG---RD-F-DVAYDIVHRIKM-GERWTGQF 205 (782)
Q Consensus 135 ile~~~d~I~v~D~dG~Ii~vN~aae~l~G---ys~eEliG~~~~~l~~~~---~~-~-~~~~~l~~~l~~-g~~~~~e~ 205 (782)
+++++++||+++|.+|+|+|+|++|+++|| +. ++++|+++.++++.. .. . .....+..++.. +.....++
T Consensus 175 ~~~~~~dGIivvD~~G~Ii~~N~aA~~ll~~lG~~-~~~iGk~l~el~~~~~~~~~~~~~~~~~l~~vl~~~~~~~~~ei 253 (305)
T 2ykf_A 175 SSPRAGDGFIRLDVDGVVSYASPNALSAYHRMGLT-TELEGVNLIDATRPLISDPFEAHEVDEHVQDLLAGDGKGMRMEV 253 (305)
Confidence 456899999999999999999999999985 54 789999999988654 11 0 011112223433 33332222
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhHHHHHHHHHHH
Q 003978 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWD 253 (782)
Q Consensus 206 ~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITerk~~E~~L~~ 253 (782)
. .+| .++.++..|+++ +|++.|++.+++|||+++++|++|+.
T Consensus 254 ~---~~~--~~l~v~~~Pi~~-~g~~~G~Vvv~rDITE~~~lE~eL~~ 295 (305)
T 2ykf_A 254 D---AGG--ATVLLRTLPLVV-AGRNVGAAILIRDVTEVKRRDRALIS 295 (305)
Confidence 1 122 467788899986 67889999999999999999999854
|
| >4dj3_A Period circadian protein homolog 3; PAS domain, circadian rhythm, protein binding; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.46 E-value=7.5e-07 Score=95.50 Aligned_cols=101 Identities=12% Similarity=0.042 Sum_probs=82.4
Q ss_pred ceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCe---EEEEEEEEcCCCCEEEE
Q 003978 141 QSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER---WTGQFPAKTKTEERVLV 217 (782)
Q Consensus 141 d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~---~~~e~~~~~kdG~~~~v 217 (782)
+-+...+.+|+|+|+|+++..++||.++|++|+++.+++++++.......+.+.++.+.. ...+++++++||..+|+
T Consensus 175 ~Fitrh~~dG~~~yvs~~~~~lLGY~peELig~s~~~~vHPdD~~~~~~~~~~~l~~~~~~~f~s~~yR~~~kdG~~vwv 254 (317)
T 4dj3_A 175 IFTTTHTPGCVFLEVDERAVPLLGYLPQDLIGTSILTYLHPEDRPLMVAIHQKVLKYAGHPPFEHSPVRFCTQNGEYVIL 254 (317)
T ss_dssp EEEEEECTTSBEEEECTTHHHHHSCCHHHHTTSBGGGGBCTTTTTHHHHHHHHHHHTTTSCCEECCCEEEECTTSCEEEE
T ss_pred ceEEEecCCCeEEEEChHHhhhcCcChHHHcCCCHHHeECHHHHHHHHHHHHHHHHcCCCccccceEEEEEccCCCEEEE
Confidence 345557889999999999999999999999999999999998876555556667776554 45689999999999999
Q ss_pred EEEEEEEECC-CCCEEEEEEEEEeh
Q 003978 218 VATNTPFYDD-DGTLVGIVCVSTDS 241 (782)
Q Consensus 218 ~~~~~Pi~d~-~G~v~g~v~i~rDI 241 (782)
.....+++|. .+++.++|+.-+-+
T Consensus 255 et~~~~~~np~s~~~e~II~~h~v~ 279 (317)
T 4dj3_A 255 DSSWSSFVNPWSRKVSFIIGRHKVR 279 (317)
T ss_dssp EEEEEEEECSSSCCEEEEEEEEEEC
T ss_pred EEEEEEEECCCCCcccEEEEEEEec
Confidence 9999999986 45666666666543
|
| >3gdi_A Period circadian protein homolog 2; tandem PAS domains, biological rhythms, cytoplasm, nucleus, phosphoprotein, transcription; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.43 E-value=1.3e-06 Score=93.44 Aligned_cols=103 Identities=10% Similarity=0.027 Sum_probs=84.0
Q ss_pred ceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCC-eEE-EEEEEEcCCCCEEEEE
Q 003978 141 QSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGE-RWT-GQFPAKTKTEERVLVV 218 (782)
Q Consensus 141 d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~-~~~-~e~~~~~kdG~~~~v~ 218 (782)
.-+...+.+|+|+|+|+++..++||.++|++|+++.+++++++.........+.++.+. ... ..++++++||..+|++
T Consensus 166 ~Fitrh~~dG~~~yvd~~~~~lLGY~peELig~s~~~~iHpdD~~~~~~~~~~~l~~~g~~~~~~~yR~~~kdG~~vwve 245 (309)
T 3gdi_A 166 IFTTTHTPNCLFQAVDERAVPLLGYLPQDLIETPVLVQLHPSDRPLMLAIHKKILQAGGQPFDYSPIRFRTRNGEYITLD 245 (309)
T ss_dssp EEEEEECTTCBEEEECTTHHHHHSCCHHHHTTSBHHHHBCTTSHHHHHHHHHHHHHTTTCCEEEEEEEEECTTSCEEEEE
T ss_pred eEEEEecCCCeEEEECcccccccCcCHHHHcCCCHHHhCCHHHHHHHHHHHHHHHhcCCceeeceEEEEEccCCCEEEEE
Confidence 34556888999999999999999999999999999999999886544445566666544 355 5899999999999999
Q ss_pred EEEEEEECC-CCCEEEEEEEEEehhH
Q 003978 219 ATNTPFYDD-DGTLVGIVCVSTDSRP 243 (782)
Q Consensus 219 ~~~~Pi~d~-~G~v~g~v~i~rDITe 243 (782)
....+++|. .+++.++|+.-+-|+.
T Consensus 246 t~~~~~~np~s~~~e~ii~~h~v~~g 271 (309)
T 3gdi_A 246 TSWSSFINPWSRKISFIIGRHKVRVG 271 (309)
T ss_dssp EEEEEEECTTTCCEEEEEEEEEEEEC
T ss_pred EEEEEEECCCCCcccEEEEEEEEccC
Confidence 999999875 5677788887776653
|
| >4dj2_A Period circadian protein homolog 1; PAS domains, circadian clock protein, protein binding; 2.75A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.39 E-value=1e-06 Score=94.59 Aligned_cols=104 Identities=12% Similarity=0.041 Sum_probs=83.5
Q ss_pred CceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHc-CCeE-EEEEEEEcCCCCEEEE
Q 003978 140 GQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKM-GERW-TGQFPAKTKTEERVLV 217 (782)
Q Consensus 140 ~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~-g~~~-~~e~~~~~kdG~~~~v 217 (782)
.+-+...+.+|+|+|+|+++..++||.++|++|+++.+++++++.......+.+.++. |... ..+++++++||..+|+
T Consensus 176 ~~Fitrh~~dG~~~yvd~~~~~lLGY~peELig~s~~~~vHPdD~~~~~~~~~~~l~~~g~~~~~~~yR~~~kdG~~vwv 255 (320)
T 4dj2_A 176 RIFTTRHTPSCLFQDVDERAAPLLGYLPQDLLGAPVLLFLHPEDRPLMLAIHKKILQLAGQPFDHSPIRFCARNGEYVTM 255 (320)
T ss_dssp CEEEEEECTTCBEEEECTTHHHHHSCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHTTSSSCCEECCCEEEECSSSCEEEE
T ss_pred ceEEEEecCCceEEEcCcceeccCCcChHHHcCCcHHHhCCHHHHHHHHHHHHHHHhcCCCcccceEEEEEccCCCEEEE
Confidence 3445668889999999999999999999999999999999998865444444555553 4445 3589999999999999
Q ss_pred EEEEEEEECC-CCCEEEEEEEEEehhH
Q 003978 218 VATNTPFYDD-DGTLVGIVCVSTDSRP 243 (782)
Q Consensus 218 ~~~~~Pi~d~-~G~v~g~v~i~rDITe 243 (782)
.....+++|. .+++.++|+.-+-|+.
T Consensus 256 et~~~~~~np~s~~~e~II~~h~v~~g 282 (320)
T 4dj2_A 256 DTSWAGFVHPWSRKVAFVLGRHKVRTA 282 (320)
T ss_dssp ECEEEEEECTTTCSEEEEEEEEEESSC
T ss_pred EEEEEEEECCCCCCccEEEEEEEEccC
Confidence 9999999875 5678888887776653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=4.3e-06 Score=89.16 Aligned_cols=75 Identities=15% Similarity=0.075 Sum_probs=56.4
Q ss_pred eeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCC---ceeEEeeeee-cCCceeEEEeecC
Q 003978 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP---NVLLFMGAVT-SPQRLCIVTEFLP 585 (782)
Q Consensus 510 ~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~-~~~~~~lv~E~~~ 585 (782)
++.++.|....||++ +..+++|+.. .......+.+|.++|+.+.+. .|.+++.+.. ..+..|+||||++
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE---CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 456788999999998 7889999852 234456788999999999642 3556666663 4556789999999
Q ss_pred CCCHHH
Q 003978 586 RGSLFR 591 (782)
Q Consensus 586 ggsL~~ 591 (782)
|..|..
T Consensus 97 G~~l~~ 102 (306)
T 3tdw_A 97 GQILGE 102 (306)
T ss_dssp SEECHH
T ss_pred CeECch
Confidence 987765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=1.1e-05 Score=83.80 Aligned_cols=132 Identities=17% Similarity=0.211 Sum_probs=91.2
Q ss_pred eccCCcE-EEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCceeEEEeecCCCC
Q 003978 513 IGQGSCG-TVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEFLPRGS 588 (782)
Q Consensus 513 IG~G~~G-~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~E~~~ggs 588 (782)
+..|..| .||+.... +..+++|+.... ....+.+|..+|+.+. +--+.++++++.+++..|+|||+++|.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 4445544 69988653 457999986543 3456788999998884 3236788888888889999999999988
Q ss_pred HHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCC---------------------------------------------
Q 003978 589 LFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN--------------------------------------------- 623 (782)
Q Consensus 589 L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~--------------------------------------------- 623 (782)
+.+...... .....++.++...|..||...
T Consensus 107 ~~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 107 AFQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 877654321 111223344455555555321
Q ss_pred -----------CCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 624 -----------PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 624 -----------~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
..++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1279999999999999877677999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=3.3e-06 Score=91.73 Aligned_cols=81 Identities=7% Similarity=0.022 Sum_probs=55.1
Q ss_pred eeEeeee-ccCCcEEEEEEEEc--------CCeEEEEEEeccC---CCHHHHHHHHHHHHHHHhCC-C--CceeEEeeee
Q 003978 507 LTIGEQI-GQGSCGTVYHAVWY--------GSDVAVKVFSRQE---YSDEVIHSFRQEVSLMKRLR-H--PNVLLFMGAV 571 (782)
Q Consensus 507 y~i~~~I-G~G~~G~Vy~~~~~--------~~~vAiK~~~~~~---~~~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~ 571 (782)
....+.| +.|....+|++... +..+++|+..... ... ...+.+|+.+|+.+. + -.+++++.+.
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~--~~~~~~E~~~l~~L~~~~~vpvP~v~~~~ 99 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP--TYRLDHQFEVIRLVGELTDVPVPRVRWIE 99 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS--CCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc--hhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence 3445778 88999999998765 6789999865432 100 134566888887773 2 2466777776
Q ss_pred ecC---CceeEEEeecCCCCH
Q 003978 572 TSP---QRLCIVTEFLPRGSL 589 (782)
Q Consensus 572 ~~~---~~~~lv~E~~~ggsL 589 (782)
... +..|+||||++|..+
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBCC
T ss_pred cCCCccCCceEEEEecCCCCh
Confidence 654 356899999987553
|
| >4f3l_A Mclock, circadian locomoter output cycles protein kaput; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.98 E-value=4.7e-05 Score=83.18 Aligned_cols=63 Identities=14% Similarity=0.169 Sum_probs=55.2
Q ss_pred HHHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHH
Q 003978 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDI 191 (782)
Q Consensus 129 ~~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l 191 (782)
+++...+++++++.|+++|.+|+|+|+|++++.++||+.+|++|+++.++++|++.......+
T Consensus 85 ~~~~~~~l~a~~~~i~v~~~~G~i~yvs~~~~~~lGy~~~el~g~~~~~~ihp~D~~~~~~~l 147 (361)
T 4f3l_A 85 EEFTQLMLEALDGFFLAIMTDGSIIYVSESVTSLLEHLPSDLVDQSIFNFIPEGEHSEVYKIL 147 (361)
T ss_dssp HHHHHHHHHHTTEEEEEEETTSBEEEECTTHHHHHCCCHHHHTTSBGGGGSCGGGHHHHHHHH
T ss_pred HHHHHHHHHhcCceEEEEcCCccEEEEechhhhhcCCCHHHhcCCcHHHhcCHHHHHHHHHHh
Confidence 456678899999999999999999999999999999999999999999999998854443333
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.95 E-value=5.9e-05 Score=80.71 Aligned_cols=138 Identities=16% Similarity=0.086 Sum_probs=77.8
Q ss_pred eeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC--CCceeEEeee------eecCCceeEEE
Q 003978 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR--HPNVLLFMGA------VTSPQRLCIVT 581 (782)
Q Consensus 510 ~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~------~~~~~~~~lv~ 581 (782)
++.|+.|..+.||++...+..+++|+.... . ..+..|+.+++.|. .-.+++++.. ....+..+++|
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EEECC----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeeccccccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 456777788999999887777999998752 2 22334555555442 1123344431 13456689999
Q ss_pred eecCCCCHH-----------HHH---hh--cCC--c---------chHHH------------------------------
Q 003978 582 EFLPRGSLF-----------RLL---QR--NTT--K---------LDWRR------------------------------ 604 (782)
Q Consensus 582 E~~~ggsL~-----------~~l---~~--~~~--~---------l~~~~------------------------------ 604 (782)
+|++|..+. ..| .. ... + ..+..
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999885431 111 10 000 0 01110
Q ss_pred -HHHHHHHHHHHHHhhhc-----------CCCCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 605 -RILMALDIARGVSYLHH-----------CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 605 -~~~i~~qll~aL~~LH~-----------~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
...+..++..++.+|+. ....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 00111123345556642 22349999999999999888899999999775
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=3e-05 Score=85.55 Aligned_cols=77 Identities=21% Similarity=0.153 Sum_probs=49.4
Q ss_pred EeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC--CH---HHHHHHHHHHHHHHhCCC--C-ceeEEeeeeecCCcee
Q 003978 509 IGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY--SD---EVIHSFRQEVSLMKRLRH--P-NVLLFMGAVTSPQRLC 578 (782)
Q Consensus 509 i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~--~~---~~~~~~~~Ei~il~~l~H--p-nIv~l~~~~~~~~~~~ 578 (782)
..+.||.|.++.||++.. .++.++||....... .. .....+..|.++|+.+.. + .+++++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 356899999999999954 467899998653211 00 012345678888887732 3 34466654 344568
Q ss_pred EEEeecCCC
Q 003978 579 IVTEFLPRG 587 (782)
Q Consensus 579 lv~E~~~gg 587 (782)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999763
|
| >4f3l_B BMAL1B; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.80 E-value=5.9e-05 Score=83.23 Aligned_cols=58 Identities=17% Similarity=0.248 Sum_probs=51.7
Q ss_pred HHHHHHHHHHcCceeEEEcCC-CcEEEecHHHHHHhCCChhhHcCCCcccccccccccc
Q 003978 129 DRQYLNILQSMGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFD 186 (782)
Q Consensus 129 ~~~~~~ile~~~d~I~v~D~d-G~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~ 186 (782)
+++...+++++++.|++++.+ |+|+|+|++++.++||+.+|++|+++.+++++++...
T Consensus 85 ~~~~~~ll~~~~gfi~v~~~~~G~i~yvs~~~~~~lG~~~~el~g~~~~~~ihp~D~~~ 143 (387)
T 4f3l_B 85 DELKHLILRAADGFLFVVGCDRGKILFVSESVFKILNYSQNDLIGQSLFDYLHPKDIAK 143 (387)
T ss_dssp HHHHHHHHHTCCSEEEEEETTTCBEEEECTTHHHHHSCCHHHHTTSBGGGGBCGGGHHH
T ss_pred HHHHHHHHhcCCCEEEEEecCCeEEEEEchhhHHHcCCCHHHHCCCcHHHhcCCCCHHH
Confidence 345567799999999999987 9999999999999999999999999999999987543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00018 Score=76.92 Aligned_cols=76 Identities=22% Similarity=0.181 Sum_probs=61.0
Q ss_pred eEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC---CCceeEEeeeeecCCceeEEEeec
Q 003978 508 TIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVLLFMGAVTSPQRLCIVTEFL 584 (782)
Q Consensus 508 ~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lv~E~~ 584 (782)
.-.+.|+.|....+|++...+..+++|+..... ...+..|...|+.|. ...+++++.+....+..|+||||+
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~-----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDEVQTVFVKINERSY-----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp CEEEEECCSSSSEEEEEESSSCEEEEEEEEGGG-----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeeEEeCCccceeeeEEEECCCeEEEEeCCccc-----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 345779999999999998878889999876432 456778988888873 356788888888778899999999
Q ss_pred CCCC
Q 003978 585 PRGS 588 (782)
Q Consensus 585 ~ggs 588 (782)
+|..
T Consensus 114 ~G~~ 117 (312)
T 3jr1_A 114 NKSK 117 (312)
T ss_dssp CCCC
T ss_pred cCCC
Confidence 8865
|
| >3rty_A Period circadian protein; PAS domain, signalling, timeless, circadian clock protein; 2.85A {Drosophila melanogaster} PDB: 1wa9_A 3gec_A | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00016 Score=78.19 Aligned_cols=97 Identities=15% Similarity=0.141 Sum_probs=66.9
Q ss_pred eEEEc-CCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeE------------EEEEEEE-
Q 003978 143 VHIFD-LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW------------TGQFPAK- 208 (782)
Q Consensus 143 I~v~D-~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~------------~~e~~~~- 208 (782)
++|++ .+|+|+|+|+++..++||+.+|++|+++.+++++++.. .++..+..+.++ ....+..
T Consensus 6 ~~vv~~~~G~i~yvS~~~~~~LGy~~~el~G~s~~d~ihp~D~~----~f~~~L~~gl~~~~~~~~~~~~~rsffcR~~r 81 (339)
T 3rty_A 6 CCVISMHDGIVLYTTPSITDVLGYPRDMWLGRSFIDFVHLKDRA----TFASQITTGIPIAESRGSVPKDAKSTFCVMLR 81 (339)
T ss_dssp EEEEETTTCBEEEECTTHHHHHCCCTTSSTTSBGGGGBCHHHHH----HHHHHHHTTSCCC----------CCEEEEEEE
T ss_pred EEEEECCCcEEEEEChHHHHHcCCCHHHHCCCcHHHhcCHHHHH----HHHHHHhcCCCCCccccCCCCCCceEEEEEEe
Confidence 45677 69999999999999999999999999999999988743 355566655332 1111111
Q ss_pred ---------------cCCCCEEEEEEEEEEEECC---------CCCEEEEEEEEEehhH
Q 003978 209 ---------------TKTEERVLVVATNTPFYDD---------DGTLVGIVCVSTDSRP 243 (782)
Q Consensus 209 ---------------~kdG~~~~v~~~~~Pi~d~---------~G~v~g~v~i~rDITe 243 (782)
.+++..+|+..+..++.++ +|.+.+++.+..+|+.
T Consensus 82 r~~~l~s~gy~v~~~~~~~~p~~l~~~~~~~~~e~~~~~~~~~~g~~~~lv~~a~~i~s 140 (339)
T 3rty_A 82 RYRGLKSGGFGVIGRPVSYEPFRLGLTFREAPEEARPDNYMVSNGTNMLLVICATPIKS 140 (339)
T ss_dssp CCC-------------CCEEEEEEEEEEEECCCC----------CCCEEEEEEEEECCC
T ss_pred ccCCCCcCCcceecccccceeEEEEEEEeccccccccccccccCCceEEEEEEcccCCc
Confidence 1223344555555566554 5667788889999874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00022 Score=79.35 Aligned_cols=76 Identities=16% Similarity=0.112 Sum_probs=48.0
Q ss_pred CeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCC-CCCcccCcccccCCC---CCchhHHHHHHHHHHHHHc
Q 003978 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK-GTPQWMAPEVLRNEP---SDEKSDVYSFGVILWELAT 700 (782)
Q Consensus 625 ~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~-Gt~~y~aPE~l~~~~---~s~~sDIwSLG~ll~ellt 700 (782)
.++|+|++|.|||++.++ ++|+||+.+...+.......... -...|++|+...... .....++..+...+|+.++
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 311 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLFN 311 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHHH
Confidence 399999999999999876 99999999876543221110000 013456666553211 1224566688888888776
Q ss_pred C
Q 003978 701 E 701 (782)
Q Consensus 701 G 701 (782)
+
T Consensus 312 ~ 312 (420)
T 2pyw_A 312 K 312 (420)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.47 E-value=0.001 Score=66.67 Aligned_cols=138 Identities=12% Similarity=0.142 Sum_probs=94.5
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccccCCC
Q 003978 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (782)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (782)
.+|.++|...+.+++++++|.++.|.+.+|.-+-.... -..+=+.|..|+|..+|.|.+.+ ..+. .
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~ 98 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ-PRHRVRSAAQIRVWRDGAVTLAP-AADD------------A 98 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-CCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc-CCceecCCcceEEecCCceeccc-cccc------------c
Confidence 38999999989999999999999999999877621110 12333457899999999998753 1110 1
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhh--
Q 003978 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHS-- 744 (782)
Q Consensus 667 Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~-- 744 (782)
....+.+||... ...+.+.=|||||++||.-+--.+| ...+..++++|..||..|...
T Consensus 99 ~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~Mt~~~~ 158 (229)
T 2yle_A 99 GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHMANTVE 158 (229)
T ss_dssp --------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHHTTCCC
T ss_pred cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHHHhccc
Confidence 123466888763 3446788999999999987643322 233457999999999999865
Q ss_pred -----------------------CCCCCCCHHHHHHH
Q 003978 745 -----------------------DPQCRPSFQELVDK 758 (782)
Q Consensus 745 -----------------------dP~~RPs~~ell~~ 758 (782)
.+..|++++++++.
T Consensus 159 d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~ 195 (229)
T 2yle_A 159 ADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKL 195 (229)
T ss_dssp --------------------CCSCCCCCCSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCcCCHHHHHHH
Confidence 24578899998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0009 Score=70.65 Aligned_cols=71 Identities=13% Similarity=0.136 Sum_probs=44.2
Q ss_pred eeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCce-eEEeeeeecCCceeEEEeec-CCC
Q 003978 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV-LLFMGAVTSPQRLCIVTEFL-PRG 587 (782)
Q Consensus 510 ~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lv~E~~-~gg 587 (782)
++.|+.|....+|++ ..+++|+...... ......+|+.+++.+...++ .+++... +..-++++||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTE---EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCcc---ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 677889999999999 6799998764311 01112457777766632122 4555543 33457899999 664
Q ss_pred CH
Q 003978 588 SL 589 (782)
Q Consensus 588 sL 589 (782)
+|
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 43
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0011 Score=70.92 Aligned_cols=140 Identities=16% Similarity=0.132 Sum_probs=72.1
Q ss_pred eeeccCCcEE-EEEEEEc-CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-C-CceeEEeeeeecCCceeEEEeecCC
Q 003978 511 EQIGQGSCGT-VYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-H-PNVLLFMGAVTSPQRLCIVTEFLPR 586 (782)
Q Consensus 511 ~~IG~G~~G~-Vy~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-H-pnIv~l~~~~~~~~~~~lv~E~~~g 586 (782)
+.|+.|.... +|+.... +..+++|....... ..+..|+.+++.+. + -.+++++.+....+ +++||++.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~ 96 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD 96 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence 4565555444 6677664 67788886544321 12334666666553 1 23456666543333 789999977
Q ss_pred CCHHHHHhhcC-------------------------CcchHHHHH-------H-H------------HHHHHHHHHhh--
Q 003978 587 GSLFRLLQRNT-------------------------TKLDWRRRI-------L-M------------ALDIARGVSYL-- 619 (782)
Q Consensus 587 gsL~~~l~~~~-------------------------~~l~~~~~~-------~-i------------~~qll~aL~~L-- 619 (782)
..+.+++.... ..+...... . + ...+...+..|
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 67765543210 001111000 0 0 00111112222
Q ss_pred --hcCCCCeeecCCCCCcEEEcCC----CcEEEEecCCCccccc
Q 003978 620 --HHCNPPIIHRDLKSSNLLVDKH----WTVKVGDFGLSRLKHE 657 (782)
Q Consensus 620 --H~~~~~ivHrDIKp~NILl~~~----~~vkL~DFGla~~~~~ 657 (782)
......++|+|+.+.|||++.+ +.+.|+||+.+.....
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~ 220 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR 220 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence 1112349999999999999874 6799999999875443
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0015 Score=68.45 Aligned_cols=80 Identities=15% Similarity=0.103 Sum_probs=56.1
Q ss_pred cccceeEeeeeccCCcEEEEEEEE-cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-C--CceeEEeeeeecCCcee
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-H--PNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~~~~~~~~ 578 (782)
....+.-++.+|.|..+.||++.. .|+.|++|+........ ...+..|+..|+.|. . --+++++++. .-+
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~ 86 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRT 86 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTE
T ss_pred cCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc----Cce
Confidence 345667788999999999999987 57899999865433211 235678999888874 2 1245566543 347
Q ss_pred EEEeecCCCC
Q 003978 579 IVTEFLPRGS 588 (782)
Q Consensus 579 lv~E~~~ggs 588 (782)
+||||+.++.
T Consensus 87 lv~e~l~~~~ 96 (288)
T 3f7w_A 87 LAMEWVDERP 96 (288)
T ss_dssp EEEECCCCCC
T ss_pred EEEEeecccC
Confidence 8999997654
|
| >1oj5_A Steroid receptor coactivator 1A; transcriptional coactivator, complex, LXXLL motif, transcriptional regulation; 2.2A {Mus musculus} SCOP: d.110.3.8 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00062 Score=62.34 Aligned_cols=81 Identities=9% Similarity=-0.019 Sum_probs=69.2
Q ss_pred EcCCCcEEEecHHHHHHhCCCh--hhHcCCCccccccccccc--cHHHHHHHHHHcCCeEEEEEEEEcCCCCEEEEEEEE
Q 003978 146 FDLSDRIIYWNRSAELLYGYSA--EEALGQDAIELLTDGRDF--DVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATN 221 (782)
Q Consensus 146 ~D~dG~Ii~vN~aae~l~Gys~--eEliG~~~~~l~~~~~~~--~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~v~~~~ 221 (782)
.|.+|+|+|+.....+ .+|.. +||+|+.+.+++++++.. ...+...+++..|+....-++++.++|..+|+....
T Consensus 13 h~~dGKf~~vDq~~~r-~~~~~g~qdLlGrsiy~f~H~~D~~~s~l~~h~~~vl~~Gq~~S~~YRfr~k~g~~V~~qT~s 91 (132)
T 1oj5_A 13 QDTTGKIISIDTSSLR-AAGRTGWEDLVRKCIYAFFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLSAHTRC 91 (132)
T ss_dssp ECTTCCEEEEECHHHH-TTCCSCHHHHHHHHHHHHTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEEEEEEE
T ss_pred ecCCCcEEEEeccccc-ccccccHHHHHHHHHHHHhCcccchHHHHHHHHHHHHHcCCccccceEEEecCCcEEEEEEEE
Confidence 6789999999999874 77777 999999999999998854 455567778888888888899999999999999998
Q ss_pred EEEECC
Q 003978 222 TPFYDD 227 (782)
Q Consensus 222 ~Pi~d~ 227 (782)
..+++.
T Consensus 92 k~f~np 97 (132)
T 1oj5_A 92 KLCYPQ 97 (132)
T ss_dssp EEECC-
T ss_pred EEecCC
Confidence 888874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0018 Score=68.80 Aligned_cols=144 Identities=17% Similarity=0.144 Sum_probs=79.0
Q ss_pred eeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCc--eeEEeee------eecCCcee
Q 003978 507 LTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN--VLLFMGA------VTSPQRLC 578 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~------~~~~~~~~ 578 (782)
..-.+.|+.|....||++...+..+++|+...... ...+..|+.+++.+...+ +++++.. ....+..+
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred ceEeeccCCCcccceEEEEeCCccEEEEEeCCCCC----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 34456788899899999988777899999875311 123455777776663111 3333322 12235678
Q ss_pred EEEeecCCCCHH-----------HHH---hhc----CCc-------chHHHHHH------------HHHHHHHHHHhhhc
Q 003978 579 IVTEFLPRGSLF-----------RLL---QRN----TTK-------LDWRRRIL------------MALDIARGVSYLHH 621 (782)
Q Consensus 579 lv~E~~~ggsL~-----------~~l---~~~----~~~-------l~~~~~~~------------i~~qll~aL~~LH~ 621 (782)
++|+|++|..+. ..+ ... ..+ ..+...+. +...+...+.++..
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 999999875421 111 100 000 01111000 00012333444432
Q ss_pred C-----CCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 622 C-----NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 622 ~-----~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
. ...++|+|+++.|||++.++.+.|+||+.+..
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 1 12399999999999999876568999998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0025 Score=71.14 Aligned_cols=71 Identities=14% Similarity=0.200 Sum_probs=47.8
Q ss_pred EeeeeccCCcEEEEEEEEc---------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCc-eeEEeeeeecCCcee
Q 003978 509 IGEQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-VLLFMGAVTSPQRLC 578 (782)
Q Consensus 509 i~~~IG~G~~G~Vy~~~~~---------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~ 578 (782)
-++.|+.|....||++... +..+++|+..... . ...+.+|..+++.+...+ .+++++.+.. .
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 3567888999999999874 4679999984321 2 123446888888774223 3567766542 3
Q ss_pred EEEeecCCC
Q 003978 579 IVTEFLPRG 587 (782)
Q Consensus 579 lv~E~~~gg 587 (782)
+||||++|.
T Consensus 149 ~v~e~l~G~ 157 (429)
T 1nw1_A 149 RLEEYIPSR 157 (429)
T ss_dssp EEECCCCEE
T ss_pred EEEEEeCCc
Confidence 899999763
|
| >4dj2_A Period circadian protein homolog 1; PAS domains, circadian clock protein, protein binding; 2.75A {Mus musculus} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.00081 Score=71.96 Aligned_cols=62 Identities=19% Similarity=0.162 Sum_probs=52.6
Q ss_pred ccCcCHHHHHHH-----HHHcCceeEEEcCC-CcEEEecHHHHHHhCCChhhHcCCCccccccccccc
Q 003978 124 AFNFTDRQYLNI-----LQSMGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDF 185 (782)
Q Consensus 124 a~~l~~~~~~~i-----le~~~d~I~v~D~d-G~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~ 185 (782)
+.-++++.|..+ |+++..=++|+..+ |+|+|+++.+..++||+.+|++|+++.+++++++..
T Consensus 15 ~~~~s~eel~~l~~e~lLqaldGF~~vvs~~~G~i~yvS~sv~~~Lg~~~~~l~g~s~~d~iHp~D~~ 82 (320)
T 4dj2_A 15 MSTYTLEELEHITSEYTLRNQDTFSVAVSFLTGRIVYISEQAGVLLRCKRDVFRGARFSELLAPQDVG 82 (320)
T ss_dssp CSEECHHHHHHHHHHHTTSCSSEEEEEEETTTCBEEEECTHHHHHHTSCSTTTTTSBGGGGBCHHHHH
T ss_pred ccccCHHHHHHHHHHHHHhccCCEEEEEECCCceEEEECcHHHHHhCcCHHHHcCCcHHHhcCHHHHH
Confidence 445678888877 66776666778875 999999999999999999999999999999998753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.48 E-value=0.02 Score=60.66 Aligned_cols=73 Identities=11% Similarity=0.050 Sum_probs=46.2
Q ss_pred eeeccCCcEEEEEEEEc-CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCC--ceeEEeee-----eecCCceeEEEe
Q 003978 511 EQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP--NVLLFMGA-----VTSPQRLCIVTE 582 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~-----~~~~~~~~lv~E 582 (782)
..|+ |....||++... |+.+++|+........ ..+..|..+++.+... .+++++.. ....+..+++|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4566 788899998764 5579999987543333 3455677777766321 24444443 122445678999
Q ss_pred ecCCC
Q 003978 583 FLPRG 587 (782)
Q Consensus 583 ~~~gg 587 (782)
+++|.
T Consensus 108 ~i~G~ 112 (328)
T 1zyl_A 108 SVGGR 112 (328)
T ss_dssp CCCCE
T ss_pred ecCCC
Confidence 99874
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.41 E-value=0.0037 Score=70.26 Aligned_cols=73 Identities=14% Similarity=0.114 Sum_probs=47.3
Q ss_pred EeeeeccCCcEEEEEEEEcC--CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCce-eEEeeeeecCCceeEEEeecC
Q 003978 509 IGEQIGQGSCGTVYHAVWYG--SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV-LLFMGAVTSPQRLCIVTEFLP 585 (782)
Q Consensus 509 i~~~IG~G~~G~Vy~~~~~~--~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lv~E~~~ 585 (782)
-++.|+.|-...+|++...+ ..+++|+...... ... ...+|..+++.|...++ +++++.+. + .+||||++
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~--~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD--EII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC--SCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh--hhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 35678889999999999876 7899998754221 000 11468888888864444 56777663 2 36999998
Q ss_pred CCC
Q 003978 586 RGS 588 (782)
Q Consensus 586 ggs 588 (782)
|.+
T Consensus 185 G~~ 187 (458)
T 2qg7_A 185 GYA 187 (458)
T ss_dssp SEE
T ss_pred Ccc
Confidence 743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.37 E-value=0.017 Score=62.10 Aligned_cols=32 Identities=22% Similarity=0.347 Sum_probs=28.0
Q ss_pred CeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 625 ~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
.++|+|+.+.||+++.++.+.|+||+.+....
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 49999999999999988889999999876543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.28 E-value=0.0051 Score=67.37 Aligned_cols=141 Identities=13% Similarity=0.164 Sum_probs=79.1
Q ss_pred ceeEeeeeccCCcEEEEEEEEc---------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCC
Q 003978 506 DLTIGEQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQ 575 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~~---------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 575 (782)
.++ ++.|..|-...+|++... +..+++|+...... ....+.+|.++++.+. +.-..++++.+..
T Consensus 52 ~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~-- 125 (379)
T 3feg_A 52 ELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ---GVDSLVLESVMFAILAERSLGPQLYGVFPE-- 125 (379)
T ss_dssp GCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT--
T ss_pred ceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--
Confidence 444 356777888899999863 36799998633211 1244557888888774 3223567776653
Q ss_pred ceeEEEeecCCCCHH--------------HHHhh-c------CCcc--hHHHHHHHHHHHHH------------------
Q 003978 576 RLCIVTEFLPRGSLF--------------RLLQR-N------TTKL--DWRRRILMALDIAR------------------ 614 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~--------------~~l~~-~------~~~l--~~~~~~~i~~qll~------------------ 614 (782)
.+||||++|..|. +.|.+ + .... -+..+..+..++-.
T Consensus 126 --g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 203 (379)
T 3feg_A 126 --GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLK 203 (379)
T ss_dssp --EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHH
T ss_pred --ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHH
Confidence 3899999875431 11110 0 0111 12333333333211
Q ss_pred -HHHh----hhc--CCCCeeecCCCCCcEEEcCC----CcEEEEecCCCcc
Q 003978 615 -GVSY----LHH--CNPPIIHRDLKSSNLLVDKH----WTVKVGDFGLSRL 654 (782)
Q Consensus 615 -aL~~----LH~--~~~~ivHrDIKp~NILl~~~----~~vkL~DFGla~~ 654 (782)
.+.. |.. ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 204 ~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 204 DEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1222 211 12348999999999999876 7899999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.26 E-value=0.0027 Score=69.02 Aligned_cols=72 Identities=11% Similarity=0.133 Sum_probs=43.2
Q ss_pred eeeeccCCcEEEEEEEEcC----------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCc-eeEEeeeeecCCcee
Q 003978 510 GEQIGQGSCGTVYHAVWYG----------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-VLLFMGAVTSPQRLC 578 (782)
Q Consensus 510 ~~~IG~G~~G~Vy~~~~~~----------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~ 578 (782)
.+.|+.|..-.||++...+ ..+++|+...... .......|..+++.+...+ ++++++... -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---ceecHHHHHHHHHHHHhcCCCCceEEecC----Cc
Confidence 4567888888999998754 6789998754211 1112356777777774223 446665542 37
Q ss_pred EEEeecCCCC
Q 003978 579 IVTEFLPRGS 588 (782)
Q Consensus 579 lv~E~~~ggs 588 (782)
+||||++|..
T Consensus 111 ~v~e~i~G~~ 120 (369)
T 3c5i_A 111 RIEEWLYGDP 120 (369)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEecCCc
Confidence 8999998743
|
| >4dj3_A Period circadian protein homolog 3; PAS domain, circadian rhythm, protein binding; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=96.12 E-value=0.0016 Score=69.50 Aligned_cols=52 Identities=12% Similarity=0.109 Sum_probs=46.5
Q ss_pred HHHHcCceeEEEcCC-CcEEEecHHHHHHhCCChhhHcCCCcccccccccccc
Q 003978 135 ILQSMGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFD 186 (782)
Q Consensus 135 ile~~~d~I~v~D~d-G~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~ 186 (782)
+|+++..=++|++.+ |+|+|+++++..++||+.+|++|+++.+++++.+...
T Consensus 31 ~L~aldgF~~vvs~~~G~i~yvS~~~~~~Lg~~~~el~g~s~~d~ihp~D~~~ 83 (317)
T 4dj3_A 31 TSKNTDTFAAVFSFLSGRLVHISEQAALILNSKRGFLKSVHFVDLLAPQDVRA 83 (317)
T ss_dssp HTSCTTEEEEEEETTTCBEEEECTTHHHHTTCCHHHHHTSBGGGGBCGGGHHH
T ss_pred HHhccCCEEEEEEcCCcEEEEECCHHHHHcCCCHHHHcCCchhhhcChhhHHH
Confidence 478887777888886 9999999999999999999999999999999988543
|
| >3gdi_A Period circadian protein homolog 2; tandem PAS domains, biological rhythms, cytoplasm, nucleus, phosphoprotein, transcription; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=95.82 E-value=0.0024 Score=68.00 Aligned_cols=52 Identities=12% Similarity=0.166 Sum_probs=37.5
Q ss_pred HHHHHcCceeEEEcCC-CcEEEecHHHHHHhCCChhhHcCCCccccccccccc
Q 003978 134 NILQSMGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDF 185 (782)
Q Consensus 134 ~ile~~~d~I~v~D~d-G~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~ 185 (782)
.+|+++..=++|++.+ |+|+|+++++..++||+.+|++|+++.+++++++..
T Consensus 19 lll~a~dgF~~vvs~~~G~i~yvS~s~~~~Lg~~~~el~g~s~~d~iHp~D~~ 71 (309)
T 3gdi_A 19 YIVKNADMFAVAVSLVSGKILYISNQVASIFHCKKDAFSDAKFVEFLAPHDVS 71 (309)
T ss_dssp ----CTTEEEEEECTTTCBEEEECTTTTTTC-------CCSBGGGGBCTTTHH
T ss_pred HHHHhcCCEEEEEECCCceEEEECCHHHHHcCCCHHHHcCCchhhccCHhHHH
Confidence 4678888888889986 999999999999999999999999999999998853
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.14 E-value=0.16 Score=56.20 Aligned_cols=73 Identities=10% Similarity=0.123 Sum_probs=47.0
Q ss_pred EeeeeccCCcEEEEEEEEc---------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCcee
Q 003978 509 IGEQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 509 i~~~IG~G~~G~Vy~~~~~---------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 578 (782)
-++.|..|-...+|++... +..+++|+..... . ..-...+|..+++.+. +.-.+++++.+. -+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~ 146 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--G-KFYDSKVELDVFRYLSNINIAPNIIADFP----EG 146 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--c-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence 3466777888999999876 5789999864422 1 1112245777777774 222456665432 37
Q ss_pred EEEeecCCCC
Q 003978 579 IVTEFLPRGS 588 (782)
Q Consensus 579 lv~E~~~ggs 588 (782)
+||||++|..
T Consensus 147 ~I~efI~G~~ 156 (424)
T 3mes_A 147 RIEEFIDGEP 156 (424)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEeCCcc
Confidence 8999998854
|
| >2ool_A Sensor protein; bacteriophytochrome, photoconversion, photoreceptor, biliver signaling protein; HET: LBV; 2.20A {Rhodopseudomonas palustris} SCOP: d.110.2.1 d.110.3.9 | Back alignment and structure |
|---|
Probab=90.53 E-value=0.36 Score=51.66 Aligned_cols=75 Identities=16% Similarity=0.102 Sum_probs=49.7
Q ss_pred eEEEcCC-CcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCe---EEEEEEEEcC-CCCEEEE
Q 003978 143 VHIFDLS-DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER---WTGQFPAKTK-TEERVLV 217 (782)
Q Consensus 143 I~v~D~d-G~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~---~~~e~~~~~k-dG~~~~v 217 (782)
++++|.+ ++|+.+|..+++++|++.++++|+++.+++++.. ...+.+.+..+.. ....+.+... +|..||+
T Consensus 45 Ll~~~~~~~~i~~~S~N~~~~lg~~~~~llG~~l~~ll~~~~----~~~l~~~l~~~~~~~~~p~~~~~~~~~~~~~f~~ 120 (337)
T 2ool_A 45 LFVVSETDLRIASVSANVEDLLRQPPASLLNVPIAHYLTAAS----AARLTHALHGGDPAAINPIRLDVVTPDGERAFNG 120 (337)
T ss_dssp EEEECTTTCBEEEEETTHHHHHSSCGGGGTTCBGGGGBCHHH----HHHHHHHHCC----CCCSEEEEEEETTEEEEEEE
T ss_pred EEEEECCCCEEEEEehhHHHHHCcCHHHHcCCCHHHHcCHHH----HHHHHHHHhcCCccccCcEEEEEeccCCCeEEEE
Confidence 4557764 8999999999999999999999999999998654 2234455543321 1223333333 3566776
Q ss_pred EEEE
Q 003978 218 VATN 221 (782)
Q Consensus 218 ~~~~ 221 (782)
.+..
T Consensus 121 ~~Hr 124 (337)
T 2ool_A 121 ILHR 124 (337)
T ss_dssp EEEE
T ss_pred EEEE
Confidence 5554
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.00 E-value=0.12 Score=56.82 Aligned_cols=29 Identities=24% Similarity=0.394 Sum_probs=24.8
Q ss_pred eeecCCCCCcEEE------cCCCcEEEEecCCCcc
Q 003978 626 IIHRDLKSSNLLV------DKHWTVKVGDFGLSRL 654 (782)
Q Consensus 626 ivHrDIKp~NILl------~~~~~vkL~DFGla~~ 654 (782)
++|+|+.+.|||+ +.+..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 3456799999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.19 E-value=1.9 Score=42.82 Aligned_cols=116 Identities=13% Similarity=0.108 Sum_probs=76.8
Q ss_pred CCCceeEEeeeeecCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc
Q 003978 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD 639 (782)
Q Consensus 560 ~HpnIv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~ 639 (782)
.||+++.. .+-+.++.+.+.++.-+.+.=+..+. .++....+.++.+|+....+++. =+|--|+|+||+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik----~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~f~ 113 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK----SFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELFFT 113 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG----GSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEEEC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH----hcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEEEc
Confidence 58888866 45566666666665543221122232 36677888888898887766553 37889999999999
Q ss_pred CCCcEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 003978 640 KHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 706 (782)
Q Consensus 640 ~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~ 706 (782)
.++.+++.-.|+-.. ++|. ..+...=+-.+=|++..+++++..|.
T Consensus 114 ~~~~p~i~~RGik~~-----------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 114 RDGLPIAKTRGLQNV-----------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp TTSCEEESCCEETTT-----------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CCCCEEEEEccCccC-----------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999975554211 1221 12333344567889999999998874
|
| >1p0z_A Sensor kinase CITA; transferase; HET: FLC MO7; 1.60A {Klebsiella pneumoniae} SCOP: d.110.6.1 PDB: 2v9a_A 2j80_A* | Back alignment and structure |
|---|
Probab=83.99 E-value=9.2 Score=34.30 Aligned_cols=87 Identities=15% Similarity=0.160 Sum_probs=50.3
Q ss_pred HHHHHHHHcC-ceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEc
Q 003978 131 QYLNILQSMG-QSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (782)
Q Consensus 131 ~~~~ile~~~-d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~ 209 (782)
.++.+-+... +-|+++|.+|.+++... .+.+|+++.. ... +..++ .|+.+.... ..
T Consensus 40 ~~~~~~~~~~~~~i~v~d~~G~~~a~~~----------~~~iG~~~~~---~~~-------~~~al-~G~~~~~~~--~g 96 (131)
T 1p0z_A 40 LIDPMRSFSDATYITVGDASGQRLYHVN----------PDEIGKSMEG---GDS-------DEALI-NAKSYVSVR--KG 96 (131)
T ss_dssp HHHHHHHHSCCSEEEEEETTSBEEECSS----------GGGTTSBCCS---SCC-------HHHHH-HCCCEEEEE--EE
T ss_pred HHHHHHHhcCCCEEEEEcCCCcEEEecC----------hhhCCCcccC---CCc-------HHHHh-CCCeEEEEE--Ec
Confidence 3444433333 57888999998776432 3447775431 111 33445 455544322 11
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEEehhH
Q 003978 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243 (782)
Q Consensus 210 kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDITe 243 (782)
..| +......||++.+|+++|+|.+-.++..
T Consensus 97 ~~g---~~~~~~~PV~~~~g~viGvv~vg~~l~~ 127 (131)
T 1p0z_A 97 SLG---SSLRGKSPIQDATGKVIGIVSVGYTIEQ 127 (131)
T ss_dssp TTE---EEEEEEEEEECTTCCEEEEEEEEEEGGG
T ss_pred cce---eeEEEEEeEECCCCCEEEEEEEEEEhHH
Confidence 222 2233444999888999999999888753
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.90 E-value=0.12 Score=58.12 Aligned_cols=61 Identities=16% Similarity=0.143 Sum_probs=17.4
Q ss_pred eEeeeeccCCcEEEEEEEEcC--CeEEE------EEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 003978 508 TIGEQIGQGSCGTVYHAVWYG--SDVAV------KVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571 (782)
Q Consensus 508 ~i~~~IG~G~~G~Vy~~~~~~--~~vAi------K~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 571 (782)
.+.++|| ||.||++.+.+ .+||+ |..+......+....+.+|..+++.++|||+++.+++.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 4556777 99999998865 47888 66654444455566788899999999999999988764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.48 E-value=5.8 Score=39.46 Aligned_cols=115 Identities=14% Similarity=0.125 Sum_probs=75.8
Q ss_pred CCCceeEEeeeeecCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHH-hhhcCCCCeeecCCCCCcEEE
Q 003978 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVS-YLHHCNPPIIHRDLKSSNLLV 638 (782)
Q Consensus 560 ~HpnIv~l~~~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~-~LH~~~~~ivHrDIKp~NILl 638 (782)
.||++ --.+-..++.+.+.++.-+++.=+..++ .++....+.++.+|+.... +++. -+|--|+|+||++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~----~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR----KTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPENLMF 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH----TSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGGGEEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH----hcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCceEEE
Confidence 57887 3333366677777776654443333443 3667788888888888777 5543 4888999999999
Q ss_pred cCCCcEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 003978 639 DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD 706 (782)
Q Consensus 639 ~~~~~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~ 706 (782)
+.++.++|.-.|+-. -++|.. .+...=+-.+=|++..++.++..|.
T Consensus 118 ~~~~~p~i~hRGi~~-----------------~lpP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 118 NRALEPFFLHVGVKE-----------------SLPPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp CTTCCEEESCCEETT-----------------TBSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eCCCcEEEEEcCCcc-----------------cCCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999997665421 122221 2222233467788889998888774
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 782 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-88 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-79 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-77 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-75 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-75 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-74 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-74 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-74 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-73 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-73 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-72 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-72 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-72 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-72 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-72 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-71 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-71 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-70 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-70 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-68 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-68 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-68 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-67 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-67 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-67 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-67 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-67 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-66 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-65 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-65 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-64 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-63 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-63 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-62 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-60 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-60 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-59 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-57 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-56 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-55 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-54 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-54 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-54 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-54 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-53 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-53 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-51 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-49 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-49 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-48 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-47 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-45 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-44 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-44 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-40 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-38 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-38 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-37 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-19 | |
| d1n9la_ | 109 | d.110.3.6 (A:) Putative blue light receptor, phot- | 1e-14 | |
| d1jnua_ | 104 | d.110.3.6 (A:) Photoreceptor phy3 flavin-binding d | 4e-12 | |
| d1mzua_ | 110 | d.110.3.1 (A:) PYP domain of sensor histidine kina | 8e-07 | |
| d1xj3a1 | 106 | d.110.3.2 (A:154-259) Histidine kinase FixL heme d | 4e-05 | |
| d1ll8a_ | 114 | d.110.3.5 (A:) N-terminal PAS domain of Pas kinase | 4e-05 | |
| d1p97a_ | 114 | d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-t | 9e-05 | |
| d1bywa_ | 110 | d.110.3.6 (A:) Erg potassium channel, N-terminal d | 2e-04 | |
| d1ew0a_ | 130 | d.110.3.2 (A:) Histidine kinase FixL heme domain { | 3e-04 | |
| d1v9ya_ | 113 | d.110.3.2 (A:) Direct oxygen sensor protein, DOS { | 7e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 277 bits (710), Expect = 3e-88
Identities = 97/275 (35%), Positives = 155/275 (56%), Gaps = 13/275 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
D+EI +T+G++IG GS GTVY W+G DVAVK+ + + + + +F+ EV ++++
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRK 60
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
RH N+LLFMG T+PQ L IVT++ SL+ L TK + + I +A A+G+ Y
Sbjct: 61 TRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE--TYLTTKTGKGTPQWMAPEV 676
LH IIHRDLKS+N+ + + TVK+GDFGL+ +K + G+ WMAPEV
Sbjct: 120 LHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 677 LRNE---PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV----GFMNQRLEIPKD 729
+R + P +SDVY+FG++L+EL T ++P+ N+N+ I + ++ +
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237
Query: 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764
++ C RP F +++ + L R
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 252 bits (645), Expect = 6e-79
Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 13/269 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 559
+ + ++L + + IG+G G V + G+ VAVK + F E S+M +L
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA----FLAEASVMTQL 57
Query: 560 RHPNVLLFMGA-VTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARGVS 617
RH N++ +G V L IVTE++ +GSL L+ R + L + +LD+ +
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL 677
YL N +HRDL + N+LV + KV DFGL++ T TGK +W APE L
Sbjct: 118 YLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEAL 172
Query: 678 RNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 736
R + KSDV+SFG++LWE+ + ++P+ + V+ V +++ P P
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYE 231
Query: 737 IVESCWHSDPQCRPSFQELVDKLRDLQRQ 765
++++CWH D RPSF +L ++L ++
Sbjct: 232 VMKNCWHLDAAMRPSFLQLREQLEHIKTH 260
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (634), Expect = 2e-77
Identities = 78/264 (29%), Positives = 129/264 (48%), Gaps = 9/264 (3%)
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
I +DLT +++G G G V + W DVA+K+ S++ F +E +M L
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLS 57
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
H ++ G T + + I+TE++ G L L+ + ++ + M D+ + YL
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG-KGTPQWMAPEVLRN 679
+HRDL + N LV+ VKV DFGLSR + T+ G K +W PEVL
Sbjct: 118 S--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 680 EPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738
KSD+++FGV++WE+ + K+P++ + + + RL P + I+
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIM 234
Query: 739 ESCWHSDPQCRPSFQELVDKLRDL 762
SCWH RP+F+ L+ + D+
Sbjct: 235 YSCWHEKADERPTFKILLSNILDV 258
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (623), Expect = 1e-75
Identities = 66/263 (25%), Positives = 117/263 (44%), Gaps = 11/263 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
ED + IG GS G G + K ++ EV+L++ L+HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 563 NVLLFMGAVT--SPQRLCIVTEFLPRGSLFRLLQRNTTK---LDWRRRILMALDIARGVS 617
N++ + + + L IV E+ G L ++ + T + LD + + + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 618 YLH---HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAP 674
H ++HRDLK +N+ +D VK+GDFGL+R+ + K GTP +M+P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 675 EVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734
E + +EKSD++S G +L+EL P+ + ++ G + + IP
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIPYRYSDEL 242
Query: 735 AAIVESCWHSDPQCRPSFQELVD 757
I+ + RPS +E+++
Sbjct: 243 NEIITRMLNLKDYHRPSVEEILE 265
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (617), Expect = 8e-75
Identities = 85/276 (30%), Positives = 143/276 (51%), Gaps = 15/276 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
++E+ E L + E++G G G V+ + + VAVK + S + +F E +LMK
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMK 63
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGV 616
+L+H ++ VT + I+TE++ GSL L+ + KL + + MA IA G+
Sbjct: 64 QLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLTTKTGKGTPQWMAPE 675
+++ N IHRDL+++N+LV + K+ DFGL+RL + Y + K +W APE
Sbjct: 123 AFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 676 VLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734
+ KSDV+SFG++L E+ T +IP+ + + +VI + R+ P +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEEL 239
Query: 735 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770
++ CW P+ RP+F L L D +F A+
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLED----FFTAT 271
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (616), Expect = 1e-74
Identities = 90/272 (33%), Positives = 128/272 (47%), Gaps = 13/272 (4%)
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSD-EVIHSFRQEVSL 555
I +DL + E++G GS G V W VAVK S E + F +EV+
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
M L H N++ G V +P + +VTE P GSL L+++ A+ +A G
Sbjct: 65 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWM 672
+ YL IHRDL + NLL+ VK+GDFGL R + Y+ + K W
Sbjct: 124 MGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 731
APE L+ SD + FGV LWE+ T + PW LN Q++ + +RL P+D
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241
Query: 732 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 763
++ CW P+ RP+F L D L + Q
Sbjct: 242 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (615), Expect = 1e-74
Identities = 88/274 (32%), Positives = 136/274 (49%), Gaps = 12/274 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEV 553
DYEI E + +G IG+G G V+ ++ + VA+K + SD V F QE
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEA 59
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
M++ HP+++ +G +T + I+ E G L LQ LD IL A ++
Sbjct: 60 LTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWM 672
++YL +HRD+ + N+LV + VK+GDFGLSR ++ TY GK +WM
Sbjct: 119 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 176
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 731
APE + SDV+ FGV +WE+ P+ + + VIG + +RL +P +
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCP 235
Query: 732 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765
P +++ CW DP RP F EL +L + +
Sbjct: 236 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (614), Expect = 2e-74
Identities = 82/265 (30%), Positives = 134/265 (50%), Gaps = 9/265 (3%)
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
I +LT ++IG G G V+ W VA+K S+E F +E +M +L
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLS 58
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
HP ++ G +C+V EF+ G L L+ + M LD+ G++YL
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTPQWMAPEVLRN 679
+IHRDL + N LV ++ +KV DFG++R + + Y ++ K +W +PEV
Sbjct: 119 E--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 680 EPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738
KSDV+SFGV++WE+ +E KIP++N ++ +V+ + RL P+ I+
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIM 235
Query: 739 ESCWHSDPQCRPSFQELVDKLRDLQ 763
CW P+ RP+F L+ +L ++
Sbjct: 236 NHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 238 bits (608), Expect = 3e-73
Identities = 93/288 (32%), Positives = 143/288 (49%), Gaps = 15/288 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
+E+ D+T+ ++G G G VY VW Y VAVK E F +E ++M
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVM 67
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL-QRNTTKLDWRRRILMALDIARG 615
K ++HPN++ +G T I+TEF+ G+L L + N ++ + MA I+
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG-KGTPQWMAP 674
+ YL N IHRDL + N LV ++ VKV DFGLSRL T G K +W AP
Sbjct: 128 MEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 675 EVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734
E L KSDV++FGV+LWE+AT + + + + + R+E P+ +
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 245
Query: 735 AAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGDSTQKEL 782
++ +CW +P RPSF E+ + ++ S++ D +KEL
Sbjct: 246 YELMRACWQWNPSDRPSFAEIHQAFETMFQE------SSISDEVEKEL 287
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (603), Expect = 7e-73
Identities = 76/271 (28%), Positives = 124/271 (45%), Gaps = 16/271 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRH 561
ED IG +G+G G VY A +A+KV + + V H R+EV + LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
PN+L G R+ ++ E+ P G+++R LQ+ + K D +R ++A +SY H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHS 124
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
+IHRD+K NLL+ +K+ DFG S + T GT ++ PE++
Sbjct: 125 KR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRM 180
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741
DEK D++S GV+ +E K P++ + + P V ++
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRL 238
Query: 742 WHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772
+P RP +E+ L+ + A+ S
Sbjct: 239 LKHNPSQRPMLREV------LEHPWITANSS 263
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (607), Expect = 1e-72
Identities = 83/315 (26%), Positives = 135/315 (42%), Gaps = 40/315 (12%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWE----DLTIGEQIGQGSCGTVYHAVWYGSD------- 530
T SS +D +Y++ WE +L G+ +G G+ G V +A YG
Sbjct: 10 VTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQ 69
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589
VAVK+ + S E E+ +M +L H N++ +GA T + ++ E+ G L
Sbjct: 70 VAVKMLKEKADSSEREA-LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 128
Query: 590 FRLLQRNTTK----------------------LDWRRRILMALDIARGVSYLHHCNPPII 627
L+ K L + + A +A+G+ +L + +
Sbjct: 129 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CV 186
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRNEPSDEK 685
HRDL + N+LV VK+ DFGL+R Y+ + +WMAPE L K
Sbjct: 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 246
Query: 686 SDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHS 744
SDV+S+G++LWE+ + P+ + + +++ P I++SCW
Sbjct: 247 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAF 306
Query: 745 DPQCRPSFQELVDKL 759
D + RPSF L L
Sbjct: 307 DSRKRPSFPNLTSFL 321
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 236 bits (604), Expect = 2e-72
Identities = 86/275 (31%), Positives = 134/275 (48%), Gaps = 15/275 (5%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEVSL 555
EI + I + IG G G V VA+K + Y+++ F E S+
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASI 80
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
M + HPNV+ G VT + I+TEF+ GSL L++N + + + M IA G
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-----KHETYLTTKTGKGTPQ 670
+ YL N +HRDL + N+LV+ + KV DFGLSR TY + GK +
Sbjct: 141 MKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKD 729
W APE ++ SDV+S+G+++WE+ + + P+ ++ + VI A+ + RL P D
Sbjct: 199 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPMD 257
Query: 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764
++ CW D RP F ++V+ L + R
Sbjct: 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 3e-72
Identities = 69/267 (25%), Positives = 123/267 (46%), Gaps = 14/267 (5%)
Query: 505 EDLTIGE-QIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 559
++L I + ++G G+ G+V V+ DVA+KV +Q +E +M +L
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQL 66
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
+P ++ +G V + L +V E G L + L ++ + ++ G+ YL
Sbjct: 67 DNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWMAPEV 676
N +HRDL + N+L+ K+ DFGLS+ Y GK +W APE
Sbjct: 126 EEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735
+ +SDV+S+GV +WE + + P+ + +V+ + +R+E P + P
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECPPELY 242
Query: 736 AIVESCWHSDPQCRPSFQELVDKLRDL 762
A++ CW + RP F + ++R
Sbjct: 243 ALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 3e-72
Identities = 72/272 (26%), Positives = 120/272 (44%), Gaps = 18/272 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+ I ++G G+ G VY A A KV + S+E + + E+ ++ HP
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHP 69
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
N++ + A L I+ EF G++ ++ L + ++ ++YLH
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL----- 677
IIHRDLK+ N+L +K+ DFG+S T + GTP WMAPEV+
Sbjct: 130 K--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 187
Query: 678 RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRWAA 736
++ P D K+DV+S G+ L E+A + P LN M+V+ + L P +
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247
Query: 737 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
++ C + R + +L LQ +
Sbjct: 248 FLKKCLEKNVDARWTTSQL------LQHPFVT 273
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 8e-72
Identities = 81/270 (30%), Positives = 130/270 (48%), Gaps = 18/270 (6%)
Query: 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
L +IG+GS TVY + +VA ++ + F++E ++K L+HPN+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 565 LLFMGAVTSPQR----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
+ F + S + + +VTE + G+L L+R + + I +G+ +LH
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH 129
Query: 621 HCNPPIIHRDLKSSN-LLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 679
PPIIHRDLK N + +VK+GD GL+ LK ++ K GTP++MAPE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYEE 187
Query: 680 EPSDEKSDVYSFGVILWELATEKIPWDNL-NSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738
DE DVY+FG+ + E+AT + P+ N+ Q+ V + K P I+
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246
Query: 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
E C + R S ++L L +FQ
Sbjct: 247 EGCIRQNKDERYSIKDL------LNHAFFQ 270
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (597), Expect = 1e-71
Identities = 90/268 (33%), Positives = 143/268 (53%), Gaps = 11/268 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-VAVKVFSRQEYSDEVIHSFRQEVSLMK 557
+EI E L + ++GQG G V+ W G+ VA+K S E +F QE +MK
Sbjct: 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMK 67
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD-WRRRILMALDIARGV 616
+LRH ++ V S + + IVTE++ +GSL L+ T K + + MA IA G+
Sbjct: 68 KLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG-KGTPQWMAPE 675
+Y+ N +HRDL+++N+LV ++ KV DFGL+RL + T + G K +W APE
Sbjct: 127 AYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 184
Query: 676 VLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRW 734
KSDV+SFG++L EL T+ ++P+ + + +V+ V R+ P +
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESL 243
Query: 735 AAIVESCWHSDPQCRPSFQELVDKLRDL 762
++ CW +P+ RP+F+ L L D
Sbjct: 244 HDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (594), Expect = 2e-71
Identities = 69/266 (25%), Positives = 123/266 (46%), Gaps = 14/266 (5%)
Query: 505 EDLTIGE-QIGQGSCGTVYHAVW----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 559
+ LT+ + ++G G+ GTV + VAVK+ + + E ++M++L
Sbjct: 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 65
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
+P ++ +G + + +V E G L + LQ+N + + I + ++ G+ YL
Sbjct: 66 DNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYL 123
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWMAPEV 676
N +HRDL + N+L+ K+ DFGLS+ Y GK +W APE
Sbjct: 124 EESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735
+ KSDV+SFGV++WE + + P+ + +V + +R+ P
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMY 240
Query: 736 AIVESCWHSDPQCRPSFQELVDKLRD 761
++ CW D + RP F + +LR+
Sbjct: 241 DLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 3e-70
Identities = 80/286 (27%), Positives = 135/286 (47%), Gaps = 26/286 (9%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIHSFRQEVSLM 556
+ W D+ + IG+G+ G V A D A+K ++ S + F E+ ++
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVL 64
Query: 557 KRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKL 600
+L HPN++ +GA L + E+ P G+L L+++ + L
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 601 DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660
++ + A D+ARG+ YL IHRDL + N+LV +++ K+ DFGLSR E Y+
Sbjct: 125 SSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYV 181
Query: 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGF 719
G+ +WMA E L SDV+S+GV+LWE+ + P+ + ++ +
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 240
Query: 720 MNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765
RLE P + D ++ CW P RPSF +++ L + +
Sbjct: 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 230 bits (587), Expect = 4e-70
Identities = 76/303 (25%), Positives = 134/303 (44%), Gaps = 37/303 (12%)
Query: 493 LDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEV 545
L+ L E ++ IG+G+ G V+ A G VAVK+ ++E S ++
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADM 59
Query: 546 IHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-------- 597
F++E +LM +PN++ +G + +C++ E++ G L L+ +
Sbjct: 60 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 598 ---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642
L ++ +A +A G++YL +HRDL + N LV ++
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENM 177
Query: 643 TVKVGDFGLSRLKH--ETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT 700
VK+ DFGLSR + + Y +WM PE + +SDV+++GV+LWE+ +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 701 -EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKL 759
P+ + +VI V L P++ ++ CW P RPSF + L
Sbjct: 238 YGLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
Query: 760 RDL 762
+ +
Sbjct: 297 QRM 299
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 2e-68
Identities = 86/290 (29%), Positives = 134/290 (46%), Gaps = 17/290 (5%)
Query: 492 DLDNDCLDYEILWEDLTI--GEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDE 544
+L I L + E IG+G G VYH +D AVK +R E
Sbjct: 12 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 71
Query: 545 VIHSFRQEVSLMKRLRHPNVLLFMGA-VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR 603
V F E +MK HPNVL +G + S +V ++ G L ++ T +
Sbjct: 72 VSQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 130
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE----TY 659
I L +A+G+ + +HRDL + N ++D+ +TVKV DFGL+R ++ +
Sbjct: 131 DLIGFGLQVAKGMK--FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188
Query: 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVG 718
K +WMA E L+ + KSDV+SFGV+LWEL T P+ ++N+ + +
Sbjct: 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL- 247
Query: 719 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
+RL P+ ++ CWH + RPSF ELV ++ + +
Sbjct: 248 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 3e-68
Identities = 61/263 (23%), Positives = 124/263 (47%), Gaps = 7/263 (2%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
E+ +D ++G G+ G V+ G +A K+ E + + +E+ ++
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHE 60
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
P ++ F GA S + I E + GSL ++L++ ++ + +++ + +G++Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTY 119
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 678
L + I+HRD+K SN+LV+ +K+ DFG+S ++ + GT +M+PE L+
Sbjct: 120 LREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQ 176
Query: 679 NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738
+SD++S G+ L E+A + P ++ ++ G + PR
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 739 ESCWHSDPQCRPSFQELVDKLRD 761
S + D + + EL+D + +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVN 259
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 4e-68
Identities = 82/301 (27%), Positives = 126/301 (41%), Gaps = 45/301 (14%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+ + E IG+G G V+ W G +VAVK+FS +E E+ LRH N+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWF---REAEIYQTVMLRHENI 59
Query: 565 LLFMGAVTSPQ----RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
L F+ A +L +V+++ GSLF L R + I +AL A G+++LH
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLH 117
Query: 621 H------CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL----KHETYLTTKTGKGTPQ 670
P I HRDLKS N+LV K+ T + D GL+ + GT +
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 671 WMAPEVLRNE------PSDEKSDVYSFGVILWELATEKIPWDNLNSMQ------------ 712
+MAPEVL + S +++D+Y+ G++ WE+A Q
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 713 ---VIGAVGFMNQRLEIPKDVDP-----RWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764
+ V R IP A I+ CW+++ R + + L L +
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
Query: 765 Q 765
Q
Sbjct: 298 Q 298
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 9e-68
Identities = 72/270 (26%), Positives = 128/270 (47%), Gaps = 14/270 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+ + +G G+ GTVY +W VA+K R+ S + E +M
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMAS 67
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
+ +P+V +G + + ++T+ +P G L ++ + + + + + IA+G++Y
Sbjct: 68 VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEV 676
L ++HRDL + N+LV VK+ DFGL++L E + GK +WMA E
Sbjct: 127 LEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 677 LRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735
+ + +SDV+S+GV +WEL T P+D + + ++ + +RL P
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDVY 243
Query: 736 AIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765
I+ CW D RP F+EL+ + + R
Sbjct: 244 MIMVKCWMIDADSRPKFRELIIEFSKMARD 273
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 224 bits (571), Expect = 1e-67
Identities = 80/264 (30%), Positives = 120/264 (45%), Gaps = 16/264 (6%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQ-EYSDEVIHSFRQEVSL 555
D E L+ DL +IG GS G VY A VA+K S + S+E +EV
Sbjct: 12 DPEKLFSDL---REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
+++LRHPN + + G +V E+ + L L + +G
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQG 127
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPE 675
++YLH N +IHRD+K+ N+L+ + VK+GDFG + + + GTP WMAPE
Sbjct: 128 LAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPE 181
Query: 676 VLR---NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 732
V+ D K DV+S G+ ELA K P N+N+M + +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 241
Query: 733 RWAAIVESCWHSDPQCRPSFQELV 756
+ V+SC PQ RP+ + L+
Sbjct: 242 YFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 1e-67
Identities = 80/303 (26%), Positives = 134/303 (44%), Gaps = 35/303 (11%)
Query: 489 NKVDLDNDCLDYEILWE----DLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFS 537
N V +D L Y+ WE L+ G+ +G G+ G V A YG VAVK+
Sbjct: 3 NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 62
Query: 538 RQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR- 595
+ E + E+ ++ L H N++ +GA T ++TE+ G L L+R
Sbjct: 63 PSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 596 ----------------NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD 639
+ LD + + +A+G+++L N IHRDL + N+L+
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT 179
Query: 640 KHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWE 697
K+ DFGL+R Y+ + +WMAPE + N +SDV+S+G+ LWE
Sbjct: 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 239
Query: 698 LATEKIPWD-NLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELV 756
L + + + R+ P+ I+++CW +DP RP+F+++V
Sbjct: 240 LFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
Query: 757 DKL 759
+
Sbjct: 300 QLI 302
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 2e-67
Identities = 78/273 (28%), Positives = 123/273 (45%), Gaps = 12/273 (4%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEVS 554
EI +T + IG G G VY + S VA+K + Y+++ F E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAG 61
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR 614
+M + H N++ G ++ + + I+TE++ G+L + L+ + + + M IA
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH---ETYLTTKTGKGTPQW 671
G + N +HRDL + N+LV+ + KV DFGLSR+ E TT GK +W
Sbjct: 122 G--MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 672 MAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 731
APE + SDV+SFG+++WE+ T S + RL P D
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 239
Query: 732 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764
++ CW + RP F ++V L L R
Sbjct: 240 SAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (568), Expect = 3e-67
Identities = 89/289 (30%), Positives = 145/289 (50%), Gaps = 23/289 (7%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQ 551
++E+ E +T+ ++GQGS G VY V G VA+K + E I F
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLN 72
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------TTKLDW 602
E S+MK +V+ +G V+ Q ++ E + RG L L+
Sbjct: 73 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 603 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE--TYL 660
+ I MA +IA G++YL+ +HRDL + N +V + +TVK+GDFG++R +E Y
Sbjct: 133 SKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGF 719
G +WM+PE L++ SDV+SFGV+LWE+AT + P+ L++ QV+ V
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-M 249
Query: 720 MNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
L+ P + ++ CW +P+ RPSF E++ +++ F+
Sbjct: 250 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 3e-67
Identities = 70/272 (25%), Positives = 129/272 (47%), Gaps = 15/272 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+ T E+IGQG+ GTVY A+ G +VA++ + Q+ + E+ +M+ ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMRENKNP 77
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
N++ ++ + L +V E+L GSL ++ + + + + +LH
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV--CRECLQALEFLHSN 135
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 682
+IHRD+KS N+L+ +VK+ DFG T GTP WMAPEV+ +
Sbjct: 136 Q--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 683 DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-RLEIPKDVDPRWAAIVESC 741
K D++S G++ E+ + P+ N N ++ + + L+ P+ + + + C
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 742 WHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773
D + R S +EL LQ Q+ + ++
Sbjct: 254 LDMDVEKRGSAKEL------LQHQFLKIAKPL 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 3e-66
Identities = 59/269 (21%), Positives = 116/269 (43%), Gaps = 10/269 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRH 561
ED G+ +G+GS TV A + A+K+ ++ E + +E +M RL H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
P + ++L + G L + +++ D +I + YLH
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHG 126
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH--ETYLTTKTGKGTPQWMAPEVLRN 679
IIHRDLK N+L+++ +++ DFG +++ + GT Q+++PE+L
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 680 EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 739
+ + + SD+++ G I+++L P+ N + + + + P+ P+ +VE
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFPKARDLVE 242
Query: 740 SCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
D R +E+ +F+
Sbjct: 243 KLLVLDATKRLGCEEMEGYGPLKAHPFFE 271
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 3e-65
Identities = 66/270 (24%), Positives = 118/270 (43%), Gaps = 16/270 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
ED + + +G+G+ G V AV VAVK+ + + + + ++E+ + K L H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHE 63
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
NV+ F G + E+ G LF ++ + + + GV YLH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTPQWMAPEVLRNE 680
I HRD+K NLL+D+ +K+ DFGL+ + + GT ++APE+L+
Sbjct: 123 G--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 681 P-SDEKSDVYSFGVILWELATEKIPWDNLN-SMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738
E DV+S G++L + ++PWD + S Q L K +D A++
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240
Query: 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
+P R + ++ + +++
Sbjct: 241 HKILVENPSARITIPDI------KKDRWYN 264
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 8e-65
Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 28/290 (9%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQ 551
+E + L +G+ +G+G+ G V A +G D VAVK+ E +
Sbjct: 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 66
Query: 552 EVSLMKRLRHPNVLLFMGAVTSP-QRLCIVTEFLPRGSLFRLLQRNTTK----------- 599
L+ H NV+ +GA T P L ++ EF G+L L+ +
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 600 ----LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL- 654
L I + +A+G+ +L IHRDL + N+L+ + VK+ DFGL+R
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDI 184
Query: 655 -KHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQ 712
K Y+ + +WMAPE + + +SDV+SFGV+LWE+ + P+ + +
Sbjct: 185 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244
Query: 713 VIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
R+ P P + CWH +P RP+F ELV+ L +L
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 3e-64
Identities = 83/292 (28%), Positives = 144/292 (49%), Gaps = 32/292 (10%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD---------VAVKVFSRQEYSDEVIHSF 549
+E+ + L +G+ +G+G+ G V A G D VAVK+ + + +++ +
Sbjct: 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDL 65
Query: 550 RQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------------ 596
E+ +MK + +H N++ +GA T L ++ E+ +G+L LQ
Sbjct: 66 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125
Query: 597 ---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+L + + A +ARG+ YL IHRDL + N+LV + +K+ DFGL+R
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 654 LKHE--TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNS 710
H Y T G+ +WMAPE L + +SDV+SFGV+LWE+ T P+ +
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 711 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762
++ + R++ P + ++ CWH+ P RP+F++LV+ L +
Sbjct: 244 EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 214 bits (545), Expect = 2e-63
Identities = 58/278 (20%), Positives = 123/278 (44%), Gaps = 17/278 (6%)
Query: 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
+++ I E++G G+ G V+ V G K + D+ ++ + E+S+M +L
Sbjct: 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQLH 84
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
HP ++ A + ++ EFL G LF + K+ I G+ ++H
Sbjct: 85 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 621 HCNPPIIHRDLKSSNLLVD--KHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 678
+ I+H D+K N++ + K +VK+ DFGL+ + + T T ++ APE++
Sbjct: 145 EHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIVD 201
Query: 679 NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL--EIPKDVDPRWAA 736
EP +D+++ GV+ + L + P+ + ++ + V + + V P
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261
Query: 737 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTV 774
+++ +P+ R + + L+ + + S +
Sbjct: 262 FIKNLLQKEPRKRLTVHDA------LEHPWLKGDHSNL 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 213 bits (544), Expect = 3e-63
Identities = 59/270 (21%), Positives = 111/270 (41%), Gaps = 17/270 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+ I E++G G+ G V+ G++ A K SD+ + R+E+ M LRHP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVLRHP 83
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
++ A + ++ EF+ G LF + K+ + + +G+ ++H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 623 NPPIIHRDLKSSNLLV--DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 680
N +H DLK N++ + +K+ DFGL+ + K GT ++ APEV +
Sbjct: 144 N--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-SVKVTTGTAEFAAPEVAEGK 200
Query: 681 PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAAIV 738
P +D++S GV+ + L + P+ N + + V N + +
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260
Query: 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
+DP R + + L+ +
Sbjct: 261 RKLLLADPNTRMTIHQA------LEHPWLT 284
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 3e-62
Identities = 55/272 (20%), Positives = 114/272 (41%), Gaps = 18/272 (6%)
Query: 503 LWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
L+E I E +G+G G V+ V S K + ++E+S++ R
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNIAR 59
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
H N+L + S + L ++ EF+ +F + + +L+ R + + + +LH
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 621 HCNPPIIHRDLKSSNLLVD--KHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 678
N I H D++ N++ + T+K+ +FG +R + P++ APEV +
Sbjct: 120 SHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVHQ 176
Query: 679 NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVDPRWAA 736
++ +D++S G +++ L + P+ + Q+I + E K++
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236
Query: 737 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
V+ + + R + E LQ + +
Sbjct: 237 FVDRLLVKERKSRMTASEA------LQHPWLK 262
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (517), Expect = 5e-60
Identities = 62/275 (22%), Positives = 116/275 (42%), Gaps = 18/275 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+ + +G G+ V A VA+K +++ + S E++++ +++HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-GSMENEIAVLHKIKHP 67
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
N++ S L ++ + + G LF + R + + V YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDL 126
Query: 623 NPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN 679
I+HRDLK NLL D+ + + DFGLS+++ + + T GTP ++APEVL
Sbjct: 127 G--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-TACGTPGYVAPEVLAQ 183
Query: 680 EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP--KDVDPRWAAI 737
+P + D +S GVI + L P+ + N ++ + + P D+
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243
Query: 738 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772
+ DP+ R + ++ LQ + +
Sbjct: 244 IRHLMEKDPEKRFTCEQA------LQHPWIAGDTA 272
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 5e-60
Identities = 65/268 (24%), Positives = 120/268 (44%), Gaps = 14/268 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLR 560
ED + + +G+GS G V+ A + A+K + D+V + ++ L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
HP + + + L V E+L G L +Q K D R A +I G+ +LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH 120
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNE 680
I++RDLK N+L+DK +K+ DFG+ + T T GTP ++APE+L +
Sbjct: 121 SKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 681 PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 740
+ D +SFGV+L+E+ + P+ + ++ ++ P+ ++ ++
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLEKEAKDLLVK 236
Query: 741 CWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
+ +P+ R + + Q F+
Sbjct: 237 LFVREPEKRLGVRGDI-----RQHPLFR 259
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 199 bits (508), Expect = 5e-59
Identities = 64/283 (22%), Positives = 117/283 (41%), Gaps = 28/283 (9%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQ-------EYSDEVIHSFRQEVS 554
+E+ E +G+G V + + AVK+ E E+ + +EV
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 555 LMKRLR-HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
+++++ HPN++ + +V + + +G LF L L + + +
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALL 120
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 673
+ LH N I+HRDLK N+L+D +K+ DFG S + GTP ++A
Sbjct: 121 EVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV-CGTPSYLA 177
Query: 674 PEVLRNEPSD------EKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIP 727
PE++ +D ++ D++S GVI++ L P+ + M ++ + N + P
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 728 --KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
D +V PQ R + +E L +FQ
Sbjct: 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEA------LAHPFFQ 274
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 193 bits (491), Expect = 9e-57
Identities = 67/275 (24%), Positives = 116/275 (42%), Gaps = 16/275 (5%)
Query: 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRL 559
L + +GE +G G V+ A DVAVKV D FR+E L
Sbjct: 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 64
Query: 560 RHPNVLLFMGAVTSP----QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
HP ++ + IV E++ +L ++ + +R I + D +
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQA 123
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWM 672
+++ H IIHRD+K +N+++ VKV DFG++R + T GT Q++
Sbjct: 124 LNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 673 APEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--LEIPKDV 730
+PE R + D +SDVYS G +L+E+ T + P+ + + V + + +
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241
Query: 731 DPRWAAIVESCWHSDPQCRP-SFQELVDKLRDLQR 764
A+V +P+ R + E+ L +
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 194 bits (494), Expect = 1e-56
Identities = 63/268 (23%), Positives = 126/268 (47%), Gaps = 14/268 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRH 561
+D I +G GS G V+ G A+KV ++ + + E ++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
P ++ G Q++ ++ +++ G LF LL+++ + + A ++ + YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLALEYLHS 122
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
II+RDLK N+L+DK+ +K+ DFG ++ + T GTP ++APEV+ +P
Sbjct: 123 --KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVVSTKP 177
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741
++ D +SFG++++E+ P+ + N+M+ + +N L P + ++
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--LNAELRFPPFFNEDVKDLLSRL 235
Query: 742 WHSDPQCRP-SFQELVDKLRDLQRQYFQ 768
D R + Q + + +F+
Sbjct: 236 ITRDLSQRLGNLQNGTEDV--KNHPWFK 261
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 6e-55
Identities = 64/265 (24%), Positives = 124/265 (46%), Gaps = 19/265 (7%)
Query: 490 KVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVI 546
KV ++ D++ L + +G+G+ G V G A+K+ ++ + + +
Sbjct: 1 KVTMN----DFDYL-------KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEV 49
Query: 547 HSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRI 606
E +++ RHP + A + RLC V E+ G LF L R + R R
Sbjct: 50 AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF 109
Query: 607 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666
A +I + + + +++RD+K NL++DK +K+ DFGL + T KT
Sbjct: 110 YGA-EIVSALE--YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 166
Query: 667 GTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEI 726
GTP+++APEVL + D + GV+++E+ ++P+ N + ++ + + + +
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRF 224
Query: 727 PKDVDPRWAAIVESCWHSDPQCRPS 751
P+ + P +++ DP+ R
Sbjct: 225 PRTLSPEAKSLLAGLLKKDPKQRLG 249
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-54
Identities = 65/287 (22%), Positives = 111/287 (38%), Gaps = 39/287 (13%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
DY++ + +G G G V A+K+ R+EV L
Sbjct: 12 DYKVT------SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELH 58
Query: 557 KRL-RHPNVL----LFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMAL 610
R + P+++ ++ + L IV E L G LF +Q R R +
Sbjct: 59 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 118
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRLKHETYLTTKTGKG 667
I + YLH N I HRD+K NLL +K+ DFG ++ + T
Sbjct: 119 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCY 175
Query: 668 TPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV--GFMNQRLE 725
TP ++APEVL E D+ D++S GVI++ L P+ + + + + + + E
Sbjct: 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235
Query: 726 IP----KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
P +V ++ + ++P R + E + +
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF------MNHPWIM 276
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (473), Expect = 5e-54
Identities = 58/280 (20%), Positives = 105/280 (37%), Gaps = 25/280 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+G +IG GS G +Y G +VA+K+ + + E + K ++ +
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGGVGI 65
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
+ + ++ L SL L + K + +L+A + + Y+H N
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN-- 123
Query: 626 IIHRDLKSSNLLV---DKHWTVKVGDFGLSRL-------KHETYLTTKTGKGTPQWMAPE 675
IHRD+K N L+ K V + DFGL++ +H Y K GT ++ +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 676 VLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR------LEIPKD 729
+ D+ S G +L +PW L + ++++ + K
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243
Query: 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL-QRQYFQ 768
+A + C +P + L R+L RQ F
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 5e-54
Identities = 55/271 (20%), Positives = 103/271 (38%), Gaps = 28/271 (10%)
Query: 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLR- 560
+G +G G G+VY + VA+K + SD EV L+K++
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 561 -HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
V+ + P ++ E L + V +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 620 HHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLR 678
H+C ++HRD+K N+L+D + +K+ DFG L +T T G T + PE +R
Sbjct: 127 HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDG--TRVYSPPEWIR 182
Query: 679 NEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAI 737
+ V+S G++L+++ IP+++ + + ++ + V +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------IRGQVFFRQRVSSECQHL 234
Query: 738 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
+ C P RP+F+E+ + Q
Sbjct: 235 IRWCLALRPSDRPTFEEI------QNHPWMQ 259
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 188 bits (478), Expect = 7e-54
Identities = 58/255 (22%), Positives = 110/255 (43%), Gaps = 13/255 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE----VIHSFRQEVSLMKR 558
D ++ IG+G G VY G A+K ++ + + + R +SL+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
P ++ A +P +L + + + G L L ++ + R A +I G+ +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEH 122
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL- 677
+H+ +++RDLK +N+L+D+H V++ D GL+ + GT +MAPEVL
Sbjct: 123 MHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQ 178
Query: 678 RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIG-AVGFMNQRLEIPKDVDPRWAA 736
+ D +D +S G +L++L P+ + + +E+P P +
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
Query: 737 IVESCWHSDPQCRPS 751
++E D R
Sbjct: 239 LLEGLLQRDVNRRLG 253
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-53
Identities = 60/273 (21%), Positives = 105/273 (38%), Gaps = 22/273 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE----VIHSFRQEVSLMKRLRH 561
GE++G G V G A K ++ +EVS++K ++H
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
PNV+ + + ++ E + G LF L L I GV +
Sbjct: 73 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVY--YL 129
Query: 622 CNPPIIHRDLKSSNLLVDKHWT----VKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVL 677
+ I H DLK N+++ +K+ DFGL+ GTP+++APE++
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPEIV 188
Query: 678 RNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL--EIPKDVDPRWA 735
EP ++D++S GVI + L + P+ + + V +N E +
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248
Query: 736 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
+ DP+ R + Q+ LQ + +
Sbjct: 249 DFIRRLLVKDPKKRMTIQDS------LQHPWIK 275
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 185 bits (470), Expect = 1e-53
Identities = 49/279 (17%), Positives = 95/279 (34%), Gaps = 26/279 (9%)
Query: 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+G +IG+GS G ++ VA+K R+ + + R E K L +
Sbjct: 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTGI 63
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
+ ++ L SL LL K + + A + V +H +
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS-- 121
Query: 626 IIHRDLKSSNLLVDKHWT-----VKVGDFGLSRL-------KHETYLTTKTGKGTPQWMA 673
+++RD+K N L+ + + + V DFG+ + +H Y K GT ++M+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 674 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNS---MQVIGAVGFMNQRL---EIP 727
+ D+ + G + +PW L + Q +G Q E+
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 728 KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766
+ + + P + L + +
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 8e-51
Identities = 68/294 (23%), Positives = 119/294 (40%), Gaps = 38/294 (12%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
E+ E+IG+G+ G VY A G VA+K ++ V + +E+SL+K L HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
N++ + + + +L +V EFL + + T + + +G+++ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP- 681
++HRDLK NLL++ +K+ DFGL+R T T + APE+L
Sbjct: 122 R--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQVI----------------GAVGFMNQRLE 725
D++S G I E+ T + + + + + G + +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 726 IPK-----------DVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
PK +D +++ H DP R S + L +FQ
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA------LAHPFFQ 287
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-49
Identities = 66/300 (22%), Positives = 114/300 (38%), Gaps = 45/300 (15%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-- 559
+ +IG+G+ G V+ A G VA+K Q + + S +EV++++ L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 560 -RHPNVLLFMGAVTSPQ-----RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
HPNV+ T + +L +V E + + L + + M +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMA 673
RG+ +LH ++HRDLK N+LV +K+ DFGL+R+ + + + T + A
Sbjct: 127 RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALTSVVVTLWYRA 183
Query: 674 PEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV---------------- 717
PEVL D++S G I E+ K + + + +G +
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 718 ---------GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
+ D+D ++ C +P R S L YFQ
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA------LSHPYFQ 297
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (441), Expect = 7e-49
Identities = 56/268 (20%), Positives = 118/268 (44%), Gaps = 14/268 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRH 561
+ + +G GS G V G+ A+K+ +Q+ + I E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
P ++ + L +V E++ G +F L+R + A I YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS 159
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEP 681
+ +I+RDLK NLL+D+ ++V DFG ++ T GTP+ +APE++ ++
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC---GTPEALAPEIILSKG 214
Query: 682 SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741
++ D ++ GV+++E+A P+ +Q+ + ++ ++ P ++ +
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--VSGKVRFPSHFSSDLKDLLRNL 272
Query: 742 WHSDPQCR-PSFQELVDKLRDLQRQYFQ 768
D R + + V+ + ++F
Sbjct: 273 LQVDLTKRFGNLKNGVNDI--KNHKWFA 298
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 171 bits (433), Expect = 1e-48
Identities = 64/293 (21%), Positives = 115/293 (39%), Gaps = 38/293 (12%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
E E+IG+G+ G VY A YG A+K ++ + + + +E+S++K L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
++ + + +RL +V E L L +LL L+ L + G++Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS- 682
++HRDLK NLL+++ +K+ DFGL+R T + AP+VL
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 683 DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV------------------------- 717
D++S G I E+ + ++ + +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 718 --GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
K +D ++ DP R + ++ L+ YF+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA------LEHAYFK 285
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-47
Identities = 61/290 (21%), Positives = 111/290 (38%), Gaps = 41/290 (14%)
Query: 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFS---RQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ +G+G TVY A VA+K R E D + + +E+ L++ L HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
+ A + +V +F+ L +++ N+ L L +G+ YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS-DE 684
I+HRDLK +NLL+D++ +K+ DFGL++ T + APE+L
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180
Query: 685 KSDVYSFGVILWELATEKIPWDNLNSMQVIGAV--------------------------G 718
D+++ G IL EL + + + +
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240
Query: 719 FMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
I +++ + +P R + + L+ +YF
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA------LKMKYFS 284
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-45
Identities = 59/278 (21%), Positives = 118/278 (42%), Gaps = 19/278 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV-----WYGSDVAVKVFSRQEYSD--EVIHSFRQEVSLMK 557
E+ + + +G G+ G V+ G A+KV + + R E +++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 558 RLRH-PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 616
+R P ++ A + +L ++ +++ G LF L + + + +I +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLAL 142
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTPQWMAPE 675
+LH II+RD+K N+L+D + V + DFGLS + GT ++MAP+
Sbjct: 143 EHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 676 VLRNEPS--DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV--GFMNQRLEIPKDVD 731
++R S D+ D +S GV+++EL T P+ + + P+++
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 732 PRWAAIVESCWHSDPQCRPSF-QELVDKLRDLQRQYFQ 768
+++ DP+ R D++ + +FQ
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEI--KEHLFFQ 296
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 5e-45
Identities = 64/300 (21%), Positives = 115/300 (38%), Gaps = 50/300 (16%)
Query: 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
T IG+G+ G V A VA+K S E +E+ ++ R RH N++
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENII 69
Query: 566 LFMGAVTSP----QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
+ +P + + L L++LL+ L I RG+ Y+H
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHS 127
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTPQWMAPEVLR 678
N ++HRDLK SNLL++ +K+ DFGL+R+ H+ T + APE++
Sbjct: 128 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 679 NE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV------------------GF 719
N + D++S G IL E+ + + + + + + +
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 720 MNQRLEIP-----------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
N L +P + D + +++ +P R ++ L Y +
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA------LAHPYLE 299
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-44
Identities = 60/315 (19%), Positives = 111/315 (35%), Gaps = 61/315 (19%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
YE L +IGQG+ G V+ A G VA+K + + + +E+ ++
Sbjct: 11 KYEKL-------AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKIL 63
Query: 557 KRLRHPNVLLFMGAVTSPQ--------RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 608
+ L+H NV+ + + + +V +F L K +
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-KFTLSEIKRV 122
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL----KHETYLTTKT 664
+ G+ Y+H I+HRD+K++N+L+ + +K+ DFGL+R K+
Sbjct: 123 MQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180
Query: 665 GKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV------ 717
T + PE+L E D++ G I+ E+ T + +
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
Query: 718 -----------GFMNQRLEIPKD-------------VDPRWAAIVESCWHSDPQCRPSFQ 753
+ ++LE+ K DP +++ DP R
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
Query: 754 ELVDKLRDLQRQYFQ 768
+ L +F
Sbjct: 301 DA------LNHDFFW 309
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 6e-44
Identities = 63/295 (21%), Positives = 116/295 (39%), Gaps = 40/295 (13%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+ E+IG+G+ GTV+ A VA+K + + V S +E+ L+K L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
N++ + S ++L +V EF + N + + + +G+ + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLF-QLLKGLGFCHSR 120
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPS 682
N ++HRDLK NLL++++ +K+ +FGL+R T + P+VL
Sbjct: 121 N--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 683 -DEKSDVYSFGVILWELATEKIPW----DNLNSMQVIGAVGFM----------------- 720
D++S G I ELA P D + ++ I +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 721 -------NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
+ + ++ ++++ +P R S +E LQ YF
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA------LQHPYFS 287
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 8e-42
Identities = 67/298 (22%), Positives = 113/298 (37%), Gaps = 50/298 (16%)
Query: 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ +G G+ G V AV G+ VA+K R S+ +E+ L+K +RH NV+
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 80
Query: 566 LFMGAVTSPQRLCIVTEF-----LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
+ T + L T+F L +L++ KL R + + +G+ Y+H
Sbjct: 81 GLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH 138
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRN- 679
HRDLK NL V++ +K+ DFGL+R T + APEV+ N
Sbjct: 139 AAGII--HRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVILNW 193
Query: 680 EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL--------------- 724
+ D++S G I+ E+ T K + + + + + +
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253
Query: 725 --------------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
I + P ++E D + R + E L YF+
Sbjct: 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA------LAHPYFE 305
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-40
Identities = 54/301 (17%), Positives = 91/301 (30%), Gaps = 52/301 (17%)
Query: 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
T + IG GS G VY A G VA+K + + +E+ +M++L H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCN 74
Query: 564 VLLFMGAVTSPQR------LCIVTEFLPRGSLFRLLQ--RNTTKLDWRRRILMALDIARG 615
++ S L +V +++P R L L + R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAP 674
++Y+H I HRD+K NLL+D +K+ DFG ++
Sbjct: 135 LAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192
Query: 675 EVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV----------------- 717
+ DV+S G +L EL + + + + + +
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 718 ----------GFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYF 767
P A+ P R + E +F
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA------CAHSFF 306
Query: 768 Q 768
Sbjct: 307 D 307
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-38
Identities = 63/265 (23%), Positives = 110/265 (41%), Gaps = 22/265 (8%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
+ +L + + IG G+ G V A +VA+K SR + +E+ LM
Sbjct: 12 TFTVL-KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70
Query: 557 KRLRHPNVLLFMGAVTSP------QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
K + H N++ + T Q + +V E + + D R +
Sbjct: 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLY 126
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ 670
+ G+ +LH IHRDLK SN++V T+K+ DFGL+R +++ T T
Sbjct: 127 QMLCGIKHLHSAGI--IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-VVTRY 183
Query: 671 WMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDV 730
+ APEV+ E D++S G I+ E+ KI + + + N+ +E
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ------WNKVIEQLGTP 237
Query: 731 DPRWAAIVESCWHSDPQCRPSFQEL 755
P + ++ + + RP + L
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGL 262
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 8e-38
Identities = 71/308 (23%), Positives = 118/308 (38%), Gaps = 53/308 (17%)
Query: 501 EILWE---DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSL 555
+ +WE +G G+ G+V A G VAVK SR S +E+ L
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 556 MKRLRHPNVLLFMGAVTSPQRLC-----IVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
+K ++H NV+ + T + L + L L +++ KL +
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIY 128
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTPQ 670
I RG+ Y+H + IIHRDLK SNL V++ +K+ DFGL+ T T
Sbjct: 129 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRW 183
Query: 671 WMAPEV-LRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVI--------------- 714
+ APE+ L ++ D++S G I+ EL T + + + + +
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 715 ------GAVGFMNQRLEIPK--------DVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 760
A ++ ++PK +P ++E D R + +
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA----- 298
Query: 761 DLQRQYFQ 768
L YF
Sbjct: 299 -LAHAYFA 305
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 141 bits (355), Expect = 2e-37
Identities = 59/319 (18%), Positives = 120/319 (37%), Gaps = 64/319 (20%)
Query: 496 DCLDYEILW---EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFR 550
D + + W +D + ++G+G V+ A+ V VK+ + +
Sbjct: 23 DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IK 77
Query: 551 QEVSLMKRLR-HPNVLLFMGAVTSP--QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 607
+E+ +++ LR PN++ V P + +V E + +L Q L
Sbjct: 78 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRF 133
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHETYLTTKTGK 666
+I + + Y H I+HRD+K N+++D +H +++ D+GL+ H
Sbjct: 134 YMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV- 190
Query: 667 GTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNS--------MQVIGAV 717
+ + PE+L + D D++S G +L + K P+ + + +V+G
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250
Query: 718 GFMNQRLEIPKDVDPRWAAI----------------------------VESCWHSDPQCR 749
+ + ++DPR+ I ++ D Q R
Sbjct: 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 310
Query: 750 PSFQELVDKLRDLQRQYFQ 768
+ +E ++ YF
Sbjct: 311 LTAREA------MEHPYFY 323
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (294), Expect = 3e-29
Identities = 50/330 (15%), Positives = 108/330 (32%), Gaps = 82/330 (24%)
Query: 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ ++G G TV+ A + VA+K+ + E + E+ L++R+ +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDADNT 72
Query: 566 L---------------FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
F + + +V E L L + + + ++
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVD------KHWTVKVGDFGLSRLKHETYLTTKT 664
+ G+ Y+H IIH D+K N+L++ +K+ D G + E Y +
Sbjct: 133 QLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI- 190
Query: 665 GKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWD------------------ 706
T ++ +PEVL P +D++S +++EL T ++
Sbjct: 191 --QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
Query: 707 ----------------------------NLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738
N++ ++ + ++ + KD + +
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308
Query: 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768
DP+ R L + + +
Sbjct: 309 SPMLQLDPRKRADAGGL------VNHPWLK 332
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.8 bits (209), Expect = 2e-19
Identities = 29/162 (17%), Positives = 55/162 (33%), Gaps = 32/162 (19%)
Query: 509 IGEQIGQGSCGTVYHAVWY-GSDVAVKVF----------------SRQEYSDEVIHSFRQ 551
IG+ +G+G V++ + VK +S I S R
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD 611
E +++L+ V ++ E + + +++ +L
Sbjct: 64 EFRALQKLQGLAVPKVYAWE----GNAVLMELIDAK------ELYRVRVENPDEVL--DM 111
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
I V+ +H I+H DL N+LV + + + DF S
Sbjct: 112 ILEEVAKFYHRG--IVHGDLSQYNVLVSEEG-IWIIDFPQSV 150
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 109 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 68.3 bits (166), Expect = 1e-14
Identities = 24/105 (22%), Positives = 39/105 (37%), Gaps = 3/105 (2%)
Query: 139 MGQSVHIFDLSD---RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRI 195
+ + + D + ++Y + + GY +E LG + L +G D I I
Sbjct: 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAI 61
Query: 196 KMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
K GE + + K + T TP DG + V V D
Sbjct: 62 KKGEACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVD 106
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} Length = 104 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Score = 61.1 bits (147), Expect = 4e-12
Identities = 20/90 (22%), Positives = 31/90 (34%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210
II+ + L Y+ EE LG + L G D I +K T Q TK
Sbjct: 14 PIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKEQRDVTVQVLNYTK 73
Query: 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ D++G + + V +
Sbjct: 74 GGRAFWNLFHLQVMRDENGDVQYFIGVQQE 103
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Score = 45.9 bits (108), Expect = 8e-07
Identities = 13/99 (13%), Positives = 24/99 (24%), Gaps = 1/99 (1%)
Query: 135 ILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHR 194
++ D S I +NR+ L G E +G++ + +
Sbjct: 8 EFDALPVGAIQVDGSGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMD 67
Query: 195 IKMGERWTGQFP-AKTKTEERVLVVATNTPFYDDDGTLV 232
+F V V D +
Sbjct: 68 GVTSGTLDARFDFVFDFQMAPVRVQIRMQNAGVPDRYWI 106
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} Length = 106 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Score = 41.3 bits (95), Expect = 4e-05
Identities = 15/102 (14%), Positives = 29/102 (28%), Gaps = 6/102 (5%)
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIK----MG 198
+ + D I ++ +AE L+G+S EA+GQ+ L+ + I
Sbjct: 3 MIVIDGHGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHI 62
Query: 199 ERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
K + + + D
Sbjct: 63 IGIGRIVTGKRRDGTTFPMHLSIGEMQSGGEP--YFTGFVRD 102
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 4e-05
Identities = 14/107 (13%), Positives = 35/107 (32%), Gaps = 6/107 (5%)
Query: 135 ILQSMGQSVHIFDLSD-RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH 193
+ +++ D I+ N A L GYS+++ +GQ + V
Sbjct: 3 MDPEFNKAIFTVDAKTTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEE 62
Query: 194 RIKMGER----WTGQFPAKTKTEERVLVVATNTPFYDDDGT-LVGIV 235
++ + +++ E++ V + V ++
Sbjct: 63 HMEADGHAAVVFGTVVDIISRSGEKIPVSVWMKRMRQERRLCCVVVL 109
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.4 bits (93), Expect = 9e-05
Identities = 20/99 (20%), Positives = 36/99 (36%), Gaps = 1/99 (1%)
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT 202
+ + + Y + L GY EE LG+ A E ++ + G+ +
Sbjct: 9 LSRHSMDMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVS 68
Query: 203 GQFPAKTKTEERVLVVATNTPFYDD-DGTLVGIVCVSTD 240
GQ+ K V + T Y+ + I+CV+
Sbjct: 69 GQYRMLAKHGGYVWLETQGTVIYNPRNLQPQCIMCVNYV 107
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 2e-04
Identities = 17/92 (18%), Positives = 28/92 (30%), Gaps = 2/92 (2%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD--FDVAYDIVHRIKMGERWTGQFPAK 208
+IY N L GYS E + + G A I + E +
Sbjct: 15 AVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFY 74
Query: 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
K L + P ++DG ++ +
Sbjct: 75 RKDGSCFLCLVDVVPVKNEDGAVIMFILNFEV 106
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Score = 39.6 bits (91), Expect = 3e-04
Identities = 17/116 (14%), Positives = 37/116 (31%), Gaps = 6/116 (5%)
Query: 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVA 188
D +IL ++ + + I+ +N +A +GY+ EE +GQ+ L+ + +
Sbjct: 15 DAHLRSILDTVPDATVVSATDGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHD 74
Query: 189 YDIVHRIKMGER----WTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ + GE+ + K + D
Sbjct: 75 GYLQRYMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRSGGER--FFTGFIRD 128
|
| >d1v9ya_ d.110.3.2 (A:) Direct oxygen sensor protein, DOS {Escherichia coli [TaxId: 562]} Length = 113 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Direct oxygen sensor protein, DOS species: Escherichia coli [TaxId: 562]
Score = 37.9 bits (86), Expect = 7e-04
Identities = 18/113 (15%), Positives = 42/113 (37%), Gaps = 6/113 (5%)
Query: 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDI 191
+ L+ + + +D ++++N +AE L+GY EE +G + L+ I
Sbjct: 3 FFPALEQNMMGAVLINENDEVMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYI 62
Query: 192 VHRIKMG----ERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
H + G E + + + K ++ + + + + D
Sbjct: 63 RHNREGGKARVEGMSRELQLEKKDGSKIWTRFALSKVSAEGKVYY--LALVRD 113
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 782 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1n9la_ | 109 | Putative blue light receptor, phot-lov1 domain {Gr | 99.78 | |
| d1bywa_ | 110 | Erg potassium channel, N-terminal domain {Human (H | 99.68 | |
| d1jnua_ | 104 | Photoreceptor phy3 flavin-binding domain, lov2 {Ma | 99.68 | |
| d1ew0a_ | 130 | Histidine kinase FixL heme domain {Rhizobium melil | 99.6 | |
| d1xj3a1 | 106 | Histidine kinase FixL heme domain {Bradyrhizobium | 99.57 | |
| d1v9ya_ | 113 | Direct oxygen sensor protein, DOS {Escherichia col | 99.56 | |
| d1p97a_ | 114 | Hypoxia-inducible factor Hif2a, C-terminal domain | 99.53 | |
| d1nwza_ | 125 | Photoactive yellow protein, PYP {Ectothiorhodospir | 99.36 | |
| d1mzua_ | 110 | PYP domain of sensor histidine kinase Ppr {Rhodosp | 99.34 | |
| d1ll8a_ | 114 | N-terminal PAS domain of Pas kinase {Human (Homo s | 99.19 | |
| d1oj5a_ | 109 | PAS domain of steroid receptor coactivator 1A, NCo | 98.77 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.32 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.69 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.32 | |
| d2oola2 | 114 | Sensor protein PhyB2 {Rhodopseudomonas palustris [ | 96.61 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.29 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.7 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.46 | |
| d2o9ca2 | 127 | Bacteriophytochrome BphP {Deinococcus radiodurans | 93.17 | |
| d2veaa3 | 127 | Phytochrome-like protein Cph1 {Synechocystis sp. p | 90.52 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-53 Score=444.14 Aligned_cols=254 Identities=30% Similarity=0.507 Sum_probs=225.9
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
.++|++++.||+|+||.||+|.+. ++.||||++.+.... ......+.+|+++|+.++|||||++++++.+++.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999984 678999999764332 12346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
||||++|+|.+++.... .+++..++.++.||+.||+|||++| ||||||||+||||+.++.+||+|||+|+......
T Consensus 85 mEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred EeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 99999999999997643 6999999999999999999999999 9999999999999999999999999997655432
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHH
Q 003978 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 740 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 740 (782)
.....||+.|||||++.+..++.++|||||||+||+|++|..||...+..+....+. ...+.+|..+++++++||.+
T Consensus 161 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~ 237 (263)
T d2j4za1 161 -RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDLISR 237 (263)
T ss_dssp -CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHHHH
T ss_pred -ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHHHHHH
Confidence 235579999999999999999999999999999999999999999988887776663 34566788899999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 741 CWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 741 cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
||..||++|||+.|+ |+|+||++-
T Consensus 238 ~L~~dp~~R~t~~ei------l~hp~~~~~ 261 (263)
T d2j4za1 238 LLKHNPSQRPMLREV------LEHPWITAN 261 (263)
T ss_dssp HTCSSGGGSCCHHHH------HTCHHHHHH
T ss_pred HccCCHhHCcCHHHH------HcCcCcCCc
Confidence 999999999999999 678999754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=445.50 Aligned_cols=256 Identities=28% Similarity=0.465 Sum_probs=226.1
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.++|+++++||+|+||+||+|.+ .++.||||+++...... .+.+.+|+.+|+.++|||||++++++..++.+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 35799999999999999999997 47889999998654332 356889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
|||+||+|.+++..+ .+++..++.++.||+.||.|||++| ||||||||+||||+.++.+||+|||+|+........
T Consensus 97 Ey~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp ECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 999999999988753 5899999999999999999999999 999999999999999999999999999876554445
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-ccccCCCCCCCHHHHHHHHH
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFM-NQRLEIPKDVDPRWAAIVES 740 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~~l~~LI~~ 740 (782)
....+||+.|||||++.+..++.++|||||||++|+|++|..||...+....+..+... ......+..+++++++||.+
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence 55678999999999999999999999999999999999999999988877766555332 22445667899999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 741 CWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 741 cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
||..||.+|||+.|+ |+|+||+...
T Consensus 253 ~L~~dP~~R~s~~ei------l~Hp~~~~~~ 277 (293)
T d1yhwa1 253 CLDMDVEKRGSAKEL------LQHQFLKIAK 277 (293)
T ss_dssp HTCSSTTTSCCHHHH------TTCGGGGGCC
T ss_pred HccCChhHCcCHHHH------hcCHhhCCCC
Confidence 999999999999999 6789997543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-52 Score=439.72 Aligned_cols=262 Identities=36% Similarity=0.618 Sum_probs=222.2
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
+||+..++|+++++||+|+||.||+|.+++ .||||+++.........+.+.+|+.+|+.++|||||++++++.. ..+|
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA 79 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence 467888999999999999999999998654 69999998776666677889999999999999999999998754 5689
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
||||||++|+|.+++......+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999999999877778999999999999999999999998 999999999999999999999999999865432
Q ss_pred --cccccCCCCCCcccCcccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc----cccCCCCC
Q 003978 659 --YLTTKTGKGTPQWMAPEVLRNE---PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN----QRLEIPKD 729 (782)
Q Consensus 659 --~~~~~~~~Gt~~y~aPE~l~~~---~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~----~~~~~p~~ 729 (782)
........||+.|||||++.+. .++.++|||||||+||||+||+.||...+.......+.... ....++..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence 2233456799999999999753 47889999999999999999999999876654443332211 12346678
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 730 ~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
+++++++||.+||..||++|||+.++++.|+.|++
T Consensus 238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999999999998875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=446.42 Aligned_cols=263 Identities=22% Similarity=0.384 Sum_probs=228.5
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
.++|++++.||+|+||+||+|.+. ++.||||++.+... .......+.+|+++|+.++|||||++++++.+++.+|+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 368999999999999999999984 77899999976432 223346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc--
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-- 658 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~-- 658 (782)
||||+||+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 87 mEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 9999999999998765 46999999999999999999999999 999999999999999999999999999865432
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 738 (782)
.......+||+.|||||++.+..++.++|||||||+||+|++|..||...+.......+. ...+.+|..+++++++||
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li 241 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLV 241 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--TTCCCCCTTCCHHHHHHH
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH--cCCCCCCccCCHHHHHHH
Confidence 223345679999999999999999999999999999999999999999988888777764 345667889999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 739 ~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
.+||..||.+|||++|++++..=+.|+||+.+.
T Consensus 242 ~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 242 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp HTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 999999999999999987765556789998763
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=439.07 Aligned_cols=253 Identities=26% Similarity=0.421 Sum_probs=210.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec--CCceeE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRLCI 579 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l 579 (782)
.++|++++.||+|+||.||+|.++ ++.||||++......+...+.+.+|+++|+.++|||||++++++.+ ++.+||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 368999999999999999999984 7789999998887777778889999999999999999999999854 567899
Q ss_pred EEeecCCCCHHHHHhh---cCCcchHHHHHHHHHHHHHHHHhhhcCC---CCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 580 VTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCN---PPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qll~aL~~LH~~~---~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
|||||++|+|.+++.+ ....+++..++.++.||+.||.|||+++ .+||||||||+||||+.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999999864 2456999999999999999999999854 249999999999999999999999999998
Q ss_pred ccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHH
Q 003978 654 LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733 (782)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 733 (782)
.............||+.|||||++.+..++.++|||||||++|||++|..||...+..+....+.. .....+|..++++
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~ 241 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSDE 241 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-TCCCCCCTTSCHH
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHH
Confidence 765544444567899999999999999999999999999999999999999999888877766643 2344677889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHH
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVD 757 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~ 757 (782)
+++||.+||..||.+|||+.|+++
T Consensus 242 l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 242 LNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHcCCChhHCcCHHHHHh
Confidence 999999999999999999999943
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-52 Score=442.94 Aligned_cols=255 Identities=28% Similarity=0.446 Sum_probs=224.0
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
+.|++++.||+|+||.||+|.+ .+..||||+++.... ...+.+.+|+++|+.++|||||++++++.+++.+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 4699999999999999999998 466799999976532 334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
||++|+|.+++......+++..+..++.||+.||.|||++| ||||||||+||||+.++.+||+|||+|+.........
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence 99999999998776677999999999999999999999999 9999999999999999999999999998665544444
Q ss_pred cCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-cccCCCCCCCHHHHH
Q 003978 663 KTGKGTPQWMAPEVLR-----NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMN-QRLEIPKDVDPRWAA 736 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~-----~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~~l~~ 736 (782)
...+||+.|||||++. +..++.++|||||||++|+|++|..||...+..+.+..+.... .....+..+++++++
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 5678999999999984 4567899999999999999999999999888877776664432 234456789999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 737 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
||.+||+.||.+|||+.|+ |+|+||+.
T Consensus 248 li~~~L~~dp~~R~t~~el------l~hp~~~~ 274 (288)
T d2jfla1 248 FLKKCLEKNVDARWTTSQL------LQHPFVTV 274 (288)
T ss_dssp HHHHHSCSSTTTSCCHHHH------TTSGGGCC
T ss_pred HHHHHccCChhHCcCHHHH------hcCcccCC
Confidence 9999999999999999999 66899864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=432.67 Aligned_cols=253 Identities=32% Similarity=0.529 Sum_probs=217.8
Q ss_pred ceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec----CCceeE
Q 003978 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----PQRLCI 579 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~l 579 (782)
.|++.++||+|+||+||+|.+. +..||+|++..........+.+.+|+++|+.++|||||+++++++. ...+||
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 4578889999999999999984 5679999998877777777889999999999999999999999864 345899
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc-CCCcEEEEecCCCcccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~-~~~~vkL~DFGla~~~~~~ 658 (782)
|||||++|+|.+++.+. ..+++..++.++.||+.||+|||+++.+||||||||+||||+ .++.+||+|||+|+.....
T Consensus 90 vmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 99999999999999765 468999999999999999999999877799999999999996 5789999999999765443
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccccCCCCCCCHHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM-QVIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
. ....+||+.|||||++.+ .++.++|||||||++|||++|+.||...... .....+........++..+++++++|
T Consensus 169 ~--~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l 245 (270)
T d1t4ha_ 169 F--AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 245 (270)
T ss_dssp S--BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred c--cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHH
Confidence 2 235689999999999876 4899999999999999999999999876544 44444443334455667789999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhh
Q 003978 738 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQ 768 (782)
Q Consensus 738 I~~cL~~dP~~RPs~~ell~~L~~L~~~~~~ 768 (782)
|.+||..||++|||+.|+ |+|+|||
T Consensus 246 i~~~l~~dp~~R~s~~el------l~Hp~fk 270 (270)
T d1t4ha_ 246 IEGCIRQNKDERYSIKDL------LNHAFFQ 270 (270)
T ss_dssp HHHHSCSSGGGSCCHHHH------HTSGGGC
T ss_pred HHHHccCCHhHCcCHHHH------hCCcccC
Confidence 999999999999999999 6789986
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-52 Score=437.59 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=215.2
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
.++|+++++||+|+||+||+|.++ ++.||||++..... .+..+.+.+|+.+|+.++|||||++++++.+++.+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 368999999999999999999984 77899999976543 233467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc--
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-- 659 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~-- 659 (782)
|||+||+|.+++... ..+++..++.++.||+.||+|||++| ||||||||+||||+.++.+||+|||+|+......
T Consensus 83 Ey~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 83 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred eccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 999999999999654 47999999999999999999999999 9999999999999999999999999998654322
Q ss_pred ccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhccccccCCCCCCCHHHHHH
Q 003978 660 LTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQ-VIGAVGFMNQRLEIPKDVDPRWAAI 737 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~~~~-s~~sDIwSLG~ll~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~p~~~~~~l~~L 737 (782)
......+||+.|||||++.+..+ +.++|||||||++|+|++|+.||....... ....+............+++++.+|
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence 22345689999999999998876 578999999999999999999997655432 2222222222333345789999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 738 VESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 738 I~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
|.+||..||++|||+.++ |+|+||+..
T Consensus 240 i~~~L~~dP~~R~t~~ei------l~hpwf~~~ 266 (271)
T d1nvra_ 240 LHKILVENPSARITIPDI------KKDRWYNKP 266 (271)
T ss_dssp HHHHSCSSTTTSCCHHHH------TTCTTTTCC
T ss_pred HHHHcCCChhHCcCHHHH------hcCHhhCcC
Confidence 999999999999999999 678999753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-51 Score=444.07 Aligned_cols=257 Identities=25% Similarity=0.451 Sum_probs=228.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (782)
..++|++++.||+|+||.||+|++ .++.||||++++... .......+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 457899999999999999999997 477899999986533 12235678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc
Q 003978 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (782)
Q Consensus 580 v~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~ 659 (782)
|||||+||+|.+++.... .+++..++.++.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+......
T Consensus 83 v~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred ceeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999999999997754 6899999999999999999999999 9999999999999999999999999998765544
Q ss_pred ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHH
Q 003978 660 LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVE 739 (782)
Q Consensus 660 ~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~ 739 (782)
......+||+.|||||++.+..|+.++|||||||++|||++|.+||...+.......+. ...+.+|..+++++++||.
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dli~ 237 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEAKSLLA 237 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHHH
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh--cCCCCCCccCCHHHHHHHH
Confidence 45556789999999999999999999999999999999999999999998887776663 3456788999999999999
Q ss_pred HhhhhCCCCCCC-----HHHHHHHHHHHHHHHhhcc
Q 003978 740 SCWHSDPQCRPS-----FQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 740 ~cL~~dP~~RPs-----~~ell~~L~~L~~~~~~~~ 770 (782)
+||.+||.+|++ +.++ +.|+||+.+
T Consensus 238 ~~L~~dP~~R~~~~~~~~~ei------l~Hp~f~~i 267 (337)
T d1o6la_ 238 GLLKKDPKQRLGGGPSDAKEV------MEHRFFLSI 267 (337)
T ss_dssp HHTCSSTTTSTTCSTTTHHHH------HTSGGGTTC
T ss_pred hhccCCchhhcccccccHHHH------HcCcccccC
Confidence 999999999994 8888 568888653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=423.88 Aligned_cols=255 Identities=31% Similarity=0.585 Sum_probs=216.4
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc-CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
.++|+++++||+|+||.||+|.+. ++.||||+++...... +.+.+|+++++.++|||||++++++..++.+|+|||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 358999999999999999999985 5679999997655444 468899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc-c
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-T 661 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~ 661 (782)
||++|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....... .
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 99999999999877778999999999999999999999998 99999999999999999999999999986544322 2
Q ss_pred ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHH
Q 003978 662 TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 740 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 740 (782)
.....||+.|||||++.+..++.++|||||||++|||+| |.+||...+..+....+.. ......|..+++++.+||.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH-TCCCCCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh-cCCCCCccccCHHHHHHHHH
Confidence 334578999999999999999999999999999999999 5777877777777666643 34566778899999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 741 CWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 741 cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
||..||++|||+++++++|+++++
T Consensus 238 cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHHHHHHHh
Confidence 999999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=442.15 Aligned_cols=260 Identities=23% Similarity=0.398 Sum_probs=216.7
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
|+..++|+++++||+|+||+||+|.+. ++.||||+++... .......+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 345678999999999999999999984 6789999997653 3344578899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~-~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
||||||+||+|.+++.+.. .+++..++.++.||+.||.|||+ ++ |+||||||+||||+.+|.+||+|||+|+....
T Consensus 81 iVmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999999997654 69999999999999999999997 58 99999999999999999999999999986544
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh-------------------
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVG------------------- 718 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~------------------- 718 (782)
.. ..+.+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.........
T Consensus 158 ~~--~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 SM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp HT--C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred Cc--cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 32 235689999999999999999999999999999999999999997654332111000
Q ss_pred ----------------------ccccccCCC-CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 719 ----------------------FMNQRLEIP-KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 719 ----------------------~~~~~~~~p-~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
.....+.++ ..+++++.+||.+||..||.+|||+.|+ |+|+||+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~------L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL------MVHAFIKRSDA 306 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHH------HTSHHHHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHH------hhCHhhCcCCc
Confidence 000011122 2468899999999999999999999999 67899986544
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.3e-51 Score=436.39 Aligned_cols=256 Identities=23% Similarity=0.379 Sum_probs=207.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
..+.|+++++||+|+||+||+|.+. ++.||||++.+..... ....+.+|+.+|+.++|||||++++++.+++.+|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4567999999999999999999984 7789999998665432 235678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc---CCCcEEEEecCCCccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~---~~~~vkL~DFGla~~~~~ 657 (782)
||||+||+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+|||+. .++.+||+|||+|+....
T Consensus 86 mE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp ECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 9999999999999764 46999999999999999999999999 99999999999995 578999999999986554
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--cCCCCCCCHHHH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--LEIPKDVDPRWA 735 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~~~~l~ 735 (782)
.. .....+||+.|||||++.+..++.++|||||||+||+|++|..||...........+...... ...+..+|++++
T Consensus 163 ~~-~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 163 GS-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred CC-eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 32 233568999999999999999999999999999999999999999998888777776543332 234467999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
+||.+||.+||++|||+.|+ ++|+||+.
T Consensus 242 ~li~~~L~~dP~~R~s~~ei------l~hp~~~~ 269 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQA------LQHPWIAG 269 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHH------HHSTTTTS
T ss_pred HHHHHHccCCHhHCcCHHHH------hcCHhhCC
Confidence 99999999999999999999 56788864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-50 Score=430.20 Aligned_cols=260 Identities=32% Similarity=0.556 Sum_probs=217.7
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEc--CC---eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GS---DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~---~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (782)
++..++|++.++||+|+||.||+|.+. ++ .||||.+.... .....+.+.+|+++|+.++|||||++++++..++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 455678999999999999999999874 22 37888775433 4556678999999999999999999999999999
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
.+|+|||||++|+|.+++......+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccceEc
Confidence 999999999999999999887778999999999999999999999998 999999999999999999999999999865
Q ss_pred ccccc-----cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCC
Q 003978 656 HETYL-----TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKD 729 (782)
Q Consensus 656 ~~~~~-----~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 729 (782)
..... ......||+.|||||++.+..++.++|||||||+||||+| |..||......+....+. ...++..|..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~ 257 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPMD 257 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTT
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcc
Confidence 43211 1122457999999999999999999999999999999998 899999998887776664 3345667888
Q ss_pred CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 730 VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 730 ~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
++.++.+||.+||..||++|||+.++++.|+++.+
T Consensus 258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 99999999999999999999999999999988754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-50 Score=430.48 Aligned_cols=258 Identities=34% Similarity=0.600 Sum_probs=223.1
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (782)
.||+..++|++.++||+|+||.||+|.+. ++.||||+++..... .+.+.+|+++|+.++|||||++++++.+++.
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 47788899999999999999999999984 678999998765543 3568899999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhh-cCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 577 LCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
+|+|||||++|+|.+++.. ....+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+..
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccceeec
Confidence 9999999999999999965 3456899999999999999999999998 999999999999999999999999999876
Q ss_pred cccccc-ccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCC-CCCCChHHHHHHhhccccccCCCCCCCHH
Q 003978 656 HETYLT-TKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIP-WDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733 (782)
Q Consensus 656 ~~~~~~-~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~P-f~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 733 (782)
...... .....|++.|||||++.+..++.++|||||||++|||++|..| |...+.......+ .....+.+|..++++
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i-~~~~~~~~~~~~~~~ 244 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPEK 244 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCCCCCCTTCCHH
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH-hcCCCCCCCccchHH
Confidence 543322 2233589999999999999999999999999999999996655 4555555444433 344567788899999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
+.+||.+||..||++|||+.++++.|+.+
T Consensus 245 l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 245 VYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 99999999999999999999998887655
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-50 Score=434.28 Aligned_cols=252 Identities=30% Similarity=0.428 Sum_probs=220.2
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 581 (782)
+.|+++++||+|+||.||+|++. ++.||||+++..... ....+.+.+|+++|+.++|||||++++++.+++.+||||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45999999999999999999974 667999999876654 355678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
|||.+|+|..++.. ..++++..++.++.||+.||.|||++| ||||||||+||||+.++.+||+|||+|+.....
T Consensus 95 E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp ECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred EecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence 99999988776654 457999999999999999999999999 999999999999999999999999999865432
Q ss_pred ccCCCCCCcccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHH
Q 003978 662 TKTGKGTPQWMAPEVLRN---EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIV 738 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~---~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI 738 (782)
....||+.|||||++.+ ..|+.++|||||||++|||++|..||...+....+..+.........+..+++++++||
T Consensus 169 -~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li 247 (309)
T d1u5ra_ 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (309)
T ss_dssp -CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHH
T ss_pred -CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence 35679999999999965 35788999999999999999999999988887777666544444445567899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 739 ESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 739 ~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
.+||..||.+|||+.++ |+|+||+.
T Consensus 248 ~~~L~~dP~~Rpt~~el------l~Hp~~~~ 272 (309)
T d1u5ra_ 248 DSCLQKIPQDRPTSEVL------LKHRFVLR 272 (309)
T ss_dssp HHHTCSSGGGSCCHHHH------TTCHHHHS
T ss_pred HHHCcCChhHCcCHHHH------HhCHHhcC
Confidence 99999999999999999 55677754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.5e-50 Score=439.10 Aligned_cols=258 Identities=22% Similarity=0.386 Sum_probs=225.8
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
..++|++++.||+|+||.||+|.+. |+.||||++.... ....+.+.+|+.+|+.++|||||++++++.+++.+|||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4578999999999999999999984 7789999996543 33457788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC--CCcEEEEecCCCcccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK--HWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~--~~~vkL~DFGla~~~~~~ 658 (782)
||||+||+|.+++......+++..++.++.||+.||.|||++| ||||||||+||||+. ++.+||+|||+|+.....
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999999999766667999999999999999999999999 999999999999964 678999999999866543
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--CCCCCCCHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL--EIPKDVDPRWAA 736 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~~~~l~~ 736 (782)
. ......||+.|||||++.+..++.++|||||||++|+|++|..||...+..+.+..+....... .....+++++++
T Consensus 180 ~-~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 258 (350)
T d1koaa2 180 Q-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258 (350)
T ss_dssp S-CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred c-ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 3 2335689999999999999999999999999999999999999999888888777765433322 233568999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 737 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
||.+||..||.+|||+.|+ |.|+||+...
T Consensus 259 li~~~L~~dP~~R~t~~ei------l~hp~~~~~~ 287 (350)
T d1koaa2 259 FIRKLLLADPNTRMTIHQA------LEHPWLTPGN 287 (350)
T ss_dssp HHHHHCCSSGGGSCCHHHH------HHSTTTSCTT
T ss_pred HHHHHccCChhHCcCHHHH------hcCcccCCCC
Confidence 9999999999999999999 6689997654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=423.25 Aligned_cols=264 Identities=25% Similarity=0.479 Sum_probs=226.7
Q ss_pred cccceeEeee-eccCCcEEEEEEEEc----CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 503 LWEDLTIGEQ-IGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 503 ~~~~y~i~~~-IG~G~~G~Vy~~~~~----~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
..++|.+.+. ||+|+||.||+|.+. +..||||+++... .....+.+.+|+++|+.++|||||++++++.. +.+
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 3467888884 999999999999763 3369999997543 45567789999999999999999999999875 468
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|||||||++|+|.+++......+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++....
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 9999999999999999776678999999999999999999999998 99999999999999999999999999986543
Q ss_pred cc---ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHH
Q 003978 658 TY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733 (782)
Q Consensus 658 ~~---~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 733 (782)
.. .......||+.|||||++.+..++.++|||||||++|||+| |..||...+..+....+. ...++.+|+.+|++
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~ 240 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECPPE 240 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHH
Confidence 22 22234568999999999999999999999999999999998 999999988877776664 34567788999999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
+.+||.+||..||++|||+.++++.|+.+...+.....
T Consensus 241 l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~ 278 (285)
T d1u59a_ 241 LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278 (285)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhccc
Confidence 99999999999999999999999887766554444443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.6e-50 Score=439.26 Aligned_cols=257 Identities=22% Similarity=0.382 Sum_probs=226.0
Q ss_pred cccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
..++|+++++||+|+||.||+|.+ .++.||||+++... ......+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 346899999999999999999998 47789999997654 23346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEc--CCCcEEEEecCCCcccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD--KHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~--~~~~vkL~DFGla~~~~~~ 658 (782)
||||+||+|.+++.....++++..++.++.||+.||.|||++| ||||||||+||||+ .++.+||+|||+|+.....
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999999999998777778999999999999999999999999 99999999999997 5789999999999876543
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--ccCCCCCCCHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ--RLEIPKDVDPRWAA 736 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~~~~l~~ 736 (782)
. ......||+.|||||++.+..++.++|||||||++|+|+||..||...+....+..+..... ....+..+++++++
T Consensus 183 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 183 E-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp S-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred C-ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 2 23345789999999999999999999999999999999999999999888887777654333 23344679999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 737 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
||.+||..||.+|||+.|+ |.|+||+..
T Consensus 262 li~~~L~~dp~~R~s~~ei------l~Hp~~~~~ 289 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDA------LEHPWLKGD 289 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHH------HTSTTTSSC
T ss_pred HHHHHccCChhHCcCHHHH------hcCHhhCCC
Confidence 9999999999999999999 568888754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=428.58 Aligned_cols=258 Identities=25% Similarity=0.373 Sum_probs=224.9
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCH----HHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (782)
..++|++++.||+|+||+||+|.++ |+.||||++++..... ...+.+.+|+.+|+.++|||||++++++.+++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4467999999999999999999984 7789999997654322 235778899999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC----cEEEEecCCC
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFGLS 652 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~----~vkL~DFGla 652 (782)
+|||||||+||+|.+++.... .+++..++.++.||+.||+|||+++ ||||||||+|||++.++ .+||+|||+|
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhh
Confidence 999999999999999997654 6999999999999999999999999 99999999999998776 5999999999
Q ss_pred cccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--cCCCCCC
Q 003978 653 RLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--LEIPKDV 730 (782)
Q Consensus 653 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~ 730 (782)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...... ...+..+
T Consensus 165 ~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (293)
T d1jksa_ 165 HKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243 (293)
T ss_dssp EECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred hhcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCC
Confidence 8765433 234568999999999999999999999999999999999999999998888877776543322 2334678
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 731 DPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 731 ~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
|+++++||.+||..||++|||+.++ |+|+||+..
T Consensus 244 s~~~~~li~~~L~~dP~~R~s~~ei------l~hp~~~~~ 277 (293)
T d1jksa_ 244 SALAKDFIRRLLVKDPKKRMTIQDS------LQHPWIKPK 277 (293)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHH------HHSTTTCC-
T ss_pred CHHHHHHHHHHccCChhHCcCHHHH------hcCcccCCC
Confidence 9999999999999999999999999 678999753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.4e-50 Score=433.33 Aligned_cols=253 Identities=25% Similarity=0.446 Sum_probs=224.6
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
.++|+++++||+|+||+||+|+++ ++.||||++++.... ....+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 468999999999999999999984 778999999764321 22356788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
||||.||+|..++... ..+++..++.++.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp ECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 9999999999998764 46788899999999999999999999 999999999999999999999999999876543
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHH
Q 003978 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 740 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 740 (782)
....+||+.|||||++.+..++.++|||||||++|+|++|+.||...+.......+. .....+|..++++++++|.+
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~ 234 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL--NAELRFPPFFNEDVKDLLSR 234 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHHHH
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHH
Confidence 235689999999999999999999999999999999999999999988888777663 34567788999999999999
Q ss_pred hhhhCCCCCC-----CHHHHHHHHHHHHHHHhhcc
Q 003978 741 CWHSDPQCRP-----SFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 741 cL~~dP~~RP-----s~~ell~~L~~L~~~~~~~~ 770 (782)
||.+||.+|+ |++++ ++|+||+.+
T Consensus 235 ~L~~dp~~R~~~~r~t~~~i------l~Hp~f~~i 263 (316)
T d1fota_ 235 LITRDLSQRLGNLQNGTEDV------KNHPWFKEV 263 (316)
T ss_dssp HTCSCTTTCTTSSTTTTHHH------HTSGGGSSC
T ss_pred HhhhCHHhccccchhhHHHH------HcCcccccC
Confidence 9999999996 89999 678888654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-50 Score=433.64 Aligned_cols=260 Identities=29% Similarity=0.486 Sum_probs=222.3
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEcCC-------eEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEee
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMG 569 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~-------~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 569 (782)
..||+..++|+++++||+|+||+||+|++.+. .||+|++.... .......+.+|+.+|..+ +|||||++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 35677889999999999999999999987432 48999886543 233446788999999998 8999999999
Q ss_pred eeecCCceeEEEeecCCCCHHHHHhhcC----------------------CcchHHHHHHHHHHHHHHHHhhhcCCCCee
Q 003978 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNT----------------------TKLDWRRRILMALDIARGVSYLHHCNPPII 627 (782)
Q Consensus 570 ~~~~~~~~~lv~E~~~ggsL~~~l~~~~----------------------~~l~~~~~~~i~~qll~aL~~LH~~~~~iv 627 (782)
++..++.+|+|||||++|+|.++|.... ..+++..++.++.||+.||+|||+++ ||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--Ii 186 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CV 186 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 9999999999999999999999997543 34788999999999999999999998 99
Q ss_pred ecCCCCCcEEEcCCCcEEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCC
Q 003978 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIP 704 (782)
Q Consensus 628 HrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~P 704 (782)
||||||+|||++.++.+||+|||+|+....... ......||+.|||||++.+..++.++|||||||+||||+| |..|
T Consensus 187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred eccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence 999999999999999999999999986544322 2234468999999999999999999999999999999997 8999
Q ss_pred CCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 003978 705 WDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLR 760 (782)
Q Consensus 705 f~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~ 760 (782)
|.+.+....+..+.....++..|..+++++++||.+||+.||++|||+.+|+++|.
T Consensus 267 f~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 99877766666665555677888899999999999999999999999999998874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=420.13 Aligned_cols=257 Identities=32% Similarity=0.578 Sum_probs=221.1
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEcC-CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (782)
.+|++..++|+++++||+|+||.||+|.+++ +.||||+++...... +.+.+|+++|+.++|||||++++++.. +.
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~ 81 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCH---HHHHHHHHHHHhCCCCCEeEEEeeecc-CC
Confidence 3567888999999999999999999999864 579999997655443 468899999999999999999998754 56
Q ss_pred eeEEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
+|+|||||++|+|.+++... ..++++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceEEc
Confidence 79999999999999987543 335899999999999999999999998 999999999999999999999999999876
Q ss_pred cccc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhccccccCCCCCCCHH
Q 003978 656 HETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733 (782)
Q Consensus 656 ~~~~-~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 733 (782)
.... .......||+.|||||++.+..++.++|||||||++|||+|| .+||...+..+....+. ...++..|..++++
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~ 238 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEE 238 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCcccChHH
Confidence 5432 233455789999999999988899999999999999999995 66677777766666654 34466778899999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVDKLRD 761 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~~L~~ 761 (782)
+.+||.+||+.||++|||++++++.|++
T Consensus 239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 239 LYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 9999999999999999999999887654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=419.70 Aligned_cols=262 Identities=33% Similarity=0.608 Sum_probs=219.3
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEcC-----CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (782)
+||+..++|++++.||+|+||.||+|.+.. ..||||.++.. ......+.+.+|+.+|+.++|||||++++++.
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 477888999999999999999999998743 24777777443 34556678999999999999999999999986
Q ss_pred CCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 574 ~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
++.+|+|||||++|+|.+++......+++..++.++.||+.||.|||+++ ||||||||+||+++.++.+||+|||+|+
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhhe
Confidence 46789999999999999998877778999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccc-cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCC
Q 003978 654 LKHET-YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVD 731 (782)
Q Consensus 654 ~~~~~-~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 731 (782)
..... ........||+.|+|||++.+..++.++|||||||++|||++ |.+||...+..+....+. ....+.+|+.+|
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~ 235 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 235 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 65432 223334578999999999999999999999999999999998 899999988887776664 344567888999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 732 PRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 732 ~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
+++.+||.+||..||++|||+.+|++.|+++.++
T Consensus 236 ~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999988654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=416.07 Aligned_cols=251 Identities=30% Similarity=0.569 Sum_probs=225.7
Q ss_pred cceeEeeeeccCCcEEEEEEEEcC-CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
++|+++++||+|+||.||+|++++ +.||||+++...... +.+.+|+.+++.++|||||++++++.+++.+++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 688999999999999999999954 479999998766554 4688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc-cc
Q 003978 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-TT 662 (782)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~ 662 (782)
|++|+|..++......+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++....... ..
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 9999999998877778999999999999999999999998 99999999999999999999999999986544322 23
Q ss_pred cCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHh
Q 003978 663 KTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESC 741 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~c 741 (782)
....||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+....+.. ..++..|..+++++.+||.+|
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~c 237 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIMYSC 237 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHT
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh-CCCCCCcccccHHHHHHHHHH
Confidence 34578999999999999999999999999999999998 8999999998888777753 446678889999999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHH
Q 003978 742 WHSDPQCRPSFQELVDKLRD 761 (782)
Q Consensus 742 L~~dP~~RPs~~ell~~L~~ 761 (782)
|+.||++|||+++++++|.+
T Consensus 238 l~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 238 WHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TCSSGGGSCCHHHHHHHHHC
T ss_pred ccCCHhHCcCHHHHHHHhhC
Confidence 99999999999999998764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9e-50 Score=435.94 Aligned_cols=253 Identities=22% Similarity=0.381 Sum_probs=224.7
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
.++|+++++||+|+||.||+|.++ ++.||||++.+.... ....+.+.+|+++|+.++|||||++++++.....+|+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 468999999999999999999984 788999999764321 23346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
|||+.+|+|..++.... .+++..++.++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.....
T Consensus 120 ~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 99999999999997654 6999999999999999999999999 999999999999999999999999999876543
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHH
Q 003978 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 740 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 740 (782)
.....||+.|||||++.+..++.++|||||||++|+|+||..||...+.......+. ...+.+|..+++++.+||.+
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~ 271 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV--SGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTCCHHHHHHHHH
T ss_pred -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHh--cCCCCCCccCCHHHHHHHHH
Confidence 235679999999999999999999999999999999999999999988887777763 34566788999999999999
Q ss_pred hhhhCCCCCC-----CHHHHHHHHHHHHHHHhhcc
Q 003978 741 CWHSDPQCRP-----SFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 741 cL~~dP~~RP-----s~~ell~~L~~L~~~~~~~~ 770 (782)
||..||.+|+ |++++ ++|+||+.+
T Consensus 272 ~L~~dP~kR~~~~r~t~~el------l~Hp~f~~~ 300 (350)
T d1rdqe_ 272 LLQVDLTKRFGNLKNGVNDI------KNHKWFATT 300 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHH------HTSGGGTTC
T ss_pred HhhhCHHhccccccccHHHH------HcCccccCC
Confidence 9999999994 89999 568888653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=416.45 Aligned_cols=260 Identities=31% Similarity=0.522 Sum_probs=219.1
Q ss_pred cccccceeEeeeeccCCcEEEEEEEEcC------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC
Q 003978 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (782)
Q Consensus 501 e~~~~~y~i~~~IG~G~~G~Vy~~~~~~------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (782)
|+...+|++.++||+|+||.||+|.+.+ ..||||+++... .......+.+|+++|+.++|||||++++++...
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 4555789999999999999999998753 259999986543 445566789999999999999999999999999
Q ss_pred CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
+.+++|||||.+++|.+++......+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhhc
Confidence 9999999999999999999877778999999999999999999999998 99999999999999999999999999986
Q ss_pred cccccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhccccccCCCCCC
Q 003978 655 KHETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDV 730 (782)
Q Consensus 655 ~~~~~~---~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 730 (782)
...... ......||+.|||||++.+..++.++|||||||++|||++| .+||...+..+....+. ...++..|..+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~~ 238 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDC 238 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTC
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh-ccCCCCCchhh
Confidence 543321 22334689999999999999999999999999999999995 55566666666665553 34466778889
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 731 DPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 731 ~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
+.++.+||.+||..||++|||+.++++.|+++.+
T Consensus 239 ~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 239 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 9999999999999999999999999999988765
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=416.11 Aligned_cols=245 Identities=27% Similarity=0.507 Sum_probs=209.6
Q ss_pred eeeccCCcEEEEEEEEcC----CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEeecCC
Q 003978 511 EQIGQGSCGTVYHAVWYG----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (782)
Q Consensus 511 ~~IG~G~~G~Vy~~~~~~----~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 586 (782)
++||+|+||.||+|.+.+ +.||||+++.........+.+.+|+++|+.++|||||++++++.. +..|||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998743 459999997765555667889999999999999999999999865 467899999999
Q ss_pred CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccc---cccc
Q 003978 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY---LTTK 663 (782)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~---~~~~ 663 (782)
|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++...... ....
T Consensus 92 g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 9999999764 46999999999999999999999998 9999999999999999999999999998654322 2223
Q ss_pred CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhh
Q 003978 664 TGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCW 742 (782)
Q Consensus 664 ~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL 742 (782)
...||+.|||||++.+..++.++|||||||++|||++ |..||...+..+....+. ...++.+|..+|+++++||.+||
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~cl 247 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMNLCW 247 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHT
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHHHHHHHc
Confidence 4578999999999999999999999999999999998 899999988887766664 34567788899999999999999
Q ss_pred hhCCCCCCCHHHHHHHHH
Q 003978 743 HSDPQCRPSFQELVDKLR 760 (782)
Q Consensus 743 ~~dP~~RPs~~ell~~L~ 760 (782)
..||++|||+.++++.|+
T Consensus 248 ~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 248 TYDVENRPGFAAVELRLR 265 (277)
T ss_dssp CSSTTTSCCHHHHHHHHH
T ss_pred CCCHhHCcCHHHHHHHhh
Confidence 999999999999977644
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=428.90 Aligned_cols=254 Identities=25% Similarity=0.432 Sum_probs=221.4
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCC-CHHHHHHHHHHHHHH-HhCCCCceeEEeeeeecCCceeEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLM-KRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
++|+++++||+|+||+||+|.+ .++.||||++++... .......+..|+.++ +.++|||||++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 6899999999999999999998 567899999976432 112234555666665 468999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~ 660 (782)
||||++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 mEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 9999999999999764 46899999999999999999999999 99999999999999999999999999986655545
Q ss_pred cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHHHHHH
Q 003978 661 TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVES 740 (782)
Q Consensus 661 ~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~ 740 (782)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+. ...+.+|..+++++++||.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dli~~ 236 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR--MDNPFYPRWLEKEAKDLLVK 236 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHHHHHH
Confidence 5556789999999999999999999999999999999999999999988888777764 34567788999999999999
Q ss_pred hhhhCCCCCCCHH-HHHHHHHHHHHHHhhc
Q 003978 741 CWHSDPQCRPSFQ-ELVDKLRDLQRQYFQA 769 (782)
Q Consensus 741 cL~~dP~~RPs~~-ell~~L~~L~~~~~~~ 769 (782)
||.+||.+||++. ++ ++|+||+.
T Consensus 237 ~L~~dP~~R~s~~~~l------~~hpff~~ 260 (320)
T d1xjda_ 237 LFVREPEKRLGVRGDI------RQHPLFRE 260 (320)
T ss_dssp HSCSSGGGSBTTBSCG------GGSGGGTT
T ss_pred hcccCCCCCcCHHHHH------HhCchhcc
Confidence 9999999999985 77 45677754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-48 Score=413.38 Aligned_cols=256 Identities=24% Similarity=0.379 Sum_probs=222.2
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCC-------HHHHHHHHHHHHHHHhCC-CCceeEEeeeeec
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-------DEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTS 573 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~-------~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 573 (782)
.++|++++.||+|+||+||+|++ .++.||||++++.... ....+.+.+|+.+|+.+. |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999998 5678999999876432 234456889999999997 9999999999999
Q ss_pred CCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 574 ~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
++.+|||||||++|+|.++|..+. .+++..++.++.||+.||+|||++| ||||||||+||||+.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchhee
Confidence 999999999999999999997644 7999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccccccCCCCCCcccCcccccC------CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--cC
Q 003978 654 LKHETYLTTKTGKGTPQWMAPEVLRN------EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--LE 725 (782)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~ 725 (782)
...... ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+...... ..
T Consensus 159 ~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 159 QLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred EccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 765543 2345689999999999863 34678999999999999999999999998887776666443332 22
Q ss_pred CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 726 IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 726 ~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
....+|+++++||.+||..||++|||+.++ |+|+||+.
T Consensus 238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~ei------l~h~~~~~ 275 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEA------LAHPFFQQ 275 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHH------TTSGGGCT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHH------HcCHHHHH
Confidence 334799999999999999999999999999 77899864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-49 Score=425.56 Aligned_cols=256 Identities=21% Similarity=0.325 Sum_probs=222.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 580 (782)
++++|++++.||+|+||+||+|.+. ++.||||+++.... ....+.+|+++|+.++|||||++++++++++.+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 5689999999999999999999984 66799999976542 234578999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC--CcEEEEecCCCcccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH--WTVKVGDFGLSRLKHET 658 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~--~~vkL~DFGla~~~~~~ 658 (782)
||||+|++|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.+ +.+||+|||+++.....
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999999999877667999999999999999999999999 9999999999999854 58999999999865443
Q ss_pred cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--cCCCCCCCHHHHH
Q 003978 659 YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR--LEIPKDVDPRWAA 736 (782)
Q Consensus 659 ~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~~~~l~~ 736 (782)
. ......||+.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+...... ...++.+++++++
T Consensus 158 ~-~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T d1tkia_ 158 D-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp C-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred C-cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence 2 223457899999999999999999999999999999999999999999888877776433222 1222478999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 737 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
||.+||..||.+|||+.|+ |.|+||+..
T Consensus 237 li~~~L~~dp~~R~s~~ei------l~hp~~~~~ 264 (321)
T d1tkia_ 237 FVDRLLVKERKSRMTASEA------LQHPWLKQK 264 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHH------HHSHHHHSC
T ss_pred HHHHHccCChhHCcCHHHH------hcCHhhccC
Confidence 9999999999999999999 568999754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-49 Score=412.11 Aligned_cols=255 Identities=33% Similarity=0.619 Sum_probs=219.5
Q ss_pred ccccccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec-CCcee
Q 003978 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQRLC 578 (782)
Q Consensus 500 ~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~ 578 (782)
|++..++|+++++||+|+||.||+|.++++.||||+++... ..+.+.+|+++++.++|||||++++++.+ ++.+|
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 67888999999999999999999999999999999997543 23568899999999999999999998854 56789
Q ss_pred EEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 579 IVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
+|||||++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceecCC
Confidence 999999999999999653 345899999999999999999999988 99999999999999999999999999986543
Q ss_pred ccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHHH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWAA 736 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 736 (782)
. .....+|+.|+|||++.+..++.++|||||||++|||+| |++||...+..+....+. ...++.+|..+++++++
T Consensus 156 ~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~ 231 (262)
T d1byga_ 156 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYE 231 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHHH
T ss_pred C---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHHH
Confidence 3 234568999999999999999999999999999999998 799999888887776664 34567888899999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 737 IVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
||.+||..||.+|||+.+++++|++++.
T Consensus 232 li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 232 VMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998865
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.5e-48 Score=411.00 Aligned_cols=259 Identities=25% Similarity=0.361 Sum_probs=216.9
Q ss_pred cccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc---
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR--- 576 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--- 576 (782)
+.++|++.+.||+|+||.||+|.+. ++.||||++++... .......+.+|+++|+.++|||||++++++...+.
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 3468999999999999999999974 77899999987655 45667789999999999999999999999876543
Q ss_pred -eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 577 -LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 577 -~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
+|||||||+|++|.+++.... .+++..++.++.||+.||+|||++| ||||||||+||||+.++.++|+|||.+...
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred eEEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhhhhh
Confidence 799999999999999987654 6899999999999999999999999 999999999999999999999999988654
Q ss_pred cccc---ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--ccCCCCCC
Q 003978 656 HETY---LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ--RLEIPKDV 730 (782)
Q Consensus 656 ~~~~---~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~ 730 (782)
.... ......+||+.|||||++.+..++.++|||||||++|+|+||.+||...+..+....+..... .......+
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence 3221 233455799999999999999999999999999999999999999998888776655543322 22345679
Q ss_pred CHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHHHH
Q 003978 731 DPRWAAIVESCWHSDPQCRP-SFQELVDKLRDLQR 764 (782)
Q Consensus 731 ~~~l~~LI~~cL~~dP~~RP-s~~ell~~L~~L~~ 764 (782)
|+++.+||.+||.+||.+|| |++++++.|.++++
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 99999999999999999999 89999998888753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-49 Score=413.85 Aligned_cols=257 Identities=33% Similarity=0.532 Sum_probs=216.7
Q ss_pred cccceeEeeeeccCCcEEEEEEEEcC-----CeEEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~~-----~~vAiK~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (782)
..++|++.+.||+|+||.||+|.+.. ..||||++++... ..+..+.+.+|+.+|+.++|||||++++++.+ ..
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 34789999999999999999998742 2589999876554 33556789999999999999999999999976 47
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
+++|||||++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 78999999999999998877778999999999999999999999998 9999999999999999999999999998654
Q ss_pred cccc---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCH
Q 003978 657 ETYL---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 732 (782)
Q Consensus 657 ~~~~---~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 732 (782)
.... ......|++.|+|||++.+..++.++|||||||++|||+| |..||...+..+....+......++.+..+|+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 242 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccH
Confidence 4321 2233467889999999999999999999999999999998 89999999999888888766667788889999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 733 RWAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 733 ~l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
++.+||.+||..||++|||+.+|++.|++.
T Consensus 243 ~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 243 DIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 999999999999999999999999888765
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-49 Score=419.68 Aligned_cols=262 Identities=26% Similarity=0.373 Sum_probs=218.2
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
++|+++++||+|+||+||+|.+. ++.||||+++...........+.+|+++|+.++|||||++++++.+++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999984 7789999997665444456788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHH-hhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccc
Q 003978 583 FLPRGSLFRLL-QRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (782)
Q Consensus 583 ~~~ggsL~~~l-~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 661 (782)
||.+ .+..++ ......+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+|+........
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 9965 555544 445567999999999999999999999999 999999999999999999999999999877665555
Q ss_pred ccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc----------------c
Q 003978 662 TKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQR----------------L 724 (782)
Q Consensus 662 ~~~~~Gt~~y~aPE~l~~~~~-s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~----------------~ 724 (782)
.....||+.|+|||++....+ +.++|||||||++|+|++|+.||...+.......+...... .
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 566789999999999877664 78999999999999999999999988876655543211000 0
Q ss_pred C-----------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcCC
Q 003978 725 E-----------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVG 775 (782)
Q Consensus 725 ~-----------~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~~ 775 (782)
. ....+++++++||.+||..||++|||+.|+ |+|+||+..+..+.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~el------l~H~ff~~~~~p~p 294 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA------LAHPFFQDVTKPVP 294 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHH------HTSGGGTTCCCCCC
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHH------hCCHhhccCCCCCC
Confidence 0 113567899999999999999999999999 67899998876543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-48 Score=428.16 Aligned_cols=256 Identities=23% Similarity=0.386 Sum_probs=215.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCC----HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCce
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS----DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (782)
.++|+++++||+|+||.||+|.+ .++.||||++.+.... .........++.+++.++|||||++++++..++.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 57899999999999999999998 4778999999754321 22223334457777888899999999999999999
Q ss_pred eEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccc
Q 003978 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~ 657 (782)
|+|||||+||+|.++|... ..+++..++.++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 9999999999999999765 46899999999999999999999999 99999999999999999999999999986554
Q ss_pred ccccccCCCCCCcccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHh-hccccccCCCCCCCHHHH
Q 003978 658 TYLTTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAV-GFMNQRLEIPKDVDPRWA 735 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~-~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i-~~~~~~~~~p~~~~~~l~ 735 (782)
. .....+||+.|||||++. +..++.++|||||||+||+|+||+.||............ ........+|..++++++
T Consensus 160 ~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 160 K--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp S--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHH
T ss_pred C--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHH
Confidence 3 234568999999999996 566899999999999999999999999865543322221 123445667788999999
Q ss_pred HHHHHhhhhCCCCCCC-----HHHHHHHHHHHHHHHhhcc
Q 003978 736 AIVESCWHSDPQCRPS-----FQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs-----~~ell~~L~~L~~~~~~~~ 770 (782)
+||.+||.+||.+||| ++++ +.|+||+..
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~ei------l~Hp~f~~i 271 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEV------KESPFFRSL 271 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHH------HTSGGGTTC
T ss_pred HHHHHHcccCHHHhCCCcccCHHHH------HcCccccCC
Confidence 9999999999999999 7888 578998754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-48 Score=414.49 Aligned_cols=266 Identities=29% Similarity=0.524 Sum_probs=216.5
Q ss_pred ccccccccccceeEeeeeccCCcEEEEEEEEcC-------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEE
Q 003978 496 DCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLF 567 (782)
Q Consensus 496 ~~~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l 567 (782)
+...|++..++|+++++||+|+||.||+|.+.+ +.||||+++... .....+.+.+|+.++.++ +|+|||.+
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 345678888999999999999999999998743 469999987544 334456677788877776 68999999
Q ss_pred eeeeecC-CceeEEEeecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 003978 568 MGAVTSP-QRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDL 631 (782)
Q Consensus 568 ~~~~~~~-~~~~lv~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDI 631 (782)
++++..+ ..+++|||||++|+|.+++.... ..+++..++.++.||+.||+|||+++ ||||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDl 160 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 160 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcC
Confidence 9987654 56899999999999999996532 34889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCC
Q 003978 632 KSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNL 708 (782)
Q Consensus 632 Kp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG-~~Pf~~~ 708 (782)
||+||||+.++.+||+|||+|+...... .......||+.|||||++.+..++.++|||||||++|||++| .+||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998654332 233456799999999999999999999999999999999986 5788877
Q ss_pred ChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 003978 709 NSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQR 764 (782)
Q Consensus 709 ~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~ 764 (782)
.....+.........+.+|..+++++++||.+||..||++|||+.+++++|+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 241 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 66555544444555678888999999999999999999999999999999998854
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=411.20 Aligned_cols=264 Identities=33% Similarity=0.594 Sum_probs=217.5
Q ss_pred ccccccccceeEeeeeccCCcEEEEEEEEcC-CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCc
Q 003978 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 498 ~~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (782)
..|++..++|++++.||+|+||.||+|++.+ ..||||+++...... +.+.+|+.+|+.++|||||++++++. ++.
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~ 85 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVS-EEP 85 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEe-cCC
Confidence 3566778899999999999999999999854 469999997665443 56889999999999999999999985 456
Q ss_pred eeEEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
+|+|||||++|+|..++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchhhhc
Confidence 89999999999999888543 346899999999999999999999999 999999999999999999999999999865
Q ss_pred cccc-ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhccccccCCCCCCCHH
Q 003978 656 HETY-LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPR 733 (782)
Q Consensus 656 ~~~~-~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 733 (782)
.... .......||+.|+|||++.+..++.++|||||||++|||++| .+||......+.+..+. .....+.+..++.+
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 242 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 242 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCHH
T ss_pred cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCCcccCHH
Confidence 4332 223345789999999999999999999999999999999995 55566666666665554 33456788899999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 734 WAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 734 l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
+++||.+||..||++||++++|++.| ++||....+
T Consensus 243 l~~li~~cl~~dP~~Rps~~~i~~~L----~~~~~~~~p 277 (285)
T d1fmka3 243 LHDLMCQCWRKEPEERPTFEYLQAFL----EDYFTSTEP 277 (285)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHH----HTTTSCSCC
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHH----hhhhcCCCC
Confidence 99999999999999999999997654 457765544
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-47 Score=410.50 Aligned_cols=260 Identities=28% Similarity=0.504 Sum_probs=226.3
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEcC-------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 571 (782)
.+|...++|++++.||+|+||+||+|++.+ +.||||+++... ..+..+.+.+|+.+|+.++||||+++++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 456677899999999999999999999854 469999987543 455677899999999999999999999999
Q ss_pred ecCCceeEEEeecCCCCHHHHHhhcC-----------------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 003978 572 TSPQRLCIVTEFLPRGSLFRLLQRNT-----------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIH 628 (782)
Q Consensus 572 ~~~~~~~lv~E~~~ggsL~~~l~~~~-----------------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivH 628 (782)
...+..+++||||.+|+|.+++.... ..+++..++.++.||+.||+|||+++ |||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivH 163 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVH 163 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEe
Confidence 99999999999999999999996432 24788999999999999999999998 999
Q ss_pred cCCCCCcEEEcCCCcEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCC-CCC
Q 003978 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEK-IPW 705 (782)
Q Consensus 629 rDIKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~-~Pf 705 (782)
|||||+||||+.++.+||+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999997543322 2233557899999999999999999999999999999999985 689
Q ss_pred CCCChHHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 706 DNLNSMQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 706 ~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
...+..+....+.. ...+.+|..+++++.+||.+||+.||++|||+.+|++.|+++
T Consensus 244 ~~~~~~e~~~~v~~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 244 YGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCHHHHHHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 98888887777643 345677889999999999999999999999999999998876
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-48 Score=411.49 Aligned_cols=255 Identities=23% Similarity=0.282 Sum_probs=210.7
Q ss_pred EeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCC---HHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 509 IGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS---DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 509 i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
.+++||+|+||+||+|.+ .++.||||+++..... ......+.+|+.+|+.++|||||++++++..++.+||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 468899999999999997 4778999998765432 22345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccccc
Q 003978 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (782)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (782)
|.++++..++ .....+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+..........
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 9776655554 44567999999999999999999999999 99999999999999999999999999987666555555
Q ss_pred CCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc------------------
Q 003978 664 TGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL------------------ 724 (782)
Q Consensus 664 ~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------------ 724 (782)
..+||+.|+|||++.+ ..++.++|||||||++|||++|..||...+..+.+..+......+
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 6789999999999875 457999999999999999999999999888877665543211100
Q ss_pred --------CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 725 --------EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 725 --------~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
.+.+.+++++.+||.+||..||++|||+.|+ |+|+||+..+.
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~------L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA------LKMKYFSNRPG 288 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHH------HTSGGGTSSSC
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHH------hCCHhhCCCCC
Confidence 0113578899999999999999999999999 67899986553
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=413.53 Aligned_cols=257 Identities=28% Similarity=0.526 Sum_probs=217.4
Q ss_pred cceeEeeeeccCCcEEEEEEEEc--CC----eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCcee
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY--GS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~--~~----~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (782)
.+|+++++||+|+||+||+|.+. ++ +||+|.++... .....+.+.+|+.+|+.++|||||++++++.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 47999999999999999999874 33 47888876432 233456789999999999999999999999864 567
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
++||||.+++|.+++......+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 889999999999999888888999999999999999999999998 999999999999999999999999999865432
Q ss_pred c--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCCCCHHHH
Q 003978 659 Y--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDPRWA 735 (782)
Q Consensus 659 ~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~ 735 (782)
. .......||+.|||||++.+..++.++|||||||++|||+| |.+||...+..+....+. ...++..|..+++++.
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~ 243 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTIDVY 243 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-HTCCCCCCTTBCHHHH
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHH
Confidence 2 22334568999999999999999999999999999999998 899999887776655543 3456677889999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 736 AIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 736 ~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
+||.+||..||.+|||+.+++++|..+.+..
T Consensus 244 ~li~~cl~~dP~~RPs~~eil~~l~~~~~~~ 274 (317)
T d1xkka_ 244 MIMVKCWMIDADSRPKFRELIIEFSKMARDP 274 (317)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred HHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence 9999999999999999999999999886543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-48 Score=411.56 Aligned_cols=260 Identities=25% Similarity=0.334 Sum_probs=215.1
Q ss_pred cceeEeeeeccCCcEEEEEEEEc---CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhC---CCCceeEEeeeee-----c
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL---RHPNVLLFMGAVT-----S 573 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~-----~ 573 (782)
++|+++++||+|+||+||+|.+. ++.||||+++...........+.+|+.+|+.+ +|||||++++++. .
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 68999999999999999999984 44689999976544332233455677776655 7999999999985 3
Q ss_pred CCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 574 ~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
...+|++||||.++.+..........+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecchhhhh
Confidence 35689999999887776666666667999999999999999999999999 9999999999999999999999999987
Q ss_pred ccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------
Q 003978 654 LKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ----------- 722 (782)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~----------- 722 (782)
...... ......||+.|||||++.+..++.++|||||||++|||++|.+||...+....+..+.....
T Consensus 165 ~~~~~~-~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 165 IYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred hhcccc-cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 654432 33467899999999999999999999999999999999999999998887766655422100
Q ss_pred --------------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 723 --------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 723 --------------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
...++..+++.+++||.+||..||++|||+.|+ |+|+||+.+..+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~------L~Hpff~~i~~~ 302 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA------LSHPYFQDLERC 302 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH------HTSGGGTTCCCC
T ss_pred cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHH------hcChhhcCchhh
Confidence 112345688999999999999999999999999 678999877544
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.7e-48 Score=408.91 Aligned_cols=256 Identities=24% Similarity=0.336 Sum_probs=213.2
Q ss_pred cceeEeeeeccCCcEEEEEEEEc-CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEee
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E~ 583 (782)
++|+++++||+|+||+||+|.++ ++.||||+++.........+.+.+|+.+|+.++|||||++++++..++..|++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 68999999999999999999984 67899999977655444457888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccccccccccc
Q 003978 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (782)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 663 (782)
+.++.+..+. .....+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||++...........
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 9765555554 44567999999999999999999999998 99999999999999999999999999987665544455
Q ss_pred CCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--------------------
Q 003978 664 TGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ-------------------- 722 (782)
Q Consensus 664 ~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~-------------------- 722 (782)
...|++.|+|||++.+. .++.++|||||||++|||++|+.||...+..+.+..+.....
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 66799999999998764 468999999999999999999999998877665554321100
Q ss_pred -------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 723 -------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 723 -------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
....+..+++++.+||.+||..||++|||+.|+ |+|+||++
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~el------l~Hp~f~~ 286 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA------LEHAYFKE 286 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHH------HTSGGGGC
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHH------hcCcccCc
Confidence 012345678999999999999999999999999 67899974
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=405.19 Aligned_cols=261 Identities=31% Similarity=0.588 Sum_probs=223.9
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEcC---------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEe
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG---------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 568 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~---------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 568 (782)
.|++..++|++++.||+|+||.||+|++.+ ..||||+++... .......+.+|+..+..+ +|||||+++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 377888999999999999999999998643 258999987644 445567788899988888 799999999
Q ss_pred eeeecCCceeEEEeecCCCCHHHHHhhcC---------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 003978 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (782)
Q Consensus 569 ~~~~~~~~~~lv~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp 633 (782)
+++.+++.+|+|||||++|+|.++|.... ..+++..++.++.||+.||+|||+++ ||||||||
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp 163 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAA 163 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecc
Confidence 99999999999999999999999996543 35899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEEecCCCcccccccc--cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 003978 634 SNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (782)
Q Consensus 634 ~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~ 710 (782)
+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++ |.+||...+.
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 999999999999999999986554322 2334578999999999999999999999999999999998 7999998888
Q ss_pred HHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 003978 711 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQ 763 (782)
Q Consensus 711 ~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~ 763 (782)
.+....+. ....+..|..+++++.+||.+||+.||.+|||+.++++.|++|.
T Consensus 244 ~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 244 EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHH-cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 87766654 35567788899999999999999999999999999999998875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=411.02 Aligned_cols=274 Identities=32% Similarity=0.532 Sum_probs=238.9
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEc-------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeee
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 571 (782)
.|++..++|+++++||+|+||.||+|.+. ++.||||+++... .......+.+|+.+++.++|||||++++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 46788899999999999999999999874 3579999997543 445567789999999999999999999999
Q ss_pred ecCCceeEEEeecCCCCHHHHHhhcC---------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC
Q 003978 572 TSPQRLCIVTEFLPRGSLFRLLQRNT---------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642 (782)
Q Consensus 572 ~~~~~~~lv~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~ 642 (782)
..+...++|||||.+|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||||+.++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF 170 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTC
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCc
Confidence 99999999999999999999986432 23688899999999999999999998 99999999999999999
Q ss_pred cEEEEecCCCccccccc--ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhc
Q 003978 643 TVKVGDFGLSRLKHETY--LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGF 719 (782)
Q Consensus 643 ~vkL~DFGla~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG-~~Pf~~~~~~~~~~~i~~ 719 (782)
++||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||+|| ..||...+..+....+.
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~- 249 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM- 249 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 99999999998654432 223345689999999999999999999999999999999998 68999988888877664
Q ss_pred cccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCcCCC
Q 003978 720 MNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRSTVGD 776 (782)
Q Consensus 720 ~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~~~~ 776 (782)
....+..|..+++.+.+||.+||+.||++|||+.+|++.|++..+++|++..-.+.+
T Consensus 250 ~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~~~~~~~ 306 (308)
T d1p4oa_ 250 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSE 306 (308)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCSTTST
T ss_pred hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCCCCCCCC
Confidence 344667788999999999999999999999999999999999999999876655543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=415.20 Aligned_cols=253 Identities=25% Similarity=0.392 Sum_probs=207.0
Q ss_pred ccccceeEee-eeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHh-CCCCceeEEeeeeec----
Q 003978 502 ILWEDLTIGE-QIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR-LRHPNVLLFMGAVTS---- 573 (782)
Q Consensus 502 ~~~~~y~i~~-~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~---- 573 (782)
...++|++.+ .||+|+||.||+|.+ .++.||||+++.. ..+.+|+.++.+ .+|||||+++++|++
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 3457899875 599999999999997 4678999999643 356679988654 589999999999865
Q ss_pred CCceeEEEeecCCCCHHHHHhhc-CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCcEEEEec
Q 003978 574 PQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDF 649 (782)
Q Consensus 574 ~~~~~lv~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~---~~~vkL~DF 649 (782)
...+|||||||+||+|.++|... ...+++..++.++.||+.||+|||++| |+||||||+|||++. .+.+||+||
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Ccccccccccccccccccccccccccc
Confidence 46689999999999999999764 346999999999999999999999999 999999999999975 567999999
Q ss_pred CCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc--cccccCCC
Q 003978 650 GLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF--MNQRLEIP 727 (782)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p 727 (782)
|+|+...... .....+||+.|||||++.+..++.++|||||||+||+|+||..||...+.......+.. ......+|
T Consensus 159 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~ 237 (335)
T d2ozaa1 159 GFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237 (335)
T ss_dssp TTCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred ceeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 9998655433 33456899999999999999999999999999999999999999977655443333221 11222333
Q ss_pred ----CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 728 ----KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 728 ----~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
..+++++++||.+||..||.+|||+.++ +.|+||+..
T Consensus 238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei------l~hp~~~~~ 278 (335)
T d2ozaa1 238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF------MNHPWIMQS 278 (335)
T ss_dssp TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHH------HHSHHHHTT
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHH------HcCHHhhCC
Confidence 2578999999999999999999999999 568998653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=408.12 Aligned_cols=259 Identities=30% Similarity=0.577 Sum_probs=220.3
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEcC--C--eEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeeeeecCCc
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG--S--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 576 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~~--~--~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 576 (782)
+.+++|++.++||+|+||.||+|.+++ . .||||.++... ..+..+.+.+|+++|..+ +|||||++++++...+.
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence 456899999999999999999998854 3 36777765433 233456789999999998 79999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhhc---------------CCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCC
Q 003978 577 LCIVTEFLPRGSLFRLLQRN---------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 641 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~ 641 (782)
+|+|||||++|+|.++|... ...+++..++.++.||+.||.|||+++ ||||||||+|||++.+
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN 163 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcCC
Confidence 99999999999999999643 356899999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhcc
Q 003978 642 WTVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATE-KIPWDNLNSMQVIGAVGFM 720 (782)
Q Consensus 642 ~~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG-~~Pf~~~~~~~~~~~i~~~ 720 (782)
+.+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++| .+||...+..+....+. .
T Consensus 164 ~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~-~ 241 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-Q 241 (309)
T ss_dssp GCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-G
T ss_pred CceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH-h
Confidence 999999999997654433 23345789999999999999999999999999999999996 56898888888777664 3
Q ss_pred ccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 721 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 721 ~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
..++.+|..+++++++||.+||..||++|||+.++++.|+++.++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 456778889999999999999999999999999999999988653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=404.31 Aligned_cols=264 Identities=28% Similarity=0.497 Sum_probs=229.3
Q ss_pred cccccccceeEeeeeccCCcEEEEEEEEcC-------CeEEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCceeEEeee
Q 003978 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 570 (782)
Q Consensus 499 ~~e~~~~~y~i~~~IG~G~~G~Vy~~~~~~-------~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 570 (782)
.|++..++|+++++||+|+||.||+|.+.+ +.||||+++... .......+.+|+.+++.+ +|||||+++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 677888999999999999999999998743 369999997654 344566789999999999 69999999999
Q ss_pred eecCCceeEEEeecCCCCHHHHHhhcC-----------------CcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 003978 571 VTSPQRLCIVTEFLPRGSLFRLLQRNT-----------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (782)
Q Consensus 571 ~~~~~~~~lv~E~~~ggsL~~~l~~~~-----------------~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp 633 (782)
+..+..+|+|||||++|+|.+++.... ..+++..++.++.||+.||+|||+++ ||||||||
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp 173 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAA 173 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccccc
Confidence 999999999999999999999996532 25889999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEEecCCCcccccc--cccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 003978 634 SNLLVDKHWTVKVGDFGLSRLKHET--YLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELAT-EKIPWDNLNS 710 (782)
Q Consensus 634 ~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~ellt-G~~Pf~~~~~ 710 (782)
+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||+| |.+||...+.
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999865543 223334578999999999999999999999999999999998 6777877776
Q ss_pred HHHHHHhhccccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 711 MQVIGAVGFMNQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 711 ~~~~~~i~~~~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
...+..+.....++..+..++.++.+||.+||..||++|||+.++++.|+++..+
T Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 6665555555567778888999999999999999999999999999999876543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=405.40 Aligned_cols=249 Identities=22% Similarity=0.414 Sum_probs=210.8
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCH----HHHHHHHHHHHHHHhCC--CCceeEEeeeeecCC
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLR--HPNVLLFMGAVTSPQ 575 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~----~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~ 575 (782)
.++|+++++||+|+||.||+|++. ++.||||++.+..... .....+.+|+.+|+.++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 368999999999999999999984 7789999997654321 11234567999999986 899999999999999
Q ss_pred ceeEEEeecCC-CCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-CCcEEEEecCCCc
Q 003978 576 RLCIVTEFLPR-GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSR 653 (782)
Q Consensus 576 ~~~lv~E~~~g-gsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~-~~~vkL~DFGla~ 653 (782)
.+|+||||+.+ +++.+++... ..+++..++.++.||+.||+|||+++ ||||||||+||||+. ++.+||+|||+|+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccce
Confidence 99999999976 5888888664 46999999999999999999999999 999999999999985 4799999999998
Q ss_pred ccccccccccCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCCCCH
Q 003978 654 LKHETYLTTKTGKGTPQWMAPEVLRNEPS-DEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLEIPKDVDP 732 (782)
Q Consensus 654 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 732 (782)
...... .....||+.|||||++.+..+ +.++|||||||++|+|++|..||...+. + ......++..+|+
T Consensus 160 ~~~~~~--~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i--~~~~~~~~~~~s~ 229 (273)
T d1xwsa_ 160 LLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------I--IRGQVFFRQRVSS 229 (273)
T ss_dssp ECCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------H--HHCCCCCSSCCCH
T ss_pred eccccc--ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------H--hhcccCCCCCCCH
Confidence 654432 335689999999999987765 5679999999999999999999975321 1 2234567788999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 733 RWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 733 ~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
++++||.+||..||++|||+.|+ ++|+||+...
T Consensus 230 ~~~~li~~~L~~dp~~R~s~~ei------l~hp~~~~~~ 262 (273)
T d1xwsa_ 230 ECQHLIRWCLALRPSDRPTFEEI------QNHPWMQDVL 262 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHH------HTSGGGSSCC
T ss_pred HHHHHHHHHccCCHhHCcCHHHH------hcCHhhCCCC
Confidence 99999999999999999999999 6789998653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=400.77 Aligned_cols=258 Identities=31% Similarity=0.517 Sum_probs=216.5
Q ss_pred eEeeeeccCCcEEEEEEEEcCC-----eEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec-CCceeEEE
Q 003978 508 TIGEQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQRLCIVT 581 (782)
Q Consensus 508 ~i~~~IG~G~~G~Vy~~~~~~~-----~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lv~ 581 (782)
.+.++||+|+||+||+|++... .||||.+++. ......+.+.+|+++|++++|||||++++++.. ++.+++||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 3468899999999999987332 4899998643 355667889999999999999999999999764 56789999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccc-
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 660 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~- 660 (782)
|||++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999999999877777889999999999999999999998 99999999999999999999999999986543221
Q ss_pred ---cccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHhhccccccCCCCCCCHHHHH
Q 003978 661 ---TTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNL-NSMQVIGAVGFMNQRLEIPKDVDPRWAA 736 (782)
Q Consensus 661 ---~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~~l~~ 736 (782)
......||+.|+|||++.+..++.++|||||||++|||+||..||... +..+....+. ...++..|..+++++.+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~-~g~~~~~p~~~~~~l~~ 265 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYE 265 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-TTCCCCCCTTCCHHHHH
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCcccCcHHHHH
Confidence 122346899999999999999999999999999999999977776543 3333333332 34566788899999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhc
Q 003978 737 IVESCWHSDPQCRPSFQELVDKLRDLQRQYFQA 769 (782)
Q Consensus 737 LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~ 769 (782)
||.+||..||++||++.|++++|+++.+.|..+
T Consensus 266 li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 266 VMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 999999999999999999999999998876654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-46 Score=403.66 Aligned_cols=254 Identities=27% Similarity=0.377 Sum_probs=212.2
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC------
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------ 575 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 575 (782)
.++|+++++||+|+||+||+|.+. ++.||||++++........+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 579999999999999999999984 788999999877667777888999999999999999999999997654
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
.+|+||||| +.+|..++... .+++..++.++.||+.||.|||++| ||||||||+|||++.++.+||+|||+|+..
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccccccccccceecc
Confidence 479999999 67888887643 5999999999999999999999999 999999999999999999999999999866
Q ss_pred ccccccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc------------
Q 003978 656 HETYLTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------ 722 (782)
Q Consensus 656 ~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~------------ 722 (782)
... .....||+.|+|||++.+. .++.++|||||||++|+|++|++||...+....+..+.....
T Consensus 172 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 172 DSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp CSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred CCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 543 2356799999999998764 568999999999999999999999998876655433221110
Q ss_pred -----------------ccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 723 -----------------RLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 723 -----------------~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
.......+++++.+||.+||..||.+|||+.|+ |+|+||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ei------L~Hp~f~~~~ 308 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA------LAHPYFESLH 308 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH------HHSGGGTTTC
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHH------hcChhhCcCC
Confidence 112345678999999999999999999999999 6789998754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-45 Score=387.80 Aligned_cols=258 Identities=24% Similarity=0.305 Sum_probs=219.0
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCCceeEEEe
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 582 (782)
++|+++++||+|+||+||+|++ .++.||||+++...........+.+|+.+|+.++|||||++++++.....++++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 6899999999999999999998 46679999998776666677889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccccccc
Q 003978 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (782)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 662 (782)
++.+++|..++.. ...+++..++.++.|++.||+|||+++ ||||||||+||||+.++.+||+|||.++.........
T Consensus 82 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 82 FCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred ecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 9988888877765 457899999999999999999999999 9999999999999999999999999998776655455
Q ss_pred cCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCC-CCChHHHHHHhhccc-------------------
Q 003978 663 KTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWD-NLNSMQVIGAVGFMN------------------- 721 (782)
Q Consensus 663 ~~~~Gt~~y~aPE~l~~~~-~s~~sDIwSLG~ll~elltG~~Pf~-~~~~~~~~~~i~~~~------------------- 721 (782)
....+++.|+|||++.+.. ++.++|||||||++|+|++|..||. ..+..+....+....
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 5567889999999988765 5899999999999999999999864 444444433332111
Q ss_pred --------cccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 722 --------QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 722 --------~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
.....+..+++.+.+||.+||+.||.+|||++|+ |+|+||++-.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~------L~Hp~f~~~~ 290 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA------LQHPYFSDFC 290 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH------TTSGGGSSCS
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHH------hcChhhcCCC
Confidence 1112334678899999999999999999999999 7789998643
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=394.00 Aligned_cols=258 Identities=23% Similarity=0.346 Sum_probs=207.5
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC----cee
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----RLC 578 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~ 578 (782)
.+|+++++||+|+||+||+|.+ .++.||||++.+.. .....+.+.+|+.+|+.++|||||++++++..+. ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 5799999999999999999997 47889999997544 4555678899999999999999999999987553 234
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~~~ 658 (782)
++|+|+.+++|.+++... .+++..++.++.||+.||+|||++| ||||||||+||||+.++.+||+|||+++.....
T Consensus 87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 455566689999999754 5899999999999999999999999 999999999999999999999999999765433
Q ss_pred c---ccccCCCCCCcccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc------------
Q 003978 659 Y---LTTKTGKGTPQWMAPEVLR-NEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------ 722 (782)
Q Consensus 659 ~---~~~~~~~Gt~~y~aPE~l~-~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~------------ 722 (782)
. ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||...+.............
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 2 1234567999999999985 45678899999999999999999999987765544333211000
Q ss_pred ------------c-----cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 723 ------------R-----LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 723 ------------~-----~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
. ......+++++++||.+||..||.+|||+.++ |+|+||+.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~------L~hpf~~~~~~~ 304 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA------LAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHH------HTSGGGTTTCCG
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHH------hcCHhhccCCCC
Confidence 0 01234678899999999999999999999999 678998755443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=390.19 Aligned_cols=258 Identities=21% Similarity=0.296 Sum_probs=207.9
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec--------
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-------- 573 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-------- 573 (782)
.++|+++++||+|+||+||+|++ .++.||||++......+.....+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47999999999999999999998 47789999987665555455678899999999999999999998754
Q ss_pred CCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 574 ~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
++.+|+|||||.++ +...+......+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++
T Consensus 89 ~~~~~iv~e~~~~~-~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEE-HHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCC-ccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeecceee
Confidence 35689999999665 44455555667899999999999999999999999 9999999999999999999999999997
Q ss_pred cccccc----ccccCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC--C
Q 003978 654 LKHETY----LTTKTGKGTPQWMAPEVLRNE-PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRLE--I 726 (782)
Q Consensus 654 ~~~~~~----~~~~~~~Gt~~y~aPE~l~~~-~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~ 726 (782)
...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+......+. .
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 544321 222345799999999999865 678999999999999999999999998877666555432211110 0
Q ss_pred C----------------------------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 727 P----------------------------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 727 p----------------------------~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
. ...++++.+||.+||..||++|||++|+ |.|+||++-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~el------L~Hpff~~~ 311 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA------LNHDFFWSD 311 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHH------HHSGGGSSS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHH------HcChhhccC
Confidence 0 0136678999999999999999999999 689999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-45 Score=397.22 Aligned_cols=253 Identities=23% Similarity=0.274 Sum_probs=205.2
Q ss_pred ceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC------Cce
Q 003978 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------QRL 577 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~~ 577 (782)
+|+.+++||+|+||+||+|++ .++.||||++..... .+.+|+++|+.++|||||+++++|... .++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 799999999999999999998 477899999976542 224699999999999999999998532 347
Q ss_pred eEEEeecCCCCHHHHH--hhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-cEEEEecCCCcc
Q 003978 578 CIVTEFLPRGSLFRLL--QRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRL 654 (782)
Q Consensus 578 ~lv~E~~~ggsL~~~l--~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~-~vkL~DFGla~~ 654 (782)
|||||||+++.+..+. ......+++..++.++.||+.||+|||++| ||||||||+||||+.++ .+||+|||+++.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhh
Confidence 8999999765333332 234557999999999999999999999999 99999999999999775 899999999986
Q ss_pred cccccccccCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------
Q 003978 655 KHETYLTTKTGKGTPQWMAPEVLRN-EPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ----------- 722 (782)
Q Consensus 655 ~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~----------- 722 (782)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+....+..+.....
T Consensus 173 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 173 LVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred ccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 54432 2335689999999999875 5689999999999999999999999988877665544321100
Q ss_pred ----c------------cCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccCc
Q 003978 723 ----R------------LEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRST 773 (782)
Q Consensus 723 ----~------------~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~~ 773 (782)
. ......+++++.+||.+||..||++|||+.|+ |+|+||+..+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~------L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA------CAHSFFDELRDP 312 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH------HTSGGGGGGGCT
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHH------hcCHhhccccCC
Confidence 0 01124578999999999999999999999999 678999876543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=398.12 Aligned_cols=260 Identities=22% Similarity=0.364 Sum_probs=215.3
Q ss_pred cccceeEeeeeccCCcEEEEEEEE-----cCCeEEEEEEeccCC--CHHHHHHHHHHHHHHHhCCC-CceeEEeeeeecC
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRH-PNVLLFMGAVTSP 574 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~-----~~~~vAiK~~~~~~~--~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~ 574 (782)
..++|+++++||+|+||+||+|.+ .++.||||++++... .....+.+.+|+++|++++| |||+++++++++.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 347899999999999999999987 356799999865432 11223567789999999976 8999999999999
Q ss_pred CceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 575 ~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
..++++||||.+++|.+++.... .+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999997754 5778889999999999999999999 99999999999999999999999999976
Q ss_pred cccc-cccccCCCCCCcccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh--ccccccCCCCC
Q 003978 655 KHET-YLTTKTGKGTPQWMAPEVLRNE--PSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVG--FMNQRLEIPKD 729 (782)
Q Consensus 655 ~~~~-~~~~~~~~Gt~~y~aPE~l~~~--~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~--~~~~~~~~p~~ 729 (782)
.... ........|++.|++||.+.+. .++.++|||||||+||+|++|..||...........+. .....+.+|..
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence 5432 2233456799999999999765 35789999999999999999999997665433332322 12345667788
Q ss_pred CCHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHHHHHHHhhccc
Q 003978 730 VDPRWAAIVESCWHSDPQCRP-----SFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 730 ~~~~l~~LI~~cL~~dP~~RP-----s~~ell~~L~~L~~~~~~~~~ 771 (782)
+++++.+||.+||.+||++|| |++|+ ++|+||+.++
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~ei------l~Hpff~~i~ 299 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEI------KEHLFFQKIN 299 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHH------HTSGGGTTCC
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHH------HcCHhhcCCC
Confidence 999999999999999999999 48888 5789986643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=385.84 Aligned_cols=256 Identities=32% Similarity=0.493 Sum_probs=199.1
Q ss_pred cceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecCC----ceeEE
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----RLCIV 580 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lv 580 (782)
++|.+.+.||+|+||.||+|+++|+.||||+++... ........|+..+..++|||||++++++..++ .+|+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 579999999999999999999999999999986543 11122233555556789999999999997654 57999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcC------CCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC------NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~------~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
||||++|+|.++|.+. .+++..++.++.|++.||+|||.. .++||||||||+||||+.++.+||+|||+++.
T Consensus 80 ~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 9999999999999864 588999999999999999999973 12399999999999999999999999999986
Q ss_pred cccccc----cccCCCCCCcccCcccccCCC------CCchhHHHHHHHHHHHHHcCCCCCCCCC---------------
Q 003978 655 KHETYL----TTKTGKGTPQWMAPEVLRNEP------SDEKSDVYSFGVILWELATEKIPWDNLN--------------- 709 (782)
Q Consensus 655 ~~~~~~----~~~~~~Gt~~y~aPE~l~~~~------~s~~sDIwSLG~ll~elltG~~Pf~~~~--------------- 709 (782)
...... ......||+.|||||++.+.. ++.++|||||||+||||+||..||....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 543321 233567999999999988753 4568999999999999999988763221
Q ss_pred hHHHHHHhhccccccCCCCC-----CCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHH
Q 003978 710 SMQVIGAVGFMNQRLEIPKD-----VDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQ 765 (782)
Q Consensus 710 ~~~~~~~i~~~~~~~~~p~~-----~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~ 765 (782)
.......+.....++.++.. ....+.+|+.+||..||.+|||+.+|++.|++|..+
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 11111122212223333332 224689999999999999999999999999988754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-43 Score=377.51 Aligned_cols=258 Identities=18% Similarity=0.279 Sum_probs=214.5
Q ss_pred ccccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCC-CceeEEeeeeecCCcee
Q 003978 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH-PNVLLFMGAVTSPQRLC 578 (782)
Q Consensus 502 ~~~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~ 578 (782)
++.++|+++++||+|+||+||+|++. ++.||||+++..... ..+.+|+++++.+.| +||+.+++++......|
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 34578999999999999999999974 678999998765432 245678899999975 89999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC-----CCcEEEEecCCCc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-----HWTVKVGDFGLSR 653 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~-----~~~vkL~DFGla~ 653 (782)
+||||| +++|.+++......+++..++.++.|++.||+|||++| ||||||||+||||+. ++.+||+|||+|+
T Consensus 78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 999999 78999999887778999999999999999999999999 999999999999974 5789999999998
Q ss_pred cccccc-------ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH---HHHHHhhcc---
Q 003978 654 LKHETY-------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSM---QVIGAVGFM--- 720 (782)
Q Consensus 654 ~~~~~~-------~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~---~~~~~i~~~--- 720 (782)
...... ......+||+.|||||++.+..++.++|||||||++|||++|..||...... .....+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 654321 1233557999999999999999999999999999999999999999755332 222222111
Q ss_pred ccccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHH
Q 003978 721 NQRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQY 766 (782)
Q Consensus 721 ~~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~ 766 (782)
.....+++.+|+++.+++..|+..+|++||+++.+.+.|+++....
T Consensus 235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 1223345678999999999999999999999999988887775443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-43 Score=378.37 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=204.1
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCce-eEEeeeeecCCceeEE
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV-LLFMGAVTSPQRLCIV 580 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lv 580 (782)
.++|+++++||+|+||.||+|++. ++.||||++...... ..+..|+++++.++|+|+ +.+.+++......++|
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 357999999999999999999984 678999998765432 246789999999987664 5556666777888999
Q ss_pred EeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcC---CCcEEEEecCCCccccc
Q 003978 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFGLSRLKHE 657 (782)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~---~~~vkL~DFGla~~~~~ 657 (782)
|||| +++|.+.+......+++..++.++.|++.||+|||++| ||||||||+|||++. +..+||+|||+|+....
T Consensus 82 me~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9999 66888888777778999999999999999999999999 999999999999864 55799999999986543
Q ss_pred cc-------ccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc------ccccc
Q 003978 658 TY-------LTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGF------MNQRL 724 (782)
Q Consensus 658 ~~-------~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~------~~~~~ 724 (782)
.. .......||+.|||||++.+..++.++|||||||++|||++|..||...........+.. .....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 21 223455799999999999999999999999999999999999999987665443322211 11122
Q ss_pred CCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 003978 725 EIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDL 762 (782)
Q Consensus 725 ~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L 762 (782)
.++..+|+++.+||.+||..||++||++.++.+.|+.+
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 34568999999999999999999999999998776654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=392.22 Aligned_cols=256 Identities=26% Similarity=0.328 Sum_probs=212.0
Q ss_pred ccceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeecC-----Cc
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----QR 576 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 576 (782)
.++|+++++||+|+||+||+|++ .++.||||++++........+.+.+|+++|+.++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 47899999999999999999997 477899999987766666777889999999999999999999998643 33
Q ss_pred eeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCcccc
Q 003978 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (782)
Q Consensus 577 ~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~~ 656 (782)
.+++|+|+.+++|.+++.. .++++..++.++.||+.||+|||++| |+||||||+|||++.++.+|++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccchhcccC
Confidence 4666777779999999964 35999999999999999999999999 9999999999999999999999999997654
Q ss_pred cccccccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc-----------
Q 003978 657 ETYLTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQRL----------- 724 (782)
Q Consensus 657 ~~~~~~~~~~Gt~~y~aPE~l~~~~-~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------- 724 (782)
.. .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+.......
T Consensus 173 ~~---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 173 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp GG---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred cc---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence 43 23567899999999977754 5889999999999999999999999887766554442111100
Q ss_pred ----------C--------CCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 003978 725 ----------E--------IPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASRS 772 (782)
Q Consensus 725 ----------~--------~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~~ 772 (782)
. ....+++++++||.+||..||.+|||+.|+ |+|+||+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~el------L~Hp~f~~~~~ 309 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA------LAHAYFAQYHD 309 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHH------HTSGGGTTTCC
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHH------hcCHhhCCCCC
Confidence 0 123578999999999999999999999999 67899986543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9e-44 Score=384.81 Aligned_cols=250 Identities=20% Similarity=0.341 Sum_probs=204.3
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeec--CCcee
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTS--PQRLC 578 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~--~~~~~ 578 (782)
.++|+++++||+|+||+||+|++. ++.||||+++... .+.+.+|+.+|+.+. ||||+++++++.. ...+|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 468999999999999999999984 7789999987543 356788999999995 9999999999874 45689
Q ss_pred EEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCC-cEEEEecCCCccccc
Q 003978 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHE 657 (782)
Q Consensus 579 lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~-~vkL~DFGla~~~~~ 657 (782)
+|||||.+++|..+. ..+++..++.++.||+.||.|||++| ||||||||+||||+.++ .+||+|||+|+....
T Consensus 109 ~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999999987654 35899999999999999999999999 99999999999998654 699999999986544
Q ss_pred ccccccCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhccc--------------
Q 003978 658 TYLTTKTGKGTPQWMAPEVLRNEP-SDEKSDVYSFGVILWELATEKIPWDNLNSMQ-VIGAVGFMN-------------- 721 (782)
Q Consensus 658 ~~~~~~~~~Gt~~y~aPE~l~~~~-~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~-~~~~i~~~~-------------- 721 (782)
.. ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||....... ....+....
T Consensus 183 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 183 GQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp TC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 32 234567899999999988754 7999999999999999999999997654322 111110000
Q ss_pred ---------------------cccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 003978 722 ---------------------QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQASR 771 (782)
Q Consensus 722 ---------------------~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~~ 771 (782)
........+++++.+||.+||..||.+|||++|+ |+|+||+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~------L~Hp~F~~v~ 326 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA------MEHPYFYTVV 326 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHH------HTSGGGTTSC
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHH------hcCcccCCCC
Confidence 0001113478999999999999999999999999 6799998765
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-44 Score=391.16 Aligned_cols=254 Identities=28% Similarity=0.352 Sum_probs=202.2
Q ss_pred ccceeEeeeeccCCcEEEEEEEEc--CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCceeEEeeeeec------CC
Q 003978 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS------PQ 575 (782)
Q Consensus 504 ~~~y~i~~~IG~G~~G~Vy~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~ 575 (782)
.++|+++++||+|+||+||+|.+. ++.||||+++...........+.+|+.+|+.++|||||+++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 478999999999999999999984 7889999998877777777889999999999999999999999853 36
Q ss_pred ceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEecCCCccc
Q 003978 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (782)
Q Consensus 576 ~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~~ 655 (782)
.+|+|||||.+ ++.+.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+|++|||+++..
T Consensus 96 ~~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 96 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eeEEEEeccch-HHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhhhhcc
Confidence 78999999965 5555553 35899999999999999999999999 999999999999999999999999998765
Q ss_pred ccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-------------
Q 003978 656 HETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQVIGAVGFMNQ------------- 722 (782)
Q Consensus 656 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~~~~~i~~~~~------------- 722 (782)
.... .....+||+.|+|||++.+..++.++||||+||++|+|++|+.||...+.......+.....
T Consensus 170 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (355)
T d2b1pa1 170 GTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred cccc-ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence 5432 33355789999999999999999999999999999999999999987776554433211000
Q ss_pred -------cc--------------CCC------CCCCHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 003978 723 -------RL--------------EIP------KDVDPRWAAIVESCWHSDPQCRPSFQELVDKLRDLQRQYFQAS 770 (782)
Q Consensus 723 -------~~--------------~~p------~~~~~~l~~LI~~cL~~dP~~RPs~~ell~~L~~L~~~~~~~~ 770 (782)
.. ..+ ...++++.+||++||..||++|||++|+ |+|+||+.-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~el------L~Hpw~~~~ 317 (355)
T d2b1pa1 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA------LQHPYINVW 317 (355)
T ss_dssp HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH------HTSTTTGGG
T ss_pred HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHH------hcCcccCCC
Confidence 00 000 1135678999999999999999999999 788999863
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-38 Score=347.82 Aligned_cols=252 Identities=19% Similarity=0.344 Sum_probs=191.8
Q ss_pred cceeEeeeeccCCcEEEEEEEE--cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-----------CCceeEEeeee
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-----------HPNVLLFMGAV 571 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~~~~ 571 (782)
.+|+++++||+|+||+||+|++ .++.||||+++... ...+.+.+|+++++.+. |+|||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4699999999999999999998 47789999997543 33456778998888775 57899999988
Q ss_pred ecC--CceeEEEeecCCCC-HHH-HHhhcCCcchHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEEcCCC----
Q 003978 572 TSP--QRLCIVTEFLPRGS-LFR-LLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHW---- 642 (782)
Q Consensus 572 ~~~--~~~~lv~E~~~ggs-L~~-~l~~~~~~l~~~~~~~i~~qll~aL~~LH~-~~~~ivHrDIKp~NILl~~~~---- 642 (782)
... ...+++|+++..+. ... ........+++..+..++.||+.||+|||+ +| |+||||||+||||+.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccc
Confidence 643 45666777664443 222 223345568899999999999999999997 77 99999999999998654
Q ss_pred --cEEEEecCCCcccccccccccCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH------HH
Q 003978 643 --TVKVGDFGLSRLKHETYLTTKTGKGTPQWMAPEVLRNEPSDEKSDVYSFGVILWELATEKIPWDNLNSMQ------VI 714 (782)
Q Consensus 643 --~vkL~DFGla~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~~sDIwSLG~ll~elltG~~Pf~~~~~~~------~~ 714 (782)
.++|+|||.+...... ....+||+.|+|||++.+..++.++|||||||++++|++|+.||....... ..
T Consensus 168 ~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred cceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 4999999999765443 235679999999999999999999999999999999999999997543211 11
Q ss_pred HHh-hccc---------------------------------------cccCCCCCCCHHHHHHHHHhhhhCCCCCCCHHH
Q 003978 715 GAV-GFMN---------------------------------------QRLEIPKDVDPRWAAIVESCWHSDPQCRPSFQE 754 (782)
Q Consensus 715 ~~i-~~~~---------------------------------------~~~~~p~~~~~~l~~LI~~cL~~dP~~RPs~~e 754 (782)
... .... .....+...++++.+||.+||..||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 000 0000 001112234578999999999999999999999
Q ss_pred HHHHHHHHHHHHhhcc
Q 003978 755 LVDKLRDLQRQYFQAS 770 (782)
Q Consensus 755 ll~~L~~L~~~~~~~~ 770 (782)
+ |+|+||+..
T Consensus 325 ~------L~Hp~f~~~ 334 (362)
T d1q8ya_ 325 L------VNHPWLKDT 334 (362)
T ss_dssp H------HTCGGGTTC
T ss_pred H------hcCcccCCC
Confidence 9 789999843
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=2.1e-22 Score=199.25 Aligned_cols=166 Identities=19% Similarity=0.166 Sum_probs=120.9
Q ss_pred eeEeeeeccCCcEEEEEEEE-cCCeEEEEEEeccCCC----------------HHHHHHHHHHHHHHHhCCCCceeEEee
Q 003978 507 LTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYS----------------DEVIHSFRQEVSLMKRLRHPNVLLFMG 569 (782)
Q Consensus 507 y~i~~~IG~G~~G~Vy~~~~-~~~~vAiK~~~~~~~~----------------~~~~~~~~~Ei~il~~l~HpnIv~l~~ 569 (782)
+.++++||+|+||.||+|.. .|+.||||+++..... ........+|...+..+.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46889999999999999987 6788999987532110 112234567889999999999998887
Q ss_pred eeecCCceeEEEeecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEcCCCcEEEEec
Q 003978 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (782)
Q Consensus 570 ~~~~~~~~~lv~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~~~ivHrDIKp~NILl~~~~~vkL~DF 649 (782)
+.. .+++|||+++..+. .++...+..++.||+.+|.|||++| |+||||||+||||+++ .++|+||
T Consensus 82 ~~~----~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 82 WEG----NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EET----TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EEEECCC
T ss_pred ecC----CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CEEEEEC
Confidence 642 37999999875432 2444556678999999999999999 9999999999999976 5899999
Q ss_pred CCCcccccccccccCCCCCCcccCc--c---cccCCCCCchhHHHHHHHHH
Q 003978 650 GLSRLKHETYLTTKTGKGTPQWMAP--E---VLRNEPSDEKSDVYSFGVIL 695 (782)
Q Consensus 650 Gla~~~~~~~~~~~~~~Gt~~y~aP--E---~l~~~~~s~~sDIwSLG~ll 695 (782)
|+|+....+... .|... + .+....|+.++|+||+.--+
T Consensus 147 G~a~~~~~~~~~--------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWR--------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHH--------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcH--------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 998755432211 11111 0 01235567889999976544
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.78 E-value=9.5e-19 Score=156.35 Aligned_cols=104 Identities=23% Similarity=0.285 Sum_probs=97.4
Q ss_pred cCceeEEEc---CCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEcCCCCEE
Q 003978 139 MGQSVHIFD---LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERV 215 (782)
Q Consensus 139 ~~d~I~v~D---~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~ 215 (782)
+.++++|+| +||+|+|||++|++|+||+++|++|+++..+++++........++++++.++.+..++..++|||+.+
T Consensus 2 i~~~~vi~Da~~pdg~Ii~vN~a~~~~~Gy~~~El~G~~~~~l~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~kdG~~~ 81 (109)
T d1n9la_ 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGTPF 81 (109)
T ss_dssp CSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEE
T ss_pred ccceEEEEeCCCCCCeEEEEcHHHHHHHCcCHHHHcCCcceeeecccCCHHHhhhhhhHhhcCCceeeeEEEEecCCeEE
Confidence 568999999 58999999999999999999999999999888877666677788999999999999999999999999
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEEehh
Q 003978 216 LVVATNTPFYDDDGTLVGIVCVSTDSR 242 (782)
Q Consensus 216 ~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (782)
|+.+++.|++|++|++.+++++++|||
T Consensus 82 w~~~~~~pi~d~~G~v~~~v~~~~DIT 108 (109)
T d1n9la_ 82 WNLLTVTPIKTPDGRVSKFVGVQVDVT 108 (109)
T ss_dssp EEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEECC
Confidence 999999999999999999999999998
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=1.2e-16 Score=142.35 Aligned_cols=103 Identities=17% Similarity=0.123 Sum_probs=91.0
Q ss_pred eeEEEc---CCCcEEEecHHHHHHhCCChhhHcCCCccccc--cccccccHHHHHHHHHHcCCeEEEEEEEEcCCCCEEE
Q 003978 142 SVHIFD---LSDRIIYWNRSAELLYGYSAEEALGQDAIELL--TDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVL 216 (782)
Q Consensus 142 ~I~v~D---~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~--~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~ 216 (782)
.++|+| +|+.|+|||++|++|+||+.+|++|+++..++ +++........+..+++.+..+..+++.++++|+.+|
T Consensus 3 ~f~i~~~~~~d~~I~~~N~a~~~l~G~~~~eiiG~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~~~g~~~w 82 (110)
T d1bywa_ 3 KFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFL 82 (110)
T ss_dssp EEEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEEE
T ss_pred eEEEEcCCCCCCEEEEEcHHHHHHhCCCHHHhcccCcccccceeeheecccccccchhhcccccccceeeeeecccceee
Confidence 367888 46789999999999999999999999987754 3444445566788999999999999999999999999
Q ss_pred EEEEEEEEECCCCCEEEEEEEEEehhHH
Q 003978 217 VVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (782)
Q Consensus 217 v~~~~~Pi~d~~G~v~g~v~i~rDITer 244 (782)
+.+++.|++|++|++++++++++|||||
T Consensus 83 ~~~~~~pi~d~~G~v~~~i~~~~DITer 110 (110)
T d1bywa_ 83 CLVDVVPVKNEDGAVIMFILNFEVVMEK 110 (110)
T ss_dssp EEEEEEEEECTTCCEEEEEEEEEEEEEC
T ss_pred eeeeEEEEECCCCCEEEEEEEEEECCCC
Confidence 9999999999999999999999999975
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Probab=99.68 E-value=1.7e-16 Score=139.83 Aligned_cols=100 Identities=23% Similarity=0.174 Sum_probs=93.9
Q ss_pred eeEEEc---CCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEcCCCCEEEEE
Q 003978 142 SVHIFD---LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVV 218 (782)
Q Consensus 142 ~I~v~D---~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~v~ 218 (782)
.++|+| +||+|+|+|++|++++||+.+|++|+++.+++++.........+...++.++.+..+++++++||..+|+.
T Consensus 2 ~fvi~d~~~pd~~I~y~N~a~~~~~G~s~~e~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~~~~~~ 81 (104)
T d1jnua_ 2 SFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKEQRDVTVQVLNYTKGGRAFWNL 81 (104)
T ss_dssp EEEEECTTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEEEEE
T ss_pred eEEEEcCCCCCCEEEEEcHHHHHHHCcCHHHHCCccceeccccccchHHHhhhhhhhhcCceeEeEEEEEecccceEEEE
Confidence 467898 58999999999999999999999999999998888777777788999999999999999999999999999
Q ss_pred EEEEEEECCCCCEEEEEEEEEeh
Q 003978 219 ATNTPFYDDDGTLVGIVCVSTDS 241 (782)
Q Consensus 219 ~~~~Pi~d~~G~v~g~v~i~rDI 241 (782)
+++.|++|++|++.+++++.+||
T Consensus 82 ~~~~pi~d~~G~v~~~i~i~~DI 104 (104)
T d1jnua_ 82 FHLQVMRDENGDVQYFIGVQQEM 104 (104)
T ss_dssp EEEEEECTTTSSCCEEEEEEEEC
T ss_pred EEEEEEECCCCCEEEEEEEEEcC
Confidence 99999999999999999999997
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Probab=99.60 E-value=1.4e-15 Score=138.88 Aligned_cols=111 Identities=14% Similarity=0.164 Sum_probs=95.0
Q ss_pred HHHHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCe----EEEEE
Q 003978 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQF 205 (782)
Q Consensus 130 ~~~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~----~~~e~ 205 (782)
++|+.++++++++|+++|.+|+|++||+++++|+||++++++|+++..++++.........+...+..+.. ...++
T Consensus 16 ~~~~~i~~~~~~~i~~~d~~g~i~~~N~~~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 95 (130)
T d1ew0a_ 16 AHLRSILDTVPDATVVSATDGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQRYMATGEKRIIGIDRVV 95 (130)
T ss_dssp SCHHHHHTTCSSEEEEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTTGGGHHHHHHHHHHHCCCSSTTSCEEE
T ss_pred HHHHHHHHcCCCeEEEEeCCccEEEEHHHHHHhhcCCHHHhcCCccccccccchhHHHHHHHHHHHHhCCCccccceeeE
Confidence 45999999999999999999999999999999999999999999999888877665544455556666654 46688
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEehh
Q 003978 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (782)
Q Consensus 206 ~~~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (782)
..+++||..+|+.++++|+.+.++ .+++++++|||
T Consensus 96 ~~~~~dG~~~~v~~~~~~i~~~~~--~~~~~i~rDIT 130 (130)
T d1ew0a_ 96 SGQRKDGSTFPMKLAVGEMRSGGE--RFFTGFIRDLT 130 (130)
T ss_dssp EEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEECC
T ss_pred EEEcCCCCEEEEEEEEEEEEECCe--EEEEEEEEECC
Confidence 889999999999999999987554 45889999997
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Probab=99.57 E-value=7.9e-15 Score=128.18 Aligned_cols=102 Identities=15% Similarity=0.112 Sum_probs=84.4
Q ss_pred ceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCe----EEEEEEEEcCCCCEEE
Q 003978 141 QSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQFPAKTKTEERVL 216 (782)
Q Consensus 141 d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~----~~~e~~~~~kdG~~~~ 216 (782)
|||+++|.+|+|+++|++|++|+||+.+|++|+++..++++.........+...+..... ...++..+++||..+|
T Consensus 1 dgi~~~D~~G~I~~~N~a~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~~~~ 80 (106)
T d1xj3a1 1 DAMIVIDGHGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRRDGTTFP 80 (106)
T ss_dssp CCEEEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECTTSCEEE
T ss_pred CEEEEECCCCcEEEEcHHHHHHhhhchHhhcCCCcccccccccccchhhhhhhhhhhcccccccccceeeeeeccceEEE
Confidence 689999999999999999999999999999999999988876654444444444444432 4567888999999999
Q ss_pred EEEEEEEEECCCCCEEEEEEEEEehhHH
Q 003978 217 VVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (782)
Q Consensus 217 v~~~~~Pi~d~~G~v~g~v~i~rDITer 244 (782)
+.+++.|+.+.++ .+++++++||||.
T Consensus 81 v~~~~~~~~~~~~--~~~~~~~~DITE~ 106 (106)
T d1xj3a1 81 MHLSIGEMQSGGE--PYFTGFVRDLTEH 106 (106)
T ss_dssp EEEEEEEEEETTE--EEEEEEEEECHHH
T ss_pred EEEEEEEEEECCe--EEEEEEEEeCCCC
Confidence 9999999997654 4688999999974
|
| >d1v9ya_ d.110.3.2 (A:) Direct oxygen sensor protein, DOS {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Direct oxygen sensor protein, DOS species: Escherichia coli [TaxId: 562]
Probab=99.56 E-value=1.1e-14 Score=129.07 Aligned_cols=107 Identities=16% Similarity=0.252 Sum_probs=86.3
Q ss_pred HHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCC----eEEEEEEE
Q 003978 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGE----RWTGQFPA 207 (782)
Q Consensus 132 ~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~----~~~~e~~~ 207 (782)
|.++|++.+++|+++|.+|+|+|+|++|++|+||+.+|++|+++..+++..........+...+..+. ....+...
T Consensus 3 ~~~~~e~~~d~i~~~d~~g~i~~~N~~~~~l~Gy~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 82 (113)
T d1v9ya_ 3 FFPALEQNMMGAVLINENDEVMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMSRELQL 82 (113)
T ss_dssp HHHHHHTCSSEEEEECTTSBEEEECHHHHHHHSCCGGGTTTSBGGGGSCGGGTTTHHHHHHHHHC----------CEEEE
T ss_pred HHHHHHcCcCcEEEEeCCCCEEEEchhHhhhhccchhhhcCcceecccccccccccccccccccccccccccccceeeee
Confidence 78899999999999999999999999999999999999999999998877665544444444444333 24557888
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEe
Q 003978 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240 (782)
Q Consensus 208 ~~kdG~~~~v~~~~~Pi~d~~G~v~g~v~i~rD 240 (782)
+++||+.+|+.+++.|+.++++. .++++++|
T Consensus 83 ~~~dG~~~~v~~~~~~i~~~~~~--~~~~v~rD 113 (113)
T d1v9ya_ 83 EKKDGSKIWTRFALSKVSAEGKV--YYLALVRD 113 (113)
T ss_dssp ECTTSCEEEEEEEEEEEEETTEE--EEEEEEEC
T ss_pred ccccceeEEEEEEEEEEEECCeE--EEEEEEEC
Confidence 99999999999999999986553 47888887
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=4.2e-15 Score=132.89 Aligned_cols=107 Identities=19% Similarity=0.259 Sum_probs=92.3
Q ss_pred CceeEE--EcCCCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCeEEEEEEEEcCCCCEEEE
Q 003978 140 GQSVHI--FDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLV 217 (782)
Q Consensus 140 ~d~I~v--~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~~~~e~~~~~kdG~~~~v 217 (782)
+...+| .|.+|+|+|+|+++++++||+.+|++|+++.+++++++.......+...+..+..+..+++++++||+.+|+
T Consensus 4 d~~~fi~r~~~dG~i~~~N~~~~~~~G~~~~el~g~~~~~~~~~ed~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~wv 83 (114)
T d1p97a_ 4 DSKTFLSRHSMDMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGGYVWL 83 (114)
T ss_dssp CCEEEEEEECTTTSCSEECTTHHHHTSSCHHHHTTSCHHHHSCSSSHHHHHHHHHHHTTTSEEEEEEEEEECTTSCEEEE
T ss_pred CcCEEEEEECCCCcEEEECHHHHHHcCCCccccccccccccccccccccceeeeeecccccceeecceeeeeecCcceEE
Confidence 344555 699999999999999999999999999999999988876555555566666666688899999999999999
Q ss_pred EEEEEEEECC-CCCEEEEEEEEEehhHHHH
Q 003978 218 VATNTPFYDD-DGTLVGIVCVSTDSRPFQE 246 (782)
Q Consensus 218 ~~~~~Pi~d~-~G~v~g~v~i~rDITerk~ 246 (782)
.++..|++|. +|++.+++++.+|||++|+
T Consensus 84 ~~~~~~~~~~~~~~~~~ii~~~~dite~k~ 113 (114)
T d1p97a_ 84 ETQGTVIYNPRNLQPQCIMCVNYVLSEIEK 113 (114)
T ss_dssp EEEEEEEECTTTCSEEEEEEEEEEEEEEEC
T ss_pred EEEEEEEEeCCCCCEEEEEEEEEECChhhc
Confidence 9999999986 6899999999999999874
|
| >d1nwza_ d.110.3.1 (A:) Photoactive yellow protein, PYP {Ectothiorhodospira halophila [TaxId: 1053]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: Photoactive yellow protein, PYP species: Ectothiorhodospira halophila [TaxId: 1053]
Probab=99.36 E-value=2.3e-12 Score=117.28 Aligned_cols=106 Identities=10% Similarity=0.000 Sum_probs=87.1
Q ss_pred HHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCcccccccccc-ccHHHHHHHHHHcCCeEEEEEEEEcC
Q 003978 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD-FDVAYDIVHRIKMGERWTGQFPAKTK 210 (782)
Q Consensus 132 ~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~-~~~~~~l~~~l~~g~~~~~e~~~~~k 210 (782)
+..+||++++||+++|.+|+|+++|+++++++||+.++++|+++.+++.|... ......+.+++..|.....+....++
T Consensus 19 ~d~~ld~~p~gi~~lD~~G~i~~~N~a~~~l~G~~~~e~iG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 98 (125)
T d1nwza_ 19 DDGQLDGLAFGAIQLDGDGNILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGNLNTMFEYTFDY 98 (125)
T ss_dssp CHHHHTTCSSEEEEEETTCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTCCEEEEEEEECT
T ss_pred HHHHHhCCCccEEEEeCCCCEEEEcHHHHHhhccchHhhcCCCHHHccCchhhhhheeeeceeeeecCCcceEEEEEecc
Confidence 56889999999999999999999999999999999999999999887765544 34455677888889887777777899
Q ss_pred CCCEEEEEEEEEEEECCCCCEEEEEEEEEeh
Q 003978 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTDS 241 (782)
Q Consensus 211 dG~~~~v~~~~~Pi~d~~G~v~g~v~i~rDI 241 (782)
+|..+|+.+.+.++.+ |.- +..+++||
T Consensus 99 ~G~~~~v~v~l~~~~~--g~~--~~v~V~di 125 (125)
T d1nwza_ 99 QMTPTKVKVHMKKALS--GDS--YWVFVKRV 125 (125)
T ss_dssp TSCCEEEEEEEEECSS--SSE--EEEEEEEC
T ss_pred CCcEEEEEEEEEEecC--CCE--EEEEEEEC
Confidence 9999999999887754 432 33467775
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Probab=99.34 E-value=1.9e-12 Score=115.20 Aligned_cols=95 Identities=13% Similarity=-0.034 Sum_probs=78.0
Q ss_pred HHHHHHHcCceeEEEcCCCcEEEecHHHHHHhCCChhhHcCCCcccccccccc-ccHHHHHHHHHHcCCeEEEEEEEEcC
Q 003978 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD-FDVAYDIVHRIKMGERWTGQFPAKTK 210 (782)
Q Consensus 132 ~~~ile~~~d~I~v~D~dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~-~~~~~~l~~~l~~g~~~~~e~~~~~k 210 (782)
+.++||++++||+++|.+|+|++||+++++|+||+++|++|+++.+++.|... ......+.+.+..|..........++
T Consensus 5 ~~A~ld~~p~gvi~~D~~G~I~~~N~aa~~~~G~~~eellG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~l~~ 84 (110)
T d1mzua_ 5 GTAEFDALPVGAIQVDGSGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGTLDARFDFVFDF 84 (110)
T ss_dssp -CTTGGGCSSEEEEEETTCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSCCEEEEEEEEEC
T ss_pred HHHHHhCCCcEEEEEcCCCCEEEeHHHHHHHHcCCHHHHcCCCHHHhcCChhhhHHHHHHHHHHHhccccCcceEEEEec
Confidence 56789999999999999999999999999999999999999999876655433 44455678889998875444444678
Q ss_pred CCCEEEEEEEEEEEEC
Q 003978 211 TEERVLVVATNTPFYD 226 (782)
Q Consensus 211 dG~~~~v~~~~~Pi~d 226 (782)
+|..++|.++..+..+
T Consensus 85 ~G~~~~v~v~~~~~~~ 100 (110)
T d1mzua_ 85 QMAPVRVQIRMQNAGV 100 (110)
T ss_dssp SSCEEEEEEEEEECSS
T ss_pred CCceEEEEEEEEEecC
Confidence 9999999999888654
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.19 E-value=2.4e-12 Score=114.89 Aligned_cols=104 Identities=15% Similarity=0.176 Sum_probs=80.6
Q ss_pred HHcCceeEEEcC-CCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCe----EEEEEEEEcCC
Q 003978 137 QSMGQSVHIFDL-SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQFPAKTKT 211 (782)
Q Consensus 137 e~~~d~I~v~D~-dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~----~~~e~~~~~kd 211 (782)
+.+.++|+++|. +|+|+++|+++++||||+++|++|+++.+++++.........+...+..+.. +..++...+++
T Consensus 5 ~~~n~AI~~id~~~G~I~~~N~a~~~l~Gy~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~ 84 (114)
T d1ll8a_ 5 PEFNKAIFTVDAKTTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEEHMEADGHAAVVFGTVVDIISRS 84 (114)
T ss_dssp TTTTCEEEEEETTTCBEEEECTTHHHHHTCCTTTTTTSBGGGGSSCTTTHHHHHTTSSTTSSSSCSSCCCSSSEEECCTT
T ss_pred hhcCcEEEEEECCCCEEEEECHHHHHhhcCCHHHHcCCCeeeecCcccHHHHHHHHHHHHhcCCCccceeeEEEEEEccC
Confidence 457789999995 6999999999999999999999999999999877653222222233443332 33367888999
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEehh
Q 003978 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (782)
Q Consensus 212 G~~~~v~~~~~Pi~d~~G~v~g~v~i~rDIT 242 (782)
|..+|+++++.++..+ |+. .++++++||+
T Consensus 85 G~~~pvevs~~~i~~~-~~~-~~l~vi~dV~ 113 (114)
T d1ll8a_ 85 GEKIPVSVWMKRMRQE-RRL-CCVVVLEPVE 113 (114)
T ss_dssp CCCEEEECCEECCBSS-SSB-EEEEEEEECC
T ss_pred CcEEEEEEEEEEEEEC-CeE-EEEEEEEECc
Confidence 9999999999999754 444 3789999994
|
| >d1oj5a_ d.110.3.8 (A:) PAS domain of steroid receptor coactivator 1A, NCo-A1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PAS domain of steroid receptor coactivator 1A, NCo-A1 domain: PAS domain of steroid receptor coactivator 1A, NCo-A1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.77 E-value=3.8e-09 Score=93.14 Aligned_cols=86 Identities=10% Similarity=0.002 Sum_probs=71.4
Q ss_pred EEcCCCcEEEecHHHHHHhCCC-hhhHcCCCcccccccccccc-HHH-HHHHHHHcCCeEEEEEEEEcCCCCEEEEEEEE
Q 003978 145 IFDLSDRIIYWNRSAELLYGYS-AEEALGQDAIELLTDGRDFD-VAY-DIVHRIKMGERWTGQFPAKTKTEERVLVVATN 221 (782)
Q Consensus 145 v~D~dG~Ii~vN~aae~l~Gys-~eEliG~~~~~l~~~~~~~~-~~~-~l~~~l~~g~~~~~e~~~~~kdG~~~~v~~~~ 221 (782)
-.|.+|+|+++|+++.+++||. .+|++|+++.+|++|++... ... .....+..|+....++++++|||..+|+..+.
T Consensus 7 rh~~~g~~~~vd~~~~~~~gy~~~eelig~s~~~f~HPeD~~~~~~~~~~~~~~~~g~~~~~~yR~~~kdG~~vWv~t~~ 86 (109)
T d1oj5a_ 7 KQDTTGKIISIDTSSLRAAGRTGWEDLVRKCIYAFFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLSAHTRC 86 (109)
T ss_dssp EECTTCCEEEEECHHHHTTCCSCHHHHHHHHHHHHTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEEEEEEE
T ss_pred EECCCceEEEECHHHhhHhhcCCHHHHcCCcHHHeECcccchHHHhhHHHHHHHhhcccchhhhhhhhccCcEEEEEEEE
Confidence 4689999999999999999998 58999999999999988643 222 34567788888888999999999999999999
Q ss_pred EEEECCCCC
Q 003978 222 TPFYDDDGT 230 (782)
Q Consensus 222 ~Pi~d~~G~ 230 (782)
.+++|..|.
T Consensus 87 ~~~~~~~~~ 95 (109)
T d1oj5a_ 87 KLCYPQSPD 95 (109)
T ss_dssp EEECC----
T ss_pred EEEECCCCC
Confidence 999986554
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.32 E-value=6.7e-07 Score=90.08 Aligned_cols=144 Identities=15% Similarity=0.037 Sum_probs=95.6
Q ss_pred cccceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecCCceeEEE
Q 003978 503 LWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVT 581 (782)
Q Consensus 503 ~~~~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~ 581 (782)
..+.|++.+..+-++...||++...+..++||+........ ...+.+|..++..+. +--+.+++.+...++..|+||
T Consensus 12 ~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~ 89 (263)
T d1j7la_ 12 LIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred hhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence 34677877776666668999998888889999886543211 124567888877764 323567888888888899999
Q ss_pred eecCCCCHHHHHhhcCCcchHHHHHHHHHHHHHHHHhhhcC---------------------------------------
Q 003978 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC--------------------------------------- 622 (782)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~--------------------------------------- 622 (782)
++++|.++........ . ...++.++...|..||+.
T Consensus 90 ~~l~G~~~~~~~~~~~---~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 90 SEADGVLCSEEYEDEQ---S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp ECCSSEEHHHHTTTCS---C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred Eecccccccccccccc---c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 9999887755432111 0 111222333333333321
Q ss_pred ------------------CCCeeecCCCCCcEEEcCCCcEEEEecCCCcc
Q 003978 623 ------------------NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (782)
Q Consensus 623 ------------------~~~ivHrDIKp~NILl~~~~~vkL~DFGla~~ 654 (782)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12279999999999999876667999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.69 E-value=3.2e-05 Score=76.92 Aligned_cols=73 Identities=18% Similarity=0.167 Sum_probs=50.0
Q ss_pred eeccCCc-EEEEEEEEcC-CeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCC--CceeEEeeeeecCCceeEEEeecCCC
Q 003978 512 QIGQGSC-GTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH--PNVLLFMGAVTSPQRLCIVTEFLPRG 587 (782)
Q Consensus 512 ~IG~G~~-G~Vy~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lv~E~~~gg 587 (782)
.+..|.. ..||++...+ ..+++|....... ..+..|...|+.+.. -.+.+++.+..+++..++||++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 3444543 6799998754 4588898755432 235567777776632 23667888888888899999999875
Q ss_pred CH
Q 003978 588 SL 589 (782)
Q Consensus 588 sL 589 (782)
++
T Consensus 92 ~~ 93 (255)
T d1nd4a_ 92 DL 93 (255)
T ss_dssp ET
T ss_pred cc
Confidence 54
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.32 E-value=0.00026 Score=75.49 Aligned_cols=77 Identities=21% Similarity=0.101 Sum_probs=48.0
Q ss_pred eeeeccCCcEEEEEEEE--cCCeEEEEEEeccC-C----CHHHHHHHHHHHHHHHhCC-C--CceeEEeeeeecCCceeE
Q 003978 510 GEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQE-Y----SDEVIHSFRQEVSLMKRLR-H--PNVLLFMGAVTSPQRLCI 579 (782)
Q Consensus 510 ~~~IG~G~~G~Vy~~~~--~~~~vAiK~~~~~~-~----~~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~~~~~~~~l 579 (782)
.+.||.|....||++.. .++.++||.-.... . .+....+...|.+.|+.+. + ..+++++.+. +...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 45689999999999975 35678999754311 0 0111234456777777662 2 3456666543 445689
Q ss_pred EEeecCCCC
Q 003978 580 VTEFLPRGS 588 (782)
Q Consensus 580 v~E~~~ggs 588 (782)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d2oola2 d.110.3.9 (A:26-139) Sensor protein PhyB2 {Rhodopseudomonas palustris [TaxId: 1076]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Sensor protein PhyB2 species: Rhodopseudomonas palustris [TaxId: 1076]
Probab=96.61 E-value=0.0012 Score=57.27 Aligned_cols=53 Identities=19% Similarity=0.157 Sum_probs=42.1
Q ss_pred eeEEEcC-CCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcC
Q 003978 142 SVHIFDL-SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMG 198 (782)
Q Consensus 142 ~I~v~D~-dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g 198 (782)
.++++|. +|+|+|+.+....++|++.++++|+++.+++++.. ...+.+.+...
T Consensus 19 ~Llvld~~d~~I~~vS~N~~~lLG~~~~~llG~~l~dll~~~~----~~~i~~~l~~~ 72 (114)
T d2oola2 19 YLFVVSETDLRIASVSANVEDLLRQPPASLLNVPIAHYLTAAS----AARLTHALHGG 72 (114)
T ss_dssp EEEEECTTTCBEEEEETTHHHHHSSCGGGGTTCBGGGGBCHHH----HHHHHHHHCC-
T ss_pred EEEEEECCCCEEEEEcCCHHHHhCCChHHHcCCCHHHhCCHHH----HHHHHHHHhcC
Confidence 3566885 79999999999999999999999999999998765 23355555443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.29 E-value=0.0065 Score=62.36 Aligned_cols=65 Identities=12% Similarity=0.076 Sum_probs=41.5
Q ss_pred EEEEEEEE-cCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCce--eEEe-----eeeecCCceeEEEeecCC
Q 003978 519 GTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV--LLFM-----GAVTSPQRLCIVTEFLPR 586 (782)
Q Consensus 519 G~Vy~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI--v~l~-----~~~~~~~~~~lv~E~~~g 586 (782)
-.||++.. .|+.|++|+.+...... ..+..|...+..|...+| +..+ ..+......+.+++++.|
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 47999986 57789999987665444 345567877777642221 1111 112345567889999976
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.70 E-value=0.027 Score=56.90 Aligned_cols=144 Identities=15% Similarity=0.028 Sum_probs=73.3
Q ss_pred ceeEeeeeccCCcEEEEEEEEcCCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCCC-----CceeEEee---eeecCCce
Q 003978 506 DLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH-----PNVLLFMG---AVTSPQRL 577 (782)
Q Consensus 506 ~y~i~~~IG~G~~G~Vy~~~~~~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~H-----pnIv~l~~---~~~~~~~~ 577 (782)
.+.-.+.|..|---+.|++...+..+++|++..... ...+..|++++..|.. |..+...+ +.......
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~----~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~ 94 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 94 (316)
T ss_dssp CEEEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred CceEeecCCCCcccCeEEEEECCCcEEEEEcCCCCC----HHHHHHHHHHHHhhhhccccccccceecCCCcceeeeccc
Confidence 344445666777788999998888899999865321 1234456677766632 22222111 11223345
Q ss_pred eEEEeecCCCCH-----H------HHHhh---c------C--C------------------cchHHHHHHHHHHHHHHHH
Q 003978 578 CIVTEFLPRGSL-----F------RLLQR---N------T--T------------------KLDWRRRILMALDIARGVS 617 (782)
Q Consensus 578 ~lv~E~~~ggsL-----~------~~l~~---~------~--~------------------~l~~~~~~~i~~qll~aL~ 617 (782)
+.++.++.+... . ..+.. . . . ..........+..+...+.
T Consensus 95 ~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 174 (316)
T d2ppqa1 95 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 174 (316)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred ceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhh
Confidence 556666654221 0 01100 0 0 0 0000011111222222222
Q ss_pred hhhc--CCCCeeecCCCCCcEEEcCCCcEEEEecCCCc
Q 003978 618 YLHH--CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (782)
Q Consensus 618 ~LH~--~~~~ivHrDIKp~NILl~~~~~vkL~DFGla~ 653 (782)
..+. ...++||+|+.++||+++.+...-|+||+.+.
T Consensus 175 ~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 175 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 2221 11339999999999999988777899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.46 E-value=0.015 Score=61.18 Aligned_cols=75 Identities=16% Similarity=0.251 Sum_probs=49.3
Q ss_pred cceeEeeeeccCCcEEEEEEEEc---------CCeEEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCceeEEeeeeecC
Q 003978 505 EDLTIGEQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSP 574 (782)
Q Consensus 505 ~~y~i~~~IG~G~~G~Vy~~~~~---------~~~vAiK~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 574 (782)
+++++ +.|+.|-.=.+|++... ...|.+++... .... ....+|..+++.+. +.-.+++++++..
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETE---SHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCH---HHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 34544 67888888999999863 23577787653 2121 23457888888874 4334577777653
Q ss_pred CceeEEEeecCCCC
Q 003978 575 QRLCIVTEFLPRGS 588 (782)
Q Consensus 575 ~~~~lv~E~~~ggs 588 (782)
++||||++|..
T Consensus 117 ---g~I~efi~g~~ 127 (395)
T d1nw1a_ 117 ---GRLEEYIPSRP 127 (395)
T ss_dssp ---EEEECCCCEEE
T ss_pred ---ceEEEEecccc
Confidence 68899997643
|
| >d2o9ca2 d.110.3.9 (A:4-130) Bacteriophytochrome BphP {Deinococcus radiodurans [TaxId: 1299]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Bacteriophytochrome BphP species: Deinococcus radiodurans [TaxId: 1299]
Probab=93.17 E-value=0.09 Score=45.86 Aligned_cols=75 Identities=12% Similarity=0.061 Sum_probs=52.0
Q ss_pred eeEEEcC-CCcEEEecHHHHHHhCCChhhHcCCCccccccccccccHHHHHHHHHHcCCe--EEEEEEEEcCCCCEEEEE
Q 003978 142 SVHIFDL-SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER--WTGQFPAKTKTEERVLVV 218 (782)
Q Consensus 142 ~I~v~D~-dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~g~~--~~~e~~~~~kdG~~~~v~ 218 (782)
.++++|. ++.|++++..+..++|++.++++|+++.++++... ..+.+.+..... ..........++..|++.
T Consensus 37 ~LLald~~~~~I~~~S~N~~~~lG~~~~~llG~~l~~ll~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~ 111 (127)
T d2o9ca2 37 ALLTADGHSGEVLQMSLNAATFLGQEPTVLRGQTLAALLPEQW-----PALQAALPPGCPDALQYRATLDWPAAGHLSLT 111 (127)
T ss_dssp EEEEEETTTCBEEEEETTHHHHHSSCHHHHTTCBHHHHCTTTH-----HHHHHHSCTTCCTTCCEEEEECCSSSSEEEEE
T ss_pred EEEEEECCCCEEEEECCCHHHHhCCChHHHcCCCHHHHCCHHH-----HHHHHHhhhcCcccccceeeeecCCCceEEEE
Confidence 3455775 79999999999999999999999999999986432 223334333322 233444445667777776
Q ss_pred EEE
Q 003978 219 ATN 221 (782)
Q Consensus 219 ~~~ 221 (782)
+..
T Consensus 112 ~Hr 114 (127)
T d2o9ca2 112 VHR 114 (127)
T ss_dssp EEE
T ss_pred EEE
Confidence 654
|
| >d2veaa3 d.110.3.9 (A:4-130) Phytochrome-like protein Cph1 {Synechocystis sp. pcc 6803 [TaxId: 1148]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Phytochrome-like protein Cph1 species: Synechocystis sp. pcc 6803 [TaxId: 1148]
Probab=90.52 E-value=0.071 Score=46.57 Aligned_cols=42 Identities=19% Similarity=0.165 Sum_probs=36.0
Q ss_pred eeEEEcC-CCcEEEecHHHHHHhCCChhhHcCCCccccccccc
Q 003978 142 SVHIFDL-SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183 (782)
Q Consensus 142 ~I~v~D~-dG~Ii~vN~aae~l~Gys~eEliG~~~~~l~~~~~ 183 (782)
.++++|. +++|+.+...+..++|++.++++|+++.+++.+..
T Consensus 28 ~LLald~~~~~I~~aS~N~~~~lG~~~~~lLG~~l~~ll~~~~ 70 (127)
T d2veaa3 28 LVVVLQEPDLTISQISANCTGILGRSPEDLLGRTLGEVFDSFQ 70 (127)
T ss_dssp EEEEEETTTTEEEEEETTHHHHTSCCTTTSSTTTTTTTSBCC-
T ss_pred EEEEEECCCCEEEEEcCCHHHHhCcChHHHcCCCHHHHCCHHH
Confidence 3455774 78999999999999999999999999999997654
|